Novel	O
Algorithms	O
Reveal	O
Streptococcal	O
Transcriptomes	O
and	O
Clues	O
about	O
Undefined	O
Genes	O

Bacteria	O
-	O
host	O
interactions	O
are	O
dynamic	O
processes	O
,	O
and	O
understanding	O
transcriptional	O
responses	O
that	O
directly	O
or	O
indirectly	O
regulate	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
initial	O
infection	O
stages	O
would	O
illuminate	O
the	O
molecular	O
events	O
that	O
result	O
in	O
host	O
colonization	O
.	O
<EOS>	B-X
Regulation	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
different	B-X
cellular	B-X
processes	B-X
,	B-X
including	B-X
posttranslational	B-X
modifications	B-X
,	B-X
is	B-X
critical	B-X
for	B-X
the	B-X
ability	B-X
of	B-X
many	B-X
viruses	B-X
to	B-X
replicate	B-X
efficiently	B-X
within	B-X
host	B-X
cells	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
E4-ORF3	B-X
functions	B-X
as	B-X
a	B-X
SUMO	B-X
E3	B-X
ligase	B-X
of	B-X
transcriptional	B-X
intermediary	B-X
factor-1	B-X
gamma	B-X
(	B-X
TIF-1γ	B-X
)	B-X
and	B-X
promotes	B-X
poly-SUMO	B-X
chain	B-X
formation	B-X
.	B-X
Bacteria-host	B-X
interactions	B-X
are	B-X
dynamic	B-X
processes	B-X
,	B-X
and	B-X
understanding	B-X
transcriptional	B-X
responses	B-X
that	B-X
directly	B-X
or	B-X
indirectly	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
initial	B-X
infection	B-X
stages	B-X
would	B-X
illuminate	B-X
the	B-X
molecular	B-X
events	B-X
that	B-X
result	B-X
in	B-X
host	B-X
colonization	B-X
.	B-X
We	B-X
used	B-X
oligonucleotide	B-X
microarrays	B-X
to	B-X
monitor	B-X
(	B-X
in	B-X
vitro	B-X
)	B-X
differential	B-X
gene	B-X
expression	B-X
in	B-X
group	B-X
A	B-X
streptococci	B-X
during	B-X
pharyngeal	B-X
cell	B-X
adherence	B-X
,	B-X
the	B-X
first	B-X
overt	B-X
infection	B-X
stage	B-X
.	B-X
We	B-X
present	B-X
neighbor	B-X
clustering	B-X
,	B-X
a	B-X
new	B-X
computational	B-X
method	B-X
for	B-X
further	B-X
analyzing	B-X
bacterial	B-X
microarray	B-X
data	B-X
that	B-X
combines	B-X
two	B-X
informative	B-X
characteristics	B-X
of	B-X
bacterial	B-X
genes	B-X
that	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
:	B-X
(	B-X
1	B-X
)	B-X
similar	B-X
gene	B-X
expression	B-X
profiles	B-X
(	B-X
i.e.	B-X
,	B-X
co-expression	B-X
)	B-X
;	B-X
and	B-X
(	B-X
2	B-X
)	B-X
physical	B-X
proximity	B-X
of	B-X
genes	B-X
on	B-X
the	B-X
chromosome	B-X
.	B-X
This	B-X
method	B-X
identifies	B-X
statistically	B-X
significant	B-X
clusters	B-X
of	B-X
co-expressed	B-X
gene	B-X
neighbors	B-X
that	B-X
potentially	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
by	B-X
coupling	B-X
statistically	B-X
analyzed	B-X
gene	B-X
expression	B-X
profiles	B-X
with	B-X
the	B-X
chromosomal	B-X
position	B-X
of	B-X
genes	B-X
.	B-X
We	B-X
applied	B-X
this	B-X
method	B-X
to	B-X
our	B-X
own	B-X
data	B-X
and	B-X
to	B-X
those	B-X
of	B-X
others	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
it	B-X
identified	B-X
a	B-X
greater	B-X
number	B-X
of	B-X
differentially	B-X
expressed	B-X
genes	B-X
,	B-X
facilitating	B-X
the	B-X
reconstruction	B-X
of	B-X
more	B-X
multimeric	B-X
proteins	B-X
and	B-X
complete	B-X
metabolic	B-X
pathways	B-X
than	B-X
would	B-X
have	B-X
been	B-X
possible	B-X
without	B-X
its	B-X
application	B-X
.	B-X
We	B-X
assessed	B-X
the	B-X
biological	B-X
significance	B-X
of	B-X
two	B-X
identified	B-X
genes	B-X
by	B-X
assaying	B-X
deletion	B-X
mutants	B-X
for	B-X
adherence	B-X
in	B-X
vitro	B-X
and	B-X
show	B-X
that	B-X
neighbor	B-X
clustering	B-X
indeed	B-X
provides	B-X
biologically	B-X
relevant	B-X
data	B-X
.	B-X
Neighbor	B-X
clustering	B-X
provides	B-X
a	B-X
more	B-X
comprehensive	B-X
view	B-X
of	B-X
the	B-X
molecular	B-X
responses	B-X
of	B-X
streptococci	B-X
during	B-X
pharyngeal	B-X
cell	B-X
adherence	B-X
.	B-X

We	O
used	O
oligonucleotide	O
microarrays	O
to	O
monitor	O
(	O
in	O
vitro	O
)	O
differential	O
gene	O
expression	O
in	O
group	O
A	O
streptococci	O
during	O
pharyngeal	O
cell	O
adherence	O
,	O
the	O
first	O
overt	O
infection	O
stage	O
.	O

We	O
present	O
neighbor	O
clustering	O
,	O
a	O
new	O
computational	O
method	O
for	O
further	O
analyzing	O
bacterial	O
microarray	O
data	O
that	O
combines	O
two	O
informative	O
characteristics	O
of	O
bacterial	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
:	O
(	O
1	O
)	O
similar	O
gene	O
expression	O
profiles	O
(	O
i	O
.	O
e	O
.	O
,	O
co	O
-	O
expression	O
)	O
;	O
and	O
(	O
2	O
)	O
physical	O
proximity	O
of	O
genes	O
on	O
the	O
chromosome	O
.	O

This	O
method	O
identifies	O
statistically	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
potentially	O
share	O
common	O
function	O
or	O
regulation	O
by	O
coupling	O
statistically	O
analyzed	O
gene	O
expression	O
profiles	O
with	O
the	O
chromosomal	O
position	O
of	O
genes	O
.	O
<EOS>	B-X
Bacteria-host	B-X
interactions	B-X
are	B-X
dynamic	B-X
processes	B-X
,	B-X
and	B-X
understanding	B-X
transcriptional	B-X
responses	B-X
that	B-X
directly	B-X
or	B-X
indirectly	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
initial	B-X
infection	B-X
stages	B-X
would	B-X
illuminate	B-X
the	B-X
molecular	B-X
events	B-X
that	B-X
result	B-X
in	B-X
host	B-X
colonization	B-X
.	B-X
We	B-X
used	B-X
oligonucleotide	B-X
microarrays	B-X
to	B-X
monitor	B-X
(	B-X
in	B-X
vitro	B-X
)	B-X
differential	B-X
gene	B-X
expression	B-X
in	B-X
group	B-X
A	B-X
streptococci	B-X
during	B-X
pharyngeal	B-X
cell	B-X
adherence	B-X
,	B-X
the	B-X
first	B-X
overt	B-X
infection	B-X
stage	B-X
.	B-X
We	B-X
present	B-X
neighbor	B-X
clustering	B-X
,	B-X
a	B-X
new	B-X
computational	B-X
method	B-X
for	B-X
further	B-X
analyzing	B-X
bacterial	B-X
microarray	B-X
data	B-X
that	B-X
combines	B-X
two	B-X
informative	B-X
characteristics	B-X
of	B-X
bacterial	B-X
genes	B-X
that	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
:	B-X
(	B-X
1	B-X
)	B-X
similar	B-X
gene	B-X
expression	B-X
profiles	B-X
(	B-X
i.e.	B-X
,	B-X
co-expression	B-X
)	B-X
;	B-X
and	B-X
(	B-X
2	B-X
)	B-X
physical	B-X
proximity	B-X
of	B-X
genes	B-X
on	B-X
the	B-X
chromosome	B-X
.	B-X
This	B-X
method	B-X
identifies	B-X
statistically	B-X
significant	B-X
clusters	B-X
of	B-X
co-expressed	B-X
gene	B-X
neighbors	B-X
that	B-X
potentially	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
by	B-X
coupling	B-X
statistically	B-X
analyzed	B-X
gene	B-X
expression	B-X
profiles	B-X
with	B-X
the	B-X
chromosomal	B-X
position	B-X
of	B-X
genes	B-X
.	B-X
We	B-X
applied	B-X
this	B-X
method	B-X
to	B-X
our	B-X
own	B-X
data	B-X
and	B-X
to	B-X
those	B-X
of	B-X
others	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
it	B-X
identified	B-X
a	B-X
greater	B-X
number	B-X
of	B-X
differentially	B-X
expressed	B-X
genes	B-X
,	B-X
facilitating	B-X
the	B-X
reconstruction	B-X
of	B-X
more	B-X
multimeric	B-X
proteins	B-X
and	B-X
complete	B-X
metabolic	B-X
pathways	B-X
than	B-X
would	B-X
have	B-X
been	B-X
possible	B-X
without	B-X
its	B-X
application	B-X
.	B-X
We	B-X
assessed	B-X
the	B-X
biological	B-X
significance	B-X
of	B-X
two	B-X
identified	B-X
genes	B-X
by	B-X
assaying	B-X
deletion	B-X
mutants	B-X
for	B-X
adherence	B-X
in	B-X
vitro	B-X
and	B-X
show	B-X
that	B-X
neighbor	B-X
clustering	B-X
indeed	B-X
provides	B-X
biologically	B-X
relevant	B-X
data	B-X
.	B-X
Neighbor	B-X
clustering	B-X
provides	B-X
a	B-X
more	B-X
comprehensive	B-X
view	B-X
of	B-X
the	B-X
molecular	B-X
responses	B-X
of	B-X
streptococci	B-X
during	B-X
pharyngeal	B-X
cell	B-X
adherence	B-X
.	B-X

We	O
applied	O
this	O
method	O
to	O
our	O
own	O
data	O
and	O
to	O
those	O
of	O
others	O
,	O
and	O
we	O
show	O
that	O
it	O
identified	O
a	O
greater	O
number	O
of	O
differentially	O
expressed	O
genes	O
,	O
facilitating	O
the	O
reconstruction	O
of	O
more	O
multimeric	O
proteins	O
and	O
complete	O
metabolic	O
pathways	O
than	O
would	O
have	O
been	O
possible	O
without	O
its	O
application	O
.	O
<EOS>	B-X
Bacteria-host	B-X
interactions	B-X
are	B-X
dynamic	B-X
processes	B-X
,	B-X
and	B-X
understanding	B-X
transcriptional	B-X
responses	B-X
that	B-X
directly	B-X
or	B-X
indirectly	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
initial	B-X
infection	B-X
stages	B-X
would	B-X
illuminate	B-X
the	B-X
molecular	B-X
events	B-X
that	B-X
result	B-X
in	B-X
host	B-X
colonization	B-X
.	B-X
We	B-X
present	B-X
neighbor	B-X
clustering	B-X
,	B-X
a	B-X
new	B-X
computational	B-X
method	B-X
for	B-X
further	B-X
analyzing	B-X
bacterial	B-X
microarray	B-X
data	B-X
that	B-X
combines	B-X
two	B-X
informative	B-X
characteristics	B-X
of	B-X
bacterial	B-X
genes	B-X
that	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
:	B-X
(	B-X
1	B-X
)	B-X
similar	B-X
gene	B-X
expression	B-X
profiles	B-X
(	B-X
i.e.	B-X
,	B-X
co-expression	B-X
)	B-X
;	B-X
and	B-X
(	B-X
2	B-X
)	B-X
physical	B-X
proximity	B-X
of	B-X
genes	B-X
on	B-X
the	B-X
chromosome	B-X
.	B-X
This	B-X
method	B-X
identifies	B-X
statistically	B-X
significant	B-X
clusters	B-X
of	B-X
co-expressed	B-X
gene	B-X
neighbors	B-X
that	B-X
potentially	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
by	B-X
coupling	B-X
statistically	B-X
analyzed	B-X
gene	B-X
expression	B-X
profiles	B-X
with	B-X
the	B-X
chromosomal	B-X
position	B-X
of	B-X
genes	B-X
.	B-X
We	B-X
applied	B-X
this	B-X
method	B-X
to	B-X
our	B-X
own	B-X
data	B-X
and	B-X
to	B-X
those	B-X
of	B-X
others	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
it	B-X
identified	B-X
a	B-X
greater	B-X
number	B-X
of	B-X
differentially	B-X
expressed	B-X
genes	B-X
,	B-X
facilitating	B-X
the	B-X
reconstruction	B-X
of	B-X
more	B-X
multimeric	B-X
proteins	B-X
and	B-X
complete	B-X
metabolic	B-X
pathways	B-X
than	B-X
would	B-X
have	B-X
been	B-X
possible	B-X
without	B-X
its	B-X
application	B-X
.	B-X
We	B-X
assessed	B-X
the	B-X
biological	B-X
significance	B-X
of	B-X
two	B-X
identified	B-X
genes	B-X
by	B-X
assaying	B-X
deletion	B-X
mutants	B-X
for	B-X
adherence	B-X
in	B-X
vitro	B-X
and	B-X
show	B-X
that	B-X
neighbor	B-X
clustering	B-X
indeed	B-X
provides	B-X
biologically	B-X
relevant	B-X
data	B-X
.	B-X

We	O
assessed	O
the	O
biological	O
significance	O
of	O
two	O
identified	O
genes	O
by	O
assaying	O
deletion	O
mutants	O
for	O
adherence	O
in	O
vitro	O
and	O
show	O
that	O
neighbor	O
clustering	O
indeed	O
provides	O
biologically	O
relevant	O
data	O
.	O
<EOS>	B-X
Bacteria-host	B-X
interactions	B-X
are	B-X
dynamic	B-X
processes	B-X
,	B-X
and	B-X
understanding	B-X
transcriptional	B-X
responses	B-X
that	B-X
directly	B-X
or	B-X
indirectly	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
initial	B-X
infection	B-X
stages	B-X
would	B-X
illuminate	B-X
the	B-X
molecular	B-X
events	B-X
that	B-X
result	B-X
in	B-X
host	B-X
colonization	B-X
.	B-X
We	B-X
used	B-X
oligonucleotide	B-X
microarrays	B-X
to	B-X
monitor	B-X
(	B-X
in	B-X
vitro	B-X
)	B-X
differential	B-X
gene	B-X
expression	B-X
in	B-X
group	B-X
A	B-X
streptococci	B-X
during	B-X
pharyngeal	B-X
cell	B-X
adherence	B-X
,	B-X
the	B-X
first	B-X
overt	B-X
infection	B-X
stage	B-X
.	B-X
We	B-X
present	B-X
neighbor	B-X
clustering	B-X
,	B-X
a	B-X
new	B-X
computational	B-X
method	B-X
for	B-X
further	B-X
analyzing	B-X
bacterial	B-X
microarray	B-X
data	B-X
that	B-X
combines	B-X
two	B-X
informative	B-X
characteristics	B-X
of	B-X
bacterial	B-X
genes	B-X
that	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
:	B-X
(	B-X
1	B-X
)	B-X
similar	B-X
gene	B-X
expression	B-X
profiles	B-X
(	B-X
i.e.	B-X
,	B-X
co-expression	B-X
)	B-X
;	B-X
and	B-X
(	B-X
2	B-X
)	B-X
physical	B-X
proximity	B-X
of	B-X
genes	B-X
on	B-X
the	B-X
chromosome	B-X
.	B-X
This	B-X
method	B-X
identifies	B-X
statistically	B-X
significant	B-X
clusters	B-X
of	B-X
co-expressed	B-X
gene	B-X
neighbors	B-X
that	B-X
potentially	B-X
share	B-X
common	B-X
function	B-X
or	B-X
regulation	B-X
by	B-X
coupling	B-X
statistically	B-X
analyzed	B-X
gene	B-X
expression	B-X
profiles	B-X
with	B-X
the	B-X
chromosomal	B-X
position	B-X
of	B-X
genes	B-X
.	B-X
We	B-X
applied	B-X
this	B-X
method	B-X
to	B-X
our	B-X
own	B-X
data	B-X
and	B-X
to	B-X
those	B-X
of	B-X
others	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
it	B-X
identified	B-X
a	B-X
greater	B-X
number	B-X
of	B-X
differentially	B-X
expressed	B-X
genes	B-X
,	B-X
facilitating	B-X
the	B-X
reconstruction	B-X
of	B-X
more	B-X
multimeric	B-X
proteins	B-X
and	B-X
complete	B-X
metabolic	B-X
pathways	B-X
than	B-X
would	B-X
have	B-X
been	B-X
possible	B-X
without	B-X
its	B-X
application	B-X
.	B-X
We	B-X
assessed	B-X
the	B-X
biological	B-X
significance	B-X
of	B-X
two	B-X
identified	B-X
genes	B-X
by	B-X
assaying	B-X
deletion	B-X
mutants	B-X
for	B-X
adherence	B-X
in	B-X
vitro	B-X
and	B-X
show	B-X
that	B-X
neighbor	B-X
clustering	B-X
indeed	B-X
provides	B-X
biologically	B-X
relevant	B-X
data	B-X
.	B-X
Neighbor	B-X
clustering	B-X
provides	B-X
a	B-X
more	B-X
comprehensive	B-X
view	B-X
of	B-X
the	B-X
molecular	B-X
responses	B-X
of	B-X
streptococci	B-X
during	B-X
pharyngeal	B-X
cell	B-X
adherence	B-X
.	B-X

Neighbor	O
clustering	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
the	O
molecular	O
responses	O
of	O
streptococci	O
during	O
pharyngeal	O
cell	O
adherence	O
.	O

Introduction	O

Microarray	O
technology	O
is	O
now	O
commonly	O
used	O
to	O
reveal	O
genome	O
-	O
wide	O
transcriptional	O
changes	O
in	O
bacterial	O
pathogens	O
during	O
interactions	O
with	O
the	O
host	O
.	O

Several	O
factors	O
,	O
however	O
,	O
limit	O
the	O
power	O
of	O
such	O
analyses	O
,	O
including	O
inadequate	O
statistical	O
analysis	O
and	O
insufficient	O
sample	O
replication	O
,	O
both	O
of	O
which	O
do	O
not	O
account	O
for	O
experimental	O
variability	O
,	O
and	O
often	O
result	O
in	O
arbitrary	O
thresholds	O
for	O
significance	O
[	O
1	O
,	O
2	O
]	O
.	O

In	O
addition	O
,	O
unknown	O
bacterial	O
genes	O
can	O
confound	O
the	O
interpretation	O
of	O
expression	O
profiles	O
,	O
restricting	O
many	O
microarray	O
studies	O
to	O
the	O
differential	O
expression	O
of	O
well	O
-	O
characterized	O
genes	O
.	O

Several	O
methods	O
are	O
available	O
to	O
organize	O
gene	O
expression	O
profiles	O
and	O
to	O
assist	O
in	O
extracting	O
functional	O
or	O
regulatory	O
gene	O
information	O
from	O
microarray	O
datasets	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
aim	B-X
to	B-X
identify	B-X
potential	B-X
crucial	B-X
genes	B-X
associated	B-X
with	B-X
AF	B-X
through	B-X
bioinformatic	B-X
analyses	B-X
of	B-X
public	B-X
datasets	B-X
.	B-X
This	B-X
research	B-X
builds	B-X
up	B-X
predictive	B-X
gene	B-X
targets	B-X
of	B-X
expression	B-X
alterations	B-X
in	B-X
GBM	B-X
utilizing	B-X
bioinformatics	B-X
analysis	B-X
.	B-X
Despite	B-X
numerous	B-X
attempts	B-X
to	B-X
understand	B-X
the	B-X
function	B-X
of	B-X
genetic	B-X
factors	B-X
in	B-X
SCZ	B-X
development	B-X
,	B-X
genetic	B-X
components	B-X
in	B-X
SCZ	B-X
pathophysiology	B-X
remain	B-X
unknown	B-X
.	B-X
The	B-X
ceRNA	B-X
hypothesis	B-X
states	B-X
that	B-X
cross-talks	B-X
between	B-X
coding	B-X
and	B-X
non-coding	B-X
RNAs	B-X
,	B-X
including	B-X
long	B-X
non-coding	B-X
RNAs	B-X
(	B-X
lncRNAs	B-X
)	B-X
,	B-X
via	B-X
miRNA	B-X
complementary	B-X
sequences	B-X
known	B-X
as	B-X
miRNA	B-X
response	B-X
elements	B-X
,	B-X
creates	B-X
a	B-X
large	B-X
regulatory	B-X
network	B-X
across	B-X
the	B-X
transcriptome	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
lncRNA-related	B-X
ceRNA	B-X
network	B-X
to	B-X
elucidate	B-X
molecular	B-X
regulatory	B-X
mechanisms	B-X
involved	B-X
in	B-X
SCZ	B-X
.	B-X
Microarray	B-X
datasets	B-X
associated	B-X
with	B-X
brain	B-X
regions	B-X
(	B-X
GSE53987	B-X
)	B-X
and	B-X
lymphoblasts	B-X
(	B-X
LBs	B-X
)	B-X
derived	B-X
from	B-X
peripheral	B-X
blood	B-X
(	B-X
sample	B-X
set	B-X
B	B-X
from	B-X
GSE73129	B-X
)	B-X
of	B-X
SCZ	B-X
patients	B-X
and	B-X
control	B-X
subjects	B-X
containing	B-X
information	B-X
about	B-X
both	B-X
mRNAs	B-X
and	B-X
lncRNAs	B-X
were	B-X
downloaded	B-X
from	B-X
the	B-X
Gene	B-X
Expression	B-X
Omnibus	B-X
database	B-X
.	B-X
Using	B-X
DIANA-LncBase	B-X
,	B-X
Human	B-X
MicroRNA	B-X
Disease	B-X
Database	B-X
(	B-X
HMDD	B-X
)	B-X
,	B-X
and	B-X
miRTarBase	B-X
,	B-X
the	B-X
lncRNA-	B-X
associated	B-X
ceRNA	B-X
network	B-X
was	B-X
generated	B-X
.	B-X
We	B-X
developed	B-X
a	B-X
protein-protein	B-X
interaction	B-X
network	B-X
of	B-X
DEmRNAs	B-X
and	B-X
identified	B-X
the	B-X
top	B-X
five	B-X
hub	B-X
genes	B-X
by	B-X
the	B-X
use	B-X
of	B-X
STRING	B-X
and	B-X
Cytoscape	B-X
,	B-X
respectively	B-X
.	B-X
Eventually	B-X
,	B-X
the	B-X
hub	B-X
genes	B-X
,	B-X
DElncRNAs	B-X
,	B-X
and	B-X
predictive	B-X
miRNAs	B-X
were	B-X
chosen	B-X
to	B-X
reconstruct	B-X
the	B-X
subceRNA	B-X
networks	B-X
.	B-X
We	B-X
also	B-X
identified	B-X
DLX6-AS1	B-X
,	B-X
NEAT1	B-X
,	B-X
MINCR	B-X
,	B-X
LINC01094	B-X
,	B-X
DLGAP1-AS1	B-X
,	B-X
BABAM2-AS1	B-X
,	B-X
PAX8-AS1	B-X
,	B-X
ZFHX4-AS1	B-X
,	B-X
XIST	B-X
,	B-X
and	B-X
MALAT1	B-X
as	B-X
key	B-X
DElncRNAs	B-X
regulating	B-X
the	B-X
genes	B-X
mentioned	B-X
above	B-X
.	B-X
Furthermore	B-X
,	B-X
expression	B-X
of	B-X
15	B-X
DEmRNAs	B-X
(	B-X
e.g.	B-X
,	B-X
ADM	B-X
and	B-X
HLA-DRB1	B-X
)	B-X
and	B-X
one	B-X
DElncRNA	B-X
(	B-X
XIST	B-X
)	B-X
were	B-X
changed	B-X
in	B-X
both	B-X
the	B-X
brain	B-X
and	B-X
LB	B-X
,	B-X
suggesting	B-X
that	B-X
they	B-X
could	B-X
be	B-X
regarded	B-X
as	B-X
candidates	B-X
for	B-X
future	B-X
biomarker	B-X
studies	B-X
.	B-X

Clustering	O
algorithms	O
group	O
genes	O
by	O
similarities	O
in	O
expression	O
patterns	O
,	O
based	O
on	O
the	O
assumption	O
that	O
co	O
-	O
expressed	O
genes	O
share	O
common	O
function	O
or	O
regulation	O
[	O
3	O
,	O
4	O
]	O
;	O
however	O
,	O
clustering	O
solely	O
by	O
co	O
-	O
expression	O
patterns	O
may	O
not	O
reveal	O
a	O
considerable	O
amount	O
of	O
information	O
contained	O
in	O
array	O
data	O
.	O
<EOS>	B-X
There	B-X
is	B-X
enormous	B-X
opportunity	B-X
for	B-X
positive	B-X
social	B-X
impact	B-X
from	B-X
the	B-X
rise	B-X
of	B-X
algorithms	B-X
and	B-X
machine	B-X
learning	B-X
.	B-X
But	B-X
this	B-X
requires	B-X
a	B-X
licence	B-X
to	B-X
operate	B-X
from	B-X
the	B-X
public	B-X
,	B-X
based	B-X
on	B-X
trustworthiness	B-X
.	B-X
There	B-X
are	B-X
a	B-X
range	B-X
of	B-X
concerns	B-X
relating	B-X
to	B-X
how	B-X
algorithms	B-X
might	B-X
be	B-X
held	B-X
to	B-X
account	B-X
in	B-X
areas	B-X
affecting	B-X
the	B-X
public	B-X
sphere	B-X
.	B-X
This	B-X
paper	B-X
outlines	B-X
a	B-X
number	B-X
of	B-X
approaches	B-X
including	B-X
greater	B-X
transparency	B-X
,	B-X
monitoring	B-X
of	B-X
outcomes	B-X
and	B-X
improved	B-X
governance	B-X
.	B-X
It	B-X
makes	B-X
a	B-X
case	B-X
that	B-X
public	B-X
sector	B-X
bodies	B-X
that	B-X
hold	B-X
datasets	B-X
should	B-X
be	B-X
more	B-X
confident	B-X
in	B-X
negotiating	B-X
terms	B-X
with	B-X
the	B-X
private	B-X
sector	B-X
.	B-X
It	B-X
also	B-X
argues	B-X
that	B-X
all	B-X
regulators	B-X
(	B-X
not	B-X
just	B-X
data	B-X
regulators	B-X
)	B-X
need	B-X
to	B-X
wake	B-X
up	B-X
to	B-X
the	B-X
challenges	B-X
posed	B-X
by	B-X
changing	B-X
technology	B-X
.	B-X
Other	B-X
improvements	B-X
include	B-X
diversity	B-X
of	B-X
the	B-X
workforce	B-X
,	B-X
ethics	B-X
training	B-X
,	B-X
codes	B-X
of	B-X
conduct	B-X
for	B-X
data	B-X
scientists	B-X
,	B-X
and	B-X
new	B-X
deliberative	B-X
bodies	B-X
.	B-X
Even	B-X
if	B-X
these	B-X
narrower	B-X
issues	B-X
are	B-X
solved	B-X
,	B-X
the	B-X
paper	B-X
poses	B-X
some	B-X
wider	B-X
concerns	B-X
including	B-X
data	B-X
monopolies	B-X
,	B-X
the	B-X
challenge	B-X
to	B-X
democracy	B-X
,	B-X
public	B-X
participation	B-X
and	B-X
maintaining	B-X
the	B-X
public	B-X
interest.This	B-X
article	B-X
is	B-X
part	B-X
of	B-X
a	B-X
discussion	B-X
meeting	B-X
issue	B-X
'The	B-X
growing	B-X
ubiquity	B-X
of	B-X
algorithms	B-X
in	B-X
society	B-X
:	B-X
implications	B-X
,	B-X
impacts	B-X
and	B-X
innovations	B-X
'	B-X
.	B-X

These	O
methods	O
often	O
:	O
(	O
1	O
)	O
produce	O
unreliable	O
data	O
by	O
missing	O
known	O
gene	O
members	O
of	O
biological	O
pathways	O
;	O
(	O
2	O
)	O
fail	O
to	O
distinguish	O
truly	O
related	O
gene	O
clusters	O
from	O
coincidental	O
groupings	O
;	O
and	O
(	O
3	O
)	O
identify	O
clusters	O
containing	O
only	O
unknown	O
genes	O
that	O
may	O
lack	O
either	O
common	O
function	O
or	O
regulation	O
,	O
a	O
considerable	O
limitation	O
for	O
genomes	O
containing	O
a	O
large	O
percentage	O
of	O
undefined	O
genes	O
[	O
1	O
,	O
2	O
]	O
.	O

Because	O
no	O
tools	O
exist	O
to	O
interpret	O
unknown	O
gene	O
clusters	O
or	O
to	O
assess	O
their	O
significance	O
and	O
completeness	O
,	O
a	O
significant	O
portion	O
of	O
bacterial	O
expression	O
profiles	O
are	O
not	O
interpretable	O
using	O
current	O
clustering	O
methods	O
.	O
<EOS>	B-X
The	B-X
use	B-X
of	B-X
bioinformatic	B-X
tools	B-X
to	B-X
interpret	B-X
the	B-X
instructions	B-X
encoded	B-X
in	B-X
microbial	B-X
biosynthetic	B-X
genes	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
circumvent	B-X
the	B-X
existing	B-X
methodological	B-X
bottlenecks	B-X
and	B-X
greatly	B-X
expand	B-X
the	B-X
scope	B-X
of	B-X
discovery	B-X
.	B-X
To	B-X
understand	B-X
the	B-X
scope	B-X
and	B-X
limitation	B-X
of	B-X
the	B-X
existing	B-X
prediction	B-X
algorithms	B-X
,	B-X
we	B-X
evaluated	B-X
their	B-X
performances	B-X
on	B-X
NRP	B-X
synthetase	B-X
biosynthetic	B-X
gene	B-X
clusters	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
benzoyl	B-X
BB	B-X
,	B-X
including	B-X
2,3-dihydroxybenzoate	B-X
(	B-X
DHB	B-X
)	B-X
,	B-X
has	B-X
been	B-X
the	B-X
most	B-X
underexplored	B-X
,	B-X
hinting	B-X
at	B-X
the	B-X
possibility	B-X
of	B-X
a	B-X
reservoir	B-X
of	B-X
as	B-X
yet	B-X
unknown	B-X
DHB	B-X
containing	B-X
NRPs	B-X
with	B-X
functional	B-X
roles	B-X
other	B-X
than	B-X
a	B-X
siderophore	B-X
.	B-X
We	B-X
also	B-X
discuss	B-X
possible	B-X
ways	B-X
bioinformaticians	B-X
and	B-X
biochemists	B-X
could	B-X
work	B-X
together	B-X
to	B-X
improve	B-X
the	B-X
existing	B-X
prediction	B-X
algorithms	B-X
.	B-X

We	O
introduce	O
neighbor	O
clustering	O
as	O
a	O
new	O
tool	O
for	O
analyzing	O
bacterial	O
microarray	O
data	O
that	O
addresses	O
some	O
of	O
these	O
limitations	O
by	O
incorporating	O
the	O
physical	O
position	O
of	O
genes	O
on	O
the	O
bacterial	O
chromosome	O
into	O
the	O
analysis	O
of	O
expression	O
data	O
.	O

Information	O
about	O
gene	O
function	O
and	O
regulation	O
is	O
stored	O
intrinsically	O
in	O
the	O
bacterial	O
genome	O
structure	O
,	O
as	O
genes	O
with	O
common	O
function	O
or	O
regulation	O
tend	O
to	O
be	O
physically	O
proximate	O
on	O
the	O
chromosome	O
and	O
often	O
linked	O
as	O
operons	O
[	O
5	O
,	O
6	O
]	O
.	O

We	O
incorporated	O
these	O
positional	O
data	O
into	O
a	O
series	O
of	O
neighbor	O
clustering	O
algorithms	O
,	O
named	O
GenomeCrawler	O
,	O
that	O
identifies	O
groupings	O
of	O
potentially	O
related	O
genes	O
from	O
array	O
data	O
by	O
combining	O
two	O
informative	O
characteristics	O
of	O
bacterial	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
[	O
3	O
-	O
6	O
]	O
:	O
(	O
1	O
)	O
similar	O
gene	O
expression	O
profiles	O
(	O
i	O
.	O
e	O
.	O
,	O
co	O
-	O
expression	O
)	O
;	O
and	O
(	O
2	O
)	O
physical	O
proximity	O
of	O
genes	O
on	O
the	O
chromosome	O
.	O

The	O
algorithms	O
also	O
recalculate	O
the	O
statistical	O
significance	O
of	O
each	O
gene	O
as	O
a	O
member	O
of	O
a	O
particular	O
cluster	O
,	O
as	O
well	O
as	O
the	O
significance	O
of	O
each	O
resulting	O
grouping	O
as	O
a	O
whole	O
,	O
to	O
ensure	O
accuracy	O
of	O
cluster	O
assignments	O
.	O

This	O
process	O
ultimately	O
identifies	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
likely	O
share	O
common	O
function	O
or	O
regulation	O
.	O
<EOS>	B-X
There	B-X
are	B-X
a	B-X
range	B-X
of	B-X
concerns	B-X
relating	B-X
to	B-X
how	B-X
algorithms	B-X
might	B-X
be	B-X
held	B-X
to	B-X
account	B-X
in	B-X
areas	B-X
affecting	B-X
the	B-X
public	B-X
sphere	B-X
.	B-X
This	B-X
paper	B-X
outlines	B-X
a	B-X
number	B-X
of	B-X
approaches	B-X
including	B-X
greater	B-X
transparency	B-X
,	B-X
monitoring	B-X
of	B-X
outcomes	B-X
and	B-X
improved	B-X
governance	B-X
.	B-X
It	B-X
makes	B-X
a	B-X
case	B-X
that	B-X
public	B-X
sector	B-X
bodies	B-X
that	B-X
hold	B-X
datasets	B-X
should	B-X
be	B-X
more	B-X
confident	B-X
in	B-X
negotiating	B-X
terms	B-X
with	B-X
the	B-X
private	B-X
sector	B-X
.	B-X
Other	B-X
improvements	B-X
include	B-X
diversity	B-X
of	B-X
the	B-X
workforce	B-X
,	B-X
ethics	B-X
training	B-X
,	B-X
codes	B-X
of	B-X
conduct	B-X
for	B-X
data	B-X
scientists	B-X
,	B-X
and	B-X
new	B-X
deliberative	B-X
bodies	B-X
.	B-X
Even	B-X
if	B-X
these	B-X
narrower	B-X
issues	B-X
are	B-X
solved	B-X
,	B-X
the	B-X
paper	B-X
poses	B-X
some	B-X
wider	B-X
concerns	B-X
including	B-X
data	B-X
monopolies	B-X
,	B-X
the	B-X
challenge	B-X
to	B-X
democracy	B-X
,	B-X
public	B-X
participation	B-X
and	B-X
maintaining	B-X
the	B-X
public	B-X
interest.This	B-X
article	B-X
is	B-X
part	B-X
of	B-X
a	B-X
discussion	B-X
meeting	B-X
issue	B-X
'The	B-X
growing	B-X
ubiquity	B-X
of	B-X
algorithms	B-X
in	B-X
society	B-X
:	B-X
implications	B-X
,	B-X
impacts	B-X
and	B-X
innovations	B-X
'	B-X
.	B-X

We	O
used	O
this	O
approach	O
to	O
analyze	O
microarray	O
expression	O
data	O
from	O
group	O
A	O
streptococci	O
(	O
Streptococcus	O
pyogenes	O
)	O
during	O
adherence	O
to	O
human	O
pharyngeal	O
cells	O
,	O
the	O
first	O
overt	O
infection	O
step	O
[	O
7	O
]	O
.	O

The	O
ability	O
of	O
all	O
bacterial	O
pathogens	O
to	O
infect	O
the	O
human	O
host	O
depends	O
upon	O
coordinated	O
regulation	O
of	O
diverse	O
gene	O
sets	O
that	O
are	O
required	O
for	O
survival	O
in	O
host	O
environments	O
.	O

Although	O
recent	O
microarray	O
studies	O
have	O
highlighted	O
the	O
molecular	O
responses	O
of	O
streptococci	O
in	O
relevant	O
host	O
conditions	O
[	O
8	O
-	O
10	O
]	O
,	O
characterizing	O
differentially	O
expressed	O
loci	O
during	O
pharyngeal	O
cell	O
adherence	O
is	O
critical	O
for	O
understanding	O
the	O
molecular	O
basis	O
for	O
host	O
colonization	O
.	O

Studies	O
from	O
our	O
laboratory	O
[	O
11	O
,	O
12	O
]	O
and	O
others	O
[	O
13	O
]	O
have	O
demonstrated	O
that	O
in	O
vitro	O
association	O
with	O
pharyngeal	O
cells	O
results	O
in	O
streptococcal	O
phage	O
induction	O
and	O
the	O
increased	O
expression	O
of	O
phage	O
-	O
encoded	O
virulence	O
factors	O
.	O

Although	O
the	O
mechanisms	O
mediating	O
these	O
responses	O
are	O
not	O
known	O
,	O
the	O
results	O
of	O
these	O
studies	O
indicate	O
that	O
streptococci	O
sense	O
and	O
,	O
on	O
a	O
transcriptional	O
level	O
,	O
respond	O
to	O
various	O
signals	O
and	O
cues	O
in	O
the	O
pharyngeal	O
cell	O
environment	O
.	O
<EOS>	B-X
The	B-X
inflammatory	B-X
response	B-X
is	B-X
a	B-X
crucial	B-X
aspect	B-X
of	B-X
the	B-X
tissues	B-X
'	B-X
responses	B-X
to	B-X
deleterious	B-X
inflammogens	B-X
.	B-X
This	B-X
complex	B-X
response	B-X
involves	B-X
leukocytes	B-X
cells	B-X
such	B-X
as	B-X
macrophages	B-X
,	B-X
neutrophils	B-X
,	B-X
and	B-X
lymphocytes	B-X
,	B-X
also	B-X
known	B-X
as	B-X
inflammatory	B-X
cells	B-X
.	B-X
In	B-X
response	B-X
to	B-X
the	B-X
inflammatory	B-X
process	B-X
,	B-X
these	B-X
cells	B-X
release	B-X
specialized	B-X
substances	B-X
which	B-X
include	B-X
vasoactive	B-X
amines	B-X
and	B-X
peptides	B-X
,	B-X
eicosanoids	B-X
,	B-X
proinflammatory	B-X
cytokines	B-X
,	B-X
and	B-X
acute-phase	B-X
proteins	B-X
,	B-X
which	B-X
mediate	B-X
the	B-X
inflammatory	B-X
process	B-X
by	B-X
preventing	B-X
further	B-X
tissue	B-X
damage	B-X
and	B-X
ultimately	B-X
resulting	B-X
in	B-X
healing	B-X
and	B-X
restoration	B-X
of	B-X
tissue	B-X
function	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
the	B-X
role	B-X
of	B-X
the	B-X
inflammatory	B-X
cells	B-X
as	B-X
well	B-X
as	B-X
their	B-X
by-products	B-X
in	B-X
the	B-X
mediation	B-X
of	B-X
inflammatory	B-X
process	B-X
.	B-X

We	O
undertook	O
the	O
present	O
study	O
to	O
understand	O
and	O
to	O
assess	O
more	O
accurately	O
the	O
genome	O
-	O
wide	O
transcriptional	O
responses	O
of	O
streptococci	O
during	O
one	O
of	O
the	O
earliest	O
recognized	O
stages	O
of	O
infection	O
,	O
namely	O
adherence	O
to	O
human	O
pharyngeal	O
cells	O
.	O

We	O
compared	O
data	O
generated	O
before	O
and	O
after	O
neighbor	O
clustering	O
to	O
show	O
that	O
this	O
method	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
transcription	O
by	O
:	O
(	O
1	O
)	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
than	O
even	O
traditional	O
,	O
rigorous	O
statistical	O
analyses	O
;	O
(	O
2	O
)	O
reconstructing	O
intact	O
biological	O
pathways	O
that	O
statistical	O
significance	O
analysis	O
could	O
not	O
reconstruct	O
;	O
and	O
(	O
3	O
)	O
providing	O
preliminary	O
insight	O
and	O
clues	O
about	O
the	O
function	O
or	O
regulation	O
of	O
uncharacterized	O
genes	O
by	O
associating	O
their	O
co	O
-	O
expression	O
with	O
physically	O
proximate	O
,	O
functionally	O
defined	O
genes	O
.	O

Results	O
/	O
Discussion	O
<EOS>	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X
Results	B-X
suggest	B-X
that	B-X
discussing	B-X
a	B-X
negative	B-X
societal	B-X
stereotype	B-X
(	B-X
relative	B-X
to	B-X
individual	B-X
rumination	B-X
in	B-X
Studies	B-X
1	B-X
and	B-X
3	B-X
and	B-X
alternative	B-X
discussions	B-X
in	B-X
Studies	B-X
2	B-X
and	B-X
3	B-X
)	B-X
increases	B-X
intentions	B-X
to	B-X
engage	B-X
in	B-X
discrimination	B-X
against	B-X
the	B-X
out-group	B-X
target	B-X
of	B-X
the	B-X
stereotype	B-X
.	B-X
Discussion	B-X
of	B-X
religion	B-X
and/or	B-X
spirituality	B-X
in	B-X
the	B-X
medical	B-X
consultation	B-X
is	B-X
desired	B-X
by	B-X
patients	B-X
and	B-X
known	B-X
to	B-X
be	B-X
beneficial	B-X
.	B-X

Adherence	O
-	O
Mediated	O
Differential	O
Expression	O
We	O
developed	O
spotted	O
oligonucleotide	O
arrays	O
of	O
the	O
S	O
.	O
pyogenes	O
SF370	O
(	O
an	O
M1	O
serotype	O
)	O
genome	O
[	O
14	O
]	O
and	O
compared	O
the	O
transcriptomes	O
of	O
streptococci	O
that	O
adhere	O
to	O
Detroit	O
562	O
human	O
pharyngeal	O
cells	O
to	O
non	O
-	O
adherent	O
(	O
"	O
associated	O
"	O
)	O
streptococci	O
within	O
the	O
same	O
experiment	O
.	O

Adherence	O
assays	O
were	O
performed	O
as	O
described	O
[	O
15	O
]	O
with	O
modifications	O
to	O
minimize	O
eukaryotic	O
cell	O
disruption	O
.	O

We	O
replicated	O
experiments	O
independently	O
and	O
used	O
dye	O
-	O
swaps	O
to	O
incorporate	O
biological	O
and	O
technical	O
variation	O
[	O
16	O
,	O
17	O
]	O
.	O

Following	O
filtering	O
and	O
normalization	O
[	O
18	O
,	O
19	O
]	O
,	O
we	O
analyzed	O
data	O
from	O
four	O
biological	O
replicates	O
[	O
16	O
]	O
with	O
robust	O
summary	O
statistics	O
[	O
20	O
]	O
,	O
Bayesian	O
statistics	O
[	O
21	O
,	O
22	O
]	O
,	O
and	O
permutation	O
algorithms	O
[	O
19	O
]	O
to	O
identify	O
genes	O
differentially	O
expressed	O
with	O
significance	O
during	O
pharyngeal	O
cell	O
adherence	O
.	O

This	O
analysis	O
identified	O
79	O
genes	O
(	O
4	O
%	O
of	O
the	O
genome	O
)	O
exhibiting	O
statistically	O
significant	O
fold	O
changes	O
in	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
during	O
adherence	O
from	O
1	O
,	O
769	O
open	O
reading	O
frames	O
represented	O
on	O
the	O
array	O
(	O
Table	O
1	O
)	O
.	O

We	O
refer	O
to	O
such	O
genes	O
as	O
"	O
differentially	O
expressed	O
.	O
"	O
We	O
present	O
the	O
entire	O
dataset	O
from	O
all	O
experiments	O
as	O
Table	O
S1	O
.	O

Genes	O
demonstrating	O
upregulation	O
(	O
n	O
=	O
45	O
)	O
and	O
downregulation	O
(	O
n	O
=	O
34	O
)	O
included	O
virulence	O
factors	O
,	O
prophage	O
-	O
encoded	O
transcripts	O
,	O
metabolic	O
genes	O
,	O
and	O
transcriptional	O
regulators	O
(	O
Table	O
2	O
)	O
.	O

Undefined	O
or	O
hypothetical	O
genes	O
comprised	O
27	O
%	O
of	O
differentially	O
expressed	O
genes	O
(	O
n	O
=	O
21	O
;	O
11	O
chromosomally	O
encoded	O
genes	O
,	O
ten	O
phage	O
-	O
encoded	O
genes	O
)	O
.	O
<EOS>	B-X
Characterized	B-X
by	B-X
a	B-X
surplus	B-X
of	B-X
whole-body	B-X
adiposity	B-X
,	B-X
obesity	B-X
is	B-X
strongly	B-X
associated	B-X
with	B-X
the	B-X
prognosis	B-X
of	B-X
atherosclerosis	B-X
,	B-X
a	B-X
hallmark	B-X
of	B-X
coronary	B-X
artery	B-X
disease	B-X
(	B-X
CAD	B-X
)	B-X
and	B-X
the	B-X
major	B-X
contributor	B-X
to	B-X
cardiovascular	B-X
disease	B-X
(	B-X
CVD	B-X
)	B-X
mortality	B-X
.	B-X
Adipose	B-X
tissue	B-X
serves	B-X
a	B-X
primary	B-X
role	B-X
as	B-X
a	B-X
lipid-storage	B-X
organ	B-X
,	B-X
secreting	B-X
cytokines	B-X
known	B-X
as	B-X
adipokines	B-X
that	B-X
affect	B-X
whole-body	B-X
metabolism	B-X
,	B-X
inflammation	B-X
,	B-X
and	B-X
endocrine	B-X
functions	B-X
.	B-X
Emerging	B-X
evidence	B-X
suggests	B-X
that	B-X
adipokines	B-X
can	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
atherosclerosis	B-X
development	B-X
,	B-X
progression	B-X
,	B-X
as	B-X
well	B-X
as	B-X
regression	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
versatile	B-X
functions	B-X
of	B-X
various	B-X
adipokines	B-X
in	B-X
atherosclerosis	B-X
and	B-X
divide	B-X
these	B-X
respective	B-X
functions	B-X
into	B-X
three	B-X
major	B-X
groups	B-X
:	B-X
protective	B-X
,	B-X
deteriorative	B-X
,	B-X
and	B-X
undefined	B-X
.	B-X
The	B-X
protective	B-X
adipokines	B-X
represented	B-X
here	B-X
are	B-X
adiponectin	B-X
,	B-X
fibroblast	B-X
growth	B-X
factor	B-X
21	B-X
(	B-X
FGF-21	B-X
)	B-X
,	B-X
C1q	B-X
tumor	B-X
necrosis	B-X
factor-related	B-X
protein	B-X
9	B-X
(	B-X
CTRP9	B-X
)	B-X
,	B-X
and	B-X
progranulin	B-X
,	B-X
while	B-X
the	B-X
deteriorative	B-X
adipokines	B-X
listed	B-X
include	B-X
leptin	B-X
,	B-X
chemerin	B-X
,	B-X
resistin	B-X
,	B-X
Interleukin-	B-X
6	B-X
(	B-X
IL-6	B-X
)	B-X
,	B-X
and	B-X
more	B-X
,	B-X
with	B-X
additional	B-X
adipokines	B-X
that	B-X
have	B-X
unclear	B-X
roles	B-X
denoted	B-X
as	B-X
undefined	B-X
adipokines	B-X
.	B-X
Comprehensively	B-X
categorizing	B-X
adipokines	B-X
in	B-X
the	B-X
context	B-X
of	B-X
atherosclerosis	B-X
can	B-X
help	B-X
elucidate	B-X
the	B-X
various	B-X
pathways	B-X
involved	B-X
and	B-X
potentially	B-X
pave	B-X
novel	B-X
therapeutic	B-X
approaches	B-X
to	B-X
treat	B-X
CVDs	B-X
.	B-X

Verification	O
by	O
Quantitative	O
Real	O
-	O
Time	O
PCR	O
<EOS>	B-X
Reverse	B-X
transcription-polymerase	B-X
chain	B-X
reaction	B-X
(	B-X
RT-PCR	B-X
)	B-X
is	B-X
an	B-X
extremely	B-X
common	B-X
clinical	B-X
method	B-X
for	B-X
detecting	B-X
pathogens	B-X
,	B-X
particularly	B-X
for	B-X
emerging	B-X
infectious	B-X
diseases	B-X
such	B-X
as	B-X
the	B-X
new	B-X
coronavirus	B-X
disease	B-X
(	B-X
COVID-19	B-X
)	B-X
.	B-X
Verification	B-X
of	B-X
miRNAs	B-X
in	B-X
ginseng	B-X
decoction	B-X
by	B-X
high-throughput	B-X
sequencing	B-X
and	B-X
quantitative	B-X
real-time	B-X
PCR	B-X
.	B-X
Based	B-X
on	B-X
our	B-X
previous	B-X
RNA-seq	B-X
and	B-X
annotation	B-X
of	B-X
D.	B-X
farinae	B-X
under	B-X
temperature	B-X
stress	B-X
,	B-X
it	B-X
is	B-X
planned	B-X
to	B-X
identify	B-X
differentially	B-X
expressed	B-X
genes	B-X
(	B-X
DEGs	B-X
)	B-X
involved	B-X
in	B-X
the	B-X
temperature	B-X
stress	B-X
response	B-X
by	B-X
quantitative	B-X
real-time	B-X
PCR	B-X
(	B-X
qRT-PCR	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
qRT-PCR	B-X
detection	B-X
results	B-X
of	B-X
15	B-X
DEGs	B-X
were	B-X
almost	B-X
identical	B-X
to	B-X
the	B-X
RNA-seq	B-X
results	B-X
,	B-X
indicating	B-X
that	B-X
α	B-X
tubulin	B-X
is	B-X
stable	B-X
as	B-X
a	B-X
reference	B-X
gene	B-X
.	B-X
This	B-X
study	B-X
provided	B-X
technical	B-X
support	B-X
for	B-X
DEGs	B-X
expression	B-X
studies	B-X
in	B-X
D.	B-X
farinae	B-X
using	B-X
qRT-PCR	B-X
.	B-X

We	O
conducted	O
TaqMan	O
(	O
qRT	O
-	O
PCR	O
)	O
analysis	O
[	O
23	O
]	O
of	O
11	O
differentially	O
expressed	O
genes	O
to	O
validate	O
selected	O
microarray	O
hybridization	O
results	O
(	O
see	O
Table	O
S2	O
for	O
genes	O
and	O
primer	O
-	O
probe	O
sequences	O
)	O
.	O

Five	O
genes	O
chosen	O
for	O
validation	O
demonstrated	O
statistically	O
significant	O
fold	O
changes	O
in	O
expression	O
by	O
microarray	O
analysis	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
;	O
two	O
upregulated	O
,	O
three	O
downregulated	O
)	O
.	O

The	O
remaining	O
six	O
genes	O
(	O
four	O
upregulated	O
,	O
two	O
downregulated	O
)	O
did	O
not	O
have	O
significant	O
PF	O
values	O
,	O
but	O
were	O
statistically	O
significant	O
as	O
members	O
of	O
particular	O
neighbor	O
clusters	O
in	O
subsequent	O
analyses	O
(	O
PE	O
<	O
0	O
.	O
05	O
)	O
as	O
detailed	O
in	O
later	O
sections	O
)	O
.	O

We	O
averaged	O
the	O
data	O
to	O
generate	O
a	O
value	O
for	O
each	O
gene	O
,	O
creating	O
a	O
set	O
of	O
11	O
paired	O
values	O
from	O
quantitative	O
real	O
-	O
time	O
(	O
qRT	O
)	O
-	O
PCR	O
and	O
microarray	O
analyses	O
(	O
Table	O
S3	O
)	O
.	O

Results	O
of	O
standard	O
linear	O
regression	O
analysis	O
demonstrated	O
a	O
strong	O
positive	O
correlation	O
(	O
r	O
=	O
0	O
.	O
9	O
)	O
between	O
data	O
obtained	O
using	O
the	O
different	O
techniques	O
(	O
see	O
Figure	O
S1	O
)	O
.	O

Virulence	O
Factors	O
<EOS>	B-X
Virulence	B-X
Factors	B-X
of	B-X
Enteric	B-X
Pathogenic	B-X
Virulence	B-X
factors	B-X
are	B-X
molecules	B-X
that	B-X
enable	B-X
plant	B-X
pathogens	B-X
to	B-X
infect	B-X
and	B-X
colonize	B-X
host	B-X
tissues	B-X
successfully	B-X
.	B-X

Streptococci	O
elaborate	O
several	O
factors	O
implicated	O
in	O
infection	O
,	O
including	O
surface	O
-	O
exposed	O
adhesins	O
and	O
secreted	O
toxigenic	O
proteins	O
(	O
reviewed	O
in	O
[	O
7	O
,	O
14	O
,	O
24	O
]	O
)	O
.	O

The	O
initial	O
statistical	O
analysis	O
identified	O
four	O
differentially	O
expressed	O
virulence	O
genes	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Genes	O
encoding	O
streptolysin	B-Protein
O	I-Protein
(	O
slo	B-Protein
or	O
spy0167	B-Protein
)	O
and	O
the	O
SpeB	B-Protein
protease	O
(	O
spy2039	B-Protein
)	O
were	O
downregulated	O
,	O
while	O
genes	O
encoding	O
pyrogenic	B-Protein
exotoxin	I-Protein
H	I-Protein
(	O
speH	B-Protein
or	O
spy1008	B-Protein
)	O
and	O
a	O
putative	B-Protein
fibronectin	I-Protein
-	I-Protein
binding	I-Protein
protein	I-Protein
(	O
spy0130	B-Protein
)	O
were	O
upregulated	O
.	O

We	O
verified	O
the	O
differential	O
expression	O
of	O
spy2039	B-Protein
and	O
spy0130	B-Protein
by	O
qRT	O
-	O
PCR	O
.	O

The	O
downregulation	O
of	O
virulence	O
loci	O
during	O
presumably	O
inappropriate	O
stages	O
of	O
infection	O
was	O
not	O
surprising	O
.	O

Streptolysin	B-Protein
O	I-Protein
is	O
a	O
cytotoxin	O
that	O
damages	O
human	O
tissue	O
and	O
increases	O
host	O
cell	O
cytotoxicity	O
[	O
7	O
,	O
25	O
]	O
.	O

The	O
resulting	O
cellular	O
damage	O
,	O
particularly	O
to	O
polymorphonuclear	O
leukocytes	O
[	O
26	O
]	O
,	O
decreases	O
internalization	O
and	O
subsequent	O
intracellular	O
killing	O
of	O
streptococci	O
[	O
27	O
]	O
.	O

Based	O
on	O
its	O
downregulation	O
during	O
adherence	O
,	O
we	O
infer	O
that	O
slo	B-Protein
was	O
transcribed	O
during	O
pre	O
-	O
adherence	O
associations	O
,	O
perhaps	O
,	O
as	O
previously	O
reported	O
,	O
to	O
protect	O
streptococci	O
from	O
phagocytic	O
killing	O
in	O
vivo	O
[	O
27	O
]	O
.	O

However	O
,	O
once	O
adhered	O
,	O
our	O
data	O
suggest	O
that	O
streptococci	O
downregulate	O
production	O
of	O
this	O
cytotoxin	O
,	O
presumably	O
to	O
prevent	O
further	O
host	O
tissue	O
destruction	O
that	O
could	O
interfere	O
with	O
adherence	O
.	O

SpeB	B-Protein
(	O
encoded	O
by	O
spy2039	B-Protein
)	O
is	O
a	O
multifunctional	O
cysteine	B-Protein
protease	I-Protein
implicated	O
in	O
numerous	O
infection	O
strategies	O
[	O
28	O
,	O
29	O
]	O
.	O

Although	O
few	O
studies	O
have	O
examined	O
gene	O
expression	O
patterns	O
during	O
adherence	O
,	O
SpeB	B-Protein
production	O
(	O
as	O
detected	O
by	O
Western	O
blot	O
analysis	O
)	O
decreases	O
during	O
co	O
-	O
culture	O
with	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
[	O
30	O
]	O
and	O
in	O
a	O
mouse	O
infection	O
model	O
[	O
31	O
]	O
.	O

When	O
SpeB	B-Protein
expression	O
is	O
limited	O
,	O
several	O
streptococcal	O
proteins	O
necessary	O
for	O
adherence	O
remain	O
intact	O
[	O
24	O
,	O
32	O
,	O
33	O
]	O
;	O
thus	O
,	O
decreased	O
SpeB	B-Protein
production	O
(	O
as	O
indicated	O
here	O
)	O
may	O
promote	O
pharyngeal	O
cell	O
attachment	O
.	O

Furthermore	O
,	O
SpeB	B-Protein
abolishes	O
internalization	O
(	O
following	O
adherence	O
)	O
of	O
certain	O
streptococcal	O
strains	O
by	O
epithelial	O
cells	O
(	O
including	O
Detroit	O
562	O
cells	O
)	O
,	O
a	O
process	O
mediated	O
in	O
part	O
by	O
the	O
fibronectin	B-Protein
-	I-Protein
binding	I-Protein
protein	I-Protein
F	I-Protein
[	O
34	O
,	O
35	O
]	O
.	O

We	O
observed	O
significant	O
upregulation	O
of	O
the	O
gene	O
spy0130	B-Protein
,	O
encoding	O
a	O
protein	O
recently	O
found	O
to	O
be	O
associated	O
with	O
the	O
production	O
of	O
surface	O
-	O
exposed	O
pili	O
on	O
strain	O
SF370	O
[	O
36	O
]	O
.	O

The	O
protein	O
shares	O
60	O
%	O
sequence	O
similarity	O
to	O
protein	B-Protein
F	I-Protein
,	O
suggesting	O
that	O
it	O
may	O
coordinate	O
a	O
similar	O
internalization	O
mechanism	O
or	O
may	O
be	O
involved	O
directly	O
in	O
adherence	O
(	O
discussed	O
later	O
in	O
detail	O
)	O
.	O

SpeB	B-Protein
downregulation	O
also	O
coincides	O
with	O
increased	O
expression	O
of	O
pyrogenic	O
exotoxins	O
[	O
33	O
,	O
37	O
]	O
that	O
reportedly	O
increase	O
streptococcal	O
survival	O
in	O
vivo	O
.	O

We	O
observed	O
that	O
the	O
exotoxin	O
-	O
encoding	O
speH	B-Protein
gene	O
[	O
38	O
]	O
was	O
upregulated	O
.	O

Taken	O
together	O
,	O
our	O
results	O
agree	O
with	O
previous	O
reports	O
on	O
SpeB	B-Protein
production	O
during	O
host	O
cell	O
interactions	O
,	O
suggesting	O
that	O
decreased	O
expression	O
may	O
promote	O
streptococcal	O
adherence	O
(	O
by	O
preventing	O
proteolytic	O
degradation	O
of	O
key	O
virulence	O
factors	O
or	O
adhesins	O
)	O
,	O
enhance	O
internalization	O
(	O
perhaps	O
through	O
a	O
fibronectin	O
-	O
mediated	O
pathway	O
)	O
,	O
and	O
increase	O
survival	O
(	O
through	O
increased	O
pyrogenic	O
exotoxin	O
production	O
,	O
discussed	O
below	O
)	O
.	O

Phage	O
-	O
Encoded	O
Genes	O
<EOS>	B-X
Phage	B-X
and	B-X
bacteria	B-X
from	B-X
water	B-X
,	B-X
soil	B-X
,	B-X
and	B-X
sediment	B-X
environments	B-X
represent	B-X
a	B-X
potential	B-X
reservoir	B-X
of	B-X
phage-	B-X
and	B-X
plasmid-encoded	B-X
exotoxin	B-X
genes	B-X
.	B-X
Phage-encoded	B-X
proteins	B-X
such	B-X
as	B-X
the	B-X
RNA-binding	B-X
MS2	B-X
protein	B-X
,	B-X
which	B-X
is	B-X
broadly	B-X
used	B-X
to	B-X
isolate	B-X
tagged	B-X
RNAs	B-X
,	B-X
also	B-X
have	B-X
been	B-X
developed	B-X
as	B-X
valuable	B-X
tools	B-X
.	B-X
Phages	B-X
also	B-X
affect	B-X
posttranscriptional	B-X
regulation	B-X
in	B-X
bacteria	B-X
through	B-X
proteins	B-X
that	B-X
inhibit	B-X
or	B-X
alter	B-X
the	B-X
activities	B-X
of	B-X
key	B-X
bacterial	B-X
proteins	B-X
involved	B-X
in	B-X
posttranscriptional	B-X
regulation	B-X
.	B-X
Phage	B-X
CP12	B-X
was	B-X
coexpressed	B-X
with	B-X
phage	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
light	B-X
reactions	B-X
,	B-X
deoxynucleotide	B-X
biosynthesis	B-X
,	B-X
and	B-X
the	B-X
PPP	B-X
,	B-X
including	B-X
a	B-X
transaldolase	B-X
gene	B-X
that	B-X
is	B-X
the	B-X
most	B-X
prevalent	B-X
PPP	B-X
gene	B-X
in	B-X
cyanophages	B-X
.	B-X
Phage	B-X
transaldolase	B-X
was	B-X
purified	B-X
to	B-X
homogeneity	B-X
from	B-X
several	B-X
strains	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
functional	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
might	B-X
facilitate	B-X
increased	B-X
flux	B-X
through	B-X
this	B-X
key	B-X
reaction	B-X
in	B-X
the	B-X
host	B-X
PPP	B-X
,	B-X
augmenting	B-X
production	B-X
of	B-X
NADPH	B-X
and	B-X
ribose	B-X
5-phosphate	B-X
.	B-X

SF370	O
contains	O
one	O
inducible	O
prophage	O
(	O
370	O
.	O
1	O
)	O
and	O
three	O
defective	O
prophages	O
(	O
370	O
.	O
2	O
,	O
370	O
.	O
3	O
,	O
and	O
370	O
.	O
4	O
)	O
that	O
produce	O
no	O
infectious	O
phage	O
[	O
39	O
]	O
.	O

We	O
identified	O
11	O
differentially	O
expressed	O
phage	O
370	O
.	O
2	O
genes	O
,	O
suggesting	O
that	O
this	O
defective	O
phage	O
is	O
not	O
transcriptionally	O
silent	O
(	O
Table	O
1	O
)	O
.	O

The	O
speH	B-Protein
gene	O
(	O
spy1008	B-Protein
)	O
was	O
induced	O
,	O
and	O
the	O
remaining	O
genes	O
,	O
hypothetically	O
involved	O
in	O
replication	O
and	O
regulation	O
[	O
39	O
]	O
,	O
were	O
downregulated	O
.	O

The	O
speH	B-Protein
gene	O
encodes	O
a	O
mitogenic	O
exotoxin	O
[	O
38	O
]	O
reportedly	O
induced	O
during	O
polymorphonuclear	O
leukocyte	O
phagocytosis	O
[	O
8	O
]	O
but	O
not	O
implicated	O
previously	O
in	O
adherence	O
.	O

Allelic	O
Replacement	O
of	O
speH	B-Protein

Increased	O
expression	O
of	O
speH	B-Protein
during	O
pharyngeal	O
cell	O
adherence	O
suggests	O
that	O
the	O
SpeH	B-Protein
exotoxin	O
is	O
either	O
necessary	O
for	O
adherence	O
,	O
or	O
is	O
a	O
component	O
of	O
a	O
downstream	O
infection	O
process	O
.	O
<EOS>	B-X
The	B-X
severity	B-X
of	B-X
TBEV-induced	B-X
neuropathogenesis	B-X
is	B-X
highly	B-X
cell-type	B-X
specific	B-X
and	B-X
the	B-X
exact	B-X
mechanism	B-X
responsible	B-X
for	B-X
such	B-X
differences	B-X
has	B-X
not	B-X
been	B-X
fully	B-X
described	B-X
yet	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
comprehensive	B-X
analysis	B-X
of	B-X
alterations	B-X
in	B-X
host	B-X
poly-	B-X
(	B-X
A	B-X
)	B-X
/miRNA/lncRNA	B-X
expression	B-X
upon	B-X
TBEV	B-X
infection	B-X
Type	B-X
I	B-X
interferons	B-X
(	B-X
IFNs	B-X
)	B-X
play	B-X
essential	B-X
roles	B-X
in	B-X
establishing	B-X
and	B-X
modulating	B-X
host	B-X
defense	B-X
against	B-X
microbial	B-X
infection	B-X
via	B-X
induction	B-X
of	B-X
IFN-stimulated	B-X
genes	B-X
(	B-X
ISGs	B-X
)	B-X
through	B-X
Janus	B-X
kinase	B-X
(	B-X
JAK	B-X
)	B-X
-signal	B-X
transducer	B-X
and	B-X
activator	B-X
of	B-X
transcription	B-X
(	B-X
STAT	B-X
)	B-X
signaling	B-X
pathway	B-X
.	B-X
Thus	B-X
,	B-X
IFN	B-X
responses	B-X
need	B-X
to	B-X
be	B-X
tightly	B-X
regulated	B-X
to	B-X
achieve	B-X
protective	B-X
immunity	B-X
against	B-X
microbial	B-X
infection	B-X
while	B-X
avoiding	B-X
harmful	B-X
toxicity	B-X
caused	B-X
by	B-X
improper	B-X
or	B-X
prolonged	B-X
IFN	B-X
signaling	B-X
.	B-X
Multiple	B-X
levels	B-X
of	B-X
cellular	B-X
and	B-X
molecular	B-X
events	B-X
act	B-X
in	B-X
a	B-X
cooperated	B-X
manner	B-X
to	B-X
regulate	B-X
IFN	B-X
responses	B-X
,	B-X
in	B-X
especial	B-X
,	B-X
post-translational	B-X
modification	B-X
(	B-X
PTMs	B-X
)	B-X
of	B-X
signaling	B-X
molecules	B-X
and	B-X
epigenetic	B-X
modification	B-X
of	B-X
gene	B-X
expression	B-X
programs	B-X
are	B-X
two	B-X
important	B-X
mechanisms	B-X
for	B-X
regulation	B-X
of	B-X
IFN	B-X
signaling	B-X
and	B-X
thus	B-X
critical	B-X
for	B-X
orchestrating	B-X
IFN-mediated	B-X
host	B-X
immune	B-X
response	B-X
to	B-X
the	B-X
complex	B-X
pathogenic	B-X
or	B-X
environmental	B-X
stimuli	B-X
.	B-X
Conventional	B-X
PTMs	B-X
such	B-X
as	B-X
phosphorylation	B-X
and	B-X
polyubiquitylation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
numerous	B-X
other	B-X
PTMs	B-X
including	B-X
acetylation	B-X
,	B-X
ISGylation	B-X
,	B-X
SUMOylation	B-X
and	B-X
methylation	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
potently	B-X
modulate	B-X
type	B-X
I	B-X
IFN	B-X
signaling	B-X
transduction	B-X
via	B-X
targeting	B-X
distinct	B-X
signaling	B-X
steps	B-X
or	B-X
components	B-X
.	B-X
Moreover	B-X
,	B-X
epigenetic	B-X
mechanisms	B-X
,	B-X
such	B-X
as	B-X
histone	B-X
modification	B-X
,	B-X
DNA	B-X
methylation	B-X
,	B-X
non-coding	B-X
RNAs	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
regulating	B-X
chromatin	B-X
structure	B-X
and	B-X
function	B-X
,	B-X
leading	B-X
to	B-X
flexible	B-X
and	B-X
dynamic	B-X
gene	B-X
expression	B-X
patterns	B-X
downstream	B-X
type	B-X
I	B-X
IFN	B-X
signaling	B-X
.	B-X

Adherence	O
-	O
mediated	O
upregulation	O
of	O
speH	B-Protein
is	O
likely	O
not	O
the	O
result	O
of	O
phage	O
induction	O
,	O
as	O
the	O
remaining	O
phage	O
370	O
.	O
2	O
genes	O
identified	O
in	O
our	O
analysis	O
were	O
downregulated	O
.	O

To	O
determine	O
if	O
SpeH	B-Protein
plays	O
a	O
direct	O
role	O
in	O
the	O
adherence	O
process	O
,	O
we	O
created	O
a	O
deletion	O
mutant	O
in	O
strain	O
SF370	O
(	O
SF370DeltaspeH	B-Protein
)	O
,	O
which	O
was	O
confirmed	O
by	O
PCR	O
(	O
unpublished	O
data	O
)	O
and	O
RT	O
-	O
PCR	O
(	O
Figure	O
1A	O
)	O
and	O
tested	O
in	O
vitro	O
for	O
adherence	O
to	O
human	O
pharyngeal	O
cells	O
.	O

We	O
observed	O
no	O
significant	O
difference	O
in	O
adherence	O
between	O
the	O
wild	O
-	O
type	O
(	O
SF370	O
)	O
and	O
mutant	O
strains	O
(	O
Figure	O
1B	O
)	O
,	O
indicating	O
that	O
SpeH	B-Protein
is	O
not	O
involved	O
directly	O
in	O
attachment	O
to	O
the	O
pharyngeal	O
cell	O
.	O

The	O
significant	O
upregulation	O
of	O
the	O
speH	B-Protein
gene	O
during	O
adherence	O
suggests	O
that	O
the	O
gene	O
product	O
may	O
function	O
instead	O
during	O
a	O
subsequent	O
stage	O
of	O
infection	O
.	O

Differential	O
Expression	O
of	O
Genes	O
from	O
Diverse	O
Functional	O
Categories	O
<EOS>	B-X
Diverse	B-X
derivation	B-X
site	B-X
of	B-X
amniocytes	B-X
and	B-X
individual	B-X
genetic	B-X
background	B-X
can	B-X
potentially	B-X
explain	B-X
the	B-X
observed	B-X
variation	B-X
in	B-X
the	B-X
expression	B-X
level	B-X
of	B-X
the	B-X
target	B-X
genes	B-X
.	B-X
Genes	B-X
involved	B-X
in	B-X
development	B-X
and	B-X
other	B-X
normal	B-X
cellular	B-X
processes	B-X
have	B-X
been	B-X
implicated	B-X
in	B-X
cancer	B-X
.	B-X
Genes	B-X
involved	B-X
in	B-X
angiogenesis	B-X
,	B-X
immune	B-X
regulation	B-X
,	B-X
cellular	B-X
responses	B-X
to	B-X
stress	B-X
,	B-X
motility	B-X
,	B-X
adhesion	B-X
and	B-X
invasion	B-X
are	B-X
also	B-X
involved	B-X
,	B-X
but	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
relationship	B-X
to	B-X
carcinogenesis	B-X
,	B-X
and	B-X
these	B-X
processes	B-X
are	B-X
not	B-X
discussed	B-X
in	B-X
this	B-X
review	B-X
.	B-X
Expression	B-X
levels	B-X
of	B-X
genes	B-X
vary	B-X
depending	B-X
on	B-X
the	B-X
experimental	B-X
conditions	B-X
and	B-X
the	B-X
cell	B-X
response	B-X
.	B-X

We	O
identified	O
a	O
number	O
of	O
genes	O
encoding	O
proteins	O
involved	O
in	O
housekeeping	O
processes	O
(	O
such	O
as	O
carbohydrate	O
and	O
coenzyme	O
metabolism	O
)	O
that	O
were	O
differentially	O
expressed	O
,	O
indicating	O
a	O
shift	O
in	O
metabolic	O
processes	O
due	O
to	O
host	O
cell	O
adherence	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

For	O
example	O
,	O
genes	O
encoding	O
proteins	O
involved	O
in	O
folate	O
biosynthesis	O
[	O
40	O
]	O
were	O
upregulated	O
,	O
suggesting	O
that	O
certain	O
cofactors	O
that	O
may	O
be	O
necessary	O
during	O
adherence	O
were	O
unavailable	O
.	O

Also	O
upregulated	O
were	O
genes	O
encoding	O
subunits	O
of	O
the	O
F0F1	O
ATPase	O
[	O
41	O
]	O
(	O
discussed	O
in	O
more	O
detail	O
later	O
)	O
,	O
which	O
may	O
indicate	O
an	O
acid	O
stress	O
response	O
to	O
maintain	O
cytoplasmic	O
pH	O
or	O
a	O
need	O
to	O
generate	O
ATP	O
in	O
response	O
to	O
increased	O
energy	O
requirements	O
.	O
<EOS>	B-X
Recently	B-X
,	B-X
a	B-X
metabolic	B-X
paradox	B-X
in	B-X
AF	B-X
pathogenesis	B-X
has	B-X
been	B-X
suggested	B-X
:	B-X
under	B-X
different	B-X
forms	B-X
of	B-X
pathogenesis	B-X
,	B-X
the	B-X
metabolic	B-X
balance	B-X
shifts	B-X
either	B-X
towards	B-X
(	B-X
e.g.	B-X
,	B-X
obesity	B-X
and	B-X
diabetes	B-X
)	B-X
or	B-X
away	B-X
from	B-X
(	B-X
e.g.	B-X
,	B-X
aging	B-X
,	B-X
heart	B-X
failure	B-X
,	B-X
and	B-X
hypertension	B-X
)	B-X
fatty	B-X
acid	B-X
oxidation	B-X
,	B-X
yet	B-X
they	B-X
all	B-X
increase	B-X
the	B-X
risk	B-X
of	B-X
AF	B-X
.	B-X
This	B-X
has	B-X
raised	B-X
the	B-X
urgent	B-X
need	B-X
for	B-X
a	B-X
general	B-X
consensus	B-X
regarding	B-X
the	B-X
metabolic	B-X
changes	B-X
that	B-X
predispose	B-X
patients	B-X
to	B-X
AF	B-X
.	B-X
``	B-X
Metabolic	B-X
flexibility	B-X
''	B-X
aptly	B-X
describes	B-X
switches	B-X
between	B-X
substrates	B-X
(	B-X
fatty	B-X
acids	B-X
,	B-X
glucose	B-X
,	B-X
amino	B-X
acids	B-X
,	B-X
and	B-X
ketones	B-X
)	B-X
in	B-X
response	B-X
to	B-X
various	B-X
energy	B-X
stresses	B-X
depending	B-X
on	B-X
availability	B-X
and	B-X
requirements	B-X
.	B-X
AF	B-X
,	B-X
characterized	B-X
by	B-X
irregular	B-X
high-frequency	B-X
excitation	B-X
and	B-X
the	B-X
contraction	B-X
of	B-X
the	B-X
atria	B-X
,	B-X
is	B-X
an	B-X
energy	B-X
challenge	B-X
and	B-X
triggers	B-X
a	B-X
metabolic	B-X
switch	B-X
from	B-X
preferential	B-X
fatty	B-X
acid	B-X
utilization	B-X
to	B-X
glucose	B-X
metabolism	B-X
to	B-X
increase	B-X
the	B-X
efficiency	B-X
of	B-X
ATP	B-X
produced	B-X
in	B-X
relation	B-X
to	B-X
oxygen	B-X
consumed	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
heart	B-X
needs	B-X
metabolic	B-X
flexibility	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
will	B-X
briefly	B-X
discuss	B-X
(	B-X
1	B-X
)	B-X
the	B-X
current	B-X
understanding	B-X
of	B-X
cardiac	B-X
metabolic	B-X
flexibility	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
the	B-X
specificity	B-X
of	B-X
atrial	B-X
metabolic	B-X
characteristics	B-X
;	B-X
(	B-X
2	B-X
)	B-X
metabolic	B-X
heterogeneity	B-X
among	B-X
AF	B-X
pathogenesis	B-X
and	B-X
metabolic	B-X
inflexibility	B-X
as	B-X
a	B-X
common	B-X
pathological	B-X
basis	B-X
for	B-X
AF	B-X
;	B-X
and	B-X
(	B-X
3	B-X
)	B-X
the	B-X
substrate-metabolism	B-X
mechanism	B-X
underlying	B-X
metabolic	B-X
inflexibility	B-X
in	B-X
AF	B-X
pathogenesis	B-X
.	B-X

We	O
also	O
identified	O
the	O
adherence	O
-	O
mediated	O
upregulation	O
of	O
four	O
transcriptional	O
regulators	O
(	O
Table	O
1	O
)	O
,	O
suggestive	O
of	O
an	O
adaptive	O
response	O
to	O
host	O
cell	O
contact	O
that	O
is	O
dynamic	O
and	O
complex	O
.	O

For	O
example	O
,	O
RopB	B-Protein
(	O
encoded	O
by	O
spy2042	B-Protein
)	O
,	O
a	O
member	O
of	O
the	O
Rgg	B-Protein
family	O
of	O
response	O
regulators	O
,	O
interacts	O
with	O
a	O
number	O
of	O
regulatory	O
networks	O
throughout	O
the	O
streptococcal	O
genome	O
(	O
e	O
.	O
g	O
.	O
,	O
mga	B-Protein
,	O
csrRS	B-Protein
,	O
sagA	B-Protein
,	O
and	O
fasBCA	B-Protein
)	O
,	O
affecting	O
the	O
transcription	O
of	O
numerous	O
proteins	O
,	O
virulence	O
factors	O
,	O
and	O
two	O
-	O
component	O
regulatory	O
systems	O
[	O
42	O
,	O
43	O
]	O
.	O

Although	O
the	O
delineation	O
of	O
genes	O
influenced	O
by	O
RopB	B-Protein
(	O
or	O
any	O
identified	O
transcriptional	O
regulator	O
)	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
,	O
our	O
initial	O
analysis	O
did	O
identify	O
the	O
upregulation	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
encoded	O
by	O
spy1236	B-Protein
-	O
1237	B-Protein
.	O

The	O
functions	O
of	O
these	O
particular	O
loci	O
are	O
not	O
yet	O
known	O
,	O
and	O
their	O
adherence	O
-	O
mediated	O
upregulation	O
represents	O
new	O
targets	O
in	O
the	O
study	O
of	O
regulators	O
that	O
function	O
during	O
host	O
cell	O
contact	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
exact	B-X
pathogenesis	B-X
and	B-X
causative	B-X
interaction	B-X
between	B-X
environment	B-X
and	B-X
genes	B-X
are	B-X
unknown	B-X
,	B-X
GD	B-X
and	B-X
HT	B-X
share	B-X
similar	B-X
immune-mediated	B-X
mechanisms	B-X
of	B-X
disease	B-X
.	B-X
Polymorphisms	B-X
in	B-X
these	B-X
immune-modulating	B-X
genes	B-X
,	B-X
in	B-X
particular	B-X
,	B-X
significantly	B-X
contribute	B-X
to	B-X
the	B-X
predisposition	B-X
for	B-X
GD	B-X
,	B-X
HT	B-X
and	B-X
,	B-X
unsurprisingly	B-X
,	B-X
other	B-X
autoimmune	B-X
diseases	B-X
.	B-X
Emerging	B-X
evidence	B-X
suggests	B-X
that	B-X
single	B-X
nucleotide	B-X
polymorphisms	B-X
(	B-X
SNPs	B-X
)	B-X
in	B-X
the	B-X
immunoregulatory	B-X
genes	B-X
may	B-X
functionally	B-X
hinder	B-X
the	B-X
proper	B-X
development	B-X
of	B-X
central	B-X
and	B-X
peripheral	B-X
tolerance	B-X
and	B-X
alter	B-X
T	B-X
cell	B-X
interactions	B-X
with	B-X
antigen	B-X
presenting	B-X
cells	B-X
(	B-X
APCs	B-X
)	B-X
in	B-X
the	B-X
immunological	B-X
synapse	B-X
.	B-X
Here	B-X
we	B-X
review	B-X
the	B-X
major	B-X
immune-modulating	B-X
genes	B-X
that	B-X
are	B-X
associated	B-X
with	B-X
AITD	B-X
and	B-X
their	B-X
potential	B-X
functional	B-X
effects	B-X
on	B-X
thyroidal	B-X
immune	B-X
dysregulation	B-X
.	B-X

Neighbor	O
Clustering	O
<EOS>	B-X
Clustering	B-X
of	B-X
single-cell	B-X
RNA	B-X
sequencing	B-X
(	B-X
scRNA-seq	B-X
)	B-X
data	B-X
enables	B-X
discovering	B-X
cell	B-X
subtypes	B-X
,	B-X
which	B-X
is	B-X
helpful	B-X
for	B-X
understanding	B-X
and	B-X
analyzing	B-X
the	B-X
processes	B-X
of	B-X
diseases	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
open-source	B-X
Python	B-X
project	B-X
CommonNNClustering	B-X
,	B-X
which	B-X
provides	B-X
an	B-X
easy-to-use	B-X
and	B-X
efficient	B-X
reimplementation	B-X
of	B-X
the	B-X
common-nearest-neighbor	B-X
(	B-X
CommonNN	B-X
)	B-X
method	B-X
.	B-X
Clustering	B-X
individual	B-X
cells	B-X
is	B-X
a	B-X
key	B-X
step	B-X
to	B-X
reveal	B-X
cell	B-X
subtypes	B-X
and	B-X
infer	B-X
cell	B-X
lineage	B-X
in	B-X
scRNA-seq	B-X
analysis	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
(	B-X
i	B-X
)	B-X
imputation	B-X
algorithms	B-X
do	B-X
typically	B-X
improve	B-X
the	B-X
performance	B-X
of	B-X
clustering	B-X
methods	B-X
,	B-X
and	B-X
the	B-X
quality	B-X
of	B-X
data	B-X
visualization	B-X
using	B-X
t-Distributed	B-X
Stochastic	B-X
Neighbor	B-X
Embedding	B-X
;	B-X
and	B-X
(	B-X
ii	B-X
)	B-X
the	B-X
performance	B-X
of	B-X
a	B-X
particular	B-X
combination	B-X
of	B-X
imputation	B-X
and	B-X
clustering	B-X
methods	B-X
varies	B-X
with	B-X
dataset	B-X
size	B-X
.	B-X
For	B-X
example	B-X
,	B-X
the	B-X
combination	B-X
of	B-X
single-cell	B-X
analysis	B-X
via	B-X
expression	B-X
recovery	B-X
and	B-X
Sparse	B-X
Subspace	B-X
Clustering	B-X
(	B-X
SSC	B-X
)	B-X
methods	B-X
usually	B-X
works	B-X
well	B-X
on	B-X
smaller	B-X
datasets	B-X
,	B-X
while	B-X
the	B-X
combination	B-X
of	B-X
adaptively-thresholded	B-X
low-rank	B-X
approximation	B-X
and	B-X
single-cell	B-X
interpretation	B-X
via	B-X
multikernel	B-X
learning	B-X
(	B-X
SIMLR	B-X
)	B-X
usually	B-X
achieves	B-X
the	B-X
best	B-X
performance	B-X
on	B-X
larger	B-X
datasets	B-X
.	B-X

Our	O
initial	O
analysis	O
revealed	O
the	O
differential	O
expression	O
of	O
a	O
wide	O
range	O
of	O
functionally	O
diverse	O
genes	O
and	O
provided	O
insight	O
into	O
the	O
adaptive	O
response	O
of	O
streptococci	O
to	O
host	O
cell	O
contact	O
.	O

However	O
,	O
despite	O
a	O
rigorous	O
statistical	O
approach	O
,	O
this	O
analysis	O
,	O
like	O
many	O
previous	O
microarray	O
studies	O
,	O
identified	O
the	O
differential	O
expression	O
of	O
a	O
large	O
number	O
of	O
unknown	O
genes	O
(	O
n	O
=	O
21	O
)	O
and	O
a	O
number	O
of	O
incomplete	O
biological	O
pathways	O
(	O
e	O
.	O
g	O
.	O
,	O
F0F1	O
ATPase	O
[	O
41	O
]	O
and	O
folate	O
biosynthesis	O
[	O
40	O
]	O
)	O
by	O
failing	O
to	O
detect	O
the	O
differential	O
expression	O
of	O
a	O
number	O
of	O
known	O
gene	O
pathway	O
members	O
(	O
Table	O
1	O
)	O
.	O

To	O
overcome	O
these	O
limitations	O
and	O
to	O
extract	O
more	O
functional	O
information	O
from	O
the	O
array	O
dataset	O
(	O
including	O
more	O
complete	O
biological	O
pathways	O
)	O
,	O
we	O
developed	O
the	O
neighbor	O
clustering	O
algorithms	O
to	O
combine	O
the	O
physical	O
position	O
of	O
genes	O
on	O
the	O
streptococcal	O
chromosome	O
with	O
gene	O
expression	O
data	O
.	O

Neighbor	O
clustering	O
was	O
designed	O
to	O
identify	O
expanded	O
groupings	O
of	O
potentially	O
related	O
genes	O
from	O
our	O
array	O
data	O
by	O
incorporating	O
two	O
reliable	O
predictors	O
of	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
,	O
namely	O
physical	O
proximity	O
and	O
similar	O
expression	O
profiles	O
[	O
5	O
,	O
6	O
]	O
.	O

We	O
implemented	O
this	O
approach	O
by	O
developing	O
an	O
algorithm	O
with	O
dynamic	O
windowing	O
(	O
GenomeCrawler	O
)	O
that	O
sequentially	O
stepped	O
through	O
the	O
microarray	O
data	O
and	O
identified	O
clusters	O
of	O
adjacent	O
genes	O
exhibiting	O
similar	O
fold	O
changes	O
in	O
expression	O
.	O

Because	O
the	O
genome	O
contains	O
many	O
possible	O
clusters	O
,	O
we	O
restricted	O
the	O
algorithm	O
'	O
s	O
search	O
space	O
to	O
identify	O
only	O
spatially	O
related	O
clusters	O
.	O

GenomeCrawler	O
applied	O
a	O
separate	O
permutation	O
algorithm	O
,	O
using	O
the	O
sum	O
of	O
each	O
gene	O
'	O
s	O
t	O
-	O
statistics	O
to	O
calculate	O
adjusted	O
P	O
values	O
(	O
PK	O
)	O
for	O
each	O
cluster	O
,	O
which	O
corresponded	O
to	O
the	O
probability	O
of	O
assembling	O
a	O
cluster	O
by	O
chance	O
.	O

Significance	O
was	O
assigned	O
to	O
clusters	O
with	O
PK	O
<	O
0	O
.	O
05	O
,	O
and	O
the	O
resulting	O
groupings	O
are	O
listed	O
in	O
Table	O
3	O
.	O

Because	O
individual	O
genes	O
could	O
be	O
members	O
of	O
many	O
different	O
significant	O
clusters	O
,	O
GenomeCrawler	O
then	O
applied	O
a	O
distinct	O
permutation	O
algorithm	O
to	O
calculate	O
the	O
probability	O
(	O
PC	O
)	O
that	O
a	O
gene	O
was	O
clustered	O
coincidentally	O
.	O

Calculation	O
of	O
PC	O
values	O
relies	O
on	O
Bayes	O
'	O
Theorem	O
,	O
in	O
which	O
the	O
probability	O
of	O
a	O
gene	O
'	O
s	O
log2	O
-	O
fold	O
change	O
(	O
PF	O
value	O
)	O
is	O
combined	O
with	O
the	O
cluster	O
probability	O
itself	O
(	O
PK	O
value	O
)	O
.	O

We	O
stress	O
that	O
PC	O
reflects	O
the	O
significance	O
of	O
a	O
gene	O
based	O
on	O
its	O
cluster	O
context	O
rather	O
than	O
a	O
recapitulation	O
of	O
PF	O
.	O

This	O
ensures	O
a	O
strong	O
dependency	O
between	O
PF	O
and	O
PC	O
,	O
preventing	O
a	O
gene	O
with	O
a	O
relatively	O
low	O
log2	O
-	O
fold	O
change	O
from	O
being	O
scored	O
as	O
significant	O
simply	O
because	O
it	O
is	O
clustered	O
with	O
a	O
gene	O
with	O
a	O
highly	O
significant	O
PF	O
value	O
.	O

Finally	O
,	O
GenomeCrawler	O
calculated	O
the	O
overall	O
significance	O
of	O
differentially	O
expressed	O
genes	O
(	O
PE	O
values	O
)	O
by	O
integrating	O
differential	O
expression	O
probabilities	O
(	O
PF	O
)	O
and	O
cluster	O
context	O
probabilities	O
(	O
PC	O
)	O
.	O

We	O
developed	O
a	O
plotting	O
application	O
(	O
GenomeSpyer	O
)	O
that	O
represents	O
the	O
chromosome	O
as	O
a	O
linear	O
molecule	O
to	O
visualize	O
GenomeCrawler	O
output	O
,	O
with	O
genes	O
displayed	O
on	O
the	O
x	O
-	O
axis	O
and	O
their	O
log2	O
-	O
fold	O
change	O
magnitudes	O
on	O
the	O
y	O
-	O
axis	O
.	O

Applications	O
and	O
all	O
datasets	O
are	O
available	O
for	O
download	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
rockefeller	O
.	O
edu	O
/	O
vaf	O
/	O
streparray	O
.	O
php	O
.	O

We	O
visually	O
inspected	O
the	O
resulting	O
clusters	O
and	O
disqualified	O
those	O
that	O
violated	O
our	O
neighbor	O
cluster	O
definition	O
(	O
see	O
Methods	O
for	O
details	O
)	O
.	O

All	O
output	O
prior	O
to	O
cluster	O
disqualifications	O
is	O
included	O
for	O
comparison	O
(	O
see	O
Table	O
S4	O
)	O
.	O

Of	O
the	O
309	O
qualifying	O
clusters	O
(	O
Table	O
S5	O
)	O
,	O
197	O
(	O
63	O
.	O
8	O
%	O
)	O
were	O
composed	O
entirely	O
of	O
known	O
,	O
functionally	O
defined	O
genes	O
;	O
however	O
,	O
26	O
(	O
13	O
%	O
)	O
of	O
these	O
were	O
incorrectly	O
assembled	O
,	O
as	O
they	O
contained	O
known	O
genes	O
that	O
are	O
functionally	O
unrelated	O
.	O

Because	O
we	O
did	O
not	O
incorporate	O
functional	O
annotations	O
of	O
genes	O
into	O
the	O
algorithms	O
(	O
i	O
.	O
e	O
.	O
,	O
to	O
keep	O
the	O
analysis	O
"	O
blind	O
"	O
)	O
,	O
we	O
anticipated	O
the	O
possibility	O
that	O
some	O
groupings	O
could	O
be	O
assembled	O
incorrectly	O
despite	O
the	O
statistical	O
framework	O
for	O
assigning	O
clusters	O
.	O

Of	O
the	O
remaining	O
283	O
(	O
91	O
.	O
6	O
%	O
)	O
groupings	O
,	O
a	O
number	O
of	O
differently	O
sized	O
clusters	O
contained	O
the	O
same	O
gene	O
(	O
Table	O
S5	O
)	O
.	O

We	O
report	O
such	O
clusters	O
first	O
by	O
highest	O
significance	O
(	O
lowest	O
PK	O
value	O
)	O
,	O
then	O
by	O
largest	O
number	O
of	O
genes	O
.	O

Thus	O
,	O
if	O
clusters	O
containing	O
a	O
particular	O
gene	O
were	O
of	O
equal	O
significance	O
,	O
we	O
report	O
the	O
cluster	O
with	O
the	O
most	O
gene	O
members	O
.	O

This	O
method	O
identified	O
47	O
significant	O
clusters	O
containing	O
173	O
differentially	O
expressed	O
genes	O
(	O
listed	O
in	O
Table	O
3	O
and	O
visualized	O
in	O
Figures	O
2	O
and	O
S2	O
-	O
S4	O
)	O
,	O
a	O
considerably	O
larger	O
group	O
than	O
could	O
have	O
been	O
compiled	O
using	O
only	O
the	O
initial	O
79	O
significant	O
genes	O
.	O

A	O
total	O
of	O
56	O
of	O
the	O
original	O
79	O
significant	O
genes	O
became	O
components	O
of	O
significant	O
clusters	O
,	O
whereas	O
23	O
remained	O
unclustered	O
.	O

We	O
subdivided	O
all	O
clusters	O
into	O
three	O
qualitative	O
types	O
based	O
on	O
the	O
functional	O
annotation	O
of	O
gene	O
members	O
.	O

We	O
present	O
examples	O
of	O
Type	O
I	O
and	O
II	O
clusters	O
:	O
Type	O
I	O
clusters	O
(	O
n	O
=	O
25	O
)	O
contained	O
only	O
functionally	O
defined	O
and	O
functionally	O
related	O
genes	O
(	O
as	O
reported	O
in	O
published	O
studies	O
)	O
,	O
such	O
as	O
biological	O
pathways	O
components	O
(	O
Figures	O
2B	O
and	O
S2	O
)	O
;	O
Type	O
II	O
clusters	O
(	O
n	O
=	O
20	O
)	O
included	O
both	O
known	O
and	O
unknown	O
genes	O
(	O
Figures	O
2C	O
and	O
S3	O
)	O
.	O

Type	O
III	O
clusters	O
(	O
n	O
=	O
2	O
)	O
were	O
composed	O
entirely	O
of	O
unknown	O
genes	O
(	O
Figures	O
2D	O
and	O
S4	O
)	O
,	O
and	O
are	O
not	O
discussed	O
in	O
detail	O
.	O

Type	O
I	O
Clusters	O
:	O
Intact	O
Metabolic	O
Pathways	O
and	O
Multimeric	O
Proteins	O

We	O
measured	O
the	O
performance	O
of	O
our	O
algorithm	O
by	O
examining	O
whether	O
it	O
identified	O
gene	O
groupings	O
known	O
to	O
be	O
functionally	O
related	O
(	O
Type	O
I	O
clusters	O
)	O
.	O

Only	O
four	O
(	O
16	O
%	O
)	O
of	O
25	O
Type	O
I	O
clusters	O
(	O
spy0080	B-Protein
-	O
0081	B-Protein
,	O
spy1236	B-Protein
-	O
1237	B-Protein
,	O
spy1707	B-Protein
-	O
1711	B-Protein
,	O
spy2041	B-Protein
-	O
2042	B-Protein
)	O
could	O
have	O
been	O
identified	O
in	O
entirety	O
by	O
significance	O
analysis	O
because	O
all	O
clustered	O
genes	O
exhibited	O
significant	O
differential	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
.	O

A	O
total	O
of	O
11	O
(	O
52	O
.	O
4	O
%	O
)	O
of	O
the	O
remaining	O
21	O
clusters	O
would	O
not	O
have	O
been	O
identified	O
in	O
their	O
entirety	O
without	O
GenomeCrawler	O
because	O
we	O
initially	O
identified	O
significant	O
fold	O
-	O
changes	O
in	O
only	O
a	O
subset	O
of	O
genes	O
necessary	O
to	O
encode	O
particular	O
pathways	O
or	O
loci	O
;	O
this	O
is	O
intuitively	O
unreasonable	O
if	O
all	O
genes	O
are	O
essential	O
for	O
functionality	O
.	O
<EOS>	B-X
This	B-X
is	B-X
an	B-X
indicator	B-X
of	B-X
speciation	B-X
involved	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
new	B-X
species	B-X
or	B-X
subspecies	B-X
,	B-X
and	B-X
it	B-X
significantly	B-X
hampers	B-X
the	B-X
utilization	B-X
of	B-X
favorable	B-X
genes	B-X
from	B-X
distant	B-X
parents	B-X
for	B-X
rice	B-X
improvement	B-X
.	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
silencing	B-X
has	B-X
recently	B-X
been	B-X
found	B-X
at	B-X
previously	B-X
unidentified	B-X
loci	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
silent	B-X
mating-type	B-X
loci	B-X
and	B-X
telomeres	B-X
,	B-X
genes	B-X
within	B-X
the	B-X
ribosomal	B-X
DNA	B-X
and	B-X
,	B-X
perhaps	B-X
,	B-X
at	B-X
undefined	B-X
aging	B-X
loci	B-X
are	B-X
silenced	B-X
.	B-X
Efficiency	B-X
of	B-X
silencing	B-X
at	B-X
different	B-X
loci	B-X
varies	B-X
and	B-X
is	B-X
affected	B-X
by	B-X
competition	B-X
between	B-X
the	B-X
loci	B-X
and	B-X
by	B-X
the	B-X
involvement	B-X
of	B-X
different	B-X
factors	B-X
in	B-X
distinct	B-X
protein	B-X
complexes	B-X
.	B-X
The	B-X
recent	B-X
discovery	B-X
of	B-X
conserved	B-X
gene	B-X
families	B-X
encoding	B-X
proteins	B-X
related	B-X
to	B-X
modulators	B-X
of	B-X
acetylation	B-X
and	B-X
deacetylation	B-X
suggests	B-X
mechanisms	B-X
for	B-X
differential	B-X
regulation	B-X
of	B-X
silencing	B-X
at	B-X
known	B-X
loci	B-X
and	B-X
the	B-X
existence	B-X
of	B-X
additional	B-X
,	B-X
as	B-X
yet	B-X
undiscovered	B-X
,	B-X
silenced	B-X
loci	B-X
.	B-X

GenomeCrawler	O
expanded	O
these	O
clusters	O
to	O
contain	O
more	O
genes	O
that	O
encode	O
intact	O
loci	O
(	O
Table	O
3	O
)	O
.	O

For	O
example	O
,	O
we	O
initially	O
identified	O
(	O
Table	O
1	O
)	O
the	O
significant	O
upregulation	O
of	O
three	O
of	O
the	O
five	O
known	O
gene	O
members	O
of	O
the	O
folate	O
biosynthetic	O
pathway	O
[	O
40	O
]	O
(	O
spy1096	B-Protein
-	O
1100	B-Protein
)	O
,	O
but	O
GenomeCrawler	O
identified	O
a	O
significant	O
cluster	O
containing	O
all	O
five	O
genes	O
(	O
Table	O
3	O
and	O
Figure	O
2B	O
)	O
.	O

We	O
obtained	O
a	O
similar	O
result	O
for	O
the	O
eight	O
-	O
gene	O
operon	O
encoding	O
the	O
F0F1	O
-	O
type	O
proton	O
translocating	O
ATPase	O
[	O
41	O
]	O
(	O
spy0754	B-Protein
-	O
0761	B-Protein
)	O
.	O

The	O
initial	O
significance	O
analysis	O
identified	O
only	O
four	O
atp	O
genes	O
(	O
Table	O
1	O
)	O
,	O
but	O
neighbor	O
clustering	O
identified	O
a	O
significant	O
cluster	O
containing	O
all	O
eight	O
genes	O
necessary	O
to	O
encode	O
a	O
functional	O
ATPase	O
(	O
Table	O
3	O
)	O
.	O

Each	O
of	O
the	O
11	O
neighbor	O
clusters	O
that	O
could	O
have	O
been	O
only	O
partially	O
identified	O
by	O
our	O
initial	O
analysis	O
alone	O
gained	O
gene	O
members	O
after	O
application	O
of	O
the	O
algorithms	O
and	O
became	O
more	O
complete	O
sets	O
of	O
functionally	O
related	O
genes	O
than	O
initially	O
identified	O
(	O
Table	O
3	O
)	O
.	O

These	O
clusters	O
encompass	O
various	O
metabolic	O
processes	O
,	O
including	O
purine	O
biosynthesis	O
(	O
spy0025	B-Protein
-	O
0028	B-Protein
)	O
,	O
lactose	O
metabolism	O
(	O
spy1916	B-Protein
-	O
1923	B-Protein
)	O
,	O
fatty	O
acid	O
biosynthesis	O
(	O
spy1743	B-Protein
-	O
1747	B-Protein
)	O
,	O
lipoteichoic	O
acid	O
synthesis	O
(	O
spy1308	B-Protein
-	O
1312	B-Protein
)	O
,	O
and	O
sugar	O
phosphotransferase	O
transport	O
(	O
spy1058	B-Protein
-	O
1060	B-Protein
)	O
[	O
14	O
]	O
,	O
suggesting	O
that	O
specific	O
changes	O
occur	O
in	O
the	O
streptococcal	O
metabolic	O
program	O
as	O
the	O
bacteria	O
adhere	O
to	O
human	O
pharyngeal	O
cells	O
in	O
vitro	O
.	O

Notably	O
,	O
the	O
remaining	O
ten	O
Type	O
I	O
clusters	O
were	O
composed	O
entirely	O
of	O
genes	O
that	O
individually	O
were	O
not	O
significant	O
;	O
however	O
,	O
after	O
applying	O
our	O
algorithms	O
,	O
the	O
combined	O
contribution	O
of	O
each	O
gene	O
resulted	O
in	O
a	O
significant	O
cluster	O
.	O

For	O
example	O
,	O
the	O
nine	O
-	O
gene	O
operon	O
that	O
spans	O
genes	O
spy0738	B-Protein
-	O
0746	B-Protein
encodes	O
streptolysin	B-Protein
S	I-Protein
,	O
a	O
potent	O
cytolytic	O
toxin	O
that	O
promotes	O
internalization	O
and	O
host	O
tissue	O
dissemination	O
[	O
25	O
,	O
44	O
]	O
.	O

Though	O
the	O
differential	O
expression	O
of	O
the	O
individual	O
genes	O
was	O
not	O
significant	O
following	O
our	O
initial	O
statistical	O
analysis	O
,	O
GenomeCrawler	O
identified	O
a	O
significant	O
downregulated	O
cluster	O
containing	O
all	O
nine	O
genes	O
(	O
Table	O
3	O
)	O
.	O
<EOS>	B-X
In	B-X
2013	B-X
,	B-X
a	B-X
precursor	B-X
study	B-X
in	B-X
humans	B-X
was	B-X
published	B-X
in	B-X
the	B-X
European	B-X
Journal	B-X
of	B-X
Translation	B-X
Myology	B-X
(	B-X
formerly	B-X
known	B-X
as	B-X
Basic	B-X
and	B-X
Applied	B-X
Myology	B-X
)	B-X
,	B-X
highlighting	B-X
the	B-X
occurrence	B-X
of	B-X
reinnervation	B-X
in	B-X
the	B-X
musculature	B-X
of	B-X
aged	B-X
,	B-X
exercise-trained	B-X
individuals	B-X
as	B-X
compared	B-X
to	B-X
the	B-X
matching	B-X
control	B-X
.	B-X
This	B-X
paper	B-X
,	B-X
entitled	B-X
«	B-X
Reinnervation	B-X
of	B-X
Vastus	B-X
lateralis	B-X
is	B-X
increased	B-X
significantly	B-X
in	B-X
seniors	B-X
(	B-X
70-years	B-X
old	B-X
)	B-X
with	B-X
a	B-X
lifelong	B-X
history	B-X
of	B-X
high-level	B-X
exercise	B-X
»	B-X
,	B-X
is	B-X
now	B-X
being	B-X
reprinted	B-X
for	B-X
the	B-X
second	B-X
issue	B-X
of	B-X
the	B-X
«	B-X
Ejtm	B-X
Seminal	B-X
Paper	B-X
Series	B-X
»	B-X
.	B-X
Implantation	B-X
is	B-X
a	B-X
milestone	B-X
event	B-X
during	B-X
mammalian	B-X
embryogenesis	B-X
.	B-X
DNA	B-X
microarrays	B-X
are	B-X
widely	B-X
used	B-X
to	B-X
investigate	B-X
gene	B-X
expression	B-X
.	B-X
Even	B-X
though	B-X
the	B-X
classical	B-X
analysis	B-X
of	B-X
microarray	B-X
data	B-X
is	B-X
based	B-X
on	B-X
the	B-X
study	B-X
of	B-X
differentially	B-X
expressed	B-X
genes	B-X
,	B-X
it	B-X
is	B-X
well	B-X
known	B-X
that	B-X
genes	B-X
do	B-X
not	B-X
act	B-X
individually	B-X
.	B-X
Network	B-X
analysis	B-X
can	B-X
be	B-X
applied	B-X
to	B-X
study	B-X
association	B-X
patterns	B-X
of	B-X
the	B-X
genes	B-X
in	B-X
a	B-X
biological	B-X
system	B-X
.	B-X
Moreover	B-X
,	B-X
it	B-X
finds	B-X
wide	B-X
application	B-X
in	B-X
differential	B-X
coexpression	B-X
analysis	B-X
between	B-X
different	B-X
systems	B-X
.	B-X
Network	B-X
based	B-X
coexpression	B-X
studies	B-X
have	B-X
for	B-X
example	B-X
been	B-X
used	B-X
in	B-X
(	B-X
complex	B-X
)	B-X
disease	B-X
gene	B-X
prioritization	B-X
,	B-X
disease	B-X
subtyping	B-X
,	B-X
and	B-X
patient	B-X
stratification.In	B-X
this	B-X
chapter	B-X
we	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
the	B-X
methods	B-X
and	B-X
tools	B-X
used	B-X
to	B-X
create	B-X
networks	B-X
from	B-X
microarray	B-X
data	B-X
and	B-X
describe	B-X
multiple	B-X
methods	B-X
on	B-X
how	B-X
to	B-X
analyze	B-X
a	B-X
single	B-X
network	B-X
or	B-X
a	B-X
group	B-X
of	B-X
networks	B-X
.	B-X
The	B-X
described	B-X
methods	B-X
range	B-X
from	B-X
topological	B-X
metrics	B-X
,	B-X
functional	B-X
group	B-X
identification	B-X
to	B-X
data	B-X
integration	B-X
strategies	B-X
,	B-X
topological	B-X
pathway	B-X
analysis	B-X
as	B-X
well	B-X
as	B-X
graphical	B-X
models	B-X
.	B-X

Adherence	O
-	O
induced	O
downregulation	O
of	O
streptolysin	B-Protein
S	I-Protein
is	O
consistent	O
with	O
its	O
previously	O
determined	O
role	O
in	O
host	O
cell	O
internalization	O
[	O
25	O
]	O
;	O
however	O
,	O
without	O
neighbor	O
clustering	O
,	O
expression	O
of	O
this	O
operon	O
was	O
not	O
evident	O
immediately	O
.	O

Although	O
individual	O
gene	O
members	O
of	O
Type	O
I	O
clusters	O
may	O
not	O
be	O
statistically	O
significant	O
as	O
a	O
result	O
of	O
technical	O
variability	O
within	O
experiments	O
[	O
17	O
]	O
,	O
the	O
genetic	O
structure	O
of	O
certain	O
Type	O
I	O
operons	O
may	O
provide	O
an	O
alternative	O
explanation	O
.	O
<EOS>	B-X
We	B-X
performed	B-X
a	B-X
genome-wide	B-X
association	B-X
study	B-X
of	B-X
41,917	B-X
bipolar	B-X
disorder	B-X
cases	B-X
and	B-X
371,549	B-X
controls	B-X
of	B-X
European	B-X
ancestry	B-X
,	B-X
which	B-X
identified	B-X
64	B-X
associated	B-X
genomic	B-X
loci	B-X
.	B-X
Bipolar	B-X
disorder	B-X
risk	B-X
alleles	B-X
were	B-X
enriched	B-X
in	B-X
genes	B-X
in	B-X
synaptic	B-X
signaling	B-X
pathways	B-X
and	B-X
brain-expressed	B-X
genes	B-X
,	B-X
particularly	B-X
those	B-X
with	B-X
high	B-X
specificity	B-X
of	B-X
expression	B-X
in	B-X
neurons	B-X
of	B-X
the	B-X
prefrontal	B-X
cortex	B-X
and	B-X
hippocampus	B-X
.	B-X
Significant	B-X
signal	B-X
enrichment	B-X
was	B-X
found	B-X
in	B-X
genes	B-X
encoding	B-X
targets	B-X
of	B-X
antipsychotics	B-X
,	B-X
calcium	B-X
channel	B-X
blockers	B-X
,	B-X
antiepileptics	B-X
and	B-X
anesthetics	B-X
.	B-X
Integrating	B-X
expression	B-X
quantitative	B-X
trait	B-X
locus	B-X
data	B-X
implicated	B-X
15	B-X
genes	B-X
robustly	B-X
linked	B-X
to	B-X
bipolar	B-X
disorder	B-X
via	B-X
gene	B-X
expression	B-X
,	B-X
encoding	B-X
druggable	B-X
targets	B-X
such	B-X
as	B-X
HTR6	B-X
,	B-X
MCHR1	B-X
,	B-X
DCLK3	B-X
and	B-X
FURIN	B-X
.	B-X
Analyses	B-X
of	B-X
bipolar	B-X
disorder	B-X
subtypes	B-X
indicated	B-X
high	B-X
but	B-X
imperfect	B-X
genetic	B-X
correlation	B-X
between	B-X
bipolar	B-X
disorder	B-X
type	B-X
I	B-X
and	B-X
II	B-X
and	B-X
identified	B-X
additional	B-X
associated	B-X
loci	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
advance	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
biological	B-X
etiology	B-X
of	B-X
bipolar	B-X
disorder	B-X
,	B-X
identify	B-X
novel	B-X
therapeutic	B-X
leads	B-X
and	B-X
prioritize	B-X
genes	B-X
for	B-X
functional	B-X
follow-up	B-X
studies	B-X
.	B-X

For	O
example	O
,	O
the	O
streptolysin	O
operon	O
encodes	O
an	O
internal	O
terminator	O
downstream	O
of	O
the	O
sagA	B-Protein
gene	O
(	O
the	O
first	O
gene	O
in	O
the	O
operon	O
)	O
,	O
which	O
modulates	O
the	O
abundance	O
of	O
particular	O
mRNA	O
species	O
(	O
e	O
.	O
g	O
.	O
,	O
sagA	B-Protein
mRNA	O
versus	O
the	O
polycistronic	O
message	O
for	O
all	O
nine	O
genes	O
)	O
under	O
different	O
environmental	O
conditions	O
[	O
45	O
]	O
.	O

If	O
transcription	O
is	O
internally	O
disrupted	O
by	O
such	O
a	O
terminator	O
,	O
the	O
abundance	O
of	O
the	O
sagA	B-Protein
transcript	O
may	O
be	O
much	O
greater	O
than	O
the	O
polycistronic	O
message	O
;	O
such	O
disproportionate	O
transcript	O
levels	O
would	O
affect	O
log2	O
-	O
fold	O
change	O
values	O
and	O
impact	O
the	O
statistical	O
significance	O
of	O
individual	O
genes	O
within	O
these	O
types	O
of	O
clusters	O
.	O

Thus	O
,	O
in	O
addition	O
to	O
helping	O
resolve	O
clusters	O
that	O
would	O
not	O
be	O
easily	O
recognized	O
because	O
of	O
experimental	O
technical	O
variability	O
,	O
the	O
neighbor	O
clustering	O
method	O
may	O
help	O
to	O
resolve	O
operons	O
with	O
such	O
internal	O
terminators	O
and	O
regulators	O
.	O
<EOS>	B-X
Automatic	B-X
detection	B-X
of	B-X
electrocardiogram	B-X
(	B-X
ECG	B-X
)	B-X
abnormalities	B-X
helps	B-X
clinicians	B-X
analyze	B-X
the	B-X
large	B-X
amount	B-X
of	B-X
data	B-X
produced	B-X
daily	B-X
by	B-X
cardiac	B-X
monitors	B-X
.	B-X
As	B-X
thenumber	B-X
of	B-X
abnormal	B-X
ECG	B-X
samples	B-X
with	B-X
cardiologist-supplied	B-X
labels	B-X
required	B-X
to	B-X
train	B-X
supervised	B-X
machine	B-X
learning	B-X
models	B-X
is	B-X
limited	B-X
,	B-X
there	B-X
is	B-X
a	B-X
growing	B-X
need	B-X
for	B-X
unsupervised	B-X
learning	B-X
methods	B-X
for	B-X
ECG	B-X
analysis	B-X
.	B-X
Unsupervised	B-X
learning	B-X
aims	B-X
to	B-X
partition	B-X
ECG	B-X
samples	B-X
into	B-X
distinct	B-X
abnormality	B-X
classes	B-X
without	B-X
cardiologist-supplied	B-X
labels-a	B-X
process	B-X
referred	B-X
to	B-X
as	B-X
ECG	B-X
clustering	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
abnormality	B-X
detection	B-X
,	B-X
ECG	B-X
clustering	B-X
has	B-X
recently	B-X
discovered	B-X
inter	B-X
and	B-X
intra-individual	B-X
patterns	B-X
that	B-X
reveal	B-X
valuable	B-X
information	B-X
about	B-X
the	B-X
whole	B-X
body	B-X
and	B-X
mind	B-X
,	B-X
such	B-X
as	B-X
emotions	B-X
,	B-X
mental	B-X
disorders	B-X
,	B-X
and	B-X
metabolic	B-X
levels	B-X
.	B-X
ECG	B-X
clustering	B-X
can	B-X
also	B-X
resolve	B-X
specific	B-X
challenges	B-X
facing	B-X
supervised	B-X
learning	B-X
systems	B-X
,	B-X
such	B-X
as	B-X
the	B-X
imbalanced	B-X
data	B-X
problem	B-X
,	B-X
and	B-X
can	B-X
enhance	B-X
biometric	B-X
systems	B-X
.	B-X
This	B-X
study	B-X
reviews	B-X
ECG	B-X
clustering	B-X
techniques	B-X
developed	B-X
mainly	B-X
in	B-X
the	B-X
last	B-X
decade	B-X
.	B-X
This	B-X
review	B-X
provides	B-X
further	B-X
insights	B-X
into	B-X
ECG	B-X
clustering	B-X
and	B-X
presents	B-X
the	B-X
necessary	B-X
information	B-X
required	B-X
to	B-X
adopt	B-X
the	B-X
appropriate	B-X
algorithm	B-X
for	B-X
a	B-X
specific	B-X
application	B-X
.	B-X

These	O
results	O
demonstrate	O
that	O
neighbor	O
clustering	O
effectively	O
reconstructed	O
a	O
number	O
of	O
complete	O
pathways	O
and	O
loci	O
from	O
processed	O
array	O
data	O
.	O

Importantly	O
,	O
because	O
functional	O
gene	O
data	O
are	O
not	O
incorporated	O
into	O
its	O
algorithms	O
,	O
GenomeCrawler	O
is	O
not	O
biased	O
toward	O
identifying	O
"	O
expected	O
"	O
clusters	O
.	O
<EOS>	B-X
First	B-X
,	B-X
diseases	B-X
are	B-X
clustered	B-X
by	B-X
gene	B-X
expression	B-X
on	B-X
the	B-X
premise	B-X
that	B-X
similar	B-X
patterns	B-X
of	B-X
altered	B-X
gene	B-X
expression	B-X
imply	B-X
critical	B-X
pathways	B-X
shared	B-X
in	B-X
different	B-X
disease	B-X
conditions	B-X
.	B-X
Next	B-X
,	B-X
drug	B-X
efficacy	B-X
is	B-X
assessed	B-X
by	B-X
the	B-X
reversibility	B-X
of	B-X
abnormal	B-X
gene	B-X
expression	B-X
,	B-X
and	B-X
results	B-X
are	B-X
clustered	B-X
to	B-X
identify	B-X
repurposing	B-X
targets	B-X
.	B-X
To	B-X
cluster	B-X
similar	B-X
diseases	B-X
,	B-X
gene	B-X
expression	B-X
data	B-X
from	B-X
262	B-X
cases	B-X
of	B-X
31	B-X
diseases	B-X
and	B-X
268	B-X
controls	B-X
were	B-X
analyzed	B-X
by	B-X
Uniform	B-X
Manifold	B-X
Approximation	B-X
and	B-X
Projection	B-X
for	B-X
Dimension	B-X
Reduction	B-X
followed	B-X
by	B-X
Rapid	B-X
modifications	B-X
of	B-X
exposed	B-X
carbohydrate	B-X
moieties	B-X
by	B-X
glycosidases	B-X
and	B-X
glycosyltransferases	B-X
,	B-X
and	B-X
the	B-X
equally	B-X
dynamic	B-X
patterns	B-X
of	B-X
expression	B-X
of	B-X
their	B-X
receptors	B-X
during	B-X
early	B-X
development	B-X
,	B-X
suggest	B-X
that	B-X
both	B-X
play	B-X
important	B-X
roles	B-X
during	B-X
embryogenesis	B-X
.	B-X
Among	B-X
a	B-X
variety	B-X
of	B-X
biological	B-X
roles	B-X
,	B-X
galectins	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
mediate	B-X
developmental	B-X
processes	B-X
,	B-X
such	B-X
as	B-X
embryo	B-X
implantation	B-X
and	B-X
myogenesis	B-X
.	B-X
However	B-X
,	B-X
the	B-X
high	B-X
functional	B-X
``	B-X
redundancy	B-X
''	B-X
of	B-X
the	B-X
galectin	B-X
repertoire	B-X
in	B-X
mammals	B-X
has	B-X
hindered	B-X
the	B-X
rigorous	B-X
characterization	B-X
of	B-X
their	B-X
specific	B-X
roles	B-X
by	B-X
gene	B-X
knockout	B-X
approaches	B-X
in	B-X
murine	B-X
models	B-X
.	B-X
In	B-X
recent	B-X
years	B-X
,	B-X
the	B-X
use	B-X
of	B-X
teleost	B-X
fish	B-X
as	B-X
alternative	B-X
models	B-X
for	B-X
addressing	B-X
developmental	B-X
questions	B-X
in	B-X
mammals	B-X
has	B-X
expanded	B-X
dramatically	B-X
,	B-X
and	B-X
we	B-X
propose	B-X
their	B-X
use	B-X
for	B-X
the	B-X
elucidation	B-X
of	B-X
biological	B-X
roles	B-X
of	B-X
galectins	B-X
in	B-X
embryogenesis	B-X
and	B-X
innate	B-X
immunity	B-X
.	B-X
All	B-X
three	B-X
major	B-X
galectin	B-X
types	B-X
,	B-X
proto	B-X
,	B-X
chimera	B-X
,	B-X
and	B-X
tandem-repeat	B-X
,	B-X
are	B-X
present	B-X
in	B-X
teleost	B-X
fish	B-X
,	B-X
and	B-X
phylogenetic	B-X
topologies	B-X
confirm	B-X
the	B-X
expected	B-X
clustering	B-X
with	B-X
their	B-X
mammalian	B-X
orthologues	B-X
.	B-X
As	B-X
a	B-X
model	B-X
organism	B-X
,	B-X
the	B-X
zebrafish	B-X
(	B-X
Danio	B-X
rerio	B-X
)	B-X
may	B-X
help	B-X
to	B-X
overcome	B-X
limitations	B-X
imposed	B-X
by	B-X
the	B-X
murine	B-X
models	B-X
because	B-X
it	B-X
offers	B-X
substantial	B-X
advantages	B-X
:	B-X
external	B-X
fertilization	B-X
,	B-X
transparent	B-X
embryos	B-X
that	B-X
develop	B-X
rapidly	B-X
in	B-X
vitro	B-X
,	B-X
a	B-X
diverse	B-X
toolbox	B-X
of	B-X
established	B-X
methods	B-X
to	B-X
manipulate	B-X
early	B-X
gene	B-X
expression	B-X
,	B-X
a	B-X
growing	B-X
collection	B-X
of	B-X
mutations	B-X
that	B-X
affect	B-X
early	B-X
embryonic	B-X
development	B-X
,	B-X
availability	B-X
of	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
most	B-X
importantly	B-X
,	B-X
an	B-X
apparently	B-X
less	B-X
diversified	B-X
galectin	B-X
repertoire	B-X
.	B-X

Curating	O
the	O
dataset	O
following	O
its	O
application	O
may	O
make	O
the	O
algorithms	O
less	O
user	O
-	O
friendly	O
;	O
however	O
,	O
the	O
elimination	O
of	O
such	O
bias	O
is	O
essential	O
for	O
this	O
type	O
of	O
analysis	O
.	O

Type	O
II	O
Clusters	O
<EOS>	B-X
Highly	B-X
specific	B-X
multi-CUT	B-X
&	B-X
Tag	B-X
maps	B-X
of	B-X
histone	B-X
marks	B-X
and	B-X
RNA	B-X
Polymerase	B-X
II	B-X
uncovered	B-X
sites	B-X
of	B-X
co-localization	B-X
in	B-X
the	B-X
same	B-X
cells	B-X
,	B-X
active	B-X
and	B-X
repressed	B-X
genes	B-X
,	B-X
and	B-X
candidate	B-X
cis-regulatory	B-X
elements	B-X
.	B-X
A	B-X
method	B-X
for	B-X
predicting	B-X
type	B-X
I	B-X
and	B-X
II	B-X
β-turns	B-X
using	B-X
nuclear	B-X
magnetic	B-X
resonance	B-X
(	B-X
NMR	B-X
)	B-X
chemical	B-X
shifts	B-X
is	B-X
proposed	B-X
.	B-X
One-dimensional	B-X
statistical	B-X
analyses	B-X
on	B-X
chemical-shift	B-X
data	B-X
of	B-X
three	B-X
classes	B-X
β-turn	B-X
(	B-X
type	B-X
I	B-X
,	B-X
II	B-X
,	B-X
and	B-X
VIII	B-X
)	B-X
showed	B-X
different	B-X
distributions	B-X
at	B-X
four	B-X
positions	B-X
,	B-X
(	B-X
i	B-X
)	B-X
to	B-X
(	B-X
i	B-X
+	B-X
3	B-X
)	B-X
.	B-X
The	B-X
distributions	B-X
of	B-X
the	B-X
central	B-X
two	B-X
residues	B-X
in	B-X
type	B-X
II	B-X
and	B-X
VIII	B-X
β-turns	B-X
were	B-X
also	B-X
distinguishable	B-X
by	B-X
trends	B-X
of	B-X
chemical	B-X
shift	B-X
values	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
propensities	B-X
of	B-X
chemical	B-X
shift	B-X
classified	B-X
as	B-X
a	B-X
function	B-X
of	B-X
position	B-X
,	B-X
rules	B-X
were	B-X
derived	B-X
using	B-X
scoring	B-X
matrices	B-X
for	B-X
four	B-X
consecutive	B-X
residues	B-X
to	B-X
predict	B-X
type	B-X
I	B-X
and	B-X
II	B-X
β-turns	B-X
.	B-X
The	B-X
proposed	B-X
method	B-X
achieves	B-X
an	B-X
overall	B-X
prediction	B-X
accuracy	B-X
of	B-X
83.2	B-X
and	B-X
84.2	B-X
%	B-X
with	B-X
the	B-X
Matthews	B-X
correlation	B-X
coefficient	B-X
values	B-X
of	B-X
0.317	B-X
and	B-X
0.632	B-X
for	B-X
type	B-X
I	B-X
and	B-X
II	B-X
β-turns	B-X
,	B-X
indicating	B-X
that	B-X
its	B-X
higher	B-X
accuracy	B-X
for	B-X
type	B-X
II	B-X
turn	B-X
prediction	B-X
.	B-X

Based	O
on	O
the	O
Type	O
I	O
cluster	O
results	O
,	O
we	O
speculated	O
that	O
genes	O
contained	O
in	O
Type	O
II	O
clusters	O
might	O
be	O
related	O
by	O
function	O
or	O
regulation	O
.	O
<EOS>	B-X
There	B-X
are	B-X
a	B-X
range	B-X
of	B-X
concerns	B-X
relating	B-X
to	B-X
how	B-X
algorithms	B-X
might	B-X
be	B-X
held	B-X
to	B-X
account	B-X
in	B-X
areas	B-X
affecting	B-X
the	B-X
public	B-X
sphere	B-X
.	B-X
In	B-X
September	B-X
2012	B-X
,	B-X
the	B-X
European	B-X
Commission	B-X
published	B-X
a	B-X
proposal	B-X
for	B-X
a	B-X
new	B-X
regulation	B-X
on	B-X
MDs	B-X
which	B-X
was	B-X
amended	B-X
by	B-X
the	B-X
Parliament	B-X
in	B-X
October	B-X
2013	B-X
.	B-X
This	B-X
new	B-X
regulation	B-X
aims	B-X
to	B-X
harmonize	B-X
practices	B-X
,	B-X
increase	B-X
transparency	B-X
and	B-X
guarantee	B-X
a	B-X
high	B-X
level	B-X
of	B-X
health	B-X
protection	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
examination	B-X
was	B-X
to	B-X
review	B-X
the	B-X
evidence	B-X
regarding	B-X
practice-level	B-X
utilization	B-X
(	B-X
PLU	B-X
)	B-X
of	B-X
NP	B-X
PLU	B-X
in	B-X
comparison	B-X
to	B-X
state-level	B-X
regulations	B-X
(	B-X
SLRs	B-X
)	B-X
.	B-X

Type	O
II	O
groupings	O
contain	O
a	O
combination	O
of	O
both	O
known	O
and	O
unknown	O
gene	O
members	O
and	O
could	O
provide	O
preliminary	O
clues	O
about	O
the	O
function	O
of	O
unknown	O
genes	O
within	O
a	O
particular	O
cluster	O
by	O
associating	O
their	O
expression	O
with	O
neighboring	O
genes	O
of	O
known	O
and	O
defined	O
function	O
.	O

Alternatively	O
,	O
co	O
-	O
expression	O
of	O
genes	O
results	O
from	O
common	O
regulation	O
,	O
and	O
Type	O
II	O
associations	O
may	O
suggest	O
shared	O
regulatory	O
mechanisms	O
for	O
clustered	O
genes	O
.	O

We	O
note	O
,	O
however	O
,	O
that	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
groupings	O
are	O
assigned	O
,	O
experimental	O
evidence	O
is	O
necessary	O
to	O
confirm	O
functional	O
or	O
regulatory	O
relatedness	O
.	O
<EOS>	B-X
Since	B-X
experimentally	B-X
testing	B-X
all	B-X
possible	B-X
species-chemical	B-X
combinations	B-X
is	B-X
impossible	B-X
,	B-X
the	B-X
ecological	B-X
risk	B-X
assessment	B-X
of	B-X
chemicals	B-X
largely	B-X
depends	B-X
on	B-X
cross-species	B-X
extrapolation	B-X
approaches	B-X
.	B-X
This	B-X
review	B-X
overviews	B-X
currently	B-X
existing	B-X
cross-species	B-X
extrapolation	B-X
methodologies	B-X
,	B-X
and	B-X
discusses	B-X
i	B-X
)	B-X
how	B-X
species	B-X
sensitivity	B-X
could	B-X
be	B-X
described	B-X
,	B-X
ii	B-X
)	B-X
which	B-X
predictors	B-X
might	B-X
be	B-X
useful	B-X
for	B-X
explaining	B-X
differences	B-X
in	B-X
species	B-X
sensitivity	B-X
,	B-X
and	B-X
iii	B-X
)	B-X
which	B-X
statistical	B-X
considerations	B-X
are	B-X
important	B-X
.	B-X
Regarding	B-X
which	B-X
predictors	B-X
are	B-X
useful	B-X
for	B-X
explaining	B-X
differences	B-X
in	B-X
species	B-X
sensitivity	B-X
,	B-X
we	B-X
review	B-X
interspecies-correlation	B-X
,	B-X
relatedness-based	B-X
,	B-X
traits-based	B-X
,	B-X
and	B-X
genomic-based	B-X
extrapolation	B-X
methods	B-X
,	B-X
describing	B-X
the	B-X
amount	B-X
of	B-X
mechanistic	B-X
information	B-X
the	B-X
predictors	B-X
contain	B-X
,	B-X
the	B-X
amount	B-X
of	B-X
input	B-X
data	B-X
the	B-X
models	B-X
require	B-X
,	B-X
and	B-X
the	B-X
extent	B-X
to	B-X
which	B-X
the	B-X
different	B-X
methods	B-X
provide	B-X
protection	B-X
for	B-X
ecological	B-X
entities	B-X
.	B-X
We	B-X
develop	B-X
a	B-X
conceptual	B-X
framework	B-X
,	B-X
incorporating	B-X
the	B-X
strengths	B-X
of	B-X
each	B-X
of	B-X
the	B-X
methods	B-X
described	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
discussion	B-X
of	B-X
statistical	B-X
considerations	B-X
reveals	B-X
that	B-X
regardless	B-X
of	B-X
the	B-X
method	B-X
used	B-X
,	B-X
statistically	B-X
significant	B-X
models	B-X
can	B-X
be	B-X
found	B-X
,	B-X
although	B-X
the	B-X
usefulness	B-X
,	B-X
applicability	B-X
,	B-X
and	B-X
understanding	B-X
of	B-X
these	B-X
models	B-X
varies	B-X
considerably	B-X
.	B-X
In	B-X
general	B-X
,	B-X
this	B-X
review	B-X
specifies	B-X
the	B-X
data	B-X
requirements	B-X
of	B-X
different	B-X
cross-species	B-X
extrapolation	B-X
methods	B-X
,	B-X
aiming	B-X
to	B-X
make	B-X
regulators	B-X
and	B-X
publishers	B-X
more	B-X
aware	B-X
that	B-X
access	B-X
to	B-X
raw-	B-X
and	B-X
meta-data	B-X
needs	B-X
to	B-X
be	B-X
improved	B-X
to	B-X
make	B-X
future	B-X
cross-species	B-X
extrapolation	B-X
efforts	B-X
successful	B-X
,	B-X
enabling	B-X
their	B-X
integration	B-X
into	B-X
the	B-X
regulatory	B-X
environment	B-X
.	B-X

We	O
do	O
not	O
suggest	O
simply	O
assigning	O
either	O
based	O
on	O
cluster	O
membership	O
;	O
rather	O
,	O
cluster	O
associations	O
may	O
provide	O
some	O
preliminary	O
functional	O
or	O
regulatory	O
clues	O
for	O
gene	O
members	O
.	O

A	O
total	O
of	O
18	O
(	O
90	O
%	O
)	O
of	O
20	O
Type	O
II	O
clusters	O
(	O
Table	O
3	O
and	O
Figure	O
S3	O
)	O
may	O
not	O
have	O
been	O
identified	O
without	O
neighbor	O
clustering	O
:	O
eight	O
(	O
44	O
.	O
4	O
%	O
)	O
of	O
18	O
gained	O
additional	O
gene	O
members	O
;	O
the	O
remaining	O
ten	O
comprised	O
genes	O
that	O
demonstrated	O
significant	O
differential	O
expression	O
only	O
after	O
applying	O
GenomeCrawler	O
.	O

Only	O
two	O
clusters	O
(	O
spy0127	B-Protein
-	O
0130	B-Protein
and	O
spy1701	B-Protein
-	O
1704	B-Protein
)	O
could	O
have	O
been	O
identified	O
without	O
neighbor	O
clustering	O
;	O
however	O
,	O
a	O
number	O
of	O
these	O
genes	O
were	O
initially	O
annotated	O
as	O
hypothetical	O
proteins	O
,	O
so	O
a	O
potential	O
relationship	O
between	O
the	O
gene	O
members	O
may	O
not	O
have	O
been	O
readily	O
apparent	O
.	O

The	O
upregulated	O
spy0127	B-Protein
-	O
0130	B-Protein
cluster	O
is	O
part	O
of	O
a	O
larger	O
genomic	O
region	O
known	O
as	O
FCT	O
(	O
for	O
fibronectin	O
-	O
and	O
collagen	O
-	O
binding	O
proteins	O
and	O
T	O
antigen	O
-	O
encoding	O
loci	O
)	O
,	O
which	O
spans	O
spy0123	B-Protein
-	O
0136	B-Protein
in	O
the	O
SF370	O
genome	O
and	O
encodes	O
surface	O
proteins	O
and	O
transcriptional	O
regulators	O
[	O
46	O
]	O
.	O

A	O
search	O
of	O
both	O
the	O
PFAM	O
database	O
[	O
47	O
]	O
(	O
http	O
:	O
/	O
/	O
pfam	O
.	O
wustl	O
.	O
edu	O
)	O
and	O
sortase	O
database	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
doe	O
-	O
mbi	O
.	O
ucla	O
.	O
edu	O
/	O
Services	O
/	O
Sortase	O
)	O
predicted	O
that	O
spy0129	B-Protein
encodes	O
a	O
sortase	O
enzyme	O
,	O
which	O
are	O
transpeptidases	O
that	O
cleave	O
protein	O
substrates	O
at	O
conserved	O
C	O
-	O
terminal	O
motifs	O
(	O
often	O
LPXTG	O
)	O
and	O
then	O
anchor	O
these	O
proteins	O
to	O
the	O
bacterial	O
cell	O
wall	O
[	O
48	O
,	O
49	O
]	O
.	O

Recently	O
,	O
it	O
was	O
reported	O
that	O
the	O
four	O
genes	O
spanning	O
spy0127	B-Protein
-	O
0130	B-Protein
encode	O
,	O
and	O
are	O
responsible	O
for	O
,	O
the	O
formation	O
of	O
surface	O
-	O
localized	O
,	O
trypsin	O
-	O
resistant	O
pili	O
that	O
induce	O
protective	O
immunity	O
against	O
a	O
lethal	O
dose	O
of	O
group	O
A	O
streptococci	O
in	O
a	O
mouse	O
model	O
of	O
infection	O
[	O
36	O
]	O
.	O

This	O
same	O
report	O
provided	O
the	O
first	O
experimental	O
evidence	O
supporting	O
the	O
sortase	B-Protein
prediction	O
,	O
indicating	O
that	O
the	O
gene	O
product	O
of	O
spy0129	B-Protein
is	O
responsible	O
for	O
the	O
cell	O
-	O
wall	O
sorting	O
of	O
the	O
proteins	O
encoded	O
by	O
both	O
spy0128	B-Protein
(	O
annotated	O
as	O
a	O
Cpa	B-Protein
homolog	O
[	O
50	O
]	O
)	O
and	O
spy0130	B-Protein
(	O
annotated	O
as	O
a	O
protein	B-Protein
F	I-Protein
homolog	O
[	O
14	O
]	O
)	O
.	O

Furthermore	O
,	O
the	O
spy0128	B-Protein
-	O
encoded	O
protein	O
is	O
the	O
structural	O
backbone	O
of	O
the	O
pili	O
,	O
and	O
the	O
gene	B-Protein
product	I-Protein
of	O
spy0130	B-Protein
may	O
be	O
involved	O
in	O
stabilizing	O
the	O
structure	O
[	O
36	O
]	O
.	O

Together	O
with	O
the	O
identification	O
of	O
this	O
cluster	O
by	O
GenomeCrawler	O
,	O
these	O
results	O
prompted	O
us	O
to	O
study	O
this	O
cluster	O
and	O
the	O
contributions	O
of	O
the	O
gene	O
products	O
to	O
pharyngeal	O
cell	O
adherence	O
.	O

We	O
determined	O
experimentally	O
that	O
cluster	O
spy0127	B-Protein
-	O
0130	B-Protein
is	O
an	O
operon	O
,	O
verifying	O
both	O
related	O
function	O
and	O
regulation	O
of	O
the	O
gene	O
members	O
.	O

Reverse	O
transcription	O
of	O
SF370	O
RNA	O
,	O
with	O
primer	O
combinations	O
that	O
spanned	O
all	O
four	O
genes	O
,	O
produced	O
cDNA	O
fragments	O
of	O
sizes	O
that	O
could	O
only	O
result	O
from	O
a	O
polycistronic	O
mRNA	O
template	O
(	O
Figure	O
3	O
)	O
.	O

In	O
silico	O
sequence	O
inspection	O
identified	O
a	O
single	O
putative	O
promoter	O
sequence	O
upstream	O
of	O
spy0127	B-Protein
(	O
see	O
Table	O
S6	O
)	O
.	O

Although	O
GenomeCrawler	O
is	O
not	O
an	O
operon	O
-	O
identifying	O
algorithm	O
,	O
these	O
results	O
show	O
that	O
it	O
could	O
(	O
1	O
)	O
identify	O
this	O
commonly	O
regulated	O
gene	O
cluster	O
and	O
(	O
2	O
)	O
define	O
the	O
cluster	O
boundaries	O
,	O
excluding	O
other	O
proximate	O
genes	O
,	O
such	O
as	O
an	O
additional	O
sortase	O
-	O
encoding	O
gene	O
,	O
spy0135	B-Protein
.	O

Allelic	O
Replacement	O
of	O
spy0129	B-Protein

We	O
created	O
a	O
spy0129	B-Protein
deletion	O
mutant	O
in	O
strain	O
SF370	O
(	O
SF370Deltaspy0129	B-Protein
)	O
to	O
determine	O
if	O
genes	O
contained	O
within	O
the	O
spy0127	B-Protein
-	O
0130	B-Protein
cluster	O
were	O
directly	O
involved	O
in	O
adherence	O
to	O
pharyngeal	O
cells	O
.	O

We	O
posited	O
that	O
a	O
deletion	O
in	O
the	O
spy0129	B-Protein
sortase	O
gene	O
may	O
have	O
the	O
greatest	O
overall	O
effect	O
on	O
the	O
production	O
and	O
processing	O
of	O
the	O
gene	O
products	O
of	O
this	O
cluster	O
,	O
since	O
both	O
the	O
spy0128	B-Protein
and	O
spy0130	B-Protein
gene	O
products	O
do	O
not	O
localize	O
to	O
the	O
cell	O
-	O
wall	O
surface	O
in	O
the	O
absence	O
of	O
the	O
sortase	B-Protein
enzyme	O
[	O
36	O
]	O
.	O

Allelic	O
replacement	O
created	O
two	O
putative	O
deletion	O
mutants	O
;	O
however	O
,	O
RT	O
-	O
PCR	O
analysis	O
(	O
Figure	O
4A	O
)	O
revealed	O
that	O
only	O
one	O
such	O
clone	O
(	O
SF370Deltaspy0129	B-Protein
.	O
2	O
)	O
was	O
a	O
true	O
knock	O
-	O
out	O
for	O
the	O
spy0129	B-Protein
gene	O
and	O
useful	O
for	O
further	O
study	O
.	O
<EOS>	B-X
The	B-X
Leishmania	B-X
genome	B-X
project	B-X
has	B-X
identified	B-X
new	B-X
genes	B-X
at	B-X
a	B-X
rapid	B-X
rate	B-X
.	B-X
The	B-X
32.8-megabase	B-X
haploid	B-X
genome	B-X
of	B-X
Leishmania	B-X
major	B-X
(	B-X
Friedlin	B-X
strain	B-X
)	B-X
is	B-X
published	B-X
and	B-X
the	B-X
comparative	B-X
analysis	B-X
of	B-X
genome	B-X
sequences	B-X
of	B-X
two	B-X
other	B-X
species	B-X
,	B-X
Leishmania	B-X
infantum	B-X
and	B-X
Leishmanai	B-X
braziliensis	B-X
has	B-X
been	B-X
done	B-X
.	B-X
The	B-X
haploid	B-X
genome	B-X
of	B-X
Leishmania	B-X
major	B-X
(	B-X
Friedlin	B-X
strain	B-X
)	B-X
has	B-X
around	B-X
8272	B-X
protein-coding	B-X
genes	B-X
,	B-X
of	B-X
which	B-X
only	B-X
36	B-X
%	B-X
can	B-X
be	B-X
ascribed	B-X
a	B-X
putative	B-X
function	B-X
.	B-X
Out	B-X
of	B-X
these	B-X
open	B-X
reading	B-X
frames	B-X
around	B-X
910	B-X
Leishmania	B-X
major	B-X
genes	B-X
have	B-X
no	B-X
orthologs	B-X
in	B-X
the	B-X
other	B-X
two	B-X
Tritryp	B-X
genomes	B-X
.	B-X
These	B-X
``	B-X
Leishmania	B-X
-restricted	B-X
''	B-X
genes	B-X
hold	B-X
a	B-X
potential	B-X
as	B-X
novel	B-X
drug	B-X
targets	B-X
and	B-X
potential	B-X
vaccine	B-X
candidates	B-X
.	B-X
Open	B-X
reading	B-X
frame	B-X
,	B-X
ORFF	B-X
,	B-X
is	B-X
a	B-X
single	B-X
copy	B-X
gene	B-X
located	B-X
on	B-X
the	B-X
chromosome	B-X
35	B-X
as	B-X
a	B-X
part	B-X
of	B-X
the	B-X
multigene	B-X
LD1	B-X
locus	B-X
.	B-X
Indirect	B-X
immunofluorescence	B-X
study	B-X
and	B-X
creation	B-X
of	B-X
ORFF-GFP	B-X
fusion	B-X
showed	B-X
that	B-X
ORFF	B-X
is	B-X
localized	B-X
in	B-X
the	B-X
DNA	B-X
containing	B-X
compartments	B-X
of	B-X
Leishmania	B-X
donovani	B-X
,	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
kinetoplast	B-X
.	B-X
In	B-X
order	B-X
to	B-X
characterize	B-X
ORFF	B-X
gene	B-X
of	B-X
L.	B-X
donovani	B-X
,	B-X
we	B-X
have	B-X
created	B-X
ORFF	B-X
over-expressors	B-X
and	B-X
single	B-X
allele	B-X
deletion	B-X
mutants	B-X
by	B-X
homologous	B-X
replacement	B-X
strategy	B-X
.	B-X
ORFF	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
an	B-X
important	B-X
gene	B-X
for	B-X
the	B-X
parasite	B-X
growth	B-X
since	B-X
results	B-X
from	B-X
over-expression	B-X
studies	B-X
and	B-X
characterization	B-X
of	B-X
ORFF	B-X
heterozygous	B-X
knockout	B-X
mutants	B-X
reveal	B-X
marked	B-X
alterations	B-X
in	B-X
the	B-X
cell	B-X
cycle	B-X
phenotype	B-X
compared	B-X
to	B-X
the	B-X
wild-type	B-X
parasites	B-X
.	B-X
Flowcytometry	B-X
based	B-X
cell	B-X
cycle	B-X
analysis	B-X
showed	B-X
selective	B-X
increase	B-X
in	B-X
the	B-X
DNA	B-X
synthetic	B-X
phase	B-X
of	B-X
the	B-X
ORFF	B-X
over-expressors	B-X
and	B-X
a	B-X
subversion	B-X
of	B-X
the	B-X
same	B-X
in	B-X
heterozygous	B-X
knockouts	B-X
of	B-X
ORFF	B-X
suggesting	B-X
its	B-X
potential	B-X
role	B-X
in	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

Because	O
the	O
gene	O
cluster	O
is	O
also	O
an	O
operon	O
,	O
expression	O
of	O
the	O
downstream	O
gene	O
spy0130	B-Protein
,	O
encoding	O
the	O
protein	O
F	O
homolog	O
/	O
pilus	O
protein	O
,	O
was	O
also	O
eliminated	O
in	O
this	O
mutant	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
vitro	O
pharyngeal	O
cell	O
adherence	O
assays	O
revealed	O
that	O
the	O
SF370Deltaspy0129	B-Protein
.	O
2	O
mutant	O
was	O
approximately	O
66	O
%	O
less	O
adherent	O
than	O
the	O
parental	O
control	O
strain	O
,	O
SF370	O
(	O
Figure	O
4B	O
;	O
p	O
=	O
0	O
.	O
03	O
as	O
determined	O
by	O
the	O
Student	O
'	O
s	O
t	O
-	O
test	O
)	O
.	O

These	O
results	O
suggest	O
that	O
either	O
the	O
spy0130	B-Protein
gene	O
product	O
is	O
involved	O
directly	O
in	O
adherence	O
,	O
or	O
that	O
due	O
to	O
the	O
elimination	O
of	O
the	O
sortase	B-Protein
,	O
the	O
pili	O
,	O
which	O
may	O
function	O
in	O
their	O
entirety	O
as	O
adhesins	O
,	O
were	O
not	O
assembled	O
on	O
the	O
surface	O
of	O
the	O
mutant	O
.	O

Because	O
the	O
spy0129	B-Protein
gene	O
product	O
is	O
not	O
expected	O
to	O
be	O
found	O
on	O
the	O
streptococcal	O
surface	O
(	O
i	O
.	O
e	O
.	O
,	O
it	O
lacks	O
a	O
cell	O
-	O
wall	O
anchoring	O
motif	O
)	O
,	O
it	O
is	O
not	O
likely	O
to	O
be	O
involved	O
directly	O
in	O
adherence	O
.	O
<EOS>	B-X
Streptococcus	B-X
pyogenes	B-X
(	B-X
group	B-X
A	B-X
Streptococcus	B-X
,	B-X
GAS	B-X
)	B-X
is	B-X
a	B-X
human-adapted	B-X
pathogen	B-X
responsible	B-X
for	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
disease	B-X
.	B-X
GAS	B-X
can	B-X
cause	B-X
relatively	B-X
mild	B-X
illnesses	B-X
,	B-X
such	B-X
as	B-X
strep	B-X
throat	B-X
or	B-X
impetigo	B-X
,	B-X
and	B-X
less	B-X
frequent	B-X
but	B-X
severe	B-X
life-threatening	B-X
diseases	B-X
such	B-X
as	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock	B-X
syndrome	B-X
.	B-X
GAS	B-X
is	B-X
an	B-X
important	B-X
public	B-X
health	B-X
problem	B-X
causing	B-X
significant	B-X
morbidity	B-X
and	B-X
mortality	B-X
worldwide	B-X
.	B-X
The	B-X
main	B-X
route	B-X
of	B-X
GAS	B-X
transmission	B-X
between	B-X
humans	B-X
is	B-X
through	B-X
close	B-X
or	B-X
direct	B-X
physical	B-X
contact	B-X
,	B-X
and	B-X
particularly	B-X
via	B-X
respiratory	B-X
droplets	B-X
.	B-X
The	B-X
upper	B-X
respiratory	B-X
tract	B-X
and	B-X
skin	B-X
are	B-X
major	B-X
reservoirs	B-X
for	B-X
GAS	B-X
infections	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
GAS	B-X
to	B-X
establish	B-X
an	B-X
infection	B-X
in	B-X
the	B-X
new	B-X
host	B-X
at	B-X
these	B-X
anatomical	B-X
sites	B-X
primarily	B-X
results	B-X
from	B-X
two	B-X
distinct	B-X
physiological	B-X
processes	B-X
,	B-X
namely	B-X
bacterial	B-X
adhesion	B-X
and	B-X
colonization	B-X
.	B-X
These	B-X
fundamental	B-X
aspects	B-X
of	B-X
pathogenesis	B-X
rely	B-X
upon	B-X
a	B-X
variety	B-X
of	B-X
GAS	B-X
virulence	B-X
factors	B-X
,	B-X
which	B-X
are	B-X
usually	B-X
under	B-X
strict	B-X
transcriptional	B-X
regulation	B-X
.	B-X
Considerable	B-X
progress	B-X
has	B-X
been	B-X
made	B-X
in	B-X
better	B-X
understanding	B-X
these	B-X
initial	B-X
infection	B-X
steps	B-X
.	B-X
This	B-X
review	B-X
summarizes	B-X
our	B-X
current	B-X
knowledge	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
GAS	B-X
adhesion	B-X
and	B-X
colonization	B-X
.	B-X

We	O
are	O
working	O
to	O
produce	O
an	O
in	O
-	O
frame	O
deletion	O
of	O
spy0128	B-Protein
and	O
a	O
spy0130	B-Protein
single	O
knock	O
-	O
out	O
mutant	O
to	O
delineate	O
the	O
contribution	O
of	O
each	O
individual	O
clustered	O
gene	O
product	O
to	O
adherence	O
.	O

These	O
results	O
show	O
that	O
neighbor	O
clustering	O
is	O
able	O
to	O
identify	O
biologically	O
relevant	O
gene	O
clusters	O
.	O
<EOS>	B-X
Several	B-X
tools	B-X
have	B-X
been	B-X
developed	B-X
to	B-X
perform	B-X
global	B-X
gene	B-X
expression	B-X
profile	B-X
data	B-X
analysis	B-X
,	B-X
to	B-X
search	B-X
for	B-X
specific	B-X
chromosomal	B-X
regions	B-X
whose	B-X
features	B-X
meet	B-X
defined	B-X
criteria	B-X
as	B-X
well	B-X
as	B-X
to	B-X
study	B-X
neighbouring	B-X
gene	B-X
expression	B-X
.	B-X
they	B-X
are	B-X
species-specific	B-X
,	B-X
or	B-X
limited	B-X
to	B-X
a	B-X
particular	B-X
data	B-X
format	B-X
)	B-X
and	B-X
they	B-X
typically	B-X
accept	B-X
only	B-X
gene	B-X
lists	B-X
as	B-X
input	B-X
.	B-X
High-throughput	B-X
genotype	B-X
(	B-X
HTG	B-X
)	B-X
data	B-X
has	B-X
been	B-X
used	B-X
primarily	B-X
in	B-X
genome-wide	B-X
association	B-X
(	B-X
GWA	B-X
)	B-X
studies	B-X
;	B-X
however	B-X
,	B-X
GWA	B-X
results	B-X
explain	B-X
only	B-X
a	B-X
limited	B-X
part	B-X
of	B-X
the	B-X
complete	B-X
genetic	B-X
variation	B-X
of	B-X
traits	B-X
.	B-X
In	B-X
systems	B-X
genetics	B-X
,	B-X
network	B-X
approaches	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
able	B-X
to	B-X
identify	B-X
pathways	B-X
and	B-X
their	B-X
underlying	B-X
causal	B-X
genes	B-X
to	B-X
unravel	B-X
the	B-X
biological	B-X
and	B-X
genetic	B-X
background	B-X
of	B-X
complex	B-X
diseases	B-X
and	B-X
traits	B-X
,	B-X
e.g.	B-X
,	B-X
the	B-X
Weighted	B-X
Gene	B-X
Co-expression	B-X
Network	B-X
Analysis	B-X
(	B-X
WGCNA	B-X
)	B-X
method	B-X
based	B-X
on	B-X
microarray	B-X
gene	B-X
expression	B-X
data	B-X
.	B-X
The	B-X
main	B-X
objective	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
develop	B-X
a	B-X
scale-free	B-X
weighted	B-X
genetic	B-X
interaction	B-X
network	B-X
method	B-X
using	B-X
whole	B-X
genome	B-X
HTG	B-X
data	B-X
in	B-X
order	B-X
to	B-X
detect	B-X
biologically	B-X
relevant	B-X
pathways	B-X
and	B-X
potential	B-X
genetic	B-X
biomarkers	B-X
for	B-X
complex	B-X
diseases	B-X
and	B-X
traits	B-X
.	B-X

This	O
attribute	O
may	O
be	O
particularly	O
important	O
for	O
datasets	O
in	O
which	O
the	O
relationship	O
between	O
clustered	O
genes	O
is	O
not	O
obvious	O
,	O
and	O
may	O
facilitate	O
the	O
organization	O
of	O
larger	O
datasets	O
into	O
more	O
manageable	O
packages	O
.	O

Additional	O
Type	O
II	O
Cluster	O
Example	O
<EOS>	B-X
In	B-X
addition	B-X
,	B-X
genetic	B-X
analyses	B-X
have	B-X
revealed	B-X
that	B-X
autoimmune	B-X
diseases	B-X
show	B-X
strong	B-X
associations	B-X
with	B-X
MHC	B-X
class	B-X
II	B-X
genes	B-X
.	B-X
The	B-X
intriguing	B-X
correlations	B-X
between	B-X
retroviral	B-X
encoded	B-X
antigens	B-X
,	B-X
MHC	B-X
class	B-X
II	B-X
genes	B-X
and	B-X
the	B-X
development	B-X
of	B-X
autoimmune	B-X
disease	B-X
merit	B-X
intense	B-X
future	B-X
investigations	B-X
of	B-X
retroelements	B-X
,	B-X
in	B-X
particular	B-X
those	B-X
endogenous	B-X
retroviruses	B-X
located	B-X
in	B-X
the	B-X
MHC	B-X
class	B-X
II	B-X
region	B-X
proper	B-X
.	B-X
When	B-X
heterogeneity	B-X
is	B-X
present	B-X
,	B-X
tests	B-X
of	B-X
fixed	B-X
effects	B-X
(	B-X
including	B-X
cross-level	B-X
interaction	B-X
terms	B-X
)	B-X
are	B-X
subject	B-X
to	B-X
inflated	B-X
type	B-X
I	B-X
or	B-X
type	B-X
II	B-X
error	B-X
.	B-X
The	B-X
phylogeny-based	B-X
KS	B-X
classification	B-X
scheme	B-X
now	B-X
recognizes	B-X
41	B-X
class	B-X
and	B-X
subclass	B-X
assignments	B-X
,	B-X
including	B-X
new	B-X
type	B-X
II	B-X
PKS	B-X
subclasses	B-X
.	B-X

Another	O
cluster	O
,	O
spy1725	B-Protein
-	O
1719	B-Protein
,	O
contained	O
six	O
genes	O
that	O
together	O
(	O
though	O
not	O
individually	O
)	O
exhibited	O
significant	O
downregulation	O
.	O

The	O
genes	O
spy1724	B-Protein
,	O
spy1722	B-Protein
,	O
spy1721	B-Protein
,	O
and	O
spy1719	B-Protein
share	O
transcriptional	O
order	O
and	O
predicted	O
function	O
with	O
homologs	O
in	O
the	O
nusA	B-Protein
-	O
infB	B-Protein
protein	O
biosynthesis	O
operon	O
of	O
Bacillus	O
subtilis	O
and	O
Escherichia	O
coli	O
[	O
51	O
]	O
.	O

We	O
examined	O
the	O
spy1725	B-Protein
and	O
spy1723	B-Protein
gene	O
products	O
(	O
annotated	O
as	O
hypothetical	O
proteins	O
[	O
14	O
]	O
)	O
for	O
similarities	O
with	O
known	O
proteins	O
that	O
might	O
indicate	O
a	O
role	O
for	O
these	O
gene	O
products	O
in	O
protein	O
biosynthesis	O
.	O

BlastP	O
analysis	O
aligned	O
the	O
spy1725	B-Protein
gene	O
product	O
,	O
which	O
has	O
homologs	O
in	O
all	O
sequenced	O
streptococcal	O
genomes	O
,	O
with	O
the	O
SP14	B-Protein
.	I-Protein
3	I-Protein
protein	O
from	O
S	O
.	O
pneumoniae	O
[	O
52	O
]	O
(	O
80	O
%	O
sequence	O
similarity	O
;	O
67	O
%	O
identity	O
)	O
.	O

Based	O
on	O
structural	O
characterization	O
,	O
SP14	B-Protein
.	I-Protein
3	I-Protein
is	O
a	O
predicted	O
RNA	O
-	O
binding	O
protein	O
.	O

The	O
spy1723	B-Protein
gene	O
product	O
has	O
similar	O
domain	O
structure	O
to	O
the	O
YlxR	B-Protein
protein	O
of	O
S	O
.	O
pneumoniae	O
,	O
an	O
RNA	O
-	O
binding	O
protein	O
implicated	O
in	O
transcription	O
termination	O
[	O
53	O
]	O
.	O

These	O
results	O
indicate	O
that	O
both	O
genes	O
likely	O
encode	O
RNA	O
-	O
binding	O
proteins	O
,	O
in	O
agreement	O
with	O
their	O
functionally	O
defined	O
cluster	O
members	O
.	O

Although	O
domain	B-Protein
and	O
homology	O
searches	O
yielded	O
the	O
functional	O
predictions	O
,	O
their	O
membership	O
within	O
a	O
protein	O
biosynthetic	O
cluster	O
provided	O
the	O
initial	O
indication	O
of	O
common	O
function	O
or	O
regulation	O
.	O
<EOS>	B-X
This	B-X
allies	B-X
industry	B-X
and	B-X
healthcare	B-X
professionals	B-X
with	B-X
a	B-X
common	B-X
and	B-X
key	B-X
ethical	B-X
arbitrator	B-X
--	B-X
the	B-X
patient	B-X
.	B-X
Self	B-X
regulation	B-X
is	B-X
increasingly	B-X
active	B-X
and	B-X
transparent	B-X
;	B-X
guidelines	B-X
,	B-X
laws	B-X
and	B-X
internal/external	B-X
regulators	B-X
exist	B-X
to	B-X
examine	B-X
industry	B-X
.	B-X
However	B-X
,	B-X
for	B-X
the	B-X
changes	B-X
in	B-X
regulations	B-X
,	B-X
behaviour	B-X
and	B-X
practices	B-X
to	B-X
be	B-X
fully	B-X
effective	B-X
,	B-X
there	B-X
is	B-X
a	B-X
need	B-X
for	B-X
dialogue	B-X
between	B-X
industry	B-X
and	B-X
healthcare	B-X
professionals	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
nursing	B-X
began	B-X
as	B-X
a	B-X
simple	B-X
registry	B-X
process	B-X
to	B-X
protect	B-X
the	B-X
nursing	B-X
title	B-X
and	B-X
the	B-X
public	B-X
.	B-X
Today	B-X
,	B-X
the	B-X
primary	B-X
purpose	B-X
is	B-X
still	B-X
the	B-X
protection	B-X
of	B-X
the	B-X
public	B-X
through	B-X
defining	B-X
nursing	B-X
practice	B-X
,	B-X
approving	B-X
nursing	B-X
education	B-X
,	B-X
and	B-X
overseeing	B-X
the	B-X
competence	B-X
of	B-X
nurses	B-X
through	B-X
licensing	B-X
and	B-X
disciplinary	B-X
rules	B-X
and	B-X
regulations	B-X
.	B-X
Each	B-X
nurse	B-X
must	B-X
understand	B-X
the	B-X
regulations	B-X
,	B-X
which	B-X
vary	B-X
from	B-X
state	B-X
to	B-X
state	B-X
,	B-X
that	B-X
directly	B-X
and	B-X
indirectly	B-X
affect	B-X
his/her	B-X
daily	B-X
practice	B-X
.	B-X

Neighbor	O
Clustering	O
and	O
Operons	O
<EOS>	B-X
Operons	B-X
are	B-X
clusters	B-X
of	B-X
genes	B-X
that	B-X
are	B-X
transcribed	B-X
as	B-X
a	B-X
single	B-X
message	B-X
,	B-X
and	B-X
regulated	B-X
by	B-X
the	B-X
same	B-X
gene	B-X
expression	B-X
machinery	B-X
.	B-X
The	B-X
Gene	B-X
Neighbor	B-X
method	B-X
(	B-X
GNM	B-X
)	B-X
utilizes	B-X
the	B-X
relatively	B-X
high	B-X
conservation	B-X
of	B-X
gene	B-X
order	B-X
in	B-X
operons	B-X
,	B-X
compared	B-X
with	B-X
genes	B-X
in	B-X
general	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
a	B-X
method	B-X
for	B-X
the	B-X
visualization	B-X
and	B-X
interpretation	B-X
of	B-X
genome-wide	B-X
functional	B-X
linkages	B-X
inferred	B-X
by	B-X
the	B-X
Rosetta	B-X
Stone	B-X
,	B-X
Phylogenetic	B-X
Profile	B-X
,	B-X
Operon	B-X
and	B-X
Conserved	B-X
Gene	B-X
Neighbor	B-X
computational	B-X
methods	B-X
.	B-X

Although	O
neighbor	O
clustering	O
is	O
not	O
an	O
operon	O
-	O
predicting	O
method	O
,	O
we	O
wanted	O
to	O
identify	O
additional	O
putative	O
operons	O
among	O
the	O
groupings	O
since	O
neighbor	O
clusters	O
by	O
definition	O
share	O
certain	O
operon	O
characteristics	O
(	O
tandemly	O
arranged	O
genes	O
,	O
separated	O
by	O
<	O
300	O
bp	O
,	O
with	O
similar	O
expression	O
patterns	O
)	O
.	O
<EOS>	B-X
Current	B-X
computational	B-X
workflows	B-X
for	B-X
comparative	B-X
analyses	B-X
of	B-X
single-cell	B-X
datasets	B-X
typically	B-X
use	B-X
discrete	B-X
clusters	B-X
as	B-X
input	B-X
when	B-X
testing	B-X
for	B-X
differential	B-X
abundance	B-X
among	B-X
experimental	B-X
conditions	B-X
.	B-X
However	B-X
,	B-X
clusters	B-X
do	B-X
not	B-X
always	B-X
provide	B-X
the	B-X
appropriate	B-X
resolution	B-X
and	B-X
can	B-X
not	B-X
capture	B-X
continuous	B-X
trajectories	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
Milo	B-X
,	B-X
a	B-X
scalable	B-X
statistical	B-X
framework	B-X
that	B-X
performs	B-X
differential	B-X
abundance	B-X
testing	B-X
by	B-X
assigning	B-X
cells	B-X
to	B-X
partially	B-X
overlapping	B-X
neighborhoods	B-X
on	B-X
a	B-X
k-nearest	B-X
neighbor	B-X
graph	B-X
.	B-X
Using	B-X
simulations	B-X
and	B-X
single-cell	B-X
RNA	B-X
sequencing	B-X
(	B-X
scRNA-seq	B-X
)	B-X
data	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Milo	B-X
can	B-X
identify	B-X
perturbations	B-X
that	B-X
are	B-X
obscured	B-X
by	B-X
discretizing	B-X
cells	B-X
into	B-X
clusters	B-X
,	B-X
that	B-X
it	B-X
maintains	B-X
false	B-X
discovery	B-X
rate	B-X
control	B-X
across	B-X
batch	B-X
effects	B-X
and	B-X
that	B-X
it	B-X
outperforms	B-X
alternative	B-X
differential	B-X
abundance	B-X
testing	B-X
strategies	B-X
.	B-X
As	B-X
Milo	B-X
is	B-X
based	B-X
on	B-X
a	B-X
cell-cell	B-X
similarity	B-X
structure	B-X
,	B-X
it	B-X
might	B-X
also	B-X
be	B-X
applicable	B-X
to	B-X
single-cell	B-X
data	B-X
other	B-X
than	B-X
scRNA-seq	B-X
.	B-X

Although	O
operon	O
-	O
modeling	O
methods	O
exist	O
[	O
54	O
,	O
55	O
]	O
,	O
we	O
inspected	O
clusters	O
in	O
silico	O
for	O
upstream	O
regulatory	O
elements	O
and	O
identified	O
17	O
candidates	O
,	O
including	O
clusters	O
such	O
as	O
streptolysin	B-Protein
S	I-Protein
that	O
have	O
been	O
previously	O
confirmed	O
as	O
operons	O
[	O
56	O
]	O
;	O
the	O
spy0127	B-Protein
-	O
0130	B-Protein
grouping	O
,	O
which	O
was	O
confirmed	O
as	O
an	O
operon	O
in	O
this	O
study	O
;	O
and	O
others	O
that	O
have	O
yet	O
to	O
be	O
verified	O
(	O
Table	O
S6	O
)	O
.	O

Experimental	O
confirmation	O
of	O
each	O
candidate	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
,	O
but	O
Northern	O
blot	O
and	O
RT	O
-	O
PCR	O
analyses	O
could	O
provide	O
such	O
information	O
.	O

Analysis	O
of	O
Previously	O
Published	O
Array	O
Data	O
<EOS>	B-X
Therefore	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
novel	B-X
algorithm	B-X
(	B-X
LAMA	B-X
:	B-X
Literature-Aided	B-X
Meta-Analysis	B-X
)	B-X
to	B-X
quantify	B-X
the	B-X
similarity	B-X
between	B-X
transcriptomics	B-X
studies	B-X
.	B-X
Array-based	B-X
platforms	B-X
for	B-X
measuring	B-X
reporter	B-X
peptide	B-X
signal	B-X
levels	B-X
allow	B-X
for	B-X
differential	B-X
phosphorylation	B-X
analysis	B-X
between	B-X
conditions	B-X
for	B-X
distinct	B-X
active	B-X
kinases	B-X
.	B-X

We	O
applied	O
the	O
statistical	O
analysis	O
and	O
the	O
GenomeCrawler	O
algorithms	O
to	O
data	O
from	O
a	O
recently	O
published	O
streptococcal	O
microarray	O
study	O
that	O
is	O
relevant	O
for	O
comparison	O
to	O
our	O
own	O
data	O
(	O
same	O
streptococcal	O
strain	O
,	O
similar	O
array	O
platform	O
)	O
[	O
57	O
]	O
.	O

In	O
this	O
study	O
,	O
the	O
transciptomes	O
of	O
S	O
.	O
pyogenes	O
strain	O
SF370	O
and	O
an	O
isogenic	O
mutant	O
deficient	O
for	O
the	O
Mga	B-Protein
regulon	O
were	O
compared	O
during	O
exponential	O
growth	O
in	O
culture	O
broth	O
.	O

The	O
Mga	B-Protein
regulator	O
is	O
a	O
growth	O
-	O
phase	O
mediator	O
of	O
a	O
number	O
of	O
surface	O
-	O
exposed	O
molecules	O
and	O
secreted	O
proteins	O
involved	O
in	O
colonization	O
and	O
immune	O
evasion	O
during	O
infection	O
[	O
58	O
]	O
.	O

Although	O
the	O
authors	O
of	O
that	O
study	O
did	O
not	O
provide	O
a	O
statistical	O
analysis	O
of	O
their	O
data	O
,	O
we	O
compared	O
the	O
published	O
results	O
for	O
the	O
magnitude	O
and	O
direction	O
of	O
fold	O
-	O
changes	O
for	O
each	O
gene	O
reported	O
in	O
this	O
study	O
with	O
those	O
obtained	O
from	O
our	O
initial	O
significance	O
analysis	O
of	O
this	O
dataset	O
(	O
presented	O
as	O
Table	O
S7	O
)	O
.	O

A	O
total	O
of	O
256	O
genes	O
reported	O
in	O
this	O
study	O
were	O
also	O
detected	O
by	O
our	O
analysis	O
,	O
and	O
the	O
magnitude	O
and	O
log2	O
-	O
fold	O
change	O
were	O
found	O
to	O
be	O
in	O
agreement	O
for	O
81	O
%	O
of	O
the	O
genes	O
.	O

We	O
suspect	O
that	O
this	O
discrepancy	O
results	O
from	O
different	O
normalization	O
methods	O
used	O
,	O
or	O
from	O
different	O
methods	O
that	O
were	O
applied	O
to	O
analyze	O
the	O
ratio	O
of	O
signal	O
intensities	O
between	O
sample	O
and	O
control	O
(	O
i	O
.	O
e	O
.	O
,	O
we	O
analyzed	O
the	O
ratios	O
of	O
the	O
median	O
rather	O
than	O
the	O
ratios	O
of	O
the	O
mean	O
[	O
57	O
]	O
)	O
.	O
<EOS>	B-X
The	B-X
aim	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
the	B-X
recommendations	B-X
regarding	B-X
the	B-X
diagnosis	B-X
and	B-X
treatment	B-X
contained	B-X
in	B-X
current	B-X
clinical	B-X
practice	B-X
guidelines	B-X
for	B-X
patients	B-X
with	B-X
non-specific	B-X
low	B-X
back	B-X
pain	B-X
in	B-X
primary	B-X
care	B-X
.	B-X
We	B-X
also	B-X
aimed	B-X
to	B-X
examine	B-X
how	B-X
recommendations	B-X
have	B-X
changed	B-X
since	B-X
our	B-X
last	B-X
overview	B-X
in	B-X
2010	B-X
.	B-X
The	B-X
prevalence	B-X
of	B-X
overweight	B-X
and	B-X
obesity	B-X
in	B-X
childhood	B-X
and	B-X
adolescence	B-X
is	B-X
high	B-X
.	B-X
Excessive	B-X
body	B-X
fat	B-X
at	B-X
a	B-X
young	B-X
age	B-X
is	B-X
likely	B-X
to	B-X
persist	B-X
into	B-X
adulthood	B-X
and	B-X
is	B-X
associated	B-X
with	B-X
physical	B-X
and	B-X
psychosocial	B-X
co-morbidities	B-X
,	B-X
as	B-X
well	B-X
as	B-X
lower	B-X
cognitive	B-X
,	B-X
school	B-X
and	B-X
later	B-X
life	B-X
achievement	B-X
.	B-X
Lifestyle	B-X
changes	B-X
,	B-X
including	B-X
reduced	B-X
caloric	B-X
intake	B-X
,	B-X
decreased	B-X
sedentary	B-X
behaviour	B-X
and	B-X
increased	B-X
physical	B-X
activity	B-X
,	B-X
are	B-X
recommended	B-X
for	B-X
prevention	B-X
and	B-X
treatment	B-X
of	B-X
child	B-X
and	B-X
adolescent	B-X
obesity	B-X
.	B-X
Evidence	B-X
suggests	B-X
that	B-X
lifestyle	B-X
interventions	B-X
can	B-X
benefit	B-X
cognitive	B-X
function	B-X
and	B-X
school	B-X
achievement	B-X
in	B-X
children	B-X
of	B-X
normal	B-X
weight	B-X
.	B-X
Similar	B-X
beneficial	B-X
effects	B-X
may	B-X
be	B-X
seen	B-X
in	B-X
overweight	B-X
or	B-X
obese	B-X
children	B-X
and	B-X
adolescents	B-X
.	B-X

Although	O
the	O
published	O
report	O
did	O
not	O
include	O
statistical	O
analysis	O
of	O
the	O
data	O
,	O
we	O
note	O
that	O
the	O
statistical	O
analysis	O
that	O
we	O
performed	O
identified	O
four	O
genes	O
with	O
significant	O
log2	O
-	O
fold	O
changes	O
in	O
expression	O
(	O
PF	O
<	O
0	O
.	O
05	O
;	O
Table	O
S8	O
)	O
.	O
<EOS>	B-X
Standards	B-X
for	B-X
reporting	B-X
exist	B-X
for	B-X
many	B-X
types	B-X
of	B-X
quantitative	B-X
research	B-X
,	B-X
but	B-X
currently	B-X
none	B-X
exist	B-X
for	B-X
the	B-X
broad	B-X
spectrum	B-X
of	B-X
qualitative	B-X
research	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
the	B-X
present	B-X
study	B-X
was	B-X
to	B-X
formulate	B-X
and	B-X
define	B-X
standards	B-X
for	B-X
reporting	B-X
qualitative	B-X
research	B-X
while	B-X
preserving	B-X
the	B-X
requisite	B-X
flexibility	B-X
to	B-X
accommodate	B-X
various	B-X
paradigms	B-X
,	B-X
approaches	B-X
,	B-X
and	B-X
methods	B-X
.	B-X
Protocols	B-X
of	B-X
systematic	B-X
reviews	B-X
and	B-X
meta-analyses	B-X
allow	B-X
for	B-X
planning	B-X
and	B-X
documentation	B-X
of	B-X
review	B-X
methods	B-X
,	B-X
act	B-X
as	B-X
a	B-X
guard	B-X
against	B-X
arbitrary	B-X
decision	B-X
making	B-X
during	B-X
review	B-X
conduct	B-X
,	B-X
enable	B-X
readers	B-X
to	B-X
assess	B-X
for	B-X
the	B-X
presence	B-X
of	B-X
selective	B-X
reporting	B-X
against	B-X
completed	B-X
reviews	B-X
,	B-X
and	B-X
,	B-X
when	B-X
made	B-X
publicly	B-X
available	B-X
,	B-X
reduce	B-X
duplication	B-X
of	B-X
efforts	B-X
and	B-X
potentially	B-X
prompt	B-X
collaboration	B-X
.	B-X
Evidence	B-X
documenting	B-X
the	B-X
existence	B-X
of	B-X
selective	B-X
reporting	B-X
and	B-X
excessive	B-X
duplication	B-X
of	B-X
reviews	B-X
on	B-X
the	B-X
same	B-X
or	B-X
similar	B-X
topics	B-X
is	B-X
accumulating	B-X
and	B-X
many	B-X
calls	B-X
have	B-X
been	B-X
made	B-X
in	B-X
support	B-X
of	B-X
the	B-X
documentation	B-X
and	B-X
public	B-X
availability	B-X
of	B-X
review	B-X
protocols	B-X
.	B-X
Furthering	B-X
these	B-X
efforts	B-X
and	B-X
building	B-X
on	B-X
the	B-X
PRISMA	B-X
(	B-X
Preferred	B-X
Reporting	B-X
Items	B-X
for	B-X
Systematic	B-X
Reviews	B-X
and	B-X
Meta-analyses	B-X
)	B-X
guidelines	B-X
,	B-X
an	B-X
international	B-X
group	B-X
of	B-X
experts	B-X
has	B-X
created	B-X
a	B-X
guideline	B-X
to	B-X
improve	B-X
the	B-X
transparency	B-X
,	B-X
accuracy	B-X
,	B-X
completeness	B-X
,	B-X
and	B-X
frequency	B-X
of	B-X
documented	B-X
systematic	B-X
review	B-X
and	B-X
meta-analysis	B-X
protocols	B-X
--	B-X
PRISMA-P	B-X
(	B-X
for	B-X
protocols	B-X
)	B-X
2015	B-X
.	B-X
The	B-X
PRISMA-P	B-X
checklist	B-X
contains	B-X
17	B-X
items	B-X
considered	B-X
to	B-X
be	B-X
essential	B-X
and	B-X
minimum	B-X
components	B-X
of	B-X
a	B-X
systematic	B-X
review	B-X
or	B-X
meta-analysis	B-X
protocol.This	B-X
PRISMA-P	B-X
2015	B-X
Explanation	B-X
and	B-X
Elaboration	B-X
paper	B-X
provides	B-X
readers	B-X
with	B-X
a	B-X
full	B-X
understanding	B-X
of	B-X
and	B-X
evidence	B-X
about	B-X
the	B-X
necessity	B-X
of	B-X
each	B-X
item	B-X
as	B-X
well	B-X
as	B-X
a	B-X
model	B-X
example	B-X
from	B-X
an	B-X
existing	B-X
published	B-X
protocol	B-X
.	B-X
This	B-X
paper	B-X
should	B-X
be	B-X
read	B-X
together	B-X
with	B-X
the	B-X
PRISMA-P	B-X
2015	B-X
statement	B-X
.	B-X

We	O
applied	O
the	O
GenomeCrawler	O
algorithms	O
to	O
the	O
statistically	O
analyzed	O
dataset	O
,	O
which	O
identified	O
an	O
expanded	O
group	O
of	O
genes	O
(	O
107	O
versus	O
four	O
)	O
contained	O
within	O
36	O
statistically	O
significant	O
clusters	O
(	O
PK	O
<	O
0	O
.	O
05	O
;	O
Table	O
S9	O
)	O
.	O

These	O
groupings	O
included	O
clusters	O
of	O
genes	O
that	O
have	O
been	O
shown	O
previously	O
in	O
streptococci	O
to	O
be	O
functionally	O
related	O
,	O
indicating	O
that	O
the	O
algorithms	O
were	O
performing	O
as	O
expected	O
.	O

Two	O
of	O
the	O
identified	O
upregulated	O
clusters	O
(	O
spy2009	B-Protein
-	O
2010	B-Protein
and	O
spy2039	B-Protein
-	O
2040	B-Protein
)	O
encoding	O
the	O
well	O
-	O
studied	O
virulence	O
factors	O
,	O
C5a	B-Protein
peptidase	I-Protein
and	O
SpeB	B-Protein
,	O
respectively	O
,	O
showed	O
consistently	O
large	O
log2	O
-	O
fold	O
changes	O
of	O
the	O
genes	O
across	O
replicates	O
[	O
57	O
]	O
.	O

GenomeCrawler	O
confirmed	O
these	O
results	O
by	O
identifying	O
both	O
groupings	O
as	O
statistically	O
significant	O
neighbor	O
clusters	O
.	O
<EOS>	B-X
Despite	B-X
prevention	B-X
efforts	B-X
,	B-X
new	B-X
HIV	B-X
diagnoses	B-X
continue	B-X
in	B-X
the	B-X
southern	B-X
United	B-X
States	B-X
,	B-X
where	B-X
the	B-X
epidemic	B-X
is	B-X
characterized	B-X
by	B-X
significant	B-X
racial/ethnic	B-X
disparities	B-X
.	B-X
In	B-X
some	B-X
areas	B-X
of	B-X
the	B-X
country	B-X
,	B-X
migrant	B-X
groups	B-X
from	B-X
neighboring	B-X
countries	B-X
that	B-X
are	B-X
still	B-X
endemic	B-X
for	B-X
LF	B-X
pose	B-X
a	B-X
risk	B-X
of	B-X
reintroduction	B-X
of	B-X
LF	B-X
to	B-X
Togo	B-X
.	B-X

GenomeCrawler	O
also	O
identified	O
a	O
number	O
of	O
clusters	O
that	O
contained	O
genes	O
known	O
to	O
share	O
common	O
function	O
or	O
regulation	O
;	O
however	O
,	O
they	O
were	O
not	O
as	O
apparent	O
in	O
the	O
dataset	O
without	O
its	O
application	O
.	O
<EOS>	B-X
This	B-X
paper	B-X
outlines	B-X
a	B-X
number	B-X
of	B-X
approaches	B-X
including	B-X
greater	B-X
transparency	B-X
,	B-X
monitoring	B-X
of	B-X
outcomes	B-X
and	B-X
improved	B-X
governance	B-X
.	B-X
It	B-X
makes	B-X
a	B-X
case	B-X
that	B-X
public	B-X
sector	B-X
bodies	B-X
that	B-X
hold	B-X
datasets	B-X
should	B-X
be	B-X
more	B-X
confident	B-X
in	B-X
negotiating	B-X
terms	B-X
with	B-X
the	B-X
private	B-X
sector	B-X
.	B-X
It	B-X
also	B-X
argues	B-X
that	B-X
all	B-X
regulators	B-X
(	B-X
not	B-X
just	B-X
data	B-X
regulators	B-X
)	B-X
need	B-X
to	B-X
wake	B-X
up	B-X
to	B-X
the	B-X
challenges	B-X
posed	B-X
by	B-X
changing	B-X
technology	B-X
.	B-X
Advances	B-X
in	B-X
science	B-X
and	B-X
technology	B-X
have	B-X
led	B-X
to	B-X
a	B-X
vast	B-X
field	B-X
of	B-X
increasingly	B-X
complicated	B-X
pharmaceutical	B-X
and	B-X
medical	B-X
device	B-X
products	B-X
;	B-X
increasing	B-X
globalization	B-X
of	B-X
the	B-X
pharmaceutical	B-X
industry	B-X
,	B-X
advances	B-X
in	B-X
digital	B-X
technology	B-X
and	B-X
the	B-X
internet	B-X
,	B-X
changing	B-X
patient	B-X
populations	B-X
,	B-X
and	B-X
shifts	B-X
in	B-X
society	B-X
also	B-X
affect	B-X
the	B-X
regulatory	B-X
environment	B-X
.	B-X
This	B-X
paper	B-X
discusses	B-X
the	B-X
range	B-X
of	B-X
initiatives	B-X
in	B-X
the	B-X
UK	B-X
and	B-X
across	B-X
Europe	B-X
to	B-X
support	B-X
innovation	B-X
in	B-X
medicines	B-X
regulation	B-X
.	B-X
The	B-X
MHRA	B-X
leads	B-X
a	B-X
number	B-X
of	B-X
initiatives	B-X
,	B-X
such	B-X
as	B-X
the	B-X
Innovation	B-X
Office	B-X
,	B-X
which	B-X
helps	B-X
innovators	B-X
to	B-X
navigate	B-X
the	B-X
regulatory	B-X
processes	B-X
to	B-X
progress	B-X
their	B-X
products	B-X
or	B-X
technologies	B-X
;	B-X
and	B-X
simplification	B-X
of	B-X
the	B-X
Clinical	B-X
Trials	B-X
Regulations	B-X
and	B-X
the	B-X
Early	B-X
Access	B-X
to	B-X
Medicines	B-X
Scheme	B-X
,	B-X
to	B-X
bring	B-X
innovative	B-X
medicines	B-X
to	B-X
patients	B-X
faster	B-X
.	B-X

For	O
example	O
,	O
the	O
algorithm	O
identified	O
a	O
significant	O
neighbor	O
cluster	O
spanning	O
spy0711	B-Protein
-	O
0712	B-Protein
.	O

This	O
grouping	O
encodes	O
two	O
known	O
virulence	O
factors	O
,	O
pyrogenic	O
exotoxin	O
SpeC	B-Protein
and	O
the	O
MF2	B-Protein
DNase	O
,	O
previously	O
shown	O
to	O
be	O
commonly	O
regulated	O
as	O
an	O
operon	O
[	O
11	O
]	O
.	O

The	O
algorithm	O
also	O
identified	O
other	O
neighbor	O
clusters	O
containing	O
genes	O
known	O
to	O
be	O
functionally	O
related	O
,	O
including	O
spy0098	B-Protein
-	O
0100	B-Protein
(	O
encoding	O
the	O
beta	O
and	O
beta	O
'	O
subunits	O
of	O
DNA	O
-	O
dependent	O
RNA	O
polymerase	O
)	O
,	O
spy2159	B-Protein
-	O
2160	B-Protein
(	O
encoding	O
the	O
50S	O
ribosomal	O
subunit	O
proteins	O
L32	B-Protein
and	O
L33	B-Protein
)	O
,	O
and	O
spy0741	B-Protein
-	O
0746	B-Protein
(	O
six	O
of	O
the	O
nine	O
streptolysin	B-Protein
S	I-Protein
-	O
encoding	O
genes	O
)	O
[	O
14	O
]	O
.	O

Although	O
the	O
analysis	O
of	O
this	O
previously	O
published	O
dataset	O
did	O
not	O
reveal	O
as	O
many	O
intact	O
biological	O
pathways	O
as	O
were	O
identified	O
from	O
the	O
pharyngeal	O
cell	O
adherence	O
data	O
,	O
the	O
inclusion	O
of	O
more	O
replicates	O
in	O
the	O
analysis	O
to	O
increase	O
statistical	O
power	O
could	O
resolve	O
such	O
loci	O
.	O
<EOS>	B-X
T	B-X
cells	B-X
form	B-X
the	B-X
major	B-X
component	B-X
of	B-X
anti-tumor	B-X
immunity	B-X
.	B-X
A	B-X
deeper	B-X
understanding	B-X
of	B-X
T	B-X
cell	B-X
exhaustion	B-X
(	B-X
TEX	B-X
)	B-X
heterogeneity	B-X
within	B-X
the	B-X
tumor	B-X
microenvironment	B-X
(	B-X
TME	B-X
)	B-X
is	B-X
key	B-X
to	B-X
overcoming	B-X
TEX	B-X
and	B-X
improving	B-X
checkpoint	B-X
blockade	B-X
immunotherapies	B-X
in	B-X
the	B-X
clinical	B-X
setting	B-X
.	B-X
The	B-X
emerging	B-X
diversity	B-X
of	B-X
single-cell	B-X
RNA-seq	B-X
datasets	B-X
allows	B-X
for	B-X
the	B-X
full	B-X
transcriptional	B-X
characterization	B-X
of	B-X
cell	B-X
types	B-X
across	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
biological	B-X
and	B-X
clinical	B-X
conditions	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
challenging	B-X
to	B-X
analyze	B-X
them	B-X
together	B-X
,	B-X
particularly	B-X
when	B-X
datasets	B-X
are	B-X
assayed	B-X
with	B-X
different	B-X
technologies	B-X
,	B-X
because	B-X
biological	B-X
and	B-X
technical	B-X
differences	B-X
are	B-X
interspersed	B-X
.	B-X
We	B-X
present	B-X
Harmony	B-X
(	B-X
https	B-X
:	B-X
//github.com/immunogenomics/harmony	B-X
)	B-X
,	B-X
an	B-X
algorithm	B-X
that	B-X
projects	B-X
cells	B-X
into	B-X
a	B-X
shared	B-X
embedding	B-X
in	B-X
which	B-X
cells	B-X
group	B-X
by	B-X
cell	B-X
type	B-X
rather	B-X
than	B-X
dataset-specific	B-X
conditions	B-X
.	B-X
Harmony	B-X
simultaneously	B-X
accounts	B-X
for	B-X
multiple	B-X
experimental	B-X
and	B-X
biological	B-X
factors	B-X
.	B-X
In	B-X
six	B-X
analyses	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
superior	B-X
performance	B-X
of	B-X
Harmony	B-X
to	B-X
previously	B-X
published	B-X
algorithms	B-X
while	B-X
requiring	B-X
fewer	B-X
computational	B-X
resources	B-X
.	B-X

However	O
,	O
these	O
results	O
provided	O
further	O
supporting	O
evidence	O
that	O
the	O
GenomeCrawler	O
algorithms	O
can	O
identify	O
(	O
1	O
)	O
a	O
larger	O
group	O
of	O
genes	O
than	O
a	O
rigorous	O
statistical	O
analysis	O
alone	O
and	O
(	O
2	O
)	O
biologically	O
relevant	O
groupings	O
in	O
other	O
microarray	O
datasets	O
,	O
even	O
if	O
they	O
contain	O
fewer	O
replicates	O
than	O
presented	O
in	O
our	O
study	O
.	O

Concluding	O
Remarks	O
<EOS>	B-X
Concluding	B-X
Remarks	B-X
.	B-X
Concluding	B-X
remarks	B-X
.	B-X
Concluding	B-X
remarks	B-X
.	B-X
Concluding	B-X
remarks	B-X
.	B-X

Although	O
GenomeCrawler	O
improves	O
bacterial	O
array	O
analyses	O
,	O
it	O
has	O
limitations	O
:	O
it	O
cannot	O
identify	O
regulons	O
comprising	O
genes	O
dispersed	O
throughout	O
the	O
genome	O
by	O
virtue	O
of	O
its	O
design	O
,	O
it	O
does	O
not	O
specifically	O
interrogate	O
single	O
-	O
gene	O
operons	O
,	O
and	O
it	O
only	O
applies	O
to	O
genomes	O
with	O
available	O
and	O
accurate	O
experimental	O
information	O
(	O
expression	O
data	O
and	O
gene	O
annotations	O
)	O
.	O

We	O
recognize	O
that	O
incorporating	O
intergenic	O
distance	O
and	O
transcription	O
direction	O
into	O
the	O
algorithms	O
would	O
reduce	O
processing	O
time	O
.	O

Adding	O
available	O
clusters	O
of	O
orthologous	O
groups	O
(	O
COG	O
)	O
information	O
into	O
a	O
downstream	O
processing	O
step	O
could	O
decrease	O
errors	O
by	O
minimizing	O
clustering	O
of	O
unrelated	O
genes	O
.	O

Nonetheless	O
,	O
neighbor	O
clustering	O
provided	O
a	O
more	O
comprehensive	O
view	O
of	O
the	O
transcriptome	O
of	O
group	O
A	O
streptococci	O
during	O
adherence	O
to	O
human	O
pharyngeal	O
cells	O
,	O
a	O
critical	O
step	O
in	O
the	O
infection	O
program	O
of	O
this	O
organism	O
.	O

We	O
found	O
that	O
even	O
a	O
rigorous	O
statistical	O
analysis	O
of	O
well	O
-	O
replicated	O
microarray	O
data	O
produced	O
a	O
dataset	O
that	O
was	O
somewhat	O
limited	O
,	O
although	O
certainly	O
more	O
informative	O
than	O
assigning	O
arbitrary	O
thresholds	O
for	O
significance	O
.	O

As	O
described	O
in	O
other	O
microarray	O
reports	O
,	O
we	O
had	O
initially	O
identified	O
a	O
number	O
of	O
incomplete	O
biological	O
pathways	O
in	O
which	O
we	O
did	O
not	O
detect	O
the	O
differential	O
expression	O
of	O
a	O
number	O
of	O
known	O
pathway	O
members	O
.	O

Neighbor	O
clustering	O
was	O
able	O
to	O
extend	O
the	O
results	O
by	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
and	O
reconstructing	O
more	O
intact	O
biological	O
pathways	O
.	O

Neighbor	O
clustering	O
,	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
it	O
assigns	O
groupings	O
,	O
would	O
be	O
valuable	O
to	O
microarray	O
data	O
analysis	O
only	O
if	O
it	O
produced	O
biologically	O
relevant	O
data	O
.	O

Although	O
biological	O
testing	O
of	O
every	O
identified	O
gene	O
or	O
cluster	O
is	O
unrealistic	O
,	O
we	O
provided	O
evidence	O
,	O
through	O
the	O
creation	O
and	O
testing	O
of	O
isogenic	O
deletion	O
mutants	O
and	O
through	O
the	O
identification	O
of	O
clusters	O
of	O
known	O
,	O
functionally	O
related	O
genes	O
from	O
a	O
published	O
streptococcal	O
array	O
study	O
,	O
that	O
the	O
algorithms	O
produce	O
results	O
that	O
are	O
pertinent	O
to	O
the	O
biology	O
of	O
streptococci	O
.	O
<EOS>	B-X
An	B-X
increasing	B-X
number	B-X
of	B-X
NFKB1	B-X
variants	B-X
are	B-X
being	B-X
identified	B-X
in	B-X
patients	B-X
with	B-X
heterogeneous	B-X
immunologic	B-X
phenotypes	B-X
.	B-X
Tumor	B-X
genetic	B-X
sequencing	B-X
identifies	B-X
potentially	B-X
targetable	B-X
genetic	B-X
alterations	B-X
with	B-X
therapeutic	B-X
implications	B-X
.	B-X
To	B-X
assess	B-X
the	B-X
safety	B-X
and	B-X
therapeutic	B-X
effects	B-X
of	B-X
allogeneic	B-X
human	B-X
dental	B-X
pulp	B-X
stem	B-X
cells	B-X
(	B-X
DPSCs	B-X
)	B-X
in	B-X
treating	B-X
severe	B-X
pneumonia	B-X
caused	B-X
by	B-X
COVID-19	B-X
.	B-X
A	B-X
single	B-X
miRNA	B-X
can	B-X
target	B-X
hundreds	B-X
of	B-X
mRNAs	B-X
and	B-X
coordinately	B-X
regulate	B-X
them	B-X
,	B-X
which	B-X
implicates	B-X
them	B-X
in	B-X
nearly	B-X
every	B-X
biological	B-X
pathway	B-X
.	B-X
We	B-X
will	B-X
recapitulate	B-X
all	B-X
the	B-X
miRNAs	B-X
involved	B-X
in	B-X
the	B-X
androgen	B-X
pathway	B-X
and	B-X
the	B-X
biology	B-X
of	B-X
PCa	B-X
,	B-X
focusing	B-X
in	B-X
PCa	B-X
initiation	B-X
and	B-X
progression	B-X
.	B-X
We	B-X
will	B-X
revise	B-X
the	B-X
recent	B-X
progress	B-X
made	B-X
understanding	B-X
the	B-X
role	B-X
of	B-X
circulating	B-X
miRNAs	B-X
identified	B-X
in	B-X
PCa	B-X
that	B-X
might	B-X
be	B-X
useful	B-X
for	B-X
PCa	B-X
patient	B-X
stratification	B-X
.	B-X

This	O
may	O
be	O
of	O
particular	O
importance	O
for	O
data	O
in	O
which	O
the	O
relationship	O
between	O
clustered	O
genes	O
is	O
not	O
obvious	O
,	O
and	O
may	O
facilitate	O
the	O
organization	O
of	O
larger	O
datasets	O
into	O
more	O
meaningful	O
packages	O
.	O

It	O
is	O
also	O
possible	O
that	O
GenomeCrawler	O
(	O
in	O
its	O
current	O
form	O
)	O
could	O
be	O
used	O
to	O
interrogate	O
intergenic	O
portions	O
of	O
the	O
genome	O
(	O
such	O
as	O
those	O
encoding	O
small	O
noncoding	O
RNAs	O
or	O
sRNAs	O
)	O
,	O
if	O
probes	O
representing	O
such	O
regions	O
were	O
included	O
on	O
the	O
microarray	O
,	O
and	O
experimental	O
conditions	O
were	O
designed	O
to	O
promote	O
their	O
differential	O
expression	O
.	O

Finally	O
,	O
because	O
of	O
the	O
common	O
architecture	O
of	O
bacterial	O
chromosomes	O
,	O
the	O
neighbor	O
clustering	O
algorithms	O
may	O
be	O
applicable	O
to	O
microarray	O
datasets	O
from	O
other	O
prokaryotes	O
.	O

Porphyromonas	O
gingivalis	O
short	O
fimbriae	O
are	O
regulated	O
by	O
a	O
FimS	B-Protein
/	O
FimR	B-Protein
two	O
-	O
component	O
system	O
<EOS>	B-X
Porphyromonas	B-X
gingivalis	B-X
possesses	B-X
two	B-X
distinct	B-X
fimbriae	B-X
.	B-X
The	B-X
long	B-X
(	B-X
FimA	B-X
)	B-X
fimbriae	B-X
have	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
fimA	B-X
gene	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
a	B-X
two-component	B-X
system	B-X
(	B-X
FimS/FimR	B-X
)	B-X
through	B-X
a	B-X
cascade	B-X
regulation	B-X
.	B-X
The	B-X
short	B-X
(	B-X
Mfa1	B-X
)	B-X
fimbriae	B-X
are	B-X
less	B-X
understood	B-X
.	B-X
The	B-X
authors	B-X
have	B-X
recently	B-X
demonstrated	B-X
that	B-X
both	B-X
fimbriae	B-X
are	B-X
required	B-X
for	B-X
formation	B-X
of	B-X
P.	B-X
gingivalis	B-X
biofilms	B-X
.	B-X
Here	B-X
,	B-X
the	B-X
novel	B-X
finding	B-X
that	B-X
FimR	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
,	B-X
is	B-X
a	B-X
transcriptional	B-X
activator	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
promoted	B-X
.	B-X
Unlike	B-X
the	B-X
regulatory	B-X
mechanism	B-X
of	B-X
FimA	B-X
by	B-X
FimR	B-X
,	B-X
this	B-X
regulation	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
accomplished	B-X
by	B-X
FimR	B-X
directly	B-X
binding	B-X
to	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
mfa1	B-X
.	B-X

Porphyromonas	O
gingivalis	O
possesses	O
two	O
distinct	O
fimbriae	O
.	O
<EOS>	B-X
Porphyromonas	B-X
gingivalis	B-X
possesses	B-X
two	B-X
distinct	B-X
fimbriae	B-X
.	B-X
The	B-X
long	B-X
(	B-X
FimA	B-X
)	B-X
fimbriae	B-X
have	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
fimA	B-X
gene	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
a	B-X
two-component	B-X
system	B-X
(	B-X
FimS/FimR	B-X
)	B-X
through	B-X
a	B-X
cascade	B-X
regulation	B-X
.	B-X
The	B-X
short	B-X
(	B-X
Mfa1	B-X
)	B-X
fimbriae	B-X
are	B-X
less	B-X
understood	B-X
.	B-X
The	B-X
authors	B-X
have	B-X
recently	B-X
demonstrated	B-X
that	B-X
both	B-X
fimbriae	B-X
are	B-X
required	B-X
for	B-X
formation	B-X
of	B-X
P.	B-X
gingivalis	B-X
biofilms	B-X
.	B-X
Here	B-X
,	B-X
the	B-X
novel	B-X
finding	B-X
that	B-X
FimR	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
,	B-X
is	B-X
a	B-X
transcriptional	B-X
activator	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
promoted	B-X
.	B-X

The	O
long	O
(	O
FimA	B-Protein
)	O
fimbriae	O
have	O
been	O
extensively	O
studied	O
.	O

Expression	O
of	O
the	O
fimA	B-Protein
gene	O
is	O
tightly	O
controlled	O
by	O
a	O
two	O
-	O
component	O
system	O
(	O
FimS	B-Protein
/	O
FimR	B-Protein
)	O
through	O
a	O
cascade	O
regulation	O
.	O
<EOS>	B-X
Porphyromonas	B-X
gingivalis	B-X
possesses	B-X
two	B-X
distinct	B-X
fimbriae	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
fimA	B-X
gene	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
a	B-X
two-component	B-X
system	B-X
(	B-X
FimS/FimR	B-X
)	B-X
through	B-X
a	B-X
cascade	B-X
regulation	B-X
.	B-X
Here	B-X
,	B-X
the	B-X
novel	B-X
finding	B-X
that	B-X
FimR	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
,	B-X
is	B-X
a	B-X
transcriptional	B-X
activator	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
promoted	B-X
.	B-X
Unlike	B-X
the	B-X
regulatory	B-X
mechanism	B-X
of	B-X
FimA	B-X
by	B-X
FimR	B-X
,	B-X
this	B-X
regulation	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
accomplished	B-X
by	B-X
FimR	B-X
directly	B-X
binding	B-X
to	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
mfa1	B-X
.	B-X

The	O
short	O
(	O
Mfa1	B-Protein
)	O
fimbriae	O
are	O
less	O
understood	O
.	O
<EOS>	B-X
Porphyromonas	B-X
gingivalis	B-X
possesses	B-X
two	B-X
distinct	B-X
fimbriae	B-X
.	B-X
The	B-X
long	B-X
(	B-X
FimA	B-X
)	B-X
fimbriae	B-X
have	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
The	B-X
short	B-X
(	B-X
Mfa1	B-X
)	B-X
fimbriae	B-X
are	B-X
less	B-X
understood	B-X
.	B-X
The	B-X
authors	B-X
have	B-X
recently	B-X
demonstrated	B-X
that	B-X
both	B-X
fimbriae	B-X
are	B-X
required	B-X
for	B-X
formation	B-X
of	B-X
P.	B-X
gingivalis	B-X
biofilms	B-X
.	B-X

The	O
authors	O
have	O
recently	O
demonstrated	O
that	O
both	O
fimbriae	O
are	O
required	O
for	O
formation	O
of	O
P	O
.	O
gingivalis	O
biofilms	O
.	O

Here	O
,	O
the	O
novel	O
finding	O
that	O
FimR	B-Protein
,	O
a	O
member	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
is	O
a	O
transcriptional	O
activator	O
of	O
the	O
mfa1	B-Protein
gene	O
is	O
promoted	O
.	O
<EOS>	B-X
Porphyromonas	B-X
gingivalis	B-X
possesses	B-X
two	B-X
distinct	B-X
fimbriae	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
fimA	B-X
gene	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
a	B-X
two-component	B-X
system	B-X
(	B-X
FimS/FimR	B-X
)	B-X
through	B-X
a	B-X
cascade	B-X
regulation	B-X
.	B-X
Here	B-X
,	B-X
the	B-X
novel	B-X
finding	B-X
that	B-X
FimR	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
,	B-X
is	B-X
a	B-X
transcriptional	B-X
activator	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
promoted	B-X
.	B-X
Unlike	B-X
the	B-X
regulatory	B-X
mechanism	B-X
of	B-X
FimA	B-X
by	B-X
FimR	B-X
,	B-X
this	B-X
regulation	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
accomplished	B-X
by	B-X
FimR	B-X
directly	B-X
binding	B-X
to	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
mfa1	B-X
.	B-X

Unlike	O
the	O
regulatory	O
mechanism	O
of	O
FimA	B-Protein
by	O
FimR	B-Protein
,	O
this	O
regulation	O
of	O
the	O
mfa1	B-Protein
gene	O
is	O
accomplished	O
by	O
FimR	B-Protein
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	B-Protein
.	O

Introduction	O

Porphyromonas	O
gingivalis	O
is	O
a	O
gram	O
-	O
negative	O
bacterium	O
,	O
which	O
is	O
considered	O
to	O
be	O
a	O
major	O
periodontal	O
pathogen	O
(	O
Socransky	O
&	O
Haffajee	O
,	O
2005	O
)	O
.	O

It	O
is	O
also	O
a	O
pathogen	O
that	O
may	O
be	O
involved	O
in	O
coronary	O
heart	O
disease	O
and	O
preterm	O
births	O
(	O
Boggess	O
et	O
al	O
.	O
,	O
2005	O
;	O
Brodala	O
et	O
al	O
.	O
,	O
2005	O
;	O
Chou	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

The	O
ability	O
of	O
P	O
.	O
gingivalis	O
to	O
initiate	O
a	O
periodontal	O
infection	O
is	O
mainly	O
dependent	O
on	O
the	O
expression	O
of	O
fimbriae	O
(	O
Malek	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Two	O
distinct	O
fimbriae	O
are	O
found	O
on	O
the	O
surface	O
of	O
the	O
organism	O
(	O
Dickinson	O
et	O
al	O
.	O
,	O
1988	O
;	O
Hamada	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

The	O
long	O
(	O
major	O
)	O
filamentous	O
structure	O
is	O
comprised	O
of	O
a	O
FimA	B-Protein
subunit	O
protein	O
encoded	O
by	O
the	O
fimA	B-Protein
gene	O
.	O

The	O
short	O
(	O
minor	O
)	O
fimbriae	O
are	O
made	O
up	O
of	O
a	O
67	O
kDa	O
protein	O
(	O
Mfa1	B-Protein
)	O
.	O

Both	O
fimbriae	O
appear	O
to	O
be	O
involved	O
in	O
bacterial	O
pathogenicity	O
(	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
function	O
of	O
the	O
FimA	B-Protein
protein	O
and	O
regulation	O
of	O
fimA	B-Protein
expression	O
have	O
been	O
extensively	O
studied	O
.	O
<EOS>	B-X
The	B-X
long	B-X
(	B-X
FimA	B-X
)	B-X
fimbriae	B-X
have	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
fimA	B-X
gene	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
a	B-X
two-component	B-X
system	B-X
(	B-X
FimS/FimR	B-X
)	B-X
through	B-X
a	B-X
cascade	B-X
regulation	B-X
.	B-X
Unlike	B-X
the	B-X
regulatory	B-X
mechanism	B-X
of	B-X
FimA	B-X
by	B-X
FimR	B-X
,	B-X
this	B-X
regulation	B-X
of	B-X
the	B-X
mfa1	B-X
gene	B-X
is	B-X
accomplished	B-X
by	B-X
FimR	B-X
directly	B-X
binding	B-X
to	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
mfa1	B-X
.	B-X
Several	B-X
important	B-X
bacterial	B-X
DEAD/DEAH-box	B-X
RNA	B-X
helicases	B-X
have	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
We	B-X
provide	B-X
insights	B-X
into	B-X
the	B-X
function	B-X
of	B-X
the	B-X
hrpB	B-X
gene	B-X
in	B-X
Xanthomonas	B-X
citri	B-X
subsp	B-X
.	B-X

The	O
FimA	B-Protein
protein	O
is	O
required	O
for	O
P	O
.	O
gingivalis	O
colonization	O
on	O
salivary	O
coated	O
surfaces	O
,	O
and	O
the	O
early	O
colonization	O
of	O
dental	O
plaque	O
(	O
Malek	O
et	O
al	O
.	O
,	O
1994	O
;	O
Levesque	O
et	O
al	O
.	O
,	O
2003	O
;	O
Maeda	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

A	O
P	O
.	O
gingivalis	O
fimA	B-Protein
mutant	O
shows	O
impaired	O
invasion	O
capability	O
of	O
epithelial	O
cells	O
compared	O
with	O
wild	O
-	O
type	O
strain	O
,	O
suggesting	O
the	O
involvement	O
of	O
FimA	B-Protein
in	O
the	O
bacterial	O
interaction	O
with	O
surface	O
receptor	O
(	O
s	O
)	O
on	O
gingival	O
cells	O
(	O
Weinberg	O
et	O
al	O
.	O
,	O
1997	O
)	O
.	O

Earlier	O
studies	O
by	O
the	O
authors	O
showed	O
that	O
FimA	B-Protein
expression	O
was	O
modulated	O
by	O
environmental	O
cues	O
,	O
including	O
temperature	O
and	O
hemin	O
concentration	O
,	O
and	O
by	O
the	O
presence	O
of	O
Streptococcus	O
cristatus	O
,	O
an	O
early	O
colonizer	O
of	O
dental	O
plaque	O
(	O
Xie	O
et	O
al	O
.	O
,	O
1997	O
,	O
2000b	O
)	O
.	O

FimR	B-Protein
,	O
a	O
response	O
regulator	O
of	O
the	O
fimS	B-Protein
/	O
fimR	B-Protein
two	O
-	O
component	O
system	O
was	O
identified	O
,	O
and	O
FimA	B-Protein
expression	O
was	O
found	O
to	O
be	O
dramatically	O
reduced	O
in	O
fimR	B-Protein
mutants	O
(	O
Hayashi	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

Investigation	O
of	O
the	O
mechanism	O
of	O
regulation	O
of	O
fimA	B-Protein
by	O
FimR	B-Protein
indicates	O
that	O
FimR	B-Protein
does	O
not	O
bind	O
directly	O
to	O
the	O
fimA	B-Protein
promoter	O
,	O
but	O
rather	O
binds	O
to	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
(	O
pg2130	B-Protein
)	O
in	O
the	O
fimA	B-Protein
cluster	O
,	O
suggesting	O
that	O
PG2130	B-Protein
is	O
the	O
FimR	B-Protein
target	O
gene	O
,	O
which	O
in	O
turn	O
regulates	O
expression	O
of	O
other	O
genes	O
in	O
the	O
fimA	B-Protein
cluster	O
,	O
including	O
the	O
fimA	B-Protein
gene	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
short	O
fimbriae	O
(	O
Mfa1	B-Protein
)	O
also	O
contribute	O
to	O
P	O
.	O
gingivalis	O
colonization	O
.	O

Coadhesion	O
and	O
biofilm	O
development	O
between	O
P	O
.	O
gingivalis	O
and	O
Streptococcus	O
gordonii	O
require	O
the	O
interaction	O
of	O
Mfa1	B-Protein
with	O
streptococcal	O
protein	O
SspB	B-Protein
(	O
Park	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

The	O
authors	O
have	O
recently	O
reported	O
that	O
the	O
short	O
fimbriae	O
are	O
required	O
for	O
P	O
.	O
gingivalis	O
cell	O
-	O
cell	O
aggregation	O
,	O
an	O
essential	O
step	O
in	O
microcolony	O
formation	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

A	O
mutant	O
with	O
a	O
deficiency	O
in	O
minor	O
fimbriae	O
binds	O
to	O
a	O
saliva	O
-	O
coated	O
surface	O
but	O
does	O
not	O
form	O
microcolonies	O
as	O
the	O
wild	O
-	O
type	O
strain	O
does	O
.	O

Mfa1	B-Protein
expression	O
appears	O
to	O
fluctuate	O
under	O
various	O
growth	O
conditions	O
(	O
Masuda	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

In	O
a	O
nutrient	O
-	O
limited	O
medium	O
,	O
expression	O
of	O
FimA	B-Protein
and	O
Mfa1	B-Protein
are	O
inhibited	O
in	O
P	O
.	O
gingivalis	O
,	O
whereas	O
such	O
differences	O
are	O
not	O
found	O
in	O
gingipain	O
expression	O
.	O

A	O
recent	O
study	O
has	O
shown	O
that	O
expression	O
of	O
mfa1	B-Protein
is	O
repressed	O
in	O
the	O
presence	O
of	O
some	O
common	O
oral	O
plaque	O
bacteria	O
such	O
as	O
S	O
.	O
gordonii	O
,	O
Streptococcus	O
sanguinis	O
and	O
Streptococcus	O
mitis	O
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

However	O
,	O
very	O
little	O
is	O
known	O
about	O
regulatory	O
mechanisms	O
of	O
mfa1	B-Protein
expression	O
.	O

In	O
this	O
study	O
,	O
it	O
is	O
demonstrated	O
that	O
FimR	B-Protein
is	O
a	O
positive	O
regulator	O
of	O
Mfa1	B-Protein
expression	O
.	O

Evidence	O
is	O
provided	O
that	O
unlike	O
FimR	B-Protein
-	O
dependent	O
fimA	B-Protein
expression	O
,	O
FimR	B-Protein
regulates	O
mfa1	B-Protein
expression	O
by	O
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	B-Protein
.	O

Results	O

Role	O
of	O
FimR	B-Protein
in	O
mfa1	B-Protein
expression	O
The	O
fimA	B-Protein
gene	O
is	O
the	O
only	O
gene	O
known	O
to	O
be	O
tightly	O
controlled	O
by	O
the	O
FimS	B-Protein
/	O
FimR	B-Protein
system	O
.	O

It	O
was	O
postulated	O
that	O
the	O
expression	O
of	O
other	O
genes	O
may	O
also	O
be	O
controlled	O
by	O
this	O
two	O
component	O
regulatory	O
system	O
.	O

To	O
investigate	O
effects	O
of	O
FimR	B-Protein
on	O
expression	O
of	O
the	O
mfa1	B-Protein
gene	O
,	O
an	O
insertional	O
fimR	B-Protein
mutant	O
was	O
constructed	O
by	O
allelic	O
replacement	O
.	O

Expression	O
of	O
fimA	B-Protein
and	O
mfa1	B-Protein
in	O
the	O
fimR	B-Protein
-	O
mutant	O
was	O
determined	O
using	O
real	O
-	O
time	O
PCR	O
analysis	O
.	O

Statistically	O
significant	O
differences	O
of	O
the	O
level	O
of	O
gene	O
expression	O
in	O
33277	O
and	O
the	O
fimR	B-Protein
-	O
mutant	O
were	O
calculated	O
by	O
a	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
<EOS>	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

1a	O
,	O
expression	O
of	O
the	O
fimA	B-Protein
gene	O
was	O
abolished	O
in	O
the	O
fimR	B-Protein
-	O
mutant	O
strain	O
FRE	O
.	O

This	O
result	O
is	O
consistent	O
with	O
previous	O
observations	O
(	O
Hayashi	O
et	O
al	O
.	O
,	O
2000	O
;	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
striking	O
finding	O
is	O
that	O
expression	O
of	O
the	O
mfa1	B-Protein
gene	O
was	O
also	O
repressed	O
threefold	O
in	O
the	O
fimR	B-Protein
-	O
mutant	O
,	O
although	O
not	O
to	O
the	O
degree	O
observed	O
with	O
the	O
fimA	B-Protein
expression	O
.	O

However	O
,	O
the	O
fimR	B-Protein
-	O
mutation	O
had	O
no	O
effect	O
on	O
expression	O
of	O
rgpA	B-Protein
,	O
a	O
gene	O
encoding	O
the	O
arginine	O
-	O
specific	O
protease	O
,	O
or	O
the	O
P	O
.	O
gingivalis	O
16S	B-Protein
RNA	I-Protein
gene	O
.	O

This	O
analysis	O
suggests	O
the	O
FimS	B-Protein
/	O
FimR	B-Protein
system	O
is	O
required	O
for	O
expression	O
of	O
both	O
major	O
and	O
minor	B-Protein
fimbriae	I-Protein
.	O

To	O
determine	O
production	O
of	O
long	O
(	O
major	O
)	O
and	O
short	O
(	O
minor	O
)	O
fimbriae	O
in	O
the	O
fimR	B-Protein
-	O
mutant	O
,	O
western	O
blotting	O
was	O
performed	O
with	O
a	O
polyclonal	O
anti	O
-	O
FimA	B-Protein
or	O
anti	O
-	O
Mfa1	B-Protein
antibody	O
to	O
compare	O
fimbrial	O
production	O
in	O
wild	O
-	O
type	O
strain	O
(	O
33277	O
)	O
,	O
the	O
fimR	B-Protein
-	O
mutant	O
(	O
FRE	O
)	O
,	O
the	O
fimA	B-Protein
-	O
mutant	O
(	O
FAT	O
)	O
and	O
the	O
mfa1	B-Protein
-	O
mutant	O
(	O
MFAE	O
)	O
.	O

Density	O
of	O
protein	O
bands	O
was	O
determined	O
by	O
UVP	O
Bioimaging	O
System	O
(	O
UVP	O
,	O
CA	O
)	O
.	O

This	O
analysis	O
revealed	O
that	O
the	O
expression	O
of	O
the	O
fimA	B-Protein
and	O
mfa1	B-Protein
genes	O
was	O
consistent	O
at	O
the	O
mRNA	O
level	O
and	O
protein	O
level	O
(	O
Fig	O
.	O
1b	O
)	O
.	O

FimA	B-Protein
protein	O
was	O
not	O
detectable	O
in	O
the	O
fimR	B-Protein
-	O
mutant	O
,	O
while	O
a	O
50	O
%	O
lower	O
level	O
of	O
Mfa1	B-Protein
protein	O
was	O
found	O
in	O
the	O
fimR	B-Protein
-	O
mutant	O
compared	O
with	O
that	O
in	O
wild	O
-	O
type	O
strain	O
33277	O
.	O
<EOS>	B-X
The	B-X
periodontal	B-X
pathogen	B-X
Porphyromonas	B-X
gingivalis	B-X
is	B-X
known	B-X
to	B-X
express	B-X
2	B-X
distinct	B-X
types	B-X
of	B-X
fimbriae	B-X
:	B-X
FimA	B-X
and	B-X
Mfa1	B-X
fimbriae	B-X
.	B-X
However	B-X
,	B-X
we	B-X
previously	B-X
reported	B-X
that	B-X
fimbria-like	B-X
structures	B-X
were	B-X
found	B-X
in	B-X
a	B-X
P.	B-X
gingivalis	B-X
strain	B-X
in	B-X
which	B-X
neither	B-X
FimA	B-X
nor	B-X
Mfa1	B-X
fimbriae	B-X
were	B-X
detected	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
major	B-X
protein	B-X
in	B-X
the	B-X
bacterial	B-X
lysates	B-X
of	B-X
the	B-X
strain	B-X
,	B-X
which	B-X
has	B-X
been	B-X
reported	B-X
as	B-X
the	B-X
53-kDa	B-X
major	B-X
outer	B-X
membrane	B-X
protein	B-X
of	B-X
P.	B-X
gingivalis	B-X
(	B-X
53K	B-X
protein	B-X
)	B-X
and	B-X
subsequently	B-X
reported	B-X
as	B-X
a	B-X
major	B-X
fimbrilin	B-X
of	B-X
a	B-X
novel-type	B-X
fimbria	B-X
.	B-X
Sequencing	B-X
of	B-X
the	B-X
chromosomal	B-X
DNA	B-X
of	B-X
the	B-X
strain	B-X
showed	B-X
that	B-X
the	B-X
53k	B-X
gene	B-X
(	B-X
encoding	B-X
the	B-X
53K	B-X
protein	B-X
)	B-X
was	B-X
located	B-X
at	B-X
a	B-X
locus	B-X
corresponding	B-X
to	B-X
the	B-X
mfa1	B-X
gene	B-X
(	B-X
encoding	B-X
the	B-X
Mfa1	B-X
protein	B-X
,	B-X
which	B-X
is	B-X
a	B-X
major	B-X
fimbrilin	B-X
of	B-X
Mfa1	B-X
fimbriae	B-X
)	B-X
of	B-X
the	B-X
ATCC	B-X
33277	B-X
type	B-X
strain	B-X
.	B-X
However	B-X
,	B-X
the	B-X
53K	B-X
and	B-X
Mfa1	B-X
proteins	B-X
showed	B-X
a	B-X
low	B-X
amino	B-X
acid	B-X
sequence	B-X
homology	B-X
and	B-X
different	B-X
antigenicity	B-X
.	B-X
The	B-X
53K	B-X
protein	B-X
was	B-X
detected	B-X
in	B-X
34	B-X
of	B-X
84	B-X
(	B-X
41	B-X
%	B-X
)	B-X
P.	B-X
gingivalis	B-X
strains	B-X
,	B-X
while	B-X
the	B-X
Mfa1	B-X
protein	B-X
was	B-X
detected	B-X
in	B-X
44	B-X
%	B-X
of	B-X
the	B-X
strains	B-X
.	B-X
No	B-X
strain	B-X
expressed	B-X
both	B-X
53K	B-X
and	B-X
Mfa1	B-X
proteins	B-X
.	B-X
Additionally	B-X
,	B-X
fimbriae	B-X
were	B-X
normally	B-X
expressed	B-X
in	B-X
mutants	B-X
in	B-X
which	B-X
the	B-X
53k	B-X
and	B-X
mfa1	B-X
genes	B-X
were	B-X
interchanged	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
53K	B-X
protein	B-X
is	B-X
another	B-X
major	B-X
fimbrilin	B-X
of	B-X
Mfa1	B-X
fimbriae	B-X
in	B-X
P.	B-X
gingivalis	B-X
.	B-X

Similarly	O
,	O
there	O
was	O
no	O
apparent	O
change	O
in	O
RgpA	B-Protein
production	O
in	O
the	O
fimR	B-Protein
-	O
mutant	O
,	O
which	O
was	O
detected	O
by	O
anti	O
-	O
RgpA	B-Protein
serum	O
.	O

Identification	O
of	O
the	O
transcriptional	O
start	O
site	O
of	O
the	O
mfa1	B-Protein
gene	O

To	O
identify	O
the	O
promoter	O
region	O
of	O
mfa1	B-Protein
,	O
the	O
transcriptional	O
start	O
site	O
was	O
first	O
determined	O
.	O

The	O
RACE	O
experiment	O
was	O
first	O
conducted	O
with	O
mfa1	B-Protein
-	O
specific	O
reverse	O
primers	O
MfaTSR1	O
located	O
at	O
135	O
bp	O
up	O
-	O
stream	O
of	O
the	O
potential	O
start	O
codon	O
and	O
MfaTSR2	O
located	O
at	O
37	O
bp	O
downstream	O
of	O
the	O
potential	O
start	O
codon	O
(	O
Fig	O
.	O
2a	O
)	O
.	O

The	O
transcriptional	O
start	O
site	O
(	O
the	O
A	O
)	O
of	O
mfa1	B-Protein
was	O
at	O
434	O
bp	O
upstream	O
from	O
the	O
potential	O
start	O
codon	O
(	O
Fig	O
.	O
2b	O
)	O
.	O

To	O
verify	O
the	O
result	O
,	O
the	O
RACE	O
experiment	O
was	O
repeated	O
with	O
mfa1	B-Protein
-	O
specific	O
reverse	O
primers	O
MfaTSR3	O
and	O
MfaTSR4	O
located	O
at	O
237	O
bp	O
upstream	O
of	O
the	O
potential	O
start	O
codon	O
.	O

The	O
same	O
transcriptional	O
start	O
site	O
was	O
identified	O
.	O
<EOS>	B-X
SETX	B-X
(	B-X
senataxin	B-X
)	B-X
is	B-X
an	B-X
RNA/DNA	B-X
helicase	B-X
that	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
transcriptional	B-X
regulation	B-X
and	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
through	B-X
resolution	B-X
of	B-X
R-loop	B-X
structures	B-X
.	B-X
The	B-X
CCAAT	B-X
box	B-X
promoter	B-X
element	B-X
and	B-X
NF-Y	B-X
,	B-X
the	B-X
transcription	B-X
factor	B-X
(	B-X
TF	B-X
)	B-X
that	B-X
binds	B-X
to	B-X
it	B-X
,	B-X
were	B-X
among	B-X
the	B-X
first	B-X
cis-elements	B-X
and	B-X
trans-acting	B-X
factors	B-X
identified	B-X
;	B-X
their	B-X
interplay	B-X
is	B-X
required	B-X
for	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
sizeable	B-X
number	B-X
of	B-X
eukaryotic	B-X
genes	B-X
.	B-X
Originally	B-X
identified	B-X
and	B-X
studied	B-X
in	B-X
yeast	B-X
and	B-X
mammals	B-X
,	B-X
NF-Y	B-X
-	B-X
also	B-X
termed	B-X
CBF	B-X
and	B-X
CP1	B-X
-	B-X
is	B-X
composed	B-X
of	B-X
three	B-X
subunits	B-X
,	B-X
NF-YA	B-X
,	B-X
NF-YB	B-X
and	B-X
NF-YC	B-X
.	B-X
A	B-X
compelling	B-X
set	B-X
of	B-X
bioinformatics	B-X
studies	B-X
clarified	B-X
that	B-X
the	B-X
NF-Y	B-X
preferred	B-X
binding	B-X
site	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
frequent	B-X
promoter	B-X
elements	B-X
(	B-X
Suzuki	B-X
et	B-X
al.	B-X
,	B-X
2001	B-X
,	B-X
2004	B-X
;	B-X
Elkon	B-X
et	B-X
al.	B-X
,	B-X
2003	B-X
;	B-X
Mariño-Ramírez	B-X
et	B-X
al.	B-X
,	B-X
2004	B-X
;	B-X
FitzGerald	B-X
et	B-X
al.	B-X
,	B-X
2004	B-X
;	B-X
Linhart	B-X
et	B-X
al.	B-X
,	B-X
2005	B-X
;	B-X
Zhu	B-X
et	B-X
al.	B-X
,	B-X
2005	B-X
;	B-X
Lee	B-X
et	B-X
al.	B-X
,	B-X
2007	B-X
;	B-X
Abnizova	B-X
et	B-X
al.	B-X
,	B-X
2007	B-X
;	B-X
Grskovic	B-X
et	B-X
al.	B-X
,	B-X
2007	B-X
;	B-X
Halperin	B-X
et	B-X
al.	B-X
,	B-X
2009	B-X
;	B-X
Häkkinen	B-X
et	B-X
al.	B-X
,	B-X
2011	B-X
)	B-X
.	B-X

To	O
confirm	O
the	O
result	O
of	O
RACE	O
,	O
reverse	O
-	O
transcriptional	O
PCR	O
using	O
three	O
sets	O
of	O
primers	O
was	O
performed	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
<EOS>	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

2c	O
,	O
the	O
PCR	O
product	O
was	O
generated	O
only	O
with	O
primers	O
MfaTSF1	O
(	O
corresponding	O
to	O
+	O
6	O
to	O
+	O
25	O
)	O
and	O
MfaTSR5	O
(	O
+	O
805	O
to	O
+	O
824	O
)	O
.	O

There	O
was	O
no	O
PCR	O
product	O
generated	O
from	O
RT	O
-	O
PCR	O
using	O
the	O
primers	O
(	O
MfaTSF3	O
,	O
from	O
-	O
139	O
to	O
-	O
121	O
or	O
MfaTSF2	O
,	O
from	O
-	O
66	O
to	O
-	O
47	O
)	O
which	O
correspond	O
to	O
the	O
DNA	O
sequences	O
upstream	O
from	O
the	O
transcriptional	O
start	O
site	O
.	O

This	O
transcriptional	O
start	O
site	O
is	O
390	O
bp	O
upstream	O
of	O
the	O
site	O
previously	O
reported	O
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

It	O
is	O
likely	O
that	O
mfa1	B-Protein
gene	O
possesses	O
two	O
functional	O
promoters	O
,	O
which	O
are	O
also	O
detected	O
in	O
the	O
fimA	B-Protein
gene	O
of	O
P	O
.	O
gingivalis	O
(	O
Xie	O
&	O
Lamont	O
,	O
1999	O
;	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

Binding	O
of	O
FimR	B-Protein
to	O
the	O
promoter	O
region	O
of	O
mfa1	B-Protein

The	O
previous	O
study	O
has	O
shown	O
that	O
the	O
mechanism	O
of	O
FimR	B-Protein
activation	O
of	O
the	O
fimA	B-Protein
gene	O
involves	O
a	O
regulatory	O
cascade	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

It	O
was	O
postulated	O
that	O
different	O
mechanisms	O
might	O
be	O
involved	O
in	O
FimR	B-Protein
-	O
mediated	O
mfa1	B-Protein
expression	O
,	O
since	O
expression	O
regulation	O
of	O
mfa1	B-Protein
by	O
FimR	B-Protein
was	O
not	O
controlled	O
as	O
tightly	O
as	O
observed	O
for	O
fimA	B-Protein
expression	O
.	O

One	O
possibility	O
is	O
that	O
FimR	B-Protein
modulates	O
mfa1	B-Protein
expression	O
by	O
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	B-Protein
.	O

To	O
test	O
this	O
hypothesis	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
were	O
performed	O
.	O
<EOS>	B-X
Gastrointestinal	B-X
dysfunction	B-X
could	B-X
be	B-X
frequently	B-X
observed	B-X
in	B-X
the	B-X
patients	B-X
suffering	B-X
from	B-X
SAH	B-X
.	B-X
This	B-X
study	B-X
test	B-X
the	B-X
hypothesis	B-X
that	B-X
experimental	B-X
SAH	B-X
could	B-X
induce	B-X
histopathological	B-X
changes	B-X
and	B-X
inflammatory	B-X
response	B-X
associating	B-X
with	B-X
NF-kappaB	B-X
activation	B-X
pathway	B-X
in	B-X
the	B-X
gut	B-X
.	B-X
Patterning	B-X
of	B-X
the	B-X
small	B-X
intestinal	B-X
epithelium	B-X
along	B-X
its	B-X
cephalocaudal	B-X
axis	B-X
establishes	B-X
three	B-X
functionally	B-X
distinct	B-X
regions	B-X
:	B-X
duodenum	B-X
,	B-X
jejunum	B-X
,	B-X
and	B-X
ileum	B-X
.	B-X
Efficient	B-X
nutrient	B-X
assimilation	B-X
and	B-X
growth	B-X
depend	B-X
on	B-X
the	B-X
proper	B-X
spatial	B-X
patterning	B-X
of	B-X
specialized	B-X
digestive	B-X
and	B-X
absorptive	B-X
functions	B-X
performed	B-X
by	B-X
duodenal	B-X
,	B-X
jejunal	B-X
,	B-X
and	B-X
ileal	B-X
enterocytes	B-X
.	B-X
When	B-X
enterocyte	B-X
function	B-X
is	B-X
disrupted	B-X
by	B-X
disease	B-X
or	B-X
injury	B-X
,	B-X
intestinal	B-X
failure	B-X
can	B-X
occur	B-X
.	B-X
One	B-X
approach	B-X
to	B-X
alleviate	B-X
intestinal	B-X
failure	B-X
would	B-X
be	B-X
to	B-X
restore	B-X
lost	B-X
enterocyte	B-X
functions	B-X
.	B-X
The	B-X
goal	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
test	B-X
the	B-X
hypothesis	B-X
that	B-X
GATA4	B-X
is	B-X
sufficient	B-X
to	B-X
confer	B-X
jejunal	B-X
identity	B-X
within	B-X
the	B-X
intestinal	B-X
epithelium	B-X
.	B-X

The	O
mfa1	B-Protein
promoter	O
(	O
positioned	O
from	O
+	O
18	O
to	O
-	O
138	O
)	O
,	O
fimA	B-Protein
promoter	O
(	O
positioned	O
from	O
-	O
22	O
to	O
-	O
190	O
)	O
(	O
Xie	O
&	O
Lamont	O
,	O
1999	O
)	O
and	O
mfa1	B-Protein
coding	O
DNA	O
(	O
positioned	O
from	O
+	O
1253	O
to	O
+	O
1373	O
)	O
were	O
generated	O
by	O
PCR	O
with	O
the	O
5	O
'	O
biotin	O
-	O
labeled	O
primers	O
(	O
Table	O
1	O
)	O
.	O

The	O
recombinant	O
FimR	B-Protein
(	O
rFimR	B-Protein
)	O
was	O
expressed	O
in	O
pET	O
expression	O
system	O
and	O
purified	O
from	O
E	O
.	O
coli	O
.	O

The	O
rHGP44	B-Protein
protein	O
,	O
a	O
binding	O
domain	O
of	O
P	O
.	O
gingivalis	O
gingipains	O
(	O
Xie	O
et	O
al	O
.	O
,	O
2006	O
)	O
,	O
expressed	O
in	O
the	O
same	O
system	O
and	O
purified	O
by	O
the	O
same	O
procedures	O
as	O
rFimR	B-Protein
was	O
used	O
as	O
a	O
control	O
.	O

Cold	O
competitor	O
chase	O
experiments	O
with	O
a	O
100	O
-	O
fold	O
excess	O
of	O
unlabeled	O
DNA	O
probe	O
as	O
a	O
specific	O
competitor	O
were	O
also	O
used	O
to	O
demonstrate	O
the	O
specificity	O
of	O
rFimR	B-Protein
binding	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
<EOS>	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

3	O
,	O
the	O
DNA	O
fragment	O
of	O
the	O
mfa1	B-Protein
promoter	O
region	O
was	O
shifted	O
in	O
the	O
presence	O
of	O
the	O
rFimR	B-Protein
.	O

Retarded	O
mfa1	B-Protein
promoter	O
-	O
rFimR	B-Protein
complex	O
was	O
detected	O
with	O
as	O
little	O
as	O
10	O
pmol	O
muL	O
-	O
1	O
rFimR	B-Protein
(	O
Fig	O
.	O
3	O
)	O
.	O

As	O
the	O
concentration	O
of	O
rFimR	B-Protein
increased	O
,	O
the	O
retarded	O
protein	O
-	O
DNA	O
complex	O
became	O
evident	O
,	O
with	O
complete	O
loss	O
of	O
the	O
mfa1	B-Protein
promoter	O
DNA	O
.	O

The	O
unlabeled	O
mfa1	B-Protein
promoter	O
fragments	O
effectively	O
competed	O
with	O
the	O
labeled	O
fragment	O
,	O
suggesting	O
a	O
specific	O
interaction	O
between	O
rFimA	B-Protein
and	O
the	O
mfa1	B-Protein
promoter	O
.	O

To	O
investigate	O
the	O
role	O
of	O
phosphorylation	O
of	O
FimR	B-Protein
in	O
its	O
binding	O
to	O
the	O
mfa1	B-Protein
promoter	O
region	O
,	O
EMSA	O
experiments	O
were	O
also	O
performed	O
with	O
the	O
phosphorylated	O
rFimR	B-Protein
.	O

No	O
significant	O
difference	O
was	O
detected	O
in	O
the	O
level	O
of	O
DNA	O
binding	O
between	O
the	O
phosphorylated	O
rFimR	B-Protein
and	O
unphosphorylated	O
rFimR	B-Protein
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
agreement	O
with	O
a	O
previous	O
report	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
rFimR	B-Protein
did	O
not	O
bind	O
to	O
the	O
fimA	B-Protein
promoter	O
region	O
,	O
suggesting	O
that	O
regulation	O
of	O
fimA	B-Protein
expression	O
by	O
FimR	B-Protein
is	O
through	O
a	O
different	O
mechanism	O
.	O

Moreover	O
,	O
incubation	O
of	O
rHGP44	B-Protein
with	O
mfa1	B-Protein
promoter	O
fragment	O
did	O
not	O
retard	O
the	O
DNA	O
movement	O
in	O
polyacrylamide	O
gel	O
.	O

There	O
was	O
also	O
no	O
DNA	O
shift	O
detected	O
when	O
rFimR	B-Protein
was	O
incubated	O
with	O
the	O
coding	O
region	O
of	O
mfa1	B-Protein
.	O

These	O
data	O
clearly	O
show	O
that	O
FimR	B-Protein
protein	O
can	O
bind	O
specifically	O
to	O
the	O
mfa1	B-Protein
promoter	O
region	O
,	O
acting	O
as	O
an	O
activator	O
of	O
mfa1	B-Protein
transcription	O
.	O

EMSA	O
experiments	O
were	O
also	O
performed	O
to	O
examine	O
whether	O
the	O
rFimR	B-Protein
binds	O
to	O
the	O
other	O
promoter	O
region	O
identified	O
by	O
Park	O
et	O
al	O
.	O

(	O
2006	O
)	O
.	O
<EOS>	B-X
Antibody	B-X
mediated	B-X
rejection	B-X
:	B-X
update	B-X
2006	B-X
.	B-X
[	B-X
Celiac	B-X
disease	B-X
in	B-X
adults	B-X
in	B-X
2006	B-X
]	B-X
.	B-X
For	B-X
the	B-X
present	B-X
update	B-X
,	B-X
we	B-X
screened	B-X
the	B-X
journals	B-X
'Contact	B-X
Dermatitis	B-X
'	B-X
(	B-X
July	B-X
2000	B-X
to	B-X
December	B-X
2006	B-X
)	B-X
;	B-X
'Dermatitis	B-X
'	B-X
,	B-X
formerly	B-X
named	B-X
'American	B-X
Journal	B-X
of	B-X
Contact	B-X
Dermatitis	B-X
'	B-X
;	B-X
'La	B-X
Lettre	B-X
du	B-X
Gerda	B-X
'	B-X
(	B-X
January	B-X
2000	B-X
to	B-X
December	B-X
2006	B-X
)	B-X
;	B-X
and	B-X
also	B-X
included	B-X
relevant	B-X
articles	B-X
from	B-X
other	B-X
journals	B-X
published	B-X
during	B-X
the	B-X
same	B-X
period	B-X
.	B-X
This	B-X
paper	B-X
describes	B-X
the	B-X
large-scale	B-X
experimental	B-X
results	B-X
from	B-X
the	B-X
Face	B-X
Recognition	B-X
Vendor	B-X
Test	B-X
(	B-X
FRVT	B-X
)	B-X
2006	B-X
and	B-X
the	B-X
Iris	B-X
Challenge	B-X
Evaluation	B-X
(	B-X
ICE	B-X
)	B-X
2006	B-X
.	B-X
The	B-X
FRVT	B-X
2006	B-X
looked	B-X
at	B-X
recognition	B-X
from	B-X
high-resolution	B-X
still	B-X
frontal	B-X
face	B-X
images	B-X
and	B-X
3D	B-X
face	B-X
images	B-X
,	B-X
and	B-X
measured	B-X
performance	B-X
for	B-X
still	B-X
frontal	B-X
face	B-X
images	B-X
taken	B-X
under	B-X
controlled	B-X
and	B-X
uncontrolled	B-X
illumination	B-X
.	B-X
The	B-X
ICE	B-X
2006	B-X
evaluation	B-X
reported	B-X
verification	B-X
performance	B-X
for	B-X
both	B-X
left	B-X
and	B-X
right	B-X
irises	B-X
.	B-X
The	B-X
images	B-X
in	B-X
the	B-X
ICE	B-X
2006	B-X
intentionally	B-X
represent	B-X
a	B-X
broader	B-X
range	B-X
of	B-X
quality	B-X
than	B-X
the	B-X
ICE	B-X
2006	B-X
sensor	B-X
would	B-X
normally	B-X
acquire	B-X
.	B-X
The	B-X
FRVT	B-X
2006	B-X
results	B-X
from	B-X
controlled	B-X
still	B-X
and	B-X
3D	B-X
images	B-X
document	B-X
at	B-X
least	B-X
an	B-X
order-of-magnitude	B-X
improvement	B-X
in	B-X
recognition	B-X
performance	B-X
over	B-X
the	B-X
FRVT	B-X
2002	B-X
.	B-X
The	B-X
FRVT	B-X
2006	B-X
and	B-X
the	B-X
ICE	B-X
2006	B-X
compared	B-X
recognition	B-X
performance	B-X
from	B-X
high-resolution	B-X
still	B-X
frontal	B-X
face	B-X
images	B-X
,	B-X
3D	B-X
face	B-X
images	B-X
,	B-X
and	B-X
the	B-X
single-iris	B-X
images	B-X
.	B-X
On	B-X
the	B-X
FRVT	B-X
2006	B-X
and	B-X
the	B-X
ICE	B-X
2006	B-X
data	B-X
sets	B-X
,	B-X
recognition	B-X
performance	B-X
was	B-X
comparable	B-X
for	B-X
high-resolution	B-X
frontal	B-X
face	B-X
,	B-X
3D	B-X
face	B-X
,	B-X
and	B-X
the	B-X
iris	B-X
images	B-X
.	B-X

The	O
biotin	O
-	O
labeled	O
DNA	O
fragment	O
corresponding	O
to	O
this	O
promoter	O
region	O
did	O
not	O
shift	O
in	O
the	O
presence	O
of	O
the	O
rFimA	B-Protein
protein	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
only	O
the	O
promoter	O
identified	O
here	O
is	O
involved	O
for	O
mfa1	B-Protein
expression	O
mediated	O
by	O
FimR	B-Protein
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

The	O
two	O
-	O
component	O
regulatory	O
system	O
is	O
a	O
major	O
mechanism	O
of	O
signal	O
transduction	O
and	O
is	O
widespread	O
in	O
bacteria	O
.	O

Six	O
putative	O
two	O
-	O
component	O
regulatory	O
systems	O
were	O
detected	O
by	O
surveying	O
the	O
P	O
.	O
gingivalis	O
W83	O
genome	O
database	O
for	O
homologues	O
of	O
the	O
two	O
-	O
component	O
sensor	O
histidine	O
kinase	O
(	O
Hasegawa	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

Although	O
most	O
target	O
genes	O
of	O
P	O
.	O
gingivalis	O
two	O
-	O
component	O
systems	O
are	O
unknown	O
,	O
the	O
role	O
of	O
the	O
FimS	B-Protein
/	O
FimR	B-Protein
in	O
expression	O
of	O
the	O
fimA	B-Protein
gene	O
is	O
well	O
defined	O
.	O

Expression	O
of	O
minor	B-Protein
fimbriae	I-Protein
(	O
mfa1	B-Protein
)	O
in	O
a	O
fimR	B-Protein
mutanthas	O
been	O
investigated	O
.	O

A	O
comparison	O
of	O
the	O
transcriptional	O
level	O
of	O
the	O
mfa1	B-Protein
in	O
P	O
.	O
gingivalis	O
wild	O
-	O
type	O
strain	O
and	O
in	O
the	O
fimR	B-Protein
mutant	O
indicates	O
that	O
the	O
FimS	B-Protein
/	O
FimR	B-Protein
system	O
is	O
a	O
positive	O
regulator	O
for	O
the	O
mfa1	B-Protein
gene	O
,	O
although	O
the	O
system	O
controls	O
two	O
fimbrial	O
genes	O
at	O
different	O
levels	O
.	O

It	O
is	O
hypothesized	O
that	O
the	O
FimS	B-Protein
/	O
FimR	B-Protein
system	O
regulates	O
expression	O
of	O
each	O
fimbrial	O
gene	O
through	O
a	O
unique	O
mechanism	O
.	O

The	O
previous	O
study	O
suggested	O
that	O
regulation	O
of	O
fimA	B-Protein
expression	O
by	O
FimR	B-Protein
is	O
through	O
a	O
regulation	O
cascade	O
involving	O
interaction	O
of	O
FimR	B-Protein
and	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
in	O
the	O
fimA	B-Protein
cluster	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

Here	O
it	O
is	O
demonstrated	O
that	O
FimR	B-Protein
binds	O
directly	O
to	O
the	O
promoter	O
region	O
of	O
the	O
mfa1	B-Protein
gene	O
,	O
suggesting	O
a	O
direct	O
role	O
of	O
FimR	B-Protein
in	O
activation	O
of	O
mfa1	B-Protein
expression	O
.	O

It	O
has	O
also	O
been	O
reported	O
previously	O
that	O
the	O
transcriptional	O
activity	O
of	O
fimA	B-Protein
was	O
reduced	O
in	O
the	O
fimA	B-Protein
mutant	O
,	O
indicating	O
multiple	O
levels	O
of	O
control	O
of	O
fimA	B-Protein
expression	O
in	O
P	O
.	O
gingivalis	O
(	O
Xie	O
et	O
al	O
.	O
,	O
2000a	O
)	O
.	O

This	O
may	O
explain	O
the	O
much	O
tighter	O
control	O
of	O
fimA	B-Protein
expression	O
by	O
FimR	B-Protein
.	O

However	O
,	O
the	O
possibility	O
cannot	O
be	O
excluded	O
that	O
other	O
regulatory	O
elements	O
are	O
also	O
involved	O
in	O
expression	O
of	O
the	O
mfa1	B-Protein
gene	O
.	O

A	O
two	O
-	O
component	O
regulatory	O
system	O
typically	O
contains	O
a	O
membrane	O
-	O
bound	O
histidine	O
kinase	O
sensor	O
and	O
a	O
cytosolic	O
response	O
regulator	O
.	O

Phosphorylation	O
,	O
mediated	O
by	O
histidine	O
kinase	O
at	O
a	O
specific	O
aspartate	O
residue	O
,	O
activates	O
DNA	O
-	O
binding	O
activity	O
of	O
the	O
response	O
regulator	O
and	O
initiates	O
the	O
corresponding	O
cellular	O
response	O
.	O

However	O
,	O
no	O
apparent	O
difference	O
was	O
found	O
in	O
DNA	O
-	O
binding	O
affinity	O
between	O
rFimRs	B-Protein
with	O
or	O
without	O
acetyl	O
phosphate	O
treatment	O
.	O
<EOS>	B-X
Catalytic	B-X
chromatography	B-X
exploits	B-X
both	B-X
specific	B-X
biological	B-X
affinity	B-X
and	B-X
catalytic	B-X
specificity	B-X
to	B-X
selectively	B-X
purify	B-X
enzymes	B-X
.	B-X
Purification	B-X
of	B-X
EcoRI	B-X
restriction	B-X
endonuclease	B-X
to	B-X
apparent	B-X
homogeneity	B-X
was	B-X
accomplished	B-X
in	B-X
a	B-X
single	B-X
step	B-X
with	B-X
significantly	B-X
greater	B-X
yield	B-X
and	B-X
purification	B-X
than	B-X
was	B-X
obtained	B-X
with	B-X
affinity	B-X
chromatography	B-X
.	B-X
An	B-X
attempt	B-X
to	B-X
purify	B-X
the	B-X
multiple	B-X
DNA	B-X
polymerase	B-X
activities	B-X
of	B-X
Escherichia	B-X
coli	B-X
was	B-X
also	B-X
developed	B-X
.	B-X
Five	B-X
well-resolved	B-X
peaks	B-X
of	B-X
DNA	B-X
polymerase	B-X
activity	B-X
were	B-X
fractionated	B-X
.	B-X

Observation	O
suggests	O
that	O
different	O
mechanisms	O
may	O
be	O
involved	O
in	O
P	O
.	O
gingivalis	O
FimR	B-Protein
activation	O
.	O

Activation	O
of	O
a	O
regulatory	O
protein	O
not	O
corresponding	O
to	O
phosphorylation	O
was	O
also	O
observed	O
in	O
Streptococcus	O
mutans	O
(	O
Biswas	O
&	O
Biswas	O
,	O
2006	O
)	O
.	O
<EOS>	B-X
To	B-X
establish	B-X
their	B-X
regulatory	B-X
potential	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
genome-wide	B-X
cis-acting	B-X
targets	B-X
(	B-X
cistromes	B-X
)	B-X
of	B-X
both	B-X
REV-ERB	B-X
isoforms	B-X
in	B-X
murine	B-X
liver	B-X
,	B-X
which	B-X
revealed	B-X
shared	B-X
recognition	B-X
at	B-X
over	B-X
50	B-X
%	B-X
of	B-X
their	B-X
total	B-X
DNA	B-X
binding	B-X
sites	B-X
and	B-X
extensive	B-X
overlap	B-X
with	B-X
the	B-X
master	B-X
circadian	B-X
regulator	B-X
BMAL1	B-X
.	B-X
Although	B-X
REV-ERB-α	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
regulate	B-X
Bmal1	B-X
expression	B-X
directly	B-X
,	B-X
our	B-X
cistromic	B-X
analysis	B-X
reveals	B-X
a	B-X
more	B-X
profound	B-X
connection	B-X
between	B-X
BMAL1	B-X
and	B-X
the	B-X
REV-ERB-α	B-X
and	B-X
REV-ERB-β	B-X
genomic	B-X
regulatory	B-X
circuits	B-X
than	B-X
was	B-X
previously	B-X
suspected	B-X
.	B-X
Exercise	B-X
stimulates	B-X
moderate	B-X
to	B-X
large	B-X
increases	B-X
in	B-X
the	B-X
circulating	B-X
concentrations	B-X
of	B-X
interleukin	B-X
(	B-X
IL	B-X
)	B-X
-6	B-X
,	B-X
IL-8	B-X
,	B-X
IL-	B-X
10	B-X
,	B-X
IL-1	B-X
receptor	B-X
antagonist	B-X
,	B-X
granulocyte-colony	B-X
stimulating	B-X
factor	B-X
,	B-X
and	B-X
smaller	B-X
increases	B-X
in	B-X
tumor	B-X
necrosis	B-X
factor-α	B-X
,	B-X
monocyte	B-X
chemotactic	B-X
protein-1	B-X
,	B-X
IL-1β	B-X
,	B-X
brain-derived	B-X
neurotrophic	B-X
factor	B-X
,	B-X
IL-12p35/p40	B-X
and	B-X
IL-15	B-X
.	B-X
Although	B-X
many	B-X
of	B-X
these	B-X
cytokines	B-X
are	B-X
also	B-X
expressed	B-X
in	B-X
skeletal	B-X
muscle	B-X
,	B-X
not	B-X
all	B-X
are	B-X
released	B-X
from	B-X
skeletal	B-X
muscle	B-X
into	B-X
the	B-X
circulation	B-X
during	B-X
exercise	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
address	B-X
these	B-X
uncertainties	B-X
by	B-X
summarizing	B-X
the	B-X
capacity	B-X
of	B-X
skeletal	B-X
muscle	B-X
cells	B-X
to	B-X
produce	B-X
cytokines	B-X
,	B-X
analyzing	B-X
other	B-X
potential	B-X
cellular	B-X
sources	B-X
of	B-X
circulating	B-X
cytokines	B-X
during	B-X
exercise	B-X
,	B-X
and	B-X
discussing	B-X
the	B-X
soluble	B-X
factors	B-X
and	B-X
intracellular	B-X
signaling	B-X
pathways	B-X
that	B-X
regulate	B-X
cytokine	B-X
synthesis	B-X
(	B-X
e.g.	B-X
,	B-X
RNA-binding	B-X
proteins	B-X
,	B-X
microRNAs	B-X
,	B-X
suppressor	B-X
of	B-X
cytokine	B-X
signaling	B-X
proteins	B-X
,	B-X
soluble	B-X
receptors	B-X
)	B-X
.	B-X

Phosphorylation	O
of	O
CovR	B-Protein
,	O
a	O
global	O
response	O
regulator	O
,	O
had	O
no	O
effect	O
on	O
its	O
DNA	O
-	O
binding	O
affinity	O
.	O

The	O
fact	O
that	O
FimR	B-Protein
was	O
not	O
activated	O
by	O
phosphorylation	O
may	O
also	O
be	O
due	O
to	O
the	O
short	O
lifetime	O
of	O
the	O
phosphorylated	O
state	O
,	O
which	O
has	O
been	O
observed	O
in	O
other	O
bacteria	O
(	O
Stock	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aimed	B-X
to	B-X
clarify	B-X
which	B-X
cognitive	B-X
and	B-X
physical	B-X
factors	B-X
are	B-X
associated	B-X
with	B-X
the	B-X
need	B-X
for	B-X
toileting	B-X
assistance	B-X
in	B-X
stroke	B-X
patients	B-X
and	B-X
to	B-X
calculate	B-X
cut-off	B-X
values	B-X
for	B-X
discriminating	B-X
between	B-X
independent	B-X
supervision	B-X
and	B-X
dependent	B-X
toileting	B-X
ability	B-X
.	B-X

The	O
transcriptional	O
start	O
site	O
of	O
the	O
mfa1	B-Protein
gene	O
located	O
at	O
434	O
bp	O
upstream	O
of	O
the	O
putative	O
start	O
codon	O
was	O
detected	O
,	O
which	O
is	O
also	O
390	O
bp	O
upstream	O
of	O
the	O
site	O
previously	O
reported	O
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
transcriptional	O
site	O
revealed	O
here	O
is	O
confirmed	O
by	O
RT	O
-	O
PCR	O
analysis	O
.	O

Data	O
of	O
this	O
study	O
suggest	O
that	O
transcription	O
of	O
the	O
mfa1	B-Protein
gene	O
originated	O
at	O
a	O
distal	O
upstream	O
transcriptional	O
start	O
site	O
and	O
read	O
through	O
the	O
promoter	O
region	O
suggested	O
by	O
Park	O
et	O
al	O
.	O

(	O
2006	O
)	O
.	O
<EOS>	B-X
Antibody	B-X
mediated	B-X
rejection	B-X
:	B-X
update	B-X
2006	B-X
.	B-X
[	B-X
Celiac	B-X
disease	B-X
in	B-X
adults	B-X
in	B-X
2006	B-X
]	B-X
.	B-X
For	B-X
the	B-X
present	B-X
update	B-X
,	B-X
we	B-X
screened	B-X
the	B-X
journals	B-X
'Contact	B-X
Dermatitis	B-X
'	B-X
(	B-X
July	B-X
2000	B-X
to	B-X
December	B-X
2006	B-X
)	B-X
;	B-X
'Dermatitis	B-X
'	B-X
,	B-X
formerly	B-X
named	B-X
'American	B-X
Journal	B-X
of	B-X
Contact	B-X
Dermatitis	B-X
'	B-X
;	B-X
'La	B-X
Lettre	B-X
du	B-X
Gerda	B-X
'	B-X
(	B-X
January	B-X
2000	B-X
to	B-X
December	B-X
2006	B-X
)	B-X
;	B-X
and	B-X
also	B-X
included	B-X
relevant	B-X
articles	B-X
from	B-X
other	B-X
journals	B-X
published	B-X
during	B-X
the	B-X
same	B-X
period	B-X
.	B-X
This	B-X
paper	B-X
describes	B-X
the	B-X
large-scale	B-X
experimental	B-X
results	B-X
from	B-X
the	B-X
Face	B-X
Recognition	B-X
Vendor	B-X
Test	B-X
(	B-X
FRVT	B-X
)	B-X
2006	B-X
and	B-X
the	B-X
Iris	B-X
Challenge	B-X
Evaluation	B-X
(	B-X
ICE	B-X
)	B-X
2006	B-X
.	B-X
The	B-X
FRVT	B-X
2006	B-X
looked	B-X
at	B-X
recognition	B-X
from	B-X
high-resolution	B-X
still	B-X
frontal	B-X
face	B-X
images	B-X
and	B-X
3D	B-X
face	B-X
images	B-X
,	B-X
and	B-X
measured	B-X
performance	B-X
for	B-X
still	B-X
frontal	B-X
face	B-X
images	B-X
taken	B-X
under	B-X
controlled	B-X
and	B-X
uncontrolled	B-X
illumination	B-X
.	B-X
The	B-X
ICE	B-X
2006	B-X
evaluation	B-X
reported	B-X
verification	B-X
performance	B-X
for	B-X
both	B-X
left	B-X
and	B-X
right	B-X
irises	B-X
.	B-X
The	B-X
images	B-X
in	B-X
the	B-X
ICE	B-X
2006	B-X
intentionally	B-X
represent	B-X
a	B-X
broader	B-X
range	B-X
of	B-X
quality	B-X
than	B-X
the	B-X
ICE	B-X
2006	B-X
sensor	B-X
would	B-X
normally	B-X
acquire	B-X
.	B-X
The	B-X
FRVT	B-X
2006	B-X
results	B-X
from	B-X
controlled	B-X
still	B-X
and	B-X
3D	B-X
images	B-X
document	B-X
at	B-X
least	B-X
an	B-X
order-of-magnitude	B-X
improvement	B-X
in	B-X
recognition	B-X
performance	B-X
over	B-X
the	B-X
FRVT	B-X
2002	B-X
.	B-X
The	B-X
FRVT	B-X
2006	B-X
and	B-X
the	B-X
ICE	B-X
2006	B-X
compared	B-X
recognition	B-X
performance	B-X
from	B-X
high-resolution	B-X
still	B-X
frontal	B-X
face	B-X
images	B-X
,	B-X
3D	B-X
face	B-X
images	B-X
,	B-X
and	B-X
the	B-X
single-iris	B-X
images	B-X
.	B-X
On	B-X
the	B-X
FRVT	B-X
2006	B-X
and	B-X
the	B-X
ICE	B-X
2006	B-X
data	B-X
sets	B-X
,	B-X
recognition	B-X
performance	B-X
was	B-X
comparable	B-X
for	B-X
high-resolution	B-X
frontal	B-X
face	B-X
,	B-X
3D	B-X
face	B-X
,	B-X
and	B-X
the	B-X
iris	B-X
images	B-X
.	B-X

Moreover	O
,	O
FimR	B-Protein
appears	O
to	O
act	O
on	O
the	O
promoter	O
region	O
identified	O
here	O
,	O
suggesting	O
that	O
this	O
promoter	O
may	O
make	O
significant	O
contributions	O
toward	O
mfa1	B-Protein
expression	O
through	O
the	O
FimS	B-Protein
/	O
FimR	B-Protein
system	O
.	O

Gene	O
expression	O
under	O
the	O
control	O
of	O
two	O
promoters	O
is	O
not	O
uncommon	O
in	O
bacteria	O
.	O
<EOS>	B-X
This	B-X
unit	B-X
describes	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
by	B-X
placing	B-X
them	B-X
under	B-X
the	B-X
control	B-X
of	B-X
the	B-X
bacteriophage	B-X
T7	B-X
RNA	B-X
polymerase	B-X
.	B-X
Consequently	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
rifampicin	B-X
to	B-X
cells	B-X
that	B-X
are	B-X
producing	B-X
T7	B-X
RNA	B-X
polymerase	B-X
results	B-X
in	B-X
the	B-X
exclusive	B-X
expression	B-X
of	B-X
genes	B-X
under	B-X
the	B-X
control	B-X
of	B-X
a	B-X
T7	B-X
RNA	B-X
polymerase	B-X
promoter	B-X
(	B-X
p	B-X
(	B-X
T7	B-X
)	B-X
)	B-X
.	B-X
In	B-X
the	B-X
Basic	B-X
Protocol	B-X
,	B-X
two	B-X
plasmids	B-X
are	B-X
maintained	B-X
within	B-X
the	B-X
same	B-X
E.	B-X
coli	B-X
cell	B-X
.	B-X
One	B-X
(	B-X
the	B-X
expression	B-X
vector	B-X
)	B-X
contains	B-X
p	B-X
(	B-X
T7	B-X
)	B-X
upstream	B-X
of	B-X
the	B-X
gene	B-X
to	B-X
be	B-X
expressed	B-X
.	B-X
The	B-X
second	B-X
contains	B-X
the	B-X
T7	B-X
RNA	B-X
polymerase	B-X
gene	B-X
under	B-X
the	B-X
control	B-X
of	B-X
a	B-X
heat-inducible	B-X
E.	B-X
coli	B-X
promoter	B-X
.	B-X
Upon	B-X
heat	B-X
induction	B-X
,	B-X
the	B-X
T7	B-X
RNA	B-X
polymerase	B-X
is	B-X
produced	B-X
and	B-X
initiates	B-X
transcription	B-X
on	B-X
the	B-X
expression	B-X
vector	B-X
,	B-X
resulting	B-X
in	B-X
turn	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
gene	B-X
(	B-X
s	B-X
)	B-X
under	B-X
the	B-X
control	B-X
of	B-X
p	B-X
(	B-X
T7	B-X
)	B-X
.	B-X

In	O
E	O
.	O
coli	O
,	O
two	O
promoters	O
direct	O
transcription	O
of	O
acs	O
encoding	O
,	O
an	O
acetate	O
-	O
scavenging	O
enzyme	O
required	O
for	O
fitness	O
during	O
periods	O
of	O
carbon	O
starvation	O
-	O
the	O
distal	O
acsP1	B-Protein
and	O
the	O
proximal	O
acsP2	B-Protein
(	O
Beatty	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

It	O
is	O
suggested	O
that	O
each	O
promoter	O
may	O
interact	O
with	O
different	O
regulatory	O
elements	O
.	O
<EOS>	B-X
The	B-X
identities	B-X
of	B-X
different	B-X
cells	B-X
and	B-X
tissues	B-X
in	B-X
multicellular	B-X
organisms	B-X
are	B-X
determined	B-X
by	B-X
tightly	B-X
controlled	B-X
transcriptional	B-X
programs	B-X
that	B-X
enable	B-X
accurate	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
RNA	B-X
polymerase	B-X
II	B-X
(	B-X
Pol	B-X
II	B-X
)	B-X
core	B-X
promoter	B-X
establishes	B-X
the	B-X
center	B-X
of	B-X
this	B-X
spatiotemporally	B-X
orchestrated	B-X
molecular	B-X
machine	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
discuss	B-X
transcription	B-X
initiation	B-X
,	B-X
diversity	B-X
in	B-X
core	B-X
promoter	B-X
composition	B-X
,	B-X
interactions	B-X
of	B-X
the	B-X
basal	B-X
transcription	B-X
machinery	B-X
with	B-X
the	B-X
core	B-X
promoter	B-X
,	B-X
enhancer-promoter	B-X
specificity	B-X
,	B-X
core	B-X
promoter-preferential	B-X
activation	B-X
,	B-X
enhancer	B-X
RNAs	B-X
,	B-X
Pol	B-X
II	B-X
pausing	B-X
,	B-X
transcription	B-X
termination	B-X
,	B-X
Pol	B-X
II	B-X
recycling	B-X
and	B-X
translation	B-X
.	B-X
We	B-X
further	B-X
discuss	B-X
recent	B-X
findings	B-X
indicating	B-X
that	B-X
promoters	B-X
and	B-X
enhancers	B-X
share	B-X
similar	B-X
features	B-X
and	B-X
may	B-X
not	B-X
substantially	B-X
differ	B-X
from	B-X
each	B-X
other	B-X
,	B-X
as	B-X
previously	B-X
assumed	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
review	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
studies	B-X
that	B-X
highlight	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
core	B-X
promoter	B-X
and	B-X
its	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
metazoan	B-X
gene	B-X
expression	B-X
and	B-X
suggest	B-X
future	B-X
research	B-X
directions	B-X
and	B-X
challenges	B-X
.	B-X

Two	O
promoter	O
regions	O
in	O
the	O
P	O
.	O
gingivalis	O
fimA	B-Protein
gene	O
were	O
also	O
reported	O
(	O
Xie	O
&	O
Lamont	O
,	O
1999	O
;	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

A	O
cascade	O
regulation	O
starting	O
with	O
FimR	B-Protein
appears	O
to	O
act	O
on	O
the	O
upstream	O
promoter	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
observations	O
that	O
FimR	B-Protein
binds	O
only	O
to	O
the	O
upstream	O
promoter	O
region	O
of	O
the	O
mfa1	B-Protein
gene	O
and	O
that	O
activity	O
of	O
the	O
downstream	O
promoter	O
is	O
inhibited	O
by	O
S	O
.	O
gordonii	O
,	O
S	O
.	O
sanguinis	O
and	O
S	O
.	O
mitis	O
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
imply	O
the	O
complexity	O
of	O
regulation	O
of	O
mfa1	B-Protein
expression	O
.	O

It	O
is	O
possible	O
that	O
two	O
promoters	O
of	O
mfa1	B-Protein
are	O
regulated	O
in	O
response	O
to	O
different	O
environmental	O
signals	O
.	O

The	O
hypothesis	O
is	O
currently	O
under	O
investigation	O
.	O
<EOS>	B-X
Concerns	B-X
surrounding	B-X
the	B-X
potential	B-X
for	B-X
thrombotic	B-X
complications	B-X
have	B-X
raised	B-X
the	B-X
hypothesis	B-X
of	B-X
adjunctive	B-X
use	B-X
of	B-X
OAC	B-X
for	B-X
patients	B-X
with	B-X
no	B-X
baseline	B-X
indications	B-X
for	B-X
anticoagulation	B-X
.	B-X
Whether	B-X
direct	B-X
oral	B-X
anticoagulant	B-X
agents	B-X
achieve	B-X
better	B-X
outcomes	B-X
than	B-X
vitamin	B-X
K	B-X
antagonists	B-X
remains	B-X
under	B-X
investigation	B-X
.	B-X
While	B-X
investigations	B-X
of	B-X
the	B-X
biological	B-X
basis	B-X
of	B-X
the	B-X
connections	B-X
between	B-X
periodontal	B-X
diseases	B-X
and	B-X
systemic	B-X
conditions	B-X
generally	B-X
emphasized	B-X
the	B-X
bacteriome	B-X
,	B-X
it	B-X
is	B-X
also	B-X
biologically	B-X
plausible	B-X
,	B-X
under	B-X
an	B-X
analogous	B-X
hypothesis	B-X
,	B-X
that	B-X
other	B-X
types	B-X
of	B-X
organisms	B-X
may	B-X
have	B-X
a	B-X
similar	B-X
role	B-X
.	B-X
Following	B-X
cases	B-X
brought	B-X
some	B-X
hypothesis	B-X
to	B-X
explain	B-X
the	B-X
cause	B-X
due	B-X
to	B-X
similarity	B-X
to	B-X
other	B-X
neurological	B-X
diseases	B-X
and	B-X
led	B-X
to	B-X
further	B-X
investigation	B-X
for	B-X
metabolic	B-X
diseases	B-X
.	B-X
This	B-X
review	B-X
highlights	B-X
clinical	B-X
presentation	B-X
in	B-X
both	B-X
classic	B-X
and	B-X
atypical	B-X
phenotypes	B-X
,	B-X
the	B-X
investigation	B-X
pathway	B-X
throughout	B-X
confirmation	B-X
emphasizing	B-X
the	B-X
underlying	B-X
genetic	B-X
heterogeneity	B-X
and	B-X
increasing	B-X
number	B-X
of	B-X
genes	B-X
assigned	B-X
to	B-X
this	B-X
syndrome	B-X
as	B-X
well	B-X
as	B-X
available	B-X
treatment	B-X
.	B-X

In	O
conclusion	O
,	O
P	O
.	O
gingivalis	O
fimbriae	O
play	O
a	O
predominant	O
role	O
in	O
the	O
attachment	O
of	O
the	O
organism	O
to	O
a	O
variety	O
of	O
oral	O
surfaces	O
(	O
Lamont	O
&	O
Jenkinson	O
,	O
2000	O
;	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
although	O
other	O
surface	O
proteins	O
,	O
such	O
as	O
gingipains	O
,	O
may	O
also	O
be	O
involved	O
in	O
the	O
bacterial	O
colonization	O
(	O
Tokuda	O
et	O
al	O
.	O
,	O
1996	O
;	O
Chen	O
et	O
al	O
.	O
,	O
2001	O
)	O
.	O

It	O
has	O
been	O
recently	O
reported	O
by	O
the	O
authors	O
that	O
both	O
major	O
fimbriae	O
and	O
minor	O
fimbriae	O
contribute	O
to	O
the	O
formation	O
of	O
P	O
.	O
gingivalis	O
biofilm	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Major	O
fimbriae	O
are	O
required	O
for	O
initial	O
attachment	O
and	O
the	O
minor	O
fimbriae	O
appear	O
to	O
play	O
an	O
important	O
role	O
in	O
microcolony	O
formation	O
by	O
facilitating	O
cell	O
-	O
cell	O
interactions	O
.	O

The	O
data	O
presented	O
here	O
provide	O
evidence	O
that	O
these	O
two	O
distinct	O
fimbriae	O
are	O
under	O
the	O
control	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
:	O
FimS	B-Protein
/	O
FimR	B-Protein
.	O

Expression	O
of	O
major	B-Protein
fimbriae	I-Protein
(	O
FimA	B-Protein
)	O
is	O
extremely	O
low	O
in	O
the	O
fimR	B-Protein
mutant	O
,	O
and	O
minor	B-Protein
fimbriae	I-Protein
production	O
in	O
this	O
mutant	O
is	O
inhibited	O
by	O
least	O
50	O
%	O
.	O

Therefore	O
,	O
it	O
is	O
proposed	O
that	O
FimR	B-Protein
can	O
be	O
an	O
attractive	O
target	O
for	O
inhibition	O
of	O
P	O
.	O
gingivalis	O
colonization	O
.	O

Control	O
of	O
M	O
.	O
tuberculosis	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
Secretion	O
and	O
Specific	O
T	O
Cell	O
Recognition	O
by	O
PhoP	B-Protein
<EOS>	B-X
Analysis	B-X
of	B-X
mycobacterial	B-X
strains	B-X
that	B-X
have	B-X
lost	B-X
their	B-X
ability	B-X
to	B-X
cause	B-X
disease	B-X
is	B-X
a	B-X
powerful	B-X
approach	B-X
to	B-X
identify	B-X
yet	B-X
unknown	B-X
virulence	B-X
determinants	B-X
and	B-X
pathways	B-X
involved	B-X
in	B-X
tuberculosis	B-X
pathogenesis	B-X
.	B-X
Two	B-X
of	B-X
the	B-X
most	B-X
widely	B-X
used	B-X
attenuated	B-X
strains	B-X
in	B-X
the	B-X
history	B-X
of	B-X
tuberculosis	B-X
research	B-X
are	B-X
Mycobacterium	B-X
bovis	B-X
BCG	B-X
(	B-X
BCG	B-X
)	B-X
and	B-X
Mycobacterium	B-X
tuberculosis	B-X
H37Ra	B-X
(	B-X
H37Ra	B-X
)	B-X
,	B-X
which	B-X
both	B-X
lost	B-X
their	B-X
virulence	B-X
during	B-X
in	B-X
vitro	B-X
serial	B-X
passage	B-X
.	B-X
Whereas	B-X
the	B-X
attenuation	B-X
of	B-X
BCG	B-X
is	B-X
due	B-X
mainly	B-X
to	B-X
loss	B-X
of	B-X
the	B-X
ESAT-6	B-X
secretion	B-X
system	B-X
,	B-X
ESX-1	B-X
,	B-X
the	B-X
reason	B-X
why	B-X
H37Ra	B-X
is	B-X
attenuated	B-X
remained	B-X
unknown	B-X
.	B-X
However	B-X
,	B-X
here	B-X
we	B-X
show	B-X
that	B-X
a	B-X
point	B-X
mutation	B-X
(	B-X
S219L	B-X
)	B-X
in	B-X
the	B-X
predicted	B-X
DNA	B-X
binding	B-X
region	B-X
of	B-X
the	B-X
regulator	B-X
PhoP	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
attenuation	B-X
of	B-X
H37Ra	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
impacts	B-X
on	B-X
the	B-X
secretion	B-X
of	B-X
the	B-X
major	B-X
T	B-X
cell	B-X
antigen	B-X
ESAT-6	B-X
.	B-X
Only	B-X
H37Ra	B-X
``	B-X
knock-ins	B-X
''	B-X
that	B-X
carried	B-X
an	B-X
integrated	B-X
cosmid	B-X
with	B-X
the	B-X
wild-type	B-X
phoP	B-X
gene	B-X
from	B-X
M.	B-X
tuberculosis	B-X
H37Rv	B-X
showed	B-X
changes	B-X
in	B-X
colony	B-X
morphology	B-X
,	B-X
increased	B-X
virulence	B-X
,	B-X
ESAT-6	B-X
secretion	B-X
,	B-X
and	B-X
induction	B-X
of	B-X
specific	B-X
T	B-X
cell	B-X
responses	B-X
,	B-X
whereas	B-X
other	B-X
H37Ra	B-X
constructs	B-X
did	B-X
not	B-X
.	B-X
This	B-X
finding	B-X
established	B-X
a	B-X
link	B-X
between	B-X
the	B-X
PhoP	B-X
regulator	B-X
and	B-X
ESAT-6	B-X
secretion	B-X
that	B-X
opens	B-X
exciting	B-X
new	B-X
perspectives	B-X
for	B-X
elucidating	B-X
virulence	B-X
regulation	B-X
in	B-X
M.	B-X
tuberculosis	B-X
.	B-X

Analysis	O
of	O
mycobacterial	O
strains	O
that	O
have	O
lost	O
their	O
ability	O
to	O
cause	O
disease	O
is	O
a	O
powerful	O
approach	O
to	O
identify	O
yet	O
unknown	O
virulence	O
determinants	O
and	O
pathways	O
involved	O
in	O
tuberculosis	O
pathogenesis	O
.	O
<EOS>	B-X
Analysis	B-X
of	B-X
mycobacterial	B-X
strains	B-X
that	B-X
have	B-X
lost	B-X
their	B-X
ability	B-X
to	B-X
cause	B-X
disease	B-X
is	B-X
a	B-X
powerful	B-X
approach	B-X
to	B-X
identify	B-X
yet	B-X
unknown	B-X
virulence	B-X
determinants	B-X
and	B-X
pathways	B-X
involved	B-X
in	B-X
tuberculosis	B-X
pathogenesis	B-X
.	B-X
Two	B-X
of	B-X
the	B-X
most	B-X
widely	B-X
used	B-X
attenuated	B-X
strains	B-X
in	B-X
the	B-X
history	B-X
of	B-X
tuberculosis	B-X
research	B-X
are	B-X
Mycobacterium	B-X
bovis	B-X
BCG	B-X
(	B-X
BCG	B-X
)	B-X
and	B-X
Mycobacterium	B-X
tuberculosis	B-X
H37Ra	B-X
(	B-X
H37Ra	B-X
)	B-X
,	B-X
which	B-X
both	B-X
lost	B-X
their	B-X
virulence	B-X
during	B-X
in	B-X
vitro	B-X
serial	B-X
passage	B-X
.	B-X
Whereas	B-X
the	B-X
attenuation	B-X
of	B-X
BCG	B-X
is	B-X
due	B-X
mainly	B-X
to	B-X
loss	B-X
of	B-X
the	B-X
ESAT-6	B-X
secretion	B-X
system	B-X
,	B-X
ESX-1	B-X
,	B-X
the	B-X
reason	B-X
why	B-X
H37Ra	B-X
is	B-X
attenuated	B-X
remained	B-X
unknown	B-X
.	B-X
However	B-X
,	B-X
here	B-X
we	B-X
show	B-X
that	B-X
a	B-X
point	B-X
mutation	B-X
(	B-X
S219L	B-X
)	B-X
in	B-X
the	B-X
predicted	B-X
DNA	B-X
binding	B-X
region	B-X
of	B-X
the	B-X
regulator	B-X
PhoP	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
attenuation	B-X
of	B-X
H37Ra	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
impacts	B-X
on	B-X
the	B-X
secretion	B-X
of	B-X
the	B-X
major	B-X
T	B-X
cell	B-X
antigen	B-X
ESAT-6	B-X
.	B-X
Only	B-X
H37Ra	B-X
``	B-X
knock-ins	B-X
''	B-X
that	B-X
carried	B-X
an	B-X
integrated	B-X
cosmid	B-X
with	B-X
the	B-X
wild-type	B-X
phoP	B-X
gene	B-X
from	B-X
M.	B-X
tuberculosis	B-X
H37Rv	B-X
showed	B-X
changes	B-X
in	B-X
colony	B-X
morphology	B-X
,	B-X
increased	B-X
virulence	B-X
,	B-X
ESAT-6	B-X
secretion	B-X
,	B-X
and	B-X
induction	B-X
of	B-X
specific	B-X
T	B-X
cell	B-X
responses	B-X
,	B-X
whereas	B-X
other	B-X
H37Ra	B-X
constructs	B-X
did	B-X
not	B-X
.	B-X
This	B-X
finding	B-X
established	B-X
a	B-X
link	B-X
between	B-X
the	B-X
PhoP	B-X
regulator	B-X
and	B-X
ESAT-6	B-X
secretion	B-X
that	B-X
opens	B-X
exciting	B-X
new	B-X
perspectives	B-X
for	B-X
elucidating	B-X
virulence	B-X
regulation	B-X
in	B-X
M.	B-X
tuberculosis	B-X
.	B-X

Two	O
of	O
the	O
most	O
widely	O
used	O
attenuated	O
strains	O
in	O
the	O
history	O
of	O
tuberculosis	O
research	O
are	O
Mycobacterium	O
bovis	O
BCG	O
(	O
BCG	O
)	O
and	O
Mycobacterium	O
tuberculosis	O
H37Ra	O
(	O
H37Ra	O
)	O
,	O
which	O
both	O
lost	O
their	O
virulence	O
during	O
in	O
vitro	O
serial	O
passage	O
.	O
<EOS>	B-X
Analysis	B-X
of	B-X
mycobacterial	B-X
strains	B-X
that	B-X
have	B-X
lost	B-X
their	B-X
ability	B-X
to	B-X
cause	B-X
disease	B-X
is	B-X
a	B-X
powerful	B-X
approach	B-X
to	B-X
identify	B-X
yet	B-X
unknown	B-X
virulence	B-X
determinants	B-X
and	B-X
pathways	B-X
involved	B-X
in	B-X
tuberculosis	B-X
pathogenesis	B-X
.	B-X
Two	B-X
of	B-X
the	B-X
most	B-X
widely	B-X
used	B-X
attenuated	B-X
strains	B-X
in	B-X
the	B-X
history	B-X
of	B-X
tuberculosis	B-X
research	B-X
are	B-X
Mycobacterium	B-X
bovis	B-X
BCG	B-X
(	B-X
BCG	B-X
)	B-X
and	B-X
Mycobacterium	B-X
tuberculosis	B-X
H37Ra	B-X
(	B-X
H37Ra	B-X
)	B-X
,	B-X
which	B-X
both	B-X
lost	B-X
their	B-X
virulence	B-X
during	B-X
in	B-X
vitro	B-X
serial	B-X
passage	B-X
.	B-X
Whereas	B-X
the	B-X
attenuation	B-X
of	B-X
BCG	B-X
is	B-X
due	B-X
mainly	B-X
to	B-X
loss	B-X
of	B-X
the	B-X
ESAT-6	B-X
secretion	B-X
system	B-X
,	B-X
ESX-1	B-X
,	B-X
the	B-X
reason	B-X
why	B-X
H37Ra	B-X
is	B-X
attenuated	B-X
remained	B-X
unknown	B-X
.	B-X
However	B-X
,	B-X
here	B-X
we	B-X
show	B-X
that	B-X
a	B-X
point	B-X
mutation	B-X
(	B-X
S219L	B-X
)	B-X
in	B-X
the	B-X
predicted	B-X
DNA	B-X
binding	B-X
region	B-X
of	B-X
the	B-X
regulator	B-X
PhoP	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
attenuation	B-X
of	B-X
H37Ra	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
impacts	B-X
on	B-X
the	B-X
secretion	B-X
of	B-X
the	B-X
major	B-X
T	B-X
cell	B-X
antigen	B-X
ESAT-6	B-X
.	B-X
Only	B-X
H37Ra	B-X
``	B-X
knock-ins	B-X
''	B-X
that	B-X
carried	B-X
an	B-X
integrated	B-X
cosmid	B-X
with	B-X
the	B-X
wild-type	B-X
phoP	B-X
gene	B-X
from	B-X
M.	B-X
tuberculosis	B-X
H37Rv	B-X
showed	B-X
changes	B-X
in	B-X
colony	B-X
morphology	B-X
,	B-X
increased	B-X
virulence	B-X
,	B-X
ESAT-6	B-X
secretion	B-X
,	B-X
and	B-X
induction	B-X
of	B-X
specific	B-X
T	B-X
cell	B-X
responses	B-X
,	B-X
whereas	B-X
other	B-X
H37Ra	B-X
constructs	B-X
did	B-X
not	B-X
.	B-X
This	B-X
finding	B-X
established	B-X
a	B-X
link	B-X
between	B-X
the	B-X
PhoP	B-X
regulator	B-X
and	B-X
ESAT-6	B-X
secretion	B-X
that	B-X
opens	B-X
exciting	B-X
new	B-X
perspectives	B-X
for	B-X
elucidating	B-X
virulence	B-X
regulation	B-X
in	B-X
M.	B-X
tuberculosis	B-X
.	B-X

Whereas	O
the	O
attenuation	O
of	O
BCG	O
is	O
due	O
mainly	O
to	O
loss	O
of	O
the	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
system	O
,	O
ESX	B-Protein
-	I-Protein
1	I-Protein
,	O
the	O
reason	O
why	O
H37Ra	O
is	O
attenuated	O
remained	O
unknown	O
.	O
<EOS>	B-X
Analysis	B-X
of	B-X
mycobacterial	B-X
strains	B-X
that	B-X
have	B-X
lost	B-X
their	B-X
ability	B-X
to	B-X
cause	B-X
disease	B-X
is	B-X
a	B-X
powerful	B-X
approach	B-X
to	B-X
identify	B-X
yet	B-X
unknown	B-X
virulence	B-X
determinants	B-X
and	B-X
pathways	B-X
involved	B-X
in	B-X
tuberculosis	B-X
pathogenesis	B-X
.	B-X
Two	B-X
of	B-X
the	B-X
most	B-X
widely	B-X
used	B-X
attenuated	B-X
strains	B-X
in	B-X
the	B-X
history	B-X
of	B-X
tuberculosis	B-X
research	B-X
are	B-X
Mycobacterium	B-X
bovis	B-X
BCG	B-X
(	B-X
BCG	B-X
)	B-X
and	B-X
Mycobacterium	B-X
tuberculosis	B-X
H37Ra	B-X
(	B-X
H37Ra	B-X
)	B-X
,	B-X
which	B-X
both	B-X
lost	B-X
their	B-X
virulence	B-X
during	B-X
in	B-X
vitro	B-X
serial	B-X
passage	B-X
.	B-X
Whereas	B-X
the	B-X
attenuation	B-X
of	B-X
BCG	B-X
is	B-X
due	B-X
mainly	B-X
to	B-X
loss	B-X
of	B-X
the	B-X
ESAT-6	B-X
secretion	B-X
system	B-X
,	B-X
ESX-1	B-X
,	B-X
the	B-X
reason	B-X
why	B-X
H37Ra	B-X
is	B-X
attenuated	B-X
remained	B-X
unknown	B-X
.	B-X
However	B-X
,	B-X
here	B-X
we	B-X
show	B-X
that	B-X
a	B-X
point	B-X
mutation	B-X
(	B-X
S219L	B-X
)	B-X
in	B-X
the	B-X
predicted	B-X
DNA	B-X
binding	B-X
region	B-X
of	B-X
the	B-X
regulator	B-X
PhoP	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
attenuation	B-X
of	B-X
H37Ra	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
impacts	B-X
on	B-X
the	B-X
secretion	B-X
of	B-X
the	B-X
major	B-X
T	B-X
cell	B-X
antigen	B-X
ESAT-6	B-X
.	B-X
Only	B-X
H37Ra	B-X
``	B-X
knock-ins	B-X
''	B-X
that	B-X
carried	B-X
an	B-X
integrated	B-X
cosmid	B-X
with	B-X
the	B-X
wild-type	B-X
phoP	B-X
gene	B-X
from	B-X
M.	B-X
tuberculosis	B-X
H37Rv	B-X
showed	B-X
changes	B-X
in	B-X
colony	B-X
morphology	B-X
,	B-X
increased	B-X
virulence	B-X
,	B-X
ESAT-6	B-X
secretion	B-X
,	B-X
and	B-X
induction	B-X
of	B-X
specific	B-X
T	B-X
cell	B-X
responses	B-X
,	B-X
whereas	B-X
other	B-X
H37Ra	B-X
constructs	B-X
did	B-X
not	B-X
.	B-X
This	B-X
finding	B-X
established	B-X
a	B-X
link	B-X
between	B-X
the	B-X
PhoP	B-X
regulator	B-X
and	B-X
ESAT-6	B-X
secretion	B-X
that	B-X
opens	B-X
exciting	B-X
new	B-X
perspectives	B-X
for	B-X
elucidating	B-X
virulence	B-X
regulation	B-X
in	B-X
M.	B-X
tuberculosis	B-X
.	B-X

However	O
,	O
here	O
we	O
show	O
that	O
a	O
point	O
mutation	O
(	O
S219L	O
)	O
in	O
the	O
predicted	O
DNA	O
binding	O
region	O
of	O
the	O
regulator	O
PhoP	B-Protein
is	O
involved	O
in	O
the	O
attenuation	O
of	O
H37Ra	O
via	O
a	O
mechanism	O
that	O
impacts	O
on	O
the	O
secretion	O
of	O
the	O
major	O
T	O
cell	O
antigen	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
.	O

Only	O
H37Ra	O
"	O
knock	O
-	O
ins	O
"	O
that	O
carried	O
an	O
integrated	O
cosmid	O
with	O
the	O
wild	O
-	O
type	O
phoP	B-Protein
gene	O
from	O
M	O
.	O
tuberculosis	O
H37Rv	O
showed	O
changes	O
in	O
colony	O
morphology	O
,	O
increased	O
virulence	O
,	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
,	O
and	O
induction	O
of	O
specific	O
T	O
cell	O
responses	O
,	O
whereas	O
other	O
H37Ra	O
constructs	O
did	O
not	O
.	O

This	O
finding	O
established	O
a	O
link	O
between	O
the	O
PhoP	B-Protein
regulator	O
and	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
that	O
opens	O
exciting	O
new	O
perspectives	O
for	O
elucidating	O
virulence	O
regulation	O
in	O
M	O
.	O
tuberculosis	O
.	O

Introduction	O

125	O
years	O
of	O
intense	O
research	O
on	O
the	O
major	O
human	O
pathogen	O
Mycobacterium	O
tuberculosis	O
have	O
passed	O
since	O
its	O
discovery	O
by	O
Robert	O
Koch	O
,	O
resulting	O
in	O
a	O
huge	O
body	O
of	O
knowledge	O
.	O

In	O
spite	O
of	O
the	O
great	O
progress	O
that	O
has	O
been	O
made	O
in	O
the	O
understanding	O
of	O
some	O
basic	O
features	O
of	O
its	O
pathogenesis	O
,	O
tuberculosis	O
remains	O
a	O
major	O
threat	O
to	O
human	O
life	O
in	O
most	O
parts	O
of	O
the	O
world	O
.	O

Indeed	O
,	O
M	O
.	O
tuberculosis	O
has	O
retained	O
many	O
secrets	O
of	O
its	O
so	O
successful	O
pathogenic	O
lifecycle	O
.	O

Among	O
the	O
different	O
possibilities	O
to	O
obtain	O
new	O
insight	O
into	O
the	O
mechanisms	O
employed	O
by	O
M	O
.	O
tuberculosis	O
to	O
infect	O
its	O
host	O
,	O
the	O
analysis	O
of	O
attenuated	O
strains	O
is	O
one	O
promising	O
approach	O
,	O
and	O
there	O
are	O
some	O
well	O
-	O
documented	O
examples	O
of	O
laboratory	O
-	O
attenuated	O
strains	O
.	O

One	O
of	O
them	O
is	O
the	O
"	O
Bacille	O
de	O
Calmette	O
et	O
Guerin	O
"	O
(	O
BCG	O
)	O
,	O
which	O
was	O
originally	O
derived	O
in	O
1921	O
from	O
a	O
virulent	O
Mycobacterium	O
bovis	O
strain	O
by	O
230	O
passages	O
on	O
potato	O
-	O
glycerol	O
-	O
ox	O
bile	O
medium	O
[	O
1	O
]	O
.	O

The	O
genetic	O
lesions	O
of	O
BCG	O
have	O
recently	O
been	O
determined	O
[	O
2	O
-	O
4	O
]	O
,	O
revealing	O
that	O
the	O
loss	O
of	O
region	O
of	O
difference	O
1	O
(	O
RD1	O
)	O
,	O
which	O
encodes	O
part	O
of	O
the	O
ESX	O
-	O
1	O
secretion	O
system	O
[	O
5	O
]	O
,	O
was	O
one	O
of	O
the	O
key	O
events	O
in	O
its	O
attenuation	O
.	O

Another	O
famous	O
example	O
of	O
an	O
attenuated	O
strain	O
is	O
M	O
.	O
tuberculosis	O
H37Ra	O
(	O
"	O
a	O
"	O
for	O
avirulent	O
)	O
(	O
H37Ra	O
)	O
.	O

This	O
strain	O
was	O
obtained	O
in	O
1934	O
by	O
serial	O
passage	O
of	O
patient	O
isolate	O
M	O
.	O
tuberculosis	O
H37	O
through	O
media	O
with	O
different	O
pHs	O
[	O
6	O
]	O
and	O
since	O
then	O
has	O
been	O
widely	O
used	O
in	O
many	O
laboratories	O
in	O
the	O
world	O
.	O

Despite	O
its	O
long	O
use	O
,	O
the	O
reasons	O
for	O
its	O
stable	O
attenuation	O
have	O
not	O
yet	O
been	O
elucidated	O
.	O
<EOS>	B-X
Despite	B-X
the	B-X
introduction	B-X
in	B-X
medical	B-X
practice	B-X
of	B-X
many	B-X
drugs	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
chronic	B-X
HF	B-X
the	B-X
lethal	B-X
outcome	B-X
associated	B-X
with	B-X
HF	B-X
remains	B-X
high	B-X
nowadays	B-X
,	B-X
which	B-X
can	B-X
be	B-X
explained	B-X
by	B-X
complexity	B-X
of	B-X
remodeling	B-X
mechanisms	B-X
characteristic	B-X
for	B-X
development	B-X
of	B-X
HF	B-X
.	B-X
A	B-X
large	B-X
number	B-X
of	B-X
studies	B-X
in	B-X
patients	B-X
with	B-X
cardiovascular	B-X
disease	B-X
have	B-X
demonstrated	B-X
that	B-X
heart	B-X
rate	B-X
(	B-X
HR	B-X
)	B-X
is	B-X
a	B-X
very	B-X
important	B-X
and	B-X
major	B-X
independent	B-X
risk	B-X
factor	B-X
for	B-X
prognosis	B-X
,	B-X
because	B-X
lowering	B-X
of	B-X
HR	B-X
reduces	B-X
cardiac	B-X
work	B-X
and	B-X
diminished	B-X
myocardial	B-X
oxygen	B-X
requirement	B-X
.	B-X
The	B-X
complex	B-X
therapy	B-X
including	B-X
ivabradine	B-X
promotes	B-X
HR	B-X
fall	B-X
,	B-X
leading	B-X
in	B-X
reduction	B-X
of	B-X
attacks	B-X
of	B-X
a	B-X
stable	B-X
angina	B-X
and	B-X
improved	B-X
quality	B-X
of	B-X
life	B-X
.	B-X

As	O
H37Ra	O
is	O
derived	O
from	O
the	O
same	O
parent	O
strain	O
as	O
M	O
.	O
tuberculosis	O
H37Rv	O
(	O
"	O
v	O
"	O
for	O
virulent	O
)	O
(	O
H37Rv	O
)	O
,	O
the	O
sequenced	O
paradigm	O
strain	O
of	O
tuberculosis	O
research	O
[	O
7	O
]	O
,	O
genomic	O
comparisons	O
of	O
the	O
attenuated	O
and	O
virulent	O
variants	O
of	O
M	O
.	O
tuberculosis	O
H37	O
are	O
particularly	O
interesting	O
and	O
have	O
the	O
potential	O
to	O
identify	O
subtle	O
genetic	O
changes	O
that	O
might	O
be	O
responsible	O
for	O
the	O
phenotypic	O
differences	O
observed	O
between	O
the	O
two	O
strains	O
.	O

In	O
a	O
previous	O
study	O
we	O
have	O
tried	O
to	O
reveal	O
these	O
determinants	O
[	O
8	O
]	O
,	O
but	O
the	O
methods	O
employed	O
only	O
identified	O
large	O
genetic	O
polymorphisms	O
,	O
associated	O
with	O
IS6110	O
,	O
which	O
were	O
not	O
found	O
to	O
be	O
responsible	O
for	O
the	O
attenuation	O
of	O
H37Ra	O
[	O
8	O
]	O
.	O

In	O
another	O
study	O
,	O
Pascopella	O
et	O
al	O
.	O

[	O
9	O
]	O
transformed	O
a	O
cosmid	O
library	O
of	O
H37Rv	O
into	O
H37Ra	O
and	O
then	O
selected	O
for	O
clones	O
that	O
were	O
enriched	O
on	O
passage	O
through	O
the	O
mouse	O
.	O

A	O
number	O
of	O
overlapping	O
cosmid	O
clones	O
that	O
gave	O
enhanced	O
growth	O
and	O
survival	O
in	O
the	O
spleens	O
of	O
infected	O
mice	O
relative	O
to	O
that	O
of	O
wild	O
-	O
type	O
H37Ra	O
were	O
identified	O
[	O
9	O
]	O
.	O

However	O
,	O
the	O
effects	O
of	O
these	O
complementation	O
attempts	O
on	O
virulence	O
remained	O
limited	O
,	O
and	O
no	O
sequence	O
information	O
was	O
described	O
,	O
which	O
makes	O
it	O
difficult	O
now	O
to	O
identify	O
the	O
genes	O
implicated	O
.	O

H37Ra	O
was	O
also	O
the	O
subject	O
of	O
extensive	O
micro	O
-	O
array	O
based	O
analyses	O
,	O
including	O
whole	O
genome	O
comparative	O
DNA	O
/	O
DNA	O
analyses	O
[	O
10	O
]	O
and	O
transcriptional	O
studies	O
[	O
11	O
,	O
12	O
]	O
,	O
which	O
have	O
identified	O
some	O
candidate	O
genes	O
that	O
were	O
consistently	O
downregulated	O
.	O

However	O
,	O
a	O
definitive	O
conclusion	O
about	O
the	O
molecular	O
determinants	O
of	O
the	O
attenuation	O
could	O
not	O
be	O
drawn	O
.	O
<EOS>	B-X
However	B-X
,	B-X
subtle	B-X
alterations	B-X
in	B-X
the	B-X
temporal	B-X
neocortex	B-X
of	B-X
FCD	B-X
IIIa	B-X
renders	B-X
presurgical	B-X
diagnosis	B-X
and	B-X
definition	B-X
of	B-X
the	B-X
resective	B-X
range	B-X
challenging	B-X
.	B-X
A	B-X
definitive	B-X
conclusion	B-X
regarding	B-X
the	B-X
potential	B-X
for	B-X
the	B-X
presence	B-X
of	B-X
neutralizing	B-X
antibody	B-X
to	B-X
epitopes	B-X
of	B-X
the	B-X
V3	B-X
loop	B-X
to	B-X
attenuate	B-X
or	B-X
prevent	B-X
vertical	B-X
transmission	B-X
of	B-X
HIV	B-X
infection	B-X
can	B-X
not	B-X
be	B-X
made	B-X
based	B-X
on	B-X
the	B-X
results	B-X
of	B-X
these	B-X
four	B-X
studies	B-X
.	B-X
However	B-X
,	B-X
the	B-X
studies	B-X
provide	B-X
an	B-X
intriguing	B-X
suggestion	B-X
that	B-X
it	B-X
may	B-X
be	B-X
possible	B-X
to	B-X
identify	B-X
an	B-X
epitope	B-X
or	B-X
array	B-X
of	B-X
epitopes	B-X
from	B-X
the	B-X
V3	B-X
loop	B-X
of	B-X
judiciously	B-X
selected	B-X
HIV	B-X
isolates	B-X
that	B-X
could	B-X
induce	B-X
protective	B-X
immunity	B-X
against	B-X
HIV	B-X
.	B-X
The	B-X
former	B-X
conclusion	B-X
seems	B-X
to	B-X
be	B-X
supported	B-X
by	B-X
the	B-X
finding	B-X
of	B-X
HIV-specific	B-X
antibodies	B-X
in	B-X
seropositive	B-X
persons	B-X
'	B-X
saliva	B-X
and	B-X
breast	B-X
milk	B-X
,	B-X
both	B-X
of	B-X
which	B-X
have	B-X
relatively	B-X
low	B-X
infectivity	B-X
,	B-X
although	B-X
the	B-X
potential	B-X
neutralizing	B-X
activities	B-X
of	B-X
these	B-X
antibodies	B-X
have	B-X
not	B-X
been	B-X
adequately	B-X
evaluated	B-X
.	B-X

As	O
all	O
these	O
previous	O
attempts	O
have	O
failed	O
to	O
identify	O
the	O
genetic	O
basis	O
for	O
the	O
attenuation	O
,	O
we	O
subjected	O
H37Ra	O
to	O
microarray	O
-	O
based	O
DNA	O
re	O
-	O
sequencing	O
(	O
NimbleGen	O
Systems	O
)	O
.	O

This	O
technique	O
has	O
previously	O
permitted	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
of	O
a	O
PA	O
-	O
824	O
drug	O
resistant	O
mutant	O
strain	O
of	O
H37Rv	O
to	O
be	O
detected	O
[	O
13	O
]	O
.	O

This	O
approach	O
was	O
combined	O
with	O
gene	O
"	O
knock	O
-	O
in	O
"	O
strategies	O
,	O
to	O
complement	O
selected	O
lesions	O
,	O
that	O
allowed	O
recombinant	O
H37Ra	O
strains	O
to	O
be	O
engineered	O
,	O
whose	O
virulence	O
and	O
immunogenicity	O
were	O
then	O
evaluated	O
in	O
in	O
vitro	O
,	O
ex	O
vivo	O
and	O
animal	O
models	O
.	O

This	O
strategy	O
led	O
us	O
to	O
identify	O
and	O
characterize	O
a	O
point	O
mutation	O
in	O
the	O
phoP	B-Protein
/	O
phoR	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
of	O
H37Ra	O
that	O
has	O
uncovered	O
novel	O
regulatory	O
links	O
,	O
which	O
impact	O
on	O
the	O
secretion	O
and	O
T	O
cell	O
recognition	O
of	O
the	O
major	O
T	O
cell	O
antigens	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
CFP	B-Protein
-	I-Protein
10	I-Protein
.	O

Results	O

Microarray	O
-	O
Based	O
Comparative	O
Genome	O
Sequencing	O
of	O
M	O
.	O
tuberculosis	O
H37Ra	O
The	O
genome	O
-	O
wide	O
comparative	O
mutational	O
analysis	O
of	O
H37Ra	O
and	O
H37Rv	O
was	O
carried	O
out	O
by	O
NimbleGen	O
Systems	O
following	O
a	O
previously	O
published	O
method	O
[	O
13	O
]	O
.	O

Putative	O
SNPs	O
with	O
high	O
probability	O
scores	O
were	O
separated	O
into	O
synonymous	O
and	O
non	O
-	O
synonymous	O
SNPs	O
of	O
which	O
the	O
latter	O
were	O
verified	O
by	O
conventional	O
dye	O
terminator	O
cycle	O
sequencing	O
.	O

By	O
this	O
combined	O
approach	O
we	O
identified	O
13	O
non	O
-	O
synonymous	O
SNPs	O
that	O
differed	O
between	O
the	O
H37Ra	O
and	O
H37Rv	O
strains	O
used	O
(	O
Table	O
S1	O
)	O
.	O

We	O
were	O
particularly	O
interested	O
in	O
a	O
C	O
to	O
T	O
mutation	O
responsible	O
for	O
the	O
serine	O
to	O
leucine	O
replacement	O
at	O
position	O
219	O
,	O
S219L	O
,	O
of	O
the	O
two	O
-	O
component	O
regulator	O
PhoP	B-Protein
as	O
this	O
protein	O
is	O
well	O
known	O
for	O
its	O
involvement	O
in	O
the	O
virulent	O
phenotype	O
of	O
M	O
.	O
tuberculosis	O
[	O
14	O
]	O
.	O

Importantly	O
,	O
on	O
inspection	O
of	O
the	O
structure	O
of	O
the	O
PhoP	B-Protein
-	O
ortholog	O
from	O
Bacillus	O
subtilis	O
,	O
it	O
was	O
found	O
that	O
the	O
equivalent	O
residue	O
Ser	O
207	O
is	O
a	O
main	O
residue	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
,	O
helix	O
alpha3	O
[	O
15	O
]	O
.	O

For	O
the	O
other	O
13	O
genes	O
we	O
found	O
no	O
indication	O
that	O
would	O
identify	O
them	O
as	O
potential	O
virulence	O
genes	O
,	O
as	O
none	O
of	O
them	O
belong	O
to	O
the	O
5	O
%	O
of	O
genes	O
that	O
were	O
previously	O
determined	O
by	O
transposon	O
site	O
hybridization	O
(	O
TraSH	O
)	O
as	O
being	O
essential	O
for	O
in	O
vivo	O
growth	O
of	O
M	O
.	O
tuberculosis	O
[	O
16	O
]	O
.	O

While	O
writing	O
this	O
article	O
,	O
the	O
whole	O
genome	O
sequence	O
of	O
H37Ra	O
became	O
publicly	O
available	O
(	O
NC	O
_	O
009525	O
)	O
,	O
and	O
comparison	O
of	O
the	O
SNP	O
data	O
obtained	O
from	O
the	O
H37Ra	O
strain	O
used	O
in	O
our	O
laboratory	O
(	O
Table	O
S1	O
)	O
with	O
the	O
NC	O
_	O
009525	O
data	O
,	O
showed	O
that	O
some	O
differences	O
existed	O
between	O
the	O
H37Ra	O
strains	O
,	O
a	O
phenomenon	O
which	O
was	O
also	O
previously	O
observed	O
for	O
BCG	O
[	O
4	O
]	O
and	O
H37Rv	O
[	O
17	O
]	O
.	O

Nevertheless	O
,	O
the	O
S129L	O
mutation	O
in	O
PhoP	B-Protein
,	O
which	O
we	O
consider	O
an	O
important	O
SNP	O
involved	O
in	O
the	O
attenuation	O
and	O
reduced	O
immunogenicity	O
of	O
H37Ra	O
,	O
is	O
identical	O
in	O
all	O
H37Ra	O
strains	O
.	O

Rationale	O
for	O
Knock	O
-	O
Ins	O

To	O
evaluate	O
the	O
phenotypic	O
effect	O
of	O
the	O
different	O
SNPs	O
and	O
to	O
assess	O
their	O
potential	O
contribution	O
to	O
the	O
attenuation	O
process	O
,	O
we	O
undertook	O
functional	O
genomic	O
analyses	O
using	O
knock	O
-	O
ins	O
of	O
H37Ra	O
,	O
as	O
described	O
previously	O
[	O
18	O
]	O
.	O

Clones	O
spanning	O
the	O
different	O
genomic	O
regions	O
of	O
non	O
-	O
synonymous	O
SNPs	O
were	O
selected	O
from	O
an	O
ordered	O
H37Rv	O
library	O
of	O
integrating	O
shuttle	O
cosmids	O
[	O
7	O
,	O
19	O
]	O
and	O
individually	O
electroporated	O
into	O
H37Ra	O
,	O
where	O
they	O
inserted	O
stably	O
into	O
the	O
attB	O
site	O
.	O

By	O
this	O
approach	O
we	O
obtained	O
appropriately	O
complemented	O
transformants	O
for	O
the	O
SNPs	O
in	O
genes	O
fadE5	B-Protein
,	O
rpsL	B-Protein
,	O
and	O
phoP	B-Protein
(	O
Table	O
S1	O
)	O
,	O
using	O
cosmids	O
I230	O
,	O
I563	O
,	O
and	O
I36	O
,	O
respectively	O
.	O

Based	O
on	O
the	O
known	O
role	O
of	O
phoP	B-Protein
in	O
virulence	O
[	O
14	O
]	O
,	O
the	O
H37Ra	O
strain	O
complemented	O
with	O
I36	O
(	O
H37Ra	O
:	O
:	O
phoP	B-Protein
)	O
was	O
accorded	O
highest	O
priority	O
for	O
further	O
molecular	O
characterization	O
and	O
functional	O
analyses	O
,	O
whereas	O
the	O
two	O
other	O
recombinants	O
(	O
H37Ra	O
:	O
:	O
fadE5	B-Protein
,	O
H37Ra	O
:	O
:	O
rpsL	B-Protein
)	O
served	O
as	O
controls	O
.	O

Figure	O
S1	O
shows	O
part	O
of	O
the	O
nucleotide	O
sequence	O
of	O
a	O
PCR	O
-	O
amplified	O
fragment	O
obtained	O
from	O
H37Ra	O
:	O
:	O
phoP	B-Protein
.	O

It	O
is	O
clearly	O
visible	O
that	O
at	O
nucleotide	O
position	O
656	O
of	O
phoP	B-Protein
two	O
peaks	O
exist	O
,	O
one	O
originating	O
from	O
the	O
SNP	O
present	O
in	O
H37Ra	O
and	O
one	O
from	O
the	O
integrated	O
cosmid	O
I36	O
carrying	O
the	O
H37Rv	O
wild	O
-	O
type	O
copy	O
of	O
phoP	B-Protein
.	O

Similar	O
results	O
were	O
also	O
obtained	O
for	O
the	O
SNPs	O
in	O
fadE5	B-Protein
and	O
rpsL	B-Protein
using	O
cosmids	O
I230	O
and	O
I563	O
,	O
respectively	O
(	O
Figure	O
S1	O
)	O
.	O

Correct	O
integration	O
of	O
I36	O
was	O
also	O
confirmed	O
by	O
Southern	O
blot	O
.	O

As	O
depicted	O
in	O
Figure	O
S2	O
,	O
hybridization	O
of	O
SpeI	B-Protein
-	O
digested	O
genomic	O
DNA	O
with	O
a	O
32P	O
labeled	O
phoP	B-Protein
probe	O
resulted	O
in	O
two	O
bands	O
of	O
different	O
sizes	O
,	O
one	O
corresponding	O
to	O
the	O
SpeI	B-Protein
fragment	O
harboring	O
the	O
H37Ra	O
phoP	B-Protein
gene	O
(	O
50	O
kb	O
)	O
,	O
and	O
the	O
other	O
to	O
the	O
larger	O
SpeI	B-Protein
fragment	O
created	O
by	O
integration	O
of	O
the	O
I36	O
cosmid	O
into	O
the	O
genome	O
of	O
H37Ra	O
at	O
the	O
attB	O
site	O
.	O

The	O
successful	O
integration	O
of	O
the	O
cosmid	O
was	O
also	O
reflected	O
by	O
a	O
change	O
in	O
colony	O
morphology	O
that	O
is	O
shown	O
in	O
Figure	O
S3	O
.	O

Indeed	O
,	O
Steenken	O
and	O
colleagues	O
originally	O
selected	O
the	O
H37Ra	O
mutants	O
mainly	O
on	O
the	O
basis	O
of	O
the	O
changes	O
in	O
colony	O
morphology	O
[	O
6	O
]	O
.	O

Ex	O
Vivo	O
Virulence	O
Studies	O
<EOS>	B-X
Experimental	B-X
tick	B-X
and	B-X
mammal	B-X
models	B-X
of	B-X
infection	B-X
can	B-X
be	B-X
used	B-X
to	B-X
characterize	B-X
determinants	B-X
of	B-X
infection	B-X
,	B-X
transmission	B-X
,	B-X
and	B-X
virulence	B-X
and	B-X
to	B-X
test	B-X
candidate	B-X
countermeasures	B-X
.	B-X
Ex	B-X
vivo	B-X
mucosal	B-X
explants	B-X
have	B-X
become	B-X
a	B-X
mainstay	B-X
of	B-X
HIV-1	B-X
studies	B-X
using	B-X
human	B-X
tissue	B-X
.	B-X

Changes	O
in	O
the	O
regulatory	O
potential	O
of	O
a	O
pathogen	O
are	O
often	O
accompanied	O
by	O
altered	O
virulence	O
.	O
<EOS>	B-X
The	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
virulence	B-X
factor	B-X
for	B-X
Shigella	B-X
flexneri	B-X
,	B-X
providing	B-X
a	B-X
conduit	B-X
through	B-X
which	B-X
host-altering	B-X
effectors	B-X
are	B-X
injected	B-X
directly	B-X
into	B-X
a	B-X
host	B-X
cell	B-X
to	B-X
promote	B-X
uptake	B-X
.	B-X
The	B-X
type	B-X
III	B-X
secretion	B-X
apparatus	B-X
(	B-X
T3SA	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
a	B-X
basal	B-X
body	B-X
,	B-X
external	B-X
needle	B-X
,	B-X
and	B-X
regulatory	B-X
tip	B-X
complex	B-X
.	B-X
Furthermore	B-X
,	B-X
intramolecular	B-X
FRET	B-X
measurements	B-X
indicated	B-X
that	B-X
movement	B-X
of	B-X
the	B-X
IpaD	B-X
distal	B-X
domain	B-X
away	B-X
from	B-X
the	B-X
protein	B-X
core	B-X
accompanied	B-X
the	B-X
binding	B-X
of	B-X
IpaB11-226	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
new	B-X
findings	B-X
provide	B-X
important	B-X
new	B-X
insight	B-X
into	B-X
the	B-X
interactions	B-X
and	B-X
potential	B-X
mechanisms	B-X
that	B-X
define	B-X
the	B-X
maturation	B-X
of	B-X
the	B-X
Shigella	B-X
T3SA	B-X
needle	B-X
tip	B-X
complex	B-X
and	B-X
provide	B-X
a	B-X
foundation	B-X
for	B-X
further	B-X
studies	B-X
probing	B-X
T3SS	B-X
activation	B-X
.	B-X

In	O
a	O
first	O
attempt	O
to	O
determine	O
the	O
virulence	O
of	O
the	O
complemented	O
H37Ra	O
knock	O
-	O
in	O
strains	O
relative	O
to	O
wild	O
-	O
type	O
H37Ra	O
and	O
H37Rv	O
,	O
bone	O
marrow	O
-	O
derived	O
murine	O
macrophages	O
(	O
BMM	O
)	O
were	O
infected	O
with	O
the	O
different	O
strains	O
at	O
a	O
multiplicity	O
of	O
infection	O
(	O
MOI	O
)	O
of	O
1	O
:	O
1	O
and	O
10	O
:	O
1	O
bacteria	O
per	O
cell	O
.	O

As	O
depicted	O
in	O
Figure	O
1	O
,	O
macrophages	O
were	O
able	O
to	O
control	O
ex	O
vivo	O
growth	O
of	O
H37Ra	O
,	O
but	O
failed	O
to	O
control	O
growth	O
of	O
H37Rv	O
,	O
confirming	O
results	O
from	O
Freeman	O
and	O
colleagues	O
[	O
20	O
]	O
.	O

When	O
H37Ra	O
knock	O
-	O
ins	O
were	O
tested	O
,	O
important	O
differences	O
in	O
their	O
ex	O
vivo	O
growth	O
characteristics	O
were	O
found	O
.	O

Whereas	O
H37Ra	O
:	O
:	O
fadE5	B-Protein
(	O
Figure	O
1	O
)	O
and	O
H37Ra	O
:	O
:	O
rpsL	B-Protein
(	O
unpublished	O
data	O
)	O
showed	O
very	O
little	O
or	O
no	O
growth	O
over	O
the	O
7	O
-	O
d	O
period	O
,	O
the	O
H37Ra	O
:	O
:	O
phoP	B-Protein
mutant	O
grew	O
more	O
vigorously	O
,	O
with	O
a	O
7	O
.	O
5	O
-	O
fold	O
increase	O
in	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
over	O
the	O
7	O
-	O
d	O
period	O
.	O

From	O
these	O
experiments	O
we	O
concluded	O
that	O
complementation	O
of	O
H37Ra	O
with	O
the	O
phoP	B-Protein
wild	O
-	O
type	O
copy	O
partially	O
restored	O
its	O
virulence	O
,	O
but	O
not	O
to	O
the	O
extent	O
of	O
the	O
fully	O
virulent	O
H37Rv	O
strain	O
.	O

Virulence	O
Studies	O
of	O
H37Ra	O
Complemented	O
Mutants	O
in	O
a	O
Mouse	O
Model	O

Further	O
assessment	O
of	O
the	O
in	O
vivo	O
growth	O
of	O
different	O
H37Ra	O
knock	O
-	O
in	O
strains	O
was	O
carried	O
out	O
by	O
intravenous	O
infection	O
of	O
severe	O
combined	O
immuno	O
-	O
deficient	O
(	O
SCID	O
)	O
mice	O
.	O

Complementation	O
of	O
H37Ra	O
with	O
the	O
PhoP	B-Protein
-	O
expressing	O
cosmid	O
increased	O
the	O
virulence	O
of	O
the	O
H37Ra	O
:	O
:	O
phoP	B-Protein
recombinant	O
relative	O
to	O
H37Ra	O
,	O
resulting	O
in	O
a	O
1	O
.	O
0	O
log	O
and	O
0	O
.	O
5	O
log	O
increase	O
in	O
CFU	O
number	O
in	O
lungs	O
and	O
spleens	O
,	O
respectively	O
.	O

In	O
contrast	O
,	O
no	O
effects	O
on	O
the	O
virulence	O
were	O
observed	O
when	O
H37Ra	O
was	O
complemented	O
with	O
fadE5	B-Protein
(	O
Figure	O
2	O
)	O
or	O
rpsL	B-Protein
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
as	O
already	O
observed	O
in	O
macrophages	O
,	O
integration	O
of	O
phoP	B-Protein
did	O
not	O
restore	O
levels	O
of	O
virulence	O
to	O
those	O
of	O
the	O
reference	O
strain	O
H37Rv	O
(	O
Figure	O
2	O
)	O
.	O

This	O
situation	O
is	O
also	O
reflected	O
in	O
the	O
sizes	O
of	O
spleens	O
,	O
which	O
correlate	O
with	O
the	O
CFU	O
data	O
in	O
spleens	O
(	O
Figure	O
S4	O
)	O
.	O

Together	O
with	O
the	O
data	O
from	O
the	O
macrophage	O
infection	O
assay	O
,	O
the	O
results	O
from	O
the	O
mouse	O
infection	O
show	O
that	O
the	O
S219L	O
mutation	O
in	O
the	O
phoP	B-Protein
gene	O
definitely	O
represents	O
one	O
genetic	O
lesion	O
that	O
contributed	O
to	O
the	O
attenuation	O
of	O
the	O
H37Ra	O
strain	O
.	O

Link	O
between	O
Mutation	O
in	O
phoP	B-Protein
and	O
Secretion	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
<EOS>	B-X
Whereas	B-X
the	B-X
attenuation	B-X
of	B-X
BCG	B-X
is	B-X
due	B-X
mainly	B-X
to	B-X
loss	B-X
of	B-X
the	B-X
ESAT-6	B-X
secretion	B-X
system	B-X
,	B-X
ESX-1	B-X
,	B-X
the	B-X
reason	B-X
why	B-X
H37Ra	B-X
is	B-X
attenuated	B-X
remained	B-X
unknown	B-X
.	B-X
However	B-X
,	B-X
here	B-X
we	B-X
show	B-X
that	B-X
a	B-X
point	B-X
mutation	B-X
(	B-X
S219L	B-X
)	B-X
in	B-X
the	B-X
predicted	B-X
DNA	B-X
binding	B-X
region	B-X
of	B-X
the	B-X
regulator	B-X
PhoP	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
attenuation	B-X
of	B-X
H37Ra	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
impacts	B-X
on	B-X
the	B-X
secretion	B-X
of	B-X
the	B-X
major	B-X
T	B-X
cell	B-X
antigen	B-X
ESAT-6	B-X
.	B-X
Only	B-X
H37Ra	B-X
``	B-X
knock-ins	B-X
''	B-X
that	B-X
carried	B-X
an	B-X
integrated	B-X
cosmid	B-X
with	B-X
the	B-X
wild-type	B-X
phoP	B-X
gene	B-X
from	B-X
M.	B-X
tuberculosis	B-X
H37Rv	B-X
showed	B-X
changes	B-X
in	B-X
colony	B-X
morphology	B-X
,	B-X
increased	B-X
virulence	B-X
,	B-X
ESAT-6	B-X
secretion	B-X
,	B-X
and	B-X
induction	B-X
of	B-X
specific	B-X
T	B-X
cell	B-X
responses	B-X
,	B-X
whereas	B-X
other	B-X
H37Ra	B-X
constructs	B-X
did	B-X
not	B-X
.	B-X
This	B-X
finding	B-X
established	B-X
a	B-X
link	B-X
between	B-X
the	B-X
PhoP	B-X
regulator	B-X
and	B-X
ESAT-6	B-X
secretion	B-X
that	B-X
opens	B-X
exciting	B-X
new	B-X
perspectives	B-X
for	B-X
elucidating	B-X
virulence	B-X
regulation	B-X
in	B-X
M.	B-X
tuberculosis	B-X
.	B-X

As	O
PhoP	B-Protein
fulfills	O
important	O
regulatory	O
functions	O
in	O
M	O
.	O
tuberculosis	O
[	O
21	O
,	O
22	O
]	O
,	O
it	O
was	O
of	O
primary	O
interest	O
to	O
identify	O
and	O
study	O
potential	O
effector	O
molecules	O
whose	O
involvement	O
in	O
host	O
pathogen	O
interaction	O
were	O
influenced	O
by	O
the	O
point	O
mutation	O
in	O
phoP	B-Protein
of	O
H37Ra	O
.	O

Since	O
secreted	O
proteins	O
of	O
the	O
ESX	O
-	O
1	O
system	O
of	O
M	O
.	O
tuberculosis	O
constitute	O
a	O
major	O
interface	O
between	O
the	O
bacterium	O
and	O
its	O
host	O
[	O
23	O
]	O
,	O
we	O
analyzed	O
the	O
different	O
strains	O
for	O
their	O
potential	O
to	O
induce	O
T	O
cell	O
responses	O
against	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
its	O
binding	O
partner	O
,	O
the	O
10	O
-	O
kD	O
culture	O
filtrate	O
protein	O
CFP	B-Protein
-	I-Protein
10	I-Protein
.	O

Groups	O
of	O
C57BL	O
/	O
6	O
mice	O
were	O
subcutaneously	O
inoculated	O
with	O
H37Rv	O
,	O
H37Ra	O
,	O
or	O
one	O
of	O
three	O
recombinant	O
H37Ra	O
strains	O
complemented	O
with	O
phoP	B-Protein
,	O
fadE5	B-Protein
,	O
or	O
rpsL	B-Protein
,	O
respectively	O
.	O
<EOS>	B-X
Molecular	B-X
analysis	B-X
of	B-X
the	B-X
rpsL	B-X
gene	B-X
has	B-X
been	B-X
used	B-X
widely	B-X
in	B-X
diagnosing	B-X
streptomycin-resistant	B-X
MTB	B-X
since	B-X
it	B-X
is	B-X
rapid	B-X
and	B-X
specific	B-X
.	B-X
The	B-X
aim	B-X
of	B-X
the	B-X
present	B-X
study	B-X
was	B-X
to	B-X
perform	B-X
a	B-X
meta-analysis	B-X
to	B-X
assess	B-X
the	B-X
accuracy	B-X
of	B-X
molecular	B-X
assay	B-X
of	B-X
the	B-X
rpsL	B-X
gene	B-X
for	B-X
the	B-X
rapid	B-X
detection	B-X
of	B-X
streptomycin-resistant	B-X
MTB	B-X
.	B-X
It	B-X
can	B-X
mostly	B-X
be	B-X
caused	B-X
by	B-X
mutations	B-X
in	B-X
four	B-X
genes	B-X
with	B-X
the	B-X
names	B-X
rpsL	B-X
,	B-X
rrs	B-X
,	B-X
gidB	B-X
,	B-X
and	B-X
whiB7	B-X
.	B-X
The	B-X
main	B-X
objective	B-X
of	B-X
this	B-X
study	B-X
was	B-X
the	B-X
evaluation	B-X
of	B-X
the	B-X
type	B-X
and	B-X
frequency	B-X
of	B-X
mutations	B-X
in	B-X
these	B-X
mentioned	B-X
genes	B-X
using	B-X
the	B-X
PCR-sequencing	B-X
method	B-X
.	B-X
Among	B-X
resistant	B-X
isolates	B-X
,	B-X
11	B-X
samples	B-X
contained	B-X
mutations	B-X
in	B-X
codon	B-X
43	B-X
of	B-X
the	B-X
rpsL	B-X
gene	B-X
,	B-X
which	B-X
caused	B-X
the	B-X
lysine	B-X
to	B-X
be	B-X
converted	B-X
to	B-X
arginine	B-X
.	B-X
Missense	B-X
mutations	B-X
in	B-X
codons	B-X
92	B-X
and	B-X
20	B-X
of	B-X
this	B-X
gene	B-X
result	B-X
in	B-X
the	B-X
amino	B-X
acids	B-X
Glutamic	B-X
acid	B-X
or	B-X
Arginine	B-X
being	B-X
changed	B-X
to	B-X
Aspartic	B-X
acid	B-X
or	B-X
Proline	B-X
,	B-X
respectively	B-X
.	B-X
Simultaneous	B-X
mutations	B-X
of	B-X
rpsL	B-X
and	B-X
gidB	B-X
were	B-X
found	B-X
in	B-X
10	B-X
isolates	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
which	B-X
were	B-X
Beijing	B-X
strain	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
the	B-X
mutations	B-X
of	B-X
rpsL	B-X
and	B-X
gidB	B-X
genes	B-X
are	B-X
mostly	B-X
responsible	B-X
for	B-X
the	B-X
streptomycin	B-X
resistance	B-X
in	B-X
the	B-X
evaluated	B-X
MTB	B-X
isolates	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
discovery	B-X
of	B-X
dual	B-X
mutations	B-X
in	B-X
Beijing	B-X
strains	B-X
highlights	B-X
the	B-X
strain	B-X
's	B-X
considerable	B-X
potential	B-X
for	B-X
developing	B-X
Tuberculosis	B-X
drug	B-X
resistance	B-X
.	B-X

Two	O
weeks	O
after	O
vaccination	O
we	O
assessed	O
the	O
interferon	B-Protein
-	I-Protein
gamma	I-Protein
(	O
IFN	B-Protein
-	I-Protein
gamma	I-Protein
)	O
production	O
of	O
splenocytes	O
mounted	O
against	O
ESX	O
-	O
1	O
antigens	O
or	O
controls	O
.	O
<EOS>	B-X
There	B-X
are	B-X
two	B-X
common	B-X
misconceptions	B-X
about	B-X
case-control	B-X
studies	B-X
:	B-X
that	B-X
matching	B-X
in	B-X
itself	B-X
eliminates	B-X
(	B-X
controls	B-X
)	B-X
confounding	B-X
by	B-X
the	B-X
matching	B-X
factors	B-X
,	B-X
and	B-X
that	B-X
if	B-X
matching	B-X
has	B-X
been	B-X
performed	B-X
,	B-X
then	B-X
a	B-X
“	B-X
matched	B-X
analysis	B-X
”	B-X
is	B-X
required	B-X
.	B-X
In	B-X
2012	B-X
,	B-X
a	B-X
group	B-X
of	B-X
experts	B-X
met	B-X
to	B-X
review	B-X
recent	B-X
experience	B-X
with	B-X
case-control	B-X
studies	B-X
evaluating	B-X
the	B-X
effectiveness	B-X
of	B-X
several	B-X
vaccines	B-X
;	B-X
here	B-X
we	B-X
summarize	B-X
the	B-X
recommendations	B-X
of	B-X
that	B-X
group	B-X
regarding	B-X
best	B-X
practices	B-X
for	B-X
planning	B-X
,	B-X
design	B-X
and	B-X
enrollment	B-X
of	B-X
cases	B-X
and	B-X
controls	B-X
.	B-X
Rigorous	B-X
planning	B-X
and	B-X
preparation	B-X
should	B-X
focus	B-X
on	B-X
understanding	B-X
the	B-X
study	B-X
context	B-X
including	B-X
healthcare-seeking	B-X
and	B-X
vaccination	B-X
practices	B-X
.	B-X
Endpoints	B-X
specific	B-X
to	B-X
the	B-X
vaccine	B-X
target	B-X
are	B-X
preferable	B-X
to	B-X
non-specific	B-X
clinical	B-X
syndromes	B-X
since	B-X
the	B-X
proportion	B-X
of	B-X
non-specific	B-X
outcomes	B-X
preventable	B-X
through	B-X
vaccination	B-X
may	B-X
vary	B-X
over	B-X
time	B-X
and	B-X
place	B-X
,	B-X
leading	B-X
to	B-X
potentially	B-X
confusing	B-X
results	B-X
.	B-X
Matching	B-X
of	B-X
controls	B-X
to	B-X
cases	B-X
for	B-X
potential	B-X
confounding	B-X
factors	B-X
is	B-X
commonly	B-X
used	B-X
,	B-X
although	B-X
should	B-X
be	B-X
reserved	B-X
for	B-X
a	B-X
limited	B-X
number	B-X
of	B-X
key	B-X
variables	B-X
believed	B-X
to	B-X
be	B-X
linked	B-X
to	B-X
both	B-X
vaccination	B-X
and	B-X
disease	B-X
.	B-X

As	O
anticipated	O
,	O
all	O
tested	O
strains	O
induced	O
IFN	B-Protein
-	I-Protein
gamma	I-Protein
production	O
in	O
response	O
to	O
purified	O
protein	O
derivative	O
(	O
PPD	O
)	O
but	O
not	O
to	O
a	O
control	O
peptide	O
(	O
Mal	O
-	O
E	O
)	O
,	O
indicating	O
successful	O
vaccination	O
(	O
Figure	O
3	O
)	O
.	O

Most	O
importantly	O
,	O
the	O
various	O
strains	O
differed	O
extensively	O
in	O
their	O
potential	O
to	O
induce	O
antigen	O
specific	O
T	O
cell	O
responses	O
towards	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
CFP	B-Protein
-	I-Protein
10	I-Protein
.	O

As	O
shown	O
in	O
Figure	O
3	O
,	O
splenocytes	O
from	O
mice	O
that	O
were	O
inoculated	O
with	O
H37Rv	O
produced	O
high	O
amounts	O
of	O
IFN	B-Protein
-	I-Protein
gamma	I-Protein
upon	O
stimulation	O
with	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
or	O
CFP	B-Protein
-	I-Protein
10	I-Protein
,	O
whereas	O
the	O
responses	O
of	O
H37Ra	O
,	O
H37Ra	O
:	O
:	O
fadE5	B-Protein
,	O
and	O
H37Ra	O
:	O
:	O
rpsL	B-Protein
infected	O
mice	O
were	O
extremely	O
weak	O
.	O

In	O
contrast	O
,	O
splenocytes	O
from	O
H37Ra	O
:	O
:	O
phoP	B-Protein
inoculated	O
mice	O
showed	O
very	O
strong	O
IFN	B-Protein
-	I-Protein
gamma	I-Protein
production	O
in	O
response	O
to	O
incubation	O
with	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
CFP	B-Protein
-	I-Protein
10	I-Protein
.	O

Exactly	O
the	O
same	O
trend	O
was	O
observed	O
when	O
a	O
highly	O
sensitive	O
T	O
cell	O
hybridoma	O
assay	O
was	O
used	O
to	O
investigate	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
.	O

This	O
test	O
is	O
based	O
on	O
the	O
presentation	O
of	O
the	O
immunodominant	O
epitope	O
contained	O
in	O
the	O
first	O
20	O
amino	O
acids	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
by	O
H37Ra	O
,	O
recombinant	O
H37Ra	O
,	O
or	O
H37Rv	O
infected	O
bone	O
marrow	O
-	O
derived	O
dendritic	O
cells	O
(	O
BM	O
-	O
DC	O
)	O
to	O
an	O
ESAT	O
-	O
6	O
-	O
specific	O
T	O
cell	O
hybridoma	O
(	O
NB11	O
)	O
,	O
restricted	O
by	O
I	O
-	O
Ab	O
.	O

Figure	O
4A	O
shows	O
that	O
infection	O
of	O
BM	O
-	O
DC	O
with	O
H37Ra	O
or	O
H37Ra	O
:	O
:	O
rpsL	B-Protein
induced	O
no	O
stimulation	O
of	O
the	O
hybridoma	O
as	O
judged	O
by	O
IL	B-Protein
-	I-Protein
2	I-Protein
production	O
,	O
while	O
H37Ra	O
:	O
:	O
phoP	B-Protein
or	O
H37Rv	O
triggered	O
high	O
amounts	O
of	O
IL	B-Protein
-	I-Protein
2	I-Protein
production	O
in	O
this	O
very	O
sensitive	O
and	O
specific	O
test	O
.	O

All	O
strains	O
behaved	O
comparably	O
towards	O
the	O
Ag85A	O
:	O
241	O
-	O
260	O
control	O
,	O
emphasizing	O
the	O
specificity	O
of	O
the	O
observed	O
phenomenon	O
for	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
(	O
Figure	O
4B	O
)	O
.	O

To	O
further	O
evaluate	O
the	O
involvement	O
of	O
phoP	B-Protein
and	O
the	O
ESX	O
-	O
1	O
system	O
in	O
immunogenicity	O
,	O
C57BL	O
/	O
6	O
mice	O
were	O
vaccinated	O
with	O
additional	O
strains	O
.	O

Firstly	O
,	O
we	O
constructed	O
a	O
partially	O
diploid	O
H37Ra	O
knock	O
-	O
in	O
strain	O
carrying	O
cosmid	O
RD1	O
-	O
ppe68	B-Protein
-	O
ko	O
that	O
,	O
in	O
BCG	O
yields	O
the	O
greatest	O
amounts	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
expression	O
and	O
secretion	O
[	O
24	O
]	O
.	O

However	O
,	O
in	O
H37Ra	O
the	O
presence	O
of	O
this	O
cosmid	O
could	O
not	O
increase	O
the	O
weak	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
CFP	B-Protein
-	I-Protein
10	I-Protein
T	O
cell	O
responses	O
(	O
Figure	O
3B	O
)	O
in	O
the	O
splenocyte	O
IFN	B-Protein
-	I-Protein
gamma	I-Protein
assay	O
.	O
<EOS>	B-X
61:742-750	B-X
,	B-X
1993	B-X
)	B-X
.	B-X
An	B-X
M.	B-X
tuberculosis	B-X
shuttle	B-X
cosmid	B-X
library	B-X
was	B-X
transferred	B-X
in	B-X
Mycobacterium	B-X
smegmatis	B-X
and	B-X
screened	B-X
with	B-X
a	B-X
competitive	B-X
enzyme-linked	B-X
immunosorbent	B-X
assay	B-X
to	B-X
detect	B-X
the	B-X
clones	B-X
expressing	B-X
the	B-X
proteins	B-X
.	B-X
An	B-X
open	B-X
reading	B-X
frame	B-X
in	B-X
the	B-X
2,061-nucleotide	B-X
sequence	B-X
codes	B-X
for	B-X
a	B-X
secreted	B-X
protein	B-X
with	B-X
a	B-X
consensus	B-X
signal	B-X
peptide	B-X
of	B-X
39	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
predicted	B-X
molecular	B-X
mass	B-X
of	B-X
28,779	B-X
Da	B-X
.	B-X
Southern	B-X
hybridization	B-X
analysis	B-X
of	B-X
digested	B-X
total	B-X
genomic	B-X
DNA	B-X
from	B-X
M.	B-X
tuberculosis	B-X
(	B-X
reference	B-X
strains	B-X
H37Rv	B-X
and	B-X
H37Ra	B-X
)	B-X
indicated	B-X
that	B-X
the	B-X
apa	B-X
gene	B-X
was	B-X
present	B-X
as	B-X
a	B-X
single	B-X
copy	B-X
on	B-X
the	B-X
genome	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
a	B-X
high	B-X
percentage	B-X
of	B-X
proline	B-X
(	B-X
21.7	B-X
%	B-X
)	B-X
was	B-X
confirmed	B-X
and	B-X
explained	B-X
the	B-X
apparent	B-X
higher	B-X
molecular	B-X
mass	B-X
(	B-X
45/47	B-X
kDa	B-X
)	B-X
determined	B-X
by	B-X
sodium	B-X
dodecyl	B-X
sulfate-polyacrylamide	B-X
gel	B-X
electrophoresis	B-X
resulting	B-X
from	B-X
the	B-X
increased	B-X
rigidity	B-X
of	B-X
molecules	B-X
due	B-X
to	B-X
proline	B-X
residues	B-X
.	B-X

Secondly	O
,	O
we	O
also	O
tested	O
the	O
previously	O
described	O
M	O
.	O
tuberculosis	O
MT103	O
phoP	B-Protein
knock	O
-	O
out	O
(	O
ko	O
)	O
strain	O
SO2	O
[	O
14	O
,	O
25	O
]	O
in	O
this	O
assay	O
and	O
found	O
that	O
this	O
strain	O
induced	O
a	O
potent	O
PPD	O
response	O
as	O
previously	O
reported	O
[	O
25	O
]	O
.	O

However	O
,	O
in	O
comparison	O
to	O
the	O
corresponding	O
MT103	O
wild	O
-	O
type	O
strain	O
,	O
the	O
SO2	O
strain	O
showed	O
a	O
strongly	O
reduced	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
CFP	B-Protein
-	I-Protein
10	I-Protein
specific	O
T	O
cell	O
response	O
,	O
corresponding	O
to	O
a	O
similar	O
low	O
level	O
as	O
the	O
H37Ra	O
strain	O
(	O
Figure	O
3B	O
)	O
.	O

Altogether	O
,	O
our	O
data	O
obtained	O
from	O
multiple	O
replicate	O
experiments	O
indicate	O
that	O
a	O
direct	O
link	O
exists	O
between	O
a	O
fully	O
functional	O
PhoP	B-Protein
and	O
the	O
ability	O
to	O
generate	O
T	O
cell	O
responses	O
against	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
CFP	B-Protein
-	I-Protein
10	I-Protein
.	O

Functional	O
Characterization	O
of	O
Knock	O
-	O
In	O
Mutants	O
<EOS>	B-X
Functional	B-X
Characterization	B-X
of	B-X
Knock-In	B-X
Mice	B-X
Expressing	B-X
a	B-X
12/15-Lipoxygenating	B-X
Alox5	B-X
Mutant	B-X
Instead	B-X
of	B-X
the	B-X
5-Lipoxygenating	B-X
Wild-Type	B-X
Enzyme	B-X
.	B-X
Functional	B-X
studies	B-X
showed	B-X
that	B-X
the	B-X
conditional	B-X
deletion	B-X
of	B-X
TgLetm1	B-X
resulted	B-X
in	B-X
growth	B-X
inhibition	B-X
,	B-X
deficiency	B-X
in	B-X
invasion	B-X
and	B-X
replication	B-X
,	B-X
and	B-X
lack	B-X
of	B-X
virulence	B-X
in	B-X
mice	B-X
.	B-X
Functional	B-X
characterisation	B-X
of	B-X
the	B-X
compact	B-X
genome	B-X
of	B-X
the	B-X
model	B-X
organism	B-X
Caenorhabditis	B-X
elegans	B-X
remains	B-X
incomplete	B-X
despite	B-X
its	B-X
sequencing	B-X
20	B-X
years	B-X
ago	B-X
.	B-X
CRISPR/Cas9-Based	B-X
Knock-Out	B-X
of	B-X
the	B-X

We	O
have	O
previously	O
shown	O
that	O
antigen	O
-	O
specific	O
IFN	B-Protein
-	I-Protein
gamma	I-Protein
production	O
of	O
splenocytes	O
is	O
a	O
reliable	O
readout	O
system	O
to	O
evaluate	O
whether	O
or	O
not	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
was	O
secreted	O
by	O
recombinant	O
strains	O
[	O
23	O
,	O
24	O
,	O
26	O
]	O
.	O
<EOS>	B-X
We	B-X
constructed	B-X
two	B-X
recombinant	B-X
Mycobacterium	B-X
bovis	B-X
BCG	B-X
(	B-X
rBCG	B-X
)	B-X
strains	B-X
expressing	B-X
ESAT-6	B-X
of	B-X
Mycobacterium	B-X
tuberculosis	B-X
,	B-X
named	B-X
rBCG-1	B-X
and	B-X
rBCG-2	B-X
.	B-X
rBCG-1	B-X
contained	B-X
the	B-X
ESAT-6	B-X
gene	B-X
linked	B-X
to	B-X
BCG	B-X
hsp60	B-X
and	B-X
expressed	B-X
a	B-X
fusion	B-X
protein	B-X
,	B-X
while	B-X
rBCG-2	B-X
,	B-X
with	B-X
a	B-X
secretory	B-X
sequence	B-X
,	B-X
could	B-X
secret	B-X
ESAT-6	B-X
into	B-X
the	B-X
culture	B-X
medium	B-X
.	B-X
There	B-X
was	B-X
no	B-X
evidence	B-X
for	B-X
increased	B-X
virulence	B-X
of	B-X
the	B-X
two	B-X
rBCG	B-X
strains	B-X
when	B-X
we	B-X
made	B-X
a	B-X
comparison	B-X
between	B-X
them	B-X
and	B-X
BCG	B-X
with	B-X
regard	B-X
to	B-X
organ	B-X
bacterial	B-X
loads	B-X
,	B-X
lung	B-X
histology	B-X
,	B-X
and	B-X
survival	B-X
time	B-X
.	B-X
rBCG-1	B-X
induced	B-X
significantly	B-X
higher	B-X
specific	B-X
antibody	B-X
titers	B-X
and	B-X
stronger	B-X
cellular	B-X
immune	B-X
response	B-X
than	B-X
BCG	B-X
,	B-X
whereas	B-X
rBCG-2	B-X
had	B-X
immunogenicity	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
parental	B-X
BCG	B-X
strain	B-X
.	B-X

Thus	O
,	O
in	O
order	O
to	O
determine	O
the	O
reason	O
for	O
the	O
observed	O
failure	O
of	O
H37Ra	O
to	O
induce	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
-	O
specific	O
responses	O
,	O
H37Rv	O
and	O
H37Ra	O
strains	O
were	O
tested	O
for	O
their	O
potential	O
to	O
express	O
and	O
secrete	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
in	O
vitro	O
.	O

The	O
western	O
blot	O
analysis	O
presented	O
in	O
Figure	O
5	O
shows	O
that	O
the	O
cell	O
lysates	O
of	O
H37Ra	O
and	O
H37Ra	O
:	O
:	O
rpsL	B-Protein
contain	O
large	O
amounts	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
,	O
indicating	O
that	O
the	O
antigen	O
is	O
properly	O
expressed	O
.	O

However	O
,	O
hardly	O
any	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
was	O
present	O
in	O
the	O
culture	O
filtrates	O
of	O
these	O
cultures	O
,	O
indicating	O
that	O
these	O
strains	O
were	O
unable	O
to	O
secrete	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
under	O
the	O
in	O
vitro	O
conditions	O
employed	O
in	O
spite	O
of	O
proper	O
expression	O
.	O

Similar	O
results	O
were	O
obtained	O
for	O
H37Ra	O
:	O
:	O
fadE5	B-Protein
(	O
unpublished	O
data	O
)	O
.	O

In	O
contrast	O
,	O
from	O
examination	O
of	O
the	O
western	O
blots	O
of	O
M	O
.	O
tuberculosis	O
H37Ra	O
:	O
:	O
phoP	B-Protein
and	O
H37Rv	O
it	O
is	O
clear	O
that	O
a	O
large	O
portion	O
of	O
their	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
protein	O
is	O
secreted	O
into	O
the	O
culture	O
filtrates	O
.	O

Analysis	O
of	O
the	O
M	O
.	O
tuberculosis	O
MT103	O
phoP	O
ko	O
strain	O
SO2	O
showed	O
strong	O
expression	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
,	O
but	O
only	O
very	O
little	O
secreted	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
(	O
Figure	O
5	O
)	O
.	O

In	O
a	O
previous	O
report	O
[	O
25	O
]	O
,	O
the	O
presence	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
in	O
cell	O
free	O
extracts	O
was	O
described	O
for	O
this	O
strain	O
,	O
but	O
no	O
secretion	O
assay	O
was	O
performed	O
.	O

Together	O
,	O
our	O
findings	O
correlate	O
perfectly	O
with	O
the	O
in	O
vivo	O
data	O
described	O
above	O
and	O
suggest	O
that	O
the	O
lack	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
specific	O
T	O
cell	O
recognition	O
for	O
H37Ra	O
,	O
H37Ra	O
:	O
:	O
fadE5	B-Protein
,	O
H37Ra	O
:	O
:	O
rpsL	B-Protein
,	O
and	O
SO2	O
is	O
not	O
caused	O
by	O
a	O
loss	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
expression	O
,	O
but	O
rather	O
due	O
to	O
a	O
failure	O
of	O
(	O
phoP	B-Protein
dependent	O
)	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
.	O

The	O
observation	O
that	O
knocking	O
-	O
in	O
the	O
ESX	B-Protein
-	I-Protein
1	I-Protein
region	O
of	O
H37Rv	O
into	O
H37Ra	O
(	O
H37Ra	O
:	O
:	O
RD1	B-Protein
-	O
ppe68	B-Protein
-	O
ko	O
)	O
,	O
and	O
the	O
resultant	O
diploidy	O
,	O
did	O
not	O
improve	O
the	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
-	O
specific	O
T	O
cell	O
responses	O
(	O
Figure	O
3B	O
)	O
,	O
further	O
argues	O
that	O
PhoP	B-Protein
-	O
dependent	O
ESAT	O
-	O
secretion	O
might	O
be	O
regulated	O
via	O
a	O
mechanism	O
that	O
lies	O
outside	O
the	O
RD1	O
region	O
.	O

As	O
closer	O
inspection	O
of	O
the	O
available	O
literature	O
on	O
transcriptional	O
analyses	O
of	O
a	O
H37Rv	O
-	O
phoP	B-Protein
ko	O
strain	O
[	O
21	O
]	O
and	O
H37Ra	O
[	O
12	O
]	O
suggested	O
that	O
the	O
expression	O
of	O
gene	O
cluster	O
rv3612c	B-Protein
-	O
rv3616c	B-Protein
is	O
reduced	O
in	O
both	O
strains	O
,	O
we	O
evaluated	O
the	O
expression	O
level	O
of	O
rv3614c	B-Protein
in	O
H37Rv	O
,	O
H37Ra	O
,	O
and	O
H37Ra	O
:	O
:	O
phoP	B-Protein
by	O
quantitative	O
real	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
.	O

In	O
previous	O
studies	O
rv3614c	B-Protein
,	O
rv3615c	B-Protein
,	O
rv3616c	B-Protein
(	O
espA	B-Protein
)	O
were	O
independently	O
shown	O
to	O
be	O
essential	O
for	O
proper	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
[	O
27	O
,	O
28	O
]	O
.	O

We	O
confirmed	O
the	O
trend	O
that	O
rv3614c	B-Protein
was	O
expressed	O
much	O
lower	O
in	O
H37Ra	O
compared	O
to	O
H37Rv	O
by	O
qRT	O
-	O
PCR	O
(	O
Figure	O
6	O
)	O
,	O
whereas	O
expression	O
of	O
rv3614c	B-Protein
in	O
H37Ra	O
:	O
:	O
phoP	B-Protein
was	O
restored	O
to	O
wild	O
-	O
type	O
levels	O
,	O
suggesting	O
that	O
the	O
rv3612c	B-Protein
-	O
rv3616c	B-Protein
gene	O
cluster	O
is	O
regulated	O
by	O
PhoP	B-Protein
.	O

Interestingly	O
,	O
expression	O
of	O
phoP	B-Protein
was	O
higher	O
in	O
H37Ra	O
than	O
in	O
H37Rv	O
(	O
Figure	O
6	O
)	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
data	O
from	O
a	O
previous	O
transcriptional	O
study	O
[	O
12	O
]	O
and	O
suggest	O
that	O
the	O
proposed	O
ability	O
of	O
PhoP	B-Protein
to	O
downregulate	O
its	O
own	O
expression	O
[	O
22	O
]	O
is	O
affected	O
by	O
the	O
S219L	O
phoP	B-Protein
mutation	O
[	O
29	O
]	O
.	O

They	O
also	O
indicate	O
that	O
it	O
is	O
not	O
a	O
lack	O
of	O
phoP	B-Protein
expression	O
that	O
is	O
causing	O
the	O
phoP	B-Protein
-	O
associated	O
effects	O
in	O
H37Ra	O
.	O
<EOS>	B-X
Accurate	B-X
prediction	B-X
of	B-X
the	B-X
adverse	B-X
effects	B-X
of	B-X
test	B-X
compounds	B-X
on	B-X
living	B-X
systems	B-X
,	B-X
detection	B-X
of	B-X
toxic	B-X
thresholds	B-X
,	B-X
and	B-X
expansion	B-X
of	B-X
experimental	B-X
data	B-X
sets	B-X
to	B-X
include	B-X
multiple	B-X
toxicity	B-X
end-point	B-X
analysis	B-X
are	B-X
required	B-X
for	B-X
any	B-X
robust	B-X
screening	B-X
regime	B-X
.	B-X
We	B-X
also	B-X
describe	B-X
recent	B-X
efforts	B-X
to	B-X
tune	B-X
functional	B-X
group	B-X
reactivities	B-X
and	B-X
stabilities	B-X
to	B-X
access	B-X
even	B-X
more	B-X
rapid	B-X
and	B-X
selective	B-X
chemistries	B-X
.	B-X
Among	B-X
them	B-X
,	B-X
FGF21	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
promising	B-X
candidates	B-X
given	B-X
its	B-X
outstanding	B-X
pharmacologic	B-X
benefits	B-X
for	B-X
nearly	B-X
each	B-X
and	B-X
every	B-X
abnormality	B-X
of	B-X
a	B-X
metabolic	B-X
disease	B-X
and	B-X
lack	B-X
of	B-X
apparent	B-X
side	B-X
effects	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
animal	B-X
models	B-X
.	B-X
The	B-X
effects	B-X
of	B-X
foreign	B-X
ions	B-X
have	B-X
been	B-X
investigated	B-X
.	B-X

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

The	O
attenuated	O
H37Ra	O
strain	O
was	O
obtained	O
at	O
the	O
Trudeau	O
Institute	O
in	O
the	O
1930s	O
in	O
an	O
attempt	O
to	O
dissociate	O
virulent	O
and	O
avirulent	O
forms	O
of	O
the	O
tubercle	O
bacillus	O
H37	O
.	O

Steenken	O
et	O
al	O
.	O
have	O
shown	O
that	O
the	O
virulence	O
of	O
the	O
H37	O
strain	O
was	O
associated	O
with	O
colony	O
morphology	O
and	O
that	O
the	O
avirulent	O
variant	O
H37Ra	O
failed	O
to	O
propagate	O
in	O
an	O
ordinarily	O
susceptible	O
host	O
while	O
the	O
virulent	O
variant	O
H37Rv	O
was	O
able	O
to	O
proliferate	O
[	O
6	O
]	O
.	O

Although	O
these	O
different	O
H37	O
daughter	O
strains	O
have	O
been	O
available	O
for	O
many	O
years	O
now	O
and	O
belong	O
to	O
the	O
standard	O
strain	O
collections	O
of	O
almost	O
every	O
tuberculosis	O
diagnostic	O
or	O
research	O
laboratory	O
in	O
the	O
world	O
[	O
30	O
,	O
31	O
]	O
,	O
the	O
genetic	O
basis	O
of	O
the	O
decreased	O
virulence	O
of	O
H37Ra	O
remained	O
unknown	O
.	O

The	O
identification	O
of	O
the	O
amino	O
acid	O
change	O
S219L	O
in	O
the	O
predicted	O
DNA	O
binding	O
region	O
of	O
the	O
C	O
-	O
terminal	O
effector	O
domain	O
of	O
PhoP	B-Protein
[	O
15	O
,	O
22	O
]	O
in	O
H37Ra	O
was	O
therefore	O
a	O
particularly	O
exciting	O
finding	O
that	O
has	O
the	O
potential	O
to	O
explain	O
part	O
of	O
the	O
attenuation	O
of	O
the	O
H37Ra	O
strain	O
and	O
to	O
elucidate	O
the	O
PhoP	B-Protein
/	O
PhoR	B-Protein
associated	O
complex	O
regulatory	O
network	O
in	O
M	O
.	O
tuberculosis	O
.	O

In	O
the	O
bacterial	O
world	O
the	O
PhoP	B-Protein
/	O
PhoR	B-Protein
like	O
two	O
-	O
component	O
systems	O
are	O
widely	O
distributed	O
and	O
fulfill	O
a	O
large	O
variety	O
of	O
functions	O
including	O
sensing	O
phosphate	O
and	O
magnesium	O
[	O
32	O
,	O
33	O
]	O
,	O
or	O
regulating	O
virulence	O
genes	O
[	O
34	O
]	O
.	O
<EOS>	B-X
For	B-X
∼30	B-X
years	B-X
,	B-X
two	B-X
distinct	B-X
groups	B-X
of	B-X
clinical	B-X
isolates	B-X
of	B-X
Klebsiella	B-X
pneumoniae	B-X
have	B-X
been	B-X
recognized	B-X
.	B-X
Hyperproduction	B-X
of	B-X
capsule	B-X
and	B-X
a	B-X
hypermucoviscous	B-X
colony	B-X
phenotype	B-X
have	B-X
been	B-X
strongly	B-X
associated	B-X
with	B-X
the	B-X
hypervirulence	B-X
of	B-X
hvKp	B-X
strains	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
begun	B-X
to	B-X
elucidate	B-X
the	B-X
relationship	B-X
between	B-X
capsule	B-X
gene	B-X
expression	B-X
,	B-X
hypermucoviscosity	B-X
and	B-X
hypervirulence	B-X
.	B-X
Additionally	B-X
,	B-X
genes	B-X
associated	B-X
with	B-X
hyperproduction	B-X
of	B-X
capsule	B-X
and	B-X
hypermucoviscosity	B-X
in	B-X
hvKp	B-X
strains	B-X
have	B-X
been	B-X
identified	B-X
in	B-X
a	B-X
few	B-X
cKp	B-X
isolates	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
not	B-X
clear	B-X
how	B-X
the	B-X
acquisition	B-X
of	B-X
these	B-X
genes	B-X
impacts	B-X
the	B-X
virulence	B-X
of	B-X
cKp	B-X
isolates	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
potential	B-X
risks	B-X
of	B-X
these	B-X
strains	B-X
is	B-X
particularly	B-X
important	B-X
given	B-X
that	B-X
many	B-X
of	B-X
them	B-X
are	B-X
resistant	B-X
to	B-X
multiple	B-X
antibiotics	B-X
,	B-X
including	B-X
carbapenems	B-X
.	B-X

For	O
M	O
.	O
tuberculosis	O
,	O
several	O
studies	O
have	O
described	O
a	O
link	O
between	O
the	O
inactivation	O
of	O
phoP	B-Protein
and	O
loss	O
of	O
virulence	O
,	O
suggesting	O
that	O
the	O
phoP	B-Protein
gene	O
is	O
required	O
for	O
intracellular	O
growth	O
of	O
M	O
.	O
tuberculosis	O
[	O
14	O
,	O
25	O
]	O
.	O

It	O
was	O
also	O
found	O
that	O
the	O
PhoP	B-Protein
-	O
PhoR	B-Protein
system	O
controls	O
the	O
biosynthesis	O
of	O
polyketide	O
-	O
derived	O
lipids	O
[	O
35	O
]	O
and	O
determines	O
the	O
amount	O
of	O
triacylated	O
and	O
monoacylated	O
lipoarabinomannans	O
in	O
M	O
.	O
tuberculosis	O
[	O
36	O
]	O
.	O

However	O
,	O
according	O
to	O
very	O
recent	O
information	O
,	O
these	O
polyketide	O
-	O
derived	O
(	O
Pks2	O
-	O
4	O
)	O
lipids	O
do	O
not	O
have	O
a	O
strong	O
impact	O
on	O
the	O
virulence	O
of	O
M	O
.	O
tuberculosis	O
[	O
29	O
]	O
.	O

Finally	O
,	O
microarray	O
-	O
based	O
trancriptome	O
analysis	O
using	O
the	O
wild	O
-	O
type	O
versus	O
a	O
phoP	B-Protein
ko	O
mutant	O
of	O
H37Rv	O
has	O
provided	O
an	O
overview	O
of	O
the	O
transcriptional	O
regulation	O
linked	O
to	O
PhoP	B-Protein
[	O
21	O
]	O
.	O

That	O
study	O
identified	O
44	O
genes	O
in	O
the	O
phoP	B-Protein
-	O
ko	O
strain	O
that	O
were	O
expressed	O
at	O
least	O
2	O
.	O
5	O
-	O
fold	O
lower	O
in	O
the	O
mutant	O
than	O
their	O
counterparts	O
in	O
the	O
M	O
.	O
tuberculosis	O
wild	O
-	O
type	O
strain	O
.	O

Most	O
interestingly	O
,	O
about	O
two	O
thirds	O
of	O
these	O
44	O
genes	O
were	O
also	O
found	O
substantially	O
lower	O
expressed	O
in	O
H37Ra	O
in	O
comparison	O
to	O
H37Rv	O
,	O
when	O
the	O
transcriptional	O
profiles	O
of	O
H37Ra	O
and	O
H37Rv	O
cultures	O
grown	O
in	O
various	O
media	O
were	O
examined	O
[	O
12	O
]	O
.	O

This	O
finding	O
argues	O
that	O
the	O
PhoP	B-Protein
S219L	O
mutation	O
likely	O
has	O
a	O
broad	O
impact	O
on	O
gene	O
regulation	O
in	O
H37Ra	O
with	O
effects	O
similar	O
to	O
those	O
seen	O
for	O
complete	O
inactivation	O
of	O
phoP	B-Protein
.	O

Among	O
the	O
genes	O
expressed	O
at	O
low	O
level	O
in	O
the	O
phoP	B-Protein
-	O
ko	O
strain	O
and	O
in	O
H37Ra	O
were	O
several	O
that	O
are	O
involved	O
in	O
lipid	O
metabolism	O
;	O
for	O
example	O
,	O
the	O
polyketide	O
synthases	O
pks2	B-Protein
(	O
rv3825c	B-Protein
)	O
or	O
the	O
Pks	O
-	O
associated	O
protein	O
papA1	B-Protein
(	O
rv3824c	B-Protein
)	O
.	O

There	O
were	O
also	O
several	O
ppe	O
genes	O
that	O
seem	O
to	O
be	O
regulated	O
by	O
phoP	B-Protein
but	O
not	O
ppe68	B-Protein
[	O
21	O
]	O
.	O
<EOS>	B-X
The	B-X
PhoPR	B-X
two-component	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
virulence	B-X
in	B-X
Mycobacterium	B-X
tuberculosis	B-X
where	B-X
it	B-X
controls	B-X
expression	B-X
of	B-X
approximately	B-X
2	B-X
%	B-X
of	B-X
the	B-X
genes	B-X
,	B-X
including	B-X
those	B-X
for	B-X
the	B-X
ESX-1	B-X
secretion	B-X
apparatus	B-X
,	B-X
a	B-X
major	B-X
virulence	B-X
determinant	B-X
.	B-X
Mutations	B-X
in	B-X
phoP	B-X
lead	B-X
to	B-X
compromised	B-X
production	B-X
of	B-X
pathogen-specific	B-X
cell	B-X
wall	B-X
components	B-X
and	B-X
attenuation	B-X
both	B-X
ex	B-X
vivo	B-X
and	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
PhoP	B-X
regulon	B-X
comprises	B-X
several	B-X
transcriptional	B-X
regulators	B-X
as	B-X
well	B-X
as	B-X
genes	B-X
for	B-X
polyketide	B-X
synthases	B-X
and	B-X
PE/PPE	B-X
proteins	B-X
.	B-X
Integration	B-X
of	B-X
ChIP-seq	B-X
results	B-X
with	B-X
high-resolution	B-X
transcriptomic	B-X
analysis	B-X
(	B-X
RNA-seq	B-X
)	B-X
revealed	B-X
that	B-X
PhoP	B-X
controls	B-X
30	B-X
genes	B-X
directly	B-X
,	B-X
whilst	B-X
regulatory	B-X
cascades	B-X
are	B-X
responsible	B-X
for	B-X
signal	B-X
amplification	B-X
and	B-X
downstream	B-X
effects	B-X
through	B-X
proteins	B-X
like	B-X
EspR	B-X
,	B-X
which	B-X
controls	B-X
Esx1	B-X
function	B-X
,	B-X
via	B-X
regulation	B-X
of	B-X
the	B-X
espACD	B-X
operon	B-X
.	B-X
Northern	B-X
blot	B-X
experiments	B-X
confirmed	B-X
the	B-X
absence	B-X
of	B-X
Mcr7	B-X
in	B-X
an	B-X
M.	B-X
tuberculosis	B-X
phoP	B-X
mutant	B-X
as	B-X
well	B-X
as	B-X
low-level	B-X
expression	B-X
of	B-X
the	B-X
ncRNA	B-X
in	B-X
M.	B-X
tuberculosis	B-X
complex	B-X
members	B-X
other	B-X
than	B-X
M.	B-X
tuberculosis	B-X
.	B-X

In	O
addition	O
,	O
NirA	B-Protein
(	O
Rv2391	B-Protein
)	O
,	O
a	O
putative	O
nitrite	O
reductase	O
and	O
MmpL10	B-Protein
-	O
FadD21	B-Protein
(	O
Rv1183	B-Protein
-	O
85c	B-Protein
)	O
,	O
which	O
were	O
all	O
identified	O
by	O
TraSH	O
analysis	O
as	O
potentially	O
implicated	O
in	O
virulence	O
[	O
16	O
]	O
,	O
seem	O
to	O
be	O
regulated	O
by	O
PhoP	B-Protein
[	O
12	O
,	O
21	O
]	O
.	O

However	O
,	O
the	O
most	O
striking	O
link	O
in	O
relation	O
to	O
our	O
results	O
on	O
phoP	B-Protein
and	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
that	O
was	O
revealed	O
by	O
these	O
two	O
transcriptional	O
analyses	O
,	O
were	O
the	O
data	O
on	O
gene	O
cluster	O
rv3612c	B-Protein
-	O
rv3616c	B-Protein
.	O

Closer	O
inspection	O
of	O
the	O
data	O
published	O
in	O
the	O
corresponding	O
supplemental	O
materials	O
showed	O
that	O
rv3612c	B-Protein
-	O
rv3616c	B-Protein
were	O
strongly	O
downregulated	O
in	O
the	O
H37Rv	O
phoP	B-Protein
ko	O
mutant	O
as	O
well	O
as	O
in	O
H37Ra	O
[	O
12	O
,	O
21	O
]	O
.	O

These	O
transcriptome	O
data	O
corroborate	O
our	O
results	O
obtained	O
by	O
quantitative	O
RT	O
-	O
PCR	O
using	O
probe	O
rv3614c	B-Protein
,	O
which	O
showed	O
that	O
gene	O
rv3614c	B-Protein
was	O
definitely	O
expressed	O
much	O
lower	O
in	O
H37Ra	O
than	O
in	O
H37Rv	O
and	O
H37Ra	O
:	O
:	O
phoP	B-Protein
strains	O
(	O
Figure	O
6	O
)	O
.	O

Since	O
in	O
previous	O
,	O
independent	O
studies	O
it	O
has	O
been	O
demonstrated	O
that	O
functions	O
of	O
the	O
rv3614c	B-Protein
-	O
rv3616c	B-Protein
(	O
espA	B-Protein
)	O
gene	O
cluster	O
were	O
essential	O
for	O
the	O
secretion	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
and	O
CFP	B-Protein
-	I-Protein
10	I-Protein
[	O
27	O
,	O
28	O
]	O
,	O
it	O
is	O
quite	O
probable	O
that	O
the	O
lack	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
-	O
specific	O
T	O
cell	O
responses	O
observed	O
for	O
strains	O
H37Ra	O
and	O
SO2	O
(	O
Figure	O
3	O
)	O
might	O
be	O
caused	O
by	O
the	O
insufficient	O
expression	O
of	O
rv3612c	B-Protein
-	O
rv3616c	B-Protein
,	O
which	O
results	O
from	O
the	O
lack	O
of	O
a	O
fully	O
functional	O
PhoP	B-Protein
in	O
these	O
strains	O
.	O

Moreover	O
,	O
the	O
expression	O
values	O
of	O
genes	O
rv3612c	B-Protein
-	O
rv3616c	B-Protein
in	O
H37Rv	O
described	O
in	O
the	O
article	O
by	O
Gao	O
et	O
al	O
.	O

[	O
12	O
]	O
show	O
substantial	O
differences	O
between	O
cultures	O
grown	O
in	O
roller	O
bottles	O
relative	O
to	O
cultures	O
grown	O
in	O
shake	O
flasks	O
,	O
arguing	O
that	O
this	O
gene	O
cluster	O
might	O
be	O
regulated	O
by	O
environmental	O
conditions	O
through	O
the	O
PhoP	B-Protein
/	O
PhoR	B-Protein
system	O
.	O

It	O
is	O
not	O
clear	O
yet	O
which	O
factors	O
might	O
contribute	O
to	O
this	O
effect	O
.	O

However	O
,	O
upregulation	O
of	O
phoP	B-Protein
and	O
rv3614c	B-Protein
-	O
rv3616c	B-Protein
was	O
observed	O
after	O
incubation	O
of	O
M	O
.	O
tuberculosis	O
in	O
5mM	O
H2O2	O
[	O
37	O
]	O
.	O

Furthermore	O
,	O
rv3614c	B-Protein
-	O
rv3616c	B-Protein
were	O
reported	O
to	O
be	O
transiently	O
upregulated	O
in	O
the	O
phagosome	O
and	O
under	O
acidic	O
stress	O
[	O
38	O
]	O
.	O

Altogether	O
,	O
from	O
these	O
reports	O
it	O
seems	O
plausible	O
that	O
the	O
pleiotropic	O
regulator	O
PhoP	B-Protein
is	O
involved	O
in	O
the	O
regulation	O
of	O
rv3612c	B-Protein
-	O
rv3616c	B-Protein
expression	O
and	O
thereby	O
influences	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
and	O
virulence	O
[	O
16	O
]	O
,	O
but	O
to	O
unambiguously	O
answer	O
this	O
question	O
,	O
virulence	O
tests	O
with	O
recombinant	O
H37Ra	O
and	O
/	O
or	O
phoP	B-Protein
ko	O
strains	O
that	O
express	O
rv3616c	B-Protein
-	O
3612c	B-Protein
under	O
a	O
constitutive	O
promoter	O
or	O
a	O
tetracycline	O
inducable	O
expression	O
system	O
[	O
39	O
]	O
will	O
be	O
needed	O
.	O

Construction	O
of	O
such	O
strains	O
has	O
recently	O
been	O
initiated	O
as	O
a	O
first	O
step	O
of	O
a	O
future	O
study	O
to	O
gain	O
deeper	O
insight	O
into	O
signaling	O
events	O
and	O
regulation	O
of	O
the	O
ESX	O
-	O
1	O
secretion	O
system	O
in	O
different	O
tubercle	O
bacilli	O
,	O
including	O
members	O
of	O
the	O
putative	O
progenitor	O
species	O
Mycobacterium	O
prototuberculosis	O
[	O
40	O
]	O
.	O

As	O
in	O
previous	O
DNA	O
/	O
DNA	O
microarray	O
analyses	O
[	O
10	O
]	O
,	O
and	O
from	O
inspection	O
of	O
the	O
very	O
recently	O
released	O
genome	O
sequence	O
of	O
H37Ra	O
,	O
no	O
significant	O
differences	O
in	O
the	O
ESX	O
-	O
1	O
encoding	O
region	O
were	O
found	O
,	O
the	O
assumption	O
that	O
the	O
observed	O
lack	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
in	O
H37Ra	O
may	O
be	O
caused	O
by	O
factors	O
outside	O
of	O
the	O
RD1	O
region	O
is	O
very	O
plausible	O
.	O

In	O
contrast	O
,	O
in	O
another	O
transcriptome	O
analysis	O
,	O
Mostowy	O
and	O
colleagues	O
[	O
11	O
]	O
found	O
several	O
genes	O
of	O
the	O
RD1	O
region	O
,	O
including	O
that	O
encoding	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
,	O
among	O
the	O
genes	O
that	O
were	O
at	O
least	O
2	O
.	O
5	O
-	O
fold	O
lower	O
expressed	O
in	O
H37Ra	O
than	O
in	O
H37Rv	O
.	O

Our	O
results	O
obtained	O
for	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
expression	O
(	O
Figure	O
5	O
)	O
and	O
the	O
transcriptome	O
data	O
from	O
Gao	O
and	O
colleagues	O
[	O
12	O
]	O
argue	O
against	O
direct	O
downregulation	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
in	O
H37Ra	O
.	O

However	O
,	O
it	O
is	O
also	O
possible	O
that	O
the	O
observed	O
differences	O
may	O
be	O
caused	O
by	O
variations	O
of	O
in	O
vitro	O
culture	O
conditions	O
.	O
<EOS>	B-X
Although	B-X
some	B-X
of	B-X
these	B-X
variations	B-X
can	B-X
be	B-X
caused	B-X
by	B-X
the	B-X
different	B-X
histological	B-X
subtypes	B-X
or	B-X
various	B-X
tumor	B-X
geometries	B-X
,	B-X
the	B-X
issue	B-X
of	B-X
varying	B-X
PS	B-X
concentration	B-X
in	B-X
the	B-X
tumor	B-X
tissue	B-X
volume	B-X
is	B-X
definitely	B-X
an	B-X
important	B-X
factor	B-X
.	B-X
A	B-X
possible	B-X
response	B-X
to	B-X
aging	B-X
is	B-X
autophagy	B-X
,	B-X
a	B-X
self-digestion	B-X
process	B-X
in	B-X
which	B-X
portions	B-X
of	B-X
cytoplasm	B-X
are	B-X
encapsulated	B-X
by	B-X
double-membrane-bound	B-X
structures	B-X
and	B-X
delivered	B-X
to	B-X
lysosome	B-X
for	B-X
degradation	B-X
.	B-X
A	B-X
previous	B-X
work	B-X
of	B-X
our	B-X
group	B-X
showed	B-X
that	B-X
astrocytes	B-X
under	B-X
starving	B-X
conditions	B-X
are	B-X
characterized	B-X
by	B-X
a	B-X
higher	B-X
upregulation	B-X
of	B-X
the	B-X
marker	B-X
of	B-X
autophagy	B-X
LC3	B-X
II	B-X
than	B-X
neurons	B-X
.	B-X
Aim	B-X
of	B-X
the	B-X
present	B-X
work	B-X
was	B-X
to	B-X
evaluate	B-X
LC3	B-X
II	B-X
expression	B-X
in	B-X
an	B-X
aging	B-X
model	B-X
consisting	B-X
in	B-X
fetal	B-X
sheep	B-X
neurons	B-X
and	B-X
astrocytes	B-X
at	B-X
10	B-X
,	B-X
20	B-X
and	B-X
30	B-X
days	B-X
of	B-X
culture	B-X
.	B-X
LC3	B-X
II	B-X
immunoreactivity	B-X
in	B-X
neurons	B-X
and	B-X
astrocytes	B-X
progressively	B-X
increased	B-X
with	B-X
time	B-X
but	B-X
differences	B-X
were	B-X
observed	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
cell	B-X
density	B-X
.	B-X
Indeed	B-X
,	B-X
LC3	B-X
II	B-X
immunoreactivity	B-X
is	B-X
higher	B-X
in	B-X
clusters	B-X
of	B-X
neurons	B-X
and	B-X
astrocytes	B-X
and	B-X
this	B-X
may	B-X
be	B-X
due	B-X
to	B-X
the	B-X
fact	B-X
that	B-X
cell-cell	B-X
contact	B-X
would	B-X
represent	B-X
a	B-X
second	B-X
stress	B-X
in	B-X
addition	B-X
to	B-X
aging	B-X
itself	B-X
.	B-X
This	B-X
may	B-X
be	B-X
due	B-X
to	B-X
the	B-X
need	B-X
of	B-X
aged	B-X
cells	B-X
to	B-X
remove	B-X
damaged	B-X
cytoplasmic	B-X
components	B-X
through	B-X
autophagic	B-X
processes	B-X
.	B-X
Such	B-X
variation	B-X
in	B-X
LC3	B-X
II	B-X
localization	B-X
could	B-X
be	B-X
caused	B-X
by	B-X
migration	B-X
from	B-X
the	B-X
nucleus	B-X
to	B-X
cytoplasm	B-X
as	B-X
well	B-X
as	B-X
possible	B-X
de	B-X
novo	B-X
intracytoplasmic	B-X
production	B-X
.	B-X
The	B-X
present	B-X
work	B-X
based	B-X
on	B-X
sheep	B-X
neural	B-X
cells	B-X
in	B-X
vitro	B-X
may	B-X
represent	B-X
a	B-X
helpful	B-X
tool	B-X
in	B-X
the	B-X
studies	B-X
on	B-X
aging	B-X
processes	B-X
in	B-X
which	B-X
autophagy	B-X
plays	B-X
a	B-X
remarkable	B-X
role	B-X
.	B-X

In	O
conclusion	O
,	O
in	O
this	O
work	O
we	O
report	O
the	O
identification	O
and	O
profound	O
consequences	O
of	O
the	O
PhoP	B-Protein
S219L	O
mutation	O
on	O
the	O
widely	O
used	O
H37Ra	O
strain	O
.	O

BLASTP	O
comparisons	O
of	O
the	O
PhoP	B-Protein
sequence	O
showed	O
that	O
the	O
predicted	O
DNA	O
binding	O
region	O
,	O
where	O
the	O
mutation	O
occurred	O
,	O
is	O
perfectly	O
conserved	O
among	O
a	O
wide	O
range	O
of	O
actinobacteria	O
,	O
with	O
H37Ra	O
being	O
the	O
only	O
strain	O
showing	O
such	O
a	O
mutation	O
.	O

By	O
complementation	O
with	O
the	O
wild	O
-	O
type	O
copy	O
of	O
PhoP	B-Protein
,	O
we	O
obtained	O
a	O
significant	O
increase	O
in	O
virulence	O
in	O
ex	O
vivo	O
and	O
animal	O
models	O
as	O
well	O
as	O
restoration	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
and	O
the	O
accompanying	O
antigen	O
-	O
specific	O
immunological	O
recognition	O
by	O
sensitized	O
splenocytes	O
or	O
T	O
cell	O
hybridomas	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
determine	B-X
the	B-X
contribution	B-X
of	B-X
the	B-X
clonotypic	B-X
T	B-X
cell	B-X
receptor	B-X
(	B-X
Ti	B-X
)	B-X
alpha	B-X
beta	B-X
heterodimer	B-X
to	B-X
the	B-X
antigen/MHC	B-X
specificity	B-X
of	B-X
mature	B-X
T	B-X
cells	B-X
,	B-X
we	B-X
have	B-X
transfected	B-X
cloned	B-X
Ti	B-X
alpha	B-X
and/or	B-X
beta	B-X
genes	B-X
into	B-X
either	B-X
human	B-X
or	B-X
mouse	B-X
T	B-X
cells	B-X
,	B-X
and	B-X
analyzed	B-X
the	B-X
transfectants	B-X
for	B-X
Ti-T3	B-X
expression	B-X
and	B-X
responses	B-X
to	B-X
antigen	B-X
and	B-X
Ia	B-X
molecules	B-X
.	B-X
Our	B-X
analysis	B-X
establishes	B-X
that	B-X
a	B-X
single	B-X
receptor	B-X
structure	B-X
(	B-X
the	B-X
Ti	B-X
alpha	B-X
beta	B-X
heterodimer	B-X
)	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
to	B-X
define	B-X
the	B-X
dual	B-X
specificity	B-X
of	B-X
T	B-X
cell	B-X
antigen	B-X
recognition	B-X
and	B-X
suggests	B-X
that	B-X
in	B-X
at	B-X
least	B-X
certain	B-X
instances	B-X
Ti	B-X
beta	B-X
chains	B-X
play	B-X
a	B-X
predominant	B-X
role	B-X
in	B-X
MHC	B-X
restriction	B-X
specificity	B-X
,	B-X
raising	B-X
the	B-X
possibility	B-X
of	B-X
a	B-X
``	B-X
one	B-X
receptor	B-X
,	B-X
two	B-X
sites	B-X
''	B-X
model	B-X
of	B-X
T	B-X
cell	B-X
recognition	B-X
.	B-X
We	B-X
have	B-X
discussed	B-X
four	B-X
specific	B-X
models	B-X
which	B-X
provide	B-X
different	B-X
kinds	B-X
of	B-X
information	B-X
about	B-X
the	B-X
requirements	B-X
for	B-X
T	B-X
cell	B-X
activation	B-X
.	B-X
The	B-X
first	B-X
utilized	B-X
a	B-X
CTL	B-X
clone	B-X
designated	B-X
L3	B-X
,	B-X
which	B-X
is	B-X
reactive	B-X
specifically	B-X
with	B-X
Ld	B-X
alloantigen	B-X
,	B-X
to	B-X
study	B-X
the	B-X
involvement	B-X
of	B-X
the	B-X
associative	B-X
recognition	B-X
structure	B-X
Lyt-2	B-X
in	B-X
cytolysis	B-X
.	B-X
The	B-X
apparent	B-X
requirements	B-X
for	B-X
activation	B-X
of	B-X
this	B-X
CTL	B-X
clone	B-X
differ	B-X
depending	B-X
on	B-X
whether	B-X
the	B-X
target	B-X
cells	B-X
bear	B-X
specific	B-X
alloantigen	B-X
or	B-X
are	B-X
hybridoma	B-X
cells	B-X
which	B-X
express	B-X
on	B-X
their	B-X
cell	B-X
surface	B-X
a	B-X
clonotypic	B-X
antibody	B-X
which	B-X
reacts	B-X
specifically	B-X
with	B-X
the	B-X
L3	B-X
T	B-X
cell	B-X
receptor	B-X
for	B-X
antigen	B-X
.	B-X
When	B-X
the	B-X
antigen	B-X
receptor	B-X
reacts	B-X
with	B-X
alloantigen	B-X
on	B-X
the	B-X
allogeneic	B-X
target	B-X
cell	B-X
,	B-X
cytolysis	B-X
is	B-X
inhibited	B-X
by	B-X
anti-Lyt-2	B-X
antibody	B-X
.	B-X
However	B-X
,	B-X
when	B-X
the	B-X
clonotypic	B-X
antibody	B-X
of	B-X
the	B-X
target	B-X
cell	B-X
reacts	B-X
with	B-X
the	B-X
antigen	B-X
receptor	B-X
of	B-X
the	B-X
T	B-X
cell	B-X
,	B-X
cytolysis	B-X
is	B-X
much	B-X
less	B-X
inhibited	B-X
by	B-X
anti-Lyt-2	B-X
antibody	B-X
.	B-X
The	B-X
antigen	B-X
receptor	B-X
seems	B-X
to	B-X
be	B-X
responsible	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
both	B-X
these	B-X
interactions	B-X
but	B-X
the	B-X
avidity	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
CTL	B-X
and	B-X
target	B-X
cell	B-X
seems	B-X
to	B-X
differ	B-X
in	B-X
the	B-X
two	B-X
situations	B-X
.	B-X
Evidence	B-X
that	B-X
participation	B-X
of	B-X
the	B-X
L3T4	B-X
associative	B-X
recognition	B-X
structure	B-X
on	B-X
HTL	B-X
is	B-X
less	B-X
important	B-X
for	B-X
cloned	B-X
T	B-X
cells	B-X
which	B-X
have	B-X
higher	B-X
affinity	B-X
antigen	B-X
receptors	B-X
was	B-X
provided	B-X
by	B-X
the	B-X
second	B-X
model	B-X
system	B-X
which	B-X
used	B-X
cloned	B-X
HTL	B-X
selected	B-X
for	B-X
optimal	B-X
responses	B-X
to	B-X
different	B-X
concentrations	B-X
of	B-X
nominal	B-X
antigen	B-X
.	B-X
Proliferative	B-X
responses	B-X
of	B-X
those	B-X
clones	B-X
which	B-X
responded	B-X
to	B-X
lower	B-X
antigen	B-X
concentrations	B-X
were	B-X
less	B-X
readily	B-X
inhibited	B-X
by	B-X
anti-L3T4	B-X
mAb	B-X
.	B-X
Evidence	B-X
provided	B-X
by	B-X
these	B-X
two	B-X
model	B-X
systems	B-X
is	B-X
consistent	B-X
with	B-X
the	B-X
concept	B-X
that	B-X
associative	B-X
recognition	B-X
structures	B-X
are	B-X
of	B-X
lesser	B-X
importance	B-X
for	B-X
T	B-X
cell	B-X
activation	B-X
for	B-X
those	B-X
T	B-X
cells	B-X
which	B-X
have	B-X
higher	B-X
affinity	B-X
antigen	B-X
receptors	B-X
.	B-X
In	B-X
the	B-X
third	B-X
model	B-X
system	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
several	B-X
monoclonal	B-X
antibodies	B-X
which	B-X
augment	B-X
proliferative	B-X
response	B-X
of	B-X
cloned	B-X
T	B-X
cells	B-X
to	B-X
sub-optimal	B-X
amounts	B-X
of	B-X
IL-2	B-X
,	B-X
probably	B-X
by	B-X
reacting	B-X
with	B-X
the	B-X
antigen	B-X
receptor	B-X
or	B-X
with	B-X
the	B-X
associated	B-X
Leu-4/T3	B-X
structure	B-X
.	B-X
Several	B-X
of	B-X
these	B-X
react	B-X
with	B-X
a	B-X
cell	B-X
surface	B-X
antigen	B-X
which	B-X
is	B-X
expressed	B-X
at	B-X
about	B-X
the	B-X
same	B-X
level	B-X
as	B-X

It	O
should	O
be	O
mentioned	O
here	O
that	O
the	O
SO2	O
phoP	B-Protein
ko	O
strain	O
,	O
which	O
showed	O
strong	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
expression	O
but	O
little	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
(	O
Figure	O
5	O
)	O
,	O
induced	O
only	O
very	O
reduced	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
-	I-Protein
specific	O
T	O
cell	O
responses	O
(	O
Figure	O
3	O
)	O
.	O

This	O
strain	O
was	O
previously	O
used	O
to	O
vaccinate	O
mice	O
and	O
guinea	O
pigs	O
and	O
conferred	O
good	O
protection	O
against	O
a	O
challenge	O
with	O
virulent	O
M	O
.	O
tuberculosis	O
[	O
25	O
]	O
.	O

As	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
-	O
specific	O
T	O
cell	O
responses	O
induced	O
by	O
this	O
strain	O
are	O
low	O
,	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
-	O
based	O
IFN	B-Protein
-	I-Protein
gamma	I-Protein
production	O
assays	O
might	O
be	O
used	O
to	O
differentiate	O
between	O
vaccination	O
with	O
SO2	B-Protein
and	O
infection	O
with	O
wild	O
-	O
type	O
M	O
.	O
tuberculosis	O
.	O

With	O
its	O
well	O
documented	O
role	O
in	O
virulence	O
and	O
strong	O
T	O
cell	O
antigenicity	O
,	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
is	O
one	O
of	O
the	O
most	O
important	O
proteins	O
of	O
M	O
.	O
tuberculosis	O
involved	O
in	O
host	O
pathogen	O
interaction	O
[	O
5	O
,	O
41	O
-	O
43	O
]	O
.	O

However	O
,	O
as	O
previously	O
observed	O
in	O
complementation	O
studies	O
of	O
BCG	O
[	O
18	O
]	O
,	O
the	O
level	O
of	O
virulence	O
displayed	O
by	O
the	O
phoP	B-Protein
complemented	O
H37Ra	O
strain	O
was	O
still	O
substantially	O
below	O
that	O
of	O
wild	O
-	O
type	O
H37Rv	O
,	O
arguing	O
that	O
the	O
strong	O
attenuation	O
of	O
the	O
H37Ra	O
strain	O
is	O
likely	O
based	O
on	O
several	O
different	O
genetic	O
lesions	O
,	O
such	O
as	O
the	O
one	O
responsible	O
for	O
the	O
absence	O
of	O
phthiocerol	O
dimycocerosates	O
(	O
PDIM	O
)	O
[	O
29	O
]	O
,	O
that	O
were	O
probably	O
introduced	O
into	O
this	O
strain	O
during	O
years	O
of	O
continued	O
culture	O
following	O
the	O
original	O
event	O
of	O
attenuation	O
described	O
by	O
Steenken	O
et	O
al	O
.	O
in	O
1934	O
[	O
6	O
]	O
.	O

Indeed	O
,	O
preliminary	O
comparison	O
of	O
the	O
4	O
.	O
4	O
-	O
Mb	O
genome	O
of	O
H37Rv	O
[	O
7	O
]	O
(	O
NC	O
_	O
000962	O
)	O
with	O
the	O
recently	O
accessible	O
H37Ra	O
genome	O
(	O
NC	O
_	O
009525	O
)	O
revealed	O
194	O
differences	O
,	O
including	O
126	O
SNPs	O
,	O
16	O
deletions	O
,	O
27	O
insertions	O
,	O
and	O
25	O
substitutions	O
.	O

At	O
present	O
,	O
we	O
do	O
not	O
know	O
how	O
many	O
of	O
these	O
differences	O
actually	O
contribute	O
to	O
the	O
attenuation	O
of	O
H37Ra	O
,	O
and	O
it	O
also	O
remains	O
to	O
be	O
determined	O
how	O
many	O
differences	O
exist	O
among	O
the	O
various	O
H37Ra	O
strains	O
that	O
are	O
presently	O
used	O
in	O
the	O
worldwide	O
tuberculosis	O
research	O
laboratories	O
.	O
<EOS>	B-X
In	B-X
1999	B-X
,	B-X
weekly	B-X
videoconferences	B-X
began	B-X
with	B-X
remote	B-X
laboratories	B-X
and	B-X
clinical	B-X
staff	B-X
in	B-X
four	B-X
peripheral	B-X
hospitals	B-X
and	B-X
the	B-X
Royal	B-X
Brisbane	B-X
Hospital	B-X
and	B-X
in	B-X
2000	B-X
biweekly	B-X
videoconference	B-X
pathology	B-X
grand	B-X
rounds	B-X
started	B-X
across	B-X
Queensland	B-X
with	B-X
up	B-X
to	B-X
six	B-X
sites	B-X
,	B-X
from	B-X
Cairns	B-X
to	B-X
the	B-X
Gold	B-X
Coast	B-X
,	B-X
joining	B-X
in	B-X
or	B-X
presenting	B-X
.	B-X
Problems	B-X
included	B-X
the	B-X
complexity	B-X
of	B-X
the	B-X
system	B-X
,	B-X
timing	B-X
and	B-X
need	B-X
for	B-X
bookings	B-X
,	B-X
coordination	B-X
of	B-X
presenters	B-X
and	B-X
presentations	B-X
,	B-X
and	B-X
the	B-X
time	B-X
needed	B-X
to	B-X
organize	B-X
sessions	B-X
,	B-X
set	B-X
up	B-X
linkages	B-X
,	B-X
advertise	B-X
sessions	B-X
and	B-X
attend	B-X
the	B-X
telepathology	B-X
conference	B-X
.	B-X
Future	B-X
needs	B-X
include	B-X
better	B-X
infrastructure	B-X
and	B-X
trained	B-X
staff	B-X
to	B-X
coordinate	B-X
the	B-X
linkages	B-X
and	B-X
presentations	B-X
.	B-X
This	B-X
development	B-X
provides	B-X
an	B-X
opportunity	B-X
for	B-X
educators	B-X
to	B-X
test	B-X
their	B-X
teaching	B-X
skills	B-X
on	B-X
what	B-X
,	B-X
for	B-X
many	B-X
,	B-X
is	B-X
a	B-X
new	B-X
platform	B-X
.	B-X
Many	B-X
of	B-X
the	B-X
basic	B-X
elements	B-X
of	B-X
what	B-X
constitutes	B-X
an	B-X
effective	B-X
presentation	B-X
are	B-X
the	B-X
same	B-X
regardless	B-X
of	B-X
whether	B-X
they	B-X
are	B-X
delivered	B-X
in	B-X
person	B-X
or	B-X
online	B-X
.	B-X
However	B-X
,	B-X
there	B-X
are	B-X
advantages	B-X
and	B-X
disadvantages	B-X
of	B-X
each	B-X
mode	B-X
of	B-X
presentation	B-X
,	B-X
and	B-X
understanding	B-X
how	B-X
to	B-X
best	B-X
leverage	B-X
the	B-X
features	B-X
of	B-X
an	B-X
online	B-X
platform	B-X
will	B-X
lead	B-X
to	B-X
a	B-X
better	B-X
educational	B-X
experience	B-X
for	B-X
the	B-X
presenter	B-X
and	B-X
audience	B-X
.	B-X
The	B-X
effectiveness	B-X
of	B-X
any	B-X
presentation	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
the	B-X
speaker	B-X
to	B-X
communicate	B-X
with	B-X
the	B-X
audience	B-X
.	B-X
Many	B-X
of	B-X
the	B-X
techniques	B-X
used	B-X
to	B-X
encourage	B-X
audience	B-X
participation	B-X
in	B-X
person	B-X
can	B-X
be	B-X
adapted	B-X
for	B-X
use	B-X
in	B-X
online	B-X
presentations	B-X
(	B-X
eg	B-X
,	B-X
the	B-X
use	B-X
of	B-X
features	B-X
such	B-X
as	B-X
chat	B-X
,	B-X
hand	B-X
raising	B-X
,	B-X
polling	B-X
,	B-X
and	B-X
question-and-answer	B-X
sessions	B-X
)	B-X
.	B-X
In	B-X
any	B-X
type	B-X
of	B-X
presentation	B-X
,	B-X
both	B-X
the	B-X
quality	B-X
of	B-X
the	B-X
content	B-X
and	B-X
the	B-X
oral	B-X
delivery	B-X
are	B-X
important	B-X
.	B-X
The	B-X
author	B-X
reviews	B-X
the	B-X
common	B-X
elements	B-X
of	B-X
an	B-X
effective	B-X
presentation	B-X
and	B-X
how	B-X
they	B-X
can	B-X
be	B-X
optimized	B-X
for	B-X
online	B-X
platforms	B-X
.	B-X

The	O
link	O
described	O
here	O
between	O
mutation	O
of	O
phoP	B-Protein
and	O
consequences	O
on	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
secretion	O
,	O
however	O
,	O
appears	O
to	O
be	O
one	O
factor	O
that	O
significantly	O
contributes	O
to	O
attenuation	O
.	O

Finally	O
,	O
it	O
is	O
intriguing	O
that	O
both	O
BCG	O
and	O
H37Ra	O
,	O
the	O
two	O
most	O
often	O
used	O
attenuated	O
tubercle	O
bacilli	O
,	O
are	O
attenuated	O
for	O
reasons	O
linked	O
to	O
loss	O
of	O
ESAT	B-Protein
-	I-Protein
6	I-Protein
functions	O
.	O

Thus	O
,	O
our	O
results	O
once	O
more	O
emphasize	O
the	O
great	O
importance	O
of	O
the	O
ESX	B-Protein
-	I-Protein
1	I-Protein
system	O
for	O
tubercle	O
bacilli	O
and	O
provide	O
important	O
new	O
information	O
about	O
the	O
phoP	B-Protein
-	O
associated	O
virulence	O
regulation	O
in	O
M	O
.	O
tuberculosis	O
.	O

Comparative	O
analysis	O
of	O
the	O
Photorhabdus	O
luminescens	O
and	O
the	O
Yersinia	O
enterocolitica	O
genomes	O
:	O
uncovering	O
candidate	O
genes	O
involved	O
in	O
insect	O
pathogenicity	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X
It	B-X
is	B-X
expected	B-X
that	B-X
both	B-X
pathogens	B-X
share	B-X
an	B-X
overlap	B-X
of	B-X
genetic	B-X
determinants	B-X
that	B-X
play	B-X
a	B-X
role	B-X
within	B-X
the	B-X
insect	B-X
host	B-X
.	B-X

Background	O
Photorhabdus	O
luminescens	O
and	O
Yersinia	O
enterocolitica	O
are	O
both	O
enteric	O
bacteria	O
which	O
are	O
associated	O
with	O
insects	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X

P	O
.	O
luminescens	O
lives	O
in	O
symbiosis	O
with	O
soil	O
nematodes	O
and	O
is	O
highly	O
pathogenic	O
towards	O
insects	O
but	O
not	O
to	O
humans	O
.	O

In	O
contrast	O
,	O
Y	O
.	O
enterocolitica	O
is	O
widely	O
found	O
in	O
the	O
environment	O
and	O
mainly	O
known	O
to	O
cause	O
gastroenteritis	O
in	O
men	O
,	O
but	O
has	O
only	O
recently	O
been	O
shown	O
to	O
be	O
also	O
toxic	O
for	O
insects	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X

It	O
is	O
expected	O
that	O
both	O
pathogens	O
share	O
an	O
overlap	O
of	O
genetic	O
determinants	O
that	O
play	O
a	O
role	O
within	O
the	O
insect	O
host	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X
It	B-X
is	B-X
expected	B-X
that	B-X
both	B-X
pathogens	B-X
share	B-X
an	B-X
overlap	B-X
of	B-X
genetic	B-X
determinants	B-X
that	B-X
play	B-X
a	B-X
role	B-X
within	B-X
the	B-X
insect	B-X
host	B-X
.	B-X

Results	O
A	O
selective	O
genome	O
comparison	O
was	O
applied	O
.	O
<EOS>	B-X
Trajectory	B-X
inference	B-X
approaches	B-X
analyze	B-X
genome-wide	B-X
omics	B-X
data	B-X
from	B-X
thousands	B-X
of	B-X
single	B-X
cells	B-X
and	B-X
computationally	B-X
infer	B-X
the	B-X
order	B-X
of	B-X
these	B-X
cells	B-X
along	B-X
developmental	B-X
trajectories	B-X
.	B-X
Next-generation	B-X
sequencing	B-X
(	B-X
NGS	B-X
)	B-X
technologies	B-X
are	B-X
frequently	B-X
used	B-X
for	B-X
resequencing	B-X
and	B-X
mining	B-X
of	B-X
single	B-X
nucleotide	B-X
polymorphisms	B-X
(	B-X
SNPs	B-X
)	B-X
by	B-X
comparison	B-X
to	B-X
a	B-X
reference	B-X
genome	B-X
.	B-X
In	B-X
crop	B-X
species	B-X
such	B-X
as	B-X
chickpea	B-X
(	B-X
Cicer	B-X
arietinum	B-X
)	B-X
that	B-X
lack	B-X
a	B-X
reference	B-X
genome	B-X
sequence	B-X
,	B-X
NGS-based	B-X
SNP	B-X
discovery	B-X
is	B-X
a	B-X
challenge	B-X
.	B-X
Therefore	B-X
,	B-X
unlike	B-X
probability-based	B-X
statistical	B-X
approaches	B-X
for	B-X
consensus	B-X
calling	B-X
and	B-X
by	B-X
comparison	B-X
with	B-X
a	B-X
reference	B-X
sequence	B-X
,	B-X
a	B-X
coverage-based	B-X
consensus	B-X
calling	B-X
(	B-X
CbCC	B-X
)	B-X
approach	B-X
was	B-X
applied	B-X
and	B-X
two	B-X
genotypes	B-X
were	B-X
compared	B-X
for	B-X
SNP	B-X
identification	B-X
.	B-X

Proteins	O
belonging	O
to	O
the	O
class	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
quorum	O
sensing	O
,	O
universal	O
stress	O
proteins	O
,	O
and	O
c	O
-	O
di	O
-	O
GMP	O
signalling	O
have	O
been	O
analysed	O
.	O

The	O
interorganismic	O
synopsis	O
of	O
selected	O
regulatory	O
systems	O
uncovered	O
common	O
and	O
distinct	O
signalling	O
mechanisms	O
of	O
both	O
pathogens	O
used	O
for	O
perception	O
of	O
signals	O
within	O
the	O
insect	O
host	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X
It	B-X
is	B-X
expected	B-X
that	B-X
both	B-X
pathogens	B-X
share	B-X
an	B-X
overlap	B-X
of	B-X
genetic	B-X
determinants	B-X
that	B-X
play	B-X
a	B-X
role	B-X
within	B-X
the	B-X
insect	B-X
host	B-X
.	B-X

Particularly	O
,	O
a	O
new	O
class	O
of	O
LuxR	B-Protein
-	O
like	O
regulators	O
was	O
identified	O
,	O
which	O
might	O
be	O
involved	O
in	O
detecting	O
insect	O
-	O
specific	O
molecules	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X
It	B-X
is	B-X
expected	B-X
that	B-X
both	B-X
pathogens	B-X
share	B-X
an	B-X
overlap	B-X
of	B-X
genetic	B-X
determinants	B-X
that	B-X
play	B-X
a	B-X
role	B-X
within	B-X
the	B-X
insect	B-X
host	B-X
.	B-X

In	O
addition	O
,	O
the	O
genetic	O
overlap	O
unravelled	O
a	O
two	O
-	O
component	O
system	O
that	O
is	O
unique	O
for	O
the	O
genera	O
Photorhabdus	O
and	O
Yersinia	O
and	O
is	O
therefore	O
suggested	O
to	O
play	O
a	O
major	O
role	O
in	O
the	O
pathogen	O
-	O
insect	O
relationship	O
.	O

Our	O
analysis	O
also	O
highlights	O
factors	O
of	O
both	O
pathogens	O
that	O
are	O
expressed	O
at	O
low	O
temperatures	O
as	O
encountered	O
in	O
insects	O
in	O
contrast	O
to	O
higher	O
(	O
body	O
)	O
temperature	O
,	O
providing	O
evidence	O
that	O
temperature	O
is	O
a	O
yet	O
under	O
-	O
investigated	O
environmental	O
signal	O
for	O
bacterial	O
adaptation	O
to	O
various	O
hosts	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X
It	B-X
is	B-X
expected	B-X
that	B-X
both	B-X
pathogens	B-X
share	B-X
an	B-X
overlap	B-X
of	B-X
genetic	B-X
determinants	B-X
that	B-X
play	B-X
a	B-X
role	B-X
within	B-X
the	B-X
insect	B-X
host	B-X
.	B-X

Common	O
degradative	O
metabolic	O
pathways	O
are	O
described	O
that	O
might	O
be	O
used	O
to	O
explore	O
nutrients	O
within	O
the	O
insect	O
gut	O
or	O
hemolymph	O
,	O
thus	O
enabling	O
the	O
proliferation	O
of	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
in	O
their	O
invertebrate	O
hosts	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X
It	B-X
is	B-X
expected	B-X
that	B-X
both	B-X
pathogens	B-X
share	B-X
an	B-X
overlap	B-X
of	B-X
genetic	B-X
determinants	B-X
that	B-X
play	B-X
a	B-X
role	B-X
within	B-X
the	B-X
insect	B-X
host	B-X
.	B-X

A	O
strikingly	O
higher	O
number	O
of	O
genes	O
encoding	O
insecticidal	O
toxins	O
and	O
other	O
virulence	O
factors	O
in	O
P	O
.	O
luminescens	O
compared	O
to	O
Y	O
.	O
enterocolitica	O
correlates	O
with	O
the	O
higher	O
virulence	O
of	O
P	O
.	O
luminescens	O
towards	O
insects	O
,	O
and	O
suggests	O
a	O
putative	O
broader	O
insect	O
host	O
spectrum	O
of	O
this	O
pathogen	O
.	O

Conclusion	O
A	O
set	O
of	O
factors	O
shared	O
by	O
the	O
two	O
pathogens	O
was	O
identified	O
including	O
those	O
that	O
are	O
involved	O
in	O
the	O
host	O
infection	O
process	O
,	O
in	O
persistence	O
within	O
the	O
insect	O
,	O
or	O
in	O
host	O
exploitation	O
.	O
<EOS>	B-X
We	B-X
discuss	B-X
activation	B-X
of	B-X
the	B-X
host	B-X
immune	B-X
system	B-X
as	B-X
a	B-X
particularly	B-X
attractive	B-X
way	B-X
to	B-X
clear	B-X
senescent	B-X
cancer	B-X
cells	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
consider	B-X
the	B-X
challenges	B-X
and	B-X
opportunities	B-X
provided	B-X
by	B-X
a	B-X
'one-two	B-X
punch	B-X
'	B-X
sequential	B-X
treatment	B-X
of	B-X
cancer	B-X
with	B-X
pro-senescence	B-X
therapy	B-X
followed	B-X
by	B-X
senolytic	B-X
therapy	B-X
.	B-X
Studies	B-X
of	B-X
the	B-X
infection	B-X
cycle	B-X
of	B-X
this	B-X
virus	B-X
revealed	B-X
potential	B-X
host	B-X
targets	B-X
important	B-X
for	B-X
the	B-X
virus	B-X
replication	B-X
cycle	B-X
.	B-X
Here	B-X
in	B-X
this	B-X
review	B-X
article	B-X
,	B-X
we	B-X
will	B-X
be	B-X
discussing	B-X
different	B-X
stages	B-X
of	B-X
the	B-X
Dengue	B-X
virus	B-X
infection	B-X
cycle	B-X
inside	B-X
mammalian	B-X
host	B-X
cells	B-X
and	B-X
how	B-X
host	B-X
proteins	B-X
are	B-X
exploited	B-X
by	B-X
the	B-X
virus	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
as	B-X
well	B-X
as	B-X
how	B-X
the	B-X
host	B-X
counteracts	B-X
the	B-X
virus	B-X
by	B-X
eliciting	B-X
different	B-X
antiviral	B-X
responses	B-X
.	B-X

Some	O
of	O
them	O
might	O
have	O
been	O
selected	O
during	O
the	O
association	O
with	O
insects	O
and	O
then	O
adapted	O
to	O
pathogenesis	O
in	O
mammalian	O
hosts	O
.	O
<EOS>	B-X
Photorhabdus	B-X
luminescens	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
are	B-X
both	B-X
enteric	B-X
bacteria	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
insects	B-X
.	B-X
P.	B-X
luminescens	B-X
lives	B-X
in	B-X
symbiosis	B-X
with	B-X
soil	B-X
nematodes	B-X
and	B-X
is	B-X
highly	B-X
pathogenic	B-X
towards	B-X
insects	B-X
but	B-X
not	B-X
to	B-X
humans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Y.	B-X
enterocolitica	B-X
is	B-X
widely	B-X
found	B-X
in	B-X
the	B-X
environment	B-X
and	B-X
mainly	B-X
known	B-X
to	B-X
cause	B-X
gastroenteritis	B-X
in	B-X
men	B-X
,	B-X
but	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
also	B-X
toxic	B-X
for	B-X
insects	B-X
.	B-X
Bacteria	B-X
of	B-X
the	B-X
Bacillus	B-X
cereus	B-X
group	B-X
colonize	B-X
several	B-X
ecological	B-X
niches	B-X
and	B-X
infect	B-X
different	B-X
hosts	B-X
.	B-X
The	B-X
rap-phr	B-X
genes	B-X
were	B-X
identified	B-X
in	B-X
all	B-X
selected	B-X
strains	B-X
with	B-X
30	B-X
%	B-X
located	B-X
on	B-X
plasmids	B-X
,	B-X
predominantly	B-X
in	B-X
B.	B-X
thuringiensis	B-X
.	B-X
Despite	B-X
a	B-X
high	B-X
variability	B-X
in	B-X
their	B-X
sequences	B-X
,	B-X
there	B-X
is	B-X
a	B-X
remarkable	B-X
association	B-X
between	B-X
closely	B-X
related	B-X
strains	B-X
and	B-X
their	B-X
Rap-Phr	B-X
profile	B-X
.	B-X

Background	O
<EOS>	B-X
Background	B-X
matching	B-X
is	B-X
the	B-X
most	B-X
familiar	B-X
and	B-X
widespread	B-X
camouflage	B-X
strategy	B-X
:	B-X
avoiding	B-X
detection	B-X
by	B-X
having	B-X
a	B-X
similar	B-X
colour	B-X
and	B-X
pattern	B-X
to	B-X
the	B-X
background	B-X
.	B-X
Background	B-X
is	B-X
thus	B-X
a	B-X
relatively	B-X
modest	B-X
correction	B-X
for	B-X
all	B-X
Z	B-X
opacity	B-X
data	B-X
published	B-X
to	B-X
date	B-X
.	B-X
Background	B-X
estimation	B-X
and	B-X
foreground	B-X
segmentation	B-X
are	B-X
important	B-X
steps	B-X
in	B-X
many	B-X
high-level	B-X
vision	B-X
tasks	B-X
.	B-X
Patient	B-X
Preference	B-X
for	B-X
Telehealth	B-X
Background	B-X
Shapes	B-X
Impressions	B-X
of	B-X
Physicians	B-X
and	B-X
Information	B-X
Recall	B-X
:	B-X
A	B-X
Randomized	B-X
Experiment	B-X
.	B-X

Pathogenicity	O
as	O
well	O
as	O
symbiosis	O
plays	O
a	O
key	O
role	O
in	O
the	O
interaction	O
of	O
bacteria	O
with	O
their	O
hosts	O
including	O
invertebrates	O
.	O

Despite	O
the	O
relevance	O
of	O
this	O
relationship	O
for	O
the	O
evolution	O
of	O
bacterial	O
pathogenicity	O
,	O
few	O
studies	O
have	O
addressed	O
this	O
subject	O
at	O
the	O
genomic	O
level	O
.	O

We	O
therefore	O
decided	O
to	O
perform	O
a	O
comparative	O
study	O
of	O
the	O
genomes	O
of	O
Photorhabdus	O
luminescens	O
and	O
Yersinia	O
enterocolitica	O
.	O

The	O
former	O
bacterium	O
is	O
a	O
representative	O
of	O
pathogens	O
highly	O
virulent	O
towards	O
insects	O
,	O
but	O
apathogenic	O
against	O
men	O
.	O

Y	O
.	O
enterocolitica	O
,	O
an	O
example	O
of	O
a	O
primarily	O
human	O
pathogen	O
,	O
also	O
confers	O
toxicity	O
to	O
insects	O
,	O
but	O
is	O
less	O
toxic	O
towards	O
these	O
hosts	O
than	O
P	O
.	O
luminescens	O
.	O

Members	O
of	O
the	O
genus	O
Yersinia	O
are	O
primarily	O
considered	O
as	O
mammalian	O
pathogens	O
.	O

However	O
,	O
Y	O
.	O
pestis	O
,	O
a	O
blood	O
-	O
borne	O
pathogen	O
and	O
the	O
etiological	O
agent	O
of	O
human	O
plague	O
,	O
has	O
long	O
been	O
known	O
to	O
be	O
transmitted	O
by	O
insects	O
,	O
specifically	O
by	O
rat	O
fleas	O
.	O

Y	O
.	O
enterocolitica	O
strains	O
have	O
been	O
isolated	O
from	O
flies	O
that	O
are	O
assumed	O
to	O
play	O
an	O
important	O
role	O
in	O
food	O
contamination	O
by	O
this	O
pathogen	O
[	O
1	O
-	O
3	O
]	O
,	O
and	O
Y	O
.	O
pseudotuberculosis	O
strains	O
were	O
recovered	O
from	O
fly	O
larvae	O
isolated	O
in	O
the	O
wild	O
[	O
4	O
]	O
.	O

More	O
recent	O
data	O
strongly	O
support	O
the	O
idea	O
that	O
yersiniae	O
are	O
capable	O
to	O
interact	O
with	O
insects	O
.	O

Loci	O
encoding	O
the	O
insecticidal	O
toxin	O
complexes	O
(	O
Tc	O
)	O
have	O
been	O
identified	O
in	O
the	O
genomes	O
of	O
Y	O
.	O
pestis	O
KIM	O
[	O
5	O
]	O
,	O
Y	O
.	O
pseudotuberculosis	O
[	O
6	O
]	O
,	O
and	O
Y	O
.	O
enterocolitica	O
[	O
7	O
]	O
.	O

Y	O
.	O
pseudotuberculosis	O
,	O
in	O
contrast	O
to	O
Y	O
.	O
pestis	O
,	O
has	O
been	O
shown	O
to	O
be	O
orally	O
toxic	O
to	O
flea	O
[	O
8	O
]	O
.	O

This	O
toxicity	O
revealed	O
to	O
be	O
independent	O
of	O
tc	O
genes	O
,	O
suggesting	O
that	O
loss	O
of	O
one	O
or	O
more	O
insect	O
gut	O
toxins	O
is	O
a	O
critical	O
step	O
in	O
the	O
change	O
of	O
the	O
Y	O
.	O
pestis	O
lifestyle	O
compared	O
with	O
the	O
Y	O
.	O
pseudotuberculosis	O
and	O
thus	O
in	O
evolution	O
of	O
flea	O
-	O
borne	O
transmission	O
[	O
8	O
]	O
.	O

While	O
Y	O
.	O
enterocolitica	O
and	O
Y	O
.	O
pseudotuberculosis	O
have	O
diverged	O
within	O
the	O
last	O
200	O
million	O
years	O
,	O
Y	O
.	O
pestis	O
has	O
emerged	O
from	O
Y	O
.	O
pseudotuberculosis	O
only	O
1	O
,	O
500	O
-	O
20	O
,	O
000	O
years	O
ago	O
[	O
9	O
]	O
.	O

Bacterial	O
lysates	O
both	O
of	O
Y	O
.	O
enterocolitica	O
and	O
Y	O
.	O
pseudotuberculosis	O
are	O
toxic	O
for	O
Manduca	O
sexta	O
neonates	O
,	O
and	O
significant	O
levels	O
of	O
natively	O
or	O
heterologously	O
expressed	O
toxins	O
were	O
observed	O
in	O
both	O
species	O
at	O
15degreesC	O
,	O
but	O
not	O
at	O
mammalian	O
body	O
temperature	O
[	O
7	O
,	O
10	O
]	O
.	O

Furthermore	O
,	O
Y	O
.	O
pseudotuberculosis	O
and	O
Y	O
.	O
enterocolitica	O
have	O
been	O
demonstrated	O
to	O
adhere	O
to	O
and	O
invade	O
cultivated	O
insect	O
cells	O
[	O
10	O
]	O
.	O

Thus	O
,	O
the	O
interaction	O
of	O
Y	O
.	O
enterocolitica	O
with	O
insects	O
is	O
an	O
important	O
link	O
in	O
the	O
ecological	O
range	O
of	O
bacteria	O
-	O
host	O
interactions	O
extending	O
from	O
entomopathogenic	O
to	O
humanpathogenic	O
bacteria	O
.	O

In	O
contrast	O
,	O
Photorhabdus	O
luminescens	O
is	O
predominantly	O
an	O
insect	O
pathogenic	O
enterobacterium	O
which	O
maintains	O
a	O
mutualistic	O
interaction	O
with	O
heterorhabditid	O
nematodes	O
,	O
and	O
can	O
infect	O
a	O
wide	O
range	O
of	O
insects	O
[	O
11	O
,	O
12	O
]	O
.	O

Interestingly	O
,	O
another	O
Photorhabdus	O
species	O
,	O
P	O
.	O
asymbiotica	O
,	O
has	O
been	O
described	O
as	O
a	O
human	O
pathogen	O
.	O
<EOS>	B-X
Photorhabdus	B-X
asymbiotica	B-X
is	B-X
one	B-X
of	B-X
the	B-X
three	B-X
recognized	B-X
species	B-X
of	B-X
the	B-X
Photorhabdus	B-X
genus	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
gram-negative	B-X
bioluminescent	B-X
bacteria	B-X
belonging	B-X
to	B-X
the	B-X
family	B-X
Morganellaceae	B-X
.	B-X
These	B-X
bacteria	B-X
live	B-X
in	B-X
a	B-X
symbiotic	B-X
relationship	B-X
with	B-X
nematodes	B-X
from	B-X
the	B-X
genus	B-X
Heterorhabditis	B-X
,	B-X
together	B-X
forming	B-X
a	B-X
complex	B-X
that	B-X
is	B-X
highly	B-X
pathogenic	B-X
for	B-X
insects	B-X
.	B-X
Unlike	B-X
other	B-X
Photorhabdus	B-X
species	B-X
,	B-X
which	B-X
are	B-X
strictly	B-X
entomopathogenic	B-X
,	B-X
P.	B-X
asymbiotica	B-X
is	B-X
unique	B-X
in	B-X
its	B-X
ability	B-X
to	B-X
act	B-X
as	B-X
an	B-X
emerging	B-X
human	B-X
pathogen	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
P.	B-X
asymbiotica	B-X
genome	B-X
identified	B-X
a	B-X
novel	B-X
fucose-binding	B-X
lectin	B-X
designated	B-X
PHL	B-X
with	B-X
a	B-X
strong	B-X
sequence	B-X
similarity	B-X
to	B-X
the	B-X
recently	B-X
described	B-X
P.	B-X
luminescens	B-X
lectin	B-X
PLL	B-X
.	B-X
Recombinant	B-X
PHL	B-X
exhibited	B-X
high	B-X
affinity	B-X
for	B-X
fucosylated	B-X
carbohydrates	B-X
and	B-X
the	B-X
unusual	B-X
disaccharide	B-X
3,6-O-Me2-Glcβ1-4	B-X
(	B-X
2,3-O-Me2	B-X
)	B-X
Rhaα-O-	B-X
(	B-X
p-C6H4	B-X
)	B-X
-OCH2CH2NH2	B-X
from	B-X
Mycobacterium	B-X
leprae	B-X
.	B-X
Based	B-X
on	B-X
its	B-X
crystal	B-X
structure	B-X
,	B-X
PHL	B-X
forms	B-X
a	B-X
seven-bladed	B-X
β-propeller	B-X
assembling	B-X
into	B-X
a	B-X
homo-dimer	B-X
with	B-X
an	B-X
inter-subunit	B-X
disulfide	B-X
bridge	B-X
.	B-X
Based	B-X
on	B-X
the	B-X
sequence	B-X
analysis	B-X
,	B-X
PHL	B-X
could	B-X
contain	B-X
up	B-X
to	B-X
twelve	B-X
binding	B-X
sites	B-X
per	B-X
monomer	B-X
.	B-X
PHL	B-X
was	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
all	B-X
types	B-X
of	B-X
red	B-X
blood	B-X
cells	B-X
and	B-X
insect	B-X
haemocytes	B-X
.	B-X
Interestingly	B-X
,	B-X
PHL	B-X
inhibited	B-X
the	B-X
production	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
induced	B-X
by	B-X
zymosan	B-X
A	B-X
in	B-X
human	B-X
blood	B-X
and	B-X
antimicrobial	B-X
activity	B-X
both	B-X
in	B-X
human	B-X
blood	B-X
,	B-X
serum	B-X
and	B-X
insect	B-X
haemolymph	B-X
.	B-X
Concurrently	B-X
,	B-X
PHL	B-X
increased	B-X
the	B-X
constitutive	B-X
level	B-X
of	B-X
oxidants	B-X
in	B-X
the	B-X
blood	B-X
and	B-X
induced	B-X
melanisation	B-X
in	B-X
haemolymph	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
PHL	B-X
might	B-X
play	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
the	B-X
interaction	B-X
of	B-X
P.	B-X
asymbiotica	B-X
with	B-X
both	B-X
human	B-X
and	B-X
insect	B-X
hosts	B-X
.	B-X

It	O
was	O
isolated	O
from	O
human	O
clinical	O
specimens	O
where	O
the	O
cells	O
caused	O
locally	O
invasive	O
soft	O
tissue	O
infections	O
[	O
13	O
,	O
14	O
]	O
.	O

It	O
is	O
assumed	O
that	O
these	O
strains	O
are	O
associated	O
with	O
spiders	O
,	O
because	O
spider	O
bites	O
where	O
attended	O
with	O
Photorhabdus	O
human	O
infections	O
[	O
15	O
]	O
.	O

However	O
,	O
bacteria	O
of	O
the	O
species	O
P	O
.	O
luminescens	O
are	O
exclusively	O
known	O
to	O
be	O
associated	O
with	O
nematodes	O
and	O
insects	O
.	O

Generally	O
,	O
the	O
bacteria	O
colonise	O
the	O
gut	O
of	O
the	O
infective	O
juvenile	O
stage	O
of	O
the	O
nematode	O
Heterorhabditis	O
bacteriophora	O
.	O

Upon	O
entering	O
an	O
insect	O
host	O
,	O
the	O
nematodes	O
release	O
the	O
bacteria	O
by	O
regurgiation	O
directly	O
into	O
the	O
insect	O
hemocoel	O
,	O
the	O
open	O
circulatory	O
system	O
of	O
the	O
insect	O
.	O

Once	O
inside	O
the	O
hemocoel	O
,	O
the	O
bacteria	O
replicate	O
rapidly	O
and	O
establish	O
a	O
lethal	O
septemica	O
in	O
the	O
host	O
by	O
the	O
production	O
of	O
virulence	O
factors	O
such	O
as	O
the	O
insecticidal	O
toxin	O
complexes	O
that	O
kill	O
the	O
insect	O
within	O
48	O
hours	O
.	O

Bioconversion	O
of	O
the	O
insect	O
'	O
s	O
body	O
by	O
P	O
.	O
luminescens	O
produces	O
a	O
rich	O
food	O
source	O
for	O
the	O
bacteria	O
as	O
well	O
as	O
for	O
the	O
nematodes	O
.	O

Nematode	O
reproduction	O
is	O
supported	O
by	O
the	O
bacteria	O
,	O
probably	O
by	O
providing	O
essential	O
nutrients	O
that	O
are	O
required	O
for	O
efficient	O
nematode	O
proliferation	O
[	O
16	O
]	O
.	O

Further	O
properties	O
of	O
P	O
.	O
luminescens	O
are	O
the	O
production	O
of	O
many	O
antimicrobial	O
substances	O
to	O
defend	O
the	O
insect	O
cadaver	O
from	O
bacterial	O
competitors	O
,	O
and	O
glowing	O
due	O
to	O
bacterial	O
luciferase	O
production	O
.	O

When	O
the	O
insect	O
cadaver	O
is	O
depleted	O
,	O
the	O
nematodes	O
and	O
bacteria	O
reassociate	O
and	O
emerge	O
from	O
the	O
carcass	O
in	O
search	O
of	O
a	O
new	O
insect	O
host	O
(	O
Fig	O
.	O
1	O
,	O
right	O
circle	O
)	O
[	O
17	O
,	O
18	O
]	O
.	O

Photorhabdus	O
species	O
exist	O
in	O
two	O
forms	O
,	O
designated	O
as	O
primary	O
and	O
secondary	O
phenotypic	O
colony	O
variants	O
,	O
which	O
differ	O
in	O
morphological	O
and	O
physiological	O
traits	O
.	O

Primary	O
variants	O
are	O
found	O
to	O
produce	O
extracellular	O
protease	O
,	O
extracellular	O
lipase	O
,	O
intracellular	O
protein	O
crystals	O
CipA	B-Protein
and	O
CipB	B-Protein
,	O
antibiotics	O
,	O
and	O
are	O
bioluminescent	O
.	O

Secondary	O
variants	O
lack	O
protease	O
,	O
lipase	O
and	O
antibiotic	O
activity	O
,	O
and	O
bioluminescence	O
is	O
strongly	O
decreased	O
.	O

They	O
also	O
differ	O
in	O
colony	O
morphology	O
,	O
pigmentation	O
,	O
dye	O
adsorption	O
,	O
metabolism	O
,	O
and	O
the	O
ability	O
to	O
support	O
growth	O
and	O
reproduction	O
of	O
the	O
nematodes	O
.	O

It	O
is	O
assumed	O
that	O
primary	O
variants	O
correspond	O
to	O
the	O
nematode	O
-	O
associated	O
form	O
,	O
and	O
secondary	O
variants	O
to	O
the	O
insect	O
-	O
associated	O
form	O
of	O
the	O
bacteria	O
[	O
19	O
,	O
20	O
]	O
.	O

Therefore	O
,	O
P	O
.	O
luminescens	O
serves	O
as	O
an	O
ideal	O
model	O
to	O
study	O
the	O
switch	O
from	O
a	O
symbiotic	O
state	O
with	O
nematodes	O
to	O
one	O
in	O
which	O
the	O
bacterium	O
is	O
pathogenic	O
to	O
insects	O
[	O
21	O
,	O
22	O
]	O
.	O

In	O
the	O
following	O
comparative	O
genome	O
analysis	O
,	O
we	O
examined	O
the	O
extent	O
to	O
which	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
share	O
factors	O
that	O
are	O
probably	O
attributed	O
to	O
insect	O
association	O
.	O

We	O
identified	O
genes	O
and	O
the	O
corresponding	O
proteins	O
involved	O
in	O
signalling	O
,	O
regulation	O
,	O
pathogenicity	O
,	O
as	O
well	O
as	O
in	O
metabolism	O
,	O
and	O
suggest	O
their	O
possible	O
function	O
during	O
colonization	O
and	O
infection	O
of	O
non	O
-	O
mammals	O
.	O

The	O
results	O
obtained	O
not	O
only	O
improve	O
our	O
understanding	O
of	O
the	O
biology	O
of	O
both	O
pathogens	O
,	O
but	O
also	O
reveal	O
some	O
implications	O
on	O
the	O
evolution	O
of	O
invertebrate	O
and	O
vertebrate	O
virulence	O
factors	O
.	O
<EOS>	B-X
Cell	B-X
death	B-X
was	B-X
once	B-X
believed	B-X
to	B-X
be	B-X
the	B-X
result	B-X
of	B-X
one	B-X
of	B-X
two	B-X
distinct	B-X
processes	B-X
,	B-X
apoptosis	B-X
(	B-X
also	B-X
known	B-X
as	B-X
programmed	B-X
cell	B-X
death	B-X
)	B-X
or	B-X
necrosis	B-X
(	B-X
uncontrolled	B-X
cell	B-X
death	B-X
)	B-X
;	B-X
in	B-X
recent	B-X
years	B-X
,	B-X
however	B-X
,	B-X
several	B-X
other	B-X
forms	B-X
of	B-X
cell	B-X
death	B-X
have	B-X
been	B-X
discovered	B-X
highlighting	B-X
that	B-X
a	B-X
cell	B-X
can	B-X
die	B-X
via	B-X
a	B-X
number	B-X
of	B-X
differing	B-X
pathways	B-X
.	B-X
An	B-X
understanding	B-X
of	B-X
the	B-X
pathways	B-X
is	B-X
therefore	B-X
important	B-X
in	B-X
developing	B-X
efficient	B-X
chemotherapeutics	B-X
.	B-X
Yet	B-X
,	B-X
knowledge	B-X
of	B-X
these	B-X
cellular	B-X
mechanisms	B-X
and	B-X
a	B-X
multitude	B-X
of	B-X
resulting	B-X
studies	B-X
have	B-X
often	B-X
failed	B-X
to	B-X
translate	B-X
into	B-X
improved	B-X
clinical	B-X
treatment	B-X
for	B-X
burn	B-X
injuries	B-X
.	B-X
Perhaps	B-X
the	B-X
most	B-X
valuable	B-X
information	B-X
to	B-X
date	B-X
is	B-X
the	B-X
years	B-X
of	B-X
clinical	B-X
experience	B-X
and	B-X
observations	B-X
in	B-X
the	B-X
management	B-X
and	B-X
treatment	B-X
of	B-X
patients	B-X
,	B-X
which	B-X
has	B-X
contributed	B-X
to	B-X
a	B-X
gradual	B-X
improvement	B-X
in	B-X
reported	B-X
outcomes	B-X
of	B-X
mortality	B-X
.	B-X

Results	O
and	O
Discussion	O
<EOS>	B-X
Discussion	B-X
of	B-X
religion	B-X
and/or	B-X
spirituality	B-X
in	B-X
the	B-X
medical	B-X
consultation	B-X
is	B-X
desired	B-X
by	B-X
patients	B-X
and	B-X
known	B-X
to	B-X
be	B-X
beneficial	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

The	O
genomes	O
of	O
P	O
.	O
luminescens	O
ssp	O
.	O
laumondii	O
TT01	O
and	O
Y	O
.	O
enterocolitica	O
8081	O
have	O
completely	O
been	O
sequenced	O
.	O

The	O
genome	O
of	O
the	O
latter	O
strain	O
has	O
a	O
size	O
of	O
~	O
4	O
.	O
6	O
Mbp	O
and	O
encodes	O
4037	O
putative	O
proteins	O
[	O
23	O
]	O
.	O

Its	O
genome	O
size	O
is	O
exceeded	O
by	O
the	O
~	O
5	O
.	O
7	O
Mbp	O
genome	O
of	O
P	O
.	O
luminescens	O
encoding	O
4839	O
putative	O
proteins	O
[	O
24	O
]	O
.	O

To	O
uncover	O
candidate	O
genes	O
which	O
are	O
involved	O
in	O
insect	O
pathogenicity	O
,	O
a	O
total	O
of	O
424	O
(	O
P	O
.	O
luminescens	O
)	O
and	O
386	O
(	O
Y	O
.	O
enterocolitica	O
)	O
genes	O
and	O
proteins	O
predicted	O
to	O
belong	O
to	O
one	O
of	O
the	O
functional	O
categories	O
described	O
in	O
the	O
text	O
were	O
analysed	O
for	O
their	O
presence	O
or	O
absence	O
in	O
both	O
organisms	O
,	O
and	O
for	O
their	O
degree	O
of	O
similarity	O
.	O
<EOS>	B-X
They	B-X
mediate	B-X
the	B-X
communication	B-X
between	B-X
the	B-X
brain	B-X
and	B-X
the	B-X
periphery	B-X
by	B-X
performing	B-X
sensory	B-X
and	B-X
secretory	B-X
roles	B-X
,	B-X
facilitated	B-X
by	B-X
increased	B-X
vascularisation	B-X
and	B-X
the	B-X
absence	B-X
of	B-X
a	B-X
blood-brain	B-X
barrier	B-X
.	B-X
Surprisingly	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
origins	B-X
of	B-X
the	B-X
CVOs	B-X
(	B-X
both	B-X
developmental	B-X
and	B-X
evolutionary	B-X
)	B-X
,	B-X
but	B-X
their	B-X
functional	B-X
and	B-X
organisational	B-X
similarities	B-X
raise	B-X
the	B-X
question	B-X
of	B-X
the	B-X
extent	B-X
of	B-X
their	B-X
relationship	B-X
.	B-X
Cross-species	B-X
comparisons	B-X
suggest	B-X
that	B-X
CVOs	B-X
also	B-X
display	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
evolutionary	B-X
flexibility	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
term	B-X
'CVO	B-X
'	B-X
is	B-X
merely	B-X
a	B-X
functional	B-X
definition	B-X
,	B-X
and	B-X
features	B-X
shared	B-X
by	B-X
multiple	B-X
CVOs	B-X
may	B-X
be	B-X
the	B-X
result	B-X
of	B-X
homoplasy	B-X
rather	B-X
than	B-X
ontogenetic	B-X
or	B-X
phylogenetic	B-X
relationships	B-X
.	B-X

House	O
-	O
keeping	O
genes	O
and	O
genes	O
of	O
unknown	O
function	O
were	O
not	O
considered	O
.	O
<EOS>	B-X
An	B-X
initial	B-X
design	B-X
,	B-X
based	B-X
on	B-X
collective	B-X
knowledge	B-X
of	B-X
molecular	B-X
biology	B-X
combined	B-X
with	B-X
limited	B-X
transposon	B-X
mutagenesis	B-X
data	B-X
,	B-X
failed	B-X
to	B-X
produce	B-X
a	B-X
viable	B-X
cell	B-X
.	B-X
Improved	B-X
transposon	B-X
mutagenesis	B-X
methods	B-X
revealed	B-X
a	B-X
class	B-X
of	B-X
quasi-essential	B-X
genes	B-X
that	B-X
are	B-X
needed	B-X
for	B-X
robust	B-X
growth	B-X
,	B-X
explaining	B-X
the	B-X
failure	B-X
of	B-X
our	B-X
initial	B-X
design	B-X
.	B-X
Three	B-X
cycles	B-X
of	B-X
design	B-X
,	B-X
synthesis	B-X
,	B-X
and	B-X
testing	B-X
,	B-X
with	B-X
retention	B-X
of	B-X
quasi-essential	B-X
genes	B-X
,	B-X
produced	B-X
JCVI-syn3.0	B-X
(	B-X
531	B-X
kilobase	B-X
pairs	B-X
,	B-X
473	B-X
genes	B-X
)	B-X
,	B-X
which	B-X
has	B-X
a	B-X
genome	B-X
smaller	B-X
than	B-X
that	B-X
of	B-X
any	B-X
autonomously	B-X
replicating	B-X
cell	B-X
found	B-X
in	B-X
nature	B-X
.	B-X
JCVI-syn3.0	B-X
retains	B-X
almost	B-X
all	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
synthesis	B-X
and	B-X
processing	B-X
of	B-X
macromolecules	B-X
.	B-X
Unexpectedly	B-X
,	B-X
it	B-X
also	B-X
contains	B-X
149	B-X
genes	B-X
with	B-X
unknown	B-X
biological	B-X
functions	B-X
.	B-X
JCVI-syn3.0	B-X
is	B-X
a	B-X
versatile	B-X
platform	B-X
for	B-X
investigating	B-X
the	B-X
core	B-X
functions	B-X
of	B-X
life	B-X
and	B-X
for	B-X
exploring	B-X
whole-genome	B-X
design	B-X
.	B-X

The	O
set	O
of	O
shared	O
genes	O
or	O
proteins	O
,	O
respectively	O
,	O
indicates	O
mechanisms	O
of	O
regulation	O
,	O
virulence	O
and	O
metabolic	O
pathways	O
similar	O
for	O
both	O
pathogens	O
,	O
and	O
moreover	O
unraveled	O
novel	O
candidate	O
genes	O
/	O
proteins	O
which	O
presumably	O
are	O
involved	O
in	O
insect	O
association	O
and	O
/	O
or	O
pathogenicity	O
.	O
<EOS>	B-X
Fusarium	B-X
is	B-X
a	B-X
genus	B-X
of	B-X
filamentous	B-X
fungi	B-X
that	B-X
contains	B-X
many	B-X
agronomically	B-X
important	B-X
plant	B-X
pathogens	B-X
,	B-X
mycotoxin	B-X
producers	B-X
,	B-X
and	B-X
opportunistic	B-X
human	B-X
pathogens	B-X
.	B-X
Comparative	B-X
analyses	B-X
have	B-X
revealed	B-X
that	B-X
the	B-X
Fusarium	B-X
genome	B-X
is	B-X
compartmentalized	B-X
into	B-X
regions	B-X
responsible	B-X
for	B-X
primary	B-X
metabolism	B-X
and	B-X
reproduction	B-X
(	B-X
core	B-X
genome	B-X
)	B-X
,	B-X
and	B-X
pathogen	B-X
virulence	B-X
,	B-X
host	B-X
specialization	B-X
,	B-X
and	B-X
possibly	B-X
other	B-X
functions	B-X
(	B-X
adaptive	B-X
genome	B-X
)	B-X
.	B-X
Genes	B-X
involved	B-X
in	B-X
virulence	B-X
and	B-X
host	B-X
specialization	B-X
are	B-X
located	B-X
on	B-X
pathogenicity	B-X
chromosomes	B-X
within	B-X
strains	B-X
pathogenic	B-X
to	B-X
tomato	B-X
(	B-X
Fusarium	B-X
oxysporum	B-X
f.	B-X
sp	B-X
.	B-X
The	B-X
experimental	B-X
transfer	B-X
of	B-X
pathogenicity	B-X
chromosomes	B-X
from	B-X
F.	B-X
oxysporum	B-X
f.	B-X
sp	B-X
.	B-X
Additional	B-X
genome-scale	B-X
comparative	B-X
and	B-X
functional	B-X
studies	B-X
are	B-X
needed	B-X
to	B-X
elucidate	B-X
the	B-X
evolution	B-X
and	B-X
diversity	B-X
of	B-X
pathogenicity	B-X
mechanisms	B-X
,	B-X
which	B-X
may	B-X
help	B-X
inform	B-X
novel	B-X
disease	B-X
management	B-X
strategies	B-X
against	B-X
fusarial	B-X
pathogens	B-X
.	B-X

Proteins	O
which	O
are	O
solely	O
present	O
in	O
either	O
one	O
of	O
the	O
organisms	O
suggest	O
a	O
distinct	O
function	O
of	O
these	O
factors	O
,	O
or	O
different	O
strategies	O
followed	O
by	O
the	O
two	O
pathogens	O
during	O
their	O
life	O
cycles	O
.	O
<EOS>	B-X
Using	B-X
primarily	B-X
Trypanosoma	B-X
brucei	B-X
as	B-X
a	B-X
model	B-X
,	B-X
the	B-X
basic	B-X
controlling	B-X
mechanisms	B-X
have	B-X
been	B-X
elucidated	B-X
and	B-X
now	B-X
researchers	B-X
are	B-X
beginning	B-X
to	B-X
define	B-X
the	B-X
cellular	B-X
factors	B-X
involved	B-X
in	B-X
the	B-X
transcription	B-X
,	B-X
processing	B-X
and	B-X
translation	B-X
of	B-X
the	B-X
mRNAs	B-X
in	B-X
these	B-X
parasites	B-X
.	B-X
We	B-X
describe	B-X
some	B-X
of	B-X
the	B-X
studies	B-X
made	B-X
on	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
that	B-X
are	B-X
differentially	B-X
expressed	B-X
during	B-X
the	B-X
life	B-X
cycles	B-X
of	B-X
T.	B-X
brucei	B-X
and	B-X
T.	B-X
cruzi	B-X
.	B-X
It	B-X
is	B-X
becoming	B-X
evident	B-X
that	B-X
the	B-X
regulatory	B-X
strategies	B-X
chosen	B-X
by	B-X
different	B-X
species	B-X
of	B-X
trypanosomatids	B-X
are	B-X
not	B-X
the	B-X
same	B-X
,	B-X
and	B-X
therefore	B-X
,	B-X
the	B-X
lessons	B-X
learned	B-X
from	B-X
one	B-X
species	B-X
do	B-X
not	B-X
necessarily	B-X
apply	B-X
to	B-X
the	B-X
others	B-X
.	B-X
CHA0	B-X
did	B-X
not	B-X
reduce	B-X
root	B-X
damages	B-X
caused	B-X
by	B-X
D.	B-X
radicum	B-X
and	B-X
had	B-X
only	B-X
small	B-X
effects	B-X
on	B-X
Delia	B-X
development	B-X
suggesting	B-X
a	B-X
rather	B-X
commensal	B-X
than	B-X
pathogenic	B-X
relationship	B-X
.	B-X
Interestingly	B-X
,	B-X
when	B-X
the	B-X
bacterium	B-X
was	B-X
fed	B-X
to	B-X
two	B-X
highly	B-X
susceptible	B-X
lepidopteran	B-X
species	B-X
,	B-X
most	B-X
of	B-X
the	B-X
insects	B-X
died	B-X
,	B-X
but	B-X
CHA0	B-X
could	B-X
persist	B-X
throughout	B-X
different	B-X
life	B-X
stages	B-X
in	B-X
surviving	B-X
individuals	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
this	B-X
study	B-X
investigated	B-X
for	B-X
the	B-X
first	B-X
time	B-X
the	B-X
interaction	B-X
of	B-X
P.	B-X
protegens	B-X
CHA0	B-X
and	B-X
related	B-X
strains	B-X
with	B-X
an	B-X
insect	B-X
present	B-X
in	B-X
their	B-X
rhizosphere	B-X
habitat	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
plant-colonizing	B-X
pseudomonads	B-X
have	B-X
different	B-X
strategies	B-X
for	B-X
interaction	B-X
with	B-X
insects	B-X
.	B-X
They	B-X
either	B-X
cause	B-X
lethal	B-X
infections	B-X
and	B-X
use	B-X
insects	B-X
as	B-X
food	B-X
source	B-X
or	B-X
they	B-X
live	B-X
inside	B-X
insect	B-X
hosts	B-X
without	B-X
causing	B-X
obvious	B-X
damages	B-X
and	B-X
might	B-X
use	B-X
insects	B-X
as	B-X
vectors	B-X
for	B-X
dispersal	B-X
,	B-X
which	B-X
implies	B-X
a	B-X
greater	B-X
ecological	B-X
versatility	B-X
of	B-X
these	B-X
bacteria	B-X
than	B-X
previously	B-X
thought	B-X
.	B-X

Sensing	O
,	O
signalling	O
,	O
and	O
regulation	O
Bacteria	O
have	O
evolved	O
several	O
regulation	O
mechanisms	O
to	O
ensure	O
a	O
proper	O
answer	O
to	O
changing	O
environments	O
.	O

Upon	O
entering	O
their	O
insect	O
hosts	O
,	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
are	O
challenged	O
by	O
varying	O
and	O
detrimental	O
surrounding	O
conditions	O
which	O
they	O
have	O
to	O
sense	O
and	O
adapt	O
to	O
for	O
further	O
persistence	O
.	O

In	O
addition	O
,	O
both	O
pathogens	O
must	O
be	O
capable	O
to	O
withstand	O
the	O
insect	O
'	O
s	O
immune	O
response	O
.	O

In	O
the	O
following	O
chapter	O
we	O
compare	O
sensing	O
and	O
regulating	O
mechanisms	O
of	O
the	O
two	O
insect	O
-	O
associated	O
organisms	O
,	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
,	O
thus	O
identifying	O
strategies	O
which	O
might	O
be	O
important	O
for	O
insect	O
colonization	O
and	O
pathogenicity	O
.	O

Two	O
-	O
component	O
signal	O
transduction	O
To	O
sense	O
their	O
environment	O
and	O
to	O
react	O
rapidly	O
to	O
changing	O
surrounding	O
conditions	O
,	O
bacteria	O
have	O
evolved	O
so	O
called	O
two	O
-	O
component	O
systems	O
(	O
TCSs	O
)	O
[	O
25	O
]	O
which	O
have	O
been	O
found	O
to	O
be	O
involved	O
in	O
the	O
control	O
of	O
virulence	O
or	O
symbiosis	O
,	O
in	O
metabolite	O
utilization	O
,	O
and	O
also	O
in	O
the	O
adaptation	O
to	O
various	O
stress	O
factors	O
[	O
26	O
]	O
.	O
<EOS>	B-X
The	B-X
gut	B-X
microbiota	B-X
produces	B-X
metabolites	B-X
that	B-X
regulate	B-X
host	B-X
immunity	B-X
,	B-X
thereby	B-X
impacting	B-X
disease	B-X
resistance	B-X
and	B-X
susceptibility	B-X
.	B-X
The	B-X
extent	B-X
to	B-X
which	B-X
commensal	B-X
bacteria	B-X
reciprocally	B-X
respond	B-X
to	B-X
immune	B-X
activation	B-X
,	B-X
however	B-X
,	B-X
remains	B-X
largely	B-X
unexplored	B-X
.	B-X
Transcriptomic	B-X
changes	B-X
include	B-X
induction	B-X
of	B-X
stress-response	B-X
mediators	B-X
and	B-X
downregulation	B-X
of	B-X
carbohydrate-degrading	B-X
factors	B-X
such	B-X
as	B-X
polysaccharide	B-X
utilization	B-X
loci	B-X
(	B-X
PULs	B-X
)	B-X
.	B-X
Flagellin	B-X
and	B-X
anti-CD3	B-X
antibody	B-X
,	B-X
two	B-X
distinct	B-X
immune	B-X
stimuli	B-X
,	B-X
induced	B-X
similar	B-X
transcriptional	B-X
profiles	B-X
,	B-X
suggesting	B-X
that	B-X
commensal	B-X
bacteria	B-X
detect	B-X
common	B-X
effectors	B-X
or	B-X
activate	B-X
shared	B-X
pathways	B-X
when	B-X
facing	B-X
different	B-X
host	B-X
responses	B-X
.	B-X
Immune	B-X
activation	B-X
altered	B-X
the	B-X
intestinal	B-X
metabolome	B-X
within	B-X
6	B-X
hours	B-X
,	B-X
decreasing	B-X
luminal	B-X
short-chain	B-X
fatty	B-X
acid	B-X
and	B-X
increasing	B-X
aromatic	B-X
metabolite	B-X
concentrations	B-X
.	B-X
Thus	B-X
,	B-X
intestinal	B-X
bacteria	B-X
,	B-X
prior	B-X
to	B-X
detectable	B-X
shifts	B-X
in	B-X
community	B-X
composition	B-X
,	B-X
respond	B-X
to	B-X
acute	B-X
host	B-X
immune	B-X
activation	B-X
by	B-X
rapidly	B-X
changing	B-X
gene	B-X
transcription	B-X
and	B-X
immunomodulatory	B-X
metabolite	B-X
production	B-X
.	B-X

A	O
basic	O
TCS	O
consists	O
of	O
two	O
proteins	O
,	O
a	O
sensor	O
histidine	O
kinase	O
and	O
a	O
response	O
regulator	O
performing	O
a	O
His	O
-	O
Asp	O
phosphotransfer	O
.	O

The	O
consisting	O
domains	O
or	O
proteins	O
can	O
also	O
be	O
organized	O
as	O
more	O
complex	O
systems	O
using	O
a	O
His	O
-	O
Asp	O
-	O
His	O
-	O
Asp	O
phosphorelay	O
.	O
<EOS>	B-X
Piezo	B-X
proteins	B-X
are	B-X
distinct	B-X
from	B-X
other	B-X
ion	B-X
channels	B-X
and	B-X
their	B-X
structure	B-X
remains	B-X
poorly	B-X
defined	B-X
,	B-X
which	B-X
impedes	B-X
detailed	B-X
study	B-X
of	B-X
their	B-X
gating	B-X
and	B-X
ion	B-X
permeation	B-X
properties	B-X
.	B-X
The	B-X
detergent-solubilized	B-X
complex	B-X
adopts	B-X
a	B-X
three-bladed	B-X
propeller	B-X
shape	B-X
with	B-X
a	B-X
curved	B-X
transmembrane	B-X
region	B-X
containing	B-X
at	B-X
least	B-X
26	B-X
transmembrane	B-X
helices	B-X
per	B-X
protomer	B-X
.	B-X
Carboxy-terminal	B-X
domains	B-X
line	B-X
the	B-X
central	B-X
ion	B-X
pore	B-X
,	B-X
and	B-X
the	B-X
channel	B-X
is	B-X
closed	B-X
by	B-X
constrictions	B-X
in	B-X
the	B-X
cytosol	B-X
.	B-X
Gene	B-X
expression	B-X
is	B-X
controlled	B-X
by	B-X
transcription	B-X
factors	B-X
(	B-X
TFs	B-X
)	B-X
that	B-X
consist	B-X
of	B-X
DNA-binding	B-X
domains	B-X
(	B-X
DBDs	B-X
)	B-X
and	B-X
activation	B-X
domains	B-X
(	B-X
ADs	B-X
)	B-X
.	B-X

The	O
number	O
of	O
TCSs	O
ranges	O
from	O
zero	O
in	O
Mycoplasma	O
genitalium	O
to	O
80	O
in	O
Syncheocystes	O
spp	O
.	O

[	O
25	O
,	O
27	O
]	O
.	O
<EOS>	B-X
Editorial	B-X
:	B-X
``	B-X
Old	B-X
lamps	B-X
for	B-X
new	B-X
''	B-X
.	B-X

Eighteen	O
of	O
these	O
TCSs	O
are	O
present	O
in	O
P	O
.	O
luminescens	O
,	O
and	O
28	O
in	O
Y	O
.	O
enterocolitica	O
,	O
of	O
which	O
17	O
are	O
shared	O
by	O
both	O
organisms	O
(	O
Fig	O
.	O
2	O
,	O
depicted	O
in	O
grey	O
)	O
.	O

The	O
additional	O
set	O
of	O
eleven	O
TCSs	O
in	O
Y	O
.	O
enterocolitica	O
(	O
Fig	O
.	O
2	O
,	O
shown	O
in	O
red	O
)	O
might	O
reflect	O
the	O
high	O
number	O
of	O
different	O
environments	O
this	O
pathogen	O
is	O
exposed	O
to	O
during	O
its	O
life	O
cycle	O
,	O
namely	O
soil	O
,	O
water	O
and	O
invertebrates	O
as	O
well	O
as	O
mammalian	O
hosts	O
.	O

In	O
contrast	O
,	O
P	O
.	O
luminescens	O
cells	O
are	O
primarily	O
restricted	O
to	O
symbiosis	O
with	O
the	O
nematode	O
species	O
H	O
.	O
bacteriophora	O
and	O
the	O
insect	O
larvae	O
as	O
hosts	O
,	O
thus	O
encountering	O
a	O
more	O
homeostatic	O
milieu	O
.	O

Among	O
the	O
eleven	O
TCSs	O
of	O
Y	O
.	O
enterocolitica	O
not	O
shared	O
by	O
P	O
.	O
luminescens	O
are	O
duplicates	O
of	O
the	O
CitA	B-Protein
/	O
CitB	B-Protein
system	O
(	O
YE2505	B-Protein
/	O
YE2506	B-Protein
and	O
YE2654	B-Protein
/	O
YE2655	B-Protein
)	O
and	O
of	O
the	O
LytS	B-Protein
/	O
LytR	B-Protein
system	O
(	O
YE1228	B-Protein
/	O
YE1227	B-Protein
and	O
YE4014	B-Protein
/	O
YE4015	B-Protein
)	O
.	O

The	O
principal	O
biological	O
reason	O
for	O
this	O
redundancy	O
remains	O
unclear	O
.	O
<EOS>	B-X
While	B-X
few	B-X
published	B-X
trials	B-X
did	B-X
report	B-X
how	B-X
they	B-X
foundered	B-X
,	B-X
the	B-X
reasons	B-X
why	B-X
they	B-X
failed	B-X
are	B-X
often	B-X
completely	B-X
unclear	B-X
.	B-X
Given	B-X
our	B-X
growing	B-X
understanding	B-X
of	B-X
the	B-X
natural	B-X
history	B-X
of	B-X
ectopic	B-X
endometrium	B-X
,	B-X
it	B-X
is	B-X
also	B-X
important	B-X
to	B-X
make	B-X
an	B-X
inventory	B-X
of	B-X
biologicals/compounds	B-X
that	B-X
are	B-X
currently	B-X
under	B-X
development	B-X
to	B-X
see	B-X
where	B-X
we	B-X
stand	B-X
and	B-X
whether	B-X
they	B-X
would	B-X
stand	B-X
a	B-X
better	B-X
chance	B-X
of	B-X
gaining	B-X
regulatory	B-X
approval	B-X
than	B-X
their	B-X
predecessors	B-X
.	B-X

Interestingly	O
,	O
one	O
TCS	O
(	O
Plu0102	B-Protein
/	O
Plu103	B-Protein
and	O
YE4185	B-Protein
/	O
YE4186	B-Protein
)	O
is	O
unique	O
for	O
the	O
genera	O
Photorhabdus	O
and	O
Yersinia	O
.	O

Both	O
sensor	O
kinases	O
Plu0102	B-Protein
and	O
YE4185	B-Protein
are	O
of	O
moderate	O
similarity	O
(	O
31	O
.	O
5	O
%	O
identity	O
,	O
48	O
.	O
5	O
%	O
homology	O
)	O
.	O

They	O
are	O
anchored	O
to	O
the	O
membrane	O
with	O
one	O
transmembrane	O
domain	O
,	O
and	O
have	O
a	O
large	O
periplasmic	O
sensing	O
domain	O
which	O
is	O
proposed	O
to	O
bind	O
a	O
specific	O
ligand	O
.	O

Therefore	O
,	O
Plu0102	B-Protein
and	O
YE4185	B-Protein
are	O
interesting	O
candidates	O
for	O
unravelling	O
invertebrate	O
-	O
specific	O
signals	O
.	O
<EOS>	B-X
We	B-X
show	B-X
that	B-X
the	B-X
cells	B-X
of	B-X
the	B-X
frontal	B-X
eye	B-X
specifically	B-X
coexpress	B-X
a	B-X
combination	B-X
of	B-X
transcription	B-X
factors	B-X
and	B-X
opsins	B-X
typical	B-X
of	B-X
the	B-X
vertebrate	B-X
eye	B-X
photoreceptors	B-X
and	B-X
an	B-X
inhibitory	B-X
Gi-type	B-X
alpha	B-X
subunit	B-X
of	B-X
the	B-X
G	B-X
protein	B-X
,	B-X
indicating	B-X
an	B-X
off-responding	B-X
phototransductory	B-X
cascade	B-X
.	B-X

The	O
putative	O
target	O
genes	O
of	O
Plu0102	B-Protein
/	O
Plu0103	B-Protein
and	O
Ye4185	B-Protein
/	O
Ye4186	B-Protein
,	O
plu0104	B-Protein
and	O
ye4187	B-Protein
,	O
respectively	O
,	O
are	O
homologues	O
and	O
encode	O
putative	O
secreted	O
proteins	O
which	O
might	O
act	O
in	O
a	O
similar	O
,	O
yet	O
unknown	O
manner	O
.	O

All	O
TCSs	O
present	O
in	O
both	O
organisms	O
are	O
depicted	O
in	O
grey	O
in	O
Fig	O
.	O

2	O
,	O
and	O
include	O
PhoP	B-Protein
/	O
PhoQ	B-Protein
,	O
and	O
AstS	B-Protein
/	O
AstR	B-Protein
(	O
BvgS	B-Protein
/	O
BvgR	B-Protein
)	O
which	O
have	O
been	O
identified	O
to	O
be	O
involved	O
in	O
virulence	O
[	O
28	O
]	O
.	O

The	O
role	O
of	O
PhoP	B-Protein
/	O
PhoQ	B-Protein
in	O
regulating	O
virulence	O
gene	O
expression	O
has	O
been	O
characterized	O
mainly	O
in	O
Salmonella	O
species	O
,	O
but	O
has	O
also	O
been	O
shown	O
,	O
in	O
addition	O
to	O
three	O
other	O
TCSs	O
,	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Y	O
.	O
pseudotuberculosis	O
[	O
29	O
,	O
30	O
]	O
.	O

In	O
P	O
.	O
luminescens	O
,	O
this	O
TCS	O
controls	O
the	O
expression	O
of	O
the	O
pbgPE	B-Protein
operon	O
which	O
is	O
involved	O
in	O
lipid	O
A	O
modification	O
and	O
thus	O
plays	O
a	O
role	O
in	O
colonization	O
and	O
infection	O
of	O
the	O
invertebrate	O
hosts	O
[	O
18	O
,	O
31	O
]	O
.	O

Furthermore	O
,	O
PhoP	B-Protein
has	O
also	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Y	O
.	O
pestis	O
[	O
32	O
]	O
,	O
but	O
its	O
function	O
in	O
Y	O
.	O
enterocolitica	O
during	O
its	O
insect	O
-	O
associated	O
phase	O
remains	O
hypothetical	O
.	O

The	O
AstS	B-Protein
/	O
AstR	B-Protein
TCS	O
is	O
required	O
for	O
the	O
correct	O
timing	O
of	O
phase	O
variant	O
switching	O
in	O
P	O
.	O
luminescens	O
[	O
28	O
]	O
.	O

BvgS	B-Protein
/	O
BvgR	B-Protein
is	O
the	O
TCS	O
of	O
Y	O
.	O
enterocolitica	O
that	O
corresponds	O
to	O
AstS	B-Protein
/	O
AstR	B-Protein
.	O

Because	O
Y	O
.	O
enterocolitica	O
is	O
not	O
known	O
to	O
switch	O
to	O
another	O
phenotypic	O
variant	O
,	O
the	O
possible	O
role	O
in	O
virulence	O
regulation	O
still	O
remains	O
to	O
be	O
elucidated	O
.	O
<EOS>	B-X
Toxigenic	B-X
Properties	B-X
of	B-X
Increasing	B-X
attention	B-X
is	B-X
being	B-X
paid	B-X
to	B-X
the	B-X
unique	B-X
roles	B-X
gut	B-X
microbes	B-X
play	B-X
in	B-X
both	B-X
physiological	B-X
and	B-X
pathological	B-X
processes	B-X
.	B-X
Crohn	B-X
's	B-X
disease	B-X
(	B-X
CD	B-X
)	B-X
is	B-X
a	B-X
chronic	B-X
,	B-X
relapsing	B-X
,	B-X
inflammatory	B-X
disease	B-X
of	B-X
the	B-X
gastrointestinal	B-X
tract	B-X
with	B-X
unknown	B-X
etiology	B-X
.	B-X
Yersinia	B-X
enterocolitica	B-X
is	B-X
an	B-X
important	B-X
foodborne	B-X
pathogen	B-X
,	B-X
but	B-X
the	B-X
prevalence	B-X
in	B-X
food	B-X
is	B-X
underestimated	B-X
due	B-X
to	B-X
drawbacks	B-X
in	B-X
the	B-X
detection	B-X
methods	B-X
.	B-X
Problems	B-X
arise	B-X
from	B-X
the	B-X
low	B-X
concentration	B-X
of	B-X
pathogenic	B-X
strains	B-X
present	B-X
in	B-X
food	B-X
samples	B-X
,	B-X
similarities	B-X
with	B-X
other	B-X
Enterobacteriaceae	B-X
and	B-X
Y.	B-X
enterocolitica-like	B-X
species	B-X
and	B-X
the	B-X
heterogeneity	B-X
of	B-X
Y.	B-X
enterocolitica	B-X
as	B-X
it	B-X
comprises	B-X
both	B-X
pathogenic	B-X
and	B-X
non-pathogenic	B-X
isolates	B-X
.	B-X
Recent	B-X
molecular	B-X
subtyping	B-X
methods	B-X
have	B-X
been	B-X
applied	B-X
to	B-X
Y.	B-X
enterocolitica	B-X
strains	B-X
to	B-X
track	B-X
infection	B-X
sources	B-X
and	B-X
to	B-X
investigate	B-X
phylogenetic	B-X
relationships	B-X
between	B-X
different	B-X
Yersinia	B-X
strains	B-X
.	B-X
Further	B-X
application	B-X
of	B-X
modern	B-X
subtyping	B-X
tools	B-X
such	B-X
as	B-X
WGS	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
bioserotypes	B-X
,	B-X
and	B-X
comparison	B-X
with	B-X
other	B-X
members	B-X
of	B-X
the	B-X
genus	B-X
will	B-X
help	B-X
to	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
virulence	B-X
determinants	B-X
of	B-X
pathogenic	B-X
Y.	B-X
enterocolitica	B-X
,	B-X
its	B-X
mechanisms	B-X
to	B-X
cope	B-X
in	B-X
the	B-X
host	B-X
environments	B-X
,	B-X
and	B-X
can	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
more	B-X
specific	B-X
detection	B-X
and	B-X
typing	B-X
strategies	B-X
.	B-X

Both	O
Y	O
.	O
enterocolitica	O
and	O
P	O
.	O
luminescens	O
produce	O
the	O
KdpD	B-Protein
/	O
KdpE	B-Protein
system	O
that	O
regulates	O
K	O
+	O
homeostasis	O
and	O
osmotic	O
stress	O
.	O

It	O
has	O
recently	O
been	O
found	O
that	O
the	O
Kdp	O
-	O
system	O
of	O
P	O
.	O
luminescens	O
is	O
important	O
for	O
insect	O
pathogenicity	O
(	O
S	O
.	O
E	O
.	O
Reynolds	O
and	O
N	O
.	O
R	O
.	O
Waterfield	O
,	O
University	O
of	O
Bath	O
,	O
UK	O
,	O
personal	O
communication	O
)	O
.	O

Therefore	O
,	O
the	O
KdpD	B-Protein
/	O
KdpE	B-Protein
system	O
is	O
also	O
a	O
further	O
candidate	O
system	O
which	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
insecticidal	O
activity	O
of	O
Y	O
.	O
enterocolitica	O
.	O

The	O
only	O
TCS	O
of	O
P	O
.	O
luminescens	O
absent	O
in	O
Y	O
.	O
enterocolitica	O
is	O
TctE	B-Protein
/	O
TctD	B-Protein
(	O
Fig	O
.	O
2	O
,	O
marked	O
in	O
blue	O
)	O
,	O
which	O
,	O
however	O
,	O
is	O
found	O
in	O
the	O
genomes	O
of	O
Y	O
.	O
intermedia	O
and	O
Y	O
.	O
frederiksenii	O
.	O

Beside	O
these	O
microorganisms	O
,	O
TctE	B-Protein
/	O
TctD	B-Protein
homologues	O
controlling	O
the	O
transport	O
of	O
tricarboxylic	O
acid	O
(	O
see	O
section	O
"	O
Tricarboxylate	O
utilization	O
"	O
)	O
are	O
present	O
in	O
the	O
genera	O
Salmonella	O
,	O
Burkholderia	O
,	O
Agrobacterium	O
,	O
Bordetella	O
,	O
Collinsella	O
,	O
Xylella	O
,	O
Xanthomonas	O
,	O
and	O
Pseudomonas	O
,	O
particularly	O
P	O
.	O
entomophila	O
,	O
all	O
of	O
which	O
are	O
found	O
in	O
association	O
with	O
eukaryotes	O
.	O

To	O
summarize	O
,	O
the	O
comparison	O
of	O
the	O
P	O
.	O
luminescens	O
and	O
the	O
Y	O
.	O
enterocolitica	O
TCSs	O
reveals	O
a	O
basal	O
set	O
of	O
signal	O
sensing	O
mechanisms	O
which	O
are	O
used	O
by	O
both	O
organisms	O
.	O

Whether	O
the	O
stimulons	O
or	O
regulons	O
which	O
are	O
regulated	O
by	O
these	O
sets	O
of	O
TCSs	O
are	O
also	O
similar	O
remains	O
to	O
be	O
examined	O
.	O
<EOS>	B-X
Desulfonative	B-X
enzymes	B-X
in	B-X
aerobic	B-X
bacteria	B-X
are	B-X
generally	B-X
regulated	B-X
by	B-X
induction	B-X
,	B-X
if	B-X
the	B-X
sulfonate	B-X
is	B-X
serving	B-X
as	B-X
a	B-X
carbon	B-X
and	B-X
energy	B-X
source	B-X
,	B-X
or	B-X
by	B-X
a	B-X
global	B-X
network	B-X
for	B-X
sulfur	B-X
scavenging	B-X
(	B-X
sulfate-starvation-induced	B-X
(	B-X
SSI	B-X
)	B-X
stimulon	B-X
)	B-X
if	B-X
the	B-X
sulfonate	B-X
is	B-X
serving	B-X
as	B-X
a	B-X
source	B-X
of	B-X
sulfur	B-X
.	B-X
The	B-X
anaerobic	B-X
bacteria	B-X
examined	B-X
can	B-X
express	B-X
the	B-X
degradative	B-X
enzymes	B-X
constitutively	B-X
,	B-X
if	B-X
the	B-X
sulfonate	B-X
is	B-X
being	B-X
utilized	B-X
as	B-X
a	B-X
carbon	B-X
source	B-X
,	B-X
but	B-X
enzyme	B-X
induction	B-X
has	B-X
also	B-X
been	B-X
observed	B-X
.	B-X
The	B-X
two	B-X
stimulons	B-X
each	B-X
contain	B-X
a	B-X
set	B-X
of	B-X
more	B-X
than	B-X
30	B-X
genes	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
in	B-X
each	B-X
stimulon	B-X
is	B-X
under	B-X
the	B-X
control	B-X
of	B-X
a	B-X
positive	B-X
regulatory	B-X
element	B-X
;	B-X
these	B-X
genes	B-X
constitute	B-X
the	B-X
OxyR	B-X
and	B-X
SoxRS	B-X
regulons	B-X
.	B-X
The	B-X
schemes	B-X
of	B-X
regulation	B-X
of	B-X
the	B-X
two	B-X
regulons	B-X
by	B-X
their	B-X
respective	B-X
regulators	B-X
are	B-X
reviewed	B-X
in	B-X
detail	B-X
,	B-X
and	B-X
the	B-X
overlaps	B-X
of	B-X
these	B-X
regulons	B-X
with	B-X
other	B-X
stress	B-X
responses	B-X
such	B-X
as	B-X
the	B-X
heat	B-X
shock	B-X
and	B-X
SOS	B-X
responses	B-X
are	B-X
discussed	B-X
.	B-X
The	B-X
products	B-X
of	B-X
Oxy-R-	B-X
and	B-X
SoxRS-regulated	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
catalases	B-X
and	B-X
superoxide	B-X
dismutases	B-X
,	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
prevention	B-X
of	B-X
oxidative	B-X
damage	B-X
,	B-X
whereas	B-X
others	B-X
,	B-X
such	B-X
as	B-X
endonuclease	B-X
IV	B-X
,	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
repair	B-X
of	B-X
oxidative	B-X
damage	B-X
.	B-X
A	B-X
brief	B-X
discussion	B-X
of	B-X
the	B-X
similarities	B-X
and	B-X
differences	B-X
between	B-X
oxidative	B-X
stress	B-X
responses	B-X
in	B-X
bacteria	B-X
and	B-X
eukaryotic	B-X
organisms	B-X
concludes	B-X
this	B-X
review	B-X
.	B-X

In	O
comparison	O
to	O
P	O
.	O
luminescens	O
,	O
Y	O
.	O
enterocolitica	O
uses	O
an	O
expanded	O
set	O
of	O
TCSs	O
,	O
possibly	O
to	O
adapt	O
to	O
its	O
various	O
hosts	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Quorum	O
sensing	O
-	O
like	O
gene	O
regulation	O
<EOS>	B-X
Bacterial	B-X
biofilm	B-X
refers	B-X
to	B-X
a	B-X
tunicate-like	B-X
biological	B-X
group	B-X
composed	B-X
of	B-X
polysaccharide	B-X
,	B-X
protein	B-X
and	B-X
nucleic	B-X
acid	B-X
secreted	B-X
by	B-X
bacteria	B-X
on	B-X
the	B-X
surface	B-X
of	B-X
the	B-X
mucous	B-X
membrane	B-X
or	B-X
biological	B-X
material	B-X
.	B-X
We	B-X
review	B-X
here	B-X
the	B-X
effects	B-X
of	B-X
related	B-X
signal	B-X
molecules	B-X
of	B-X
Quorum	B-X
Sensing	B-X
,	B-X
cyclic	B-X
diguanylate	B-X
,	B-X
Two-Component	B-X
Systems	B-X
and	B-X
sRNA	B-X
on	B-X
the	B-X
biofilm	B-X
formation	B-X
.	B-X
Focusing	B-X
on	B-X
these	B-X
regulation	B-X
mechanism	B-X
of	B-X
signal	B-X
molecules	B-X
in	B-X
the	B-X
process	B-X
of	B-X
biofilm	B-X
formation	B-X
is	B-X
necessary	B-X
for	B-X
the	B-X
prevention	B-X
and	B-X
treatment	B-X
of	B-X
some	B-X
chronic	B-X
diseases	B-X
.	B-X
Quorum	B-X
sensing	B-X
(	B-X
QS	B-X
)	B-X
,	B-X
a	B-X
density-dependent	B-X
signaling	B-X
mechanism	B-X
of	B-X
microbial	B-X
cells	B-X
,	B-X
involves	B-X
an	B-X
exchange	B-X
and	B-X
sense	B-X
of	B-X
low	B-X
molecular	B-X
weight	B-X
signaling	B-X
compounds	B-X
called	B-X
autoinducers	B-X
.	B-X
With	B-X
the	B-X
increase	B-X
in	B-X
population	B-X
density	B-X
,	B-X
the	B-X
autoinducers	B-X
accumulate	B-X
in	B-X
the	B-X
extracellular	B-X
environment	B-X
and	B-X
once	B-X
their	B-X
concentration	B-X
reaches	B-X
a	B-X
threshold	B-X
,	B-X
many	B-X
genes	B-X
are	B-X
either	B-X
expressed	B-X
or	B-X
repressed	B-X
.	B-X
This	B-X
cell	B-X
density-dependent	B-X
signaling	B-X
mechanism	B-X
enables	B-X
single	B-X
cells	B-X
to	B-X
behave	B-X
as	B-X
multicellular	B-X
organisms	B-X
and	B-X
regulates	B-X
different	B-X
microbial	B-X
behaviors	B-X
like	B-X
morphogenesis	B-X
,	B-X
pathogenesis	B-X
,	B-X
competence	B-X
,	B-X
biofilm	B-X
formation	B-X
,	B-X
bioluminescence	B-X
,	B-X
etc	B-X
guided	B-X
by	B-X
environmental	B-X
cues	B-X
.	B-X
Pathogenic	B-X
microorganisms	B-X
primarily	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
virulence	B-X
genes	B-X
using	B-X
QS	B-X
systems	B-X
.	B-X
A	B-X
related	B-X
phenomenon	B-X
of	B-X
quorum	B-X
sensing	B-X
inhibition	B-X
(	B-X
QSI	B-X
)	B-X
performed	B-X
by	B-X
small	B-X
inhibitor	B-X
molecules	B-X
called	B-X
quorum	B-X
sensing	B-X
inhibitors	B-X
(	B-X
QSIs	B-X
)	B-X
has	B-X
an	B-X
ability	B-X
for	B-X
efficient	B-X
reduction	B-X
of	B-X
gene	B-X
expression	B-X
regulated	B-X
by	B-X
quorum	B-X
sensing	B-X
.	B-X
In	B-X
the	B-X
present	B-X
review	B-X
,	B-X
recent	B-X
advancements	B-X
in	B-X
the	B-X
study	B-X
of	B-X
different	B-X
fungal	B-X
quorum	B-X
sensing	B-X
molecules	B-X
(	B-X
QSMs	B-X
)	B-X
and	B-X
quorum	B-X
sensing	B-X
inhibitors	B-X
(	B-X
QSIs	B-X
)	B-X
of	B-X
fungal	B-X
origin	B-X
along	B-X
with	B-X
their	B-X
mechanism	B-X
of	B-X
action	B-X
and/or	B-X
role/s	B-X
are	B-X
discussed	B-X
.	B-X

Regulation	O
by	O
AHL	O
-	O
LuxR	B-Protein
-	O
like	O
receptors	O
Virulence	O
,	O
bioluminescence	O
,	O
mutualism	O
,	O
antibiotic	O
production	O
and	O
biofilm	O
formation	O
are	O
often	O
regulated	O
by	O
LuxI	B-Protein
/	O
LuxR	B-Protein
quorum	O
sensing	O
systems	O
in	O
Gram	O
-	O
negative	O
bacteria	O
.	O

They	O
produce	O
membrane	O
diffusible	O
signalling	O
molecules	O
,	O
acyl	O
homoserine	O
lactones	O
(	O
AHLs	O
)	O
,	O
which	O
are	O
sensed	O
by	O
the	O
receptor	O
/	O
regulator	O
LuxR	B-Protein
when	O
exceeding	O
a	O
threshold	O
concentration	O
.	O

These	O
AHLs	O
are	O
produced	O
by	O
an	O
autoinductor	O
synthase	O
named	O
LuxI	B-Protein
.	O

Upon	O
autoinductor	O
-	O
binding	O
,	O
the	O
receptor	O
LuxR	B-Protein
binds	O
to	O
the	O
promoter	O
/	O
operator	O
regions	O
of	O
the	O
target	O
genes	O
or	O
operons	O
,	O
resulting	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
in	O
response	O
to	O
the	O
cell	O
number	O
[	O
33	O
]	O
.	O

Y	O
.	O
enterocolitica	O
possesses	O
a	O
typical	O
quorum	O
sensing	O
pair	O
of	O
homologues	O
,	O
YenI	B-Protein
/	O
YenR	B-Protein
(	O
YE1600	B-Protein
/	O
YE1599	B-Protein
)	O
,	O
and	O
it	O
has	O
recently	O
been	O
shown	O
that	O
swimming	O
and	O
swarming	O
motility	O
is	O
regulated	O
by	O
3	O
-	O
oxo	O
-	O
C6	O
-	O
AHL	O
and	O
C6	O
-	O
AHL	O
,	O
which	O
are	O
synthesized	O
by	O
YenI	B-Protein
[	O
34	O
]	O
.	O

In	O
Y	O
.	O
pestis	O
,	O
the	O
production	O
of	O
YspI	B-Protein
and	O
YspR	B-Protein
,	O
the	O
homologues	O
of	O
YenI	B-Protein
and	O
YenR	B-Protein
,	O
is	O
induced	O
at	O
26degreesC	O
(	O
Table	O
1	O
)	O
.	O

Moreover	O
,	O
we	O
identified	O
a	O
second	O
AHL	O
-	O
LuxR	B-Protein
regulator	O
,	O
YE1026	B-Protein
,	O
which	O
lacks	O
a	O
separate	O
AHL	O
synthase	O
(	O
Fig	O
.	O
3	O
)	O
.	O

It	O
is	O
not	O
known	O
if	O
this	O
receptor	O
also	O
binds	O
the	O
AHLs	O
produced	O
by	O
YenI	B-Protein
.	O

In	O
the	O
genome	O
of	O
P	O
.	O
luminescens	O
,	O
two	O
genes	O
encoding	O
putative	O
AHL	O
-	O
LuxR	B-Protein
-	O
like	O
receptors	O
,	O
plu0320	B-Protein
and	O
plu4562	B-Protein
,	O
but	O
no	O
luxI	B-Protein
genes	O
are	O
present	O
(	O
Fig	O
.	O
3	O
)	O
.	O

This	O
suggests	O
that	O
P	O
.	O
luminescens	O
does	O
not	O
produce	O
its	O
own	O
AHL	O
signalling	O
molecule	O
,	O
but	O
might	O
be	O
able	O
to	O
sense	O
those	O
produced	O
by	O
other	O
bacteria	O
and	O
therefore	O
to	O
detect	O
mixed	O
microbial	O
communities	O
as	O
demonstrated	O
for	O
Salmonella	O
enterica	O
and	O
Escherichia	O
coli	O
[	O
35	O
-	O
37	O
]	O
.	O

A	O
similar	O
function	O
in	O
Y	O
.	O
enterocolitica	O
might	O
be	O
provided	O
by	O
YE1026	B-Protein
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
Sodalis	O
glossinidius	O
strain	O
morsitans	O
,	O
an	O
endosymbiont	O
of	O
the	O
tse	O
tse	O
fly	O
Glossina	O
morsitans	O
morsitans	O
[	O
38	O
]	O
,	O
also	O
has	O
two	O
pontential	O
AHL	O
-	O
LuxR	B-Protein
receptors	O
,	O
SG1740	B-Protein
and	O
SG0285	B-Protein
,	O
but	O
no	O
luxI	B-Protein
homologue	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Instead	O
of	O
producing	O
AHLs	O
to	O
regulate	O
quorum	O
dependent	O
genes	O
,	O
a	O
common	O
strategy	O
of	O
insect	O
-	O
colonizing	O
bacteria	O
might	O
be	O
the	O
detection	O
of	O
AHLs	O
as	O
a	O
signal	O
for	O
the	O
presence	O
of	O
other	O
bacteria	O
such	O
as	O
those	O
colonizing	O
the	O
insect	O
intestinal	O
tract	O
or	O
living	O
in	O
soil	O
.	O
<EOS>	B-X
Biochar	B-X
has	B-X
caught	B-X
great	B-X
attention	B-X
over	B-X
the	B-X
last	B-X
decade	B-X
with	B-X
the	B-X
loose	B-X
and	B-X
porous	B-X
structure	B-X
,	B-X
and	B-X
carbon	B-X
stability	B-X
provides	B-X
suitable	B-X
living	B-X
conditions	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
activity	B-X
of	B-X
microorganisms	B-X
.	B-X
This	B-X
review	B-X
provided	B-X
a	B-X
comprehensive	B-X
summary	B-X
of	B-X
biochar	B-X
immobilization	B-X
microbe	B-X
(	B-X
BIM	B-X
)	B-X
in	B-X
water	B-X
and	B-X
soil	B-X
decontamination	B-X
.	B-X
Firstly	B-X
,	B-X
the	B-X
bacterial	B-X
immobilization	B-X
techniques	B-X
including	B-X
adsorption	B-X
,	B-X
entrapping	B-X
,	B-X
and	B-X
covalence	B-X
methods	B-X
were	B-X
exhibited	B-X
.	B-X
Secondly	B-X
,	B-X
the	B-X
applications	B-X
of	B-X
BIM	B-X
in	B-X
water	B-X
and	B-X
soil	B-X
environmental	B-X
remediation	B-X
were	B-X
introduced	B-X
,	B-X
mainly	B-X
including	B-X
the	B-X
treatment	B-X
of	B-X
organic	B-X
pollutants	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
and	B-X
N/P	B-X
,	B-X
among	B-X
which	B-X
the	B-X
most	B-X
frequently	B-X
immobilized	B-X
microorganism	B-X
was	B-X
Bacillus	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
paper	B-X
is	B-X
to	B-X
provide	B-X
useful	B-X
background	B-X
information	B-X
for	B-X
the	B-X
selection	B-X
of	B-X
better	B-X
biochar	B-X
fixation	B-X
microorganisms	B-X
for	B-X
water	B-X
and	B-X
soil	B-X
remediation	B-X
.	B-X

Regulation	O
by	O
AI	O
-	O
2	O
<EOS>	B-X
Peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
agonists	B-X
and	B-X
antagonists	B-X
:	B-X
a	B-X
patent	B-X
review	B-X
(	B-X
2014-present	B-X
)	B-X
.	B-X
Fibroblasts	B-X
derived	B-X
from	B-X
the	B-X
lungs	B-X
of	B-X
patients	B-X
with	B-X
idiopathic	B-X
pulmonary	B-X
fibrosis	B-X
(	B-X
IPF	B-X
)	B-X
and	B-X
systemic	B-X
sclerosis	B-X
(	B-X
SSc	B-X
)	B-X
produce	B-X
low	B-X
levels	B-X
of	B-X
prostaglandin	B-X
(	B-X
PG	B-X
)	B-X
E2	B-X
,	B-X
due	B-X
to	B-X
a	B-X
limited	B-X
capacity	B-X
to	B-X
up-regulate	B-X
cyclooxygenase-2	B-X
(	B-X
COX-2	B-X
)	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
examined	B-X
whether	B-X
the	B-X
reduced	B-X
level	B-X
of	B-X
COX-2	B-X
mRNA	B-X
expression	B-X
observed	B-X
in	B-X
fibrotic	B-X
lung	B-X
fibroblasts	B-X
is	B-X
regulated	B-X
epigenetically	B-X
.	B-X
The	B-X
DNA	B-X
methylation	B-X
inhibitor	B-X
,	B-X
5-aza-2'-deoxycytidine	B-X
(	B-X
5AZA	B-X
)	B-X
restored	B-X
COX-2	B-X
mRNA	B-X
expression	B-X
by	B-X
fibrotic	B-X
lung	B-X
fibroblasts	B-X
dose	B-X
dependently	B-X
.	B-X
Functionally	B-X
,	B-X
this	B-X
resulted	B-X
in	B-X
normalization	B-X
of	B-X
fibroblast	B-X
phenotype	B-X
in	B-X
terms	B-X
of	B-X
PGE2	B-X
production	B-X
,	B-X
collagen	B-X
mRNA	B-X
expression	B-X
and	B-X
sensitivity	B-X
to	B-X
apoptosis	B-X
.	B-X
COX-2	B-X
methylation	B-X
assessed	B-X
by	B-X
bisulfite	B-X
sequencing	B-X
and	B-X
methylation	B-X
microarrays	B-X
was	B-X
not	B-X
different	B-X
in	B-X
fibrotic	B-X
fibroblasts	B-X
compared	B-X
with	B-X
controls	B-X
.	B-X
siRNA	B-X
knockdown	B-X
of	B-X
c8orf4	B-X
in	B-X
control	B-X
fibroblasts	B-X
down-regulated	B-X
COX-2	B-X
and	B-X
PGE2	B-X
production	B-X
generating	B-X
a	B-X
phenotype	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
in	B-X
fibrotic	B-X
lung	B-X
fibroblasts	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
demonstrated	B-X
that	B-X
c8orf4	B-X
regulates	B-X
COX-2	B-X
expression	B-X
in	B-X
lung	B-X
fibroblasts	B-X
through	B-X
binding	B-X
of	B-X
the	B-X
proximal	B-X
promoter	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
decreased	B-X
capacity	B-X
of	B-X
fibrotic	B-X
lung	B-X
fibroblasts	B-X
to	B-X
up-regulate	B-X
COX-2	B-X
expression	B-X
and	B-X
COX-2-derived	B-X
PGE2	B-X
synthesis	B-X
is	B-X
due	B-X
to	B-X
an	B-X
indirect	B-X
epigenetic	B-X
mechanism	B-X
involving	B-X
hypermethylation	B-X
of	B-X
the	B-X
transcriptional	B-X
regulator	B-X
,	B-X
c8orf4	B-X
.	B-X

Beside	O
AHL	O
,	O
other	O
putative	O
quorum	O
sensing	O
signalling	O
molecules	O
have	O
been	O
identified	O
.	O

One	O
of	O
them	O
is	O
autoinductor	O
2	O
(	O
AI	O
-	O
2	O
)	O
,	O
furanosyl	O
borate	O
diester	O
,	O
which	O
is	O
synthesized	O
by	O
the	O
luxS	B-Protein
product	O
[	O
39	O
,	O
40	O
]	O
of	O
which	O
homologues	O
are	O
present	O
in	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
(	O
plu1253	B-Protein
,	O
ye0839	B-Protein
)	O
.	O

It	O
has	O
been	O
shown	O
that	O
the	O
luxS	B-Protein
pathway	O
negatively	O
controls	O
the	O
expression	O
of	O
genes	O
for	O
carbapenem	O
antibiotic	O
biosynthesis	O
in	O
P	O
.	O
luminescens	O
[	O
41	O
]	O
.	O

Overall	O
,	O
more	O
than	O
300	O
AI	O
-	O
2	O
regulated	O
genes	O
involved	O
in	O
regulation	O
,	O
metabolic	O
activity	O
,	O
stress	O
response	O
and	O
pathogenicity	O
are	O
known	O
in	O
P	O
.	O
luminescens	O
[	O
42	O
]	O
.	O

For	O
example	O
,	O
the	O
expression	O
of	O
tcdA1	B-Protein
and	O
tccC1	B-Protein
encoding	O
subunits	O
of	O
the	O
insecticidal	O
toxin	O
complexes	O
and	O
the	O
production	O
of	O
mcf2	B-Protein
encoding	O
the	O
"	O
Makes	O
caterpillar	O
floppy	O
"	O
toxin	O
was	O
identified	O
to	O
be	O
luxS	B-Protein
dependent	O
.	O

The	O
DeltaluxS	B-Protein
mutant	O
also	O
showed	O
decreased	O
expression	O
of	O
virulence	O
factors	O
such	O
as	O
the	O
cytotoxic	O
protein	O
CcdB	B-Protein
,	O
the	O
hemolysin	O
secretion	O
protein	O
HlyD	B-Protein
(	O
Plu0635	B-Protein
)	O
,	O
and	O
the	O
toxin	O
ABC	O
transporter	O
subunits	O
RtxD	B-Protein
/	O
RtxB	B-Protein
.	O

Homologues	O
of	O
these	O
proteins	O
are	O
present	O
in	O
Y	O
.	O
enterocolitica	O
(	O
see	O
chapter	O
2	O
)	O
,	O
suggesting	O
their	O
possible	O
regulation	O
by	O
AI	O
-	O
2	O
also	O
in	O
this	O
bacterium	O
.	O

Furthermore	O
,	O
the	O
P	O
.	O
luminescens	O
luxS	B-Protein
-	O
negative	O
strain	O
exhibited	O
decreased	O
biofilm	O
formation	O
,	O
increased	O
type	O
IV	O
/	O
V	O
pilus	O
-	O
dependent	O
twitching	O
motility	O
,	O
and	O
attenuated	O
virulence	O
against	O
insect	O
larvae	O
[	O
42	O
]	O
.	O

Taken	O
together	O
,	O
a	O
similar	O
and	O
AI	O
-	O
2	O
dependent	O
mechanism	O
for	O
the	O
regulation	O
of	O
insect	O
colonization	O
and	O
insect	O
pathogenicity	O
might	O
be	O
used	O
by	O
both	O
organisms	O
.	O

Whether	O
they	O
sense	O
self	O
-	O
produced	O
or	O
external	O
AI	O
-	O
2	O
,	O
or	O
a	O
combination	O
of	O
both	O
,	O
indicating	O
a	O
quorum	O
sensing	O
mechanism	O
or	O
a	O
regulation	O
similar	O
to	O
AHL	O
as	O
described	O
above	O
,	O
remains	O
to	O
be	O
elucidated	O
.	O
<EOS>	B-X
Earlier	B-X
theories	B-X
of	B-X
sense	B-X
of	B-X
agency	B-X
have	B-X
attributed	B-X
the	B-X
capacity	B-X
for	B-X
perception	B-X
of	B-X
self-agency	B-X
to	B-X
the	B-X
comparator	B-X
process	B-X
of	B-X
the	B-X
motor-control/action	B-X
system	B-X
.	B-X
However	B-X
,	B-X
with	B-X
the	B-X
advent	B-X
of	B-X
the	B-X
findings	B-X
implying	B-X
a	B-X
role	B-X
of	B-X
non-motor	B-X
cues	B-X
(	B-X
like	B-X
affective	B-X
states	B-X
,	B-X
beliefs	B-X
,	B-X
primed	B-X
concepts	B-X
,	B-X
and	B-X
social	B-X
instructions	B-X
or	B-X
previews	B-X
of	B-X
actions	B-X
)	B-X
in	B-X
the	B-X
sense	B-X
of	B-X
agency	B-X
literature	B-X
,	B-X
the	B-X
perception	B-X
of	B-X
self-agency	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
generated	B-X
even	B-X
by	B-X
non-motor	B-X
cues	B-X
(	B-X
based	B-X
on	B-X
their	B-X
relative	B-X
reliability	B-X
or	B-X
weighting	B-X
estimate	B-X
)	B-X
;	B-X
and	B-X
,	B-X
this	B-X
theory	B-X
is	B-X
come	B-X
to	B-X
be	B-X
known	B-X
as	B-X
the	B-X
cue-integration	B-X
of	B-X
sense	B-X
of	B-X
agency	B-X
.	B-X
However	B-X
,	B-X
the	B-X
cue-integration	B-X
theory	B-X
motivates	B-X
skepticism	B-X
about	B-X
whether	B-X
it	B-X
is	B-X
falsifiable	B-X
and	B-X
whether	B-X
it	B-X
is	B-X
plausible	B-X
that	B-X
non-motor	B-X
cues	B-X
that	B-X
are	B-X
sensorily	B-X
unrelated	B-X
to	B-X
typical	B-X
sensory	B-X
processes	B-X
of	B-X
self-agency	B-X
have	B-X
the	B-X
capacity	B-X
to	B-X
produce	B-X
a	B-X
perception	B-X
of	B-X
self-agency	B-X
.	B-X
To	B-X
substantiate	B-X
this	B-X
skepticism	B-X
,	B-X
I	B-X
critically	B-X
analyze	B-X
the	B-X
experimental	B-X
operationalizations	B-X
of	B-X
cue-integration-with	B-X
the	B-X
(	B-X
classic	B-X
)	B-X
vicarious	B-X
agency	B-X
experiment	B-X
as	B-X
a	B-X
case	B-X
study-to	B-X
show	B-X
that	B-X
(	B-X
1	B-X
)	B-X
the	B-X
participants	B-X
in	B-X
these	B-X
experiments	B-X
are	B-X
ambiguous	B-X
about	B-X
their	B-X
causal	B-X
agency	B-X
over	B-X
motor	B-X
actions	B-X
,	B-X
(	B-X
2	B-X
)	B-X
thus	B-X
,	B-X
these	B-X
participants	B-X
resort	B-X
to	B-X
reports	B-X
of	B-X
self-agency	B-X
as	B-X
heuristic	B-X
judgments	B-X
(	B-X
under	B-X
ambiguity	B-X
)	B-X
rather	B-X
than	B-X
due	B-X
to	B-X
cue-integration	B-X
per	B-X
se	B-X
,	B-X
and	B-X
(	B-X
3	B-X
)	B-X
there	B-X
might	B-X
not	B-X
have	B-X
occurred	B-X
cue-integration	B-X
based	B-X
self-agency	B-X
reports	B-X
if	B-X
these	B-X
experimental	B-X
operationalizations	B-X
had	B-X
eliminated	B-X
ambiguity	B-X
about	B-X
the	B-X
causal	B-X
agency	B-X
.	B-X
Thus	B-X
,	B-X
I	B-X
conclude	B-X
that	B-X
the	B-X
reports	B-X
of	B-X
self-agency	B-X
(	B-X
observed	B-X
in	B-X
typical	B-X
non-motor	B-X
cues	B-X
based	B-X
cue-integration	B-X
experiments	B-X
)	B-X
are	B-X
not	B-X
instances	B-X
of	B-X
perceptual	B-X
effect-that	B-X
are	B-X
hypothesized	B-X
to	B-X
be	B-X
produced	B-X
by	B-X
non-motor	B-X
cues-but	B-X
are	B-X
of	B-X
heuristic	B-X
judgment	B-X
effect	B-X
.	B-X

Regulation	O
by	O
PAS	B-Protein
_	I-Protein
4	I-Protein
/	O
LuxR	B-Protein
-	O
like	O
receptors	O

In	O
P	O
.	O
luminescens	O
,	O
the	O
amount	O
of	O
luxR	B-Protein
-	O
like	O
genes	O
is	O
overrepresented	O
with	O
39	O
copies	O
in	O
the	O
genome	O
.	O

35	O
of	O
these	O
potential	O
LuxR	B-Protein
-	O
like	O
receptors	O
exhibit	O
PAS	B-Protein
_	I-Protein
4	I-Protein
signal	O
binding	O
domains	O
instead	O
of	O
an	O
AHL	O
-	O
binding	O
domain	O
,	O
and	O
two	O
have	O
a	O
signalling	O
domain	O
with	O
a	O
yet	O
unidentified	O
motif	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Most	O
of	O
the	O
genes	O
are	O
located	O
in	O
two	O
large	O
gene	O
clusters	O
(	O
plu0918	B-Protein
-	O
0925	B-Protein
and	O
plu2001	B-Protein
-	O
2019	B-Protein
)	O
.	O

Interestingly	O
,	O
eleven	O
of	O
those	O
LuxR	B-Protein
-	O
like	O
receptors	O
are	O
present	O
in	O
Y	O
.	O
enterocolitica	O
of	O
which	O
five	O
are	O
located	O
in	O
a	O
cluster	O
(	O
ye0035	B-Protein
-	O
0039	B-Protein
)	O
.	O

Nine	O
of	O
these	O
have	O
a	O
so	O
-	O
called	O
PAS	B-Protein
_	I-Protein
4	I-Protein
signal	O
binding	O
domains	O
of	O
yet	O
unknown	O
function	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
there	O
is	O
only	O
one	O
bacterium	O
else	O
,	O
the	O
insect	O
colonizing	O
S	O
.	O
glossinidius	O
,	O
whose	O
genome	O
also	O
carries	O
a	O
series	O
of	O
unclustered	O
genes	O
coding	O
for	O
PAS	B-Protein
_	I-Protein
4	I-Protein
/	O
LuxR	B-Protein
-	O
like	O
receptors	O
,	O
indicating	O
that	O
this	O
kind	O
of	O
receptors	O
plays	O
a	O
role	O
during	O
insect	O
infection	O
.	O

PAS	O
-	O
domains	O
have	O
been	O
suspected	O
to	O
act	O
as	O
insect	O
juvenile	O
hormone	O
(	O
JH	O
)	O
receptors	O
in	O
the	O
fruit	O
fly	O
Drosophila	O
melanogaster	O
[	O
43	O
,	O
44	O
]	O
.	O

The	O
methoprene	O
-	O
tolerant	O
gene	O
(	O
met	B-Protein
,	O
also	O
called	O
Resistance	O
to	O
Juvenile	O
Hormone	O
Rst1JH	B-Protein
)	O
of	O
D	O
.	O
melanogaster	O
encodes	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
transcriptional	O
regulator	O
combined	O
with	O
a	O
PAS	B-Protein
_	I-Protein
3	I-Protein
domain	O
[	O
45	O
]	O
.	O

Met	B-Protein
has	O
been	O
shown	O
to	O
bind	O
JH	O
at	O
physiological	O
concentrations	O
and	O
is	O
therefore	O
suspected	O
to	O
act	O
as	O
a	O
JH	O
receptor	O
[	O
46	O
,	O
47	O
]	O
.	O

Therefore	O
,	O
the	O
potential	O
PAS	B-Protein
_	I-Protein
4	I-Protein
/	O
LuxR	B-Protein
-	O
like	O
receptors	O
of	O
P	O
.	O
luminescens	O
,	O
Y	O
.	O
enterocolitica	O
,	O
and	O
S	O
.	O
glossinidius	O
might	O
sense	O
JH	O
or	O
other	O
eukaryotic	O
hormones	O
of	O
the	O
insect	O
to	O
adapt	O
their	O
gene	O
expression	O
to	O
the	O
insect	O
host	O
.	O

The	O
high	O
number	O
of	O
35	O
highly	O
homologous	O
receptor	O
proteins	O
in	O
P	O
.	O
luminescens	O
might	O
be	O
the	O
reason	O
for	O
the	O
wide	O
insect	O
host	O
spectrum	O
this	O
pathogen	O
is	O
capable	O
to	O
infect	O
.	O

Although	O
Y	O
.	O
enterocolitica	O
protein	O
extracts	O
confer	O
toxicity	O
against	O
M	O
.	O
sexta	O
larvae	O
[	O
7	O
]	O
,	O
its	O
host	O
spectrum	O
still	O
remains	O
to	O
be	O
defined	O
.	O

The	O
difference	O
in	O
the	O
number	O
of	O
the	O
uncommon	O
LuxR	B-Protein
-	O
like	O
receptors	O
(	O
35	O
in	O
P	O
.	O
luminescens	O
,	O
nine	O
in	O
Y	O
.	O
enterocolitica	O
)	O
gives	O
rise	O
to	O
speculations	O
that	O
the	O
insect	O
host	O
spectrum	O
is	O
constricted	O
for	O
Y	O
.	O
enterocolitica	O
compared	O
with	O
P	O
.	O
luminescens	O
.	O

This	O
hypothesis	O
is	O
underlined	O
by	O
the	O
fact	O
that	O
not	O
more	O
than	O
five	O
PAS	B-Protein
_	I-Protein
4	I-Protein
/	O
LuxR	B-Protein
-	O
like	O
receptors	O
are	O
present	O
in	O
S	O
.	O
glossinidius	O
for	O
which	O
only	O
one	O
insect	O
host	O
has	O
been	O
reported	O
.	O
<EOS>	B-X
Fibroblast	B-X
growth	B-X
factor-23	B-X
(	B-X
FGF23	B-X
)	B-X
is	B-X
a	B-X
mainly	B-X
osteocytic	B-X
hormone	B-X
which	B-X
increases	B-X
renal	B-X
phosphate	B-X
excretion	B-X
and	B-X
reduces	B-X
calcitriol	B-X
synthesis	B-X
.	B-X
This	B-X
hypothesis	B-X
offers	B-X
fascinating	B-X
prospects	B-X
in	B-X
terms	B-X
of	B-X
therapeutic	B-X
interventions	B-X
,	B-X
specifically	B-X
in	B-X
patients	B-X
with	B-X
chronic	B-X
kidney	B-X
disease	B-X
(	B-X
CKD	B-X
)	B-X
in	B-X
whom	B-X
the	B-X
FGF23	B-X
system	B-X
is	B-X
strongly	B-X
stimulated	B-X
and	B-X
in	B-X
whom	B-X
left-ventricular	B-X
dysfunction	B-X
is	B-X
a	B-X
major	B-X
disease	B-X
burden	B-X
.	B-X
However	B-X
,	B-X
novel	B-X
data	B-X
challenges	B-X
the	B-X
previous	B-X
stand-alone	B-X
hypothesis	B-X
about	B-X
a	B-X
one-way	B-X
road	B-X
which	B-X
guides	B-X
unidirectionally	B-X
skeletal	B-X
FGF23	B-X
toward	B-X
cardiotoxic	B-X
effects	B-X
.	B-X
In	B-X
fact	B-X
,	B-X
recent	B-X
data	B-X
point	B-X
toward	B-X
local	B-X
myocardial	B-X
production	B-X
and	B-X
release	B-X
of	B-X
FGF23	B-X
in	B-X
cases	B-X
where	B-X
(	B-X
acute	B-X
)	B-X
myocardial	B-X
damage	B-X
occurs	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
while	B-X
FGF23	B-X
is	B-X
an	B-X
interesting	B-X
link	B-X
between	B-X
mineral	B-X
metabolism	B-X
and	B-X
cardiac	B-X
function	B-X
underlining	B-X
the	B-X
meaning	B-X
of	B-X
the	B-X
bone-heart	B-X
axis	B-X
,	B-X
more	B-X
research	B-X
is	B-X
needed	B-X
before	B-X
therapeutic	B-X
interventions	B-X
may	B-X
be	B-X
considered	B-X
.	B-X

Regulation	O
by	O
uncommon	O
LuxR	B-Protein
-	O
like	O
receptors	O

LuxR	B-Protein
-	O
like	O
receptors	O
in	O
Y	O
.	O
enterocolitica	O
with	O
a	O
yet	O
unidentified	O
signalling	O
binding	O
-	O
site	O
are	O
YE2705	B-Protein
and	O
YE3014	B-Protein
,	O
both	O
of	O
which	O
are	O
also	O
present	O
in	O
Y	O
.	O
pestis	O
(	O
YPO2955	B-Protein
and	O
YPO2593	B-Protein
)	O
and	O
in	O
S	O
.	O
glossinidius	O
(	O
SGP1	B-Protein
_	I-Protein
007	I-Protein
,	O
SG1174	B-Protein
,	O
SG1480	B-Protein
,	O
and	O
SG1698	B-Protein
)	O
,	O
but	O
not	O
in	O
P	O
.	O
luminescens	O
(	O
Fig	O
.	O
3	O
)	O
.	O

It	O
might	O
be	O
possible	O
that	O
signalling	O
molecules	O
of	O
mammals	O
and	O
hormones	O
of	O
adult	O
insects	O
are	O
sensed	O
via	O
these	O
receptors	O
by	O
Y	O
.	O
enterocolitica	O
and	O
S	O
.	O
glossinidius	O
,	O
respectively	O
,	O
hosts	O
which	O
P	O
.	O
luminescens	O
does	O
not	O
specifically	O
interact	O
with	O
during	O
its	O
life	O
cycle	O
.	O

In	O
P	O
.	O
luminescens	O
,	O
two	O
LuxR	B-Protein
-	O
like	O
receptors	O
with	O
a	O
yet	O
unidentified	O
signalling	O
binding	O
site	O
are	O
present	O
,	O
Plu4274	B-Protein
and	O
Plu1817	B-Protein
,	O
the	O
latter	O
of	O
which	O
is	O
shared	O
by	O
Y	O
.	O
enterocolitica	O
(	O
YE1621	B-Protein
)	O
,	O
but	O
not	O
by	O
S	O
.	O
glossinidius	O
.	O

Universal	O
stress	O
proteins	O
<EOS>	B-X
Chaperone	B-X
proteins	B-X
have	B-X
crucial	B-X
roles	B-X
to	B-X
play	B-X
in	B-X
all	B-X
animal	B-X
species	B-X
and	B-X
are	B-X
involved	B-X
in	B-X
mediating	B-X
both	B-X
the	B-X
folding	B-X
of	B-X
newly	B-X
synthesized	B-X
peptides	B-X
into	B-X
their	B-X
mature	B-X
conformation	B-X
,	B-X
the	B-X
refolding	B-X
of	B-X
misfolded	B-X
proteins	B-X
,	B-X
and	B-X
the	B-X
trafficking	B-X
of	B-X
proteins	B-X
between	B-X
subcellular	B-X
compartments	B-X
.	B-X
These	B-X
highly	B-X
conserved	B-X
proteins	B-X
have	B-X
particularly	B-X
important	B-X
roles	B-X
to	B-X
play	B-X
in	B-X
dealing	B-X
with	B-X
disruptions	B-X
of	B-X
the	B-X
proteome	B-X
as	B-X
a	B-X
result	B-X
of	B-X
environmental	B-X
stress	B-X
since	B-X
abiotic	B-X
factors	B-X
,	B-X
including	B-X
temperature	B-X
,	B-X
pressure	B-X
,	B-X
oxygen	B-X
,	B-X
water	B-X
availability	B-X
,	B-X
and	B-X
pollutants	B-X
can	B-X
readily	B-X
disrupt	B-X
the	B-X
conformation	B-X
and/or	B-X
function	B-X
of	B-X
all	B-X
types	B-X
of	B-X
proteins	B-X
,	B-X
e.g.	B-X
,	B-X
enzymes	B-X
,	B-X
transporters	B-X
,	B-X
and	B-X
structural	B-X
proteins	B-X
.	B-X
The	B-X
current	B-X
review	B-X
provides	B-X
an	B-X
update	B-X
on	B-X
recent	B-X
advances	B-X
in	B-X
understanding	B-X
the	B-X
roles	B-X
and	B-X
responses	B-X
of	B-X
chaperones	B-X
in	B-X
aiding	B-X
animals	B-X
to	B-X
deal	B-X
with	B-X
environmental	B-X
stress	B-X
,	B-X
offering	B-X
new	B-X
information	B-X
on	B-X
chaperone	B-X
action	B-X
in	B-X
supporting	B-X
survival	B-X
strategies	B-X
including	B-X
torpor	B-X
,	B-X
hibernation	B-X
,	B-X
anaerobiosis	B-X
,	B-X
estivation	B-X
,	B-X
and	B-X
cold/freeze	B-X
tolerance	B-X
among	B-X
both	B-X
vertebrate	B-X
and	B-X
invertebrate	B-X
species	B-X
.	B-X
Universal	B-X
stress	B-X
proteins	B-X
(	B-X
USPs	B-X
)	B-X
exist	B-X
across	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
species	B-X
and	B-X
are	B-X
vital	B-X
for	B-X
survival	B-X
under	B-X
stressful	B-X
conditions	B-X
.	B-X
Due	B-X
to	B-X
the	B-X
increasingly	B-X
harsh	B-X
global	B-X
environmental	B-X
conditions	B-X
,	B-X
it	B-X
is	B-X
increasingly	B-X
important	B-X
to	B-X
study	B-X
the	B-X
role	B-X
of	B-X
USPs	B-X
in	B-X
achieving	B-X
stress	B-X
tolerance	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
the	B-X
role	B-X
of	B-X
USPs	B-X
in	B-X
organisms	B-X
from	B-X
three	B-X
aspects	B-X
:	B-X
(	B-X
1	B-X
)	B-X
organisms	B-X
generally	B-X
have	B-X
multiple	B-X
USP	B-X
genes	B-X
that	B-X
play	B-X
specific	B-X
roles	B-X
at	B-X
different	B-X
developmental	B-X
periods	B-X
of	B-X
the	B-X
organism	B-X
,	B-X
and	B-X
,	B-X
due	B-X
to	B-X
their	B-X
ubiquity	B-X
,	B-X
USPs	B-X
can	B-X
be	B-X
used	B-X
as	B-X
an	B-X
important	B-X
indicator	B-X
to	B-X
study	B-X
species	B-X
evolution	B-X
;	B-X
(	B-X
2	B-X
)	B-X
a	B-X
comparison	B-X
of	B-X
the	B-X
structures	B-X
of	B-X
USPs	B-X
reveals	B-X
that	B-X
they	B-X
generally	B-X
bind	B-X
ATP	B-X
or	B-X
its	B-X
analogs	B-X
at	B-X
similar	B-X
sequence	B-X
positions	B-X
,	B-X
which	B-X
may	B-X
underlie	B-X
the	B-X
regulatory	B-X
role	B-X
of	B-X
USPs	B-X
;	B-X
and	B-X
(	B-X
3	B-X
)	B-X
the	B-X
functions	B-X
of	B-X
USPs	B-X
in	B-X
species	B-X
are	B-X
diverse	B-X
,	B-X
and	B-X
are	B-X
generally	B-X
directly	B-X
related	B-X
to	B-X
the	B-X
stress	B-X
tolerance	B-X
.	B-X
In	B-X
microorganisms	B-X
,	B-X
USPs	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
membrane	B-X
formation	B-X
,	B-X
whereas	B-X
in	B-X
plants	B-X
they	B-X
may	B-X
act	B-X
as	B-X
protein	B-X
chaperones	B-X
or	B-X
RNA	B-X
chaperones	B-X
to	B-X
help	B-X
plants	B-X
withstand	B-X
stress	B-X
at	B-X
the	B-X
molecular	B-X
level	B-X
and	B-X
may	B-X
also	B-X
interact	B-X
with	B-X
other	B-X
proteins	B-X
to	B-X
regulate	B-X
normal	B-X
plant	B-X
activities	B-X
.	B-X
This	B-X
review	B-X
will	B-X
provide	B-X
directions	B-X
for	B-X
future	B-X
research	B-X
,	B-X
focusing	B-X
on	B-X
USPs	B-X
to	B-X
provide	B-X
clues	B-X
for	B-X
the	B-X
development	B-X
of	B-X
stress-tolerant	B-X
crop	B-X
varieties	B-X
and	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
novel	B-X
green	B-X
pesticide	B-X
formulations	B-X
in	B-X
agriculture	B-X
,	B-X
and	B-X
to	B-X
better	B-X
understand	B-X
the	B-X
evolution	B-X
of	B-X
drug	B-X
resistance	B-X
in	B-X
pathogenic	B-X
microorganisms	B-X
in	B-X
medicine	B-X
.	B-X

Universal	O
stress	O
proteins	O
(	O
Usp	O
)	O
are	O
small	O
soluble	O
proteins	O
found	O
in	O
bacteria	O
,	O
archaea	O
and	O
plants	O
.	O

The	O
production	O
of	O
these	O
proteins	O
is	O
induced	O
upon	O
global	O
stress	O
conditions	O
such	O
as	O
nutrient	O
starvation	O
,	O
heat	O
stress	O
,	O
osmotic	O
stress	O
,	O
oxidative	O
stress	O
,	O
or	O
the	O
presence	O
of	O
toxic	O
compounds	O
.	O
<EOS>	B-X
There	B-X
is	B-X
overwhelming	B-X
evidence	B-X
that	B-X
the	B-X
microbiome	B-X
must	B-X
be	B-X
considered	B-X
when	B-X
evaluating	B-X
the	B-X
toxicity	B-X
of	B-X
chemicals	B-X
.	B-X
Disruption	B-X
of	B-X
the	B-X
normal	B-X
microbial	B-X
flora	B-X
is	B-X
a	B-X
known	B-X
effect	B-X
of	B-X
toxic	B-X
exposure	B-X
,	B-X
and	B-X
these	B-X
disruptions	B-X
may	B-X
lead	B-X
to	B-X
human	B-X
health	B-X
effects	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
biotransformation	B-X
of	B-X
numerous	B-X
compounds	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
dependent	B-X
on	B-X
microbial	B-X
enzymes	B-X
,	B-X
with	B-X
the	B-X
potential	B-X
for	B-X
different	B-X
host	B-X
health	B-X
outcomes	B-X
resulting	B-X
from	B-X
variations	B-X
in	B-X
the	B-X
microbiome	B-X
.	B-X
Evidence	B-X
suggests	B-X
that	B-X
such	B-X
metabolism	B-X
of	B-X
environmental	B-X
chemicals	B-X
by	B-X
enzymes	B-X
from	B-X
the	B-X
host	B-X
's	B-X
microbiota	B-X
can	B-X
affect	B-X
the	B-X
toxicity	B-X
of	B-X
that	B-X
chemical	B-X
to	B-X
the	B-X
host	B-X
.	B-X
MMT	B-X
refers	B-X
to	B-X
transformation	B-X
of	B-X
a	B-X
chemical	B-X
by	B-X
microbial	B-X
enzymes	B-X
or	B-X
metabolites	B-X
to	B-X
modify	B-X
the	B-X
chemical	B-X
in	B-X
a	B-X
way	B-X
that	B-X
makes	B-X
it	B-X
more	B-X
or	B-X
less	B-X
toxic	B-X
.	B-X
Certain	B-X
microbiomes	B-X
or	B-X
microbiota	B-X
may	B-X
become	B-X
associated	B-X
with	B-X
different	B-X
health	B-X
outcomes	B-X
,	B-X
such	B-X
as	B-X
resistance	B-X
or	B-X
susceptibility	B-X
to	B-X
exposure	B-X
to	B-X
certain	B-X
toxic	B-X
chemicals	B-X
,	B-X
the	B-X
ability	B-X
to	B-X
recover	B-X
following	B-X
a	B-X
chemical-induced	B-X
injury	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
disease-associated	B-X
phenotypes	B-X
,	B-X
and	B-X
the	B-X
effectiveness	B-X
of	B-X
immune	B-X
responses	B-X
.	B-X
Future	B-X
work	B-X
in	B-X
toxicology	B-X
will	B-X
require	B-X
an	B-X
understanding	B-X
of	B-X
how	B-X
the	B-X
microbiome	B-X
interacts	B-X
with	B-X
toxicants	B-X
to	B-X
fully	B-X
elucidate	B-X
how	B-X
a	B-X
compound	B-X
will	B-X
affect	B-X
a	B-X
diverse	B-X
,	B-X
real-world	B-X
population	B-X
.	B-X

The	O
protein	O
family	O
is	O
divided	O
into	O
the	O
UspA	B-Protein
subfamily	O
and	O
the	O
UspFG	B-Protein
subfamily	O
.	O

The	O
functional	O
mechanism	O
of	O
these	O
Usp	O
proteins	O
is	O
not	O
known	O
[	O
48	O
]	O
.	O
<EOS>	B-X
In	B-X
this	B-X
chapter	B-X
,	B-X
we	B-X
introduce	B-X
the	B-X
basic	B-X
organization	B-X
of	B-X
the	B-X
OE	B-X
and	B-X
focus	B-X
on	B-X
the	B-X
molecular	B-X
mechanisms	B-X
involved	B-X
in	B-X
odorant	B-X
perception	B-X
.	B-X
We	B-X
also	B-X
describe	B-X
recent	B-X
experiments	B-X
that	B-X
address	B-X
the	B-X
mechanisms	B-X
of	B-X
OSNs	B-X
regeneration	B-X
in	B-X
response	B-X
to	B-X
neuronal	B-X
injury	B-X
.	B-X
Understanding	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
pathological	B-X
cardiac	B-X
hypertrophy	B-X
will	B-X
contribute	B-X
to	B-X
the	B-X
treatment	B-X
of	B-X
heart	B-X
failure	B-X
.	B-X
This	B-X
study	B-X
set	B-X
out	B-X
to	B-X
investigate	B-X
the	B-X
role	B-X
and	B-X
molecular	B-X
mechanism	B-X
of	B-X
a	B-X
DUB	B-X
,	B-X
USP25	B-X
(	B-X
ubiquitin-specific	B-X
peptidase	B-X
25	B-X
)	B-X
,	B-X
in	B-X
pathological	B-X
cardiac	B-X
hypertrophy	B-X
.	B-X

Because	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
are	O
exposed	O
to	O
those	O
stresses	O
upon	O
infecting	O
and	O
colonizing	O
the	O
insect	O
host	O
,	O
we	O
compared	O
their	O
set	O
of	O
Usp	O
proteins	O
(	O
Table	O
2	O
)	O
.	O

Both	O
genomes	O
share	O
an	O
UspA	B-Protein
-	O
like	O
(	O
Plu0121	B-Protein
and	O
YE4050	B-Protein
)	O
and	O
an	O
UspE	B-Protein
-	O
like	O
(	O
Plu2178	B-Protein
and	O
YE2076	B-Protein
)	O
homologue	O
.	O

In	O
E	O
.	O
coli	O
,	O
the	O
sequence	O
motif	O
of	O
Usp	O
proteins	O
is	O
not	O
highly	O
conserved	O
:	O
UspA	B-Protein
and	O
UspC	B-Protein
show	O
a	O
sequence	O
identity	O
of	O
37	O
%	O
and	O
a	O
homology	O
of	O
57	O
%	O
,	O
for	O
example	O
.	O

In	O
contrast	O
,	O
the	O
UspA	B-Protein
and	O
the	O
UspE	B-Protein
homologues	O
of	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
are	O
nearly	O
similar	O
,	O
indicating	O
that	O
an	O
identical	O
stress	O
response	O
is	O
regulated	O
by	O
these	O
proteins	O
.	O

Homologues	O
of	O
these	O
proteins	O
are	O
also	O
present	O
in	O
P	O
.	O
aeruginosa	O
,	O
namely	O
PA4352	B-Protein
and	O
PA3309	B-Protein
,	O
a	O
tandem	O
-	O
type	O
Usp	O
protein	O
and	O
a	O
UspA	B-Protein
-	O
like	O
protein	O
,	O
respectively	O
.	O

They	O
are	O
essential	O
for	O
survival	O
under	O
anaerobic	O
growth	O
and	O
therefore	O
biofilm	O
formation	O
,	O
a	O
situation	O
cells	O
are	O
exposed	O
to	O
when	O
colonizing	O
the	O
cystic	O
fibrosis	O
lung	O
in	O
hosts	O
[	O
49	O
,	O
50	O
]	O
.	O

The	O
Usp	O
homologues	O
of	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
might	O
also	O
be	O
important	O
during	O
infection	O
of	O
the	O
insect	O
host	O
.	O

In	O
P	O
.	O
luminescens	O
,	O
expression	O
of	O
UspA	B-Protein
has	O
been	O
shown	O
to	O
be	O
under	O
control	O
of	O
the	O
AstS	B-Protein
/	O
AstR	B-Protein
TCS	O
,	O
which	O
is	O
important	O
for	O
the	O
correct	O
timing	O
of	O
phase	O
variant	O
switching	O
[	O
28	O
]	O
.	O

It	O
is	O
discussed	O
that	O
the	O
AstS	B-Protein
/	O
AstR	B-Protein
-	O
system	O
prevents	O
or	O
delays	O
phenotypic	O
variation	O
by	O
protecting	O
the	O
cell	O
from	O
stress	O
[	O
18	O
]	O
.	O
<EOS>	B-X
But	B-X
in	B-X
the	B-X
context	B-X
of	B-X
multicellular	B-X
differentiation	B-X
processes	B-X
,	B-X
antimicrobial	B-X
compounds	B-X
sometimes	B-X
also	B-X
play	B-X
a	B-X
role	B-X
in	B-X
intraspecies	B-X
competition	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
death	B-X
of	B-X
a	B-X
sub-population	B-X
of	B-X
genetically	B-X
identical	B-X
siblings	B-X
for	B-X
the	B-X
benefit	B-X
of	B-X
the	B-X
population	B-X
.	B-X
Such	B-X
a	B-X
strategy	B-X
is	B-X
based	B-X
on	B-X
the	B-X
diversification	B-X
and	B-X
hence	B-X
phenotypic	B-X
heterogeneity	B-X
of	B-X
an	B-X
isogenic	B-X
bacterial	B-X
population	B-X
.	B-X
In	B-X
Bacillus	B-X
subtilis	B-X
,	B-X
cannibalism	B-X
is	B-X
a	B-X
differentiation	B-X
strategy	B-X
that	B-X
enhances	B-X
biofilm	B-X
formation	B-X
,	B-X
prolongs	B-X
or	B-X
potentially	B-X
even	B-X
prevents	B-X
full	B-X
commitment	B-X
to	B-X
endospore	B-X
formation	B-X
under	B-X
starvation	B-X
conditions	B-X
,	B-X
and	B-X
protects	B-X
cells	B-X
within	B-X
the	B-X
biofilm	B-X
against	B-X
competing	B-X
species	B-X
.	B-X
The	B-X
nutrients	B-X
released	B-X
by	B-X
lysed	B-X
cells	B-X
can	B-X
be	B-X
used	B-X
by	B-X
the	B-X
toxin	B-X
producers	B-X
,	B-X
thereby	B-X
delaying	B-X
the	B-X
full	B-X
activation	B-X
of	B-X
the	B-X
master	B-X
regulator	B-X
of	B-X
sporulation	B-X
.	B-X
In	B-X
Myxococcus	B-X
xanthus	B-X
,	B-X
a	B-X
large	B-X
fraction	B-X
of	B-X
the	B-X
population	B-X
undergoes	B-X
programmed	B-X
cell	B-X
death	B-X
during	B-X
the	B-X
formation	B-X
of	B-X
fruiting	B-X
bodies	B-X
.	B-X
The	B-X
biological	B-X
relevance	B-X
and	B-X
underlying	B-X
regulatory	B-X
mechanisms	B-X
of	B-X
these	B-X
three	B-X
processes	B-X
will	B-X
be	B-X
discussed	B-X
in	B-X
order	B-X
to	B-X
extract	B-X
common	B-X
features	B-X
of	B-X
such	B-X
strategies	B-X
.	B-X

Because	O
Y	O
.	O
enterocolitica	O
produces	O
the	O
corresponding	O
TCS	O
BvgS	B-Protein
/	O
BvgR	B-Protein
,	O
but	O
is	O
not	O
known	O
to	O
switch	O
to	O
another	O
phenotypic	O
variant	O
,	O
the	O
possible	O
role	O
of	O
UspA	B-Protein
in	O
global	O
regulation	O
still	O
remains	O
to	O
be	O
elucidated	O
.	O

Phenotypic	O
variation	O
and	O
thus	O
the	O
switch	O
between	O
mutualism	O
and	O
pathogenicity	O
in	O
P	O
.	O
luminescens	O
is	O
proposed	O
to	O
be	O
regulated	O
by	O
a	O
Ner	B-Protein
-	O
like	O
and	O
a	O
HexA	B-Protein
-	O
like	O
regulator	O
that	O
repress	O
primary	O
variant	O
specific	O
genes	O
in	O
the	O
stage	O
of	O
the	O
secondary	O
variant	O
[	O
17	O
]	O
.	O

Therefore	O
,	O
UspA	B-Protein
might	O
have	O
a	O
global	O
importance	O
in	O
P	O
.	O
luminescens	O
notifying	O
stress	O
and	O
transmitting	O
signals	O
for	O
HexA	B-Protein
[	O
18	O
]	O
.	O

In	O
Y	O
.	O
enterocolitica	O
,	O
the	O
transcriptional	O
repressor	O
RovM	B-Protein
(	O
YE1343	B-Protein
)	O
is	O
similar	O
to	O
HexA	B-Protein
of	O
P	O
.	O
luminescens	O
(	O
61	O
%	O
identity	O
and	O
75	O
%	O
homology	O
)	O
,	O
and	O
has	O
only	O
recently	O
been	O
shown	O
to	O
control	O
cell	O
invasion	O
,	O
virulence	O
and	O
motility	O
in	O
Y	O
.	O
pseudotuberculosis	O
,	O
Y	O
.	O
pestis	O
and	O
Y	O
.	O
enterocolitica	O
[	O
51	O
-	O
53	O
]	O
.	O

This	O
fact	O
suggests	O
a	O
similar	O
UspA	B-Protein
-	O
dependent	O
regulatory	O
mechanism	O
used	O
by	O
the	O
two	O
bacteria	O
compared	O
here	O
.	O

P	O
.	O
luminescens	O
,	O
but	O
not	O
Y	O
.	O
enterocolitica	O
,	O
produces	O
two	O
members	O
of	O
the	O
UspFG	B-Protein
family	O
,	O
the	O
UspG	B-Protein
homologues	O
Plu2030	B-Protein
and	O
Plu2032	B-Protein
(	O
Tab	O
.	O
2	O
)	O
,	O
indicating	O
a	O
global	O
stress	O
response	O
induced	O
by	O
those	O
Usp	O
proteins	O
that	O
is	O
different	O
in	O
both	O
organisms	O
.	O
<EOS>	B-X
Phenotypic	B-X
heterogeneity	B-X
in	B-X
bacterial	B-X
cell	B-X
populations	B-X
allows	B-X
genetically	B-X
identical	B-X
organisms	B-X
to	B-X
different	B-X
behavior	B-X
under	B-X
similar	B-X
environmental	B-X
conditions	B-X
.	B-X
The	B-X
Gram-negative	B-X
bacterium	B-X
Photorhabdus	B-X
luminescens	B-X
is	B-X
an	B-X
excellent	B-X
organism	B-X
to	B-X
study	B-X
phenotypic	B-X
heterogeneity	B-X
since	B-X
their	B-X
life	B-X
cycle	B-X
involves	B-X
a	B-X
symbiotic	B-X
interaction	B-X
with	B-X
soil	B-X
nematodes	B-X
as	B-X
well	B-X
as	B-X
a	B-X
pathogenic	B-X
association	B-X
with	B-X
insect	B-X
larvae	B-X
.	B-X
Phenotypic	B-X
heterogeneity	B-X
is	B-X
highly	B-X
distinct	B-X
in	B-X
P.	B-X
luminescens	B-X
.	B-X
The	B-X
bacteria	B-X
exist	B-X
in	B-X
two	B-X
phenotypic	B-X
forms	B-X
that	B-X
differ	B-X
in	B-X
various	B-X
morphologic	B-X
and	B-X
phenotypic	B-X
traits	B-X
and	B-X
are	B-X
therefore	B-X
distinguished	B-X
as	B-X
primary	B-X
(	B-X
1°	B-X
)	B-X
and	B-X
secondary	B-X
(	B-X
2°	B-X
)	B-X
cells	B-X
.	B-X
The	B-X
2°	B-X
cells	B-X
lack	B-X
all	B-X
these	B-X
1°-specific	B-X
phenotypes	B-X
.	B-X
During	B-X
insect	B-X
infection	B-X
,	B-X
up	B-X
to	B-X
the	B-X
half	B-X
number	B-X
of	B-X
1°	B-X
cells	B-X
undergo	B-X
phenotypic	B-X
switching	B-X
and	B-X
convert	B-X
to	B-X
2°	B-X
cells	B-X
.	B-X
Since	B-X
the	B-X
2°	B-X
cells	B-X
are	B-X
not	B-X
able	B-X
to	B-X
live	B-X
in	B-X
nematode	B-X
symbiosis	B-X
any	B-X
more	B-X
,	B-X
they	B-X
can	B-X
not	B-X
re-associate	B-X
with	B-X
their	B-X
symbiosis	B-X
partners	B-X
after	B-X
the	B-X
infection	B-X
and	B-X
remain	B-X
in	B-X
the	B-X
soil	B-X
.	B-X
Phenotypic	B-X
switching	B-X
in	B-X
P.	B-X
luminescens	B-X
has	B-X
to	B-X
be	B-X
tightly	B-X
regulated	B-X
since	B-X
a	B-X
high	B-X
switching	B-X
frequency	B-X
would	B-X
lead	B-X
to	B-X
a	B-X
complete	B-X
break-down	B-X
of	B-X
the	B-X
nematode-bacteria	B-X
life	B-X
cycle	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
present	B-X
the	B-X
main	B-X
regulatory	B-X
mechanisms	B-X
known	B-X
to-date	B-X
that	B-X
are	B-X
important	B-X
for	B-X
phenotypic	B-X
switching	B-X
in	B-X
P.	B-X
luminescens	B-X
cell	B-X
populations	B-X
and	B-X
discuss	B-X
the	B-X
biological	B-X
reason	B-X
as	B-X
well	B-X
as	B-X
the	B-X
fate	B-X
of	B-X
the	B-X
2°	B-X
cells	B-X
in	B-X
the	B-X
soil	B-X
.	B-X

It	O
is	O
known	O
that	O
UspG	B-Protein
of	O
E	O
.	O
coli	O
interacts	O
with	O
the	O
chaperonin	O
GroEL	B-Protein
[	O
54	O
]	O
,	O
which	O
promotes	O
the	O
correct	O
folding	O
of	O
many	O
cytosolic	O
proteins	O
[	O
55	O
]	O
.	O

A	O
GroEL	B-Protein
homologue	O
is	O
present	O
in	O
P	O
.	O
luminescens	O
(	O
Plu4134	B-Protein
)	O
which	O
the	O
P	O
.	O
luminescens	O
UspG	B-Protein
homologues	O
might	O
interact	O
with	O
.	O

In	O
contrast	O
to	O
P	O
.	O
luminescens	O
,	O
Y	O
.	O
enterocolitica	O
encodes	O
another	O
member	O
of	O
the	O
UspA	B-Protein
subfamily	O
,	O
the	O
UspC	B-Protein
homologue	O
YE2583	B-Protein
(	O
Tab	O
.	O
2	O
)	O
,	O
which	O
is	O
not	O
present	O
in	O
P	O
.	O
luminescens	O
.	O

Therefore	O
,	O
an	O
UspC	B-Protein
mediated	O
stress	O
response	O
is	O
not	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
insect	O
pathogenicity	O
.	O

Summarizing	O
,	O
the	O
set	O
of	O
the	O
shared	O
and	O
different	O
Usp	O
proteins	O
reveals	O
a	O
partially	O
similar	O
and	O
a	O
partially	O
different	O
(	O
fine	O
)	O
-	O
regulation	O
of	O
the	O
global	O
stress	O
response	O
modules	O
in	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
.	O

This	O
pattern	O
corresponds	O
to	O
the	O
overlapping	O
life	O
cycles	O
of	O
both	O
pathogens	O
(	O
Fig	O
.	O
1	O
)	O
.	O

The	O
UspA	B-Protein
and	O
the	O
UspE	B-Protein
homologues	O
are	O
predicted	O
here	O
to	O
be	O
relevant	O
for	O
insect	O
infection	O
,	O
whereas	O
UspC	B-Protein
is	O
assumed	O
be	O
more	O
important	O
for	O
Y	O
.	O
enterocolitica	O
in	O
other	O
environments	O
/	O
hosts	O
.	O

The	O
two	O
UspG	B-Protein
homologues	O
might	O
constitute	O
a	O
set	O
of	O
Usp	O
proteins	O
that	O
play	O
a	O
specific	O
role	O
in	O
P	O
.	O
luminescens	O
infection	O
or	O
in	O
symbiosis	O
with	O
the	O
nematode	O
host	O
.	O
<EOS>	B-X
The	B-X
microbiota	B-X
plays	B-X
a	B-X
fundamental	B-X
role	B-X
on	B-X
the	B-X
induction	B-X
,	B-X
training	B-X
,	B-X
and	B-X
function	B-X
of	B-X
the	B-X
host	B-X
immune	B-X
system	B-X
.	B-X
In	B-X
return	B-X
,	B-X
the	B-X
immune	B-X
system	B-X
has	B-X
largely	B-X
evolved	B-X
as	B-X
a	B-X
means	B-X
to	B-X
maintain	B-X
the	B-X
symbiotic	B-X
relationship	B-X
of	B-X
the	B-X
host	B-X
with	B-X
these	B-X
highly	B-X
diverse	B-X
and	B-X
evolving	B-X
microbes	B-X
.	B-X
However	B-X
,	B-X
in	B-X
high-income	B-X
countries	B-X
,	B-X
overuse	B-X
of	B-X
antibiotics	B-X
,	B-X
changes	B-X
in	B-X
diet	B-X
,	B-X
and	B-X
elimination	B-X
of	B-X
constitutive	B-X
partners	B-X
,	B-X
such	B-X
as	B-X
nematodes	B-X
,	B-X
may	B-X
have	B-X
selected	B-X
for	B-X
a	B-X
microbiota	B-X
that	B-X
lack	B-X
the	B-X
resilience	B-X
and	B-X
diversity	B-X
required	B-X
to	B-X
establish	B-X
balanced	B-X
immune	B-X
responses	B-X
.	B-X
Parasites	B-X
and	B-X
bacteria	B-X
have	B-X
co-evolved	B-X
with	B-X
humankind	B-X
,	B-X
and	B-X
they	B-X
interact	B-X
all	B-X
the	B-X
time	B-X
in	B-X
a	B-X
myriad	B-X
of	B-X
ways	B-X
.	B-X
For	B-X
example	B-X
,	B-X
some	B-X
bacterial	B-X
infections	B-X
result	B-X
from	B-X
parasite-dwelling	B-X
bacteria	B-X
as	B-X
in	B-X
the	B-X
case	B-X
of	B-X
Salmonella	B-X
infection	B-X
during	B-X
schistosomiasis	B-X
.	B-X
Other	B-X
bacteria	B-X
synergize	B-X
with	B-X
parasites	B-X
in	B-X
the	B-X
evolution	B-X
of	B-X
human	B-X
disease	B-X
as	B-X
in	B-X
the	B-X
case	B-X
of	B-X
the	B-X
interplay	B-X
between	B-X
Wolbachia	B-X
endosymbiont	B-X
bacteria	B-X
and	B-X
filarial	B-X
nematodes	B-X
as	B-X
well	B-X
as	B-X
the	B-X
interaction	B-X
between	B-X
Gram-negative	B-X
bacteria	B-X
and	B-X
Schistosoma	B-X
haematobium	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
urinary	B-X
bladder	B-X
cancer	B-X
.	B-X
Moreover	B-X
,	B-X
secondary	B-X
bacterial	B-X
infections	B-X
may	B-X
complicate	B-X
several	B-X
parasitic	B-X
diseases	B-X
such	B-X
as	B-X
visceral	B-X
leishmaniasis	B-X
and	B-X
malaria	B-X
,	B-X
due	B-X
to	B-X
immunosuppression	B-X
of	B-X
the	B-X
host	B-X
during	B-X
parasitic	B-X
infections	B-X
.	B-X
Remarkably	B-X
,	B-X
some	B-X
parasitic	B-X
helminths	B-X
and	B-X
arthropods	B-X
exhibit	B-X
antibacterial	B-X
activity	B-X
usually	B-X
by	B-X
the	B-X
release	B-X
of	B-X
specific	B-X
antimicrobial	B-X
products	B-X
.	B-X
Lastly	B-X
,	B-X
some	B-X
parasite-bacteria	B-X
interactions	B-X
are	B-X
induced	B-X
as	B-X
when	B-X
using	B-X
probiotic	B-X
bacteria	B-X
to	B-X
modulate	B-X
the	B-X
outcome	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
parasitic	B-X
infections	B-X
.	B-X
However	B-X
,	B-X
understanding	B-X
and	B-X
exploiting	B-X
these	B-X
interactions	B-X
could	B-X
have	B-X
prophylactic	B-X
and	B-X
curative	B-X
potential	B-X
for	B-X
infections	B-X
by	B-X
both	B-X
types	B-X
of	B-X
pathogens	B-X
.	B-X

Regulation	O
via	O
c	O
-	O
di	O
-	O
GMP	O
as	O
a	O
second	O
messenger	O

Cyclic	O
diguanylate	O
(	O
c	O
-	O
di	O
-	O
GMP	O
)	O
is	O
a	O
bacterial	O
second	O
messenger	O
that	O
activates	O
biofilm	O
formation	O
while	O
inhibiting	O
motility	O
,	O
thus	O
regulating	O
the	O
switch	O
between	O
a	O
planktonic	O
and	O
a	O
sessile	O
lifestyle	O
.	O

In	O
addition	O
to	O
phenotypes	O
that	O
affect	O
virulence	O
properties	O
indirectly	O
,	O
c	O
-	O
di	O
-	O
GMP	O
can	O
also	O
directly	O
regulate	O
virulence	O
factors	O
[	O
56	O
,	O
57	O
]	O
.	O

Proteins	O
containing	O
a	O
so	O
-	O
called	O
GGDEF	B-Protein
domain	O
are	O
responsible	O
for	O
the	O
synthesis	O
of	O
c	O
-	O
di	O
-	O
GMP	O
,	O
and	O
those	O
with	O
a	O
so	O
-	O
called	O
EAL	B-Protein
domain	O
for	O
its	O
degradation	O
.	O
<EOS>	B-X
The	B-X
motile-to-sessile	B-X
transition	B-X
is	B-X
an	B-X
important	B-X
lifestyle	B-X
switch	B-X
in	B-X
diverse	B-X
bacteria	B-X
and	B-X
is	B-X
often	B-X
regulated	B-X
by	B-X
the	B-X
intracellular	B-X
second	B-X
messenger	B-X
cyclic	B-X
diguanylate	B-X
monophosphate	B-X
(	B-X
c-di-GMP	B-X
)	B-X
.	B-X
In	B-X
general	B-X
,	B-X
high	B-X
c-di-GMP	B-X
concentrations	B-X
promote	B-X
attachment	B-X
to	B-X
surfaces	B-X
,	B-X
whereas	B-X
cells	B-X
with	B-X
low	B-X
levels	B-X
of	B-X
signal	B-X
remain	B-X
motile	B-X
.	B-X
In	B-X
the	B-X
plant	B-X
pathogen	B-X
Agrobacterium	B-X
tumefaciens	B-X
,	B-X
c-di-GMP	B-X
controls	B-X
attachment	B-X
and	B-X
biofilm	B-X
formation	B-X
via	B-X
regulation	B-X
of	B-X
a	B-X
unipolar	B-X
polysaccharide	B-X
(	B-X
UPP	B-X
)	B-X
adhesin	B-X
.	B-X
The	B-X
levels	B-X
of	B-X
c-di-GMP	B-X
in	B-X
A.	B-X
tumefaciens	B-X
are	B-X
controlled	B-X
in	B-X
part	B-X
by	B-X
the	B-X
dual-function	B-X
diguanylate	B-X
cyclase-phosphodiesterase	B-X
(	B-X
DGC-PDE	B-X
)	B-X
protein	B-X
DcpA	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
that	B-X
DcpA	B-X
possesses	B-X
both	B-X
c-di-GMP	B-X
synthesizing	B-X
and	B-X
degrading	B-X
activities	B-X
in	B-X
heterologous	B-X
and	B-X
native	B-X
genetic	B-X
backgrounds	B-X
,	B-X
a	B-X
binary	B-X
capability	B-X
that	B-X
is	B-X
unusual	B-X
among	B-X
GGDEF-EAL	B-X
domain-containing	B-X
proteins	B-X
.	B-X
DcpA	B-X
activity	B-X
is	B-X
modulated	B-X
by	B-X
a	B-X
pteridine	B-X
reductase	B-X
called	B-X
PruA	B-X
,	B-X
with	B-X
DcpA	B-X
acting	B-X
as	B-X
a	B-X
PDE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
PruA	B-X
and	B-X
a	B-X
DGC	B-X
in	B-X
its	B-X
absence	B-X
.	B-X
PruA	B-X
enzymatic	B-X
activity	B-X
is	B-X
required	B-X
for	B-X
the	B-X
control	B-X
of	B-X
DcpA	B-X
and	B-X
through	B-X
this	B-X
control	B-X
,	B-X
attachment	B-X
and	B-X
biofilm	B-X
formation	B-X
.	B-X
Intracellular	B-X
pterin	B-X
analysis	B-X
demonstrates	B-X
that	B-X
PruA	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
production	B-X
of	B-X
a	B-X
novel	B-X
pterin	B-X
species	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
control	B-X
of	B-X
DcpA	B-X
activity	B-X
also	B-X
requires	B-X
PruR	B-X
,	B-X
a	B-X
protein	B-X
encoded	B-X
directly	B-X
upstream	B-X
of	B-X
DcpA	B-X
with	B-X
a	B-X
predicted	B-X
molybdopterin-binding	B-X
domain	B-X
.	B-X
PruR	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
potential	B-X
signaling	B-X
intermediate	B-X
between	B-X
PruA	B-X
and	B-X
DcpA	B-X
through	B-X
an	B-X
as-yet-unidentified	B-X
mechanism	B-X
.	B-X
This	B-X
study	B-X
provides	B-X
the	B-X
first	B-X
prokaryotic	B-X
example	B-X
of	B-X
a	B-X
pterin-mediated	B-X
signaling	B-X
pathway	B-X
and	B-X
a	B-X
new	B-X
model	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
dual-function	B-X
DGC-PDE	B-X
proteins	B-X
.	B-X

The	O
expression	O
and	O
activity	O
of	O
those	O
GGDEF	B-Protein
and	O
EAL	B-Protein
domain	O
containing	O
proteins	O
is	O
regulated	O
by	O
factors	O
with	O
a	O
PilZ	B-Protein
domain	O
that	O
binds	O
c	O
-	O
di	O
-	O
GMP	O
.	O
<EOS>	B-X
Klebsiella	B-X
pneumoniae	B-X
causes	B-X
significant	B-X
morbidity	B-X
and	B-X
mortality	B-X
worldwide	B-X
,	B-X
particularly	B-X
amongst	B-X
hospitalized	B-X
individuals	B-X
.	B-X
The	B-X
principle	B-X
mechanism	B-X
for	B-X
pathogenesis	B-X
in	B-X
hospital	B-X
environments	B-X
involves	B-X
the	B-X
formation	B-X
of	B-X
biofilms	B-X
,	B-X
primarily	B-X
on	B-X
implanted	B-X
medical	B-X
devices	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
constructed	B-X
a	B-X
transposon	B-X
mutant	B-X
library	B-X
in	B-X
a	B-X
clinical	B-X
isolate	B-X
,	B-X
K.	B-X
pneumoniae	B-X
AJ218	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
genes	B-X
and	B-X
pathways	B-X
implicated	B-X
in	B-X
biofilm	B-X
formation	B-X
.	B-X
Three	B-X
mutants	B-X
severely	B-X
defective	B-X
in	B-X
biofilm	B-X
formation	B-X
contained	B-X
insertions	B-X
within	B-X
the	B-X
mrkABCDF	B-X
genes	B-X
encoding	B-X
the	B-X
main	B-X
structural	B-X
subunit	B-X
and	B-X
assembly	B-X
machinery	B-X
for	B-X
type	B-X
3	B-X
fimbriae	B-X
.	B-X
Two	B-X
other	B-X
mutants	B-X
carried	B-X
insertions	B-X
within	B-X
the	B-X
yfiN	B-X
and	B-X
mrkJ	B-X
genes	B-X
,	B-X
which	B-X
encode	B-X
GGDEF	B-X
domain-	B-X
and	B-X
EAL	B-X
domain-containing	B-X
c-di-GMP	B-X
turnover	B-X
enzymes	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
remaining	B-X
two	B-X
isolates	B-X
contained	B-X
insertions	B-X
that	B-X
inactivated	B-X
the	B-X
mrkH	B-X
and	B-X
mrkI	B-X
genes	B-X
,	B-X
which	B-X
encode	B-X
for	B-X
novel	B-X
proteins	B-X
with	B-X
a	B-X
c-di-GMP-binding	B-X
PilZ	B-X
domain	B-X
and	B-X
a	B-X
LuxR-type	B-X
transcriptional	B-X
regulator	B-X
,	B-X
respectively	B-X
.	B-X
Biochemical	B-X
and	B-X
functional	B-X
assays	B-X
indicated	B-X
that	B-X
the	B-X
effects	B-X
of	B-X
these	B-X
factors	B-X
on	B-X
biofilm	B-X
formation	B-X
accompany	B-X
concomitant	B-X
changes	B-X
in	B-X
type	B-X
3	B-X
fimbriae	B-X
expression	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
transcriptional	B-X
start	B-X
site	B-X
of	B-X
mrkA	B-X
,	B-X
demonstrated	B-X
that	B-X
MrkH	B-X
directly	B-X
activates	B-X
transcription	B-X
of	B-X
the	B-X
mrkA	B-X
promoter	B-X
and	B-X
showed	B-X
that	B-X
MrkH	B-X
binds	B-X
strongly	B-X
to	B-X
the	B-X
mrkA	B-X
regulatory	B-X
region	B-X
only	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
c-di-GMP	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
putative	B-X
c-di-GMP-binding	B-X
domain	B-X
of	B-X
MrkH	B-X
completely	B-X
abolished	B-X
its	B-X
function	B-X
as	B-X
a	B-X
transcriptional	B-X
activator	B-X
.	B-X
In	B-X
vivo	B-X
analysis	B-X
of	B-X
the	B-X
yfiN	B-X
and	B-X
mrkJ	B-X
genes	B-X
strongly	B-X
indicated	B-X
their	B-X
c-di-GMP-specific	B-X
function	B-X
as	B-X
diguanylate	B-X
cyclase	B-X
and	B-X
phosphodiesterase	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
in	B-X
vitro	B-X
assays	B-X
showed	B-X
that	B-X
purified	B-X
MrkJ	B-X
protein	B-X
has	B-X
strong	B-X
c-di-GMP	B-X
phosphodiesterase	B-X
activity	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
c-di-GMP	B-X
can	B-X
function	B-X
as	B-X
an	B-X
effector	B-X
to	B-X
stimulate	B-X
the	B-X
activity	B-X
of	B-X
a	B-X
transcriptional	B-X
activator	B-X
,	B-X
and	B-X
explain	B-X
how	B-X
type	B-X
3	B-X
fimbriae	B-X
expression	B-X
is	B-X
coordinated	B-X
with	B-X
other	B-X
gene	B-X
expression	B-X
programs	B-X
in	B-X
K.	B-X
pneumoniae	B-X
to	B-X
promote	B-X
biofilm	B-X
formation	B-X
to	B-X
implanted	B-X
medical	B-X
devices	B-X
.	B-X

The	O
PilZ	B-Protein
domain	O
is	O
found	O
as	O
a	O
stand	O
-	O
alone	O
domain	O
or	O
in	O
combination	O
with	O
GGDEF	B-Protein
,	O
EAL	B-Protein
and	O
other	O
domains	O
,	O
thus	O
assumed	O
to	O
function	O
also	O
as	O
an	O
allosteric	O
domain	O
to	O
control	O
other	O
regulatory	O
enzymes	O
[	O
58	O
,	O
59	O
]	O
.	O
<EOS>	B-X
In	B-X
Myxococcus	B-X
xanthus	B-X
,	B-X
c-di-GMP	B-X
regulates	B-X
type	B-X
IV	B-X
pilus-dependent	B-X
motility	B-X
and	B-X
the	B-X
starvation-induced	B-X
developmental	B-X
program	B-X
that	B-X
results	B-X
in	B-X
formation	B-X
of	B-X
spore-filled	B-X
fruiting	B-X
bodies	B-X
;	B-X
however	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
effectors	B-X
that	B-X
bind	B-X
c-di-GMP	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
systematically	B-X
inactivated	B-X
all	B-X
24	B-X
genes	B-X
encoding	B-X
PilZ	B-X
domain-containing	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
among	B-X
the	B-X
most	B-X
common	B-X
c-di-GMP	B-X
effectors	B-X
.	B-X
We	B-X
confirm	B-X
that	B-X
the	B-X
stand-alone	B-X
PilZ	B-X
domain	B-X
protein	B-X
PlpA	B-X
is	B-X
important	B-X
for	B-X
regulation	B-X
of	B-X
motility	B-X
independently	B-X
of	B-X
the	B-X
Frz	B-X
chemosensory	B-X
system	B-X
and	B-X
that	B-X
Pkn1	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
a	B-X
Ser/Thr	B-X
kinase	B-X
domain	B-X
and	B-X
a	B-X
PilZ	B-X
domain	B-X
,	B-X
is	B-X
specifically	B-X
important	B-X
for	B-X
development	B-X
.	B-X
Moreover	B-X
,	B-X
we	B-X
identify	B-X
two	B-X
PilZ	B-X
domain	B-X
proteins	B-X
that	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
regulating	B-X
motility	B-X
and	B-X
development	B-X
.	B-X
PixB	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
two	B-X
PilZ	B-X
domains	B-X
and	B-X
an	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
binds	B-X
c-di-GMP	B-X

In	O
Y	O
.	O
enterocolitica	O
,	O
we	O
identified	O
22	O
putative	O
proteins	O
containing	O
GGDEF	B-Protein
and	O
EAL	B-Protein
domains	O
.	O

Eleven	O
of	O
these	O
proteins	O
solely	O
contain	O
a	O
GGDEF	B-Protein
-	O
domain	O
and	O
six	O
solely	O
an	O
EAL	B-Protein
-	O
domain	O
,	O
and	O
both	O
domains	O
are	O
found	O
in	O
tandem	O
in	O
five	O
proteins	O
.	O

The	O
protein	O
AdrA	B-Protein
(	O
YE3010	B-Protein
,	O
GGDEF	B-Protein
domain	O
)	O
is	O
annotated	O
as	O
a	O
putative	O
diguanylate	O
cyclase	O
,	O
YE2278	B-Protein
(	O
GGDEF	B-Protein
+	O
EAL	B-Protein
)	O
as	O
a	O
putative	O
phosphodiesterase	O
,	O
YE3818	B-Protein
(	O
GGDEF	B-Protein
)	O
as	O
a	O
putative	O
regulator	O
,	O
and	O
YE3806	B-Protein
(	O
GGDEF	B-Protein
+	O
EAL	B-Protein
)	O
as	O
a	O
putative	O
exported	O
protein	O
.	O

All	O
other	O
GGDEF	B-Protein
and	O
EAL	B-Protein
domain	O
-	O
containing	O
proteins	O
are	O
of	O
unknown	O
function	O
.	O
<EOS>	B-X
The	B-X
intracellular	B-X
level	B-X
of	B-X
c-di-GMP	B-X
is	B-X
controlled	B-X
by	B-X
diguanylate	B-X
cyclases	B-X
(	B-X
DGCs	B-X
)	B-X
with	B-X
GGDEF	B-X
domain	B-X
and	B-X
phosphodiesterases	B-X
(	B-X
PDEs	B-X
)	B-X
with	B-X
either	B-X
EAL	B-X
or	B-X
HD-GYP	B-X
domain	B-X
.	B-X
Pseudomonas	B-X
putida	B-X
KT2440	B-X
has	B-X
a	B-X
large	B-X
group	B-X
of	B-X
genes	B-X
on	B-X
its	B-X
genome	B-X
encoding	B-X
proteins	B-X
with	B-X
GGDEF/EAL/HD-GYP	B-X
domains	B-X
.	B-X
However	B-X
,	B-X
phenotypic-genotypic	B-X
correlation	B-X
and	B-X
c-di-GMP	B-X
metabolism	B-X
of	B-X
these	B-X
genes	B-X
were	B-X
largely	B-X
unknown	B-X
.	B-X
Subsequent	B-X
results	B-X
from	B-X
protein	B-X
sequence	B-X
alignments	B-X
and	B-X
cellular	B-X
c-di-GMP	B-X
assessment	B-X
indicated	B-X
that	B-X
25	B-X
out	B-X
of	B-X
the	B-X
42	B-X
genes	B-X
were	B-X
likely	B-X
to	B-X
encode	B-X
DGCs	B-X
,	B-X
nine	B-X
genes	B-X
were	B-X
predicted	B-X
to	B-X
encode	B-X
PDEs	B-X
,	B-X
four	B-X
genes	B-X
encoded	B-X
bifunctional	B-X
enzymes	B-X
and	B-X
the	B-X
other	B-X
four	B-X
genes	B-X
encoded	B-X
enzymatically	B-X
inactive	B-X
proteins	B-X
.	B-X
This	B-X
study	B-X
offers	B-X
a	B-X
basic	B-X
understanding	B-X
of	B-X
the	B-X
roles	B-X
of	B-X
these	B-X
42	B-X
genes	B-X
and	B-X
can	B-X
serve	B-X
as	B-X
a	B-X
toolkit	B-X
for	B-X
investigators	B-X
to	B-X
further	B-X
elucidate	B-X
the	B-X
functions	B-X
of	B-X
these	B-X
GGDEF	B-X
and	B-X
EAL/HD-GYP	B-X
domain-containing	B-X
proteins	B-X
.	B-X

Furthermore	O
,	O
two	O
proteins	O
with	O
PilZ	B-Protein
domain	O
exist	O
in	O
Y	O
.	O
enterocolitica	O
,	O
namely	O
YE3197	B-Protein
and	O
BcsA	B-Protein
(	O
YE4074	B-Protein
)	O
,	O
a	O
putative	O
cellulose	O
synthase	O
.	O

Cellulose	O
synthesis	O
in	O
bacteria	O
has	O
been	O
identified	O
to	O
be	O
important	O
for	O
the	O
protection	O
from	O
chemical	O
or	O
mechanical	O
stress	O
by	O
forming	O
a	O
hydrophobic	O
extracellular	O
matrix	O
[	O
60	O
]	O
.	O
<EOS>	B-X
O1	B-X
Regulation	B-X
of	B-X
genes	B-X
by	B-X
telomere	B-X
length	B-X
over	B-X
long	B-X
distances	B-X
Jerry	B-X
W.	B-X
Shay	B-X
O2	B-X
The	B-X
microtubule	B-X
destabilizer	B-X
KIF2A	B-X
regulates	B-X
the	B-X
postnatal	B-X
establishment	B-X
of	B-X
neuronal	B-X
circuits	B-X
in	B-X
addition	B-X
to	B-X
prenatal	B-X
cell	B-X
survival	B-X
,	B-X
cell	B-X
migration	B-X
,	B-X
and	B-X
axon	B-X
elongation	B-X
,	B-X
and	B-X
its	B-X
loss	B-X
leading	B-X
to	B-X
malformation	B-X
of	B-X
cortical	B-X
development	B-X
and	B-X
severe	B-X
epilepsy	B-X
Noriko	B-X
Homma	B-X
,	B-X
Ruyun	B-X
Zhou	B-X
,	B-X
Muhammad	B-X
Imran	B-X
Naseer	B-X
,	B-X
Adeel	B-X
G.	B-X
Chaudhary	B-X
,	B-X
Mohammed	B-X
Al-Qahtani	B-X
,	B-X
Nobutaka	B-X
Hirokawa	B-X
O3	B-X
Integration	B-X
of	B-X
metagenomics	B-X
and	B-X
metabolomics	B-X
in	B-X
gut	B-X
microbiome	B-X
research	B-X
Maryam	B-X
Goudarzi	B-X
,	B-X
Albert	B-X
J.	B-X
Fornace	B-X
Jr.	B-X
O4	B-X
A	B-X
unique	B-X
integrated	B-X
system	B-X
to	B-X
discern	B-X
pathogenesis	B-X
of	B-X
central	B-X
nervous	B-X
system	B-X
tumors	B-X
Saleh	B-X
Baeesa	B-X
,	B-X
Deema	B-X
Hussain	B-X
,	B-X
Mohammed	B-X
Bangash	B-X
,	B-X
Fahad	B-X
Alghamdi	B-X
,	B-X
Hans-Juergen	B-X
Schulten	B-X
,	B-X
Angel	B-X
Carracedo	B-X
,	B-X
Ishaq	B-X
Khan	B-X
,	B-X
Hanadi	B-X
Qashqari	B-X
,	B-X
Nawal	B-X
Madkhali	B-X
,	B-X
Mohamad	B-X
Saka	B-X
,	B-X
Kulvinder	B-X
S.	B-X
Saini	B-X
,	B-X
Awatif	B-X
Jamal	B-X
,	B-X
Jaudah	B-X
Al-Maghrabi	B-X
,	B-X
Adel	B-X
Abuzenadah	B-X
,	B-X
Adeel	B-X
Chaudhary	B-X
,	B-X
Mohammed	B-X
Al	B-X
Qahtani	B-X
,	B-X
Ghazi	B-X
Damanhouri	B-X
O5	B-X
RPL27A	B-X
is	B-X
a	B-X
target	B-X
of	B-X
miR-595	B-X
and	B-X
deficiency	B-X
contributes	B-X
to	B-X
ribosomal	B-X
dysgenesis	B-X
Heba	B-X
Alkhatabi	B-X
O6	B-X
Next	B-X
generation	B-X
DNA	B-X
sequencing	B-X
panels	B-X
for	B-X
haemostatic	B-X
and	B-X
platelet	B-X
disorders	B-X
and	B-X
for	B-X
Fanconi	B-X
anaemia	B-X
in	B-X
routine	B-X
diagnostic	B-X
service	B-X
Anne	B-X
Goodeve	B-X
,	B-X
Laura	B-X
Crookes	B-X
,	B-X
Nikolas	B-X
Niksic	B-X
,	B-X
Nicholas	B-X
Beauchamp	B-X
O7	B-X
Targeted	B-X
sequencing	B-X
panels	B-X
and	B-X
their	B-X
utilization	B-X
in	B-X
personalized	B-X
medicine	B-X
Adel	B-X
M.	B-X
Abuzenadah	B-X
O8	B-X
International	B-X
biobanking	B-X
in	B-X
the	B-X
era	B-X
of	B-X
precision	B-X
medicine	B-X
Jim	B-X
Vaught	B-X
O9	B-X
Biobank	B-X
and	B-X
biodata	B-X
for	B-X
clinical	B-X
and	B-X
forensic	B-X
applications	B-X
Bruce	B-X
Budowle	B-X
,	B-X
Mourad	B-X
Assidi	B-X
,	B-X
Abdelbaset	B-X
Buhmeida	B-X
O10	B-X
Tissue	B-X
microarray	B-X
technique	B-X
:	B-X
a	B-X
powerful	B-X
adjunct	B-X
tool	B-X
for	B-X
molecular	B-X
profiling	B-X
of	B-X
solid	B-X
tumors	B-X
Jaudah	B-X
Al-Maghrabi	B-X
O11	B-X
The	B-X
CEGMR	B-X
biobanking	B-X
unit	B-X
:	B-X
achievements	B-X
,	B-X
challenges	B-X
and	B-X
future	B-X
plans	B-X
Abdelbaset	B-X
Buhmeida	B-X
,	B-X
Mourad	B-X
Assidi	B-X
,	B-X
Leena	B-X
Merdad	B-X
O12	B-X
Phylomedicine	B-X
of	B-X
tumors	B-X
Sudhir	B-X
Kumar	B-X
,	B-X
Sayaka	B-X
Miura	B-X
,	B-X
Karen	B-X
Gomez	B-X
O13	B-X
Clinical	B-X
implementation	B-X
of	B-X
pharmacogenomics	B-X
for	B-X
colorectal	B-X
cancer	B-X
treatment	B-X
Angel	B-X
Carracedo	B-X
,	B-X
Mahmood	B-X
Rasool	B-X
O14	B-X
From	B-X
association	B-X
to	B-X
causality	B-X
:	B-X
translation	B-X
of	B-X
GWAS	B-X
findings	B-X
for	B-X
genomic	B-X
medicine	B-X
Ahmed	B-X
Rebai	B-X
O15	B-X
E-GRASP	B-X
:	B-X
an	B-X
interactive	B-X
database	B-X
and	B-X
web	B-X
application	B-X
for	B-X
efficient	B-X
analysis	B-X
of	B-X
disease-associated	B-X
genetic	B-X
information	B-X
Sajjad	B-X
Karim	B-X
,	B-X
Hend	B-X
F	B-X
Nour	B-X
Eldin	B-X
,	B-X
Heba	B-X
Abusamra	B-X
,	B-X
Elham	B-X
M	B-X
Alhathli	B-X
,	B-X
Nada	B-X
Salem	B-X
,	B-X
Mohammed	B-X
H	B-X
Al-Qahtani	B-X
,	B-X
Sudhir	B-X
Kumar	B-X
O16	B-X
The	B-X
supercomputer	B-X
facility	B-X
“	B-X
AZIZ	B-X
”	B-X
at	B-X
KAU	B-X
:	B-X
utility	B-X
and	B-X
future	B-X
prospects	B-X
Hossam	B-X
Faheem	B-X
O17	B-X
New	B-X
research	B-X
into	B-X
the	B-X
causes	B-X
of	B-X
male	B-X
infertility	B-X
Ashok	B-X
Agarwa	B-X
O18	B-X
The	B-X
Klinefelter	B-X
syndrome	B-X
:	B-X
recent	B-X
progress	B-X
in	B-X
pathophysiology	B-X
and	B-X
management	B-X
Eberhard	B-X
Nieschlag	B-X
,	B-X
Joachim	B-X
Wistuba	B-X
,	B-X
Oliver	B-X
S.	B-X
Damm	B-X
,	B-X
Mohd	B-X
A.	B-X
Beg	B-X
,	B-X
Taha	B-X
A.	B-X
Abdel-Meguid	B-X
,	B-X
Hisham	B-X
A.	B-X
Mosli	B-X
,	B-X
Osama	B-X
S.	B-X
Bajouh	B-X
,	B-X
Adel	B-X
M.	B-X
Abuzenadah	B-X
,	B-X
Mohammed	B-X
H.	B-X
Al-Qahtani	B-X
O19	B-X
A	B-X
new	B-X
look	B-X
to	B-X
reproductive	B-X
medicine	B-X
in	B-X
the	B-X
era	B-X
of	B-X
genomics	B-X
Serdar	B-X
Coskun	B-X
P1	B-X
Wnt	B-X
signalling	B-X
receptors	B-X
expression	B-X
in	B-X
Saudi	B-X
breast	B-X
cancer	B-X
patients	B-X
Muhammad	B-X
Abu-Elmagd	B-X
,	B-X
Abdelbaset	B-X
Buhmeida	B-X
,	B-X
Ashraf	B-X
Dallol	B-X
,	B-X
Jaudah	B-X
Al-Maghrabi	B-X
,	B-X
Sahar	B-X
Hakamy	B-X
,	B-X
Wejdan	B-X
Al-Qahtani	B-X
,	B-X
Asia	B-X
Al-Harbi	B-X
,	B-X
Shireen	B-X
Hussain	B-X
,	B-X
Mourad	B-X
Assidi	B-X
,	B-X
Mohammed	B-X
Al-Qahtani	B-X
,	B-X

The	O
expression	O
of	O
two	O
of	O
those	O
EAL	B-Protein
-	O
domain	O
containing	O
proteins	O
,	O
YE4063	B-Protein
and	O
YE1324	B-Protein
,	O
is	O
induced	O
at	O
low	O
temperature	O
(	O
Tab	O
.	O
1	O
)	O
.	O

These	O
two	O
factors	O
might	O
therefore	O
be	O
important	O
for	O
insect	O
colonization	O
instead	O
for	O
virulence	O
against	O
mammals	O
.	O

The	O
presence	O
of	O
c	O
-	O
di	O
-	O
GMP	O
mediated	O
regulation	O
in	O
Y	O
.	O
enterocolitica	O
is	O
therefore	O
suggested	O
to	O
play	O
a	O
central	O
role	O
in	O
switching	O
from	O
biofilm	O
formation	O
to	O
the	O
human	O
as	O
well	O
as	O
to	O
the	O
insect	O
environment	O
.	O

P	O
.	O
luminescens	O
contains	O
no	O
protein	O
with	O
GGDEF	B-Protein
,	O
EAL	B-Protein
or	O
PilZ	B-Protein
domain	O
.	O
<EOS>	B-X
The	B-X
PilZ	B-X
protein	B-X
was	B-X
originally	B-X
identified	B-X
as	B-X
necessary	B-X
for	B-X
type	B-X
IV	B-X
pilus	B-X
(	B-X
T4P	B-X
)	B-X
biogenesis	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
a	B-X
large	B-X
and	B-X
diverse	B-X
family	B-X
of	B-X
bacterial	B-X
PilZ	B-X
homology	B-X
domains	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
some	B-X
of	B-X
which	B-X
have	B-X
been	B-X
implicated	B-X
in	B-X
signaling	B-X
pathways	B-X
that	B-X
control	B-X
important	B-X
processes	B-X
,	B-X
including	B-X
motility	B-X
,	B-X
virulence	B-X
and	B-X
biofilm	B-X
formation	B-X
.	B-X
Furthermore	B-X
,	B-X
many	B-X
PilZ	B-X
homology	B-X
domains	B-X
,	B-X
though	B-X
not	B-X
PilZ	B-X
itself	B-X
,	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
important	B-X
bacterial	B-X
second	B-X
messenger	B-X
bis	B-X
(	B-X
3	B-X
'	B-X
--	B-X
>	B-X
5	B-X
'	B-X
)	B-X
cyclic	B-X
diGMP	B-X
(	B-X
c-diGMP	B-X
)	B-X
.	B-X
The	B-X
crystal	B-X
structures	B-X
of	B-X
the	B-X
PilZ	B-X
orthologs	B-X
from	B-X
Xanthomonas	B-X
axonopodis	B-X
pv	B-X
citri	B-X
(	B-X
PilZ	B-X
(	B-X
XAC1133	B-X
)	B-X
,	B-X
this	B-X
work	B-X
)	B-X
and	B-X
from	B-X
Xanthomonas	B-X
campestris	B-X
pv	B-X
campestris	B-X
(	B-X
XC1028	B-X
)	B-X
present	B-X
significant	B-X
structural	B-X
differences	B-X
to	B-X
other	B-X
PilZ	B-X
homologs	B-X
that	B-X
explain	B-X
its	B-X
failure	B-X
to	B-X
bind	B-X
c-diGMP	B-X
.	B-X
NMR	B-X
analysis	B-X
of	B-X
PilZ	B-X
(	B-X
XAC1133	B-X
)	B-X
shows	B-X
that	B-X
these	B-X
structural	B-X
differences	B-X
are	B-X
maintained	B-X
in	B-X
solution	B-X
.	B-X
In	B-X
spite	B-X
of	B-X
their	B-X
emerging	B-X
importance	B-X
in	B-X
bacterial	B-X
signaling	B-X
,	B-X
the	B-X
means	B-X
by	B-X
which	B-X
PilZ	B-X
proteins	B-X
regulate	B-X
specific	B-X
processes	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
PilZ	B-X
(	B-X
XAC1133	B-X
)	B-X
binds	B-X
to	B-X
PilB	B-X
,	B-X
an	B-X
ATPase	B-X
required	B-X
for	B-X
T4P	B-X
polymerization	B-X
,	B-X
and	B-X
to	B-X
the	B-X
EAL	B-X
domain	B-X
of	B-X
FimX	B-X
(	B-X
XAC2398	B-X
)	B-X
,	B-X
which	B-X
regulates	B-X
T4P	B-X
biogenesis	B-X
and	B-X
localization	B-X
in	B-X
other	B-X
bacterial	B-X
species	B-X
.	B-X
These	B-X
interactions	B-X
were	B-X
confirmed	B-X
in	B-X
NMR	B-X
,	B-X
two-hybrid	B-X
and	B-X
far-Western	B-X
blot	B-X
assays	B-X
and	B-X
are	B-X
the	B-X
first	B-X
interactions	B-X
observed	B-X
between	B-X
any	B-X
PilZ	B-X
domain	B-X
and	B-X
a	B-X
target	B-X
protein	B-X
.	B-X
While	B-X
we	B-X
were	B-X
unable	B-X
to	B-X
detect	B-X
phosphodiesterase	B-X
activity	B-X
for	B-X
FimX	B-X
(	B-X
XAC2398	B-X
)	B-X
in	B-X
vitro	B-X
,	B-X
we	B-X
show	B-X
that	B-X
it	B-X
binds	B-X
c-diGMP	B-X
both	B-X
in	B-X
the	B-X
presence	B-X
and	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
PilZ	B-X
(	B-X
XAC1133	B-X
)	B-X
.	B-X
Site-directed	B-X
mutagenesis	B-X
studies	B-X
for	B-X
conserved	B-X
and	B-X
exposed	B-X
residues	B-X
suggest	B-X
that	B-X
PilZ	B-X
(	B-X
XAC1133	B-X
)	B-X
interactions	B-X
with	B-X
FimX	B-X
(	B-X
XAC2398	B-X
)	B-X
and	B-X
PilB	B-X
(	B-X
XAC3239	B-X
)	B-X
are	B-X
mediated	B-X
through	B-X
a	B-X
hydrophobic	B-X
surface	B-X
and	B-X
an	B-X
unstructured	B-X
C-terminal	B-X
extension	B-X
conserved	B-X
only	B-X
in	B-X
PilZ	B-X
orthologs	B-X
.	B-X
The	B-X
FimX-PilZ-PilB	B-X
interactions	B-X
involve	B-X
a	B-X
full	B-X
set	B-X
of	B-X
``	B-X
degenerate	B-X
''	B-X
GGDEF	B-X
,	B-X
EAL	B-X
and	B-X
PilZ	B-X
domains	B-X
and	B-X
provide	B-X
the	B-X
first	B-X
evidence	B-X
of	B-X
the	B-X
means	B-X
by	B-X
which	B-X
PilZ	B-X
orthologs	B-X
and	B-X
FimX	B-X
interact	B-X
directly	B-X
with	B-X
the	B-X
TP4	B-X
machinery	B-X
.	B-X

This	O
phenomenon	O
is	O
quite	O
surprising	O
,	O
because	O
with	O
few	O
exceptions	O
such	O
as	O
Helicobacter	O
pylori	O
,	O
nearly	O
all	O
pathogenic	O
bacteria	O
use	O
c	O
-	O
di	O
-	O
GMP	O
as	O
a	O
second	O
messenger	O
.	O

It	O
has	O
been	O
reported	O
that	O
P	O
.	O
luminescens	O
forms	O
biofilms	O
in	O
vitro	O
,	O
and	O
that	O
a	O
luxS	B-Protein
-	O
deficient	O
mutant	O
unable	O
to	O
synthesize	O
the	O
quorum	O
-	O
sensing	O
inducer	O
AI	B-Protein
-	I-Protein
2	I-Protein
showed	O
a	O
decreased	O
biofilm	O
formation	O
[	O
42	O
]	O
.	O

The	O
lack	O
of	O
these	O
protein	O
domains	O
in	O
P	O
.	O
luminescens	O
reveals	O
that	O
c	O
-	O
di	O
-	O
GMP	O
signalling	O
plays	O
a	O
major	O
role	O
in	O
pathogenic	O
bacteria	O
when	O
colonizing	O
a	O
mammalian	O
host	O
,	O
and	O
a	O
minor	O
for	O
invertebrate	O
colonization	O
of	O
entomopathogenic	O
or	O
entomoinfecting	O
bacteria	O
.	O
<EOS>	B-X
One	B-X
of	B-X
the	B-X
current	B-X
priorities	B-X
of	B-X
the	B-X
World	B-X
Health	B-X
Organization	B-X
is	B-X
multidrug-resistant	B-X
bacteria	B-X
,	B-X
because	B-X
they	B-X
are	B-X
a	B-X
global	B-X
problem	B-X
due	B-X
to	B-X
their	B-X
rapid	B-X
spread	B-X
and	B-X
the	B-X
difficulty	B-X
of	B-X
their	B-X
treatment	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
they	B-X
are	B-X
associated	B-X
with	B-X
high	B-X
morbidity	B-X
,	B-X
mortality	B-X
and	B-X
high	B-X
economic	B-X
costs	B-X
.	B-X
There	B-X
are	B-X
multidrug-resistant	B-X
bacteria	B-X
,	B-X
both	B-X
Gram-positive	B-X
and	B-X
Gram-negative	B-X
,	B-X
including	B-X
Pseudomonas	B-X
aeruginosa	B-X
and	B-X
Acinetobacter	B-X
baumannii	B-X
resistant	B-X
to	B-X
carbapenems	B-X
,	B-X
enterobacteria	B-X
producing	B-X
carbapenemases	B-X
,	B-X
Staphylococcus	B-X
aureus	B-X
resistant	B-X
to	B-X
methicillin	B-X
and/or	B-X
with	B-X
intermediate	B-X
sensitivity	B-X
to	B-X
vancomycin	B-X
,	B-X
and	B-X
Enterococcus	B-X
faecium	B-X
(	B-X
and	B-X
less	B-X
frequently	B-X
Enterococcus	B-X
faecalis	B-X
)	B-X
resistant	B-X
to	B-X
vancomycin	B-X
.	B-X
This	B-X
review	B-X
will	B-X
comment	B-X
on	B-X
the	B-X
new	B-X
antibiotics	B-X
that	B-X
have	B-X
been	B-X
incorporated	B-X
into	B-X
the	B-X
therapeutic	B-X
arsenal	B-X
in	B-X
recent	B-X
years	B-X
,	B-X
as	B-X
well	B-X
as	B-X
other	B-X
promising	B-X
antibiotics	B-X
that	B-X
are	B-X
in	B-X
their	B-X
final	B-X
stages	B-X
of	B-X
development	B-X
.	B-X

Virulence	O
factors	O
<EOS>	B-X
Virulence	B-X
Factors	B-X
of	B-X
Enteric	B-X
Pathogenic	B-X
In	B-X
addition	B-X
to	B-X
continued	B-X
,	B-X
intense	B-X
efforts	B-X
in	B-X
understanding	B-X
bacterial	B-X
pathogenesis	B-X
of	B-X
P.	B-X
aeruginosa	B-X
including	B-X
virulence	B-X
factors	B-X
(	B-X
LPS	B-X
,	B-X
quorum	B-X
sensing	B-X
,	B-X
two-component	B-X
systems	B-X
,	B-X
6	B-X
type	B-X
secretion	B-X
systems	B-X
,	B-X
outer	B-X
membrane	B-X
vesicles	B-X
(	B-X
OMVs	B-X
)	B-X
,	B-X
CRISPR-Cas	B-X
and	B-X
their	B-X
regulation	B-X
)	B-X
,	B-X
rapid	B-X
progress	B-X
has	B-X
been	B-X
made	B-X
in	B-X
further	B-X
studying	B-X
host-pathogen	B-X
interaction	B-X
,	B-X
particularly	B-X
host	B-X
immune	B-X
networks	B-X
involving	B-X
autophagy	B-X
,	B-X
inflammasome	B-X
,	B-X
non-coding	B-X
RNAs	B-X
,	B-X
cGAS	B-X
,	B-X
etc	B-X
.	B-X
Nevertheless	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
uncovered	B-X
about	B-X
interactions	B-X
between	B-X
P.	B-X
aeruginosa	B-X
and	B-X
host	B-X
immune	B-X
responses	B-X
,	B-X
including	B-X
mechanisms	B-X
of	B-X
drug	B-X
resistance	B-X
by	B-X
known	B-X
or	B-X
unannotated	B-X
bacterial	B-X
virulence	B-X
factors	B-X
as	B-X
well	B-X
as	B-X
mammalian	B-X
cell	B-X
signaling	B-X
pathways	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
comprehensively	B-X
review	B-X
the	B-X
progress	B-X
and	B-X
discuss	B-X
the	B-X
current	B-X
status	B-X
of	B-X
P.	B-X
aeruginosa	B-X
biophysical	B-X
traits	B-X
,	B-X
behaviors	B-X
,	B-X
virulence	B-X
factors	B-X
,	B-X
invasive	B-X
regulators	B-X
,	B-X
and	B-X
host	B-X
defense	B-X
patterns	B-X
against	B-X
its	B-X
infection	B-X
,	B-X
which	B-X
point	B-X
out	B-X
new	B-X
directions	B-X
for	B-X
future	B-X
investigation	B-X
and	B-X
add	B-X
to	B-X
the	B-X
design	B-X
of	B-X
novel	B-X
and/or	B-X
alternative	B-X
therapeutics	B-X
to	B-X
combat	B-X
this	B-X
clinically	B-X
significant	B-X
pathogen	B-X
.	B-X

So	O
-	O
called	O
offensive	O
virulence	O
factors	O
actively	O
contribute	O
to	O
a	O
successful	O
infection	O
by	O
colonization	O
of	O
and	O
toxicity	O
towards	O
the	O
host	O
organism	O
.	O

We	O
compared	O
both	O
genomes	O
with	O
respect	O
to	O
genes	O
encoding	O
toxins	O
,	O
adhesins	O
or	O
invasines	O
that	O
are	O
common	O
to	O
both	O
pathogens	O
.	O
<EOS>	B-X
Colonization	B-X
,	B-X
Infection	B-X
,	B-X
and	B-X
the	B-X
Accessory	B-X
Genome	B-X
of	B-X
Although	B-X
C.	B-X
auris	B-X
belongs	B-X
to	B-X
the	B-X
CTG	B-X
clade	B-X
(	B-X
its	B-X
constituent	B-X
species	B-X
translate	B-X
the	B-X
CTG	B-X
codon	B-X
as	B-X
serine	B-X
instead	B-X
of	B-X
leucine	B-X
,	B-X
as	B-X
in	B-X
the	B-X
standard	B-X
code	B-X
)	B-X
,	B-X
C.	B-X
auris	B-X
is	B-X
a	B-X
haploid	B-X
fungal	B-X
species	B-X
that	B-X
is	B-X
more	B-X
closely	B-X
related	B-X
to	B-X
the	B-X
haploid	B-X
and	B-X
often	B-X
multidrug-resistant	B-X
species	B-X
Candida	B-X
haemulonii	B-X
and	B-X
Candida	B-X
lusitaniae	B-X
and	B-X
is	B-X
distantly	B-X
related	B-X
to	B-X
the	B-X
diploid	B-X
and	B-X
clinically	B-X
common	B-X
fungal	B-X
pathogens	B-X
Candida	B-X
albicans	B-X
and	B-X
Candida	B-X
tropicalis	B-X
.	B-X
Future	B-X
efforts	B-X
should	B-X
be	B-X
directed	B-X
toward	B-X
understanding	B-X
the	B-X
mechanistic	B-X
details	B-X
of	B-X
its	B-X
biology	B-X
,	B-X
epidemiology	B-X
,	B-X
antifungal	B-X
resistance	B-X
,	B-X
and	B-X
pathogenesis	B-X
with	B-X
a	B-X
goal	B-X
of	B-X
developing	B-X
novel	B-X
tools	B-X
and	B-X
methods	B-X
for	B-X
the	B-X
prevention	B-X
,	B-X
diagnosis	B-X
,	B-X
and	B-X
treatment	B-X
of	B-X
C.	B-X
auris	B-X
infections	B-X
.	B-X
Results	B-X
of	B-X
such	B-X
studies	B-X
are	B-X
expected	B-X
to	B-X
further	B-X
contribute	B-X
to	B-X
improve	B-X
the	B-X
fight	B-X
against	B-X
the	B-X
most	B-X
common	B-X
human	B-X
pathogenic	B-X
bacteria	B-X
.	B-X

All	O
virulence	O
factors	O
described	O
in	O
the	O
following	O
are	O
summarized	O
in	O
Fig	O
.	O

4	O
.	O
<EOS>	B-X
Effect	B-X
of	B-X
chloroquine	B-X
on	B-X
cultured	B-X
fibroblasts	B-X
:	B-X
release	B-X
of	B-X
lysosomal	B-X
hydrolases	B-X
and	B-X
inhibition	B-X
of	B-X
their	B-X
uptake	B-X
.	B-X

Toxins	O
Insecticidal	O
toxins	O
The	O
insecticidal	O
toxin	O
complex	O
(	O
Tc	O
)	O
proteins	O
were	O
first	O
purified	O
from	O
P	O
.	O
luminescens	O
[	O
61	O
]	O
.	O

Tc	O
homologues	O
have	O
also	O
been	O
described	O
to	O
be	O
present	O
in	O
Yersinia	O
spp	O
.	O
and	O
in	O
other	O
insect	O
-	O
associated	O
bacteria	O
such	O
as	O
Serratia	O
entomophila	O
and	O
Xenorhabdus	O
nematophilus	O
[	O
62	O
,	O
63	O
]	O
.	O

The	O
respective	O
genes	O
encoding	O
four	O
high	O
molecular	O
weight	O
toxin	O
complexes	O
are	O
termed	O
tca	O
,	O
tcb	O
,	O
tcc	O
and	O
tcd	O
.	O

Further	O
experiments	O
supported	O
the	O
hypothesis	O
that	O
TccC	B-Protein
-	O
like	O
proteins	O
might	O
act	O
as	O
universal	O
activators	O
of	O
,	O
or	O
chaperons	O
for	O
,	O
different	O
toxin	O
proteins	O
,	O
while	O
Tca	O
-	O
like	O
and	O
Tcd	O
-	O
like	O
proteins	O
contribute	O
predominantly	O
to	O
the	O
oral	O
toxicity	O
of	O
bacterial	O
supernatants	O
[	O
17	O
]	O
.	O

It	O
is	O
speculated	O
that	O
the	O
Tc	O
toxins	O
are	O
active	O
against	O
different	O
tissues	O
within	O
individual	O
hosts	O
,	O
namely	O
Tcb	O
against	O
hemocytes	O
and	O
Tcd	O
and	O
Tca	O
against	O
cells	O
of	O
the	O
insect	O
gut	O
.	O

In	O
Y	O
.	O
enterocolitica	O
,	O
the	O
insecticidal	O
toxin	O
genes	O
are	O
located	O
on	O
a	O
distinct	O
genomic	O
island	O
termed	O
tc	O
-	O
PAIYe	O
of	O
21	O
kb	O
,	O
and	O
are	O
low	O
-	O
temperature	O
induced	O
[	O
7	O
]	O
.	O

Similar	O
islands	O
in	O
which	O
regulatory	O
genes	O
are	O
followed	O
by	O
three	O
tca	O
genes	O
,	O
phage	O
-	O
related	O
genes	O
and	O
one	O
or	O
two	O
tccC	B-Protein
genes	O
,	O
are	O
present	O
in	O
the	O
genomes	O
of	O
Y	O
.	O
pseudotuberculosis	O
IP32953	O
and	O
Y	O
.	O
pestis	O
KIM	O
.	O

In	O
P	O
.	O
luminescens	O
,	O
the	O
insecticidal	O
genes	O
are	O
organized	O
in	O
the	O
tcd	O
island	O
harbouring	O
nine	O
tcd	O
-	O
and	O
tcc	O
-	O
like	O
genes	O
and	O
several	O
non	O
tc	O
-	O
like	O
genes	O
,	O
while	O
further	O
nine	O
tcc	O
-	O
like	O
genes	O
are	O
scattered	O
over	O
the	O
chromosome	O
[	O
24	O
]	O
.	O

The	O
reason	O
for	O
the	O
over	O
-	O
represence	O
of	O
tc	O
-	O
like	O
genes	O
in	O
the	O
P	O
.	O
luminescens	O
genome	O
might	O
reflect	O
the	O
different	O
strategies	O
followed	O
by	O
both	O
bacteria	O
within	O
insects	O
,	O
namely	O
the	O
rapid	O
killing	O
for	O
exploiting	O
the	O
victim	O
as	O
a	O
food	O
source	O
in	O
case	O
of	O
P	O
.	O
luminescens	O
,	O
and	O
infection	O
of	O
and	O
persistance	O
within	O
the	O
invertebrate	O
host	O
as	O
possibly	O
preferred	O
by	O
Y	O
.	O
enterocolitica	O
.	O

Hemolysins	O
or	O
hemagglutinin	O
-	O
related	O
proteins	O
<EOS>	B-X
Hemolysins	B-X
are	B-X
a	B-X
class	B-X
of	B-X
proteins	B-X
defined	B-X
by	B-X
their	B-X
ability	B-X
to	B-X
lyse	B-X
red	B-X
cells	B-X
but	B-X
have	B-X
been	B-X
described	B-X
to	B-X
exhibit	B-X
pleiotropic	B-X
functions	B-X
.	B-X
These	B-X
proteins	B-X
have	B-X
been	B-X
extensively	B-X
studied	B-X
in	B-X
bacteria	B-X
and	B-X
more	B-X
recently	B-X
in	B-X
fungi	B-X
.	B-X
Within	B-X
the	B-X
last	B-X
decade	B-X
,	B-X
a	B-X
number	B-X
of	B-X
studies	B-X
have	B-X
characterized	B-X
fungal	B-X
hemolysins	B-X
and	B-X
revealed	B-X
a	B-X
fascinating	B-X
yet	B-X
diverse	B-X
group	B-X
of	B-X
proteins	B-X
.	B-X
In	B-X
all	B-X
the	B-X
species	B-X
studied	B-X
so	B-X
far	B-X
,	B-X
hemolytic	B-X
activity	B-X
depends	B-X
on	B-X
proteins	B-X
which	B-X
possess	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
reactivity	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
some	B-X
analogies	B-X
with	B-X
vertebrate	B-X
lytic	B-X
molecules	B-X
it	B-X
is	B-X
conceivable	B-X
that	B-X
the	B-X
hemolysins	B-X
evolved	B-X
from	B-X
a	B-X
common	B-X
ancestral	B-X
gene	B-X
which	B-X
also	B-X
led	B-X
to	B-X
vertebrate	B-X
pore-forming	B-X
proteins	B-X
.	B-X

These	O
extracellular	O
toxins	O
target	O
red	O
blood	O
cells	O
to	O
provide	O
access	O
to	O
iron	O
,	O
but	O
often	O
show	O
activity	O
against	O
immune	O
cells	O
,	O
thus	O
contributing	O
to	O
the	O
bacterial	O
response	O
to	O
the	O
immune	O
system	O
of	O
hosts	O
,	O
including	O
phagocytosis	O
by	O
insect	O
blood	O
cells	O
[	O
64	O
]	O
.	O

Hemolysins	O
or	O
surface	O
-	O
associated	O
adhesins	O
,	O
together	O
with	O
their	O
transporters	O
,	O
are	O
sometimes	O
organized	O
as	O
two	O
-	O
partner	O
secretion	O
(	O
TPS	O
)	O
systems	O
,	O
a	O
specialized	O
mechanism	O
for	O
the	O
delivery	O
of	O
large	O
exoproteins	O
[	O
65	O
]	O
.	O
<EOS>	B-X
Hemolysins	B-X
are	B-X
a	B-X
class	B-X
of	B-X
proteins	B-X
defined	B-X
by	B-X
their	B-X
ability	B-X
to	B-X
lyse	B-X
red	B-X
cells	B-X
but	B-X
have	B-X
been	B-X
described	B-X
to	B-X
exhibit	B-X
pleiotropic	B-X
functions	B-X
.	B-X
The	B-X
hemolysins	B-X
of	B-X
Staphylococcus	B-X
aureus	B-X
.	B-X
beta-toxin	B-X
of	B-X
Clostridium	B-X
perfringens	B-X
,	B-X
hemolysin	B-X
II	B-X
and	B-X
cytotoxin	B-X
K	B-X
of	B-X
Bacillus	B-X
cereus	B-X
,	B-X
but	B-X
also	B-X
the	B-X
staphylococcal	B-X
bi-component	B-X
toxins	B-X
,	B-X
like	B-X
gamma-hemolysins	B-X
and	B-X
leucocidins	B-X
,	B-X
which	B-X
are	B-X
only	B-X
active	B-X
as	B-X
the	B-X
combination	B-X
of	B-X
two	B-X
similar	B-X
proteins	B-X
which	B-X
form	B-X
hetero-oligomers	B-X
.	B-X
This	B-X
article	B-X
reviews	B-X
the	B-X
literature	B-X
regarding	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
two	B-X
types	B-X
of	B-X
exotoxins	B-X
expressed	B-X
by	B-X
Staphylococcus	B-X
aureus	B-X
,	B-X
pyrogenic	B-X
toxin	B-X
superantigens	B-X
(	B-X
PTSAgs	B-X
)	B-X
and	B-X
hemolysins	B-X
.	B-X
The	B-X
molecular	B-X
basis	B-X
of	B-X
PTSAg	B-X
toxicity	B-X
is	B-X
presented	B-X
in	B-X
the	B-X
context	B-X
of	B-X
two	B-X
diseases	B-X
known	B-X
to	B-X
be	B-X
caused	B-X
by	B-X
these	B-X
exotoxins	B-X
:	B-X
toxic	B-X
shock	B-X
syndrome	B-X
and	B-X
staphylococcal	B-X
food	B-X
poisoning	B-X
.	B-X
A	B-X
detailed	B-X
review	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
the	B-X
toxicity	B-X
of	B-X
the	B-X
staphylococcal	B-X
hemolysins	B-X
is	B-X
also	B-X
presented	B-X
.	B-X

TPS	O
systems	O
have	O
been	O
characterized	O
mainly	O
in	O
pathogenic	O
bacteria	O
,	O
but	O
are	O
also	O
present	O
in	O
other	O
microorganisms	O
.	O

P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
TPS	O
systems	O
include	O
the	O
calcium	O
-	O
independent	O
hemolysin	O
PhlA	B-Protein
that	O
is	O
transported	O
through	O
the	O
outer	O
membrane	O
and	O
activated	O
by	O
PhlB	B-Protein
.	O

Remarkably	O
,	O
their	O
expression	O
is	O
induced	O
by	O
low	O
iron	O
concentration	O
as	O
encountered	O
in	O
the	O
insect	O
host	O
,	O
and	O
phlA	B-Protein
/	O
phlB	B-Protein
are	O
up	O
-	O
regulated	O
at	O
18degreesC	O
compared	O
to	O
28degreesC	O
in	O
Y	O
.	O
ruckeri	O
[	O
66	O
]	O
.	O

Eight	O
other	O
TPS	O
systems	O
are	O
present	O
in	O
P	O
.	O
luminescens	O
,	O
namely	O
Plu0225	B-Protein
/	O
Plu0226	B-Protein
,	O
Plu0548	B-Protein
/	O
Plu0549	B-Protein
,	O
Plu1149	B-Protein
/	O
Plu1150	B-Protein
,	O
Plu1367	B-Protein
/	O
Plu1368	B-Protein
,	O
Plu3064	B-Protein
/	O
Plu3065	B-Protein
,	O
Plu3125	B-Protein
-	O
3127	B-Protein
/	O
3128	B-Protein
,	O
Plu3667	B-Protein
/	O
Plu3668	B-Protein
,	O
and	O
Plu3718	B-Protein
/	O
Plu3719	B-Protein
,	O
and	O
further	O
three	O
genes	O
for	O
which	O
the	O
partner	O
locus	O
has	O
not	O
been	O
identified	O
(	O
Fig	O
.	O
4	O
)	O
.	O

In	O
the	O
genome	O
of	O
Y	O
.	O
enterocolitica	O
,	O
only	O
three	O
complete	O
TPS	O
systems	O
are	O
present	O
,	O
namely	O
YE0479	B-Protein
/	O
YE0480	B-Protein
,	O
YE2407	B-Protein
/	O
YE2408	B-Protein
,	O
(	O
YE4084	B-Protein
)	O
YE4085	B-Protein
/	O
YE4086	B-Protein
,	O
and	O
YE3454	B-Protein
which	O
lacks	O
the	O
activator	O
partner	O
.	O

Except	O
YE0479	B-Protein
/	O
YE0480	B-Protein
,	O
all	O
have	O
counterparts	O
in	O
the	O
P	O
.	O
luminescens	O
genome	O
.	O

Recently	O
,	O
we	O
have	O
shown	O
that	O
a	O
luciferase	O
reporter	O
insertion	O
into	O
YE0480	B-Protein
is	O
induced	O
at	O
low	O
temperature	O
[	O
67	O
]	O
,	O
indicating	O
that	O
this	O
TPS	O
system	O
might	O
contribute	O
to	O
insect	O
pathogenicity	O
and	O
possibly	O
to	O
the	O
host	O
-	O
specificity	O
of	O
Y	O
.	O
enterocolitica	O
.	O

The	O
genomes	O
of	O
both	O
pathogens	O
also	O
carry	O
three	O
and	O
five	O
,	O
respectively	O
,	O
further	O
hemolysin	O
/	O
hemagglutinin	O
-	O
related	O
proteins	O
which	O
are	O
absent	O
in	O
the	O
other	O
pathogen	O
(	O
Fig	O
.	O
4	O
)	O
.	O

FhaC	B-Protein
which	O
belongs	O
to	O
a	O
family	O
of	O
hemolysin	O
activator	O
proteins	O
related	O
to	O
ShlA	B-Protein
from	O
Serratia	O
marcescens	O
is	O
present	O
in	O
both	O
pathogens	O
and	O
also	O
induced	O
at	O
low	O
temperature	O
[	O
67	O
]	O
.	O

The	O
genome	O
sequence	O
of	O
P	O
.	O
luminescens	O
exhibits	O
more	O
toxin	O
genes	O
than	O
found	O
in	O
any	O
other	O
bacterial	O
genome	O
sequenced	O
yet	O
,	O
including	O
the	O
genome	O
of	O
Y	O
.	O
enterocolitica	O
.	O

Hemolysin	O
-	O
related	O
factors	O
and	O
their	O
transporters	O
discussed	O
above	O
are	O
an	O
example	O
for	O
this	O
redundancy	O
.	O

However	O
,	O
the	O
majority	O
of	O
these	O
P	O
.	O
luminescens	O
toxins	O
exhibit	O
highly	O
significant	O
similarities	O
to	O
those	O
of	O
Y	O
.	O
enterocolitica	O
,	O
suggesting	O
common	O
progenitors	O
of	O
hemolysins	O
.	O

It	O
is	O
therefore	O
tempting	O
to	O
speculate	O
that	O
hemolytic	O
activities	O
of	O
bacteria	O
had	O
been	O
evolved	O
during	O
the	O
association	O
with	O
insects	O
and	O
then	O
adapted	O
to	O
mammalian	O
hosts	O
.	O

Although	O
it	O
can	O
not	O
be	O
excluded	O
that	O
the	O
hemolysins	O
of	O
Y	O
.	O
enterocolitica	O
act	O
on	O
the	O
immune	O
systems	O
of	O
both	O
the	O
insect	O
and	O
the	O
mammalian	O
host	O
,	O
the	O
genetic	O
overlap	O
of	O
this	O
group	O
of	O
virulence	O
factor	O
between	O
both	O
pathogens	O
,	O
and	O
the	O
low	O
-	O
temperature	O
expression	O
of	O
YE0479	B-Protein
/	O
YE0480	B-Protein
and	O
fhaC	B-Protein
,	O
indicates	O
the	O
presence	O
of	O
insect	O
-	O
specific	O
hemolysins	O
in	O
the	O
genome	O
of	O
Y	O
.	O
enterocolitica	O
.	O

Repeats	O
-	O
in	O
-	O
toxin	O
(	O
RTX	O
)	O
and	O
other	O
toxins	O
<EOS>	B-X
The	B-X
Repeats-in-Toxins	B-X
(	B-X
RTX	B-X
)	B-X
family	B-X
of	B-X
proteins	B-X
classically	B-X
consists	B-X
of	B-X
cytolysins	B-X
and	B-X
hemolysins	B-X
.	B-X
These	B-X
are	B-X
all	B-X
repetitive	B-X
proteins	B-X
ranging	B-X
in	B-X
size	B-X
from	B-X
200	B-X
to	B-X
900	B-X
kDa	B-X
that	B-X
function	B-X
as	B-X
toxins	B-X
or	B-X
adhesins	B-X
.	B-X
One	B-X
major	B-X
new	B-X
subfamily	B-X
is	B-X
the	B-X
large	B-X
repetitive	B-X
RTX	B-X
adhesins	B-X
and	B-X
biofilm-associated	B-X
proteins	B-X
.	B-X
The	B-X
second	B-X
major	B-X
new	B-X
subfamily	B-X
is	B-X
the	B-X
multifunctional-autoprocessing	B-X
RTX	B-X
toxins	B-X
,	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
cytotoxicity	B-X
and	B-X
pathogenesis	B-X
.	B-X
These	B-X
proteins	B-X
are	B-X
in	B-X
turn	B-X
distantly	B-X
related	B-X
to	B-X
Yersinia	B-X
hypothetical	B-X
RTX	B-X
proteins	B-X
that	B-X
may	B-X
autoprocess	B-X
by	B-X
a	B-X
similar	B-X
mechanism	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
current	B-X
knowledge	B-X
regarding	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
these	B-X
new	B-X
subfamilies	B-X
of	B-X
RTX	B-X
proteins	B-X
.	B-X

RTX	O
proteins	O
constitute	O
another	O
family	O
of	O
toxins	O
that	O
may	O
contribute	O
to	O
the	O
insecticidal	O
activity	O
of	O
the	O
two	O
pathogens	O
.	O

A	O
putative	O
RTX	O
-	O
family	O
toxin	O
transporter	O
is	O
common	O
to	O
both	O
pathogens	O
(	O
YE1998	B-Protein
-	O
2000	B-Protein
,	O
Plu0634	B-Protein
/	O
Plu0635	B-Protein
)	O
.	O

The	O
P	O
.	O
luminescens	O
genome	O
comprises	O
a	O
gene	O
cluster	O
encoding	O
RTX	O
proteins	O
,	O
namely	O
plu1330	B-Protein
-	O
1369	B-Protein
.	O

Further	O
RTX	O
toxins	O
are	O
encoded	O
by	O
plu3217	B-Protein
,	O
plu3324	B-Protein
(	O
both	O
RTX	O
A	O
-	O
family	O
)	O
,	O
plu4117	B-Protein
(	O
own	O
family	O
)	O
,	O
and	O
plu3668	B-Protein
(	O
RTX	O
cytotoxin	O
)	O
,	O
none	O
of	O
which	O
is	O
present	O
in	O
Y	O
.	O
enterocolitica	O
.	O

This	O
pathogen	O
produces	O
only	O
one	O
RTX	O
protein	O
(	O
YE1322	B-Protein
)	O
for	O
which	O
a	O
truncated	O
homologue	O
is	O
found	O
in	O
P	O
.	O
luminescens	O
(	O
Plu3209	B-Protein
)	O
.	O

Other	O
examples	O
of	O
toxins	O
common	O
for	O
both	O
bacterial	O
species	O
compared	O
here	O
are	O
homologues	O
of	O
XaxAB	B-Protein
,	O
an	O
apoptotic	O
AB	O
toxin	O
of	O
X	O
.	O
nematophila	O
[	O
68	O
]	O
,	O
and	O
proteins	O
encoded	O
by	O
the	O
macrophage	O
toxin	O
(	O
mt	O
)	O
-	O
like	O
genes	O
Plu2288	B-Protein
and	O
Plu0359	B-Protein
with	O
high	O
similarity	O
to	O
YE2685	B-Protein
.	O
cnf	O
encoding	O
the	O
cytonecrosis	O
factor	O
-	O
like	O
toxin	O
is	O
present	O
in	O
Y	O
.	O
enterocolitica	O
(	O
YE2091	B-Protein
)	O
and	O
P	O
.	O
luminescens	O
ssp	O
.	O
akhurstii	O
strain	O
W14	O
,	O
but	O
not	O
in	O
P	O
.	O
luminescens	O
ssp	O
.	O
laumondii	O
strain	O
TT01	O
(	O
Fig	O
.	O
4	O
)	O
.	O

P	O
.	O
luminescens	O
produces	O
a	O
series	O
of	O
proteins	O
similar	O
to	O
toxins	O
that	O
have	O
been	O
identified	O
in	O
other	O
bacteria	O
,	O
but	O
are	O
absent	O
in	O
Y	O
.	O
enterocolitica	O
.	O

Examples	O
identified	O
are	O
Txp40	B-Protein
,	O
a	O
40	O
kD	O
insecticidal	O
toxin	O
[	O
69	O
]	O
,	O
the	O
nematicidal	O
toxin	O
(	O
Xnp2	B-Protein
)	O
first	O
described	O
in	O
X	O
.	O
bovienii	O
(	O
accession	O
number	O
AJ296651	O
.	O
1	O
)	O
,	O
galA	B-Protein
(	O
plu0840	B-Protein
)	O
similar	O
to	O
the	O
enterotoxin	O
Ast	O
of	O
Aeromonas	O
hydrophila	O
which	O
is	O
involved	O
in	O
carbohydrate	O
transport	O
and	O
metabolism	O
[	O
70	O
]	O
,	O
and	O
two	O
dermonecrotizing	O
toxin	O
-	O
(	O
dnt	O
-	O
)	O
like	O
factors	O
(	O
plu2400	B-Protein
and	O
plu2420	B-Protein
)	O
.	O

In	O
addition	O
,	O
neither	O
the	O
crystal	O
proteins	O
encoded	O
by	O
cipA	B-Protein
and	O
cipB	B-Protein
in	O
P	O
.	O
luminescens	O
nor	O
a	O
Bt	O
-	O
like	O
toxin	O
(	O
plu1537	B-Protein
)	O
could	O
be	O
found	O
in	O
Y	O
.	O
enterocolitica	O
.	O

A	O
cytonecrosis	O
factor	O
(	O
CNF	O
)	O
-	O
like	O
protein	O
,	O
Pnf	B-Protein
,	O
was	O
identified	O
in	O
P	O
.	O
luminescens	O
ssp	O
.	O
akhurstii	O
strain	O
W14	O
,	O
but	O
not	O
in	O
P	O
.	O
luminescens	O
ssp	O
.	O
laumondii	O
strain	O
TT01	O
.	O

In	O
P	O
.	O
luminescens	O
,	O
the	O
two	O
paralogs	O
plu4092	B-Protein
and	O
plu4436	B-Protein
encode	O
juvenile	O
hormone	O
esterases	O
(	O
JHE	O
)	O
for	O
which	O
insect	O
toxicity	O
has	O
already	O
been	O
demonstrated	O
[	O
24	O
]	O
.	O

Additionally	O
,	O
neither	O
the	O
locus	O
mcf	O
that	O
confers	O
insecticidal	O
activity	O
of	O
P	O
.	O
luminescens	O
towards	O
M	O
.	O
sexta	O
[	O
71	O
]	O
by	O
inducing	O
apoptosis	O
[	O
72	O
]	O
,	O
nor	O
the	O
homologous	O
gene	O
locus	O
mcf2	B-Protein
(	O
plu3128	B-Protein
)	O
[	O
73	O
]	O
are	O
present	O
in	O
the	O
genome	O
of	O
Y	O
.	O
enterocolitica	O
.	O

Most	O
of	O
these	O
toxins	O
probably	O
contribute	O
to	O
the	O
higher	O
insect	O
toxicity	O
of	O
P	O
.	O
luminescens	O
against	O
the	O
tobacco	O
hornworm	O
in	O
comparison	O
with	O
Y	O
.	O
enterocolitica	O
.	O

No	O
homologues	O
of	O
the	O
Y	O
.	O
pestis	O
gene	O
coding	O
for	O
enhancin	O
(	O
YPO0339	B-Protein
)	O
could	O
be	O
found	O
for	O
which	O
a	O
role	O
in	O
flea	O
colonization	O
was	O
predicted	O
[	O
74	O
]	O
.	O

We	O
also	O
identified	O
several	O
virulence	O
genes	O
and	O
operons	O
that	O
are	O
present	O
in	O
Y	O
.	O
enterocolitica	O
,	O
but	O
not	O
in	O
P	O
.	O
luminescens	O
,	O
suggesting	O
that	O
they	O
have	O
been	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
from	O
other	O
bacteria	O
and	O
do	O
not	O
play	O
a	O
role	O
in	O
bacteria	O
-	O
insect	O
association	O
.	O

Examples	O
are	O
SopB	B-Protein
,	O
a	O
host	O
cell	O
invasion	O
factor	O
translocated	O
via	O
the	O
type	O
-	O
III	O
secretion	O
system	O
that	O
is	O
present	O
in	O
the	O
emerging	O
human	O
pathogen	O
P	O
.	O
asymbiotica	O
,	O
but	O
not	O
in	O
the	O
insect	O
pathogen	O
P	O
.	O
luminescens	O
[	O
14	O
]	O
,	O
a	O
putative	O
effector	O
protein	O
(	O
YE2447	B-Protein
)	O
with	O
proteolytic	O
activity	O
,	O
and	O
a	O
homologue	O
of	O
SrfA	B-Protein
which	O
is	O
negatively	O
regulated	O
by	O
PhoP	B-Protein
in	O
S	O
.	O
typhimurium	O
[	O
75	O
]	O
.	O

The	O
SrfA	B-Protein
homologue	O
has	O
been	O
demonstrated	O
to	O
be	O
up	O
-	O
regulated	O
by	O
environmental	O
temperature	O
[	O
67	O
]	O
.	O

Other	O
virulence	O
factors	O
absent	O
in	O
P	O
.	O
luminescens	O
are	O
the	O
opg	O
cluster	O
(	O
YE1604	B-Protein
-	O
1606	B-Protein
)	O
and	O
ProP	B-Protein
(	O
YE3594	B-Protein
)	O
,	O
both	O
involved	O
in	O
osmoprotection	O
[	O
76	O
]	O
,	O
cellulose	O
biosynthesis	O
(	O
YE4072	B-Protein
-	O
4078	B-Protein
)	O
associated	O
with	O
protection	O
from	O
chemical	O
and	O
mechanical	O
stress	O
[	O
60	O
]	O
,	O
the	O
methionine	O
-	O
salvage	O
pathway	O
(	O
YE3228	B-Protein
-	O
3235	B-Protein
)	O
also	O
involved	O
in	O
AHL	O
production	O
[	O
23	O
]	O
,	O
the	O
putative	O
ADP	O
-	O
ribosyltransferase	O
toxin	O
encoded	O
by	O
ytxAB	B-Protein
(	O
ye2124	B-Protein
/	O
ye2123	B-Protein
)	O
[	O
77	O
]	O
,	O
and	O
the	O
Yersinia	O
heat	O
-	O
stable	O
toxin	O
Yst	O
[	O
78	O
]	O
which	O
is	O
stronger	O
expressed	O
at	O
28degreesC	O
than	O
at	O
37degreesC	O
(	O
Table	O
1	O
)	O
.	O

Summarizing	O
,	O
the	O
large	O
variety	O
of	O
diverse	O
toxins	O
present	O
in	O
P	O
.	O
luminescens	O
,	O
but	O
absent	O
in	O
Y	O
.	O
enterocolitica	O
,	O
might	O
contribute	O
to	O
the	O
higher	O
toxicity	O
towards	O
insects	O
of	O
P	O
.	O
luminescens	O
in	O
comparison	O
to	O
Y	O
.	O
enterocolitica	O
.	O

Toxins	O
only	O
present	O
in	O
Y	O
.	O
enterocolitica	O
are	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
its	O
pathogenicity	O
towards	O
mammalians	O
,	O
and	O
some	O
of	O
them	O
might	O
have	O
been	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
.	O

Examples	O
of	O
those	O
factors	O
are	O
shown	O
in	O
Fig	O
.	O
<EOS>	B-X
A	B-X
factor	B-X
extrinsic	B-X
to	B-X
the	B-X
insulin	B-X
receptor	B-X
,	B-X
presumably	B-X
a	B-X
serine/threonine	B-X
kinase	B-X
,	B-X
causes	B-X
this	B-X
abnormality	B-X
and	B-X
is	B-X
an	B-X
example	B-X
of	B-X
an	B-X
important	B-X
new	B-X
mechanism	B-X
for	B-X
human	B-X
insulin	B-X
resistance	B-X
related	B-X
to	B-X
factors	B-X
controlling	B-X
insulin	B-X
receptor	B-X
signaling	B-X
.	B-X
It	B-X
is	B-X
thus	B-X
possible	B-X
that	B-X
a	B-X
single	B-X
defect	B-X
produces	B-X
both	B-X
the	B-X
insulin	B-X
resistance	B-X
and	B-X
the	B-X
hyperandrogenism	B-X
in	B-X
some	B-X
PCOS	B-X
women	B-X
(	B-X
Fig	B-X
.	B-X
The	B-X
purpose	B-X
high	B-X
performance	B-X
liquid	B-X
chromatography	B-X
(	B-X
HPLC	B-X
)	B-X
analysis	B-X
of	B-X
any	B-X
drugs	B-X
is	B-X
to	B-X
confirm	B-X
the	B-X
identity	B-X
of	B-X
a	B-X
drug	B-X
and	B-X
provide	B-X
quantitative	B-X
results	B-X
and	B-X
also	B-X
to	B-X
monitor	B-X
the	B-X
progress	B-X
of	B-X
the	B-X
therapy	B-X
of	B-X
a	B-X
disease.1	B-X
)	B-X
Measuring	B-X
presented	B-X
on	B-X
the	B-X
Fig	B-X
.	B-X
The	B-X
three	B-X
classes	B-X
of	B-X
CCK	B-X
antagonists	B-X
illustrate	B-X
the	B-X
various	B-X
factors	B-X
governing	B-X
affinity	B-X
of	B-X
the	B-X
antagonists	B-X
for	B-X
the	B-X
CCK	B-X
receptor	B-X
.	B-X
The	B-X
most	B-X
potent	B-X
CCK	B-X
antagonist	B-X
in	B-X
each	B-X
of	B-X
the	B-X
three	B-X
classes	B-X
is	B-X
illustrated	B-X
in	B-X
Fig	B-X
.	B-X

5	O
.	O
<EOS>	B-X
Atomic	B-X
models	B-X
for	B-X
the	B-X
polypeptide	B-X
backbones	B-X
of	B-X
myohemerythrin	B-X
and	B-X
hemerythrin	B-X
.	B-X

Adhesins	O
and	O
invasins	O
<EOS>	B-X
Pathogens	B-X
utilize	B-X
surface-located	B-X
adhesins/invasins	B-X
for	B-X
specific	B-X
interaction	B-X
with	B-X
host	B-X
cell	B-X
receptors	B-X
.	B-X
The	B-X
three-dimensional	B-X
structures	B-X
of	B-X
a	B-X
number	B-X
of	B-X
adhesins/invasins	B-X
show	B-X
that	B-X
many	B-X
are	B-X
elongated	B-X
molecules	B-X
containing	B-X
domains	B-X
commonly	B-X
found	B-X
in	B-X
eukaryotic	B-X
proteins	B-X
.	B-X
Staphylococcus	B-X
aureus	B-X
pathogenesis	B-X
:	B-X
secretion	B-X
systems	B-X
,	B-X
adhesins	B-X
,	B-X
and	B-X
invasins	B-X
.	B-X
However	B-X
,	B-X
in	B-X
recent	B-X
years	B-X
,	B-X
some	B-X
cell-surface	B-X
adhesins	B-X
and	B-X
invasins	B-X
of	B-X
Gram-positive	B-X
bacteria	B-X
have	B-X
been	B-X
described	B-X
that	B-X
do	B-X
not	B-X
possess	B-X
a	B-X
signal	B-X
sequence	B-X
or	B-X
a	B-X
membrane	B-X
anchor	B-X
.	B-X
These	B-X
anchorless	B-X
but	B-X
surface-located	B-X
adhesins	B-X
and	B-X
invasins	B-X
represent	B-X
a	B-X
new	B-X
class	B-X
of	B-X
virulence	B-X
factors	B-X
.	B-X

Colonization	O
and	O
penetration	O
of	O
epithelial	O
cells	O
,	O
and	O
interaction	O
with	O
immune	O
cells	O
,	O
are	O
key	O
steps	O
during	O
the	O
host	O
infection	O
by	O
pathogens	O
.	O
<EOS>	B-X
Streptococci	B-X
are	B-X
common	B-X
human	B-X
pathogens	B-X
,	B-X
colonizing	B-X
multiple	B-X
parts	B-X
of	B-X
the	B-X
human	B-X
body	B-X
such	B-X
as	B-X
the	B-X
upper	B-X
respiratory	B-X
tract	B-X
,	B-X
urethra	B-X
,	B-X
gastrointestinal	B-X
tract	B-X
,	B-X
and	B-X
oral	B-X
cavity	B-X
.	B-X
Since	B-X
they	B-X
cause	B-X
a	B-X
variety	B-X
of	B-X
serious	B-X
infections	B-X
including	B-X
heart	B-X
diseases	B-X
,	B-X
meningitis	B-X
,	B-X
and	B-X
oral	B-X
diseases	B-X
,	B-X
streptococci	B-X
are	B-X
considered	B-X
to	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
human	B-X
diseases	B-X
.	B-X
Two	B-X
critical	B-X
steps	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
streptococcal	B-X
infection	B-X
are	B-X
the	B-X
adhesion	B-X
to	B-X
and	B-X
invasion	B-X
of	B-X
host	B-X
cells	B-X
.	B-X
This	B-X
invasion	B-X
is	B-X
a	B-X
strategy	B-X
of	B-X
streptococci	B-X
to	B-X
evade	B-X
the	B-X
host	B-X
immune	B-X
response	B-X
and	B-X
antibiotic	B-X
therapy	B-X
,	B-X
as	B-X
well	B-X
as	B-X
to	B-X
penetrate	B-X
to	B-X
deeper	B-X
tissues	B-X
.	B-X
To	B-X
establish	B-X
interaction	B-X
between	B-X
bacteria	B-X
and	B-X
host	B-X
cells	B-X
,	B-X
adhesion	B-X
is	B-X
the	B-X
initial	B-X
step	B-X
.	B-X
To	B-X
effectively	B-X
adhere	B-X
to	B-X
host	B-X
cells	B-X
,	B-X
streptococci	B-X
express	B-X
multiple	B-X
adhesins	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
different	B-X
adhesins	B-X
may	B-X
lead	B-X
to	B-X
distinct	B-X
mechanisms	B-X
of	B-X
subsequent	B-X
invasion	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
streptococcal	B-X
molecules	B-X
to	B-X
host	B-X
proteins	B-X
triggers	B-X
downstream	B-X
signal	B-X
transduction	B-X
in	B-X
the	B-X
host	B-X
cells	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
uptake	B-X
of	B-X
bacteria	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
present	B-X
the	B-X
adhesion	B-X
and	B-X
invasion	B-X
mechanisms	B-X
of	B-X
different	B-X
streptococci	B-X
and	B-X
the	B-X
interaction	B-X
with	B-X
host	B-X
cells	B-X
leading	B-X
to	B-X
internalization	B-X
.	B-X

Many	O
of	O
the	O
pathogen	O
-	O
receptor	O
molecules	O
such	O
as	O
Toll	O
-	O
like	O
receptors	O
or	O
integrins	O
are	O
conserved	O
between	O
invertebrates	O
and	O
mammalians	O
[	O
79	O
]	O
.	O
<EOS>	B-X
Macrophages	B-X
and	B-X
dendritic	B-X
cells	B-X
play	B-X
a	B-X
leading	B-X
role	B-X
in	B-X
innate	B-X
immunity	B-X
,	B-X
using	B-X
pattern	B-X
recognition	B-X
receptors	B-X
(	B-X
PRRs	B-X
)	B-X
to	B-X
sense	B-X
both	B-X
pathogen	B-X
invasion	B-X
and	B-X
danger	B-X
signals	B-X
.	B-X
Among	B-X
these	B-X
PRRs	B-X
,	B-X
the	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
the	B-X
immune	B-X
response	B-X
by	B-X
recognizing	B-X
not	B-X
only	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
from	B-X
bacteria	B-X
and	B-X
viruses	B-X
but	B-X
also	B-X
damage-associated	B-X
molecular	B-X
patterns	B-X
from	B-X
dying	B-X
or	B-X
injured	B-X
cells	B-X
.	B-X
These	B-X
TLR	B-X
family	B-X
molecules	B-X
facilitate	B-X
not	B-X
only	B-X
the	B-X
elimination	B-X
of	B-X
pathogens	B-X
but	B-X
also	B-X
the	B-X
development	B-X
of	B-X
various	B-X
disorders	B-X
,	B-X
including	B-X
arteriosclerosis	B-X
,	B-X
cancer	B-X
,	B-X
and	B-X
metabolic	B-X
syndrome	B-X
.	B-X
TLRs	B-X
activate	B-X
signaling	B-X
pathways	B-X
that	B-X
result	B-X
in	B-X
the	B-X
production	B-X
of	B-X
cytokines	B-X
,	B-X
chemokines	B-X
,	B-X
and	B-X
various	B-X
inducible	B-X
molecules	B-X
associated	B-X
with	B-X
the	B-X
immune	B-X
response	B-X
.	B-X

We	O
therefore	O
investigated	O
if	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
that	O
interact	O
with	O
the	O
midgut	O
of	O
diverse	O
hosts	O
use	O
the	O
same	O
adhesion	O
and	O
invasive	O
factors	O
.	O

The	O
most	O
prominent	O
protein	O
of	O
Y	O
.	O
enterocolitica	O
involved	O
in	O
attachment	O
to	O
and	O
invasion	O
of	O
mammalian	O
cells	O
is	O
Ail	B-Protein
(	O
YE1820	B-Protein
)	O
that	O
is	O
homologue	O
to	O
three	O
P	O
.	O
luminescens	O
proteins	O
encoded	O
by	O
plu2481	B-Protein
,	O
plu2480	B-Protein
,	O
and	O
plu1967	B-Protein
,	O
and	O
InvA	B-Protein
(	O
YE2564	B-Protein
)	O
with	O
high	O
similarity	O
to	O
Plu2057	B-Protein
.	O

Further	O
invasin	O
genes	O
of	O
Y	O
.	O
enterocolitica	O
with	O
counterparts	O
in	O
P	O
.	O
luminescens	O
are	O
ysaV	B-Protein
(	O
ye3546	B-Protein
/	O
plu3761	B-Protein
)	O
and	O
invF	B-Protein
(	O
ye3549	B-Protein
/	O
plu3775	B-Protein
)	O
.	O

Y	O
.	O
enterocolitica	O
genes	O
not	O
present	O
in	O
P	O
.	O
luminescens	O
are	O
ye1873	B-Protein
encoding	O
the	O
adhesin	O
YadA	B-Protein
which	O
is	O
maximally	O
expressed	O
at	O
37degreesC	O
,	O
and	O
the	O
invasin	O
genes	O
invE	B-Protein
,	O
ysaH	B-Protein
,	O
ye3550	B-Protein
,	O
and	O
ye3555	B-Protein
.	O
<EOS>	B-X
The	B-X
Most	B-X
Important	B-X
Virulence	B-X
Markers	B-X
of	B-X
Toxigenic	B-X
Properties	B-X
of	B-X
During	B-X
infections	B-X
of	B-X
the	B-X
intestinal	B-X
tract	B-X
Yersinia	B-X
pseudotuberculosis	B-X
penetrates	B-X
the	B-X
epithelial	B-X
cell	B-X
layer	B-X
through	B-X
M-cells	B-X
into	B-X
the	B-X
Peyer	B-X
's	B-X
patches	B-X
.	B-X
This	B-X
early	B-X
step	B-X
in	B-X
the	B-X
infection	B-X
process	B-X
is	B-X
primarily	B-X
mediated	B-X
by	B-X
the	B-X
outer	B-X
membrane	B-X
protein	B-X
invasin	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
invasin	B-X
gene	B-X
is	B-X
activated	B-X
by	B-X
the	B-X
MarR-type	B-X
regulatory	B-X
protein	B-X
RovA	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
conditions	B-X
,	B-X
including	B-X
temperature	B-X
and	B-X
growth	B-X
phase	B-X
.	B-X
In	B-X
order	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
nature	B-X
of	B-X
the	B-X
underlying	B-X
control	B-X
systems	B-X
,	B-X
mutagenesis	B-X
and	B-X
gene	B-X
bank	B-X
screens	B-X
were	B-X
used	B-X
to	B-X
identify	B-X
regula	B-X
components	B-X
modulating	B-X
the	B-X
levels	B-X
of	B-X
invasin	B-X
and	B-X
RovA	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inv	B-X
and	B-X
rovA	B-X
genes	B-X
were	B-X
both	B-X
subjected	B-X
to	B-X
silencing	B-X
by	B-X
the	B-X
nucleoid-associated	B-X
protein	B-X
H-NS	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
LysR-type	B-X
regulatory	B-X
protein	B-X
,	B-X
RovM	B-X
with	B-X
homology	B-X
to	B-X
HexA/PecT	B-X
of	B-X
phytopathogenic	B-X
Erwinia	B-X
species	B-X
was	B-X
shown	B-X
to	B-X
interact	B-X
specifically	B-X
with	B-X
the	B-X
rovA	B-X
regulatory	B-X
region	B-X
and	B-X
represses	B-X
rovA	B-X
transcription	B-X
in	B-X
addition	B-X
to	B-X
H-NS	B-X
.	B-X

The	O
function	O
of	O
the	O
latter	O
two	O
in	O
cell	O
recognition	O
is	O
predicted	O
,	O
but	O
has	O
not	O
yet	O
been	O
demonstrated	O
experimentally	O
.	O
<EOS>	B-X
Intron	B-X
removal	B-X
during	B-X
pre-mRNA	B-X
splicing	B-X
in	B-X
higher	B-X
eukaryotes	B-X
requires	B-X
the	B-X
accurate	B-X
identification	B-X
of	B-X
the	B-X
two	B-X
splice	B-X
sites	B-X
at	B-X
the	B-X
ends	B-X
of	B-X
the	B-X
exons	B-X
,	B-X
or	B-X
exon	B-X
definition	B-X
.	B-X
Additional	B-X
information	B-X
used	B-X
for	B-X
exon	B-X
recognition	B-X
resides	B-X
in	B-X
a	B-X
large	B-X
number	B-X
of	B-X
positively	B-X
or	B-X
negatively	B-X
acting	B-X
elements	B-X
that	B-X
lie	B-X
both	B-X
within	B-X
exons	B-X
and	B-X
in	B-X
the	B-X
adjacent	B-X
introns	B-X
.	B-X
These	B-X
motifs	B-X
have	B-X
been	B-X
identified	B-X
both	B-X
by	B-X
empirical	B-X
experiments	B-X
and	B-X
by	B-X
computational	B-X
predictions	B-X
,	B-X
the	B-X
validity	B-X
of	B-X
the	B-X
latter	B-X
being	B-X
confirmed	B-X
by	B-X
experimental	B-X
verification	B-X
.	B-X
These	B-X
various	B-X
methods	B-X
have	B-X
sought	B-X
to	B-X
provide	B-X
global	B-X
definitions	B-X
of	B-X
motifs	B-X
,	B-X
yet	B-X
the	B-X
motifs	B-X
are	B-X
distinctive	B-X
to	B-X
the	B-X
method	B-X
used	B-X
for	B-X
identification	B-X
and	B-X
display	B-X
little	B-X
overlap	B-X
.	B-X
A	B-X
present	B-X
challenge	B-X
lies	B-X
in	B-X
understanding	B-X
how	B-X
the	B-X
cell	B-X
integrates	B-X
this	B-X
surfeit	B-X
of	B-X
information	B-X
to	B-X
generate	B-X
what	B-X
is	B-X
usually	B-X
a	B-X
binary	B-X
splicing	B-X
decision	B-X
.	B-X

In	O
contrast	O
,	O
P	O
.	O
luminescens	O
produces	O
several	O
factors	O
involved	O
in	O
host	O
cell	O
interaction	O
without	O
homologues	O
in	O
Y	O
.	O
enterocolitica	O
,	O
namely	O
Plu2096	B-Protein
which	O
is	O
similar	O
to	O
lectin	B-Protein
PA	B-Protein
-	I-Protein
I	I-Protein
,	O
Plu1561	B-Protein
with	O
strong	O
homology	O
to	O
a	O
Ca2	O
+	O
dependent	O
adhesion	O
molecule	O
,	O
the	O
adhesin	O
Plu2433	B-Protein
similar	O
to	O
a	O
virulence	O
factor	O
of	O
the	O
Gram	O
-	O
negative	O
plant	O
pathogen	O
Erwinia	O
carotovora	O
,	O
EvF	B-Protein
,	O
which	O
is	O
involved	O
in	O
colonisation	O
of	O
the	O
D	O
.	O
melanogaster	O
gut	O
epithelium	O
[	O
80	O
]	O
,	O
and	O
the	O
putative	O
invasin	O
Plu2064	B-Protein
.	O

In	O
P	O
.	O
luminescens	O
,	O
eleven	O
fimbrial	O
gene	O
cluster	O
have	O
been	O
identified	O
,	O
four	O
of	O
which	O
(	O
V	B-Protein
,	O
VII	B-Protein
,	O
IX	B-Protein
and	O
X	B-Protein
)	O
are	O
also	O
present	O
in	O
Y	O
.	O
enterocolitica	O
.	O

Unique	O
for	O
the	O
human	O
pathogen	O
in	O
comparison	O
to	O
P	O
.	O
luminescens	O
are	O
the	O
two	O
fimbrial	O
gene	O
cluster	O
ye2664	B-Protein
-	O
2668	B-Protein
and	O
ye2692	B-Protein
-	O
2700	B-Protein
,	O
both	O
of	O
yet	O
hypothetical	O
function	O
.	O

Thus	O
,	O
invasin	O
and	O
adhesin	O
homologues	O
similar	O
in	O
the	O
two	O
pathogens	O
might	O
contribute	O
to	O
the	O
infection	O
of	O
insect	O
or	O
mammalian	O
hosts	O
,	O
but	O
candidates	O
for	O
insect	O
-	O
and	O
mammalian	O
-	O
specific	O
colonization	O
factors	O
have	O
also	O
been	O
revealed	O
by	O
the	O
genome	O
comparison	O
performed	O
here	O
.	O

Defensive	O
mechanisms	O
<EOS>	B-X
Understanding	B-X
defense	B-X
mechanisms	B-X
is	B-X
an	B-X
important	B-X
part	B-X
of	B-X
psychotherapy	B-X
.	B-X
A	B-X
series	B-X
of	B-X
empirical	B-X
research	B-X
studies	B-X
that	B-X
demonstrate	B-X
the	B-X
functioning	B-X
of	B-X
defense	B-X
mechanisms	B-X
and	B-X
that	B-X
support	B-X
the	B-X
theory	B-X
is	B-X
presented	B-X
.	B-X
The	B-X
challenges	B-X
faced	B-X
by	B-X
professionals	B-X
when	B-X
working	B-X
in	B-X
the	B-X
field	B-X
of	B-X
psychiatry	B-X
require	B-X
the	B-X
development	B-X
of	B-X
adequate	B-X
defensive	B-X
and	B-X
coping	B-X
mechanisms	B-X
.	B-X
This	B-X
study	B-X
aimed	B-X
to	B-X
explore	B-X
both	B-X
coping	B-X
strategies	B-X
and	B-X
defense	B-X
mechanisms	B-X
and	B-X
their	B-X
relationship	B-X
in	B-X
psychiatry	B-X
trainees	B-X
in	B-X
Romania	B-X
.	B-X

Antimicrobials	O
The	O
production	O
of	O
antibiotics	O
is	O
mainly	O
restricted	O
to	O
P	O
.	O
luminescens	O
,	O
whereas	O
factors	O
combating	O
antimicrobial	O
host	O
substances	O
play	O
an	O
important	O
role	O
during	O
the	O
infection	O
process	O
of	O
both	O
pathogens	O
compared	O
here	O
.	O

In	O
the	O
genome	O
of	O
P	O
.	O
luminescens	O
ssp	O
.	O
laumondii	O
strain	O
TT01	O
,	O
many	O
loci	O
involved	O
in	O
the	O
defense	O
of	O
the	O
insect	O
cadaver	O
against	O
different	O
microbial	O
competitors	O
are	O
present	O
,	O
including	O
nearly	O
50	O
genes	O
encoding	O
proteins	O
such	O
as	O
polyketide	O
and	O
peptide	O
synthases	O
putatively	O
involved	O
in	O
antibiotic	O
synthesis	O
and	O
efflux	O
.	O

Interestingly	O
,	O
none	O
of	O
these	O
genes	O
showed	O
significant	O
similarities	O
to	O
sequences	O
of	O
the	O
Y	O
.	O
enterocolitica	O
genome	O
.	O

Phage	O
-	O
derived	O
bacteriocins	O
in	O
entomopathogenic	O
bacteria	O
are	O
also	O
presumed	O
to	O
eliminate	O
competing	O
bacteria	O
.	O

More	O
than	O
twenty	O
colicin	O
/	O
pyocin	O
-	O
like	O
factors	O
and	O
putative	O
immunity	O
proteins	O
are	O
unique	O
to	O
P	O
.	O
luminescens	O
in	O
comparison	O
to	O
Y	O
.	O
enterocolitica	O
.	O

Remarkable	O
exceptions	O
are	O
the	O
toxin	O
/	O
antitoxin	O
system	O
ccdA	B-Protein
/	O
ccdB	B-Protein
,	O
the	O
tolQRAB	B-Protein
/	O
pal	B-Protein
operon	O
involved	O
in	O
group	O
A	O
colicin	O
translocation	O
,	O
and	O
a	O
colicin	O
production	O
and	O
secretion	O
system	O
(	O
Plu3168	B-Protein
/	O
Plu3869	B-Protein
;	O
YE0791	B-Protein
/	O
YE1314	B-Protein
)	O
.	O

Recently	O
,	O
it	O
was	O
reported	O
that	O
PrtS	B-Protein
(	O
Plu1382	B-Protein
)	O
secreted	O
by	O
P	O
.	O
luminescens	O
,	O
a	O
metalloprotease	O
without	O
counterpart	O
in	O
Y	O
.	O
enterocolitica	O
,	O
specifically	O
induces	O
melanization	O
of	O
the	O
hemolymph	O
,	O
probably	O
to	O
circumvent	O
the	O
innate	O
immune	O
response	O
of	O
the	O
insect	O
[	O
81	O
]	O
.	O

Oxygenases	O
and	O
hydrolases	O
<EOS>	B-X
In	B-X
nature	B-X
,	B-X
enzymatic	B-X
degradation	B-X
of	B-X
recalcitrant	B-X
polysaccharides	B-X
such	B-X
as	B-X
chitin	B-X
and	B-X
cellulose	B-X
takes	B-X
place	B-X
by	B-X
a	B-X
synergistic	B-X
interaction	B-X
between	B-X
glycoside	B-X
hydrolases	B-X
(	B-X
GHs	B-X
)	B-X
and	B-X
lytic	B-X
polysaccharide	B-X
monooxygenases	B-X
(	B-X
LPMOs	B-X
)	B-X
.	B-X
The	B-X
epoxide	B-X
hydrolases	B-X
(	B-X
EC	B-X
3.3.2.-	B-X
)	B-X
catalyze	B-X
the	B-X
hydrolytic	B-X
ring	B-X
opening	B-X
of	B-X
epoxides	B-X
producing	B-X
the	B-X
corresponding	B-X
vicinal	B-X
diol	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
glycoside	B-X
hydrolases	B-X
,	B-X
LPMOs	B-X
are	B-X
active	B-X
on	B-X
the	B-X
crystalline	B-X
regions	B-X
of	B-X
polysaccharides	B-X
and	B-X
thus	B-X
synergize	B-X
with	B-X
hydrolytic	B-X
enzymes	B-X
.	B-X
The	B-X
epoxide	B-X
hydrolases	B-X
(	B-X
E.C	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
the	B-X
epoxide	B-X
hydrolases	B-X
are	B-X
a	B-X
class	B-X
of	B-X
proteins	B-X
that	B-X
catalyze	B-X
the	B-X
hydration	B-X
of	B-X
chemically	B-X
reactive	B-X
epoxides	B-X
to	B-X
their	B-X
corresponding	B-X
dihydrodiol	B-X
products	B-X
.	B-X
Table	B-X
1	B-X
illustrates	B-X
some	B-X
general	B-X
properties	B-X
for	B-X
each	B-X
of	B-X
these	B-X
classes	B-X
of	B-X
hydrolases	B-X
.	B-X

P	O
.	O
luminescens	O
produces	O
proteins	O
similar	O
to	O
monooxygenases	O
,	O
dioxygenases	O
and	O
hydroxylases	O
that	O
have	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
rapid	O
elimination	O
of	O
insect	O
polyphenols	O
or	O
in	O
the	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
generated	O
by	O
the	O
invaded	O
host	O
[	O
24	O
]	O
.	O
<EOS>	B-X
Among	B-X
the	B-X
NADPH	B-X
oxidases	B-X
,	B-X
the	B-X
dual	B-X
oxidases	B-X
,	B-X
DUOX1	B-X
and	B-X
DUOX2	B-X
,	B-X
constitute	B-X
a	B-X
distinct	B-X
subfamily	B-X
initially	B-X
called	B-X
thyroid	B-X
oxidases	B-X
,	B-X
based	B-X
on	B-X
their	B-X
high	B-X
level	B-X
of	B-X
expression	B-X
in	B-X
thyroid	B-X
tissue	B-X
.	B-X
However	B-X
,	B-X
a	B-X
growing	B-X
list	B-X
of	B-X
biological	B-X
functions	B-X
triggered	B-X
by	B-X
DUOX-dependent	B-X
reactive	B-X
oxygen	B-X
species	B-X
(	B-X
ROS	B-X
)	B-X
in	B-X
highly	B-X
differentiated	B-X
mucosae	B-X
have	B-X
recently	B-X
emerged	B-X
.	B-X
The	B-X
opportunistic	B-X
human	B-X
fungal	B-X
pathogen	B-X
Candida	B-X
albicans	B-X
encounters	B-X
diverse	B-X
environmental	B-X
stresses	B-X
when	B-X
it	B-X
is	B-X
in	B-X
contact	B-X
with	B-X
its	B-X
host	B-X
.	B-X
When	B-X
colonizing	B-X
and	B-X
invading	B-X
human	B-X
tissues	B-X
,	B-X
C.	B-X
albicans	B-X
is	B-X
exposed	B-X
to	B-X
ROS	B-X
(	B-X
reactive	B-X
oxygen	B-X
species	B-X
)	B-X
and	B-X
RNIs	B-X
(	B-X
reactive	B-X
nitrogen	B-X
intermediates	B-X
)	B-X
.	B-X
ROS	B-X
and	B-X
RNIs	B-X
are	B-X
generated	B-X
in	B-X
the	B-X
first	B-X
line	B-X
of	B-X
host	B-X
defence	B-X
by	B-X
phagocytic	B-X
cells	B-X
such	B-X
as	B-X
macrophages	B-X
and	B-X
neutrophils	B-X
.	B-X
In	B-X
order	B-X
to	B-X
escape	B-X
these	B-X
host-induced	B-X
oxidative	B-X
and	B-X
nitrosative	B-X
stresses	B-X
,	B-X
C.	B-X
albicans	B-X
has	B-X
developed	B-X
various	B-X
detoxification	B-X
mechanisms	B-X
.	B-X
One	B-X
such	B-X
mechanism	B-X
is	B-X
the	B-X
detoxification	B-X
of	B-X
NO	B-X
(	B-X
nitric	B-X
oxide	B-X
)	B-X
to	B-X
nitrate	B-X
by	B-X
the	B-X
flavohaemoglobin	B-X
enzyme	B-X
CaYhb1	B-X
.	B-X
Flavohaemoglobins	B-X
have	B-X
a	B-X
dioxygenase	B-X
activity	B-X
[	B-X
NOD	B-X
(	B-X
NO	B-X
dioxygenase	B-X
domain	B-X
)	B-X
]	B-X
and	B-X
contain	B-X
three	B-X
domains	B-X
:	B-X
a	B-X
globin	B-X
domain	B-X
,	B-X
an	B-X
FAD-binding	B-X
domain	B-X
and	B-X
an	B-X
NAD	B-X
(	B-X
P	B-X
)	B-X
-binding	B-X
domain	B-X
.	B-X
We	B-X
compare	B-X
their	B-X
enzymatic	B-X
and	B-X
non-enzymatic	B-X
NO	B-X
and	B-X
RNI	B-X
detoxification	B-X
mechanisms	B-X
and	B-X
summarize	B-X
fungal	B-X
responses	B-X
to	B-X
nitrosative	B-X
stress	B-X
.	B-X

Examples	O
are	O
the	O
product	O
of	O
plu4258	B-Protein
,	O
adjacent	O
to	O
a	O
gene	O
encoding	O
glutathione	O
transferase	O
(	O
plu4259	B-Protein
)	O
,	O
a	O
putative	O
steroid	O
monooxygenase	O
(	O
Plu4232	B-Protein
)	O
,	O
and	O
a	O
glycine	O
oxidase	O
(	O
Plu2242	B-Protein
)	O
,	O
all	O
of	O
which	O
have	O
no	O
counterparts	O
in	O
Y	O
.	O
enterocolitica	O
.	O

Factors	O
present	O
in	O
both	O
pathogens	O
are	O
two	O
monooxigenases	O
encoded	O
by	O
ye1945	B-Protein
/	O
hpaC	B-Protein
(	O
plu0974	B-Protein
)	O
and	O
ye3394	B-Protein
/	O
plu3599	B-Protein
,	O
and	O
two	O
hydroxylases	O
encoded	O
by	O
ubiH	B-Protein
(	O
ye3395	B-Protein
/	O
plu3600	B-Protein
)	O
and	O
ubiF	B-Protein
(	O
ye2984	B-Protein
/	O
plu1313	B-Protein
)	O
.	O

It	O
is	O
therefore	O
possible	O
that	O
the	O
Y	O
.	O
enterocolitica	O
homologues	O
of	O
these	O
enzymes	O
are	O
involved	O
in	O
persistence	O
within	O
the	O
insect	O
,	O
a	O
mechanism	O
which	O
is	O
also	O
used	O
by	O
P	O
.	O
luminescens	O
.	O

Secretion	O
and	O
exoenzymes	O
<EOS>	B-X
Probiotics	B-X
can	B-X
also	B-X
induce	B-X
host	B-X
digestive	B-X
protease	B-X
and	B-X
peptidase	B-X
activity	B-X
,	B-X
and	B-X
some	B-X
can	B-X
release	B-X
exoenzymes	B-X
involved	B-X
in	B-X
the	B-X
digestion	B-X
of	B-X
proteins	B-X
.	B-X
The	B-X
family	B-X
of	B-X
C3-like	B-X
exoenzymes	B-X
comprises	B-X
seven	B-X
bacterial	B-X
ADP-ribosyltransferases	B-X
of	B-X
different	B-X
origin	B-X
.	B-X
The	B-X
common	B-X
hallmark	B-X
of	B-X
these	B-X
exoenzymes	B-X
is	B-X
the	B-X
selective	B-X
N-ADP-ribosylation	B-X
of	B-X
the	B-X
low	B-X
molecular	B-X
mass	B-X
GTP-binding	B-X
proteins	B-X
RhoA	B-X
,	B-X
B	B-X
,	B-X
and	B-X
C	B-X
and	B-X
inhibition	B-X
of	B-X
signal	B-X
pathways	B-X
controlled	B-X
by	B-X
Rho	B-X
GTPases	B-X
.	B-X
Therefore	B-X
,	B-X
C3-like	B-X
exoenzymes	B-X
were	B-X
applied	B-X
as	B-X
pharmacological	B-X
tools	B-X
for	B-X
analyses	B-X
of	B-X
cellular	B-X
functions	B-X
of	B-X
Rho	B-X
protein	B-X
in	B-X
numerous	B-X
studies	B-X
.	B-X
Recent	B-X
structural	B-X
and	B-X
functional	B-X
analyses	B-X
of	B-X
C3-like	B-X
exoenzymes	B-X
provide	B-X
detailed	B-X
information	B-X
on	B-X
the	B-X
molecular	B-X
mechanisms	B-X
and	B-X
functional	B-X
consequences	B-X
of	B-X
ADP-ribosylation	B-X
catalyzed	B-X
by	B-X
these	B-X
toxins	B-X
.	B-X
These	B-X
results	B-X
add	B-X
novel	B-X
information	B-X
on	B-X
the	B-X
molecular	B-X
mode	B-X
of	B-X
action	B-X
(	B-X
s	B-X
)	B-X
of	B-X
C3-like	B-X
exoenzymes	B-X
and	B-X
are	B-X
discussed	B-X
in	B-X
this	B-X
review	B-X
.	B-X

In	O
Y	O
.	O
enterocolitica	O
,	O
two	O
type	O
-	O
III	O
secretion	O
systems	O
(	O
T3SS	O
)	O
essential	O
for	O
virulence	O
in	O
the	O
mammalian	O
host	O
are	O
encoded	O
on	O
pYV	O
and	O
by	O
the	O
ysa	O
operon	O
(	O
YE3533	B-Protein
-	O
3561	B-Protein
)	O
[	O
23	O
,	O
82	O
]	O
.	O

The	O
P	O
.	O
luminescens	O
genome	O
encodes	O
one	O
T3SS	O
which	O
is	O
highly	O
similar	O
to	O
the	O
plasmid	O
-	O
encoded	O
T3SS	O
of	O
Y	O
.	O
enterocolitica	O
and	O
probably	O
involved	O
in	O
the	O
secretion	O
of	O
virulence	O
proteins	O
or	O
in	O
immunomodulation	O
of	O
the	O
insect	O
response	O
to	O
an	O
infection	O
.	O

Interestingly	O
,	O
the	O
T3SS	O
of	O
Y	O
.	O
pestis	O
has	O
recently	O
been	O
demonstrated	O
to	O
translocate	O
insecticidal	O
toxins	O
,	O
providing	O
evidence	O
that	O
they	O
support	O
the	O
transmission	O
of	O
the	O
plague	O
agent	O
by	O
insects	O
[	O
83	O
]	O
.	O

Furthermore	O
,	O
the	O
flagellar	O
export	O
apparatus	O
of	O
Y	O
.	O
pseudotuberculosis	O
functions	O
as	O
a	O
secretion	O
system	O
for	O
the	O
virulence	O
-	O
associated	O
phospholipase	O
YplA	B-Protein
[	O
84	O
]	O
.	O

The	O
typical	O
effector	O
proteins	O
of	O
Y	O
.	O
enterocolitica	O
are	O
also	O
present	O
in	O
P	O
.	O
luminescens	O
.	O

The	O
P	O
.	O
luminescens	O
Lop	O
effector	O
proteins	O
are	O
homologs	O
of	O
the	O
Yop	O
effector	O
proteins	O
of	O
Y	O
.	O
enterocolitica	O
[	O
85	O
]	O
.	O

The	O
LopT	B-Protein
effector	O
protein	O
of	O
P	O
.	O
luminescens	O
can	O
be	O
injected	O
by	O
Y	O
.	O
enterocolitica	O
into	O
mammal	O
cells	O
[	O
86	O
]	O
,	O
underlining	O
the	O
idea	O
that	O
both	O
T3SS	O
act	O
similarly	O
.	O

Furthermore	O
,	O
we	O
found	O
homologues	O
of	O
the	O
Y	O
.	O
enterocolitica	O
low	O
-	O
calcium	O
-	O
response	O
genes	O
(	O
lcrH	B-Protein
,	O
lcrV	B-Protein
,	O
and	O
lrcD	B-Protein
)	O
in	O
P	O
.	O
luminescens	O
(	O
plu3757	B-Protein
,	O
plu3758	B-Protein
,	O
sctV	B-Protein
)	O
which	O
further	O
supports	O
this	O
hypothesis	O
.	O

The	O
fact	O
that	O
Y	O
.	O
enterocolitica	O
a	O
second	O
T3SS	O
(	O
Ysa	O
)	O
is	O
not	O
shared	O
by	O
P	O
.	O
luminescens	O
confirms	O
its	O
solely	O
role	O
in	O
human	O
pathogenicity	O
[	O
87	O
]	O
.	O

Both	O
P	O
.	O
luminesens	O
and	O
Y	O
.	O
enterocolitica	O
share	O
a	O
Sec	O
protein	O
translocation	O
system	O
that	O
belongs	O
to	O
the	O
type	O
-	O
II	O
secretion	O
systems	O
(	O
T2SS	O
)	O
.	O

These	O
are	O
substrate	O
-	O
specific	O
secretion	O
machineries	O
that	O
share	O
a	O
similar	O
architecture	O
and	O
secretion	O
mechanism	O
[	O
88	O
]	O
.	O

Proteins	O
secreted	O
by	O
these	O
systems	O
are	O
mainly	O
virulence	O
determinants	O
such	O
as	O
exotoxins	O
like	O
the	O
Cholera	O
toxin	O
of	O
Vibrio	O
cholerae	O
,	O
pili	O
,	O
and	O
S	O
-	O
layer	O
components	O
(	O
see	O
[	O
89	O
]	O
for	O
review	O
)	O
.	O

Additionally	O
to	O
the	O
Sec	O
-	O
system	O
,	O
Y	O
.	O
enterocolitica	O
produces	O
a	O
T2SS	O
named	O
Yts1	B-Protein
,	O
which	O
has	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
in	O
mice	O
[	O
90	O
]	O
.	O

Because	O
there	O
is	O
no	O
counterpart	O
of	O
Yts1	B-Protein
present	O
in	O
P	O
.	O
luminescens	O
,	O
one	O
can	O
speculate	O
that	O
the	O
major	O
parts	O
of	O
type	O
-	O
II	O
dependent	O
secreted	O
proteins	O
which	O
are	O
important	O
for	O
insect	O
association	O
of	O
Y	O
.	O
enterocolitica	O
are	O
translocated	O
via	O
the	O
Sec	O
system	O
.	O

Recently	O
,	O
a	O
novel	O
protein	O
secretion	O
mechanism	O
translocating	O
proteins	O
without	O
an	O
N	O
-	O
terminal	O
leader	O
sequence	O
has	O
been	O
described	O
,	O
termed	O
type	O
-	O
VI	O
secretion	O
system	O
,	O
T6SS	O
(	O
see	O
[	O
91	O
]	O
for	O
review	O
)	O
.	O

The	O
genes	O
encoding	O
these	O
kinds	O
of	O
secretion	O
systems	O
were	O
named	O
vas	O
(	O
virulence	O
associated	O
secretion	O
)	O
,	O
and	O
homologues	O
are	O
widespread	O
in	O
Gram	O
-	O
negative	O
bacteria	O
.	O

VAS	O
-	O
dependent	O
secretion	O
has	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Vibrio	O
cholerae	O
[	O
92	O
]	O
as	O
well	O
as	O
for	O
Pseudomonas	O
aeruginosa	O
[	O
93	O
]	O
,	O
and	O
T6SS	O
are	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
virulence	O
in	O
many	O
Gram	O
-	O
negative	O
bacteria	O
[	O
91	O
]	O
.	O

P	O
.	O
luminescens	O
as	O
well	O
as	O
Y	O
.	O
enterocolitica	O
harbour	O
homologues	O
of	O
the	O
vas	O
genes	O
,	O
indicating	O
that	O
several	O
proteins	O
involved	O
in	O
virulence	O
are	O
secreted	O
via	O
this	O
pathway	O
.	O

Both	O
pathogens	O
secrete	O
lipases	O
and	O
proteases	O
that	O
are	O
assumed	O
to	O
contribute	O
to	O
immunosuppression	O
,	O
degradation	O
of	O
insect	O
tissues	O
or	O
antibacterial	O
peptides	O
,	O
and	O
host	O
bioconversion	O
(	O
Fig	O
.	O
4	O
)	O
.	O

One	O
of	O
those	O
exoenzymes	O
is	O
the	O
phospholipase	B-Protein
A	I-Protein
(	O
YplA	B-Protein
)	O
with	O
an	O
accessory	O
protein	O
(	O
YplB	B-Protein
)	O
of	O
Y	O
.	O
enterocolitica	O
(	O
YE1005	B-Protein
/	O
YE1006	B-Protein
)	O
which	O
are	O
also	O
present	O
in	O
P	O
.	O
luminescens	O
(	O
Plu3370	B-Protein
/	O
Plu3369	B-Protein
)	O
.	O

YplA	B-Protein
contributes	O
to	O
pathogenesis	O
of	O
Y	O
.	O
enterocolitica	O
in	O
a	O
mouse	O
model	O
[	O
94	O
]	O
,	O
suggesting	O
a	O
role	O
in	O
virulence	O
against	O
insects	O
for	O
the	O
P	O
.	O
luminescens	O
homologue	O
.	O

Remarkably	O
,	O
yplA	B-Protein
is	O
induced	O
at	O
low	O
temperature	O
(	O
Table	O
1	O
)	O
,	O
and	O
its	O
expression	O
is	O
known	O
to	O
be	O
regulated	O
by	O
the	O
master	O
regulator	O
FlhDC	B-Protein
[	O
94	O
]	O
,	O
indicating	O
that	O
YplA	B-Protein
plays	O
a	O
role	O
in	O
pathogenicity	O
both	O
against	O
human	O
and	O
insect	O
hosts	O
.	O

Two	O
additional	O
phospholipases	O
are	O
present	O
in	O
Y	O
.	O
enterocolitica	O
,	O
namely	O
PdlA	B-Protein
(	O
YE0203	B-Protein
)	O
and	O
PdlB	B-Protein
(	O
YE0207	B-Protein
)	O
,	O
the	O
latter	O
one	O
a	O
homologue	O
of	O
Plu4619	B-Protein
.	O

This	O
overlap	O
is	O
another	O
example	O
for	O
Y	O
.	O
enterocolitica	O
enzymes	O
probably	O
involved	O
rather	O
in	O
the	O
association	O
with	O
invertebrates	O
than	O
in	O
pathogenicity	O
towards	O
mammalians	O
.	O

Plu1971	B-Protein
of	O
P	O
.	O
luminescens	O
is	O
a	O
protein	O
which	O
contains	O
two	O
phospholipase	B-Protein
D	I-Protein
motifs	O
.	O

Furthermore	O
,	O
it	O
shares	O
homologies	O
to	O
the	O
plasmid	O
(	O
pMT1	O
)	O
-	O
encoded	O
murine	O
toxin	O
(	O
Ymt	B-Protein
)	O
of	O
Y	O
.	O
pestis	O
.	O

It	O
was	O
suggested	O
that	O
ymt	B-Protein
has	O
been	O
acquired	O
by	O
Y	O
.	O
pestis	O
from	O
P	O
.	O
luminescens	O
or	O
a	O
close	O
relative	O
[	O
24	O
]	O
.	O
<EOS>	B-X
This	B-X
paper	B-X
provides	B-X
an	B-X
interdisciplinary	B-X
review	B-X
of	B-X
research	B-X
from	B-X
anthropology	B-X
,	B-X
nursing	B-X
,	B-X
pediatrics	B-X
,	B-X
sociology	B-X
,	B-X
social	B-X
work	B-X
,	B-X
public	B-X
health	B-X
,	B-X
family	B-X
studies	B-X
,	B-X
and	B-X
psychology	B-X
to	B-X
focus	B-X
on	B-X
the	B-X
role	B-X
of	B-X
physical	B-X
touch	B-X
in	B-X
the	B-X
context	B-X
of	B-X
co-sleeping	B-X
,	B-X
and	B-X
how	B-X
close	B-X
physical	B-X
contact	B-X
in	B-X
this	B-X
context	B-X
affects	B-X
infants	B-X
and	B-X
their	B-X
caregivers	B-X
.	B-X
For	B-X
families	B-X
trying	B-X
to	B-X
retain	B-X
physical	B-X
closeness	B-X
between	B-X
parent	B-X
(	B-X
s	B-X
)	B-X
and	B-X
infants	B-X
in	B-X
the	B-X
context	B-X
of	B-X
modern	B-X
(	B-X
especially	B-X
Western	B-X
)	B-X
infant	B-X
care	B-X
practices	B-X
that	B-X
have	B-X
reduced	B-X
this	B-X
physical	B-X
contact	B-X
,	B-X
co-sleeping	B-X
can	B-X
be	B-X
an	B-X
important	B-X
developmental	B-X
context	B-X
for	B-X
encouraging	B-X
and	B-X
engaging	B-X
in	B-X
sensitive	B-X
and	B-X
responsive	B-X
caregiving	B-X
and	B-X
providing	B-X
a	B-X
context	B-X
for	B-X
maternal-infant	B-X
physiological	B-X
synchrony	B-X
and	B-X
regulation	B-X
.	B-X
One	B-X
,	B-X
from	B-X
the	B-X
relatives	B-X
of	B-X
nursing	B-X
home	B-X
residents	B-X
,	B-X
hospitalised	B-X
and	B-X
dead	B-X
during	B-X
the	B-X
pandemics	B-X
,	B-X
without	B-X
any	B-X
contact	B-X
with	B-X
their	B-X
relatives	B-X
(	B-X
edited	B-X
by	B-X
Anchise	B-X
Comitato	B-X
Nazionale	B-X
Famiglie	B-X
RSA	B-X
RSD	B-X
Sanità	B-X
)	B-X
,	B-X
which	B-X
in	B-X
sometimes	B-X
very	B-X
harsh	B-X
,	B-X
but	B-X
hardly	B-X
contestable	B-X
tones	B-X
,	B-X
at	B-X
the	B-X
end	B-X
of	B-X
August	B-X
22	B-X
launched	B-X
an	B-X
appeal	B-X
(	B-X
which	B-X
is	B-X
still	B-X
little	B-X
heeded	B-X
)	B-X
to	B-X
the	B-X
future	B-X
government	B-X
,	B-X
to	B-X
reopen	B-X
the	B-X
doors	B-X
of	B-X
hospitals	B-X
and	B-X
nursing	B-X
homes	B-X
.	B-X
The	B-X
other	B-X
,	B-X
a	B-X
press	B-X
release	B-X
of	B-X
December	B-X
2022	B-X
,	B-X
from	B-X
the	B-X
Nursing	B-X
College	B-X
of	B-X
Trento	B-X
,	B-X
reaffirms	B-X
the	B-X
importance	B-X
of	B-X
family	B-X
visits	B-X
as	B-X
a	B-X
right	B-X
and	B-X
responsibility	B-X
to	B-X
guarantee	B-X
the	B-X
care	B-X
and	B-X
caring	B-X
of	B-X
the	B-X
person	B-X
being	B-X
cared	B-X
for	B-X
,	B-X
recalling	B-X
the	B-X
attention	B-X
and	B-X
responsibility	B-X
of	B-X
nurses	B-X
,	B-X
who	B-X
should	B-X
consider	B-X
a	B-X
fundamental	B-X
care	B-X
to	B-X
be	B-X
able	B-X
to	B-X
care	B-X
for	B-X
patients	B-X
with	B-X
the	B-X
closeness	B-X
of	B-X
the	B-X
family	B-X
.	B-X

Ymt	B-Protein
is	O
essential	O
for	O
flea	O
colonization	O
by	O
Y	O
.	O
pestis	O
and	O
is	O
regulated	O
by	O
AHL	O
both	O
in	O
Y	O
.	O
pestis	O
[	O
95	O
]	O
and	O
P	O
.	O
luminescens	O
(	O
R	O
.	O
Heermann	O
,	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
Ymt	B-Protein
is	O
also	O
required	O
for	O
insect	O
colonization	O
by	O
P	O
.	O
luminescens	O
.	O

Due	O
to	O
its	O
absence	O
in	O
Y	O
.	O
enterocolitica	O
,	O
Ymt	B-Protein
is	O
another	O
example	O
for	O
the	O
high	O
diversity	O
of	O
genetic	O
determinants	O
that	O
are	O
used	O
by	O
closely	O
related	O
bacterial	O
pathogens	O
to	O
interact	O
with	O
their	O
insect	O
hosts	O
.	O

There	O
are	O
several	O
other	O
exoenzymes	O
present	O
either	O
in	O
Y	O
.	O
enterocolitica	O
or	O
in	O
P	O
.	O
luminescens	O
,	O
which	O
do	O
not	O
have	O
a	O
homologue	O
counterpart	O
in	O
the	O
other	O
bacterium	O
.	O

Examples	O
are	O
the	O
ten	O
triacylglycerol	O
lipases	O
of	O
P	O
.	O
luminescens	O
or	O
the	O
three	O
identified	O
lipases	O
of	O
Y	O
.	O
enterocolitica	O
.	O
<EOS>	B-X
Yersinia	B-X
enterocolitica	B-X
has	B-X
three	B-X
type	B-X
three	B-X
secretion	B-X
systems	B-X
,	B-X
the	B-X
flagellar	B-X
,	B-X
the	B-X
plasmid	B-X
Ysc	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
,	B-X
and	B-X
the	B-X
chromosomal	B-X
Ysa	B-X
T3SS	B-X
.	B-X
The	B-X
Ysc	B-X
T3SS	B-X
,	B-X
through	B-X
the	B-X
proteins	B-X
it	B-X
secretes	B-X
(	B-X
Yops	B-X
)	B-X
,	B-X
prevents	B-X
phagocytosis	B-X
of	B-X
Y.	B-X
enterocolitica	B-X
and	B-X
is	B-X
required	B-X
for	B-X
disease	B-X
processes	B-X
in	B-X
the	B-X
mouse	B-X
host	B-X
.	B-X
This	B-X
work	B-X
characterizes	B-X
the	B-X
discovery	B-X
of	B-X
a	B-X
newly	B-X
identified	B-X
Ysa	B-X
type	B-X
III	B-X
secreted	B-X
protein	B-X
,	B-X
YspM	B-X
.	B-X
YspM	B-X
is	B-X
homologous	B-X
to	B-X
proteins	B-X
classified	B-X
as	B-X
GDSL	B-X
bacterial	B-X
lipases	B-X
,	B-X
which	B-X
possess	B-X
a	B-X
catalytic	B-X
triad	B-X
of	B-X
amino	B-X
acids	B-X
(	B-X
Ser	B-X
,	B-X
Asp	B-X
,	B-X
and	B-X
His	B-X
)	B-X
located	B-X
in	B-X
three	B-X
of	B-X
five	B-X
blocks	B-X
of	B-X
amino	B-X
acid	B-X
identity	B-X
.	B-X
Sequence	B-X
analysis	B-X
of	B-X
the	B-X
JB580v	B-X
strain	B-X
of	B-X
Y.	B-X
enterocolitica	B-X
shows	B-X
that	B-X
,	B-X
due	B-X
to	B-X
a	B-X
premature	B-X
stop	B-X
codon	B-X
,	B-X
it	B-X
no	B-X
longer	B-X
encodes	B-X
the	B-X
fifth	B-X
block	B-X
of	B-X
amino	B-X
acid	B-X
identity	B-X
containing	B-X
the	B-X
predicted	B-X
catalytic	B-X
histidine	B-X
.	B-X

However	O
,	O
homologies	O
are	O
observed	O
for	O
six	O
secreted	O
proteases	O
of	O
both	O
organisms	O
.	O
<EOS>	B-X
However	B-X
,	B-X
very	B-X
few	B-X
of	B-X
these	B-X
interfaces	B-X
are	B-X
well	B-X
understood	B-X
at	B-X
the	B-X
functional	B-X
level	B-X
.	B-X
One	B-X
method	B-X
to	B-X
achieve	B-X
this	B-X
is	B-X
the	B-X
2001	B-X
FAO/WHO	B-X
Decision	B-X
Tree	B-X
recommended	B-X
for	B-X
evaluation	B-X
of	B-X
proteins	B-X
from	B-X
genetically	B-X
modified	B-X
organisms	B-X
(	B-X
GMOs	B-X
)	B-X
.	B-X
A	B-X
database	B-X
search	B-X
showed	B-X
that	B-X
the	B-X
enzyme	B-X
has	B-X
no	B-X
homology	B-X
with	B-X
known	B-X
allergens	B-X
,	B-X
down	B-X
to	B-X
a	B-X
match	B-X
of	B-X
six	B-X
contiguous	B-X
amino	B-X
acids	B-X
,	B-X
which	B-X
meets	B-X
the	B-X
requirements	B-X
of	B-X
the	B-X
decision	B-X
tree	B-X
.	B-X
However	B-X
,	B-X
there	B-X
is	B-X
a	B-X
match	B-X
at	B-X
the	B-X
five	B-X
contiguous	B-X
amino	B-X
acid	B-X
level	B-X
to	B-X
the	B-X
major	B-X
codfish	B-X
allergen	B-X
Gad	B-X
c1	B-X
.	B-X
No	B-X
binding	B-X
between	B-X
patient	B-X
IgE	B-X
and	B-X
m-TG	B-X
was	B-X
observed	B-X
.	B-X

Among	O
them	O
is	O
PrtA	B-Protein
(	O
Plu0655	B-Protein
/	O
YE4052	B-Protein
)	O
,	O
a	O
zinc	O
metalloprotease	O
that	O
is	O
involved	O
in	O
the	O
immunosuppressive	O
activity	O
of	O
X	O
.	O
nematophila	O
[	O
96	O
]	O
,	O
and	O
that	O
has	O
also	O
been	O
shown	O
to	O
be	O
involved	O
in	O
insect	O
gut	O
colonization	O
of	O
P	O
.	O
luminescens	O
[	O
97	O
]	O
.	O

Further	O
examples	O
for	O
shared	O
proteases	O
are	O
another	O
Zn	O
-	O
dependent	O
protease	O
(	O
Plu0306	B-Protein
/	O
YE4066	B-Protein
)	O
,	O
the	O
protease	O
III	O
(	O
Plu0631	B-Protein
/	O
YE3311	B-Protein
)	O
,	O
and	O
DegQ	B-Protein
/	O
DegS	B-Protein
(	O
YE3744	B-Protein
/	O
YE3745	B-Protein
/	O
Plu4018	B-Protein
/	O
Plu4022	B-Protein
)	O
.	O

The	O
high	O
number	O
of	O
homologs	O
in	O
both	O
organisms	O
suggests	O
an	O
important	O
and	O
similar	O
role	O
of	O
these	O
exoproteases	O
in	O
the	O
infection	O
process	O
.	O

We	O
also	O
identified	O
two	O
proteases	O
in	O
each	O
pathogen	O
(	O
Plu4291	B-Protein
,	O
Plu0631	B-Protein
,	O
YE0320	B-Protein
,	O
and	O
YE2087	B-Protein
)	O
without	O
a	O
homologue	O
in	O
the	O
other	O
bacterium	O
.	O
<EOS>	B-X
Mass-spectrometric	B-X
analysis	B-X
of	B-X
tryptic	B-X
fragments	B-X
identified	B-X
the	B-X
autotransporters	B-X
IgA	B-X
protease	B-X
and	B-X
App	B-X
,	B-X
a	B-X
homologue	B-X
of	B-X
the	B-X
adhesin	B-X
Hap	B-X
of	B-X
Haemophilus	B-X
influenzae	B-X
,	B-X
as	B-X
the	B-X
major	B-X
secreted	B-X
proteins	B-X
.	B-X
Type	B-X
IV	B-X
pili	B-X
are	B-X
long	B-X
,	B-X
thin	B-X
fibres	B-X
,	B-X
which	B-X
extend	B-X
from	B-X
the	B-X
surface	B-X
of	B-X
the	B-X
bacterial	B-X
pathogen	B-X
Neisseria	B-X
meningitidis	B-X
;	B-X
they	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
adhesion	B-X
and	B-X
colonisation	B-X
of	B-X
host	B-X
cells	B-X
.	B-X
There	B-X
is	B-X
also	B-X
a	B-X
short	B-X
segment	B-X
of	B-X
3	B-X
(	B-X
10	B-X
)	B-X
helix	B-X
at	B-X
the	B-X
N-terminal	B-X
part	B-X
of	B-X
the	B-X
folded	B-X
domain	B-X
.	B-X
Over	B-X
40	B-X
homologues	B-X
of	B-X
PilP	B-X
have	B-X
been	B-X
identified	B-X
in	B-X
Gram-negative	B-X
bacteria	B-X
and	B-X
the	B-X
majority	B-X
of	B-X
conserved	B-X
residues	B-X
lie	B-X
within	B-X
the	B-X
folded	B-X
domain	B-X
.	B-X
The	B-X
fourth	B-X
beta-strand	B-X
and	B-X
adjacent	B-X
loop	B-X
regions	B-X
contain	B-X
a	B-X
high	B-X
proportion	B-X
of	B-X
conserved	B-X
residues	B-X
,	B-X
including	B-X
three	B-X
glycine	B-X
residues	B-X
,	B-X
which	B-X
seem	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
linking	B-X
the	B-X
two	B-X
beta-sheets	B-X
.	B-X
The	B-X
two	B-X
beta-sheets	B-X
pack	B-X
together	B-X
to	B-X
form	B-X
a	B-X
crevice	B-X
,	B-X
lined	B-X
with	B-X
conserved	B-X
hydrophobic	B-X
residues	B-X
:	B-X
we	B-X
suggest	B-X
that	B-X
this	B-X
feature	B-X
could	B-X
act	B-X
as	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
a	B-X
small	B-X
ligand	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
PilP	B-X
and	B-X
its	B-X
homologues	B-X
have	B-X
a	B-X
conserved	B-X
,	B-X
folded	B-X
domain	B-X
at	B-X
the	B-X
C-terminal	B-X
end	B-X
of	B-X
the	B-X
protein	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
mediating	B-X
binding	B-X
to	B-X
hydrophobic	B-X
ligands	B-X
.	B-X

We	O
speculate	O
that	O
these	O
Y	O
.	O
enterocolitica	O
proteases	O
could	O
be	O
involved	O
in	O
the	O
infection	O
process	O
in	O
mammals	O
,	O
whereas	O
the	O
P	O
.	O
luminescens	O
proteases	O
are	O
rather	O
used	O
for	O
nutrient	O
bioconversion	O
than	O
for	O
the	O
infection	O
process	O
.	O

Metabolism	O

While	O
many	O
specific	O
virulence	O
factors	O
,	O
which	O
enable	O
the	O
microbes	O
to	O
overcome	O
the	O
various	O
physical	O
and	O
biochemical	O
barriers	O
of	O
the	O
infected	O
hosts	O
,	O
have	O
been	O
investigated	O
in	O
detail	O
,	O
little	O
attention	O
has	O
been	O
given	O
to	O
the	O
metabolic	O
requirements	O
and	O
substrate	O
availability	O
of	O
bacteria	O
in	O
vivo	O
.	O

Both	O
in	O
insects	O
and	O
mammals	O
,	O
pathogens	O
get	O
access	O
to	O
host	O
-	O
specific	O
nutrients	O
,	O
but	O
also	O
encounter	O
substrate	O
limitations	O
such	O
as	O
low	O
iron	O
concentration	O
.	O

In	O
this	O
chapter	O
,	O
we	O
focus	O
on	O
metabolic	O
pathways	O
of	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
absent	O
in	O
E	O
.	O
coli	O
,	O
induced	O
at	O
low	O
temperature	O
,	O
or	O
already	O
known	O
to	O
be	O
virulence	O
-	O
associated	O
.	O
<EOS>	B-X
In	B-X
2019	B-X
,	B-X
the	B-X
United	B-X
States	B-X
experienced	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
vaping-associated	B-X
lung	B-X
injury	B-X
(	B-X
VALI	B-X
)	B-X
epidemic	B-X
.	B-X
Vaping	B-X
is	B-X
now	B-X
known	B-X
to	B-X
result	B-X
in	B-X
the	B-X
development	B-X
and	B-X
progression	B-X
of	B-X
severe	B-X
lung	B-X
disease	B-X
in	B-X
the	B-X
young	B-X
and	B-X
healthy	B-X
.	B-X
E-cigarette	B-X
vapor	B-X
is	B-X
shown	B-X
to	B-X
affect	B-X
numerous	B-X
cellular	B-X
processes	B-X
,	B-X
cellular	B-X
metabolism	B-X
,	B-X
and	B-X
cause	B-X
DNA	B-X
damage	B-X
(	B-X
which	B-X
has	B-X
implications	B-X
for	B-X
cancer	B-X
)	B-X
.	B-X
E-cigarette	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
a	B-X
higher	B-X
risk	B-X
of	B-X
developing	B-X
crippling	B-X
lung	B-X
conditions	B-X
such	B-X
as	B-X
chronic	B-X
obstructive	B-X
pulmonary	B-X
disease	B-X
(	B-X
COPD	B-X
)	B-X
,	B-X
which	B-X
would	B-X
develop	B-X
several	B-X
years	B-X
from	B-X
now	B-X
,	B-X
increasing	B-X
the	B-X
already	B-X
existent	B-X
smoking-related	B-X
burden	B-X
.	B-X
The	B-X
role	B-X
of	B-X
vaping	B-X
and	B-X
virus	B-X
susceptibility	B-X
is	B-X
yet	B-X
to	B-X
be	B-X
determined	B-X
;	B-X
however	B-X
,	B-X
vaping	B-X
can	B-X
increase	B-X
the	B-X
virulence	B-X
and	B-X
inflammatory	B-X
potential	B-X
of	B-X
several	B-X
lung	B-X
pathogens	B-X
and	B-X
is	B-X
also	B-X
linked	B-X
to	B-X
an	B-X
increased	B-X
risk	B-X
of	B-X
pneumonia	B-X
.	B-X
E-cigarettes	B-X
and	B-X
their	B-X
modifiable	B-X
nature	B-X
are	B-X
harmful	B-X
,	B-X
as	B-X
the	B-X
lungs	B-X
are	B-X
not	B-X
designed	B-X
for	B-X
the	B-X
chronic	B-X
inhalation	B-X
of	B-X
e-cigarette	B-X
vapor	B-X
.	B-X

Degradative	O
pathways	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
share	O
loci	O
encoding	O
several	O
common	O
degradation	O
pathways	O
that	O
are	O
absent	O
in	O
E	O
.	O
coli	O
K	O
-	O
12	O
,	O
including	O
the	O
urease	O
operon	O
(	O
ureABCEFGD	B-Protein
)	O
,	O
the	O
genes	O
involved	O
in	O
myo	O
-	O
inositol	O
degradation	O
,	O
and	O
the	O
histidine	O
degradation	O
operon	O
(	O
hutHUCGI	B-Protein
)	O
.	O

These	O
pathways	O
might	O
help	O
the	O
bacteria	O
to	O
gain	O
access	O
to	O
sufficient	O
amounts	O
of	O
substrates	O
and	O
thus	O
to	O
proliferate	O
in	O
the	O
hemolymph	O
of	O
the	O
insect	O
larvae	O
.	O

We	O
recently	O
reported	O
that	O
the	O
genes	O
of	O
the	O
urease	O
operon	O
as	O
well	O
as	O
a	O
histidine	O
ammonia	O
lyase	O
(	O
ye3021	B-Protein
/	O
plu1240	B-Protein
)	O
,	O
which	O
deaminates	O
histidine	O
to	O
urocanic	O
acid	O
,	O
are	O
highly	O
induced	O
in	O
Y	O
.	O
enterocolitica	O
upon	O
temperature	O
decrease	O
[	O
67	O
]	O
.	O

Beside	O
arginine	O
(	O
5	O
.	O
17	O
mumol	O
/	O
g	O
)	O
,	O
lysine	O
(	O
12	O
.	O
23	O
mumol	O
/	O
g	O
)	O
,	O
serine	O
(	O
6	O
.	O
77	O
mumol	O
/	O
g	O
)	O
and	O
proline	O
(	O
6	O
.	O
40	O
mumol	O
/	O
g	O
)	O
,	O
histidine	O
(	O
5	O
.	O
04	O
mumol	O
/	O
g	O
)	O
is	O
the	O
most	O
abundant	O
free	O
amino	O
acids	O
in	O
the	O
Hyalophora	O
gloveri	O
fat	O
body	O
[	O
98	O
]	O
.	O

The	O
synthesis	O
of	O
vitamin	O
B12	O
that	O
occurs	O
only	O
anaerobically	O
is	O
required	O
for	O
the	O
degradation	O
of	O
1	O
,	O
2	O
-	O
propanediol	O
by	O
the	O
products	O
of	O
the	O
pdu	O
operon	O
,	O
as	O
well	O
as	O
of	O
ethanolamine	O
by	O
the	O
eutABC	B-Protein
-	O
encoded	O
enzymes	O
.	O

The	O
cobalamine	O
-	O
dependent	O
anaerobic	O
growth	O
of	O
Salmonella	O
typhimurium	O
on	O
both	O
these	O
substrates	O
has	O
been	O
shown	O
to	O
be	O
supported	O
by	O
the	O
alternative	O
electron	O
acceptor	O
tetrathionate	O
whose	O
respiration	O
is	O
facilitated	O
by	O
the	O
tetrathionate	O
reductase	O
gene	O
cluster	O
ttr	O
[	O
99	O
,	O
100	O
]	O
.	O

Beside	O
S	O
.	O
typhimurium	O
,	O
all	O
these	O
genetic	O
determinants	O
were	O
found	O
only	O
in	O
few	O
other	O
bacteria	O
,	O
namely	O
the	O
human	O
pathogens	O
Listeria	O
monocytogenes	O
,	O
and	O
Clostridium	O
perfringens	O
[	O
101	O
]	O
.	O

Y	O
.	O
enterocolitica	O
carries	O
the	O
genes	O
encoding	O
tetrathionate	O
reductase	O
(	O
ttrABC	B-Protein
)	O
and	O
the	O
TCS	O
TtrRS	B-Protein
(	O
YE1613	B-Protein
-	O
1617	B-Protein
)	O
.	O

The	O
gene	O
clusters	O
for	O
cobalamin	O
synthesis	O
and	O
propanediol	O
degradation	O
are	O
located	O
on	O
a	O
40	O
-	O
kb	O
genomic	O
island	O
(	O
ye2707	B-Protein
-	O
2750	B-Protein
)	O
,	O
but	O
the	O
eutABC	B-Protein
operon	O
is	O
missing	O
.	O

Propanediol	O
degradation	O
by	O
Y	O
.	O
enterocolitica	O
might	O
also	O
be	O
supported	O
by	O
YE4187	B-Protein
with	O
a	O
putative	O
GlcG	B-Protein
domain	O
which	O
is	O
predicted	O
to	O
be	O
involved	O
in	O
glycolate	O
and	O
propanediol	O
utilization	O
.	O

The	O
cobalamine	O
synthesis	O
genes	O
and	O
the	O
eutABC	B-Protein
operon	O
,	O
but	O
not	O
ttrC	B-Protein
,	O
ttrR	B-Protein
,	O
ttrS	B-Protein
and	O
the	O
propanediol	O
utilization	O
gene	O
cluster	O
,	O
are	O
also	O
present	O
in	O
the	O
genome	O
of	O
P	O
.	O
luminescens	O
,	O
suggesting	O
the	O
degradation	O
of	O
phosphatidylethanolamine	O
as	O
additional	O
energy	O
source	O
in	O
the	O
insect	O
host	O
[	O
102	O
]	O
.	O
<EOS>	B-X
Clostridium	B-X
perfringens	B-X
possesses	B-X
the	B-X
ethanolamine	B-X
(	B-X
EA	B-X
)	B-X
utilization	B-X
(	B-X
eut	B-X
)	B-X
system	B-X
encoded	B-X
within	B-X
the	B-X
eut	B-X
operon	B-X
,	B-X
which	B-X
utilizes	B-X
the	B-X
EA	B-X
as	B-X
a	B-X
carbon	B-X
,	B-X
nitrogen	B-X
and	B-X
energy	B-X
source	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
role	B-X
of	B-X
the	B-X
eut	B-X
system	B-X
in	B-X
C.	B-X
perfringens	B-X
growth	B-X
,	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
the	B-X
eutABC	B-X
genes	B-X
was	B-X
made	B-X
in	B-X
strain	B-X
HN13	B-X
to	B-X
generate	B-X
the	B-X
eutABC-deleted	B-X
mutant	B-X
strain	B-X
HY1701	B-X
.	B-X
The	B-X
two-component	B-X
regulatory	B-X
system	B-X
EutVW	B-X
is	B-X
needed	B-X
to	B-X
induce	B-X
eut	B-X
gene	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
EA	B-X
whereas	B-X
the	B-X
global	B-X
virulence	B-X
regulator	B-X
VirRS	B-X
differentially	B-X
controlled	B-X
eut	B-X
gene	B-X
expression	B-X
depending	B-X
on	B-X
glucose	B-X
and	B-X
EA	B-X
availability	B-X
.	B-X
PCR	B-X
screening	B-X
demonstrated	B-X
that	B-X
C.	B-X
perfringens	B-X
isolated	B-X
from	B-X
gas	B-X
gangrene	B-X
and	B-X
sporadic	B-X
diarrhea	B-X
cases	B-X
carried	B-X
both	B-X
eut	B-X
genes	B-X
and	B-X
the	B-X
perfringolysin	B-X
O	B-X
gene	B-X
(	B-X
pfoA	B-X
)	B-X
as	B-X
well	B-X
as	B-X
the	B-X
phospholipase	B-X
C	B-X
gene	B-X
(	B-X
plc	B-X
)	B-X
.	B-X

Further	O
metabolic	O
genes	O
common	O
to	O
both	O
pathogens	O
are	O
dctA	B-Protein
responsible	O
for	O
transport	O
of	O
C4	O
-	O
dicarboxylates	O
across	O
the	O
membrane	O
,	O
the	O
UhpABC	B-Protein
regulatory	O
system	O
controlling	O
the	O
hexose	O
phosphate	O
transport	O
by	O
UhpT	B-Protein
,	O
and	O
the	O
three	O
Mg2	O
+	O
transport	O
systems	O
CorA	B-Protein
,	O
MgtA	B-Protein
and	O
MgtB	B-Protein
.	O

The	O
uhpABC	B-Protein
operon	O
as	O
well	O
as	O
mgtC	B-Protein
encoding	O
the	O
Mg2	O
+	O
transport	O
ATPase	O
subunit	O
have	O
been	O
found	O
to	O
be	O
induced	O
at	O
low	O
temperature	O
in	O
Y	O
.	O
enterocolitica	O
[	O
67	O
]	O
,	O
indicating	O
a	O
relevance	O
for	O
these	O
metabolic	O
genes	O
for	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
during	O
insect	O
infection	O
.	O

Another	O
gene	O
,	O
gltP	B-Protein
encoding	O
a	O
glutamate	O
-	O
aspartate	O
symporter	O
,	O
is	O
also	O
up	O
-	O
regulated	O
at	O
low	O
temperature	O
in	O
Y	O
.	O
enterocolitica	O
,	O
but	O
lacks	O
a	O
counterpart	O
in	O
P	O
.	O
luminescens	O
.	O

Furthermore	O
,	O
both	O
insecticidal	O
bacteria	O
produce	O
a	O
chitin	O
-	O
binding	O
-	O
like	O
protein	O
(	O
Plu2352	B-Protein
,	O
YE3576	B-Protein
)	O
,	O
but	O
chitinase	O
-	O
like	O
proteins	O
(	O
Plu2235	B-Protein
,	O
Plu2458	B-Protein
and	O
Plu2461	B-Protein
)	O
are	O
without	O
homologues	O
in	O
Y	O
.	O
enterocolitica	O
.	O

This	O
fact	O
correlates	O
once	O
more	O
with	O
the	O
separate	O
lifestyle	O
of	O
both	O
bacteria	O
,	O
e	O
.	O
g	O
.	O
association	O
with	O
the	O
host	O
and	O
persistence	O
for	O
Y	O
.	O
enterocolitica	O
,	O
and	O
association	O
and	O
bioconversion	O
of	O
the	O
insect	O
in	O
case	O
of	O
P	O
.	O
luminescens	O
.	O

Iron	O
uptake	O
<EOS>	B-X
Iron	B-X
is	B-X
a	B-X
vital	B-X
although	B-X
biologically	B-X
inaccessible	B-X
trace	B-X
nutrient	B-X
for	B-X
nearly	B-X
all	B-X
forms	B-X
of	B-X
life	B-X
but	B-X
``	B-X
free	B-X
''	B-X
iron	B-X
can	B-X
be	B-X
deleterious	B-X
to	B-X
cells	B-X
and	B-X
thus	B-X
iron	B-X
uptake	B-X
and	B-X
storage	B-X
must	B-X
be	B-X
carefully	B-X
controlled	B-X
.	B-X
The	B-X
marine	B-X
environment	B-X
is	B-X
particularly	B-X
iron	B-X
poor	B-X
making	B-X
mechanisms	B-X
for	B-X
its	B-X
uptake	B-X
and	B-X
storage	B-X
even	B-X
more	B-X
imperative	B-X
.	B-X
In	B-X
this	B-X
brief	B-X
review	B-X
we	B-X
explore	B-X
the	B-X
known	B-X
and	B-X
potential	B-X
iron	B-X
uptake	B-X
and	B-X
storage	B-X
pathways	B-X
for	B-X
the	B-X
biologically	B-X
and	B-X
economically	B-X
important	B-X
marine	B-X
brown	B-X
macroalgae	B-X
(	B-X
seaweeds/kelps	B-X
)	B-X
.	B-X
Many	B-X
recently	B-X
identified	B-X
proteins	B-X
are	B-X
involved	B-X
in	B-X
absorption	B-X
,	B-X
storage	B-X
,	B-X
and	B-X
cellular	B-X
export	B-X
of	B-X
nonheme	B-X
iron	B-X
and	B-X
in	B-X
erythroblast	B-X
uptake	B-X
and	B-X
utilization	B-X
of	B-X
iron	B-X
.	B-X
Erythroblast	B-X
heme	B-X
levels	B-X
regulate	B-X
uptake	B-X
of	B-X
iron	B-X
and	B-X
globin	B-X
synthesis	B-X
such	B-X
that	B-X
iron	B-X
deficiency	B-X
causes	B-X
anemia	B-X
by	B-X
retarded	B-X
production	B-X
rates	B-X
with	B-X
smaller	B-X
,	B-X
less	B-X
hemoglobinized	B-X
erythrocytes	B-X
.	B-X

Bacteria	O
use	O
two	O
different	O
strategies	O
to	O
acquire	O
sufficient	O
amounts	O
of	O
iron	O
,	O
namely	O
the	O
expression	O
and	O
secretion	O
of	O
high	O
-	O
affinity	O
iron	O
-	O
binding	O
compounds	O
called	O
siderophores	O
,	O
and	O
the	O
production	O
of	O
receptors	O
for	O
iron	O
carriers	O
such	O
as	O
heme	O
.	O

Genes	O
involved	O
in	O
the	O
biosynthesis	O
,	O
transport	O
and	O
regulation	O
of	O
the	O
siderophore	O
yersiniabactin	O
are	O
clustered	O
in	O
the	O
high	O
pathogenicity	O
island	O
of	O
Y	O
.	O
enterocolitica	O
[	O
103	O
]	O
and	O
have	O
counterparts	O
in	O
P	O
.	O
luminescens	O
(	O
plu2316	O
-	O
2324	O
)	O
.	O

Remarkably	O
,	O
yersiniabactin	O
is	O
absent	O
in	O
all	O
Y	O
.	O
enterocolitica	O
strains	O
beside	O
biovar	O
1B	O
.	O

Present	O
in	O
both	O
bacterial	O
organisms	O
compared	O
here	O
are	O
also	O
genes	O
encoding	O
a	O
hemine	O
uptake	O
system	O
(	O
ye0323	B-Protein
-	O
0332	B-Protein
/	O
plu2631	B-Protein
-	O
2636	B-Protein
)	O
,	O
the	O
YfeABCD	B-Protein
transporter	O
system	O
of	O
chelated	O
iron	O
,	O
the	O
ferrous	O
(	O
Fe2	O
+	O
)	O
iron	O
transporter	O
proteins	O
FeoAB	B-Protein
,	O
the	O
AfuABC	B-Protein
/	O
SfuABC	B-Protein
ferric	O
(	O
Fe3	O
+	O
)	O
transporter	O
,	O
the	O
enterobactin	O
and	O
its	O
transporter	O
(	O
FepBDCG	B-Protein
)	O
,	O
the	O
FecABCDE	B-Protein
ABC	O
transporter	O
system	O
,	O
and	O
several	O
putative	O
hemin	O
/	O
siderophore	O
/	O
iron	O
uptake	O
proteins	O
(	O
YE1459	B-Protein
-	O
1461	B-Protein
/	O
Plu2850	B-Protein
-	O
2852	B-Protein
)	O
,	O
YE3190	B-Protein
/	O
Plu2853	B-Protein
,	O
and	O
YE0555	B-Protein
/	O
Plu3738	B-Protein
)	O
.	O

The	O
proteins	O
encoded	O
by	O
the	O
P	O
.	O
luminescens	O
fecIRABCDE	B-Protein
operon	O
are	O
similar	O
to	O
the	O
components	O
of	O
the	O
E	O
.	O
coli	O
Fe3	O
+	O
-	O
dicitrate	O
transport	O
system	O
.	O

Homologues	O
are	O
present	O
in	O
the	O
genome	O
of	O
Y	O
.	O
enterocolitica	O
,	O
but	O
scattered	O
over	O
the	O
chromosome	O
.	O

In	O
addition	O
,	O
Y	O
.	O
enterocolitica	O
produces	O
two	O
heme	O
-	O
protein	O
acquisition	O
sytems	O
(	O
YE0123	B-Protein
-	O
126	B-Protein
,	O
YE2180	B-Protein
-	O
2182	B-Protein
)	O
,	O
a	O
second	O
SfuABC	B-Protein
system	O
,	O
the	O
ferrichrome	O
binding	O
and	O
transport	O
proteins	O
(	O
YE0730	B-Protein
-	O
0732	B-Protein
)	O
,	O
a	O
putative	O
siderophore	O
(	O
YE0704	B-Protein
)	O
,	O
and	O
a	O
hemin	O
storage	O
system	O
(	O
YE2481	B-Protein
-	O
2484	B-Protein
)	O
.	O

None	O
of	O
these	O
iron	O
acquisition	O
systems	O
is	O
present	O
in	O
P	O
.	O
luminescens	O
which	O
in	O
contrast	O
produces	O
the	O
siderophore	O
photobactin	O
[	O
104	O
]	O
.	O

Furthermore	O
,	O
P	O
.	O
luminescens	O
encodes	O
two	O
putative	O
heme	O
-	O
binding	O
hemopexin	O
-	O
like	O
proteins	O
,	O
the	O
photopexins	O
PpxA	B-Protein
(	O
Plu4242	B-Protein
)	O
and	O
PpxB	B-Protein
(	O
Plu4243	B-Protein
)	O
,	O
which	O
are	O
the	O
first	O
hemopexins	O
found	O
in	O
bacteria	O
.	O

It	O
is	O
suggested	O
that	O
the	O
photopexins	O
may	O
be	O
used	O
by	O
P	O
.	O
luminescens	O
to	O
scavenge	O
iron	O
containing	O
compounds	O
from	O
insects	O
[	O
105	O
]	O
.	O

Interestingly	O
,	O
three	O
gene	O
loci	O
involved	O
in	O
iron	O
acquisition	O
,	O
namely	O
the	O
genes	O
encoding	O
the	O
hemin	O
storage	O
system	O
,	O
the	O
yersiniabactin	O
and	O
the	O
enterobactin	O
transporter	O
FepG	B-Protein
,	O
have	O
been	O
demonstrated	O
to	O
be	O
up	O
-	O
regulated	O
upon	O
temperature	O
decrease	O
in	O
Y	O
.	O
pestis	O
or	O
Y	O
.	O
ruckeri	O
,	O
respectively	O
(	O
Table	O
1	O
)	O
.	O

This	O
large	O
set	O
of	O
iron	O
,	O
hemin	O
,	O
heme	O
and	O
siderophore	O
transporters	O
underlines	O
the	O
importance	O
of	O
iron	O
availability	O
for	O
the	O
life	O
cycles	O
of	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
.	O

It	O
also	O
indicates	O
that	O
iron	O
acquisition	O
is	O
a	O
prerequisite	O
for	O
the	O
infection	O
process	O
of	O
pathogenic	O
bacteria	O
not	O
only	O
in	O
mammalian	O
,	O
but	O
also	O
in	O
invertebrate	O
hosts	O
,	O
and	O
underlines	O
the	O
suggestion	O
that	O
genetic	O
determinants	O
of	O
invertebrate	O
pathogens	O
such	O
as	O
P	O
.	O
luminescens	O
include	O
the	O
progenitors	O
of	O
virulence	O
factors	O
against	O
vertebrates	O
[	O
79	O
,	O
106	O
]	O
.	O

Tricarboxylate	O
utilization	O
<EOS>	B-X
Thus	B-X
,	B-X
PC	B-X
activity	B-X
may	B-X
be	B-X
essential	B-X
to	B-X
link	B-X
energy	B-X
substrate	B-X
utilization	B-X
with	B-X
cancer	B-X
progression	B-X
and	B-X
to	B-X
enable	B-X
the	B-X
metabolic	B-X
flexibility	B-X
necessary	B-X
for	B-X
cell	B-X
resilience	B-X
to	B-X
changing	B-X
and	B-X
adverse	B-X
conditions	B-X
during	B-X
the	B-X
metastatic	B-X
process	B-X
.	B-X
CAI	B-X
suppressed	B-X
glucose	B-X
and	B-X
lipid	B-X
metabolism	B-X
utilization	B-X
,	B-X
causing	B-X
inhibition	B-X
of	B-X
mitochondrial	B-X
respiratory	B-X
chain	B-X
complex	B-X
I	B-X
,	B-X
thus	B-X
producing	B-X
reactive	B-X
oxygen	B-X
species	B-X
(	B-X
ROS	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reducing	B-X
dietary	B-X
fructose	B-X
or	B-X
pharmacological	B-X
blockade	B-X
of	B-X
fructose	B-X
utilization	B-X
significantly	B-X
reduced	B-X
CRC	B-X
growth	B-X
and	B-X
sensitized	B-X
CRC	B-X
cells	B-X
to	B-X
chemotherapy	B-X
in	B-X
vivo	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
findings	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
elevated	B-X
fructose	B-X
utilization	B-X
mediated	B-X
by	B-X
the	B-X
GLUT5-KHK	B-X
axis	B-X
in	B-X
governing	B-X
CRC	B-X
growth	B-X
and	B-X
imply	B-X
that	B-X
efforts	B-X
to	B-X
refine	B-X
fructose	B-X
intake	B-X
or	B-X
inhibit	B-X
fructose-mediated	B-X
actions	B-X
may	B-X
serve	B-X
as	B-X
potential	B-X
therapeutic	B-X
strategies	B-X
.	B-X

The	O
TctE	B-Protein
/	O
TctD	B-Protein
system	O
is	O
the	O
only	O
TCS	O
of	O
P	O
.	O
luminescens	O
without	O
homologue	O
in	O
Y	O
.	O
enterocolitica	O
(	O
see	O
section	O
"	O
Two	O
-	O
component	O
signal	O
transduction	O
"	O
,	O
Fig	O
.	O
2	O
)	O
.	O

It	O
controls	O
the	O
expression	O
of	O
the	O
tctCBA	B-Protein
operon	O
encoding	O
the	O
tricarboxylic	O
acid	O
transport	O
system	O
TctCBA	B-Protein
[	O
107	O
]	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
membrane	B-X
transport	B-X
process	B-X
for	B-X
the	B-X
tricarboxylic	B-X
acid	B-X
cycle	B-X
intermediates	B-X
citrate	B-X
and	B-X
Genome	B-X
analysis	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
two	B-X
putative	B-X
citrate	B-X
transport	B-X
systems	B-X
.	B-X
The	B-X
permease	B-X
encoded	B-X
by	B-X
citH	B-X
belongs	B-X
to	B-X
the	B-X
citrate-Mg	B-X
(	B-X
2+	B-X
)	B-X
:	B-X
H	B-X
(	B-X
+	B-X
)	B-X
/citrate-Ca	B-X
(	B-X
2+	B-X
)	B-X
:	B-X
H	B-X
(	B-X
+	B-X
)	B-X
symporter	B-X
family	B-X
,	B-X
whereas	B-X
the	B-X
permease	B-X
encoded	B-X
by	B-X
the	B-X
tctCBA	B-X
operon	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
tripartite	B-X
tricarboxylate	B-X
transporter	B-X
family	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
citH	B-X
or	B-X
tctCBA	B-X
in	B-X
Escherichia	B-X
coli	B-X
enabled	B-X
this	B-X
species	B-X
to	B-X
utilize	B-X
citrate	B-X
aerobically	B-X
,	B-X
indicating	B-X
that	B-X
both	B-X
CitH	B-X
and	B-X
TctABC	B-X
are	B-X
functional	B-X
citrate	B-X
transporters	B-X
.	B-X
Each	B-X
of	B-X
the	B-X
two	B-X
transporters	B-X
alone	B-X
was	B-X
sufficient	B-X
for	B-X
growth	B-X
on	B-X
citrate	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
citH	B-X
and	B-X
tctCBA	B-X
was	B-X
activated	B-X
by	B-X
citrate	B-X
in	B-X
the	B-X
growth	B-X
medium	B-X
,	B-X
independent	B-X
of	B-X
the	B-X
presence	B-X
or	B-X
absence	B-X
of	B-X
glucose	B-X
.	B-X
This	B-X
activation	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
two-component	B-X
signal	B-X
transduction	B-X
system	B-X
CitAB	B-X
,	B-X
composed	B-X
of	B-X
the	B-X
sensor	B-X
kinase	B-X
CitA	B-X
and	B-X
the	B-X
response	B-X
regulator	B-X
CitB	B-X
.	B-X
CitAB	B-X
belongs	B-X
to	B-X
the	B-X
CitAB/DcuSR	B-X
family	B-X
of	B-X
two-component	B-X
systems	B-X
,	B-X
whose	B-X
members	B-X
control	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
transport	B-X
and	B-X
catabolism	B-X
of	B-X
tricarboxylates	B-X
or	B-X
dicarboxylates	B-X
.	B-X

The	O
transporter	O
is	O
supposed	O
to	O
facilitate	O
uptake	O
of	O
citrate	O
,	O
fluorocitrate	O
,	O
isocitrate	O
and	O
cis	O
-	O
acconitate	O
for	O
aerobic	O
utilization	O
[	O
108	O
,	O
109	O
]	O
.	O

The	O
Na	O
+	O
dependent	O
citrate	O
symporter	O
CitS	B-Protein
of	O
S	O
.	O
enterica	O
,	O
which	O
the	O
Y	O
.	O
enterocolitica	O
protein	O
YE2507	B-Protein
is	O
homologous	O
to	O
,	O
is	O
induced	O
by	O
the	O
CitA	B-Protein
/	O
CitB	B-Protein
system	O
for	O
fermentation	O
of	O
citrate	O
under	O
anoxic	O
conditions	O
[	O
110	O
]	O
,	O
indicating	O
a	O
general	O
difference	O
of	O
citrate	O
utilization	O
in	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
.	O

While	O
Y	O
.	O
enterocolitica	O
explores	O
citrate	O
for	O
anaerobic	O
metabolism	O
,	O
it	O
is	O
most	O
likely	O
that	O
the	O
specific	O
uptake	O
of	O
citrate	O
and	O
other	O
tricarboxylic	O
acids	O
by	O
TctCBA	O
is	O
used	O
by	O
P	O
.	O
luminescens	O
upon	O
entering	O
the	O
insect	O
host	O
where	O
enough	O
citrate	O
is	O
available	O
.	O

The	O
specific	O
up	O
-	O
regulation	O
of	O
the	O
tricarboxylic	O
acid	O
cycle	O
(	O
TCA	O
)	O
enzymes	O
within	O
a	O
host	O
has	O
also	O
been	O
described	O
for	O
other	O
microorganisms	O
.	O

For	O
example	O
,	O
sucA	B-Protein
encoding	O
a	O
subunit	O
of	O
alpha	O
-	O
ketoglutarate	O
synthase	O
and	O
acnA	B-Protein
encoding	O
the	O
aconitase	O
have	O
been	O
found	O
to	O
be	O
induced	O
in	O
V	O
.	O
cholerae	O
during	O
host	O
infection	O
[	O
111	O
,	O
112	O
]	O
,	O
and	O
a	O
complete	O
TCA	O
cycle	O
is	O
also	O
required	O
for	O
S	O
.	O
typhimurium	O
virulence	O
[	O
113	O
]	O
.	O

We	O
also	O
observed	O
induction	O
of	O
sucA	B-Protein
in	O
P	O
.	O
luminescens	O
in	O
the	O
insect	O
host	O
Galleria	O
mellonella	O
(	O
R	O
.	O
Heermann	O
,	O
unpublished	O
data	O
)	O
.	O

This	O
finding	O
underlines	O
the	O
hypothesis	O
that	O
the	O
citric	O
cycle	O
enzymes	O
used	O
under	O
aerobic	O
conditions	O
are	O
up	O
-	O
regulated	O
as	O
a	O
specific	O
adaptation	O
of	O
the	O
metabolic	O
activity	O
in	O
the	O
nutrient	O
rich	O
insect	O
host	O
.	O

To	O
guarantee	O
an	O
optimal	O
amount	O
of	O
tricarboxylic	O
acids	O
within	O
the	O
cell	O
,	O
TctE	B-Protein
might	O
specifically	O
sense	O
the	O
presence	O
of	O
tricarboxylic	O
acids	O
and	O
/	O
or	O
signals	O
of	O
the	O
host	O
.	O
<EOS>	B-X
The	B-X
cGAS-STING	B-X
signalling	B-X
pathway	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
key	B-X
mediator	B-X
of	B-X
inflammation	B-X
in	B-X
the	B-X
settings	B-X
of	B-X
infection	B-X
,	B-X
cellular	B-X
stress	B-X
and	B-X
tissue	B-X
damage	B-X
.	B-X
Underlying	B-X
this	B-X
broad	B-X
involvement	B-X
of	B-X
the	B-X
cGAS-STING	B-X
pathway	B-X
is	B-X
its	B-X
capacity	B-X
to	B-X
sense	B-X
and	B-X
regulate	B-X
the	B-X
cellular	B-X
response	B-X
towards	B-X
microbial	B-X
and	B-X
host-derived	B-X
DNAs	B-X
,	B-X
which	B-X
serve	B-X
as	B-X
ubiquitous	B-X
danger-associated	B-X
molecules	B-X
.	B-X
While	B-X
the	B-X
proinflammatory	B-X
properties	B-X
of	B-X
IL-17	B-X
are	B-X
key	B-X
to	B-X
its	B-X
host-protective	B-X
capacity	B-X
,	B-X
unrestrained	B-X
IL-17	B-X
signaling	B-X
is	B-X
associated	B-X
with	B-X
immunopathology	B-X
,	B-X
autoimmune	B-X
disease	B-X
,	B-X
and	B-X
cancer	B-X
progression	B-X
.	B-X
We	B-X
highlight	B-X
the	B-X
surprisingly	B-X
diverse	B-X
means	B-X
by	B-X
which	B-X
these	B-X
regulators	B-X
control	B-X
expression	B-X
of	B-X
IL-17-dependent	B-X
inflammatory	B-X
genes	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
major	B-X
target	B-X
cells	B-X
that	B-X
respond	B-X
to	B-X
IL-17	B-X
signaling	B-X
.	B-X

Y	O
.	O
enterocolitica	O
and	O
Y	O
.	O
pestis	O
,	O
in	O
contrast	O
exhibit	O
upregulation	O
of	O
all	O
TCA	O
genes	O
upon	O
temperature	O
shift	O
from	O
26degreesC	O
to	O
37degreesC	O
[	O
114	O
,	O
115	O
]	O
.	O

Therefore	O
,	O
it	O
is	O
obvious	O
that	O
Y	O
.	O
enterocolitica	O
and	O
P	O
.	O
luminescens	O
use	O
different	O
sensing	O
and	O
utilization	O
strategies	O
for	O
tricarboxylates	O
.	O

Temperature	O
-	O
dependent	O
genes	O
<EOS>	B-X
The	B-X
Listeria	B-X
monocytogenes	B-X
genome	B-X
contains	B-X
genes	B-X
encoding	B-X
several	B-X
internalins	B-X
and	B-X
internalin-like	B-X
proteins	B-X
.	B-X
As	B-X
L.	B-X
monocytogenes	B-X
is	B-X
present	B-X
in	B-X
many	B-X
environments	B-X
and	B-X
can	B-X
infect	B-X
numerous	B-X
,	B-X
diverse	B-X
host	B-X
species	B-X
,	B-X
the	B-X
environmental	B-X
temperature	B-X
was	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
signal	B-X
that	B-X
might	B-X
affect	B-X
internalin	B-X
gene	B-X
transcription	B-X
.	B-X
A	B-X
subgenomic	B-X
microarray	B-X
was	B-X
used	B-X
to	B-X
investigate	B-X
temperature-dependent	B-X
transcription	B-X
of	B-X
24	B-X
members	B-X
of	B-X
the	B-X
internalin	B-X
gene	B-X
family	B-X
in	B-X
L.	B-X
monocytogenes	B-X
10403S	B-X
.	B-X
The	B-X
levels	B-X
of	B-X
internalin	B-X
gene	B-X
transcripts	B-X
for	B-X
cells	B-X
grown	B-X
at	B-X
37	B-X
degrees	B-X
C	B-X
were	B-X
compared	B-X
to	B-X
the	B-X
levels	B-X
of	B-X
transcripts	B-X
for	B-X
cells	B-X
grown	B-X
at	B-X
16	B-X
,	B-X
30	B-X
,	B-X
and	B-X
42	B-X
degrees	B-X
C	B-X
using	B-X
competitive	B-X
microarray	B-X
hybridization	B-X
,	B-X
and	B-X
the	B-X
results	B-X
were	B-X
confirmed	B-X
by	B-X
performing	B-X
quantitative	B-X
reverse	B-X
transcriptase	B-X
PCR	B-X
for	B-X
14	B-X
internalin	B-X
genes	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
studies	B-X
,	B-X
the	B-X
internalin	B-X
genes	B-X
can	B-X
be	B-X
grouped	B-X
into	B-X
the	B-X
following	B-X
five	B-X
temperature-dependent	B-X
categories	B-X
:	B-X
(	B-X
i	B-X
)	B-X
four	B-X
sigma	B-X
(	B-X
B	B-X
)	B-X
-dependent	B-X
internalin	B-X
genes	B-X
(	B-X
inlC2	B-X
,	B-X
inlD	B-X
,	B-X
lmo0331	B-X
,	B-X
and	B-X
lmo0610	B-X
)	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
16	B-X
degrees	B-X
C	B-X
and	B-X
generally	B-X
the	B-X
lowest	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
37	B-X
degrees	B-X
C	B-X
;	B-X
(	B-X
ii	B-X
)	B-X
three	B-X
partially	B-X
PrfA-dependent	B-X
internalin	B-X
genes	B-X
(	B-X
inlA	B-X
,	B-X
inlB	B-X
,	B-X
and	B-X
inlC	B-X
)	B-X
with	B-X
the	B-X
lowest	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
16	B-X
degrees	B-X
C	B-X
and	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
37	B-X
and	B-X
42	B-X
degrees	B-X
C	B-X
;	B-X
(	B-X
iii	B-X
)	B-X
four	B-X
genes	B-X
(	B-X
inlG	B-X
,	B-X
inlJ	B-X
,	B-X
lmo0514	B-X
,	B-X
and	B-X
lmo1290	B-X
)	B-X
with	B-X
the	B-X
lowest	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
16	B-X
degrees	B-X
C	B-X
and	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
30	B-X
and/or	B-X
37	B-X
degrees	B-X
C	B-X
;	B-X
(	B-X
iv	B-X
)	B-X
one	B-X
gene	B-X
(	B-X
lmo0327	B-X
)	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
16	B-X
degrees	B-X
C	B-X
and	B-X
low	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
higher	B-X
temperatures	B-X
;	B-X
and	B-X
(	B-X
v	B-X
)	B-X
12	B-X
internalin	B-X
genes	B-X
with	B-X
no	B-X
differences	B-X
in	B-X
the	B-X
levels	B-X
of	B-X
transcripts	B-X
at	B-X
the	B-X
temperatures	B-X
used	B-X
in	B-X
this	B-X
study	B-X
.	B-X
The	B-X
temperature-dependent	B-X
transcription	B-X
patterns	B-X
suggest	B-X
that	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
different	B-X
internalins	B-X
varies	B-X
by	B-X
environment	B-X
,	B-X
which	B-X
may	B-X
provide	B-X
insight	B-X
into	B-X
the	B-X
specific	B-X
functions	B-X
of	B-X
these	B-X
proteins	B-X
.	B-X

Temperature	O
is	O
a	O
key	O
environmental	O
signal	O
to	O
enable	O
bacterial	O
adaptation	O
to	O
diverse	O
hosts	O
.	O
<EOS>	B-X
RpoE	B-X
is	B-X
an	B-X
alternative	B-X
sigma	B-X
(	B-X
σ	B-X
)	B-X
factor	B-X
involved	B-X
in	B-X
regulated	B-X
intramembrane	B-X
proteolytic	B-X
(	B-X
RIP	B-X
)	B-X
cascade	B-X
,	B-X
enabling	B-X
bacterial	B-X
pathogens	B-X
to	B-X
coordinate	B-X
the	B-X
expression	B-X
of	B-X
genetic	B-X
traits	B-X
associated	B-X
with	B-X
stress	B-X
adaptation	B-X
and	B-X
virulence	B-X
determinants	B-X
in	B-X
response	B-X
to	B-X
diverse	B-X
stimuli	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
of	B-X
the	B-X
hosts	B-X
.	B-X
RpoE	B-X
regulon	B-X
genes	B-X
are	B-X
involved	B-X
in	B-X
various	B-X
processes	B-X
associated	B-X
with	B-X
bacterial	B-X
signal	B-X
transduction	B-X
,	B-X
membrane	B-X
homeostasis	B-X
,	B-X
energy	B-X
metabolism	B-X
and	B-X
virulence	B-X
.	B-X
Collectively	B-X
,	B-X
RpoE-centered	B-X
RIP	B-X
cascade	B-X
appeared	B-X
to	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
control	B-X
of	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
adaptation	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
niches	B-X
by	B-X
thermal	B-X
sensing	B-X
in	B-X
P.	B-X
plecoglossicida	B-X
.	B-X
These	B-X
results	B-X
facilitates	B-X
to	B-X
reveal	B-X
the	B-X
pathogenic	B-X
mechanisms	B-X
of	B-X
P.	B-X
plecoglossicida	B-X
causing	B-X
fish	B-X
diseases	B-X
and	B-X
provides	B-X
new	B-X
perspectives	B-X
to	B-X
control	B-X
bacterial	B-X
infection	B-X
.	B-X

In	O
Yersinia	O
,	O
temperature	O
-	O
dependent	O
gene	O
expression	O
has	O
been	O
described	O
to	O
be	O
an	O
important	O
theme	O
in	O
bacterial	O
mechanisms	O
of	O
pathogenesis	O
towards	O
humans	O
[	O
116	O
]	O
.	O

However	O
,	O
the	O
biological	O
role	O
of	O
genes	O
repressed	O
at	O
body	O
temperature	O
,	O
but	O
induced	O
at	O
environmental	O
temperature	O
,	O
has	O
been	O
underinvestigated	O
so	O
far	O
.	O

By	O
data	O
mining	O
,	O
we	O
identified	O
32	O
genes	O
or	O
gene	O
loci	O
of	O
Yersinia	O
spp	O
.	O
that	O
exhibit	O
stronger	O
expression	O
with	O
temperature	O
decrease	O
(	O
Table	O
1	O
)	O
.	O
<EOS>	B-X
Hence	B-X
,	B-X
the	B-X
ability	B-X
to	B-X
predict	B-X
sponges	B-X
from	B-X
the	B-X
analysis	B-X
of	B-X
large	B-X
expression	B-X
data	B-X
sets	B-X
(	B-X
e.g	B-X
.	B-X
from	B-X
international	B-X
cancer	B-X
projects	B-X
)	B-X
has	B-X
become	B-X
an	B-X
important	B-X
data	B-X
mining	B-X
task	B-X
in	B-X
bioinformatics	B-X
.	B-X
We	B-X
present	B-X
a	B-X
technique	B-X
designed	B-X
to	B-X
mine	B-X
sponge	B-X
phenomena	B-X
whose	B-X
presence	B-X
or	B-X
absence	B-X
may	B-X
discriminate	B-X
between	B-X
healthy	B-X
and	B-X
unhealthy	B-X
populations	B-X
of	B-X
samples	B-X
in	B-X
tumoral	B-X
or	B-X
normal	B-X
expression	B-X
data	B-X
sets	B-X
,	B-X
thus	B-X
providing	B-X
lists	B-X
of	B-X
candidates	B-X
potentially	B-X
relevant	B-X
in	B-X
the	B-X
pathology	B-X
.	B-X
The	B-X
results	B-X
on	B-X
tumoral	B-X
expression	B-X
data	B-X
,	B-X
concerning	B-X
five	B-X
different	B-X
cancer	B-X
types	B-X
,	B-X
confirmed	B-X
the	B-X
effectiveness	B-X
of	B-X
the	B-X
approach	B-X
in	B-X
mining	B-X
interesting	B-X
knowledge	B-X
.	B-X
Indeed	B-X
,	B-X
32	B-X
out	B-X
of	B-X
33	B-X
miRNAs	B-X
and	B-X
22	B-X
out	B-X
of	B-X
25	B-X
protein-coding	B-X
genes	B-X
identified	B-X
as	B-X
top	B-X
scoring	B-X
in	B-X
our	B-X
analysis	B-X
are	B-X
corroborated	B-X
by	B-X
having	B-X
been	B-X
similarly	B-X
associated	B-X
with	B-X
cancer	B-X
processes	B-X
in	B-X
independent	B-X
studies	B-X
.	B-X
In	B-X
fact	B-X
,	B-X
the	B-X
subset	B-X
of	B-X
miRNAs	B-X
selected	B-X
by	B-X
the	B-X
sponge	B-X
analysis	B-X
results	B-X
in	B-X
a	B-X
significant	B-X
enrichment	B-X
of	B-X
annotation	B-X
for	B-X
the	B-X
KEGG32	B-X
pathway	B-X
``	B-X
microRNAs	B-X
in	B-X
cancer	B-X
''	B-X
when	B-X
tested	B-X
with	B-X
the	B-X
commonly	B-X
used	B-X
bioinformatic	B-X
resource	B-X
DAVID	B-X
.	B-X
Moreover	B-X
,	B-X
often	B-X
the	B-X
cancer	B-X
datasets	B-X
where	B-X
our	B-X
sponge	B-X
analysis	B-X
identified	B-X
a	B-X
miRNA	B-X
as	B-X
top	B-X
scoring	B-X
match	B-X
the	B-X
one	B-X
reported	B-X
already	B-X
in	B-X
the	B-X
pertaining	B-X
literature	B-X
.	B-X

19	O
of	O
them	O
have	O
a	O
homologue	O
in	O
P	O
.	O
luminescens	O
.	O

Most	O
genes	O
belong	O
to	O
the	O
groups	O
of	O
offensive	O
virulence	O
factors	O
,	O
regulators	O
,	O
and	O
metabolic	O
enzymes	O
.	O

The	O
data	O
have	O
derived	O
from	O
expression	O
profiling	O
in	O
vitro	O
and	O
cannot	O
directly	O
be	O
translated	O
to	O
the	O
in	O
vivo	O
situation	O
.	O

Moreover	O
,	O
several	O
genes	O
induced	O
at	O
lower	O
temperature	O
such	O
as	O
inv	B-Protein
,	O
yst	B-Protein
or	O
yplA	B-Protein
affect	O
the	O
virulence	O
properties	O
of	O
Y	O
.	O
enterocolitica	O
in	O
mice	O
[	O
87	O
]	O
.	O

However	O
,	O
low	O
temperature	O
-	O
dependent	O
expression	O
of	O
the	O
genes	O
in	O
Table	O
1	O
suggests	O
that	O
they	O
also	O
play	O
a	O
role	O
during	O
the	O
insect	O
stage	O
of	O
Y	O
.	O
enterocolitica	O
,	O
or	O
that	O
they	O
have	O
evolved	O
from	O
bacteria	O
-	O
insect	O
interaction	O
and	O
then	O
adapted	O
to	O
pathogenicity	O
towards	O
mammals	O
.	O
<EOS>	B-X
In	B-X
view	B-X
of	B-X
this	B-X
,	B-X
metabolism	B-X
is	B-X
considered	B-X
the	B-X
driving	B-X
factor	B-X
upon	B-X
the	B-X
interactions	B-X
of	B-X
GLS-producing	B-X
plants	B-X
with	B-X
other	B-X
organisms	B-X
,	B-X
also	B-X
influenced	B-X
by	B-X
plant	B-X
and	B-X
plant	B-X
attacking	B-X
or	B-X
digesting	B-X
organism	B-X
characteristics	B-X
.	B-X
Several	B-X
microbial	B-X
pathogens	B-X
and	B-X
insects	B-X
have	B-X
evolved	B-X
the	B-X
capacity	B-X
to	B-X
detoxify	B-X
GLS-hydrolysis	B-X
products	B-X
or	B-X
inhibit	B-X
their	B-X
formation	B-X
via	B-X
different	B-X
means	B-X
,	B-X
highlighting	B-X
the	B-X
relevance	B-X
of	B-X
their	B-X
metabolic	B-X
abilities	B-X
for	B-X
the	B-X
plants	B-X
'	B-X
defense	B-X
system	B-X
activation	B-X
and	B-X
target	B-X
organism	B-X
detoxification	B-X
.	B-X
Strikingly	B-X
,	B-X
some	B-X
bacteria	B-X
,	B-X
fungi	B-X
and	B-X
insects	B-X
can	B-X
likewise	B-X
produce	B-X
their	B-X
own	B-X
myrosinase	B-X
(	B-X
MYR	B-X
)	B-X
-like	B-X
enzymes	B-X
in	B-X
one	B-X
of	B-X
the	B-X
most	B-X
important	B-X
adaptation	B-X
strategies	B-X
against	B-X
the	B-X
GLS-MYR	B-X
plant	B-X
defense	B-X
system	B-X
.	B-X
However	B-X
,	B-X
the	B-X
efficiency	B-X
of	B-X
such	B-X
approaches	B-X
is	B-X
dependent	B-X
on	B-X
GLS	B-X
bioavailability	B-X
and	B-X
metabolism	B-X
,	B-X
which	B-X
largely	B-X
involves	B-X
the	B-X
human	B-X
gut	B-X
microbiome	B-X
.	B-X
Deciphering	B-X
GLS	B-X
metabolic	B-X
pathways	B-X
provides	B-X
critical	B-X
information	B-X
for	B-X
catalyzing	B-X
all	B-X
types	B-X
of	B-X
GLS	B-X
towards	B-X
the	B-X
generation	B-X
of	B-X
ITCs	B-X
as	B-X
the	B-X
biologically	B-X
most	B-X
active	B-X
metabolites	B-X
.	B-X
This	B-X
review	B-X
provides	B-X
an	B-X
overview	B-X
on	B-X
contrasting	B-X
metabolic	B-X
pathways	B-X
in	B-X
plants	B-X
,	B-X
bacteria	B-X
,	B-X
fungi	B-X
,	B-X
insects	B-X
and	B-X
humans	B-X
towards	B-X
GLS	B-X
activation	B-X
or	B-X
detoxification	B-X
.	B-X

Some	O
of	O
these	O
low	O
temperature	O
-	O
induced	O
genes	O
are	O
restricted	O
to	O
a	O
narrow	O
spectrum	O
of	O
bacterial	O
genera	O
such	O
as	O
Burkholderia	O
,	O
Pseudomonas	O
,	O
Serratia	O
,	O
or	O
Erwinia	O
,	O
all	O
of	O
which	O
are	O
known	O
to	O
be	O
associated	O
with	O
soil	O
,	O
plants	O
or	O
insects	O
.	O
<EOS>	B-X
Parasitoids	B-X
depend	B-X
on	B-X
other	B-X
insects	B-X
for	B-X
the	B-X
development	B-X
of	B-X
their	B-X
offspring	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
symbionts	B-X
of	B-X
herbivorous	B-X
and	B-X
hematophagous	B-X
insects	B-X
,	B-X
parasitoid	B-X
symbionts	B-X
do	B-X
not	B-X
provide	B-X
nutrients	B-X
.	B-X
Moreover	B-X
,	B-X
recent	B-X
research	B-X
has	B-X
shown	B-X
that	B-X
parasitoid	B-X
symbionts	B-X
such	B-X
as	B-X
polydnaviruses	B-X
may	B-X
also	B-X
influence	B-X
plant-mediated	B-X
interactions	B-X
among	B-X
members	B-X
of	B-X
plant-associated	B-X
communities	B-X
at	B-X
different	B-X
trophic	B-X
levels	B-X
,	B-X
such	B-X
as	B-X
herbivores	B-X
,	B-X
parasitoids	B-X
,	B-X
and	B-X
hyperparasitoids	B-X
.	B-X
Research	B-X
over	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
ranging	B-X
from	B-X
the	B-X
biophysics	B-X
of	B-X
sound	B-X
reception	B-X
to	B-X
molecular	B-X
aspects	B-X
of	B-X
auditory	B-X
transduction	B-X
to	B-X
the	B-X
neuronal	B-X
mechanisms	B-X
of	B-X
auditory	B-X
signal	B-X
processing	B-X
,	B-X
has	B-X
greatly	B-X
advanced	B-X
our	B-X
understanding	B-X
of	B-X
how	B-X
insects	B-X
hear	B-X
.	B-X
Apart	B-X
from	B-X
evolutionary	B-X
innovations	B-X
that	B-X
seem	B-X
unique	B-X
to	B-X
insect	B-X
hearing	B-X
,	B-X
parallels	B-X
between	B-X
insect	B-X
and	B-X
vertebrate	B-X
auditory	B-X
systems	B-X
have	B-X
been	B-X
uncovered	B-X
,	B-X
and	B-X
the	B-X
auditory	B-X
sensory	B-X
cells	B-X
of	B-X
insects	B-X
and	B-X
vertebrates	B-X
turned	B-X
out	B-X
to	B-X
be	B-X
evolutionarily	B-X
related	B-X
.	B-X

Other	O
genes	O
of	O
Table	O
1	O
are	O
present	O
in	O
a	O
broader	O
range	O
of	O
bacteria	O
,	O
and	O
their	O
expression	O
might	O
depend	O
on	O
regulatory	O
mechanisms	O
different	O
from	O
that	O
of	O
Y	O
.	O
enterocolitica	O
.	O

This	O
pathogen	O
is	O
non	O
-	O
motile	O
at	O
body	O
temperature	O
,	O
and	O
a	O
connection	O
between	O
motility	O
and	O
virulence	O
is	O
well	O
-	O
documented	O
[	O
116	O
,	O
117	O
]	O
.	O

For	O
example	O
,	O
a	O
non	O
-	O
motile	O
flhDC	B-Protein
mutant	O
of	O
Y	O
.	O
enterocolitica	O
secretes	O
larger	O
amounts	O
of	O
Yop	O
proteins	O
encoded	O
by	O
the	O
pYV	O
plasmid	O
than	O
the	O
wild	O
-	O
type	O
bacteria	O
[	O
118	O
]	O
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
the	O
flagellar	O
master	O
-	O
operon	O
of	O
X	O
.	O
nematophila	O
regulates	O
the	O
expression	O
of	O
a	O
novel	O
hemolysin	O
which	O
is	O
required	O
for	O
full	O
virulence	O
of	O
X	O
.	O
nematophila	O
against	O
insects	O
[	O
119	O
]	O
.	O

We	O
therefore	O
speculate	O
that	O
motility	O
essentially	O
contributes	O
to	O
the	O
control	O
of	O
the	O
Y	O
.	O
enterocolitica	O
switch	O
between	O
two	O
pathogenicity	O
phases	O
towards	O
mammalians	O
and	O
invertebrates	O
[	O
120	O
]	O
.	O

In	O
evolutionary	O
terms	O
,	O
environmental	O
temperature	O
,	O
but	O
not	O
37degreesC	O
,	O
appears	O
as	O
the	O
ancient	O
signal	O
for	O
the	O
expression	O
of	O
many	O
genes	O
involved	O
in	O
pathogenicity	O
,	O
confirming	O
the	O
idea	O
that	O
the	O
biological	O
function	O
of	O
many	O
virulence	O
factors	O
has	O
been	O
evolved	O
during	O
the	O
association	O
of	O
bacteria	O
with	O
poikilothermic	O
organisms	O
(	O
see	O
below	O
)	O
.	O
<EOS>	B-X
Stresses	B-X
within	B-X
,	B-X
and	B-X
stress	B-X
tolerance	B-X
of	B-X
,	B-X
microbial	B-X
systems	B-X
lie	B-X
at	B-X
the	B-X
crux	B-X
of	B-X
critical	B-X
global	B-X
challenges	B-X
,	B-X
such	B-X
as	B-X
optimising	B-X
soil-	B-X
and	B-X
plant-health	B-X
and	B-X
crop	B-X
yields	B-X
;	B-X
reducing	B-X
food	B-X
spoilage	B-X
;	B-X
bioremediation	B-X
of	B-X
polluted	B-X
environments	B-X
;	B-X
effective	B-X
biological	B-X
control	B-X
and	B-X
biofuel	B-X
production	B-X
;	B-X
gaining	B-X
insight	B-X
into	B-X
aging	B-X
processes	B-X
in	B-X
humans	B-X
;	B-X
and	B-X
understanding	B-X
astrobiology	B-X
.	B-X
'Stress	B-X
'	B-X
implies	B-X
that	B-X
physical	B-X
forces	B-X
act	B-X
on	B-X
the	B-X
microbial	B-X
system	B-X
in	B-X
such	B-X
a	B-X
way	B-X
that	B-X
impairs	B-X
its	B-X
ability	B-X
to	B-X
function	B-X
.	B-X
Stresses	B-X
induced	B-X
by	B-X
temperature	B-X
,	B-X
pH	B-X
,	B-X
water	B-X
activity	B-X
,	B-X
chaotropicity	B-X
,	B-X
reactive	B-X
oxygen	B-X
species	B-X
,	B-X
dehydration-rehydration	B-X
cycles	B-X
,	B-X
ionizing	B-X
radiation	B-X
,	B-X
and	B-X
changes	B-X
in	B-X
turgor	B-X
or	B-X
other	B-X
mechanical	B-X
forces	B-X
are	B-X
well-known	B-X
.	B-X
Our	B-X
knowledge	B-X
of	B-X
cellular	B-X
stress	B-X
responses	B-X
,	B-X
such	B-X
as	B-X
signal-transduction	B-X
pathways	B-X
,	B-X
compatible-solute	B-X
metabolism	B-X
,	B-X
protein-stabilization	B-X
proteins	B-X
,	B-X
and	B-X
plasma-membrane	B-X
adaptations	B-X
,	B-X
is	B-X
also	B-X
considerable	B-X
.	B-X
However	B-X
,	B-X
we	B-X
have	B-X
limited	B-X
understanding	B-X
of	B-X
the	B-X
complex	B-X
and	B-X
dynamic	B-X
stresses	B-X
that	B-X
typically	B-X
occur	B-X
in	B-X
microbial	B-X
habitats	B-X
or	B-X
industrial	B-X
systems	B-X
,	B-X
and	B-X
how	B-X
these	B-X
impact	B-X
the	B-X
biophysics	B-X
,	B-X
cellular	B-X
biology	B-X
and	B-X
evolutionary	B-X
trajectories	B-X
of	B-X
microbes	B-X
.	B-X
Whereas	B-X
terms	B-X
such	B-X
as	B-X
'rapid-growth	B-X
stress	B-X
'	B-X
,	B-X
'nutrient	B-X
stress	B-X
'	B-X
and	B-X
'biotic	B-X
stress	B-X
'	B-X
span	B-X
a	B-X
range	B-X
of	B-X
logical	B-X
categories	B-X
,	B-X
their	B-X
modes-of-action	B-X
do	B-X
usually	B-X
involve	B-X
a	B-X
biophysical	B-X
component	B-X
.	B-X
Stress	B-X
can	B-X
impact	B-X
all	B-X
levels	B-X
of	B-X
biology	B-X
(	B-X
from	B-X
biomacromolecules	B-X
to	B-X
ecosystems	B-X
)	B-X
,	B-X
is	B-X
a	B-X
potent	B-X
driver	B-X
for	B-X
evolutionary	B-X
processes	B-X
and	B-X
-	B-X
it	B-X
could	B-X
be	B-X
argued	B-X
-	B-X
is	B-X
an	B-X
inherent	B-X
property	B-X
of	B-X
life	B-X
itself	B-X
.	B-X

Evolution	O
of	O
pathogenicity	O
<EOS>	B-X
Evolution	B-X
of	B-X
Tuberculosis	B-X
Pathogenesis	B-X
.	B-X
Genes	B-X
involved	B-X
in	B-X
virulence	B-X
and	B-X
host	B-X
specialization	B-X
are	B-X
located	B-X
on	B-X
pathogenicity	B-X
chromosomes	B-X
within	B-X
strains	B-X
pathogenic	B-X
to	B-X
tomato	B-X
(	B-X
Fusarium	B-X
oxysporum	B-X
f.	B-X
sp	B-X
.	B-X
The	B-X
experimental	B-X
transfer	B-X
of	B-X
pathogenicity	B-X
chromosomes	B-X
from	B-X
F.	B-X
oxysporum	B-X
f.	B-X
sp	B-X
.	B-X
Additional	B-X
genome-scale	B-X
comparative	B-X
and	B-X
functional	B-X
studies	B-X
are	B-X
needed	B-X
to	B-X
elucidate	B-X
the	B-X
evolution	B-X
and	B-X
diversity	B-X
of	B-X
pathogenicity	B-X
mechanisms	B-X
,	B-X
which	B-X
may	B-X
help	B-X
inform	B-X
novel	B-X
disease	B-X
management	B-X
strategies	B-X
against	B-X
fusarial	B-X
pathogens	B-X
.	B-X

It	O
has	O
been	O
suggested	O
that	O
bacteria	O
-	O
invertebrate	O
interactions	O
do	O
not	O
only	O
play	O
a	O
role	O
in	O
the	O
transmission	O
of	O
human	O
pathogens	O
but	O
have	O
also	O
shaped	O
their	O
evolution	O
[	O
79	O
]	O
.	O
<EOS>	B-X
The	B-X
human	B-X
gut	B-X
harbors	B-X
diverse	B-X
microbes	B-X
that	B-X
play	B-X
a	B-X
fundamental	B-X
role	B-X
in	B-X
the	B-X
well-being	B-X
of	B-X
their	B-X
host	B-X
.	B-X
The	B-X
constituents	B-X
of	B-X
the	B-X
microbiota	B-X
--	B-X
bacteria	B-X
,	B-X
viruses	B-X
,	B-X
and	B-X
eukaryotes	B-X
--	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
one	B-X
another	B-X
and	B-X
with	B-X
the	B-X
host	B-X
immune	B-X
system	B-X
in	B-X
ways	B-X
that	B-X
influence	B-X
the	B-X
development	B-X
of	B-X
disease	B-X
.	B-X
We	B-X
review	B-X
these	B-X
interactions	B-X
and	B-X
suggest	B-X
that	B-X
a	B-X
holistic	B-X
approach	B-X
to	B-X
studying	B-X
the	B-X
microbiota	B-X
that	B-X
goes	B-X
beyond	B-X
characterization	B-X
of	B-X
community	B-X
composition	B-X
and	B-X
encompasses	B-X
dynamic	B-X
interactions	B-X
between	B-X
all	B-X
components	B-X
of	B-X
the	B-X
microbiota	B-X
and	B-X
host	B-X
tissue	B-X
over	B-X
time	B-X
will	B-X
be	B-X
crucial	B-X
for	B-X
building	B-X
predictive	B-X
models	B-X
for	B-X
diagnosis	B-X
and	B-X
treatment	B-X
of	B-X
diseases	B-X
linked	B-X
to	B-X
imbalances	B-X
in	B-X
our	B-X
microbiota	B-X
.	B-X
Despite	B-X
the	B-X
fact	B-X
that	B-X
all	B-X
vertically	B-X
transmitted	B-X
symbionts	B-X
sequester	B-X
resources	B-X
from	B-X
their	B-X
hosts	B-X
and	B-X
are	B-X
therefore	B-X
costly	B-X
to	B-X
maintain	B-X
,	B-X
there	B-X
is	B-X
an	B-X
extraordinary	B-X
diversity	B-X
of	B-X
them	B-X
in	B-X
invertebrates	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
I	B-X
explore	B-X
the	B-X
evolutionary	B-X
ecology	B-X
of	B-X
vertically	B-X
transmitted	B-X
symbionts	B-X
and	B-X
their	B-X
impact	B-X
on	B-X
host	B-X
resistance	B-X
,	B-X
and	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
the	B-X
evidence	B-X
for	B-X
the	B-X
three-way	B-X
interactions	B-X
between	B-X
these	B-X
symbionts	B-X
,	B-X
natural	B-X
enemies	B-X
and	B-X
invertebrate	B-X
hosts	B-X
.	B-X
A	B-X
number	B-X
of	B-X
recent	B-X
empirical	B-X
and	B-X
theoretical	B-X
studies	B-X
suggest	B-X
that	B-X
vertically	B-X
transmitted	B-X
symbionts	B-X
may	B-X
protect	B-X
their	B-X
hosts	B-X
from	B-X
pathogens	B-X
.	B-X
If	B-X
this	B-X
'symbiont-mediated	B-X
protection	B-X
'	B-X
is	B-X
widespread	B-X
,	B-X
it	B-X
is	B-X
likely	B-X
that	B-X
vertically	B-X
transmitted	B-X
symbionts	B-X
contribute	B-X
significantly	B-X
to	B-X
variation	B-X
in	B-X
measures	B-X
of	B-X
invertebrate	B-X
resistance	B-X
to	B-X
natural	B-X
enemies	B-X
.	B-X

We	O
identified	O
several	O
common	O
loci	O
representing	O
ancestral	O
clusters	O
of	O
genes	O
important	O
in	O
Y	O
.	O
enterocolitica	O
and	O
P	O
.	O
luminescens	O
pathogenesis	O
that	O
might	O
have	O
evolved	O
during	O
the	O
association	O
of	O
bacteria	O
with	O
invertebrates	O
,	O
the	O
so	O
-	O
called	O
"	O
pre	O
-	O
vertebrate	O
"	O
pathosphere	O
[	O
121	O
]	O
and	O
then	O
been	O
adapted	O
to	O
more	O
recent	O
pathologies	O
in	O
mammalians	O
.	O

Examples	O
are	O
yersiniabactin	O
,	O
quorum	O
sensing	O
-	O
like	O
regulators	O
,	O
or	O
the	O
urease	O
operon	O
.	O
<EOS>	B-X
Pathogenesis	B-X
of	B-X
Application	B-X
of	B-X
wild	B-X
type	B-X
Azotobacters	B-X
results	B-X
in	B-X
better	B-X
yield	B-X
of	B-X
cereals	B-X
like	B-X
corn	B-X
,	B-X
wheat	B-X
,	B-X
oat	B-X
,	B-X
barley	B-X
,	B-X
rice	B-X
,	B-X
pearl	B-X
millet	B-X
and	B-X
sorghum	B-X
,	B-X
of	B-X
oil	B-X
seeds	B-X
like	B-X
mustard	B-X
and	B-X
sunflower	B-X
,	B-X
of	B-X
vegetable	B-X
crops	B-X
like	B-X
tomato	B-X
,	B-X
eggplant	B-X
,	B-X
carrot	B-X
,	B-X
chillies	B-X
,	B-X
onion	B-X
,	B-X
potato	B-X
,	B-X
beans	B-X
and	B-X
sugar	B-X
beet	B-X
,	B-X
of	B-X
fruits	B-X
like	B-X
mango	B-X
and	B-X
sugar	B-X
cane	B-X
,	B-X
of	B-X
fiber	B-X
crops	B-X
like	B-X
jute	B-X
and	B-X
cotton	B-X
and	B-X
of	B-X
tree	B-X
like	B-X
oak	B-X
.	B-X
NifA	B-X
must	B-X
bind	B-X
upstream	B-X
of	B-X
the	B-X
promoters	B-X
of	B-X
all	B-X
nif	B-X
operons	B-X
for	B-X
enabling	B-X
their	B-X
expression	B-X
.	B-X
The	B-X
urease	B-X
gene	B-X
complex	B-X
ureABC	B-X
has	B-X
been	B-X
deleted	B-X
,	B-X
the	B-X
ammonia	B-X
transport	B-X
gene	B-X
amtB	B-X
has	B-X
been	B-X
disrupted	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
glutamine	B-X
synthase	B-X
gene	B-X
has	B-X
been	B-X
regulated	B-X
to	B-X
enhance	B-X
urea	B-X
and	B-X
ammonia	B-X
excretion	B-X
.	B-X

The	O
complexity	O
of	O
this	O
evolutionary	O
concept	O
is	O
also	O
demonstrated	O
by	O
the	O
fact	O
that	O
the	O
immune	O
systems	O
both	O
of	O
invertebrates	O
and	O
vertebrates	O
are	O
based	O
on	O
phagocytic	O
cells	O
that	O
are	O
attacked	O
by	O
hemolysins	O
,	O
T3SS	O
effector	O
proteins	O
,	O
and	O
many	O
other	O
toxins	O
described	O
above	O
.	O

Thus	O
,	O
it	O
can	O
not	O
be	O
excluded	O
that	O
these	O
virulence	O
factors	O
are	O
able	O
to	O
act	O
on	O
both	O
immune	O
systems	O
[	O
121	O
]	O
.	O

The	O
fact	O
that	O
P	O
.	O
asymbiotica	O
has	O
been	O
found	O
to	O
be	O
pathogenic	O
against	O
humans	O
[	O
14	O
]	O
strengthens	O
this	O
hypothesis	O
.	O

Thus	O
,	O
P	O
.	O
asymbiotica	O
might	O
be	O
an	O
evolutionary	O
link	O
that	O
is	O
evolving	O
from	O
an	O
insect	O
to	O
a	O
mammal	O
-	O
pathogen	O
.	O

Another	O
example	O
that	O
might	O
enlighten	O
the	O
evolution	O
of	O
bacterial	O
pathogenicity	O
is	O
the	O
plasticity	O
zone	O
(	O
PZ	O
)	O
of	O
Y	O
.	O
enterocolitica	O
,	O
a	O
199	O
kb	O
key	O
locus	O
for	O
high	O
pathogenicity	O
that	O
includes	O
YAPIYe	O
,	O
secretion	O
systems	O
,	O
hydrogenase	O
loci	O
essential	O
for	O
gut	O
colonization	O
of	O
S	O
.	O
typhimurium	O
and	O
H	O
.	O
pylori	O
[	O
122	O
]	O
,	O
and	O
iron	O
acquisition	O
systems	O
.	O

A	O
second	O
flagellar	O
cluster	O
,	O
Flag	B-Protein
-	I-Protein
2	I-Protein
,	O
is	O
also	O
located	O
within	O
the	O
PZ	O
of	O
Y	O
.	O
enterocolitica	O
biotypes	O
2	O
-	O
5	O
[	O
120	O
]	O
.	O

It	O
is	O
assumed	O
that	O
the	O
PZ	O
has	O
not	O
been	O
acquired	O
by	O
a	O
single	O
event	O
of	O
gene	O
transfer	O
,	O
but	O
through	O
a	O
series	O
of	O
independent	O
insertions	O
[	O
23	O
]	O
.	O
<EOS>	B-X
It	B-X
is	B-X
assumed	B-X
that	B-X
anti-CTLA-4	B-X
antibodies	B-X
cause	B-X
tumor	B-X
rejection	B-X
by	B-X
blocking	B-X
negative	B-X
signaling	B-X
from	B-X
B7-CTLA-4	B-X
interactions	B-X
.	B-X
Consequently	B-X
,	B-X
Ipilimumab	B-X
does	B-X
not	B-X
increase	B-X
B7	B-X
on	B-X
dendritic	B-X
cells	B-X
(	B-X
DCs	B-X
)	B-X
from	B-X
either	B-X
CTLA4	B-X
gene	B-X
humanized	B-X
(	B-X
Ctla4	B-X
Since	B-X
the	B-X
discovery	B-X
of	B-X
1α,25	B-X
(	B-X
OH	B-X
)	B-X
2D3	B-X
in	B-X
the	B-X
early	B-X
1970s	B-X
,	B-X
it	B-X
has	B-X
been	B-X
widely	B-X
accepted	B-X
that	B-X
this	B-X
metabolite	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
biological	B-X
actions	B-X
of	B-X
vitamin	B-X
D.	B-X
Likewise	B-X
,	B-X
we	B-X
have	B-X
assumed	B-X
that	B-X
25	B-X
(	B-X
OH	B-X
)	B-X
-19-nor-D3-dependent	B-X
growth	B-X
inhibition	B-X
of	B-X
human	B-X
prostate	B-X
PZ-HPV-7	B-X
cells	B-X
was	B-X
the	B-X
result	B-X
of	B-X
its	B-X
subsequent	B-X
conversion	B-X
to	B-X
1α,25	B-X
(	B-X
OH	B-X
)	B-X
2-19-nor-D3	B-X
,	B-X
catalyzed	B-X
by	B-X
CYP27B1	B-X
within	B-X
the	B-X
prostate	B-X
cells	B-X
.	B-X
When	B-X
25	B-X
(	B-X
OH	B-X
)	B-X
-19-nor-D3	B-X
was	B-X
added	B-X
to	B-X
cultured	B-X
PZ-HPV-7	B-X
cells	B-X
,	B-X
eight	B-X
metabolites	B-X
were	B-X
detected	B-X
,	B-X
while	B-X
no	B-X
1α,25	B-X
(	B-X
OH	B-X
)	B-X
2-19-nor-D3	B-X
was	B-X
found	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
time	B-X
course	B-X
of	B-X
VDR	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
induced	B-X
by	B-X
100	B-X
nM	B-X
25	B-X
(	B-X
OH	B-X
)	B-X
-19-nor-D3	B-X
,	B-X
and	B-X
the	B-X
subsequent	B-X
transactivation	B-X
of	B-X
CYP24A1	B-X
gene	B-X
were	B-X
almost	B-X
identical	B-X
to	B-X
those	B-X
induced	B-X
by	B-X
1	B-X
nM	B-X
1α,25	B-X
(	B-X
OH	B-X
)	B-X
2-19-nor-D3	B-X
.	B-X
These	B-X
results	B-X
strongly	B-X
suggest	B-X
that	B-X
25	B-X
(	B-X
OH	B-X
)	B-X
-19-nor-D3	B-X
binds	B-X
directly	B-X
to	B-X
VDR	B-X
as	B-X
a	B-X
ligand	B-X
to	B-X
transport	B-X
VDR	B-X
into	B-X
the	B-X
nucleus	B-X
to	B-X
induce	B-X
CYP24A1	B-X
gene	B-X
transactivation	B-X
.	B-X
Furthermore	B-X
,	B-X
knockdown	B-X
of	B-X
CYP27B1	B-X
gene	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
antiproliferative	B-X
activity	B-X
of	B-X
25	B-X
(	B-X
OH	B-X
)	B-X
-19-nor-D3	B-X
,	B-X
whereas	B-X
VDR	B-X
knockdown	B-X
attenuated	B-X
the	B-X
effect	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
antiproliferative	B-X
activity	B-X
of	B-X
25	B-X
(	B-X
OH	B-X
)	B-X
-19-nor-D3	B-X
is	B-X
VDR	B-X
dependent	B-X
but	B-X
CYP27B1	B-X
independent	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
recent	B-X
studies	B-X
using	B-X
the	B-X
same	B-X
cell	B-X
line	B-X
demonstrate	B-X
that	B-X
25	B-X
(	B-X
OH	B-X
)	B-X
D3	B-X
can	B-X
act	B-X
as	B-X
a	B-X
VDR	B-X
agonist	B-X
to	B-X
induce	B-X
gene	B-X
transactivation	B-X
.	B-X

A	O
comparison	O
of	O
the	O
PZ	O
sequence	O
with	O
the	O
genome	O
of	O
P	O
.	O
luminescens	O
is	O
depicted	O
in	O
Fig	O
.	O

5	O
.	O
<EOS>	B-X
Atomic	B-X
models	B-X
for	B-X
the	B-X
polypeptide	B-X
backbones	B-X
of	B-X
myohemerythrin	B-X
and	B-X
hemerythrin	B-X
.	B-X

A	O
region	O
highly	O
similar	O
to	O
YAPIYe	O
is	O
the	O
genome	O
island	O
plu0958	B-Protein
-	O
1166	B-Protein
carrying	O
a	O
hemolysin	O
,	O
hypothetical	O
genes	O
,	O
the	O
toxin	O
/	O
antitoxin	O
system	O
CcdA	B-Protein
/	O
CcdB	B-Protein
,	O
and	O
the	O
type	O
IV	O
pilus	O
.	O

Only	O
few	O
other	O
genes	O
or	O
operons	O
of	O
the	O
PZ	O
are	O
also	O
present	O
in	O
P	O
.	O
luminescens	O
,	O
namely	O
a	O
chitinase	O
,	O
two	O
iron	O
acquisition	O
systems	O
,	O
and	O
three	O
ysa	O
genes	O
,	O
thus	O
confirming	O
the	O
idea	O
of	O
a	O
patchwork	O
of	O
horizontally	O
acquired	O
genes	O
within	O
the	O
PZ	O
[	O
23	O
]	O
.	O
<EOS>	B-X
The	B-X
MYC	B-X
proto-oncogenes	B-X
encode	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
that	B-X
are	B-X
among	B-X
the	B-X
most	B-X
commonly	B-X
activated	B-X
oncoproteins	B-X
in	B-X
human	B-X
neoplasias	B-X
.	B-X
In	B-X
the	B-X
past	B-X
few	B-X
years	B-X
,	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
MYC	B-X
signalling	B-X
can	B-X
enable	B-X
tumour	B-X
cells	B-X
to	B-X
dysregulate	B-X
their	B-X
microenvironment	B-X
and	B-X
evade	B-X
the	B-X
host	B-X
immune	B-X
response	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
discuss	B-X
how	B-X
MYC	B-X
pathways	B-X
not	B-X
only	B-X
dictate	B-X
cancer	B-X
cell	B-X
pathophysiology	B-X
but	B-X
also	B-X
suppress	B-X
the	B-X
host	B-X
immune	B-X
response	B-X
against	B-X
that	B-X
cancer	B-X
.	B-X
We	B-X
also	B-X
propose	B-X
that	B-X
therapies	B-X
targeting	B-X
the	B-X
MYC	B-X
pathway	B-X
will	B-X
be	B-X
key	B-X
to	B-X
reversing	B-X
cancerous	B-X
growth	B-X
and	B-X
restoring	B-X
antitumour	B-X
immune	B-X
responses	B-X
in	B-X
patients	B-X
with	B-X
MYC-driven	B-X
cancers	B-X
.	B-X

However	O
,	O
given	O
the	O
extensive	O
transfer	O
of	O
virulence	O
factors	O
between	O
bacteria	O
,	O
the	O
history	O
of	O
pathogen	O
evolution	O
still	O
requires	O
further	O
investigation	O
.	O

Conclusion	O
<EOS>	B-X
Conclusion	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X

The	O
comparison	O
of	O
Y	O
.	O
enterocolitica	O
and	O
P	O
.	O
luminescens	O
at	O
the	O
genomic	O
level	O
performed	O
here	O
provides	O
the	O
database	O
for	O
a	O
better	O
understanding	O
of	O
the	O
genetic	O
basis	O
for	O
their	O
distinct	O
behaviour	O
towards	O
invertebrates	O
and	O
mammals	O
.	O

Y	O
.	O
enterocolitica	O
is	O
expected	O
to	O
switch	O
between	O
two	O
pathogenicity	O
phases	O
against	O
insects	O
and	O
mammalians	O
,	O
while	O
the	O
genome	O
of	O
P	O
.	O
luminescens	O
must	O
contain	O
the	O
modulators	O
and	O
regulators	O
necessary	O
to	O
change	O
the	O
bacterium	O
from	O
a	O
state	O
of	O
symbiosis	O
with	O
nematodes	O
to	O
pathogenicity	O
against	O
insects	O
,	O
and	O
also	O
from	O
symbiosis	O
-	O
proficient	O
primary	O
variants	O
to	O
symbiosis	O
-	O
deficient	O
secondary	O
variants	O
[	O
17	O
]	O
.	O

Those	O
adaptational	O
processes	O
must	O
be	O
precisely	O
regulated	O
by	O
the	O
bacteria	O
.	O
<EOS>	B-X
Second	B-X
,	B-X
when	B-X
these	B-X
sequences	B-X
are	B-X
transcribed	B-X
and	B-X
precisely	B-X
processed	B-X
into	B-X
small	B-X
RNAs	B-X
,	B-X
they	B-X
guide	B-X
a	B-X
multifunctional	B-X
protein	B-X
complex	B-X
(	B-X
Cas	B-X
proteins	B-X
)	B-X
to	B-X
recognize	B-X
and	B-X
cleave	B-X
incoming	B-X
foreign	B-X
genetic	B-X
material	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
antagonism	B-X
between	B-X
bacteria	B-X
or	B-X
bacteria	B-X
and	B-X
fungi	B-X
can	B-X
be	B-X
achieved	B-X
by	B-X
direct	B-X
destruction	B-X
of	B-X
the	B-X
targeted	B-X
cells	B-X
through	B-X
the	B-X
regulated	B-X
production	B-X
of	B-X
antimicrobial	B-X
metabolites	B-X
or	B-X
by	B-X
controlling	B-X
their	B-X
adaptive	B-X
mechanisms	B-X
,	B-X
such	B-X
as	B-X
the	B-X
formation	B-X
of	B-X
biofilms	B-X
.	B-X
The	B-X
main	B-X
focus	B-X
will	B-X
be	B-X
on	B-X
Gram-positive	B-X
bacteria	B-X
that	B-X
have	B-X
practical	B-X
applications	B-X
,	B-X
such	B-X
as	B-X
starter	B-X
cultures	B-X
for	B-X
food	B-X
fermentation	B-X
,	B-X
probiotics	B-X
,	B-X
and	B-X
other	B-X
microorganisms	B-X
of	B-X
biotechnological	B-X
importance	B-X
.	B-X
The	B-X
possible	B-X
evolutionary	B-X
role	B-X
of	B-X
quorum-quenching	B-X
mechanisms	B-X
during	B-X
the	B-X
development	B-X
of	B-X
interspecies	B-X
interactions	B-X
of	B-X
bacteria	B-X
is	B-X
also	B-X
considered	B-X
.	B-X

It	O
was	O
assumed	O
that	O
there	O
are	O
parallels	O
in	O
the	O
regulation	O
of	O
pathogenicity	O
in	O
mammals	O
and	O
insect	O
pathogens	O
[	O
41	O
,	O
123	O
]	O
.	O

However	O
,	O
molecular	O
components	O
of	O
the	O
regulatory	O
networks	O
controlling	O
pathogenicity	O
and	O
mutualism	O
have	O
recently	O
been	O
demonstrated	O
to	O
be	O
very	O
different	O
between	O
P	O
.	O
luminescens	O
and	O
X	O
.	O
nematophilus	O
with	O
similar	O
life	O
cycles	O
[	O
124	O
]	O
.	O

Dissecting	O
the	O
genomes	O
of	O
Y	O
.	O
enterocolitica	O
and	O
P	O
.	O
luminescens	O
for	O
putative	O
key	O
regulators	O
,	O
we	O
identified	O
factor	O
groups	O
(	O
AI	B-Protein
-	I-Protein
2	I-Protein
,	O
PAS	B-Protein
-	I-Protein
4	I-Protein
/	O
LuxR	B-Protein
like	O
receptors	O
)	O
possibly	O
involved	O
in	O
pathogen	O
-	O
insect	O
association	O
only	O
,	O
those	O
with	O
members	O
contributing	O
to	O
either	O
insect	O
or	O
mammalian	O
pathogenicity	O
(	O
QS	O
,	O
TKS	O
,	O
Usp	O
)	O
,	O
and	O
c	O
-	O
di	O
-	O
GMP	O
signalling	O
probably	O
not	O
involved	O
in	O
regulation	O
of	O
activities	O
against	O
insects	O
.	O

Certainly	O
,	O
the	O
question	O
whether	O
fundamental	O
differences	O
in	O
regulatory	O
networks	O
reflect	O
how	O
each	O
of	O
these	O
two	O
bacteria	O
specifically	O
interacts	O
with	O
either	O
the	O
insect	O
or	O
the	O
human	O
host	O
remains	O
to	O
be	O
addressed	O
in	O
more	O
detail	O
.	O
<EOS>	B-X
The	B-X
prevalence	B-X
of	B-X
OBI	B-X
varies	B-X
tremendously	B-X
across	B-X
patient	B-X
populations	B-X
owing	B-X
to	B-X
numerous	B-X
factors	B-X
,	B-X
such	B-X
as	B-X
geographic	B-X
location	B-X
,	B-X
assay	B-X
characteristics	B-X
,	B-X
host	B-X
immune	B-X
response	B-X
,	B-X
coinfection	B-X
with	B-X
other	B-X
viruses	B-X
,	B-X
and	B-X
vaccination	B-X
status	B-X
.	B-X
Whether	B-X
this	B-X
is	B-X
because	B-X
structural	B-X
pathology	B-X
is	B-X
traditionally	B-X
viewed	B-X
as	B-X
deleterious	B-X
,	B-X
and	B-X
whether	B-X
this	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
is	B-X
a	B-X
fundamental	B-X
misinterpretation	B-X
of	B-X
the	B-X
relationship	B-X
between	B-X
pathology	B-X
and	B-X
pathogenesis	B-X
across	B-X
the	B-X
spectrum	B-X
of	B-X
chronic	B-X
diseases	B-X
,	B-X
remains	B-X
to	B-X
be	B-X
determined	B-X
.	B-X
As	B-X
more	B-X
and	B-X
more	B-X
detailed	B-X
information	B-X
about	B-X
the	B-X
biochemical	B-X
constituents	B-X
of	B-X
AD	B-X
lesions	B-X
becomes	B-X
available	B-X
,	B-X
it	B-X
may	B-X
also	B-X
be	B-X
argued	B-X
that	B-X
just	B-X
as	B-X
much	B-X
knowledge	B-X
of	B-X
cellular	B-X
physiology	B-X
as	B-X
pathophysiology	B-X
has	B-X
been	B-X
gained	B-X
.	B-X
As	B-X
the	B-X
medical	B-X
science	B-X
community	B-X
continues	B-X
to	B-X
pursue	B-X
lesion	B-X
targeting	B-X
for	B-X
therapeutic	B-X
purposes	B-X
,	B-X
the	B-X
notion	B-X
that	B-X
AD	B-X
pathology	B-X
is	B-X
indicative	B-X
of	B-X
an	B-X
active	B-X
host	B-X
response	B-X
or	B-X
environmental	B-X
adaptation	B-X
,	B-X
and	B-X
therefore	B-X
a	B-X
poor	B-X
target	B-X
,	B-X
is	B-X
becoming	B-X
clearer	B-X
.	B-X

Bioconversion	O
of	O
its	O
insect	O
hosts	O
is	O
an	O
important	O
stage	O
in	O
the	O
lifecycle	O
of	O
P	O
.	O
luminescens	O
.	O

This	O
fact	O
might	O
explain	O
the	O
high	O
number	O
of	O
antibacterial	O
factors	O
directed	O
against	O
possible	O
competitors	O
that	O
are	O
going	O
to	O
colonize	O
the	O
same	O
insect	O
cadaver	O
or	O
that	O
are	O
already	O
present	O
in	O
the	O
insect	O
gut	O
flora	O
[	O
17	O
]	O
.	O
<EOS>	B-X
The	B-X
label	B-X
,	B-X
``	B-X
The	B-X
Beehive	B-X
Theory	B-X
''	B-X
,	B-X
is	B-X
drawn	B-X
from	B-X
the	B-X
well-known	B-X
fact	B-X
that	B-X
disturbing	B-X
a	B-X
tranquil	B-X
beehive	B-X
with	B-X
a	B-X
blow	B-X
can	B-X
cause	B-X
a	B-X
swarm	B-X
of	B-X
angry	B-X
bees	B-X
to	B-X
exit	B-X
their	B-X
dwelling	B-X
place	B-X
and	B-X
attack	B-X
nearby	B-X
humans	B-X
.	B-X
Similarly	B-X
,	B-X
an	B-X
impact	B-X
to	B-X
the	B-X
head	B-X
can	B-X
initiate	B-X
dislocations	B-X
and	B-X
disruptions	B-X
in	B-X
the	B-X
microbiota	B-X
present	B-X
in	B-X
the	B-X
brain	B-X
and	B-X
body	B-X
.	B-X
Second	B-X
,	B-X
upon	B-X
impact	B-X
commensal	B-X
microbes	B-X
already	B-X
resident	B-X
on	B-X
surfaces	B-X
of	B-X
the	B-X
nose	B-X
,	B-X
mouth	B-X
,	B-X
and	B-X
eyes	B-X
,	B-X
and	B-X
potentially	B-X
harmful	B-X
organisms	B-X
from	B-X
the	B-X
environment	B-X
,	B-X
may	B-X
gain	B-X
access	B-X
to	B-X
the	B-X
brain	B-X
through	B-X
the	B-X
distal	B-X
ends	B-X
of	B-X
the	B-X
olfactory	B-X
and	B-X
optic	B-X
nerves	B-X
or	B-X
even	B-X
a	B-X
disrupted	B-X
blood-brain	B-X
barrier	B-X
.	B-X
Fourth	B-X
,	B-X
the	B-X
impact	B-X
may	B-X
cause	B-X
dysbiosis	B-X
in	B-X
the	B-X
gastrointestinal	B-X
microbiome	B-X
,	B-X
thereby	B-X
disrupting	B-X
signaling	B-X
via	B-X
the	B-X
gut-brain	B-X
axis	B-X
.	B-X
Possible	B-X
preventatives	B-X
or	B-X
therapeutics	B-X
that	B-X
would	B-X
address	B-X
the	B-X
adverse	B-X
contributions	B-X
of	B-X
microbes	B-X
to	B-X
the	B-X
late	B-X
sequelae	B-X
of	B-X
traumatic	B-X
brain	B-X
injury	B-X
include	B-X
anti-inflammatories	B-X
,	B-X
antibacterials	B-X
,	B-X
antivirals	B-X
,	B-X
and	B-X
probiotics	B-X
.	B-X

However	O
,	O
no	O
corresponding	O
determinants	O
were	O
identified	O
in	O
the	O
genome	O
of	O
Y	O
.	O
enterocolitica	O
.	O
<EOS>	B-X
Domestic	B-X
pigs	B-X
as	B-X
well	B-X
as	B-X
wild	B-X
boars	B-X
and	B-X
other	B-X
wild-life	B-X
have	B-X
been	B-X
identified	B-X
as	B-X
reservoirs	B-X
of	B-X
these	B-X
bacteria	B-X
.	B-X
The	B-X
new	B-X
protocol	B-X
performed	B-X
as	B-X
well	B-X
as	B-X
or	B-X
better	B-X
than	B-X
the	B-X
established	B-X
ISO-standards	B-X
for	B-X
detection	B-X
and	B-X
cultivation	B-X
of	B-X
Y.	B-X
enterocolitica	B-X
and	B-X
Salmonella	B-X
spp.	B-X
,	B-X
however	B-X
for	B-X
cultivation	B-X
of	B-X
Y.	B-X
pseudotuberculosis	B-X
,	B-X
further	B-X
development	B-X
is	B-X
needed	B-X
.	B-X
and	B-X
Y.	B-X
enterocolitica	B-X
.	B-X
In	B-X
total	B-X
,	B-X
ten	B-X
isolates	B-X
of	B-X
Y.	B-X
enterocolitica	B-X
of	B-X
various	B-X
bio-serotypes	B-X
were	B-X
obtained	B-X
,	B-X
and	B-X
the	B-X
MLVA-profile	B-X
of	B-X
these	B-X
isolates	B-X
were	B-X
consistent	B-X
with	B-X
the	B-X
profiles	B-X
from	B-X
the	B-X
corresponding	B-X
enrichment	B-X
broth	B-X
.	B-X

Moreover	O
,	O
P	O
.	O
luminescens	O
is	O
pathogenic	O
to	O
a	O
variety	O
of	O
insect	O
larvae	O
,	O
and	O
a	O
dose	O
of	O
<	O
5	O
colony	O
-	O
forming	O
units	O
directly	O
injected	O
into	O
the	O
blood	O
system	O
is	O
sufficient	O
to	O
kill	O
within	O
48	O
-	O
72	O
h	O
[	O
124	O
]	O
.	O

In	O
contrast	O
,	O
only	O
highly	O
concentrated	O
protein	O
extracts	O
of	O
Y	O
.	O
enterocolitica	O
are	O
toxic	O
for	O
M	O
.	O
sexta	O
[	O
7	O
]	O
,	O
and	O
a	O
low	O
insect	O
larvae	O
mortality	O
has	O
been	O
observed	O
following	O
injection	O
of	O
approximately	O
3	O
.	O
5	O
x	O
106	O
Y	O
.	O
enterocolitica	O
cells	O
into	O
the	O
hemolymph	O
(	O
T	O
.	O
M	O
.	O
Fuchs	O
,	O
unpublished	O
data	O
)	O
.	O

This	O
data	O
strongly	O
suggests	O
that	O
Y	O
.	O
enterocolitica	O
,	O
similar	O
to	O
Y	O
.	O
pestis	O
,	O
has	O
developed	O
a	O
strategy	O
to	O
infect	O
and	O
proliferate	O
in	O
insects	O
,	O
and	O
use	O
these	O
organisms	O
rather	O
as	O
transmission	O
vectors	O
than	O
as	O
pure	O
nutrient	O
source	O
.	O

Summarizing	O
,	O
Y	O
.	O
enterocolitica	O
and	O
P	O
.	O
luminescens	O
have	O
evolved	O
partially	O
different	O
and	O
partially	O
similar	O
and	O
therefore	O
probably	O
conserved	O
mechanisms	O
to	O
detect	O
and	O
to	O
react	O
on	O
the	O
insect	O
host	O
.	O

Up	O
to	O
the	O
present	O
time	O
,	O
we	O
are	O
far	O
away	O
from	O
understanding	O
the	O
complexity	O
of	O
bacteria	O
-	O
invertebrate	O
interactions	O
.	O

With	O
the	O
genome	O
comparison	O
carried	O
out	O
here	O
,	O
however	O
,	O
we	O
uncovered	O
several	O
genes	O
which	O
are	O
promising	O
candidate	O
genes	O
involved	O
in	O
insect	O
association	O
and	O
pathogenicity	O
,	O
and	O
therefore	O
created	O
a	O
promising	O
basis	O
for	O
future	O
experimental	O
work	O
.	O

The	O
GraRS	B-Protein
regulatory	O
system	O
controls	O
Staphylococcus	O
aureus	O
susceptibility	O
to	O
antimicrobial	O
host	O
defenses	O
<EOS>	B-X
Modification	B-X
of	B-X
teichoic	B-X
acids	B-X
with	B-X
D-alanine	B-X
by	B-X
the	B-X
products	B-X
of	B-X
the	B-X
dlt	B-X
operon	B-X
protects	B-X
Gram-positive	B-X
bacteria	B-X
against	B-X
major	B-X
antimicrobial	B-X
host	B-X
defense	B-X
molecules	B-X
such	B-X
as	B-X
defensins	B-X
,	B-X
cathelicidins	B-X
,	B-X
myeloperoxidase	B-X
or	B-X
phospholipase	B-X
.	B-X
The	B-X
graRS	B-X
regulatory	B-X
genes	B-X
have	B-X
recently	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
D-alanylation	B-X
in	B-X
Staphylococcus	B-X
aureus	B-X
.	B-X

Background	O
Modification	O
of	O
teichoic	O
acids	O
with	O
D	O
-	O
alanine	O
by	O
the	O
products	O
of	O
the	O
dlt	O
operon	O
protects	O
Gram	O
-	O
positive	O
bacteria	O
against	O
major	O
antimicrobial	O
host	O
defense	O
molecules	O
such	O
as	O
defensins	O
,	O
cathelicidins	O
,	O
myeloperoxidase	B-Protein
or	O
phospholipase	O
.	O
<EOS>	B-X
Tremendous	B-X
advances	B-X
in	B-X
understanding	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
phospholipases	B-X
have	B-X
occurred	B-X
in	B-X
the	B-X
last	B-X
decades	B-X
.	B-X
This	B-X
introductory	B-X
chapter	B-X
is	B-X
aimed	B-X
at	B-X
providing	B-X
a	B-X
general	B-X
framework	B-X
of	B-X
the	B-X
current	B-X
understanding	B-X
of	B-X
phospholipases	B-X
and	B-X
a	B-X
discussion	B-X
of	B-X
their	B-X
mechanisms	B-X
of	B-X
action	B-X
and	B-X
emerging	B-X
biological	B-X
functions	B-X
.	B-X
They	B-X
hydrolyze	B-X
phospholipids	B-X
,	B-X
which	B-X
are	B-X
major	B-X
components	B-X
of	B-X
cell	B-X
membrane	B-X
that	B-X
can	B-X
generate	B-X
many	B-X
bioactive	B-X
lipid	B-X
mediators	B-X
,	B-X
such	B-X
as	B-X
diacylglycerol	B-X
,	B-X
phosphatidic	B-X
acid	B-X
,	B-X
lysophosphatidic	B-X
acid	B-X
,	B-X
and	B-X
arachidonic	B-X
acid	B-X
.	B-X
Enzymatic	B-X
processing	B-X
of	B-X
phospholipids	B-X
by	B-X
phospholipases	B-X
converts	B-X
these	B-X
molecules	B-X
into	B-X
lipid	B-X
mediators	B-X
that	B-X
regulate	B-X
multiple	B-X
cellular	B-X
processes	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
can	B-X
promote	B-X
breast	B-X
cancer	B-X
progression	B-X
.	B-X
Thus	B-X
,	B-X
dysregulation	B-X
of	B-X
phospholipases	B-X
contributes	B-X
to	B-X
a	B-X
number	B-X
of	B-X
human	B-X
diseases	B-X
,	B-X
including	B-X
cancer	B-X
.	B-X
This	B-X
review	B-X
describes	B-X
how	B-X
phospholipases	B-X
regulate	B-X
multiple	B-X
cancer-associated	B-X
cellular	B-X
processes	B-X
,	B-X
and	B-X
the	B-X
interplay	B-X
among	B-X
different	B-X
phospholipases	B-X
in	B-X
breast	B-X
cancer	B-X
.	B-X
A	B-X
thorough	B-X
understanding	B-X
of	B-X
the	B-X
breast	B-X
cancer-associated	B-X
signaling	B-X
networks	B-X
of	B-X
phospholipases	B-X
is	B-X
necessary	B-X
to	B-X
determine	B-X
whether	B-X
these	B-X
enzymes	B-X
are	B-X
potential	B-X
targets	B-X
for	B-X
innovative	B-X
therapeutic	B-X
strategies	B-X
.	B-X

The	O
graRS	B-Protein
regulatory	O
genes	O
have	O
recently	O
been	O
implicated	O
in	O
the	O
control	O
of	O
D	O
-	O
alanylation	O
in	O
Staphylococcus	O
aureus	O
.	O
<EOS>	B-X
The	B-X
graRS	B-X
regulatory	B-X
genes	B-X
have	B-X
recently	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
D-alanylation	B-X
in	B-X
Staphylococcus	B-X
aureus	B-X
.	B-X

Results	O
To	O
determine	O
the	O
impact	O
of	O
the	O
GraRS	B-Protein
regulatory	O
system	O
on	O
resistance	O
to	O
antimicrobial	O
host	O
defense	O
mechanisms	O
and	O
virulence	O
of	O
S	O
.	O
aureus	O
,	O
we	O
compared	O
inactivation	O
of	O
S	O
.	O
aureus	O
SA113	O
wild	O
type	O
and	O
its	O
isogenic	O
graRS	B-Protein
deletion	O
mutant	O
by	O
the	O
human	O
cathelicidin	O
LL	B-Protein
-	I-Protein
37	I-Protein
or	O
human	O
neutrophil	O
granulocytes	O
in	O
vitro	O
,	O
and	O
the	O
ability	O
to	O
cause	O
infection	O
in	O
vivo	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
reported	B-X
ability	B-X
of	B-X
Mycobacterium	B-X
tuberculosis	B-X
to	B-X
restrict	B-X
apoptotic	B-X
pathways	B-X
in	B-X
macrophages	B-X
in	B-X
vitro	B-X
has	B-X
led	B-X
to	B-X
apoptosis	B-X
being	B-X
dismissed	B-X
as	B-X
a	B-X
host-protective	B-X
process	B-X
in	B-X
tuberculosis	B-X
despite	B-X
a	B-X
lack	B-X
of	B-X
in	B-X
vivo	B-X
evidence	B-X
.	B-X
Here	B-X
we	B-X
define	B-X
crucial	B-X
in	B-X
vivo	B-X
functions	B-X
of	B-X
the	B-X
death	B-X
receptor-mediated	B-X
and	B-X
BCL-2-regulated	B-X
apoptosis	B-X
pathways	B-X
in	B-X
mediating	B-X
protection	B-X
against	B-X
tuberculosis	B-X
by	B-X
eliminating	B-X
distinct	B-X
populations	B-X
of	B-X
infected	B-X
macrophages	B-X
and	B-X
neutrophils	B-X
and	B-X
priming	B-X
T	B-X
cell	B-X
responses	B-X
.	B-X
These	B-X
findings	B-X
reveal	B-X
that	B-X
any	B-X
inhibition	B-X
of	B-X
apoptosis	B-X
by	B-X
M.	B-X
tuberculosis	B-X
is	B-X
incomplete	B-X
in	B-X
vivo	B-X
,	B-X
advancing	B-X
our	B-X
understanding	B-X
of	B-X
host-protective	B-X
responses	B-X
to	B-X
tuberculosis	B-X
(	B-X
TB	B-X
)	B-X
and	B-X
revealing	B-X
host	B-X
pathways	B-X
that	B-X
may	B-X
be	B-X
targetable	B-X
for	B-X
treatment	B-X
of	B-X
disease	B-X
.	B-X
Recent	B-X
studies	B-X
indicated	B-X
that	B-X
excessive	B-X
neutrophil	B-X
extracellular	B-X
traps	B-X
(	B-X
NETs	B-X
)	B-X
contributed	B-X
to	B-X
immunothrombosis	B-X
,	B-X
thereby	B-X
leading	B-X
to	B-X
extensive	B-X
intravascular	B-X
coagulopathy	B-X
and	B-X
multiple	B-X
organ	B-X
dysfunction	B-X
.	B-X
Thus	B-X
,	B-X
understanding	B-X
the	B-X
mechanism	B-X
of	B-X
severe	B-X
acute	B-X
respiratory	B-X
syndrome	B-X
coronavirus	B-X
2	B-X
(	B-X
SARS-CoV-2	B-X
)	B-X
-induced	B-X
NET	B-X
formation	B-X
would	B-X
be	B-X
helpful	B-X
to	B-X
reduce	B-X
thrombosis	B-X
and	B-X
prevent	B-X
ARDS	B-X
in	B-X
severe	B-X
acute	B-X
respiratory	B-X
syndrome	B-X
coronavirus	B-X
2	B-X
(	B-X
SARS-CoV-2	B-X
)	B-X
infection	B-X
.	B-X

We	O
show	O
here	O
that	O
graRS	B-Protein
deletion	O
considerably	O
alters	O
bacterial	O
surface	O
charge	O
,	O
increases	O
susceptibility	O
to	O
killing	O
by	O
human	O
neutrophils	O
or	O
the	O
defense	O
peptide	O
LL	B-Protein
-	I-Protein
37	I-Protein
,	O
and	O
attenuates	O
virulence	O
of	O
S	O
.	O
aureus	O
in	O
a	O
mouse	O
infection	O
model	O
.	O
<EOS>	B-X
Modification	B-X
of	B-X
teichoic	B-X
acids	B-X
with	B-X
D-alanine	B-X
by	B-X
the	B-X
products	B-X
of	B-X
the	B-X
dlt	B-X
operon	B-X
protects	B-X
Gram-positive	B-X
bacteria	B-X
against	B-X
major	B-X
antimicrobial	B-X
host	B-X
defense	B-X
molecules	B-X
such	B-X
as	B-X
defensins	B-X
,	B-X
cathelicidins	B-X
,	B-X
myeloperoxidase	B-X
or	B-X
phospholipase	B-X
.	B-X
The	B-X
graRS	B-X
regulatory	B-X
genes	B-X
have	B-X
recently	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
D-alanylation	B-X
in	B-X
Staphylococcus	B-X
aureus	B-X
.	B-X

Conclusion	O
Our	O
results	O
indicate	O
that	O
S	O
.	O
aureus	O
can	O
regulate	O
its	O
surface	O
properties	O
in	O
order	O
to	O
overcome	O
innate	O
host	O
defenses	O
.	O
<EOS>	B-X
Modification	B-X
of	B-X
teichoic	B-X
acids	B-X
with	B-X
D-alanine	B-X
by	B-X
the	B-X
products	B-X
of	B-X
the	B-X
dlt	B-X
operon	B-X
protects	B-X
Gram-positive	B-X
bacteria	B-X
against	B-X
major	B-X
antimicrobial	B-X
host	B-X
defense	B-X
molecules	B-X
such	B-X
as	B-X
defensins	B-X
,	B-X
cathelicidins	B-X
,	B-X
myeloperoxidase	B-X
or	B-X
phospholipase	B-X
.	B-X
The	B-X
graRS	B-X
regulatory	B-X
genes	B-X
have	B-X
recently	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
D-alanylation	B-X
in	B-X
Staphylococcus	B-X
aureus	B-X
.	B-X

Background	O
<EOS>	B-X
Background	B-X
matching	B-X
is	B-X
the	B-X
most	B-X
familiar	B-X
and	B-X
widespread	B-X
camouflage	B-X
strategy	B-X
:	B-X
avoiding	B-X
detection	B-X
by	B-X
having	B-X
a	B-X
similar	B-X
colour	B-X
and	B-X
pattern	B-X
to	B-X
the	B-X
background	B-X
.	B-X
Background	B-X
is	B-X
thus	B-X
a	B-X
relatively	B-X
modest	B-X
correction	B-X
for	B-X
all	B-X
Z	B-X
opacity	B-X
data	B-X
published	B-X
to	B-X
date	B-X
.	B-X
Background	B-X
estimation	B-X
and	B-X
foreground	B-X
segmentation	B-X
are	B-X
important	B-X
steps	B-X
in	B-X
many	B-X
high-level	B-X
vision	B-X
tasks	B-X
.	B-X
Patient	B-X
Preference	B-X
for	B-X
Telehealth	B-X
Background	B-X
Shapes	B-X
Impressions	B-X
of	B-X
Physicians	B-X
and	B-X
Information	B-X
Recall	B-X
:	B-X
A	B-X
Randomized	B-X
Experiment	B-X
.	B-X

Staphylococcus	O
aureus	O
,	O
a	O
frequent	O
cause	O
of	O
human	O
infections	O
,	O
is	O
highly	O
resistant	O
to	O
antimicrobial	O
factors	O
of	O
the	O
innate	O
immune	O
system	O
such	O
as	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAMPs	O
)	O
[	O
1	O
,	O
2	O
]	O
which	O
are	O
produced	O
by	O
epithelial	O
cells	O
and	O
neutrophils	O
[	O
3	O
,	O
4	O
]	O
.	O

These	O
peptides	O
generally	O
contain	O
10	O
-	O
50	O
amino	O
acids	O
and	O
have	O
positive	O
net	O
charges	O
[	O
5	O
]	O
.	O
<EOS>	B-X
We	B-X
prepared	B-X
ten	B-X
analogues	B-X
that	B-X
were	B-X
modified	B-X
by	B-X
the	B-X
incorporation	B-X
of	B-X
Ala	B-X
,	B-X
Tyr	B-X
,	B-X
Trp	B-X
,	B-X
Met	B-X
and	B-X
Arg	B-X
residues	B-X
,	B-X
which	B-X
are	B-X
amino	B-X
acids	B-X
known	B-X
to	B-X
be	B-X
important	B-X
for	B-X
the	B-X
antibacterial	B-X
activity	B-X
of	B-X
longer	B-X
derivatives	B-X
of	B-X
lactoferricins	B-X
.	B-X
All	B-X
undecapeptides	B-X
contained	B-X
the	B-X
native	B-X
Trp	B-X
residues	B-X
in	B-X
positions	B-X
6	B-X
and	B-X
8	B-X
,	B-X
and	B-X
the	B-X
Arg	B-X
residues	B-X
in	B-X
positions	B-X
5	B-X
and	B-X
9	B-X
.	B-X
Generally	B-X
,	B-X
the	B-X
Gram-positive	B-X
bacterium	B-X
Staphylococcus	B-X
aureus	B-X
was	B-X
more	B-X
susceptible	B-X
to	B-X
these	B-X
undecapeptides	B-X
than	B-X
the	B-X
Gram-negative	B-X
bacteria	B-X
,	B-X
and	B-X
a	B-X
higher	B-X
antibacterial	B-X
activity	B-X
was	B-X
observed	B-X
against	B-X
Escherichia	B-X
coli	B-X
than	B-X
against	B-X
Pseudomonas	B-X
aeruginosa	B-X
.	B-X
The	B-X
only	B-X
exception	B-X
was	B-X
the	B-X
peptide	B-X
Undeca	B-X
9	B-X
(	B-X
RRWYRWAWRMR-NH2	B-X
)	B-X
,	B-X
which	B-X
was	B-X
almost	B-X
equally	B-X
active	B-X
against	B-X
all	B-X
three	B-X
test	B-X
strains	B-X
,	B-X
displaying	B-X
minimal	B-X
inhibitory	B-X
concentrations	B-X
of	B-X
10	B-X
microg/ml	B-X
(	B-X
5.8	B-X
microM	B-X
)	B-X
,	B-X
7.5	B-X
microg/ml	B-X
(	B-X
4.4	B-X
microM	B-X
)	B-X
and	B-X
5	B-X
microg/ml	B-X
(	B-X
2.9	B-X
microM	B-X
)	B-X
against	B-X
Escherichia	B-X
coli	B-X
,	B-X
Pseudomonas	B-X
aeruginosa	B-X
and	B-X
Staphylococcus	B-X
aureus	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
peptides	B-X
Undeca	B-X
6	B-X
(	B-X
YRAWRWAWRWR-NH2	B-X
)	B-X
and	B-X
Undeca	B-X
7	B-X
(	B-X
YRMWRWAWRWR-NH2	B-X
)	B-X
were	B-X
the	B-X
two	B-X
most	B-X
active	B-X
undecapeptides	B-X
against	B-X
Staphylococcus	B-X
aureus	B-X
,	B-X
both	B-X
displaying	B-X
a	B-X
minimal	B-X
inhibitory	B-X
concentration	B-X
of	B-X
2.5	B-X
microg/ml	B-X
(	B-X
1.5	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
study	B-X
showed	B-X
that	B-X
a	B-X
level	B-X
was	B-X
reached	B-X
in	B-X
which	B-X
undecapeptides	B-X
having	B-X
a	B-X
net	B-X
charge	B-X
above	B-X
+4	B-X
and	B-X
containing	B-X
three	B-X
or	B-X
four	B-X
Trp	B-X
residues	B-X
all	B-X
displayed	B-X
a	B-X
high	B-X
antibacterial	B-X
activity	B-X
.	B-X
All	B-X
undecapeptides	B-X
prepared	B-X
were	B-X
essentially	B-X
non-haemolytic	B-X
,	B-X
but	B-X
undecapeptides	B-X
containing	B-X
more	B-X
than	B-X
three	B-X
Trp	B-X
residues	B-X
displayed	B-X
50	B-X
%	B-X
haemolysis	B-X
of	B-X
human	B-X
red	B-X
blood	B-X
cells	B-X
at	B-X
concentrations	B-X
above	B-X
400	B-X
microg/ml	B-X
(	B-X
>	B-X
230	B-X
microM	B-X
)	B-X
.	B-X

Due	O
to	O
their	O
cationic	O
properties	O
,	O
CAMPs	O
can	O
easily	O
bind	O
to	O
the	O
highly	O
negatively	O
charged	O
bacterial	O
cell	O
envelope	O
and	O
inactivate	O
bacteria	O
,	O
e	O
.	O
g	O
.	O
by	O
forming	O
pores	O
in	O
the	O
bacterial	O
membrane	O
leading	O
to	O
bacterial	O
lysis	O
[	O
6	O
]	O
.	O

S	O
.	O
aureus	O
has	O
evolved	O
mechanisms	O
to	O
alter	O
the	O
anionic	O
charge	O
of	O
cell	O
surface	O
components	O
to	O
gain	O
resistance	O
to	O
a	O
broad	O
variety	O
of	O
cationic	O
antimicrobial	O
factors	O
such	O
as	O
CAMPs	O
[	O
7	O
]	O
,	O
phospholipase	B-Protein
A2	I-Protein
[	O
8	O
]	O
,	O
myeloperoxidase	B-Protein
[	O
9	O
]	O
,	O
or	O
lysozyme	O
[	O
10	O
]	O
.	O
<EOS>	B-X
In	B-X
the	B-X
first	B-X
section	B-X
the	B-X
assay	B-X
methods	B-X
of	B-X
lysozyme	B-X
are	B-X
reviewed	B-X
.	B-X
In	B-X
the	B-X
second	B-X
chapter	B-X
serum	B-X
or	B-X
urinary	B-X
lysozyme	B-X
levels	B-X
are	B-X
discussed	B-X
in	B-X
the	B-X
states	B-X
of	B-X
diseases	B-X
.	B-X
The	B-X
high	B-X
levels	B-X
are	B-X
induced	B-X
by	B-X
cell	B-X
proliferation	B-X
which	B-X
are	B-X
producing	B-X
lysozyme	B-X
.	B-X
The	B-X
type	B-X
of	B-X
cells	B-X
and	B-X
their	B-X
nature	B-X
may	B-X
infer	B-X
different	B-X
lysozymes	B-X
that	B-X
has	B-X
no	B-X
clear	B-X
evidences	B-X
yet	B-X
.	B-X
In	B-X
the	B-X
third	B-X
part	B-X
lysozyme	B-X
is	B-X
reviewed	B-X
as	B-X
protein	B-X
and	B-X
product	B-X
of	B-X
gene	B-X
.	B-X
In	B-X
the	B-X
final	B-X
,	B-X
enzyme	B-X
kinetics	B-X
are	B-X
the	B-X
subject	B-X
of	B-X
investigation	B-X
,	B-X
and	B-X
further	B-X
studies	B-X
may	B-X
by	B-X
chance	B-X
conduct	B-X
us	B-X
to	B-X
find	B-X
out	B-X
new	B-X
isozymes	B-X
of	B-X
lysozyme	B-X
in	B-X
near	B-X
future	B-X
.	B-X

One	O
such	O
mechanism	O
is	O
based	O
upon	O
modification	O
of	O
phospholipids	O
in	O
the	O
cytoplasmic	O
membrane	O
by	O
introducing	O
a	O
positively	O
charged	O
lysyl	O
group	O
into	O
anionic	O
phosphatidylglycerol	O
by	O
the	O
MprF	B-Protein
protein	O
,	O
thereby	O
neutralizing	O
the	O
net	O
charge	O
of	O
the	O
membrane	O
surface	O
[	O
11	O
,	O
12	O
]	O
.	O

A	O
similar	O
reaction	O
is	O
mediated	O
by	O
products	O
of	O
the	O
dltABCD	B-Protein
operon	O
,	O
which	O
are	O
responsible	O
for	O
attachment	O
of	O
positively	O
charged	O
D	O
-	O
alanine	O
residues	O
into	O
negatively	O
charged	O
phosphate	O
groups	O
in	O
the	O
backbone	O
of	O
teichoic	O
acids	O
[	O
7	O
,	O
9	O
]	O
.	O

Mechanisms	O
involved	O
in	O
the	O
regulation	O
of	O
these	O
resistance	O
factors	O
are	O
not	O
yet	O
well	O
understood	O
in	O
Gram	O
-	O
positive	O
bacteria	O
.	O
<EOS>	B-X
WRKY	B-X
transcription	B-X
factors	B-X
are	B-X
one	B-X
of	B-X
the	B-X
largest	B-X
families	B-X
of	B-X
transcriptional	B-X
regulators	B-X
in	B-X
plants	B-X
and	B-X
form	B-X
integral	B-X
parts	B-X
of	B-X
signalling	B-X
webs	B-X
that	B-X
modulate	B-X
many	B-X
plant	B-X
processes	B-X
.	B-X
New	B-X
findings	B-X
illustrate	B-X
that	B-X
WRKY	B-X
proteins	B-X
often	B-X
act	B-X
as	B-X
repressors	B-X
as	B-X
well	B-X
as	B-X
activators	B-X
,	B-X
and	B-X
that	B-X
members	B-X
of	B-X
the	B-X
family	B-X
play	B-X
roles	B-X
in	B-X
both	B-X
the	B-X
repression	B-X
and	B-X
de-repression	B-X
of	B-X
important	B-X
plant	B-X
processes	B-X
.	B-X
Furthermore	B-X
,	B-X
it	B-X
is	B-X
becoming	B-X
clear	B-X
that	B-X
a	B-X
single	B-X
WRKY	B-X
transcription	B-X
factor	B-X
might	B-X
be	B-X
involved	B-X
in	B-X
regulating	B-X
several	B-X
seemingly	B-X
disparate	B-X
processes	B-X
.	B-X
Mechanisms	B-X
of	B-X
signalling	B-X
and	B-X
transcriptional	B-X
regulation	B-X
are	B-X
being	B-X
dissected	B-X
,	B-X
uncovering	B-X
WRKY	B-X
protein	B-X
functions	B-X
via	B-X
interactions	B-X
with	B-X
a	B-X
diverse	B-X
array	B-X
of	B-X
protein	B-X
partners	B-X
,	B-X
including	B-X
MAP	B-X
kinases	B-X
,	B-X
MAP	B-X
kinase	B-X
kinases	B-X
,	B-X
14-3-3	B-X
proteins	B-X
,	B-X
calmodulin	B-X
,	B-X
histone	B-X
deacetylases	B-X
,	B-X
resistance	B-X
proteins	B-X
and	B-X
other	B-X
WRKY	B-X
transcription	B-X
factors	B-X
.	B-X
WRKY	B-X
genes	B-X
exhibit	B-X
extensive	B-X
autoregulation	B-X
and	B-X
cross-regulation	B-X
that	B-X
facilitates	B-X
transcriptional	B-X
reprogramming	B-X
in	B-X
a	B-X
dynamic	B-X
web	B-X
with	B-X
built-in	B-X
redundancy	B-X
.	B-X

Herbert	O
et	O
al	O
.	O
recently	O
found	O
that	O
the	O
S	O
.	O
aureus	O
two	O
-	O
component	O
regulatory	O
system	O
graRS	B-Protein
positively	O
regulates	O
expression	O
of	O
the	O
dlt	O
operon	O
.	O

In	O
a	O
S	O
.	O
aureus	O
SA113	O
graRS	B-Protein
deletion	O
mutant	O
,	O
the	O
content	O
of	O
D	O
-	O
alanine	O
in	O
teichoic	O
acids	O
was	O
reduced	O
by	O
47	O
%	O
and	O
the	O
mutant	O
showed	O
reduced	O
resistance	O
to	O
various	O
antibiotics	O
including	O
polymyxin	O
B	O
,	O
gallidermin	O
,	O
and	O
vancomycin	O
[	O
10	O
,	O
13	O
]	O
.	O

Accordingly	O
,	O
graRS	B-Protein
have	O
previously	O
been	O
implicated	O
in	O
regulation	O
of	O
vancomycin	O
intermediary	O
resistance	O
[	O
14	O
]	O
.	O

As	O
the	O
dlt	O
operon	O
plays	O
a	O
key	O
role	O
in	O
S	O
.	O
aureus	O
resistance	O
to	O
cationic	O
antimicrobial	O
host	O
molecules	O
,	O
the	O
graRS	B-Protein
system	O
may	O
be	O
important	O
in	O
evasion	O
of	O
host	O
defense	O
mechanisms	O
such	O
as	O
cationic	O
antimicrobial	O
peptides	O
and	O
neutrophil	O
killing	O
.	O

Results	O

The	O
graRS	B-Protein
mutant	O
shows	O
altered	O
cell	O
surface	O
charge	O
but	O
unaltered	O
lysyl	O
-	O
phosphatidylglycerol	O
(	O
LPG	O
)	O
content	O
In	O
order	O
to	O
study	O
if	O
reduced	O
expression	O
of	O
the	O
dlt	O
operon	O
upon	O
graRS	B-Protein
disruption	O
results	O
in	O
altered	O
cell	O
surface	O
charge	O
,	O
we	O
compared	O
binding	O
of	O
the	O
red	O
-	O
coloured	O
,	O
cationic	O
protein	O
cytochrome	B-Protein
c	I-Protein
to	O
wild	O
type	O
S	O
.	O
aureus	O
SA113	O
(	O
WT	O
)	O
,	O
the	O
isogenic	O
graRS	B-Protein
mutant	O
,	O
and	O
the	O
plasmid	O
-	O
complemented	O
mutant	O
.	O

The	O
graRS	B-Protein
mutant	O
bound	O
significantly	O
more	O
cytochrome	B-Protein
c	I-Protein
than	O
the	O
WT	O
or	O
the	O
complemented	O
mutant	O
(	O
Fig	O
.	O
1A	O
)	O
,	O
which	O
is	O
in	O
accordance	O
with	O
the	O
recently	O
described	O
reduced	O
content	O
of	O
D	O
-	O
alanine	O
residues	O
in	O
the	O
teichoic	O
acids	O
of	O
the	O
mutant	O
[	O
10	O
]	O
.	O

To	O
analyse	O
whether	O
increased	O
binding	O
of	O
cytochrome	B-Protein
c	I-Protein
by	O
the	O
graRS	B-Protein
mutant	O
is	O
in	O
fact	O
due	O
to	O
altered	O
cell	O
surface	O
charge	O
by	O
decreased	O
teichoic	O
acid	O
alanylation	O
or	O
the	O
altered	O
expression	O
of	O
other	O
surface	O
-	O
exposed	O
molecules	O
,	O
we	O
also	O
examined	O
binding	O
of	O
cytochrome	B-Protein
c	I-Protein
to	O
a	O
dltA	B-Protein
deletion	O
mutant	O
,	O
which	O
completely	O
lacks	O
D	O
-	O
alanine	O
substitution	O
of	O
teichoic	O
acids	O
[	O
7	O
]	O
,	O
and	O
a	O
dltA	B-Protein
/	O
graRS	B-Protein
double	O
deletion	O
mutant	O
,	O
which	O
was	O
generated	O
by	O
transducing	O
the	O
graRS	B-Protein
mutation	O
into	O
the	O
dltA	B-Protein
mutant	O
.	O

Due	O
to	O
the	O
high	O
binding	O
capacities	O
of	O
the	O
dltA	B-Protein
and	O
the	O
dltA	B-Protein
/	O
graRS	B-Protein
mutant	O
we	O
modified	O
the	O
conditions	O
in	O
order	O
to	O
prevent	O
limitation	O
of	O
applied	O
cytochrome	B-Protein
c	I-Protein
.	O

Deletion	O
of	O
the	O
graRS	B-Protein
genes	O
in	O
the	O
dlt	O
mutant	O
background	O
did	O
not	O
lead	O
to	O
further	O
increased	O
binding	O
of	O
cytochrome	B-Protein
c	I-Protein
compared	O
to	O
the	O
dltA	B-Protein
mutant	O
(	O
Fig	O
.	O
1B	O
)	O
.	O
<EOS>	B-X
Modification	B-X
of	B-X
teichoic	B-X
acids	B-X
with	B-X
D-alanine	B-X
by	B-X
the	B-X
products	B-X
of	B-X
the	B-X
dlt	B-X
operon	B-X
protects	B-X
Gram-positive	B-X
bacteria	B-X
against	B-X
major	B-X
antimicrobial	B-X
host	B-X
defense	B-X
molecules	B-X
such	B-X
as	B-X
defensins	B-X
,	B-X
cathelicidins	B-X
,	B-X
myeloperoxidase	B-X
or	B-X
phospholipase	B-X
.	B-X
The	B-X
graRS	B-X
regulatory	B-X
genes	B-X
have	B-X
recently	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
D-alanylation	B-X
in	B-X
Staphylococcus	B-X
aureus	B-X
.	B-X

This	O
finding	O
indicates	O
that	O
the	O
increased	O
binding	O
of	O
cytochrome	B-Protein
c	I-Protein
by	O
the	O
graRS	B-Protein
mutant	O
is	O
due	O
to	O
decreased	O
alanylation	O
of	O
teichoic	O
acids	O
and	O
that	O
the	O
resulting	O
surface	O
charge	O
alteration	O
does	O
not	O
result	O
from	O
other	O
regulatory	O
effects	O
mediated	O
by	O
GraRS	B-Protein
.	O

Increased	O
binding	O
of	O
cationic	O
proteins	O
may	O
also	O
result	O
from	O
reduced	O
mprF	B-Protein
expression	O
and	O
,	O
accordingly	O
,	O
reduced	O
lysylphosphatidylglycerol	O
(	O
LPG	O
)	O
content	O
.	O

To	O
control	O
for	O
this	O
possibility	O
,	O
we	O
compared	O
patterns	O
of	O
membrane	O
lipids	O
from	O
log	O
-	O
phase	O
bacteria	O
by	O
thin	O
-	O
layer	O
chromatography	O
.	O

The	O
amounts	O
of	O
LPG	O
from	O
WT	O
and	O
graRS	B-Protein
mutant	O
were	O
indistinguishable	O
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
corroborates	O
recent	O
findings	O
that	O
mprF	B-Protein
is	O
not	O
among	O
the	O
graRS	B-Protein
-	O
regulated	O
genes	O
in	O
S	O
.	O
aureus	O
SA113	O
[	O
10	O
]	O
.	O

The	O
graRS	B-Protein
mutant	O
is	O
more	O
susceptible	O
to	O
killing	O
by	O
LL	B-Protein
-	I-Protein
37	I-Protein
and	O
human	O
neutrophil	O
granulocytes	O
in	O
vitro	O
In	O
an	O
attempt	O
to	O
test	O
whether	O
the	O
increased	O
affinity	O
of	O
the	O
graRS	B-Protein
mutant	O
to	O
cationic	O
molecules	O
leads	O
to	O
higher	O
susceptibility	O
to	O
human	O
host	O
defense	O
peptides	O
,	O
we	O
compared	O
inactivation	O
of	O
WT	O
and	O
graRS	B-Protein
mutant	O
by	O
the	O
human	O
cathelicidin	O
LL	B-Protein
-	I-Protein
37	I-Protein
.	O

This	O
antimicrobial	O
peptide	O
is	O
active	O
against	O
S	O
.	O
aureus	O
at	O
high	O
concentrations	O
or	O
long	O
exposure	O
[	O
15	O
]	O
but	O
in	O
this	O
experiment	O
we	O
chose	O
conditions	O
under	O
which	O
the	O
LL	B-Protein
-	I-Protein
37	I-Protein
did	O
not	O
affect	O
viability	O
of	O
the	O
S	O
.	O
aureus	O
WT	O
.	O
<EOS>	B-X
Antibacterial	B-X
Peptides	B-X
Resistance	B-X
in	B-X
Defensin	B-X
peptide	B-X
isolated	B-X
from	B-X
plants	B-X
are	B-X
often	B-X
heterogeneous	B-X
in	B-X
length	B-X
,	B-X
sequence	B-X
and	B-X
structure	B-X
,	B-X
but	B-X
they	B-X
are	B-X
mostly	B-X
small	B-X
,	B-X
cationic	B-X
and	B-X
amphipathic	B-X
.	B-X
The	B-X
Andrias	B-X
davidianus	B-X
has	B-X
been	B-X
known	B-X
as	B-X
a	B-X
traditional	B-X
Chinese	B-X
medicine	B-X
for	B-X
a	B-X
long	B-X
time	B-X
.	B-X
Although	B-X
there	B-X
are	B-X
reports	B-X
on	B-X
isolation	B-X
of	B-X
the	B-X
antimicrobial	B-X
peptides	B-X
from	B-X
different	B-X
resources	B-X
,	B-X
there	B-X
are	B-X
no	B-X
reports	B-X
of	B-X
their	B-X
isolation	B-X
from	B-X
A.	B-X
davidianus	B-X
blood	B-X
.	B-X
In	B-X
this	B-X
work	B-X
,	B-X
an	B-X
antimicrobial	B-X
peptide	B-X
,	B-X
andricin	B-X
B	B-X
,	B-X
was	B-X
isolated	B-X
from	B-X
the	B-X
blood	B-X
of	B-X
A.	B-X
davidianus	B-X
by	B-X
an	B-X
innovative	B-X
method	B-X
in	B-X
which	B-X
the	B-X
magnetic	B-X
liposome	B-X
adsorption	B-X
was	B-X
combined	B-X
with	B-X
reversed-phase	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
.	B-X
The	B-X
structure	B-X
,	B-X
antimicrobial	B-X
activity	B-X
and	B-X
safety	B-X
of	B-X
andricin	B-X
B	B-X
were	B-X
further	B-X
investigated	B-X
.	B-X
Andricin	B-X
B	B-X
was	B-X
found	B-X
to	B-X
be	B-X
active	B-X
against	B-X
all	B-X
bacteria	B-X
tested	B-X
in	B-X
this	B-X
study	B-X
as	B-X
well	B-X
as	B-X
some	B-X
fungi	B-X
.	B-X
The	B-X
minimum	B-X
inhibitory	B-X
concentrations	B-X
(	B-X
MICs	B-X
)	B-X
were	B-X
in	B-X
the	B-X
range	B-X
8-64	B-X
μg	B-X
ml	B-X

Accordingly	O
,	O
the	O
WT	O
and	O
complemented	O
mutant	O
strains	O
showed	O
no	O
significant	O
decrease	O
in	O
CFU	O
following	O
LL	B-Protein
-	I-Protein
37	I-Protein
exposure	O
,	O
whereas	O
the	O
number	O
of	O
graRS	B-Protein
mutant	O
bacteria	O
recovered	O
was	O
only	O
25	O
%	O
of	O
the	O
original	O
inoculum	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Next	O
we	O
investigated	O
whether	O
the	O
graRS	B-Protein
mutant	O
is	O
killed	O
faster	O
than	O
the	O
parental	O
strain	O
by	O
human	O
neutrophils	O
,	O
which	O
produce	O
high	O
amounts	O
of	O
LL	B-Protein
-	I-Protein
37	I-Protein
and	O
other	O
CAMPs	O
as	O
components	O
of	O
their	O
antibacterial	O
killing	O
arsenal	O
.	O

The	O
graRS	B-Protein
mutant	O
was	O
killed	O
by	O
neutrophils	O
considerably	O
faster	O
than	O
the	O
WT	O
strain	O
.	O

After	O
15	O
and	O
30	O
min	O
,	O
the	O
recovered	O
CFU	O
of	O
the	O
graRS	B-Protein
mutant	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
the	O
WT	O
(	O
Fig	O
2B	O
)	O
.	O

Of	O
note	O
,	O
our	O
previous	O
studies	O
had	O
shown	O
that	O
altered	O
alanylation	O
of	O
teichoic	O
acids	O
does	O
not	O
affect	O
the	O
rate	O
of	O
PMN	O
phagocytosis	O
[	O
9	O
]	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
graRS	B-Protein
-	O
mediated	O
control	O
of	O
CAMP	O
resistance	O
mechanisms	O
is	O
of	O
importance	O
for	O
S	O
.	O
aureus	O
evasion	O
from	O
neutrophil	O
killing	O
.	O

Deletion	O
of	O
graRS	B-Protein
leads	O
to	O
attenuated	O
virulence	O
in	O
a	O
mouse	O
infection	O
model	O

To	O
investigate	O
the	O
impact	O
of	O
reduced	O
resistance	O
of	O
the	O
graRS	B-Protein
mutant	O
to	O
neutrophil	O
and	O
CAMP	O
-	O
mediated	O
killing	O
on	O
the	O
ability	O
of	O
the	O
bacteria	O
to	O
cause	O
infections	O
in	O
vivo	O
,	O
we	O
compared	O
the	O
virulence	O
of	O
WT	O
and	O
mutant	O
bacteria	O
in	O
a	O
mouse	O
challenge	O
model	O
.	O

Therefore	O
female	O
BALB	O
/	O
c	O
mice	O
(	O
12	O
to	O
15	O
weeks	O
old	O
)	O
were	O
infected	O
with	O
S	O
.	O
aureus	O
WT	O
or	O
graRS	B-Protein
mutant	O
bacteria	O
.	O
<EOS>	B-X
Modification	B-X
of	B-X
teichoic	B-X
acids	B-X
with	B-X
D-alanine	B-X
by	B-X
the	B-X
products	B-X
of	B-X
the	B-X
dlt	B-X
operon	B-X
protects	B-X
Gram-positive	B-X
bacteria	B-X
against	B-X
major	B-X
antimicrobial	B-X
host	B-X
defense	B-X
molecules	B-X
such	B-X
as	B-X
defensins	B-X
,	B-X
cathelicidins	B-X
,	B-X
myeloperoxidase	B-X
or	B-X
phospholipase	B-X
.	B-X
The	B-X
graRS	B-X
regulatory	B-X
genes	B-X
have	B-X
recently	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
D-alanylation	B-X
in	B-X
Staphylococcus	B-X
aureus	B-X
.	B-X
The	B-X
two-component	B-X
regulatory	B-X
system	B-X
,	B-X
GraRS	B-X
,	B-X
appears	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
staphylococcal	B-X
responses	B-X
to	B-X
cationic	B-X
antimicrobial	B-X
peptides	B-X
(	B-X
CAPs	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
by	B-X
which	B-X
GraRS	B-X
is	B-X
induced	B-X
,	B-X
regulated	B-X
,	B-X
and	B-X
modulated	B-X
remain	B-X
undefined	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two	B-X
well-characterized	B-X
MRSA	B-X
strains	B-X
(	B-X
Mu50	B-X
and	B-X
COL	B-X
)	B-X
and	B-X
their	B-X
respective	B-X
mutants	B-X
of	B-X
graR	B-X
and	B-X
vraG	B-X
(	B-X
encoding	B-X
the	B-X
ABC	B-X
transporter-dependent	B-X
efflux	B-X
pump	B-X
immediately	B-X
downstream	B-X
of	B-X
graRS	B-X
)	B-X
,	B-X
and	B-X
show	B-X
that	B-X
(	B-X
i	B-X
)	B-X
the	B-X
expression	B-X
of	B-X
two	B-X
key	B-X
determinants	B-X
of	B-X
net	B-X
positive	B-X
surface	B-X
charge	B-X
(	B-X
mprF	B-X
and	B-X
dlt	B-X
)	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
cotranscription	B-X
of	B-X
both	B-X
graR	B-X
and	B-X
vraG	B-X
,	B-X
(	B-X
ii	B-X
)	B-X
reduced	B-X
expression	B-X
of	B-X
mprF	B-X
and	B-X
dlt	B-X
in	B-X
graR	B-X
mutants	B-X
was	B-X
phenotypically	B-X
associated	B-X
with	B-X
reduced	B-X
surface-positive	B-X
charge	B-X
,	B-X
(	B-X
iii	B-X
)	B-X
this	B-X
net	B-X
reduction	B-X
in	B-X
surface-positive	B-X
charge	B-X
in	B-X
graR	B-X
and	B-X
vraG	B-X
mutants	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
correlated	B-X
with	B-X
enhanced	B-X
killing	B-X
by	B-X
a	B-X
range	B-X
of	B-X
CAPs	B-X
of	B-X
diverse	B-X
structure	B-X
and	B-X
origin	B-X
,	B-X
including	B-X
those	B-X
from	B-X
mammalian	B-X
platelets	B-X
(	B-X
tPMPs	B-X
)	B-X
and	B-X
neutrophils	B-X
(	B-X
hNP-1	B-X
)	B-X
and	B-X
from	B-X
bacteria	B-X
(	B-X
polymyxin	B-X
B	B-X
)	B-X
,	B-X
and	B-X
(	B-X
iv	B-X
)	B-X
the	B-X
synthesis	B-X
and	B-X
translocation	B-X
of	B-X
membrane	B-X
lysyl-phosphatidylglycerol	B-X
(	B-X
an	B-X
mprF-dependent	B-X
function	B-X
)	B-X
was	B-X
substantially	B-X
lower	B-X
in	B-X
graR	B-X
and	B-X
vraG	B-X
mutants	B-X
than	B-X
in	B-X
parental	B-X
strains	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
inducibility	B-X
of	B-X
mprF	B-X
and	B-X
dlt	B-X
transcription	B-X
via	B-X
the	B-X
graRS-vraFG	B-X
pathway	B-X
was	B-X
selective	B-X
,	B-X
with	B-X
induction	B-X
by	B-X
sublethal	B-X
exposure	B-X
to	B-X
the	B-X
CAPs	B-X
,	B-X
RP-1	B-X
(	B-X
platelets	B-X
)	B-X
,	B-X
and	B-X
polymyxin	B-X
B	B-X
,	B-X
but	B-X
not	B-X
by	B-X
other	B-X
cationic	B-X
molecules	B-X
(	B-X
hNP-1	B-X
,	B-X
vancomycin	B-X
,	B-X
gentamicin	B-X
,	B-X
or	B-X
calcium-daptomycin	B-X
)	B-X
.	B-X
Although	B-X
graR	B-X
regulates	B-X
expression	B-X
of	B-X
vraG	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
graR	B-X
was	B-X
codependent	B-X
on	B-X
an	B-X
intact	B-X
downstream	B-X
vraG	B-X
locus	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
data	B-X
support	B-X
an	B-X
important	B-X
role	B-X
of	B-X
the	B-X
graRS	B-X
and	B-X
vraFG	B-X
loci	B-X
in	B-X
the	B-X
sensing	B-X
of	B-X
and	B-X
response	B-X
to	B-X
specific	B-X
CAPs	B-X
involved	B-X
in	B-X
innate	B-X
host	B-X
defenses	B-X
.	B-X

72	O
h	O
after	O
infection	O
numbers	O
of	O
CFU	O
/	O
kidney	O
were	O
determined	O
.	O
<EOS>	B-X
The	B-X
ability	B-X
of	B-X
Candida	B-X
albicans	B-X
to	B-X
infect	B-X
thermally	B-X
injured	B-X
mice	B-X
was	B-X
studied	B-X
.	B-X
Female	B-X
mice	B-X
were	B-X
either	B-X
left	B-X
unburned	B-X
or	B-X
given	B-X
a	B-X
20	B-X
%	B-X
total	B-X
body	B-X
surface	B-X
area	B-X
2-s	B-X
or	B-X
7-s	B-X
scald	B-X
burn	B-X
.	B-X
The	B-X
wound	B-X
or	B-X
skin	B-X
surface	B-X
was	B-X
then	B-X
inoculated	B-X
with	B-X
a	B-X
human	B-X
burn	B-X
wound	B-X
isolate	B-X
of	B-X
C.	B-X
albicans	B-X
.	B-X
At	B-X
4	B-X
h	B-X
postburn	B-X
,	B-X
approximately	B-X
10	B-X
(	B-X
2	B-X
)	B-X
to	B-X
10	B-X
(	B-X
3	B-X
)	B-X
CFU/g	B-X
of	B-X
tissue	B-X
could	B-X
be	B-X
recovered	B-X
from	B-X
the	B-X
skin	B-X
of	B-X
burned	B-X
and	B-X
unburned	B-X
animals	B-X
.	B-X
Unburned	B-X
mice	B-X
cleared	B-X
the	B-X
organisms	B-X
from	B-X
the	B-X
skin	B-X
by	B-X
72	B-X
h	B-X
,	B-X
whereas	B-X
in	B-X
7-s-burned	B-X
animals	B-X
,	B-X
the	B-X
candida	B-X
increased	B-X
in	B-X
numbers	B-X
to	B-X
approximately	B-X
10	B-X
(	B-X
7	B-X
)	B-X
CFU/g	B-X
of	B-X
tissue	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
the	B-X
organisms	B-X
to	B-X
invade	B-X
systemically	B-X
after	B-X
wound	B-X
surface	B-X
inoculation	B-X
was	B-X
examined	B-X
in	B-X
mice	B-X
given	B-X
either	B-X
a	B-X
2-s	B-X
or	B-X
a	B-X
7-s	B-X
scald	B-X
burn	B-X
.	B-X
Each	B-X
injury	B-X
was	B-X
histologically	B-X
confirmed	B-X
as	B-X
a	B-X
full-thickness	B-X
(	B-X
third	B-X
degree	B-X
)	B-X
burn	B-X
,	B-X
with	B-X
slightly	B-X
deeper	B-X
tissue	B-X
damage	B-X
observed	B-X
with	B-X
the	B-X
7-s	B-X
burn	B-X
.	B-X
At	B-X
each	B-X
time	B-X
period	B-X
examined	B-X
(	B-X
1	B-X
,	B-X
4	B-X
,	B-X
7	B-X
,	B-X
and	B-X
10	B-X
days	B-X
)	B-X
,	B-X
there	B-X
were	B-X
significantly	B-X
fewer	B-X
organisms	B-X
in	B-X
the	B-X
wounds	B-X
of	B-X
mice	B-X
given	B-X
the	B-X
2-s	B-X
injury	B-X
than	B-X
in	B-X
wounds	B-X
of	B-X
mice	B-X
burned	B-X
for	B-X
7	B-X
s	B-X
(	B-X
P	B-X
less	B-X
than	B-X
0.05	B-X
)	B-X
.	B-X
In	B-X
3	B-X
of	B-X
33	B-X
mice	B-X
given	B-X
a	B-X
7-s	B-X
injury	B-X
,	B-X
organisms	B-X
were	B-X
recovered	B-X
from	B-X
the	B-X
kidneys	B-X
at	B-X
the	B-X
time	B-X
of	B-X
sacrifice	B-X
,	B-X
whereas	B-X
no	B-X
evidence	B-X
of	B-X
invasion	B-X
into	B-X
the	B-X
kidneys	B-X
was	B-X
noted	B-X
in	B-X
mice	B-X
given	B-X
a	B-X
2-s	B-X
thermal	B-X
injury	B-X
.	B-X
This	B-X
study	B-X
demonstrated	B-X
that	B-X
thermal	B-X
injury	B-X
enhances	B-X
the	B-X
ability	B-X
of	B-X
C.	B-X
albicans	B-X
to	B-X
infect	B-X
mice	B-X
and	B-X
that	B-X
the	B-X
depth	B-X
of	B-X
burn	B-X
appears	B-X
to	B-X
be	B-X
an	B-X
important	B-X
factor	B-X
in	B-X
determining	B-X
whether	B-X
the	B-X
organisms	B-X
can	B-X
invade	B-X
the	B-X
burn	B-X
wound	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
This	B-X
animal	B-X
model	B-X
should	B-X
be	B-X
valuable	B-X
in	B-X
elucidating	B-X
the	B-X
virulence	B-X
factors	B-X
of	B-X
C.	B-X
albicans	B-X
that	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
candidiasis	B-X
after	B-X
thermal	B-X
injury	B-X
.	B-X

Significantly	O
less	O
bacteria	O
were	O
detected	O
in	O
the	O
kidneys	O
of	O
animals	O
,	O
which	O
had	O
been	O
infected	O
with	O
the	O
graRS	B-Protein
mutant	O
than	O
those	O
infected	O
with	O
the	O
WT	O
bacteria	O
.	O

(	O
Fig	O
.	O
3	O
)	O
This	O
finding	O
is	O
in	O
coincidence	O
with	O
the	O
increased	O
susceptibility	O
to	O
clearance	O
by	O
CAMPs	O
and	O
neutrophils	O
,	O
corroborating	O
the	O
central	O
importance	O
of	O
these	O
host	O
factors	O
in	O
innate	O
defense	O
.	O

Incompetence	O
of	O
Neutrophils	O
to	O
Invasive	O
Group	O
A	O
streptococcus	O
Is	O
Attributed	O
to	O
Induction	O
of	O
Plural	O
Virulence	O
Factors	O
by	O
Dysfunction	O
of	O
a	O
Regulator	O
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X

Group	O
A	O
streptococcus	O
(	O
GAS	O
)	O
causes	O
variety	O
of	O
diseases	O
ranging	O
from	O
common	O
pharyngitis	O
to	O
life	O
-	O
threatening	O
severe	O
invasive	O
diseases	O
,	O
including	O
necrotizing	O
fasciitis	O
and	O
streptococcal	O
toxic	O
shock	O
-	O
like	O
syndrome	O
.	O
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X
The	B-X
characteristic	B-X
of	B-X
invasive	B-X
GAS	B-X
infections	B-X
has	B-X
been	B-X
thought	B-X
to	B-X
attribute	B-X
to	B-X
genetic	B-X
changes	B-X
in	B-X
bacteria	B-X
,	B-X
however	B-X
,	B-X
no	B-X
clear	B-X
evidence	B-X
has	B-X
shown	B-X
due	B-X
to	B-X
lack	B-X
of	B-X
an	B-X
intriguingly	B-X
study	B-X
using	B-X
serotype-matched	B-X
isolates	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
infections	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
rare	B-X
outbreaks	B-X
of	B-X
invasive	B-X
infections	B-X
and	B-X
their	B-X
distinctive	B-X
pathology	B-X
in	B-X
which	B-X
infectious	B-X
foci	B-X
without	B-X
neutrophil	B-X
infiltration	B-X
hypothesized	B-X
us	B-X
invasive	B-X
GAS	B-X
could	B-X
evade	B-X
host	B-X
defense	B-X
,	B-X
especially	B-X
neutrophil	B-X
functions	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
a	B-X
panel	B-X
of	B-X
serotype-matched	B-X
GAS	B-X
,	B-X
which	B-X
were	B-X
clinically	B-X
isolated	B-X
from	B-X
severe	B-X
invasive	B-X
but	B-X
not	B-X
from	B-X
non-invaive	B-X
infections	B-X
,	B-X
could	B-X
abrogate	B-X
functions	B-X
of	B-X
human	B-X
polymorphnuclear	B-X
neutrophils	B-X
(	B-X
PMN	B-X
)	B-X
in	B-X
at	B-X
least	B-X
two	B-X
independent	B-X
ways	B-X
;	B-X
due	B-X
to	B-X
inducing	B-X
necrosis	B-X
to	B-X
PMN	B-X
by	B-X
enhanced	B-X
production	B-X
of	B-X
a	B-X
pore-forming	B-X
toxin	B-X
streptolysin	B-X
O	B-X
(	B-X
SLO	B-X
)	B-X
and	B-X
due	B-X
to	B-X
impairment	B-X
of	B-X
PMN	B-X
migration	B-X
via	B-X
digesting	B-X
interleukin-8	B-X
,	B-X
a	B-X
PMN	B-X
attracting	B-X
chemokine	B-X
,	B-X
by	B-X
increased	B-X
production	B-X
of	B-X
a	B-X
serine	B-X
protease	B-X
ScpC	B-X
.	B-X
Expression	B-X
of	B-X
genes	B-X
was	B-X
upregulated	B-X
by	B-X
a	B-X
loss	B-X
of	B-X
repressive	B-X
function	B-X
with	B-X
the	B-X
mutation	B-X
of	B-X
csrS	B-X
gene	B-X
in	B-X
the	B-X
all	B-X
emm49	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
.	B-X
The	B-X
csrS	B-X
mutants	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
exhibited	B-X
high	B-X
mortality	B-X
and	B-X
disseminated	B-X
infection	B-X
with	B-X
paucity	B-X
of	B-X
neutrophils	B-X
,	B-X
a	B-X
characteristic	B-X
pathology	B-X
seen	B-X
in	B-X
human	B-X
invasive	B-X
GAS	B-X
infection	B-X
,	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
.	B-X
However	B-X
,	B-X
GAS	B-X
which	B-X
lack	B-X
either	B-X
SLO	B-X
or	B-X
ScpC	B-X
exhibit	B-X
much	B-X
less	B-X
mortality	B-X
than	B-X
the	B-X
csrS-mutated	B-X
parent	B-X
invasive	B-X
GAS	B-X
isolate	B-X
to	B-X
the	B-X
infected	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
abilities	B-X
of	B-X
GAS	B-X
to	B-X
abrogate	B-X
PMN	B-X
functions	B-X
can	B-X
determine	B-X
the	B-X
onset	B-X
and	B-X
severity	B-X
of	B-X
invasive	B-X
GAS	B-X
infection	B-X
.	B-X

The	O
characteristic	O
of	O
invasive	O
GAS	O
infections	O
has	O
been	O
thought	O
to	O
attribute	O
to	O
genetic	O
changes	O
in	O
bacteria	O
,	O
however	O
,	O
no	O
clear	O
evidence	O
has	O
shown	O
due	O
to	O
lack	O
of	O
an	O
intriguingly	O
study	O
using	O
serotype	O
-	O
matched	O
isolates	O
from	O
clinical	O
severe	O
invasive	O
GAS	O
infections	O
.	O
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X
The	B-X
characteristic	B-X
of	B-X
invasive	B-X
GAS	B-X
infections	B-X
has	B-X
been	B-X
thought	B-X
to	B-X
attribute	B-X
to	B-X
genetic	B-X
changes	B-X
in	B-X
bacteria	B-X
,	B-X
however	B-X
,	B-X
no	B-X
clear	B-X
evidence	B-X
has	B-X
shown	B-X
due	B-X
to	B-X
lack	B-X
of	B-X
an	B-X
intriguingly	B-X
study	B-X
using	B-X
serotype-matched	B-X
isolates	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
infections	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
rare	B-X
outbreaks	B-X
of	B-X
invasive	B-X
infections	B-X
and	B-X
their	B-X
distinctive	B-X
pathology	B-X
in	B-X
which	B-X
infectious	B-X
foci	B-X
without	B-X
neutrophil	B-X
infiltration	B-X
hypothesized	B-X
us	B-X
invasive	B-X
GAS	B-X
could	B-X
evade	B-X
host	B-X
defense	B-X
,	B-X
especially	B-X
neutrophil	B-X
functions	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
a	B-X
panel	B-X
of	B-X
serotype-matched	B-X
GAS	B-X
,	B-X
which	B-X
were	B-X
clinically	B-X
isolated	B-X
from	B-X
severe	B-X
invasive	B-X
but	B-X
not	B-X
from	B-X
non-invaive	B-X
infections	B-X
,	B-X
could	B-X
abrogate	B-X
functions	B-X
of	B-X
human	B-X
polymorphnuclear	B-X
neutrophils	B-X
(	B-X
PMN	B-X
)	B-X
in	B-X
at	B-X
least	B-X
two	B-X
independent	B-X
ways	B-X
;	B-X
due	B-X
to	B-X
inducing	B-X
necrosis	B-X
to	B-X
PMN	B-X
by	B-X
enhanced	B-X
production	B-X
of	B-X
a	B-X
pore-forming	B-X
toxin	B-X
streptolysin	B-X
O	B-X
(	B-X
SLO	B-X
)	B-X
and	B-X
due	B-X
to	B-X
impairment	B-X
of	B-X
PMN	B-X
migration	B-X
via	B-X
digesting	B-X
interleukin-8	B-X
,	B-X
a	B-X
PMN	B-X
attracting	B-X
chemokine	B-X
,	B-X
by	B-X
increased	B-X
production	B-X
of	B-X
a	B-X
serine	B-X
protease	B-X
ScpC	B-X
.	B-X
Expression	B-X
of	B-X
genes	B-X
was	B-X
upregulated	B-X
by	B-X
a	B-X
loss	B-X
of	B-X
repressive	B-X
function	B-X
with	B-X
the	B-X
mutation	B-X
of	B-X
csrS	B-X
gene	B-X
in	B-X
the	B-X
all	B-X
emm49	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
.	B-X
The	B-X
csrS	B-X
mutants	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
exhibited	B-X
high	B-X
mortality	B-X
and	B-X
disseminated	B-X
infection	B-X
with	B-X
paucity	B-X
of	B-X
neutrophils	B-X
,	B-X
a	B-X
characteristic	B-X
pathology	B-X
seen	B-X
in	B-X
human	B-X
invasive	B-X
GAS	B-X
infection	B-X
,	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
.	B-X
However	B-X
,	B-X
GAS	B-X
which	B-X
lack	B-X
either	B-X
SLO	B-X
or	B-X
ScpC	B-X
exhibit	B-X
much	B-X
less	B-X
mortality	B-X
than	B-X
the	B-X
csrS-mutated	B-X
parent	B-X
invasive	B-X
GAS	B-X
isolate	B-X
to	B-X
the	B-X
infected	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
abilities	B-X
of	B-X
GAS	B-X
to	B-X
abrogate	B-X
PMN	B-X
functions	B-X
can	B-X
determine	B-X
the	B-X
onset	B-X
and	B-X
severity	B-X
of	B-X
invasive	B-X
GAS	B-X
infection	B-X
.	B-X

In	O
addition	O
,	O
rare	O
outbreaks	O
of	O
invasive	O
infections	O
and	O
their	O
distinctive	O
pathology	O
in	O
which	O
infectious	O
foci	O
without	O
neutrophil	O
infiltration	O
hypothesized	O
us	O
invasive	O
GAS	O
could	O
evade	O
host	O
defense	O
,	O
especially	O
neutrophil	O
functions	O
.	O
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X
The	B-X
characteristic	B-X
of	B-X
invasive	B-X
GAS	B-X
infections	B-X
has	B-X
been	B-X
thought	B-X
to	B-X
attribute	B-X
to	B-X
genetic	B-X
changes	B-X
in	B-X
bacteria	B-X
,	B-X
however	B-X
,	B-X
no	B-X
clear	B-X
evidence	B-X
has	B-X
shown	B-X
due	B-X
to	B-X
lack	B-X
of	B-X
an	B-X
intriguingly	B-X
study	B-X
using	B-X
serotype-matched	B-X
isolates	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
infections	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
rare	B-X
outbreaks	B-X
of	B-X
invasive	B-X
infections	B-X
and	B-X
their	B-X
distinctive	B-X
pathology	B-X
in	B-X
which	B-X
infectious	B-X
foci	B-X
without	B-X
neutrophil	B-X
infiltration	B-X
hypothesized	B-X
us	B-X
invasive	B-X
GAS	B-X
could	B-X
evade	B-X
host	B-X
defense	B-X
,	B-X
especially	B-X
neutrophil	B-X
functions	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
a	B-X
panel	B-X
of	B-X
serotype-matched	B-X
GAS	B-X
,	B-X
which	B-X
were	B-X
clinically	B-X
isolated	B-X
from	B-X
severe	B-X
invasive	B-X
but	B-X
not	B-X
from	B-X
non-invaive	B-X
infections	B-X
,	B-X
could	B-X
abrogate	B-X
functions	B-X
of	B-X
human	B-X
polymorphnuclear	B-X
neutrophils	B-X
(	B-X
PMN	B-X
)	B-X
in	B-X
at	B-X
least	B-X
two	B-X
independent	B-X
ways	B-X
;	B-X
due	B-X
to	B-X
inducing	B-X
necrosis	B-X
to	B-X
PMN	B-X
by	B-X
enhanced	B-X
production	B-X
of	B-X
a	B-X
pore-forming	B-X
toxin	B-X
streptolysin	B-X
O	B-X
(	B-X
SLO	B-X
)	B-X
and	B-X
due	B-X
to	B-X
impairment	B-X
of	B-X
PMN	B-X
migration	B-X
via	B-X
digesting	B-X
interleukin-8	B-X
,	B-X
a	B-X
PMN	B-X
attracting	B-X
chemokine	B-X
,	B-X
by	B-X
increased	B-X
production	B-X
of	B-X
a	B-X
serine	B-X
protease	B-X
ScpC	B-X
.	B-X
Expression	B-X
of	B-X
genes	B-X
was	B-X
upregulated	B-X
by	B-X
a	B-X
loss	B-X
of	B-X
repressive	B-X
function	B-X
with	B-X
the	B-X
mutation	B-X
of	B-X
csrS	B-X
gene	B-X
in	B-X
the	B-X
all	B-X
emm49	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
.	B-X
The	B-X
csrS	B-X
mutants	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
exhibited	B-X
high	B-X
mortality	B-X
and	B-X
disseminated	B-X
infection	B-X
with	B-X
paucity	B-X
of	B-X
neutrophils	B-X
,	B-X
a	B-X
characteristic	B-X
pathology	B-X
seen	B-X
in	B-X
human	B-X
invasive	B-X
GAS	B-X
infection	B-X
,	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
.	B-X
However	B-X
,	B-X
GAS	B-X
which	B-X
lack	B-X
either	B-X
SLO	B-X
or	B-X
ScpC	B-X
exhibit	B-X
much	B-X
less	B-X
mortality	B-X
than	B-X
the	B-X
csrS-mutated	B-X
parent	B-X
invasive	B-X
GAS	B-X
isolate	B-X
to	B-X
the	B-X
infected	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
abilities	B-X
of	B-X
GAS	B-X
to	B-X
abrogate	B-X
PMN	B-X
functions	B-X
can	B-X
determine	B-X
the	B-X
onset	B-X
and	B-X
severity	B-X
of	B-X
invasive	B-X
GAS	B-X
infection	B-X
.	B-X

Herein	O
we	O
report	O
that	O
a	O
panel	O
of	O
serotype	O
-	O
matched	O
GAS	O
,	O
which	O
were	O
clinically	O
isolated	O
from	O
severe	O
invasive	O
but	O
not	O
from	O
non	O
-	O
invaive	O
infections	O
,	O
could	O
abrogate	O
functions	O
of	O
human	O
polymorphnuclear	O
neutrophils	O
(	O
PMN	O
)	O
in	O
at	O
least	O
two	O
independent	O
ways	O
;	O
due	O
to	O
inducing	O
necrosis	O
to	O
PMN	O
by	O
enhanced	O
production	O
of	O
a	O
pore	O
-	O
forming	O
toxin	O
streptolysin	B-Protein
O	I-Protein
(	O
SLO	B-Protein
)	O
and	O
due	O
to	O
impairment	O
of	O
PMN	O
migration	O
via	O
digesting	O
interleukin	B-Protein
-	I-Protein
8	I-Protein
,	O
a	O
PMN	O
attracting	O
chemokine	O
,	O
by	O
increased	O
production	O
of	O
a	O
serine	O
protease	O
ScpC	B-Protein
.	O

Expression	O
of	O
genes	O
was	O
upregulated	O
by	O
a	O
loss	O
of	O
repressive	O
function	O
with	O
the	O
mutation	O
of	O
csrS	B-Protein
gene	O
in	O
the	O
all	O
emm49	B-Protein
severe	O
invasive	O
GAS	O
isolates	O
.	O
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X
The	B-X
characteristic	B-X
of	B-X
invasive	B-X
GAS	B-X
infections	B-X
has	B-X
been	B-X
thought	B-X
to	B-X
attribute	B-X
to	B-X
genetic	B-X
changes	B-X
in	B-X
bacteria	B-X
,	B-X
however	B-X
,	B-X
no	B-X
clear	B-X
evidence	B-X
has	B-X
shown	B-X
due	B-X
to	B-X
lack	B-X
of	B-X
an	B-X
intriguingly	B-X
study	B-X
using	B-X
serotype-matched	B-X
isolates	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
infections	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
rare	B-X
outbreaks	B-X
of	B-X
invasive	B-X
infections	B-X
and	B-X
their	B-X
distinctive	B-X
pathology	B-X
in	B-X
which	B-X
infectious	B-X
foci	B-X
without	B-X
neutrophil	B-X
infiltration	B-X
hypothesized	B-X
us	B-X
invasive	B-X
GAS	B-X
could	B-X
evade	B-X
host	B-X
defense	B-X
,	B-X
especially	B-X
neutrophil	B-X
functions	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
a	B-X
panel	B-X
of	B-X
serotype-matched	B-X
GAS	B-X
,	B-X
which	B-X
were	B-X
clinically	B-X
isolated	B-X
from	B-X
severe	B-X
invasive	B-X
but	B-X
not	B-X
from	B-X
non-invaive	B-X
infections	B-X
,	B-X
could	B-X
abrogate	B-X
functions	B-X
of	B-X
human	B-X
polymorphnuclear	B-X
neutrophils	B-X
(	B-X
PMN	B-X
)	B-X
in	B-X
at	B-X
least	B-X
two	B-X
independent	B-X
ways	B-X
;	B-X
due	B-X
to	B-X
inducing	B-X
necrosis	B-X
to	B-X
PMN	B-X
by	B-X
enhanced	B-X
production	B-X
of	B-X
a	B-X
pore-forming	B-X
toxin	B-X
streptolysin	B-X
O	B-X
(	B-X
SLO	B-X
)	B-X
and	B-X
due	B-X
to	B-X
impairment	B-X
of	B-X
PMN	B-X
migration	B-X
via	B-X
digesting	B-X
interleukin-8	B-X
,	B-X
a	B-X
PMN	B-X
attracting	B-X
chemokine	B-X
,	B-X
by	B-X
increased	B-X
production	B-X
of	B-X
a	B-X
serine	B-X
protease	B-X
ScpC	B-X
.	B-X
Expression	B-X
of	B-X
genes	B-X
was	B-X
upregulated	B-X
by	B-X
a	B-X
loss	B-X
of	B-X
repressive	B-X
function	B-X
with	B-X
the	B-X
mutation	B-X
of	B-X
csrS	B-X
gene	B-X
in	B-X
the	B-X
all	B-X
emm49	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
.	B-X
The	B-X
csrS	B-X
mutants	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
exhibited	B-X
high	B-X
mortality	B-X
and	B-X
disseminated	B-X
infection	B-X
with	B-X
paucity	B-X
of	B-X
neutrophils	B-X
,	B-X
a	B-X
characteristic	B-X
pathology	B-X
seen	B-X
in	B-X
human	B-X
invasive	B-X
GAS	B-X
infection	B-X
,	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
.	B-X
However	B-X
,	B-X
GAS	B-X
which	B-X
lack	B-X
either	B-X
SLO	B-X
or	B-X
ScpC	B-X
exhibit	B-X
much	B-X
less	B-X
mortality	B-X
than	B-X
the	B-X
csrS-mutated	B-X
parent	B-X
invasive	B-X
GAS	B-X
isolate	B-X
to	B-X
the	B-X
infected	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
abilities	B-X
of	B-X
GAS	B-X
to	B-X
abrogate	B-X
PMN	B-X
functions	B-X
can	B-X
determine	B-X
the	B-X
onset	B-X
and	B-X
severity	B-X
of	B-X
invasive	B-X
GAS	B-X
infection	B-X
.	B-X

The	O
csrS	B-Protein
mutants	O
from	O
clinical	O
severe	O
invasive	O
GAS	O
isolates	O
exhibited	O
high	O
mortality	O
and	O
disseminated	O
infection	O
with	O
paucity	O
of	O
neutrophils	O
,	O
a	O
characteristic	O
pathology	O
seen	O
in	O
human	O
invasive	O
GAS	O
infection	O
,	O
in	O
a	O
mouse	O
model	O
.	O

However	O
,	O
GAS	O
which	O
lack	O
either	O
SLO	B-Protein
or	O
ScpC	B-Protein
exhibit	O
much	O
less	O
mortality	O
than	O
the	O
csrS	B-Protein
-	O
mutated	O
parent	O
invasive	O
GAS	O
isolate	O
to	O
the	O
infected	O
mice	O
.	O
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X
The	B-X
characteristic	B-X
of	B-X
invasive	B-X
GAS	B-X
infections	B-X
has	B-X
been	B-X
thought	B-X
to	B-X
attribute	B-X
to	B-X
genetic	B-X
changes	B-X
in	B-X
bacteria	B-X
,	B-X
however	B-X
,	B-X
no	B-X
clear	B-X
evidence	B-X
has	B-X
shown	B-X
due	B-X
to	B-X
lack	B-X
of	B-X
an	B-X
intriguingly	B-X
study	B-X
using	B-X
serotype-matched	B-X
isolates	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
infections	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
rare	B-X
outbreaks	B-X
of	B-X
invasive	B-X
infections	B-X
and	B-X
their	B-X
distinctive	B-X
pathology	B-X
in	B-X
which	B-X
infectious	B-X
foci	B-X
without	B-X
neutrophil	B-X
infiltration	B-X
hypothesized	B-X
us	B-X
invasive	B-X
GAS	B-X
could	B-X
evade	B-X
host	B-X
defense	B-X
,	B-X
especially	B-X
neutrophil	B-X
functions	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
a	B-X
panel	B-X
of	B-X
serotype-matched	B-X
GAS	B-X
,	B-X
which	B-X
were	B-X
clinically	B-X
isolated	B-X
from	B-X
severe	B-X
invasive	B-X
but	B-X
not	B-X
from	B-X
non-invaive	B-X
infections	B-X
,	B-X
could	B-X
abrogate	B-X
functions	B-X
of	B-X
human	B-X
polymorphnuclear	B-X
neutrophils	B-X
(	B-X
PMN	B-X
)	B-X
in	B-X
at	B-X
least	B-X
two	B-X
independent	B-X
ways	B-X
;	B-X
due	B-X
to	B-X
inducing	B-X
necrosis	B-X
to	B-X
PMN	B-X
by	B-X
enhanced	B-X
production	B-X
of	B-X
a	B-X
pore-forming	B-X
toxin	B-X
streptolysin	B-X
O	B-X
(	B-X
SLO	B-X
)	B-X
and	B-X
due	B-X
to	B-X
impairment	B-X
of	B-X
PMN	B-X
migration	B-X
via	B-X
digesting	B-X
interleukin-8	B-X
,	B-X
a	B-X
PMN	B-X
attracting	B-X
chemokine	B-X
,	B-X
by	B-X
increased	B-X
production	B-X
of	B-X
a	B-X
serine	B-X
protease	B-X
ScpC	B-X
.	B-X
Expression	B-X
of	B-X
genes	B-X
was	B-X
upregulated	B-X
by	B-X
a	B-X
loss	B-X
of	B-X
repressive	B-X
function	B-X
with	B-X
the	B-X
mutation	B-X
of	B-X
csrS	B-X
gene	B-X
in	B-X
the	B-X
all	B-X
emm49	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
.	B-X
The	B-X
csrS	B-X
mutants	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
exhibited	B-X
high	B-X
mortality	B-X
and	B-X
disseminated	B-X
infection	B-X
with	B-X
paucity	B-X
of	B-X
neutrophils	B-X
,	B-X
a	B-X
characteristic	B-X
pathology	B-X
seen	B-X
in	B-X
human	B-X
invasive	B-X
GAS	B-X
infection	B-X
,	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
.	B-X
However	B-X
,	B-X
GAS	B-X
which	B-X
lack	B-X
either	B-X
SLO	B-X
or	B-X
ScpC	B-X
exhibit	B-X
much	B-X
less	B-X
mortality	B-X
than	B-X
the	B-X
csrS-mutated	B-X
parent	B-X
invasive	B-X
GAS	B-X
isolate	B-X
to	B-X
the	B-X
infected	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
abilities	B-X
of	B-X
GAS	B-X
to	B-X
abrogate	B-X
PMN	B-X
functions	B-X
can	B-X
determine	B-X
the	B-X
onset	B-X
and	B-X
severity	B-X
of	B-X
invasive	B-X
GAS	B-X
infection	B-X
.	B-X

These	O
results	O
suggest	O
that	O
the	O
abilities	O
of	O
GAS	O
to	O
abrogate	O
PMN	O
functions	O
can	O
determine	O
the	O
onset	O
and	O
severity	O
of	O
invasive	O
GAS	O
infection	O
.	O
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X
The	B-X
characteristic	B-X
of	B-X
invasive	B-X
GAS	B-X
infections	B-X
has	B-X
been	B-X
thought	B-X
to	B-X
attribute	B-X
to	B-X
genetic	B-X
changes	B-X
in	B-X
bacteria	B-X
,	B-X
however	B-X
,	B-X
no	B-X
clear	B-X
evidence	B-X
has	B-X
shown	B-X
due	B-X
to	B-X
lack	B-X
of	B-X
an	B-X
intriguingly	B-X
study	B-X
using	B-X
serotype-matched	B-X
isolates	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
infections	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
rare	B-X
outbreaks	B-X
of	B-X
invasive	B-X
infections	B-X
and	B-X
their	B-X
distinctive	B-X
pathology	B-X
in	B-X
which	B-X
infectious	B-X
foci	B-X
without	B-X
neutrophil	B-X
infiltration	B-X
hypothesized	B-X
us	B-X
invasive	B-X
GAS	B-X
could	B-X
evade	B-X
host	B-X
defense	B-X
,	B-X
especially	B-X
neutrophil	B-X
functions	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
a	B-X
panel	B-X
of	B-X
serotype-matched	B-X
GAS	B-X
,	B-X
which	B-X
were	B-X
clinically	B-X
isolated	B-X
from	B-X
severe	B-X
invasive	B-X
but	B-X
not	B-X
from	B-X
non-invaive	B-X
infections	B-X
,	B-X
could	B-X
abrogate	B-X
functions	B-X
of	B-X
human	B-X
polymorphnuclear	B-X
neutrophils	B-X
(	B-X
PMN	B-X
)	B-X
in	B-X
at	B-X
least	B-X
two	B-X
independent	B-X
ways	B-X
;	B-X
due	B-X
to	B-X
inducing	B-X
necrosis	B-X
to	B-X
PMN	B-X
by	B-X
enhanced	B-X
production	B-X
of	B-X
a	B-X
pore-forming	B-X
toxin	B-X
streptolysin	B-X
O	B-X
(	B-X
SLO	B-X
)	B-X
and	B-X
due	B-X
to	B-X
impairment	B-X
of	B-X
PMN	B-X
migration	B-X
via	B-X
digesting	B-X
interleukin-8	B-X
,	B-X
a	B-X
PMN	B-X
attracting	B-X
chemokine	B-X
,	B-X
by	B-X
increased	B-X
production	B-X
of	B-X
a	B-X
serine	B-X
protease	B-X
ScpC	B-X
.	B-X
Expression	B-X
of	B-X
genes	B-X
was	B-X
upregulated	B-X
by	B-X
a	B-X
loss	B-X
of	B-X
repressive	B-X
function	B-X
with	B-X
the	B-X
mutation	B-X
of	B-X
csrS	B-X
gene	B-X
in	B-X
the	B-X
all	B-X
emm49	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
.	B-X
The	B-X
csrS	B-X
mutants	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
exhibited	B-X
high	B-X
mortality	B-X
and	B-X
disseminated	B-X
infection	B-X
with	B-X
paucity	B-X
of	B-X
neutrophils	B-X
,	B-X
a	B-X
characteristic	B-X
pathology	B-X
seen	B-X
in	B-X
human	B-X
invasive	B-X
GAS	B-X
infection	B-X
,	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
.	B-X
However	B-X
,	B-X
GAS	B-X
which	B-X
lack	B-X
either	B-X
SLO	B-X
or	B-X
ScpC	B-X
exhibit	B-X
much	B-X
less	B-X
mortality	B-X
than	B-X
the	B-X
csrS-mutated	B-X
parent	B-X
invasive	B-X
GAS	B-X
isolate	B-X
to	B-X
the	B-X
infected	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
abilities	B-X
of	B-X
GAS	B-X
to	B-X
abrogate	B-X
PMN	B-X
functions	B-X
can	B-X
determine	B-X
the	B-X
onset	B-X
and	B-X
severity	B-X
of	B-X
invasive	B-X
GAS	B-X
infection	B-X
.	B-X

Introduction	O

Streptococcus	O
pyogenes	O
(	O
group	O
A	O
streptococcus	O
;	O
GAS	O
)	O
is	O
one	O
of	O
the	O
most	O
common	O
human	O
pathogens	O
.	O
<EOS>	B-X
Streptococcus	B-X
pyogenes	B-X
.	B-X
Group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
is	B-X
a	B-X
leading	B-X
human	B-X
bacterial	B-X
pathogen	B-X
with	B-X
diverse	B-X
clinical	B-X
manifestations	B-X
.	B-X
Macrophages	B-X
constitute	B-X
a	B-X
critical	B-X
first	B-X
line	B-X
of	B-X
host	B-X
defense	B-X
against	B-X
GAS	B-X
infection	B-X
,	B-X
using	B-X
numerous	B-X
surface	B-X
and	B-X
intracellular	B-X
receptors	B-X
such	B-X
as	B-X
Toll-like	B-X
receptors	B-X
and	B-X
inflammasomes	B-X
for	B-X
pathogen	B-X
recognition	B-X
and	B-X
activation	B-X
of	B-X
inflammatory	B-X
signaling	B-X
pathways	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
intensity	B-X
of	B-X
the	B-X
GAS	B-X
infection	B-X
,	B-X
activation	B-X
of	B-X
these	B-X
signaling	B-X
cascades	B-X
may	B-X
provide	B-X
a	B-X
beneficial	B-X
early	B-X
alarm	B-X
for	B-X
effective	B-X
immune	B-X
clearance	B-X
,	B-X
or	B-X
conversely	B-X
,	B-X
may	B-X
cause	B-X
hyperinflammation	B-X
and	B-X
tissue	B-X
injury	B-X
during	B-X
severe	B-X
invasive	B-X
infection	B-X
.	B-X
Although	B-X
traditionally	B-X
considered	B-X
an	B-X
extracellular	B-X
pathogen	B-X
,	B-X
GAS	B-X
can	B-X
invade	B-X
and	B-X
replicate	B-X
within	B-X
macrophages	B-X
using	B-X
specific	B-X
molecular	B-X
mechanisms	B-X
to	B-X
resist	B-X
phagolysosomal	B-X
and	B-X
xenophagic	B-X
killing	B-X
.	B-X
Unraveling	B-X
GAS-macrophage	B-X
encounters	B-X
may	B-X
reveal	B-X
new	B-X
treatment	B-X
options	B-X
for	B-X
this	B-X
leading	B-X
agent	B-X
of	B-X
infection-associated	B-X
mortality	B-X
.	B-X

It	O
causes	O
a	O
wide	O
variety	O
of	O
infections	O
ranging	O
from	O
uncomplicated	O
pharyngitis	O
and	O
skin	O
infections	O
to	O
severe	O
and	O
even	O
life	O
-	O
threatening	O
manifestations	O
,	O
such	O
as	O
necrotizing	O
fasciitis	O
(	O
NF	O
)	O
and	O
streptococcal	O
toxic	O
shock	O
-	O
like	O
syndrome	O
(	O
STSS	O
)	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
with	O
high	O
mortality	O
rates	O
ranging	O
from	O
20	O
%	O
to	O
60	O
%	O
[	O
3	O
]	O
.	O

Several	O
streptococcal	O
virulence	O
factors	O
,	O
including	O
streptolysin	O
,	O
and	O
M	B-Protein
protein	I-Protein
,	O
have	O
been	O
reported	O
to	O
be	O
involved	O
in	O
these	O
diseases	O
,	O
by	O
genetic	O
studies	O
or	O
animal	O
-	O
passaged	O
models	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
[	O
4	O
]	O
-	O
[	O
6	O
]	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
review	B-X
attempts	B-X
to	B-X
understand	B-X
the	B-X
molecular	B-X
basis	B-X
of	B-X
encephalitis	B-X
and	B-X
virulence	B-X
for	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
(	B-X
CNS	B-X
)	B-X
in	B-X
mouse	B-X
models	B-X
.	B-X
Neurovirulence	B-X
was	B-X
found	B-X
to	B-X
be	B-X
associated	B-X
with	B-X
damage	B-X
to	B-X
neurons	B-X
in	B-X
the	B-X
CNS	B-X
.	B-X
It	B-X
mapped	B-X
mainly	B-X
to	B-X
the	B-X
E2	B-X
region	B-X
of	B-X
the	B-X
genome	B-X
,	B-X
and	B-X
to	B-X
the	B-X
nsP3	B-X
gene	B-X
.	B-X
Also	B-X
,	B-X
avirulent	B-X
natural	B-X
isolates	B-X
of	B-X
both	B-X
SINV	B-X
and	B-X
SFV	B-X
have	B-X
been	B-X
found	B-X
to	B-X
have	B-X
more	B-X
rapid	B-X
cleavage	B-X
of	B-X
nonstructural	B-X
proteins	B-X
due	B-X
to	B-X
mutations	B-X
in	B-X
the	B-X
nsP1-nsP2	B-X
cleavage	B-X
site	B-X
.	B-X
Experiments	B-X
on	B-X
SINV	B-X
and	B-X
SFV	B-X
have	B-X
indicated	B-X
that	B-X
virulence	B-X
may	B-X
be	B-X
related	B-X
to	B-X
the	B-X
resistance	B-X
of	B-X
virulent	B-X
virus	B-X
to	B-X
interferon	B-X
action	B-X
.	B-X
Although	B-X
the	B-X
E2	B-X
protein	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
tropism	B-X
for	B-X
neurons	B-X
and	B-X
passage	B-X
across	B-X
the	B-X
blood-brain	B-X
barrier	B-X
,	B-X
the	B-X
role	B-X
of	B-X
the	B-X
nsP3	B-X
protein	B-X
during	B-X
infection	B-X
of	B-X
neurons	B-X
is	B-X
unknown	B-X
.	B-X
More	B-X
information	B-X
in	B-X
these	B-X
areas	B-X
may	B-X
help	B-X
to	B-X
further	B-X
explain	B-X
the	B-X
neurovirulence	B-X
of	B-X
alphaviruses	B-X
.	B-X

However	O
,	O
which	O
of	O
factors	O
are	O
involved	O
in	O
pathogenesis	O
mediated	O
by	O
clinically	O
isolated	O
severe	O
invasive	O
GAS	O
remains	O
obscure	O
.	O

The	O
strains	O
of	O
emm1	B-Protein
genotype	O
,	O
among	O
more	O
than	O
100	O
emm	B-Protein
genes	O
encoding	O
the	O
serotype	O
-	O
determinant	O
M	B-Protein
protein	I-Protein
,	O
are	O
the	O
predominant	O
cause	O
of	O
severe	O
GAS	O
infections	O
in	O
Japan	O
[	O
7	O
]	O
.	O

Recently	O
,	O
GAS	O
with	O
diverse	O
emm	B-Protein
genotypes	O
,	O
especially	O
,	O
emm49	B-Protein
-	O
genotype	O
,	O
have	O
been	O
isolated	O
from	O
patients	O
of	O
severe	O
invasive	O
GAS	O
infections	O
since	O
2000	O
;	O
however	O
,	O
these	O
genotypes	O
were	O
not	O
isolated	O
before	O
1999	O
in	O
Japan	O
[	O
8	O
]	O
.	O

Therefore	O
,	O
emm49	B-Protein
GAS	O
isolated	O
from	O
invasive	O
infections	O
seems	O
to	O
acquire	O
the	O
novel	O
or	O
altered	O
virulence	O
factors	O
by	O
mutations	O
,	O
genomic	O
additions	O
,	O
or	O
deletions	O
.	O
<EOS>	B-X
We	B-X
have	B-X
systematically	B-X
made	B-X
a	B-X
set	B-X
of	B-X
precisely	B-X
defined	B-X
,	B-X
single-gene	B-X
deletions	B-X
of	B-X
all	B-X
nonessential	B-X
genes	B-X
in	B-X
Escherichia	B-X
coli	B-X
K-12	B-X
.	B-X
Open-reading	B-X
frame	B-X
coding	B-X
regions	B-X
were	B-X
replaced	B-X
with	B-X
a	B-X
kanamycin	B-X
cassette	B-X
flanked	B-X
by	B-X
FLP	B-X
recognition	B-X
target	B-X
sites	B-X
by	B-X
using	B-X
a	B-X
one-step	B-X
method	B-X
for	B-X
inactivation	B-X
of	B-X
chromosomal	B-X
genes	B-X
and	B-X
primers	B-X
designed	B-X
to	B-X
create	B-X
in-frame	B-X
deletions	B-X
upon	B-X
excision	B-X
of	B-X
the	B-X
resistance	B-X
cassette	B-X
.	B-X
A	B-X
major	B-X
contribution	B-X
to	B-X
the	B-X
genome	B-X
variability	B-X
among	B-X
individuals	B-X
comes	B-X
from	B-X
deletions	B-X
and	B-X
duplications	B-X
-	B-X
collectively	B-X
termed	B-X
copy	B-X
number	B-X
variations	B-X
(	B-X
CNVs	B-X
)	B-X
-	B-X
which	B-X
alter	B-X
the	B-X
diploid	B-X
status	B-X
of	B-X
DNA	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
commonly	B-X
used	B-X
methods	B-X
to	B-X
generate	B-X
gene	B-X
deletions	B-X
,	B-X
to	B-X
integrate	B-X
mutated	B-X
versions	B-X
of	B-X
a	B-X
gene	B-X
into	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
and	B-X
to	B-X
construct	B-X
N-	B-X
and	B-X
C-terminal	B-X
gene	B-X
fusions	B-X
.	B-X

Epidemiological	O
and	O
pathological	O
findings	O
,	O
including	O
sporadic	O
incidents	O
of	O
severe	O
invasive	O
GAS	O
infections	O
[	O
9	O
]	O
,	O
high	O
frequency	O
of	O
severe	O
invasive	O
infections	O
in	O
immunocompromised	O
host	O
[	O
9	O
]	O
,	O
and	O
aggregation	O
of	O
bacteria	O
and	O
a	O
paucity	O
of	O
polymorphnuclear	O
neutrophils	O
(	O
PMN	O
)	O
in	O
foci	O
of	O
invasive	O
GAS	O
infection	O
[	O
10	O
]	O
suggest	O
that	O
host	O
defense	O
factors	O
play	O
an	O
important	O
role	O
in	O
the	O
onset	O
of	O
invasive	O
infections	O
.	O

These	O
findings	O
led	O
us	O
to	O
postulate	O
that	O
invasive	O
GAS	O
infections	O
hampered	O
host	O
innate	O
immune	O
defense	O
,	O
especially	O
on	O
PMN	O
,	O
providing	O
the	O
front	O
-	O
line	O
defense	O
against	O
GAS	O
infection	O
by	O
quick	O
recruitment	O
to	O
infection	O
site	O
and	O
clearance	O
of	O
bacteria	O
following	O
phagocytosis	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
.	O

So	O
far	O
,	O
using	O
animal	O
-	O
passaged	O
GAS	O
mutants	O
,	O
gene	O
-	O
manipulated	O
GAS	O
,	O
many	O
virulence	O
-	O
associated	O
molecules	O
are	O
pointed	O
out	O
to	O
play	O
some	O
roles	O
in	O
the	O
bacterial	O
evasion	O
from	O
phagocytic	O
ingestion	O
by	O
neutrophils	O
[	O
13	O
]	O
.	O

However	O
,	O
restricted	O
availability	O
of	O
clinical	O
isolates	O
with	O
the	O
same	O
serotypes	O
fail	O
to	O
elucidate	O
direct	O
relationship	O
between	O
definitive	O
genetic	O
changes	O
in	O
clinically	O
isolated	O
severe	O
invasive	O
GAS	O
and	O
the	O
lack	O
of	O
PMN	O
at	O
the	O
site	O
of	O
bacterial	O
growth	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
aimed	O
to	O
explore	O
the	O
crucial	O
factors	O
in	O
the	O
pathogenesis	O
of	O
severe	O
invasive	O
GAS	O
infections	O
in	O
the	O
context	O
of	O
PMN	O
-	O
GAS	O
relationship	O
,	O
using	O
a	O
panel	O
of	O
emm49	B-Protein
clinical	O
isolates	O
from	O
patients	O
with	O
or	O
without	O
severe	O
invasive	O
infection	O
,	O
and	O
their	O
gene	O
-	O
manipulated	O
mutants	O
.	O
<EOS>	B-X
The	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
;	B-X
Streptococcus	B-X
pyogenes	B-X
)	B-X
causes	B-X
an	B-X
elaborate	B-X
array	B-X
of	B-X
human	B-X
diseases	B-X
.	B-X
In	B-X
part	B-X
,	B-X
such	B-X
variability	B-X
in	B-X
disease	B-X
potential	B-X
is	B-X
a	B-X
consequence	B-X
of	B-X
GAS	B-X
manipulating	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
catalogue	B-X
of	B-X
virulence	B-X
factors	B-X
,	B-X
with	B-X
regulation	B-X
occurring	B-X
at	B-X
both	B-X
the	B-X
transcriptional	B-X
and	B-X
posttranscriptional	B-X
levels	B-X
.	B-X
The	B-X
GAS	B-X
small	B-X
regulatory	B-X
RNA	B-X
(	B-X
sRNA	B-X
)	B-X
FasX	B-X
contributes	B-X
to	B-X
this	B-X
regulatory	B-X
activity	B-X
,	B-X
enhancing	B-X
expression	B-X
of	B-X
the	B-X
thrombolytic	B-X
agent	B-X
streptokinase	B-X
,	B-X
and	B-X
reducing	B-X
expression	B-X
of	B-X
collagen	B-X
(	B-X
pili	B-X
)	B-X
and	B-X
fibronectin	B-X
(	B-X
PrtF1	B-X
and	B-X
PrtF2	B-X
)	B-X
-binding	B-X
adhesins	B-X
.	B-X
Importantly	B-X
,	B-X
investigation	B-X
of	B-X
the	B-X
consequences	B-X
of	B-X
FasX-mediated	B-X
regulation	B-X
led	B-X
to	B-X
the	B-X
discovery	B-X
that	B-X
FasX	B-X
is	B-X
a	B-X
major	B-X
positive	B-X
regulator	B-X
of	B-X
GAS	B-X
survival	B-X
and	B-X
proliferation	B-X
in	B-X
non-immune	B-X
whole	B-X
human	B-X
blood	B-X
,	B-X
with	B-X
a	B-X
30-fold	B-X
difference	B-X
in	B-X
GAS	B-X
cell	B-X
numbers	B-X
between	B-X
a	B-X

We	O
now	O
show	O
a	O
direct	O
and	O
previously	O
unrecognized	O
link	O
between	O
functional	O
loss	O
of	O
a	O
factor	O
CsrS	B-Protein
of	O
two	O
-	O
component	O
sensor	O
/	O
regulator	O
system	O
(	O
CsrS	B-Protein
/	O
CsrR	B-Protein
:	O
also	O
known	O
as	O
CovS	B-Protein
/	O
CovR	B-Protein
)	O
and	O
escape	O
from	O
killing	O
by	O
PMN	O
via	O
inducing	O
necrosis	O
to	O
them	O
and	O
digesting	O
IL	B-Protein
-	I-Protein
8	I-Protein
,	O
a	O
PMN	O
-	O
attracting	O
chemokine	O
.	O

We	O
further	O
determined	O
CsrS	B-Protein
mutations	O
in	O
the	O
severe	O
invasive	O
GAS	O
was	O
essential	O
to	O
control	O
the	O
expression	O
of	O
various	O
virulence	O
genes	O
and	O
contributed	O
to	O
the	O
in	O
vivo	O
virulence	O
and	O
disease	O
-	O
specific	O
pathophysiology	O
in	O
a	O
mouse	O
model	O
.	O

These	O
data	O
may	O
participate	O
in	O
prediction	O
of	O
GAS	O
potential	O
for	O
future	O
invasive	O
infection	O
as	O
well	O
as	O
risk	O
assessment	O
of	O
patients	O
by	O
measuring	O
PMN	O
function	O
.	O

Results	O

Group	O
A	O
streptococcus	O
isolates	O
from	O
severe	O
invasive	O
infections	O
is	O
resistant	O
to	O
killing	O
by	O
human	O
PMN	O
To	O
examine	O
whether	O
emm49	B-Protein
GAS	O
isolated	O
from	O
severe	O
invasive	O
infection	O
might	O
alter	O
human	O
PMN	O
function	O
,	O
we	O
performed	O
phagocytosis	O
assay	O
in	O
vitro	O
.	O

As	O
non	O
-	O
opsonized	O
GAS	O
was	O
resistant	O
to	O
the	O
phagocytosis	O
by	O
PMN	O
[	O
14	O
]	O
,	O
we	O
opsonized	O
GAS	O
with	O
human	O
plasma	O
in	O
advance	O
to	O
the	O
assay	O
.	O

As	O
shown	O
in	O
Figure	O
1A	O
,	O
there	O
was	O
no	O
significant	O
difference	O
between	O
GAS	O
that	O
were	O
isolated	O
from	O
non	O
-	O
invasive	O
and	O
severe	O
invasive	O
infections	O
in	O
phagocytosis	O
by	O
PMN	O
(	O
p	O
=	O
0	O
.	O
5556	O
)	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
1B	O
,	O
in	O
vitro	O
killing	O
assay	O
revealed	O
that	O
PMN	O
killed	O
non	O
-	O
invasive	O
GAS	O
,	O
resulting	O
in	O
15	O
-	O
42	O
%	O
of	O
initial	O
number	O
of	O
bacteria	O
,	O
but	O
not	O
invasive	O
GAS	O
(	O
p	O
=	O
0	O
.	O
019	O
)	O
.	O

The	O
similar	O
results	O
were	O
obtained	O
when	O
opsonized	O
with	O
either	O
FCS	O
or	O
human	O
serum	O
regardless	O
of	O
complements	O
immobilization	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
were	O
common	O
among	O
all	O
PMN	O
donors	O
.	O
<EOS>	B-X
In	B-X
this	B-X
manuscript	B-X
,	B-X
we	B-X
present	B-X
the	B-X
results	B-X
of	B-X
the	B-X
multicenter	B-X
study	B-X
Mye-EUNITER	B-X
MDSC	B-X
Monitoring	B-X
Initiative	B-X
,	B-X
that	B-X
involved	B-X
13	B-X
laboratories	B-X
and	B-X
compared	B-X
circulating	B-X
MDSC	B-X
subsets	B-X
across	B-X
multiple	B-X
diseases	B-X
,	B-X
using	B-X
a	B-X
common	B-X
protocol	B-X
for	B-X
the	B-X
isolation	B-X
,	B-X
identification	B-X
and	B-X
characterization	B-X
of	B-X
these	B-X
cells	B-X
.	B-X
Severe	B-X
lung	B-X
inflammation	B-X
is	B-X
common	B-X
in	B-X
life-threatening	B-X
coronavirus	B-X
disease	B-X
2019	B-X
(	B-X
COVID-19	B-X
)	B-X
.	B-X
This	B-X
study	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
polymorphonuclear	B-X
(	B-X
PMN	B-X
,	B-X
neutrophil	B-X
)	B-X
phenotype	B-X
early	B-X
in	B-X
the	B-X
course	B-X
of	B-X
disease	B-X
progression	B-X
would	B-X
predict	B-X
peak	B-X
lung	B-X
disease	B-X
severity	B-X
in	B-X
patients	B-X
infected	B-X
with	B-X
severe	B-X
acute	B-X
respiratory	B-X
syndrome	B-X
coronavirus	B-X
2	B-X
(	B-X
SARS-CoV-2	B-X
)	B-X
.	B-X
It	B-X
is	B-X
increasingly	B-X
evident	B-X
that	B-X
PMN	B-X
activation	B-X
contributes	B-X
to	B-X
tissue	B-X
injury	B-X
resulting	B-X
from	B-X
extracellular	B-X
reactive	B-X
oxygen	B-X
species	B-X
generation	B-X
,	B-X
granule	B-X
exocytosis	B-X
with	B-X
release	B-X
of	B-X
proteases	B-X
,	B-X
neutrophil	B-X
extracellular	B-X
trap	B-X
(	B-X
NET	B-X
)	B-X
formation	B-X
,	B-X
and	B-X
release	B-X
of	B-X
cytokines	B-X
.	B-X
The	B-X
current	B-X
study	B-X
focuses	B-X
on	B-X
PMN	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
SARS-CoV-2	B-X
infection	B-X
,	B-X
specifically	B-X
,	B-X
the	B-X
association	B-X
between	B-X
NETs	B-X
and	B-X
lung	B-X
disease	B-X
.	B-X
Neutrophils	B-X
from	B-X
COVID-19	B-X
patients	B-X
displayed	B-X
greater	B-X
IL-8	B-X
expression	B-X
,	B-X
elastase	B-X
release	B-X
,	B-X
and	B-X
NET	B-X
formation	B-X
as	B-X
compared	B-X
with	B-X
neutrophils	B-X
from	B-X
healthy	B-X
donors	B-X
.	B-X
Importantly	B-X
,	B-X
neutrophils	B-X
from	B-X
COVID-19	B-X
patients	B-X
had	B-X
enhanced	B-X
NET	B-X
formation	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
any	B-X
additional	B-X
stimulus	B-X
,	B-X
not	B-X
seen	B-X
in	B-X
PMN	B-X
from	B-X
healthy	B-X
donors	B-X
.	B-X
Moreover	B-X
,	B-X
PMA-elicited	B-X
NET	B-X
formation	B-X
by	B-X
circulating	B-X
PMN	B-X
correlated	B-X
with	B-X
severity	B-X
of	B-X
lung	B-X
disease	B-X
.	B-X

These	O
data	O
indicated	O
that	O
clinically	O
isolated	O
severe	O
invasive	O
GAS	O
were	O
phagocytosed	O
,	O
but	O
escaped	O
from	O
killing	O
by	O
human	O
PMN	O
.	O

Severe	O
invasive	O
GAS	O
rapidly	O
induce	O
necrosis	O
to	O
human	O
PMN	O

In	O
an	O
acute	O
bacterial	O
infection	O
,	O
PMN	O
were	O
quickly	O
recruited	O
at	O
the	O
site	O
of	O
infectious	O
foci	O
according	O
to	O
the	O
gradient	O
of	O
chemoattractants	O
.	O

Therefore	O
,	O
we	O
examined	O
whether	O
GAS	O
clinically	O
isolated	O
from	O
severe	O
invasive	O
infections	O
could	O
affect	O
the	O
migration	O
ability	O
of	O
PMN	O
in	O
response	O
to	O
chemokines	O
.	O

As	O
a	O
model	O
of	O
local	O
infection	O
of	O
the	O
initial	O
phase	O
,	O
we	O
utilized	O
a	O
transwell	O
system	O
and	O
added	O
IL	B-Protein
-	I-Protein
8	I-Protein
and	O
GAS	O
in	O
culture	O
medium	O
within	O
the	O
lower	O
wells	O
.	O

PMN	O
were	O
applied	O
in	O
the	O
upper	O
wells	O
and	O
subsequently	O
incubated	O
for	O
90	O
min	O
.	O

As	O
shown	O
in	O
Figure	O
2A	O
and	O
2B	O
,	O
a	O
substantial	O
number	O
of	O
PMN	O
,	O
consisted	O
largely	O
of	O
viable	O
cells	O
,	O
was	O
detected	O
in	O
the	O
lower	O
wells	O
consisted	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
and	O
non	O
-	O
invasive	O
GAS	O
,	O
as	O
a	O
control	O
.	O

Contrarily	O
,	O
number	O
of	O
PMN	O
was	O
significantly	O
low	O
in	O
the	O
presence	O
of	O
severe	O
invasive	O
GAS	O
(	O
p	O
=	O
0	O
.	O
016	O
)	O
compared	O
to	O
that	O
of	O
control	O
culture	O
.	O

Flow	O
cytometry	O
analysis	O
suggested	O
that	O
although	O
PMN	O
was	O
detected	O
in	O
the	O
lower	O
well	O
consisted	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
and	O
severe	O
invasive	O
GAS	O
,	O
but	O
most	O
of	O
them	O
were	O
dead	O
as	O
defined	O
by	O
propidium	O
iodine	O
staining	O
(	O
p	O
=	O
0	O
.	O
016	O
)	O
(	O
Figure	O
2A	O
and	O
2C	O
)	O
demonstrating	O
that	O
severe	O
invasive	O
GAS	O
affected	O
survival	O
of	O
PMN	O
and	O
its	O
migration	O
activity	O
in	O
a	O
transwell	O
system	O
.	O

PMN	O
were	O
killed	O
by	O
streptolysin	B-Protein
O	I-Protein
(	O
SLO	B-Protein
)	O
from	O
severe	O
invasive	O
GAS	O

PMN	O
death	O
was	O
induced	O
shortly	O
after	O
encounter	O
with	O
severe	O
invasive	O
GAS	O
,	O
and	O
PMN	O
were	O
not	O
in	O
apoptotic	O
death	O
because	O
of	O
low	O
frequency	O
of	O
cells	O
positive	O
for	O
annexin	B-Protein
V	I-Protein
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
was	O
seen	O
in	O
the	O
case	O
of	O
cytolysin	O
-	O
dependent	O
cell	O
injury	O
[	O
15	O
]	O
.	O

GAS	O
produce	O
two	O
cytolysins	O
that	O
may	O
contribute	O
to	O
pathogenesis	O
.	O
<EOS>	B-X
S.	B-X
iniae	B-X
produces	B-X
a	B-X
cytolysin	B-X
that	B-X
confers	B-X
a	B-X
hemolytic	B-X
phenotype	B-X
on	B-X
blood	B-X
agar	B-X
media	B-X
.	B-X
Analysis	B-X
of	B-X
two	B-X
nonhemolytic	B-X
mutants	B-X
identified	B-X
a	B-X
chromosomal	B-X
locus	B-X
comprising	B-X
9	B-X
genes	B-X
with	B-X
73	B-X
%	B-X
homology	B-X
to	B-X
the	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
sag	B-X
operon	B-X
for	B-X
streptolysin	B-X
S	B-X
(	B-X
SLS	B-X
)	B-X
biosynthesis	B-X
.	B-X
Confirmation	B-X
that	B-X
the	B-X
S.	B-X
iniae	B-X
cytolysin	B-X
is	B-X
a	B-X
functional	B-X
homologue	B-X
of	B-X
SLS	B-X
was	B-X
achieved	B-X
by	B-X
PCR	B-X
ligation	B-X
mutagenesis	B-X
,	B-X
complementation	B-X
of	B-X
an	B-X
SLS-negative	B-X
GAS	B-X
mutant	B-X
,	B-X
and	B-X
use	B-X
of	B-X
the	B-X
SLS	B-X
inhibitor	B-X
trypan	B-X
blue	B-X
.	B-X
These	B-X
studies	B-X
demonstrated	B-X
that	B-X
S.	B-X
iniae	B-X
SLS	B-X
expression	B-X
is	B-X
required	B-X
for	B-X
local	B-X
tissue	B-X
necrosis	B-X
but	B-X
does	B-X
not	B-X
contribute	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
bacteremia	B-X
or	B-X
to	B-X
resistance	B-X
to	B-X
phagocytic	B-X
clearance	B-X
.	B-X

Streptolysin	B-Protein
S	I-Protein
(	O
SLS	B-Protein
)	O
is	O
an	O
oxygen	O
-	O
stable	O
beta	O
-	O
hemolysin	O
and	O
Streptolysin	B-Protein
O	I-Protein
(	O
SLO	B-Protein
)	O
is	O
a	O
pore	O
-	O
forming	O
cholesterol	O
-	O
binding	O
toxin	O
[	O
16	O
]	O
.	O

Therefore	O
,	O
to	O
know	O
the	O
mechanism	O
underlying	O
GAS	O
-	O
mediated	O
killing	O
of	O
PMN	O
,	O
we	O
investigated	O
whether	O
SLO	B-Protein
produced	O
by	O
invasive	O
GAS	O
affect	O
survival	O
of	O
PMN	O
in	O
an	O
in	O
vitro	O
migration	O
assay	O
system	O
.	O

Figure	O
3A	O
shows	O
that	O
PMN	O
killing	O
by	O
invasive	O
GAS	O
was	O
blocked	O
by	O
anti	O
-	O
SLO	B-Protein
Ab	O
in	O
culture	O
medium	O
within	O
lower	O
wells	O
of	O
a	O
transwell	O
system	O
(	O
p	O
=	O
0	O
.	O
018	O
compared	O
with	O
control	O
Ig	O
)	O
,	O
at	O
similar	O
extent	O
by	O
adding	O
free	O
cholesterol	O
in	O
the	O
medium	O
(	O
data	O
not	O
shown	O
)	O
.	O

Furthermore	O
,	O
an	O
SLO	B-Protein
deficient	O
mutant	O
from	O
a	O
STSS	O
isolate	O
NIH230	O
(	O
NIH230slo	B-Protein
)	O
lost	O
the	O
killing	O
activity	O
for	O
PMN	O
(	O
Figure	O
3A	O
)	O
,	O
thereby	O
,	O
strongly	O
suggesting	O
that	O
SLO	B-Protein
is	O
a	O
key	O
element	O
for	O
PMN	O
killing	O
mediated	O
by	O
invasive	O
GAS	O
.	O

Contrarily	O
,	O
SLS	B-Protein
-	O
deficient	O
mutant	O
from	O
NIH230	O
strain	O
(	O
NIH230sagA	B-Protein
)	O
killed	O
PMN	O
,	O
as	O
efficiently	O
as	O
did	O
parent	O
strain	O
,	O
indicating	O
that	O
SLS	B-Protein
is	O
dispensable	O
for	O
killing	O
of	O
PMN	O
mediated	O
by	O
invasive	O
GAS	O
.	O

SLO	B-Protein
and	O
SLS	B-Protein
double	O
mutant	O
GAS	O
from	O
NIH230	O
strain	O
(	O
NIH230slosagA	B-Protein
)	O
displayed	O
the	O
killing	O
activity	O
indistinguishable	O
from	O
that	O
of	O
NIH230slo	B-Protein
,	O
confirming	O
the	O
primarily	O
role	O
of	O
SLO	B-Protein
for	O
GAS	O
-	O
mediated	O
PMN	O
killing	O
.	O

As	O
shown	O
in	O
Figure	O
3B	O
,	O
incubation	O
of	O
PMN	O
with	O
supernatant	O
from	O
co	O
-	O
culture	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
and	O
invasive	O
or	O
non	O
-	O
invasive	O
GAS	O
did	O
not	O
affect	O
PMN	O
viability	O
,	O
suggesting	O
that	O
severe	O
invasive	O
GAS	O
causes	O
PMN	O
killing	O
following	O
encounter	O
with	O
bacteria	O
in	O
a	O
contact	O
-	O
dependent	O
manner	O
.	O
<EOS>	B-X
Non-invasive	B-X
ventilation	B-X
may	B-X
be	B-X
a	B-X
means	B-X
to	B-X
temporarily	B-X
reverse	B-X
or	B-X
slow	B-X
the	B-X
progression	B-X
of	B-X
respiratory	B-X
failure	B-X
in	B-X
cystic	B-X
fibrosis	B-X
by	B-X
providing	B-X
ventilatory	B-X
support	B-X
and	B-X
avoiding	B-X
tracheal	B-X
intubation	B-X
.	B-X
Using	B-X
non-invasive	B-X
ventilation	B-X
,	B-X
in	B-X
the	B-X
appropriate	B-X
situation	B-X
or	B-X
individuals	B-X
,	B-X
can	B-X
improve	B-X
lung	B-X
mechanics	B-X
through	B-X
increasing	B-X
airflow	B-X
and	B-X
gas	B-X
exchange	B-X
and	B-X
decreasing	B-X
the	B-X
work	B-X
of	B-X
breathing	B-X
.	B-X
Non-invasive	B-X
ventilation	B-X
thus	B-X
acts	B-X
as	B-X
an	B-X
external	B-X
respiratory	B-X
muscle	B-X
.	B-X
Multiple	B-X
,	B-X
complex	B-X
molecular	B-X
events	B-X
characterize	B-X
cancer	B-X
development	B-X
and	B-X
progression	B-X
.	B-X
Deciphering	B-X
the	B-X
molecular	B-X
networks	B-X
that	B-X
distinguish	B-X
organ-confined	B-X
disease	B-X
from	B-X
metastatic	B-X
disease	B-X
may	B-X
lead	B-X
to	B-X
the	B-X
identification	B-X
of	B-X
critical	B-X
biomarkers	B-X
for	B-X
cancer	B-X
invasion	B-X
and	B-X
disease	B-X
aggressiveness	B-X
.	B-X
Using	B-X
a	B-X
combination	B-X
of	B-X
high-throughput	B-X
liquid-and-gas-chromatography-based	B-X
mass	B-X
spectrometry	B-X
,	B-X
we	B-X
profiled	B-X
more	B-X
than	B-X
1,126	B-X
metabolites	B-X
across	B-X
262	B-X
clinical	B-X
samples	B-X
related	B-X
to	B-X
prostate	B-X
cancer	B-X
(	B-X
42	B-X
tissues	B-X
and	B-X
110	B-X
each	B-X
of	B-X
urine	B-X
and	B-X
plasma	B-X
)	B-X
.	B-X
Sarcosine	B-X
,	B-X
an	B-X
N-methyl	B-X
derivative	B-X
of	B-X
the	B-X
amino	B-X
acid	B-X
glycine	B-X
,	B-X
was	B-X
identified	B-X
as	B-X
a	B-X
differential	B-X
metabolite	B-X
that	B-X
was	B-X
highly	B-X
increased	B-X
during	B-X
prostate	B-X
cancer	B-X
progression	B-X
to	B-X
metastasis	B-X
and	B-X
can	B-X
be	B-X
detected	B-X
non-invasively	B-X
in	B-X
urine	B-X
.	B-X
Sarcosine	B-X
levels	B-X
were	B-X
also	B-X
increased	B-X
in	B-X
invasive	B-X
prostate	B-X
cancer	B-X
cell	B-X
lines	B-X
relative	B-X
to	B-X
benign	B-X
prostate	B-X
epithelial	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
glycine-N-methyl	B-X
transferase	B-X
,	B-X
the	B-X
enzyme	B-X
that	B-X
generates	B-X
sarcosine	B-X
from	B-X
glycine	B-X
,	B-X
attenuated	B-X
prostate	B-X
cancer	B-X
invasion	B-X
.	B-X
Addition	B-X
of	B-X
exogenous	B-X
sarcosine	B-X
or	B-X
knockdown	B-X
of	B-X
the	B-X
enzyme	B-X
that	B-X
leads	B-X
to	B-X
sarcosine	B-X
degradation	B-X
,	B-X
sarcosine	B-X
dehydrogenase	B-X
,	B-X
induced	B-X
an	B-X
invasive	B-X
phenotype	B-X
in	B-X
benign	B-X
prostate	B-X
epithelial	B-X
cells	B-X
.	B-X
Androgen	B-X
receptor	B-X
and	B-X
the	B-X
ERG	B-X
gene	B-X
fusion	B-X
product	B-X
coordinately	B-X
regulate	B-X
components	B-X
of	B-X
the	B-X
sarcosine	B-X
pathway	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
profiling	B-X
the	B-X
metabolomic	B-X
alterations	B-X
of	B-X
prostate	B-X
cancer	B-X
progression	B-X
,	B-X
we	B-X
reveal	B-X
sarcosine	B-X
as	B-X
a	B-X
potentially	B-X
important	B-X
metabolic	B-X
intermediary	B-X
of	B-X
cancer	B-X
cell	B-X
invasion	B-X
and	B-X
aggressivity	B-X
.	B-X

To	O
confirm	O
that	O
SLO	B-Protein
activity	O
is	O
increased	O
in	O
invasive	O
GAS	O
strain	O
,	O
we	O
measured	O
SLO	B-Protein
hemolytic	O
activity	O
of	O
GAS	O
strains	O
used	O
in	O
this	O
study	O
.	O

As	O
shown	O
in	O
Figure	O
3C	O
,	O
SLO	B-Protein
activity	O
of	O
severe	O
invasive	O
isolate	O
NIH230	O
is	O
increased	O
as	O
twice	O
as	O
that	O
of	O
non	O
-	O
invasive	O
strain	O
1566	O
(	O
p	O
=	O
0	O
.	O
017	O
)	O
.	O

Impaired	O
migration	O
of	O
PMN	O
is	O
due	O
to	O
degradation	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
by	O
serine	O
proteinase	O
ScpC	B-Protein

Although	O
NIH230slo	B-Protein
lost	O
the	O
killing	O
activity	O
for	O
PMN	O
,	O
migration	O
of	O
PMN	O
in	O
response	O
to	O
IL	B-Protein
-	I-Protein
8	I-Protein
in	O
a	O
transwell	O
system	O
was	O
not	O
restored	O
in	O
the	O
presence	O
of	O
this	O
mutant	O
(	O
Figure	O
4A	O
)	O
,	O
thereby	O
,	O
suggesting	O
that	O
severe	O
invasive	O
GAS	O
blocks	O
PMN	O
migration	O
by	O
influence	O
on	O
IL	B-Protein
-	I-Protein
8	I-Protein
activity	O
.	O

Therefore	O
,	O
we	O
quantified	O
the	O
amount	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
in	O
culture	O
before	O
and	O
after	O
co	O
-	O
culture	O
with	O
clinically	O
isolated	O
GAS	O
or	O
its	O
mutants	O
.	O
<EOS>	B-X
Streptococcus	B-X
mutans	B-X
primary	B-X
thrives	B-X
on	B-X
the	B-X
biofilm	B-X
formation	B-X
on	B-X
the	B-X
tooth	B-X
surface	B-X
in	B-X
sticky	B-X
biofilms	B-X
and	B-X
under	B-X
certain	B-X
conditions	B-X
can	B-X
lead	B-X
to	B-X
carious	B-X
lesions	B-X
on	B-X
the	B-X
tooth	B-X
surface	B-X
.	B-X
To	B-X
search	B-X
for	B-X
a	B-X
new	B-X
preventive	B-X
material	B-X
for	B-X
oral	B-X
biofilm-associated	B-X
diseases	B-X
,	B-X
including	B-X
dental	B-X
caries	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
effects	B-X
of	B-X
polypyrrole	B-X
,	B-X
which	B-X
contains	B-X
an	B-X
electrochemical	B-X
polymer	B-X
and	B-X
causes	B-X
protonation	B-X
and	B-X
incorporation	B-X
of	B-X
anion	B-X
under	B-X
low	B-X
pH	B-X
condition	B-X
,	B-X
on	B-X
the	B-X
biofilm	B-X
formation	B-X
of	B-X
S.	B-X
mutans	B-X
and	B-X
other	B-X
streptococci	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
polypyrrole	B-X
was	B-X
applied	B-X
in	B-X
biofilm	B-X
formation	B-X
assays	B-X
with	B-X
the	B-X
S.	B-X
mutans	B-X
strains	B-X
UA159	B-X
and	B-X
its	B-X
gtfB	B-X
and	B-X
gtfC	B-X
double	B-X
mutant	B-X
(	B-X
gtfBC	B-X
mutant	B-X
)	B-X
,	B-X
S.	B-X
sanguinis	B-X
,	B-X
S.	B-X
mitis	B-X
and	B-X
S.	B-X
gordonii	B-X
on	B-X
human	B-X
saliva	B-X
and	B-X
bovine	B-X
serum	B-X
albumin-coated	B-X
96-well	B-X
microtiter	B-X
plates	B-X
in	B-X
tryptic	B-X
soy	B-X
broth	B-X
supplemented	B-X
with	B-X
0.25	B-X
%	B-X
sucrose	B-X
.	B-X
High	B-X
concentrations	B-X
of	B-X
polypyrrole	B-X
significantly	B-X
inhibited	B-X
the	B-X
biofilm	B-X
formation	B-X
of	B-X
S.	B-X
mutans	B-X
UA159	B-X
and	B-X
S.	B-X
sanguinis	B-X
.	B-X
As	B-X
an	B-X
inhibition	B-X
mechanism	B-X
,	B-X
polypyrrole	B-X
attached	B-X
to	B-X
the	B-X
surface	B-X
of	B-X
bacterial	B-X
cells	B-X
,	B-X
increased	B-X
chains	B-X
and	B-X
aggregates	B-X
,	B-X
and	B-X
incorporated	B-X
proteins	B-X
involving	B-X
GTF-I	B-X
and	B-X
GTF-SI	B-X
produced	B-X
by	B-X
S.	B-X
mutans	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
biofilm	B-X
formation	B-X
of	B-X
gtfBC	B-X
mutant	B-X
,	B-X
S.	B-X
sanguinis	B-X
,	B-X
S.	B-X
mitis	B-X
and	B-X
S.	B-X
gordonii	B-X
was	B-X
temporarily	B-X
induced	B-X
by	B-X
the	B-X
addition	B-X
of	B-X
low	B-X
polypyrrole	B-X
concentrations	B-X
on	B-X
human	B-X
saliva-coated	B-X
plate	B-X
but	B-X
not	B-X
on	B-X
the	B-X
uncoated	B-X
and	B-X
bovine	B-X
serum	B-X
albumin-coated	B-X
plates	B-X
.	B-X
Moreover	B-X
,	B-X
biofilm	B-X
formation	B-X
depended	B-X
on	B-X
live	B-X
cells	B-X
and	B-X
,	B-X
likewise	B-X
,	B-X
specific	B-X
interaction	B-X
between	B-X
cells	B-X
and	B-X
binding	B-X
components	B-X
in	B-X
saliva	B-X
.	B-X
In	B-X
this	B-X
regard	B-X
,	B-X
the	B-X
physical	B-X
and	B-X
electrochemical	B-X
properties	B-X
in	B-X
polypyrrole	B-X
worked	B-X
effectively	B-X
in	B-X
the	B-X
removal	B-X
of	B-X
streptococci	B-X
biofilms	B-X
.	B-X

Figure	O
4B	O
shows	O
that	O
the	O
amount	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
was	O
significantly	O
reduced	O
by	O
60	O
-	O
min	O
co	O
-	O
culture	O
with	O
NIH230	O
,	O
as	O
well	O
as	O
NIH230slo	B-Protein
,	O
but	O
not	O
with	O
non	O
-	O
invasive	O
GAS	O
1556	O
.	O

As	O
previous	O
reports	O
suggested	O
that	O
the	O
GAS	O
envelope	O
peptidase	O
ScpC	B-Protein
(	O
also	O
known	O
as	O
SpyCEP	B-Protein
)	O
degrades	O
the	O
CXC	O
chemokines	O
,	O
such	O
as	O
human	O
IL	B-Protein
-	I-Protein
8	I-Protein
,	O
Groalpha	B-Protein
,	O
murine	O
KC	B-Protein
and	O
MIP	B-Protein
-	I-Protein
2	I-Protein
[	O
17	O
]	O
-	O
[	O
19	O
]	O
,	O
we	O
established	O
a	O
NIH230	O
mutant	O
deficient	O
with	O
ScpC	B-Protein
(	O
NIH230scpC	B-Protein
)	O
and	O
analyzed	O
the	O
property	O
in	O
a	O
PMN	O
migration	O
assay	O
.	O

The	O
results	O
showed	O
that	O
NIH230scpC	B-Protein
neither	O
digested	O
IL	B-Protein
-	I-Protein
8	I-Protein
,	O
like	O
1566	O
strain	O
,	O
(	O
Figure	O
4B	O
)	O
nor	O
abrogated	O
the	O
migration	O
of	O
PMN	O
in	O
response	O
to	O
IL	B-Protein
-	I-Protein
8	I-Protein
,	O
comparable	O
to	O
1566	O
strain	O
(	O
Figure	O
4A	O
)	O
,	O
whereas	O
the	O
mutant	O
killed	O
the	O
migrated	O
PMN	O
as	O
well	O
as	O
the	O
parent	O
strain	O
NIH230	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
demonstrate	O
that	O
clinically	O
isolated	O
invasive	O
GAS	O
impaired	O
PMN	O
recruitment	O
and	O
its	O
survival	O
,	O
as	O
a	O
result	O
of	O
productions	O
of	O
ScpC	B-Protein
and	O
SLO	B-Protein
,	O
respectively	O
.	O

Enhanced	O
expression	O
of	O
the	O
slo	B-Protein
and	O
the	O
scpC	B-Protein
genes	O
in	O
severe	O
invasive	O
GAS	O
is	O
attributed	O
to	O
mutation	O
of	O
a	O
transcriptional	O
regulator	O
CsrS	B-Protein
<EOS>	B-X
Group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
causes	B-X
variety	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
common	B-X
pharyngitis	B-X
to	B-X
life-threatening	B-X
severe	B-X
invasive	B-X
diseases	B-X
,	B-X
including	B-X
necrotizing	B-X
fasciitis	B-X
and	B-X
streptococcal	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X
The	B-X
characteristic	B-X
of	B-X
invasive	B-X
GAS	B-X
infections	B-X
has	B-X
been	B-X
thought	B-X
to	B-X
attribute	B-X
to	B-X
genetic	B-X
changes	B-X
in	B-X
bacteria	B-X
,	B-X
however	B-X
,	B-X
no	B-X
clear	B-X
evidence	B-X
has	B-X
shown	B-X
due	B-X
to	B-X
lack	B-X
of	B-X
an	B-X
intriguingly	B-X
study	B-X
using	B-X
serotype-matched	B-X
isolates	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
infections	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
rare	B-X
outbreaks	B-X
of	B-X
invasive	B-X
infections	B-X
and	B-X
their	B-X
distinctive	B-X
pathology	B-X
in	B-X
which	B-X
infectious	B-X
foci	B-X
without	B-X
neutrophil	B-X
infiltration	B-X
hypothesized	B-X
us	B-X
invasive	B-X
GAS	B-X
could	B-X
evade	B-X
host	B-X
defense	B-X
,	B-X
especially	B-X
neutrophil	B-X
functions	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
a	B-X
panel	B-X
of	B-X
serotype-matched	B-X
GAS	B-X
,	B-X
which	B-X
were	B-X
clinically	B-X
isolated	B-X
from	B-X
severe	B-X
invasive	B-X
but	B-X
not	B-X
from	B-X
non-invaive	B-X
infections	B-X
,	B-X
could	B-X
abrogate	B-X
functions	B-X
of	B-X
human	B-X
polymorphnuclear	B-X
neutrophils	B-X
(	B-X
PMN	B-X
)	B-X
in	B-X
at	B-X
least	B-X
two	B-X
independent	B-X
ways	B-X
;	B-X
due	B-X
to	B-X
inducing	B-X
necrosis	B-X
to	B-X
PMN	B-X
by	B-X
enhanced	B-X
production	B-X
of	B-X
a	B-X
pore-forming	B-X
toxin	B-X
streptolysin	B-X
O	B-X
(	B-X
SLO	B-X
)	B-X
and	B-X
due	B-X
to	B-X
impairment	B-X
of	B-X
PMN	B-X
migration	B-X
via	B-X
digesting	B-X
interleukin-8	B-X
,	B-X
a	B-X
PMN	B-X
attracting	B-X
chemokine	B-X
,	B-X
by	B-X
increased	B-X
production	B-X
of	B-X
a	B-X
serine	B-X
protease	B-X
ScpC	B-X
.	B-X
Expression	B-X
of	B-X
genes	B-X
was	B-X
upregulated	B-X
by	B-X
a	B-X
loss	B-X
of	B-X
repressive	B-X
function	B-X
with	B-X
the	B-X
mutation	B-X
of	B-X
csrS	B-X
gene	B-X
in	B-X
the	B-X
all	B-X
emm49	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
.	B-X
The	B-X
csrS	B-X
mutants	B-X
from	B-X
clinical	B-X
severe	B-X
invasive	B-X
GAS	B-X
isolates	B-X
exhibited	B-X
high	B-X
mortality	B-X
and	B-X
disseminated	B-X
infection	B-X
with	B-X
paucity	B-X
of	B-X
neutrophils	B-X
,	B-X
a	B-X
characteristic	B-X
pathology	B-X
seen	B-X
in	B-X
human	B-X
invasive	B-X
GAS	B-X
infection	B-X
,	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
.	B-X
However	B-X
,	B-X
GAS	B-X
which	B-X
lack	B-X
either	B-X
SLO	B-X
or	B-X
ScpC	B-X
exhibit	B-X
much	B-X
less	B-X
mortality	B-X
than	B-X
the	B-X
csrS-mutated	B-X
parent	B-X
invasive	B-X
GAS	B-X
isolate	B-X
to	B-X
the	B-X
infected	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
abilities	B-X
of	B-X
GAS	B-X
to	B-X
abrogate	B-X
PMN	B-X
functions	B-X
can	B-X
determine	B-X
the	B-X
onset	B-X
and	B-X
severity	B-X
of	B-X
invasive	B-X
GAS	B-X
infection	B-X
.	B-X

Although	O
sequences	O
of	O
the	O
slo	B-Protein
gene	O
and	O
the	O
scpC	B-Protein
gene	O
were	O
identical	O
among	O
clinically	O
isolated	O
non	O
-	O
invasive	O
and	O
severe	O
invasive	O
GAS	O
(	O
data	O
not	O
shown	O
)	O
,	O
Figure	O
5A	O
shows	O
that	O
the	O
slo	B-Protein
and	O
the	O
scpC	B-Protein
genes	O
were	O
expressed	O
in	O
the	O
severe	O
invasive	O
GAS	O
greater	O
in	O
extent	O
than	O
those	O
in	O
the	O
non	O
-	O
invasive	O
GAS	O
.	O

The	O
expression	O
of	O
the	O
other	O
virulence	O
-	O
associated	O
genes	O
,	O
such	O
as	O
IgG	B-Protein
degrading	O
protease	O
of	O
GAS	B-Protein
,	O
Mac	B-Protein
-	I-Protein
1	I-Protein
-	O
like	O
protein	O
(	O
mac	B-Protein
)	O
,	O
nicotine	O
adenine	O
dinucleotide	O
glycohydrolase	O
(	O
nga	B-Protein
)	O
,	O
polysaccharide	O
capsule	O
production	O
(	O
hasA	B-Protein
)	O
,	O
and	O
C5a	O
peptidase	O
(	O
scpA	B-Protein
)	O
,	O
was	O
also	O
upregulted	O
in	O
the	O
severe	O
invasive	O
GAS	O
,	O
greater	O
than	O
that	O
detected	O
in	O
the	O
non	O
-	O
invasive	O
GAS	O
(	O
Figure	O
5A	O
)	O
.	O

Contrarily	O
,	O
the	O
levels	O
of	O
streptococcal	O
pyrogenic	O
endotoxin	O
(	O
speB	B-Protein
)	O
,	O
SLS	B-Protein
(	O
sagA	B-Protein
)	O
,	O
and	O
mitogenic	O
factor	O
(	O
speF	B-Protein
)	O
genes	O
were	O
downregulated	O
in	O
the	O
severe	O
invasive	O
GAS	O
,	O
compared	O
to	O
that	O
found	O
in	O
the	O
non	O
-	O
invasive	O
GAS	O
(	O
Figure	O
5A	O
and	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
demonstrate	O
the	O
prominent	O
changes	O
in	O
the	O
transcriptional	O
profile	O
of	O
several	O
virulence	O
-	O
associated	O
genes	O
,	O
including	O
the	O
slo	B-Protein
and	O
the	O
scpC	B-Protein
,	O
in	O
the	O
all	O
severe	O
invasive	O
GAS	O
.	O

Mutation	O
of	O
csrR	B-Protein
or	O
csrS	B-Protein
can	O
cause	O
significant	O
alterations	O
in	O
virulence	O
in	O
mouse	O
models	O
of	O
infection	O
,	O
either	O
increasing	O
lethality	O
or	O
the	O
severity	O
of	O
localized	O
soft	O
tissue	O
lesions	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
.	O
<EOS>	B-X
A	B-X
classification	B-X
report	B-X
,	B-X
which	B-X
is	B-X
currently	B-X
in	B-X
use	B-X
,	B-X
divides	B-X
patients	B-X
into	B-X
three	B-X
categories	B-X
according	B-X
to	B-X
the	B-X
risk	B-X
of	B-X
having	B-X
BM	B-X
:	B-X
low	B-X
risk	B-X
(	B-X
PSA	B-X
<	B-X
10ng/mL	B-X
,	B-X
clinical	B-X
stage	B-X
T1-T2a	B-X
,	B-X
Gleason	B-X
Score	B-X
≤6	B-X
)	B-X
,	B-X
intermediate	B-X
risk	B-X
(	B-X
PSA	B-X
10.1-20ng/mL	B-X
,	B-X
clinical	B-X
stage	B-X
T2b-T2c	B-X
,	B-X
Gleason	B-X
Score=7	B-X
)	B-X
and	B-X
high	B-X
risk	B-X
(	B-X
PSA	B-X
>	B-X
20ng/mL	B-X
,	B-X
clinical	B-X
stage	B-X
T3a	B-X
or	B-X
higher	B-X
,	B-X
or	B-X
Gleason	B-X
Score	B-X
≥8	B-X
)	B-X
.	B-X
Even	B-X
though	B-X
PSA	B-X
remains	B-X
the	B-X
only	B-X
biomarker	B-X
of	B-X
this	B-X
disease	B-X
in	B-X
clinical	B-X
practice	B-X
,	B-X
it	B-X
is	B-X
not	B-X
always	B-X
analogue	B-X
with	B-X
the	B-X
severity	B-X
of	B-X
the	B-X
disease	B-X
and	B-X
should	B-X
be	B-X
evaluated	B-X
along	B-X
with	B-X
the	B-X
clinical	B-X
and	B-X
diagnostic	B-X
imaging	B-X
findings	B-X
.	B-X
Foot	B-X
infections	B-X
in	B-X
patients	B-X
with	B-X
diabetes	B-X
cause	B-X
substantial	B-X
morbidity	B-X
and	B-X
frequent	B-X
visits	B-X
to	B-X
health	B-X
care	B-X
professionals	B-X
and	B-X
may	B-X
lead	B-X
to	B-X
amputation	B-X
of	B-X
a	B-X
lower	B-X
extremity	B-X
.	B-X
Diabetic	B-X
foot	B-X
infections	B-X
require	B-X
attention	B-X
to	B-X
local	B-X
(	B-X
foot	B-X
)	B-X
and	B-X
systemic	B-X
(	B-X
metabolic	B-X
)	B-X
issues	B-X
and	B-X
coordinated	B-X
management	B-X
,	B-X
preferably	B-X
by	B-X
a	B-X
multidisciplinary	B-X
foot-care	B-X
team	B-X
(	B-X
A-II	B-X
)	B-X
.	B-X
The	B-X
team	B-X
managing	B-X
these	B-X
infections	B-X
should	B-X
include	B-X
,	B-X
or	B-X
have	B-X
ready	B-X
access	B-X
to	B-X
,	B-X
an	B-X
infectious	B-X
diseases	B-X
specialist	B-X
or	B-X
a	B-X
medical	B-X
microbiologist	B-X
(	B-X
B-II	B-X
)	B-X
.	B-X
The	B-X
major	B-X
predisposing	B-X
factor	B-X
to	B-X
these	B-X
infections	B-X
is	B-X
foot	B-X
ulceration	B-X
,	B-X
which	B-X
is	B-X
usually	B-X
related	B-X
to	B-X
peripheral	B-X
neuropathy	B-X
.	B-X
Aerobic	B-X
Gram-positive	B-X
cocci	B-X
(	B-X
especially	B-X
Staphylococcus	B-X
aureus	B-X
)	B-X
are	B-X
the	B-X
predominant	B-X
pathogens	B-X
in	B-X
diabetic	B-X
foot	B-X
infections	B-X
.	B-X
5	B-X
.	B-X
Wound	B-X
infections	B-X
must	B-X
be	B-X
diagnosed	B-X
clinically	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
local	B-X
(	B-X
and	B-X
occasionally	B-X
systemic	B-X
)	B-X
signs	B-X
and	B-X
symptoms	B-X
of	B-X
inflammation	B-X
.	B-X
Laboratory	B-X
(	B-X
including	B-X
microbiological	B-X
)	B-X
investigations	B-X
are	B-X
of	B-X
limited	B-X
use	B-X
for	B-X
diagnosing	B-X
infection	B-X
,	B-X
except	B-X
in	B-X
cases	B-X
of	B-X
osteomyelitis	B-X
(	B-X
B-II	B-X
)	B-X
.	B-X
6	B-X
.	B-X
Send	B-X
appropriately	B-X
obtained	B-X
specimens	B-X
for	B-X
culture	B-X
before	B-X
starting	B-X
empirical	B-X
antibiotic	B-X
therapy	B-X
in	B-X
all	B-X
cases	B-X
of	B-X
infection	B-X
,	B-X
except	B-X
perhaps	B-X
those	B-X
that	B-X
are	B-X
mild	B-X
and	B-X
previously	B-X
untreated	B-X
(	B-X
B-III	B-X
)	B-X
.	B-X
Imaging	B-X
studies	B-X
may	B-X
help	B-X
diagnose	B-X
or	B-X
better	B-X
define	B-X
deep	B-X
,	B-X
soft-tissue	B-X
purulent	B-X
collections	B-X
and	B-X
are	B-X
usually	B-X
needed	B-X
to	B-X
detect	B-X
pathological	B-X
findings	B-X
in	B-X
bone	B-X
.	B-X
Plain	B-X
radiography	B-X
may	B-X
be	B-X
adequate	B-X
in	B-X
many	B-X
cases	B-X
,	B-X
but	B-X
MRI	B-X
(	B-X
in	B-X
preference	B-X
to	B-X
isotope	B-X
scanning	B-X
)	B-X
is	B-X
more	B-X
sensitive	B-X
and	B-X
specific	B-X
,	B-X
especially	B-X
for	B-X
detection	B-X
of	B-X
soft-tissue	B-X
lesions	B-X
(	B-X
A-I	B-X
)	B-X
.	B-X
Infections	B-X
should	B-X
be	B-X
categorized	B-X
by	B-X
their	B-X
severity	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
readily	B-X
assessable	B-X
clinical	B-X
and	B-X
laboratory	B-X
features	B-X
(	B-X
B-II	B-X
)	B-X
.	B-X
Most	B-X
important	B-X
among	B-X
these	B-X
are	B-X
the	B-X
specific	B-X
tissues	B-X
involved	B-X
,	B-X
the	B-X
adequacy	B-X
of	B-X
arterial	B-X
perfusion	B-X
,	B-X
and	B-X
the	B-X
presence	B-X
of	B-X
systemic	B-X
toxicity	B-X
or	B-X
metabolic	B-X
instability	B-X
.	B-X
Select	B-X
an	B-X
empirical	B-X
antibiotic	B-X
regimen	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
the	B-X
severity	B-X
of	B-X
the	B-X
infection	B-X
and	B-X
the	B-X
likely	B-X
etiologic	B-X
agent	B-X
(	B-X
s	B-X
)	B-X
(	B-X
B-II	B-X
)	B-X
.	B-X
Therapy	B-X
aimed	B-X
solely	B-X
at	B-X
aerobic	B-X
Gram-positive	B-X
cocci	B-X
may	B-X
be	B-X
sufficient	B-X
for	B-X
mild-to-moderate	B-X
infections	B-X
in	B-X
patients	B-X
who	B-X
have	B-X
not	B-X
recently	B-X
received	B-X
antibiotic	B-X
therapy	B-X
(	B-X
A-II	B-X
)	B-X
.	B-X
Broad-spectrum	B-X
empirical	B-X
therapy	B-X
is	B-X
not	B-X
routinely	B-X
required	B-X
but	B-X
is	B-X

GAS	O
isolates	O
from	O
mice	O
with	O
severe	O
invasive	O
disease	O
had	O
mutations	O
in	O
csrS	B-Protein
,	O
raising	O
the	O
notion	O
that	O
CsrR	B-Protein
/	O
S	B-Protein
function	O
is	O
important	O
in	O
modulating	O
gene	O
expression	O
during	O
infection	O
.	O

Therefore	O
,	O
we	O
analyzed	O
the	O
linkage	O
between	O
the	O
csrS	B-Protein
and	O
/	O
or	O
csrR	B-Protein
genes	O
and	O
the	O
property	O
of	O
invasive	O
GAS	O
infection	O
by	O
sequencing	O
these	O
genes	O
in	O
the	O
emm49	B-Protein
strains	O
used	O
in	O
this	O
study	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
csrR	B-Protein
gene	O
was	O
identical	O
in	O
all	O
the	O
isolates	O
,	O
and	O
that	O
of	O
the	O
csrS	B-Protein
gene	O
was	O
identical	O
among	O
the	O
all	O
non	O
-	O
invasive	O
GAS	O
isolates	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
5B	O
,	O
the	O
csrS	B-Protein
genes	O
of	O
all	O
clinically	O
isolated	O
severe	O
invasive	O
GAS	O
had	O
a	O
deletion	O
,	O
a	O
point	O
mutation	O
,	O
or	O
an	O
insertion	O
,	O
thereby	O
,	O
resulting	O
in	O
the	O
creation	O
of	O
translational	O
stop	O
codons	O
(	O
NIH147	O
,	O
NIH226	O
,	O
NIH230	O
,	O
and	O
NIH269	O
)	O
or	O
in	O
a	O
mutation	O
in	O
the	O
presumed	O
kinase	O
domain	O
(	O
NIH200	O
)	O
.	O

In	O
order	O
to	O
clarify	O
the	O
role	O
of	O
CsrS	B-Protein
regarding	O
expression	O
of	O
the	O
virulence	O
-	O
associated	O
genes	O
and	O
resistance	O
to	O
PMN	O
killing	O
,	O
we	O
introduced	O
the	O
intact	O
csrS	B-Protein
gene	O
of	O
the	O
1566	O
strain	O
into	O
the	O
severe	O
invasive	O
GAS	O
(	O
see	O
Figure	O
5A	O
)	O
.	O

The	O
csrS	B-Protein
-	O
introduced	O
severe	O
invasive	O
GAS	O
reduced	O
the	O
expression	O
levels	O
of	O
the	O
slo	B-Protein
and	O
the	O
scpC	B-Protein
genes	O
,	O
comparable	O
to	O
those	O
detected	O
in	O
the	O
non	O
-	O
invasive	O
GAS	O
.	O

In	O
contrast	O
,	O
the	O
expression	O
of	O
speB	B-Protein
was	O
upregulated	O
to	O
the	O
level	O
observed	O
in	O
the	O
non	O
-	O
invasive	O
GAS	O
(	O
Figure	O
5A	O
)	O
.	O

In	O
parallel	O
with	O
the	O
expression	O
profile	O
of	O
slo	B-Protein
and	O
scpC	B-Protein
in	O
the	O
severe	O
invasive	O
GAS	O
,	O
introduction	O
of	O
the	O
intact	O
csrS	B-Protein
gene	O
into	O
the	O
severe	O
invasive	O
GAS	O
restored	O
the	O
susceptibility	O
to	O
the	O
killing	O
by	O
PMN	O
(	O
p	O
=	O
0	O
.	O
015	O
compared	O
with	O
severe	O
invasive	O
isolates	O
+	O
CsrS	B-Protein
)	O
(	O
Figure	O
6A	O
)	O
,	O
abrogated	O
the	O
inhibition	O
of	O
PMN	O
migration	O
by	O
degradation	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
(	O
p	O
=	O
0	O
.	O
002	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	B-Protein
)	O
(	O
Figure	O
4A	O
,	O
4B	O
,	O
and	O
6B	O
)	O
,	O
and	O
diminished	O
the	O
killing	O
activity	O
for	O
PMN	O
by	O
necrosis	O
(	O
p	O
=	O
0	O
.	O
00016	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	B-Protein
)	O
(	O
Figure	O
3A	O
,	O
3C	O
,	O
and	O
6C	O
)	O
,	O
These	O
results	O
strongly	O
suggest	O
that	O
mutations	O
in	O
the	O
csrS	B-Protein
gene	O
correspond	O
to	O
the	O
immunocompromized	O
activity	O
in	O
the	O
severe	O
invasive	O
isolates	O
,	O
associated	O
with	O
inhibition	O
of	O
PMN	O
recruitment	O
and	O
survival	O
.	O

csrS	B-Protein
mutation	O
is	O
important	O
in	O
the	O
pathogenesis	O
of	O
invasive	O
infections	O
in	O
a	O
mouse	O
model	O

In	O
order	O
to	O
elucidate	O
the	O
role	O
of	O
csrS	B-Protein
,	O
in	O
infections	O
in	O
vivo	O
,	O
we	O
compared	O
the	O
virulence	O
of	O
GAS	O
isolates	O
using	O
a	O
mouse	O
model	O
which	O
infected	O
GAS	O
intraperitoneally	O
.	O

The	O
non	O
-	O
invasive	O
1566	O
strain	O
displayed	O
the	O
LD50	O
value	O
approximately	O
100	O
-	O
fold	O
higher	O
than	O
that	O
of	O
the	O
severe	O
invasive	O
NIH230	O
strain	O
(	O
Table	O
1	O
)	O
,	O
whereas	O
a	O
csrS	B-Protein
deletion	O
(	O
1566DeltacsrS	B-Protein
)	O
caused	O
an	O
increase	O
in	O
the	O
LD50	O
value	O
comparable	O
to	O
that	O
of	O
the	O
NIH230	O
strain	O
.	O

Consistently	O
,	O
an	O
introduction	O
of	O
the	O
intact	O
csrS	B-Protein
gene	O
into	O
the	O
NIH230	O
strain	O
(	O
NIH230	O
:	O
:	O
csrS	B-Protein
+	I-Protein
)	O
reduced	O
the	O
LD50	O
value	O
to	O
the	O
level	O
observed	O
in	O
the	O
non	O
-	O
invasive	O
strain	O
.	O

These	O
results	O
indicate	O
that	O
csrS	B-Protein
is	O
an	O
important	O
virulence	O
factor	O
in	O
the	O
mouse	O
model	O
of	O
lethal	O
infections	O
.	O

As	O
shown	O
in	O
Figure	O
7A	O
,	O
the	O
NIH230	O
strain	O
caused	O
bacteremia	O
in	O
mice	O
24	O
h	O
after	O
intraperitoneal	O
injection	O
whereas	O
the	O
bacteremia	O
was	O
barely	O
detected	O
in	O
mice	O
infected	O
with	O
NIH230	O
:	O
:	O
csrS	B-Protein
+	I-Protein
as	O
well	O
as	O
the	O
1566	O
strain	O
(	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
non	O
-	O
invasive	O
isolates	O
,	O
and	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	B-Protein
)	O
.	O

Histopathologically	O
,	O
in	O
the	O
mice	O
injected	O
with	O
the	O
NIH230	O
strain	O
,	O
bacteria	O
formed	O
clusters	O
in	O
interstitial	O
tissues	O
in	O
the	O
kidneys	O
and	O
the	O
lungs	O
,	O
accompanied	O
congestion	O
and	O
no	O
inflammatory	O
cells	O
at	O
infectious	O
foci	O
(	O
Figure	O
7B	O
,	O
7C	O
and	O
data	O
not	O
shown	O
)	O
.	O

Contrarily	O
,	O
no	O
significant	O
pathological	O
alterations	O
were	O
observed	O
in	O
the	O
mice	O
injected	O
with	O
the	O
1566	O
and	O
NIH230	O
:	O
:	O
csrS	B-Protein
+	I-Protein
strains	O
(	O
Figure	O
7B	O
and	O
7C	O
)	O
.	O

Figure	O
7D	O
shows	O
that	O
subcutaneous	O
infection	O
of	O
NIH230	O
formed	O
the	O
infected	O
lesions	O
with	O
area	O
significantly	O
larger	O
than	O
those	O
of	O
1566	O
and	O
NIH230	O
:	O
:	O
csrS	B-Protein
+	I-Protein
.	O

These	O
results	O
suggest	O
that	O
the	O
invasive	O
GAS	O
isolates	O
are	O
more	O
virulent	O
in	O
vivo	O
than	O
non	O
-	O
invasive	O
GAS	O
,	O
and	O
impair	O
PMN	O
function	O
in	O
vivo	O
,	O
owing	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
mutations	O
in	O
the	O
csrS	B-Protein
gene	O
.	O

scpC	B-Protein
and	O
slo	B-Protein
are	O
insufficient	O
singly	O
for	O
the	O
pathogenesis	O
of	O
invasive	O
infections	O

Finally	O
,	O
we	O
assessed	O
the	O
influence	O
of	O
enhanced	O
expression	O
of	O
the	O
scpC	B-Protein
or	O
the	O
slo	B-Protein
gene	O
on	O
the	O
virulence	O
in	O
a	O
mouse	O
model	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
NIH230scpC	B-Protein
and	O
NIH230slo	B-Protein
exerted	O
the	O
LD50	O
value	O
3	O
-	O
10	O
fold	O
lower	O
than	O
that	O
of	O
the	O
non	O
-	O
invasive	O
isolate	O
1566	O
,	O
but	O
10	O
-	O
30	O
fold	O
higher	O
than	O
that	O
of	O
severe	O
invasive	O
isolates	O
.	O

Subcutaneous	O
inoculation	O
of	O
NIH230scpC	B-Protein
and	O
NIH230slo	B-Protein
yielded	O
the	O
local	O
infected	O
lesions	O
with	O
area	O
comparable	O
to	O
those	O
of	O
1566	O
and	O
NIH230	O
:	O
:	O
csrS	B-Protein
+	I-Protein
during	O
the	O
course	O
of	O
infection	O
(	O
Figure	O
7D	O
)	O
.	O

These	O
results	O
suggest	O
that	O
enhanced	O
expression	O
of	O
ScpC	B-Protein
and	O
SLO	B-Protein
in	O
invasive	O
GAS	O
plays	O
an	O
important	O
role	O
in	O
vivo	O
virulence	O
of	O
GAS	O
infection	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

It	O
have	O
been	O
demonstrated	O
that	O
CsrS	B-Protein
/	O
R	B-Protein
is	O
a	O
member	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
systems	O
for	O
regulating	O
the	O
multipe	O
virulence	O
factors	O
of	O
GAS	O
,	O
by	O
using	O
genetically	O
-	O
manipulated	O
GAS	O
mutants	O
[	O
20	O
]	O
.	O

The	O
present	O
study	O
demonstrate	O
that	O
the	O
loss	O
-	O
of	O
-	O
functional	O
mutations	O
in	O
csrS	B-Protein
gene	O
which	O
were	O
accumulated	O
in	O
clinically	O
isolated	O
GAS	O
from	O
patients	O
with	O
severe	O
invasive	O
infections	O
,	O
but	O
not	O
with	O
emm	O
-	O
matched	O
non	O
-	O
invasive	O
strains	O
.	O

The	O
csrS	B-Protein
mutations	O
enhanced	O
the	O
expression	O
of	O
scpC	B-Protein
and	O
slo	B-Protein
,	O
associated	O
with	O
the	O
evasion	O
of	O
PMN	O
functions	O
and	O
in	O
vivo	O
virulence	O
.	O

Introduction	O
of	O
the	O
intact	O
csrS	B-Protein
gene	O
into	O
the	O
severe	O
invasive	O
GAS	O
restored	O
the	O
susceptibility	O
to	O
the	O
killing	O
by	O
PMN	O
and	O
abrogated	O
the	O
activity	O
for	O
inhibition	O
of	O
PMN	O
recruitment	O
and	O
survival	O
,	O
thus	O
,	O
demonstrating	O
an	O
instructional	O
role	O
of	O
the	O
loss	O
-	O
of	O
-	O
functional	O
mutations	O
in	O
csrS	B-Protein
gene	O
for	O
the	O
evasion	O
of	O
PMN	O
functions	O
,	O
providing	O
unique	O
pathophysiology	O
of	O
invasive	O
GAS	O
infections	O
.	O

Previous	O
studies	O
using	O
animal	O
-	O
passaged	O
GAS	O
have	O
shown	O
that	O
mutations	O
in	O
both	O
csrS	B-Protein
and	O
csrR	B-Protein
gene	O
are	O
important	O
for	O
the	O
invasive	O
phenotype	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
and	O
mutation	O
frequency	O
of	O
csrS	B-Protein
and	O
csrR	B-Protein
seems	O
to	O
be	O
the	O
same	O
[	O
21	O
]	O
.	O

However	O
,	O
the	O
severe	O
invasive	O
isolates	O
analyzed	O
in	O
this	O
study	O
accumulated	O
mutations	O
in	O
the	O
csrS	B-Protein
gene	O
but	O
not	O
in	O
the	O
csrR	B-Protein
gene	O
(	O
Figure	O
5B	O
and	O
data	O
not	O
shown	O
)	O
.	O

Then	O
we	O
further	O
examined	O
whether	O
severe	O
invasive	O
isolates	O
of	O
other	O
than	O
emm49	B-Protein
genotype	O
have	O
the	O
mutation	O
of	O
the	O
csrS	B-Protein
and	O
the	O
csrR	B-Protein
genes	O
.	O

The	O
frequency	O
of	O
the	O
mutation	O
in	O
the	O
csrS	B-Protein
gene	O
is	O
higher	O
than	O
that	O
in	O
csrR	B-Protein
(	O
csrS	B-Protein
mutation	O
:	O
csrR	B-Protein
mutation	O
=	O
59	O
:	O
19	O
)	O
(	O
manuscript	O
in	O
preparation	O
)	O
,	O
suggesting	O
the	O
csrS	B-Protein
mutation	O
is	O
more	O
important	O
in	O
comparison	O
with	O
that	O
of	O
csrR	B-Protein
in	O
the	O
clinical	O
isolates	O
regardless	O
of	O
emm	B-Protein
genotypes	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
some	O
human	O
invasive	O
disease	O
-	O
associated	O
genes	O
[	O
5	O
]	O
including	O
slo	B-Protein
was	O
enhanced	O
in	O
the	O
csrS	B-Protein
mutant	O
(	O
Figure	O
5B	O
)	O
,	O
but	O
not	O
in	O
the	O
csrR	B-Protein
mutant	O
[	O
20	O
]	O
.	O

On	O
the	O
contrary	O
of	O
a	O
dogma	O
that	O
CsrS	B-Protein
/	O
R	B-Protein
is	O
a	O
definitive	O
member	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
which	O
involve	O
a	O
coordinate	O
pair	O
of	O
proteins	O
known	O
as	O
the	O
sensor	O
kinase	O
and	O
the	O
response	O
regulator	O
[	O
20	O
]	O
,	O
CsrS	B-Protein
may	O
transmit	O
a	O
signal	O
not	O
only	O
to	O
CsrR	B-Protein
but	O
also	O
to	O
other	O
regulators	O
.	O

This	O
dominant	O
role	O
of	O
CsrS	B-Protein
is	O
the	O
first	O
important	O
observation	O
in	O
this	O
study	O
,	O
and	O
its	O
mutation	O
is	O
possibly	O
more	O
important	O
than	O
that	O
of	O
csrR	B-Protein
in	O
terms	O
of	O
etiopathogenesis	O
of	O
human	O
severe	O
invasive	O
diseases	O
.	O

Numbers	O
of	O
studies	O
has	O
pointed	O
out	O
virulent	O
factors	O
to	O
evade	O
host	O
defense	O
using	O
genetically	O
-	O
manipulated	O
GAS	O
and	O
animal	O
models	O
[	O
18	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
,	O
although	O
the	O
significance	O
of	O
each	O
factor	O
to	O
invasive	O
infection	O
is	O
diverse	O
and	O
sometimes	O
controversial	O
,	O
perhaps	O
due	O
to	O
lack	O
of	O
proper	O
non	O
-	O
invasive	O
counterpart	O
.	O

As	O
examples	O
,	O
SpeB	B-Protein
[	O
22	O
]	O
and	O
SLS	B-Protein
[	O
23	O
]	O
have	O
been	O
proposed	O
as	O
an	O
invasive	O
infection	O
-	O
associated	O
factor	O
by	O
its	O
cytotoxic	O
effect	O
,	O
however	O
,	O
speB	B-Protein
and	O
sagA	B-Protein
expression	O
is	O
not	O
enhanced	O
in	O
any	O
csrS	B-Protein
-	O
mutated	O
severe	O
invasive	O
GAS	O
isolate	O
used	O
in	O
this	O
study	O
and	O
others	O
[	O
5	O
]	O
,	O
[	O
24	O
]	O
.	O

Furthermore	O
,	O
SLS	B-Protein
hemolytic	O
activity	O
of	O
invasive	O
GAS	O
is	O
significantly	O
decreased	O
as	O
compared	O
with	O
non	O
-	O
invasive	O
strains	O
(	O
data	O
not	O
shown	O
)	O
and	O
SLS	B-Protein
-	O
deletion	O
in	O
invasive	O
GAS	O
did	O
not	O
affect	O
PMN	O
survival	O
at	O
all	O
,	O
excluding	O
the	O
possibility	O
for	O
the	O
role	O
of	O
SLS	B-Protein
in	O
PMN	O
necrosis	O
seen	O
in	O
this	O
study	O
.	O

Extracellular	B-Protein
deoxyribonuclease	I-Protein
(	O
DNase	B-Protein
)	O
is	O
a	O
virulence	O
factor	O
that	O
protects	O
emm1	B-Protein
type	O
GAS	O
against	O
neutrophil	O
killing	O
by	O
degrading	O
the	O
DNA	O
framework	O
of	O
neutrophil	O
extracelluar	O
traps	O
(	O
NETs	O
)	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

However	O
,	O
we	O
confirmed	O
that	O
addition	O
of	O
DNase	B-Protein
in	O
the	O
culture	O
did	O
not	O
alter	O
the	O
level	O
of	O
PI	O
-	O
positive	O
PMN	O
,	O
meaning	O
bright	O
PI	O
staining	O
of	O
PMN	O
is	O
not	O
due	O
to	O
release	O
of	O
NETs	O
from	O
PMN	O
(	O
Figure	O
S1A	O
)	O
.	O
<EOS>	B-X
Since	B-X
selection	B-X
of	B-X
recombinant	B-X
cell	B-X
lines	B-X
in	B-X
the	B-X
GS-CHO	B-X
system	B-X
is	B-X
based	B-X
on	B-X
the	B-X
balance	B-X
between	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
GS	B-X
gene	B-X
introduced	B-X
by	B-X
the	B-X
expression	B-X
plasmid	B-X
and	B-X
the	B-X
addition	B-X
of	B-X
the	B-X
GS	B-X
inhibitor	B-X
,	B-X
L-MSX	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
GS	B-X
from	B-X
the	B-X
endogenous	B-X
GS	B-X
gene	B-X
in	B-X
parental	B-X
CHOK1SV	B-X
cells	B-X
will	B-X
likely	B-X
interfere	B-X
with	B-X
the	B-X
selection	B-X
process	B-X
.	B-X
GS	B-X
enzyme	B-X
function	B-X
disruption	B-X
was	B-X
confirmed	B-X
by	B-X
the	B-X
observation	B-X
of	B-X
glutamine-dependent	B-X
growth	B-X
of	B-X
all	B-X
GS-knockout	B-X
cell	B-X
lines	B-X
.	B-X
Full	B-X
evaluation	B-X
of	B-X
the	B-X
GS-knockout	B-X
cell	B-X
lines	B-X
in	B-X
a	B-X
standard	B-X
industrial	B-X
cell	B-X
culture	B-X
process	B-X
was	B-X
performed	B-X
.	B-X
Bulk	B-X
culture	B-X
productivity	B-X
improved	B-X
two-	B-X
to	B-X
three-fold	B-X
through	B-X
the	B-X
use	B-X
of	B-X
GS-knockout	B-X
cells	B-X
as	B-X
parent	B-X
cells	B-X
.	B-X

DNase	B-Protein
activity	O
of	O
the	O
emm49	B-Protein
severe	O
invasive	O
GAS	O
was	O
lower	O
than	O
that	O
of	O
non	O
-	O
invasive	O
GAS	O
(	O
Figure	O
S1B	O
)	O
,	O
possibly	O
due	O
to	O
the	O
difference	O
of	O
emm	O
type	O
.	O

The	O
expression	O
of	O
DNase	B-Protein
as	O
well	O
as	O
the	O
slo	B-Protein
and	O
the	O
scpC	B-Protein
genes	O
in	O
emm1	B-Protein
-	O
genotype	O
strains	O
was	O
enhanced	O
under	O
the	O
csrS	B-Protein
mutation	O
[	O
5	O
]	O
.	O

These	O
suggest	O
that	O
DNase	B-Protein
may	O
be	O
important	O
but	O
redundant	O
for	O
induction	O
of	O
invasive	O
diseases	O
.	O

Therefore	O
,	O
the	O
second	O
important	O
observation	O
in	O
the	O
present	O
study	O
is	O
that	O
an	O
essential	O
requirement	O
of	O
csrS	B-Protein
mutation	O
for	O
invasive	O
infection	O
is	O
associated	O
with	O
increased	O
expression	O
of	O
ScpC	B-Protein
and	O
SLO	B-Protein
and	O
in	O
vitro	O
evasion	O
of	O
PMN	O
functions	O
,	O
though	O
we	O
do	O
not	O
exclude	O
the	O
possibility	O
that	O
other	O
CsrS	B-Protein
-	O
regulating	O
factors	O
contribute	O
to	O
the	O
escape	O
of	O
invasive	O
GAS	O
from	O
host	O
defense	O
.	O

SLO	B-Protein
and	O
ScpC	B-Protein
independently	O
enable	O
GAS	O
to	O
escape	O
from	O
PMN	O
functions	O
;	O
Present	O
data	O
using	O
clinical	O
isolated	O
GAS	O
and	O
a	O
scpC	B-Protein
-	O
deletion	O
mutant	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
show	O
that	O
enhanced	O
production	O
of	O
serine	O
proteinase	O
ScpC	B-Protein
in	O
virulent	O
GAS	O
is	O
essential	O
to	O
impair	O
PMN	O
migration	O
in	O
vitro	O
by	O
degradation	O
of	O
IL	B-Protein
-	I-Protein
8	I-Protein
,	O
as	O
others	O
partially	O
have	O
demonstrated	O
[	O
17	O
]	O
-	O
[	O
19	O
]	O
.	O

The	O
present	O
study	O
also	O
uncovers	O
that	O
increased	O
activity	O
of	O
SLO	B-Protein
from	O
invasive	O
GAS	O
isolates	O
induces	O
rapid	O
and	O
extensive	O
necrosis	O
to	O
human	O
PMN	O
.	O

SLO	B-Protein
is	O
a	O
cholesterol	O
-	O
binding	O
pore	O
-	O
forming	O
hemolysin	O
as	O
well	O
as	O
cytotoxic	O
for	O
other	O
cells	O
[	O
15	O
]	O
.	O

A	O
study	O
has	O
demonstrated	O
SLO	B-Protein
from	O
invasive	O
GAS	O
lyse	O
PMN	O
[	O
27	O
]	O
,	O
however	O
this	O
effect	O
is	O
likely	O
due	O
to	O
complement	O
activation	O
by	O
SLO	B-Protein
[	O
28	O
]	O
or	O
PMN	O
activation	O
[	O
29	O
]	O
but	O
not	O
due	O
to	O
cytotoxity	O
of	O
SLO	B-Protein
itself	O
as	O
judged	O
by	O
their	O
flow	O
cytometry	O
profiles	O
which	O
are	O
distinct	O
from	O
ours	O
(	O
Figure	O
2A	O
)	O
.	O
<EOS>	B-X
This	B-X
systematic	B-X
review	B-X
and	B-X
network	B-X
meta-analysis	B-X
(	B-X
NMA	B-X
)	B-X
aimed	B-X
to	B-X
compare	B-X
the	B-X
long-term	B-X
effects	B-X
of	B-X
different	B-X
training	B-X
modalities	B-X
on	B-X
anthropometric	B-X
outcomes	B-X
in	B-X
patients	B-X
with	B-X
obesity	B-X
.	B-X
Immune	B-X
activation	B-X
at	B-X
the	B-X
maternal-fetal	B-X
interface	B-X
is	B-X
a	B-X
main	B-X
pathogenic	B-X
factor	B-X
of	B-X
preeclampsia	B-X
(	B-X
PE	B-X
)	B-X
.	B-X
Neutrophils	B-X
(	B-X
PMNs	B-X
)	B-X
are	B-X
activated	B-X
in	B-X
PE	B-X
patients	B-X
,	B-X
but	B-X
the	B-X
mechanism	B-X
and	B-X
consequences	B-X
of	B-X
PMN	B-X
activation	B-X
need	B-X
to	B-X
be	B-X
further	B-X
explored	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
interleukin-32	B-X
(	B-X
IL-32	B-X
)	B-X
expression	B-X
was	B-X
significantly	B-X
upregulated	B-X
in	B-X
syncytiotrophoblasts	B-X
(	B-X
STBs	B-X
)	B-X
and	B-X
that	B-X
IL-32β	B-X
was	B-X
the	B-X
major	B-X
isoform	B-X
with	B-X
increased	B-X
expression	B-X
in	B-X
the	B-X
placenta	B-X
of	B-X
severe	B-X
PE	B-X
(	B-X
sPE	B-X
)	B-X
patients	B-X
.	B-X
Then	B-X
,	B-X
in	B-X
vitro	B-X
experiments	B-X
showed	B-X
that	B-X
IL-32β	B-X
could	B-X
highly	B-X
activate	B-X
PMNs	B-X
and	B-X
that	B-X
these	B-X
IL-32β-activated	B-X
PMNs	B-X
were	B-X
better	B-X
able	B-X
to	B-X
adhere	B-X
to	B-X
endothelial	B-X
cells	B-X
(	B-X
HUVECs	B-X
)	B-X
and	B-X
enhance	B-X
the	B-X
expression	B-X
of	B-X
vascular	B-X
cell	B-X
adhesion	B-X
molecule-1	B-X
(	B-X
VCAM-1	B-X
)	B-X
and	B-X
intercellular	B-X
cell	B-X
adhesion	B-X
molecule-1	B-X
(	B-X
ICAM-1	B-X
)	B-X
in	B-X
HUVECs	B-X
,	B-X
which	B-X
could	B-X
be	B-X
reversed	B-X
by	B-X
preincubation	B-X
with	B-X
the	B-X
NADPH	B-X
oxidase	B-X
inhibitor	B-X
VAS	B-X
2870	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
IL-32β	B-X
mainly	B-X
activated	B-X
PMNs	B-X
by	B-X
binding	B-X
to	B-X
proteinase	B-X
3	B-X
.	B-X
This	B-X
study	B-X
provides	B-X
evidence	B-X
of	B-X
the	B-X
involvement	B-X
of	B-X
IL-32β	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
PE	B-X
.	B-X

In	O
the	O
present	O
study	O
,	O
we	O
observed	O
that	O
SLO	B-Protein
concentration	O
in	O
a	O
short	O
-	O
time	O
culture	O
with	O
severe	O
invasive	O
GAS	O
did	O
not	O
reach	O
the	O
threshold	O
level	O
to	O
kill	O
PMN	O
by	O
formation	O
of	O
pores	O
(	O
data	O
not	O
shown	O
)	O
and	O
that	O
PMN	O
did	O
not	O
undergo	O
necrosis	O
upon	O
incubation	O
with	O
culture	O
media	O
of	O
severe	O
invasive	O
GAS	O
(	O
Figure	O
3B	O
)	O
,	O
leading	O
to	O
the	O
novel	O
possibility	O
that	O
PMN	O
are	O
probably	O
killed	O
following	O
encounter	O
with	O
invasive	O
GAS	O
in	O
a	O
contact	O
-	O
dependent	O
manner	O
.	O

PMN	O
-	O
binding	O
GAS	O
may	O
make	O
a	O
small	O
interface	O
containing	O
a	O
high	O
concentration	O
of	O
SLO	B-Protein
between	O
bacteria	O
and	O
PMN	O
,	O
which	O
resembles	O
to	O
killing	O
mechanism	O
of	O
killer	O
cells	O
to	O
target	O
cells	O
[	O
30	O
]	O
.	O

Collaboration	O
of	O
SLO	B-Protein
with	O
other	O
toxins	O
may	O
be	O
critical	O
to	O
induce	O
PMN	O
necrosis	O
as	O
similarly	O
mechanism	O
has	O
been	O
reported	O
[	O
31	O
]	O
,	O
although	O
it	O
remains	O
to	O
be	O
examined	O
whether	O
there	O
exist	O
explore	O
interaction	O
-	O
associated	O
molecules	O
on	O
both	O
host	O
and	O
bacterial	O
membrane	O
is	O
needed	O
.	O

In	O
contrast	O
to	O
the	O
previous	O
view	O
[	O
18	O
]	O
,	O
we	O
observed	O
that	O
both	O
of	O
ScpC	B-Protein
and	O
SLO	B-Protein
together	O
,	O
but	O
not	O
each	O
of	O
them	O
,	O
mediated	O
sufficient	O
in	O
vivo	O
virulence	O
(	O
Table	O
1	O
)	O
,	O
thus	O
compatible	O
with	O
the	O
notion	O
that	O
plural	O
virulence	O
-	O
associated	O
factors	O
under	O
the	O
regulation	O
of	O
csrS	B-Protein
abrogate	O
PMN	O
bactericidal	O
functions	O
and	O
induce	O
invasive	O
diseases	O
in	O
in	O
vivo	O
animal	O
model	O
.	O

Consistently	O
,	O
the	O
high	O
mortality	O
and	O
histopathological	O
findings	O
which	O
lacks	O
PMN	O
infiltration	O
in	O
mice	O
tissues	O
infected	O
with	O
csrS	B-Protein
-	O
mutated	O
GAS	O
(	O
Figure	O
7	O
)	O
are	O
similar	O
to	O
those	O
seen	O
in	O
clinical	O
invasive	O
GAS	O
infections	O
[	O
32	O
]	O
.	O

Thus	O
,	O
these	O
results	O
suggest	O
that	O
the	O
ability	O
of	O
incompetence	O
for	O
PMN	O
functions	O
by	O
individual	O
GAS	O
strain	O
may	O
determine	O
the	O
induction	O
and	O
clinical	O
outcome	O
of	O
invasive	O
diseases	O
.	O

Several	O
clinical	O
reports	O
seem	O
to	O
support	O
this	O
hypothesis	O
;	O
Leukocytopenia	O
seen	O
in	O
patients	O
with	O
STSS	O
is	O
more	O
severe	O
than	O
that	O
with	O
non	O
-	O
STSS	O
[	O
33	O
]	O
,	O
and	O
invasive	O
GAS	O
-	O
infected	O
patients	O
with	O
leukocytopenia	O
show	O
worse	O
prognosis	O
than	O
those	O
without	O
leukocytopenia	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O
<EOS>	B-X
Recently	B-X
,	B-X
however	B-X
,	B-X
many	B-X
studies	B-X
have	B-X
reported	B-X
the	B-X
presence	B-X
of	B-X
prominent	B-X
delta	B-X
activity	B-X
during	B-X
conscious	B-X
states	B-X
,	B-X
which	B-X
casts	B-X
doubt	B-X
on	B-X
the	B-X
hypothesis	B-X
that	B-X
high	B-X
amplitude	B-X
delta	B-X
oscillations	B-X
are	B-X
an	B-X
indicator	B-X
of	B-X
unconsciousness	B-X
.	B-X
The	B-X
foregoing	B-X
studies	B-X
complement	B-X
an	B-X
older	B-X
,	B-X
yet	B-X
largely	B-X
unacknowledged	B-X
,	B-X
body	B-X
of	B-X
literature	B-X
that	B-X
has	B-X
documented	B-X
awake	B-X
,	B-X
conscious	B-X
patients	B-X
with	B-X
high	B-X
amplitude	B-X
delta	B-X
oscillations	B-X
in	B-X
clinical	B-X
reports	B-X
from	B-X
Rett	B-X
syndrome	B-X
,	B-X
Lennox-Gastaut	B-X
syndrome	B-X
,	B-X
schizophrenia	B-X
,	B-X
mitochondrial	B-X
diseases	B-X
,	B-X
hepatic	B-X
encephalopathy	B-X
,	B-X
and	B-X
non-convulsive	B-X
status	B-X
epilepticus	B-X
.	B-X
Having	B-X
reviewed	B-X
this	B-X
literature	B-X
,	B-X
we	B-X
discuss	B-X
plausible	B-X
mechanisms	B-X
that	B-X
would	B-X
resolve	B-X
the	B-X
seeming	B-X
contradiction	B-X
between	B-X
high	B-X
amplitude	B-X
delta	B-X
oscillations	B-X
and	B-X
consciousness	B-X
.	B-X
We	B-X
also	B-X
consider	B-X
implications	B-X
concerning	B-X
theories	B-X
of	B-X
consciousness	B-X
,	B-X
such	B-X
as	B-X
integrated	B-X
information	B-X
theory	B-X
and	B-X
the	B-X
entropic	B-X
brain	B-X
hypothesis	B-X
.	B-X

Furthermore	O
,	O
predisposing	O
factors	O
for	O
severe	O
invasive	O
GAS	O
infection	O
[	O
9	O
]	O
,	O
such	O
as	O
diabetes	O
mellitus	O
[	O
35	O
]	O
,	O
liver	O
cirrhosis	O
[	O
36	O
]	O
,	O
and	O
congestive	O
heart	O
failure	O
[	O
37	O
]	O
are	O
known	O
to	O
impair	O
PMN	O
function	O
.	O

These	O
evidences	O
suggest	O
that	O
the	O
level	O
of	O
PMN	O
function	O
is	O
one	O
of	O
the	O
critical	O
factors	O
to	O
determine	O
the	O
threshold	O
for	O
the	O
onset	O
of	O
invasive	O
GAS	O
infection	O
,	O
which	O
may	O
be	O
the	O
reason	O
for	O
rare	O
outbreaks	O
of	O
invasive	O
GAS	O
infections	O
.	O

Thus	O
,	O
enhanced	O
expression	O
of	O
virulence	O
factors	O
that	O
could	O
evade	O
PMN	O
function	O
is	O
a	O
key	O
issue	O
at	O
first	O
step	O
to	O
cause	O
invasive	O
bacterial	O
infections	O
.	O

A	O
further	O
study	O
in	O
which	O
collates	O
clinical	O
with	O
bacterial	O
/	O
immunological	O
data	O
may	O
provide	O
with	O
novel	O
clues	O
for	O
early	O
diagnosis	O
and	O
therapeutics	O
of	O
invasive	O
bacterial	O
infections	O
.	O

Extracellular	O
DNA	O
Chelates	O
Cations	O
and	O
Induces	O
Antibiotic	O
Resistance	O
in	O
Pseudomonas	O
aeruginosa	O
Biofilms	O
<EOS>	B-X
Biofilms	B-X
are	B-X
surface-adhered	B-X
bacterial	B-X
communities	B-X
encased	B-X
in	B-X
an	B-X
extracellular	B-X
matrix	B-X
composed	B-X
of	B-X
DNA	B-X
,	B-X
bacterial	B-X
polysaccharides	B-X
and	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
up	B-X
to	B-X
1000-fold	B-X
more	B-X
antibiotic	B-X
resistant	B-X
than	B-X
planktonic	B-X
cultures	B-X
.	B-X
To	B-X
date	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
function	B-X
as	B-X
a	B-X
structural	B-X
support	B-X
to	B-X
maintain	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm	B-X
architecture	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA	B-X
is	B-X
a	B-X
multifaceted	B-X
component	B-X
of	B-X
P.	B-X
aeruginosa	B-X
biofilms	B-X
.	B-X
At	B-X
physiologically	B-X
relevant	B-X
concentrations	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
antimicrobial	B-X
activity	B-X
,	B-X
causing	B-X
cell	B-X
lysis	B-X
by	B-X
chelating	B-X
cations	B-X
that	B-X
stabilize	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
and	B-X
the	B-X
outer	B-X
membrane	B-X
(	B-X
OM	B-X
)	B-X
.	B-X
DNA-mediated	B-X
killing	B-X
occurred	B-X
within	B-X
minutes	B-X
,	B-X
as	B-X
a	B-X
result	B-X
of	B-X
perturbation	B-X
of	B-X
both	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
membrane	B-X
(	B-X
IM	B-X
)	B-X
and	B-X
the	B-X
release	B-X
of	B-X
cytoplasmic	B-X
contents	B-X
,	B-X
including	B-X
genomic	B-X
DNA	B-X
.	B-X
Sub-inhibitory	B-X
concentrations	B-X
of	B-X
DNA	B-X
created	B-X
a	B-X
cation-limited	B-X
environment	B-X
that	B-X
resulted	B-X
in	B-X
induction	B-X
of	B-X
the	B-X
PhoPQ-	B-X
and	B-X
PmrAB-regulated	B-X
cationic	B-X
antimicrobial	B-X
peptide	B-X
resistance	B-X
operon	B-X
PA3552-PA3559	B-X
in	B-X
P.	B-X
aeruginosa	B-X
.	B-X
Furthermore	B-X
,	B-X
DNA-induced	B-X
expression	B-X
of	B-X
this	B-X
operon	B-X
resulted	B-X
in	B-X
up	B-X
to	B-X
2560-fold	B-X
increased	B-X
resistance	B-X
to	B-X
cationic	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
640-fold	B-X
increased	B-X
resistance	B-X
to	B-X
aminoglycosides	B-X
,	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
beta-lactam	B-X
and	B-X
fluoroquinolone	B-X
resistance	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
extracellular	B-X
DNA	B-X
in	B-X
the	B-X
biofilm	B-X
matrix	B-X
contributes	B-X
to	B-X
cation	B-X
gradients	B-X
,	B-X
genomic	B-X
DNA	B-X
release	B-X
and	B-X
inducible	B-X
antibiotic	B-X
resistance	B-X
.	B-X
DNA-rich	B-X
environments	B-X
,	B-X
including	B-X
biofilms	B-X
and	B-X
other	B-X
infection	B-X
sites	B-X
like	B-X
the	B-X
CF	B-X
lung	B-X
,	B-X
are	B-X
likely	B-X
the	B-X
in	B-X
vivo	B-X
environments	B-X
where	B-X
extracellular	B-X
pathogens	B-X
such	B-X
as	B-X
P.	B-X
aeruginosa	B-X
encounter	B-X
cation	B-X
limitation	B-X
.	B-X

Biofilms	O
are	O
surface	O
-	O
adhered	O
bacterial	O
communities	O
encased	O
in	O
an	O
extracellular	O
matrix	O
composed	O
of	O
DNA	O
,	O
bacterial	O
polysaccharides	O
and	O
proteins	O
,	O
which	O
are	O
up	O
to	O
1000	O
-	O
fold	O
more	O
antibiotic	O
resistant	O
than	O
planktonic	O
cultures	O
.	O

To	O
date	O
,	O
extracellular	O
DNA	O
has	O
been	O
shown	O
to	O
function	O
as	O
a	O
structural	O
support	O
to	O
maintain	O
Pseudomonas	O
aeruginosa	O
biofilm	O
architecture	O
.	O
<EOS>	B-X
Biofilms	B-X
are	B-X
surface-adhered	B-X
bacterial	B-X
communities	B-X
encased	B-X
in	B-X
an	B-X
extracellular	B-X
matrix	B-X
composed	B-X
of	B-X
DNA	B-X
,	B-X
bacterial	B-X
polysaccharides	B-X
and	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
up	B-X
to	B-X
1000-fold	B-X
more	B-X
antibiotic	B-X
resistant	B-X
than	B-X
planktonic	B-X
cultures	B-X
.	B-X
To	B-X
date	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
function	B-X
as	B-X
a	B-X
structural	B-X
support	B-X
to	B-X
maintain	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm	B-X
architecture	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA	B-X
is	B-X
a	B-X
multifaceted	B-X
component	B-X
of	B-X
P.	B-X
aeruginosa	B-X
biofilms	B-X
.	B-X
At	B-X
physiologically	B-X
relevant	B-X
concentrations	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
antimicrobial	B-X
activity	B-X
,	B-X
causing	B-X
cell	B-X
lysis	B-X
by	B-X
chelating	B-X
cations	B-X
that	B-X
stabilize	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
and	B-X
the	B-X
outer	B-X
membrane	B-X
(	B-X
OM	B-X
)	B-X
.	B-X
DNA-mediated	B-X
killing	B-X
occurred	B-X
within	B-X
minutes	B-X
,	B-X
as	B-X
a	B-X
result	B-X
of	B-X
perturbation	B-X
of	B-X
both	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
membrane	B-X
(	B-X
IM	B-X
)	B-X
and	B-X
the	B-X
release	B-X
of	B-X
cytoplasmic	B-X
contents	B-X
,	B-X
including	B-X
genomic	B-X
DNA	B-X
.	B-X
Sub-inhibitory	B-X
concentrations	B-X
of	B-X
DNA	B-X
created	B-X
a	B-X
cation-limited	B-X
environment	B-X
that	B-X
resulted	B-X
in	B-X
induction	B-X
of	B-X
the	B-X
PhoPQ-	B-X
and	B-X
PmrAB-regulated	B-X
cationic	B-X
antimicrobial	B-X
peptide	B-X
resistance	B-X
operon	B-X
PA3552-PA3559	B-X
in	B-X
P.	B-X
aeruginosa	B-X
.	B-X
Furthermore	B-X
,	B-X
DNA-induced	B-X
expression	B-X
of	B-X
this	B-X
operon	B-X
resulted	B-X
in	B-X
up	B-X
to	B-X
2560-fold	B-X
increased	B-X
resistance	B-X
to	B-X
cationic	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
640-fold	B-X
increased	B-X
resistance	B-X
to	B-X
aminoglycosides	B-X
,	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
beta-lactam	B-X
and	B-X
fluoroquinolone	B-X
resistance	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
extracellular	B-X
DNA	B-X
in	B-X
the	B-X
biofilm	B-X
matrix	B-X
contributes	B-X
to	B-X
cation	B-X
gradients	B-X
,	B-X
genomic	B-X
DNA	B-X
release	B-X
and	B-X
inducible	B-X
antibiotic	B-X
resistance	B-X
.	B-X
DNA-rich	B-X
environments	B-X
,	B-X
including	B-X
biofilms	B-X
and	B-X
other	B-X
infection	B-X
sites	B-X
like	B-X
the	B-X
CF	B-X
lung	B-X
,	B-X
are	B-X
likely	B-X
the	B-X
in	B-X
vivo	B-X
environments	B-X
where	B-X
extracellular	B-X
pathogens	B-X
such	B-X
as	B-X
P.	B-X
aeruginosa	B-X
encounter	B-X
cation	B-X
limitation	B-X
.	B-X

Here	O
we	O
show	O
that	O
DNA	O
is	O
a	O
multifaceted	O
component	O
of	O
P	O
.	O
aeruginosa	O
biofilms	O
.	O
<EOS>	B-X
The	B-X
significance	B-X
of	B-X
extracellular	B-X
DNA	B-X
(	B-X
eDNA	B-X
)	B-X
in	B-X
biofilms	B-X
was	B-X
overlooked	B-X
until	B-X
researchers	B-X
added	B-X
DNAse	B-X
to	B-X
a	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm	B-X
and	B-X
watched	B-X
the	B-X
biofilm	B-X
disappear	B-X
.	B-X
Now	B-X
,	B-X
a	B-X
decade	B-X
later	B-X
,	B-X
the	B-X
widespread	B-X
importance	B-X
of	B-X
eDNA	B-X
in	B-X
biofilm	B-X
formation	B-X
is	B-X
undisputed	B-X
,	B-X
but	B-X
detailed	B-X
knowledge	B-X
about	B-X
how	B-X
it	B-X
promotes	B-X
biofilm	B-X
formation	B-X
and	B-X
conveys	B-X
antimicrobial	B-X
resistance	B-X
is	B-X
only	B-X
just	B-X
starting	B-X
to	B-X
emerge	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
discuss	B-X
how	B-X
eDNA	B-X
is	B-X
produced	B-X
,	B-X
how	B-X
it	B-X
aids	B-X
bacterial	B-X
adhesion	B-X
,	B-X
secures	B-X
the	B-X
structural	B-X
stability	B-X
of	B-X
biofilms	B-X
and	B-X
contributes	B-X
to	B-X
antimicrobial	B-X
resistance	B-X
.	B-X
The	B-X
appearance	B-X
of	B-X
eDNA	B-X
in	B-X
biofilms	B-X
is	B-X
no	B-X
accident	B-X
:	B-X
It	B-X
is	B-X
produced	B-X
by	B-X
active	B-X
secretion	B-X
or	B-X
controlled	B-X
cell	B-X
lysis	B-X
-	B-X
sometimes	B-X
linked	B-X
to	B-X
competence	B-X
development	B-X
.	B-X
eDNA	B-X
adsorbs	B-X
to	B-X
and	B-X
extends	B-X
from	B-X
the	B-X
cell	B-X
surface	B-X
,	B-X
promoting	B-X
adhesion	B-X
to	B-X
abiotic	B-X
surfaces	B-X
through	B-X
acid-base	B-X
interactions	B-X
.	B-X
In	B-X
the	B-X
biofilm	B-X
,	B-X
is	B-X
it	B-X
less	B-X
clear	B-X
how	B-X
eDNA	B-X
interacts	B-X
with	B-X
cells	B-X
and	B-X
matrix	B-X
components	B-X
.	B-X
A	B-X
few	B-X
eDNA-binding	B-X
biomolecules	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
revealing	B-X
new	B-X
concepts	B-X
in	B-X
biofilm	B-X
formation	B-X
.	B-X
Being	B-X
anionic	B-X
,	B-X
eDNA	B-X
chelates	B-X
cations	B-X
and	B-X
restricts	B-X
diffusion	B-X
of	B-X
cationic	B-X
antimicrobials	B-X
.	B-X
The	B-X
multifaceted	B-X
role	B-X
of	B-X
eDNA	B-X
makes	B-X
it	B-X
an	B-X
attractive	B-X
target	B-X
to	B-X
sensitize	B-X
biofilms	B-X
to	B-X
conventional	B-X
antimicrobial	B-X
treatment	B-X
or	B-X
development	B-X
of	B-X
new	B-X
strategies	B-X
to	B-X
combat	B-X
biofilms	B-X
.	B-X

At	O
physiologically	O
relevant	O
concentrations	O
,	O
extracellular	O
DNA	O
has	O
antimicrobial	O
activity	O
,	O
causing	O
cell	O
lysis	O
by	O
chelating	O
cations	O
that	O
stabilize	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
the	O
outer	O
membrane	O
(	O
OM	O
)	O
.	O
<EOS>	B-X
Biofilms	B-X
are	B-X
surface-adhered	B-X
bacterial	B-X
communities	B-X
encased	B-X
in	B-X
an	B-X
extracellular	B-X
matrix	B-X
composed	B-X
of	B-X
DNA	B-X
,	B-X
bacterial	B-X
polysaccharides	B-X
and	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
up	B-X
to	B-X
1000-fold	B-X
more	B-X
antibiotic	B-X
resistant	B-X
than	B-X
planktonic	B-X
cultures	B-X
.	B-X
To	B-X
date	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
function	B-X
as	B-X
a	B-X
structural	B-X
support	B-X
to	B-X
maintain	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm	B-X
architecture	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA	B-X
is	B-X
a	B-X
multifaceted	B-X
component	B-X
of	B-X
P.	B-X
aeruginosa	B-X
biofilms	B-X
.	B-X
At	B-X
physiologically	B-X
relevant	B-X
concentrations	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
antimicrobial	B-X
activity	B-X
,	B-X
causing	B-X
cell	B-X
lysis	B-X
by	B-X
chelating	B-X
cations	B-X
that	B-X
stabilize	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
and	B-X
the	B-X
outer	B-X
membrane	B-X
(	B-X
OM	B-X
)	B-X
.	B-X
DNA-mediated	B-X
killing	B-X
occurred	B-X
within	B-X
minutes	B-X
,	B-X
as	B-X
a	B-X
result	B-X
of	B-X
perturbation	B-X
of	B-X
both	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
membrane	B-X
(	B-X
IM	B-X
)	B-X
and	B-X
the	B-X
release	B-X
of	B-X
cytoplasmic	B-X
contents	B-X
,	B-X
including	B-X
genomic	B-X
DNA	B-X
.	B-X
Sub-inhibitory	B-X
concentrations	B-X
of	B-X
DNA	B-X
created	B-X
a	B-X
cation-limited	B-X
environment	B-X
that	B-X
resulted	B-X
in	B-X
induction	B-X
of	B-X
the	B-X
PhoPQ-	B-X
and	B-X
PmrAB-regulated	B-X
cationic	B-X
antimicrobial	B-X
peptide	B-X
resistance	B-X
operon	B-X
PA3552-PA3559	B-X
in	B-X
P.	B-X
aeruginosa	B-X
.	B-X
Furthermore	B-X
,	B-X
DNA-induced	B-X
expression	B-X
of	B-X
this	B-X
operon	B-X
resulted	B-X
in	B-X
up	B-X
to	B-X
2560-fold	B-X
increased	B-X
resistance	B-X
to	B-X
cationic	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
640-fold	B-X
increased	B-X
resistance	B-X
to	B-X
aminoglycosides	B-X
,	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
beta-lactam	B-X
and	B-X
fluoroquinolone	B-X
resistance	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
extracellular	B-X
DNA	B-X
in	B-X
the	B-X
biofilm	B-X
matrix	B-X
contributes	B-X
to	B-X
cation	B-X
gradients	B-X
,	B-X
genomic	B-X
DNA	B-X
release	B-X
and	B-X
inducible	B-X
antibiotic	B-X
resistance	B-X
.	B-X
DNA-rich	B-X
environments	B-X
,	B-X
including	B-X
biofilms	B-X
and	B-X
other	B-X
infection	B-X
sites	B-X
like	B-X
the	B-X
CF	B-X
lung	B-X
,	B-X
are	B-X
likely	B-X
the	B-X
in	B-X
vivo	B-X
environments	B-X
where	B-X
extracellular	B-X
pathogens	B-X
such	B-X
as	B-X
P.	B-X
aeruginosa	B-X
encounter	B-X
cation	B-X
limitation	B-X
.	B-X

DNA	O
-	O
mediated	O
killing	O
occurred	O
within	O
minutes	O
,	O
as	O
a	O
result	O
of	O
perturbation	O
of	O
both	O
the	O
outer	O
and	O
inner	O
membrane	O
(	O
IM	O
)	O
and	O
the	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
genomic	O
DNA	O
.	O
<EOS>	B-X
Biofilms	B-X
are	B-X
surface-adhered	B-X
bacterial	B-X
communities	B-X
encased	B-X
in	B-X
an	B-X
extracellular	B-X
matrix	B-X
composed	B-X
of	B-X
DNA	B-X
,	B-X
bacterial	B-X
polysaccharides	B-X
and	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
up	B-X
to	B-X
1000-fold	B-X
more	B-X
antibiotic	B-X
resistant	B-X
than	B-X
planktonic	B-X
cultures	B-X
.	B-X
To	B-X
date	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
function	B-X
as	B-X
a	B-X
structural	B-X
support	B-X
to	B-X
maintain	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm	B-X
architecture	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA	B-X
is	B-X
a	B-X
multifaceted	B-X
component	B-X
of	B-X
P.	B-X
aeruginosa	B-X
biofilms	B-X
.	B-X
At	B-X
physiologically	B-X
relevant	B-X
concentrations	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
antimicrobial	B-X
activity	B-X
,	B-X
causing	B-X
cell	B-X
lysis	B-X
by	B-X
chelating	B-X
cations	B-X
that	B-X
stabilize	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
and	B-X
the	B-X
outer	B-X
membrane	B-X
(	B-X
OM	B-X
)	B-X
.	B-X
DNA-mediated	B-X
killing	B-X
occurred	B-X
within	B-X
minutes	B-X
,	B-X
as	B-X
a	B-X
result	B-X
of	B-X
perturbation	B-X
of	B-X
both	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
membrane	B-X
(	B-X
IM	B-X
)	B-X
and	B-X
the	B-X
release	B-X
of	B-X
cytoplasmic	B-X
contents	B-X
,	B-X
including	B-X
genomic	B-X
DNA	B-X
.	B-X
Sub-inhibitory	B-X
concentrations	B-X
of	B-X
DNA	B-X
created	B-X
a	B-X
cation-limited	B-X
environment	B-X
that	B-X
resulted	B-X
in	B-X
induction	B-X
of	B-X
the	B-X
PhoPQ-	B-X
and	B-X
PmrAB-regulated	B-X
cationic	B-X
antimicrobial	B-X
peptide	B-X
resistance	B-X
operon	B-X
PA3552-PA3559	B-X
in	B-X
P.	B-X
aeruginosa	B-X
.	B-X
Furthermore	B-X
,	B-X
DNA-induced	B-X
expression	B-X
of	B-X
this	B-X
operon	B-X
resulted	B-X
in	B-X
up	B-X
to	B-X
2560-fold	B-X
increased	B-X
resistance	B-X
to	B-X
cationic	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
640-fold	B-X
increased	B-X
resistance	B-X
to	B-X
aminoglycosides	B-X
,	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
beta-lactam	B-X
and	B-X
fluoroquinolone	B-X
resistance	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
extracellular	B-X
DNA	B-X
in	B-X
the	B-X
biofilm	B-X
matrix	B-X
contributes	B-X
to	B-X
cation	B-X
gradients	B-X
,	B-X
genomic	B-X
DNA	B-X
release	B-X
and	B-X
inducible	B-X
antibiotic	B-X
resistance	B-X
.	B-X
DNA-rich	B-X
environments	B-X
,	B-X
including	B-X
biofilms	B-X
and	B-X
other	B-X
infection	B-X
sites	B-X
like	B-X
the	B-X
CF	B-X
lung	B-X
,	B-X
are	B-X
likely	B-X
the	B-X
in	B-X
vivo	B-X
environments	B-X
where	B-X
extracellular	B-X
pathogens	B-X
such	B-X
as	B-X
P.	B-X
aeruginosa	B-X
encounter	B-X
cation	B-X
limitation	B-X
.	B-X

Sub	O
-	O
inhibitory	O
concentrations	O
of	O
DNA	O
created	O
a	O
cation	O
-	O
limited	O
environment	O
that	O
resulted	O
in	O
induction	O
of	O
the	O
PhoPQ	B-Protein
-	O
and	O
PmrAB	B-Protein
-	O
regulated	O
cationic	O
antimicrobial	O
peptide	O
resistance	O
operon	O
PA3552	B-Protein
-	O
PA3559	B-Protein
in	O
P	O
.	O
aeruginosa	O
.	O

Furthermore	O
,	O
DNA	O
-	O
induced	O
expression	O
of	O
this	O
operon	O
resulted	O
in	O
up	O
to	O
2560	O
-	O
fold	O
increased	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
and	O
640	O
-	O
fold	O
increased	O
resistance	O
to	O
aminoglycosides	O
,	O
but	O
had	O
no	O
effect	O
on	O
beta	O
-	O
lactam	O
and	O
fluoroquinolone	O
resistance	O
.	O
<EOS>	B-X
Biofilms	B-X
are	B-X
surface-adhered	B-X
bacterial	B-X
communities	B-X
encased	B-X
in	B-X
an	B-X
extracellular	B-X
matrix	B-X
composed	B-X
of	B-X
DNA	B-X
,	B-X
bacterial	B-X
polysaccharides	B-X
and	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
up	B-X
to	B-X
1000-fold	B-X
more	B-X
antibiotic	B-X
resistant	B-X
than	B-X
planktonic	B-X
cultures	B-X
.	B-X
To	B-X
date	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
function	B-X
as	B-X
a	B-X
structural	B-X
support	B-X
to	B-X
maintain	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm	B-X
architecture	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA	B-X
is	B-X
a	B-X
multifaceted	B-X
component	B-X
of	B-X
P.	B-X
aeruginosa	B-X
biofilms	B-X
.	B-X
At	B-X
physiologically	B-X
relevant	B-X
concentrations	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
antimicrobial	B-X
activity	B-X
,	B-X
causing	B-X
cell	B-X
lysis	B-X
by	B-X
chelating	B-X
cations	B-X
that	B-X
stabilize	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
and	B-X
the	B-X
outer	B-X
membrane	B-X
(	B-X
OM	B-X
)	B-X
.	B-X
DNA-mediated	B-X
killing	B-X
occurred	B-X
within	B-X
minutes	B-X
,	B-X
as	B-X
a	B-X
result	B-X
of	B-X
perturbation	B-X
of	B-X
both	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
membrane	B-X
(	B-X
IM	B-X
)	B-X
and	B-X
the	B-X
release	B-X
of	B-X
cytoplasmic	B-X
contents	B-X
,	B-X
including	B-X
genomic	B-X
DNA	B-X
.	B-X
Sub-inhibitory	B-X
concentrations	B-X
of	B-X
DNA	B-X
created	B-X
a	B-X
cation-limited	B-X
environment	B-X
that	B-X
resulted	B-X
in	B-X
induction	B-X
of	B-X
the	B-X
PhoPQ-	B-X
and	B-X
PmrAB-regulated	B-X
cationic	B-X
antimicrobial	B-X
peptide	B-X
resistance	B-X
operon	B-X
PA3552-PA3559	B-X
in	B-X
P.	B-X
aeruginosa	B-X
.	B-X
Furthermore	B-X
,	B-X
DNA-induced	B-X
expression	B-X
of	B-X
this	B-X
operon	B-X
resulted	B-X
in	B-X
up	B-X
to	B-X
2560-fold	B-X
increased	B-X
resistance	B-X
to	B-X
cationic	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
640-fold	B-X
increased	B-X
resistance	B-X
to	B-X
aminoglycosides	B-X
,	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
beta-lactam	B-X
and	B-X
fluoroquinolone	B-X
resistance	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
extracellular	B-X
DNA	B-X
in	B-X
the	B-X
biofilm	B-X
matrix	B-X
contributes	B-X
to	B-X
cation	B-X
gradients	B-X
,	B-X
genomic	B-X
DNA	B-X
release	B-X
and	B-X
inducible	B-X
antibiotic	B-X
resistance	B-X
.	B-X
DNA-rich	B-X
environments	B-X
,	B-X
including	B-X
biofilms	B-X
and	B-X
other	B-X
infection	B-X
sites	B-X
like	B-X
the	B-X
CF	B-X
lung	B-X
,	B-X
are	B-X
likely	B-X
the	B-X
in	B-X
vivo	B-X
environments	B-X
where	B-X
extracellular	B-X
pathogens	B-X
such	B-X
as	B-X
P.	B-X
aeruginosa	B-X
encounter	B-X
cation	B-X
limitation	B-X
.	B-X

Thus	O
,	O
the	O
presence	O
of	O
extracellular	O
DNA	O
in	O
the	O
biofilm	O
matrix	O
contributes	O
to	O
cation	O
gradients	O
,	O
genomic	O
DNA	O
release	O
and	O
inducible	O
antibiotic	O
resistance	O
.	O
<EOS>	B-X
Biofilms	B-X
are	B-X
surface-adhered	B-X
bacterial	B-X
communities	B-X
encased	B-X
in	B-X
an	B-X
extracellular	B-X
matrix	B-X
composed	B-X
of	B-X
DNA	B-X
,	B-X
bacterial	B-X
polysaccharides	B-X
and	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
up	B-X
to	B-X
1000-fold	B-X
more	B-X
antibiotic	B-X
resistant	B-X
than	B-X
planktonic	B-X
cultures	B-X
.	B-X
To	B-X
date	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
function	B-X
as	B-X
a	B-X
structural	B-X
support	B-X
to	B-X
maintain	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm	B-X
architecture	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA	B-X
is	B-X
a	B-X
multifaceted	B-X
component	B-X
of	B-X
P.	B-X
aeruginosa	B-X
biofilms	B-X
.	B-X
At	B-X
physiologically	B-X
relevant	B-X
concentrations	B-X
,	B-X
extracellular	B-X
DNA	B-X
has	B-X
antimicrobial	B-X
activity	B-X
,	B-X
causing	B-X
cell	B-X
lysis	B-X
by	B-X
chelating	B-X
cations	B-X
that	B-X
stabilize	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
and	B-X
the	B-X
outer	B-X
membrane	B-X
(	B-X
OM	B-X
)	B-X
.	B-X
DNA-mediated	B-X
killing	B-X
occurred	B-X
within	B-X
minutes	B-X
,	B-X
as	B-X
a	B-X
result	B-X
of	B-X
perturbation	B-X
of	B-X
both	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
membrane	B-X
(	B-X
IM	B-X
)	B-X
and	B-X
the	B-X
release	B-X
of	B-X
cytoplasmic	B-X
contents	B-X
,	B-X
including	B-X
genomic	B-X
DNA	B-X
.	B-X
Sub-inhibitory	B-X
concentrations	B-X
of	B-X
DNA	B-X
created	B-X
a	B-X
cation-limited	B-X
environment	B-X
that	B-X
resulted	B-X
in	B-X
induction	B-X
of	B-X
the	B-X
PhoPQ-	B-X
and	B-X
PmrAB-regulated	B-X
cationic	B-X
antimicrobial	B-X
peptide	B-X
resistance	B-X
operon	B-X
PA3552-PA3559	B-X
in	B-X
P.	B-X
aeruginosa	B-X
.	B-X
Furthermore	B-X
,	B-X
DNA-induced	B-X
expression	B-X
of	B-X
this	B-X
operon	B-X
resulted	B-X
in	B-X
up	B-X
to	B-X
2560-fold	B-X
increased	B-X
resistance	B-X
to	B-X
cationic	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
640-fold	B-X
increased	B-X
resistance	B-X
to	B-X
aminoglycosides	B-X
,	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
beta-lactam	B-X
and	B-X
fluoroquinolone	B-X
resistance	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
extracellular	B-X
DNA	B-X
in	B-X
the	B-X
biofilm	B-X
matrix	B-X
contributes	B-X
to	B-X
cation	B-X
gradients	B-X
,	B-X
genomic	B-X
DNA	B-X
release	B-X
and	B-X
inducible	B-X
antibiotic	B-X
resistance	B-X
.	B-X
DNA-rich	B-X
environments	B-X
,	B-X
including	B-X
biofilms	B-X
and	B-X
other	B-X
infection	B-X
sites	B-X
like	B-X
the	B-X
CF	B-X
lung	B-X
,	B-X
are	B-X
likely	B-X
the	B-X
in	B-X
vivo	B-X
environments	B-X
where	B-X
extracellular	B-X
pathogens	B-X
such	B-X
as	B-X
P.	B-X
aeruginosa	B-X
encounter	B-X
cation	B-X
limitation	B-X
.	B-X

DNA	O
-	O
rich	O
environments	O
,	O
including	O
biofilms	O
and	O
other	O
infection	O
sites	O
like	O
the	O
CF	O
lung	O
,	O
are	O
likely	O
the	O
in	O
vivo	O
environments	O
where	O
extracellular	O
pathogens	O
such	O
as	O
P	O
.	O
aeruginosa	O
encounter	O
cation	O
limitation	O
.	O

Introduction	O

Pseudomonas	O
aeruginosa	O
is	O
an	O
opportunistic	O
pathogen	O
capable	O
of	O
causing	O
both	O
acute	O
and	O
chronic	O
infections	O
.	O
<EOS>	B-X
Small	B-X
Is	B-X
Mighty-Chemical	B-X
Communication	B-X
Systems	B-X
in	B-X
The	B-X
opportunistic	B-X
pathogen	B-X
Pseudomonas	B-X
aeruginosa	B-X
is	B-X
ubiquitous	B-X
in	B-X
the	B-X
environment	B-X
,	B-X
and	B-X
in	B-X
humans	B-X
,	B-X
it	B-X
is	B-X
capable	B-X
of	B-X
causing	B-X
acute	B-X
or	B-X
chronic	B-X
infections	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
impact	B-X
of	B-X
long-term	B-X
exposure	B-X
of	B-X
P.	B-X
aeruginosa	B-X
to	B-X
predation	B-X
pressure	B-X
.	B-X
P.	B-X
aeruginosa	B-X
persisted	B-X
when	B-X
coincubated	B-X
with	B-X
the	B-X
bacterivorous	B-X
Acanthamoeba	B-X
castellanii	B-X
for	B-X
extended	B-X
periods	B-X
and	B-X
produced	B-X
genetic	B-X
and	B-X
phenotypic	B-X
variants	B-X
.	B-X
Sequencing	B-X
of	B-X
late-stage	B-X
amoeba-adapted	B-X
P.	B-X
aeruginosa	B-X
isolates	B-X
demonstrated	B-X
single	B-X
nucleotide	B-X
polymorphisms	B-X
within	B-X
genes	B-X
that	B-X
encode	B-X
known	B-X
virulence	B-X
factors	B-X
,	B-X
and	B-X
this	B-X
correlated	B-X
with	B-X
a	B-X
reduction	B-X
in	B-X
expression	B-X
of	B-X
virulence	B-X
traits	B-X
.	B-X
Virulence	B-X
for	B-X
the	B-X
nematode	B-X
Caenorhabditis	B-X
elegans	B-X
was	B-X
attenuated	B-X
in	B-X
late-stage	B-X
amoeba-adapted	B-X
P.	B-X
aeruginosa	B-X
compared	B-X
to	B-X
early-stage	B-X
amoeba-adapted	B-X
and	B-X
nonadapted	B-X
counterparts	B-X
.	B-X
Further	B-X
,	B-X
late-stage	B-X
amoeba-adapted	B-X
P.	B-X
aeruginosa	B-X
showed	B-X
increased	B-X
competitive	B-X
fitness	B-X
and	B-X
enhanced	B-X
survival	B-X
in	B-X
amoebae	B-X
as	B-X
well	B-X
as	B-X
in	B-X
macrophage	B-X
and	B-X
neutrophils	B-X
.	B-X
Interestingly	B-X
,	B-X
our	B-X
findings	B-X
indicate	B-X
that	B-X
the	B-X
selection	B-X
imposed	B-X
by	B-X
amoebae	B-X
resulted	B-X
in	B-X
P.	B-X
aeruginosa	B-X
isolates	B-X
with	B-X
reduced	B-X
virulence	B-X
and	B-X
enhanced	B-X
fitness	B-X
,	B-X
similar	B-X
to	B-X
those	B-X
recovered	B-X
from	B-X
chronic	B-X
cystic	B-X
fibrosis	B-X
infections	B-X
.	B-X

It	O
is	O
the	O
third	O
-	O
leading	O
cause	O
of	O
nosocomial	O
infections	O
and	O
is	O
the	O
predominant	O
pathogen	O
associated	O
with	O
morbidity	O
and	O
mortality	O
of	O
CF	O
patients	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

The	O
biofilm	O
-	O
forming	O
ability	O
of	O
P	O
.	O
aeruginosa	O
,	O
and	O
indeed	O
other	O
bacteria	O
,	O
is	O
thought	O
to	O
contribute	O
to	O
their	O
ability	O
to	O
thrive	O
in	O
hostile	O
host	O
environments	O
and	O
result	O
in	O
chronic	O
infection	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

Biofilms	O
are	O
multicellular	O
surface	O
-	O
associated	O
microbial	O
communities	O
encased	O
in	O
an	O
extracellular	O
matrix	O
which	O
display	O
a	O
characteristic	O
structure	O
and	O
increased	O
resistance	O
to	O
antimicrobial	O
compounds	O
and	O
environmental	O
stresses	O
.	O

P	O
.	O
aeruginosa	O
biofilms	O
are	O
up	O
to	O
1000	O
-	O
fold	O
more	O
antibiotic	O
tolerant	O
than	O
planktonic	O
cells	O
,	O
to	O
single	O
and	O
combination	O
antibiotics	O
[	O
5	O
]	O
-	O
[	O
7	O
]	O
.	O

As	O
acute	O
CF	O
exacerbations	O
caused	O
by	O
P	O
.	O
aeruginosa	O
are	O
often	O
treated	O
with	O
combination	O
antibiotic	O
therapy	O
[	O
8	O
]	O
-	O
[	O
10	O
]	O
,	O
the	O
increased	O
resistance	O
of	O
biofilms	O
to	O
combination	O
antibiotics	O
is	O
of	O
direct	O
clinical	O
relevance	O
.	O

Eighty	O
five	O
percent	O
of	O
P	O
.	O
aeruginosa	O
strains	O
isolated	O
from	O
the	O
lungs	O
of	O
CF	O
patients	O
with	O
advanced	O
stages	O
of	O
disease	O
have	O
a	O
distinctive	O
mucoid	O
colony	O
morphology	O
[	O
11	O
]	O
.	O

This	O
mucoid	O
phenotype	O
is	O
a	O
result	O
of	O
overproduction	O
of	O
the	O
alginate	O
exopolysaccharide	O
(	O
EPS	O
)	O
[	O
1	O
]	O
,	O
[	O
12	O
]	O
.	O

Alginate	O
production	O
has	O
been	O
shown	O
to	O
inhibit	O
phagocytic	O
killing	O
of	O
Pseudomonas	O
,	O
to	O
protect	O
from	O
antibiotic	O
exposure	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
and	O
is	O
associated	O
with	O
poor	O
prognosis	O
for	O
the	O
infected	O
patients	O
[	O
15	O
]	O
,	O
[	O
16	O
]	O
.	O

The	O
direct	O
observation	O
of	O
P	O
.	O
aeruginosa	O
microcolonies	O
encased	O
in	O
an	O
alginate	O
matrix	O
in	O
microscopy	O
studies	O
of	O
CF	O
bronchial	O
samples	O
[	O
17	O
]	O
,	O
along	O
with	O
a	O
large	O
body	O
of	O
additional	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
[	O
7	O
]	O
,	O
[	O
18	O
]	O
-	O
[	O
21	O
]	O
suggests	O
that	O
P	O
.	O
aeruginosa	O
forms	O
biofilms	O
in	O
the	O
lungs	O
of	O
CF	O
patients	O
.	O

The	O
mechanisms	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
are	O
distinct	O
from	O
the	O
well	O
studied	O
intrinsic	O
resistance	O
mechanisms	O
such	O
as	O
drug	O
efflux	O
,	O
drug	O
inactivation	O
,	O
membrane	O
permeability	O
and	O
target	O
site	O
alterations	O
.	O

Although	O
the	O
basis	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
is	O
not	O
fully	O
understood	O
,	O
it	O
is	O
likely	O
that	O
multiple	O
mechanisms	O
operate	O
simultaneously	O
in	O
biofilms	O
to	O
contribute	O
to	O
antibiotic	O
resistance	O
.	O
<EOS>	B-X
Furthermore	B-X
LGG	B-X
is	B-X
able	B-X
to	B-X
produces	B-X
both	B-X
a	B-X
biofilm	B-X
that	B-X
can	B-X
mechanically	B-X
protect	B-X
the	B-X
mucosa	B-X
,	B-X
and	B-X
different	B-X
soluble	B-X
factors	B-X
beneficial	B-X
to	B-X
the	B-X
gut	B-X
by	B-X
enhancing	B-X
intestinal	B-X
crypt	B-X
survival	B-X
,	B-X
diminishing	B-X
apoptosis	B-X
of	B-X
the	B-X
intestinal	B-X
epithelium	B-X
,	B-X
and	B-X
preserving	B-X
cytoskeletal	B-X
integrity	B-X
.	B-X
A	B-X
large	B-X
number	B-X
of	B-X
research	B-X
data	B-X
on	B-X
Lactobacillus	B-X
GG	B-X
is	B-X
the	B-X
basis	B-X
for	B-X
the	B-X
use	B-X
of	B-X
this	B-X
probiotic	B-X
for	B-X
human	B-X
health	B-X
.	B-X
The	B-X
effectiveness	B-X
of	B-X
LGG	B-X
in	B-X
gastrointestinal	B-X
infections	B-X
and	B-X
diarrhea	B-X
,	B-X
antibiotic	B-X
and	B-X
Clostridium	B-X
difficile	B-X
associated	B-X
diarrhea	B-X
,	B-X
irritable	B-X
bowel	B-X
syndrome	B-X
,	B-X
inflammatory	B-X
bowel	B-X
disease	B-X
,	B-X
respiratory	B-X
tract	B-X
infections	B-X
,	B-X
allergy	B-X
,	B-X
cardiovascular	B-X
diseases	B-X
,	B-X
nonalcoholic	B-X
fatty	B-X
liver	B-X
disease	B-X
,	B-X
nonalcoholic	B-X
steatohepatitis	B-X
,	B-X
cystic	B-X
fibrosis	B-X
,	B-X
cancer	B-X
,	B-X
elderly	B-X
end	B-X
sport	B-X
were	B-X
analyzed	B-X
.	B-X
The	B-X
current	B-X
review	B-X
focuses	B-X
on	B-X
the	B-X
recent	B-X
perspectives	B-X
on	B-X
biofilms	B-X
formation	B-X
by	B-X
these	B-X
bacteria	B-X
.	B-X
Pel	B-X
,	B-X
psl	B-X
and	B-X
alg	B-X
operons	B-X
present	B-X
in	B-X
P.	B-X
aeruginosa	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
biosynthesis	B-X
of	B-X
extracellular	B-X
polysaccharide	B-X
which	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
cell	B-X
surface	B-X
interactions	B-X
during	B-X
biofilm	B-X
formation	B-X
.	B-X
Recent	B-X
studies	B-X
suggested	B-X
that	B-X
cAMP	B-X
signalling	B-X
pathway	B-X
,	B-X
quorum-sensing	B-X
pathway	B-X
,	B-X
Gac/Rsm	B-X
pathway	B-X
and	B-X
c-di-GMP	B-X
signalling	B-X
pathway	B-X
are	B-X
the	B-X
main	B-X
mechanism	B-X
that	B-X
leads	B-X
to	B-X
the	B-X
biofilm	B-X
formation	B-X
.	B-X
Understanding	B-X
the	B-X
bacterial	B-X
virulence	B-X
depends	B-X
on	B-X
a	B-X
number	B-X
of	B-X
cell-associated	B-X
and	B-X
extracellular	B-X
factors	B-X
and	B-X
is	B-X
very	B-X
essential	B-X
for	B-X
the	B-X
development	B-X
of	B-X
potential	B-X
drug	B-X
targets	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
review	B-X
focuses	B-X
on	B-X
the	B-X
major	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
biofilm	B-X
formation	B-X
,	B-X
the	B-X
state	B-X
of	B-X
art	B-X
update	B-X
on	B-X
the	B-X
biofilm	B-X
treatment	B-X
and	B-X
the	B-X
dispersal	B-X
approaches	B-X
such	B-X
as	B-X
targeting	B-X
adhesion	B-X
and	B-X
maturation	B-X
,	B-X
targeting	B-X
virulence	B-X
factors	B-X
and	B-X
other	B-X
strategies	B-X
such	B-X
as	B-X
small	B-X
molecule-based	B-X
inhibitors	B-X
,	B-X
phytochemicals	B-X
,	B-X
bacteriophage	B-X
therapy	B-X
,	B-X
photodynamic	B-X
therapy	B-X
,	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
natural	B-X
therapies	B-X
and	B-X
vaccines	B-X
to	B-X
curtail	B-X
the	B-X
biofilm	B-X
formation	B-X
by	B-X
P.	B-X
aeruginosa	B-X
.	B-X

Cells	O
in	O
a	O
biofilm	O
may	O
be	O
protected	O
from	O
antibiotic	O
exposure	O
due	O
to	O
the	O
restricted	O
penetration	O
of	O
antibiotics	O
through	O
the	O
biofilm	O
matrix	O
[	O
19	O
]	O
.	O

However	O
,	O
while	O
the	O
biofilm	O
matrix	O
may	O
limit	O
diffusion	O
initially	O
for	O
certain	O
antibiotics	O
such	O
as	O
beta	O
-	O
lactams	O
and	O
aminoglycosides	O
[	O
14	O
]	O
,	O
[	O
22	O
]	O
,	O
the	O
penetration	O
of	O
fluoroquinolones	O
occurs	O
immediately	O
and	O
without	O
delay	O
[	O
23	O
]	O
-	O
[	O
25	O
]	O
.	O

The	O
rate	O
of	O
diffusion	O
through	O
the	O
matrix	O
is	O
presumably	O
dependent	O
on	O
binding	O
of	O
the	O
antibiotic	O
molecules	O
to	O
the	O
EPS	O
matrix	O
.	O

Once	O
the	O
matrix	O
becomes	O
saturated	O
,	O
diffusion	O
and	O
antimicrobial	O
activity	O
of	O
the	O
drug	O
will	O
resume	O
[	O
26	O
]	O
.	O

It	O
is	O
the	O
general	O
consensus	O
that	O
reduced	O
diffusion	O
through	O
the	O
biofilm	O
matrix	O
only	O
provides	O
a	O
short	O
-	O
term	O
protective	O
effect	O
and	O
does	O
not	O
play	O
a	O
significant	O
role	O
during	O
long	O
-	O
term	O
antibiotic	O
exposure	O
[	O
26	O
]	O
.	O

Other	O
resistance	O
mechanisms	O
include	O
the	O
presence	O
of	O
subpopulations	O
of	O
multidrug	O
tolerant	O
persister	O
cells	O
[	O
27	O
]	O
-	O
[	O
29	O
]	O
,	O
drug	O
indifference	O
of	O
slow	O
-	O
growing	O
,	O
nutrient	O
-	O
limited	O
cells	O
[	O
30	O
]	O
,	O
and	O
unique	O
resistance	O
mechanisms	O
specifically	O
associated	O
with	O
biofilms	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
.	O

Despite	O
the	O
fact	O
that	O
biofilms	O
are	O
recognized	O
as	O
the	O
predominant	O
mode	O
of	O
bacterial	O
growth	O
in	O
nature	O
and	O
are	O
responsible	O
for	O
the	O
majority	O
of	O
refractory	O
bacterial	O
infections	O
[	O
19	O
]	O
,	O
little	O
is	O
known	O
regarding	O
the	O
mechanisms	O
of	O
biofilm	O
-	O
specific	O
antibiotic	O
resistance	O
.	O

Furthering	O
our	O
understanding	O
of	O
the	O
mechanisms	O
underlying	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
will	O
significantly	O
improve	O
the	O
treatment	O
options	O
available	O
to	O
patients	O
with	O
chronic	O
bacterial	O
infections	O
.	O

Signal	O
transduction	O
systems	O
have	O
been	O
documented	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
biofilm	O
formation	O
in	O
multiple	O
bacterial	O
species	O
including	O
P	O
.	O
aeruginosa	O
,	O
S	O
.	O
aureus	O
,	O
E	O
.	O
coli	O
and	O
V	O
.	O
fischeri	O
[	O
33	O
]	O
-	O
[	O
38	O
]	O
.	O

These	O
two	O
component	O
systems	O
(	O
TCS	O
)	O
are	O
comprised	O
of	O
an	O
membrane	O
-	O
anchored	O
histidine	O
kinase	O
sensor	O
and	O
a	O
cytoplasmic	O
response	O
regulator	O
.	O

After	O
detecting	O
specific	O
environmental	O
signals	O
,	O
a	O
signal	O
transduction	O
cascade	O
is	O
initiated	O
that	O
results	O
in	O
phosphorylation	O
of	O
the	O
response	O
regulator	O
,	O
which	O
activates	O
or	O
represses	O
the	O
necessary	O
target	O
genes	O
.	O
<EOS>	B-X
Dysregulation	B-X
of	B-X
the	B-X
epitranscriptome	B-X
causes	B-X
abnormal	B-X
expression	B-X
of	B-X
oncogenes	B-X
in	B-X
the	B-X
tumorigenic	B-X
process	B-X
.	B-X
Deregulated	B-X
PDGFR	B-X
activity	B-X
contributes	B-X
to	B-X
various	B-X
pathological	B-X
conditions	B-X
,	B-X
and	B-X
hence	B-X
the	B-X
PDGF/PDGFR	B-X
family	B-X
members	B-X
are	B-X
viable	B-X
therapeutic	B-X
targets	B-X
.	B-X
An	B-X
increased	B-X
appreciation	B-X
of	B-X
which	B-X
PDGFR	B-X
contributes	B-X
to	B-X
pathology	B-X
,	B-X
biomarkers	B-X
that	B-X
indicate	B-X
the	B-X
amplitude	B-X
and	B-X
mode	B-X
of	B-X
activation	B-X
,	B-X
and	B-X
receptor-specific	B-X
antagonists	B-X
are	B-X
necessary	B-X
for	B-X
the	B-X
development	B-X
of	B-X
next-generation	B-X
therapies	B-X
that	B-X
target	B-X
the	B-X
PDGF/PDGFR	B-X
family	B-X
.	B-X
Cancer	B-X
immunotherapies	B-X
targeting	B-X
the	B-X
interaction	B-X
between	B-X
Programmed	B-X
death	B-X
1	B-X
(	B-X
PD-1	B-X
)	B-X
and	B-X
Programmed	B-X
death	B-X
ligand	B-X
1	B-X
(	B-X
PD-L1	B-X
)	B-X
have	B-X
recently	B-X
been	B-X
approved	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
multiple	B-X
cancer	B-X
types	B-X
,	B-X
including	B-X
gastric	B-X
cancer	B-X
.	B-X
A	B-X
partial	B-X
predictive	B-X
biomarker	B-X
for	B-X
positive	B-X
response	B-X
to	B-X
PD-1/PD-L1	B-X
therapy	B-X
is	B-X
PD-L1	B-X
expression	B-X
,	B-X
which	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
under	B-X
strict	B-X
post-transcriptional	B-X
control	B-X
in	B-X
cancer	B-X
.	B-X
By	B-X
fractionating	B-X
the	B-X
PD-L1	B-X
3	B-X
'	B-X
untranslated	B-X
region	B-X
(	B-X
3'UTR	B-X
)	B-X
into	B-X
multiple	B-X
overlapping	B-X
fragments	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
small	B-X
100-nucleotide-long	B-X
cis-acting	B-X
region	B-X
as	B-X
being	B-X
necessary	B-X
and	B-X
sufficient	B-X
for	B-X
post-transcriptional	B-X
repression	B-X
of	B-X
PD-L1	B-X
expression	B-X
in	B-X
gastric	B-X
cancer	B-X
.	B-X

A	O
number	O
of	O
regulatory	O
systems	O
that	O
influence	O
biofilm	O
formation	O
have	O
been	O
described	O
.	O

These	O
include	O
,	O
but	O
are	O
not	O
limited	O
to	O
,	O
the	O
global	O
virulence	O
factor	O
regulator	O
GacA	B-Protein
,	O
mutation	O
of	O
which	O
results	O
in	O
a	O
10	O
-	O
fold	O
decrease	O
in	O
biofilm	O
formation	O
and	O
failure	O
to	O
form	O
microcolony	O
structures	O
[	O
33	O
]	O
.	O
<EOS>	B-X
The	B-X
rich	B-X
,	B-X
multidisciplinary	B-X
history	B-X
of	B-X
cancer	B-X
prevention	B-X
recounted	B-X
here	B-X
begins	B-X
with	B-X
surgical	B-X
and	B-X
workplace	B-X
recommendations	B-X
of	B-X
the	B-X
1700s	B-X
and	B-X
ends	B-X
with	B-X
2009	B-X
results	B-X
of	B-X
the	B-X
enormous	B-X
(	B-X
35,535	B-X
men	B-X
)	B-X
Selenium	B-X
and	B-X
Vitamin	B-X
E	B-X
[	B-X
prostate	B-X
]	B-X
Cancer	B-X
Prevention	B-X
Trial	B-X
(	B-X
SELECT	B-X
)	B-X
.	B-X
Preclinical	B-X
milestones	B-X
of	B-X
cancer	B-X
prevention	B-X
include	B-X
the	B-X
1913	B-X
and	B-X
1916	B-X
mouse	B-X
studies	B-X
by	B-X
Lathrop	B-X
and	B-X
Loeb	B-X
of	B-X
cancer	B-X
development	B-X
associated	B-X
with	B-X
pregnancy	B-X
or	B-X
cancer	B-X
prevention	B-X
through	B-X
castration	B-X
(	B-X
oophorectomy	B-X
)	B-X
,	B-X
preventing	B-X
chemically	B-X
induced	B-X
mouse	B-X
carcinogenesis	B-X
as	B-X
early	B-X
as	B-X
1929	B-X
,	B-X
energy	B-X
restriction	B-X
studies	B-X
in	B-X
the	B-X
1940s	B-X
,	B-X
the	B-X
1950s	B-X
discoveries	B-X
and	B-X
later	B-X
molecular	B-X
characterizations	B-X
of	B-X
field	B-X
cancerization	B-X
and	B-X
multistep	B-X
carcinogenesis	B-X
,	B-X
and	B-X
the	B-X
effects	B-X
of	B-X
angiogenesis	B-X
inhibition	B-X
in	B-X
genetically	B-X
engineered	B-X
mice	B-X
reported	B-X
in	B-X
2009	B-X
.	B-X
The	B-X
extraordinary	B-X
panoply	B-X
of	B-X
clinical	B-X
research	B-X
includes	B-X
numerous	B-X
large	B-X
and	B-X
smaller	B-X
chemoprevention	B-X
studies	B-X
of	B-X
nutritional	B-X
supplements	B-X
,	B-X
other	B-X
dietary	B-X
approaches	B-X
,	B-X
a	B-X
Bacillus	B-X
Calmette-Guérin	B-X
trial	B-X
in	B-X
1976	B-X
,	B-X
molecular-targeted	B-X
agents	B-X
,	B-X
and	B-X
agents	B-X
to	B-X
prevent	B-X
infection-related	B-X
cancers	B-X
such	B-X
as	B-X
hepatitis	B-X
B	B-X
virus	B-X
vaccine	B-X
to	B-X
prevent	B-X
liver	B-X
cancer	B-X
in	B-X
1984	B-X
.	B-X
Clinical	B-X
surgical	B-X
prevention	B-X
includes	B-X
removal	B-X
of	B-X
intraepithelial	B-X
neoplasia	B-X
detected	B-X
by	B-X
screening	B-X
(	B-X
including	B-X
Pap	B-X
testing	B-X
developed	B-X
in	B-X
1929	B-X
and	B-X
culposcopy	B-X
for	B-X
cervical	B-X
premalignancy	B-X
and	B-X
colonoscopy	B-X
and	B-X
polypectomy	B-X
to	B-X
prevent	B-X
colorectal	B-X
cancer	B-X
begun	B-X
in	B-X
the	B-X
1960s	B-X
)	B-X
and	B-X
prophylactic	B-X
surgeries	B-X
,	B-X
such	B-X
as	B-X
in	B-X
Lynch	B-X
syndrome	B-X
patients	B-X
begun	B-X
in	B-X
1977	B-X
.	B-X
Behavioral	B-X
studies	B-X
include	B-X
smoking	B-X
cessation	B-X
and	B-X
control	B-X
beginning	B-X
in	B-X
the	B-X
1950s	B-X
,	B-X
obesity	B-X
control	B-X
rooted	B-X
in	B-X
studies	B-X
of	B-X
1841	B-X
,	B-X
and	B-X
genetic-counseling	B-X
and	B-X
cancer-survivorship	B-X
studies	B-X
.	B-X

Additionally	O
,	O
the	O
hybrid	O
sensor	O
kinases	O
,	O
LadS	B-Protein
and	O
RetS	B-Protein
appear	O
to	O
work	O
upstream	O
of	O
GacA	B-Protein
to	O
possibly	O
control	O
the	O
switch	O
to	O
a	O
biofilm	O
lifestyle	O
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

Mutations	O
in	O
algR	B-Protein
,	O
a	O
response	O
regulator	O
protein	O
required	O
for	O
synthesis	O
of	O
alginate	O
,	O
which	O
is	O
a	O
major	O
component	O
of	O
the	O
matrix	O
of	O
biofilms	O
in	O
the	O
cystic	O
fibrosis	O
lung	O
[	O
1	O
]	O
results	O
in	O
a	O
P	O
.	O
aeruginosa	O
strain	O
that	O
has	O
decreased	O
type	O
IV	O
pili	O
-	O
dependent	O
motility	O
and	O
biofilm	O
formation	O
[	O
39	O
]	O
.	O

The	O
three	O
-	O
component	O
system	O
SadARS	B-Protein
which	O
regulates	O
the	O
formation	O
of	O
mature	O
microcolonies	O
[	O
40	O
]	O
and	O
PvrR	B-Protein
,	O
a	O
response	O
regulator	O
involved	O
in	O
the	O
switch	O
from	O
planktonic	O
to	O
antibiotic	O
-	O
resistant	O
biofilm	O
cells	O
in	O
P	O
.	O
aeruginosa	O
are	O
additional	O
examples	O
of	O
regulators	O
of	O
biofilm	O
formation	O
[	O
41	O
]	O
.	O

During	O
the	O
course	O
of	O
an	O
infection	O
,	O
one	O
of	O
the	O
first	O
lines	O
of	O
defense	O
encountered	O
by	O
colonizing	O
bacteria	O
is	O
the	O
production	O
of	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAPs	O
)	O
by	O
a	O
variety	O
of	O
host	O
cells	O
including	O
neutrophils	O
,	O
platelets	O
and	O
epithelia	O
.	O

CAPs	O
are	O
short	O
,	O
amphipathic	O
peptides	O
that	O
bind	O
to	O
and	O
disrupt	O
both	O
the	O
outer	O
and	O
cytoplasmic	O
membranes	O
resulting	O
in	O
cell	O
death	O
.	O

The	O
broad	O
-	O
spectrum	O
antimicrobial	O
activity	O
of	O
CAPs	O
against	O
Gram	O
-	O
negative	O
and	O
Gram	O
-	O
positive	O
bacteria	O
accounts	O
for	O
their	O
role	O
as	O
an	O
essential	O
component	O
of	O
the	O
innate	O
immune	O
response	O
of	O
humans	O
,	O
animals	O
and	O
insects	O
.	O

Cationic	O
peptides	O
,	O
which	O
have	O
antimicrobial	O
and	O
immunomodulatory	O
activities	O
,	O
are	O
being	O
developed	O
as	O
a	O
promising	O
new	O
class	O
of	O
therapeutically	O
relevant	O
drugs	O
[	O
42	O
]	O
.	O

In	O
P	O
.	O
aeruginosa	O
,	O
resistance	O
to	O
CAPs	O
is	O
inducible	O
by	O
the	O
PhoPQ	B-Protein
and	O
PmrAB	B-Protein
TCSs	O
,	O
both	O
of	O
which	O
are	O
activated	O
independently	O
in	O
response	O
to	O
limiting	O
Mg2	O
+	O
[	O
43	O
]	O
-	O
[	O
46	O
]	O
.	O

Under	O
conditions	O
of	O
limiting	O
magnesium	O
,	O
PhoP	B-Protein
and	O
PmrA	B-Protein
bind	O
to	O
the	O
promoter	O
of	O
the	O
CAP	O
resistance	O
operon	O
PA3552	B-Protein
-	O
PA3559	B-Protein
(	O
arnBCADTEF	B-Protein
-	O
ugd	B-Protein
)	O
and	O
induce	O
its	O
expression	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
.	O

These	O
genes	O
encode	O
an	O
LPS	O
modification	O
pathway	O
required	O
for	O
the	O
addition	O
of	O
aminoarabinose	O
to	O
lipid	O
A	O
,	O
which	O
reduces	O
the	O
OM	O
permeability	O
to	O
CAPs	O
[	O
48	O
]	O
.	O

The	O
PhoPQ	B-Protein
and	O
PmrAB	B-Protein
regulatory	O
systems	O
are	O
well	O
studied	O
in	O
planktonic	O
cultures	O
and	O
have	O
been	O
shown	O
to	O
induce	O
modest	O
resistance	O
to	O
CAPs	O
(	O
8	O
-	O
fold	O
)	O
under	O
low	O
Mg2	O
+	O
conditions	O
[	O
45	O
]	O
.	O

However	O
,	O
while	O
the	O
PA3552	B-Protein
-	O
PA3559	B-Protein
operon	O
has	O
been	O
reported	O
to	O
be	O
expressed	O
in	O
biofilms	O
cultivated	O
in	O
flowcells	O
,	O
and	O
is	O
required	O
for	O
survival	O
in	O
response	O
to	O
colistin	O
treatment	O
[	O
49	O
]	O
,	O
little	O
else	O
is	O
known	O
regarding	O
these	O
systems	O
and	O
the	O
role	O
they	O
may	O
play	O
in	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
.	O

The	O
extracellular	O
matrix	O
of	O
P	O
.	O
aeruginosa	O
biofilms	O
includes	O
extracellular	O
DNA	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
multiple	O
bacterial	O
exopolysaccharides	O
and	O
host	O
proteins	O
[	O
4	O
]	O
,	O
[	O
52	O
]	O
.	O

Extracellular	O
DNA	O
,	O
which	O
is	O
a	O
matrix	O
component	O
of	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacterial	O
biofilms	O
[	O
51	O
]	O
,	O
[	O
53	O
]	O
,	O
functions	O
to	O
maintain	O
the	O
3D	O
biofilm	O
architecture	O
by	O
acting	O
as	O
a	O
cell	O
-	O
cell	O
interconnecting	O
compound	O
[	O
50	O
]	O
.	O

Genomic	O
DNA	O
has	O
been	O
shown	O
to	O
localize	O
to	O
the	O
biofilm	O
surface	O
,	O
surrounding	O
the	O
mushroom	O
-	O
shaped	O
microcolonies	O
[	O
51	O
]	O
.	O

DNA	O
in	O
the	O
biofilm	O
matrix	O
is	O
likely	O
released	O
by	O
dead	O
bacteria	O
or	O
immune	O
cells	O
.	O
<EOS>	B-X
Cancer	B-X
vaccines	B-X
aim	B-X
to	B-X
direct	B-X
the	B-X
immune	B-X
system	B-X
to	B-X
eradicate	B-X
cancer	B-X
cells	B-X
.	B-X
Immunotherapy	B-X
using	B-X
dendritic	B-X
cell	B-X
(	B-X
DC	B-X
)	B-X
-based	B-X
vaccination	B-X
is	B-X
an	B-X
approved	B-X
approach	B-X
for	B-X
harnessing	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
patient	B-X
's	B-X
own	B-X
immune	B-X
system	B-X
to	B-X
eliminate	B-X
tumor	B-X
cells	B-X
in	B-X
metastatic	B-X
hormone-refractory	B-X
cancer	B-X
.	B-X
Following	B-X
the	B-X
infection	B-X
with	B-X
the	B-X
viral	B-X
antigen	B-X
,	B-X
adaptive	B-X
immune	B-X
responses	B-X
are	B-X
activated	B-X
mainly	B-X
by	B-X
viral	B-X
particle	B-X
encounters	B-X
with	B-X
the	B-X
antigen-presenting	B-X
cells	B-X
or	B-X
B	B-X
cell	B-X
receptors	B-X
,	B-X
which	B-X
induce	B-X
further	B-X
biological	B-X
interactions	B-X
to	B-X
defend	B-X
the	B-X
host	B-X
against	B-X
the	B-X
virus	B-X
.	B-X
T	B-X
cells	B-X
also	B-X
play	B-X
an	B-X
irreplaceable	B-X
part	B-X
in	B-X
a	B-X
humoral	B-X
immune	B-X
reaction	B-X
as	B-X
the	B-X
backbone	B-X
of	B-X
a	B-X
cellular	B-X
immune	B-X
response	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
interpret	B-X
the	B-X
recent	B-X
SARS-CoV-2	B-X
available	B-X
research	B-X
,	B-X
which	B-X
encompasses	B-X
the	B-X
significance	B-X
and	B-X
the	B-X
current	B-X
understanding	B-X
of	B-X
adaptive	B-X
immune	B-X
activity	B-X
,	B-X
and	B-X
compare	B-X
it	B-X
among	B-X
naive	B-X
,	B-X
exposed	B-X
,	B-X
and	B-X
vaccinated	B-X
blood	B-X
donors	B-X
.	B-X

It	O
has	O
been	O
reported	O
that	O
prophage	O
-	O
mediated	O
cell	O
death	O
is	O
an	O
important	O
mechanism	O
in	O
the	O
differentiation	O
and	O
dispersal	O
of	O
biofilms	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

Additional	O
sources	O
of	O
DNA	O
in	O
biofilms	O
may	O
include	O
the	O
quorum	O
sensing	O
regulated	O
release	O
of	O
DNA	O
[	O
51	O
]	O
and	O
/	O
or	O
DNA	O
contained	O
within	O
outer	O
membrane	O
vesicles	O
(	O
OMV	O
)	O
that	O
bleb	O
and	O
are	O
released	O
from	O
the	O
OM	O
of	O
living	O
P	O
.	O
aeruginosa	O
cells	O
[	O
56	O
]	O
,	O
[	O
57	O
]	O
.	O

Furthermore	O
,	O
while	O
a	O
specific	O
mechanism	O
of	O
DNA	O
release	O
has	O
not	O
been	O
reported	O
for	O
P	O
.	O
aeruginosa	O
it	O
is	O
possible	O
that	O
such	O
a	O
method	O
may	O
exist	O
,	O
similar	O
to	O
the	O
autolysin	O
-	O
mediated	O
DNA	O
release	O
observed	O
in	O
Staphylococcus	O
epidermidis	O
biofilms	O
[	O
53	O
]	O
.	O
<EOS>	B-X
XBP1	B-X
modulates	B-X
the	B-X
macrophage	B-X
proinflammatory	B-X
response	B-X
,	B-X
but	B-X
its	B-X
function	B-X
in	B-X
macrophage	B-X
stimulator	B-X
of	B-X
interferon	B-X
genes	B-X
(	B-X
STING	B-X
)	B-X
activation	B-X
and	B-X
liver	B-X
fibrosis	B-X
is	B-X
unknown	B-X
.	B-X
X-box	B-X
binding	B-X
protein	B-X
1	B-X
(	B-X
XBP1	B-X
)	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
promote	B-X
macrophage	B-X
nucleotide-binding	B-X
oligomerization	B-X
domain	B-X
,	B-X
leucine-rich	B-X
repeat	B-X
and	B-X
pyrin	B-X
domain-containing	B-X
3	B-X
(	B-X
NLRP3	B-X
)	B-X
activation	B-X
in	B-X
steatohepatitis	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
aimed	B-X
to	B-X
explore	B-X
the	B-X
underlying	B-X
mechanism	B-X
of	B-X
XBP1	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
STING	B-X
signalling	B-X
and	B-X
the	B-X
subsequent	B-X
NLRP3	B-X
activation	B-X
during	B-X
liver	B-X
fibrosis	B-X
.	B-X
Cytosolic	B-X
double-stranded	B-X
DNA	B-X
(	B-X
dsDNA	B-X
)	B-X
is	B-X
a	B-X
danger	B-X
signal	B-X
that	B-X
is	B-X
tightly	B-X
monitored	B-X
and	B-X
sensed	B-X
by	B-X
nucleic	B-X
acid-sensing	B-X
pattern	B-X
recognition	B-X
receptors	B-X
.	B-X
We	B-X
study	B-X
the	B-X
inflammatory	B-X
cascade	B-X
on	B-X
dsDNA	B-X
recognition	B-X
and	B-X
investigate	B-X
the	B-X
neuroprotective	B-X
effect	B-X
of	B-X
cyclic	B-X
GMP-AMP	B-X
(	B-X
cGAMP	B-X
)	B-X
synthase	B-X
(	B-X
cGAS	B-X
)	B-X
antagonist	B-X
A151	B-X
and	B-X
its	B-X
mechanisms	B-X
of	B-X
neuroprotection	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
of	B-X
experimental	B-X
stroke	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
found	B-X
that	B-X
cerebral	B-X
ischemia	B-X
promoted	B-X
the	B-X
release	B-X
of	B-X
dsDNA	B-X
into	B-X
the	B-X
cytosol	B-X
,	B-X
where	B-X
it	B-X
initiated	B-X
inflammatory	B-X
responses	B-X
by	B-X
activating	B-X
the	B-X
cGAS	B-X
.	B-X
Furthermore	B-X
,	B-X
mice	B-X
treated	B-X
with	B-X
A151	B-X
showed	B-X
a	B-X
dampened	B-X
immune	B-X
response	B-X
to	B-X
stroke	B-X
,	B-X
with	B-X
reduced	B-X
counts	B-X
of	B-X
neutrophils	B-X
,	B-X
microglia	B-X
,	B-X
and	B-X
microglial	B-X
production	B-X
of	B-X
IL-6	B-X
and	B-X
TNF-α	B-X
after	B-X
MCAO	B-X
.	B-X
Notably	B-X
,	B-X
the	B-X
protective	B-X
effect	B-X
of	B-X
A151	B-X
was	B-X
blocked	B-X
in	B-X
a	B-X
microglia-specific	B-X
cGAS	B-X
knockout	B-X
mouse	B-X
.	B-X

In	O
this	O
study	O
we	O
sought	O
to	O
examine	O
if	O
the	O
presence	O
of	O
DNA	O
in	O
biofilms	O
may	O
contribute	O
to	O
biofilm	O
-	O
specific	O
antibiotic	O
resistance	O
.	O

Here	O
we	O
identify	O
a	O
novel	O
cation	O
chelating	O
property	O
of	O
DNA	O
,	O
which	O
has	O
several	O
important	O
consequences	O
for	O
biofilm	O
physiology	O
and	O
antibiotic	O
resistance	O
in	O
biofilms	O
.	O

Results	O

Extracellular	O
DNA	O
has	O
antimicrobial	O
activity	O
To	O
study	O
the	O
role	O
of	O
the	O
matrix	O
component	O
DNA	O
on	O
biofilm	O
formation	O
and	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
,	O
we	O
first	O
examined	O
the	O
influence	O
of	O
extracellular	O
DNA	O
on	O
P	O
.	O
aeruginosa	O
growth	O
in	O
rich	O
and	O
defined	O
media	O
,	O
LB	O
and	O
BM2	O
,	O
respectively	O
.	O

Addition	O
of	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
(	O
5	O
mg	O
/	O
ml	O
)	O
or	O
greater	O
extracellular	O
DNA	O
to	O
LB	O
or	O
1	O
%	O
(	O
w	O
/	O
v	O
)	O
or	O
greater	O
DNA	O
to	O
BM2	O
media	O
inhibited	O
growth	O
of	O
P	O
.	O
aeruginosa	O
(	O
Fig	O
1A	O
and	O
1B	O
)	O
.	O

The	O
kinetics	O
of	O
killing	O
by	O
extracellular	O
DNA	O
was	O
determined	O
by	O
measuring	O
the	O
loss	O
of	O
luminescence	O
from	O
a	O
chromosomally	O
-	O
tagged	O
luminescent	O
P	O
.	O
aeruginosa	O
strain	O
,	O
PAO1	O
:	O
:	O
p16Slux	O
.	O

DNA	O
-	O
mediated	O
killing	O
was	O
fast	O
,	O
within	O
minutes	O
,	O
as	O
measured	O
by	O
the	O
rapid	O
loss	O
of	O
luminescence	O
upon	O
exposure	O
to	O
1	O
.	O
25	O
%	O
(	O
w	O
/	O
v	O
)	O
DNA	O
,	O
or	O
greater	O
(	O
Fig	O
1C	O
)	O
.	O
<EOS>	B-X
Historical	B-X
loss	B-X
in	B-X
American	B-X
Indians	B-X
(	B-X
AIs	B-X
)	B-X
is	B-X
believed	B-X
to	B-X
contribute	B-X
to	B-X
high	B-X
incidence	B-X
of	B-X
mental	B-X
health	B-X
disorders	B-X
,	B-X
yet	B-X
less	B-X
is	B-X
known	B-X
about	B-X
the	B-X
associations	B-X
between	B-X
historical	B-X
loss	B-X
and	B-X
physical	B-X
health	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
group	B-X
of	B-X
8	B-X
(	B-X
among	B-X
39	B-X
)	B-X
human	B-X
tumour	B-X
cell	B-X
strains	B-X
deficient	B-X
in	B-X
the	B-X
ability	B-X
to	B-X
support	B-X
the	B-X
growth	B-X
of	B-X
adenovirus	B-X
5	B-X
preparations	B-X
treated	B-X
with	B-X
N-methyl-N'-nitro-N-nitrosoguanidine	B-X
(	B-X
MNNG	B-X
)	B-X
,	B-X
but	B-X
able	B-X
to	B-X
support	B-X
the	B-X
growth	B-X
of	B-X
non-treated	B-X
adenovirus	B-X
normally	B-X
.	B-X
This	B-X
deficient	B-X
behaviour	B-X
defines	B-X
the	B-X
Mer-	B-X
phenotype	B-X
.	B-X
Strains	B-X
having	B-X
the	B-X
Mer-	B-X
phenotype	B-X
were	B-X
found	B-X
to	B-X
arise	B-X
from	B-X
tumours	B-X
originating	B-X
in	B-X
four	B-X
different	B-X
organs	B-X
.	B-X
Relative	B-X
to	B-X
Mer+	B-X
strains	B-X
,	B-X
Mer-	B-X
tumour	B-X
strains	B-X
showed	B-X
greater	B-X
sensitivity	B-X
to	B-X
MNNG-produced	B-X
killing	B-X
,	B-X
greater	B-X
MNNG-stimulated	B-X
``	B-X
DNA	B-X
repair	B-X
synthesis	B-X
and	B-X
a	B-X
more	B-X
rapid	B-X
MNNG-produced	B-X
decrease	B-X
in	B-X
semi-conservative	B-X
DNA	B-X
synthesis	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
(	B-X
1	B-X
)	B-X
Mer-	B-X
strains	B-X
are	B-X
deficient	B-X
in	B-X
removing	B-X
O6-methylguanine	B-X
(	B-X
O6-MeG	B-X
)	B-X
from	B-X
their	B-X
DNA	B-X
after	B-X
[	B-X
Me-14C	B-X
]	B-X
MMNG	B-X
treatment	B-X
(	B-X
Table	B-X
1	B-X
)	B-X
;	B-X
(	B-X
2	B-X
)	B-X
Mer-	B-X
tumour	B-X
strains	B-X
originate	B-X
from	B-X
tumours	B-X
arising	B-X
in	B-X
patients	B-X
having	B-X
Mer+	B-X
normal	B-X
fibroblasts	B-X
(	B-X
Fig	B-X
.	B-X
1a	B-X
,	B-X
b	B-X
)	B-X
;	B-X
(	B-X
3	B-X
)	B-X
SV40	B-X
transformation	B-X
of	B-X
(	B-X
Mer+	B-X
)	B-X
human	B-X
fibroblasts	B-X
often	B-X
converts	B-X
them	B-X
to	B-X
Mer-	B-X
strains	B-X
(	B-X
Fig	B-X
.	B-X
1c	B-X
,	B-X
d	B-X
)	B-X
;	B-X
(	B-X
4	B-X
)	B-X
MNNG	B-X
produces	B-X
more	B-X
sister	B-X
chromatid	B-X
exchanges	B-X
(	B-X
SCEs	B-X
)	B-X
in	B-X
Mer-	B-X
than	B-X
in	B-X
Mer+	B-X
cell	B-X
strains	B-X
(	B-X
Fig	B-X
.	B-X

Killing	O
was	O
dose	O
-	O
dependent	O
,	O
with	O
faster	O
killing	O
observed	O
as	O
the	O
DNA	O
concentration	O
increased	O
(	O
Fig	O
1C	O
)	O
.	O

The	O
rapid	O
decrease	O
in	O
luminescence	O
corresponded	O
with	O
a	O
loss	O
of	O
bacterial	O
viability	O
,	O
as	O
determined	O
by	O
plating	O
(	O
Fig	O
1D	O
)	O
.	O

One	O
percent	O
(	O
w	O
/	O
v	O
)	O
extracellular	O
DNA	O
in	O
LB	O
also	O
inhibited	O
the	O
growth	O
of	O
Escherichia	O
coli	O
,	O
Staphylococcus	O
aureus	O
and	O
Burkholderia	O
cenocepacia	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
the	O
antimicrobial	O
activity	O
of	O
DNA	O
is	O
not	O
unique	O
to	O
P	O
.	O
aeruginosa	O
.	O

Extracellular	O
DNA	O
induces	O
cell	O
death	O
by	O
membrane	O
perturbation	O
and	O
cell	O
lysis	O

DNA	O
is	O
a	O
highly	O
anionic	O
polymer	O
due	O
to	O
the	O
phosphates	O
in	O
the	O
deoxyribose	O
backbone	O
.	O

This	O
property	O
,	O
in	O
combination	O
with	O
the	O
fast	O
-	O
killing	O
observed	O
in	O
response	O
to	O
extracellular	O
DNA	O
led	O
us	O
to	O
hypothesize	O
that	O
addition	O
of	O
exogenous	O
DNA	O
resulted	O
in	O
the	O
loss	O
of	O
membrane	O
integrity	O
through	O
cation	O
chelation	O
,	O
in	O
a	O
manner	O
similar	O
to	O
that	O
observed	O
with	O
the	O
known	O
cation	O
chelator	O
EDTA	O
[	O
58	O
]	O
.	O

The	O
OM	O
of	O
P	O
.	O
aeruginosa	O
contains	O
a	O
20	O
:	O
1	O
ratio	O
of	O
Mg2	O
+	O
:	O
Ca2	O
+	O
cations	O
[	O
59	O
]	O
,	O
which	O
bind	O
to	O
and	O
stabilize	O
LPS	O
in	O
the	O
outer	O
leaflet	O
of	O
the	O
OM	O
[	O
58	O
]	O
.	O

EDTA	O
treatment	O
of	O
cells	O
resulted	O
in	O
chelation	O
and	O
removal	O
of	O
divalent	O
cations	O
from	O
the	O
OM	O
,	O
leading	O
to	O
disruption	O
of	O
the	O
OM	O
[	O
58	O
]	O
.	O

To	O
determine	O
the	O
effect	O
of	O
DNA	O
on	O
membrane	O
integrity	O
,	O
microscopic	O
analysis	O
in	O
response	O
to	O
lethal	O
concentrations	O
of	O
DNA	O
and	O
relevant	O
controls	O
was	O
performed	O
.	O

Lipoproteins	O
are	O
lipid	O
-	O
modified	O
proteins	O
anchored	O
in	O
the	O
outer	O
leaflet	O
of	O
the	O
IM	O
or	O
the	O
inner	O
leaflet	O
of	O
the	O
OM	O
.	O
<EOS>	B-X
The	B-X
outer	B-X
membrane	B-X
(	B-X
OM	B-X
)	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
is	B-X
an	B-X
asymmetric	B-X
lipid	B-X
bilayer	B-X
that	B-X
consists	B-X
of	B-X
inner	B-X
leaflet	B-X
phospholipids	B-X
and	B-X
outer	B-X
leaflet	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
asymmetric	B-X
character	B-X
and	B-X
unique	B-X
biochemistry	B-X
of	B-X
LPS	B-X
molecules	B-X
contribute	B-X
to	B-X
the	B-X
OM	B-X
's	B-X
ability	B-X
to	B-X
function	B-X
as	B-X
a	B-X
molecular	B-X
permeability	B-X
barrier	B-X
that	B-X
protects	B-X
the	B-X
bacterium	B-X
against	B-X
hazards	B-X
in	B-X
the	B-X
environment	B-X
.	B-X
Assembly	B-X
and	B-X
regulation	B-X
of	B-X
the	B-X
OM	B-X
have	B-X
been	B-X
extensively	B-X
studied	B-X
for	B-X
understanding	B-X
mechanisms	B-X
of	B-X
antibiotic	B-X
resistance	B-X
and	B-X
bacterial	B-X
defense	B-X
against	B-X
host	B-X
immunity	B-X
;	B-X
however	B-X
,	B-X
there	B-X
is	B-X
little	B-X
knowledge	B-X
on	B-X
how	B-X
Gram-negative	B-X
bacteria	B-X
release	B-X
their	B-X
OMs	B-X
into	B-X
their	B-X
environment	B-X
to	B-X
manipulate	B-X
their	B-X
hosts	B-X
.	B-X
Discoveries	B-X
in	B-X
bacterial	B-X
lipid	B-X
trafficking	B-X
,	B-X
OM	B-X
lipid	B-X
homeostasis	B-X
,	B-X
and	B-X
host	B-X
recognition	B-X
of	B-X
microbial	B-X
patterns	B-X
have	B-X
shed	B-X
new	B-X
light	B-X
on	B-X
how	B-X
microbes	B-X
secrete	B-X
OM	B-X
vesicles	B-X
(	B-X
OMVs	B-X
)	B-X
to	B-X
influence	B-X
inflammation	B-X
,	B-X
cell	B-X
death	B-X
,	B-X
and	B-X
disease	B-X
pathogenesis	B-X
.	B-X
Pathogens	B-X
release	B-X
OMVs	B-X
that	B-X
contain	B-X
phospholipids	B-X
,	B-X
like	B-X
cardiolipins	B-X
,	B-X
and	B-X
components	B-X
of	B-X
LPS	B-X
molecules	B-X
,	B-X
like	B-X
lipid	B-X
A	B-X
endotoxins	B-X
.	B-X
These	B-X
multiacylated	B-X
lipid	B-X
amphiphiles	B-X
are	B-X
molecular	B-X
patterns	B-X
that	B-X
are	B-X
differentially	B-X
detected	B-X
by	B-X
host	B-X
receptors	B-X
like	B-X
the	B-X
Toll-like	B-X
receptor	B-X
4/myeloid	B-X
differentiation	B-X
factor	B-X
2	B-X
complex	B-X
(	B-X
TLR4/MD-2	B-X
)	B-X
,	B-X
mouse	B-X
caspase-11	B-X
,	B-X
and	B-X
human	B-X
caspases	B-X
4	B-X
and	B-X
5	B-X
.	B-X
We	B-X
discuss	B-X
how	B-X
lipid	B-X
ligands	B-X
on	B-X
OMVs	B-X
engage	B-X
these	B-X
pattern	B-X
recognition	B-X
receptors	B-X
on	B-X
the	B-X
membranes	B-X
and	B-X
in	B-X
the	B-X
cytosol	B-X
of	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
then	B-X
detail	B-X
how	B-X
bacteria	B-X
regulate	B-X
OM	B-X
lipid	B-X
asymmetry	B-X
,	B-X
negative	B-X
membrane	B-X
curvature	B-X
,	B-X
and	B-X
the	B-X
phospholipid-to-LPS	B-X
ratio	B-X
to	B-X
control	B-X
OMV	B-X
formation	B-X
.	B-X
The	B-X
goal	B-X
is	B-X
to	B-X
highlight	B-X
intersections	B-X
between	B-X
OM	B-X
lipid	B-X
regulation	B-X
and	B-X
host	B-X
immunity	B-X
and	B-X
to	B-X
provide	B-X
working	B-X
models	B-X
for	B-X
how	B-X
bacterial	B-X
lipids	B-X
influence	B-X
vesicle	B-X
formation	B-X
.	B-X

P	O
.	O
aeruginosa	O
cells	O
producing	O
mCherry	O
fluorescent	O
membrane	O
-	O
anchored	O
lipoproteins	O
(	O
lipoChFP	O
)	O
that	O
are	O
localized	O
to	O
either	O
the	O
OM	O
or	O
IM	O
[	O
60	O
]	O
,	O
[	O
61	O
]	O
were	O
used	O
as	O
markers	O
of	O
OM	O
and	O
IM	O
integrity	O
.	O

LipoChFP	O
-	O
labelled	O
P	O
.	O
aeruginosa	O
cells	O
showed	O
dramatic	O
membrane	O
perturbations	O
when	O
exposed	O
to	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
DNA	O
,	O
but	O
showed	O
uniform	O
membrane	O
staining	O
patterns	O
in	O
untreated	O
cells	O
(	O
Fig	O
2A	O
)	O
.	O

The	O
OM	O
perturbations	O
in	O
DNA	O
-	O
exposed	O
cells	O
included	O
regions	O
of	O
patchy	O
fluorescence	O
and	O
the	O
release	O
of	O
OMVs	O
,	O
while	O
the	O
IM	O
perturbations	O
were	O
visualized	O
simply	O
as	O
patchy	O
and	O
irregular	O
regions	O
of	O
membrane	O
fluorescence	O
(	O
Fig	O
2A	O
)	O
.	O

EDTA	O
,	O
the	O
known	O
cation	O
chelator	O
caused	O
comparable	O
IM	O
and	O
OM	O
perturbations	O
as	O
those	O
observed	O
in	O
cells	O
exposed	O
to	O
extracellular	O
DNA	O
.	O

Propidium	O
iodide	O
(	O
PI	O
)	O
stains	O
extracellular	O
DNA	O
and	O
DNA	O
in	O
dead	O
cells	O
.	O
<EOS>	B-X
Combining	B-X
membrane	B-X
impermeable	B-X
DNA-binding	B-X
stain	B-X
propidium	B-X
iodide	B-X
(	B-X
PI	B-X
)	B-X
with	B-X
membrane-permeable	B-X
DNA-binding	B-X
counterstains	B-X
is	B-X
a	B-X
widely	B-X
used	B-X
approach	B-X
for	B-X
bacterial	B-X
viability	B-X
staining	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
show	B-X
that	B-X
PI	B-X
staining	B-X
of	B-X
adherent	B-X
cells	B-X
in	B-X
biofilms	B-X
may	B-X
significantly	B-X
underestimate	B-X
bacterial	B-X
viability	B-X
due	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
extracellular	B-X
nucleic	B-X
acids	B-X
(	B-X
eNA	B-X
)	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
gram-positive	B-X
Staphylococcus	B-X
epidermidis	B-X
and	B-X
gram-negative	B-X
Escherichia	B-X
coli	B-X
24-hour	B-X
initial	B-X
biofilms	B-X
on	B-X
glass	B-X
consist	B-X
of	B-X
76	B-X
and	B-X
96	B-X
%	B-X
PI-positive	B-X
red	B-X
cells	B-X
in	B-X
situ	B-X
,	B-X
respectively	B-X
,	B-X
even	B-X
though	B-X
68	B-X
%	B-X
the	B-X
cells	B-X
of	B-X
either	B-X
species	B-X
in	B-X
these	B-X
aggregates	B-X
are	B-X
metabolically	B-X
active	B-X
.	B-X
Confocal	B-X
laser	B-X
scanning	B-X
microscopy	B-X
(	B-X
CLSM	B-X
)	B-X
revealed	B-X
that	B-X
this	B-X
false	B-X
dead	B-X
layer	B-X
of	B-X
red	B-X
cells	B-X
is	B-X
due	B-X
to	B-X
a	B-X
subpopulation	B-X
of	B-X
double-stained	B-X
cells	B-X
that	B-X
have	B-X
green	B-X
interiors	B-X
under	B-X
red	B-X
coating	B-X
layer	B-X
which	B-X
hints	B-X
at	B-X
eNA	B-X
being	B-X
stained	B-X
outside	B-X
intact	B-X
membranes	B-X
.	B-X
Therefore	B-X
,	B-X
viability	B-X
staining	B-X
results	B-X
of	B-X
adherent	B-X
cells	B-X
should	B-X
always	B-X
be	B-X
validated	B-X
by	B-X
an	B-X
alternative	B-X
method	B-X
for	B-X
estimating	B-X
viability	B-X
,	B-X
preferably	B-X
by	B-X
cultivation	B-X
.	B-X

PI	O
staining	O
was	O
observed	O
in	O
cells	O
exposed	O
to	O
DNA	O
and	O
EDTA	O
,	O
confirming	O
that	O
this	O
treatment	O
was	O
lethal	O
(	O
Fig	O
2B	O
)	O
.	O

PI	O
staining	O
also	O
revealed	O
the	O
presence	O
of	O
long	O
strands	O
of	O
genomic	O
DNA	O
,	O
presumably	O
as	O
a	O
consequence	O
of	O
the	O
loss	O
of	O
membrane	O
integrity	O
,	O
cell	O
lysis	O
and	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
DNA	O
(	O
Fig	O
2B	O
)	O
.	O

The	O
DNA	O
released	O
by	O
lysed	O
cells	O
formed	O
a	O
mesh	O
-	O
like	O
coating	O
surrounding	O
and	O
connecting	O
individual	O
bacterial	O
cells	O
(	O
Fig	O
2B	O
)	O
.	O

Degradation	O
of	O
these	O
strands	O
by	O
DNAse	O
treatment	O
of	O
lysed	O
cells	O
confirmed	O
that	O
these	O
fibres	O
were	O
composed	O
of	O
DNA	O
(	O
Fig	O
S1	O
)	O
.	O

Pseudomonas	O
specific	O
semi	O
-	O
quantitative	O
PCR	O
(	O
qPCR	O
)	O
was	O
also	O
performed	O
to	O
confirm	O
that	O
the	O
DNA	O
released	O
following	O
DNA	O
or	O
EDTA	O
treated	O
cells	O
was	O
in	O
fact	O
genomic	O
DNA	O
from	O
P	O
.	O
aeruginosa	O
(	O
Fig	O
2C	O
)	O
.	O

Buffer	O
treated	O
control	O
cells	O
showed	O
intense	O
green	O
staining	O
with	O
syto9	O
(	O
indicating	O
viability	O
)	O
and	O
a	O
lack	O
of	O
PI	O
staining	O
(	O
indicating	O
no	O
dead	O
/	O
dying	O
cells	O
or	O
DNA	O
release	O
)	O
(	O
Fig	O
S1	O
)	O
.	O

DNA	O
has	O
cation	O
chelating	O
activity	O
<EOS>	B-X
Our	B-X
particular	B-X
focus	B-X
is	B-X
on	B-X
the	B-X
key	B-X
biological	B-X
activity	B-X
imparted	B-X
by	B-X
each	B-X
biomolecule	B-X
toward	B-X
prevention	B-X
of	B-X
dental	B-X
and	B-X
oral	B-X
diseases	B-X
as	B-X
well	B-X
as	B-X
restoration	B-X
of	B-X
oral	B-X
health	B-X
.	B-X
Additional	B-X
emphasis	B-X
is	B-X
placed	B-X
on	B-X
the	B-X
structure-function	B-X
relationships	B-X
between	B-X
biomolecules	B-X
and	B-X
their	B-X
biological	B-X
activity	B-X
,	B-X
the	B-X
unique	B-X
challenges	B-X
of	B-X
each	B-X
clinical	B-X
condition	B-X
,	B-X
limitations	B-X
of	B-X
conventional	B-X
therapies	B-X
,	B-X
and	B-X
the	B-X
advantages	B-X
of	B-X
each	B-X
class	B-X
of	B-X
biomolecule	B-X
for	B-X
said	B-X
challenge	B-X
.	B-X
Pseudomonas	B-X
aeruginosa	B-X
airway	B-X
infection	B-X
is	B-X
common	B-X
in	B-X
cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
,	B-X
a	B-X
disease	B-X
also	B-X
characterized	B-X
by	B-X
abundant	B-X
extracellular	B-X
DNA	B-X
(	B-X
eDNA	B-X
)	B-X
in	B-X
the	B-X
airways	B-X
.	B-X
The	B-X
eDNA	B-X
is	B-X
mainly	B-X
derived	B-X
from	B-X
neutrophils	B-X
accumulating	B-X
in	B-X
the	B-X
airways	B-X
and	B-X
contributes	B-X
to	B-X
a	B-X
high	B-X
sputum	B-X
viscosity	B-X
.	B-X
Furthermore	B-X
,	B-X
DNA	B-X
from	B-X
the	B-X
sputum	B-X
of	B-X
CF	B-X
patients	B-X
showed	B-X
increased	B-X
bactericidal	B-X
activity	B-X
after	B-X
treatment	B-X
with	B-X
DNase	B-X
ex	B-X
vivo	B-X
.	B-X
Both	B-X
degraded	B-X
DNA	B-X
of	B-X
neutrophil	B-X
extracellular	B-X
traps	B-X
(	B-X
NETs	B-X
)	B-X
and	B-X
genomic	B-X
DNA	B-X
degraded	B-X
by	B-X
serum	B-X
,	B-X
acquired	B-X
bactericidal	B-X
activity	B-X
against	B-X
P.	B-X
aeruginosa	B-X
In	B-X
vitro	B-X
,	B-X
small	B-X
synthetic	B-X
DNA-fragments	B-X
(	B-X
<	B-X
100	B-X
base	B-X
pairs	B-X
)	B-X
but	B-X
not	B-X
large	B-X
fragments	B-X
nor	B-X
genomic	B-X
DNA	B-X
,	B-X
were	B-X
bactericidal	B-X
against	B-X
Gram-negative	B-X
but	B-X
not	B-X
Gram-positive	B-X
bacteria	B-X
.	B-X
The	B-X
addition	B-X
of	B-X
divalent	B-X
cations	B-X
reduced	B-X
bacterial	B-X
killing	B-X
,	B-X
suggesting	B-X
that	B-X
chelation	B-X
of	B-X
divalent	B-X
cations	B-X
by	B-X
DNA	B-X
results	B-X
in	B-X
destabilization	B-X
of	B-X
the	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
envelope	B-X
.	B-X
This	B-X
is	B-X
a	B-X
novel	B-X
antibacterial	B-X
strategy	B-X
where	B-X
fragmentation	B-X
of	B-X
eDNA	B-X
and	B-X
DNA-fragments	B-X
can	B-X
be	B-X
used	B-X
to	B-X
treat	B-X
P.	B-X
aeruginosa	B-X
airway	B-X
infection	B-X
.	B-X

The	O
observation	O
that	O
DNA	O
disrupted	O
the	O
integrity	O
of	O
the	O
cell	O
envelope	O
causing	O
cell	O
lysis	O
suggested	O
that	O
DNA	O
was	O
acting	O
as	O
a	O
cation	O
chelator	O
.	O

To	O
confirm	O
that	O
DNA	O
-	O
mediated	O
killing	O
was	O
a	O
result	O
of	O
cation	O
chelation	O
,	O
excess	O
Mg2	O
+	O
,	O
Ca2	O
+	O
,	O
Mn2	O
+	O
,	O
and	O
Zn2	O
+	O
were	O
added	O
to	O
P	O
.	O
aeruginosa	O
cultures	O
.	O

The	O
rapidity	O
of	O
DNA	O
-	O
induced	O
cell	O
death	O
ruled	O
out	O
the	O
possibility	O
that	O
death	O
,	O
or	O
lack	O
of	O
growth	O
,	O
was	O
simply	O
due	O
to	O
cation	O
starvation	O
.	O

Addition	O
of	O
excess	O
cations	O
to	O
planktonic	O
cultures	O
inhibited	O
the	O
fast	O
-	O
acting	O
antimicrobial	O
effects	O
of	O
DNA	O
(	O
Fig	O
3A	O
)	O
.	O

Protection	O
was	O
measured	O
in	O
response	O
to	O
a	O
range	O
of	O
cation	O
concentrations	O
,	O
where	O
the	O
highest	O
concentration	O
tested	O
was	O
that	O
which	O
remained	O
soluble	O
in	O
the	O
presence	O
of	O
DNA	O
(	O
3	O
.	O
125	O
-	O
25	O
mM	O
)	O
.	O

The	O
concentration	O
at	O
which	O
maximal	O
protection	O
was	O
obtained	O
for	O
each	O
cation	O
is	O
represented	O
in	O
Fig	O
3A	O
(	O
25	O
mM	O
Mg2	O
+	O
;	O
6	O
.	O
25	O
mM	O
Ca2	O
+	O
;	O
6	O
.	O
25	O
Mn2	O
+	O
;	O
3	O
.	O
125	O
mM	O
Zn2	O
+	O
)	O
.	O

Kill	O
curve	O
assays	O
indicated	O
that	O
the	O
addition	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
provided	O
protection	O
from	O
DNA	O
-	O
induced	O
lysis	O
,	O
however	O
,	O
the	O
addition	O
of	O
Zn2	O
+	O
did	O
not	O
protect	O
from	O
DNA	O
-	O
mediated	O
killing	O
(	O
Fig	O
3A	O
)	O
.	O

In	O
a	O
similar	O
manner	O
,	O
the	O
addition	O
of	O
excess	O
Mg2	O
+	O
,	O
Ca2	O
+	O
and	O
Mn2	O
+	O
restored	O
growth	O
of	O
P	O
.	O
aeruginosa	O
in	O
BM2	O
media	O
.	O

Only	O
partial	O
restoration	O
of	O
growth	O
was	O
observed	O
in	O
the	O
presence	O
of	O
Zn2	O
+	O
(	O
Fig	O
3B	O
)	O
.	O

The	O
increased	O
protection	O
observed	O
following	O
addition	O
of	O
Mg2	O
+	O
and	O
Ca2	O
+	O
is	O
likely	O
due	O
to	O
their	O
importance	O
in	O
membrane	O
integrity	O
where	O
they	O
function	O
to	O
stabilize	O
the	O
OM	O
by	O
crosslinking	O
adjacent	O
LPS	O
molecules	O
[	O
58	O
]	O
.	O

Cations	O
play	O
diverse	O
physiologically	O
important	O
roles	O
within	O
a	O
cell	O
;	O
from	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
and	O
co	O
-	O
factors	O
for	O
enzymes	O
to	O
the	O
stabilization	O
of	O
macromolecules	O
within	O
the	O
cell	O
[	O
62	O
]	O
.	O
<EOS>	B-X
In	B-X
the	B-X
context	B-X
of	B-X
ion	B-X
channels	B-X
,	B-X
they	B-X
are	B-X
unique	B-X
for	B-X
their	B-X
broad	B-X
diversity	B-X
of	B-X
activation	B-X
mechanisms	B-X
and	B-X
their	B-X
cation	B-X
selectivity	B-X
.	B-X
TRP	B-X
channels	B-X
are	B-X
involved	B-X
in	B-X
a	B-X
diverse	B-X
range	B-X
of	B-X
physiological	B-X
processes	B-X
including	B-X
chemical	B-X
sensing	B-X
,	B-X
nociception	B-X
,	B-X
and	B-X
mediating	B-X
cytokine	B-X
release	B-X
.	B-X
They	B-X
also	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
inflammation	B-X
through	B-X
sensory	B-X
function	B-X
and	B-X
the	B-X
release	B-X
of	B-X
neuropeptides	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
discuss	B-X
the	B-X
functional	B-X
contribution	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
TRP	B-X
channels	B-X
(	B-X
TRPV1	B-X
,	B-X
TRPV4	B-X
,	B-X
TRPM3	B-X
,	B-X
TRPM8	B-X
,	B-X
and	B-X
TRPA1	B-X
)	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
body	B-X
's	B-X
immune	B-X
responses	B-X
,	B-X
particularly	B-X
in	B-X
relation	B-X
to	B-X
inflammation	B-X
.	B-X
We	B-X
focus	B-X
on	B-X
these	B-X
five	B-X
TRP	B-X
channels	B-X
because	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
being	B-X
expressed	B-X
in	B-X
many	B-X
somatic	B-X
cell	B-X
types	B-X
,	B-X
these	B-X
channels	B-X
are	B-X
also	B-X
expressed	B-X
on	B-X
peripheral	B-X
ganglia	B-X
and	B-X
nerves	B-X
that	B-X
innervate	B-X
visceral	B-X
organs	B-X
and	B-X
tissues	B-X
throughout	B-X
the	B-X
body	B-X
.	B-X
Activation	B-X
of	B-X
these	B-X
neural	B-X
TRP	B-X
channels	B-X
enables	B-X
crosstalk	B-X
between	B-X
neurons	B-X
,	B-X
immune	B-X
cells	B-X
,	B-X
and	B-X
epithelial	B-X
cells	B-X
to	B-X
regulate	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
inflammatory	B-X
actions	B-X
.	B-X
TRP	B-X
channels	B-X
act	B-X
either	B-X
through	B-X
direct	B-X
effects	B-X
on	B-X
cation	B-X
levels	B-X
or	B-X
through	B-X
indirect	B-X
modulation	B-X
of	B-X
intracellular	B-X
pathways	B-X
to	B-X
trigger	B-X
pro-	B-X
or	B-X
anti-inflammatory	B-X
mechanisms	B-X
,	B-X
depending	B-X
on	B-X
the	B-X
inflammatory	B-X
disease	B-X
context	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
TRP	B-X
channels	B-X
on	B-X
both	B-X
neural	B-X
and	B-X
immune	B-X
cells	B-X
has	B-X
made	B-X
them	B-X
an	B-X
attractive	B-X
drug	B-X
target	B-X
in	B-X
diseases	B-X
involving	B-X
inflammation	B-X
.	B-X
Future	B-X
work	B-X
in	B-X
this	B-X
domain	B-X
will	B-X
likely	B-X
yield	B-X
important	B-X
new	B-X
pathways	B-X
and	B-X
therapies	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
disorders	B-X
including	B-X
colitis	B-X
,	B-X
dermatitis	B-X
,	B-X
sepsis	B-X
,	B-X
asthma	B-X
,	B-X
and	B-X
pain	B-X
.	B-X

Since	O
Mg2	O
+	O
limitation	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
CAP	O
resistance	O
in	O
P	O
.	O
aeruginosa	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
47	O
]	O
,	O
we	O
sought	O
to	O
determine	O
if	O
Mg2	O
+	O
chelation	O
by	O
DNA	O
may	O
account	O
,	O
at	O
least	O
in	O
part	O
,	O
for	O
the	O
increased	O
antibiotic	O
resistance	O
observed	O
in	O
biofilms	O
.	O

Extracellular	O
DNA	O
induces	O
expression	O
of	O
the	O
PA3552	B-Protein
-	O
PA3559	B-Protein
CAP	O
resistance	O
operon	O
in	O
planktonic	O
cultures	O

In	O
P	O
.	O
aeruginosa	O
,	O
the	O
PhoPQ	B-Protein
and	O
PmrAB	B-Protein
-	O
controlled	O
response	O
to	O
magnesium	O
limitation	O
includes	O
the	O
induction	O
of	O
the	O
PA3552	B-Protein
and	O
its	O
neighbouring	O
genes	O
.	O

The	O
genes	O
PA3552	B-Protein
-	O
PA3559	B-Protein
are	O
co	O
-	O
regulated	O
under	O
low	O
Mg2	O
+	O
conditions	O
and	O
are	O
thought	O
to	O
be	O
organized	O
as	O
an	O
operon	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
.	O

These	O
genes	O
encode	O
an	O
LPS	O
modification	O
pathway	O
required	O
for	O
the	O
addition	O
of	O
aminoarabinose	O
to	O
lipid	O
A	O
,	O
which	O
reduces	O
the	O
OM	O
permeability	O
to	O
CAPs	O
,	O
thus	O
conferring	O
resistance	O
[	O
48	O
]	O
.	O

To	O
determine	O
if	O
extracellular	O
DNA	O
imposes	O
Mg2	O
+	O
limitation	O
,	O
we	O
measured	O
the	O
gene	O
expression	O
of	O
a	O
chromosomally	O
encoded	O
transcriptional	O
lux	B-Protein
(	O
bioluminescence	O
)	O
fusion	O
to	O
PA3553	B-Protein
,	O
as	O
a	O
measure	O
of	O
the	O
CAP	O
resistance	O
operon	O
expression	O
in	O
planktonic	O
cultures	O
.	O

PA3553	B-Protein
:	O
:	O
lux	B-Protein
expression	O
was	O
strongly	O
induced	O
(	O
up	O
to	O
10	O
-	O
fold	O
)	O
by	O
sub	O
-	O
inhibitory	O
concentrations	O
of	O
low	O
molecular	O
weight	O
salmon	O
sperm	O
DNA	O
(	O
Fig	O
4A	O
)	O
.	O

Induction	O
of	O
the	O
CAP	O
resistance	O
operon	O
was	O
dose	O
-	O
dependent	O
with	O
increasing	O
DNA	O
concentrations	O
up	O
to	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
DNA	O
,	O
at	O
which	O
growth	O
is	O
inhibited	O
(	O
Fig	O
4A	O
)	O
.	O

Addition	O
of	O
excess	O
Mg2	O
+	O
(	O
5	O
mM	O
)	O
to	O
the	O
growth	O
medium	O
completely	O
repressed	O
the	O
expression	O
of	O
PA3553	B-Protein
in	O
cultures	O
supplemented	O
with	O
DNA	O
,	O
except	O
at	O
the	O
highest	O
DNA	O
concentration	O
tested	O
(	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
(	O
Fig	O
4B	O
)	O
.	O

A	O
similar	O
induction	O
profile	O
of	O
PA3553	B-Protein
:	O
:	O
lux	B-Protein
was	O
observed	O
following	O
exposure	O
to	O
high	O
molecular	O
weight	O
P	O
.	O
aeruginosa	O
genomic	O
DNA	O
(	O
not	O
shown	O
)	O
or	O
P	O
.	O
aeruginosa	O
genomic	O
DNA	O
that	O
was	O
mechanically	O
sheared	O
by	O
sonication	O
(	O
Fig	O
4C	O
)	O
.	O

P	O
.	O
aeruginosa	O
genomic	O
DNA	O
inhibited	O
growth	O
at	O
similar	O
concentrations	O
as	O
salmon	O
sperm	O
DNA	O
.	O

Thus	O
,	O
the	O
ability	O
of	O
extracellular	O
DNA	O
to	O
chelate	O
magnesium	O
is	O
independent	O
of	O
origin	O
and	O
molecular	O
weight	O
,	O
indicating	O
that	O
chelation	O
is	O
a	O
general	O
property	O
of	O
this	O
negatively	O
charged	O
polymer	O
.	O

To	O
ensure	O
that	O
induction	O
of	O
PA3553	B-Protein
expression	O
was	O
specific	O
to	O
the	O
ability	O
of	O
DNA	O
to	O
chelate	O
cations	O
,	O
DNAse	O
treated	O
DNA	O
was	O
assessed	O
for	O
its	O
ability	O
to	O
induce	O
PA3553	B-Protein
gene	O
expression	O
(	O
Fig	O
4D	O
)	O
.	O

DNAse	O
treated	O
DNA	O
failed	O
to	O
induce	O
PA3553	B-Protein
gene	O
expression	O
.	O
<EOS>	B-X
Inhibition	B-X
of	B-X
histone	B-X
deacetylase	B-X
(	B-X
HDAC	B-X
)	B-X
proteins	B-X
or	B-X
the	B-X
proteasome	B-X
differ	B-X
from	B-X
chemotherapy	B-X
in	B-X
that	B-X
they	B-X
eliminate	B-X
cancer	B-X
cells	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
or	B-X
cellular	B-X
protein	B-X
equilibrium	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
HDAC	B-X
inhibitors	B-X
vorinostat/SAHA	B-X
and	B-X
romidepsin/FK288	B-X
were	B-X
found	B-X
to	B-X
induce	B-X
DNA	B-X
damage	B-X
,	B-X
and	B-X
mis-repair	B-X
of	B-X
this	B-X
damage	B-X
manifested	B-X
into	B-X
mutations	B-X
in	B-X
clonogenically	B-X
viable	B-X
surviving	B-X
cells	B-X
.	B-X
DNA	B-X
damage	B-X
and	B-X
mutations	B-X
were	B-X
also	B-X
detected	B-X
in	B-X
cells	B-X
treated	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
bortezomib	B-X
.	B-X
Inhibition	B-X
of	B-X
caspases	B-X
protected	B-X
cells	B-X
from	B-X
bortezomib-induced	B-X
acute	B-X
(	B-X
but	B-X
not	B-X
clonogenic	B-X
)	B-X
death	B-X
and	B-X
mutagenesis	B-X
,	B-X
implying	B-X
caspases	B-X
were	B-X
required	B-X
for	B-X
the	B-X
mutagenic	B-X
action	B-X
of	B-X
bortezomib	B-X
.	B-X
This	B-X
was	B-X
also	B-X
observed	B-X
for	B-X
second	B-X
generation	B-X
proteasome	B-X
inhibitors	B-X
.	B-X
Cells	B-X
deficient	B-X
in	B-X
caspase-activated	B-X
DNase	B-X
(	B-X
CAD	B-X
)	B-X
also	B-X
failed	B-X
to	B-X
acquire	B-X
DNA	B-X
damage	B-X
or	B-X
mutations	B-X
following	B-X
treatment	B-X
with	B-X
bortezomib	B-X
.	B-X
If	B-X
recapitulated	B-X
in	B-X
vivo	B-X
,	B-X
the	B-X
mutagenicity	B-X
of	B-X
these	B-X
agents	B-X
may	B-X
influence	B-X
the	B-X
treatment	B-X
of	B-X
cancer	B-X
patients	B-X
who	B-X
are	B-X
more	B-X
susceptible	B-X
to	B-X
oncogenic	B-X
mutations	B-X
due	B-X
to	B-X
dysfunctional	B-X
DNA	B-X
repair	B-X
pathways	B-X
.	B-X

However	O
the	O
addition	O
of	O
DNAse	O
buffer	O
to	O
cells	O
in	O
our	O
buffer	O
control	O
experiment	O
also	O
abolished	O
induction	O
of	O
PA3553	B-Protein
.	O

This	O
is	O
due	O
to	O
the	O
addition	O
of	O
excess	O
Mg2	O
+	O
ions	O
as	O
part	O
of	O
the	O
DNAse	O
buffer	O
,	O
which	O
is	O
required	O
for	O
DNAse	O
activity	O
.	O

Thus	O
,	O
it	O
is	O
impossible	O
to	O
determine	O
conclusively	O
if	O
DNAse	O
treatment	O
of	O
DNA	O
abolished	O
PA3553	B-Protein
gene	O
expression	O
.	O

Expression	O
of	O
the	O
CAP	O
resistance	O
operon	O
PA3552	B-Protein
-	O
PA3559	B-Protein
is	O
induced	O
in	O
biofilms	O
in	O
response	O
to	O
extracellular	O
DNA	O

To	O
determine	O
the	O
influence	O
of	O
extracellular	O
DNA	O
on	O
PA3553	B-Protein
gene	O
expression	O
in	O
biofilms	O
,	O
DNA	O
-	O
enriched	O
biofilms	O
were	O
cultivated	O
on	O
the	O
surface	O
of	O
polystyrene	O
pegs	O
.	O

Consistent	O
with	O
previous	O
reports	O
that	O
DNA	O
is	O
a	O
component	O
of	O
biofilms	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
we	O
observed	O
DNA	O
in	O
24	O
h	O
old	O
peg	O
-	O
adhered	O
biofilms	O
(	O
Fig	O
5A	O
and	O
5B	O
)	O
.	O

Double	O
staining	O
of	O
P	O
.	O
aeruginosa	O
with	O
syto9	O
(	O
stains	O
viable	O
cells	O
green	O
)	O
and	O
the	O
extracellular	O
DNA	O
stain	O
DDAO	O
(	O
red	O
)	O
[	O
51	O
]	O
was	O
used	O
to	O
visualize	O
DNA	O
as	O
a	O
loose	O
lattice	O
in	O
biofilms	O
formed	O
on	O
polystyrene	O
pegs	O
after	O
24	O
h	O
(	O
Fig	O
5A	O
)	O
.	O

DNA	O
was	O
also	O
visualized	O
(	O
PI	O
stained	O
)	O
as	O
a	O
mesh	O
-	O
like	O
DNA	O
matrix	O
in	O
1	O
day	O
-	O
old	O
peg	O
-	O
adhered	O
biofilm	O
monolayers	O
(	O
Fig	O
5B	O
)	O
,	O
which	O
resembled	O
the	O
thread	O
-	O
like	O
projections	O
of	O
genomic	O
DNA	O
observed	O
in	O
DNA	O
or	O
EDTA	O
-	O
lysed	O
cells	O
(	O
Fig	O
2B	O
)	O
.	O

These	O
localization	O
patterns	O
of	O
extracellular	O
DNA	O
are	O
suggestive	O
of	O
DNA	O
gradients	O
within	O
biofilms	O
.	O

Biofilm	O
formation	O
was	O
inhibited	O
at	O
extracellular	O
DNA	O
concentrations	O
>	O
/	O
=	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
(	O
Fig	O
6A	O
)	O
.	O

This	O
is	O
consistent	O
with	O
the	O
observed	O
growth	O
inhibition	O
of	O
planktonic	O
cells	O
at	O
similar	O
DNA	O
concentrations	O
(	O
Fig	O
1A	O
)	O
.	O

One	O
-	O
day	O
old	O
PA3553	B-Protein
:	O
:	O
lux	B-Protein
biofilms	O
were	O
washed	O
to	O
remove	O
non	O
-	O
adhered	O
cells	O
and	O
gene	O
expression	O
was	O
measured	O
from	O
the	O
cells	O
adhered	O
to	O
the	O
polystyrene	O
peg	O
surface	O
.	O

PA3553	B-Protein
gene	O
expression	O
was	O
strongly	O
induced	O
,	O
up	O
to	O
20	O
-	O
fold	O
,	O
in	O
peg	O
-	O
adhered	O
biofilms	O
,	O
with	O
the	O
highest	O
induction	O
at	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
extracellular	O
DNA	O
(	O
Fig	O
6B	O
)	O
.	O

Although	O
gene	O
expression	O
was	O
measured	O
in	O
a	O
mutant	O
background	O
,	O
both	O
PAO1	O
and	O
PA3553	B-Protein
:	O
:	O
lux	B-Protein
had	O
similar	O
biofilm	O
phenotypes	O
in	O
each	O
condition	O
tested	O
(	O
Fig	O
6A	O
)	O
.	O

In	O
biofilms	O
cultivated	O
in	O
the	O
presence	O
of	O
extracellular	O
DNA	O
supplemented	O
with	O
excess	O
Mg2	O
+	O
(	O
5	O
mM	O
)	O
,	O
PA3553	B-Protein
gene	O
expression	O
was	O
completely	O
repressed	O
(	O
data	O
not	O
shown	O
)	O
.	O

DNA	O
chelation	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
but	O
not	O
Zn2	O
+	O
induces	O
PA3553	B-Protein
expression	O
<EOS>	B-X
Manganese	B-X
(	B-X
Mn2+	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
trace	B-X
element	B-X
within	B-X
organisms	B-X
spanning	B-X
the	B-X
entire	B-X
tree	B-X
of	B-X
life	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
Mn2+	B-X
transport	B-X
and	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
homeostasis	B-X
in	B-X
bacteria	B-X
,	B-X
with	B-X
a	B-X
focus	B-X
on	B-X
its	B-X
functions	B-X
beyond	B-X
being	B-X
a	B-X
cofactor	B-X
for	B-X
enzymes	B-X
.	B-X
Crucial	B-X
differences	B-X
in	B-X
Mn2+	B-X
homeostasis	B-X
exist	B-X
between	B-X
bacterial	B-X
species	B-X
that	B-X
can	B-X
be	B-X
characterized	B-X
to	B-X
have	B-X
an	B-X
iron-	B-X
or	B-X
manganese-centric	B-X
metabolism	B-X
.	B-X
Highly	B-X
iron-centric	B-X
species	B-X
require	B-X
minimal	B-X
Mn2+	B-X
and	B-X
mostly	B-X
use	B-X
it	B-X
as	B-X
a	B-X
mechanism	B-X
to	B-X
cope	B-X
with	B-X
oxidative	B-X
stress	B-X
.	B-X
As	B-X
a	B-X
consequence	B-X
,	B-X
tight	B-X
regulation	B-X
of	B-X
Mn2+	B-X
uptake	B-X
is	B-X
required	B-X
,	B-X
while	B-X
organisms	B-X
that	B-X
use	B-X
both	B-X
Fe2+	B-X
and	B-X
Mn2+	B-X
need	B-X
other	B-X
layers	B-X
of	B-X
regulation	B-X
for	B-X
maintaining	B-X
homeostasis	B-X
.	B-X
We	B-X
will	B-X
focus	B-X
in	B-X
detail	B-X
on	B-X
manganese-centric	B-X
bacterial	B-X
species	B-X
,	B-X
in	B-X
particular	B-X
lactobacilli	B-X
,	B-X
that	B-X
require	B-X
little	B-X
to	B-X
no	B-X
Fe2+	B-X
and	B-X
use	B-X
Mn2+	B-X
for	B-X
a	B-X
wider	B-X
variety	B-X
of	B-X
functions	B-X
.	B-X
These	B-X
organisms	B-X
can	B-X
accumulate	B-X
extraordinarily	B-X
high	B-X
amounts	B-X
of	B-X
Mn2+	B-X
intracellularly	B-X
,	B-X
enabling	B-X
the	B-X
nonenzymatic	B-X
use	B-X
of	B-X
Mn2+	B-X
for	B-X
decomposition	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
while	B-X
simultaneously	B-X
functioning	B-X
as	B-X
a	B-X
mechanism	B-X
of	B-X
competitive	B-X
exclusion	B-X
.	B-X
We	B-X
further	B-X
discuss	B-X
how	B-X
Mn2+	B-X
accumulation	B-X
can	B-X
provide	B-X
both	B-X
beneficial	B-X
and	B-X
pathogenic	B-X
bacteria	B-X
with	B-X
advantages	B-X
in	B-X
thriving	B-X
in	B-X
their	B-X
niches	B-X
.	B-X

At	O
lethal	O
concentrations	O
,	O
extracellular	O
DNA	O
induced	O
cell	O
lysis	O
by	O
chelating	O
cations	O
from	O
the	O
OM	O
.	O

This	O
antimicrobial	O
activity	O
can	O
be	O
prevented	O
if	O
DNA	O
is	O
pre	O
-	O
loaded	O
with	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
,	O
but	O
not	O
Zn2	O
+	O
,	O
prior	O
to	O
treatment	O
of	O
cells	O
(	O
Fig	O
3A	O
and	O
3B	O
)	O
.	O
<EOS>	B-X
Manganese	B-X
(	B-X
Mn2+	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
trace	B-X
element	B-X
within	B-X
organisms	B-X
spanning	B-X
the	B-X
entire	B-X
tree	B-X
of	B-X
life	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
Mn2+	B-X
transport	B-X
and	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
homeostasis	B-X
in	B-X
bacteria	B-X
,	B-X
with	B-X
a	B-X
focus	B-X
on	B-X
its	B-X
functions	B-X
beyond	B-X
being	B-X
a	B-X
cofactor	B-X
for	B-X
enzymes	B-X
.	B-X
Crucial	B-X
differences	B-X
in	B-X
Mn2+	B-X
homeostasis	B-X
exist	B-X
between	B-X
bacterial	B-X
species	B-X
that	B-X
can	B-X
be	B-X
characterized	B-X
to	B-X
have	B-X
an	B-X
iron-	B-X
or	B-X
manganese-centric	B-X
metabolism	B-X
.	B-X
Highly	B-X
iron-centric	B-X
species	B-X
require	B-X
minimal	B-X
Mn2+	B-X
and	B-X
mostly	B-X
use	B-X
it	B-X
as	B-X
a	B-X
mechanism	B-X
to	B-X
cope	B-X
with	B-X
oxidative	B-X
stress	B-X
.	B-X
As	B-X
a	B-X
consequence	B-X
,	B-X
tight	B-X
regulation	B-X
of	B-X
Mn2+	B-X
uptake	B-X
is	B-X
required	B-X
,	B-X
while	B-X
organisms	B-X
that	B-X
use	B-X
both	B-X
Fe2+	B-X
and	B-X
Mn2+	B-X
need	B-X
other	B-X
layers	B-X
of	B-X
regulation	B-X
for	B-X
maintaining	B-X
homeostasis	B-X
.	B-X
We	B-X
will	B-X
focus	B-X
in	B-X
detail	B-X
on	B-X
manganese-centric	B-X
bacterial	B-X
species	B-X
,	B-X
in	B-X
particular	B-X
lactobacilli	B-X
,	B-X
that	B-X
require	B-X
little	B-X
to	B-X
no	B-X
Fe2+	B-X
and	B-X
use	B-X
Mn2+	B-X
for	B-X
a	B-X
wider	B-X
variety	B-X
of	B-X
functions	B-X
.	B-X
These	B-X
organisms	B-X
can	B-X
accumulate	B-X
extraordinarily	B-X
high	B-X
amounts	B-X
of	B-X
Mn2+	B-X
intracellularly	B-X
,	B-X
enabling	B-X
the	B-X
nonenzymatic	B-X
use	B-X
of	B-X
Mn2+	B-X
for	B-X
decomposition	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
while	B-X
simultaneously	B-X
functioning	B-X
as	B-X
a	B-X
mechanism	B-X
of	B-X
competitive	B-X
exclusion	B-X
.	B-X
We	B-X
further	B-X
discuss	B-X
how	B-X
Mn2+	B-X
accumulation	B-X
can	B-X
provide	B-X
both	B-X
beneficial	B-X
and	B-X
pathogenic	B-X
bacteria	B-X
with	B-X
advantages	B-X
in	B-X
thriving	B-X
in	B-X
their	B-X
niches	B-X
.	B-X

To	O
determine	O
the	O
specificity	O
of	O
cation	O
chelation	O
,	O
flame	O
atomic	O
absorption	O
spectroscopy	O
was	O
employed	O
to	O
quantitate	O
DNA	O
-	O
dependent	O
removal	O
of	O
cations	O
from	O
buffer	O
containing	O
known	O
concentrations	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
,	O
Mn2	O
+	O
or	O
Zn2	O
+	O
and	O
a	O
combination	O
of	O
all	O
four	O
cations	O
.	O

DNA	O
was	O
capable	O
of	O
binding	O
all	O
four	O
cations	O
at	O
similar	O
levels	O
(	O
80	O
-	O
88	O
%	O
)	O
,	O
whether	O
alone	O
(	O
Fig	O
7A	O
)	O
or	O
in	O
combination	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
Combinative	B-X
treatment	B-X
of	B-X
β-elemene	B-X
and	B-X
cetuximab	B-X
is	B-X
sensitive	B-X
to	B-X
KRAS	B-X
mutant	B-X
colorectal	B-X
cancer	B-X
cells	B-X
by	B-X
inducing	B-X
ferroptosis	B-X
and	B-X
inhibiting	B-X
epithelial-mesenchymal	B-X
transformation	B-X
.	B-X
New	B-X
data	B-X
have	B-X
emerged	B-X
that	B-X
show	B-X
synergy	B-X
of	B-X
radiotherapy	B-X
with	B-X
immunotherapy	B-X
to	B-X
control	B-X
or	B-X
eradicate	B-X
cancer	B-X
.	B-X
Different	B-X
doses	B-X
of	B-X
hypofractionated	B-X
radiotherapy	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
induce	B-X
immunogenic	B-X
cell	B-X
death	B-X
and	B-X
in-situ	B-X
vaccination	B-X
in	B-X
several	B-X
tumour	B-X
models	B-X
.	B-X
We	B-X
provide	B-X
emerging	B-X
preclinical	B-X
and	B-X
clinical	B-X
data	B-X
for	B-X
combining	B-X
immunotherapy	B-X
with	B-X
radiotherapy	B-X
for	B-X
ovarian	B-X
cancer	B-X
treatment	B-X
and	B-X
offer	B-X
a	B-X
clinical	B-X
development	B-X
roadmap	B-X
to	B-X
guide	B-X
the	B-X
next	B-X
generation	B-X
of	B-X
clinical	B-X
trials	B-X
for	B-X
this	B-X
combination	B-X
strategy	B-X
for	B-X
this	B-X
disease	B-X
.	B-X

To	O
ensure	O
binding	O
was	O
specific	O
to	O
DNA	O
a	O
negative	O
control	O
was	O
included	O
.	O
<EOS>	B-X
A	B-X
hierarchy	B-X
of	B-X
transcriptional	B-X
regulators	B-X
controlling	B-X
lateral	B-X
root	B-X
formation	B-X
in	B-X
Arabidopsis	B-X
thaliana	B-X
has	B-X
been	B-X
identified	B-X
,	B-X
including	B-X
the	B-X
AUXIN	B-X
RESPONSE	B-X
FACTOR	B-X
7	B-X
(	B-X
ARF7	B-X
)	B-X
/ARF19-LATERAL	B-X
ORGAN	B-X
BOUNDARIES	B-X
DOMAIN	B-X
16	B-X
(	B-X
LBD16	B-X
)	B-X
/LBD18	B-X
transcriptional	B-X
network	B-X
;	B-X
however	B-X
,	B-X
their	B-X
feedback	B-X
regulation	B-X
mechanisms	B-X
are	B-X
not	B-X
known	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
LBD18	B-X
controls	B-X
ARF	B-X
activity	B-X
using	B-X
the	B-X
dual	B-X
mode	B-X
of	B-X
a	B-X
positive	B-X
feedback	B-X
loop	B-X
.	B-X
A	B-X
variety	B-X
of	B-X
molecular	B-X
and	B-X
biochemical	B-X
experiments	B-X
demonstrated	B-X
that	B-X
LBD18	B-X
binds	B-X
a	B-X
specific	B-X
DNA	B-X
motif	B-X
in	B-X
the	B-X
ARF19	B-X
promoter	B-X
to	B-X
regulate	B-X
its	B-X
expression	B-X
in	B-X
vivo	B-X
as	B-X
well	B-X
as	B-X
in	B-X
vitro	B-X
.	B-X
LBD18	B-X
interacts	B-X
with	B-X
ARFs	B-X
including	B-X
ARF7	B-X
and	B-X
ARF19	B-X
via	B-X
the	B-X
Phox	B-X
and	B-X
Bem1	B-X
domain	B-X
of	B-X
ARF	B-X
to	B-X
enhance	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
ARF7	B-X
on	B-X
AuxRE	B-X
,	B-X
and	B-X
competes	B-X
with	B-X
auxin/indole-3-acetic	B-X
acid	B-X
(	B-X
IAA	B-X
)	B-X
repressors	B-X
for	B-X
ARF	B-X
binding	B-X
,	B-X
overriding	B-X
the	B-X
negative	B-X
feedback	B-X
loop	B-X
exerted	B-X
by	B-X
Aux/IAA	B-X
repressors	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
results	B-X
show	B-X
that	B-X
LBD18	B-X
and	B-X
ARFs	B-X
form	B-X
a	B-X
double	B-X
positive	B-X
feedback	B-X
loop	B-X
,	B-X
and	B-X
that	B-X
LBD18	B-X
uses	B-X
the	B-X
dual	B-X
mode	B-X
of	B-X
a	B-X
positive	B-X
feedback	B-X
loop	B-X
by	B-X
binding	B-X
directly	B-X
to	B-X
the	B-X
ARF19	B-X
promoter	B-X
and	B-X
through	B-X
the	B-X
protein-protein	B-X
interactions	B-X
with	B-X
ARF7	B-X
and	B-X
ARF19	B-X
.	B-X
This	B-X
novel	B-X
mechanism	B-X
of	B-X
feedback	B-X
loops	B-X
may	B-X
constitute	B-X
a	B-X
robust	B-X
feedback	B-X
mechanism	B-X
that	B-X
ensures	B-X
continued	B-X
lateral	B-X
root	B-X
growth	B-X
in	B-X
response	B-X
to	B-X
auxin	B-X
in	B-X
Arabidopsis	B-X
.	B-X

The	O
concentration	O
of	O
Mg2	O
+	O
that	O
bound	O
to	O
the	O
column	O
in	O
the	O
absence	O
of	O
DNA	O
is	O
indicated	O
.	O

At	O
sub	O
-	O
lethal	O
concentrations	O
,	O
extracellular	O
DNA	O
imposes	O
a	O
cation	O
limitation	O
that	O
leads	O
to	O
induction	O
of	O
PA3553	B-Protein
(	O
Fig	O
4A	O
)	O
,	O
which	O
can	O
be	O
repressed	O
by	O
excess	O
Mg2	O
+	O
(	O
Fig	O
4B	O
)	O
,	O
indicating	O
that	O
P	O
.	O
aeruginosa	O
senses	O
Mg2	O
+	O
.	O

The	O
P	O
.	O
aeruginosa	O
PhoQ	B-Protein
sensor	O
kinase	O
protein	O
has	O
been	O
shown	O
to	O
bind	O
to	O
and	O
be	O
repressed	O
by	O
Mg2	O
+	O
and	O
Ca2	O
+	O
cations	O
[	O
63	O
]	O
,	O
[	O
64	O
]	O
.	O

Under	O
limiting	O
Mg2	O
+	O
conditions	O
,	O
the	O
addition	O
of	O
excess	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
,	O
but	O
not	O
Zn2	O
+	O
,	O
repressed	O
PA3553	B-Protein
expression	O
(	O
Fig	O
7B	O
)	O
.	O
<EOS>	B-X
Manganese	B-X
(	B-X
Mn2+	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
trace	B-X
element	B-X
within	B-X
organisms	B-X
spanning	B-X
the	B-X
entire	B-X
tree	B-X
of	B-X
life	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
Mn2+	B-X
transport	B-X
and	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
homeostasis	B-X
in	B-X
bacteria	B-X
,	B-X
with	B-X
a	B-X
focus	B-X
on	B-X
its	B-X
functions	B-X
beyond	B-X
being	B-X
a	B-X
cofactor	B-X
for	B-X
enzymes	B-X
.	B-X
Crucial	B-X
differences	B-X
in	B-X
Mn2+	B-X
homeostasis	B-X
exist	B-X
between	B-X
bacterial	B-X
species	B-X
that	B-X
can	B-X
be	B-X
characterized	B-X
to	B-X
have	B-X
an	B-X
iron-	B-X
or	B-X
manganese-centric	B-X
metabolism	B-X
.	B-X
Highly	B-X
iron-centric	B-X
species	B-X
require	B-X
minimal	B-X
Mn2+	B-X
and	B-X
mostly	B-X
use	B-X
it	B-X
as	B-X
a	B-X
mechanism	B-X
to	B-X
cope	B-X
with	B-X
oxidative	B-X
stress	B-X
.	B-X
As	B-X
a	B-X
consequence	B-X
,	B-X
tight	B-X
regulation	B-X
of	B-X
Mn2+	B-X
uptake	B-X
is	B-X
required	B-X
,	B-X
while	B-X
organisms	B-X
that	B-X
use	B-X
both	B-X
Fe2+	B-X
and	B-X
Mn2+	B-X
need	B-X
other	B-X
layers	B-X
of	B-X
regulation	B-X
for	B-X
maintaining	B-X
homeostasis	B-X
.	B-X
We	B-X
will	B-X
focus	B-X
in	B-X
detail	B-X
on	B-X
manganese-centric	B-X
bacterial	B-X
species	B-X
,	B-X
in	B-X
particular	B-X
lactobacilli	B-X
,	B-X
that	B-X
require	B-X
little	B-X
to	B-X
no	B-X
Fe2+	B-X
and	B-X
use	B-X
Mn2+	B-X
for	B-X
a	B-X
wider	B-X
variety	B-X
of	B-X
functions	B-X
.	B-X
These	B-X
organisms	B-X
can	B-X
accumulate	B-X
extraordinarily	B-X
high	B-X
amounts	B-X
of	B-X
Mn2+	B-X
intracellularly	B-X
,	B-X
enabling	B-X
the	B-X
nonenzymatic	B-X
use	B-X
of	B-X
Mn2+	B-X
for	B-X
decomposition	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
while	B-X
simultaneously	B-X
functioning	B-X
as	B-X
a	B-X
mechanism	B-X
of	B-X
competitive	B-X
exclusion	B-X
.	B-X
We	B-X
further	B-X
discuss	B-X
how	B-X
Mn2+	B-X
accumulation	B-X
can	B-X
provide	B-X
both	B-X
beneficial	B-X
and	B-X
pathogenic	B-X
bacteria	B-X
with	B-X
advantages	B-X
in	B-X
thriving	B-X
in	B-X
their	B-X
niches	B-X
.	B-X

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
P	O
.	O
aeruginosa	O
can	O
sense	O
the	O
presence	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
and	O
that	O
chelation	O
of	O
these	O
same	O
cations	O
by	O
DNA	O
results	O
in	O
induction	O
of	O
the	O
PA3552	B-Protein
-	O
PA3559	B-Protein
LPS	O
modification	O
operon	O
.	O

DNA	O
induces	O
resistance	O
to	O
CAPs	O
and	O
aminoglycosides	O

To	O
determine	O
if	O
DNA	O
-	O
induced	O
expression	O
of	O
PA3552	B-Protein
-	O
PA3559	B-Protein
resulted	O
in	O
increased	O
resistance	O
to	O
antimicrobials	O
,	O
antibiotic	O
susceptibility	O
testing	O
of	O
P	O
.	O
aeruginosa	O
biofilms	O
grown	O
in	O
the	O
presence	O
and	O
absence	O
of	O
extracellular	O
DNA	O
was	O
performed	O
.	O

Biofilms	O
were	O
cultivated	O
on	O
96	O
-	O
well	O
format	O
,	O
polystyrene	O
pegs	O
submerged	O
in	O
BM2	O
defined	O
media	O
,	O
with	O
or	O
without	O
sub	O
-	O
inhibitory	O
concentrations	O
of	O
extracellular	O
DNA	O
(	O
0	O
.	O
75	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
,	O
and	O
challenged	O
with	O
antibiotics	O
.	O

After	O
antibiotic	O
challenge	O
,	O
this	O
assay	O
allows	O
for	O
determination	O
of	O
both	O
the	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
planktonic	O
cultures	O
and	O
the	O
minimum	O
biofilm	O
eradication	O
concentration	O
(	O
MBEC	O
)	O
.	O

Consistent	O
with	O
previous	O
results	O
reporting	O
on	O
the	O
antibiotic	O
resistance	O
phenotype	O
of	O
bacterial	O
biofilms	O
[	O
6	O
]	O
,	O
[	O
19	O
]	O
,	O
the	O
MBEC	O
values	O
of	O
biofilms	O
cultivated	O
in	O
magnesium	O
-	O
replete	O
conditions	O
and	O
treated	O
with	O
CAPs	O
(	O
polymyxin	O
B	O
,	O
colistin	O
)	O
or	O
aminoglycosides	O
(	O
gentamycin	O
,	O
tobramycin	O
)	O
were	O
up	O
to	O
64	O
-	O
fold	O
higher	O
than	O
the	O
MIC	O
values	O
of	O
planktonic	O
cultures	O
(	O
Table	O
1	O
)	O
.	O

The	O
MBEC	O
values	O
of	O
biofilms	O
supplemented	O
with	O
extracellular	O
DNA	O
were	O
8	O
and	O
64	O
-	O
fold	O
more	O
CAP	O
and	O
aminoglycoside	O
resistant	O
than	O
biofilms	O
without	O
exogenous	O
DNA	O
,	O
respectively	O
(	O
Table	O
1	O
)	O
.	O

DNA	O
-	O
enriched	O
biofilms	O
were	O
dramatically	O
more	O
resistant	O
than	O
planktonic	O
cultures	O
,	O
up	O
to	O
256	O
-	O
fold	O
,	O
and	O
this	O
resistance	O
phenotype	O
to	O
CAPs	O
and	O
aminoglycosides	O
was	O
also	O
observed	O
in	O
planktonic	O
cultures	O
supplemented	O
with	O
DNA	O
.	O

The	O
simple	O
addition	O
of	O
sub	O
-	O
inhibitory	O
DNA	O
amounts	O
to	O
planktonic	O
cultures	O
closely	O
simulated	O
the	O
resistance	O
-	O
inducing	O
effects	O
of	O
DNA	O
in	O
a	O
biofilm	O
(	O
Table	O
1	O
)	O
.	O

The	O
MIC	O
values	O
for	O
polymyxin	O
B	O
and	O
gentamicin	O
are	O
equal	O
to	O
1	O
microg	O
/	O
ml	O
and	O
2	O
microg	O
/	O
ml	O
,	O
respectively	O
,	O
using	O
the	O
standard	O
microbroth	O
dilution	O
method	O
for	O
antimicrobial	O
susceptibility	O
testing	O
(	O
National	O
Committee	O
on	O
Clinical	O
Laboratory	O
Standards	O
(	O
NCCLS	O
)	O
protocol	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
depending	O
on	O
the	O
method	O
used	O
to	O
determine	O
the	O
MIC	O
(	O
CBD	O
or	O
NCCLS	O
protocol	O
)	O
,	O
DNA	O
-	O
enriched	O
biofilms	O
can	O
be	O
up	O
to	O
2560	O
-	O
fold	O
more	O
polymyxin	O
B	O
resistant	O
and	O
up	O
to	O
640	O
-	O
fold	O
more	O
aminoglycoside	O
resistant	O
than	O
planktonic	O
cultures	O
.	O

DNA	O
-	O
enriched	O
biofilms	O
did	O
not	O
show	O
an	O
increased	O
tolerance	O
to	O
ceftazidime	O
(	O
beta	O
-	O
lactam	O
)	O
or	O
ciprofloxacin	O
(	O
fluoroquinolone	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
To	B-X
provide	B-X
the	B-X
reader	B-X
with	B-X
a	B-X
review	B-X
of	B-X
the	B-X
literature	B-X
that	B-X
evaluates	B-X
whether	B-X
a	B-X
pharmacokinetic	B-X
or	B-X
pharmacodynamic	B-X
drug	B-X
interaction	B-X
exists	B-X
between	B-X
ciprofloxacin	B-X
and	B-X
cyclosporine	B-X
.	B-X
A	B-X
Medline	B-X
search	B-X
(	B-X
1985	B-X
to	B-X
May	B-X
1999	B-X
)	B-X
of	B-X
ciprofloxacin	B-X
,	B-X
norfloxacin	B-X
,	B-X
levofloxacin	B-X
,	B-X
ofloxacin	B-X
,	B-X
trovafloxacin	B-X
,	B-X
enoxacin	B-X
,	B-X
sparfloxacin	B-X
,	B-X
grepafloxacin	B-X
,	B-X
gatifloxacin	B-X
,	B-X
clinafloxacin	B-X
and	B-X
moxifloxacin	B-X
was	B-X
conducted	B-X
to	B-X
ascertain	B-X
the	B-X
incidence	B-X
and	B-X
features	B-X
of	B-X
fluoroquinolone	B-X
nephrotoxicity	B-X
.	B-X
Unfortunately	B-X
,	B-X
the	B-X
data	B-X
primarily	B-X
consist	B-X
of	B-X
case	B-X
reports	B-X
and	B-X
temporally	B-X
related	B-X
events	B-X
.	B-X
While	B-X
the	B-X
use	B-X
of	B-X
ciprofloxacin	B-X
appears	B-X
to	B-X
increase	B-X
the	B-X
risk	B-X
,	B-X
this	B-X
may	B-X
be	B-X
due	B-X
to	B-X
its	B-X
longer	B-X
and	B-X
more	B-X
widespread	B-X
use	B-X
when	B-X
compared	B-X
with	B-X
the	B-X
newer	B-X
agents	B-X
.	B-X

Since	O
extracellular	O
DNA	O
is	O
a	O
natural	O
matrix	O
component	O
of	O
PAO1	O
biofilms	O
(	O
Fig	O
5A	O
and	O
5B	O
)	O
,	O
DNA	O
-	O
induced	O
antibiotic	O
resistance	O
is	O
likely	O
to	O
be	O
a	O
phenomenon	O
unique	O
to	O
biofilms	O
or	O
other	O
DNA	O
rich	O
environments	O
.	O
<EOS>	B-X
The	B-X
base	B-X
sequences	B-X
of	B-X
DNA	B-X
are	B-X
endowed	B-X
with	B-X
the	B-X
rich	B-X
structural	B-X
and	B-X
functional	B-X
information	B-X
and	B-X
are	B-X
available	B-X
for	B-X
the	B-X
precise	B-X
construction	B-X
of	B-X
the	B-X
2D	B-X
and	B-X
3D	B-X
macro	B-X
products	B-X
.	B-X
The	B-X
hydrogels	B-X
formed	B-X
by	B-X
DNA	B-X
are	B-X
biocompatible	B-X
,	B-X
stable	B-X
,	B-X
tunable	B-X
and	B-X
biologically	B-X
versatile	B-X
,	B-X
thus	B-X
,	B-X
these	B-X
have	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
promising	B-X
applications	B-X
in	B-X
bioanalysis	B-X
and	B-X
biomedicine	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
the	B-X
stimuli-responsive	B-X
DNA	B-X
hydrogels	B-X
(	B-X
smart	B-X
DNA	B-X
hydrogels	B-X
)	B-X
,	B-X
which	B-X
exhibit	B-X
a	B-X
reversible	B-X
and	B-X
switchable	B-X
hydrogel	B-X
to	B-X
sol	B-X
transition	B-X
under	B-X
different	B-X
triggers	B-X
,	B-X
have	B-X
emerged	B-X
as	B-X
smart	B-X
materials	B-X
for	B-X
sensing	B-X
.	B-X
Thus	B-X
far	B-X
,	B-X
the	B-X
combination	B-X
of	B-X
the	B-X
stimuli-responsive	B-X
DNA	B-X
hydrogels	B-X
and	B-X
multiple	B-X
sensing	B-X
platforms	B-X
is	B-X
considered	B-X
as	B-X
biocompatible	B-X
and	B-X
is	B-X
useful	B-X
as	B-X
the	B-X
flexible	B-X
recognition	B-X
components	B-X
.	B-X
A	B-X
review	B-X
of	B-X
the	B-X
stimuli-responsive	B-X
DNA	B-X
hydrogels	B-X
and	B-X
their	B-X
biosensing	B-X
applications	B-X
has	B-X
been	B-X
presented	B-X
in	B-X
this	B-X
study	B-X
.	B-X
The	B-X
synthesis	B-X
methods	B-X
to	B-X
prepare	B-X
the	B-X
DNA	B-X
hydrogels	B-X
have	B-X
been	B-X
introduced	B-X
.	B-X
Subsequently	B-X
,	B-X
the	B-X
current	B-X
status	B-X
of	B-X
the	B-X
stimuli-responsive	B-X
DNA	B-X
hydrogels	B-X
in	B-X
biosensing	B-X
has	B-X
been	B-X
described	B-X
.	B-X
The	B-X
analytical	B-X
mechanisms	B-X
are	B-X
further	B-X
elaborated	B-X
by	B-X
the	B-X
combination	B-X
of	B-X
the	B-X
stimuli-responsive	B-X
DNA	B-X
hydrogels	B-X
with	B-X
the	B-X
optical	B-X
,	B-X
electrochemical	B-X
,	B-X
point-of-care	B-X
testing	B-X
(	B-X
POCT	B-X
)	B-X
and	B-X
other	B-X
detection	B-X
platforms	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
prospects	B-X
of	B-X
the	B-X
application	B-X
of	B-X
the	B-X
stimuli-responsive	B-X
DNA	B-X
hydrogels	B-X
in	B-X
biosensing	B-X
are	B-X
presented	B-X
.	B-X

The	O
presence	O
of	O
DNA	O
in	O
peg	O
-	O
cultivated	O
biofilms	O
(	O
Fig	O
5A	O
)	O
,	O
grown	O
in	O
the	O
absence	O
of	O
exogenous	O
DNA	O
,	O
likely	O
contributes	O
to	O
the	O
increased	O
antibiotic	O
resistance	O
generally	O
observed	O
in	O
biofilms	O
(	O
Table	O
1	O
)	O
.	O

We	O
have	O
shown	O
previously	O
that	O
the	O
PA3552	B-Protein
-	O
PA3559	B-Protein
operon	O
is	O
required	O
for	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
in	O
planktonic	O
cultures	O
grown	O
in	O
limiting	O
magnesium	O
conditions	O
[	O
47	O
]	O
.	O

To	O
determine	O
if	O
DNA	O
-	O
induced	O
resistance	O
requires	O
these	O
genes	O
in	O
biofilms	O
,	O
the	O
resistance	O
phenotype	O
of	O
the	O
PA3553	B-Protein
:	O
:	O
lux	B-Protein
mutant	O
was	O
determined	O
.	O

PA3553	B-Protein
:	O
:	O
lux	B-Protein
had	O
no	O
significant	O
DNA	O
-	O
induced	O
CAP	O
resistance	O
in	O
biofilm	O
or	O
planktonic	O
cultures	O
,	O
confirming	O
that	O
these	O
genes	O
are	O
essential	O
for	O
CAP	O
resistance	O
in	O
the	O
presence	O
of	O
extracellular	O
DNA	O
(	O
Table	O
1	O
)	O
.	O

The	O
PA3553	B-Protein
mutant	O
also	O
displayed	O
decreased	O
DNA	O
-	O
induced	O
resistance	O
to	O
aminoglycosides	O
compared	O
to	O
PAO1	O
.	O

The	O
differences	O
observed	O
between	O
CAP	O
and	O
aminoglycoside	O
resistance	O
in	O
PA3553	B-Protein
:	O
:	O
lux	B-Protein
suggests	O
that	O
DNA	O
-	O
induced	O
resistance	O
to	O
aminoglycosides	O
is	O
not	O
limited	O
to	O
PA3553	B-Protein
induction	O
.	O

The	O
biofilms	O
formed	O
by	O
the	O
PA3553	B-Protein
:	O
:	O
lux	B-Protein
mutant	O
were	O
unaltered	O
compared	O
to	O
PAO1	O
biofilms	O
under	O
these	O
conditions	O
,	O
ensuring	O
that	O
the	O
difference	O
observed	O
was	O
not	O
due	O
to	O
an	O
altered	O
biofilm	O
phenotype	O
(	O
Fig	O
6B	O
)	O
.	O

The	O
CAP	O
resistance	O
phenotype	O
of	O
biofilms	O
grown	O
in	O
limiting	O
magnesium	O
(	O
20	O
microM	O
)	O
was	O
similar	O
to	O
biofilms	O
grown	O
in	O
DNA	O
,	O
confirming	O
that	O
DNA	O
imposes	O
a	O
magnesium	O
limitation	O
stress	O
(	O
Table	O
2	O
)	O
.	O

Biofilms	O
that	O
were	O
exposed	O
to	O
DNA	O
during	O
either	O
the	O
cultivation	O
or	O
challenge	O
stages	O
only	O
,	O
showed	O
similar	O
resistance	O
profiles	O
to	O
biofilms	O
grown	O
and	O
challenged	O
in	O
magnesium	O
-	O
replete	O
conditions	O
(	O
Tables	O
1	O
-	O
2	O
)	O
.	O
<EOS>	B-X
Host	B-X
factors	B-X
abolish	B-X
the	B-X
need	B-X
for	B-X
polysaccharides	B-X
and	B-X
extracellular	B-X
matrix-binding	B-X
protein	B-X
in	B-X
Ecotoxicological	B-X
experiments	B-X
were	B-X
performed	B-X
in	B-X
laboratory-scale	B-X
microcosms	B-X
to	B-X
investigate	B-X
community-level	B-X
structural	B-X
responses	B-X
of	B-X
river	B-X
phototrophic	B-X
biofilms	B-X
from	B-X
different	B-X
environments	B-X
to	B-X
herbicide	B-X
exposure	B-X
.	B-X
Biofilms	B-X
were	B-X
initially	B-X
cultivated	B-X
on	B-X
artificial	B-X
supports	B-X
placed	B-X
in	B-X
situ	B-X
for	B-X
4	B-X
weeks	B-X
at	B-X
two	B-X
sites	B-X
,	B-X
site	B-X
M	B-X
,	B-X
located	B-X
in	B-X
an	B-X
agricultural	B-X
watershed	B-X
basin	B-X
and	B-X
site	B-X
S	B-X
,	B-X
located	B-X
in	B-X
a	B-X
forested	B-X
watershed	B-X
basin	B-X
.	B-X
The	B-X
biofilms	B-X
were	B-X
subsequently	B-X
transferred	B-X
to	B-X
microcosms	B-X
and	B-X
,	B-X
after	B-X
an	B-X
acclimatisation	B-X
phase	B-X
of	B-X
7	B-X
days	B-X
were	B-X
exposed	B-X
to	B-X
alachlor	B-X
at	B-X
10	B-X
and	B-X
30	B-X
μg	B-X
L	B-X
(	B-X
-1	B-X
)	B-X
for	B-X
23	B-X
days	B-X
.	B-X
Alachlor	B-X
impacted	B-X
the	B-X
chlorophyll	B-X
a	B-X
and	B-X
ash-free	B-X
dry	B-X
mass	B-X
levels	B-X
of	B-X
phototrophic	B-X
biofilms	B-X
previously	B-X
cultivated	B-X
at	B-X
site	B-X
S.	B-X
The	B-X
structural	B-X
responses	B-X
of	B-X
bacterial	B-X
and	B-X
diatom	B-X
communities	B-X
were	B-X
difficult	B-X
to	B-X
distinguish	B-X
from	B-X
changes	B-X
linked	B-X
to	B-X
the	B-X
microcosm	B-X
incubation	B-X
period	B-X
.	B-X
Phototrophic	B-X
biofilms	B-X
from	B-X
site	B-X
S	B-X
exposed	B-X
at	B-X
30	B-X
μg	B-X
L	B-X
(	B-X
-1	B-X
)	B-X
alachlor	B-X
were	B-X
characterised	B-X
by	B-X
an	B-X
increase	B-X
of	B-X
Achnanthidium	B-X
minutissimum	B-X
(	B-X
K-z	B-X
.	B-X
)	B-X
Thus	B-X
,	B-X
phototrophic	B-X
biofilms	B-X
with	B-X
different	B-X
histories	B-X
,	B-X
exhibited	B-X
different	B-X
responses	B-X
to	B-X
alachlor	B-X
exposure	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
growth	B-X
environment	B-X
.	B-X

Therefore	O
,	O
the	O
DNA	O
-	O
induced	O
resistance	O
of	O
biofilms	O
requires	O
both	O
the	O
cultivation	O
and	O
challenge	O
under	O
cation	O
-	O
limiting	O
conditions	O
.	O

These	O
latter	O
two	O
observations	O
rule	O
out	O
the	O
possibility	O
that	O
negatively	O
charged	O
DNA	O
simply	O
interacts	O
with	O
cationic	O
antimicrobial	O
peptides	O
and	O
prevents	O
their	O
access	O
to	O
bacterial	O
cells	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Infections	O
caused	O
by	O
P	O
.	O
aeruginosa	O
continue	O
to	O
be	O
a	O
leading	O
cause	O
of	O
mortality	O
among	O
immunocompromised	O
patients	O
.	O
<EOS>	B-X
P001	B-X
-	B-X
Sepsis	B-X
impairs	B-X
the	B-X
capillary	B-X
response	B-X
within	B-X
hypoxic	B-X
capillaries	B-X
and	B-X
decreases	B-X
erythrocyte	B-X
oxygen-dependent	B-X
ATP	B-X
efflux	B-X
R.	B-X
M.	B-X
Bateman	B-X
,	B-X
M.	B-X
D.	B-X
Sharpe	B-X
,	B-X
J.	B-X
E.	B-X
Jagger	B-X
,	B-X
C.	B-X
G.	B-X
Ellis	B-X
P002	B-X
-	B-X
Lower	B-X
serum	B-X
immunoglobulin	B-X
G2	B-X
level	B-X
does	B-X
not	B-X
predispose	B-X
to	B-X
severe	B-X
flu	B-X
.	B-X
J.	B-X
Solé-Violán	B-X
,	B-X
M.	B-X
López-Rodríguez	B-X
,	B-X
E.	B-X
Herrera-Ramos	B-X
,	B-X
J.	B-X
Ruíz-Hernández	B-X
,	B-X
L.	B-X
Borderías	B-X
,	B-X
J.	B-X
Horcajada	B-X
,	B-X
N.	B-X
González-Quevedo	B-X
,	B-X
O.	B-X
Rajas	B-X
,	B-X
M.	B-X
Briones	B-X
,	B-X
F.	B-X
Rodríguez	B-X
de	B-X
Castro	B-X
,	B-X
C.	B-X
Rodríguez	B-X
Gallego	B-X
P003	B-X
-	B-X
Brain	B-X
protective	B-X
effects	B-X
of	B-X
intravenous	B-X
immunoglobulin	B-X
through	B-X
inhibition	B-X
of	B-X
complement	B-X
activation	B-X
and	B-X
apoptosis	B-X
in	B-X
a	B-X
rat	B-X
model	B-X
of	B-X
sepsis	B-X
F.	B-X
Esen	B-X
,	B-X
G.	B-X
Orhun	B-X
,	B-X
P.	B-X
Ergin	B-X
Ozcan	B-X
,	B-X
E.	B-X
Senturk	B-X
,	B-X
C.	B-X
Ugur	B-X
Yilmaz	B-X
,	B-X
N.	B-X
Orhan	B-X
,	B-X
N.	B-X
Arican	B-X
,	B-X
M.	B-X
Kaya	B-X
,	B-X
M.	B-X
Kucukerden	B-X
,	B-X
M.	B-X
Giris	B-X
,	B-X
U.	B-X
Akcan	B-X
,	B-X
S.	B-X
Bilgic	B-X
Gazioglu	B-X
,	B-X
E.	B-X
Tuzun	B-X
P004	B-X
-	B-X
Adenosine	B-X
a1	B-X
receptor	B-X
dysfunction	B-X
is	B-X
associated	B-X
with	B-X
leukopenia	B-X
:	B-X
A	B-X
possible	B-X
mechanism	B-X
for	B-X
sepsis-induced	B-X
leukopenia	B-X
R.	B-X
Riff	B-X
,	B-X
O.	B-X
Naamani	B-X
,	B-X
A.	B-X
Douvdevani	B-X
P005	B-X
-	B-X
Analysis	B-X
of	B-X
neutrophil	B-X
by	B-X
hyper	B-X
spectral	B-X
imaging	B-X
-	B-X
A	B-X
preliminary	B-X
report	B-X
R.	B-X
Takegawa	B-X
,	B-X
H.	B-X
Yoshida	B-X
,	B-X
T.	B-X
Hirose	B-X
,	B-X
N.	B-X
Yamamoto	B-X
,	B-X
H.	B-X
Hagiya	B-X
,	B-X
M.	B-X
Ojima	B-X
,	B-X
Y.	B-X
Akeda	B-X
,	B-X
O.	B-X
Tasaki	B-X
,	B-X
K.	B-X
Tomono	B-X
,	B-X
T.	B-X
Shimazu	B-X
P006	B-X
-	B-X
Chemiluminescent	B-X
intensity	B-X
assessed	B-X
by	B-X
eaa	B-X
predicts	B-X
the	B-X
incidence	B-X
of	B-X
postoperative	B-X
infectious	B-X
complications	B-X
following	B-X
gastrointestinal	B-X
surgery	B-X
S.	B-X
Ono	B-X
,	B-X
T.	B-X
Kubo	B-X
,	B-X
S.	B-X
Suda	B-X
,	B-X
T.	B-X
Ueno	B-X
,	B-X
T.	B-X
Ikeda	B-X
P007	B-X
-	B-X
Serial	B-X
change	B-X
of	B-X
c1	B-X
inhibitor	B-X
in	B-X
patients	B-X
with	B-X
sepsis	B-X
–	B-X
A	B-X
prospective	B-X
observational	B-X
study	B-X
T.	B-X
Hirose	B-X
,	B-X
H.	B-X
Ogura	B-X
,	B-X
H.	B-X
Takahashi	B-X
,	B-X
M.	B-X
Ojima	B-X
,	B-X
J.	B-X
Kang	B-X
,	B-X
Y.	B-X
Nakamura	B-X
,	B-X
T.	B-X
Kojima	B-X
,	B-X
T.	B-X
Shimazu	B-X
P008	B-X
-	B-X
Comparison	B-X
of	B-X
bacteremia	B-X
and	B-X
sepsis	B-X
on	B-X
sepsis	B-X
related	B-X
biomarkers	B-X
T.	B-X
Ikeda	B-X
,	B-X
S.	B-X
Suda	B-X
,	B-X
Y.	B-X
Izutani	B-X
,	B-X
T.	B-X
Ueno	B-X
,	B-X
S.	B-X
Ono	B-X
P009	B-X
-	B-X
The	B-X
changes	B-X
of	B-X
procalcitonin	B-X
levels	B-X
in	B-X
critical	B-X
patients	B-X
with	B-X
abdominal	B-X
septic	B-X
shock	B-X
during	B-X
blood	B-X
purification	B-X
T.	B-X
Taniguchi	B-X
,	B-X
M.	B-X
O	B-X
P010	B-X
-	B-X
Validation	B-X
of	B-X
a	B-X
new	B-X
sensitive	B-X
point	B-X
of	B-X
care	B-X
device	B-X
for	B-X
rapid	B-X
measurement	B-X
of	B-X
procalcitonin	B-X
C.	B-X
Dinter	B-X
,	B-X
J.	B-X
Lotz	B-X
,	B-X
B.	B-X
Eilers	B-X
,	B-X
C.	B-X
Wissmann	B-X
,	B-X
R.	B-X
Lott	B-X
P011	B-X
-	B-X
Infection	B-X
biomarkers	B-X
in	B-X
primary	B-X
care	B-X
patients	B-X
with	B-X
acute	B-X
respiratory	B-X
tract	B-X
infections	B-X
–	B-X
Comparison	B-X
of	B-X
procalcitonin	B-X
and	B-X
C-reactive	B-X
protein	B-X
M.	B-X
M.	B-X
Meili	B-X
,	B-X
P.	B-X
S.	B-X
Schuetz	B-X
P012	B-X
-	B-X
Do	B-X
we	B-X
need	B-X
a	B-X
lower	B-X
procalcitonin	B-X
cut	B-X
off	B-X
?	B-X
H.	B-X
Hawa	B-X
,	B-X
M.	B-X
Sharshir	B-X
,	B-X
M.	B-X
Aburageila	B-X
,	B-X
N.	B-X
Salahuddin	B-X
P013	B-X
-	B-X
The	B-X
predictive	B-X
role	B-X
of	B-X
C-reactive	B-X
protein	B-X
and	B-X
procalcitonin	B-X
biomarkers	B-X
in	B-X
central	B-X
nervous	B-X
system	B-X
infections	B-X
with	B-X
extensively	B-X
drug	B-X
resistant	B-X
bacteria	B-X
V.	B-X
Chantziara	B-X
,	B-X
S.	B-X
Georgiou	B-X
,	B-X
A.	B-X
Tsimogianni	B-X
,	B-X
P.	B-X
Alexandropoulos	B-X
,	B-X
A.	B-X
Vassi	B-X
,	B-X
F.	B-X
Lagiou	B-X
,	B-X
M.	B-X
Valta	B-X
,	B-X
G.	B-X
Micha	B-X
,	B-X
E.	B-X
Chinou	B-X
,	B-X
G.	B-X
Michaloudis	B-X
P014	B-X
-	B-X
Changes	B-X
in	B-X
endotoxin	B-X
activity	B-X
assay	B-X
and	B-X
procalcitonin	B-X
levels	B-X
after	B-X
direct	B-X
hemoperfusion	B-X
with	B-X
polymyxin-b	B-X
immobilized	B-X
fiber	B-X
A.	B-X
Kodaira	B-X
,	B-X
T.	B-X
Ikeda	B-X
,	B-X
S.	B-X
Ono	B-X
,	B-X
T.	B-X
Ueno	B-X
,	B-X
S.	B-X
Suda	B-X
,	B-X
Y.	B-X
Izutani	B-X
,	B-X
H.	B-X

The	O
ability	O
of	O
P	O
.	O
aeruginosa	O
to	O
form	O
biofilms	O
promotes	O
survival	O
of	O
the	O
bacteria	O
in	O
the	O
presence	O
of	O
antimicrobials	O
and	O
host	O
defense	O
mechanisms	O
and	O
is	O
thought	O
to	O
contribute	O
significantly	O
to	O
its	O
ability	O
to	O
survive	O
long	O
-	O
term	O
within	O
the	O
hostile	O
environment	O
of	O
chronically	O
-	O
infected	O
patients	O
.	O

Understanding	O
the	O
mechanisms	O
underlying	O
antibiotic	O
resistance	O
and	O
especially	O
biofilm	O
-	O
specific	O
antimicrobial	O
resistance	O
is	O
of	O
significant	O
importance	O
in	O
the	O
development	O
of	O
new	O
treatment	O
options	O
and	O
/	O
or	O
strategies	O
.	O
<EOS>	B-X
The	B-X
management	B-X
of	B-X
patients	B-X
has	B-X
dramatically	B-X
changed	B-X
with	B-X
the	B-X
advent	B-X
of	B-X
anti-HER2	B-X
treatment	B-X
,	B-X
especially	B-X
the	B-X
monoclonal	B-X
antibodies	B-X
since	B-X
2000	B-X
in	B-X
the	B-X
metastatic	B-X
and	B-X
(	B-X
neo	B-X
)	B-X
-adjuvant	B-X
setting	B-X
,	B-X
leading	B-X
to	B-X
an	B-X
improvement	B-X
of	B-X
patient	B-X
outcomes	B-X
.	B-X
If	B-X
therapeutic	B-X
arsenal	B-X
has	B-X
been	B-X
gradually	B-X
enhanced	B-X
with	B-X
the	B-X
targeting	B-X
of	B-X
HER	B-X
receptors	B-X
family	B-X
,	B-X
resistances	B-X
to	B-X
these	B-X
treatments	B-X
are	B-X
observed	B-X
,	B-X
hence	B-X
the	B-X
development	B-X
of	B-X
new	B-X
therapeutic	B-X
strategies	B-X
.	B-X
This	B-X
review	B-X
provides	B-X
an	B-X
updated	B-X
look	B-X
of	B-X
novel	B-X
therapeutic	B-X
strategies	B-X
in	B-X
HER2-positive	B-X
breast	B-X
cancer	B-X
,	B-X
as	B-X
well	B-X
as	B-X
future	B-X
perspectives	B-X
,	B-X
both	B-X
in	B-X
the	B-X
adjuvant	B-X
and	B-X
metastatic	B-X
setting	B-X
.	B-X
Identifying	B-X
,	B-X
developing	B-X
,	B-X
and	B-X
testing	B-X
implementation	B-X
strategies	B-X
are	B-X
important	B-X
goals	B-X
of	B-X
implementation	B-X
science	B-X
.	B-X
However	B-X
,	B-X
these	B-X
efforts	B-X
have	B-X
been	B-X
complicated	B-X
by	B-X
the	B-X
use	B-X
of	B-X
inconsistent	B-X
language	B-X
and	B-X
inadequate	B-X
descriptions	B-X
of	B-X
implementation	B-X
strategies	B-X
in	B-X
the	B-X
literature	B-X
.	B-X

We	O
have	O
identified	O
a	O
novel	O
mechanism	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
in	O
which	O
the	O
presence	O
of	O
DNA	O
in	O
the	O
extracellular	O
matrix	O
of	O
biofilms	O
creates	O
a	O
localized	O
cation	O
-	O
limited	O
environment	O
that	O
is	O
detected	O
by	O
P	O
.	O
aeruginosa	O
leading	O
to	O
the	O
induction	O
of	O
LPS	O
modification	O
genes	O
and	O
resistance	O
to	O
antimicrobials	O
.	O

Magnesium	O
limitation	O
has	O
long	O
been	O
known	O
as	O
an	O
in	O
vitro	O
signal	O
that	O
induces	O
resistance	O
to	O
CAPs	O
in	O
P	O
.	O
aeruginosa	O
[	O
59	O
]	O
.	O

As	O
an	O
intracellular	O
pathogen	O
,	O
the	O
PhoPQ	B-Protein
system	O
of	O
Salmonella	O
typhimurium	O
is	O
activated	O
by	O
limiting	O
magnesium	O
in	O
vitro	O
and	O
phoP	B-Protein
-	O
regulated	O
genes	O
are	O
also	O
induced	O
after	O
invasion	O
of	O
macrophages	O
and	O
epithelial	O
cells	O
[	O
65	O
]	O
.	O

These	O
observations	O
suggested	O
that	O
Mg2	O
+	O
is	O
limiting	O
within	O
host	O
cells	O
,	O
but	O
it	O
was	O
recently	O
shown	O
that	O
vacuole	O
acidification	O
and	O
low	O
pH	O
is	O
the	O
crucial	O
environmental	O
trigger	O
of	O
PhoPQ	B-Protein
activation	O
[	O
66	O
]	O
.	O

Many	O
extracellular	O
pathogens	O
possess	O
homologs	O
of	O
the	O
cation	O
-	O
sensing	O
PhoPQ	B-Protein
TCS	O
that	O
responds	O
to	O
magnesium	O
limitation	O
and	O
induces	O
genes	O
necessary	O
for	O
surviving	O
this	O
environmental	O
challenge	O
[	O
65	O
]	O
.	O

However	O
,	O
to	O
date	O
the	O
identification	O
of	O
a	O
relevant	O
in	O
vivo	O
environment	O
for	O
P	O
.	O
aeruginosa	O
which	O
is	O
cation	O
limited	O
has	O
remained	O
elusive	O
.	O

We	O
have	O
demonstrated	O
that	O
DNA	O
-	O
rich	O
environments	O
,	O
such	O
as	O
biofilms	O
,	O
are	O
cation	O
limited	O
.	O

While	O
Mg2	O
+	O
limitation	O
has	O
been	O
identified	O
as	O
a	O
signal	O
involved	O
in	O
induced	O
resistance	O
to	O
aminoglycosides	O
in	O
P	O
.	O
aeruginosa	O
[	O
59	O
]	O
,	O
the	O
contribution	O
of	O
the	O
PhoPQ	B-Protein
-	O
regulated	O
LPS	O
modifications	O
has	O
not	O
been	O
clearly	O
determined	O
.	O

PhoQ	B-Protein
mutants	O
,	O
which	O
constitutively	O
express	O
phoP	B-Protein
and	O
are	O
constitutively	O
resistant	O
to	O
cationic	O
antimicrobial	O
peptides	O
,	O
are	O
also	O
more	O
resistant	O
to	O
aminoglycosides	O
[	O
43	O
]	O
.	O

In	O
S	O
.	O
typhimurium	O
,	O
PhoPQ	B-Protein
regulates	O
multiple	O
LPS	O
modifications	O
that	O
decrease	O
the	O
OM	O
permeability	O
to	O
membrane	O
cationic	O
dyes	O
,	O
bile	O
salts	O
and	O
antibiotics	O
,	O
including	O
gentamicin	O
[	O
67	O
]	O
.	O

We	O
report	O
here	O
that	O
DNA	O
-	O
induces	O
aminoglycoside	O
resistance	O
in	O
P	O
.	O
aeruginosa	O
biofilms	O
,	O
and	O
this	O
resistance	O
is	O
partially	O
dependent	O
on	O
the	O
LPS	O
modification	O
operon	O
PA3552	B-Protein
-	O
PA3559	B-Protein
.	O

The	O
aminoarabinose	O
modification	O
likely	O
blocks	O
the	O
self	O
-	O
promoted	O
uptake	O
of	O
aminoglycosides	O
,	O
which	O
normally	O
bind	O
and	O
displace	O
cations	O
that	O
crosslink	O
adjacent	O
LPS	O
molecules	O
[	O
68	O
]	O
.	O

Previous	O
reports	O
have	O
documented	O
the	O
involvement	O
of	O
P	O
.	O
aeruginosa	O
PmrAB	B-Protein
[	O
49	O
]	O
and	O
the	O
E	O
.	O
coli	O
PmrAB	B-Protein
homologs	O
BasRS	B-Protein
[	O
69	O
]	O
in	O
regulating	O
the	O
formation	O
of	O
an	O
antimicrobial	O
peptide	O
-	O
tolerant	O
subpopulation	O
within	O
biofilms	O
.	O

In	O
pure	O
culture	O
P	O
.	O
aeruginosa	O
biofilms	O
,	O
genomic	O
DNA	O
localizes	O
throughout	O
the	O
biofilm	O
surface	O
monolayer	O
and	O
surrounds	O
the	O
mushroom	O
-	O
shaped	O
microcolonies	O
[	O
51	O
]	O
.	O

This	O
coincides	O
with	O
the	O
localization	O
of	O
a	O
CAP	O
-	O
tolerant	O
subpopulation	O
of	O
bacteria	O
that	O
expresses	O
the	O
PA3552	B-Protein
-	O
PA3559	B-Protein
operon	O
along	O
the	O
surface	O
of	O
mushroom	O
-	O
structured	O
P	O
.	O
aeruginosa	O
biofilms	O
[	O
49	O
]	O
.	O

To	O
date	O
,	O
it	O
was	O
thought	O
unlikely	O
that	O
a	O
biofilm	O
environment	O
may	O
be	O
cation	O
limited	O
.	O

However	O
,	O
our	O
data	O
indicates	O
that	O
the	O
presence	O
of	O
DNA	O
in	O
biofilms	O
does	O
indeed	O
result	O
in	O
a	O
cation	O
-	O
limited	O
environment	O
,	O
resulting	O
in	O
the	O
induction	O
of	O
the	O
LPS	O
modification	O
operon	O
PA3552	B-Protein
-	O
PA3559	B-Protein
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
report	O
to	O
identify	O
the	O
antimicrobial	O
properties	O
of	O
DNA	O
.	O
<EOS>	B-X
Also	B-X
being	B-X
reported	B-X
to	B-X
have	B-X
anti-inflammatory	B-X
,	B-X
antimicrobial	B-X
,	B-X
antioxidant	B-X
,	B-X
antidiarrheal	B-X
,	B-X
antimutagenic	B-X
properties	B-X
(	B-X
Somu	B-X
,	B-X
2012	B-X
)	B-X
.	B-X
For	B-X
further	B-X
confirmation	B-X
,	B-X
from	B-X
a	B-X
purified	B-X
isolate	B-X
GWD10	B-X
,	B-X
genomic	B-X
DNA	B-X
was	B-X
extracted	B-X
.	B-X
MN	B-X
365128	B-X
&	B-X
MT952139	B-X
)	B-X
on	B-X
BLAST	B-X
analysis	B-X
showed	B-X
100	B-X
%	B-X
homology	B-X
for	B-X
ITS	B-X
and	B-X
TEF	B-X
with	B-X
Ceratocystis	B-X
manginecans	B-X
(	B-X
Accession	B-X
No.	B-X
,	B-X
KC261852	B-X
CMW	B-X
13582	B-X
Voucher	B-X
,	B-X
NR-119532.1	B-X
type	B-X
material	B-X
,	B-X
MH863135	B-X
;	B-X
EF433317	B-X
,	B-X
respectively	B-X
)	B-X
reported	B-X
from	B-X
Oman	B-X
and	B-X
Pakistan	B-X
(	B-X
Van	B-X
Wyk	B-X
et	B-X
al.	B-X
,	B-X
2007	B-X
&	B-X
Vu	B-X
et	B-X
al.	B-X
,	B-X
2019	B-X
)	B-X
.	B-X
To	B-X
our	B-X
knowledge	B-X
,	B-X
this	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
Ceratocystis	B-X
manginecans	B-X
causing	B-X
quick	B-X
decline	B-X
of	B-X
P.	B-X
guajava	B-X
worldwide	B-X
.	B-X

Above	O
certain	O
concentrations	O
(	O
approximately0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
extracellular	O
DNA	O
inhibited	O
planktonic	O
growth	O
and	O
biofilm	O
formation	O
.	O

Recently	O
,	O
a	O
novel	O
host	O
defense	O
mechanism	O
was	O
discovered	O
whereby	O
stimulated	O
neutrophils	O
ejected	O
a	O
mesh	O
-	O
like	O
net	O
of	O
intracellular	O
DNA	O
and	O
proteins	O
that	O
functions	O
to	O
trap	O
and	O
kill	O
pathogens	O
[	O
70	O
]	O
.	O

The	O
antimicrobial	O
property	O
of	O
neutrophil	O
nets	O
was	O
attributed	O
to	O
DNA	O
-	O
associated	O
histones	O
and	O
other	O
antimicrobial	O
peptides	O
[	O
70	O
]	O
.	O

However	O
,	O
our	O
results	O
demonstrate	O
that	O
above	O
certain	O
concentrations	O
,	O
the	O
DNA	O
itself	O
is	O
antimicrobial	O
due	O
to	O
cation	O
chelation	O
.	O

In	O
principle	O
,	O
cation	O
chelation	O
by	O
DNA	O
is	O
similar	O
to	O
another	O
recently	O
identified	O
host	O
defense	O
mechanism	O
,	O
where	O
the	O
Mn2	O
+	O
and	O
Zn2	O
+	O
metal	O
chelation	O
properties	O
of	O
the	O
host	O
innate	O
-	O
immune	O
protein	O
calprotectin	O
was	O
shown	O
to	O
limit	O
Staphylococcus	O
aureus	O
growth	O
in	O
tissue	O
abscesses	O
[	O
71	O
]	O
.	O

Staining	O
of	O
peg	O
-	O
adhered	O
biofilms	O
indicated	O
that	O
DNA	O
was	O
present	O
throughout	O
the	O
biofilm	O
.	O

(	O
Fig	O
5B	O
)	O
.	O
<EOS>	B-X
Following	B-X
the	B-X
publication	B-X
of	B-X
this	B-X
paper	B-X
,	B-X
it	B-X
was	B-X
drawn	B-X
to	B-X
the	B-X
Editors	B-X
'	B-X
attention	B-X
by	B-X
a	B-X
concerned	B-X
reader	B-X
that	B-X
the	B-X
western	B-X
blotting	B-X
data	B-X
featured	B-X
in	B-X
Fig	B-X
.	B-X
5B	B-X
and	B-X
C	B-X
,	B-X
and	B-X
also	B-X
in	B-X
Fig	B-X
.	B-X
Following	B-X
the	B-X
publication	B-X
of	B-X
this	B-X
paper	B-X
,	B-X
it	B-X
was	B-X
drawn	B-X
to	B-X
the	B-X
Editors	B-X
'	B-X
attention	B-X
by	B-X
a	B-X
concerned	B-X
reader	B-X
that	B-X
various	B-X
panels	B-X
showing	B-X
the	B-X
western	B-X
blotting	B-X
data	B-X
in	B-X
Figs	B-X
.	B-X
1D	B-X
,	B-X
3A	B-X
,	B-X
6A	B-X
and	B-X
C	B-X
,	B-X
9B	B-X
and	B-X
10A	B-X
,	B-X
the	B-X
Transwell	B-X
migration	B-X
and	B-X
invasion	B-X
assays	B-X
in	B-X
Fig	B-X
.	B-X
10C	B-X
,	B-X
and	B-X
the	B-X
H	B-X
&	B-X
E	B-X
staining	B-X
images	B-X
from	B-X
the	B-X
lung	B-X
portrayed	B-X
in	B-X
Fig	B-X
.	B-X
5B	B-X
were	B-X
strikingly	B-X
similar	B-X
to	B-X
data	B-X
largely	B-X
appearing	B-X
in	B-X
different	B-X
form	B-X
in	B-X
other	B-X
articles	B-X
by	B-X
different	B-X
authors	B-X
from	B-X
different	B-X
research	B-X
institutions	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
data	B-X
panels	B-X
showing	B-X
the	B-X
Transwell	B-X
migration	B-X
and	B-X
assay	B-X
experiments	B-X
in	B-X
Figs	B-X
.	B-X

This	O
data	O
supports	O
the	O
hypothesis	O
that	O
the	O
release	O
of	O
genomic	O
DNA	O
by	O
lysed	O
cells	O
following	O
exposure	O
to	O
inhibitory	O
concentrations	O
of	O
extracellular	O
DNA	O
may	O
result	O
in	O
a	O
continual	O
release	O
of	O
DNA	O
by	O
dying	O
cells	O
and	O
a	O
DNA	O
gradient	O
within	O
the	O
biofilm	O
.	O

Our	O
observation	O
that	O
DNA	O
imposes	O
a	O
cation	O
gradient	O
in	O
biofilm	O
is	O
also	O
consistent	O
with	O
previous	O
reports	O
of	O
oxygen	O
and	O
nutrient	O
gradients	O
within	O
biofilms	O
,	O
which	O
result	O
in	O
diverse	O
physiological	O
cellular	O
states	O
within	O
a	O
biofilm	O
community	O
[	O
72	O
]	O
.	O

Although	O
DNA	O
is	O
toxic	O
at	O
high	O
concentrations	O
,	O
it	O
functions	O
as	O
a	O
double	O
-	O
edged	O
sword	O
whereby	O
sub	O
-	O
inhibitory	O
DNA	O
concentrations	O
serve	O
to	O
protect	O
bacteria	O
from	O
antibiotic	O
exposure	O
,	O
either	O
from	O
the	O
host	O
immune	O
response	O
or	O
from	O
antimicrobial	O
treatment	O
.	O
<EOS>	B-X
The	B-X
drivers	B-X
of	B-X
antimicrobial	B-X
resistance	B-X
include	B-X
antimicrobial	B-X
use	B-X
and	B-X
abuse	B-X
in	B-X
human	B-X
,	B-X
animal	B-X
,	B-X
and	B-X
environmental	B-X
sectors	B-X
and	B-X
the	B-X
spread	B-X
of	B-X
resistant	B-X
bacteria	B-X
and	B-X
resistance	B-X
determinants	B-X
within	B-X
and	B-X
between	B-X
these	B-X
sectors	B-X
and	B-X
around	B-X
the	B-X
globe	B-X
.	B-X
Most	B-X
of	B-X
the	B-X
classes	B-X
of	B-X
antimicrobials	B-X
used	B-X
to	B-X
treat	B-X
bacterial	B-X
infections	B-X
in	B-X
humans	B-X
are	B-X
also	B-X
used	B-X
in	B-X
animals	B-X
.	B-X
Given	B-X
the	B-X
important	B-X
and	B-X
interdependent	B-X
human	B-X
,	B-X
animal	B-X
,	B-X
and	B-X
environmental	B-X
dimensions	B-X
of	B-X
antimicrobial	B-X
resistance	B-X
,	B-X
it	B-X
is	B-X
logical	B-X
to	B-X
take	B-X
a	B-X
One	B-X
Health	B-X
approach	B-X
when	B-X
addressing	B-X
this	B-X
problem	B-X
.	B-X
This	B-X
includes	B-X
taking	B-X
steps	B-X
to	B-X
preserve	B-X
the	B-X
continued	B-X
effectiveness	B-X
of	B-X
existing	B-X
antimicrobials	B-X
by	B-X
eliminating	B-X
their	B-X
inappropriate	B-X
use	B-X
and	B-X
by	B-X
limiting	B-X
the	B-X
spread	B-X
of	B-X
infection	B-X
.	B-X
Major	B-X
concerns	B-X
in	B-X
the	B-X
animal	B-X
health	B-X
and	B-X
agriculture	B-X
sectors	B-X
are	B-X
mass	B-X
medication	B-X
of	B-X
animals	B-X
with	B-X
antimicrobials	B-X
that	B-X
are	B-X
critically	B-X
important	B-X
for	B-X
humans	B-X
,	B-X
such	B-X
as	B-X
third-generation	B-X
cephalosporins	B-X
and	B-X
fluoroquinolones	B-X
,	B-X
and	B-X
the	B-X
long-term	B-X
,	B-X
in-feed	B-X
use	B-X
of	B-X
medically	B-X
important	B-X
antimicrobials	B-X
,	B-X
such	B-X
as	B-X
colistin	B-X
,	B-X
tetracyclines	B-X
,	B-X
and	B-X
macrolides	B-X
,	B-X
for	B-X
growth	B-X
promotion	B-X
.	B-X
In	B-X
the	B-X
human	B-X
sector	B-X
it	B-X
is	B-X
essential	B-X
to	B-X
prevent	B-X
infections	B-X
,	B-X
reduce	B-X
over-prescribing	B-X
of	B-X
antimicrobials	B-X
,	B-X
improve	B-X
sanitation	B-X
,	B-X
and	B-X
improve	B-X
hygiene	B-X
and	B-X
infection	B-X
control	B-X
.	B-X
Pollution	B-X
from	B-X
inadequate	B-X
treatment	B-X
of	B-X
industrial	B-X
,	B-X
residential	B-X
,	B-X
and	B-X
farm	B-X
waste	B-X
is	B-X
expanding	B-X
the	B-X
resistome	B-X
in	B-X
the	B-X
environment	B-X
.	B-X
Numerous	B-X
countries	B-X
and	B-X
several	B-X
international	B-X
agencies	B-X
have	B-X
included	B-X
a	B-X
One	B-X
Health	B-X
approach	B-X
within	B-X
their	B-X
action	B-X
plans	B-X
to	B-X
address	B-X
antimicrobial	B-X
resistance	B-X
.	B-X
Necessary	B-X
actions	B-X
include	B-X
improvements	B-X
in	B-X
antimicrobial	B-X
use	B-X
regulation	B-X
and	B-X
policy	B-X
,	B-X
surveillance	B-X
,	B-X
stewardship	B-X
,	B-X
infection	B-X
control	B-X
,	B-X
sanitation	B-X
,	B-X
animal	B-X
husbandry	B-X
,	B-X
and	B-X
alternatives	B-X
to	B-X
antimicrobials	B-X
.	B-X
WHO	B-X
recently	B-X
has	B-X
launched	B-X
new	B-X
guidelines	B-X
on	B-X
the	B-X
use	B-X
of	B-X
medically	B-X
important	B-X
antimicrobials	B-X
in	B-X
food-producing	B-X
animals	B-X
,	B-X
recommending	B-X
that	B-X
farmers	B-X
and	B-X
the	B-X
food	B-X
industry	B-X
stop	B-X
using	B-X
antimicrobials	B-X
routinely	B-X
to	B-X
promote	B-X
growth	B-X
and	B-X
prevent	B-X
disease	B-X
in	B-X
healthy	B-X
animals	B-X
.	B-X
These	B-X
guidelines	B-X
aim	B-X
to	B-X
help	B-X
preserve	B-X
the	B-X
effectiveness	B-X
of	B-X
antimicrobials	B-X
that	B-X
are	B-X
important	B-X
for	B-X
human	B-X
medicine	B-X
by	B-X
reducing	B-X
their	B-X
use	B-X
in	B-X
animals	B-X
.	B-X

It	O
has	O
previously	O
been	O
reported	O
that	O
Mg2	O
+	O
concentrations	O
within	O
the	O
airway	O
surface	O
fluid	O
are	O
high	O
(	O
2	O
.	O
2	O
mM	O
)	O
[	O
73	O
]	O
,	O
[	O
74	O
]	O
.	O

However	O
,	O
sputum	O
samples	O
from	O
the	O
lungs	O
of	O
CF	O
patients	O
have	O
very	O
high	O
concentrations	O
of	O
DNA	O
,	O
up	O
to	O
20	O
mg	O
/	O
ml	O
(	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
[	O
75	O
]	O
,	O
[	O
76	O
]	O
.	O

It	O
is	O
likely	O
that	O
within	O
the	O
CF	O
lung	O
,	O
localized	O
cation	O
limited	O
environments	O
exist	O
within	O
DNA	O
-	O
rich	O
microcolonies	O
.	O

It	O
is	O
also	O
known	O
that	O
CF	O
airway	O
fluid	O
contains	O
high	O
levels	O
of	O
neutrophil	O
defensins	O
[	O
77	O
]	O
and	O
that	O
sub	O
-	O
lethal	O
doses	O
of	O
CAPs	O
induce	O
PA3553	B-Protein
gene	O
expression	O
,	O
although	O
independently	O
of	O
PhoPQ	B-Protein
and	O
PmrAB	B-Protein
[	O
45	O
]	O
.	O

Therefore	O
,	O
it	O
appears	O
that	O
there	O
are	O
multiple	O
environmental	O
signals	O
in	O
the	O
CF	O
lung	O
that	O
can	O
induce	O
the	O
expression	O
the	O
PA3552	B-Protein
-	O
PA3559	B-Protein
operon	O
,	O
which	O
may	O
explain	O
why	O
many	O
P	O
.	O
aeruginosa	O
CF	O
isolates	O
show	O
LPS	O
modifications	O
such	O
as	O
aminoarabinose	O
addition	O
to	O
lipid	O
A	O
[	O
78	O
]	O
.	O

As	O
many	O
P	O
.	O
aeruginosa	O
strains	O
isolated	O
from	O
the	O
CF	O
lung	O
overproduce	O
the	O
negatively	O
charged	O
EPS	O
alginate	O
,	O
we	O
hypothesized	O
that	O
alginate	O
may	O
also	O
be	O
a	O
relevant	O
in	O
vivo	O
signal	O
inducing	O
expression	O
of	O
the	O
PA3552	B-Protein
-	O
PA3559	B-Protein
operon	O
.	O

However	O
,	O
induction	O
of	O
PA3553	B-Protein
gene	O
expression	O
does	O
not	O
occur	O
in	O
the	O
presence	O
of	O
alginate	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
Transcription	B-X
can	B-X
be	B-X
strongly	B-X
repressed	B-X
by	B-X
lac	B-X
repressor	B-X
bound	B-X
to	B-X
an	B-X
operator	B-X
centered	B-X
15	B-X
base-pairs	B-X
downstream	B-X
from	B-X
the	B-X
RNA	B-X
start	B-X
,	B-X
but	B-X
T7	B-X
RNA	B-X
polymerase	B-X
initiates	B-X
transcription	B-X
very	B-X
actively	B-X
from	B-X
this	B-X
T7lac	B-X
promoter-operator	B-X
combination	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
repressor	B-X
,	B-X
or	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
repressor	B-X
plus	B-X
inducer	B-X
.	B-X
The	B-X
pET-10	B-X
and	B-X
pET-11	B-X
series	B-X
of	B-X
plasmid	B-X
vectors	B-X
have	B-X
been	B-X
constructed	B-X
to	B-X
allow	B-X
target	B-X
genes	B-X
to	B-X
be	B-X
placed	B-X
under	B-X
control	B-X
of	B-X
the	B-X
T7lac	B-X
promoter	B-X
and	B-X
to	B-X
be	B-X
expressed	B-X
in	B-X
BL21	B-X
(	B-X
DE3	B-X
)	B-X
or	B-X
HMS174	B-X
(	B-X
DE3	B-X
)	B-X
,	B-X
which	B-X
carry	B-X
an	B-X
inducible	B-X
gene	B-X
for	B-X
T7	B-X
RNA	B-X
polymerase	B-X
.	B-X
These	B-X
vectors	B-X
carry	B-X
a	B-X
lacI	B-X
gene	B-X
that	B-X
provides	B-X
enough	B-X
lac	B-X
repressor	B-X
to	B-X
repress	B-X
both	B-X
the	B-X
T7lac	B-X
promoter	B-X
in	B-X
the	B-X
multicopy	B-X
vectors	B-X
and	B-X
the	B-X
chromosomal	B-X
gene	B-X
for	B-X
T7	B-X
RNA	B-X
polymerase	B-X
,	B-X
which	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
lacUV5	B-X
promoter	B-X
.	B-X
Very	B-X
low	B-X
basal	B-X
expression	B-X
of	B-X
target	B-X
genes	B-X
is	B-X
achieved	B-X
,	B-X
but	B-X
the	B-X
usual	B-X
high	B-X
levels	B-X
of	B-X
expression	B-X
are	B-X
obtained	B-X
upon	B-X
induction	B-X
.	B-X
Addition	B-X
of	B-X
T7	B-X
lysozyme	B-X
can	B-X
reduce	B-X
basal	B-X
expression	B-X
even	B-X
further	B-X
and	B-X
still	B-X
allow	B-X
high	B-X
levels	B-X
of	B-X
expression	B-X
upon	B-X
induction	B-X
.	B-X

The	O
observation	O
that	O
DNA	O
is	O
present	O
in	O
the	O
lungs	O
of	O
CF	O
patients	O
has	O
prompted	O
the	O
use	O
of	O
DNAseI	O
as	O
a	O
therapeutic	O
agent	O
to	O
reduce	O
the	O
sputum	O
viscosity	O
and	O
improve	O
lung	O
function	O
[	O
75	O
]	O
,	O
[	O
76	O
]	O
.	O

However	O
,	O
our	O
data	O
suggests	O
that	O
the	O
success	O
of	O
DNAseI	O
therapy	O
may	O
,	O
in	O
part	O
,	O
be	O
attributed	O
to	O
the	O
degradation	O
of	O
DNA	O
and	O
subsequent	O
disarming	O
of	O
the	O
PhoPQ	B-Protein
/	O
PmrAB	B-Protein
response	O
and	O
antibiotic	O
resistance	O
mechanisms	O
.	O

While	O
previous	O
studies	O
have	O
shown	O
the	O
biofilm	O
matrix	O
to	O
function	O
as	O
a	O
diffusion	O
barrier	O
to	O
antibiotics	O
,	O
these	O
results	O
demonstrate	O
a	O
novel	O
function	O
of	O
the	O
biofilm	O
matrix	O
component	O
DNA	O
,	O
where	O
the	O
cation	O
chelating	O
properties	O
of	O
DNA	O
in	O
biofilms	O
induces	O
resistance	O
to	O
host	O
-	O
derived	O
or	O
therapeutic	O
antimicrobials	O
.	O
<EOS>	B-X
The	B-X
drivers	B-X
of	B-X
antimicrobial	B-X
resistance	B-X
include	B-X
antimicrobial	B-X
use	B-X
and	B-X
abuse	B-X
in	B-X
human	B-X
,	B-X
animal	B-X
,	B-X
and	B-X
environmental	B-X
sectors	B-X
and	B-X
the	B-X
spread	B-X
of	B-X
resistant	B-X
bacteria	B-X
and	B-X
resistance	B-X
determinants	B-X
within	B-X
and	B-X
between	B-X
these	B-X
sectors	B-X
and	B-X
around	B-X
the	B-X
globe	B-X
.	B-X
Most	B-X
of	B-X
the	B-X
classes	B-X
of	B-X
antimicrobials	B-X
used	B-X
to	B-X
treat	B-X
bacterial	B-X
infections	B-X
in	B-X
humans	B-X
are	B-X
also	B-X
used	B-X
in	B-X
animals	B-X
.	B-X
Given	B-X
the	B-X
important	B-X
and	B-X
interdependent	B-X
human	B-X
,	B-X
animal	B-X
,	B-X
and	B-X
environmental	B-X
dimensions	B-X
of	B-X
antimicrobial	B-X
resistance	B-X
,	B-X
it	B-X
is	B-X
logical	B-X
to	B-X
take	B-X
a	B-X
One	B-X
Health	B-X
approach	B-X
when	B-X
addressing	B-X
this	B-X
problem	B-X
.	B-X
This	B-X
includes	B-X
taking	B-X
steps	B-X
to	B-X
preserve	B-X
the	B-X
continued	B-X
effectiveness	B-X
of	B-X
existing	B-X
antimicrobials	B-X
by	B-X
eliminating	B-X
their	B-X
inappropriate	B-X
use	B-X
and	B-X
by	B-X
limiting	B-X
the	B-X
spread	B-X
of	B-X
infection	B-X
.	B-X
Major	B-X
concerns	B-X
in	B-X
the	B-X
animal	B-X
health	B-X
and	B-X
agriculture	B-X
sectors	B-X
are	B-X
mass	B-X
medication	B-X
of	B-X
animals	B-X
with	B-X
antimicrobials	B-X
that	B-X
are	B-X
critically	B-X
important	B-X
for	B-X
humans	B-X
,	B-X
such	B-X
as	B-X
third-generation	B-X
cephalosporins	B-X
and	B-X
fluoroquinolones	B-X
,	B-X
and	B-X
the	B-X
long-term	B-X
,	B-X
in-feed	B-X
use	B-X
of	B-X
medically	B-X
important	B-X
antimicrobials	B-X
,	B-X
such	B-X
as	B-X
colistin	B-X
,	B-X
tetracyclines	B-X
,	B-X
and	B-X
macrolides	B-X
,	B-X
for	B-X
growth	B-X
promotion	B-X
.	B-X
In	B-X
the	B-X
human	B-X
sector	B-X
it	B-X
is	B-X
essential	B-X
to	B-X
prevent	B-X
infections	B-X
,	B-X
reduce	B-X
over-prescribing	B-X
of	B-X
antimicrobials	B-X
,	B-X
improve	B-X
sanitation	B-X
,	B-X
and	B-X
improve	B-X
hygiene	B-X
and	B-X
infection	B-X
control	B-X
.	B-X
Numerous	B-X
countries	B-X
and	B-X
several	B-X
international	B-X
agencies	B-X
have	B-X
included	B-X
a	B-X
One	B-X
Health	B-X
approach	B-X
within	B-X
their	B-X
action	B-X
plans	B-X
to	B-X
address	B-X
antimicrobial	B-X
resistance	B-X
.	B-X
Necessary	B-X
actions	B-X
include	B-X
improvements	B-X
in	B-X
antimicrobial	B-X
use	B-X
regulation	B-X
and	B-X
policy	B-X
,	B-X
surveillance	B-X
,	B-X
stewardship	B-X
,	B-X
infection	B-X
control	B-X
,	B-X
sanitation	B-X
,	B-X
animal	B-X
husbandry	B-X
,	B-X
and	B-X
alternatives	B-X
to	B-X
antimicrobials	B-X
.	B-X
WHO	B-X
recently	B-X
has	B-X
launched	B-X
new	B-X
guidelines	B-X
on	B-X
the	B-X
use	B-X
of	B-X
medically	B-X
important	B-X
antimicrobials	B-X
in	B-X
food-producing	B-X
animals	B-X
,	B-X
recommending	B-X
that	B-X
farmers	B-X
and	B-X
the	B-X
food	B-X
industry	B-X
stop	B-X
using	B-X
antimicrobials	B-X
routinely	B-X
to	B-X
promote	B-X
growth	B-X
and	B-X
prevent	B-X
disease	B-X
in	B-X
healthy	B-X
animals	B-X
.	B-X
These	B-X
guidelines	B-X
aim	B-X
to	B-X
help	B-X
preserve	B-X
the	B-X
effectiveness	B-X
of	B-X
antimicrobials	B-X
that	B-X
are	B-X
important	B-X
for	B-X
human	B-X
medicine	B-X
by	B-X
reducing	B-X
their	B-X
use	B-X
in	B-X
animals	B-X
.	B-X

Furthermore	O
,	O
these	O
findings	O
indicate	O
that	O
DNA	O
-	O
rich	O
environments	O
,	O
such	O
as	O
bacterial	O
biofilms	O
or	O
the	O
CF	O
lung	O
,	O
may	O
represent	O
the	O
natural	O
setting	O
where	O
bacterial	O
growth	O
is	O
cation	O
limited	O
,	O
and	O
highlight	O
the	O
importance	O
of	O
the	O
PhoPQ	B-Protein
/	O
PmrAB	B-Protein
controlled	O
response	O
and	O
LPS	O
modifications	O
in	O
antibiotic	O
resistance	O
in	O
biofilms	O
.	O
<EOS>	B-X
Pigment	B-X
analysis	B-X
showed	B-X
cyanobacterial	B-X
pigments	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
pigments	B-X
from	B-X
purple	B-X
sulfur	B-X
bacteria	B-X
(	B-X
PSB	B-X
)	B-X
,	B-X
green	B-X
sulfur	B-X
bacteria	B-X
(	B-X
GSB	B-X
)	B-X
and	B-X
Chloroflexus-like	B-X
bacteria	B-X
(	B-X
CLB	B-X
)	B-X
.	B-X
Analysis	B-X
of	B-X
intact	B-X
polar	B-X
lipids	B-X
(	B-X
IPLs	B-X
)	B-X
in	B-X
the	B-X
source	B-X
sediment	B-X
confirmed	B-X
the	B-X
presence	B-X
of	B-X
phototrophic	B-X
organisms	B-X
via	B-X
diacylglycerol	B-X
phospholipids	B-X
and	B-X
betaine	B-X
lipids	B-X
,	B-X
whereas	B-X
glyceroldialkylglyceroltetraether	B-X
additionally	B-X
indicated	B-X
the	B-X
presence	B-X
of	B-X
archaea	B-X
.	B-X
(	B-X
13	B-X
)	B-X
C-bicarbonate-	B-X
and	B-X
-acetate-labeling	B-X
experiments	B-X
indicated	B-X
cyanobacteria	B-X
as	B-X
predominant	B-X
phototrophs	B-X
in	B-X
the	B-X
source	B-X
sediment	B-X
,	B-X
carbon	B-X
was	B-X
actively	B-X
fixed	B-X
by	B-X
PSB/CLB/GSB	B-X
in	B-X
purple	B-X
streamers	B-X
by	B-X
using	B-X
near	B-X
infrared	B-X
light	B-X
.	B-X
Our	B-X
investigations	B-X
furthermore	B-X
indicated	B-X
photoheterotrophy	B-X
as	B-X
an	B-X
important	B-X
process	B-X
in	B-X
both	B-X
habitats	B-X
.	B-X

The	O
Two	O
-	O
Component	O
Regulatory	O
System	O
VicRK	B-Protein
is	O
Important	O
to	O
Virulence	O
of	O
Streptococcus	O
equi	O
Subspecies	O
equi	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

This	O
study	O
aims	O
at	O
evaluating	O
the	O
importance	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
VicRK	B-Protein
to	O
virulence	O
of	O
the	O
horse	O
pathogen	O
Streptococcus	O
equi	O
subspecies	O
equi	O
and	O
the	O
potential	O
of	O
a	O
vicK	B-Protein
mutant	O
as	O
a	O
live	O
vaccine	O
candidate	O
using	O
mouse	O
infection	O
models	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
vicK	B-X
gene	B-X
was	B-X
deleted	B-X
by	B-X
gene	B-X
replacement	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

The	O
vicK	B-Protein
gene	O
was	O
deleted	O
by	O
gene	O
replacement	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
vicK	B-X
gene	B-X
was	B-X
deleted	B-X
by	B-X
gene	B-X
replacement	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

The	O
DeltavicK	B-Protein
mutant	O
is	O
attenuated	O
in	O
virulence	O
in	O
both	O
subcutaneous	O
and	O
intranasal	O
infections	O
in	O
mice	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

DeltavicK	B-Protein
grows	O
less	O
slowly	O
than	O
the	O
parent	O
strain	O
but	O
retains	O
the	O
ability	O
of	O
S	O
.	O
equi	O
to	O
resist	O
to	O
phagocytosis	O
by	O
polymorphoneuclear	O
leukocytes	O
,	O
suggesting	O
that	O
the	O
vicK	B-Protein
deletion	O
causes	O
growth	O
defect	O
.	O

DeltavicK	B-Protein
infection	O
protects	O
mice	O
against	O
reinfection	O
with	O
a	O
wild	O
-	O
type	O
S	O
.	O
equi	O
strain	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

Intranasal	O
DeltavicK	B-Protein
infection	O
induces	O
production	O
of	O
anti	O
-	O
SeM	B-Protein
mucosal	O
IgA	B-Protein
and	O
systemic	O
IgG	B-Protein
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

These	O
results	O
indicate	O
that	O
VicRK	B-Protein
is	O
important	O
to	O
S	O
.	O
equi	O
growth	O
and	O
virulence	O
and	O
suggest	O
that	O
DeltavicK	B-Protein
has	O
the	O
potential	O
to	O
be	O
developed	O
as	O
a	O
live	O
S	O
.	O
equi	O
vaccine	O
.	O

INTRODUCTION	O

Bacterial	O
pathogens	O
produce	O
many	O
two	O
-	O
component	O
regulatory	O
systems	O
to	O
regulate	O
gene	O
expression	O
by	O
specific	O
environmental	O
signals	O
[	O
1	O
]	O
.	O
<EOS>	B-X
Transposon	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
identify	B-X
genes	B-X
necessary	B-X
for	B-X
the	B-X
expression	B-X
of	B-X
Pseudomonas	B-X
aeruginosa	B-X
type	B-X
4	B-X
fimbriae	B-X
.	B-X
In	B-X
a	B-X
library	B-X
of	B-X
12,700	B-X
mutants	B-X
,	B-X
147	B-X
were	B-X
observed	B-X
to	B-X
have	B-X
lost	B-X
the	B-X
spreading	B-X
colony	B-X
morphology	B-X
associated	B-X
with	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
fimbriae	B-X
.	B-X
Of	B-X
these	B-X
,	B-X
28	B-X
had	B-X
also	B-X
acquired	B-X
resistance	B-X
to	B-X
the	B-X
fimbrial-specific	B-X
bacteriophage	B-X
PO4	B-X
.	B-X
The	B-X
mutations	B-X
conferring	B-X
this	B-X
phage	B-X
resistance	B-X
were	B-X
found	B-X
to	B-X
have	B-X
occurred	B-X
at	B-X
at	B-X
least	B-X
six	B-X
different	B-X
loci	B-X
,	B-X
including	B-X
the	B-X
three	B-X
that	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
fimbrial	B-X
biosynthesis	B-X
or	B-X
function	B-X
:	B-X
the	B-X
structural	B-X
subunit	B-X
(	B-X
pilA	B-X
)	B-X
and	B-X
adjacent	B-X
genes	B-X
(	B-X
pilB	B-X
,	B-X
C	B-X
,	B-X
D	B-X
)	B-X
,	B-X
the	B-X
twitching	B-X
motility	B-X
gene	B-X
(	B-X
pilT	B-X
)	B-X
,	B-X
and	B-X
the	B-X
sigma	B-X
54	B-X
RNA	B-X
polymerase	B-X
initiation	B-X
factor	B-X
gene	B-X
(	B-X
rpoN	B-X
)	B-X
.	B-X
These	B-X
mutants	B-X
had	B-X
no	B-X
detectable	B-X
transcription	B-X
of	B-X
pilA	B-X
and	B-X
did	B-X
not	B-X
produce	B-X
fimbriae	B-X
.	B-X
A	B-X
probe	B-X
derived	B-X
from	B-X
inverse	B-X
polymerase	B-X
chain	B-X
reaction	B-X
was	B-X
used	B-X
to	B-X
isolate	B-X
the	B-X
corresponding	B-X
wild-type	B-X
sequences	B-X
from	B-X
a	B-X
P.	B-X
aeruginosa	B-X
PAO	B-X
cosmid	B-X
reference	B-X
library	B-X
,	B-X
and	B-X
two	B-X
adjacent	B-X
genes	B-X
affected	B-X
by	B-X
transposon	B-X
insertions	B-X
,	B-X
pilS	B-X
and	B-X
pilR	B-X
,	B-X
were	B-X
located	B-X
and	B-X
sequenced	B-X
.	B-X
These	B-X
genes	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
capable	B-X
of	B-X
complementing	B-X
the	B-X
corresponding	B-X
mutants	B-X
,	B-X
both	B-X
at	B-X
the	B-X
level	B-X
of	B-X
restoring	B-X
the	B-X
phenotypes	B-X
associated	B-X
with	B-X
functional	B-X
fimbriae	B-X
and	B-X
by	B-X
the	B-X
restoration	B-X
of	B-X
pilA	B-X
transcription	B-X
.	B-X
The	B-X
pilSR	B-X
operon	B-X
was	B-X
physically	B-X
mapped	B-X
to	B-X
Spel	B-X
fragment	B-X
5	B-X
(	B-X
corresponding	B-X
to	B-X
about	B-X
72-75/0	B-X
min	B-X
on	B-X
the	B-X
genetic	B-X
map	B-X
)	B-X
,	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
located	B-X
approximately	B-X
25	B-X
kb	B-X
from	B-X
pilA-D.	B-X
PilS	B-X
and	B-X
PilR	B-X
clearly	B-X
belong	B-X
to	B-X
the	B-X
family	B-X
of	B-X
two-component	B-X
transcriptional	B-X
regulatory	B-X
systems	B-X
which	B-X
have	B-X
been	B-X
described	B-X
in	B-X
many	B-X
bacterial	B-X
species	B-X
.	B-X
PilS	B-X
is	B-X
predicted	B-X
to	B-X
be	B-X
a	B-X
sensor	B-X
protein	B-X
which	B-X
when	B-X
stimulated	B-X
by	B-X
the	B-X
appropriate	B-X
environmental	B-X
signals	B-X
activates	B-X
PilR	B-X
through	B-X
kinase	B-X
activity	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
pilS	B-X
and	B-X
pilR	B-X
makes	B-X
possible	B-X
a	B-X
more	B-X
thorough	B-X
examination	B-X
of	B-X
the	B-X
signal	B-X
transduction	B-X
systems	B-X
controlling	B-X
expression	B-X
of	B-X
virulence	B-X
factors	B-X
in	B-X
P.	B-X
aeruginosa	B-X
.	B-X

These	O
systems	O
consist	O
of	O
membrane	O
protein	O
sensors	O
and	O
cognate	O
cytoplasmic	O
response	O
regulators	O
.	O
<EOS>	B-X
Two-component	B-X
signal-transducing	B-X
systems	B-X
are	B-X
ubiquitously	B-X
distributed	B-X
communication	B-X
interfaces	B-X
in	B-X
bacteria	B-X
.	B-X
They	B-X
consist	B-X
of	B-X
a	B-X
histidine	B-X
kinase	B-X
that	B-X
senses	B-X
a	B-X
specific	B-X
environmental	B-X
stimulus	B-X
and	B-X
a	B-X
cognate	B-X
response	B-X
regulator	B-X
that	B-X
mediates	B-X
the	B-X
cellular	B-X
response	B-X
,	B-X
mostly	B-X
through	B-X
differential	B-X
expression	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
Histidine	B-X
kinases	B-X
are	B-X
typically	B-X
transmembrane	B-X
proteins	B-X
harboring	B-X
at	B-X
least	B-X
two	B-X
domains	B-X
:	B-X
an	B-X
input	B-X
(	B-X
or	B-X
sensor	B-X
)	B-X
domain	B-X
and	B-X
a	B-X
cytoplasmic	B-X
transmitter	B-X
(	B-X
or	B-X
kinase	B-X
)	B-X
domain	B-X
.	B-X
They	B-X
can	B-X
be	B-X
identified	B-X
and	B-X
classified	B-X
by	B-X
virtue	B-X
of	B-X
their	B-X
conserved	B-X
cytoplasmic	B-X
kinase	B-X
domains	B-X
.	B-X
In	B-X
order	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
mechanisms	B-X
of	B-X
stimulus	B-X
perception	B-X
by	B-X
bacterial	B-X
histidine	B-X
kinases	B-X
,	B-X
we	B-X
here	B-X
survey	B-X
sensor	B-X
domain	B-X
architecture	B-X
and	B-X
topology	B-X
within	B-X
the	B-X
bacterial	B-X
membrane	B-X
,	B-X
functional	B-X
aspects	B-X
related	B-X
to	B-X
this	B-X
topology	B-X
,	B-X
and	B-X
sequence	B-X
and	B-X
phylogenetic	B-X
conservation	B-X
.	B-X
(	B-X
ii	B-X
)	B-X
Histidine	B-X
kinases	B-X
with	B-X
sensing	B-X
mechanisms	B-X
linked	B-X
to	B-X
the	B-X
transmembrane	B-X
regions	B-X
detect	B-X
stimuli	B-X
(	B-X
usually	B-X
membrane-associated	B-X
stimuli	B-X
,	B-X
such	B-X
as	B-X
ionic	B-X
strength	B-X
,	B-X
osmolarity	B-X
,	B-X
turgor	B-X
,	B-X
or	B-X
functional	B-X
state	B-X
of	B-X
the	B-X
cell	B-X
envelope	B-X
)	B-X
via	B-X
their	B-X
membrane-spanning	B-X
segments	B-X
and	B-X
sometimes	B-X
via	B-X
additional	B-X
short	B-X
extracellular	B-X
loops	B-X
.	B-X
(	B-X
iii	B-X
)	B-X
Cytoplasmic-sensing	B-X
histidine	B-X
kinases	B-X
(	B-X
either	B-X
membrane	B-X
anchored	B-X
or	B-X
soluble	B-X
)	B-X
detect	B-X
cellular	B-X
or	B-X
diffusible	B-X
signals	B-X
reporting	B-X
the	B-X
metabolic	B-X
or	B-X
developmental	B-X
state	B-X
of	B-X
the	B-X
cell	B-X
.	B-X

The	O
regulator	O
is	O
phosphorylated	O
by	O
the	O
sensor	O
in	O
response	O
to	O
a	O
specific	O
signal	O
,	O
activating	O
or	O
repressing	O
the	O
transcription	O
of	O
target	O
genes	O
.	O
<EOS>	B-X
Nrf2	B-X
:	B-X
INrf2	B-X
(	B-X
Keap1	B-X
)	B-X
are	B-X
cellular	B-X
sensors	B-X
of	B-X
oxidative	B-X
and	B-X
electrophilic	B-X
stress	B-X
.	B-X
Nrf2	B-X
is	B-X
a	B-X
nuclear	B-X
factor	B-X
that	B-X
controls	B-X
the	B-X
expression	B-X
and	B-X
coordinated	B-X
induction	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
genes	B-X
that	B-X
encode	B-X
detoxifying	B-X
enzymes	B-X
,	B-X
drug	B-X
transporters	B-X
,	B-X
antiapoptotic	B-X
proteins	B-X
,	B-X
and	B-X
proteasomes	B-X
.	B-X
The	B-X
signaling	B-X
events	B-X
involve	B-X
preinduction	B-X
,	B-X
induction	B-X
,	B-X
and	B-X
postinduction	B-X
responses	B-X
that	B-X
tightly	B-X
control	B-X
Nrf2	B-X
activation	B-X
and	B-X
repression	B-X
back	B-X
to	B-X
the	B-X
basal	B-X
state	B-X
.	B-X
Oxidative/electrophilic	B-X
signals	B-X
activate	B-X
unknown	B-X
tyrosine	B-X
kinases	B-X
in	B-X
a	B-X
preinduction	B-X
response	B-X
that	B-X
phosphorylates	B-X
specific	B-X
residues	B-X
on	B-X
Nrf2	B-X
negative	B-X
regulators	B-X
,	B-X
INrf2	B-X
,	B-X
Fyn	B-X
,	B-X
and	B-X
Bach1	B-X
,	B-X
leading	B-X
to	B-X
their	B-X
nuclear	B-X
export	B-X
,	B-X
ubiquitination	B-X
,	B-X
and	B-X
degradation	B-X
.	B-X
Oxidative/electrophilic	B-X
modification	B-X
of	B-X
INrf2	B-X
cysteine	B-X
151	B-X
followed	B-X
by	B-X
PKC	B-X
phosphorylation	B-X
of	B-X
Nrf2	B-X
serine	B-X
40	B-X
in	B-X
the	B-X
induction	B-X
response	B-X
results	B-X
in	B-X
the	B-X
escape	B-X
or	B-X
release	B-X
of	B-X
Nrf2	B-X
from	B-X
INrf2	B-X
.	B-X
This	B-X
is	B-X
followed	B-X
by	B-X
a	B-X
postinduction	B-X
response	B-X
that	B-X
controls	B-X
the	B-X
``	B-X
switching	B-X
off	B-X
''	B-X
of	B-X
Nrf2-activated	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
deregulation	B-X
of	B-X
INrf2	B-X
and	B-X
Nrf2	B-X
due	B-X
to	B-X
mutations	B-X
may	B-X
lead	B-X
to	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Nrf2	B-X
that	B-X
reduces	B-X
apoptosis	B-X
and	B-X
promotes	B-X
oncogenesis	B-X
and	B-X
drug	B-X
resistance	B-X
.	B-X

The	O
two	O
-	O
component	O
regulatory	O
system	O
VicRK	B-Protein
or	O
YycFG	B-Protein
is	O
specific	O
for	O
Gram	O
-	O
positive	O
bacteria	O
.	O
<EOS>	B-X
The	B-X
VicRK	B-X
Two-Component	B-X
System	B-X
Regulates	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

The	O
regulator	O
component	O
VicR	B-Protein
is	O
essential	O
in	O
Bacillus	O
subtilis	O
[	O
2	O
]	O
,	O
Staphylococcus	O
aureus	O
[	O
3	O
]	O
,	O
and	O
Streptococcus	O
pneumoniae	O
[	O
4	O
-	O
5	O
]	O
but	O
appears	O
not	O
to	O
be	O
essential	O
in	O
Streptococcus	O
pyogenes	O
[	O
6	O
]	O
.	O

The	O
deletion	O
of	O
the	O
vicK	B-Protein
gene	O
can	O
be	O
readily	O
inactivated	O
in	O
S	O
.	O
pneumoniae	O
[	O
7	O
]	O
,	O
Streptococcus	O
mutans	O
[	O
8	O
]	O
,	O
and	O
S	O
.	O
pyogenes	O
[	O
6	O
]	O
but	O
not	O
in	O
B	O
.	O
subtilis	O
[	O
2	O
]	O
and	O
S	O
.	O
aureus	O
[	O
3	O
]	O
.	O

Conditional	O
and	O
unconditional	O
vicRK	B-Protein
mutants	O
display	O
various	O
phenotypes	O
,	O
including	O
defects	O
in	O
morphology	O
and	O
cell	O
wall	O
synthesis	O
,	O
decreased	O
competence	O
,	O
sensitivity	O
to	O
antibiotics	O
and	O
fatty	O
acids	O
,	O
defects	O
in	O
biofilm	O
formation	O
,	O
and	O
attenuated	O
virulence	O
,	O
growth	O
defect	O
,	O
and	O
sensitivity	O
to	O
osmotic	O
pressure	O
[	O
3	O
,	O
6	O
,	O
8	O
-	O
11	O
]	O
.	O

The	O
vicRK	B-Protein
system	O
of	O
Gram	O
-	O
positive	O
bacterium	O
Streptococcus	O
equi	O
subspecies	O
equi	O
(	O
S	O
.	O
equi	O
)	O
has	O
not	O
been	O
studied	O
.	O

This	O
pathogen	O
causes	O
equine	O
strangles	O
,	O
a	O
highly	O
contagious	O
purulent	O
lymphadenitis	O
[	O
12	O
-	O
13	O
]	O
.	O
<EOS>	B-X
equi	B-X
)	B-X
,	B-X
a	B-X
Lancefield	B-X
group	B-X
C	B-X
streptococcus	B-X
,	B-X
causes	B-X
strangles	B-X
,	B-X
a	B-X
highly	B-X
contagious	B-X
purulent	B-X
lymphadenitis	B-X
and	B-X
pharyngitis	B-X
of	B-X
members	B-X
of	B-X
the	B-X
family	B-X
Equidae	B-X
.	B-X
Both	B-X
proteins	B-X
bind	B-X
equine	B-X
fibrinogen	B-X
.	B-X
The	B-X
results	B-X
taken	B-X
together	B-X
support	B-X
previous	B-X
evidence	B-X
that	B-X
S.	B-X
equi	B-X
is	B-X
a	B-X
clonal	B-X
pathogen	B-X
originating	B-X
from	B-X
an	B-X
ancestral	B-X
strain	B-X
of	B-X
S.	B-X
zooepidemicus	B-X
.	B-X

The	O
infection	O
initially	O
causes	O
nasal	O
discharge	O
and	O
fever	O
and	O
,	O
then	O
,	O
leads	O
to	O
abscess	O
formation	O
in	O
local	O
lymph	O
nodes	O
,	O
causing	O
respiratory	O
difficulty	O
.	O

Although	O
the	O
infection	O
at	O
the	O
lymph	O
nodes	O
cause	O
massive	O
infiltration	O
of	O
polymorphoneuclear	O
leukocytes	O
(	O
PMNs	O
)	O
[	O
14	O
]	O
,	O
S	O
.	O
equi	O
resists	O
phagocytosis	O
by	O
PMNs	O
and	O
rapidly	O
multiplies	O
,	O
forming	O
an	O
abscess	O
of	O
large	O
numbers	O
of	O
degenerating	O
PMNs	O
and	O
long	O
chains	O
of	O
S	O
.	O
equi	O
[	O
15	O
]	O
.	O

The	O
hyaluronic	O
acid	O
capsule	O
and	O
S	O
.	O
equi	O
M	B-Protein
-	I-Protein
like	I-Protein
protein	I-Protein
(	O
SeM	B-Protein
)	O
are	O
both	O
required	O
for	O
the	O
resistance	O
to	O
phagocytosis	O
by	O
PMNs	O
[	O
16	O
-	O
17	O
]	O
.	O

Most	O
horses	O
recovered	O
from	O
strangles	O
have	O
immunity	O
against	O
S	O
.	O
equi	O
reinfection	O
for	O
up	O
to	O
5	O
years	O
[	O
18	O
]	O
.	O

It	O
is	O
believed	O
that	O
the	O
immunity	O
is	O
mediated	O
by	O
mucosal	O
antibodies	O
specific	O
to	O
SeM	B-Protein
and	O
other	O
protective	O
antigens	O
.	O

An	O
intranasal	O
vaccine	O
made	O
of	O
live	O
attenuated	O
strain	O
has	O
been	O
used	O
in	O
USA	O
,	O
which	O
lacks	O
the	O
hyaluronic	O
acid	O
capsule	O
,	O
and	O
various	O
adverse	O
effects	O
,	O
including	O
pharyngeal	O
lymphadenopathy	O
,	O
limb	O
edema	O
,	O
and	O
bastard	O
strangles	O
abscesses	O
,	O
have	O
been	O
reported	O
[	O
15	O
]	O
.	O

This	O
study	O
aims	O
at	O
evaluating	O
the	O
importance	O
of	O
VicRK	B-Protein
to	O
S	O
.	O
equi	O
virulence	O
and	O
the	O
potential	O
of	O
a	O
vicK	B-Protein
deletion	O
mutant	O
as	O
a	O
live	O
vaccine	O
using	O
mouse	O
infection	O
models	O
.	O

We	O
found	O
that	O
the	O
vicK	B-Protein
deletion	O
attenuated	O
S	O
.	O
equi	O
virulence	O
in	O
mouse	O
models	O
of	O
subcutaneous	O
and	O
intranasal	O
infections	O
and	O
that	O
infection	O
with	O
a	O
vicK	B-Protein
deletion	O
mutant	O
confers	O
protection	O
against	O
subsequent	O
infection	O
with	O
wild	O
-	O
type	O
S	O
.	O
equi	O
and	O
induces	O
production	O
of	O
mucosal	O
and	O
systemic	O
immunoglobins	O
to	O
SeM	B-Protein
in	O
nasal	O
infection	O
.	O

RESULTS	O

S	O
.	O
equi	O
vicK	B-Protein
Deletion	O
Mutant	O
The	O
S	O
.	O
equi	O
vicRK	B-Protein
genes	O
were	O
found	O
by	O
blasting	O
the	O
S	O
.	O
equi	O
genome	O
database	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
sanger	O
.	O
ac	O
.	O
uk	O
/	O
Projects	O
/	O
S	O
_	O
equi	O
)	O
with	O
the	O
S	O
.	O
pyogenes	O
vicRK	B-Protein
sequence	O
.	O

Gene	O
replacement	O
strategy	O
was	O
used	O
to	O
generate	O
vicK	B-Protein
-	O
deletion	O
mutant	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

The	O
vector	O
pGRV	O
has	O
two	O
genes	O
aad	B-Protein
and	O
cmR	B-Protein
for	O
selections	O
with	O
spectinomycin	O
and	O
chloramphenicol	O
,	O
respectively	O
.	O

The	O
two	O
upstream	O
and	O
downstream	O
flanking	O
fragments	O
of	O
the	O
internal	O
vicK	B-Protein
fragment	O
from	O
Tyr151	O
to	O
Ser427	O
to	O
be	O
deleted	O
were	O
cloned	O
at	O
the	O
upstream	O
and	O
downstream	O
ends	O
of	O
the	O
aad	B-Protein
gene	O
,	O
respectively	O
,	O
resulting	O
in	O
suicide	O
plasmid	O
pGRV	O
-	O
DeltavicK	B-Protein
.	O

Single	O
crossover	O
between	O
one	O
flanking	O
fragment	O
in	O
pGRV	O
-	O
DeltavicK	B-Protein
and	O
the	O
homologous	O
region	O
in	O
the	O
genome	O
would	O
lead	O
to	O
the	O
insertion	O
of	O
the	O
whole	O
plasmid	O
into	O
S	O
.	O
equi	O
genome	O
,	O
resulting	O
in	O
strains	O
resistant	O
to	O
both	O
spectinomycin	O
and	O
chloramphenicol	O
.	O

Double	O
crossoverat	O
both	O
of	O
the	O
flanking	O
fragments	O
would	O
lead	O
to	O
the	O
replacement	O
of	O
the	O
vicK	B-Protein
internal	O
fragment	O
with	O
the	O
aad	B-Protein
gene	O
,	O
resulting	O
in	O
vicK	B-Protein
deletion	O
strains	O
with	O
resistance	O
only	O
to	O
spectinomycin	O
.	O

The	O
colonies	O
on	O
spectinomycin	O
agar	O
plates	O
were	O
tested	O
for	O
resistance	O
to	O
chloramphenicol	O
.	O

Three	O
putative	O
DeltavicK	B-Protein
strains	O
,	O
which	O
were	O
spectinomycin	O
-	O
resistant	O
and	O
chloramphenicol	O
-	O
sensitive	O
,	O
were	O
obtained	O
.	O

PCR	O
analyses	O
using	O
the	O
primers	O
located	O
beyond	O
the	O
deleted	O
fragment	O
resulted	O
in	O
the	O
PCR	O
product	O
from	O
these	O
strains	O
that	O
were	O
expectedly	O
bigger	O
than	O
that	O
from	O
the	O
wild	O
-	O
type	O
strain	O
because	O
the	O
replacing	O
fragment	O
was	O
bigger	O
than	O
the	O
displaced	O
vicK	B-Protein
fragment	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

DNA	O
sequencing	O
confirmed	O
the	O
desired	O
deletion	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
outline	B-X
a	B-X
homologous	B-X
recombination-based	B-X
method	B-X
developed	B-X
to	B-X
delete	B-X
or	B-X
add	B-X
genes	B-X
to	B-X
the	B-X
genome	B-X
of	B-X
a	B-X
nonmodel	B-X
bacterium	B-X
,	B-X
Zymomonas	B-X
mobilis	B-X
,	B-X
at	B-X
the	B-X
desired	B-X
locus	B-X
using	B-X
a	B-X
suicide	B-X
plasmid	B-X
that	B-X
contains	B-X
gfp	B-X
as	B-X
a	B-X
fluorescence	B-X
marker	B-X
to	B-X
track	B-X
its	B-X
presence	B-X
in	B-X
cells	B-X
.	B-X
The	B-X
suicide	B-X
plasmid	B-X
is	B-X
engineered	B-X
to	B-X
contain	B-X
two	B-X
500	B-X
bp	B-X
regions	B-X
homologous	B-X
to	B-X
the	B-X
DNA	B-X
sequence	B-X
immediately	B-X
flanking	B-X
the	B-X
target	B-X
locus	B-X
.	B-X
A	B-X
single	B-X
crossover	B-X
event	B-X
at	B-X
one	B-X
of	B-X
the	B-X
two	B-X
homologous	B-X
regions	B-X
facilitates	B-X
insertion	B-X
of	B-X
the	B-X
plasmid	B-X
into	B-X
the	B-X
genome	B-X
and	B-X
subsequent	B-X
homologous	B-X
recombination	B-X
events	B-X
excise	B-X
the	B-X
plasmid	B-X
from	B-X
the	B-X
genome	B-X
,	B-X
leaving	B-X
either	B-X
the	B-X
original	B-X
genotype	B-X
or	B-X
the	B-X
desired	B-X
modified	B-X
genotype	B-X
.	B-X
Subsequent	B-X
PCR	B-X
amplification	B-X
of	B-X
genomic	B-X
DNA	B-X
from	B-X
strains	B-X
lacking	B-X
GFP	B-X
allows	B-X
rapid	B-X
identification	B-X
of	B-X
the	B-X
desired	B-X
genotype	B-X
,	B-X
which	B-X
is	B-X
confirmed	B-X
by	B-X
DNA	B-X
sequencing	B-X
.	B-X

One	O
deletion	O
strain	O
was	O
randomly	O
chosen	O
for	O
further	O
characterization	O
.	O

Growth	O
of	O
DeltavicK	B-Protein
in	O
THY	O
and	O
Rabbit	O
Blood	O

The	O
growth	O
curve	O
of	O
the	O
DeltavicK	B-Protein
mutant	O
in	O
THY	O
displays	O
a	O
longer	O
early	O
growth	O
phase	O
and	O
smaller	O
slope	O
in	O
the	O
exponential	O
growth	O
phase	O
than	O
that	O
of	O
the	O
parent	O
strain	O
(	O
Fig	O
.	O
2A	O
)	O
,	O
indicating	O
that	O
the	O
vicK	B-Protein
deletion	O
detrimentally	O
affects	O
S	O
.	O
equi	O
growth	O
.	O

The	O
effect	O
of	O
the	O
deletion	O
on	O
S	O
.	O
equi	O
growth	O
in	O
blood	O
was	O
also	O
examined	O
.	O

The	O
wild	O
-	O
type	O
and	O
DeltavicK	B-Protein
S	O
.	O
equi	O
strains	O
were	O
inoculated	O
into	O
1	O
ml	O
heparinized	O
rabbit	O
blood	O
at	O
an	O
inoculum	O
of	O
approximately	O
20	O
,	O
000	O
cfu	O
.	O

The	O
samples	O
were	O
incubated	O
for	O
4	O
h	O
,	O
and	O
the	O
numbers	O
of	O
the	O
bacteria	O
in	O
the	O
samples	O
and	O
inocula	O
at	O
time	O
zero	O
were	O
determined	O
by	O
plating	O
.	O

The	O
growth	O
factors	O
,	O
the	O
ratio	O
of	O
cfu	O
in	O
the	O
sample	O
at	O
4	O
h	O
over	O
cfu	O
at	O
time	O
zero	O
,	O
were	O
250	O
and	O
66	O
for	O
the	O
wild	O
type	O
and	O
DeltavicK	B-Protein
strains	O
,	O
respectively	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Thus	O
,	O
the	O
DeltavicK	B-Protein
mutant	O
has	O
significantly	O
reduced	O
ability	O
to	O
grow	O
in	O
rabbit	O
blood	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

No	O
Effect	O
of	O
the	O
vicK	B-Protein
Deletion	O
on	O
Resistance	O
of	O
S	O
.	O
equi	O
to	O
Phagocytosis	O
by	O
PMNs	O

To	O
determine	O
whether	O
the	O
DeltavicK	B-Protein
deletion	O
affects	O
the	O
resistance	O
of	O
S	O
.	O
equi	O
to	O
phagocytosis	O
by	O
PMNs	O
,	O
the	O
phagocytosis	O
of	O
wild	O
-	O
type	O
and	O
DeltavicK	B-Protein
bacteria	O
by	O
PMNs	O
in	O
non	O
-	O
immune	O
horse	O
and	O
rabbit	O
blood	O
was	O
compared	O
.	O

FITC	O
-	O
labeled	O
wild	O
-	O
type	O
S	O
.	O
equi	O
,	O
DeltavicK	B-Protein
mutant	O
,	O
and	O
S	O
.	O
pyogenes	O
spy1718	B-Protein
:	O
:	O
aad	B-Protein
mutant	O
were	O
incubated	O
with	O
heparinized	O
horse	O
or	O
rabbit	O
blood	O
for	O
5	O
and	O
15	O
min	O
,	O
and	O
percentages	O
of	O
PMNs	O
associated	O
with	O
fluorescent	O
bacteria	O
were	O
quantified	O
using	O
flow	O
cytometry	O
analysis	O
.	O

The	O
spy1718	B-Protein
:	O
:	O
aad	B-Protein
mutant	O
of	O
S	O
.	O
pyogenes	O
,	O
which	O
is	O
no	O
longer	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
,	O
was	O
used	O
as	O
a	O
positive	O
control	O
in	O
the	O
assay	O
.	O

The	O
percentages	O
of	O
PMNs	O
with	O
associated	O
wild	O
-	O
type	O
S	O
.	O
equi	O
and	O
spy1718	B-Protein
:	O
:	O
aad	B-Protein
were	O
low	O
and	O
high	O
,	O
respectively	O
,	O
indicating	O
that	O
the	O
assay	O
worked	O
well	O
to	O
evaluate	O
resistance	O
of	O
the	O
bacteria	O
to	O
phagocytosis	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
percentages	O
of	O
PMNs	O
associated	O
with	O
wild	O
-	O
type	O
and	O
DeltavicK	B-Protein
bacteria	O
at	O
both	O
time	O
points	O
and	O
in	O
both	O
horse	O
and	O
rabbit	O
blood	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
the	O
DeltavicK	B-Protein
mutant	O
retains	O
the	O
ability	O
of	O
S	O
.	O
equi	O
to	O
resist	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

Attenuation	O
of	O
S	O
.	O
equi	O
Virulence	O
by	O
vicK	B-Protein
Deletion	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
vicK	B-X
gene	B-X
was	B-X
deleted	B-X
by	B-X
gene	B-X
replacement	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

Group	O
of	O
8	O
mice	O
were	O
subcutaneously	O
inoculated	O
with	O
1	O
.	O
1	O
x	O
108	O
cfu	O
wild	O
-	O
type	O
or	O
DeltavicK	B-Protein
mutant	O
strains	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

Seven	O
of	O
the	O
8	O
mice	O
infected	O
with	O
the	O
wild	O
-	O
type	O
S	O
.	O
equi	O
strain	O
died	O
,	O
whereas	O
7	O
of	O
the	O
8	O
mice	O
inoculated	O
with	O
DeltavicK	B-Protein
survived	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

The	O
infection	O
was	O
performed	O
in	O
a	O
model	O
of	O
intranasal	O
infection	O
as	O
well	O
.	O

All	O
the	O
8	O
mice	O
infected	O
with	O
DeltavicK	B-Protein
survived	O
,	O
whereas	O
5	O
of	O
the	O
8	O
mice	O
infected	O
with	O
the	O
wild	O
-	O
type	O
S	O
.	O
equi	O
strain	O
died	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
vicK	B-Protein
deletion	O
significantly	O
attenuated	O
S	O
.	O
equi	O
virulence	O
in	O
both	O
mouse	O
models	O
of	O
subcutaneous	O
(	O
P	O
=	O
0	O
.	O
0066	O
)	O
and	O
nasal	O
(	O
P	O
=	O
0	O
.	O
0085	O
)	O
infections	O
.	O

DeltavicK	B-Protein
Infection	O
Confers	O
Protection	O
of	O
Mice	O
against	O
Reinfection	O
with	O
Wild	O
-	O
Type	O
S	O
.	O
equi	O

To	O
test	O
whether	O
DeltavicK	B-Protein
infection	O
confers	O
immunity	O
against	O
S	O
.	O
equi	O
infection	O
,	O
the	O
seven	O
mice	O
recovered	O
from	O
the	O
subcutaneous	O
DeltavicK	B-Protein
infection	O
was	O
reinfected	O
subcutaneously	O
with	O
1	O
.	O
5	O
x	O
108	O
cfu	O
wild	O
-	O
type	O
S	O
.	O
equi	O
30	O
days	O
after	O
the	O
first	O
infection	O
and	O
monitored	O
for	O
18	O
days	O
.	O

Six	O
of	O
the	O
7	O
mice	O
survived	O
the	O
reinfection	O
(	O
Fig	O
.	O
4A	O
)	O
,	O
suggesting	O
that	O
the	O
DeltavicK	B-Protein
infection	O
induces	O
immunity	O
against	O
S	O
.	O
equi	O
infection	O
.	O

Intranasal	O
DeltavicK	B-Protein
Infection	O
Induces	O
SeM	B-Protein
-	O
Specific	O
Mucosal	O
IgA	B-Protein
and	O
Systemic	O
IgG	B-Protein

To	O
examine	O
the	O
humoral	O
immune	O
responses	O
in	O
the	O
intranasal	O
DeltavicK	B-Protein
infection	O
,	O
nasal	O
wash	O
and	O
serum	O
samples	O
were	O
collected	O
from	O
the	O
8	O
mice	O
infected	O
intranasally	O
with	O
DeltavicK	B-Protein
and	O
3	O
surviving	O
mice	O
infected	O
with	O
the	O
wild	O
-	O
type	O
S	O
.	O
equi	O
30	O
days	O
after	O
infection	O
.	O

Half	O
of	O
the	O
nasal	O
wash	O
samples	O
from	O
the	O
mice	O
infected	O
with	O
DeltavicK	B-Protein
had	O
similar	O
levels	O
of	O
SeM38	B-Protein
-	O
260	B-Protein
-	O
IgA	B-Protein
reactivity	O
with	O
those	O
from	O
the	O
mice	O
infected	O
with	O
the	O
wild	O
-	O
type	O
strains	O
.	O

Similarly	O
,	O
these	O
4	O
mice	O
with	O
higher	O
IgA	B-Protein
levels	O
also	O
had	O
higher	O
levels	O
of	O
SeM	B-Protein
-	O
specific	O
systemic	O
IgG	B-Protein
(	O
Fig	O
.	O
5B	O
)	O
.	O

Western	O
blotting	O
analysis	O
was	O
used	O
to	O
confirm	O
the	O
presence	O
of	O
SeM	B-Protein
-	O
specific	O
IgG	B-Protein
.	O

The	O
wild	O
-	O
type	O
sera	O
and	O
5	O
of	O
the	O
8	O
DeltavicK	B-Protein
samples	O
had	O
strong	O
immunoreactions	O
with	O
SeM38	B-Protein
-	O
260	B-Protein
in	O
Western	O
blotting	O
analysis	O
(	O
Fig	O
.	O
5C	O
)	O
.	O

Thus	O
,	O
the	O
DeltavicK	B-Protein
mutant	O
has	O
the	O
ability	O
to	O
induce	O
mucosal	O
and	O
systemic	O
immune	O
responses	O
,	O
though	O
there	O
was	O
host	O
variation	O
in	O
these	O
responses	O
caused	O
by	O
DeltavicK	B-Protein
infection	O
.	O

DISCUSSION	O

VicK	B-Protein
is	O
essential	O
in	O
B	O
.	O
subtilis	O
[	O
2	O
]	O
and	O
S	O
.	O
aureus	O
[	O
3	O
]	O
but	O
not	O
in	O
S	O
.	O
pneumoniae	O
[	O
7	O
]	O
,	O
S	O
.	O
mutans	O
[	O
8	O
]	O
,	O
and	O
S	O
.	O
pyogenes	O
[	O
6	O
]	O
.	O

We	O
successfully	O
deleted	O
the	O
vicK	B-Protein
gene	O
of	O
S	O
.	O
equi	O
.	O

Thus	O
,	O
VicK	B-Protein
is	O
not	O
essential	O
in	O
S	O
.	O
equi	O
.	O
<EOS>	B-X
Vick	B-X
's	B-X
Floral	B-X
Guide	B-X
.	B-X
The	B-X
S.	B-X
mutans	B-X
diagnosis	B-X
by	B-X
PCR	B-X
for	B-X
Sanger	B-X
Sequencing	B-X
technique	B-X
by	B-X
using	B-X
VicK	B-X
gene	B-X
sequences	B-X
(	B-X
1300bp	B-X
)	B-X
.	B-X
The	B-X
VicK	B-X
genes	B-X
isolates	B-X
'	B-X
phylogenetic	B-X
trees	B-X
revealed	B-X
a	B-X
genotype	B-X
that	B-X
was	B-X
closely	B-X
connected	B-X
to	B-X
other	B-X
isolates	B-X
in	B-X
GenBank	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
involvement	B-X
of	B-X
the	B-X
S.	B-X
mutans	B-X
VicK	B-X
sensor	B-X
kinase	B-X
in	B-X
both	B-X
the	B-X
acidogenicity	B-X
and	B-X
the	B-X
aciduricity	B-X
of	B-X
this	B-X
bacterium	B-X
.	B-X
When	B-X
cultures	B-X
were	B-X
supplemented	B-X
with	B-X
glucose	B-X
,	B-X
the	B-X
glycolytic	B-X
rate	B-X
of	B-X
a	B-X
VicK	B-X
null	B-X
mutant	B-X
was	B-X
significantly	B-X
decreased	B-X
compared	B-X
to	B-X
the	B-X
glycolytic	B-X
rate	B-X
of	B-X
the	B-X
wild	B-X
type	B-X
(	B-X
P	B-X
<	B-X
0.05	B-X
)	B-X
,	B-X
suggesting	B-X
that	B-X
there	B-X
was	B-X
impaired	B-X
acid	B-X
production	B-X
.	B-X
Not	B-X
surprisingly	B-X
,	B-X
the	B-X
VicK	B-X
deletion	B-X
mutant	B-X
produced	B-X
less	B-X
lactic	B-X
acid	B-X
,	B-X
while	B-X
an	B-X
acid	B-X
tolerance	B-X
response	B-X
assay	B-X
revealed	B-X
that	B-X
loss	B-X
of	B-X
VicK	B-X
significantly	B-X
enhanced	B-X
the	B-X
survival	B-X
of	B-X
S.	B-X
mutans	B-X
(	B-X
P	B-X
<	B-X
0.05	B-X
)	B-X
.	B-X
Compared	B-X
to	B-X
the	B-X
survival	B-X
rates	B-X
of	B-X
the	B-X
wild	B-X
type	B-X
,	B-X
the	B-X
survival	B-X
rates	B-X
of	B-X
the	B-X
VicK-deficient	B-X
mutant	B-X
were	B-X
drastically	B-X
increased	B-X
when	B-X
cultures	B-X
were	B-X
grown	B-X
at	B-X
pH	B-X
3.5	B-X
with	B-X
or	B-X
without	B-X
preexposure	B-X
to	B-X
a	B-X
signal	B-X
pH	B-X
(	B-X
pH	B-X
5.5	B-X
)	B-X
.	B-X
Global	B-X
transcriptional	B-X
analysis	B-X
using	B-X
DNA	B-X
microarrays	B-X
and	B-X
S.	B-X
mutans	B-X
wild-type	B-X
UA159	B-X
and	B-X
VicK	B-X
deletion	B-X
mutant	B-X
strains	B-X
grown	B-X
at	B-X
neutral	B-X
and	B-X
low	B-X
pH	B-X
values	B-X
revealed	B-X
that	B-X
loss	B-X
of	B-X
VicK	B-X
significantly	B-X
affected	B-X
expression	B-X
of	B-X
89	B-X
transcripts	B-X
more	B-X
than	B-X
twofold	B-X
at	B-X
pH	B-X
5.5	B-X
(	B-X
P	B-X
<	B-X
0.001	B-X
)	B-X
.	B-X
While	B-X
our	B-X
results	B-X
provide	B-X
insight	B-X
into	B-X
the	B-X
acid-inducible	B-X
regulon	B-X
of	B-X
S.	B-X
mutans	B-X
,	B-X
here	B-X
we	B-X
imply	B-X
a	B-X
novel	B-X
role	B-X
for	B-X
VicK	B-X
in	B-X
regulating	B-X
intracellular	B-X
pH	B-X
homeostasis	B-X
in	B-X
S.	B-X
mutans	B-X
.	B-X

However	O
,	O
the	O
DeltavicK	B-Protein
mutant	O
is	O
attenuated	O
in	O
virulence	O
in	O
both	O
mouse	O
models	O
of	O
subcutaneous	O
and	O
intranasal	O
S	O
.	O
equi	O
infections	O
,	O
indicating	O
that	O
VicRK	B-Protein
is	O
important	O
to	O
virulence	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

The	O
results	O
provide	O
the	O
further	O
evidence	O
for	O
the	O
importance	O
of	O
VicRK	B-Protein
to	O
virulence	O
of	O
Gram	O
-	O
positive	O
pathogens	O
.	O

S	O
.	O
equi	O
DeltavicK	B-Protein
mutant	O
does	O
not	O
grow	O
as	O
well	O
as	O
the	O
wild	O
-	O
type	O
strain	O
in	O
both	O
THY	O
and	O
blood	O
,	O
suggesting	O
that	O
the	O
vicK	B-Protein
deletion	O
causes	O
defect	O
in	O
growth	O
,	O
a	O
plausible	O
reason	O
that	O
likely	O
contributes	O
to	O
the	O
attenuation	O
of	O
S	O
.	O
equi	O
virulence	O
in	O
the	O
mouse	O
infection	O
models	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aims	B-X
at	B-X
evaluating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
VicRK	B-X
to	B-X
virulence	B-X
of	B-X
the	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
and	B-X
the	B-X
potential	B-X
of	B-X
a	B-X
vicK	B-X
mutant	B-X
as	B-X
a	B-X
live	B-X
vaccine	B-X
candidate	B-X
using	B-X
mouse	B-X
infection	B-X
models	B-X
.	B-X
The	B-X
vicK	B-X
gene	B-X
was	B-X
deleted	B-X
by	B-X
gene	B-X
replacement	B-X
.	B-X
The	B-X
DeltavicK	B-X
mutant	B-X
is	B-X
attenuated	B-X
in	B-X
virulence	B-X
in	B-X
both	B-X
subcutaneous	B-X
and	B-X
intranasal	B-X
infections	B-X
in	B-X
mice	B-X
.	B-X
DeltavicK	B-X
grows	B-X
less	B-X
slowly	B-X
than	B-X
the	B-X
parent	B-X
strain	B-X
but	B-X
retains	B-X
the	B-X
ability	B-X
of	B-X
S.	B-X
equi	B-X
to	B-X
resist	B-X
to	B-X
phagocytosis	B-X
by	B-X
polymorphoneuclear	B-X
leukocytes	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
vicK	B-X
deletion	B-X
causes	B-X
growth	B-X
defect	B-X
.	B-X
DeltavicK	B-X
infection	B-X
protects	B-X
mice	B-X
against	B-X
reinfection	B-X
with	B-X
a	B-X
wild-type	B-X
S.	B-X
equi	B-X
strain	B-X
.	B-X
Intranasal	B-X
DeltavicK	B-X
infection	B-X
induces	B-X
production	B-X
of	B-X
anti-SeM	B-X
mucosal	B-X
IgA	B-X
and	B-X
systemic	B-X
IgG	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
VicRK	B-X
is	B-X
important	B-X
to	B-X
S.	B-X
equi	B-X
growth	B-X
and	B-X
virulence	B-X
and	B-X
suggest	B-X
that	B-X
DeltavicK	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
developed	B-X
as	B-X
a	B-X
live	B-X
S.	B-X
equi	B-X
vaccine	B-X
.	B-X

This	O
suggestion	O
is	O
further	O
supported	O
by	O
the	O
observations	O
that	O
both	O
the	O
wild	O
-	O
type	O
and	O
DeltavicK	B-Protein
mutant	O
strains	O
are	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
,	O
which	O
suggest	O
that	O
VicRK	B-Protein
is	O
not	O
required	O
for	O
the	O
evasion	O
of	O
S	O
.	O
equi	O
to	O
the	O
innate	O
immunity	O
.	O

As	O
introduced	O
earlier	O
,	O
the	O
various	O
phenotypes	O
have	O
been	O
described	O
for	O
the	O
vicRK	B-Protein
mutants	O
of	O
the	O
various	O
pathogens	O
.	O

Whether	O
the	O
phenotypes	O
are	O
specific	O
to	O
particular	O
organisms	O
is	O
not	O
known	O
.	O
<EOS>	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
the	B-X
current	B-X
state	B-X
of	B-X
exRNA	B-X
profiling	B-X
in	B-X
various	B-X
body	B-X
fluids	B-X
and	B-X
discuss	B-X
age-related	B-X
changes	B-X
in	B-X
exRNA	B-X
abundance	B-X
that	B-X
have	B-X
been	B-X
identified	B-X
in	B-X
humans	B-X
and	B-X
other	B-X
model	B-X
organisms	B-X
.	B-X
miRNAs	B-X
,	B-X
in	B-X
particular	B-X
,	B-X
are	B-X
a	B-X
major	B-X
focus	B-X
of	B-X
current	B-X
research	B-X
and	B-X
we	B-X
will	B-X
highlight	B-X
and	B-X
discuss	B-X
the	B-X
potential	B-X
role	B-X
that	B-X
specific	B-X
miRNAs	B-X
might	B-X
play	B-X
in	B-X
age-related	B-X
phenotypes	B-X
and	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
because	B-X
of	B-X
the	B-X
novelty	B-X
of	B-X
these	B-X
tests	B-X
which	B-X
provide	B-X
information	B-X
regarding	B-X
microbial	B-X
identification	B-X
and	B-X
whether	B-X
specific	B-X
antibiotic-resistance	B-X
mutations	B-X
were	B-X
detected	B-X
,	B-X
many	B-X
front-line	B-X
providers	B-X
still	B-X
delay	B-X
final	B-X
decisions	B-X
until	B-X
complete	B-X
phenotypic	B-X
susceptibility	B-X
results	B-X
are	B-X
available	B-X
several	B-X
days	B-X
later	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
antimicrobial	B-X
therapy	B-X
,	B-X
additional	B-X
diagnostic	B-X
or	B-X
therapeutic	B-X
interventions	B-X
are	B-X
recommended	B-X
for	B-X
particular	B-X
organisms	B-X
and	B-X
clinical	B-X
settings	B-X
to	B-X
either	B-X
determine	B-X
the	B-X
extent	B-X
of	B-X
infection	B-X
or	B-X
control	B-X
its	B-X
source	B-X
.	B-X

The	O
phenotypes	O
of	O
the	O
S	O
.	O
equi	O
DeltavicK	B-Protein
mutant	O
are	O
similar	O
to	O
those	O
of	O
the	O
S	O
.	O
pyogenes	O
DeltavicK	B-Protein
mutant	O
[	O
6	O
]	O
,	O
suggesting	O
that	O
the	O
growth	O
defect	O
phenotype	O
may	O
be	O
a	O
common	O
feature	O
of	O
the	O
vicRK	B-Protein
mutants	O
of	O
various	O
Gram	O
-	O
positive	O
pathogens	O
.	O

The	O
DeltavicK	B-Protein
mutant	O
appears	O
to	O
possess	O
the	O
properties	O
of	O
a	O
potential	O
live	O
vaccine	O
.	O

First	O
,	O
it	O
is	O
attenuated	O
in	O
virulence	O
in	O
the	O
mouse	O
infection	O
models	O
.	O
<EOS>	B-X
The	B-X
quorum	B-X
sensing	B-X
(	B-X
QS	B-X
)	B-X
circuit	B-X
plays	B-X
a	B-X
role	B-X
in	B-X
the	B-X
precise	B-X
regulation	B-X
of	B-X
genes	B-X
controlling	B-X
virulence	B-X
factors	B-X
and	B-X
biofilm	B-X
formation	B-X
in	B-X
Pseudomonas	B-X
aeruginosa	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
baicalin	B-X
exerted	B-X
dose-dependent	B-X
inhibitory	B-X
effects	B-X
on	B-X
virulence	B-X
phenotypes	B-X
(	B-X
LasA	B-X
protease	B-X
,	B-X
LasB	B-X
elastase	B-X
,	B-X
pyocyanin	B-X
,	B-X
rhamnolipid	B-X
,	B-X
motilities	B-X
and	B-X
exotoxin	B-X
A	B-X
)	B-X
regulated	B-X
by	B-X
QS	B-X
in	B-X
Pseudomonas	B-X
aeruginosa	B-X
.	B-X
Greater	B-X
worm	B-X
survival	B-X
in	B-X
the	B-X
baicalin-treated	B-X
group	B-X
manifested	B-X
as	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
LT50	B-X
from	B-X
24	B-X
to	B-X
96	B-X
h.	B-X
In	B-X
a	B-X
mouse	B-X
peritoneal	B-X
implant	B-X
infection	B-X
model	B-X
,	B-X
baicalin	B-X
treatment	B-X
enhanced	B-X
the	B-X
clearance	B-X
of	B-X
Pseudomonas	B-X
aeruginosa	B-X
from	B-X
the	B-X
implants	B-X
of	B-X
mice	B-X
infected	B-X
with	B-X
Pseudomonas	B-X
aeruginosa	B-X
compared	B-X
with	B-X
the	B-X
control	B-X
group	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
results	B-X
,	B-X
baicalin	B-X
might	B-X
be	B-X
a	B-X
potent	B-X
QS	B-X
inhibitor	B-X
and	B-X
anti-biofilm	B-X
agent	B-X
for	B-X
combating	B-X
Pseudomonas	B-X
aeruginosa	B-X
biofilm-related	B-X
infections	B-X
.	B-X

Secondly	O
,	O
DeltavicK	B-Protein
inoculation	O
protects	O
mice	O
against	O
subsequent	O
infection	O
with	O
wild	O
-	O
type	O
S	O
.	O
equi	O
.	O

Thirdly	O
,	O
most	O
of	O
the	O
mice	O
with	O
intranasal	O
DeltavicK	B-Protein
infection	O
produce	O
mucosal	O
IgA	B-Protein
and	O
systemic	O
IgG	B-Protein
specific	O
to	O
protective	O
antigen	O
SeM	B-Protein
.	O

However	O
,	O
whether	O
DeltavicK	B-Protein
can	O
be	O
an	O
effective	O
live	O
vaccine	O
and	O
whether	O
the	O
DeltavicK	B-Protein
mutant	O
has	O
any	O
advantages	O
over	O
the	O
current	O
live	O
S	O
.	O
equi	O
vaccine	O
require	O
the	O
test	O
of	O
the	O
mutant	O
in	O
horses	O
since	O
S	O
.	O
equi	O
does	O
not	O
naturally	O
infect	O
mice	O
.	O

We	O
hope	O
to	O
perform	O
this	O
expensive	O
test	O
in	O
future	O
when	O
funds	O
are	O
available	O

Coordinated	O
Regulation	O
of	O
Virulence	O
during	O
Systemic	O
Infection	O
of	O
Salmonella	O
enterica	O
Serovar	O
Typhimurium	O
<EOS>	B-X
To	B-X
cause	B-X
a	B-X
systemic	B-X
infection	B-X
,	B-X
Salmonella	B-X
must	B-X
respond	B-X
to	B-X
many	B-X
environmental	B-X
cues	B-X
during	B-X
mouse	B-X
infection	B-X
and	B-X
express	B-X
specific	B-X
subsets	B-X
of	B-X
genes	B-X
in	B-X
a	B-X
temporal	B-X
and	B-X
spatial	B-X
manner	B-X
,	B-X
but	B-X
the	B-X
regulatory	B-X
pathways	B-X
are	B-X
poorly	B-X
established	B-X
.	B-X
To	B-X
unravel	B-X
how	B-X
micro-environmental	B-X
signals	B-X
are	B-X
processed	B-X
and	B-X
integrated	B-X
into	B-X
coordinated	B-X
action	B-X
,	B-X
we	B-X
constructed	B-X
in-frame	B-X
non-polar	B-X
deletions	B-X
of	B-X
83	B-X
regulators	B-X
inferred	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Salmonella	B-X
enteriditis	B-X
Typhimurium	B-X
(	B-X
STM	B-X
)	B-X
virulence	B-X
and	B-X
tested	B-X
them	B-X
in	B-X
three	B-X
virulence	B-X
assays	B-X
(	B-X
intraperitoneal	B-X
[	B-X
i.p	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X

To	O
cause	O
a	O
systemic	O
infection	O
,	O
Salmonella	O
must	O
respond	O
to	O
many	O
environmental	O
cues	O
during	O
mouse	O
infection	O
and	O
express	O
specific	O
subsets	O
of	O
genes	O
in	O
a	O
temporal	O
and	O
spatial	O
manner	O
,	O
but	O
the	O
regulatory	O
pathways	O
are	O
poorly	O
established	O
.	O

To	O
unravel	O
how	O
micro	O
-	O
environmental	O
signals	O
are	O
processed	O
and	O
integrated	O
into	O
coordinated	O
action	O
,	O
we	O
constructed	O
in	O
-	O
frame	O
non	O
-	O
polar	O
deletions	O
of	O
83	O
regulators	O
inferred	O
to	O
play	O
a	O
role	O
in	O
Salmonella	O
enteriditis	O
Typhimurium	O
(	O
STM	O
)	O
virulence	O
and	O
tested	O
them	O
in	O
three	O
virulence	O
assays	O
(	O
intraperitoneal	O
[	O
i	O
.	O
p	O
.	O
]	O
,	O
and	O
intragastric	O
[	O
i	O
.	O
g	O
.	O
]	O
infection	O
in	O
BALB	O
/	O
c	O
mice	O
,	O
and	O
persistence	O
in	O
129X1	O
/	O
SvJ	O
mice	O
)	O
.	O
<EOS>	B-X
To	B-X
cause	B-X
a	B-X
systemic	B-X
infection	B-X
,	B-X
Salmonella	B-X
must	B-X
respond	B-X
to	B-X
many	B-X
environmental	B-X
cues	B-X
during	B-X
mouse	B-X
infection	B-X
and	B-X
express	B-X
specific	B-X
subsets	B-X
of	B-X
genes	B-X
in	B-X
a	B-X
temporal	B-X
and	B-X
spatial	B-X
manner	B-X
,	B-X
but	B-X
the	B-X
regulatory	B-X
pathways	B-X
are	B-X
poorly	B-X
established	B-X
.	B-X
To	B-X
unravel	B-X
how	B-X
micro-environmental	B-X
signals	B-X
are	B-X
processed	B-X
and	B-X
integrated	B-X
into	B-X
coordinated	B-X
action	B-X
,	B-X
we	B-X
constructed	B-X
in-frame	B-X
non-polar	B-X
deletions	B-X
of	B-X
83	B-X
regulators	B-X
inferred	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Salmonella	B-X
enteriditis	B-X
Typhimurium	B-X
(	B-X
STM	B-X
)	B-X
virulence	B-X
and	B-X
tested	B-X
them	B-X
in	B-X
three	B-X
virulence	B-X
assays	B-X
(	B-X
intraperitoneal	B-X
[	B-X
i.p	B-X
.	B-X
]	B-X
,	B-X
and	B-X
intragastric	B-X
[	B-X
i.g	B-X
.	B-X
]	B-X
infection	B-X
in	B-X
BALB/c	B-X
mice	B-X
,	B-X
and	B-X
persistence	B-X
in	B-X
129X1/SvJ	B-X
mice	B-X
)	B-X
.	B-X
Overall	B-X
,	B-X
35	B-X
regulators	B-X
were	B-X
identified	B-X
whose	B-X
absence	B-X
attenuated	B-X
virulence	B-X
in	B-X
at	B-X
least	B-X
one	B-X
assay	B-X
,	B-X
and	B-X
of	B-X
those	B-X
,	B-X
14	B-X
regulators	B-X
were	B-X
required	B-X
for	B-X
systemic	B-X
mouse	B-X
infection	B-X
,	B-X
the	B-X
most	B-X
stringent	B-X
virulence	B-X
assay	B-X
.	B-X
As	B-X
a	B-X
first	B-X
step	B-X
towards	B-X
understanding	B-X
the	B-X
interplay	B-X
between	B-X
a	B-X
pathogen	B-X
and	B-X
its	B-X
host	B-X
from	B-X
a	B-X
systems	B-X
biology	B-X
standpoint	B-X
,	B-X
we	B-X
focused	B-X
on	B-X
these	B-X
14	B-X
genes	B-X
.	B-X
Transcriptional	B-X
profiles	B-X
were	B-X
obtained	B-X
for	B-X
deletions	B-X
of	B-X
each	B-X
of	B-X
these	B-X
14	B-X
regulators	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
environmental	B-X
conditions	B-X
.	B-X
These	B-X
results	B-X
,	B-X
as	B-X
well	B-X
as	B-X
publicly	B-X
available	B-X
transcriptional	B-X
profiles	B-X
,	B-X
were	B-X
analyzed	B-X
using	B-X
both	B-X
network	B-X
inference	B-X
and	B-X
cluster	B-X
analysis	B-X
algorithms	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X
These	B-X
experiments	B-X
validated	B-X
the	B-X
regulatory	B-X
model	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
response	B-X
regulator	B-X
SsrB	B-X
and	B-X
the	B-X
MarR	B-X
type	B-X
regulator	B-X
,	B-X
SlyA	B-X
,	B-X
are	B-X
the	B-X
terminal	B-X
regulators	B-X
in	B-X
a	B-X
cascade	B-X
that	B-X
integrates	B-X
multiple	B-X
signals	B-X
.	B-X
Furthermore	B-X
,	B-X
experiments	B-X
to	B-X
demonstrate	B-X
epistatic	B-X
relationships	B-X
showed	B-X
that	B-X
SsrB	B-X
can	B-X
replace	B-X
SlyA	B-X
and	B-X
,	B-X
in	B-X
some	B-X
cases	B-X
,	B-X
SlyA	B-X
can	B-X
replace	B-X
SsrB	B-X
for	B-X
expression	B-X
of	B-X
SPI-2	B-X
encoded	B-X
virulence	B-X
factors	B-X
.	B-X

Overall	O
,	O
35	O
regulators	O
were	O
identified	O
whose	O
absence	O
attenuated	O
virulence	O
in	O
at	O
least	O
one	O
assay	O
,	O
and	O
of	O
those	O
,	O
14	O
regulators	O
were	O
required	O
for	O
systemic	O
mouse	O
infection	O
,	O
the	O
most	O
stringent	O
virulence	O
assay	O
.	O
<EOS>	B-X
To	B-X
cause	B-X
a	B-X
systemic	B-X
infection	B-X
,	B-X
Salmonella	B-X
must	B-X
respond	B-X
to	B-X
many	B-X
environmental	B-X
cues	B-X
during	B-X
mouse	B-X
infection	B-X
and	B-X
express	B-X
specific	B-X
subsets	B-X
of	B-X
genes	B-X
in	B-X
a	B-X
temporal	B-X
and	B-X
spatial	B-X
manner	B-X
,	B-X
but	B-X
the	B-X
regulatory	B-X
pathways	B-X
are	B-X
poorly	B-X
established	B-X
.	B-X
To	B-X
unravel	B-X
how	B-X
micro-environmental	B-X
signals	B-X
are	B-X
processed	B-X
and	B-X
integrated	B-X
into	B-X
coordinated	B-X
action	B-X
,	B-X
we	B-X
constructed	B-X
in-frame	B-X
non-polar	B-X
deletions	B-X
of	B-X
83	B-X
regulators	B-X
inferred	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Salmonella	B-X
enteriditis	B-X
Typhimurium	B-X
(	B-X
STM	B-X
)	B-X
virulence	B-X
and	B-X
tested	B-X
them	B-X
in	B-X
three	B-X
virulence	B-X
assays	B-X
(	B-X
intraperitoneal	B-X
[	B-X
i.p	B-X
.	B-X
infection	B-X
in	B-X
BALB/c	B-X
mice	B-X
,	B-X
and	B-X
persistence	B-X
in	B-X
129X1/SvJ	B-X
mice	B-X
)	B-X
.	B-X
Overall	B-X
,	B-X
35	B-X
regulators	B-X
were	B-X
identified	B-X
whose	B-X
absence	B-X
attenuated	B-X
virulence	B-X
in	B-X
at	B-X
least	B-X
one	B-X
assay	B-X
,	B-X
and	B-X
of	B-X
those	B-X
,	B-X
14	B-X
regulators	B-X
were	B-X
required	B-X
for	B-X
systemic	B-X
mouse	B-X
infection	B-X
,	B-X
the	B-X
most	B-X
stringent	B-X
virulence	B-X
assay	B-X
.	B-X
As	B-X
a	B-X
first	B-X
step	B-X
towards	B-X
understanding	B-X
the	B-X
interplay	B-X
between	B-X
a	B-X
pathogen	B-X
and	B-X
its	B-X
host	B-X
from	B-X
a	B-X
systems	B-X
biology	B-X
standpoint	B-X
,	B-X
we	B-X
focused	B-X
on	B-X
these	B-X
14	B-X
genes	B-X
.	B-X
Transcriptional	B-X
profiles	B-X
were	B-X
obtained	B-X
for	B-X
deletions	B-X
of	B-X
each	B-X
of	B-X
these	B-X
14	B-X
regulators	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
environmental	B-X
conditions	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X
These	B-X
experiments	B-X
validated	B-X
the	B-X
regulatory	B-X
model	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
response	B-X
regulator	B-X
SsrB	B-X
and	B-X
the	B-X
MarR	B-X
type	B-X
regulator	B-X
,	B-X
SlyA	B-X
,	B-X
are	B-X
the	B-X
terminal	B-X
regulators	B-X
in	B-X
a	B-X
cascade	B-X
that	B-X
integrates	B-X
multiple	B-X
signals	B-X
.	B-X
Furthermore	B-X
,	B-X
experiments	B-X
to	B-X
demonstrate	B-X
epistatic	B-X
relationships	B-X
showed	B-X
that	B-X
SsrB	B-X
can	B-X
replace	B-X
SlyA	B-X
and	B-X
,	B-X
in	B-X
some	B-X
cases	B-X
,	B-X
SlyA	B-X
can	B-X
replace	B-X
SsrB	B-X
for	B-X
expression	B-X
of	B-X
SPI-2	B-X
encoded	B-X
virulence	B-X
factors	B-X
.	B-X

As	O
a	O
first	O
step	O
towards	O
understanding	O
the	O
interplay	O
between	O
a	O
pathogen	O
and	O
its	O
host	O
from	O
a	O
systems	O
biology	O
standpoint	O
,	O
we	O
focused	O
on	O
these	O
14	O
genes	O
.	O
<EOS>	B-X
To	B-X
cause	B-X
a	B-X
systemic	B-X
infection	B-X
,	B-X
Salmonella	B-X
must	B-X
respond	B-X
to	B-X
many	B-X
environmental	B-X
cues	B-X
during	B-X
mouse	B-X
infection	B-X
and	B-X
express	B-X
specific	B-X
subsets	B-X
of	B-X
genes	B-X
in	B-X
a	B-X
temporal	B-X
and	B-X
spatial	B-X
manner	B-X
,	B-X
but	B-X
the	B-X
regulatory	B-X
pathways	B-X
are	B-X
poorly	B-X
established	B-X
.	B-X
Overall	B-X
,	B-X
35	B-X
regulators	B-X
were	B-X
identified	B-X
whose	B-X
absence	B-X
attenuated	B-X
virulence	B-X
in	B-X
at	B-X
least	B-X
one	B-X
assay	B-X
,	B-X
and	B-X
of	B-X
those	B-X
,	B-X
14	B-X
regulators	B-X
were	B-X
required	B-X
for	B-X
systemic	B-X
mouse	B-X
infection	B-X
,	B-X
the	B-X
most	B-X
stringent	B-X
virulence	B-X
assay	B-X
.	B-X
As	B-X
a	B-X
first	B-X
step	B-X
towards	B-X
understanding	B-X
the	B-X
interplay	B-X
between	B-X
a	B-X
pathogen	B-X
and	B-X
its	B-X
host	B-X
from	B-X
a	B-X
systems	B-X
biology	B-X
standpoint	B-X
,	B-X
we	B-X
focused	B-X
on	B-X
these	B-X
14	B-X
genes	B-X
.	B-X
Transcriptional	B-X
profiles	B-X
were	B-X
obtained	B-X
for	B-X
deletions	B-X
of	B-X
each	B-X
of	B-X
these	B-X
14	B-X
regulators	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
environmental	B-X
conditions	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X

Transcriptional	O
profiles	O
were	O
obtained	O
for	O
deletions	O
of	O
each	O
of	O
these	O
14	O
regulators	O
grown	O
under	O
four	O
different	O
environmental	O
conditions	O
.	O
<EOS>	B-X
To	B-X
cause	B-X
a	B-X
systemic	B-X
infection	B-X
,	B-X
Salmonella	B-X
must	B-X
respond	B-X
to	B-X
many	B-X
environmental	B-X
cues	B-X
during	B-X
mouse	B-X
infection	B-X
and	B-X
express	B-X
specific	B-X
subsets	B-X
of	B-X
genes	B-X
in	B-X
a	B-X
temporal	B-X
and	B-X
spatial	B-X
manner	B-X
,	B-X
but	B-X
the	B-X
regulatory	B-X
pathways	B-X
are	B-X
poorly	B-X
established	B-X
.	B-X
To	B-X
unravel	B-X
how	B-X
micro-environmental	B-X
signals	B-X
are	B-X
processed	B-X
and	B-X
integrated	B-X
into	B-X
coordinated	B-X
action	B-X
,	B-X
we	B-X
constructed	B-X
in-frame	B-X
non-polar	B-X
deletions	B-X
of	B-X
83	B-X
regulators	B-X
inferred	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Salmonella	B-X
enteriditis	B-X
Typhimurium	B-X
(	B-X
STM	B-X
)	B-X
virulence	B-X
and	B-X
tested	B-X
them	B-X
in	B-X
three	B-X
virulence	B-X
assays	B-X
(	B-X
intraperitoneal	B-X
[	B-X
i.p	B-X
.	B-X
Overall	B-X
,	B-X
35	B-X
regulators	B-X
were	B-X
identified	B-X
whose	B-X
absence	B-X
attenuated	B-X
virulence	B-X
in	B-X
at	B-X
least	B-X
one	B-X
assay	B-X
,	B-X
and	B-X
of	B-X
those	B-X
,	B-X
14	B-X
regulators	B-X
were	B-X
required	B-X
for	B-X
systemic	B-X
mouse	B-X
infection	B-X
,	B-X
the	B-X
most	B-X
stringent	B-X
virulence	B-X
assay	B-X
.	B-X
As	B-X
a	B-X
first	B-X
step	B-X
towards	B-X
understanding	B-X
the	B-X
interplay	B-X
between	B-X
a	B-X
pathogen	B-X
and	B-X
its	B-X
host	B-X
from	B-X
a	B-X
systems	B-X
biology	B-X
standpoint	B-X
,	B-X
we	B-X
focused	B-X
on	B-X
these	B-X
14	B-X
genes	B-X
.	B-X
Transcriptional	B-X
profiles	B-X
were	B-X
obtained	B-X
for	B-X
deletions	B-X
of	B-X
each	B-X
of	B-X
these	B-X
14	B-X
regulators	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
environmental	B-X
conditions	B-X
.	B-X
These	B-X
results	B-X
,	B-X
as	B-X
well	B-X
as	B-X
publicly	B-X
available	B-X
transcriptional	B-X
profiles	B-X
,	B-X
were	B-X
analyzed	B-X
using	B-X
both	B-X
network	B-X
inference	B-X
and	B-X
cluster	B-X
analysis	B-X
algorithms	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X
These	B-X
experiments	B-X
validated	B-X
the	B-X
regulatory	B-X
model	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
response	B-X
regulator	B-X
SsrB	B-X
and	B-X
the	B-X
MarR	B-X
type	B-X
regulator	B-X
,	B-X
SlyA	B-X
,	B-X
are	B-X
the	B-X
terminal	B-X
regulators	B-X
in	B-X
a	B-X
cascade	B-X
that	B-X
integrates	B-X
multiple	B-X
signals	B-X
.	B-X

These	O
results	O
,	O
as	O
well	O
as	O
publicly	O
available	O
transcriptional	O
profiles	O
,	O
were	O
analyzed	O
using	O
both	O
network	O
inference	O
and	O
cluster	O
analysis	O
algorithms	O
.	O
<EOS>	B-X
Transcriptional	B-X
profiles	B-X
were	B-X
obtained	B-X
for	B-X
deletions	B-X
of	B-X
each	B-X
of	B-X
these	B-X
14	B-X
regulators	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
environmental	B-X
conditions	B-X
.	B-X
These	B-X
results	B-X
,	B-X
as	B-X
well	B-X
as	B-X
publicly	B-X
available	B-X
transcriptional	B-X
profiles	B-X
,	B-X
were	B-X
analyzed	B-X
using	B-X
both	B-X
network	B-X
inference	B-X
and	B-X
cluster	B-X
analysis	B-X
algorithms	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X

The	O
analysis	O
predicts	O
a	O
regulatory	O
network	O
in	O
which	O
all	O
14	O
regulators	O
control	O
the	O
same	O
set	O
of	O
genes	O
necessary	O
for	O
Salmonella	O
to	O
cause	O
systemic	O
infection	O
.	O
<EOS>	B-X
To	B-X
cause	B-X
a	B-X
systemic	B-X
infection	B-X
,	B-X
Salmonella	B-X
must	B-X
respond	B-X
to	B-X
many	B-X
environmental	B-X
cues	B-X
during	B-X
mouse	B-X
infection	B-X
and	B-X
express	B-X
specific	B-X
subsets	B-X
of	B-X
genes	B-X
in	B-X
a	B-X
temporal	B-X
and	B-X
spatial	B-X
manner	B-X
,	B-X
but	B-X
the	B-X
regulatory	B-X
pathways	B-X
are	B-X
poorly	B-X
established	B-X
.	B-X
To	B-X
unravel	B-X
how	B-X
micro-environmental	B-X
signals	B-X
are	B-X
processed	B-X
and	B-X
integrated	B-X
into	B-X
coordinated	B-X
action	B-X
,	B-X
we	B-X
constructed	B-X
in-frame	B-X
non-polar	B-X
deletions	B-X
of	B-X
83	B-X
regulators	B-X
inferred	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Salmonella	B-X
enteriditis	B-X
Typhimurium	B-X
(	B-X
STM	B-X
)	B-X
virulence	B-X
and	B-X
tested	B-X
them	B-X
in	B-X
three	B-X
virulence	B-X
assays	B-X
(	B-X
intraperitoneal	B-X
[	B-X
i.p	B-X
.	B-X
infection	B-X
in	B-X
BALB/c	B-X
mice	B-X
,	B-X
and	B-X
persistence	B-X
in	B-X
129X1/SvJ	B-X
mice	B-X
)	B-X
.	B-X
Overall	B-X
,	B-X
35	B-X
regulators	B-X
were	B-X
identified	B-X
whose	B-X
absence	B-X
attenuated	B-X
virulence	B-X
in	B-X
at	B-X
least	B-X
one	B-X
assay	B-X
,	B-X
and	B-X
of	B-X
those	B-X
,	B-X
14	B-X
regulators	B-X
were	B-X
required	B-X
for	B-X
systemic	B-X
mouse	B-X
infection	B-X
,	B-X
the	B-X
most	B-X
stringent	B-X
virulence	B-X
assay	B-X
.	B-X
As	B-X
a	B-X
first	B-X
step	B-X
towards	B-X
understanding	B-X
the	B-X
interplay	B-X
between	B-X
a	B-X
pathogen	B-X
and	B-X
its	B-X
host	B-X
from	B-X
a	B-X
systems	B-X
biology	B-X
standpoint	B-X
,	B-X
we	B-X
focused	B-X
on	B-X
these	B-X
14	B-X
genes	B-X
.	B-X
Transcriptional	B-X
profiles	B-X
were	B-X
obtained	B-X
for	B-X
deletions	B-X
of	B-X
each	B-X
of	B-X
these	B-X
14	B-X
regulators	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
environmental	B-X
conditions	B-X
.	B-X
These	B-X
results	B-X
,	B-X
as	B-X
well	B-X
as	B-X
publicly	B-X
available	B-X
transcriptional	B-X
profiles	B-X
,	B-X
were	B-X
analyzed	B-X
using	B-X
both	B-X
network	B-X
inference	B-X
and	B-X
cluster	B-X
analysis	B-X
algorithms	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X
These	B-X
experiments	B-X
validated	B-X
the	B-X
regulatory	B-X
model	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
response	B-X
regulator	B-X
SsrB	B-X
and	B-X
the	B-X
MarR	B-X
type	B-X
regulator	B-X
,	B-X
SlyA	B-X
,	B-X
are	B-X
the	B-X
terminal	B-X
regulators	B-X
in	B-X
a	B-X
cascade	B-X
that	B-X
integrates	B-X
multiple	B-X
signals	B-X
.	B-X

We	O
tested	O
the	O
regulatory	O
model	O
by	O
expressing	O
a	O
subset	O
of	O
the	O
regulators	O
in	O
trans	O
and	O
monitoring	O
transcription	O
of	O
7	O
known	O
virulence	O
factors	O
located	O
within	O
Salmonella	O
pathogenicity	O
island	O
2	O
(	O
SPI	O
-	O
2	O
)	O
.	O
<EOS>	B-X
To	B-X
cause	B-X
a	B-X
systemic	B-X
infection	B-X
,	B-X
Salmonella	B-X
must	B-X
respond	B-X
to	B-X
many	B-X
environmental	B-X
cues	B-X
during	B-X
mouse	B-X
infection	B-X
and	B-X
express	B-X
specific	B-X
subsets	B-X
of	B-X
genes	B-X
in	B-X
a	B-X
temporal	B-X
and	B-X
spatial	B-X
manner	B-X
,	B-X
but	B-X
the	B-X
regulatory	B-X
pathways	B-X
are	B-X
poorly	B-X
established	B-X
.	B-X
To	B-X
unravel	B-X
how	B-X
micro-environmental	B-X
signals	B-X
are	B-X
processed	B-X
and	B-X
integrated	B-X
into	B-X
coordinated	B-X
action	B-X
,	B-X
we	B-X
constructed	B-X
in-frame	B-X
non-polar	B-X
deletions	B-X
of	B-X
83	B-X
regulators	B-X
inferred	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Salmonella	B-X
enteriditis	B-X
Typhimurium	B-X
(	B-X
STM	B-X
)	B-X
virulence	B-X
and	B-X
tested	B-X
them	B-X
in	B-X
three	B-X
virulence	B-X
assays	B-X
(	B-X
intraperitoneal	B-X
[	B-X
i.p	B-X
.	B-X
infection	B-X
in	B-X
BALB/c	B-X
mice	B-X
,	B-X
and	B-X
persistence	B-X
in	B-X
129X1/SvJ	B-X
mice	B-X
)	B-X
.	B-X
Overall	B-X
,	B-X
35	B-X
regulators	B-X
were	B-X
identified	B-X
whose	B-X
absence	B-X
attenuated	B-X
virulence	B-X
in	B-X
at	B-X
least	B-X
one	B-X
assay	B-X
,	B-X
and	B-X
of	B-X
those	B-X
,	B-X
14	B-X
regulators	B-X
were	B-X
required	B-X
for	B-X
systemic	B-X
mouse	B-X
infection	B-X
,	B-X
the	B-X
most	B-X
stringent	B-X
virulence	B-X
assay	B-X
.	B-X
Transcriptional	B-X
profiles	B-X
were	B-X
obtained	B-X
for	B-X
deletions	B-X
of	B-X
each	B-X
of	B-X
these	B-X
14	B-X
regulators	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
environmental	B-X
conditions	B-X
.	B-X
These	B-X
results	B-X
,	B-X
as	B-X
well	B-X
as	B-X
publicly	B-X
available	B-X
transcriptional	B-X
profiles	B-X
,	B-X
were	B-X
analyzed	B-X
using	B-X
both	B-X
network	B-X
inference	B-X
and	B-X
cluster	B-X
analysis	B-X
algorithms	B-X
.	B-X
The	B-X
analysis	B-X
predicts	B-X
a	B-X
regulatory	B-X
network	B-X
in	B-X
which	B-X
all	B-X
14	B-X
regulators	B-X
control	B-X
the	B-X
same	B-X
set	B-X
of	B-X
genes	B-X
necessary	B-X
for	B-X
Salmonella	B-X
to	B-X
cause	B-X
systemic	B-X
infection	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X
These	B-X
experiments	B-X
validated	B-X
the	B-X
regulatory	B-X
model	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
response	B-X
regulator	B-X
SsrB	B-X
and	B-X
the	B-X
MarR	B-X
type	B-X
regulator	B-X
,	B-X
SlyA	B-X
,	B-X
are	B-X
the	B-X
terminal	B-X
regulators	B-X
in	B-X
a	B-X
cascade	B-X
that	B-X
integrates	B-X
multiple	B-X
signals	B-X
.	B-X
Furthermore	B-X
,	B-X
experiments	B-X
to	B-X
demonstrate	B-X
epistatic	B-X
relationships	B-X
showed	B-X
that	B-X
SsrB	B-X
can	B-X
replace	B-X
SlyA	B-X
and	B-X
,	B-X
in	B-X
some	B-X
cases	B-X
,	B-X
SlyA	B-X
can	B-X
replace	B-X
SsrB	B-X
for	B-X
expression	B-X
of	B-X
SPI-2	B-X
encoded	B-X
virulence	B-X
factors	B-X
.	B-X

These	O
experiments	O
validated	O
the	O
regulatory	O
model	O
and	O
showed	O
that	O
the	O
response	O
regulator	O
SsrB	B-Protein
and	O
the	O
MarR	B-Protein
type	O
regulator	O
,	O
SlyA	B-Protein
,	O
are	O
the	O
terminal	O
regulators	O
in	O
a	O
cascade	O
that	O
integrates	O
multiple	O
signals	O
.	O

Furthermore	O
,	O
experiments	O
to	O
demonstrate	O
epistatic	O
relationships	O
showed	O
that	O
SsrB	B-Protein
can	O
replace	O
SlyA	B-Protein
and	O
,	O
in	O
some	O
cases	O
,	O
SlyA	B-Protein
can	O
replace	O
SsrB	B-Protein
for	O
expression	O
of	O
SPI	O
-	O
2	O
encoded	O
virulence	O
factors	O
.	O
<EOS>	B-X
To	B-X
unravel	B-X
how	B-X
micro-environmental	B-X
signals	B-X
are	B-X
processed	B-X
and	B-X
integrated	B-X
into	B-X
coordinated	B-X
action	B-X
,	B-X
we	B-X
constructed	B-X
in-frame	B-X
non-polar	B-X
deletions	B-X
of	B-X
83	B-X
regulators	B-X
inferred	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Salmonella	B-X
enteriditis	B-X
Typhimurium	B-X
(	B-X
STM	B-X
)	B-X
virulence	B-X
and	B-X
tested	B-X
them	B-X
in	B-X
three	B-X
virulence	B-X
assays	B-X
(	B-X
intraperitoneal	B-X
[	B-X
i.p	B-X
.	B-X
infection	B-X
in	B-X
BALB/c	B-X
mice	B-X
,	B-X
and	B-X
persistence	B-X
in	B-X
129X1/SvJ	B-X
mice	B-X
)	B-X
.	B-X
Overall	B-X
,	B-X
35	B-X
regulators	B-X
were	B-X
identified	B-X
whose	B-X
absence	B-X
attenuated	B-X
virulence	B-X
in	B-X
at	B-X
least	B-X
one	B-X
assay	B-X
,	B-X
and	B-X
of	B-X
those	B-X
,	B-X
14	B-X
regulators	B-X
were	B-X
required	B-X
for	B-X
systemic	B-X
mouse	B-X
infection	B-X
,	B-X
the	B-X
most	B-X
stringent	B-X
virulence	B-X
assay	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X
These	B-X
experiments	B-X
validated	B-X
the	B-X
regulatory	B-X
model	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
response	B-X
regulator	B-X
SsrB	B-X
and	B-X
the	B-X
MarR	B-X
type	B-X
regulator	B-X
,	B-X
SlyA	B-X
,	B-X
are	B-X
the	B-X
terminal	B-X
regulators	B-X
in	B-X
a	B-X
cascade	B-X
that	B-X
integrates	B-X
multiple	B-X
signals	B-X
.	B-X
Furthermore	B-X
,	B-X
experiments	B-X
to	B-X
demonstrate	B-X
epistatic	B-X
relationships	B-X
showed	B-X
that	B-X
SsrB	B-X
can	B-X
replace	B-X
SlyA	B-X
and	B-X
,	B-X
in	B-X
some	B-X
cases	B-X
,	B-X
SlyA	B-X
can	B-X
replace	B-X
SsrB	B-X
for	B-X
expression	B-X
of	B-X
SPI-2	B-X
encoded	B-X
virulence	B-X
factors	B-X
.	B-X

Introduction	O

Gastrointestinal	O
infections	O
are	O
the	O
second	O
most	O
common	O
cause	O
of	O
childhood	O
mortality	O
in	O
the	O
developing	O
world	O
and	O
Typhoid	O
alone	O
(	O
caused	O
by	O
serovar	O
Typhi	O
)	O
is	O
estimated	O
to	O
result	O
in	O
500	O
,	O
000	O
deaths	O
per	O
year	O
[	O
1	O
]	O
.	O

In	O
addition	O
to	O
fluid	O
and	O
electrolyte	O
loss	O
,	O
non	O
-	O
typhoidal	O
Salmonella	O
often	O
results	O
in	O
septicemia	O
in	O
children	O
and	O
in	O
HIV	O
infected	O
adults	O
in	O
developing	O
countries	O
with	O
a	O
fatality	O
rate	O
of	O
25	O
%	O
or	O
greater	O
[	O
2	O
]	O
.	O
<EOS>	B-X
Their	B-X
UVA	B-X
maximum	B-X
absorption	B-X
lies	B-X
at	B-X
325	B-X
and	B-X
330	B-X
nm	B-X
,	B-X
respectively	B-X
.	B-X
They	B-X
complex	B-X
to	B-X
DNA	B-X
in	B-X
the	B-X
dark	B-X
,	B-X
and	B-X
,	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
UVA	B-X
,	B-X
produce	B-X
only	B-X
monoadditions	B-X
to	B-X
DNA	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
fluorescence	B-X
and	B-X
DNA	B-X
denaturation-renaturation	B-X
studies	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
the	B-X
following	B-X
ranges	B-X
of	B-X
effectiveness	B-X
are	B-X
found	B-X
:	B-X
inhibition	B-X
of	B-X
DNA	B-X
synthesis	B-X
in	B-X
human	B-X
fibroblasts	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
8-MOP	B-X
;	B-X
mutagenic	B-X
activity	B-X
in	B-X
V79	B-X
Chinese	B-X
hamster	B-X
cells	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
8-MOP	B-X
;	B-X
cell	B-X
transforming	B-X
ability	B-X
in	B-X
C3H	B-X
embryonic	B-X
mouse	B-X
cells	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
8-MOP	B-X
greater	B-X
than	B-X
PP	B-X
as	B-X
a	B-X
function	B-X
of	B-X
UVA	B-X
dose	B-X
,	B-X
and	B-X
:	B-X
8-MOP	B-X
greater	B-X
than	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
as	B-X
a	B-X
function	B-X
of	B-X
survival	B-X
;	B-X
induction	B-X
of	B-X
sister	B-X
chromatic	B-X
exchanges	B-X
(	B-X
SCE	B-X
)	B-X
per	B-X
unit	B-X
dose	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
8-MOP	B-X
in	B-X
the	B-X
linear	B-X
part	B-X
of	B-X
the	B-X
induction	B-X
curve	B-X
,	B-X
and	B-X
:	B-X
8-MOP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
MPP	B-X
at	B-X
the	B-X
maximum	B-X
level	B-X
of	B-X
SCE	B-X
obtained	B-X
.	B-X
(	B-X
ABSTRACT	B-X
TRUNCATED	B-X
AT	B-X
250	B-X
WORDS	B-X
)	B-X

Salmonella	O
enteriditis	O
serotype	O
Typhimurium	O
(	O
referred	O
to	O
simply	O
as	O
Salmonella	O
or	O
Typhimurium	O
below	O
)	O
is	O
a	O
paradigm	O
for	O
understanding	O
intracellular	O
pathogenesis	O
because	O
of	O
its	O
established	O
genetics	O
and	O
simple	O
and	O
inexpensive	O
animal	O
model	O
-	O
the	O
mouse	O
.	O

All	O
strains	O
of	O
Salmonella	O
enteriditis	O
share	O
at	O
least	O
95	O
%	O
sequence	O
identity	O
;	O
the	O
differences	O
are	O
associated	O
with	O
growth	O
in	O
a	O
specific	O
host	O
or	O
survival	O
in	O
an	O
environmental	O
niche	O
.	O

More	O
than	O
4	O
%	O
of	O
the	O
entire	O
genome	O
is	O
required	O
for	O
Typhimurium	O
to	O
infect	O
the	O
mouse	O
[	O
3	O
]	O
.	O

These	O
genes	O
are	O
widely	O
distributed	O
around	O
the	O
entire	O
circular	O
chromosome	O
including	O
many	O
genes	O
not	O
involved	O
in	O
metabolic	O
processes	O
nor	O
required	O
for	O
growth	O
under	O
laboratory	O
conditions	O
.	O

Numerous	O
studies	O
have	O
assigned	O
a	O
small	O
fraction	O
of	O
these	O
genes	O
to	O
specific	O
steps	O
in	O
mouse	O
infection	O
but	O
most	O
are	O
still	O
a	O
mystery	O
.	O

Many	O
virulence	O
genes	O
are	O
attributable	O
to	O
horizontally	O
acquired	O
DNA	O
sequences	O
that	O
are	O
not	O
present	O
in	O
nonpathogenic	O
but	O
related	O
bacteria	O
.	O
<EOS>	B-X
Many	B-X
bacterial	B-X
virulence	B-X
attributes	B-X
,	B-X
like	B-X
toxins	B-X
,	B-X
adhesins	B-X
,	B-X
invasins	B-X
,	B-X
iron	B-X
uptake	B-X
systems	B-X
,	B-X
are	B-X
encoded	B-X
within	B-X
specific	B-X
regions	B-X
of	B-X
the	B-X
bacterial	B-X
genome	B-X
.	B-X
Per	B-X
definition	B-X
PAIs	B-X
are	B-X
exclusively	B-X
found	B-X
in	B-X
pathogenic	B-X
strains	B-X
and	B-X
are	B-X
often	B-X
inserted	B-X
near	B-X
transfer-RNA	B-X
genes	B-X
.	B-X
Nevertheless	B-X
,	B-X
non-pathogenic	B-X
bacteria	B-X
also	B-X
possess	B-X
foreign	B-X
DNA	B-X
elements	B-X
that	B-X
confer	B-X
advantageous	B-X
features	B-X
,	B-X
leading	B-X
to	B-X
improved	B-X
fitness	B-X
.	B-X
These	B-X
additional	B-X
DNA	B-X
elements	B-X
as	B-X
well	B-X
as	B-X
PAIs	B-X
are	B-X
termed	B-X
genomic	B-X
islands	B-X
and	B-X
were	B-X
acquired	B-X
during	B-X
bacterial	B-X
evolution	B-X
.	B-X
Significant	B-X
G+C	B-X
content	B-X
deviation	B-X
in	B-X
pathogenicity	B-X
islands	B-X
with	B-X
respect	B-X
to	B-X
the	B-X
rest	B-X
of	B-X
the	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
direct	B-X
repeat	B-X
sequences	B-X
at	B-X
the	B-X
flanking	B-X
regions	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
integrase	B-X
gene	B-X
determinants	B-X
as	B-X
other	B-X
mobility	B-X
features	B-X
,	B-X
the	B-X
particular	B-X
insertion	B-X
site	B-X
(	B-X
tRNA	B-X
gene	B-X
)	B-X
as	B-X
well	B-X
as	B-X
the	B-X
observed	B-X
genetic	B-X
instability	B-X
suggests	B-X
that	B-X
pathogenicity	B-X
islands	B-X
were	B-X
acquired	B-X
by	B-X
horizontal	B-X
gene	B-X
transfer	B-X
.	B-X
PAIs	B-X
are	B-X
the	B-X
fascinating	B-X
proof	B-X
of	B-X
the	B-X
plasticity	B-X
of	B-X
bacterial	B-X
genomes	B-X
.	B-X
In	B-X
the	B-X
meantime	B-X
PAIs	B-X
have	B-X
been	B-X
found	B-X
in	B-X
various	B-X
pathogenic	B-X
bacteria	B-X
of	B-X
humans	B-X
,	B-X
animals	B-X
and	B-X
even	B-X
plants	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
it	B-X
also	B-X
confers	B-X
pathogenicity	B-X
to	B-X
the	B-X
related	B-X
species	B-X
Citrobacter	B-X
(	B-X
C.	B-X
)	B-X
rodentium	B-X
and	B-X
Escherichia	B-X
(	B-X
E.	B-X
)	B-X
alvei	B-X
.	B-X
The	B-X
LEE	B-X
is	B-X
an	B-X
important	B-X
virulence	B-X
feature	B-X
of	B-X
several	B-X
animal	B-X
pathogens	B-X
.	B-X
The	B-X
LEE	B-X
encoded	B-X
virulence	B-X
features	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
so	B-X
called	B-X
attaching	B-X
and	B-X
effacing	B-X
(	B-X
AE	B-X
)	B-X
lesions	B-X
in	B-X
the	B-X
intestinal	B-X
epithelium	B-X
.	B-X

These	O
regions	O
include	O
two	O
40	O
kb	O
stretches	O
of	O
DNA	O
termed	O
Salmonella	O
pathogenicity	O
islands	O
1	O
(	O
SPI	O
-	O
1	O
)	O
and	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
4	O
]	O
-	O
[	O
9	O
]	O
.	O

SPI	O
-	O
1	O
and	O
SPI	O
-	O
2	O
encode	O
a	O
secretion	O
apparatus	O
resembling	O
a	O
needle	O
and	O
related	O
to	O
the	O
bacterial	O
flagella	O
that	O
uses	O
the	O
proton	O
motive	O
force	O
to	O
secrete	O
proteins	O
directly	O
into	O
the	O
cytoplasm	O
of	O
the	O
eukaryotic	O
cell	O
[	O
10	O
]	O
.	O

Secretion	O
can	O
take	O
place	O
from	O
extracellular	O
bacteria	O
that	O
are	O
juxtaposed	O
to	O
the	O
surface	O
of	O
the	O
cell	O
or	O
from	O
intracellular	O
bacteria	O
located	O
in	O
vacuoles	O
.	O
<EOS>	B-X
Despite	B-X
numerous	B-X
reviews	B-X
,	B-X
there	B-X
continues	B-X
to	B-X
be	B-X
confusion	B-X
regarding	B-X
acceptable	B-X
methods	B-X
to	B-X
evaluate	B-X
autophagy	B-X
,	B-X
especially	B-X
in	B-X
multicellular	B-X
eukaryotes	B-X
.	B-X
Along	B-X
similar	B-X
lines	B-X
,	B-X
because	B-X
multiple	B-X
proteins	B-X
involved	B-X
in	B-X
autophagy	B-X
also	B-X
regulate	B-X
other	B-X
cellular	B-X
pathways	B-X
including	B-X
apoptosis	B-X
,	B-X
not	B-X
all	B-X
of	B-X
them	B-X
can	B-X
be	B-X
used	B-X
as	B-X
a	B-X
specific	B-X
marker	B-X
for	B-X
Histopathological	B-X
examination	B-X
of	B-X
jejunal	B-X
biopsies	B-X
from	B-X
infected	B-X
individuals	B-X
showed	B-X
mild	B-X
to	B-X
moderate	B-X
acute	B-X
inflammation	B-X
of	B-X
the	B-X
lamina	B-X
propria	B-X
and	B-X
surface	B-X
epithelial	B-X
disarray	B-X
.	B-X
Parasitophorous	B-X
vacuoles	B-X
containing	B-X
sexual	B-X
and	B-X
asexual	B-X
forms	B-X
of	B-X
Cycl	B-X
.	B-X
cayetanensis	B-X
were	B-X
located	B-X
in	B-X
the	B-X
cytoplasm	B-X
of	B-X
epithelial	B-X
cells	B-X
.	B-X

The	O
two	O
type	O
III	O
secretion	O
systems	O
are	O
expressed	O
under	O
different	O
environmental	O
conditions	O
and	O
play	O
distinct	O
roles	O
in	O
pathogenesis	O
.	O

SPI	O
-	O
2	O
is	O
known	O
to	O
be	O
required	O
for	O
systemic	O
infection	O
whereas	O
SPI	O
-	O
1	O
plays	O
an	O
essential	O
role	O
during	O
intestinal	O
infection	O
and	O
in	O
mouse	O
persistence	O
[	O
11	O
]	O
-	O
[	O
14	O
]	O
.	O

During	O
the	O
course	O
of	O
systemic	O
infection	O
in	O
mice	O
,	O
bacteria	O
are	O
found	O
within	O
neutrophils	O
,	O
monocytes	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
and	O
T	O
cells	O
but	O
are	O
not	O
found	O
extracellularly	O
until	O
the	O
last	O
one	O
or	O
two	O
days	O
immediately	O
before	O
death	O
of	O
the	O
mouse	O
[	O
15	O
]	O
-	O
[	O
17	O
]	O
.	O
<EOS>	B-X
The	B-X
effects	B-X
of	B-X
adenosine	B-X
on	B-X
the	B-X
acute	B-X
toxicity	B-X
and	B-X
oncolytic	B-X
activity	B-X
of	B-X
adriamycin	B-X
(	B-X
ADR	B-X
)	B-X
were	B-X
evaluated	B-X
in	B-X
mice	B-X
.	B-X
injection	B-X
of	B-X
17.5	B-X
mg/kg	B-X
,	B-X
adriamycin	B-X
produced	B-X
death	B-X
in	B-X
all	B-X
mice	B-X
within	B-X
12	B-X
days	B-X
after	B-X
treatment	B-X
,	B-X
with	B-X
a	B-X
mean	B-X
survival	B-X
time	B-X
of	B-X
5-9	B-X
days	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
mean	B-X
survival	B-X
time	B-X
of	B-X
mice	B-X
administered	B-X
adenosine	B-X
subcutaneously	B-X
(	B-X
200	B-X
mg/kg	B-X
)	B-X
in	B-X
addition	B-X
to	B-X
adriamycin	B-X
was	B-X
significantly	B-X
increased	B-X
compared	B-X
to	B-X
adriamycin-treated	B-X
mice	B-X
.	B-X
Although	B-X
a	B-X
number	B-X
of	B-X
adenosine	B-X
treatment	B-X
schedules	B-X
were	B-X
tested	B-X
,	B-X
it	B-X
was	B-X
found	B-X
that	B-X
adenosine	B-X
given	B-X
immediately	B-X
after	B-X
adriamycin	B-X
was	B-X
as	B-X
effective	B-X
as	B-X
multiple	B-X
adenosine	B-X
injections	B-X
.	B-X
Two	B-X
grossly	B-X
observable	B-X
effects	B-X
of	B-X
adenosine	B-X
administration	B-X
were	B-X
lethargy	B-X
and	B-X
peripheral	B-X
hypothermia	B-X
,	B-X
which	B-X
were	B-X
first	B-X
noticed	B-X
approximately	B-X
15	B-X
min	B-X
after	B-X
adenosine	B-X
administration	B-X
and	B-X
which	B-X
lasted	B-X
for	B-X
up	B-X
to	B-X
2	B-X
hr	B-X
.	B-X
Finally	B-X
,	B-X
adenosine	B-X
had	B-X
no	B-X
adverse	B-X
effect	B-X
on	B-X
the	B-X
antitumor	B-X
efficacy	B-X
of	B-X
adriamycin	B-X
against	B-X
L1210	B-X
ascites	B-X
cells	B-X
inoculated	B-X
i.p	B-X
.	B-X
to	B-X
BDF1	B-X
mice	B-X
.	B-X

How	O
Salmonella	O
survives	O
and	O
replicates	O
within	O
the	O
host	O
and	O
how	O
it	O
expresses	O
virulence	O
genes	O
at	O
the	O
appropriate	O
time	O
during	O
systemic	O
infection	O
is	O
little	O
understood	O
and	O
the	O
subject	O
of	O
this	O
work	O
.	O

Technological	O
advances	O
in	O
the	O
last	O
10	O
years	O
such	O
as	O
microarrays	O
,	O
whole	O
genome	O
sequences	O
,	O
and	O
global	O
proteomics	O
have	O
provided	O
a	O
more	O
complete	O
picture	O
of	O
gene	O
expression	O
for	O
a	O
number	O
of	O
bacteria	O
.	O

The	O
goal	O
of	O
the	O
current	O
work	O
is	O
to	O
develop	O
a	O
predictive	O
model	O
for	O
host	O
-	O
pathogen	O
interactions	O
that	O
will	O
provide	O
insight	O
into	O
how	O
Salmonella	O
responds	O
to	O
specific	O
conditions	O
in	O
the	O
host	O
.	O

This	O
approach	O
was	O
based	O
on	O
identification	O
of	O
regulators	O
that	O
were	O
necessary	O
for	O
Salmonella	O
to	O
cause	O
a	O
systemic	O
infection	O
and	O
transcriptional	O
profiling	O
of	O
isogenic	O
derivatives	O
missing	O
the	O
regulator	O
under	O
a	O
variety	O
of	O
growth	O
conditions	O
.	O

The	O
transcriptional	O
profiles	O
provided	O
more	O
than	O
300	O
,	O
000	O
data	O
point	O
,	O
necessitating	O
computer	O
analysis	O
.	O

We	O
have	O
used	O
SEBINI	O
(	O
Software	O
Environment	O
for	O
Biological	O
Network	O
Inference	O
;	O
[	O
18	O
]	O
)	O
to	O
directly	O
compare	O
multiple	O
network	O
algorithms	O
.	O
<EOS>	B-X
The	B-X
Software	B-X
Environment	B-X
for	B-X
BIological	B-X
Network	B-X
Inference	B-X
(	B-X
SEBINI	B-X
)	B-X
has	B-X
been	B-X
created	B-X
to	B-X
provide	B-X
an	B-X
interactive	B-X
environment	B-X
for	B-X
the	B-X
deployment	B-X
and	B-X
evaluation	B-X
of	B-X
algorithms	B-X
used	B-X
to	B-X
reconstruct	B-X
the	B-X
structure	B-X
of	B-X
biological	B-X
regulatory	B-X
and	B-X
interaction	B-X
networks	B-X
.	B-X
SEBINI	B-X
can	B-X
be	B-X
used	B-X
to	B-X
compare	B-X
and	B-X
train	B-X
network	B-X
inference	B-X
methods	B-X
on	B-X
artificial	B-X
networks	B-X
and	B-X
simulated	B-X
gene	B-X
expression	B-X
perturbation	B-X
data	B-X
.	B-X
It	B-X
also	B-X
allows	B-X
the	B-X
analysis	B-X
within	B-X
the	B-X
same	B-X
framework	B-X
of	B-X
experimental	B-X
high-throughput	B-X
expression	B-X
data	B-X
using	B-X
the	B-X
suite	B-X
of	B-X
(	B-X
trained	B-X
)	B-X
inference	B-X
methods	B-X
;	B-X
hence	B-X
SEBINI	B-X
should	B-X
be	B-X
useful	B-X
to	B-X
software	B-X
developers	B-X
wishing	B-X
to	B-X
evaluate	B-X
,	B-X
compare	B-X
,	B-X
refine	B-X
or	B-X
combine	B-X
inference	B-X
techniques	B-X
,	B-X
and	B-X
to	B-X
bioinformaticians	B-X
analyzing	B-X
experimental	B-X
data	B-X
.	B-X
SEBINI	B-X
provides	B-X
a	B-X
platform	B-X
that	B-X
aids	B-X
in	B-X
more	B-X
accurate	B-X
reconstruction	B-X
of	B-X
biological	B-X
networks	B-X
,	B-X
with	B-X
less	B-X
effort	B-X
,	B-X
in	B-X
less	B-X
time	B-X
.	B-X

The	O
network	O
inference	O
algorithm	O
that	O
we	O
have	O
used	O
is	O
the	O
context	O
likelihood	O
of	O
relatedness	O
(	O
CLR	O
)	O
to	O
analyze	O
the	O
gene	O
expression	O
profiles	O
[	O
19	O
]	O
.	O

CLR	O
is	O
an	O
extension	O
of	O
the	O
relevance	O
network	O
class	O
of	O
machine	O
learning	O
algorithms	O
[	O
20	O
]	O
and	O
provides	O
the	O
highest	O
precision	O
of	O
several	O
algorithms	O
tested	O
[	O
19	O
]	O
.	O

At	O
a	O
60	O
%	O
true	O
positive	O
rate	O
,	O
CLR	O
identified	O
1	O
,	O
079	O
regulatory	O
interactions	O
in	O
E	O
.	O
coli	O
,	O
of	O
which	O
338	O
were	O
in	O
previously	O
known	O
networks	O
and	O
741	O
were	O
novel	O
predictions	O
(	O
ibid	O
)	O
.	O

The	O
analysis	O
of	O
our	O
data	O
provided	O
a	O
testable	O
regulatory	O
hierarchy	O
and	O
a	O
list	O
of	O
genes	O
with	O
similar	O
expression	O
profiles	O
as	O
described	O
below	O
.	O

Results	O

Salmonella	O
regulators	O
required	O
for	O
systemic	O
mouse	O
infection	O
Typhimurium	O
encodes	O
a	O
surfeit	O
of	O
regulators	O
(	O
more	O
than	O
330	O
based	O
on	O
annotation	O
cited	O
in	O
NCBI	O
)	O
presumably	O
because	O
it	O
can	O
survive	O
and	O
replicate	O
in	O
many	O
different	O
environments	O
,	O
cause	O
infection	O
in	O
diverse	O
hosts	O
,	O
and	O
can	O
use	O
multiple	O
carbon	O
sources	O
and	O
terminal	O
electron	O
acceptors	O
.	O

We	O
focused	O
on	O
83	O
regulators	O
presumed	O
to	O
play	O
roles	O
in	O
virulence	O
,	O
based	O
on	O
published	O
data	O
including	O
negative	O
selection	O
experiments	O
[	O
13	O
]	O
,	O
[	O
21	O
]	O
-	O
[	O
23	O
]	O
.	O

We	O
constructed	O
non	O
-	O
polar	O
in	O
-	O
frame	O
deletions	O
in	O
which	O
each	O
regulator	O
gene	O
was	O
replaced	O
with	O
a	O
"	O
scar	O
"	O
sequence	O
using	O
bacteriophage	O
lambda	O
-	O
mediated	O
recombination	O
[	O
24	O
]	O
,	O
[	O
25	O
]	O
.	O

The	O
list	O
of	O
83	O
regulator	O
genes	O
is	O
provided	O
in	O
Supporting	O
Information	O
(	O
Table	O
S1	O
)	O
.	O

For	O
the	O
two	O
-	O
component	O
regulator	O
ssrA	B-Protein
/	O
ssrB	B-Protein
we	O
constructed	O
in	O
-	O
frame	O
deletions	O
missing	O
ssrA	B-Protein
,	O
ssrB	B-Protein
or	O
both	O
;	O
for	O
the	O
other	O
two	O
two	O
-	O
component	O
regulators	O
,	O
phoP	B-Protein
/	O
phoQ	B-Protein
and	O
ompR	B-Protein
/	O
envZ	B-Protein
,	O
both	O
the	O
signal	O
sensor	O
and	O
response	O
regulator	O
were	O
deleted	O
.	O

As	O
an	O
initial	O
screen	O
two	O
4	O
-	O
6	O
weeks	O
-	O
old	O
BALB	O
/	O
c	O
mice	O
were	O
infected	O
intraperitoneally	O
(	O
i	O
.	O
p	O
.	O
)	O
with	O
200	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
of	O
each	O
deleted	O
strain	O
(	O
about	O
100x	O
the	O
LD50	O
)	O
.	O

Mutations	O
that	O
resulted	O
in	O
either	O
no	O
deaths	O
,	O
one	O
death	O
,	O
or	O
delayed	O
death	O
of	O
infected	O
mice	O
were	O
retested	O
with	O
groups	O
of	O
5	O
mice	O
at	O
the	O
same	O
dose	O
(	O
Figure	O
1A	O
)	O
.	O
<EOS>	B-X
The	B-X
evolutionarily	B-X
conserved	B-X
p53	B-X
protein	B-X
and	B-X
its	B-X
cellular	B-X
pathways	B-X
mediate	B-X
tumour	B-X
suppression	B-X
through	B-X
an	B-X
informed	B-X
,	B-X
regulated	B-X
and	B-X
integrated	B-X
set	B-X
of	B-X
responses	B-X
to	B-X
environmental	B-X
perturbations	B-X
resulting	B-X
in	B-X
either	B-X
cellular	B-X
death	B-X
or	B-X
the	B-X
maintenance	B-X
of	B-X
cellular	B-X
homeostasis	B-X
.	B-X
The	B-X
p53	B-X
and	B-X
MDM2	B-X
proteins	B-X
form	B-X
a	B-X
central	B-X
hub	B-X
in	B-X
this	B-X
pathway	B-X
that	B-X
receives	B-X
stressful	B-X
inputs	B-X
via	B-X
MDM2	B-X
and	B-X
respond	B-X
via	B-X
p53	B-X
by	B-X
informing	B-X
and	B-X
altering	B-X
a	B-X
great	B-X
many	B-X
other	B-X
pathways	B-X
and	B-X
functions	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
The	B-X
MDM2-p53	B-X
hub	B-X
is	B-X
one	B-X
of	B-X
the	B-X
hubs	B-X
most	B-X
highly	B-X
connected	B-X
to	B-X
other	B-X
signalling	B-X
pathways	B-X
in	B-X
the	B-X
cell	B-X
,	B-X
and	B-X
this	B-X
may	B-X
be	B-X
why	B-X
TP53	B-X
is	B-X
the	B-X
most	B-X
commonly	B-X
mutated	B-X
gene	B-X
in	B-X
human	B-X
cancers	B-X
.	B-X
Initial	B-X
or	B-X
truncal	B-X
TP53	B-X
gene	B-X
mutations	B-X
(	B-X
the	B-X
first	B-X
mutations	B-X
in	B-X
a	B-X
stem	B-X
cell	B-X
)	B-X
are	B-X
selected	B-X
for	B-X
early	B-X
in	B-X
cancer	B-X
development	B-X
inectodermal	B-X
and	B-X
mesodermal-derived	B-X
tissue-specific	B-X
stem	B-X
and	B-X
progenitor	B-X
cells	B-X
and	B-X
then	B-X
,	B-X
following	B-X
additional	B-X
mutations	B-X
,	B-X
produce	B-X
tumours	B-X
from	B-X
those	B-X
tissue	B-X
types	B-X
.	B-X
In	B-X
endodermal-derived	B-X
tissue-specific	B-X
stem	B-X
or	B-X
progenitor	B-X
cells	B-X
,	B-X
TP53	B-X
mutations	B-X
are	B-X
functionally	B-X
selected	B-X
as	B-X
late	B-X
mutations	B-X
transitioning	B-X
the	B-X
mutated	B-X
cell	B-X
into	B-X
a	B-X
malignant	B-X
tumour	B-X
.	B-X

Based	O
on	O
this	O
preliminary	O
screen	O
we	O
chose	O
the	O
regulators	O
spvR	B-Protein
,	O
fruR	B-Protein
,	O
himD	B-Protein
,	O
phoP	B-Protein
/	O
phoQ	B-Protein
,	O
ssrA	B-Protein
/	O
ssrB	B-Protein
,	O
slyA	B-Protein
,	O
hnr	B-Protein
,	O
rpoE	B-Protein
,	O
smpB	B-Protein
,	O
csrA	B-Protein
,	O
rpoS	B-Protein
,	O
crp	B-Protein
,	O
ompR	B-Protein
/	O
envZ	B-Protein
,	O
and	O
hfq	B-Protein
for	O
further	O
investigation	O
(	O
see	O
Figure	O
1	O
and	O
Table	O
1	O
for	O
references	O
and	O
descriptions	O
;	O
a	O
complete	O
list	O
of	O
virulence	O
phenotypes	O
is	O
provided	O
in	O
Table	O
S1	O
)	O
.	O

It	O
is	O
possible	O
that	O
additional	O
regulators	O
would	O
be	O
identified	O
if	O
a	O
larger	O
group	O
of	O
mice	O
were	O
used	O
in	O
the	O
initial	O
screen	O
.	O

The	O
LD50	O
for	O
each	O
of	O
the	O
mutants	O
was	O
computed	O
as	O
shown	O
in	O
Figure	O
1B	O
.	O

Compared	O
to	O
the	O
parental	O
strain	O
(	O
ATCC14028	O
)	O
,	O
which	O
has	O
an	O
LD50	O
of	O
1	O
-	O
2	O
cfu	O
,	O
all	O
of	O
the	O
derivatives	O
were	O
attenuated	O
for	O
virulence	O
.	O

The	O
14	O
deletion	O
strains	O
lacking	O
regulators	O
reported	O
in	O
this	O
study	O
were	O
selected	O
from	O
i	O
.	O
p	O
.	O

BALB	O
/	O
c	O
mice	O
infection	O
to	O
eliminate	O
other	O
regulators	O
required	O
only	O
for	O
gastrointestinal	O
infection	O
or	O
persistence	O
but	O
most	O
of	O
these	O
strains	O
were	O
avirulent	O
in	O
another	O
strain	O
of	O
mice	O
(	O
129X1	O
/	O
SvJ	O
)	O
and	O
by	O
other	O
route	O
(	O
intragastric	O
)	O
of	O
infection	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Therefore	O
the	O
regulators	O
investigated	O
in	O
this	O
study	O
might	O
be	O
considered	O
the	O
most	O
central	O
regulators	O
for	O
virulence	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
effects	B-X
of	B-X
p53	B-X
on	B-X
HSV-1	B-X
infection	B-X
in	B-X
vivo	B-X
using	B-X
p53-deficient	B-X
mice	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
host	B-X
cell	B-X
regulator	B-X
of	B-X
HSV-1	B-X
replication	B-X
and	B-X
pathogenesis	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
(	B-X
CNS	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
the	B-X
viral	B-X
effects	B-X
of	B-X
CV-A16	B-X
on	B-X
the	B-X
cellular	B-X
circRNA	B-X
transcriptome	B-X
were	B-X
investigated	B-X
using	B-X
next-generation	B-X
sequencing	B-X
technology	B-X
.	B-X
The	B-X
common	B-X
differentially	B-X
expressed	B-X
circRNAs	B-X
were	B-X
used	B-X
for	B-X
functional	B-X
annotation	B-X
analysis	B-X
,	B-X
and	B-X
it	B-X
was	B-X
found	B-X
that	B-X
the	B-X
parent	B-X
genes	B-X
of	B-X
differentially	B-X
expressed	B-X
circRNAs	B-X
might	B-X
be	B-X
associated	B-X
with	B-X
the	B-X
viral	B-X
infection	B-X
process	B-X
,	B-X
especially	B-X
the	B-X
``	B-X
Immune	B-X
system	B-X
process	B-X
''	B-X
in	B-X
GO	B-X
analysis	B-X
and	B-X
the	B-X
``	B-X
Inflammation	B-X
mediated	B-X
by	B-X
chemokine	B-X
and	B-X
cytokine	B-X
signaling	B-X
pathway	B-X
''	B-X
in	B-X
KEGG	B-X
analysis	B-X
.	B-X
Considering	B-X
all	B-X
of	B-X
these	B-X
results	B-X
,	B-X
to	B-X
the	B-X
best	B-X
of	B-X
our	B-X
knowledge	B-X
,	B-X
this	B-X
study	B-X
is	B-X
the	B-X
first	B-X
to	B-X
present	B-X
a	B-X
comprehensive	B-X
overview	B-X
of	B-X
circRNAs	B-X
induced	B-X
by	B-X
CV-A16	B-X
infection	B-X
,	B-X
and	B-X
this	B-X
research	B-X
demonstrated	B-X
that	B-X
a	B-X
network	B-X
of	B-X
enriched	B-X
circRNAs	B-X
and	B-X
circRNA-associated	B-X
competitive	B-X
endogenous	B-X
RNAs	B-X
(	B-X
ceRNAs	B-X
)	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
CV-A16	B-X
infection	B-X
,	B-X
thereby	B-X
helping	B-X
to	B-X
elucidate	B-X
the	B-X
mechanisms	B-X
underlying	B-X
CV-A16-host	B-X
interactions	B-X
.	B-X

In	O
the	O
other	O
virulence	O
assays	O
,	O
the	O
83	O
derivatives	O
were	O
tested	O
for	O
virulence	O
by	O
intragastric	O
(	O
i	O
.	O
g	O
.	O
)	O
BALB	O
/	O
c	O
infection	O
and	O
by	O
a	O
more	O
sensitive	O
competitive	O
index	O
(	O
CI	O
)	O
experiment	O
.	O

In	O
the	O
competitive	O
index	O
experiment	O
all	O
mutants	O
were	O
co	O
-	O
administered	O
to	O
129X1	O
/	O
SvJ	O
mice	O
and	O
the	O
number	O
of	O
each	O
surviving	O
mutant	O
bacteria	O
was	O
determined	O
7	O
days	O
after	O
i	O
.	O
p	O
.	O
inoculation	O
.	O

BALB	O
/	O
c	O
mice	O
are	O
missing	O
natural	O
resistance	O
-	O
associated	O
macrophage	O
protein	O
(	O
Nramp1	B-Protein
)	O
and	O
thus	O
succumb	O
to	O
Typhimurium	O
infection	O
within	O
a	O
week	O
when	O
mice	O
are	O
infected	O
i	O
.	O
p	O
.	O
with	O
less	O
than	O
10	O
bacteria	O
of	O
the	O
strain	O
employed	O
here	O
(	O
14028	O
)	O
.	O

Unlike	O
BALB	O
/	O
c	O
,	O
129X1	O
/	O
SvJ	O
mice	O
have	O
a	O
functional	O
copy	O
of	O
Nramp1	B-Protein
and	O
the	O
bacteria	O
persist	O
for	O
several	O
weeks	O
without	O
killing	O
the	O
mouse	O
[	O
13	O
]	O
,	O
[	O
26	O
]	O
.	O

The	O
CI	O
test	O
identified	O
30	O
(	O
out	O
of	O
83	O
)	O
regulator	O
mutants	O
that	O
were	O
attenuated	O
in	O
comparison	O
to	O
the	O
wild	O
type	O
control	O
(	O
see	O
Table	O
S1	O
)	O
.	O

The	O
14	O
derivatives	O
chosen	O
for	O
this	O
study	O
were	O
among	O
those	O
showing	O
the	O
poorest	O
survival	O
by	O
comparison	O
to	O
the	O
parent	O
in	O
this	O
competitive	O
index	O
experiment	O
.	O

The	O
14	O
regulators	O
identified	O
were	O
diverse	O
and	O
included	O
alternative	O
sigma	O
factors	O
(	O
rpoS	B-Protein
and	O
rpoE	B-Protein
)	O
,	O
two	O
-	O
component	O
regulators	O
(	O
ompR	B-Protein
/	O
envZ	B-Protein
,	O
phoP	B-Protein
/	O
phoQ	B-Protein
,	O
and	O
ssrA	B-Protein
/	O
ssrB	B-Protein
)	O
,	O
a	O
response	O
regulator	O
for	O
which	O
the	O
signal	O
sensor	O
is	O
unknown	O
(	O
hnr	B-Protein
or	O
mviA	B-Protein
)	O
,	O
post	O
-	O
transcriptional	O
regulators	O
(	O
csrA	B-Protein
,	O
hfq	B-Protein
and	O
smpB	B-Protein
)	O
,	O
a	O
bending	O
protein	O
essential	O
for	O
some	O
types	O
of	O
recombination	O
(	O
ihf	B-Protein
)	O
and	O
an	O
assortment	O
of	O
other	O
DNA	O
binding	O
proteins	O
(	O
fruR	B-Protein
,	O
spvR	B-Protein
,	O
crp	B-Protein
,	O
and	O
slyA	B-Protein
)	O
.	O

Transcription	O
profiling	O
was	O
carried	O
out	O
for	O
isogenic	O
deletion	O
mutants	O
in	O
each	O
of	O
these	O
14	O
genes	O
under	O
four	O
different	O
conditions	O
and	O
analyzed	O
to	O
infer	O
a	O
regulatory	O
hierarchy	O
during	O
systemic	O
infection	O
.	O

Salmonella	O
transcription	O
profiles	O
for	O
the	O
following	O
regulators	O
have	O
already	O
been	O
reported	O
:	O
rpoE	B-Protein
[	O
27	O
]	O
;	O
phoP	B-Protein
/	O
phoQ	B-Protein
[	O
28	O
]	O
;	O
ssrA	B-Protein
/	O
ssrB	B-Protein
[	O
29	O
]	O
;	O
csrA	B-Protein
[	O
30	O
]	O
;	O
slyA	B-Protein
[	O
31	O
]	O
;	O
ihf	B-Protein
[	O
32	O
]	O
;	O
hfq	B-Protein
[	O
33	O
]	O
.	O

Our	O
results	O
closely	O
match	O
these	O
published	O
results	O
.	O
<EOS>	B-X
Literature	B-X
focus	B-X
is	B-X
mainly	B-X
on	B-X
treatment	B-X
and	B-X
no	B-X
specific	B-X
review	B-X
on	B-X
the	B-X
prevalence	B-X
of	B-X
NF1	B-X
has	B-X
been	B-X
published	B-X
.	B-X
We	B-X
conducted	B-X
a	B-X
comprehensive	B-X
literature	B-X
review	B-X
on	B-X
this	B-X
topic	B-X
and	B-X
compared	B-X
results	B-X
with	B-X
our	B-X
study	B-X
population	B-X
.	B-X
Twenty-one	B-X
out	B-X
of	B-X
twenty-five	B-X
patients	B-X
in	B-X
the	B-X
study	B-X
population	B-X
matched	B-X
the	B-X
NIH	B-X
diagnostic	B-X
criteria	B-X
for	B-X
NF1	B-X
(	B-X
84.0	B-X
%	B-X
,	B-X
CI95	B-X
=	B-X
69.6-98.4	B-X
%	B-X
)	B-X
.	B-X
These	B-X
results	B-X
are	B-X
higher	B-X
than	B-X
the	B-X
prevalence	B-X
reported	B-X
in	B-X
the	B-X
literature	B-X
(	B-X
55.4	B-X
%	B-X
,	B-X
CI95	B-X
=	B-X
50.4-60.4	B-X
%	B-X
)	B-X
.	B-X

The	O
large	O
degree	O
of	O
attenuation	O
we	O
observed	O
for	O
an	O
spvR	B-Protein
mutation	O
following	O
i	O
.	O
p	O
.	O
infection	O
was	O
surprising	O
,	O
as	O
most	O
studies	O
had	O
limited	O
its	O
effect	O
to	O
the	O
i	O
.	O
g	O
.	O
route	O
of	O
infection	O
.	O

To	O
validate	O
this	O
result	O
we	O
complemented	O
the	O
spvR	B-Protein
mutation	O
in	O
trans	O
and	O
found	O
complete	O
complementation	O
in	O
mouse	O
virulence	O
(	O
Figure	O
S1	O
)	O
.	O

The	O
differences	O
between	O
our	O
results	O
and	O
others	O
are	O
most	O
likely	O
related	O
to	O
the	O
different	O
strains	O
of	O
Salmonella	O
used	O
in	O
the	O
studies	O
[	O
34	O
]	O
.	O

For	O
the	O
other	O
mutations	O
we	O
have	O
mobilized	O
the	O
mutation	O
into	O
a	O
new	O
genetic	O
background	O
by	O
P22	B-Protein
transduction	O
to	O
ensure	O
that	O
there	O
is	O
no	O
secondary	O
mutation	O
that	O
influences	O
the	O
results	O
[	O
35	O
]	O
.	O

The	O
ability	O
of	O
Salmonella	O
to	O
survive	O
and	O
replicate	O
in	O
macrophages	O
is	O
necessary	O
but	O
not	O
sufficient	O
for	O
mouse	O
virulence	O
<EOS>	B-X
Salmonella	B-X
spp	B-X
.	B-X
can	B-X
survive	B-X
and	B-X
replicate	B-X
in	B-X
macrophage	B-X
cells	B-X
to	B-X
cause	B-X
persistent	B-X
infection	B-X
,	B-X
SpiC	B-X
is	B-X
a	B-X
necessary	B-X
T3SS	B-X
effector	B-X
,	B-X
but	B-X
its	B-X
pathogenic	B-X
mechanism	B-X
is	B-X
still	B-X
not	B-X
known	B-X
completely	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
Salmonella	B-X
Enteritidis	B-X
spiC	B-X
mutant	B-X
(	B-X
SEΔspiC	B-X
)	B-X
was	B-X
found	B-X
to	B-X
have	B-X
stronger	B-X
swarming	B-X
motility	B-X
and	B-X
intramacrophage	B-X
hyperproliferation	B-X
which	B-X
was	B-X
closely	B-X
related	B-X
to	B-X
glucose	B-X
metabolism	B-X
.	B-X
SEΔspiC	B-X
wbaP	B-X
:	B-X
:Tn5	B-X
mutant	B-X
was	B-X
screened	B-X
out	B-X
by	B-X
transposon	B-X
mutagenesis	B-X
,	B-X
which	B-X
had	B-X
weaker	B-X
swarming	B-X
motility	B-X
and	B-X
intramacrophage	B-X
replication	B-X
ability	B-X
than	B-X
SEΔspiC	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
glucose	B-X
.	B-X
Bioinformatics	B-X
displayed	B-X
that	B-X
undecaprenyl-phosphate	B-X
galactose	B-X
phosphotransferase	B-X
(	B-X
Wbap	B-X
)	B-X
,	B-X
encoded	B-X
by	B-X
wbaP	B-X
gene	B-X
,	B-X
was	B-X
a	B-X
key	B-X
enzyme	B-X
for	B-X
glucose	B-X
metabolism	B-X
and	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
synthesis	B-X
,	B-X
which	B-X
confirmed	B-X
our	B-X
outcome	B-X
that	B-X
Wbap	B-X
was	B-X
involved	B-X
in	B-X
intramacrophage	B-X
replication	B-X
ability	B-X
by	B-X
glucose	B-X
use	B-X
in	B-X
addition	B-X
to	B-X
swarming	B-X
motility	B-X
based	B-X
on	B-X
SEΔspiC	B-X
.	B-X
This	B-X
discovery	B-X
will	B-X
further	B-X
promote	B-X
the	B-X
understanding	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
wbaP	B-X
gene	B-X
and	B-X
spiC	B-X
gene	B-X
and	B-X
the	B-X
intracellular	B-X
Salmonella	B-X
replication	B-X
mechanism	B-X
.	B-X

Previous	O
work	O
demonstrated	O
that	O
Salmonella	O
mutants	O
that	O
were	O
unable	O
to	O
survive	O
within	O
elicited	O
peritoneal	O
macrophages	O
were	O
attenuated	O
for	O
virulence	O
during	O
systemic	O
mouse	O
infection	O
[	O
36	O
]	O
.	O

In	O
fact	O
,	O
fluorescence	O
-	O
activated	O
cell	O
sorting	O
analysis	O
of	O
infected	O
blood	O
and	O
spleen	O
using	O
Salmonella	O
that	O
expresses	O
green	O
fluorescent	O
protein	O
does	O
not	O
identify	O
any	O
extracellular	O
bacteria	O
[	O
16	O
]	O
,	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
.	O

Salmonella	O
is	O
within	O
blood	O
monocytes	O
and	O
in	O
other	O
WBC	O
in	O
the	O
spleen	O
including	O
neutrophils	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
and	O
T	O
cells	O
in	O
these	O
reports	O
(	O
ibid	O
)	O
.	O

It	O
is	O
possible	O
that	O
growth	O
in	O
cells	O
types	O
other	O
than	O
macrophages	O
is	O
necessary	O
for	O
Salmonella	O
to	O
cause	O
a	O
systemic	O
infection	O
in	O
mice	O
following	O
i	O
.	O
p	O
.	O
administration	O
.	O

Thus	O
,	O
some	O
of	O
the	O
regulatory	O
mutations	O
described	O
here	O
may	O
affect	O
growth	O
in	O
cells	O
types	O
other	O
than	O
macrophages	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
immune	B-X
system	B-X
may	B-X
provide	B-X
early	B-X
protection	B-X
against	B-X
cancer	B-X
,	B-X
tumors	B-X
may	B-X
exploit	B-X
the	B-X
healing	B-X
arm	B-X
of	B-X
the	B-X
immune	B-X
system	B-X
to	B-X
enhance	B-X
their	B-X
growth	B-X
and	B-X
metastasis	B-X
.	B-X
For	B-X
example	B-X
,	B-X
myeloid	B-X
derived	B-X
suppressor	B-X
cells	B-X
(	B-X
MDSCs	B-X
)	B-X
are	B-X
thought	B-X
to	B-X
promote	B-X
tumor	B-X
growth	B-X
by	B-X
several	B-X
mechanisms	B-X
,	B-X
including	B-X
the	B-X
suppression	B-X
of	B-X
T	B-X
cell	B-X
activity	B-X
.	B-X
It	B-X
has	B-X
been	B-X
suggested	B-X
that	B-X
STAT3	B-X
activation	B-X
in	B-X
myeloid	B-X
cells	B-X
modulates	B-X
multiple	B-X
aspects	B-X
of	B-X
MDSC	B-X
physiology	B-X
,	B-X
including	B-X
their	B-X
expansion	B-X
and	B-X
activity	B-X
.	B-X
Whereas	B-X
most	B-X
animal	B-X
studies	B-X
investigating	B-X
tumor	B-X
immunology	B-X
have	B-X
used	B-X
tumor	B-X
implants	B-X
,	B-X
we	B-X
used	B-X
transgenic	B-X
mice	B-X
(	B-X
Smo	B-X
*	B-X
)	B-X
that	B-X
spontaneously	B-X
develop	B-X
medulloblastoma	B-X
brain	B-X
tumors	B-X
to	B-X
investigate	B-X
the	B-X
temporal	B-X
accumulation	B-X
of	B-X
MDSCs	B-X
within	B-X
tumors	B-X
and	B-X
how	B-X
myeloid	B-X
STAT3	B-X
disruption	B-X
affects	B-X
MDSC	B-X
and	B-X
other	B-X
immune	B-X
cell	B-X
types	B-X
.	B-X
We	B-X
found	B-X
distinct	B-X
populations	B-X
of	B-X
MDSC	B-X
in	B-X
medulloblastoma	B-X
tumors	B-X
,	B-X
with	B-X
a	B-X
high	B-X
prevalence	B-X
of	B-X
CD11b	B-X
(	B-X
+	B-X
)	B-X
Ly6G	B-X
(	B-X
+	B-X
)	B-X
Ly6C	B-X
(	B-X
low/-	B-X
)	B-X
cells	B-X
,	B-X
described	B-X
previously	B-X
by	B-X
others	B-X
as	B-X
G-MDSCs	B-X
.	B-X
In	B-X
fully	B-X
developed	B-X
tumors	B-X
,	B-X
pSTAT3	B-X
was	B-X
found	B-X
in	B-X
the	B-X
majority	B-X
of	B-X
these	B-X
cells	B-X
.	B-X
Conditional	B-X
STAT3	B-X
gene	B-X
disruption	B-X
in	B-X
myeloid	B-X
cells	B-X
resulted	B-X
in	B-X
an	B-X
enhanced	B-X
proinflammatory	B-X
phenotype	B-X
of	B-X
macrophages	B-X
in	B-X
Smo	B-X
*	B-X
mice	B-X
.	B-X
Moreover	B-X
,	B-X
a	B-X
significant	B-X
reduction	B-X
in	B-X
the	B-X
abundance	B-X
of	B-X
G-MDSCs	B-X
and	B-X
Tregs	B-X
was	B-X
observed	B-X
within	B-X
tumors	B-X
along	B-X
with	B-X
an	B-X
increased	B-X
presence	B-X
of	B-X
CD4	B-X
(	B-X
+	B-X
)	B-X
and	B-X
CD8	B-X
(	B-X
+	B-X
)	B-X
cells	B-X
.	B-X
Despite	B-X
these	B-X
alterations	B-X
in	B-X
immune	B-X
cells	B-X
induced	B-X
by	B-X
myeloid	B-X
STAT3	B-X
disruption	B-X
,	B-X
we	B-X
found	B-X
no	B-X
effect	B-X
on	B-X
tumor	B-X
incidence	B-X
in	B-X
Smo	B-X
*	B-X
mice	B-X
with	B-X
this	B-X
deletion	B-X
.	B-X

We	O
therefore	O
wished	O
to	O
determine	O
if	O
there	O
is	O
a	O
direct	O
relationship	O
between	O
growth	O
in	O
macrophages	O
and	O
mouse	O
virulence	O
.	O

In	O
these	O
studies	O
we	O
used	O
primary	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDM	O
)	O
from	O
the	O
same	O
strain	O
of	O
mouse	O
as	O
used	O
in	O
the	O
original	O
identification	O
of	O
attenuated	O
regulatory	O
mutants	O
(	O
BALB	O
/	O
c	O
)	O
.	O

The	O
identical	O
number	O
of	O
input	O
bacteria	O
and	O
the	O
identical	O
number	O
of	O
macrophages	O
were	O
used	O
in	O
every	O
infection	O
experiment	O
.	O

As	O
observed	O
by	O
others	O
,	O
following	O
phagocytosis	O
there	O
is	O
some	O
bacterial	O
killing	O
that	O
varied	O
from	O
strain	O
to	O
strain	O
followed	O
by	O
intracellular	O
growth	O
.	O

We	O
monitored	O
the	O
number	O
of	O
intracellular	O
bacteria	O
at	O
an	O
early	O
time	O
(	O
30	O
min	O
)	O
to	O
determine	O
the	O
number	O
of	O
bacteria	O
internalized	O
(	O
Figure	O
2	O
)	O
.	O

Even	O
at	O
the	O
shortest	O
time	O
few	O
intracellular	O
bacteria	O
were	O
recovered	O
from	O
macrophage	O
infection	O
with	O
an	O
rpoE	B-Protein
mutant	O
,	O
suggesting	O
that	O
this	O
strain	O
is	O
very	O
sensitive	O
to	O
microbicidal	O
factors	O
released	O
by	O
macrophages	O
on	O
contact	O
with	O
bacteria	O
or	O
doesn	O
'	O
t	O
get	O
internalized	O
very	O
well	O
.	O

At	O
2	O
.	O
0	O
hrs	O
post	O
infection	O
there	O
was	O
a	O
decrease	O
in	O
bacterial	O
numbers	O
that	O
varied	O
from	O
strain	O
to	O
strain	O
presumably	O
reflecting	O
variation	O
in	O
the	O
sensitivity	O
to	O
bacterial	O
killing	O
by	O
the	O
oxidative	O
burst	O
,	O
acidic	O
pH	O
,	O
and	O
antimicrobial	O
peptides	O
.	O

Finally	O
,	O
at	O
18	O
hrs	O
bacterial	O
numbers	O
were	O
enumerated	O
to	O
monitor	O
intracellular	O
replication	O
as	O
well	O
as	O
the	O
ability	O
to	O
withstand	O
nitrous	O
oxide	O
oxidation	O
and	O
other	O
late	O
antimicrobial	O
factors	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

No	O
effect	O
was	O
found	O
at	O
any	O
time	O
point	O
for	O
a	O
mutant	O
in	O
the	O
plasmid	O
-	O
encoded	O
regulator	O
spvR	B-Protein
in	O
murine	O
macrophages	O
in	O
agreement	O
with	O
other	O
investigators	O
[	O
41	O
]	O
,	O
[	O
42	O
]	O
.	O

Small	O
differences	O
in	O
intracellular	O
growth	O
were	O
observed	O
for	O
ssrA	B-Protein
/	O
ssrB	B-Protein
and	O
slyA	B-Protein
compared	O
to	O
the	O
parent	O
although	O
larger	O
differences	O
have	O
been	O
observed	O
previously	O
[	O
43	O
]	O
-	O
[	O
45	O
]	O
perhaps	O
reflecting	O
BMDM	O
preparation	O
techniques	O
,	O
bacterial	O
strain	O
differences	O
,	O
or	O
opsonization	O
differences	O
[	O
46	O
]	O
.	O
<EOS>	B-X
Pathogens	B-X
are	B-X
also	B-X
phagocytosed	B-X
by	B-X
complement	B-X
receptors	B-X
after	B-X
relatively	B-X
nonspecific	B-X
opsonization	B-X
with	B-X
complement	B-X
and	B-X
by	B-X
Fc	B-X
receptors	B-X
after	B-X
specific	B-X
opsonization	B-X
with	B-X
antibodies	B-X
.	B-X
However	B-X
,	B-X
important	B-X
differences	B-X
in	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
phagocytosis	B-X
by	B-X
different	B-X
receptors	B-X
are	B-X
now	B-X
being	B-X
appreciated	B-X
.	B-X
These	B-X
include	B-X
differences	B-X
in	B-X
the	B-X
cytoskeletal	B-X
elements	B-X
that	B-X
mediate	B-X
ingestion	B-X
,	B-X
differences	B-X
in	B-X
vacuole	B-X
maturation	B-X
,	B-X
and	B-X
differences	B-X
in	B-X
inflammatory	B-X
responses	B-X
.	B-X
The	B-X
unique	B-X
features	B-X
of	B-X
this	B-X
receptor	B-X
as	B-X
compared	B-X
with	B-X
classical	B-X
complement	B-X
receptors	B-X
,	B-X
CR3	B-X
and	B-X
CR4	B-X
,	B-X
have	B-X
heralded	B-X
the	B-X
emergence	B-X
of	B-X
new	B-X
concepts	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
innate	B-X
and	B-X
adaptive	B-X
immunity	B-X
.	B-X
Accumulating	B-X
evidence	B-X
from	B-X
mouse	B-X
experimental	B-X
models	B-X
indicates	B-X
a	B-X
potential	B-X
role	B-X
for	B-X
CRIg	B-X
in	B-X
protection	B-X
against	B-X
bacterial	B-X
infection	B-X
and	B-X
inflammatory	B-X
diseases	B-X
,	B-X
such	B-X
as	B-X
rheumatoid	B-X
arthritis	B-X
,	B-X
type	B-X
1	B-X
diabetes	B-X
and	B-X
systemic	B-X
lupus	B-X
erythematosus	B-X
,	B-X
and	B-X
also	B-X
in	B-X
promotion	B-X
of	B-X
tumour	B-X
growth	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
CRIg	B-X
to	B-X
suppress	B-X
cytotoxic	B-X
T	B-X
cell	B-X
proliferation	B-X
and	B-X
function	B-X
may	B-X
underlie	B-X
its	B-X
promotion	B-X
of	B-X
cancer	B-X
growth	B-X
.	B-X

Mutations	O
of	O
himD	B-Protein
,	O
rpoE	B-Protein
,	O
crp	B-Protein
,	O
or	O
hfq	B-Protein
drastically	O
reduce	O
the	O
number	O
of	O
viable	O
bacteria	O
that	O
can	O
be	O
recovered	O
from	O
macrophages	O
even	O
at	O
short	O
times	O
(	O
Figure	O
2	O
)	O
.	O

These	O
results	O
also	O
demonstrated	O
that	O
growth	O
in	O
macrophages	O
per	O
se	O
does	O
not	O
duplicate	O
in	O
vivo	O
infection	O
and	O
that	O
some	O
regulator	O
mutants	O
that	O
were	O
totally	O
avirulent	O
in	O
the	O
mouse	O
showed	O
no	O
differences	O
in	O
growth	O
in	O
these	O
primary	O
macrophages	O
.	O
<EOS>	B-X
Serum	B-X
prostate-specific	B-X
antigen	B-X
(	B-X
PSA	B-X
)	B-X
is	B-X
at	B-X
present	B-X
the	B-X
most	B-X
commonly	B-X
used	B-X
biomarker	B-X
for	B-X
PCa	B-X
screening	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
reliable	B-X
marker	B-X
of	B-X
disease	B-X
recurrence	B-X
after	B-X
initial	B-X
treatment	B-X
.	B-X
Bone	B-X
metastases	B-X
(	B-X
BM	B-X
)	B-X
are	B-X
present	B-X
in	B-X
advanced	B-X
stages	B-X
of	B-X
the	B-X
disease	B-X
.	B-X
Imaging	B-X
of	B-X
BM	B-X
is	B-X
important	B-X
not	B-X
only	B-X
for	B-X
localization	B-X
and	B-X
characterization	B-X
,	B-X
but	B-X
also	B-X
to	B-X
evaluate	B-X
their	B-X
size	B-X
and	B-X
number	B-X
,	B-X
as	B-X
well	B-X
as	B-X
to	B-X
follow-up	B-X
the	B-X
disease	B-X
during	B-X
and	B-X
after	B-X
therapy	B-X
.	B-X
Bone	B-X
metastases	B-X
formation	B-X
is	B-X
triggered	B-X
by	B-X
cancer	B-X
initiating	B-X
cells	B-X
in	B-X
the	B-X
bone	B-X
marrow	B-X
and	B-X
is	B-X
facilitated	B-X
by	B-X
the	B-X
release	B-X
of	B-X
several	B-X
growth	B-X
factors	B-X
.	B-X
Although	B-X
BM	B-X
from	B-X
PCa	B-X
are	B-X
very	B-X
heterogenic	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
them	B-X
are	B-X
described	B-X
as	B-X
``	B-X
osteoblastic	B-X
''	B-X
,	B-X
while	B-X
pure	B-X
``	B-X
osteolytic	B-X
''	B-X
metastases	B-X
are	B-X
very	B-X
rare	B-X
.	B-X
A	B-X
classification	B-X
report	B-X
,	B-X
which	B-X
is	B-X
currently	B-X
in	B-X
use	B-X
,	B-X
divides	B-X
patients	B-X
into	B-X
three	B-X
categories	B-X
according	B-X
to	B-X
the	B-X
risk	B-X
of	B-X
having	B-X
BM	B-X
:	B-X
low	B-X
risk	B-X
(	B-X
PSA	B-X
<	B-X
10ng/mL	B-X
,	B-X
clinical	B-X
stage	B-X
T1-T2a	B-X
,	B-X
Gleason	B-X
Score	B-X
≤6	B-X
)	B-X
,	B-X
intermediate	B-X
risk	B-X
(	B-X
PSA	B-X
10.1-20ng/mL	B-X
,	B-X
clinical	B-X
stage	B-X
T2b-T2c	B-X
,	B-X
Gleason	B-X
Score=7	B-X
)	B-X
and	B-X
high	B-X
risk	B-X
(	B-X
PSA	B-X
>	B-X
20ng/mL	B-X
,	B-X
clinical	B-X
stage	B-X
T3a	B-X
or	B-X
higher	B-X
,	B-X
or	B-X
Gleason	B-X
Score	B-X
≥8	B-X
)	B-X
.	B-X
Even	B-X
though	B-X
PSA	B-X
remains	B-X
the	B-X
only	B-X
biomarker	B-X
of	B-X
this	B-X
disease	B-X
in	B-X
clinical	B-X
practice	B-X
,	B-X
it	B-X
is	B-X
not	B-X
always	B-X
analogue	B-X
with	B-X
the	B-X
severity	B-X
of	B-X
the	B-X
disease	B-X
and	B-X
should	B-X
be	B-X
evaluated	B-X
along	B-X
with	B-X
the	B-X
clinical	B-X
and	B-X
diagnostic	B-X
imaging	B-X
findings	B-X
.	B-X
Detection	B-X
of	B-X
BM	B-X
is	B-X
not	B-X
always	B-X
easy	B-X
,	B-X
as	B-X
there	B-X
may	B-X
be	B-X
unexpected	B-X
sites	B-X
and	B-X
occult	B-X
metastases	B-X
.	B-X
Such	B-X
a	B-X
single	B-X
occult	B-X
metastasis	B-X
causing	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
PSA	B-X
has	B-X
been	B-X
presented	B-X
using	B-X
technetium-99m	B-X
(	B-X

Transcription	O
profiling	O
of	O
avirulent	O
strains	O
<EOS>	B-X
Herein	B-X
,	B-X
we	B-X
perform	B-X
whole	B-X
protein	B-X
identification	B-X
and	B-X
quantification	B-X
of	B-X
biotype	B-X
1	B-X
and	B-X
biotype	B-X
2	B-X
strains	B-X
of	B-X
Y.	B-X
ruckeri	B-X
grown	B-X
under	B-X
standard	B-X
culture	B-X
conditions	B-X
using	B-X
a	B-X
shotgun	B-X
proteomic	B-X
approach	B-X
.	B-X
SWATH-MS	B-X
technology	B-X
and	B-X
sophisticated	B-X
statistical	B-X
analyses	B-X
were	B-X
used	B-X
to	B-X
identify	B-X
proteome	B-X
differences	B-X
among	B-X
virulent	B-X
and	B-X
avirulent	B-X
strains	B-X
.	B-X
In	B-X
virulent	B-X
strains	B-X
,	B-X
a	B-X
total	B-X
of	B-X
16	B-X
proteins	B-X
were	B-X
upregulated	B-X
including	B-X
anti-sigma	B-X
regulatory	B-X
factor	B-X
,	B-X
arginine	B-X
deiminase	B-X
,	B-X
phosphate-binding	B-X
protein	B-X
PstS	B-X
and	B-X
superoxide	B-X
dismutase	B-X
Cu-Zu	B-X
.	B-X
Here	B-X
we	B-X
used	B-X
iron	B-X
deprivation	B-X
by	B-X
addition	B-X
of	B-X
the	B-X
chelator	B-X
2	B-X
'	B-X
2-dipyridyl	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
such	B-X
virulence	B-X
factors	B-X
in	B-X
three	B-X
isolates	B-X
of	B-X
Aeromonas	B-X
salmonicida	B-X
(	B-X
one	B-X
avirulent	B-X
and	B-X
two	B-X
virulent	B-X
)	B-X
.	B-X

Because	O
some	O
of	O
the	O
Typhimurium	O
regulator	O
mutants	O
survived	O
so	O
poorly	O
within	O
macrophages	O
that	O
preparing	O
mRNA	O
from	O
intracellular	O
bacteria	O
was	O
not	O
possible	O
we	O
have	O
used	O
in	O
vitro	O
growth	O
conditions	O
that	O
duplicate	O
some	O
of	O
the	O
intracellular	O
conditions	O
(	O
low	O
pH	O
,	O
minimal	O
media	O
;	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
)	O
.	O

The	O
14	O
virulence	O
regulators	O
,	O
whose	O
absence	O
was	O
identified	O
by	O
attenuated	O
virulence	O
in	O
vivo	O
in	O
this	O
study	O
,	O
presumably	O
sense	O
specific	O
environmental	O
signals	O
within	O
the	O
host	O
and	O
respond	O
by	O
expressing	O
the	O
appropriate	O
complement	O
of	O
virulence	O
factors	O
.	O

However	O
the	O
specific	O
environmental	O
signals	O
are	O
not	O
known	O
and	O
therefore	O
each	O
strain	O
was	O
grown	O
in	O
four	O
different	O
conditions	O
;	O
to	O
log	O
phase	O
or	O
stationary	O
phase	O
in	O
Luria	O
-	O
Bertani	O
(	O
LB	O
)	O
broth	O
and	O
in	O
a	O
low	O
pH	O
/	O
low	O
magnesium	O
,	O
minimal	O
medium	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O
<EOS>	B-X
Initially	B-X
considered	B-X
by-products	B-X
from	B-X
aerobic	B-X
metabolism	B-X
,	B-X
reactive	B-X
oxygen	B-X
species	B-X
(	B-X
ROS	B-X
)	B-X
have	B-X
emerged	B-X
as	B-X
major	B-X
regulatory	B-X
molecules	B-X
in	B-X
plants	B-X
and	B-X
their	B-X
roles	B-X
in	B-X
early	B-X
signaling	B-X
events	B-X
initiated	B-X
by	B-X
cellular	B-X
metabolic	B-X
perturbation	B-X
and	B-X
environmental	B-X
stimuli	B-X
are	B-X
now	B-X
established	B-X
.	B-X
Compartment-specific	B-X
and	B-X
cross-compartmental	B-X
signaling	B-X
pathways	B-X
initiated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
ROS	B-X
are	B-X
discussed	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
outline	B-X
the	B-X
most	B-X
challenging	B-X
contemporary	B-X
questions	B-X
in	B-X
the	B-X
field	B-X
of	B-X
plant	B-X
ROS	B-X
biology	B-X
and	B-X
the	B-X
need	B-X
to	B-X
further	B-X
elucidate	B-X
mechanisms	B-X
allowing	B-X
sensing	B-X
,	B-X
signaling	B-X
specificity	B-X
,	B-X
and	B-X
coordination	B-X
of	B-X
multiple	B-X
signals	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
metabolites	B-X
from	B-X
the	B-X
intermediary	B-X
metabolism	B-X
act	B-X
mainly	B-X
as	B-X
metabolic	B-X
stress-induced	B-X
autocrine	B-X
and	B-X
paracrine	B-X
signals	B-X
in	B-X
adipose	B-X
tissue	B-X
,	B-X
the	B-X
liver	B-X
,	B-X
and	B-X
the	B-X
endocrine	B-X
pancreas	B-X
.	B-X
Importantly	B-X
,	B-X
distinct	B-X
metabolite	B-X
GPCRs	B-X
act	B-X
as	B-X
efficient	B-X
pro-	B-X
and	B-X
anti-inflammatory	B-X
regulators	B-X
of	B-X
key	B-X
immune	B-X
cells	B-X
,	B-X
and	B-X
signaling	B-X
metabolites	B-X
may	B-X
thus	B-X
function	B-X
as	B-X
important	B-X
drivers	B-X
of	B-X
the	B-X
low-grade	B-X
inflammation	B-X
associated	B-X
with	B-X
insulin	B-X
resistance	B-X
and	B-X
obesity	B-X
.	B-X
The	B-X
concept	B-X
of	B-X
key	B-X
metabolites	B-X
as	B-X
ligands	B-X
for	B-X
specific	B-X
GPCRs	B-X
has	B-X
broadened	B-X
our	B-X
understanding	B-X
of	B-X
metabolic	B-X
signaling	B-X
significantly	B-X
and	B-X
provides	B-X
a	B-X
number	B-X
of	B-X
novel	B-X
potential	B-X
drug	B-X
targets	B-X
.	B-X

Two	O
different	O
minimal	O
media	O
conditions	O
were	O
used	O
depending	O
only	O
on	O
pre	O
-	O
growth	O
conditions	O
as	O
described	O
in	O
the	O
Materials	O
and	O
Methods	O
(	O
called	O
acidic	O
minimal	O
media	O
(	O
AMM	O
)	O
1	O
and	O
AMM2	O
here	O
)	O
;	O
these	O
conditions	O
are	O
identical	O
to	O
conditions	O
previously	O
reported	O
for	O
expression	O
of	O
SPI	O
-	O
2	O
;	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

The	O
fate	O
of	O
intracellular	O
Typhimurium	O
is	O
determined	O
by	O
pre	O
-	O
growth	O
conditions	O
prior	O
to	O
macrophage	O
infection	O
and	O
for	O
that	O
reason	O
we	O
used	O
both	O
conditions	O
AMM1	O
and	O
2	O
[	O
49	O
]	O
.	O

To	O
identify	O
global	O
transcriptional	O
changes	O
for	O
each	O
regulator	O
,	O
mRNAs	O
were	O
isolated	O
from	O
each	O
strain	O
grown	O
under	O
the	O
four	O
conditions	O
,	O
converted	O
to	O
cDNA	O
,	O
and	O
used	O
to	O
probe	O
a	O
spotted	O
non	O
-	O
redundant	O
pan	O
-	O
Salmonella	O
orf	O
microarray	O
using	O
hybridization	O
of	O
total	O
genomic	O
Salmonella	O
DNA	O
as	O
an	O
internal	O
control	O
[	O
50	O
]	O
.	O

Each	O
microarray	O
was	O
probed	O
with	O
RNA	O
from	O
the	O
parent	O
or	O
an	O
isogenic	O
deletion	O
of	O
one	O
of	O
the	O
regulator	O
mutants	O
prepared	O
from	O
bacterial	O
cells	O
grown	O
under	O
one	O
of	O
the	O
four	O
conditions	O
.	O
<EOS>	B-X
Oltipraz	B-X
and	B-X
related	B-X
dithiolethiones	B-X
constitute	B-X
an	B-X
important	B-X
class	B-X
of	B-X
chemopreventive	B-X
agents	B-X
that	B-X
enhance	B-X
the	B-X
expression	B-X
of	B-X
carcinogen	B-X
detoxication	B-X
and	B-X
antioxidant	B-X
genes	B-X
.	B-X
Dose-response	B-X
studies	B-X
were	B-X
undertaken	B-X
to	B-X
characterize	B-X
the	B-X
cancer	B-X
chemopreventive	B-X
activities	B-X
of	B-X
several	B-X
dithiolethiones	B-X
that	B-X
are	B-X
at	B-X
least	B-X
as	B-X
active	B-X
as	B-X
oltipraz	B-X
as	B-X
inducers	B-X
.	B-X
In	B-X
the	B-X
tumorigenesis	B-X
experiment	B-X
,	B-X
the	B-X
dithiolethiones	B-X
were	B-X
orally	B-X
gavaged	B-X
3	B-X
days/week	B-X
for	B-X
3	B-X
successive	B-X
weeks	B-X
and	B-X
at	B-X
four	B-X
doses	B-X
ranging	B-X
from	B-X
0.03	B-X
to	B-X
0.3	B-X
mmol/kg	B-X
body	B-X
wt	B-X
.	B-X
AFB1	B-X
was	B-X
gavaged	B-X
beginning	B-X
1	B-X
week	B-X
after	B-X
the	B-X
start	B-X
of	B-X
the	B-X
dithiolethiones	B-X
and	B-X
for	B-X
two	B-X
successive	B-X
weeks	B-X
.	B-X
The	B-X
burden	B-X
of	B-X
AFB1-induced	B-X
putative	B-X
pre-neoplastic	B-X
lesions	B-X
(	B-X
glutathione	B-X
S-transferase-placental	B-X
isoform	B-X
positive	B-X
foci	B-X
)	B-X
was	B-X
quantified	B-X
by	B-X
light	B-X
microscopy	B-X
.	B-X
Both	B-X
the	B-X
parent	B-X
1,2-dithiole-3-thione	B-X
(	B-X
D3T	B-X
)	B-X
and	B-X
its	B-X
5-tert-butyl	B-X
derivative	B-X
were	B-X
more	B-X
potent	B-X
inhibitors	B-X
than	B-X
oltipraz	B-X
against	B-X
these	B-X
endpoints	B-X
,	B-X
while	B-X
two	B-X
of	B-X
the	B-X
seven	B-X
tested	B-X
analogs	B-X
were	B-X
slightly	B-X
less	B-X
inhibitory	B-X
.	B-X
D3T	B-X
,	B-X
the	B-X
most	B-X
potent	B-X
dithiolethione	B-X
of	B-X
this	B-X
series	B-X
,	B-X
was	B-X
examined	B-X
by	B-X
microarray	B-X
analysis	B-X
for	B-X
induction	B-X
of	B-X
hepatic	B-X
genes	B-X
at	B-X
an	B-X
intermediate	B-X
chemopreventive	B-X
dose	B-X
(	B-X
0.1	B-X
mmol/kg	B-X
)	B-X
.	B-X
Transcript	B-X
levels	B-X
of	B-X
eight	B-X
genes	B-X
,	B-X
including	B-X
two	B-X
known	B-X
to	B-X
detoxify	B-X
aflatoxin	B-X
,	B-X
namely	B-X
,	B-X
glutathione	B-X
S-transferase	B-X
A5	B-X
(	B-X
GSTA5	B-X
)	B-X
and	B-X
AFB1	B-X
aldehyde	B-X
reductase	B-X
(	B-X
AFAR	B-X
)	B-X
were	B-X
elevated	B-X
.	B-X

In	O
all	O
there	O
were	O
4	O
biological	O
replicates	O
of	O
the	O
parent	O
strain	O
but	O
one	O
for	O
each	O
mutant	O
under	O
each	O
growth	O
condition	O
.	O
<EOS>	B-X
Persistent	B-X
infection	B-X
with	B-X
mouse	B-X
hepatitis	B-X
virus	B-X
(	B-X
MHV	B-X
)	B-X
strain	B-X
A59	B-X
in	B-X
murine	B-X
DBT	B-X
(	B-X
delayed	B-X
brain	B-X
tumor	B-X
)	B-X
cells	B-X
resulted	B-X
in	B-X
the	B-X
emergence	B-X
of	B-X
host	B-X
range	B-X
variants	B-X
,	B-X
designated	B-X
V51A	B-X
and	B-X
V51B	B-X
,	B-X
at	B-X
210	B-X
days	B-X
postinfection	B-X
.	B-X
These	B-X
host	B-X
range	B-X
mutants	B-X
replicated	B-X
efficiently	B-X
in	B-X
normally	B-X
nonpermissive	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
(	B-X
CHO	B-X
)	B-X
,	B-X
in	B-X
human	B-X
hepatocarcinoma	B-X
(	B-X
HepG2	B-X
)	B-X
,	B-X
and	B-X
to	B-X
a	B-X
lesser	B-X
extent	B-X
in	B-X
human	B-X
breast	B-X
carcinoma	B-X
(	B-X
MCF7	B-X
)	B-X
cell	B-X
lines	B-X
.	B-X
Pretreatment	B-X
of	B-X
HepG2	B-X
cells	B-X
with	B-X
a	B-X
polyclonal	B-X
antibody	B-X
directed	B-X
against	B-X
human	B-X
carcinoembryonic	B-X
antigens	B-X
(	B-X
CEA	B-X
)	B-X
or	B-X
with	B-X
some	B-X
monoclonal	B-X
antibodies	B-X
(	B-X
Col-1	B-X
,	B-X
Col-4	B-X
,	B-X
Col-12	B-X
,	B-X
and	B-X
Col-14	B-X
)	B-X
that	B-X
bind	B-X
human	B-X
CEA	B-X
significantly	B-X
inhibited	B-X
V51B	B-X
infection	B-X
.	B-X
Under	B-X
identical	B-X
conditions	B-X
,	B-X
little	B-X
or	B-X
no	B-X
blockade	B-X
was	B-X
evident	B-X
with	B-X
other	B-X
monoclonal	B-X
antibodies	B-X
(	B-X
kat4c	B-X
or	B-X
Col-6	B-X
)	B-X
which	B-X
also	B-X
bind	B-X
the	B-X
human	B-X
CEA	B-X
glycoproteins	B-X
.	B-X
Pretreatment	B-X
with	B-X
the	B-X
Col-4	B-X
and	B-X
Col-14	B-X
antibodies	B-X
did	B-X
not	B-X
block	B-X
Sindbis	B-X
virus	B-X
replication	B-X
in	B-X
HepG2	B-X
cells	B-X
or	B-X
MHV	B-X
infection	B-X
in	B-X
DBT	B-X
cells	B-X
,	B-X
suggesting	B-X
that	B-X
one	B-X
or	B-X
more	B-X
CEA	B-X
glycoproteins	B-X
likely	B-X
functioned	B-X
as	B-X
receptors	B-X
for	B-X
V51B	B-X
entry	B-X
into	B-X
human	B-X
cell	B-X
lines	B-X
.	B-X
To	B-X
test	B-X
this	B-X
hypothesis	B-X
,	B-X
the	B-X
human	B-X
biliary	B-X
glycoprotein	B-X
(	B-X
Bgp	B-X
)	B-X
and	B-X
CEA	B-X
genes	B-X
were	B-X
cloned	B-X
and	B-X
expressed	B-X
in	B-X
normally	B-X
nonpermissive	B-X
BHK	B-X
cell	B-X
lines	B-X
by	B-X
using	B-X
noncytopathic	B-X
Sindbis	B-X
virus	B-X
replicons	B-X
(	B-X
pSinRep19	B-X
)	B-X
.	B-X
By	B-X
growth	B-X
curves	B-X
and	B-X
FA	B-X
staining	B-X
,	B-X
human	B-X
CEA	B-X
and	B-X
to	B-X
a	B-X
much	B-X
lesser	B-X
extent	B-X
human	B-X
Bgp	B-X
functioned	B-X
as	B-X
receptors	B-X
for	B-X
V51B	B-X
entry	B-X
.	B-X
Under	B-X
identical	B-X
conditions	B-X
,	B-X
the	B-X
parental	B-X
MHV	B-X
strain	B-X
A59	B-X
failed	B-X
to	B-X
replicate	B-X
in	B-X
BHK	B-X
cells	B-X
expressing	B-X
human	B-X
Bgp	B-X
or	B-X
CEA	B-X
.	B-X

Transcriptional	O
profiles	O
were	O
significantly	O
different	O
from	O
the	O
parent	O
for	O
known	O
virulence	O
factors	O
required	O
during	O
systemic	O
infection	O
,	O
but	O
only	O
if	O
cells	O
were	O
grown	O
in	O
acidic	O
minimal	O
media	O
(	O
AMM1	O
or	O
AMM2	O
;	O
see	O
Figure	O
3	O
;	O
complete	O
microarray	O
data	O
available	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
ohsu	O
.	O
edu	O
/	O
microbiology	O
/	O
heffron	O
/	O
r01	O
.	O
html	O
)	O
.	O
<EOS>	B-X
Reducing	B-X
the	B-X
weight	B-X
of	B-X
electric	B-X
conductors	B-X
is	B-X
an	B-X
important	B-X
task	B-X
in	B-X
the	B-X
design	B-X
of	B-X
future	B-X
electric	B-X
air	B-X
and	B-X
ground	B-X
vehicles	B-X
.	B-X
Multifunctional	B-X
composite	B-X
materials	B-X
with	B-X
both	B-X
adequate	B-X
structural	B-X
and	B-X
electrical	B-X
properties	B-X
are	B-X
a	B-X
promising	B-X
approach	B-X
to	B-X
substituting	B-X
conventional	B-X
monofunctional	B-X
components	B-X
and	B-X
achieving	B-X
considerable	B-X
mass	B-X
reductions	B-X
.	B-X
It	B-X
is	B-X
found	B-X
that	B-X
a	B-X
volume	B-X
fraction	B-X
of	B-X
about	B-X
10	B-X
%	B-X
work-hardened	B-X
aluminum	B-X
fibers	B-X
does	B-X
not	B-X
affect	B-X
the	B-X
static	B-X
fiber-parallel	B-X
material	B-X
properties	B-X
significantly	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
material	B-X
’	B-X
s	B-X
capability	B-X
of	B-X
carrying	B-X
currents	B-X
up	B-X
to	B-X
0.32	B-X
A/mm2	B-X
(	B-X
current	B-X
density	B-X
of	B-X
4.5	B-X
A/mm2	B-X
in	B-X
the	B-X
aluminum	B-X
phase	B-X
)	B-X
is	B-X
proven	B-X
.	B-X
Under	B-X
combined	B-X
electrical-mechanical	B-X
loads	B-X
,	B-X
a	B-X
notable	B-X
reduction	B-X
in	B-X
the	B-X
fatigue	B-X
life	B-X
(	B-X
−20	B-X
%	B-X
)	B-X
is	B-X
found	B-X
at	B-X
low	B-X
fatigue	B-X
loads	B-X
,	B-X
which	B-X
is	B-X
attributed	B-X
to	B-X
ohmic	B-X
specimen	B-X
heating	B-X
.	B-X

Z	O
-	O
scores	O
(	O
(	O
score	O
-	O
mean	O
)	O
/	O
standard	O
deviation	O
)	O
were	O
computed	O
for	O
each	O
gene	O
in	O
the	O
Typhimurium	O
genome	O
in	O
each	O
mutant	O
background	O
under	O
each	O
growth	O
condition	O
(	O
Table	O
S2	O
)	O
.	O

Statistical	O
analysis	O
of	O
the	O
complete	O
transcriptional	O
data	O
for	O
gene	O
expression	O
in	O
AMM1	O
identified	O
at	O
least	O
237	O
genes	O
that	O
were	O
reduced	O
4	O
-	O
fold	O
or	O
more	O
in	O
common	O
comparing	O
the	O
mutations	O
to	O
the	O
parent	O
strain	O
(	O
at	O
least	O
3	O
standard	O
deviation	O
based	O
on	O
the	O
technical	O
replicates	O
)	O
.	O

Because	O
transcription	O
is	O
reduced	O
in	O
the	O
mutant	O
compared	O
to	O
the	O
parent	O
,	O
it	O
suggests	O
that	O
normally	O
the	O
regulator	O
activates	O
transcription	O
of	O
these	O
genes	O
as	O
is	O
shown	O
dramatically	O
in	O
Figure	O
3	O
for	O
all	O
SPI	O
-	O
2	O
encoded	O
virulence	O
genes	O
.	O

Conversely	O
,	O
only	O
45	O
genes	O
showed	O
a	O
4	O
-	O
fold	O
or	O
more	O
up	O
-	O
regulation	O
in	O
the	O
mutant	O
backgrounds	O
when	O
cells	O
were	O
prepared	O
under	O
the	O
same	O
growth	O
condition	O
,	O
suggesting	O
that	O
the	O
regulator	O
normally	O
represses	O
these	O
genes	O
.	O
<EOS>	B-X
To	B-X
investigate	B-X
whether	B-X
polymorphisms	B-X
in	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
repair	B-X
of	B-X
oxidative	B-X
DNA	B-X
damage	B-X
,	B-X
modulate	B-X
,	B-X
and/or	B-X
interact	B-X
with	B-X
antioxidants	B-X
to	B-X
influence	B-X
prostate	B-X
cancer	B-X
risk	B-X
in	B-X
a	B-X
population-based	B-X
case-control	B-X
study	B-X
in	B-X
Central	B-X
Arkansas	B-X
.	B-X
Accumulating	B-X
evidence	B-X
indicates	B-X
that	B-X
oxidative	B-X
stress	B-X
plays	B-X
a	B-X
role	B-X
in	B-X
prostate	B-X
carcinogenesis	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
transcription	B-X
and	B-X
translation	B-X
regulation	B-X
of	B-X
pyruvate	B-X
carboxylase	B-X
(	B-X
PC	B-X
)	B-X
expression	B-X
during	B-X
development	B-X
and	B-X
in	B-X
genetically	B-X
obese	B-X
rats	B-X
.	B-X
The	B-X
abundance	B-X
of	B-X
PC	B-X
mRNAs	B-X
was	B-X
low	B-X
in	B-X
fetal	B-X
liver	B-X
but	B-X
increased	B-X
by	B-X
2-4-fold	B-X
within	B-X
7	B-X
days	B-X
after	B-X
birth	B-X
,	B-X
concomitant	B-X
with	B-X
an	B-X
8-fold	B-X
increase	B-X
in	B-X
the	B-X
amount	B-X
of	B-X
immunoreactive	B-X
PC	B-X
and	B-X
its	B-X
activity	B-X
and	B-X
then	B-X
decreased	B-X
during	B-X
the	B-X
weaning	B-X
period	B-X
.	B-X
In	B-X
genetically	B-X
obese	B-X
Zucker	B-X
rats	B-X
,	B-X
adipose	B-X
PC	B-X
was	B-X
4-5-fold	B-X
increased	B-X
,	B-X
concomitant	B-X
with	B-X
a	B-X
5-6-fold	B-X
increase	B-X
in	B-X
mRNA	B-X
level	B-X
.	B-X
Reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
analysis	B-X
also	B-X
showed	B-X
that	B-X
the	B-X
proximal	B-X
promoter	B-X
was	B-X
activated	B-X
in	B-X
the	B-X
hyperlipogenic	B-X
condition	B-X
.	B-X
Conversely	B-X
,	B-X
transcription	B-X
of	B-X
the	B-X
proximal	B-X
promoter	B-X
was	B-X
not	B-X
detectable	B-X
in	B-X
various	B-X
liver	B-X
cell	B-X
lines	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
promoter	B-X
was	B-X
not	B-X
functional	B-X
under	B-X
cell	B-X
culture	B-X
conditions	B-X
.	B-X
In	B-X
rat	B-X
pancreatic	B-X
islets	B-X
and	B-X
insulinoma	B-X
cells	B-X
,	B-X
only	B-X
transcripts	B-X
D	B-X
and	B-X
E	B-X
,	B-X
generated	B-X
from	B-X
the	B-X
distal	B-X
promoter	B-X
of	B-X
the	B-X
PC	B-X
gene	B-X
,	B-X
were	B-X
expressed	B-X
.	B-X
Glucose	B-X
increased	B-X
PC	B-X
transcripts	B-X
from	B-X
the	B-X
distal	B-X
promoter	B-X
when	B-X
the	B-X
insulinoma	B-X
cells	B-X
were	B-X
maintained	B-X
in	B-X
10	B-X
mM	B-X
glucose	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
the	B-X
rat	B-X
PC	B-X
gene	B-X
plays	B-X
a	B-X
major	B-X
role	B-X
in	B-X
gluconeogenesis	B-X
and	B-X
lipogenesis	B-X
,	B-X
whereas	B-X
the	B-X
distal	B-X
promoter	B-X
is	B-X
necessary	B-X
for	B-X
anaplerosis	B-X
.	B-X
In	B-X
vitro	B-X
translation	B-X
and	B-X
in	B-X
vivo	B-X
polysome	B-X
profile	B-X
analysis	B-X
indicated	B-X
that	B-X
transcripts	B-X
C	B-X
and	B-X
E	B-X
were	B-X
translated	B-X
with	B-X
similar	B-X
translational	B-X
efficiencies	B-X
that	B-X
are	B-X
substantially	B-X
greater	B-X
than	B-X
that	B-X
of	B-X
transcript	B-X
D	B-X
,	B-X
suggesting	B-X
that	B-X
5'-untranslated	B-X
regions	B-X
play	B-X
a	B-X
role	B-X
in	B-X
translational	B-X
control	B-X
.	B-X

A	O
more	O
precise	O
statistical	O
analysis	O
of	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
SPI	O
-	O
2	O
is	O
provided	O
below	O
(	O
Table	O
2	O
)	O
.	O

All	O
in	O
all	O
,	O
these	O
results	O
suggest	O
that	O
the	O
normal	O
function	O
of	O
each	O
of	O
the	O
14	O
regulators	O
is	O
to	O
activate	O
transcription	O
of	O
virulence	O
factors	O
necessary	O
for	O
systemic	O
infection	O
but	O
only	O
under	O
specific	O
environmental	O
conditions	O
.	O

Acidic	O
minimal	O
media	O
(	O
AMM1	O
)	O
provides	O
the	O
best	O
induction	O
condition	O
of	O
those	O
that	O
were	O
examined	O
.	O

Validation	O
of	O
SPI	O
-	O
2	O
regulation	O
<EOS>	B-X
infection	B-X
in	B-X
BALB/c	B-X
mice	B-X
,	B-X
and	B-X
persistence	B-X
in	B-X
129X1/SvJ	B-X
mice	B-X
)	B-X
.	B-X
We	B-X
tested	B-X
the	B-X
regulatory	B-X
model	B-X
by	B-X
expressing	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
regulators	B-X
in	B-X
trans	B-X
and	B-X
monitoring	B-X
transcription	B-X
of	B-X
7	B-X
known	B-X
virulence	B-X
factors	B-X
located	B-X
within	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
experiments	B-X
to	B-X
demonstrate	B-X
epistatic	B-X
relationships	B-X
showed	B-X
that	B-X
SsrB	B-X
can	B-X
replace	B-X
SlyA	B-X
and	B-X
,	B-X
in	B-X
some	B-X
cases	B-X
,	B-X
SlyA	B-X
can	B-X
replace	B-X
SsrB	B-X
for	B-X
expression	B-X
of	B-X
SPI-2	B-X
encoded	B-X
virulence	B-X
factors	B-X
.	B-X
Known	B-X
virulence	B-X
factors	B-X
of	B-X
Salmonella	B-X
are	B-X
expressed	B-X
during	B-X
infection	B-X
of	B-X
macrophages	B-X
,	B-X
such	B-X
as	B-X
SPI-2	B-X
encoded	B-X
genes	B-X
,	B-X
supporting	B-X
the	B-X
validity	B-X
of	B-X
the	B-X
model	B-X
;	B-X
however	B-X
,	B-X
many	B-X
genes	B-X
of	B-X
unknown	B-X
functions	B-X
are	B-X
also	B-X
expressed	B-X
.	B-X

SPI	O
-	O
2	O
encodes	O
a	O
type	O
III	O
secretion	O
system	O
and	O
secreted	O
effectors	O
required	O
for	O
systemic	O
mouse	O
infection	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

To	O
assess	O
the	O
effects	O
of	O
growth	O
conditions	O
on	O
expression	O
of	O
the	O
SPI	O
-	O
2	O
secretion	O
apparatus	O
we	O
constructed	O
a	O
lacZ	B-Protein
transcriptional	O
fusion	O
to	O
ssaG	B-Protein
,	O
a	O
component	O
of	O
the	O
secretion	O
apparatus	O
,	O
and	O
tested	O
expression	O
in	O
each	O
mutant	O
background	O
under	O
each	O
of	O
the	O
four	O
growth	O
conditions	O
.	O

At	O
the	O
same	O
time	O
we	O
determined	O
transcript	O
levels	O
via	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
,	O
using	O
transcripts	O
from	O
rpoD	B-Protein
and	O
gyrB	B-Protein
as	O
controls	O
[	O
51	O
]	O
.	O

We	O
observed	O
that	O
the	O
results	O
determined	O
by	O
these	O
two	O
methods	O
matched	O
closely	O
(	O
Figure	O
S2	O
)	O
and	O
that	O
the	O
level	O
of	O
transcription	O
of	O
ssaG	B-Protein
was	O
highest	O
when	O
Salmonella	O
was	O
grown	O
in	O
minimal	O
acidic	O
media	O
.	O

In	O
agreement	O
with	O
the	O
microarrays	O
,	O
the	O
effect	O
of	O
these	O
regulators	O
on	O
ssaG	B-Protein
expression	O
was	O
minimal	O
if	O
the	O
bacteria	O
were	O
grown	O
in	O
rich	O
media	O
(	O
LB	O
broth	O
)	O
.	O

Because	O
the	O
type	O
III	O
secretion	O
system	O
and	O
associated	O
virulence	O
factors	O
encoded	O
within	O
SPI	O
-	O
2	O
were	O
most	O
highly	O
expressed	O
in	O
acidic	O
minimal	O
media	O
we	O
therefore	O
focused	O
on	O
growth	O
in	O
this	O
media	O
and	O
used	O
qRT	O
-	O
PCR	O
to	O
measure	O
transcript	O
levels	O
.	O

To	O
validate	O
the	O
transcriptional	O
profiles	O
we	O
prepared	O
RNA	O
from	O
mutants	O
and	O
parent	O
bacteria	O
grown	O
in	O
acidic	O
minimal	O
medium	O
and	O
used	O
as	O
template	O
for	O
qRT	O
-	O
PCR	O
.	O

Six	O
promoters	O
have	O
been	O
identified	O
for	O
the	O
type	O
III	O
secretion	O
system	O
encoded	O
within	O
SPI	O
-	O
2	O
(	O
see	O
Figure	O
4	O
;	O
[	O
52	O
]	O
)	O
.	O

We	O
monitored	O
transcription	O
of	O
seven	O
genes	O
within	O
SPI	O
-	O
2	O
,	O
covering	O
each	O
operon	O
at	O
least	O
once	O
,	O
and	O
used	O
gyrB	B-Protein
transcript	O
as	O
an	O
internal	O
control	O
.	O

We	O
observed	O
a	O
decrease	O
in	O
transcription	O
of	O
all	O
7	O
genes	O
in	O
11	O
of	O
the	O
14	O
mutants	O
.	O
<EOS>	B-X
The	B-X
activity	B-X
of	B-X
bacteriophage	B-X
T7	B-X
RNA	B-X
polymerase	B-X
(	B-X
RNAP	B-X
)	B-X
at	B-X
a	B-X
collection	B-X
of	B-X
T7	B-X
promoter	B-X
mutants	B-X
having	B-X
all	B-X
possible	B-X
single	B-X
base-pair	B-X
substitutions	B-X
in	B-X
the	B-X
region	B-X
from	B-X
-15	B-X
to	B-X
-6	B-X
was	B-X
determined	B-X
by	B-X
transcription	B-X
in	B-X
vitro	B-X
,	B-X
thus	B-X
establishing	B-X
a	B-X
hierarchy	B-X
of	B-X
base-pair	B-X
preference	B-X
at	B-X
each	B-X
position	B-X
.	B-X
Under	B-X
stringent	B-X
conditions	B-X
(	B-X
20	B-X
mM-MgCl2	B-X
)	B-X
,	B-X
T7	B-X
RNAP	B-X
is	B-X
highly	B-X
permissive	B-X
for	B-X
all	B-X
base-pair	B-X
substitutions	B-X
at	B-X
-13	B-X
and	B-X
-12	B-X
.	B-X
The	B-X
RNAP	B-X
is	B-X
partially	B-X
permissive	B-X
at	B-X
-15	B-X
,	B-X
-14	B-X
,	B-X
-11	B-X
,	B-X
-10	B-X
and	B-X
-6	B-X
,	B-X
and	B-X
exhibits	B-X
a	B-X
clear	B-X
pattern	B-X
of	B-X
base-pair	B-X
preference	B-X
at	B-X
these	B-X
positions	B-X
.	B-X
The	B-X
RNAP	B-X
is	B-X
non-permissive	B-X
for	B-X
substitutions	B-X
at	B-X
-9	B-X
to	B-X
-7	B-X
,	B-X
and	B-X
will	B-X
accept	B-X
only	B-X
the	B-X
consensus	B-X
base-pairs	B-X
at	B-X
these	B-X
positions	B-X
.	B-X
Under	B-X
lower	B-X
stringency	B-X
conditions	B-X
(	B-X
8	B-X
mM-MgCl2	B-X
,	B-X
or	B-X
additionally	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
dimethylsulfoxide	B-X
)	B-X
a	B-X
decrease	B-X
in	B-X
specificity	B-X
is	B-X
observed	B-X
at	B-X
most	B-X
positions	B-X
except	B-X
-9	B-X
.	B-X

The	O
three	O
exceptions	O
were	O
spvR	B-Protein
,	O
fruR	B-Protein
,	O
and	O
rpoS	B-Protein
.	O

Strains	O
containing	O
mutations	O
in	O
phoP	B-Protein
/	O
phoQ	B-Protein
,	O
ssrA	B-Protein
/	O
ssrB	B-Protein
,	O
slyA	B-Protein
,	O
and	O
ompR	B-Protein
/	O
envZ	B-Protein
showed	O
at	O
least	O
100	O
-	O
fold	O
decreases	O
in	O
transcription	O
of	O
all	O
SPI	O
-	O
2	O
genes	O
(	O
Figure	O
4	O
)	O
.	O

Mutations	O
of	O
ihf	B-Protein
(	O
himD	B-Protein
)	O
and	O
csrA	B-Protein
showed	O
an	O
intermediate	O
level	O
of	O
8	O
-	O
16	O
-	O
fold	O
decreased	O
transcription	O
whereas	O
hnr	B-Protein
,	O
rpoE	B-Protein
,	O
smpB	B-Protein
,	O
crp	B-Protein
and	O
hfq	B-Protein
showed	O
a	O
modest	O
decrease	O
of	O
2	O
-	O
8	O
-	O
fold	O
.	O

The	O
results	O
of	O
this	O
analysis	O
are	O
generally	O
concordant	O
with	O
the	O
microarray	O
results	O
although	O
the	O
dynamic	O
range	O
was	O
larger	O
for	O
qRT	O
-	O
PCR	O
than	O
for	O
the	O
microarrays	O
as	O
has	O
been	O
observed	O
before	O
[	O
53	O
]	O
.	O

Note	O
that	O
rpoE	B-Protein
and	O
hfq	B-Protein
mutants	O
showed	O
a	O
dramatic	O
reduction	O
in	O
macrophage	O
survival	O
,	O
but	O
little	O
difference	O
in	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
during	O
growth	O
in	O
AMM	O
.	O

It	O
has	O
recently	O
been	O
reported	O
that	O
the	O
translational	O
regulator	O
Hfq	B-Protein
,	O
regulates	O
translation	O
of	O
RpoE	B-Protein
explaining	O
in	O
part	O
why	O
the	O
two	O
mutations	O
behave	O
similarly	O
[	O
54	O
]	O
.	O

Furthermore	O
,	O
Hfq	B-Protein
regulates	O
translation	O
of	O
more	O
than	O
20	O
%	O
of	O
all	O
Salmonella	O
proteins	O
explaining	O
why	O
a	O
mutation	O
in	O
this	O
gene	O
has	O
such	O
a	O
dramatic	O
phenotype	O
(	O
[	O
54	O
]	O
;	O
Charles	O
Ansong	O
,	O
Hyunjin	O
Yoon	O
,	O
Steffen	O
Porwollik	O
,	O
Heather	O
Mottaz	O
-	O
Brewer	O
,	O
Briana	O
Ogata	O
-	O
Petritis	O
,	O
Navdeep	O
Jaitly	O
,	O
Joshua	O
N	O
.	O
Adkins	O
,	O
Michael	O
McClelland	O
,	O
Fred	O
Heffron	O
,	O
and	O
Richard	O
D	O
.	O
Smith	O
;	O
Global	O
systems	O
-	O
level	O
analysis	O
of	O
small	O
RNA	O
-	O
mediated	O
translational	O
regulation	O
:	O
Implications	O
for	O
virulence	O
and	O
global	O
protein	O
translation	O
;	O
Submitted	O
)	O
.	O

Cluster	O
analysis	O
identifies	O
additional	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
known	O
virulence	O
factors	O

The	O
results	O
from	O
the	O
microarray	O
analysis	O
identified	O
many	O
genes	O
that	O
appeared	O
to	O
be	O
coordinately	O
regulated	O
including	O
all	O
SPI	O
-	O
2	O
encoded	O
genes	O
that	O
are	O
part	O
of	O
the	O
type	O
III	O
secretion	O
system	O
(	O
Table	O
S2	O
)	O
.	O

We	O
searched	O
for	O
additional	O
previously	O
unidentified	O
virulence	O
factors	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
that	O
show	O
the	O
same	O
pattern	O
of	O
expression	O
as	O
those	O
located	O
within	O
SPI	O
-	O
2	O
.	O

A	O
systematic	O
way	O
of	O
identifying	O
co	O
-	O
regulation	O
is	O
with	O
one	O
of	O
several	O
computer	O
algorithms	O
that	O
group	O
genes	O
together	O
if	O
their	O
expression	O
is	O
similarly	O
changed	O
under	O
like	O
conditions	O
.	O

The	O
diverse	O
growth	O
conditions	O
used	O
in	O
this	O
study	O
,	O
as	O
well	O
as	O
differences	O
between	O
isogenic	O
strains	O
containing	O
mutations	O
in	O
virulence	O
regulators	O
,	O
make	O
our	O
data	O
set	O
ideal	O
for	O
this	O
type	O
of	O
analysis	O
.	O

In	O
addition	O
,	O
we	O
also	O
performed	O
cluster	O
analysis	O
using	O
public	O
data	O
sets	O
acquired	O
from	O
the	O
NIH	O
sponsored	O
public	O
repository	O
of	O
microarray	O
data	O
,	O
gene	O
expression	O
omnibus	O
(	O
GEO	O
)	O
.	O

We	O
chose	O
120	O
transcriptional	O
profiles	O
from	O
GEO	O
that	O
were	O
derived	O
by	O
extracting	O
RNA	O
from	O
the	O
same	O
parent	O
Salmonella	O
strain	O
grown	O
under	O
a	O
wide	O
variety	O
of	O
culture	O
conditions	O
(	O
GSE2456	O
;	O
G	O
.	O
Yun	O
et	O
al	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

Expression	O
profiles	O
for	O
all	O
genes	O
were	O
uploaded	O
to	O
SEBINI	O
(	O
Software	O
Environment	O
for	O
Biological	O
Network	O
Inference	O
[	O
18	O
]	O
)	O
.	O

SEBINI	O
incorporates	O
statistical	O
and	O
network	O
algorithms	O
into	O
a	O
framework	O
for	O
network	O
inference	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

To	O
detect	O
dependencies	O
among	O
genes	O
over	O
different	O
conditions	O
we	O
employed	O
the	O
context	O
likelihood	O
of	O
relatedness	O
algorithm	O
(	O
CLR	O
;	O
[	O
19	O
]	O
)	O
,	O
which	O
is	O
a	O
plugin	O
for	O
SEBINI	O
.	O

The	O
results	O
were	O
visualized	O
as	O
a	O
network	O
of	O
similarity	O
relationships	O
using	O
Cytoscape	O
[	O
57	O
]	O
.	O
<EOS>	B-X
Large	B-X
networks	B-X
are	B-X
quintessential	B-X
to	B-X
bioinformatics	B-X
,	B-X
knowledge	B-X
graphs	B-X
,	B-X
social	B-X
network	B-X
analysis	B-X
,	B-X
and	B-X
graph-based	B-X
learning	B-X
.	B-X
CompositeView	B-X
is	B-X
a	B-X
Python-based	B-X
open-source	B-X
application	B-X
that	B-X
improves	B-X
interactive	B-X
complex	B-X
network	B-X
visualization	B-X
and	B-X
extraction	B-X
of	B-X
actionable	B-X
insight	B-X
.	B-X
CompositeView	B-X
utilizes	B-X
specifically	B-X
formatted	B-X
input	B-X
data	B-X
to	B-X
calculate	B-X
composite	B-X
scores	B-X
and	B-X
display	B-X
them	B-X
using	B-X
the	B-X
Cytoscape	B-X
component	B-X
of	B-X
Dash	B-X
.	B-X
Visualized	B-X
interactive	B-X
results	B-X
are	B-X
user-refined	B-X
via	B-X
filtering	B-X
elements	B-X
such	B-X
as	B-X
node	B-X
value	B-X
and	B-X
edge	B-X
weight	B-X
sliders	B-X
and	B-X
graph	B-X
manipulation	B-X
options	B-X
(	B-X
e.g.	B-X
,	B-X
node	B-X
color	B-X
and	B-X
layout	B-X
spread	B-X
)	B-X
.	B-X
The	B-X
primary	B-X
difference	B-X
between	B-X
CompositeView	B-X
and	B-X
other	B-X
network	B-X
visualization	B-X
tools	B-X
is	B-X
its	B-X
ability	B-X
to	B-X
auto-calculate	B-X
and	B-X
auto-update	B-X
composite	B-X
scores	B-X
as	B-X
the	B-X
user	B-X
interactively	B-X
filters	B-X
or	B-X
aggregates	B-X
data	B-X
.	B-X
CompositeView	B-X
was	B-X
developed	B-X
to	B-X
visualize	B-X
network	B-X
relevance	B-X
rankings	B-X
,	B-X
but	B-X
it	B-X
performs	B-X
well	B-X
with	B-X
non-network	B-X
data	B-X
.	B-X
CompositeView	B-X
was	B-X
stress	B-X
tested	B-X
to	B-X
construct	B-X
reference	B-X
benchmarks	B-X
that	B-X
define	B-X
breadth	B-X
and	B-X
size	B-X
of	B-X
data	B-X
effectively	B-X
visualized	B-X
.	B-X
Finally	B-X
,	B-X
CompositeView	B-X
is	B-X
compared	B-X
to	B-X
Excel	B-X
,	B-X
Tableau	B-X
,	B-X
Cytoscape	B-X
,	B-X
neo4j	B-X
,	B-X
NodeXL	B-X
,	B-X
and	B-X
Gephi	B-X
.	B-X

A	O
recent	O
study	O
with	O
E	O
.	O
coli	O
shows	O
that	O
the	O
CLR	O
algorithm	O
was	O
the	O
most	O
accurate	O
in	O
computing	O
the	O
correct	O
network	O
for	O
experimentally	O
verified	O
regulatory	O
interactions	O
[	O
19	O
]	O
.	O

The	O
results	O
shown	O
in	O
Figure	O
5	O
use	O
a	O
force	O
-	O
directed	O
network	O
layout	O
algorithm	O
where	O
genes	O
(	O
shown	O
as	O
small	O
colored	O
circles	O
)	O
are	O
generally	O
closer	O
together	O
when	O
their	O
statistical	O
association	O
,	O
and	O
thus	O
degree	O
of	O
predicted	O
co	O
-	O
regulation	O
,	O
is	O
stronger	O
(	O
the	O
cutoff	O
for	O
the	O
genes	O
shown	O
is	O
5	O
standard	O
deviations	O
from	O
the	O
mean	O
or	O
greater	O
;	O
p	O
<	O
.	O
0001	O
)	O
.	O
<EOS>	B-X
Aiming	B-X
to	B-X
decrease	B-X
the	B-X
acute	B-X
side	B-X
effects	B-X
and	B-X
genotoxic	B-X
hazards	B-X
of	B-X
PUVA	B-X
,	B-X
pyrido	B-X
(	B-X
3,4-C	B-X
)	B-X
psoralen	B-X
(	B-X
PP	B-X
)	B-X
and	B-X
7-methyl	B-X
pyrido	B-X
(	B-X
3,4-C	B-X
)	B-X
psoralen	B-X
(	B-X
MPP	B-X
)	B-X
were	B-X
synthesized	B-X
and	B-X
studied	B-X
.	B-X
Their	B-X
UVA	B-X
maximum	B-X
absorption	B-X
lies	B-X
at	B-X
325	B-X
and	B-X
330	B-X
nm	B-X
,	B-X
respectively	B-X
.	B-X
Their	B-X
photostability	B-X
is	B-X
comparable	B-X
to	B-X
that	B-X
of	B-X
8-MOP	B-X
.	B-X
They	B-X
complex	B-X
to	B-X
DNA	B-X
in	B-X
the	B-X
dark	B-X
,	B-X
and	B-X
,	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
UVA	B-X
,	B-X
produce	B-X
only	B-X
monoadditions	B-X
to	B-X
DNA	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
fluorescence	B-X
and	B-X
DNA	B-X
denaturation-renaturation	B-X
studies	B-X
.	B-X
In	B-X
diploid	B-X
eukaryotic	B-X
yeast	B-X
they	B-X
are	B-X
more	B-X
effective	B-X
than	B-X
8-MOP	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
lethal	B-X
effects	B-X
and	B-X
mitochondrial	B-X
damage	B-X
.	B-X
Their	B-X
mutagenic	B-X
activity	B-X
per	B-X
unit	B-X
dose	B-X
of	B-X
UVA	B-X
is	B-X
in	B-X
the	B-X
same	B-X
range	B-X
as	B-X
that	B-X
of	B-X
8-MOP	B-X
.	B-X
However	B-X
,	B-X
per	B-X
viable	B-X
cell	B-X
they	B-X
are	B-X
clearly	B-X
less	B-X
mutagenic	B-X
than	B-X
8-MOP	B-X
.	B-X
This	B-X
difference	B-X
is	B-X
also	B-X
observed	B-X
for	B-X
recombinogenic	B-X
activity	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
the	B-X
following	B-X
ranges	B-X
of	B-X
effectiveness	B-X
are	B-X
found	B-X
:	B-X
inhibition	B-X
of	B-X
DNA	B-X
synthesis	B-X
in	B-X
human	B-X
fibroblasts	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
8-MOP	B-X
;	B-X
mutagenic	B-X
activity	B-X
in	B-X
V79	B-X
Chinese	B-X
hamster	B-X
cells	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
8-MOP	B-X
;	B-X
cell	B-X
transforming	B-X
ability	B-X
in	B-X
C3H	B-X
embryonic	B-X
mouse	B-X
cells	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
8-MOP	B-X
greater	B-X
than	B-X
PP	B-X
as	B-X
a	B-X
function	B-X
of	B-X
UVA	B-X
dose	B-X
,	B-X
and	B-X
:	B-X
8-MOP	B-X
greater	B-X
than	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
as	B-X
a	B-X
function	B-X
of	B-X
survival	B-X
;	B-X
induction	B-X
of	B-X
sister	B-X
chromatic	B-X
exchanges	B-X
(	B-X
SCE	B-X
)	B-X
per	B-X
unit	B-X
dose	B-X
:	B-X
MPP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
8-MOP	B-X
in	B-X
the	B-X
linear	B-X
part	B-X
of	B-X
the	B-X
induction	B-X
curve	B-X
,	B-X
and	B-X
:	B-X
8-MOP	B-X
greater	B-X
than	B-X
PP	B-X
greater	B-X
than	B-X
MPP	B-X
at	B-X
the	B-X
maximum	B-X
level	B-X
of	B-X
SCE	B-X
obtained	B-X
.	B-X
(	B-X
ABSTRACT	B-X
TRUNCATED	B-X
AT	B-X
250	B-X
WORDS	B-X
)	B-X

All	O
SPI	O
-	O
2	O
secretion	O
apparatus	O
genes	O
as	O
well	O
as	O
associated	O
effectors	O
and	O
chaperones	O
were	O
found	O
to	O
very	O
tightly	O
cluster	O
in	O
the	O
network	O
.	O

In	O
support	O
of	O
this	O
conclusion	O
,	O
the	O
cluster	O
analyses	O
based	O
on	O
our	O
data	O
and	O
based	O
on	O
publicly	O
available	O
data	O
sets	O
are	O
consistent	O
.	O

The	O
cluster	O
analysis	O
identified	O
92	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
the	O
SPI	O
-	O
2	O
encoded	O
type	O
III	O
secretion	O
system	O
but	O
not	O
located	O
within	O
SPI	O
-	O
2	O
.	O

This	O
includes	O
known	O
SPI	O
-	O
2	O
secreted	O
effectors	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
as	O
well	O
as	O
many	O
genes	O
for	O
which	O
no	O
function	O
has	O
been	O
assigned	O
(	O
all	O
total	O
123	O
genes	O
;	O
see	O
Table	O
2	O
)	O
.	O

Several	O
of	O
these	O
genes	O
are	O
A	O
+	O
T	O
rich	O
(	O
>	O
60	O
%	O
compared	O
to	O
48	O
%	O
for	O
the	O
Salmonella	O
chromosome	O
)	O
and	O
located	O
within	O
sequences	O
that	O
are	O
not	O
present	O
in	O
close	O
relatives	O
of	O
Salmonella	O
suggesting	O
that	O
they	O
may	O
be	O
unidentified	O
secreted	O
effectors	O
or	O
other	O
virulence	O
determinants	O
that	O
have	O
been	O
acquired	O
from	O
other	O
pathogens	O
.	O
<EOS>	B-X
Colonization	B-X
,	B-X
Infection	B-X
,	B-X
and	B-X
the	B-X
Accessory	B-X
Genome	B-X
of	B-X
Streptococcus	B-X
mutans	B-X
,	B-X
one	B-X
of	B-X
the	B-X
many	B-X
etiological	B-X
factors	B-X
of	B-X
dental	B-X
caries	B-X
,	B-X
is	B-X
a	B-X
microorganism	B-X
which	B-X
is	B-X
able	B-X
to	B-X
acquire	B-X
new	B-X
properties	B-X
allowing	B-X
for	B-X
the	B-X
expression	B-X
of	B-X
pathogenicity	B-X
determinants	B-X
determining	B-X
its	B-X
virulence	B-X
in	B-X
specific	B-X
environmental	B-X
conditions	B-X
.	B-X
This	B-X
review	B-X
is	B-X
an	B-X
attempt	B-X
to	B-X
establish	B-X
which	B-X
characteristics	B-X
associated	B-X
with	B-X
biofilm	B-X
formation	B-X
--	B-X
virulence	B-X
determinants	B-X
of	B-X
S.	B-X
mutans	B-X
--	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
development	B-X
of	B-X
dental	B-X
caries	B-X
.	B-X
To	B-X
what	B-X
extent	B-X
do	B-X
microorganisms	B-X
of	B-X
the	B-X
cariogenic	B-X
flora	B-X
exemplified	B-X
by	B-X
S.	B-X
mutans	B-X
differ	B-X
in	B-X
virulence	B-X
determinants	B-X
``	B-X
expression	B-X
''	B-X
from	B-X
microorganisms	B-X
of	B-X
physiological	B-X
flora	B-X
?	B-X

All	O
in	O
all	O
,	O
the	O
implication	O
of	O
the	O
cluster	O
data	O
is	O
that	O
the	O
genes	O
shown	O
in	O
Table	O
2	O
are	O
co	O
-	O
regulated	O
with	O
SPI	O
-	O
2	O
.	O

One	O
interesting	O
point	O
is	O
that	O
the	O
algorithm	O
does	O
not	O
distinguish	O
between	O
positive	O
and	O
negative	O
regulation	O
only	O
that	O
it	O
is	O
coincident	O
.	O
<EOS>	B-X
In	B-X
Literature	B-X
,	B-X
in	B-X
order	B-X
to	B-X
solve	B-X
the	B-X
issue	B-X
of	B-X
diversity	B-X
and	B-X
convergence	B-X
in	B-X
MaOPs	B-X
,	B-X
many	B-X
approaches	B-X
are	B-X
proposed	B-X
using	B-X
different	B-X
multi	B-X
objective	B-X
evolutionary	B-X
algorithms	B-X
(	B-X
MOEAs	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
to	B-X
get	B-X
better	B-X
results	B-X
,	B-X
the	B-X
researchers	B-X
use	B-X
the	B-X
sets	B-X
of	B-X
reference	B-X
points	B-X
to	B-X
differentiate	B-X
the	B-X
solutions	B-X
and	B-X
to	B-X
model	B-X
the	B-X
search	B-X
process	B-X
,	B-X
it	B-X
further	B-X
evaluates	B-X
and	B-X
selects	B-X
the	B-X
non-dominating	B-X
solutions	B-X
by	B-X
using	B-X
the	B-X
reference	B-X
set	B-X
of	B-X
solutions	B-X
.	B-X
Furthermore	B-X
,	B-X
this	B-X
technique	B-X
is	B-X
used	B-X
in	B-X
some	B-X
of	B-X
the	B-X
swarm-based	B-X
evolutionary	B-X
algorithms	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
,	B-X
we	B-X
have	B-X
used	B-X
some	B-X
effective	B-X
adaptations	B-X
of	B-X
bat	B-X
algorithm	B-X
with	B-X
the	B-X
previous	B-X
mentioned	B-X
approach	B-X
to	B-X
effectively	B-X
handle	B-X
the	B-X
many	B-X
objective	B-X
problems	B-X
.	B-X
Moreover	B-X
,	B-X
we	B-X
have	B-X
called	B-X
this	B-X
algorithm	B-X
as	B-X
many	B-X
objective	B-X
bat	B-X
algorithm	B-X
(	B-X
MaOBAT	B-X
)	B-X
.	B-X
This	B-X
algorithm	B-X
is	B-X
a	B-X
biologically	B-X
inspired	B-X
algorithm	B-X
,	B-X
which	B-X
uses	B-X
echolocation	B-X
power	B-X
of	B-X
micro	B-X
bats	B-X
.	B-X
In	B-X
our	B-X
proposed	B-X
strategy	B-X
,	B-X
dynamically	B-X
allocated	B-X
set	B-X
of	B-X
reference	B-X
points	B-X
are	B-X
used	B-X
,	B-X
allowing	B-X
the	B-X
algorithm	B-X
to	B-X
have	B-X
good	B-X
convergence	B-X
and	B-X
high	B-X
diversity	B-X
pareto	B-X
fronts	B-X
(	B-X
PF	B-X
)	B-X
.	B-X
The	B-X
experimental	B-X
results	B-X
show	B-X
that	B-X
the	B-X
proposed	B-X
algorithm	B-X
has	B-X
significant	B-X
advantages	B-X
over	B-X
several	B-X
state-of-the-art	B-X
algorithms	B-X
in	B-X
terms	B-X
of	B-X
the	B-X
quality	B-X
of	B-X
the	B-X
solution	B-X
.	B-X

We	O
analyzed	O
expression	O
of	O
each	O
of	O
the	O
123	O
genes	O
and	O
found	O
that	O
only	O
two	O
genes	O
(	O
pepA	B-Protein
and	O
mopB	B-Protein
)	O
are	O
negatively	O
regulated	O
;	O
the	O
remaining	O
121	O
are	O
positively	O
regulated	O
.	O

Computer	O
aided	O
analysis	O
of	O
the	O
regulatory	O
network	O
<EOS>	B-X
Surgical	B-X
Data	B-X
Science	B-X
(	B-X
SDS	B-X
)	B-X
is	B-X
a	B-X
new	B-X
research	B-X
field	B-X
that	B-X
aims	B-X
to	B-X
improve	B-X
the	B-X
quality	B-X
of	B-X
interventional	B-X
healthcare	B-X
through	B-X
the	B-X
capture	B-X
,	B-X
organization	B-X
,	B-X
analysis	B-X
and	B-X
modeling	B-X
of	B-X
data	B-X
.	B-X
Based	B-X
on	B-X
an	B-X
international	B-X
workshop	B-X
involving	B-X
leading	B-X
researchers	B-X
in	B-X
the	B-X
field	B-X
of	B-X
SDS	B-X
,	B-X
we	B-X
review	B-X
current	B-X
practice	B-X
,	B-X
key	B-X
achievements	B-X
and	B-X
initiatives	B-X
as	B-X
well	B-X
as	B-X
available	B-X
standards	B-X
and	B-X
tools	B-X
for	B-X
a	B-X
number	B-X
of	B-X
topics	B-X
relevant	B-X
to	B-X
the	B-X
field	B-X
,	B-X
namely	B-X
(	B-X
1	B-X
)	B-X
infrastructure	B-X
for	B-X
data	B-X
acquisition	B-X
,	B-X
storage	B-X
and	B-X
access	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
regulatory	B-X
constraints	B-X
,	B-X
(	B-X
2	B-X
)	B-X
data	B-X
annotation	B-X
and	B-X
sharing	B-X
and	B-X
(	B-X
3	B-X
)	B-X
data	B-X
analytics	B-X
.	B-X
Computational	B-X
and	B-X
mathematical	B-X
models	B-X
have	B-X
significantly	B-X
contributed	B-X
to	B-X
the	B-X
rapid	B-X
progress	B-X
in	B-X
the	B-X
study	B-X
of	B-X
gene	B-X
regulatory	B-X
networks	B-X
(	B-X
GRN	B-X
)	B-X
,	B-X
but	B-X
researchers	B-X
still	B-X
lack	B-X
a	B-X
reliable	B-X
model-based	B-X
framework	B-X
for	B-X
computer-aided	B-X
analysis	B-X
and	B-X
design	B-X
.	B-X
Such	B-X
tool	B-X
should	B-X
both	B-X
reveal	B-X
the	B-X
relation	B-X
between	B-X
network	B-X
structure	B-X
and	B-X
dynamics	B-X
and	B-X
find	B-X
parameter	B-X
values	B-X
and/or	B-X
constraints	B-X
that	B-X
enable	B-X
the	B-X
simulated	B-X
dynamics	B-X
to	B-X
reproduce	B-X
specific	B-X
behaviors	B-X
.	B-X
This	B-X
paper	B-X
addresses	B-X
these	B-X
issues	B-X
and	B-X
proposes	B-X
a	B-X
computational	B-X
framework	B-X
that	B-X
facilitates	B-X
network	B-X
analysis	B-X
or	B-X
design	B-X
.	B-X
It	B-X
follows	B-X
a	B-X
modeling	B-X
cycle	B-X
that	B-X
alternates	B-X
phases	B-X
of	B-X
hypothesis	B-X
testing	B-X
with	B-X
parameter	B-X
space	B-X
refinement	B-X
to	B-X
ultimately	B-X
propose	B-X
a	B-X
network	B-X
that	B-X
exhibits	B-X
specified	B-X
behaviors	B-X
with	B-X
the	B-X
highest	B-X
probability	B-X
.	B-X
Parameter	B-X
space	B-X
refinement	B-X
,	B-X
grounded	B-X
on	B-X
a	B-X
method	B-X
that	B-X
considers	B-X
the	B-X
intrinsic	B-X
stochasticity	B-X
of	B-X
regulation	B-X
by	B-X
expressing	B-X
network	B-X
uncertainty	B-X
with	B-X
fluctuations	B-X
in	B-X
parameter	B-X
values	B-X
only	B-X
,	B-X
optimizes	B-X
parameter	B-X
stochastic	B-X
values	B-X
initialized	B-X
by	B-X
probability	B-X
distributions	B-X
with	B-X
large	B-X
variances	B-X
.	B-X
The	B-X
power	B-X
and	B-X
ease	B-X
of	B-X
our	B-X
framework	B-X
is	B-X
demonstrated	B-X
by	B-X
working	B-X
out	B-X
a	B-X
benchmark	B-X
synthetic	B-X
network	B-X
to	B-X
get	B-X
a	B-X
synthetic	B-X
oscillator	B-X
.	B-X

The	O
fact	O
that	O
all	O
of	O
the	O
14	O
regulators	O
in	O
this	O
study	O
have	O
biological	O
functions	O
during	O
infection	O
suggests	O
they	O
could	O
be	O
part	O
of	O
a	O
coordinated	O
network	O
.	O

Acidic	O
minimal	O
medium	O
is	O
a	O
well	O
-	O
established	O
in	O
vitro	O
condition	O
for	O
SPI	O
-	O
2	O
expression	O
;	O
accordingly	O
,	O
we	O
focused	O
on	O
examining	O
regulation	O
of	O
genes	O
expressed	O
under	O
these	O
conditions	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
,	O
[	O
58	O
]	O
.	O

To	O
identify	O
coordinated	O
regulation	O
we	O
compared	O
expression	O
of	O
each	O
regulator	O
in	O
each	O
mutant	O
background	O
when	O
grown	O
in	O
minimal	O
acidic	O
medium	O
(	O
Figure	O
6A	O
)	O
.	O

RNA	O
samples	O
were	O
prepared	O
from	O
three	O
separate	O
cultures	O
and	O
used	O
as	O
a	O
template	O
in	O
separate	O
qRT	O
-	O
PCR	O
experiments	O
.	O

A	O
matrix	O
with	O
14	O
mutants	O
in	O
columns	O
and	O
14	O
regulatory	O
genes	O
and	O
SPI	O
-	O
2	O
genes	O
(	O
6	O
genes	O
except	O
for	O
ssrB	B-Protein
as	O
used	O
in	O
Figure	O
4	O
)	O
in	O
rows	O
was	O
constructed	O
based	O
on	O
qRT	O
-	O
PCR	O
data	O
and	O
z	O
-	O
scores	O
were	O
calculated	O
based	O
on	O
average	O
and	O
standard	O
deviations	O
from	O
columns	O
and	O
rows	O
.	O

A	O
network	O
among	O
regulators	O
and	O
SPI	O
-	O
2	O
was	O
mapped	O
as	O
described	O
in	O
Lee	O
et	O
al	O
.	O
by	O
sorting	O
out	O
values	O
that	O
changed	O
in	O
a	O
specific	O
mutant	O
background	O
[	O
59	O
]	O
.	O

We	O
visualized	O
the	O
resulting	O
relationships	O
using	O
Cytoscape	O
[	O
57	O
]	O
.	O
<EOS>	B-X
BACKGROUND	B-X
This	B-X
study	B-X
aimed	B-X
to	B-X
identify	B-X
significantly	B-X
altered	B-X
circRNAs/lncRNAs/miRNAs/mRNAs	B-X
pathways	B-X
in	B-X
preeclampsia	B-X
(	B-X
PE	B-X
)	B-X
,	B-X
investigate	B-X
their	B-X
target	B-X
relationships	B-X
,	B-X
and	B-X
determine	B-X
their	B-X
biological	B-X
functions	B-X
.	B-X
Differentially	B-X
expressed	B-X
RNAs	B-X
were	B-X
determined	B-X
using	B-X
the	B-X
Limma	B-X
package	B-X
in	B-X
R.	B-X
Gene	B-X
set	B-X
enrichment	B-X
analysis	B-X
(	B-X
GSEA	B-X
)	B-X
was	B-X
performed	B-X
using	B-X
GSEA	B-X
software	B-X
(	B-X
v.	B-X
3.0	B-X
)	B-X
and	B-X
illustrated	B-X
by	B-X
ClusterProfiler	B-X
and	B-X
ggplot2	B-X
package	B-X
in	B-X
R.	B-X
DAVID	B-X
database	B-X
(	B-X
v.	B-X
6.8	B-X
)	B-X
was	B-X
implemented	B-X
to	B-X
analyze	B-X
functional	B-X
categories	B-X
and	B-X
the	B-X
association	B-X
between	B-X
genes	B-X
and	B-X
the	B-X
corresponding	B-X
Gene	B-X
Ontology	B-X
(	B-X
GO	B-X
)	B-X
classification	B-X
.	B-X
The	B-X
R	B-X
visualization	B-X
package	B-X
GOPlot	B-X
was	B-X
used	B-X
to	B-X
get	B-X
a	B-X
better	B-X
visualization	B-X
of	B-X
the	B-X
relationships	B-X
between	B-X
genes	B-X
and	B-X
the	B-X
selected	B-X
functional	B-X
categories	B-X
.	B-X
CeRNA	B-X
networks	B-X
which	B-X
visualized	B-X
the	B-X
correlations	B-X
between	B-X
circRNA/lncRNA-miRNA-mRNA	B-X
were	B-X
constructed	B-X
using	B-X
Cytoscape	B-X
software	B-X
(	B-X
v.	B-X
3.6.0	B-X
)	B-X
.	B-X
Targetscan	B-X
and	B-X
miRanda	B-X
database	B-X
were	B-X
used	B-X
to	B-X
predict	B-X
target	B-X
relationships	B-X
between	B-X
circRNA/lncRNA-miRNA-mRNA	B-X
.	B-X

Nodes	O
indicate	O
regulators	O
or	O
SPI	O
-	O
2	O
and	O
red	O
and	O
blue	O
arrows	O
indicate	O
activation	O
and	O
repression	O
respectively	O
(	O
see	O
Figure	O
6B	O
)	O
.	O
<EOS>	B-X
Analysis	B-X
by	B-X
RT-PCR	B-X
indicates	B-X
that	B-X
alpha1	B-X
,	B-X
alpha2	B-X
,	B-X
and	B-X
alpha3	B-X
isoforms	B-X
are	B-X
all	B-X
present	B-X
in	B-X
murine	B-X
lymphoid	B-X
cells	B-X
obtained	B-X
from	B-X
thymus	B-X
,	B-X
lymph	B-X
nodes	B-X
,	B-X
and	B-X
spleen	B-X
.	B-X
In	B-X
other	B-X
systems	B-X
,	B-X
the	B-X
Na	B-X
,	B-X
K-ATPase	B-X
acts	B-X
as	B-X
a	B-X
signal	B-X
transducer	B-X
in	B-X
addition	B-X
to	B-X
being	B-X
an	B-X
ion	B-X
pump	B-X
,	B-X
and	B-X
ouabain	B-X
is	B-X
capable	B-X
of	B-X
inducing	B-X
the	B-X
activation	B-X
of	B-X
various	B-X
signal	B-X
transduction	B-X
cascades	B-X
.	B-X
The	B-X
pathway	B-X
induced	B-X
by	B-X
ouabain	B-X
in	B-X
lymphoid	B-X
cells	B-X
is	B-X
still	B-X
unclear	B-X
but	B-X
might	B-X
vary	B-X
with	B-X
the	B-X
type	B-X
and	B-X
state	B-X
of	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
Increasing	B-X
evidence	B-X
indicates	B-X
that	B-X
Wnt/β-catenin	B-X
signaling	B-X
,	B-X
one	B-X
of	B-X
the	B-X
best-characterized	B-X
cancer	B-X
drivers	B-X
,	B-X
promotes	B-X
cancer	B-X
progression	B-X
by	B-X
regulating	B-X
the	B-X
tumor-immune	B-X
cycle	B-X
in	B-X
most	B-X
of	B-X
the	B-X
nodes	B-X
,	B-X
including	B-X
dendritic	B-X
cells	B-X
,	B-X
T	B-X
cells	B-X
,	B-X
and	B-X
tumor	B-X
cells	B-X
.	B-X
Specifically	B-X
,	B-X
abnormal	B-X
Wnt/β-catenin	B-X
signaling	B-X
directly	B-X
alters	B-X
a	B-X
number	B-X
of	B-X
regulators	B-X
critical	B-X
for	B-X
the	B-X
antitumor	B-X
activities	B-X
of	B-X
T	B-X
cells	B-X
,	B-X
especially	B-X
effector	B-X
T	B-X
cells	B-X
,	B-X
T	B-X
helper	B-X
cells	B-X
,	B-X
and	B-X
regulatory	B-X
T	B-X
cells	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
targeting	B-X
Wnt/β-catenin	B-X
signaling	B-X
would	B-X
potentially	B-X
improve	B-X
clinical	B-X
outcomes	B-X
of	B-X
cancer	B-X
patients	B-X
by	B-X
overcoming	B-X
the	B-X
primary	B-X
,	B-X
adaptive	B-X
,	B-X
and	B-X
acquired	B-X
resistance	B-X
to	B-X
immunotherapy	B-X
.	B-X

In	O
the	O
computed	O
network	O
multiple	O
regulators	O
act	O
both	O
directly	O
and	O
indirectly	O
to	O
control	O
SPI	O
-	O
2	O
expression	O
.	O

However	O
,	O
direct	O
or	O
indirect	O
regulation	O
cannot	O
be	O
distinguished	O
without	O
additional	O
experimental	O
verification	O
.	O
<EOS>	B-X
Directional	B-X
cell	B-X
migration	B-X
normally	B-X
relies	B-X
on	B-X
a	B-X
variety	B-X
of	B-X
external	B-X
signals	B-X
,	B-X
such	B-X
as	B-X
chemical	B-X
,	B-X
mechanical	B-X
,	B-X
or	B-X
electrical	B-X
,	B-X
which	B-X
instruct	B-X
cells	B-X
in	B-X
which	B-X
direction	B-X
to	B-X
move	B-X
.	B-X
Many	B-X
of	B-X
the	B-X
major	B-X
molecular	B-X
and	B-X
physical	B-X
effects	B-X
derived	B-X
from	B-X
these	B-X
cues	B-X
are	B-X
now	B-X
understood	B-X
,	B-X
leading	B-X
to	B-X
questions	B-X
about	B-X
whether	B-X
directional	B-X
cell	B-X
migration	B-X
is	B-X
alike	B-X
or	B-X
distinct	B-X
under	B-X
these	B-X
different	B-X
signals	B-X
,	B-X
and	B-X
how	B-X
cells	B-X
might	B-X
be	B-X
directed	B-X
by	B-X
multiple	B-X
simultaneous	B-X
cues	B-X
,	B-X
which	B-X
would	B-X
be	B-X
expected	B-X
in	B-X
complex	B-X
in	B-X
vivo	B-X
environments	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
compare	B-X
how	B-X
different	B-X
stimuli	B-X
are	B-X
spatially	B-X
distributed	B-X
,	B-X
often	B-X
as	B-X
gradients	B-X
,	B-X
to	B-X
direct	B-X
cell	B-X
movement	B-X
and	B-X
the	B-X
mechanisms	B-X
by	B-X
which	B-X
they	B-X
steer	B-X
cells	B-X
.	B-X
A	B-X
comparison	B-X
of	B-X
the	B-X
downstream	B-X
effectors	B-X
of	B-X
directional	B-X
cues	B-X
suggests	B-X
that	B-X
different	B-X
external	B-X
signals	B-X
regulate	B-X
a	B-X
common	B-X
set	B-X
of	B-X
components	B-X
:	B-X
small	B-X
GTPases	B-X
and	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
,	B-X
which	B-X
implies	B-X
that	B-X
the	B-X
mechanisms	B-X
downstream	B-X
of	B-X
different	B-X
signals	B-X
are	B-X
likely	B-X
to	B-X
be	B-X
closely	B-X
related	B-X
and	B-X
underlies	B-X
the	B-X
idea	B-X
that	B-X
cell	B-X
migration	B-X
operates	B-X
by	B-X
a	B-X
common	B-X
set	B-X
of	B-X
physical	B-X
principles	B-X
,	B-X
irrespective	B-X
of	B-X
the	B-X
input	B-X
.	B-X

So	O
,	O
in	O
Figure	O
6B	O
all	O
regulatory	O
effects	O
on	O
SPI	O
-	O
2	O
have	O
been	O
removed	O
except	O
for	O
those	O
mediated	O
directly	O
by	O
slyA	B-Protein
and	O
ssrB	B-Protein
based	O
on	O
additional	O
genetic	O
data	O
as	O
described	O
below	O
.	O

The	O
network	O
suggests	O
that	O
both	O
slyA	B-Protein
and	O
ssrA	B-Protein
/	O
ssrB	B-Protein
could	O
coordinate	O
regulation	O
of	O
SPI	O
-	O
2	O
and	O
other	O
virulence	O
factors	O
by	O
integrating	O
signals	O
from	O
multiple	O
regulators	O
as	O
was	O
tested	O
next	O
.	O

An	O
overall	O
network	O
was	O
also	O
generated	O
by	O
integrating	O
4	O
data	O
sets	O
;	O
two	O
CLR	O
algorithm	O
data	O
from	O
the	O
complete	O
microarray	O
results	O
and	O
GSE2456	O
public	O
microarray	O
database	O
and	O
two	O
matrix	O
analysis	O
data	O
from	O
the	O
transcription	O
profiles	O
and	O
qRT	O
-	O
PCR	O
results	O
(	O
Figure	O
S3	O
;	O
the	O
limitation	O
is	O
that	O
no	O
distinction	O
is	O
made	O
between	O
positive	O
and	O
negative	O
regulation	O
in	O
CLR	O
algorithm	O
data	O
)	O
.	O
<EOS>	B-X
Systems	B-X
biology	B-X
aims	B-X
at	B-X
understanding	B-X
the	B-X
behavior	B-X
of	B-X
biological	B-X
networks	B-X
by	B-X
mathematical	B-X
modeling	B-X
based	B-X
on	B-X
experimental	B-X
data	B-X
.	B-X
However	B-X
,	B-X
frequently	B-X
experimental	B-X
data	B-X
is	B-X
derived	B-X
from	B-X
poorly	B-X
defined	B-X
cellular	B-X
systems	B-X
,	B-X
the	B-X
procedures	B-X
of	B-X
data	B-X
generation	B-X
are	B-X
insufficiently	B-X
documented	B-X
and	B-X
data	B-X
processing	B-X
is	B-X
arbitrary	B-X
.	B-X
Minimum	B-X
information	B-X
standards	B-X
for	B-X
the	B-X
description	B-X
of	B-X
data	B-X
sets	B-X
and	B-X
common	B-X
languages	B-X
for	B-X
the	B-X
description	B-X
of	B-X
biological	B-X
pathways	B-X
as	B-X
well	B-X
as	B-X
for	B-X
mathematical	B-X
modeling	B-X
are	B-X
being	B-X
developed	B-X
.	B-X
Standardization	B-X
is	B-X
required	B-X
to	B-X
facilitate	B-X
data	B-X
exchange	B-X
between	B-X
different	B-X
research	B-X
groups	B-X
and	B-X
finally	B-X
the	B-X
assembly	B-X
of	B-X
large	B-X
integrated	B-X
models	B-X
providing	B-X
novel	B-X
biological	B-X
insights	B-X
.	B-X

The	O
consensus	O
network	O
combining	O
all	O
data	O
reported	O
in	O
this	O
study	O
includes	O
the	O
network	O
computed	O
from	O
qRT	O
-	O
PCR	O
(	O
Figure	O
6B	O
)	O
in	O
part	O
and	O
suggests	O
a	O
predictive	O
regulatory	O
cascade	O
that	O
merits	O
a	O
test	O
.	O

SsrB	B-Protein
can	O
complement	O
other	O
regulators	O
of	O
SPI	O
-	O
2	O
transcription	O

SsrB	B-Protein
binds	O
within	O
SPI	O
-	O
2	O
and	O
activates	O
SPI	O
-	O
2	O
genes	O
for	O
transcription	O
.	O
<EOS>	B-X
OmpR	B-X
activates	B-X
expression	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
located	B-X
on	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
that	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
,	B-X
as	B-X
well	B-X
as	B-X
many	B-X
other	B-X
genes	B-X
required	B-X
for	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
Measurements	B-X
of	B-X
SsrA	B-X
and	B-X
SsrB	B-X
protein	B-X
levels	B-X
under	B-X
different	B-X
growth	B-X
conditions	B-X
indicate	B-X
that	B-X
expression	B-X
of	B-X
these	B-X
two	B-X
components	B-X
is	B-X
uncoupled	B-X
,	B-X
i.e	B-X
.	B-X
SsrB	B-X
is	B-X
produced	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
ssrA	B-X
and	B-X
vice	B-X
versa	B-X
.	B-X
The	B-X
isolated	B-X
C-terminus	B-X
of	B-X
SsrB	B-X
binds	B-X
to	B-X
DNA	B-X
and	B-X
protects	B-X
regions	B-X
upstream	B-X
of	B-X
ssrA	B-X
,	B-X
ssrB	B-X
and	B-X
srfH	B-X
from	B-X
DNase	B-X
I	B-X
digestion	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
C-terminus	B-X
of	B-X
SsrB	B-X
alone	B-X
is	B-X
capable	B-X
of	B-X
activating	B-X
transcription	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
N-terminus	B-X
.	B-X
A	B-X
previous	B-X
study	B-X
from	B-X
our	B-X
laboratory	B-X
reported	B-X
that	B-X
ssrA-lacZ	B-X
and	B-X
ssrB-lacZ	B-X
transcriptional	B-X
fusions	B-X
were	B-X
substantially	B-X
reduced	B-X
in	B-X
an	B-X
ssrB	B-X
null	B-X
strain	B-X
.	B-X
Results	B-X
from	B-X
DNase	B-X
I	B-X
protection	B-X
assays	B-X
provide	B-X
direct	B-X
evidence	B-X
that	B-X
SsrB	B-X
binds	B-X
at	B-X
ssrA	B-X
and	B-X
ssrB	B-X
,	B-X
although	B-X
the	B-X
binding	B-X
sites	B-X
lie	B-X
within	B-X
the	B-X
transcribed	B-X
regions	B-X
.	B-X
Additional	B-X
regulators	B-X
clearly	B-X
affect	B-X
gene	B-X
expression	B-X
at	B-X
this	B-X
important	B-X
locus	B-X
,	B-X
and	B-X
here	B-X
we	B-X
provide	B-X
evidence	B-X
that	B-X
SlyA	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
contributes	B-X
to	B-X
Salmonella	B-X
virulence	B-X
,	B-X
also	B-X
affects	B-X
ssrA/B	B-X
gene	B-X
expression	B-X
.	B-X

However	O
the	O
location	O
of	O
binding	O
sites	O
varies	O
suggesting	O
that	O
SsrB	B-Protein
regulation	O
is	O
unusual	O
[	O
52	O
]	O
.	O

Some	O
of	O
the	O
14	O
regulators	O
in	O
this	O
study	O
have	O
been	O
previously	O
shown	O
to	O
directly	O
regulate	O
ssrA	B-Protein
/	O
ssrB	B-Protein
;	O
OmpR	B-Protein
binding	O
to	O
PssrA	B-Protein
/	O
ssrB	B-Protein
[	O
60	O
]	O
,	O
[	O
61	O
]	O
;	O
SlyA	B-Protein
binding	O
to	O
PssrA	B-Protein
[	O
62	O
]	O
;	O
PhoP	B-Protein
binding	O
to	O
PssrB	B-Protein
[	O
45	O
]	O
.	O

To	O
distinguish	O
direct	O
from	O
indirect	O
effects	O
,	O
we	O
carried	O
out	O
epistasis	O
experiments	O
and	O
determined	O
if	O
ssrB	B-Protein
expression	O
could	O
suppress	O
the	O
phenotype	O
of	O
the	O
other	O
regulators	O
of	O
SPI	O
-	O
2	O
expression	O
.	O

Each	O
isogenic	O
derivative	O
was	O
transformed	O
with	O
either	O
pBAD30SsrB	B-Protein
or	O
the	O
empty	O
vector	O
control	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
examined	B-X
the	B-X
trophoblast	B-X
potential	B-X
of	B-X
isogenic	B-X
naïve	B-X
and	B-X
primed	B-X
hPSCs	B-X
.	B-X
Differential	B-X
ultracentrifugation	B-X
was	B-X
used	B-X
to	B-X
extracted	B-X
the	B-X
exosomes	B-X
from	B-X
the	B-X
culture	B-X
medium	B-X
of	B-X
gastric	B-X
cancer	B-X
cell	B-X
line	B-X
AGS-TOB1	B-X
ectopically	B-X
overexpressing	B-X
TOB1	B-X
(	B-X
exo-AGS-TOB1	B-X
,	B-X
experimental	B-X
group	B-X
)	B-X
and	B-X
AGS-empty-vector	B-X
cell	B-X
line	B-X
with	B-X
low	B-X
expression	B-X
of	B-X
endogenous	B-X
TOB1	B-X
(	B-X
exo-AGS-Vector	B-X
,	B-X
control	B-X
group	B-X
)	B-X
.	B-X
When	B-X
the	B-X
exosomes	B-X
of	B-X
exo-AGS-TOB1	B-X
and	B-X
exo-AGS-Vector	B-X
were	B-X
cocultured	B-X
with	B-X
TOB1	B-X
knockdown	B-X
gastric	B-X
cancer	B-X
cell	B-X
line	B-X
HGC-27-TOB1-6E12	B-X
for	B-X
48	B-X
hours	B-X
,	B-X
the	B-X
conversion	B-X
of	B-X
autophagy-related	B-X
protein	B-X
LC3-I	B-X
to	B-X
LC3-II	B-X
in	B-X
HGC-27-TOB1-6E12	B-X
gastric	B-X
cancer	B-X
cells	B-X
cocultured	B-X
with	B-X
exo-AGS-TOB1	B-X
was	B-X
significantly	B-X
higher	B-X
than	B-X
that	B-X
in	B-X
the	B-X
control	B-X
group	B-X
,	B-X
and	B-X
the	B-X
ratio	B-X
of	B-X
LC3-II/LC3-I	B-X
was	B-X
statistically	B-X
different	B-X
(	B-X
The	B-X
control	B-X
of	B-X
mammalian	B-X
pests	B-X
relies	B-X
heavily	B-X
on	B-X
the	B-X
use	B-X
of	B-X
pesticides	B-X
that	B-X
are	B-X
often	B-X
avoided	B-X
and	B-X
are	B-X
not	B-X
species-specific	B-X
.	B-X
These	B-X
problems	B-X
are	B-X
particularly	B-X
acute	B-X
for	B-X
pesticides	B-X
used	B-X
to	B-X
control	B-X
rats	B-X
(	B-X
Rattus	B-X
spp.	B-X
)	B-X
.	B-X
The	B-X
efficacy	B-X
and	B-X
targeting	B-X
of	B-X
control	B-X
could	B-X
be	B-X
improved	B-X
by	B-X
attracting	B-X
animals	B-X
to	B-X
control	B-X
measures	B-X
using	B-X
species-specific	B-X
cues	B-X
.	B-X
Here	B-X
we	B-X
test	B-X
the	B-X
potential	B-X
of	B-X
these	B-X
rat	B-X
calls	B-X
as	B-X
a	B-X
species-specific	B-X
attractant	B-X
by	B-X
examining	B-X
the	B-X
response	B-X
of	B-X
laboratory	B-X
rats	B-X
(	B-X
Rattus	B-X
norvegicus	B-X
;	B-X
n	B-X
=	B-X
48	B-X
)	B-X
and	B-X
non-target	B-X
bank	B-X
voles	B-X
(	B-X
Myodes	B-X
glareolus	B-X
;	B-X
n	B-X
=	B-X
16	B-X
)	B-X
to	B-X
50	B-X
kHz	B-X
calls	B-X
from	B-X
either	B-X
sex	B-X
in	B-X
a	B-X
compartmentalised	B-X
laboratory	B-X
arena	B-X
.	B-X
Sounds	B-X
of	B-X
rat	B-X
movement	B-X
and	B-X
white	B-X
noise	B-X
acted	B-X
as	B-X
control	B-X
treatments	B-X
,	B-X
with	B-X
each	B-X
sound	B-X
tested	B-X
against	B-X
a	B-X
silent	B-X
control	B-X
in	B-X
the	B-X
opposite	B-X
side	B-X
of	B-X
the	B-X
arena	B-X
.	B-X
When	B-X
sound	B-X
cues	B-X
were	B-X
played	B-X
above	B-X
an	B-X
empty	B-X
bait	B-X
box	B-X
,	B-X
rats	B-X
were	B-X
attracted	B-X
to	B-X
spend	B-X
time	B-X
close	B-X
to	B-X
50	B-X
kHz	B-X
rat	B-X
calls	B-X
,	B-X
climbing	B-X
on	B-X
top	B-X
of	B-X
boxes	B-X
,	B-X
regardless	B-X
of	B-X
the	B-X
sex	B-X
of	B-X
subject	B-X
or	B-X
caller	B-X
.	B-X
When	B-X
either	B-X
50	B-X
kHz	B-X
rat	B-X
calls	B-X
or	B-X
rat	B-X
movement	B-X
sounds	B-X
were	B-X
played	B-X
inside	B-X
an	B-X
empty	B-X
bait	B-X
box	B-X
,	B-X
rats	B-X
of	B-X
both	B-X
sexes	B-X
spent	B-X
3-4	B-X
fold	B-X
more	B-X
time	B-X
inside	B-X
boxes	B-X
and	B-X
visited	B-X
more	B-X
frequently	B-X
.	B-X
Bank	B-X
voles	B-X
were	B-X
neither	B-X
attracted	B-X
to	B-X
,	B-X
nor	B-X
avoided	B-X
,	B-X
50	B-X
kHz	B-X
rat	B-X
calls	B-X
played	B-X
inside	B-X
empty	B-X
bait	B-X
boxes	B-X
.	B-X

We	O
investigated	O
the	O
same	O
seven	O
SPI	O
-	O
2	O
genes	O
as	O
in	O
the	O
qRT	O
-	O
PCR	O
assays	O
above	O
,	O
and	O
results	O
are	O
shown	O
in	O
Figure	O
7A	O
[	O
52	O
]	O
.	O

Expression	O
of	O
an	O
episomal	O
copy	O
of	O
ssrB	B-Protein
resulted	O
in	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
in	O
each	O
mutant	O
background	O
,	O
suggesting	O
that	O
SsrB	B-Protein
is	O
epistatic	O
to	O
other	O
regulators	O
for	O
SPI	O
-	O
2	O
transcription	O
.	O

This	O
result	O
is	O
in	O
agreement	O
with	O
the	O
model	O
shown	O
in	O
Figure	O
6	O
where	O
all	O
positive	O
regulation	O
takes	O
place	O
via	O
either	O
ssrB	B-Protein
or	O
slyA	B-Protein
or	O
both	O
as	O
tested	O
further	O
below	O
.	O
<EOS>	B-X
Virulence	B-X
gene	B-X
regulators	B-X
RovA	B-X
,	B-X
SlyA	B-X
and	B-X
PecS	B-X
comprise	B-X
a	B-X
subset	B-X
of	B-X
the	B-X
MarR/SlyA	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
,	B-X
which	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
virulence	B-X
genes	B-X
.	B-X
These	B-X
regulators	B-X
have	B-X
all	B-X
been	B-X
shown	B-X
to	B-X
both	B-X
positively	B-X
and	B-X
negatively	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
multiple	B-X
genes	B-X
,	B-X
involving	B-X
several	B-X
different	B-X
mechanisms	B-X
.	B-X
RovA	B-X
,	B-X
SlyA	B-X
and	B-X
PecS	B-X
have	B-X
all	B-X
been	B-X
shown	B-X
to	B-X
act	B-X
as	B-X
derepressors	B-X
by	B-X
competing	B-X
for	B-X
binding	B-X
sites	B-X
with	B-X
repressors	B-X
.	B-X
Despite	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
slyA	B-X
gene	B-X
in	B-X
Shigella	B-X
flexneri	B-X
nearly	B-X
2	B-X
decades	B-X
ago	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
significant	B-X
conservation	B-X
of	B-X
SlyA	B-X
among	B-X
enteric	B-X
bacteria	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SlyA	B-X
in	B-X
Shigella	B-X
remains	B-X
unknown	B-X
.	B-X
By	B-X
characterizing	B-X
the	B-X
expression	B-X
of	B-X
slyA	B-X
and	B-X
determining	B-X
its	B-X
ultimate	B-X
effect	B-X
in	B-X
this	B-X
highly	B-X
virulent	B-X
organism	B-X
,	B-X
we	B-X
postulated	B-X
that	B-X
novel	B-X
SlyA-regulated	B-X
virulence	B-X
phenotypes	B-X
would	B-X
be	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
the	B-X
first	B-X
analysis	B-X
of	B-X
SlyA	B-X
in	B-X
Shigella	B-X
and	B-X
show	B-X
that	B-X
(	B-X
i	B-X
)	B-X
the	B-X
slyA	B-X
gene	B-X
is	B-X
transcribed	B-X
and	B-X
ultimately	B-X
translated	B-X
into	B-X
protein	B-X
,	B-X
(	B-X
ii	B-X
)	B-X
slyA	B-X
promoter	B-X
activity	B-X
is	B-X
maximal	B-X
during	B-X
stationary	B-X
phase	B-X
and	B-X
is	B-X
negatively	B-X
autoregulated	B-X
and	B-X
positively	B-X
regulated	B-X
by	B-X
the	B-X
PhoP	B-X
response	B-X
regulator	B-X
,	B-X
(	B-X
iii	B-X
)	B-X
the	B-X
exogenous	B-X
expression	B-X
of	B-X
slyA	B-X
rescues	B-X
transcription	B-X
and	B-X
virulence-associated	B-X
deficiencies	B-X
during	B-X
virulence-repressed	B-X
conditions	B-X
,	B-X
and	B-X
(	B-X
iv	B-X
)	B-X
the	B-X
absence	B-X
of	B-X
slyA	B-X
significantly	B-X
decreases	B-X
acid	B-X
resistance	B-X
,	B-X
demonstrating	B-X
a	B-X
novel	B-X
and	B-X
important	B-X
role	B-X
in	B-X
Shigella	B-X
virulence	B-X
.	B-X
Cumulatively	B-X
,	B-X
our	B-X
study	B-X
illustrates	B-X
unexpected	B-X
parallels	B-X
between	B-X
the	B-X
less	B-X
conserved	B-X
S.	B-X
flexneri	B-X
and	B-X
S	B-X
Typhimurium	B-X
slyA	B-X
promoters	B-X
as	B-X
well	B-X
as	B-X
a	B-X
unique	B-X
role	B-X
for	B-X
SlyA	B-X
in	B-X
Shigella	B-X
virulence	B-X
that	B-X
has	B-X
not	B-X
been	B-X
described	B-X
previously	B-X
in	B-X
any	B-X
closely	B-X
related	B-X
organism	B-X
.	B-X

Furthermore	O
,	O
SsrB	B-Protein
could	O
complement	O
all	O
three	O
deletions	O
DeltassrB	B-Protein
,	O
DeltassrA	B-Protein
,	O
and	O
DeltassrA	B-Protein
/	O
ssrB	B-Protein
(	O
Figure	O
7B	O
)	O
,	O
suggesting	O
that	O
over	O
-	O
expression	O
of	O
SsrB	B-Protein
may	O
compensate	O
for	O
differences	O
in	O
phosphorylation	O
that	O
normally	O
play	O
a	O
role	O
in	O
regulation	O
[	O
52	O
]	O
.	O

SlyA	B-Protein
can	O
complement	O
other	O
regulators	O
for	O
SPI	O
-	O
2	O
expression	O

The	O
number	O
of	O
inputs	O
at	O
each	O
regulator	O
shown	O
in	O
Figure	O
6B	O
corresponds	O
to	O
the	O
number	O
of	O
regulators	O
that	O
directly	O
or	O
indirectly	O
control	O
its	O
expression	O
.	O
<EOS>	B-X
Uncontrolled	B-X
overgrowth	B-X
of	B-X
cells	B-X
,	B-X
such	B-X
as	B-X
in	B-X
cancer	B-X
,	B-X
is	B-X
an	B-X
unavoidable	B-X
risk	B-X
in	B-X
life	B-X
that	B-X
affects	B-X
nearly	B-X
every	B-X
second	B-X
individual	B-X
in	B-X
industrialized	B-X
countries	B-X
.	B-X
However	B-X
,	B-X
in	B-X
part	B-X
this	B-X
risk	B-X
can	B-X
be	B-X
controlled	B-X
through	B-X
lifestyle	B-X
adjustments	B-X
,	B-X
such	B-X
as	B-X
the	B-X
avoidance	B-X
of	B-X
smoking	B-X
,	B-X
unhealthy	B-X
diet	B-X
,	B-X
obesity	B-X
,	B-X
physical	B-X
inactivity	B-X
and	B-X
other	B-X
cancer	B-X
risk	B-X
factors	B-X
.	B-X
Transcription	B-X
of	B-X
mtDNA	B-X
requires	B-X
a	B-X
small	B-X
number	B-X
of	B-X
nucleus-encoded	B-X
proteins	B-X
including	B-X
a	B-X
single	B-X
RNA	B-X
polymerase	B-X
(	B-X
POLRMT	B-X
)	B-X
,	B-X
auxiliary	B-X
factors	B-X
necessary	B-X
for	B-X
promoter	B-X
recognition	B-X
(	B-X
TFB1M	B-X
,	B-X
TFB2M	B-X
)	B-X
and	B-X
activation	B-X
(	B-X
Tfam	B-X
)	B-X
,	B-X
and	B-X
a	B-X
termination	B-X
factor	B-X
(	B-X
mTERF	B-X
)	B-X
.	B-X
This	B-X
relatively	B-X
simple	B-X
system	B-X
can	B-X
account	B-X
for	B-X
the	B-X
bidirectional	B-X
transcription	B-X
of	B-X
mtDNA	B-X
from	B-X
divergent	B-X
promoters	B-X
and	B-X
key	B-X
termination	B-X
events	B-X
controlling	B-X
the	B-X
rRNA/mRNA	B-X
ratio	B-X
.	B-X
These	B-X
factors	B-X
are	B-X
in	B-X
turn	B-X
activated	B-X
directly	B-X
or	B-X
indirectly	B-X
by	B-X
PGC-1	B-X
family	B-X
coactivators	B-X
whose	B-X
differential	B-X
expression	B-X
is	B-X
controlled	B-X
by	B-X
an	B-X
array	B-X
of	B-X
environmental	B-X
signals	B-X
including	B-X
temperature	B-X
,	B-X
energy	B-X
deprivation	B-X
,	B-X
and	B-X
availability	B-X
of	B-X
nutrients	B-X
and	B-X
growth	B-X
factors	B-X
.	B-X

The	O
number	O
of	O
regulators	O
that	O
act	O
on	O
slyA	B-Protein
was	O
surprising	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
confirmed	O
that	O
slyA	B-Protein
transcription	O
was	O
reduced	O
in	O
11	O
of	O
14	O
mutant	O
backgrounds	O
(	O
Figure	O
6A	O
)	O
.	O

slyA	B-Protein
transcriptional	O
activation	O
by	O
PhoP	B-Protein
has	O
been	O
reported	O
[	O
63	O
]	O
,	O
[	O
64	O
]	O
.	O

The	O
complementation	O
result	O
suggests	O
that	O
many	O
of	O
the	O
regulators	O
may	O
function	O
on	O
SPI	O
-	O
2	O
through	O
SlyA	B-Protein
activation	O
of	O
ssrB	B-Protein
or	O
alternatively	O
via	O
both	O
regulators	O
(	O
slyA	B-Protein
and	O
ssrB	B-Protein
)	O
acting	O
together	O
.	O

To	O
determine	O
epistatic	O
relationships	O
,	O
we	O
introduced	O
a	O
slyA	B-Protein
-	O
expressing	O
plasmid	O
,	O
pBAD30SlyA	B-Protein
,	O
into	O
each	O
regulatory	O
mutant	O
and	O
examined	O
complementation	O
in	O
each	O
mutant	O
background	O
compared	O
to	O
an	O
empty	O
vector	O
control	O
(	O
Figure	O
7C	O
)	O
.	O

The	O
construct	O
strongly	O
complemented	O
ompR	B-Protein
/	O
envZ	B-Protein
,	O
phoP	B-Protein
/	O
phoQ	B-Protein
,	O
csrA	B-Protein
and	O
himD	B-Protein
,	O
suggesting	O
that	O
the	O
effect	O
of	O
these	O
regulators	O
on	O
SPI	O
-	O
2	O
expression	O
may	O
be	O
indirect	O
via	O
regulation	O
of	O
slyA	B-Protein
.	O

Surprisingly	O
,	O
the	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
depended	O
upon	O
slyA	B-Protein
even	O
in	O
an	O
ssrA	B-Protein
/	O
ssrB	B-Protein
deleted	O
strain	O
.	O

This	O
suggests	O
that	O
slyA	B-Protein
can	O
regulate	O
expression	O
of	O
SPI	O
-	O
2	O
in	O
a	O
way	O
that	O
is	O
independent	O
of	O
ssrB	B-Protein
.	O

To	O
test	O
this	O
possibility	O
we	O
constructed	O
double	O
deletions	O
of	O
ssrAB	B-Protein
/	O
ompRenvZ	B-Protein
,	O
ssrAB	B-Protein
/	O
phoPQ	B-Protein
,	O
ssrAB	B-Protein
/	O
csrA	B-Protein
and	O
ssrAB	B-Protein
/	O
himD	B-Protein
.	O

As	O
shown	O
in	O
Figure	O
7D	O
,	O
slyA	B-Protein
is	O
capable	O
of	O
activating	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
independently	O
of	O
ssrB	B-Protein
,	O
ompR	B-Protein
/	O
envZ	B-Protein
,	O
phoP	B-Protein
/	O
phoQ	B-Protein
,	O
csrA	B-Protein
and	O
himD	B-Protein
(	O
ihf	B-Protein
)	O
,	O
although	O
the	O
effects	O
are	O
not	O
as	O
strong	O
as	O
ssrB	B-Protein
.	O

Furthermore	O
there	O
was	O
a	O
clear	O
dichotomy	O
in	O
expression	O
between	O
the	O
first	O
two	O
SPI	O
-	O
2	O
operons	O
encoding	O
ssaB	B-Protein
-	O
ssaE	B-Protein
and	O
sseA	B-Protein
-	O
sseG	B-Protein
and	O
the	O
operons	O
further	O
downstream	O
(	O
ssaG	B-Protein
-	O
ssaQ	B-Protein
)	O
suggesting	O
that	O
slyA	B-Protein
may	O
act	O
at	O
different	O
sites	O
within	O
SPI	O
-	O
2	O
.	O

However	O
,	O
these	O
experiments	O
are	O
based	O
on	O
over	O
-	O
expression	O
of	O
slyA	B-Protein
that	O
may	O
complicate	O
the	O
analysis	O
because	O
of	O
binding	O
to	O
sites	O
that	O
would	O
normally	O
not	O
be	O
occupied	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

During	O
systemic	O
mouse	O
infection	O
,	O
Salmonella	O
processes	O
multiple	O
environmental	O
cues	O
via	O
more	O
than	O
14	O
regulators	O
We	O
performed	O
virulence	O
assays	O
on	O
83	O
regulators	O
previously	O
identified	O
as	O
required	O
for	O
Salmonella	O
enteriditis	O
virulence	O
by	O
one	O
or	O
more	O
negative	O
selection	O
experiments	O
in	O
various	O
hosts	O
including	O
calves	O
,	O
chickens	O
,	O
and	O
mice	O
[	O
13	O
]	O
,	O
[	O
21	O
]	O
-	O
[	O
23	O
]	O
.	O

The	O
mutant	O
strains	O
devoid	O
of	O
83	O
regulators	O
were	O
tested	O
in	O
three	O
mouse	O
virulence	O
assays	O
to	O
identify	O
a	O
subset	O
of	O
14	O
that	O
were	O
most	O
highly	O
attenuated	O
in	O
a	O
systemic	O
mouse	O
infection	O
model	O
.	O

These	O
14	O
regulators	O
are	O
very	O
diverse	O
including	O
alternative	O
sigma	O
factors	O
(	O
rpoS	B-Protein
and	O
rpoE	B-Protein
)	O
,	O
two	O
-	O
component	O
regulators	O
(	O
ompR	B-Protein
/	O
envZ	B-Protein
,	O
phoP	B-Protein
/	O
phoQ	B-Protein
,	O
and	O
ssrA	B-Protein
/	O
ssrB	B-Protein
)	O
,	O
post	O
-	O
transcriptional	O
regulators	O
(	O
csrA	B-Protein
,	O
hfq	B-Protein
and	O
smpB	B-Protein
)	O
,	O
a	O
bending	O
protein	O
(	O
ihf	B-Protein
)	O
and	O
an	O
assortment	O
of	O
other	O
DNA	O
binding	O
proteins	O
(	O
fruR	B-Protein
,	O
spvR	B-Protein
,	O
crp	B-Protein
,	O
slyA	B-Protein
,	O
and	O
hnr	B-Protein
;	O
see	O
Table	O
1	O
for	O
references	O
)	O
.	O

Salmonella	O
follows	O
a	O
short	O
course	O
of	O
infection	O
after	O
intraperitoneal	O
infection	O
,	O
as	O
we	O
have	O
used	O
here	O
,	O
passing	O
through	O
the	O
lymph	O
nodes	O
in	O
the	O
peritoneal	O
cavity	O
to	O
the	O
blood	O
stream	O
and	O
then	O
colonizing	O
and	O
replicating	O
within	O
the	O
spleen	O
and	O
liver	O
.	O

During	O
this	O
entire	O
trip	O
the	O
bacteria	O
are	O
located	O
within	O
cells	O
either	O
neutrophiles	O
or	O
monocytes	O
although	O
at	O
lower	O
numbers	O
in	O
B	O
and	O
T	O
cells	O
and	O
dendritic	O
cells	O
of	O
every	O
subclass	O
[	O
16	O
]	O
,	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
,	O
[	O
65	O
]	O
,	O
[	O
66	O
]	O
.	O

Because	O
the	O
bacteria	O
are	O
exclusively	O
intracellular	O
we	O
tested	O
the	O
hypothesis	O
that	O
replication	O
in	O
macrophages	O
could	O
be	O
a	O
surrogate	O
for	O
systemic	O
mouse	O
infection	O
.	O

Mutations	O
that	O
were	O
attenuated	O
for	O
growth	O
in	O
primary	O
macrophages	O
were	O
also	O
attenuated	O
in	O
the	O
mouse	O
but	O
the	O
converse	O
was	O
not	O
always	O
true	O
.	O
<EOS>	B-X
However	B-X
,	B-X
despite	B-X
this	B-X
change	B-X
,	B-X
htrA	B-X
mutants	B-X
are	B-X
still	B-X
attenuated	B-X
in	B-X
normal	B-X
mice	B-X
.	B-X
Infection	B-X
with	B-X
htrA	B-X
mutants	B-X
caused	B-X
little	B-X
damage	B-X
to	B-X
primary	B-X
bone	B-X
marrow	B-X
macrophage	B-X
cultures	B-X
from	B-X
normal	B-X
mice	B-X
;	B-X
conversely	B-X
,	B-X
they	B-X
caused	B-X
extensive	B-X
damage	B-X
to	B-X
macrophages	B-X
from	B-X
gp9lphox-/-	B-X
mice	B-X
,	B-X
with	B-X
more	B-X
than	B-X
60	B-X
%	B-X
reduction	B-X
in	B-X
cell	B-X
numbers	B-X
2.5h	B-X
after	B-X
being	B-X
infected	B-X
.	B-X
The	B-X
parental	B-X
wild	B-X
type	B-X
strain	B-X
similarly	B-X
caused	B-X
extensive	B-X
damage	B-X
to	B-X
macrophages	B-X
from	B-X
both	B-X
normal	B-X
and	B-X
gp9lphox-/-	B-X
mice	B-X
,	B-X
whereas	B-X
an	B-X
aroA	B-X
live	B-X
vaccine	B-X
strain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
either	B-X
normal	B-X
or	B-X
gp9lphox-/-	B-X
macrophages	B-X
.	B-X
Taken	B-X
collectively	B-X
,	B-X
the	B-X
present	B-X
results	B-X
suggest	B-X
that	B-X
htrA	B-X
is	B-X
somehow	B-X
involved	B-X
in	B-X
resistance	B-X
to	B-X
oxidative	B-X
stress	B-X
in	B-X
vivo	B-X
,	B-X
with	B-X
the	B-X
avirulence	B-X
of	B-X
htrA	B-X
mutants	B-X
in	B-X
mice	B-X
being	B-X
due	B-X
to	B-X
mechanisms	B-X
which	B-X
involve	B-X
NADPH	B-X
oxidase	B-X
and	B-X
suppression	B-X
of	B-X
bacterial	B-X
growth	B-X
within	B-X
macrophages	B-X
.	B-X

Next	O
,	O
we	O
used	O
expression	O
profiling	O
to	O
define	O
the	O
regulatory	O
pathways	O
.	O
<EOS>	B-X
These	B-X
alterations	B-X
defined	B-X
a	B-X
core	B-X
set	B-X
of	B-X
12	B-X
cellular	B-X
signaling	B-X
pathways	B-X
and	B-X
processes	B-X
that	B-X
were	B-X
each	B-X
genetically	B-X
altered	B-X
in	B-X
67	B-X
to	B-X
100	B-X
%	B-X
of	B-X
the	B-X
tumors	B-X
.	B-X
Analysis	B-X
of	B-X
these	B-X
tumors	B-X
'	B-X
transcriptomes	B-X
with	B-X
next-generation	B-X
sequencing-by-synthesis	B-X
technologies	B-X
provided	B-X
independent	B-X
evidence	B-X
for	B-X
the	B-X
importance	B-X
of	B-X
these	B-X
pathways	B-X
and	B-X
processes	B-X
.	B-X
Our	B-X
data	B-X
indicate	B-X
that	B-X
genetically	B-X
altered	B-X
core	B-X
pathways	B-X
and	B-X
regulatory	B-X
processes	B-X
only	B-X
become	B-X
evident	B-X
once	B-X
the	B-X
coding	B-X
regions	B-X
of	B-X
the	B-X
genome	B-X
are	B-X
analyzed	B-X
in	B-X
depth	B-X
.	B-X
Dysregulation	B-X
of	B-X
these	B-X
core	B-X
pathways	B-X
and	B-X
processes	B-X
through	B-X
mutation	B-X
can	B-X
explain	B-X
the	B-X
major	B-X
features	B-X
of	B-X
pancreatic	B-X
tumorigenesis	B-X
.	B-X

Transcriptional	O
profiles	O
from	O
intracellular	O
bacteria	O
at	O
different	O
times	O
after	O
infection	O
are	O
likely	O
to	O
match	O
most	O
closely	O
the	O
environments	O
encountered	O
by	O
Salmonella	O
during	O
infection	O
.	O

However	O
,	O
isolation	O
of	O
RNA	O
from	O
intracellular	O
bacteria	O
was	O
not	O
used	O
because	O
we	O
wished	O
to	O
test	O
a	O
spectrum	O
of	O
regulatory	O
mutants	O
several	O
of	O
which	O
simply	O
did	O
not	O
survive	O
within	O
cells	O
long	O
enough	O
to	O
allow	O
RNA	O
preparation	O
.	O
<EOS>	B-X
In	B-X
bacteria	B-X
,	B-X
mRNA	B-X
decay	B-X
is	B-X
controlled	B-X
by	B-X
megadalton	B-X
scale	B-X
macromolecular	B-X
assemblies	B-X
called	B-X
,	B-X
``	B-X
RNA	B-X
degradosomes	B-X
,	B-X
''	B-X
composed	B-X
of	B-X
nucleases	B-X
and	B-X
other	B-X
RNA	B-X
decay	B-X
associated	B-X
proteins	B-X
.	B-X
Recent	B-X
advances	B-X
in	B-X
bacterial	B-X
cell	B-X
biology	B-X
have	B-X
shown	B-X
that	B-X
RNA	B-X
degradosomes	B-X
can	B-X
assemble	B-X
into	B-X
phase-separated	B-X
structures	B-X
,	B-X
termed	B-X
bacterial	B-X
ribonucleoprotein	B-X
bodies	B-X
(	B-X
BR-bodies	B-X
)	B-X
,	B-X
with	B-X
many	B-X
analogous	B-X
properties	B-X
to	B-X
eukaryotic	B-X
processing	B-X
bodies	B-X
and	B-X
stress	B-X
granules	B-X
.	B-X
This	B-X
review	B-X
will	B-X
highlight	B-X
the	B-X
functional	B-X
role	B-X
that	B-X
BR-bodies	B-X
play	B-X
in	B-X
the	B-X
mRNA	B-X
decay	B-X
process	B-X
through	B-X
its	B-X
organization	B-X
into	B-X
a	B-X
membraneless	B-X
organelle	B-X
in	B-X
the	B-X
bacterial	B-X
cytoplasm	B-X
.	B-X
This	B-X
review	B-X
will	B-X
also	B-X
highlight	B-X
the	B-X
phylogenetic	B-X
distribution	B-X
of	B-X
BR-bodies	B-X
across	B-X
bacterial	B-X
species	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
these	B-X
phase-separated	B-X
structures	B-X
are	B-X
broadly	B-X
distributed	B-X
across	B-X
bacteria	B-X
,	B-X
and	B-X
in	B-X
evolutionarily	B-X
related	B-X
mitochondria	B-X
and	B-X
chloroplasts	B-X
.	B-X
This	B-X
article	B-X
is	B-X
categorized	B-X
under	B-X
:	B-X
RNA	B-X
Turnover	B-X
and	B-X
Surveillance	B-X
>	B-X
Turnover/Surveillance	B-X
Mechanisms	B-X
RNA	B-X
Interactions	B-X
with	B-X
Proteins	B-X
and	B-X
Other	B-X
Molecules	B-X
>	B-X
RNA-Protein	B-X
Complexes	B-X
RNA	B-X
Export	B-X
and	B-X
Localization	B-X
>	B-X
RNA	B-X
Localization	B-X
RNA	B-X
Turnover	B-X
and	B-X
Surveillance	B-X
>	B-X
Regulation	B-X
of	B-X
RNA	B-X
Stability	B-X
.	B-X

RNA	O
was	O
therefore	O
prepared	O
using	O
four	O
laboratory	O
growth	O
conditions	O
two	O
of	O
which	O
partially	O
mimic	O
the	O
intracellular	O
environment	O
(	O
acidic	O
minimal	O
media	O
)	O
.	O

We	O
compared	O
the	O
transcriptional	O
profiles	O
we	O
observed	O
using	O
laboratory	O
growth	O
conditions	O
that	O
mimic	O
intracellular	O
conditions	O
,	O
to	O
those	O
that	O
have	O
been	O
performed	O
during	O
intracellular	O
replication	O
within	O
J774	O
macrophage	O
like	O
cells	O
.	O

We	O
computed	O
the	O
z	O
-	O
score	O
for	O
each	O
Salmonella	O
gene	O
from	O
our	O
data	O
and	O
from	O
the	O
data	O
provided	O
by	O
Eriksson	O
et	O
al	O
.	O

[	O
67	O
]	O
thus	O
providing	O
a	O
value	O
that	O
can	O
be	O
compared	O
across	O
different	O
experiments	O
.	O
<EOS>	B-X
A	B-X
series	B-X
of	B-X
experiments	B-X
in	B-X
stationary	B-X
and	B-X
moving	B-X
passenger	B-X
railcars	B-X
was	B-X
conducted	B-X
to	B-X
measure	B-X
the	B-X
removal	B-X
rates	B-X
of	B-X
particles	B-X
in	B-X
the	B-X
size	B-X
ranges	B-X
of	B-X
SARS-CoV-2	B-X
viral	B-X
aerosols	B-X
,	B-X
and	B-X
the	B-X
air	B-X
changes	B-X
per	B-X
hour	B-X
provided	B-X
by	B-X
the	B-X
existing	B-X
and	B-X
modified	B-X
air	B-X
handling	B-X
systems	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
ventilation	B-X
and	B-X
air	B-X
filtration	B-X
systems	B-X
on	B-X
removal	B-X
rates	B-X
and	B-X
their	B-X
effects	B-X
on	B-X
estimated	B-X
probability	B-X
(	B-X
i.e.	B-X
,	B-X
risk	B-X
)	B-X
of	B-X
infection	B-X
was	B-X
evaluated	B-X
in	B-X
a	B-X
range	B-X
of	B-X
representative	B-X
conditions	B-X
:	B-X
(	B-X
1	B-X
)	B-X
for	B-X
two	B-X
different	B-X
ratios	B-X
of	B-X
recirculated	B-X
air	B-X
(	B-X
RA	B-X
)	B-X
to	B-X
outdoor	B-X
air	B-X
(	B-X
OA	B-X
)	B-X
(	B-X
90:10	B-X
RA	B-X
:	B-X
OA	B-X
and	B-X
67:33	B-X
RA	B-X
:	B-X
OA	B-X
)	B-X
;	B-X
(	B-X
2	B-X
)	B-X
using	B-X
minimum	B-X
efficiency	B-X
reporting	B-X
value	B-X
(	B-X
MERV	B-X
)	B-X
filters	B-X
with	B-X
standard	B-X
(	B-X
MERV-8	B-X
)	B-X
and	B-X
increased	B-X
(	B-X
MERV-13	B-X
)	B-X
filtration	B-X
ratings	B-X
;	B-X
and	B-X
(	B-X
3	B-X
)	B-X
in	B-X
the	B-X
presence	B-X
and	B-X
absence	B-X
of	B-X
a	B-X
portable	B-X
high-efficiency	B-X
particulate-air	B-X
(	B-X
HEPA	B-X
)	B-X
room	B-X
air	B-X
purifier	B-X
system	B-X
operated	B-X
at	B-X
clean	B-X
air	B-X
delivery	B-X
rate	B-X
(	B-X
CADR	B-X
)	B-X
of	B-X
150	B-X
and	B-X
550	B-X
cfm	B-X
.	B-X
In	B-X
the	B-X
late	B-X
summer	B-X
,	B-X
ADG	B-X
was	B-X
0.15	B-X
kg	B-X
less	B-X
(	B-X
P	B-X
<	B-X
0.01	B-X
)	B-X
for	B-X
CONT	B-X
than	B-X
ROT	B-X
in	B-X
yr	B-X
1	B-X
,	B-X
were	B-X
not	B-X
different	B-X
(	B-X
P	B-X
=	B-X
0.23	B-X
)	B-X
in	B-X
yr	B-X
2	B-X
,	B-X
and	B-X
were	B-X
0.29	B-X
kg	B-X
less	B-X
(	B-X
P	B-X
<	B-X
0.01	B-X
)	B-X
for	B-X
CONT	B-X
than	B-X
ROT	B-X
in	B-X
yr	B-X
3	B-X
.	B-X
Over	B-X
the	B-X
entire	B-X
experimental	B-X
period	B-X
,	B-X
ADG	B-X
did	B-X
not	B-X
differ	B-X
(	B-X
P	B-X
≥	B-X
0.67	B-X
)	B-X
in	B-X
yr	B-X
1	B-X
or	B-X
2	B-X
,	B-X
but	B-X
tended	B-X
(	B-X
P	B-X
=	B-X
0.09	B-X
)	B-X
to	B-X
be	B-X
0.10	B-X
kg	B-X
greater	B-X
for	B-X
ROT	B-X
than	B-X
CONT	B-X
in	B-X
yr	B-X
3	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
at	B-X
equal	B-X
stocking	B-X
rates	B-X
,	B-X
ROT	B-X
can	B-X
maintain	B-X
greater	B-X
alfalfa	B-X
persistence	B-X
,	B-X
forage	B-X
nutritive	B-X
quality	B-X
,	B-X
and	B-X
forage	B-X
allowance	B-X
compared	B-X
with	B-X
continuous	B-X
grazing	B-X
and	B-X
provided	B-X
increased	B-X
animal	B-X
performance	B-X
during	B-X
the	B-X
late	B-X
summer	B-X
when	B-X
the	B-X
alfalfa	B-X
stand	B-X
was	B-X
reduced	B-X
in	B-X
CONT	B-X
pastures	B-X
.	B-X

To	O
compare	O
the	O
two	O
sets	O
of	O
data	O
we	O
subtracted	O
the	O
z	O
-	O
scores	O
computed	O
from	O
our	O
data	O
for	O
AMM1	O
from	O
that	O
computed	O
from	O
expression	O
profiles	O
of	O
intracellular	O
Salmonella	O
.	O

As	O
the	O
expression	O
pattern	O
changes	O
with	O
time	O
after	O
infection	O
we	O
computed	O
the	O
difference	O
for	O
each	O
time	O
as	O
well	O
as	O
an	O
average	O
for	O
all	O
three	O
-	O
time	O
points	O
reported	O
(	O
4	O
,	O
8	O
,	O
and	O
12	O
hours	O
after	O
infection	O
)	O
.	O

There	O
were	O
102	O
genes	O
where	O
the	O
difference	O
in	O
z	O
-	O
score	O
was	O
2	O
or	O
greater	O
,	O
and	O
54	O
genes	O
of	O
102	O
were	O
annotated	O
as	O
putative	O
,	O
hypothetical	O
,	O
or	O
conserved	O
hypothetical	O
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
Serine/Threonine	B-X
(	B-X
Ser/Thr	B-X
)	B-X
protein	B-X
kinase	B-X
,	B-X
which	B-X
belongs	B-X
to	B-X
phosphatidylinositol-3-kinase-related	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
protein	B-X
family	B-X
.	B-X
mTOR	B-X
exists	B-X
as	B-X
two	B-X
types	B-X
of	B-X
protein	B-X
complex	B-X
:	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
,	B-X
which	B-X
act	B-X
as	B-X
central	B-X
controller	B-X
regulating	B-X
processes	B-X
of	B-X
cell	B-X
metabolism	B-X
,	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
survival	B-X
and	B-X
autophagy	B-X
.	B-X
Among	B-X
them	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
the	B-X
structure	B-X
of	B-X
mTOR	B-X
inhibitors	B-X
and	B-X
try	B-X
to	B-X
analyze	B-X
the	B-X
structure-activity	B-X
relationship	B-X
.	B-X
In	B-X
this	B-X
article	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
target	B-X
,	B-X
binding	B-X
mode	B-X
and	B-X
structure-activity	B-X
relationship	B-X
of	B-X
each	B-X
generation	B-X
of	B-X
mTOR	B-X
inhibitors	B-X
and	B-X
proposed	B-X
two	B-X
hypothetic	B-X
scaffolds	B-X
(	B-X
the	B-X
inverted-Y-shape	B-X
scaffold	B-X
and	B-X
the	B-X
C-shape	B-X
scaffold	B-X
)	B-X
for	B-X
the	B-X
second	B-X
generation	B-X
of	B-X
mTOR	B-X
inhibitors	B-X
.	B-X

Four	O
of	O
the	O
5	O
most	O
strongly	O
differentially	O
induced	O
genes	O
include	O
magnesium	O
transporters	O
(	O
mgtB	B-Protein
and	O
mgtC	B-Protein
)	O
,	O
an	O
acid	O
shock	O
protein	O
(	O
STM1485	B-Protein
)	O
,	O
and	O
a	O
high	O
affinity	O
phosphate	O
transporter	O
(	O
pstS	B-Protein
)	O
suggesting	O
that	O
the	O
acidic	O
minimal	O
media	O
we	O
used	O
may	O
not	O
be	O
low	O
enough	O
in	O
magnesium	O
,	O
phosphate	O
,	O
or	O
may	O
not	O
be	O
sufficiently	O
acidic	O
.	O

Many	O
genes	O
are	O
transcribed	O
inside	O
cells	O
but	O
may	O
be	O
only	O
weakly	O
transcribed	O
or	O
not	O
at	O
all	O
transcribed	O
in	O
acidic	O
minimal	O
media	O
.	O
<EOS>	B-X
Expression	B-X
of	B-X
ldc	B-X
from	B-X
its	B-X
own	B-X
promoter	B-X
was	B-X
very	B-X
weak	B-X
for	B-X
cells	B-X
growing	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
media	B-X
,	B-X
although	B-X
a	B-X
low	B-X
level	B-X
of	B-X
lysine	B-X
decarboxylase	B-X
was	B-X
present	B-X
in	B-X
cells	B-X
that	B-X
carried	B-X
the	B-X
ldc	B-X
region	B-X
on	B-X
an	B-X
oligo-copy	B-X
plasmid	B-X
when	B-X
these	B-X
were	B-X
grown	B-X
in	B-X
minimal-glucose	B-X
medium	B-X
.	B-X
Northern	B-X
analysis	B-X
of	B-X
RNA	B-X
extracted	B-X
from	B-X
such	B-X
cells	B-X
revealed	B-X
a	B-X
transcript	B-X
whose	B-X
length	B-X
corresponded	B-X
to	B-X
that	B-X
of	B-X
the	B-X
ldc	B-X
gene	B-X
,	B-X
suggesting	B-X
that	B-X
ldc	B-X
is	B-X
normally	B-X
transcribed	B-X
from	B-X
a	B-X
promoter	B-X
immediately	B-X
upstream	B-X
.	B-X
The	B-X
low	B-X
level	B-X
of	B-X
expression	B-X
in	B-X
single	B-X
copy	B-X
,	B-X
the	B-X
emergence	B-X
of	B-X
expression	B-X
when	B-X
the	B-X
gene	B-X
is	B-X
present	B-X
at	B-X
moderate	B-X
copy	B-X
number	B-X
,	B-X
and	B-X
the	B-X
derepression	B-X
by	B-X
the	B-X
upstream	B-X
sequence	B-X
in	B-X
trans	B-X
imply	B-X
that	B-X
this	B-X
second	B-X
lysine	B-X
decarboxylase	B-X
gene	B-X
may	B-X
not	B-X
be	B-X
constitutive	B-X
but	B-X
subject	B-X
to	B-X
specific	B-X
repression	B-X
by	B-X
a	B-X
factor	B-X
which	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
The	B-X
alpha-acetolactate	B-X
decarboxylase	B-X
(	B-X
ALDC	B-X
)	B-X
gene	B-X
,	B-X
aldB	B-X
,	B-X
is	B-X
the	B-X
penultimate	B-X
gene	B-X
of	B-X
the	B-X
leu-ilv-ald	B-X
operon	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
three	B-X
branched-chain	B-X
amino	B-X
acid	B-X
(	B-X
BCAA	B-X
)	B-X
biosynthesis	B-X
genes	B-X
in	B-X
Lactococcus	B-X
lactis	B-X
.	B-X
It	B-X
can	B-X
be	B-X
transcribed	B-X
from	B-X
the	B-X
two	B-X
promoters	B-X
present	B-X
upstream	B-X
of	B-X
the	B-X
leu	B-X
and	B-X
ilv	B-X
genes	B-X
(	B-X
P1	B-X
and	B-X
P2	B-X
)	B-X
or	B-X
independently	B-X
under	B-X
the	B-X
control	B-X
of	B-X
its	B-X
own	B-X
promoter	B-X
(	B-X
P3	B-X
)	B-X
.	B-X
Second	B-X
,	B-X
although	B-X
aldB	B-X
is	B-X
actively	B-X
transcribed	B-X
from	B-X
P1	B-X
and	B-X
P2	B-X
during	B-X
BCAA	B-X
starvation	B-X
,	B-X
ALDC	B-X
is	B-X
not	B-X
significantly	B-X
produced	B-X
from	B-X
these	B-X
transcripts	B-X
.	B-X
The	B-X
function	B-X
of	B-X
the	B-X
structure	B-X
was	B-X
studied	B-X
by	B-X
mutagenesis	B-X
,	B-X
using	B-X
translational	B-X
fusions	B-X
with	B-X
luciferase	B-X
genes	B-X
to	B-X
assess	B-X
its	B-X
activity	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
the	B-X
structure-dependent	B-X
regulation	B-X
could	B-X
be	B-X
to	B-X
ensure	B-X
the	B-X
minimal	B-X
production	B-X
of	B-X
ALDC	B-X
required	B-X
for	B-X
the	B-X
control	B-X
of	B-X
the	B-X
acetolactate	B-X
pool	B-X
during	B-X
BCAA	B-X
synthesis	B-X
but	B-X
to	B-X
avoid	B-X
its	B-X
overproduction	B-X
,	B-X
which	B-X
would	B-X
dissipate	B-X
acetolactate	B-X
.	B-X

Examples	O
of	O
such	O
genes	O
include	O
sifA	B-Protein
and	O
the	O
operon	O
STM3117	B-Protein
-	O
3120	B-Protein
.	O

This	O
operon	O
encodes	O
some	O
of	O
the	O
most	O
abundantly	O
expressed	O
proteins	O
by	O
intracellular	O
Salmonella	O
.	O

This	O
result	O
is	O
striking	O
,	O
given	O
that	O
STM3117	B-Protein
-	O
3120	B-Protein
are	O
not	O
transcribed	O
under	O
a	O
variety	O
of	O
in	O
vitro	O
conditions	O
including	O
AMM1	O
and	O
2	O
and	O
the	O
many	O
conditions	O
corresponding	O
to	O
the	O
transcriptional	O
profiles	O
reported	O
for	O
microarrays	O
archived	O
in	O
GEO	O
(	O
[	O
68	O
]	O
,	O
J	O
.	O
McDermott	O
and	O
L	O
Shi	O
,	O
Unpubl	O
.	O
Obs	O
.	O
)	O
.	O

The	O
nature	O
of	O
the	O
inducing	O
signal	O
(	O
s	O
)	O
that	O
results	O
in	O
expression	O
of	O
these	O
genes	O
during	O
intracellular	O
growth	O
is	O
not	O
known	O
.	O

The	O
regulatory	O
network	O
controlling	O
expression	O
of	O
the	O
genes	O
necessary	O
for	O
systemic	O
infection	O
is	O
complex	O
.	O

In	O
our	O
transcriptional	O
network	O
each	O
pink	O
node	O
represents	O
a	O
regulator	O
(	O
Figure	O
6	O
B	O
)	O
and	O
lines	O
represent	O
positive	O
or	O
negative	O
transcriptional	O
interactions	O
(	O
positive	O
in	O
red	O
and	O
negative	O
in	O
blue	O
)	O
.	O
<EOS>	B-X
In	B-X
blue	B-X
or	B-X
white	B-X
light	B-X
,	B-X
roots	B-X
exhibit	B-X
negative	B-X
phototropism	B-X
,	B-X
but	B-X
red	B-X
light	B-X
induces	B-X
positive	B-X
phototropism	B-X
in	B-X
Arabidopsis	B-X
roots	B-X
.	B-X
Phytochrome	B-X
A	B-X
(	B-X
phyA	B-X
)	B-X
and	B-X
phyB	B-X
mediate	B-X
the	B-X
positive	B-X
red-light-based	B-X
photoresponse	B-X
in	B-X
roots	B-X
since	B-X
single	B-X
mutants	B-X
(	B-X
and	B-X
the	B-X
double	B-X
phyAB	B-X
mutant	B-X
)	B-X
were	B-X
severely	B-X
impaired	B-X
in	B-X
this	B-X
response	B-X
.	B-X
In	B-X
blue-light-based	B-X
negative	B-X
phototropism	B-X
,	B-X
phyA	B-X
and	B-X
phyAB	B-X
(	B-X
but	B-X
not	B-X
phyB	B-X
)	B-X
were	B-X
inhibited	B-X
in	B-X
the	B-X
response	B-X
relative	B-X
to	B-X
the	B-X
WT	B-X
.	B-X
In	B-X
root	B-X
gravitropism	B-X
,	B-X
phyB	B-X
and	B-X
phyAB	B-X
(	B-X
but	B-X
not	B-X
phyA	B-X
)	B-X
were	B-X
inhibited	B-X
in	B-X
the	B-X
response	B-X
compared	B-X
to	B-X
the	B-X
WT	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
study	B-X
shows	B-X
that	B-X
the	B-X
blue-light	B-X
and	B-X
red-light	B-X
systems	B-X
interact	B-X
in	B-X
roots	B-X
and	B-X
that	B-X
phytochrome	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
plant	B-X
development	B-X
by	B-X
integrating	B-X
multiple	B-X
environmental	B-X
stimuli	B-X
.	B-X

In	O
E	O
.	O
coli	O
most	O
regulation	O
has	O
been	O
shown	O
to	O
follow	O
one	O
of	O
three	O
motifs	O
:	O
feedforward	O
in	O
which	O
a	O
regulator	O
controls	O
a	O
second	O
regulator	O
,	O
single	O
input	O
in	O
which	O
a	O
regulator	O
uniquely	O
controls	O
a	O
set	O
of	O
downstream	O
genes	O
,	O
and	O
so	O
called	O
dense	O
overlapping	O
regulons	O
in	O
which	O
there	O
are	O
multiple	O
regulatory	O
inputs	O
to	O
a	O
single	O
operon	O
[	O
69	O
]	O
.	O

A	O
feedforward	O
loop	O
can	O
act	O
as	O
an	O
electronic	O
"	O
AND	O
-	O
gate	O
"	O
preventing	O
expression	O
except	O
when	O
two	O
or	O
more	O
signals	O
are	O
sensed	O
as	O
we	O
see	O
for	O
slyA	B-Protein
(	O
upstream	O
)	O
and	O
ssrB	B-Protein
(	O
downstream	O
)	O
;	O
fruR	B-Protein
(	O
upstream	O
)	O
and	O
crp	B-Protein
(	O
downstream	O
)	O
.	O

Many	O
of	O
these	O
predicted	O
relationships	O
have	O
been	O
demonstrated	O
already	O
but	O
some	O
are	O
new	O
and	O
merit	O
further	O
investigation	O
.	O

The	O
single	O
input	O
motif	O
is	O
found	O
in	O
systems	O
of	O
genes	O
that	O
form	O
a	O
protein	O
complex	O
such	O
as	O
both	O
of	O
the	O
type	O
III	O
secretion	O
systems	O
in	O
Salmonella	O
.	O

For	O
SPI	O
-	O
2	O
ssrB	B-Protein
plays	O
this	O
role	O
and	O
for	O
SPI	O
-	O
1	O
hilA	B-Protein
is	O
the	O
central	O
regulator	O
.	O

The	O
multiple	O
promoters	O
located	O
within	O
SPI	O
-	O
2	O
presumably	O
respond	O
to	O
differences	O
in	O
ssrB	B-Protein
/	O
slyA	B-Protein
activation	O
,	O
perhaps	O
establishing	O
part	O
of	O
the	O
temporal	O
order	O
of	O
expression	O
following	O
phagocytosis	O
of	O
Salmonella	O
.	O

There	O
are	O
other	O
regulators	O
required	O
for	O
systemic	O
infection	O
in	O
BALB	O
/	O
c	O
mice	O
,	O
including	O
those	O
whose	O
absence	O
reduces	O
viability	O
without	O
a	O
compensating	O
mutation	O
(	O
hns	B-Protein
;	O
[	O
70	O
]	O
)	O
,	O
those	O
that	O
require	O
deletion	O
of	O
two	O
unlinked	O
genes	O
for	O
inactivation	O
(	O
ppGpp	O
;	O
reviewed	O
in	O
[	O
71	O
]	O
and	O
ydgT	B-Protein
/	O
hha	B-Protein
[	O
48	O
]	O
)	O
,	O
or	O
those	O
that	O
were	O
simply	O
missed	O
in	O
the	O
screens	O
(	O
STM0410	B-Protein
;	O
[	O
72	O
]	O
)	O
;	O
these	O
regulators	O
will	O
be	O
included	O
in	O
subsequent	O
analyses	O
.	O

What	O
are	O
the	O
signals	O
being	O
sensed	O
during	O
systemic	O
infection	O
and	O
how	O
are	O
they	O
integrated	O
to	O
express	O
virulence	O
factors	O
appropriately	O
?	O
<EOS>	B-X
PhoP-Mediated	B-X
Repression	B-X
of	B-X
the	B-X
SPI1	B-X
Type	B-X
3	B-X
Secretion	B-X
System	B-X
in	B-X
Salmonella	B-X
enterica	B-X
Serovar	B-X
Typhimurium	B-X
.	B-X
Candida	B-X
albicans	B-X
Augments	B-X
Staphylococcus	B-X
aureus	B-X
Virulence	B-X
by	B-X
Engaging	B-X
the	B-X
Staphylococcal	B-X

There	O
have	O
been	O
several	O
studies	O
to	O
identify	O
environmental	O
factors	O
that	O
regulate	O
expression	O
of	O
the	O
type	O
III	O
secretion	O
system	O
encoded	O
within	O
SPI	O
-	O
2	O
.	O
<EOS>	B-X
The	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
TTSS	B-X
)	B-X
is	B-X
an	B-X
important	B-X
virulence	B-X
determinant	B-X
of	B-X
Gram-negative	B-X
bacterial	B-X
pathogens	B-X
.	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
encodes	B-X
two	B-X
virulence	B-X
associated	B-X
TTSSs	B-X
encoded	B-X
by	B-X
the	B-X
Salmonella	B-X
Pathogenicity	B-X
Islands	B-X
(	B-X
SPI	B-X
)	B-X
1	B-X
and	B-X
2	B-X
that	B-X
are	B-X
required	B-X
for	B-X
the	B-X
intestinal	B-X
and	B-X
systemic	B-X
phases	B-X
of	B-X
the	B-X
infection	B-X
,	B-X
respectively	B-X
.	B-X
However	B-X
,	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
the	B-X
roles	B-X
of	B-X
these	B-X
TTSSs	B-X
are	B-X
not	B-X
restricted	B-X
to	B-X
these	B-X
compartments	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
TTSSs	B-X
in	B-X
Salmonella	B-X
is	B-X
very	B-X
complex	B-X
with	B-X
several	B-X
regulators	B-X
operating	B-X
to	B-X
activate	B-X
or	B-X
to	B-X
repress	B-X
expression	B-X
depending	B-X
on	B-X
the	B-X
environmental	B-X
conditions	B-X
.	B-X

Carbon	O
limitation	O
,	O
low	O
concentrations	O
of	O
Mg2	O
+	O
or	O
Ca2	O
+	O
[	O
73	O
]	O
,	O
and	O
acidic	O
pH	O
[	O
47	O
]	O
,	O
[	O
61	O
]	O
induce	O
SPI	O
-	O
2	O
expression	O
in	O
vitro	O
.	O
<EOS>	B-X
Decreasing	B-X
relative	B-X
water	B-X
content	B-X
(	B-X
RWC	B-X
)	B-X
of	B-X
leaves	B-X
progressively	B-X
decreases	B-X
stomatal	B-X
conductance	B-X
(	B-X
gs	B-X
)	B-X
,	B-X
slowing	B-X
CO2	B-X
assimilation	B-X
(	B-X
A	B-X
)	B-X
which	B-X
eventually	B-X
stops	B-X
,	B-X
after	B-X
which	B-X
CO2	B-X
is	B-X
evolved	B-X
.	B-X
In	B-X
some	B-X
studies	B-X
,	B-X
photosynthetic	B-X
potential	B-X
(	B-X
Apot	B-X
)	B-X
,	B-X
measured	B-X
under	B-X
saturating	B-X
CO2	B-X
,	B-X
is	B-X
unaffected	B-X
by	B-X
a	B-X
small	B-X
loss	B-X
of	B-X
RWC	B-X
but	B-X
becomes	B-X
progressively	B-X
more	B-X
inhibited	B-X
,	B-X
and	B-X
less	B-X
stimulated	B-X
by	B-X
elevated	B-X
CO2	B-X
,	B-X
below	B-X
a	B-X
threshold	B-X
RWC	B-X
(	B-X
Type	B-X
1	B-X
response	B-X
)	B-X
.	B-X
In	B-X
other	B-X
studies	B-X
,	B-X
Apot	B-X
and	B-X
the	B-X
stimulation	B-X
of	B-X
A	B-X
by	B-X
elevated	B-X
CO2	B-X
decreases	B-X
progressively	B-X
as	B-X
RWC	B-X
falls	B-X
(	B-X
Type	B-X
2	B-X
response	B-X
)	B-X
.	B-X
Consequently	B-X
,	B-X
as	B-X
RWC	B-X
declines	B-X
,	B-X
the	B-X
relative	B-X
limitation	B-X
of	B-X
A	B-X
by	B-X
g	B-X
(	B-X
s	B-X
)	B-X
decreases	B-X
,	B-X
and	B-X
metabolic	B-X
limitation	B-X
increases	B-X
.	B-X
Limitation	B-X
of	B-X
ribulose	B-X
bisphosphate	B-X
(	B-X
RuBP	B-X
)	B-X
synthesis	B-X
is	B-X
the	B-X
likely	B-X
cause	B-X
of	B-X
decreased	B-X
Apot	B-X
at	B-X
low	B-X
RWC	B-X
,	B-X
not	B-X
inhibition	B-X
or	B-X
loss	B-X
of	B-X
photosynthetic	B-X
carbon	B-X
reduction	B-X
cycle	B-X
enzymes	B-X
,	B-X
including	B-X
RuBP	B-X
carboxylase/oxygenase	B-X
(	B-X
Rubisco	B-X
)	B-X
.	B-X
Limitation	B-X
of	B-X
RuBP	B-X
synthesis	B-X
is	B-X
probably	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
ATP	B-X
synthesis	B-X
,	B-X
due	B-X
to	B-X
progressive	B-X
inactivation	B-X
or	B-X
loss	B-X
of	B-X
Coupling	B-X
Factor	B-X
resulting	B-X
from	B-X
increasing	B-X
ionic	B-X
(	B-X
Mg2+	B-X
)	B-X
concentration	B-X
,	B-X
not	B-X
to	B-X
reduced	B-X
capacity	B-X
for	B-X
electron	B-X
or	B-X
proton	B-X
transport	B-X
,	B-X
or	B-X
inadequate	B-X
trans-thylakoid	B-X
proton	B-X
gradient	B-X
(	B-X
ApH	B-X
)	B-X
.	B-X

Inside	O
professional	O
phagocytic	O
cells	O
divalent	O
cation	O
concentrations	O
and	O
the	O
presence	O
of	O
defensin	O
-	O
like	O
molecules	O
signal	O
through	O
phoP	B-Protein
/	O
phoQ	B-Protein
[	O
74	O
]	O
,	O
[	O
75	O
]	O
,	O
and	O
acidic	O
pH	O
and	O
osmolarity	O
signal	O
through	O
ompR	B-Protein
/	O
envZ	B-Protein
[	O
76	O
]	O
.	O

OmpR	B-Protein
has	O
been	O
shown	O
to	O
respond	O
to	O
acidic	O
pH	O
via	O
cadC	B-Protein
[	O
77	O
]	O
.	O

The	O
signal	O
(	O
s	O
)	O
received	O
by	O
SsrA	B-Protein
,	O
the	O
sensor	O
of	O
the	O
SsrA	B-Protein
/	O
SsrB	B-Protein
system	O
,	O
is	O
not	O
yet	O
established	O
.	O

It	O
is	O
surprising	O
that	O
over	O
-	O
expression	O
of	O
ssrB	B-Protein
can	O
compensate	O
for	O
a	O
deletion	O
of	O
ssrA	B-Protein
or	O
ssrA	B-Protein
/	O
ssrB	B-Protein
.	O
<EOS>	B-X
The	B-X
two-component	B-X
system	B-X
SsrA-SsrB	B-X
activates	B-X
expression	B-X
of	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
required	B-X
for	B-X
replication	B-X
in	B-X
macrophages	B-X
and	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
previously	B-X
demonstrated	B-X
that	B-X
ssrA	B-X
and	B-X
ssrB	B-X
transcription	B-X
is	B-X
uncoupled	B-X
.	B-X
Overexpression	B-X
of	B-X
SsrB	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
its	B-X
cognate	B-X
kinase	B-X
,	B-X
SsrA	B-X
,	B-X
is	B-X
sufficient	B-X
to	B-X
activate	B-X
SPI-2	B-X
transcription	B-X
.	B-X
The	B-X
nucleoid	B-X
structuring	B-X
protein	B-X
H-NS	B-X
represses	B-X
horizontally	B-X
acquired	B-X
genes	B-X
;	B-X
we	B-X
confirmed	B-X
that	B-X
H-NS	B-X
is	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
SPI-2	B-X
gene	B-X
expression	B-X
.	B-X
SsrB	B-X
appears	B-X
to	B-X
possess	B-X
dual	B-X
activities	B-X
to	B-X
promote	B-X
SPI-2	B-X
gene	B-X
expression	B-X
:	B-X
activation	B-X
of	B-X
transcription	B-X
and	B-X
relief	B-X
of	B-X
H-NS-mediated	B-X
repression	B-X
.	B-X

Previous	O
results	O
have	O
shown	O
that	O
a	O
conservative	O
replacement	O
of	O
the	O
amino	O
acid	O
that	O
is	O
the	O
essential	O
phosphate	O
acceptor	O
eliminated	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
suggesting	O
that	O
SsrB	B-Protein
requires	O
phosphorylation	O
for	O
activity	O
.	O

Yet	O
,	O
expression	O
of	O
ssrB	B-Protein
without	O
ssrA	B-Protein
results	O
in	O
expression	O
of	O
all	O
7	O
SPI	O
-	O
2	O
genes	O
examined	O
(	O
Figure	O
7A	O
)	O
.	O

It	O
is	O
possible	O
that	O
SsrB	B-Protein
can	O
be	O
phosphorylated	O
from	O
other	O
sources	O
as	O
noted	O
by	O
Walthers	O
et	O
al	O
.	O

[	O
52	O
]	O
or	O
that	O
the	O
over	O
-	O
expression	O
results	O
in	O
dimerization	O
and	O
self	O
activation	O
similar	O
to	O
what	O
has	O
been	O
observed	O
for	O
PhoP	B-Protein
[	O
78	O
]	O
.	O

Mutations	O
in	O
rpoE	B-Protein
,	O
smpB	B-Protein
,	O
rpoS	B-Protein
,	O
and	O
hfq	B-Protein
showed	O
only	O
small	O
decreases	O
in	O
SPI	O
-	O
2	O
gene	O
transcription	O
during	O
growth	O
in	O
minimal	O
acidic	O
media	O
but	O
some	O
of	O
them	O
showed	O
large	O
defects	O
in	O
survival	O
assays	O
performed	O
in	O
murine	O
macrophages	O
.	O

For	O
rpoE	B-Protein
and	O
rpoS	B-Protein
it	O
is	O
possible	O
that	O
the	O
environmental	O
conditions	O
that	O
distinguish	O
growth	O
in	O
minimal	O
media	O
from	O
those	O
in	O
the	O
SCV	O
inside	O
hosts	O
are	O
sensed	O
via	O
these	O
two	O
alternative	O
sigma	O
factors	O
.	O

Figure	O
6B	O
shows	O
that	O
there	O
is	O
a	O
close	O
relationship	O
between	O
these	O
two	O
regulators	O
and	O
that	O
they	O
can	O
both	O
affect	O
each	O
other	O
through	O
the	O
ompR	B-Protein
/	O
envZ	B-Protein
two	O
-	O
component	O
regulator	O
.	O

Post	O
-	O
transcriptional	O
SPI	O
-	O
2	O
regulation	O
is	O
a	O
likely	O
explanation	O
for	O
the	O
large	O
intracellular	O
growth	O
defects	O
observed	O
in	O
the	O
mutant	O
smpB	B-Protein
and	O
hfq	B-Protein
derivatives	O
despite	O
relative	O
small	O
transcriptional	O
effects	O
.	O

Strains	O
containing	O
mutations	O
in	O
spvR	B-Protein
and	O
hnr	B-Protein
showed	O
comparable	O
survival	O
levels	O
to	O
wild	O
-	O
type	O
in	O
macrophages	O
from	O
BALB	O
/	O
c	O
mice	O
despite	O
the	O
fact	O
that	O
they	O
are	O
attenuated	O
in	O
the	O
same	O
mouse	O
strain	O
.	O

Perhaps	O
these	O
regulators	O
are	O
selected	O
during	O
growth	O
in	O
other	O
cell	O
types	O
or	O
within	O
phagocytic	O
cells	O
that	O
are	O
activated	O
as	O
a	O
consequence	O
of	O
the	O
inflammatory	O
response	O
generated	O
by	O
the	O
bacteria	O
.	O
<EOS>	B-X
A	B-X
common	B-X
way	B-X
for	B-X
bacteria	B-X
to	B-X
acquire	B-X
this	B-X
nutrient	B-X
is	B-X
through	B-X
the	B-X
secretion	B-X
of	B-X
siderophores	B-X
,	B-X
which	B-X
are	B-X
secondary	B-X
metabolites	B-X
that	B-X
scavenge	B-X
iron	B-X
from	B-X
environmental	B-X
stocks	B-X
and	B-X
deliver	B-X
it	B-X
to	B-X
cells	B-X
via	B-X
specific	B-X
receptors	B-X
.	B-X
While	B-X
there	B-X
has	B-X
been	B-X
tremendous	B-X
interest	B-X
in	B-X
understanding	B-X
the	B-X
molecular	B-X
basis	B-X
of	B-X
siderophore	B-X
synthesis	B-X
,	B-X
uptake	B-X
and	B-X
regulation	B-X
,	B-X
questions	B-X
about	B-X
the	B-X
ecological	B-X
and	B-X
evolutionary	B-X
consequences	B-X
of	B-X
siderophore	B-X
secretion	B-X
have	B-X
only	B-X
recently	B-X
received	B-X
increasing	B-X
attention	B-X
.	B-X
During	B-X
cell	B-X
division	B-X
,	B-X
it	B-X
is	B-X
critical	B-X
to	B-X
properly	B-X
partition	B-X
functional	B-X
sets	B-X
of	B-X
organelles	B-X
to	B-X
each	B-X
daughter	B-X
cell	B-X
.	B-X
The	B-X
partitioning	B-X
of	B-X
mitochondria	B-X
shares	B-X
some	B-X
common	B-X
features	B-X
with	B-X
that	B-X
of	B-X
other	B-X
organelles	B-X
,	B-X
particularly	B-X
in	B-X
the	B-X
use	B-X
of	B-X
interactions	B-X
with	B-X
cytoskeletal	B-X
elements	B-X
to	B-X
facilitate	B-X
delivery	B-X
to	B-X
the	B-X
daughter	B-X
cells	B-X
.	B-X
Consequently	B-X
,	B-X
mechanisms	B-X
have	B-X
evolved	B-X
to	B-X
regulate	B-X
mitochondrial	B-X
segregation	B-X
during	B-X
cell	B-X
division	B-X
,	B-X
oogenesis	B-X
,	B-X
fertilization	B-X
and	B-X
tissue	B-X
development	B-X
,	B-X
as	B-X
well	B-X
as	B-X
to	B-X
ensure	B-X
the	B-X
integrity	B-X
of	B-X
these	B-X
organelles	B-X
and	B-X
their	B-X
DNA	B-X
,	B-X
including	B-X
fusion-fission	B-X
dynamics	B-X
,	B-X
organelle	B-X
transport	B-X
,	B-X
mitophagy	B-X
and	B-X
genetic	B-X
selection	B-X
of	B-X
functional	B-X
genomes	B-X
.	B-X
Defects	B-X
in	B-X
these	B-X
processes	B-X
can	B-X
lead	B-X
to	B-X
cell	B-X
and	B-X
tissue	B-X
pathologies	B-X
.	B-X

SlyA	B-Protein
and	O
SsrA	B-Protein
/	O
SsrB	B-Protein
together	O
activate	O
transcription	O
of	O
the	O
SPI	O
-	O
2	O
encoded	O
secretion	O
apparatus	O

SlyA	B-Protein
is	O
a	O
DNA	O
-	O
binding	O
protein	O
with	O
high	O
affinity	O
for	O
inverted	O
repeat	O
sequences	O
[	O
79	O
]	O
and	O
the	O
binding	O
ability	O
of	O
SlyA	B-Protein
to	O
the	O
ssrA	B-Protein
promoter	O
region	O
was	O
previously	O
reported	O
[	O
62	O
]	O
.	O

SlyA	B-Protein
binds	O
to	O
a	O
specific	O
palindromic	O
sequence	O
,	O
but	O
also	O
to	O
other	O
binding	O
sites	O
that	O
do	O
not	O
fit	O
a	O
consensus	O
sequence	O
[	O
79	O
]	O
,	O
[	O
80	O
]	O
.	O

Similarly	O
SsrB	B-Protein
binds	O
upstream	O
of	O
ssrA	B-Protein
in	O
a	O
region	O
of	O
the	O
promoter	O
typical	O
of	O
response	O
regulators	O
but	O
has	O
no	O
obvious	O
recognition	O
site	O
and	O
binds	O
within	O
the	O
operons	O
that	O
encode	O
structural	O
components	O
of	O
the	O
type	O
III	O
secretion	O
system	O
[	O
52	O
]	O
,	O
[	O
81	O
]	O
.	O

Four	O
nucleoid	O
-	O
like	O
proteins	O
in	O
enteric	O
bacteria	O
,	O
H	B-Protein
-	I-Protein
NS	I-Protein
,	O
StpA	B-Protein
,	O
Hha	B-Protein
,	O
and	O
YdgT	B-Protein
have	O
a	O
predilection	O
for	O
binding	O
to	O
A	O
+	O
T	O
rich	O
sequences	O
and	O
repress	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
(	O
rev	O
.	O
in	O
[	O
14	O
]	O
)	O
.	O

These	O
proteins	O
have	O
a	O
degenerate	O
recognition	O
sequence	O
and	O
the	O
ability	O
to	O
polymerize	O
along	O
and	O
bridge	O
adjacent	O
stretches	O
of	O
DNA	O
repressing	O
transcription	O
apparently	O
by	O
occlusion	O
of	O
RNA	O
polymerase	O
.	O

It	O
has	O
been	O
shown	O
that	O
virulence	O
regulator	O
slyA	B-Protein
,	O
and	O
close	O
homologues	O
rovA	B-Protein
[	O
82	O
]	O
and	O
toxT	B-Protein
[	O
83	O
]	O
act	O
to	O
relieve	O
the	O
repression	O
caused	O
by	O
H	B-Protein
-	I-Protein
NS	I-Protein
at	O
specific	O
promoters	O
[	O
48	O
]	O
,	O
[	O
70	O
]	O
,	O
[	O
84	O
]	O
,	O
[	O
85	O
]	O
.	O

SPI	O
-	O
2	O
regulation	O
by	O
SsrB	B-Protein
and	O
SlyA	B-Protein
may	O
be	O
explained	O
in	O
a	O
similar	O
mechanism	O
where	O
both	O
SlyA	B-Protein
and	O
SsrB	B-Protein
counteract	O
the	O
silencing	O
activity	O
of	O
H	B-Protein
-	I-Protein
NS	I-Protein
/	O
YdgT	B-Protein
/	O
Hha	B-Protein
by	O
competing	O
for	O
binding	O
to	O
the	O
same	O
target	O
sequences	O
or	O
by	O
altering	O
the	O
structure	O
of	O
the	O
DNA	O
to	O
promote	O
transcription	O
for	O
SPI	O
-	O
2	O
.	O

Walthers	O
et	O
al	O
.	O

[	O
52	O
]	O
and	O
Feng	O
et	O
al	O
.	O
<EOS>	B-X
Questions	B-X
remain	B-X
as	B-X
to	B-X
whether	B-X
sufficient	B-X
evidence	B-X
supports	B-X
adoption	B-X
of	B-X
these	B-X
biomarkers	B-X
for	B-X
clinical	B-X
use	B-X
.	B-X
Embolic	B-X
strokes	B-X
of	B-X
undetermined	B-X
source	B-X
represent	B-X
20	B-X
%	B-X
of	B-X
ischemic	B-X
strokes	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
high	B-X
rate	B-X
of	B-X
recurrence	B-X
.	B-X
Anticoagulant	B-X
treatment	B-X
with	B-X
rivaroxaban	B-X
,	B-X
an	B-X
oral	B-X
factor	B-X
Xa	B-X
inhibitor	B-X
,	B-X
may	B-X
result	B-X
in	B-X
a	B-X
lower	B-X
risk	B-X
of	B-X
recurrent	B-X
stroke	B-X
than	B-X
aspirin	B-X
.	B-X
Therapy-related	B-X
myelodysplastic	B-X
syndrome	B-X
and	B-X
acute	B-X
leukemias	B-X
(	B-X
t-MDS/AL	B-X
)	B-X
are	B-X
a	B-X
major	B-X
cause	B-X
of	B-X
nonrelapse	B-X
mortality	B-X
among	B-X
pediatric	B-X
cancer	B-X
survivors	B-X
.	B-X
Although	B-X
the	B-X
presence	B-X
of	B-X
clonal	B-X
hematopoiesis	B-X
(	B-X
CH	B-X
)	B-X
in	B-X
adult	B-X
patients	B-X
at	B-X
cancer	B-X
diagnosis	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
t-MDS/AL	B-X
,	B-X
there	B-X
is	B-X
limited	B-X
published	B-X
literature	B-X
describing	B-X
t-MDS/AL	B-X
development	B-X
in	B-X
children	B-X
.	B-X

[	O
81	O
]	O
found	O
that	O
there	O
was	O
no	O
consensus	O
SsrB	B-Protein
binding	O
site	O
or	O
distance	O
relative	O
to	O
the	O
transcription	O
start	O
sites	O
and	O
Walthers	O
(	O
ibid	O
)	O
proposes	O
that	O
different	O
promoters	O
may	O
be	O
activated	O
by	O
distinct	O
SsrB	B-Protein
mechanisms	O
.	O

Our	O
results	O
support	O
this	O
conclusion	O
and	O
extend	O
the	O
observation	O
to	O
slyA	B-Protein
at	O
least	O
for	O
specific	O
SPI	O
-	O
2	O
transcripts	O
.	O

A	O
proposed	O
mechanism	O
for	O
activation	O
is	O
that	O
SlyA	B-Protein
competes	O
with	O
a	O
repressor	O
for	O
binding	O
to	O
the	O
promoter	O
and	O
subsequently	O
facilitates	O
RNA	O
polymerase	O
access	O
[	O
80	O
]	O
.	O

This	O
model	O
is	O
supported	O
by	O
SlyA	B-Protein
binding	O
sites	O
that	O
are	O
located	O
downstream	O
of	O
transcriptional	O
start	O
sites	O
[	O
31	O
]	O
,	O
[	O
86	O
]	O
,	O
which	O
is	O
unusual	O
for	O
a	O
traditional	O
transcriptional	O
activator	O
.	O

In	O
agreement	O
with	O
this	O
model	O
,	O
SlyA	B-Protein
and	O
PhoP	B-Protein
counteract	O
H	B-Protein
-	I-Protein
NS	I-Protein
silencing	O
at	O
pagC	B-Protein
[	O
85	O
]	O
,	O
[	O
87	O
]	O
.	O

Thus	O
,	O
one	O
explanation	O
for	O
the	O
transcription	O
we	O
observe	O
following	O
over	O
-	O
expression	O
of	O
ssrB	B-Protein
or	O
slyA	B-Protein
may	O
be	O
that	O
both	O
SlyA	B-Protein
and	O
SsrB	B-Protein
counteract	O
binding	O
of	O
small	O
nucleoid	O
-	O
like	O
proteins	O
including	O
both	O
H	B-Protein
-	I-Protein
NS	I-Protein
and	O
YdgD	B-Protein
/	O
Hha	B-Protein
in	O
this	O
A	O
+	O
T	O
rich	O
SPI	O
-	O
2	O
region	O
[	O
70	O
]	O
.	O

This	O
possibility	O
may	O
be	O
reflected	O
in	O
the	O
differences	O
in	O
expression	O
of	O
the	O
five	O
operons	O
within	O
SPI	O
-	O
2	O
following	O
ssrB	B-Protein
and	O
slyA	B-Protein
over	O
-	O
expression	O
.	O

Clustering	O
analysis	O
and	O
co	O
-	O
expression	O
<EOS>	B-X
Protein	B-X
physical	B-X
interactions	B-X
are	B-X
complemented	B-X
by	B-X
other	B-X
types	B-X
of	B-X
functional	B-X
relationship	B-X
data	B-X
including	B-X
genetic	B-X
interactions	B-X
,	B-X
knowledge	B-X
about	B-X
co-expression	B-X
,	B-X
and	B-X
evolutionary	B-X
pathways	B-X
.	B-X
Existing	B-X
algorithms	B-X
integrate	B-X
protein	B-X
interaction	B-X
and	B-X
gene	B-X
expression	B-X
data	B-X
to	B-X
retrieve	B-X
context-specific	B-X
subnetworks	B-X
composed	B-X
of	B-X
genes/proteins	B-X
with	B-X
known	B-X
and	B-X
unknown	B-X
functions	B-X
.	B-X
We	B-X
develop	B-X
a	B-X
novel	B-X
integrative	B-X
method	B-X
based	B-X
on	B-X
differential	B-X
Co-expression	B-X
analysis	B-X
and	B-X
Neighbor-voting	B-X
algorithm	B-X
for	B-X
Protein	B-X
Function	B-X
Prediction	B-X
,	B-X
namely	B-X
CNPFP	B-X
.	B-X
CNPFP	B-X
performs	B-X
three	B-X
tasks	B-X
:	B-X
clustering	B-X
,	B-X
differential	B-X
co-expression	B-X
analysis	B-X
,	B-X
and	B-X
predicts	B-X
protein	B-X
functions	B-X
.	B-X
We	B-X
identify	B-X
eight	B-X
condition-specific	B-X
modules	B-X
.	B-X
We	B-X
present	B-X
comprehensive	B-X
annotations	B-X
for	B-X
3538	B-X

The	O
complex	O
regulatory	O
network	O
suggested	O
by	O
these	O
studies	O
has	O
been	O
partially	O
confirmed	O
.	O
<EOS>	B-X
In	B-X
the	B-X
last	B-X
decade	B-X
,	B-X
case	B-X
studies	B-X
in	B-X
plants	B-X
and	B-X
animals	B-X
provided	B-X
increasing	B-X
insight	B-X
into	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
developmental	B-X
plasticity	B-X
.	B-X
When	B-X
complemented	B-X
with	B-X
evolutionary	B-X
and	B-X
ecological	B-X
analyses	B-X
,	B-X
these	B-X
studies	B-X
suggest	B-X
that	B-X
plasticity	B-X
represents	B-X
a	B-X
mechanism	B-X
facilitating	B-X
adaptive	B-X
change	B-X
,	B-X
increasing	B-X
diversity	B-X
and	B-X
fostering	B-X
the	B-X
evolution	B-X
of	B-X
novelty	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
genetic	B-X
,	B-X
molecular	B-X
and	B-X
evolutionary	B-X
studies	B-X
on	B-X
developmental	B-X
plasticity	B-X
of	B-X
feeding	B-X
structures	B-X
in	B-X
nematodes	B-X
,	B-X
focusing	B-X
on	B-X
the	B-X
model	B-X
organism	B-X
Physical	B-X
and	B-X
Functional	B-X
Interplay	B-X
between	B-X
MazF	B-X

Complete	O
elucidation	O
of	O
the	O
virulence	O
pathways	O
must	O
include	O
proteomic	O
studies	O
to	O
identify	O
steps	O
that	O
require	O
translational	O
regulation	O
,	O
binding	O
studies	O
to	O
distinguish	O
direct	O
from	O
indirect	O
effects	O
and	O
additional	O
regulators	O
not	O
included	O
in	O
this	O
preliminary	O
group	O
of	O
14	O
.	O

In	O
this	O
study	O
,	O
cluster	O
analysis	O
was	O
used	O
to	O
identify	O
genes	O
that	O
show	O
similar	O
expression	O
profiles	O
under	O
a	O
variety	O
of	O
environmental	O
conditions	O
and	O
from	O
the	O
isogenic	O
Salmonella	O
regulatory	O
mutants	O
we	O
describe	O
.	O

The	O
average	O
G	O
+	O
C	O
content	O
of	O
the	O
92	O
genes	O
outside	O
of	O
SPI	O
-	O
2	O
that	O
show	O
the	O
same	O
regulation	O
as	O
SPI	O
-	O
2	O
is	O
47	O
%	O
while	O
the	O
average	O
for	O
Salmonella	O
is	O
52	O
%	O
(	O
p	O
<	O
e	O
-	O
25	O
)	O
.	O

Most	O
of	O
these	O
genes	O
are	O
not	O
found	O
in	O
closely	O
related	O
non	O
-	O
pathogenic	O
bacteria	O
(	O
overall	O
comparison	O
eliminating	O
SPI	O
-	O
2	O
genes	O
p	O
<	O
e	O
-	O
15	O
)	O
.	O
<EOS>	B-X
We	B-X
established	B-X
a	B-X
genome-wide	B-X
compendium	B-X
of	B-X
somatic	B-X
mutation	B-X
events	B-X
in	B-X
3949	B-X
whole	B-X
cancer	B-X
genomes	B-X
representing	B-X
19	B-X
tumor	B-X
types	B-X
.	B-X
Protein-coding	B-X
events	B-X
captured	B-X
well-established	B-X
drivers	B-X
.	B-X
Noncoding	B-X
events	B-X
near	B-X
tissue-specific	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
Enhancers	B-X
are	B-X
cis-regulatory	B-X
elements	B-X
that	B-X
can	B-X
activate	B-X
transcription	B-X
remotely	B-X
to	B-X
regulate	B-X
a	B-X
specific	B-X
pattern	B-X
of	B-X
a	B-X
gene	B-X
's	B-X
expression	B-X
.	B-X
Genes	B-X
typically	B-X
have	B-X
many	B-X
enhancers	B-X
that	B-X
are	B-X
often	B-X
intermingled	B-X
in	B-X
the	B-X
loci	B-X
of	B-X
other	B-X
genes	B-X
.	B-X
To	B-X
regulate	B-X
expression	B-X
,	B-X
enhancers	B-X
must	B-X
therefore	B-X
activate	B-X
their	B-X
correct	B-X
promoter	B-X
while	B-X
ignoring	B-X
others	B-X
that	B-X
may	B-X
be	B-X
in	B-X
closer	B-X
linear	B-X
proximity	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
discuss	B-X
mechanisms	B-X
by	B-X
which	B-X
enhancers	B-X
engage	B-X
with	B-X
promoters	B-X
,	B-X
including	B-X
recent	B-X
findings	B-X
on	B-X
the	B-X
role	B-X
of	B-X
cohesin	B-X
and	B-X
the	B-X
Mediator	B-X
complex	B-X
,	B-X
and	B-X
how	B-X
this	B-X
specificity	B-X
in	B-X
enhancer-promoter	B-X
communication	B-X
is	B-X
encoded	B-X
.	B-X
Genetic	B-X
dissection	B-X
of	B-X
model	B-X
loci	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
more	B-X
recent	B-X
findings	B-X
using	B-X
genome-wide	B-X
approaches	B-X
,	B-X
highlight	B-X
the	B-X
core	B-X
promoter	B-X
sequence	B-X
,	B-X
its	B-X
accessibility	B-X
,	B-X
cofactor-promoter	B-X
preference	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
surrounding	B-X
genomic	B-X
context	B-X
,	B-X
as	B-X
key	B-X
components	B-X
.	B-X

Thus	O
application	O
of	O
the	O
CLR	O
algorithm	O
identified	O
a	O
very	O
interesting	O
group	O
of	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
SPI	O
-	O
2	O
and	O
were	O
horizontally	O
transferred	O
to	O
Salmonella	O
.	O

Analysis	O
of	O
microarrays	O
and	O
other	O
expression	O
data	O
was	O
used	O
to	O
construct	O
a	O
predictive	O
model	O
for	O
how	O
the	O
regulators	O
may	O
interact	O
and	O
coordinate	O
regulation	O
within	O
the	O
host	O
.	O

A	O
few	O
of	O
the	O
predictions	O
have	O
been	O
verified	O
and	O
more	O
are	O
being	O
tested	O
.	O
<EOS>	B-X
The	B-X
latter-cited	B-X
remain	B-X
to	B-X
be	B-X
verified	B-X
,	B-X
while	B-X
findings	B-X
in	B-X
chronic	B-X
patients	B-X
remain	B-X
to	B-X
be	B-X
tested	B-X
in	B-X
acute	B-X
.	B-X
Whether	B-X
use	B-X
of	B-X
this	B-X
information	B-X
can	B-X
be	B-X
extended	B-X
and	B-X
verified	B-X
for	B-X
use	B-X
in	B-X
therapeutic	B-X
decision	B-X
making	B-X
for	B-X
neoadjuvant	B-X
chemotherapy	B-X
or	B-X
various	B-X
escalated	B-X
chemotherapy	B-X
regimens	B-X
remains	B-X
to	B-X
be	B-X
established	B-X
.	B-X
All	B-X
the	B-X
clinical	B-X
data	B-X
and	B-X
imaging	B-X
features	B-X
of	B-X
these	B-X
patients	B-X
were	B-X
retrospectively	B-X
reviewed	B-X
and	B-X
medical	B-X
records	B-X
were	B-X
verified	B-X
for	B-X
follow	B-X
up	B-X
care	B-X
.	B-X
Baseline	B-X
impulsive	B-X
choice	B-X
was	B-X
robustly	B-X
associated	B-X
with	B-X
biochemically	B-X
verified	B-X
7-day	B-X
point-prevalence	B-X
abstinence	B-X
12	B-X
weeks	B-X
'	B-X
postquit	B-X
,	B-X
such	B-X
that	B-X
those	B-X
with	B-X
lower	B-X
delay	B-X
discounting	B-X
were	B-X
more	B-X
likely	B-X
to	B-X
achieve	B-X
abstinence	B-X
.	B-X

The	O
construction	O
of	O
a	O
complete	O
interaction	O
network	O
describing	O
both	O
the	O
host	O
and	O
pathogen	O
is	O
a	O
long	O
-	O
term	O
goal	O
of	O
this	O
and	O
other	O
related	O
research	O
efforts	O
.	O

Mycobacterium	O
tuberculosis	O
Universal	O
Stress	O
Protein	O
Rv2623	B-Protein
Regulates	O
Bacillary	O
Growth	O
by	O
ATP	O
-	O
Binding	O
:	O
Requirement	O
for	O
Establishing	O
Chronic	O
Persistent	O
Infection	O
<EOS>	B-X
Tuberculous	B-X
latency	B-X
and	B-X
reactivation	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
tuberculosis	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
that	B-X
regulate	B-X
these	B-X
processes	B-X
remain	B-X
unclear	B-X
.	B-X
The	B-X
Mycobacterium	B-X
tuberculosisuniversal	B-X
stress	B-X
protein	B-X
(	B-X
USP	B-X
)	B-X
homolog	B-X
,	B-X
rv2623	B-X
,	B-X
is	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
induced	B-X
genes	B-X
when	B-X
the	B-X
tubercle	B-X
bacillus	B-X
is	B-X
subjected	B-X
to	B-X
hypoxia	B-X
and	B-X
nitrosative	B-X
stress	B-X
,	B-X
conditions	B-X
thought	B-X
to	B-X
promote	B-X
latency	B-X
.	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

Tuberculous	O
latency	O
and	O
reactivation	O
play	O
a	O
significant	O
role	O
in	O
the	O
pathogenesis	O
of	O
tuberculosis	O
,	O
yet	O
the	O
mechanisms	O
that	O
regulate	O
these	O
processes	O
remain	O
unclear	O
.	O
<EOS>	B-X
Tuberculous	B-X
latency	B-X
and	B-X
reactivation	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
tuberculosis	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
that	B-X
regulate	B-X
these	B-X
processes	B-X
remain	B-X
unclear	B-X
.	B-X
The	B-X
Mycobacterium	B-X
tuberculosisuniversal	B-X
stress	B-X
protein	B-X
(	B-X
USP	B-X
)	B-X
homolog	B-X
,	B-X
rv2623	B-X
,	B-X
is	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
induced	B-X
genes	B-X
when	B-X
the	B-X
tubercle	B-X
bacillus	B-X
is	B-X
subjected	B-X
to	B-X
hypoxia	B-X
and	B-X
nitrosative	B-X
stress	B-X
,	B-X
conditions	B-X
thought	B-X
to	B-X
promote	B-X
latency	B-X
.	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
in	B-X
vivo	B-X
growth-regulatory	B-X
role	B-X
,	B-X
constitutive	B-X
overexpression	B-X
of	B-X
rv2623	B-X
attenuates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X

The	O
Mycobacterium	O
tuberculosis	O
universal	O
stress	O
protein	O
(	O
USP	O
)	O
homolog	O
,	O
rv2623	B-Protein
,	O
is	O
among	O
the	O
most	O
highly	O
induced	O
genes	O
when	O
the	O
tubercle	O
bacillus	O
is	O
subjected	O
to	O
hypoxia	O
and	O
nitrosative	O
stress	O
,	O
conditions	O
thought	O
to	O
promote	O
latency	O
.	O
<EOS>	B-X
Tuberculous	B-X
latency	B-X
and	B-X
reactivation	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
tuberculosis	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
that	B-X
regulate	B-X
these	B-X
processes	B-X
remain	B-X
unclear	B-X
.	B-X
The	B-X
Mycobacterium	B-X
tuberculosisuniversal	B-X
stress	B-X
protein	B-X
(	B-X
USP	B-X
)	B-X
homolog	B-X
,	B-X
rv2623	B-X
,	B-X
is	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
induced	B-X
genes	B-X
when	B-X
the	B-X
tubercle	B-X
bacillus	B-X
is	B-X
subjected	B-X
to	B-X
hypoxia	B-X
and	B-X
nitrosative	B-X
stress	B-X
,	B-X
conditions	B-X
thought	B-X
to	B-X
promote	B-X
latency	B-X
.	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
in	B-X
vivo	B-X
growth-regulatory	B-X
role	B-X
,	B-X
constitutive	B-X
overexpression	B-X
of	B-X
rv2623	B-X
attenuates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

Induction	O
of	O
rv2623	B-Protein
also	O
occurs	O
when	O
M	O
.	O
tuberculosis	O
encounters	O
conditions	O
associated	O
with	O
growth	O
arrest	O
,	O
such	O
as	O
the	O
intracellular	O
milieu	O
of	O
macrophages	O
and	O
in	O
the	O
lungs	O
of	O
mice	O
with	O
chronic	O
tuberculosis	O
.	O

Therefore	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
Rv2623	B-Protein
regulates	O
tuberculosis	O
latency	O
.	O
<EOS>	B-X
Tuberculous	B-X
latency	B-X
and	B-X
reactivation	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
tuberculosis	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
that	B-X
regulate	B-X
these	B-X
processes	B-X
remain	B-X
unclear	B-X
.	B-X
The	B-X
Mycobacterium	B-X
tuberculosisuniversal	B-X
stress	B-X
protein	B-X
(	B-X
USP	B-X
)	B-X
homolog	B-X
,	B-X
rv2623	B-X
,	B-X
is	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
induced	B-X
genes	B-X
when	B-X
the	B-X
tubercle	B-X
bacillus	B-X
is	B-X
subjected	B-X
to	B-X
hypoxia	B-X
and	B-X
nitrosative	B-X
stress	B-X
,	B-X
conditions	B-X
thought	B-X
to	B-X
promote	B-X
latency	B-X
.	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

We	O
observed	O
that	O
an	O
Rv2623	B-Protein
-	O
deficient	O
mutant	O
fails	O
to	O
establish	O
chronic	O
tuberculous	O
infection	O
in	O
guinea	O
pigs	O
and	O
mice	O
,	O
exhibiting	O
a	O
hypervirulence	O
phenotype	O
associated	O
with	O
increased	O
bacterial	O
burden	O
and	O
mortality	O
.	O
<EOS>	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
in	B-X
vivo	B-X
growth-regulatory	B-X
role	B-X
,	B-X
constitutive	B-X
overexpression	B-X
of	B-X
rv2623	B-X
attenuates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

Consistent	O
with	O
this	O
in	O
vivo	O
growth	O
-	O
regulatory	O
role	O
,	O
constitutive	O
overexpression	O
of	O
rv2623	B-Protein
attenuates	O
mycobacterial	O
growth	O
in	O
vitro	O
.	O
<EOS>	B-X
Tuberculous	B-X
latency	B-X
and	B-X
reactivation	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
tuberculosis	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
that	B-X
regulate	B-X
these	B-X
processes	B-X
remain	B-X
unclear	B-X
.	B-X
The	B-X
Mycobacterium	B-X
tuberculosisuniversal	B-X
stress	B-X
protein	B-X
(	B-X
USP	B-X
)	B-X
homolog	B-X
,	B-X
rv2623	B-X
,	B-X
is	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
induced	B-X
genes	B-X
when	B-X
the	B-X
tubercle	B-X
bacillus	B-X
is	B-X
subjected	B-X
to	B-X
hypoxia	B-X
and	B-X
nitrosative	B-X
stress	B-X
,	B-X
conditions	B-X
thought	B-X
to	B-X
promote	B-X
latency	B-X
.	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
in	B-X
vivo	B-X
growth-regulatory	B-X
role	B-X
,	B-X
constitutive	B-X
overexpression	B-X
of	B-X
rv2623	B-X
attenuates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X

Biochemical	O
analysis	O
of	O
purified	O
Rv2623	B-Protein
suggested	O
that	O
this	O
mycobacterial	O
USP	O
binds	O
ATP	O
,	O
and	O
the	O
2	O
.	O
9	O
-	O
A	O
-	O
resolution	O
crystal	O
structure	O
revealed	O
that	O
Rv2623	B-Protein
engages	O
ATP	O
in	O
a	O
novel	O
nucleotide	O
-	O
binding	O
pocket	O
.	O

Structure	O
-	O
guided	O
mutagenesis	O
yielded	O
Rv2623	B-Protein
mutants	O
with	O
reduced	O
ATP	O
-	O
binding	O
capacity	O
.	O
<EOS>	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

Analysis	O
of	O
mycobacteria	O
overexpressing	O
these	O
mutants	O
revealed	O
that	O
the	O
in	O
vitro	O
growth	O
-	O
inhibitory	O
property	O
of	O
Rv2623	B-Protein
correlates	O
with	O
its	O
ability	O
to	O
bind	O
ATP	O
.	O
<EOS>	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
in	B-X
vivo	B-X
growth-regulatory	B-X
role	B-X
,	B-X
constitutive	B-X
overexpression	B-X
of	B-X
rv2623	B-X
attenuates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

Together	O
,	O
the	O
results	O
indicate	O
that	O
i	O
)	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
regulates	O
mycobacterial	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
ii	O
)	O
Rv2623	B-Protein
is	O
required	O
for	O
the	O
entry	O
of	O
the	O
tubercle	O
bacillus	O
into	O
the	O
chronic	O
phase	O
of	O
infection	O
in	O
the	O
host	O
;	O
in	O
addition	O
,	O
iii	O
)	O
Rv2623	B-Protein
binds	O
ATP	O
;	O
and	O
iv	O
)	O
the	O
growth	O
-	O
regulatory	O
attribute	O
of	O
this	O
USP	O
is	O
dependent	O
on	O
its	O
ATP	O
-	O
binding	O
activity	O
.	O

We	O
propose	O
that	O
Rv2623	B-Protein
may	O
function	O
as	O
an	O
ATP	O
-	O
dependent	O
signaling	O
intermediate	O
in	O
a	O
pathway	O
that	O
promotes	O
persistent	O
infection	O
.	O

Introduction	O

Mycobacterium	O
tuberculosis	O
,	O
one	O
of	O
the	O
most	O
successful	O
human	O
pathogens	O
,	O
infects	O
one	O
-	O
third	O
of	O
the	O
world	O
'	O
s	O
population	O
,	O
causing	O
nearly	O
two	O
million	O
deaths	O
per	O
year	O
[	O
1	O
]	O
.	O

Epidemiological	O
data	O
estimate	O
that	O
,	O
in	O
the	O
immunocompetent	O
host	O
,	O
only	O
approximately10	O
%	O
of	O
M	O
.	O
tuberculosis	O
infection	O
progress	O
to	O
active	O
pulmonary	O
disease	O
.	O

The	O
remaining	O
90	O
%	O
of	O
the	O
infected	O
individuals	O
are	O
asymptomatic	O
,	O
and	O
are	O
generally	O
believed	O
to	O
harbor	O
latent	O
bacilli	O
that	O
can	O
reactivate	O
to	O
cause	O
tuberculous	O
diseases	O
,	O
sometimes	O
decades	O
after	O
the	O
initial	O
infection	O
.	O

Recrudescence	O
of	O
latent	O
bacilli	O
contributes	O
significantly	O
to	O
the	O
incidence	O
of	O
adult	O
tuberculosis	O
[	O
2	O
]	O
,	O
yet	O
the	O
physiological	O
state	O
of	O
latent	O
bacilli	O
and	O
the	O
signals	O
that	O
promote	O
dormancy	O
in	O
the	O
host	O
remain	O
incompletely	O
defined	O
.	O

Understanding	O
the	O
dynamic	O
interaction	O
between	O
host	O
and	O
pathogen	O
during	O
the	O
establishment	O
of	O
persistent	O
M	O
.	O
tuberculosis	O
infection	O
will	O
guide	O
the	O
design	O
of	O
novel	O
treatment	O
for	O
the	O
latently	O
infected	O
population	O
.	O

An	O
intracellular	O
pathogen	O
,	O
M	O
.	O
tuberculosis	O
must	O
possess	O
a	O
finely	O
tuned	O
signaling	O
network	O
to	O
sense	O
and	O
transduce	O
complex	O
environmental	O
signals	O
,	O
ensuring	O
survival	O
of	O
the	O
bacilli	O
within	O
host	O
cells	O
.	O

Nitric	O
oxide	O
(	O
NO	O
)	O
produced	O
by	O
infected	O
macrophages	O
and	O
relative	O
hypoxia	O
are	O
signals	O
likely	O
to	O
be	O
encountered	O
within	O
tuberculous	O
lesions	O
that	O
are	O
believed	O
,	O
based	O
on	O
in	O
vitro	O
studies	O
,	O
to	O
promote	O
latency	O
by	O
prompting	O
the	O
M	O
.	O
tuberculosis	O
dormancy	O
response	O
.	O

Exposure	O
to	O
these	O
stimuli	O
results	O
in	O
the	O
induction	O
of	O
approximately50	O
M	O
.	O
tuberculosis	O
genes	O
,	O
designated	O
the	O
dormancy	O
regulon	O
,	O
via	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
DosR	B-Protein
-	O
DosS	B-Protein
(	O
see	O
Table	O
S1	O
for	O
accession	O
numbers	O
)	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

Among	O
this	O
set	O
of	O
genes	O
is	O
rv2623	B-Protein
,	O
one	O
of	O
eight	O
M	O
.	O
tuberculosis	O
genes	O
annotated	O
as	O
containing	O
the	O
universal	O
stress	O
protein	O
(	O
USP	O
)	O
domain	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Members	O
of	O
this	O
ancient	O
and	O
conserved	O
family	O
of	O
proteins	O
are	O
found	O
in	O
all	O
forms	O
of	O
life	O
and	O
can	O
be	O
induced	O
by	O
a	O
variety	O
of	O
environmental	O
stresses	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

However	O
,	O
the	O
roles	O
of	O
USP	O
proteins	O
in	O
microbial	O
pathogenesis	O
are	O
incompletely	O
understood	O
.	O

Interestingly	O
,	O
rv2623	B-Protein
is	O
one	O
of	O
the	O
most	O
strongly	O
induced	O
transcripts	O
of	O
the	O
dormancy	O
regulon	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

Increased	O
expression	O
of	O
rv2623	B-Protein
was	O
also	O
observed	O
following	O
phagocytosis	O
by	O
macrophages	O
[	O
10	O
]	O
and	O
in	O
the	O
lungs	O
of	O
chronically	O
infected	O
mice	O
[	O
11	O
]	O
,	O
supporting	O
a	O
functional	O
role	O
during	O
persistent	O
M	O
.	O
tuberculosis	O
infection	O
.	O

The	O
present	O
study	O
reveals	O
that	O
:	O
i	O
)	O
deletion	O
of	O
rv2623	B-Protein
confers	O
hypervirulence	O
on	O
the	O
tubercle	O
bacillus	O
in	O
animal	O
models	O
,	O
suggesting	O
that	O
expression	O
of	O
Rv2623	B-Protein
may	O
be	O
conducive	O
to	O
the	O
establishment	O
of	O
persistence	O
in	O
vivo	O
;	O
ii	O
)	O
overexpression	O
of	O
Rv2623	B-Protein
results	O
in	O
growth	O
retardation	O
of	O
recipient	O
strains	O
in	O
vitro	O
,	O
further	O
supporting	O
a	O
growth	O
-	O
regulatory	O
role	O
;	O
iii	O
)	O
Rv2623	B-Protein
binds	O
ATP	O
;	O
and	O
finally	O
,	O
through	O
mutagenesis	O
study	O
guided	O
by	O
crystallographic	O
analysis	O
of	O
Rv2623	B-Protein
(	O
the	O
first	O
such	O
study	O
for	O
a	O
tandem	O
-	O
domain	O
USP	O
)	O
,	O
we	O
show	O
that	O
iv	O
)	O
the	O
growth	O
-	O
regulating	O
attribute	O
of	O
this	O
M	O
.	O
tuberculosis	O
USP	O
is	O
linked	O
to	O
its	O
ATP	O
-	O
binding	O
capacity	O
.	O

Results	O

Mycobacterium	O
tuberculosis	O
Rv2623	B-Protein
regulates	O
growth	O
in	O
vitro	O
An	O
rv2623	B-Protein
-	O
deletion	O
mutant	O
of	O
the	O
virulent	O
M	O
.	O
tuberculosis	O
Erdman	O
strain	O
was	O
generated	O
by	O
specialized	O
transduction	O
[	O
12	O
]	O
.	O

The	O
rv2623	B-Protein
-	O
specific	O
allelic	O
exchange	O
construct	O
was	O
delivered	O
via	O
recombinant	O
mycobacteriophage	O
phAE159	O
and	O
transformants	O
were	O
analyzed	O
by	O
Southern	O
blot	O
,	O
confirming	O
replacement	O
of	O
rv2623	B-Protein
with	O
the	O
hyg	O
gene	O
,	O
which	O
confers	O
hygromycin	O
resistance	O
(	O
Figure	O
1A	O
)	O
.	O

Aliquots	O
of	O
a	O
single	O
knockout	O
clone	O
,	O
designated	O
as	O
Deltarv2623	B-Protein
,	O
were	O
stored	O
at	O
-	O
70degreesC	O
.	O

Deletion	O
of	O
rv2623	B-Protein
is	O
not	O
likely	O
to	O
affect	O
transcription	O
of	O
neighboring	O
genes	O
,	O
given	O
the	O
sequence	O
-	O
confirmed	O
precise	O
excision	O
of	O
the	O
rv2623	B-Protein
coding	O
region	O
and	O
the	O
gene	O
organization	O
at	O
the	O
rv2623	B-Protein
locus	O
(	O
the	O
downstream	O
rv2624c	B-Protein
is	O
transcribed	O
in	O
the	O
direction	O
opposite	O
to	O
that	O
of	O
rv2623	B-Protein
)	O
(	O
Figure	O
1B	O
)	O
.	O

Deletion	O
of	O
specific	O
USPs	O
in	O
E	O
.	O
coli	O
results	O
in	O
growth	O
defects	O
in	O
vitro	O
[	O
8	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

For	O
example	O
,	O
an	O
E	O
.	O
coli	O
strain	O
deficient	O
for	O
UspA	B-Protein
exhibits	O
reduced	O
survival	O
in	O
stationary	O
phase	O
culture	O
[	O
14	O
]	O
.	O

However	O
,	O
the	O
in	O
vitro	O
growth	O
kinetics	O
of	O
Deltarv2623	B-Protein
M	O
.	O
tuberculosis	O
in	O
OADC	O
-	O
supplemented	O
Middlebrook	O
7H9	O
or	O
minimal	O
Sauton	O
'	O
s	O
medium	O
is	O
comparable	O
to	O
that	O
of	O
wildtype	O
Erdman	O
up	O
to	O
14	O
days	O
post	O
-	O
inoculation	O
(	O
Figure	O
2A	O
)	O
.	O

We	O
reasoned	O
that	O
a	O
potential	O
growth	O
-	O
regulating	O
attribute	O
of	O
Rv2623	B-Protein
might	O
be	O
masked	O
by	O
functional	O
redundancy	O
among	O
the	O
M	O
.	O
tuberculosis	O
USP	O
homologs	O
.	O

Indeed	O
,	O
partial	O
functional	O
overlap	O
has	O
been	O
demonstrated	O
among	O
the	O
E	O
.	O
coli	O
USPs	O
[	O
9	O
]	O
,	O
[	O
15	O
]	O
.	O

We	O
therefore	O
examined	O
the	O
effect	O
of	O
overexpression	O
of	O
this	O
USP	O
in	O
the	O
rapidly	O
growing	O
M	O
.	O
smegmatis	O
strain	O
mc2155	O
[	O
16	O
]	O
.	O

As	O
seen	O
in	O
Figure	O
2B	O
,	O
constitutive	O
overexpression	O
of	O
M	O
.	O
tuberculosis	O
rv2623	B-Protein
using	O
the	O
multi	O
-	O
copy	O
plasmid	O
pMV261	O
resulted	O
in	O
growth	O
deficiency	O
of	O
the	O
recipient	O
strain	O
both	O
on	O
solid	O
medium	O
(	O
Middlebrook	O
7H10	O
agar	O
)	O
and	O
in	O
the	O
liquid	O
medium	O
-	O
based	O
BD	O
BACTEC	O
9000MB	O
system	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
regulates	O
mycobacterial	O
growth	O
in	O
vitro	O
.	O

Rv2623	B-Protein
regulates	O
mycobacterial	O
growth	O
in	O
vivo	O
<EOS>	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
in	B-X
vivo	B-X
growth-regulatory	B-X
role	B-X
,	B-X
constitutive	B-X
overexpression	B-X
of	B-X
rv2623	B-X
attenuates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

Although	O
USP	O
family	O
proteins	O
are	O
expressed	O
by	O
many	O
bacterial	O
pathogens	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
to	O
date	O
,	O
there	O
has	O
only	O
been	O
one	O
in	O
vivo	O
study	O
,	O
which	O
showed	O
that	O
a	O
Salmonella	O
USP	O
promotes	O
virulence	O
in	O
mice	O
[	O
17	O
]	O
.	O

The	O
observation	O
that	O
Rv2623	B-Protein
modulates	O
mycobacterial	O
growth	O
in	O
vitro	O
prompted	O
us	O
to	O
examine	O
the	O
effect	O
of	O
this	O
USP	O
on	O
the	O
in	O
vivo	O
kinetics	O
of	O
M	O
.	O
tuberculosis	O
infection	O
.	O

Low	O
dose	O
aerosol	O
infection	O
of	O
outbred	O
Hartley	O
guinea	O
pigs	O
with	O
approximately30	O
CFU	O
revealed	O
a	O
clear	O
growth	O
advantage	O
of	O
the	O
Deltarv2623	B-Protein
mutant	O
strain	O
relative	O
to	O
wildtype	O
.	O

As	O
early	O
as	O
20	O
days	O
post	O
-	O
infection	O
,	O
the	O
number	O
of	O
M	O
.	O
tuberculosis	O
bacilli	O
present	O
in	O
the	O
lungs	O
of	O
Deltarv2623	B-Protein
-	O
infected	O
guinea	O
pigs	O
was	O
approximately10	O
-	O
fold	O
higher	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
than	O
those	O
infected	O
with	O
wildtype	O
Erdman	O
,	O
and	O
continued	O
to	O
rise	O
,	O
attaining	O
a	O
15	O
-	O
fold	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
difference	O
by	O
60	O
days	O
post	O
-	O
infection	O
(	O
Figure	O
3A	O
)	O
.	O

Guinea	O
pigs	O
are	O
able	O
to	O
control	O
the	O
growth	O
of	O
Erdman	O
bacilli	O
following	O
the	O
onset	O
of	O
adaptive	O
immunity	O
at	O
approximately3	O
weeks	O
post	O
-	O
infection	O
,	O
as	O
evident	O
by	O
the	O
relatively	O
stable	O
pulmonary	O
bacterial	O
burden	O
beyond	O
the	O
3	O
week	O
time	O
point	O
,	O
yet	O
levels	O
of	O
Deltarv2623	B-Protein
bacilli	O
continued	O
to	O
increase	O
at	O
a	O
reduced	O
but	O
steady	O
rate	O
resulting	O
in	O
a	O
rapidly	O
progressing	O
infection	O
.	O

Moreover	O
,	O
Deltarv2623	B-Protein
-	O
infected	O
guinea	O
pigs	O
were	O
moribund	O
at	O
60	O
days	O
post	O
-	O
infection	O
,	O
while	O
those	O
challenged	O
with	O
wildtype	O
Erdman	O
remained	O
relatively	O
healthy	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
mutant	O
strain	O
is	O
hypervirulent	O
in	O
this	O
model	O
.	O

Finally	O
,	O
complementation	O
with	O
a	O
single	O
integrated	O
copy	O
of	O
rv2623	B-Protein
expressed	O
from	O
a	O
constitutive	O
mycobacterial	O
promoter	O
(	O
Deltarv2623	B-Protein
attB	B-Protein
:	O
:	O
Phsp60Rv2623	B-Protein
)	O
abrogated	O
the	O
growth	O
advantage	O
of	O
the	O
deletion	O
mutant	O
(	O
Figure	O
3A	O
)	O
.	O

Also	O
consistent	O
with	O
the	O
fulminate	O
disease	O
progression	O
displayed	O
by	O
Deltarv2623	B-Protein
-	O
infected	O
guinea	O
pigs	O
are	O
the	O
more	O
severe	O
pathological	O
changes	O
observed	O
as	O
early	O
as	O
20	O
days	O
post	O
-	O
infection	O
in	O
the	O
lungs	O
of	O
these	O
animals	O
,	O
as	O
assessed	O
by	O
histopathological	O
studies	O
,	O
including	O
the	O
semi	O
-	O
quantitative	O
Total	O
Lung	O
Score	O
analysis	O
(	O
Figure	O
3B	O
and	O
Protocol	O
S1	O
)	O
.	O

Overall	O
,	O
the	O
progression	O
of	O
pulmonic	O
lesions	O
was	O
accelerated	O
in	O
Deltarv2623	B-Protein
-	O
infected	O
animals	O
compared	O
to	O
those	O
infected	O
with	O
wildtype	O
Erdman	O
,	O
accompanied	O
by	O
more	O
extensive	O
necrosis	O
and	O
widespread	O
fibrosis	O
.	O

This	O
increase	O
in	O
lung	O
pathology	O
was	O
also	O
largely	O
reversed	O
in	O
animals	O
infected	O
with	O
the	O
complemented	O
Deltarv2623	B-Protein
attB	B-Protein
:	O
:	O
Phsp60Rv2623	B-Protein
strain	O
(	O
Figure	O
3B	O
and	O
C	O
)	O
.	O

Results	O
of	O
the	O
complementation	O
experiments	O
were	O
further	O
validated	O
using	O
a	O
complemented	O
strain	O
Deltarv2623	B-Protein
attB	B-Protein
:	O
:	O
Prv2623Rv2623	B-Protein
,	O
whose	O
expression	O
of	O
the	O
wildtype	O
universal	O
stress	O
protein	O
is	O
driven	O
by	O
the	O
native	O
rv2623	B-Protein
promoter	O
[	O
18	O
]	O
(	O
Figure	O
3D	O
and	O
E	O
)	O
.	O

In	O
contrast	O
to	O
the	O
result	O
of	O
the	O
guinea	O
pig	O
study	O
,	O
we	O
observed	O
no	O
difference	O
in	O
the	O
kinetics	O
of	O
infection	O
between	O
C57BL	O
/	O
6	O
mice	O
infected	O
with	O
wildtype	O
M	O
.	O
tuberculosis	O
,	O
Deltarv2623	B-Protein
,	O
or	O
the	O
attB	B-Protein
:	O
:	O
Phsp60	B-Protein
Rv2623	B-Protein
complemented	O
strain	O
in	O
a	O
low	O
dose	O
aerogenic	O
model	O
[	O
19	O
]	O
,	O
as	O
assessed	O
by	O
lung	O
bacterial	O
burden	O
(	O
Figure	O
4A	O
)	O
.	O

However	O
,	O
the	O
mouse	O
is	O
a	O
relatively	O
resistant	O
host	O
to	O
M	O
.	O
tuberculosis	O
,	O
particularly	O
in	O
strains	O
such	O
as	O
C57BL	O
/	O
6	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

In	O
fact	O
,	O
evidence	O
exists	O
that	O
M	O
.	O
tuberculosis	O
triggers	O
an	O
immune	O
response	O
in	O
mice	O
that	O
is	O
in	O
excess	O
of	O
that	O
required	O
for	O
controlling	O
the	O
infection	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

Thus	O
,	O
the	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	B-Protein
observed	O
in	O
the	O
susceptible	O
guinea	O
pig	O
model	O
could	O
have	O
been	O
masked	O
in	O
the	O
C57BL	O
/	O
6	O
mice	O
.	O

Consequently	O
,	O
we	O
examined	O
the	O
virulence	O
of	O
Deltarv2623	B-Protein
in	O
the	O
relatively	O
susceptible	O
C3H	O
/	O
HeJ	O
mouse	O
strain	O
[	O
24	O
]	O
.	O

Indeed	O
,	O
the	O
Deltarv2623	B-Protein
mutant	O
was	O
markedly	O
more	O
virulent	O
relative	O
to	O
wildtype	O
Erdman	O
M	O
.	O
tuberculosis	O
following	O
aerogenic	O
infection	O
,	O
as	O
assessed	O
by	O
the	O
mean	O
survival	O
time	O
of	O
C3H	O
/	O
HeJ	O
mice	O
infected	O
with	O
these	O
strains	O
(	O
62	O
and	O
25	O
.	O
5	O
days	O
post	O
infection	O
for	O
Erdman	O
-	O
and	O
Deltarv2623	B-Protein
-	O
infected	O
mice	O
,	O
respectively	O
,	O
p	O
=	O
0	O
.	O
0014	O
;	O
Figure	O
4B	O
)	O
.	O

In	O
agreement	O
with	O
the	O
survival	O
data	O
,	O
quantification	O
of	O
tissue	O
bacterial	O
burden	O
revealed	O
a	O
growth	O
advantage	O
for	O
the	O
Rv2623	B-Protein
-	O
deficient	O
mutant	O
relative	O
to	O
wildtype	O
M	O
.	O
tuberculosis	O
Erdman	O
(	O
Figure	O
4C	O
)	O
.	O

Manifestation	O
of	O
this	O
hypervirulence	O
phenotype	O
is	O
apparent	O
as	O
early	O
as	O
3	O
weeks	O
post	O
-	O
infection	O
,	O
with	O
the	O
lung	O
bacterial	O
burden	O
of	O
mice	O
infected	O
with	O
Deltarv2623	B-Protein
M	O
.	O
tuberculosis	O
approximately100	O
fold	O
higher	O
than	O
that	O
in	O
the	O
wildtype	O
-	O
infected	O
animals	O
.	O

As	O
in	O
the	O
guinea	O
pig	O
studies	O
,	O
results	O
of	O
complementation	O
experiments	O
involving	O
the	O
reintroduction	O
of	O
a	O
single	O
copy	O
of	O
wildtype	O
rv2623	B-Protein
into	O
Deltarv2623	B-Protein
M	O
.	O
tuberculosis	O
reverses	O
the	O
hypervirulence	O
(	O
Figure	O
4C	O
)	O
exhibited	O
in	O
the	O
C3H	O
/	O
HeJ	O
model	O
,	O
thus	O
indicating	O
that	O
the	O
observed	O
growth	O
phenotype	O
of	O
the	O
tubercle	O
bacillus	O
deficient	O
for	O
the	O
universal	O
stress	O
protein	O
is	O
rv2623	B-Protein
-	O
specific	O
.	O

Finally	O
,	O
survival	O
of	O
Deltarv2623	B-Protein
-	O
infected	O
mice	O
was	O
also	O
significantly	O
reduced	O
in	O
another	O
susceptible	O
mouse	O
strain	O
,	O
C3HeB	O
/	O
FeJ	O
(	O
Figure	O
S1	O
)	O
.	O

Together	O
,	O
the	O
animal	O
studies	O
provide	O
strong	O
evidence	O
that	O
Rv2623	B-Protein
regulates	O
the	O
growth	O
of	O
M	O
.	O
tuberculosis	O
in	O
vivo	O
:	O
in	O
the	O
absence	O
of	O
Rv2623	B-Protein
,	O
the	O
tubercle	O
bacillus	O
fails	O
to	O
establish	O
a	O
chronic	O
persistent	O
infection	O
,	O
exhibiting	O
a	O
hypervirulent	O
phenotype	O
.	O

Effects	O
of	O
environmental	O
stress	O
on	O
growth	O
of	O
M	O
.	O
tuberculosis	O
Deltarv2623	B-Protein
in	O
vitro	O

Although	O
the	O
functions	O
of	O
universal	O
stress	O
proteins	O
have	O
yet	O
to	O
be	O
completely	O
defined	O
,	O
there	O
is	O
evidence	O
that	O
many	O
USPs	O
play	O
differential	O
roles	O
in	O
protecting	O
microbes	O
against	O
various	O
environmental	O
stresses	O
[	O
9	O
]	O
.	O

Therefore	O
,	O
the	O
hypervirulence	O
of	O
Deltarv2623	B-Protein
in	O
guinea	O
pigs	O
and	O
susceptible	O
mice	O
is	O
intriguing	O
;	O
if	O
Rv2623	B-Protein
provides	O
M	O
.	O
tuberculosis	O
protection	O
against	O
stress	O
,	O
it	O
might	O
be	O
expected	O
that	O
the	O
Rv2623	B-Protein
-	O
deficient	O
mutant	O
would	O
be	O
attenuated	O
in	O
vivo	O
.	O

The	O
growth	O
kinetics	O
and	O
survival	O
of	O
the	O
Deltarv2623	B-Protein
strain	O
was	O
examined	O
under	O
various	O
stress	O
conditions	O
,	O
including	O
those	O
likely	O
to	O
be	O
present	O
during	O
M	O
.	O
tuberculosis	O
infection	O
.	O

These	O
included	O
oxidative	O
stress	O
(	O
superoxide	O
anion	O
,	O
O2	O
-	O
)	O
,	O
DNA	O
damage	O
(	O
UV	O
irradiation	O
,	O
mitomycin	O
C	O
)	O
,	O
heat	O
shock	O
(	O
53degreesC	O
)	O
,	O
and	O
acidic	O
culture	O
(	O
pH	O
4	O
.	O
0	O
)	O
.	O

The	O
use	O
of	O
streptonigrin	O
,	O
an	O
antibiotic	O
whose	O
toxicity	O
correlates	O
with	O
levels	O
of	O
free	O
iron	O
,	O
was	O
based	O
on	O
the	O
observation	O
that	O
the	O
intracellular	O
environment	O
of	O
macrophages	O
can	O
induce	O
a	O
iron	O
-	O
scavenging	O
response	O
in	O
mycobacteria	O
[	O
25	O
]	O
,	O
perhaps	O
as	O
a	O
means	O
of	O
maintaining	O
adequate	O
levels	O
of	O
this	O
important	O
growth	O
factor	O
,	O
and	O
that	O
an	O
E	O
.	O
coli	O
USP	O
was	O
shown	O
to	O
regulate	O
iron	O
uptake	O
[	O
9	O
]	O
.	O

The	O
results	O
showed	O
that	O
the	O
mutant	O
strain	O
was	O
no	O
more	O
susceptible	O
to	O
growth	O
inhibition	O
than	O
was	O
wild	O
type	O
Erdman	O
under	O
all	O
of	O
the	O
stress	O
conditions	O
tested	O
(	O
Figure	O
S2	O
)	O
.	O

These	O
results	O
support	O
the	O
notion	O
that	O
it	O
is	O
unlikely	O
that	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
is	O
essential	O
for	O
resistance	O
to	O
stresses	O
encountered	O
in	O
the	O
host	O
,	O
which	O
is	O
consistent	O
with	O
the	O
observed	O
in	O
vivo	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	B-Protein
.	O

M	O
.	O
tuberculosis	O
Rv2623	B-Protein
is	O
a	O
nucleotide	O
-	O
binding	O
protein	O
<EOS>	B-X
Tuberculous	B-X
latency	B-X
and	B-X
reactivation	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
tuberculosis	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
that	B-X
regulate	B-X
these	B-X
processes	B-X
remain	B-X
unclear	B-X
.	B-X
The	B-X
Mycobacterium	B-X
tuberculosisuniversal	B-X
stress	B-X
protein	B-X
(	B-X
USP	B-X
)	B-X
homolog	B-X
,	B-X
rv2623	B-X
,	B-X
is	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
induced	B-X
genes	B-X
when	B-X
the	B-X
tubercle	B-X
bacillus	B-X
is	B-X
subjected	B-X
to	B-X
hypoxia	B-X
and	B-X
nitrosative	B-X
stress	B-X
,	B-X
conditions	B-X
thought	B-X
to	B-X
promote	B-X
latency	B-X
.	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

We	O
began	O
a	O
biochemical	O
characterization	O
of	O
Rv2623	B-Protein
in	O
order	O
to	O
gain	O
insight	O
into	O
the	O
relationship	O
between	O
the	O
molecular	O
structure	O
/	O
function	O
of	O
this	O
USP	O
and	O
it	O
'	O
s	O
growth	O
-	O
regulatory	O
properties	O
.	O

M	O
.	O
tuberculosis	O
Rv2623	B-Protein
was	O
expressed	O
in	O
E	O
.	O
coli	O
and	O
purified	O
to	O
homogeneity	O
for	O
biochemical	O
studies	O
.	O

SDS	O
-	O
PAGE	O
analysis	O
of	O
affinity	O
-	O
purified	O
His6	O
-	O
Rv2623	B-Protein
revealed	O
a	O
single	O
band	O
that	O
approximates	O
the	O
predicted	O
molecular	O
mass	O
of	O
approximately31	O
.	O
6	O
kDa	O
,	O
which	O
was	O
identified	O
by	O
immunoblotting	O
as	O
Rv2623	B-Protein
(	O
Figure	O
S3	O
)	O
.	O

Gel	O
filtration	O
analysis	O
of	O
native	O
His6	O
-	O
Rv2623	B-Protein
revealed	O
that	O
the	O
purified	O
protein	O
exists	O
primarily	O
as	O
a	O
single	O
species	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
61	O
+	O
/	O
-	O
1	O
kDa	O
;	O
suggesting	O
that	O
Rv2623	B-Protein
is	O
a	O
dimer	O
under	O
native	O
conditions	O
(	O
Figure	O
S3	O
)	O
,	O
an	O
observation	O
that	O
was	O
later	O
confirmed	O
using	O
nano	O
electrospray	O
ionization	O
(	O
nano	O
ESI	O
)	O
mass	O
spectrometry	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
nucleotide	O
-	O
binding	O
capacity	O
of	O
a	O
subset	O
of	O
USPs	O
was	O
discovered	O
following	O
the	O
observation	O
that	O
MJ0577	B-Protein
,	O
a	O
single	O
-	O
domain	O
USP	O
from	O
Methanococcus	O
jannaschii	O
,	O
co	O
-	O
purifies	O
and	O
co	O
-	O
crystallizes	O
with	O
ATP	O
[	O
26	O
]	O
.	O

On	O
the	O
basis	O
of	O
structures	O
of	O
ATP	O
-	O
binding	O
and	O
non	O
-	O
ATP	O
-	O
binding	O
USPs	O
,	O
a	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motif	O
was	O
suggested	O
to	O
be	O
essential	O
for	O
the	O
binding	O
of	O
ATP	O
[	O
27	O
]	O
.	O

The	O
presence	O
of	O
this	O
motif	O
in	O
each	O
of	O
the	O
two	O
tandem	O
USP	O
domains	O
of	O
Rv2623	B-Protein
[	O
7	O
]	O
raised	O
the	O
possibility	O
that	O
this	O
protein	O
possesses	O
ATP	O
binding	O
activity	O
.	O

An	O
HPLC	O
-	O
based	O
examination	O
of	O
supernatants	O
from	O
boiled	O
samples	O
of	O
His6	O
-	O
Rv2623	B-Protein
demonstrated	O
that	O
His6	O
-	O
Rv2623	B-Protein
co	O
-	O
purifies	O
with	O
both	O
ATP	O
and	O
ADP	O
(	O
Figure	O
5	O
)	O
.	O

Analysis	O
of	O
E	O
.	O
coli	O
-	O
expressed	O
Rv2623	B-Protein
using	O
nano	O
ESI	O
mass	O
spectrometry	O
also	O
demonstrated	O
that	O
an	O
ATP	O
-	O
saturated	O
form	O
of	O
dimeric	O
Rv2623	B-Protein
(	O
composed	O
of	O
2	O
bound	O
ATP	O
molecules	O
per	O
monomer	O
)	O
constitutes	O
at	O
least	O
half	O
of	O
the	O
purified	O
sample	O
(	O
data	O
not	O
shown	O
)	O
.	O

Measurement	O
of	O
the	O
binding	O
stoichiometry	O
,	O
which	O
comprised	O
HPLC	O
-	O
based	O
quantification	O
of	O
adenine	O
nucleotides	O
from	O
the	O
boiled	O
supernatant	O
and	O
spectral	O
analysis	O
of	O
heat	O
denatured	O
Rv2623	B-Protein
following	O
reconstitution	O
in	O
6	O
M	O
guanidine	O
-	O
HCl	O
,	O
yields	O
1	O
.	O
4	O
+	O
/	O
-	O
0	O
.	O
2	O
nucleotide	O
equivalents	O
/	O
monomer	O
with	O
an	O
overall	O
content	O
of	O
86	O
+	O
/	O
-	O
4	O
%	O
ATP	O
(	O
14	O
+	O
/	O
-	O
4	O
%	O
ADP	O
)	O
.	O

Thus	O
,	O
Rv2623	B-Protein
binds	O
endogenous	O
adenine	O
nucleotides	O
in	O
E	O
.	O
coli	O
,	O
and	O
the	O
association	O
is	O
sufficiently	O
tight	O
that	O
nearly	O
75	O
%	O
of	O
the	O
nucleotide	O
binding	O
sites	O
are	O
occupied	O
upon	O
purification	O
.	O

Indeed	O
,	O
nucleotide	O
did	O
not	O
completely	O
dissociate	O
from	O
the	O
protein	O
following	O
an	O
extensive	O
,	O
two	O
-	O
week	O
dialysis	O
with	O
multiple	O
changes	O
against	O
nucleotide	O
-	O
free	O
buffer	O
(	O
approximately	O
0	O
.	O
3	O
nucleotide	O
equivalents	O
per	O
monomer	O
remain	O
)	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
propose	B-X
that	B-X
the	B-X
metabolism	B-X
of	B-X
cancer	B-X
cells	B-X
,	B-X
and	B-X
indeed	B-X
all	B-X
proliferating	B-X
cells	B-X
,	B-X
is	B-X
adapted	B-X
to	B-X
facilitate	B-X
the	B-X
uptake	B-X
and	B-X
incorporation	B-X
of	B-X
nutrients	B-X
into	B-X
the	B-X
biomass	B-X
(	B-X
e.g.	B-X
,	B-X
nucleotides	B-X
,	B-X
amino	B-X
acids	B-X
,	B-X
and	B-X
lipids	B-X
)	B-X
needed	B-X
to	B-X
produce	B-X
a	B-X
new	B-X
cell	B-X
.	B-X
They	B-X
are	B-X
members	B-X
of	B-X
a	B-X
family	B-X
of	B-X
proteins	B-X
that	B-X
includes	B-X
11	B-X
subfamilies	B-X
with	B-X
different	B-X
substrate	B-X
specificities	B-X
.	B-X
cAMP	B-X
and	B-X
cGMP	B-X
are	B-X
two	B-X
key	B-X
second	B-X
messengers	B-X
that	B-X
modulate	B-X
a	B-X
wide	B-X
array	B-X
of	B-X
intracellular	B-X
processes	B-X
and	B-X
neurobehavioral	B-X
functions	B-X
,	B-X
including	B-X
memory	B-X
and	B-X
cognition	B-X
.	B-X
Indeed	B-X
,	B-X
clinical	B-X
trials	B-X
are	B-X
in	B-X
progress	B-X
to	B-X
treat	B-X
patients	B-X
with	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
schizophrenia	B-X
,	B-X
depression	B-X
,	B-X
and	B-X
autism	B-X
spectrum	B-X
disorders	B-X
.	B-X
Among	B-X
the	B-X
most	B-X
recent	B-X
results	B-X
,	B-X
the	B-X
application	B-X
of	B-X
some	B-X
PDE	B-X
inhibitors	B-X
(	B-X
PDE2A	B-X
,	B-X
PDE3	B-X
,	B-X
PDE4/4D	B-X
,	B-X
and	B-X
PDE10A	B-X
)	B-X
to	B-X
treat	B-X
neurodevelopmental	B-X
diseases	B-X
,	B-X
including	B-X
autism	B-X
spectrum	B-X
disorders	B-X
and	B-X
intellectual	B-X
disability	B-X
,	B-X
is	B-X
a	B-X
significant	B-X
advance	B-X
,	B-X
since	B-X
no	B-X
specific	B-X
therapies	B-X
are	B-X
available	B-X
for	B-X
these	B-X
disorders	B-X
that	B-X
have	B-X
a	B-X
large	B-X
prevalence	B-X
.	B-X

It	O
is	O
conceivable	O
that	O
the	O
presence	O
of	O
ADP	O
is	O
the	O
consequence	O
of	O
an	O
Rv2623	B-Protein
-	O
associated	O
ATP	O
activity	O
and	O
this	O
putative	O
ATPase	O
function	O
is	O
currently	O
under	O
investigation	O
.	O

The	O
crystal	O
structure	O
of	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
:	O
Dimer	O
assembly	O
and	O
ATP	O
-	O
binding	O
capacity	O

To	O
examine	O
the	O
biochemical	O
mechanisms	O
responsible	O
for	O
Rv2623	B-Protein
function	O
,	O
we	O
determined	O
the	O
crystal	O
structure	O
of	O
wild	O
-	O
type	O
Rv2623	B-Protein
at	O
a	O
resolution	O
of	O
2	O
.	O
9	O
A	O
.	O

The	O
structure	O
reveals	O
a	O
compact	O
,	O
2	O
-	O
fold	O
symmetric	O
dimer	O
.	O
<EOS>	B-X
p53	B-X
stability	B-X
is	B-X
regulated	B-X
by	B-X
the	B-X
protein	B-X
Hdm2	B-X
,	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
that	B-X
binds	B-X
to	B-X
p53	B-X
and	B-X
promotes	B-X
its	B-X
ubiquitination	B-X
and	B-X
degradation	B-X
.	B-X
The	B-X
C-terminal	B-X
domain	B-X
of	B-X
Hdm2	B-X
,	B-X
which	B-X
is	B-X
critical	B-X
for	B-X
this	B-X
activity	B-X
,	B-X
has	B-X
been	B-X
classified	B-X
as	B-X
a	B-X
RING	B-X
domain	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
sequence	B-X
homology	B-X
,	B-X
although	B-X
it	B-X
lacks	B-X
the	B-X
canonical	B-X
set	B-X
of	B-X
zinc	B-X
ligands	B-X
(	B-X
RING	B-X
domains	B-X
typically	B-X
have	B-X
C3HC4	B-X
or	B-X
C4C4	B-X
zinc	B-X
coordination	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
the	B-X
solution	B-X
structure	B-X
of	B-X
the	B-X
C2H2C4	B-X
RING	B-X
domain	B-X
of	B-X
Hdm2	B-X
(	B-X
429-491	B-X
)	B-X
,	B-X
which	B-X
reveals	B-X
a	B-X
symmetrical	B-X
dimer	B-X
with	B-X
a	B-X
unique	B-X
cross-brace	B-X
zinc-binding	B-X
scheme	B-X
.	B-X
Each	B-X
subunit	B-X
has	B-X
one	B-X
Cys4	B-X
Zn	B-X
site	B-X
and	B-X
one	B-X
His2Cys2	B-X
Zn	B-X
site	B-X
.	B-X
The	B-X
global	B-X
fold	B-X
of	B-X
each	B-X
subunit	B-X
is	B-X
similar	B-X
to	B-X
those	B-X
reported	B-X
for	B-X
other	B-X
RING	B-X
domains	B-X
,	B-X
with	B-X
a	B-X
compact	B-X
betabetaalphabeta	B-X
fold	B-X
,	B-X
a	B-X
small	B-X
hydrophobic	B-X
core	B-X
,	B-X
and	B-X
two	B-X
Zn	B-X
ions	B-X
,	B-X
which	B-X
are	B-X
essential	B-X
for	B-X
maintaining	B-X
the	B-X
domain	B-X
structure	B-X
.	B-X
The	B-X
dimer	B-X
structure	B-X
is	B-X
maintained	B-X
by	B-X
an	B-X
extensive	B-X
interface	B-X
that	B-X
buries	B-X
a	B-X
large	B-X
hydrophobic	B-X
area	B-X
on	B-X
each	B-X
subunit	B-X
.	B-X
It	B-X
has	B-X
been	B-X
proposed	B-X
that	B-X
Hdm2	B-X
and	B-X
its	B-X
homologue	B-X
HdmX	B-X
form	B-X
a	B-X
stable	B-X
heterodimer	B-X
through	B-X
their	B-X
RING	B-X
domains	B-X
,	B-X
resulting	B-X
in	B-X
a	B-X
synergistic	B-X
increase	B-X
in	B-X
observed	B-X
E3	B-X
activity	B-X
.	B-X
To	B-X
test	B-X
this	B-X
proposal	B-X
,	B-X
we	B-X
prepared	B-X
an	B-X
HdmX	B-X
RING	B-X
construct	B-X
and	B-X
showed	B-X
by	B-X
NMR	B-X
titration	B-X
that	B-X
it	B-X
forms	B-X
a	B-X
tight	B-X
1:1	B-X
complex	B-X
with	B-X
the	B-X
Hdm2	B-X
RING	B-X
.	B-X
The	B-X
resonances	B-X
most	B-X
perturbed	B-X
by	B-X
heterodimer	B-X
formation	B-X
are	B-X
located	B-X
within	B-X
the	B-X
subunit	B-X
interface	B-X
of	B-X
the	B-X
homodimer	B-X
,	B-X
far	B-X
removed	B-X
from	B-X
the	B-X
surface	B-X
expected	B-X
to	B-X
form	B-X
the	B-X
docking	B-X
site	B-X
of	B-X
the	B-X
E2	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
,	B-X
providing	B-X
a	B-X
structure-based	B-X
rationale	B-X
for	B-X
the	B-X
function	B-X
of	B-X
the	B-X
RING	B-X
domains	B-X
in	B-X
p53	B-X
ubiquitination	B-X
.	B-X

Each	O
monomer	O
is	O
composed	O
of	O
tandem	O
USP	O
domains	O
[	O
residues	O
6	O
-	O
154	O
(	O
domain	O
1	O
)	O
,	O
155	O
-	O
294	O
(	O
domain2	O
)	O
]	O
that	O
share	O
26	O
%	O
sequence	O
identity	O
and	O
significant	O
structural	O
homology	O
(	O
residues	O
6	O
-	O
154	O
and	O
155	O
-	O
294	O
comprise	O
domains	O
1	O
and	O
2	O
,	O
respectively	O
;	O
interdomain	O
rms	O
=	O
2	O
.	O
04	O
A	O
for	O
140	O
equivalent	O
Calpha	O
'	O
s	O
)	O
.	O

Individual	O
domains	O
,	O
which	O
consist	O
of	O
a	O
twisted	O
,	O
five	O
-	O
stranded	O
,	O
parallel	O
beta	O
sheet	O
flanked	O
by	O
four	O
alpha	O
helices	O
,	O
unite	O
through	O
an	O
antiparallel	O
,	O
cross	O
-	O
strand	O
(	O
beta5	O
-	O
beta10	O
)	O
interaction	O
that	O
produces	O
a	O
central	O
dyad	O
axis	O
between	O
beta5	O
/	O
beta10	O
and	O
a	O
continuous	O
,	O
ten	O
-	O
stranded	O
,	O
mixed	O
beta	O
sheet	O
in	O
the	O
complete	O
monomer	O
.	O

Each	O
domain	O
possesses	O
a	O
pair	O
of	O
conserved	O
betaalphabeta	O
motifs	O
(	O
domain	O
1	O
:	O
beta1	O
-	O
L1	O
-	O
alpha1	O
-	O
beta2	O
,	O
beta4	O
-	O
L2	O
-	O
alpha4	O
-	O
beta5	O
;	O
domain	O
2	O
:	O
beta6	O
-	O
L3	O
-	O
alpha5	O
-	O
beta7	O
,	O
beta9	O
-	O
L4	O
-	O
alpha8	O
-	O
beta10	O
)	O
that	O
encompass	O
four	O
loops	O
(	O
designated	O
L1	O
-	O
L4	O
)	O
responsible	O
for	O
ATP	O
recognition	O
(	O
Figure	O
6A	O
and	O
C	O
)	O
.	O

A	O
"	O
U	O
-	O
shaped	O
"	O
ATP	O
molecule	O
that	O
lies	O
within	O
a	O
cleft	O
near	O
the	O
monomer	O
surface	O
is	O
stabilized	O
by	O
1	O
)	O
a	O
cluster	O
of	O
hydrophobic	O
residues	O
(	O
I14	O
,	O
V41	O
,	O
H42	O
,	O
V116	O
/	O
132	O
/	O
261	O
/	O
277	O
/	O
281	O
,	O
L136	O
,	O
A175	O
)	O
that	O
forge	O
the	O
adenine	O
/	O
ribose	O
-	O
binding	O
scaffold	O
,	O
2	O
)	O
a	O
pair	O
of	O
conserved	O
L1	O
/	O
L3	O
aspartates	O
(	O
D15	O
-	O
L1	O
/	O
D167	O
-	O
L3	O
)	O
,	O
and	O
3	O
)	O
small	O
phosphoryl	O
/	O
ribosyl	O
-	O
binding	O
residues	O
within	O
the	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motifs	O
that	O
comprise	O
L2	O
/	O
L4	O
(	O
G120	O
/	O
265	O
/	O
267	O
/	O
268	O
and	O
S131	O
/	O
276	O
)	O
(	O
Figures	O
6A	O
,	O
C	O
and	O
7A	O
)	O
.	O

Dimerization	O
of	O
Rv2623	B-Protein
occurs	O
along	O
a	O
2	O
-	O
fold	O
axis	O
orthogonal	O
to	O
the	O
intramonomer	O
dyad	O
and	O
juxtaposes	O
ATP	O
binding	O
pockets	O
from	O
opposing	O
monomers	O
(	O
Figure	O
6B	O
)	O
.	O

Phylogenomic	O
analysis	O
places	O
Rv2623	B-Protein
in	O
a	O
Uniprot	O
/	O
TrEMBL	O
family	O
(	O
Q5YVE7	O
)	O
of	O
370	O
tandem	O
-	O
domain	O
USPs	O
,	O
and	O
a	O
113	O
-	O
member	O
subfamily	O
(	O
N631	O
)	O
that	O
consists	O
almost	O
exclusively	O
of	O
actinobacterial	O
representatives	O
(	O
Text	O
S1	O
)	O
.	O

Structure	O
-	O
based	O
sequence	O
alignments	O
of	O
both	O
Rv2623	B-Protein
domains	O
with	O
the	O
N631	O
consensus	O
suggest	O
that	O
domain	O
2	O
,	O
which	O
exhibits	O
significantly	O
higher	O
conservation	O
than	O
domain	O
1	O
across	O
global	O
and	O
ATP	O
-	O
binding	O
subfamily	O
consensus	O
sequences	O
,	O
represents	O
the	O
ancestral	O
domain	O
among	O
ATP	O
-	O
binding	O
USPs	O
with	O
tandem	O
-	O
type	O
architectures	O
.	O

Interestingly	O
,	O
the	O
domain	O
fold	O
and	O
interdomain	O
organization	O
observed	O
for	O
Rv2623	B-Protein
is	O
broadly	O
conserved	O
:	O
these	O
features	O
are	O
shared	O
among	O
single	O
domain	O
USP	O
structures	O
,	O
both	O
monomeric	O
and	O
dimeric	O
,	O
that	O
are	O
presently	O
represented	O
within	O
the	O
PDB	O
.	O

As	O
this	O
manuscript	O
was	O
under	O
preparation	O
,	O
a	O
second	O
,	O
lower	O
resolution	O
(	O
3	O
.	O
2	O
A	O
)	O
crystal	O
form	O
of	O
Rv2623	B-Protein
(	O
PDB	O
ID	O
2JAX	O
)	O
was	O
released	O
for	O
public	O
access	O
.	O

This	O
structure	O
is	O
nearly	O
identical	O
to	O
the	O
present	O
model	O
as	O
demonstrated	O
by	O
superposition	O
over	O
the	O
ATP	O
ligands	O
and	O
the	O
monomeric	O
and	O
dimeric	O
forms	O
(	O
rmsds	O
are	O
0	O
.	O
57	O
and	O
0	O
.	O
81	O
for	O
258	O
and	O
517	O
matched	O
CA	O
'	O
s	O
,	O
respectively	O
)	O
.	O

The	O
differences	O
localize	O
primarily	O
to	O
flexible	O
loop	O
regions	O
(	O
residues	O
44	O
-	O
58	O
,	O
150	O
-	O
159	O
)	O
that	O
,	O
while	O
disordered	O
in	O
2JAX	O
,	O
are	O
partially	O
stabilized	O
in	O
the	O
present	O
structure	O
by	O
local	O
crystal	O
contacts	O
.	O

To	O
gain	O
insight	O
into	O
the	O
ATP	O
-	O
binding	O
mode	O
(	O
s	O
)	O
exhibited	O
by	O
Rv2623	B-Protein
,	O
the	O
structural	O
features	O
of	O
the	O
ATP	O
-	O
binding	O
pocket	O
of	O
domains	O
1	O
/	O
2	O
were	O
compared	O
to	O
the	O
monomer	O
fold	O
of	O
the	O
representative	O
ATP	O
-	O
binding	O
USP	O
,	O
MJ0577	B-Protein
(	O
PDBID	O
1MJH	O
)	O
[	O
26	O
]	O
.	O

Overlay	O
of	O
these	O
structures	O
reveals	O
very	O
considerable	O
similarity	O
for	O
the	O
residues	O
that	O
form	O
the	O
binding	O
pockets	O
and	O
the	O
associated	O
ATP	O
molecules	O
,	O
for	O
which	O
the	O
triphosphoryl	O
moieties	O
assume	O
virtually	O
indistinguishable	O
conformations	O
.	O

Relatively	O
subtle	O
structural	O
and	O
phylogenetic	O
differences	O
that	O
exist	O
between	O
the	O
ATP	O
-	O
binding	O
pockets	O
might	O
nevertheless	O
confer	O
divergent	O
binding	O
and	O
/	O
or	O
regulatory	O
properties	O
to	O
the	O
tandem	O
domains	O
.	O

Generation	O
and	O
analysis	O
of	O
ATP	O
-	O
binding	O
-	O
deficient	O
Rv2623	B-Protein
mutants	O

To	O
explore	O
the	O
relationship	O
between	O
the	O
putative	O
ATP	O
-	O
dependent	O
biochemical	O
function	O
of	O
Rv2623	B-Protein
and	O
the	O
growth	O
-	O
regulating	O
attribute	O
of	O
Rv2623	B-Protein
,	O
we	O
engineered	O
mutations	O
within	O
the	O
L1	O
(	O
D15E	O
)	O
and	O
beta4	O
(	O
G117A	O
)	O
conserved	O
residues	O
that	O
were	O
predicted	O
,	O
on	O
the	O
basis	O
of	O
the	O
crystal	O
structure	O
,	O
to	O
disrupt	O
ATP	O
recognition	O
(	O
Figure	O
7A	O
)	O
.	O

In	O
silico	O
replacement	O
of	O
the	O
beta4	O
G117	O
side	O
chain	O
hydrogen	O
with	O
a	O
methyl	O
group	O
suggested	O
that	O
any	O
residue	O
larger	O
than	O
glycine	O
at	O
this	O
position	O
is	O
likely	O
to	O
perturb	O
both	O
of	O
the	O
conserved	O
loop	O
regions	O
in	O
contact	O
with	O
the	O
nucleotide	O
.	O

Similarly	O
,	O
extension	O
of	O
the	O
D15	O
side	O
chain	O
to	O
glutamate	O
was	O
also	O
predicted	O
to	O
interfere	O
with	O
the	O
ATP	O
-	O
binding	O
conformation	O
(	O
Figure	O
7A	O
)	O
.	O

HPLC	O
analysis	O
of	O
nucleotides	O
extracted	O
from	O
Rv2623D15E	B-Protein
and	O
Rv2623G117A	B-Protein
revealed	O
that	O
the	O
mutant	O
proteins	O
are	O
indeed	O
deficient	O
in	O
ATP	O
-	O
binding	O
,	O
exhibiting	O
approximately34	O
%	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
approximately29	O
%	O
(	O
p	O
=	O
0	O
.	O
0018	O
)	O
of	O
the	O
amount	O
of	O
ATP	O
bound	O
by	O
wild	O
-	O
type	O
Rv2623	B-Protein
,	O
respectively	O
(	O
Figure	O
7B	O
)	O
.	O

Likewise	O
,	O
following	O
an	O
overnight	O
incubation	O
with	O
[	O
alpha	O
-	O
33P	O
]	O
ATP	O
at	O
4degreesC	O
,	O
the	O
amount	O
of	O
protein	O
-	O
bound	O
radioactivity	O
,	O
which	O
represented	O
a	O
very	O
small	O
fraction	O
of	O
the	O
total	O
ATP	O
binding	O
sites	O
,	O
was	O
significantly	O
less	O
for	O
the	O
mutant	O
proteins	O
than	O
wild	O
-	O
type	O
Rv2623	B-Protein
(	O
data	O
not	O
shown	O
)	O
.	O

Importantly	O
,	O
thermal	O
denaturation	O
profiles	O
of	O
wild	O
-	O
type	O
Rv2623	B-Protein
,	O
Rv2623D15E	B-Protein
and	O
Rv2623G117A	B-Protein
demonstrated	O
virtually	O
identical	O
Tm	O
values	O
,	O
implying	O
that	O
the	O
native	O
Rv2623	B-Protein
fold	O
was	O
not	O
destabilized	O
by	O
these	O
mutations	O
(	O
Figure	O
7C	O
)	O
.	O

It	O
is	O
therefore	O
likely	O
that	O
the	O
D15E	O
and	O
G117A	O
mutations	O
produced	O
local	O
structural	O
changes	O
in	O
the	O
ATP	O
binding	O
loops	O
that	O
contributed	O
directly	O
to	O
the	O
reduced	O
levels	O
of	O
bound	O
ATP	O
in	O
comparing	O
to	O
wild	O
-	O
type	O
Rv2623	B-Protein
.	O

The	O
growth	O
-	O
regulating	O
property	O
of	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
is	O
dependent	O
on	O
its	O
ability	O
to	O
bind	O
ATP	O
<EOS>	B-X
Tuberculous	B-X
latency	B-X
and	B-X
reactivation	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
tuberculosis	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
that	B-X
regulate	B-X
these	B-X
processes	B-X
remain	B-X
unclear	B-X
.	B-X
The	B-X
Mycobacterium	B-X
tuberculosisuniversal	B-X
stress	B-X
protein	B-X
(	B-X
USP	B-X
)	B-X
homolog	B-X
,	B-X
rv2623	B-X
,	B-X
is	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
induced	B-X
genes	B-X
when	B-X
the	B-X
tubercle	B-X
bacillus	B-X
is	B-X
subjected	B-X
to	B-X
hypoxia	B-X
and	B-X
nitrosative	B-X
stress	B-X
,	B-X
conditions	B-X
thought	B-X
to	B-X
promote	B-X
latency	B-X
.	B-X
Induction	B-X
of	B-X
rv2623	B-X
also	B-X
occurs	B-X
when	B-X
M.	B-X
tuberculosis	B-X
encounters	B-X
conditions	B-X
associated	B-X
with	B-X
growth	B-X
arrest	B-X
,	B-X
such	B-X
as	B-X
the	B-X
intracellular	B-X
milieu	B-X
of	B-X
macrophages	B-X
and	B-X
in	B-X
the	B-X
lungs	B-X
of	B-X
mice	B-X
with	B-X
chronic	B-X
tuberculosis	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
Rv2623	B-X
regulates	B-X
tuberculosis	B-X
latency	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
an	B-X
Rv2623-deficient	B-X
mutant	B-X
fails	B-X
to	B-X
establish	B-X
chronic	B-X
tuberculous	B-X
infection	B-X
in	B-X
guinea	B-X
pigs	B-X
and	B-X
mice	B-X
,	B-X
exhibiting	B-X
a	B-X
hypervirulence	B-X
phenotype	B-X
associated	B-X
with	B-X
increased	B-X
bacterial	B-X
burden	B-X
and	B-X
mortality	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
in	B-X
vivo	B-X
growth-regulatory	B-X
role	B-X
,	B-X
constitutive	B-X
overexpression	B-X
of	B-X
rv2623	B-X
attenuates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
.	B-X
Biochemical	B-X
analysis	B-X
of	B-X
purified	B-X
Rv2623	B-X
suggested	B-X
that	B-X
this	B-X
mycobacterial	B-X
USP	B-X
binds	B-X
ATP	B-X
,	B-X
and	B-X
the	B-X
2.9-A-resolution	B-X
crystal	B-X
structure	B-X
revealed	B-X
that	B-X
Rv2623	B-X
engages	B-X
ATP	B-X
in	B-X
a	B-X
novel	B-X
nucleotide-binding	B-X
pocket	B-X
.	B-X
Structure-guided	B-X
mutagenesis	B-X
yielded	B-X
Rv2623	B-X
mutants	B-X
with	B-X
reduced	B-X
ATP-binding	B-X
capacity	B-X
.	B-X
Analysis	B-X
of	B-X
mycobacteria	B-X
overexpressing	B-X
these	B-X
mutants	B-X
revealed	B-X
that	B-X
the	B-X
in	B-X
vitro	B-X
growth-inhibitory	B-X
property	B-X
of	B-X
Rv2623	B-X
correlates	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
ATP	B-X
.	B-X
Together	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
i	B-X
)	B-X
M.	B-X
tuberculosis	B-X
Rv2623	B-X
regulates	B-X
mycobacterial	B-X
growth	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
ii	B-X
)	B-X
Rv2623	B-X
is	B-X
required	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
the	B-X
tubercle	B-X
bacillus	B-X
into	B-X
the	B-X
chronic	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
the	B-X
host	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
iii	B-X
)	B-X
Rv2623	B-X
binds	B-X
ATP	B-X
;	B-X
and	B-X
iv	B-X
)	B-X
the	B-X
growth-regulatory	B-X
attribute	B-X
of	B-X
this	B-X
USP	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
ATP-binding	B-X
activity	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Rv2623	B-X
may	B-X
function	B-X
as	B-X
an	B-X
ATP-dependent	B-X
signaling	B-X
intermediate	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
promotes	B-X
persistent	B-X
infection	B-X
.	B-X

We	O
next	O
sought	O
to	O
probe	O
the	O
relationship	O
between	O
the	O
nucleotide	O
-	O
binding	O
capacity	O
and	O
growth	O
regulation	O
by	O
this	O
mycobacterial	O
USP	O
.	O

Both	O
the	O
D15E	O
and	O
G117A	O
mutant	O
proteins	O
were	O
overexpressed	O
in	O
M	O
.	O
smegmatis	O
mc2155	O
at	O
levels	O
equivalent	O
to	O
that	O
of	O
wild	O
-	O
type	O
Rv2623	B-Protein
(	O
Figure	O
S4	O
)	O
.	O

Results	O
of	O
these	O
studies	O
demonstrated	O
that	O
while	O
overexpression	O
of	O
wildtype	O
Rv2623	B-Protein
retards	O
the	O
growth	O
of	O
the	O
recipient	O
strain	O
relative	O
to	O
cells	O
transformed	O
with	O
vector	O
alone	O
,	O
growth	O
of	O
the	O
strains	O
overexpressing	O
ATP	O
-	O
binding	O
-	O
deficient	O
mutant	O
Rv2623	B-Protein
are	O
only	O
minimally	O
affected	O
by	O
overexpression	O
as	O
assessed	O
by	O
spotting	O
serial	O
dilutions	O
of	O
the	O
cultures	O
of	O
the	O
appropriate	O
strains	O
onto	O
solid	O
Middlebrook	O
7H10	O
agar	O
(	O
data	O
not	O
shown	O
)	O
as	O
well	O
as	O
by	O
monitoring	O
the	O
time	O
to	O
detection	O
using	O
the	O
BD	O
BACTEC	O
9000MB	O
system	O
(	O
Figure	O
8A	O
)	O
.	O

The	O
distinct	O
effects	O
exhibited	O
by	O
the	O
wild	O
type	O
and	O
the	O
G117A	O
and	O
D15E	O
mutants	O
defective	O
in	O
ATP	O
binding	O
suggests	O
a	O
direct	O
correlation	O
between	O
growth	O
attenuation	O
and	O
ATP	O
binding	O
(	O
Figure	O
7B	O
)	O
.	O

To	O
examine	O
whether	O
the	O
effects	O
of	O
overexpression	O
of	O
Rv2623	B-Protein
on	O
M	O
.	O
smegmatis	O
are	O
operative	O
in	O
virulent	O
M	O
.	O
tuberculosis	O
,	O
the	O
growth	O
kinetics	O
of	O
the	O
Erdman	O
strain	O
overexpressing	O
wildtype	O
Rv2623	B-Protein
,	O
as	O
well	O
as	O
the	O
Rv2623G117A	B-Protein
and	O
the	O
Rv2623D15E	B-Protein
mutant	O
proteins	O
,	O
were	O
evaluated	O
in	O
vitro	O
using	O
the	O
BACTEC	O
9000MB	O
system	O
(	O
Figure	O
8B	O
)	O
.	O

As	O
in	O
the	O
M	O
.	O
smegmatis	O
studies	O
,	O
the	O
results	O
show	O
that	O
overexpression	O
of	O
Rv2623	B-Protein
in	O
M	O
.	O
tuberculosis	O
results	O
in	O
marked	O
retardation	O
of	O
growth	O
.	O

Furthermore	O
,	O
this	O
growth	O
attenuation	O
is	O
not	O
observed	O
in	O
M	O
.	O
tuberculosis	O
strains	O
overexpressing	O
the	O
G117A	O
or	O
the	O
D15E	O
mutant	O
Rv2623	B-Protein
(	O
Figure	O
8B	O
)	O
.	O
<EOS>	B-X
Furthermore	B-X
,	B-X
attenuation	B-X
of	B-X
this	B-X
phosphorylation	B-X
of	B-X
YAP	B-X
or	B-X
Yorkie	B-X
(	B-X
Yki	B-X
)	B-X
,	B-X
the	B-X
Drosophila	B-X
homolog	B-X
of	B-X
YAP	B-X
,	B-X
potentiates	B-X
their	B-X
growth-promoting	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
Interestingly	B-X
,	B-X
we	B-X
observed	B-X
that	B-X
YAP	B-X
protein	B-X
is	B-X
elevated	B-X
and	B-X
nuclear	B-X
localized	B-X
in	B-X
some	B-X
human	B-X
liver	B-X
and	B-X
prostate	B-X
cancers	B-X
.	B-X
Furthermore	B-X
,	B-X
8q	B-X
gain-driven	B-X
overexpression	B-X
of	B-X
ribosome	B-X
biogenesis	B-X
regulator	B-X
(	B-X
Ipragliflozin	B-X
at	B-X
1-50	B-X
μM	B-X
significantly	B-X
and	B-X
dose-dependently	B-X
suppressed	B-X
the	B-X
growth	B-X
of	B-X
MCF-7	B-X
cells	B-X
.	B-X
When	B-X
we	B-X
treated	B-X
MCF-7	B-X
cells	B-X
with	B-X
ipragliflozin	B-X
or	B-X
glucose-free	B-X
medium	B-X
,	B-X
membrane	B-X
hyperpolarization	B-X
was	B-X
observed	B-X
.	B-X
Furthermore	B-X
,	B-X
JC-1	B-X
green	B-X
fluorescence	B-X
was	B-X
significantly	B-X
increased	B-X
by	B-X
ipragliflozin	B-X
,	B-X
suggesting	B-X
the	B-X
change	B-X
of	B-X
mitochondrial	B-X
membrane	B-X
potential	B-X
.	B-X

Taken	O
together	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
the	O
ability	O
of	O
Rv2623	B-Protein
to	O
regulate	O
growth	O
of	O
M	O
.	O
smegmatis	O
and	O
M	O
.	O
tuberculosis	O
is	O
dependent	O
on	O
an	O
ATP	O
-	O
dependent	O
process	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Despite	O
the	O
significance	O
of	O
M	O
.	O
tuberculosis	O
latency	O
in	O
pathogenesis	O
,	O
the	O
mechanisms	O
by	O
which	O
the	O
tubercle	O
bacillus	O
establishes	O
and	O
maintains	O
the	O
latent	O
state	O
remain	O
incompletely	O
defined	O
.	O

Identification	O
of	O
M	O
.	O
tuberculosis	O
genes	O
that	O
are	O
induced	O
by	O
hypoxia	O
and	O
nitric	O
oxide	O
(	O
NO	O
)	O
in	O
vitro	O
provides	O
a	O
framework	O
for	O
understanding	O
the	O
physiology	O
of	O
dormant	O
bacilli	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

These	O
genes	O
,	O
referred	O
to	O
as	O
the	O
dormancy	O
regulon	O
,	O
are	O
transcriptionally	O
regulated	O
by	O
the	O
mycobacterial	O
two	O
-	O
component	O
system	O
DosR	B-Protein
-	O
DosS	B-Protein
under	O
hypoxic	O
conditions	O
[	O
4	O
]	O
.	O

Indeed	O
,	O
it	O
has	O
been	O
shown	O
that	O
both	O
the	O
cognate	O
sensor	O
histidine	O
kinase	O
DosS	B-Protein
(	O
a	O
member	O
of	O
the	O
dormancy	O
regulon	O
)	O
as	O
well	O
as	O
an	O
"	O
orphan	O
"	O
kinase	O
,	O
DosT	B-Protein
,	O
functioning	O
as	O
redox	O
and	O
hypoxia	O
sensors	O
,	O
respectively	O
;	O
can	O
regulate	O
DosR	B-Protein
activity	O
,	O
and	O
that	O
O2	O
,	O
NO	O
,	O
and	O
CO	O
can	O
modulate	O
the	O
activity	O
of	O
these	O
two	O
kinases	O
via	O
interaction	O
with	O
a	O
haem	O
prosthetic	O
group	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
.	O

The	O
biological	O
significance	O
of	O
the	O
dormancy	O
regulon	O
has	O
been	O
underscored	O
by	O
in	O
vitro	O
studies	O
of	O
dosR	B-Protein
mutants	O
of	O
BCG	O
and	O
M	O
.	O
tuberculosis	O
,	O
which	O
demonstrated	O
the	O
requirement	O
of	O
this	O
transcription	O
factor	O
for	O
survival	O
under	O
hypoxic	O
conditions	O
[	O
3	O
]	O
,	O
[	O
33	O
]	O
.	O

Further	O
,	O
upregulation	O
of	O
the	O
expression	O
of	O
certain	O
dormancy	O
regulon	O
genes	O
have	O
been	O
implicated	O
in	O
tuberculosis	O
transmission	O
as	O
well	O
as	O
the	O
virulence	O
of	O
the	O
epidemiologically	O
important	O
W	O
-	O
Beijing	O
lineage	O
of	O
M	O
.	O
tuberculosis	O
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

There	O
are	O
eight	O
genes	O
in	O
the	O
M	O
.	O
tuberculosis	O
genome	O
annotated	O
to	O
encode	O
USP	O
family	O
proteins	O
[	O
7	O
]	O
.	O

We	O
studied	O
the	O
M	O
.	O
tuberculosis	O
USP	O
rv2623	B-Protein
because	O
it	O
is	O
one	O
of	O
the	O
most	O
highly	O
induced	O
genes	O
in	O
the	O
dormancy	O
regulon	O
when	O
bacilli	O
are	O
subjected	O
to	O
hypoxia	O
and	O
nitrosative	O
stress	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
,	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

More	O
important	O
,	O
rv2623	B-Protein
was	O
also	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
when	O
the	O
tubercle	O
bacillus	O
is	O
internalized	O
by	O
human	O
and	O
mouse	O
macrophages	O
[	O
10	O
]	O
,	O
[	O
38	O
]	O
as	O
well	O
as	O
in	O
the	O
lungs	O
of	O
mice	O
with	O
persistent	O
M	O
.	O
tuberculosis	O
infection	O
[	O
11	O
]	O
.	O

These	O
latter	O
observations	O
suggest	O
that	O
the	O
induction	O
of	O
rv2623	B-Protein
may	O
have	O
biological	O
relevance	O
.	O

The	O
precise	O
mechanisms	O
by	O
which	O
Rv2623	B-Protein
expression	O
is	O
regulated	O
remain	O
to	O
be	O
defined	O
.	O

Recent	O
transcriptional	O
analysis	O
of	O
Rv2623	B-Protein
,	O
while	O
confirming	O
the	O
essentiality	O
of	O
the	O
two	O
18	O
bp	O
palindromic	O
DosR	B-Protein
-	O
binding	O
motifs	O
that	O
are	O
present	O
in	O
the	O
promoter	O
region	O
of	O
this	O
gene	O
[	O
38	O
]	O
for	O
induction	O
of	O
Rv2623	B-Protein
under	O
low	O
oxygen	O
conditions	O
,	O
also	O
demonstrated	O
the	O
presence	O
of	O
additional	O
regulatory	O
elements	O
within	O
the	O
rv2623	B-Protein
5	O
'	O
-	O
untranslated	O
region	O
[	O
18	O
]	O
.	O

These	O
results	O
suggest	O
that	O
the	O
regulation	O
of	O
Rv2623	B-Protein
is	O
likely	O
complex	O
.	O

The	O
M	O
.	O
tuberculosis	O
dormancy	O
response	O
features	O
a	O
dramatic	O
decrease	O
in	O
metabolic	O
activity	O
,	O
resulting	O
in	O
a	O
rapid	O
decrease	O
in	O
bacterial	O
replication	O
[	O
39	O
]	O
.	O

Therefore	O
,	O
it	O
is	O
possible	O
that	O
deficiency	O
in	O
certain	O
members	O
of	O
the	O
dormancy	O
regulon	O
could	O
result	O
in	O
inability	O
of	O
the	O
tubercle	O
bacillus	O
to	O
enter	O
a	O
latent	O
state	O
in	O
the	O
infected	O
host	O
,	O
leading	O
to	O
unrestrained	O
growth	O
and	O
thus	O
,	O
hypervirulence	O
.	O

Indeed	O
,	O
specific	O
members	O
of	O
the	O
M	O
.	O
tuberculosis	O
dormancy	O
regulon	O
whose	O
insufficiency	O
results	O
in	O
a	O
hypervirulence	O
phenotype	O
have	O
been	O
reported	O
[	O
40	O
]	O
,	O
[	O
41	O
]	O
.	O

In	O
certain	O
experimental	O
tuberculosis	O
animal	O
models	O
,	O
DosR	B-Protein
deficiency	O
has	O
been	O
associated	O
with	O
a	O
hypervirulence	O
phenotype	O
[	O
41	O
]	O
.	O

However	O
,	O
DosR	B-Protein
deficiency	O
has	O
also	O
been	O
reported	O
to	O
have	O
no	O
effect	O
on	O
M	O
.	O
tuberculosis	O
virulence	O
or	O
to	O
lead	O
to	O
an	O
attenuated	O
phenotype	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

The	O
discrepancies	O
regarding	O
M	O
.	O
tuberculosis	O
virulence	O
in	O
these	O
DosR	B-Protein
studies	O
are	O
unclear	O
,	O
but	O
could	O
be	O
due	O
to	O
differences	O
in	O
experimental	O
systems	O
employed	O
.	O

Insufficiency	O
of	O
the	O
chaperone	O
-	O
like	O
alpha	B-Protein
-	I-Protein
crystallin	I-Protein
encoded	O
by	O
M	O
.	O
tuberculosis	O
hspX	B-Protein
(	O
acr	B-Protein
)	O
has	O
also	O
been	O
shown	O
to	O
be	O
associated	O
with	O
hypervirulence	O
in	O
a	O
BALB	O
/	O
c	O
mouse	O
model	O
of	O
tuberculosis	O
[	O
40	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
an	O
rv2623	B-Protein
knockout	O
mutant	O
of	O
virulent	O
M	O
.	O
tuberculosis	O
Erdman	O
fails	O
to	O
establish	O
a	O
chronic	O
persistent	O
infection	O
,	O
displaying	O
a	O
hypervirulent	O
phenotype	O
in	O
susceptible	O
hosts	O
,	O
as	O
assessed	O
by	O
lung	O
bacterial	O
burden	O
,	O
histopathology	O
,	O
and	O
mortality	O
.	O

Results	O
of	O
the	O
complementation	O
studies	O
indicate	O
that	O
the	O
phenotype	O
is	O
Rv2623	B-Protein
-	O
specific	O
.	O

This	O
growth	O
-	O
regulating	O
phenomenon	O
is	O
echoed	O
by	O
the	O
observation	O
that	O
ectopic	O
overexpression	O
of	O
Rv2623	B-Protein
results	O
in	O
attenuation	O
of	O
mycobacterial	O
growth	O
.	O

Together	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
the	O
M	O
.	O
tuberculosis	O
USP	O
Rv2623	B-Protein
has	O
the	O
ability	O
to	O
regulate	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
is	O
required	O
for	O
the	O
establishment	O
of	O
a	O
persistent	O
infection	O
.	O

Intriguingly	O
,	O
ectopic	O
overexpression	O
of	O
HspX	B-Protein
by	O
the	O
same	O
means	O
employed	O
by	O
our	O
study	O
also	O
resulted	O
in	O
an	O
attenuated	O
growth	O
phenotype	O
compared	O
with	O
LacZ	B-Protein
-	O
overexpressing	O
controls	O
[	O
44	O
]	O
,	O
suggesting	O
that	O
these	O
two	O
tightly	O
co	O
-	O
regulated	O
"	O
stress	O
"	O
proteins	O
might	O
have	O
similar	O
growth	O
-	O
regulatory	O
roles	O
during	O
dormancy	O
.	O

Bioinformatic	O
and	O
experimental	O
evidence	O
suggest	O
that	O
nucleotide	O
-	O
binding	O
capacity	O
represents	O
a	O
discriminating	O
biochemical	O
feature	O
that	O
facilitates	O
USP	O
protein	O
classification	O
.	O

Putative	O
functional	O
differences	O
between	O
USPs	O
are	O
implied	O
by	O
their	O
assignment	O
to	O
two	O
subclasses	O
:	O
one	O
whose	O
members	O
do	O
not	O
bind	O
ATP	O
and	O
another	O
whose	O
constituents	O
bind	O
and	O
hydrolyze	O
adenine	O
nucleotide	O
substrates	O
[	O
8	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

A	O
structural	O
comparison	O
between	O
the	O
prototypic	O
members	O
of	O
the	O
two	O
subclasses	O
,	O
the	O
non	O
-	O
ATP	O
-	O
binding	O
UspA	B-Protein
homolog	O
(	O
H	O
.	O
influenzae	O
,	O
PDB	O
ID	O
1JMV	O
)	O
and	O
the	O
ATP	O
-	O
binding	O
USP	O
,	O
MJ0577	B-Protein
(	O
M	O
.	O
jannaschii	O
,	O
PDB	O
ID	O
1MJH	O
)	O
revealed	O
that	O
while	O
both	O
proteins	O
exhibit	O
a	O
similar	O
fold	O
,	O
conserved	O
glycine	O
residues	O
within	O
the	O
ATP	O
-	O
binding	O
loop	O
of	O
the	O
latter	O
are	O
substituted	O
with	O
bulky	O
amino	O
acids	O
that	O
preclude	O
ATP	O
recognition	O
in	O
the	O
former	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

The	O
unique	O
nucleotide	O
-	O
binding	O
pocket	O
of	O
this	O
protein	O
family	O
is	O
structurally	O
distinct	O
from	O
those	O
commonly	O
encountered	O
in	O
ATP	O
-	O
binding	O
proteins	O
[	O
26	O
]	O
,	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

Specific	O
roles	O
for	O
USP	O
family	O
proteins	O
are	O
just	O
beginning	O
to	O
be	O
characterized	O
,	O
and	O
early	O
functional	O
classifications	O
have	O
been	O
informed	O
by	O
ATP	O
-	O
binding	O
capacity	O
[	O
9	O
]	O
.	O

While	O
the	O
non	O
-	O
ATP	O
-	O
binding	O
UspA	B-Protein
homologs	O
appear	O
to	O
play	O
diverse	O
roles	O
in	O
promoting	O
survival	O
under	O
a	O
variety	O
of	O
environmental	O
insults	O
[	O
15	O
]	O
,	O
[	O
49	O
]	O
,	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
the	O
function	O
(	O
s	O
)	O
of	O
ATP	O
-	O
binding	O
type	O
USPs	O
remain	O
unclear	O
[	O
9	O
]	O
.	O

Based	O
on	O
in	O
silico	O
analyses	O
,	O
Florczyk	O
et	O
al	O
.	O
classified	O
Rv2623	B-Protein
as	O
belonging	O
to	O
a	O
novel	O
class	O
of	O
ATPases	O
[	O
52	O
]	O
,	O
although	O
formal	O
evidence	O
for	O
ATP	O
binding	O
by	O
this	O
protein	O
has	O
not	O
been	O
reported	O
.	O

This	O
study	O
has	O
provided	O
substantial	O
biochemical	O
and	O
structural	O
evidence	O
that	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
is	O
a	O
bona	O
fide	O
nucleotide	O
-	O
binding	O
USP	O
:	O
i	O
)	O
E	O
.	O
coli	O
-	O
expressed	O
His6	O
-	O
Rv2623	B-Protein
co	O
-	O
purifies	O
with	O
tightly	O
bound	O
ATP	O
and	O
ADP	O
;	O
ii	O
)	O
analysis	O
of	O
the	O
2	O
.	O
9	O
A	O
-	O
resolution	O
Rv2623	B-Protein
crystal	O
structure	O
,	O
the	O
first	O
molecular	O
model	O
of	O
a	O
tandem	O
-	O
type	O
USP	O
,	O
reveals	O
four	O
ATP	O
-	O
bound	O
nucleotide	O
-	O
binding	O
pockets	O
;	O
and	O
iii	O
)	O
point	O
mutations	O
(	O
D15E	O
,	O
G117A	O
)	O
within	O
the	O
conserved	O
L1	O
(	O
D15E	O
)	O
and	O
beta4	O
(	O
G117A	O
)	O
regions	O
of	O
the	O
structure	O
,	O
which	O
were	O
predicted	O
to	O
disrupt	O
nucleotide	O
-	O
binding	O
,	O
yielded	O
mutant	O
proteins	O
with	O
attenuated	O
ATP	O
-	O
binding	O
capacity	O
.	O

Furthermore	O
,	O
given	O
that	O
the	O
attenuated	O
growth	O
phenotype	O
caused	O
by	O
overexpression	O
of	O
Rv2623	B-Protein
could	O
be	O
abrogated	O
by	O
mutations	O
that	O
interfere	O
with	O
the	O
binding	O
of	O
this	O
protein	O
to	O
its	O
nucleotide	O
substrate	O
,	O
it	O
is	O
likely	O
that	O
the	O
mycobacterial	O
growth	O
-	O
regulatory	O
faculty	O
of	O
Rv2623	B-Protein
is	O
mediated	O
by	O
an	O
ATP	O
-	O
dependent	O
function	O
.	O

In	O
summary	O
,	O
the	O
results	O
of	O
the	O
present	O
study	O
have	O
revealed	O
that	O
the	O
M	O
.	O
tuberculosis	O
USP	O
Rv2623	B-Protein
has	O
the	O
ability	O
to	O
regulate	O
mycobacterial	O
growth	O
,	O
as	O
evident	O
by	O
the	O
in	O
vivo	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	B-Protein
,	O
which	O
fails	O
to	O
establish	O
a	O
persistent	O
infection	O
in	O
susceptible	O
hosts	O
,	O
as	O
well	O
as	O
the	O
growth	O
attenuation	O
observed	O
in	O
mycobacteria	O
overexpressing	O
this	O
USP	O
.	O

Thus	O
,	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
may	O
serve	O
the	O
function	O
of	O
promoting	O
mycobacterial	O
transition	O
into	O
latency	O
.	O

The	O
latent	O
state	O
allows	O
persistence	O
in	O
infected	O
individuals	O
of	O
tubercle	O
bacilli	O
that	O
can	O
reactivate	O
to	O
cause	O
active	O
disease	O
and	O
to	O
disseminate	O
when	O
the	O
immune	O
status	O
of	O
the	O
host	O
is	O
compromised	O
.	O

As	O
a	O
result	O
,	O
Rv2623	B-Protein
may	O
contribute	O
significantly	O
to	O
the	O
propagation	O
of	O
the	O
tubercle	O
bacillus	O
in	O
the	O
human	O
host	O
and	O
the	O
difficulties	O
in	O
eradicating	O
tuberculosis	O
.	O

Mechanistically	O
,	O
results	O
of	O
the	O
mutagenesis	O
studies	O
have	O
shown	O
that	O
Rv2623	B-Protein
regulates	O
growth	O
through	O
ATP	O
-	O
dependent	O
function	O
.	O

Clearly	O
,	O
much	O
remains	O
to	O
be	O
learned	O
regarding	O
how	O
the	O
ATP	O
-	O
dependent	O
function	O
of	O
Rv2623	B-Protein
contributes	O
to	O
growth	O
regulation	O
.	O

It	O
has	O
been	O
proposed	O
that	O
a	O
nucleotide	O
-	O
binding	O
USP	O
from	O
M	O
.	O
jannaschii	O
,	O
MJ0577	B-Protein
,	O
whose	O
ability	O
to	O
hydrolyze	O
ATP	O
is	O
dependent	O
on	O
interaction	O
with	O
factor	O
(	O
s	O
)	O
present	O
in	O
the	O
cell	O
extract	O
of	O
this	O
hyperthermophile	O
[	O
26	O
]	O
,	O
functions	O
as	O
a	O
molecular	O
switch	O
much	O
like	O
the	O
Ras	O
protein	O
family	O
,	O
whose	O
GTP	O
hydrolysis	O
ability	O
is	O
modulated	O
by	O
interaction	O
with	O
a	O
number	O
of	O
regulatory	O
proteins	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

The	O
fact	O
that	O
E	O
.	O
coli	O
-	O
expressed	O
Rv2623	B-Protein
co	O
-	O
purifies	O
with	O
ADP	O
as	O
well	O
as	O
ATP	O
suggests	O
the	O
possibility	O
that	O
this	O
mycobacterial	O
USP	O
,	O
like	O
MJ0577	B-Protein
,	O
is	O
capable	O
of	O
ATP	O
hydrolysis	O
.	O

It	O
is	O
therefore	O
conceivable	O
that	O
M	O
.	O
tuberculosis	O
Rv2623	B-Protein
,	O
as	O
a	O
component	O
of	O
the	O
yet	O
-	O
to	O
-	O
be	O
defined	O
dormancy	O
signaling	O
pathway	O
(	O
s	O
)	O
,	O
functions	O
as	O
a	O
molecular	O
switch	O
by	O
virtue	O
of	O
its	O
ATP	O
-	O
binding	O
and	O
putative	O
ATP	O
-	O
hydrolyzing	O
properties	O
,	O
to	O
mediate	O
the	O
establishment	O
of	O
tuberculous	O
latency	O
.	O

Experiments	O
designed	O
to	O
investigate	O
the	O
potential	O
ATP	O
-	O
hydrolyzing	O
activity	O
of	O
Rv2623	B-Protein
are	O
currently	O
underway	O
.	O

Recent	O
identification	O
of	O
the	O
DosR	B-Protein
-	O
dependent	O
dormancy	O
regulon	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
;	O
the	O
DosR	B-Protein
-	O
independent	O
enduring	O
hypoxic	O
response	O
,	O
which	O
involves	O
over	O
200	O
mycobacterial	O
genes	O
,	O
including	O
those	O
known	O
to	O
regulate	O
bacteriostasis	O
[	O
42	O
]	O
;	O
and	O
the	O
demonstration	O
that	O
M	O
.	O
tuberculosis	O
redox	O
and	O
hypoxia	O
sensors	O
can	O
interact	O
with	O
multiple	O
ligands	O
that	O
differentially	O
modulate	O
the	O
activity	O
of	O
these	O
important	O
kinases	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
,	O
predict	O
a	O
complex	O
regulatory	O
network	O
for	O
tuberculous	O
latency	O
.	O

Elucidation	O
of	O
how	O
ATP	O
-	O
binding	O
and	O
,	O
potentially	O
,	O
the	O
hydrolysis	O
of	O
ATP	O
by	O
Rv2623	B-Protein
regulate	O
M	O
.	O
tuberculosis	O
dormancy	O
-	O
signaling	O
pathways	O
will	O
likely	O
illuminate	O
the	O
mechanisms	O
by	O
which	O
the	O
tubercle	O
bacillus	O
establishes	O
persistence	O
.	O

A	O
Novel	O
Signaling	O
Network	O
Essential	O
for	O
Regulating	O
Pseudomonas	O
aeruginosa	O
Biofilm	O
Development	O
<EOS>	B-X
The	B-X
important	B-X
human	B-X
pathogen	B-X
Pseudomonas	B-X
aeruginosa	B-X
has	B-X
been	B-X
linked	B-X
to	B-X
numerous	B-X
biofilm-related	B-X
chronic	B-X
infections	B-X
.	B-X
This	B-X
work	B-X
describes	B-X
a	B-X
novel	B-X
signal	B-X
transduction	B-X
network	B-X
regulating	B-X
committed	B-X
biofilm	B-X
developmental	B-X
steps	B-X
following	B-X
attachment	B-X
,	B-X
in	B-X
which	B-X
phosphorelays	B-X
and	B-X
two	B-X
sigma	B-X
factor-dependent	B-X
response	B-X
regulators	B-X
appear	B-X
to	B-X
be	B-X
key	B-X
components	B-X
of	B-X
the	B-X
regulatory	B-X
machinery	B-X
that	B-X
coordinates	B-X
gene	B-X
expression	B-X
during	B-X
P.	B-X
aeruginosa	B-X
biofilm	B-X
development	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
cues	B-X
.	B-X

The	O
important	O
human	O
pathogen	O
Pseudomonas	O
aeruginosa	O
has	O
been	O
linked	O
to	O
numerous	O
biofilm	O
-	O
related	O
chronic	O
infections	O
.	O
<EOS>	B-X
The	B-X
important	B-X
human	B-X
pathogen	B-X
Pseudomonas	B-X
aeruginosa	B-X
has	B-X
been	B-X
linked	B-X
to	B-X
numerous	B-X
biofilm-related	B-X
chronic	B-X
infections	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
biofilm	B-X
formation	B-X
following	B-X
the	B-X
transition	B-X
to	B-X
the	B-X
surface	B-X
attached	B-X
lifestyle	B-X
is	B-X
regulated	B-X
by	B-X
three	B-X
previously	B-X
undescribed	B-X
two-component	B-X
systems	B-X
:	B-X
BfiSR	B-X
(	B-X
PA4196-4197	B-X
)	B-X
harboring	B-X
an	B-X
RpoD-like	B-X
domain	B-X
,	B-X
an	B-X
OmpR-like	B-X
BfmSR	B-X
(	B-X
PA4101-4102	B-X
)	B-X
,	B-X
and	B-X
MifSR	B-X
(	B-X
PA5511-5512	B-X
)	B-X
belonging	B-X
to	B-X
the	B-X
family	B-X
of	B-X
NtrC-like	B-X
transcriptional	B-X
regulators	B-X
.	B-X
These	B-X
two-component	B-X
systems	B-X
become	B-X
sequentially	B-X
phosphorylated	B-X
during	B-X
biofilm	B-X
formation	B-X
.	B-X
Inactivation	B-X
of	B-X
bfiS	B-X
,	B-X
bfmR	B-X
,	B-X
and	B-X
mifR	B-X
arrested	B-X
biofilm	B-X
formation	B-X
at	B-X
the	B-X
transition	B-X
to	B-X
the	B-X
irreversible	B-X
attachment	B-X
,	B-X
maturation-1	B-X
and	B-X
-2	B-X
stages	B-X
,	B-X
respectively	B-X
,	B-X
as	B-X
indicated	B-X
by	B-X
analyses	B-X
of	B-X
biofilm	B-X
architecture	B-X
,	B-X
and	B-X
protein	B-X
and	B-X
phosphoprotein	B-X
patterns	B-X
.	B-X
Moreover	B-X
,	B-X
discontinuation	B-X
of	B-X
bfiS	B-X
,	B-X
bfmR	B-X
,	B-X
and	B-X
mifR	B-X
expression	B-X
in	B-X
established	B-X
biofilms	B-X
resulted	B-X
in	B-X
the	B-X
collapse	B-X
of	B-X
biofilms	B-X
to	B-X
an	B-X
earlier	B-X
developmental	B-X
stage	B-X
,	B-X
indicating	B-X
a	B-X
requirement	B-X
for	B-X
these	B-X
regulatory	B-X
systems	B-X
for	B-X
the	B-X
development	B-X
and	B-X
maintenance	B-X
of	B-X
normal	B-X
biofilm	B-X
architecture	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
interdependency	B-X
of	B-X
this	B-X
two-component	B-X
systems	B-X
network	B-X
with	B-X
GacS	B-X
(	B-X
PA0928	B-X
)	B-X
,	B-X
which	B-X
was	B-X
found	B-X
to	B-X
play	B-X
a	B-X
dual	B-X
role	B-X
in	B-X
biofilm	B-X
formation	B-X
.	B-X
This	B-X
work	B-X
describes	B-X
a	B-X
novel	B-X
signal	B-X
transduction	B-X
network	B-X
regulating	B-X
committed	B-X
biofilm	B-X
developmental	B-X
steps	B-X
following	B-X
attachment	B-X
,	B-X
in	B-X
which	B-X
phosphorelays	B-X
and	B-X
two	B-X
sigma	B-X
factor-dependent	B-X
response	B-X
regulators	B-X
appear	B-X
to	B-X
be	B-X
key	B-X
components	B-X
of	B-X
the	B-X
regulatory	B-X
machinery	B-X
that	B-X
coordinates	B-X
gene	B-X
expression	B-X
during	B-X
P.	B-X
aeruginosa	B-X
biofilm	B-X
development	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
cues	B-X
.	B-X

Here	O
,	O
we	O
demonstrate	O
that	O
biofilm	O
formation	O
following	O
the	O
transition	O
to	O
the	O
surface	O
attached	O
lifestyle	O
is	O
regulated	O
by	O
three	O
previously	O
undescribed	O
two	O
-	O
component	O
systems	O
:	O
BfiSR	B-Protein
(	O
PA4196	B-Protein
-	O
4197	B-Protein
)	O
harboring	O
an	O
RpoD	B-Protein
-	O
like	O
domain	O
,	O
an	O
OmpR	B-Protein
-	O
like	O
BfmSR	B-Protein
(	O
PA4101	B-Protein
-	O
4102	B-Protein
)	O
,	O
and	O
MifSR	B-Protein
(	O
PA5511	B-Protein
-	O
5512	B-Protein
)	O
belonging	O
to	O
the	O
family	O
of	O
NtrC	B-Protein
-	O
like	O
transcriptional	O
regulators	O
.	O

These	O
two	O
-	O
component	O
systems	O
become	O
sequentially	O
phosphorylated	O
during	O
biofilm	O
formation	O
.	O
<EOS>	B-X
The	B-X
important	B-X
human	B-X
pathogen	B-X
Pseudomonas	B-X
aeruginosa	B-X
has	B-X
been	B-X
linked	B-X
to	B-X
numerous	B-X
biofilm-related	B-X
chronic	B-X
infections	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
biofilm	B-X
formation	B-X
following	B-X
the	B-X
transition	B-X
to	B-X
the	B-X
surface	B-X
attached	B-X
lifestyle	B-X
is	B-X
regulated	B-X
by	B-X
three	B-X
previously	B-X
undescribed	B-X
two-component	B-X
systems	B-X
:	B-X
BfiSR	B-X
(	B-X
PA4196-4197	B-X
)	B-X
harboring	B-X
an	B-X
RpoD-like	B-X
domain	B-X
,	B-X
an	B-X
OmpR-like	B-X
BfmSR	B-X
(	B-X
PA4101-4102	B-X
)	B-X
,	B-X
and	B-X
MifSR	B-X
(	B-X
PA5511-5512	B-X
)	B-X
belonging	B-X
to	B-X
the	B-X
family	B-X
of	B-X
NtrC-like	B-X
transcriptional	B-X
regulators	B-X
.	B-X
These	B-X
two-component	B-X
systems	B-X
become	B-X
sequentially	B-X
phosphorylated	B-X
during	B-X
biofilm	B-X
formation	B-X
.	B-X
Inactivation	B-X
of	B-X
bfiS	B-X
,	B-X
bfmR	B-X
,	B-X
and	B-X
mifR	B-X
arrested	B-X
biofilm	B-X
formation	B-X
at	B-X
the	B-X
transition	B-X
to	B-X
the	B-X
irreversible	B-X
attachment	B-X
,	B-X
maturation-1	B-X
and	B-X
-2	B-X
stages	B-X
,	B-X
respectively	B-X
,	B-X
as	B-X
indicated	B-X
by	B-X
analyses	B-X
of	B-X
biofilm	B-X
architecture	B-X
,	B-X
and	B-X
protein	B-X
and	B-X
phosphoprotein	B-X
patterns	B-X
.	B-X
Moreover	B-X
,	B-X
discontinuation	B-X
of	B-X
bfiS	B-X
,	B-X
bfmR	B-X
,	B-X
and	B-X
mifR	B-X
expression	B-X
in	B-X
established	B-X
biofilms	B-X
resulted	B-X
in	B-X
the	B-X
collapse	B-X
of	B-X
biofilms	B-X
to	B-X
an	B-X
earlier	B-X
developmental	B-X
stage	B-X
,	B-X
indicating	B-X
a	B-X
requirement	B-X
for	B-X
these	B-X
regulatory	B-X
systems	B-X
for	B-X
the	B-X
development	B-X
and	B-X
maintenance	B-X
of	B-X
normal	B-X
biofilm	B-X
architecture	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
interdependency	B-X
of	B-X
this	B-X
two-component	B-X
systems	B-X
network	B-X
with	B-X
GacS	B-X
(	B-X
PA0928	B-X
)	B-X
,	B-X
which	B-X
was	B-X
found	B-X
to	B-X
play	B-X
a	B-X
dual	B-X
role	B-X
in	B-X
biofilm	B-X
formation	B-X
.	B-X
This	B-X
work	B-X
describes	B-X
a	B-X
novel	B-X
signal	B-X
transduction	B-X
network	B-X
regulating	B-X
committed	B-X
biofilm	B-X
developmental	B-X
steps	B-X
following	B-X
attachment	B-X
,	B-X
in	B-X
which	B-X
phosphorelays	B-X
and	B-X
two	B-X
sigma	B-X
factor-dependent	B-X
response	B-X
regulators	B-X
appear	B-X
to	B-X
be	B-X
key	B-X
components	B-X
of	B-X
the	B-X
regulatory	B-X
machinery	B-X
that	B-X
coordinates	B-X
gene	B-X
expression	B-X
during	B-X
P.	B-X
aeruginosa	B-X
biofilm	B-X
development	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
cues	B-X
.	B-X

Inactivation	O
of	O
bfiS	B-Protein
,	O
bfmR	B-Protein
,	O
and	O
mifR	B-Protein
arrested	O
biofilm	O
formation	O
at	O
the	O
transition	O
to	O
the	O
irreversible	O
attachment	O
,	O
maturation	O
-	O
1	O
and	O
-	O
2	O
stages	O
,	O
respectively	O
,	O
as	O
indicated	O
by	O
analyses	O
of	O
biofilm	O
architecture	O
,	O
and	O
protein	O
and	O
phosphoprotein	O
patterns	O
.	O

Moreover	O
,	O
discontinuation	O
of	O
bfiS	B-Protein
,	O
bfmR	B-Protein
,	O
and	O
mifR	B-Protein
expression	O
in	O
established	O
biofilms	O
resulted	O
in	O
the	O
collapse	O
of	O
biofilms	O
to	O
an	O
earlier	O
developmental	O
stage	O
,	O
indicating	O
a	O
requirement	O
for	O
these	O
regulatory	O
systems	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
normal	O
biofilm	O
architecture	O
.	O

Interestingly	O
,	O
inactivation	O
did	O
not	O
affect	O
planktonic	O
growth	O
,	O
motility	O
,	O
polysaccharide	O
production	O
,	O
or	O
initial	O
attachment	O
.	O
<EOS>	B-X
A	B-X
conceptual	B-X
framework	B-X
on	B-X
human	B-X
attachments	B-X
is	B-X
presented	B-X
,	B-X
integrating	B-X
insights	B-X
from	B-X
animal	B-X
research	B-X
with	B-X
neuroimaging	B-X
studies	B-X
.	B-X
Humans	B-X
'	B-X
representation-based	B-X
attachments	B-X
are	B-X
characterized	B-X
by	B-X
biobehavioral	B-X
synchrony	B-X
and	B-X
integrate	B-X
subcortical	B-X
with	B-X
cortical	B-X
networks	B-X
implicated	B-X
in	B-X
reward/motivation	B-X
,	B-X
embodied	B-X
simulation	B-X
,	B-X
and	B-X
mentalization	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
compare	B-X
the	B-X
efficacy	B-X
of	B-X
Invisalign	B-X
's	B-X
(	B-X
Align	B-X
Technology	B-X
,	B-X
Santa	B-X
Clara	B-X
,	B-X
Calif	B-X
)	B-X
optimized	B-X
and	B-X
conventional	B-X
attachments	B-X
on	B-X
rotational	B-X
and	B-X
extrusive	B-X
tooth	B-X
movements	B-X
.	B-X
The	B-X
formation	B-X
of	B-X
complex	B-X
bacterial	B-X
communities	B-X
known	B-X
as	B-X
biofilms	B-X
begins	B-X
with	B-X
the	B-X
interaction	B-X
of	B-X
planktonic	B-X
cells	B-X
with	B-X
a	B-X
surface	B-X
in	B-X
response	B-X
to	B-X
appropriate	B-X
environmental	B-X
signals	B-X
.	B-X
These	B-X
mutants	B-X
are	B-X
designated	B-X
surface	B-X
attachment	B-X
defective	B-X
(	B-X
sad	B-X
)	B-X
.	B-X
Two	B-X
classes	B-X
of	B-X
sad	B-X
mutants	B-X
were	B-X
analysed	B-X
:	B-X
(	B-X
i	B-X
)	B-X
mutants	B-X
defective	B-X
in	B-X
flagellar-mediated	B-X
motility	B-X
and	B-X
(	B-X
ii	B-X
)	B-X
mutants	B-X
defective	B-X
in	B-X
biogenesis	B-X
of	B-X
the	B-X
polar-localized	B-X
type	B-X
IV	B-X
pili	B-X
.	B-X
Very	B-X
few	B-X
cells	B-X
of	B-X
a	B-X
non-motile	B-X
strain	B-X
(	B-X
carrying	B-X
a	B-X
mutation	B-X
in	B-X
flgK	B-X
)	B-X
attached	B-X
to	B-X
PVC	B-X
even	B-X
after	B-X
8	B-X
h	B-X
of	B-X
incubation	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
flagella	B-X
and/or	B-X
motility	B-X
in	B-X
the	B-X
initial	B-X
cell-to-surface	B-X
interactions	B-X
.	B-X

Further	O
,	O
we	O
demonstrate	O
the	O
interdependency	O
of	O
this	O
two	O
-	O
component	O
systems	O
network	O
with	O
GacS	B-Protein
(	O
PA0928	B-Protein
)	O
,	O
which	O
was	O
found	O
to	O
play	O
a	O
dual	O
role	O
in	O
biofilm	O
formation	O
.	O
<EOS>	B-X
The	B-X
important	B-X
human	B-X
pathogen	B-X
Pseudomonas	B-X
aeruginosa	B-X
has	B-X
been	B-X
linked	B-X
to	B-X
numerous	B-X
biofilm-related	B-X
chronic	B-X
infections	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
biofilm	B-X
formation	B-X
following	B-X
the	B-X
transition	B-X
to	B-X
the	B-X
surface	B-X
attached	B-X
lifestyle	B-X
is	B-X
regulated	B-X
by	B-X
three	B-X
previously	B-X
undescribed	B-X
two-component	B-X
systems	B-X
:	B-X
BfiSR	B-X
(	B-X
PA4196-4197	B-X
)	B-X
harboring	B-X
an	B-X
RpoD-like	B-X
domain	B-X
,	B-X
an	B-X
OmpR-like	B-X
BfmSR	B-X
(	B-X
PA4101-4102	B-X
)	B-X
,	B-X
and	B-X
MifSR	B-X
(	B-X
PA5511-5512	B-X
)	B-X
belonging	B-X
to	B-X
the	B-X
family	B-X
of	B-X
NtrC-like	B-X
transcriptional	B-X
regulators	B-X
.	B-X
These	B-X
two-component	B-X
systems	B-X
become	B-X
sequentially	B-X
phosphorylated	B-X
during	B-X
biofilm	B-X
formation	B-X
.	B-X
Inactivation	B-X
of	B-X
bfiS	B-X
,	B-X
bfmR	B-X
,	B-X
and	B-X
mifR	B-X
arrested	B-X
biofilm	B-X
formation	B-X
at	B-X
the	B-X
transition	B-X
to	B-X
the	B-X
irreversible	B-X
attachment	B-X
,	B-X
maturation-1	B-X
and	B-X
-2	B-X
stages	B-X
,	B-X
respectively	B-X
,	B-X
as	B-X
indicated	B-X
by	B-X
analyses	B-X
of	B-X
biofilm	B-X
architecture	B-X
,	B-X
and	B-X
protein	B-X
and	B-X
phosphoprotein	B-X
patterns	B-X
.	B-X
Moreover	B-X
,	B-X
discontinuation	B-X
of	B-X
bfiS	B-X
,	B-X
bfmR	B-X
,	B-X
and	B-X
mifR	B-X
expression	B-X
in	B-X
established	B-X
biofilms	B-X
resulted	B-X
in	B-X
the	B-X
collapse	B-X
of	B-X
biofilms	B-X
to	B-X
an	B-X
earlier	B-X
developmental	B-X
stage	B-X
,	B-X
indicating	B-X
a	B-X
requirement	B-X
for	B-X
these	B-X
regulatory	B-X
systems	B-X
for	B-X
the	B-X
development	B-X
and	B-X
maintenance	B-X
of	B-X
normal	B-X
biofilm	B-X
architecture	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
interdependency	B-X
of	B-X
this	B-X
two-component	B-X
systems	B-X
network	B-X
with	B-X
GacS	B-X
(	B-X
PA0928	B-X
)	B-X
,	B-X
which	B-X
was	B-X
found	B-X
to	B-X
play	B-X
a	B-X
dual	B-X
role	B-X
in	B-X
biofilm	B-X
formation	B-X
.	B-X
This	B-X
work	B-X
describes	B-X
a	B-X
novel	B-X
signal	B-X
transduction	B-X
network	B-X
regulating	B-X
committed	B-X
biofilm	B-X
developmental	B-X
steps	B-X
following	B-X
attachment	B-X
,	B-X
in	B-X
which	B-X
phosphorelays	B-X
and	B-X
two	B-X
sigma	B-X
factor-dependent	B-X
response	B-X
regulators	B-X
appear	B-X
to	B-X
be	B-X
key	B-X
components	B-X
of	B-X
the	B-X
regulatory	B-X
machinery	B-X
that	B-X
coordinates	B-X
gene	B-X
expression	B-X
during	B-X
P.	B-X
aeruginosa	B-X
biofilm	B-X
development	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
cues	B-X
.	B-X

This	O
work	O
describes	O
a	O
novel	O
signal	O
transduction	O
network	O
regulating	O
committed	O
biofilm	O
developmental	O
steps	O
following	O
attachment	O
,	O
in	O
which	O
phosphorelays	O
and	O
two	O
sigma	O
factor	O
-	O
dependent	O
response	O
regulators	O
appear	O
to	O
be	O
key	O
components	O
of	O
the	O
regulatory	O
machinery	O
that	O
coordinates	O
gene	O
expression	O
during	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
in	O
response	O
to	O
environmental	O
cues	O
.	O

Introduction	O

Biofilms	O
are	O
composed	O
of	O
microorganisms	O
attached	O
to	O
a	O
solid	O
surface	O
and	O
encased	O
in	O
a	O
hydrated	O
polymeric	O
matrix	O
of	O
their	O
own	O
synthesis	O
.	O

Biofilms	O
form	O
when	O
bacteria	O
adhere	O
to	O
surfaces	O
in	O
moist	O
environments	O
.	O

Biofilm	O
-	O
associated	O
microorganisms	O
have	O
been	O
shown	O
to	O
colonize	O
a	O
wide	O
variety	O
of	O
medical	O
devices	O
and	O
have	O
been	O
implicated	O
in	O
over	O
80	O
%	O
of	O
chronic	O
inflammatory	O
and	O
infectious	O
diseases	O
including	O
chronic	O
otitis	O
media	O
,	O
native	O
valve	O
endocarditis	O
,	O
gastrointestinal	O
ulcers	O
,	O
urinary	O
tract	O
and	O
middle	O
ear	O
infections	O
,	O
and	O
chronic	O
lung	O
infections	O
in	O
cystic	O
fibrosis	O
(	O
CF	O
)	O
patients	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

The	O
human	O
pathogen	O
Pseudomonas	O
aeruginosa	O
is	O
considered	O
one	O
of	O
the	O
primary	O
causes	O
of	O
mortality	O
in	O
patients	O
with	O
CF	O
,	O
the	O
most	O
common	O
life	O
-	O
threatening	O
hereditary	O
disease	O
in	O
Caucasians	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

In	O
addition	O
,	O
P	O
.	O
aeruginosa	O
causes	O
a	O
variety	O
of	O
diseases	O
in	O
individuals	O
predisposed	O
to	O
infections	O
as	O
the	O
result	O
of	O
severe	O
burns	O
,	O
wounds	O
,	O
urinary	O
tract	O
or	O
corneal	O
injury	O
,	O
or	O
immunocompromised	O
status	O
[	O
5	O
]	O
-	O
[	O
8	O
]	O
.	O
<EOS>	B-X
The	B-X
corneal	B-X
wound	B-X
healing	B-X
response	B-X
is	B-X
typically	B-X
initiated	B-X
by	B-X
injuries	B-X
to	B-X
the	B-X
epithelium	B-X
and/or	B-X
endothelium	B-X
that	B-X
may	B-X
also	B-X
involve	B-X
the	B-X
stroma	B-X
.	B-X
For	B-X
mild	B-X
injuries	B-X
or	B-X
infections	B-X
,	B-X
such	B-X
as	B-X
epithelial	B-X
abrasions	B-X
or	B-X
mild	B-X
controlled	B-X
microbial	B-X
infections	B-X
,	B-X
limited	B-X
keratocyte	B-X
apoptosis	B-X
occurs	B-X
and	B-X
the	B-X
epithelium	B-X
or	B-X
endothelium	B-X
regenerates	B-X
,	B-X
the	B-X
epithelial	B-X
basement	B-X
membrane	B-X
(	B-X
EBM	B-X
)	B-X
and/or	B-X
Descemet	B-X
's	B-X
basement	B-X
membrane	B-X
(	B-X
DBM	B-X
)	B-X
is	B-X
repaired	B-X
,	B-X
and	B-X
keratocyte-	B-X
or	B-X
fibrocyte-derived	B-X
myofibroblast	B-X
precursors	B-X
either	B-X
undergo	B-X
apoptosis	B-X
or	B-X
revert	B-X
to	B-X
the	B-X
parent	B-X
cell	B-X
types	B-X
.	B-X
For	B-X
more	B-X
severe	B-X
injuries	B-X
with	B-X
extensive	B-X
damage	B-X
to	B-X
EBM	B-X
and/or	B-X
DBM	B-X
,	B-X
delayed	B-X
regeneration	B-X
of	B-X
the	B-X
basement	B-X
membranes	B-X
leads	B-X
to	B-X
ongoing	B-X
penetration	B-X
of	B-X
the	B-X
pro-fibrotic	B-X
cytokines	B-X
transforming	B-X
growth	B-X
factor	B-X
(	B-X
TGF	B-X
)	B-X
β1	B-X
,	B-X
TGFβ2	B-X
and	B-X
platelet-derived	B-X
growth	B-X
factor	B-X
(	B-X
PDGF	B-X
)	B-X
that	B-X
drive	B-X
the	B-X
development	B-X
of	B-X
mature	B-X
alpha-smooth	B-X
muscle	B-X
actin	B-X
(	B-X
SMA	B-X
)	B-X
+	B-X
myofibroblasts	B-X
that	B-X
secrete	B-X
large	B-X
amounts	B-X
of	B-X
disordered	B-X
extracellular	B-X
matrix	B-X
(	B-X
ECM	B-X
)	B-X
components	B-X
to	B-X
produce	B-X
scarring	B-X
stromal	B-X
fibrosis	B-X
.	B-X
Ocular	B-X
injuries	B-X
,	B-X
infections	B-X
,	B-X
and	B-X
genetic	B-X
factors	B-X
affect	B-X
corneal	B-X
function	B-X
and	B-X
cause	B-X
vision	B-X
impairment	B-X
.	B-X
Presently	B-X
,	B-X
a	B-X
variety	B-X
of	B-X
laser/non-laser	B-X
surgeries	B-X
,	B-X
immunosuppressants	B-X
,	B-X
and/or	B-X
corneal	B-X
transplants	B-X
are	B-X
predominantly	B-X
used	B-X
to	B-X
revive	B-X
sight	B-X
in	B-X
human	B-X
patients	B-X
.	B-X
The	B-X
development	B-X
of	B-X
novel	B-X
,	B-X
precision-guided	B-X
,	B-X
and	B-X
tissue-targeted	B-X
non-surgical	B-X
therapies	B-X
promoting	B-X
corneal	B-X
repair	B-X
and	B-X
regeneration	B-X
based	B-X
on	B-X
mechanistic	B-X
understanding	B-X
is	B-X
of	B-X
paramount	B-X
importance	B-X
to	B-X
reduce	B-X
the	B-X
impact	B-X
of	B-X
global	B-X
blindness	B-X
.	B-X
Research	B-X
over	B-X
the	B-X
past	B-X
decade	B-X
revealed	B-X
that	B-X
modulation	B-X
of	B-X
pathological	B-X
signaling	B-X
pathways	B-X
and	B-X
factors	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
therapeutic	B-X
delivery	B-X
methods	B-X
effectively	B-X
treats	B-X
corneal	B-X
disorders	B-X
including	B-X
corneal	B-X
scar/haze	B-X
,	B-X
inflammation	B-X
,	B-X
and	B-X
angiogenesis	B-X
in	B-X
various	B-X
pre-clinical	B-X
animal	B-X
models	B-X
and	B-X
are	B-X
primed	B-X
for	B-X
human	B-X
translation	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
recent	B-X
advances	B-X
in	B-X
the	B-X
areas	B-X
of	B-X
corneal	B-X
repair	B-X
,	B-X
restoration	B-X
,	B-X
and	B-X
regeneration	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
evolving	B-X
approaches	B-X
and	B-X
therapeutic	B-X
modalities	B-X
that	B-X
have	B-X
shown	B-X
great	B-X
promise	B-X
in	B-X
reviving	B-X
corneal	B-X
transparency	B-X
and	B-X
function	B-X
through	B-X
the	B-X
use	B-X
of	B-X
small	B-X
drug	B-X
molecules	B-X
,	B-X
gene	B-X
therapy	B-X
,	B-X
nanomedicine	B-X
,	B-X
stem	B-X
cells	B-X
,	B-X
trophic	B-X
factors	B-X
,	B-X
exosomes	B-X
,	B-X
stromal	B-X
equivalents	B-X
,	B-X
bioengineered	B-X
stromal	B-X
scaffolds	B-X
,	B-X
tissue	B-X
adhesives	B-X
,	B-X
and	B-X
3D	B-X
bioprinting	B-X
.	B-X

Biofilm	O
cells	O
differ	O
from	O
their	O
planktonic	O
counterparts	O
in	O
the	O
genes	O
and	O
proteins	O
that	O
they	O
express	O
,	O
resulting	O
in	O
distinct	O
phenotypes	O
including	O
altered	O
resistance	O
to	O
antibiotics	O
and	O
the	O
human	O
immune	O
system	O
[	O
2	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Thus	O
,	O
it	O
is	O
not	O
surprising	O
that	O
biofilms	O
are	O
considered	O
to	O
be	O
differentiated	O
communities	O
compared	O
to	O
their	O
planktonic	O
counterparts	O
[	O
9	O
]	O
,	O
[	O
11	O
]	O
.	O

This	O
is	O
supported	O
by	O
the	O
finding	O
that	O
various	O
microorganisms	O
,	O
including	O
P	O
.	O
aeruginosa	O
have	O
been	O
shown	O
to	O
form	O
biofilms	O
in	O
a	O
stage	O
-	O
specific	O
and	O
coordinated	O
manner	O
.	O

Biofilm	O
formation	O
is	O
initiated	O
with	O
surface	O
attachment	O
by	O
planktonic	O
bacteria	O
,	O
followed	O
by	O
formation	O
of	O
clusters	O
and	O
microcolonies	O
and	O
subsequent	O
development	O
of	O
differentiated	O
structures	O
in	O
which	O
individual	O
bacteria	O
as	O
well	O
as	O
the	O
entire	O
community	O
are	O
surrounded	O
by	O
exopolysaccharides	O
.	O

The	O
biofilm	O
developmental	O
cycle	O
comes	O
full	O
circle	O
when	O
biofilms	O
disperse	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
.	O

This	O
process	O
has	O
been	O
shown	O
to	O
be	O
governed	O
by	O
the	O
activities	O
of	O
regulatory	O
networks	O
that	O
coordinate	O
the	O
temporal	O
expression	O
of	O
various	O
motility	O
,	O
adhesion	O
,	O
and	O
exopolysaccharide	O
genes	O
in	O
response	O
to	O
inter	O
-	O
and	O
intracellular	O
signaling	O
molecules	O
and	O
environmental	O
cues	O
.	O

Vallet	O
et	O
al	O
.	O
<EOS>	B-X
The	B-X
present	B-X
study	B-X
shows	B-X
a	B-X
statistically	B-X
significant	B-X
correlation	B-X
of	B-X
the	B-X
AP-1	B-X
family	B-X
member	B-X
JunB	B-X
with	B-X
VEGF	B-X
,	B-X
VEGFB	B-X
,	B-X
and	B-X
IGF1	B-X
expression	B-X
levels	B-X
in	B-X
MM	B-X
.	B-X
Results	B-X
in	B-X
tumor-cell	B-X
models	B-X
that	B-X
allow	B-X
the	B-X
induction	B-X
of	B-X
JunB	B-X
knockdown	B-X
or	B-X
JunB	B-X
activation	B-X
,	B-X
respectively	B-X
,	B-X
corroborated	B-X
the	B-X
functional	B-X
role	B-X
of	B-X
JunB	B-X
in	B-X
the	B-X
production	B-X
and	B-X
secretion	B-X
of	B-X
these	B-X
angiogenic	B-X
factors	B-X
(	B-X
AFs	B-X
)	B-X
.	B-X
The	B-X
impact	B-X
of	B-X
JunB	B-X
on	B-X
MM	B-X
BM	B-X
angiogenesis	B-X
was	B-X
finally	B-X
confirmed	B-X
in	B-X
a	B-X
dynamic	B-X
3D	B-X
model	B-X
of	B-X
the	B-X
BM	B-X
microenvironment	B-X
,	B-X
a	B-X
xenograft	B-X
mouse	B-X
model	B-X
as	B-X
well	B-X
as	B-X
in	B-X
patient-derived	B-X
BM	B-X
sections	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
in	B-X
continuation	B-X
of	B-X
our	B-X
previous	B-X
study	B-X
(	B-X
Fan	B-X
et	B-X
al.	B-X
,	B-X
2017	B-X
)	B-X
,	B-X
the	B-X
present	B-X
report	B-X
reveals	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
JunB	B-X
is	B-X
not	B-X
only	B-X
a	B-X
mediator	B-X
of	B-X
MM	B-X
cell	B-X
survival	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
drug	B-X
resistance	B-X
,	B-X
but	B-X
also	B-X
a	B-X
promoter	B-X
of	B-X
AF	B-X
transcription	B-X
and	B-X
consequently	B-X
of	B-X
MM	B-X
BM	B-X
angiogenesis	B-X
.	B-X
Our	B-X
results	B-X
thereby	B-X
underscore	B-X
worldwide	B-X
efforts	B-X
to	B-X
target	B-X
AP-1	B-X
transcription	B-X
factors	B-X
such	B-X
as	B-X
JunB	B-X
as	B-X
a	B-X
promising	B-X
strategy	B-X
in	B-X
MM	B-X
therapy	B-X
.	B-X

[	O
14	O
]	O
described	O
a	O
transcriptional	O
regulator	O
MvaT	B-Protein
in	O
P	O
.	O
aeruginosa	O
that	O
represses	O
the	O
expression	O
of	O
cup	O
genes	O
involved	O
in	O
the	O
chaperone	O
-	O
usher	O
fimbrial	O
assembly	O
pathway	O
.	O

MvaT	B-Protein
deletion	O
mutants	O
exhibited	O
enhanced	O
attachment	O
.	O

In	O
contrast	O
,	O
type	O
IV	O
pili	O
and	O
flagella	O
deletion	O
mutants	O
exhibited	O
reduced	O
attachment	O
indicating	O
that	O
attachment	O
and	O
biofilm	O
formation	O
are	O
mediated	O
by	O
extracellular	O
appendages	O
[	O
12	O
]	O
,	O
[	O
15	O
]	O
-	O
[	O
17	O
]	O
.	O

Furthermore	O
,	O
the	O
intracellular	O
signaling	O
molecule	O
bis	O
-	O
(	O
3	O
'	O
-	O
5	O
'	O
)	O
-	O
cyclic	O
diguanylic	O
guanosine	O
monophosphate	O
(	O
cyclic	O
-	O
di	O
-	O
GMP	O
)	O
,	O
first	O
described	O
to	O
control	O
extracellular	O
cellulose	O
biosynthesis	O
in	O
Acetobacter	O
xylinum	O
[	O
18	O
]	O
,	O
[	O
19	O
]	O
,	O
has	O
been	O
demonstrated	O
in	O
several	O
microorganisms	O
to	O
modulate	O
biofilm	O
formation	O
via	O
the	O
production	O
of	O
exopolysaccharides	O
or	O
matrix	O
components	O
,	O
control	O
auto	O
-	O
aggregation	O
of	O
planktonic	O
cells	O
,	O
and	O
regulate	O
swarming	O
motility	O
[	O
20	O
]	O
-	O
[	O
32	O
]	O
.	O

In	O
P	O
.	O
aeruginosa	O
,	O
at	O
least	O
two	O
pathways	O
have	O
been	O
identified	O
to	O
modulate	O
cyclic	O
-	O
di	O
-	O
GMP	O
and	O
thus	O
,	O
biofilm	O
formation	O
.	O

These	O
are	O
the	O
wsp	O
chemosensory	O
signal	O
transduction	O
pathway	O
[	O
25	O
]	O
and	O
a	O
genetic	O
pathway	O
composed	O
of	O
the	O
phosphodiesterase	O
BifA	B-Protein
,	O
the	O
inner	O
membrane	O
-	O
localized	O
diguanylate	O
cyclase	O
SadC	B-Protein
and	O
the	O
cytoplasmic	O
protein	O
SadB	B-Protein
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
33	O
]	O
.	O

Both	O
are	O
involved	O
in	O
the	O
reciprocal	O
cyclic	O
-	O
di	O
-	O
GMP	O
-	O
dependent	O
regulation	O
of	O
Pel	B-Protein
and	O
Psl	B-Protein
exopolysaccharide	O
production	O
as	O
P	O
.	O
aeruginosa	O
transitions	O
from	O
a	O
planktonic	O
to	O
a	O
surface	O
associated	O
lifestyle	O
.	O

Both	O
Pel	B-Protein
and	O
Psl	B-Protein
exopolysaccharides	O
contribute	O
to	O
the	O
overall	O
architecture	O
of	O
biofilms	O
and	O
are	O
essential	O
for	O
surface	O
interaction	O
and	O
biofilm	O
initiation	O
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

Expression	O
of	O
the	O
pel	B-Protein
and	O
psl	B-Protein
genes	O
is	O
coordinated	O
by	O
the	O
global	O
regulator	O
RetS	B-Protein
,	O
a	O
hybrid	O
sensor	O
kinase	O
-	O
response	O
regulator	O
protein	O
,	O
that	O
plays	O
a	O
key	O
role	O
in	O
the	O
reciprocal	O
regulation	O
of	O
virulence	O
factors	O
and	O
biofilm	O
formation	O
required	O
for	O
acute	O
versus	O
chronic	O
infection	O
[	O
36	O
]	O
.	O

RetS	B-Protein
belongs	O
to	O
the	O
family	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCS	O
)	O
which	O
translate	O
external	O
signals	O
into	O
adaptive	O
responses	O
by	O
a	O
variety	O
of	O
mechanisms	O
,	O
including	O
control	O
of	O
gene	O
expression	O
and	O
methylation	O
of	O
target	O
proteins	O
.	O

RetS	B-Protein
is	O
postulated	O
to	O
act	O
in	O
concert	O
with	O
two	O
other	O
TCS	O
sensor	O
kinase	O
-	O
response	O
regulator	O
hybrids	O
,	O
GacS	B-Protein
and	O
LadS	B-Protein
,	O
to	O
coordinate	O
the	O
expression	O
of	O
determinants	O
involved	O
in	O
biofilm	O
formation	O
and	O
the	O
production	O
of	O
determinants	O
required	O
for	O
cytotoxicity	O
in	O
P	O
.	O
aeruginosa	O
via	O
the	O
small	O
regulatory	O
RNA	O
rsmZ	B-Protein
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

Inactivation	O
of	O
RetS	B-Protein
results	O
in	O
reduced	O
cytotoxicity	O
but	O
increased	O
attachment	O
and	O
biofilm	O
formation	O
,	O
while	O
inactivation	O
of	O
both	O
LadS	B-Protein
and	O
GacS	B-Protein
results	O
in	O
increased	O
virulence	O
but	O
decreased	O
biofilm	O
formation	O
capacity	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

This	O
multi	O
-	O
component	O
switch	O
thus	O
orchestrates	O
the	O
transition	O
from	O
the	O
planktonic	O
to	O
the	O
biofilm	O
mode	O
of	O
growth	O
by	O
P	O
.	O
aeruginosa	O
via	O
phosphorylation	O
events	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
GacA	B-Protein
/	O
GacS	B-Protein
[	O
36	O
]	O
-	O
[	O
38	O
]	O
.	O

Overall	O
,	O
the	O
findings	O
suggest	O
that	O
the	O
transition	O
to	O
a	O
surface	O
associated	O
lifestyle	O
proceeds	O
via	O
several	O
pathways	O
,	O
probably	O
in	O
response	O
to	O
environmental	O
cues	O
or	O
signals	O
present	O
during	O
attachment	O
,	O
and	O
involves	O
the	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
via	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCS	O
)	O
.	O

This	O
raises	O
the	O
question	O
of	O
whether	O
the	O
transition	O
to	O
later	O
stages	O
of	O
biofilm	O
formation	O
,	O
which	O
coincide	O
with	O
distinct	O
phenotypes	O
compared	O
to	O
planktonic	O
and	O
initial	O
attached	O
bacterial	O
cells	O
,	O
also	O
involves	O
sensing	O
of	O
environmental	O
signal	O
(	O
s	O
)	O
and	O
requires	O
the	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
(	O
phosphorelays	O
)	O
.	O

Here	O
we	O
demonstrate	O
that	O
P	O
.	O
aeruginosa	O
exhibits	O
distinct	O
protein	O
phosphorylation	O
patterns	O
at	O
various	O
stages	O
of	O
biofilm	O
development	O
.	O

Furthermore	O
,	O
we	O
report	O
the	O
identification	O
of	O
three	O
novel	O
two	O
-	O
component	O
regulatory	O
systems	O
named	O
BfiRS	B-Protein
(	O
PA4196	B-Protein
-	O
4197	B-Protein
)	O
,	O
BfmRS	B-Protein
(	O
PA4101	B-Protein
-	O
4102	B-Protein
)	O
,	O
and	O
MifRS	B-Protein
(	O
PA5511	B-Protein
-	O
5512	B-Protein
)	O
that	O
coordinate	O
phosphorylation	O
events	O
required	O
for	O
the	O
progression	O
of	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

These	O
systems	O
together	O
form	O
a	O
coordinated	O
signaling	O
network	O
that	O
regulates	O
three	O
committed	O
steps	O
of	O
the	O
P	O
.	O
aeruginosa	O
biofilm	O
life	O
cycle	O
,	O
in	O
particular	O
the	O
transition	O
to	O
three	O
later	O
biofilm	O
developmental	O
stages	O
following	O
initial	O
attachment	O
,	O
namely	O
initiation	O
of	O
biofilm	O
formation	O
(	O
BfiRS	B-Protein
)	O
,	O
biofilm	O
maturation	O
(	O
BfmRS	B-Protein
)	O
,	O
and	O
microcolony	O
formation	O
(	O
MifRS	B-Protein
)	O
.	O

Results	O

The	O
formation	O
of	O
biofilms	O
has	O
been	O
proposed	O
to	O
be	O
controlled	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
39	O
]	O
.	O
<EOS>	B-X
Microfluidics	B-X
is	B-X
revolutionizing	B-X
the	B-X
way	B-X
we	B-X
study	B-X
the	B-X
motile	B-X
behavior	B-X
of	B-X
cells	B-X
,	B-X
by	B-X
enabling	B-X
observations	B-X
at	B-X
high	B-X
spatial	B-X
and	B-X
temporal	B-X
resolution	B-X
in	B-X
carefully	B-X
controlled	B-X
microenvironments	B-X
.	B-X
An	B-X
important	B-X
class	B-X
of	B-X
such	B-X
behavior	B-X
is	B-X
bacterial	B-X
chemotaxis	B-X
,	B-X
which	B-X
plays	B-X
a	B-X
fundamental	B-X
role	B-X
in	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
processes	B-X
,	B-X
including	B-X
disease	B-X
pathogenesis	B-X
,	B-X
biofilm	B-X
formation	B-X
,	B-X
bioremediation	B-X
,	B-X
and	B-X
even	B-X
carbon	B-X
cycling	B-X
in	B-X
the	B-X
ocean	B-X
.	B-X
tuning	B-X
of	B-X
response	B-X
sensitivity	B-X
,	B-X
discrimination	B-X
between	B-X
conflicting	B-X
gradients	B-X
)	B-X
and	B-X
the	B-X
large-scale	B-X
consequences	B-X
of	B-X
chemotaxis	B-X
(	B-X
e.g	B-X
.	B-X
Here	B-X
we	B-X
outline	B-X
the	B-X
principles	B-X
underlying	B-X
recently	B-X
proposed	B-X
gradient	B-X
generators	B-X
for	B-X
bacterial	B-X
chemotaxis	B-X
,	B-X
illustrate	B-X
the	B-X
advantage	B-X
of	B-X
the	B-X
microfluidic	B-X
approach	B-X
through	B-X
selected	B-X
examples	B-X
,	B-X
and	B-X
identify	B-X
a	B-X
broader	B-X
set	B-X
of	B-X
scientific	B-X
questions	B-X
that	B-X
may	B-X
now	B-X
be	B-X
addressed	B-X
with	B-X
this	B-X
rapidly	B-X
developing	B-X
technology	B-X
.	B-X

Given	O
that	O
protein	O
phosphorylation	O
is	O
a	O
common	O
modification	O
system	O
used	O
in	O
signal	O
transduction	O
that	O
changes	O
the	O
function	O
of	O
proteins	O
in	O
response	O
to	O
environmental	O
stimuli	O
[	O
38	O
]	O
,	O
we	O
chose	O
a	O
phosphoproteomic	O
approach	O
for	O
the	O
detection	O
and	O
identification	O
of	O
regulatory	O
pathways	O
active	O
following	O
the	O
transition	O
to	O
the	O
surface	O
attached	O
mode	O
of	O
growth	O
.	O

Detection	O
of	O
differentially	O
phosphorylated	O
proteins	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
While	O
phosphoproteomic	O
analyses	O
have	O
become	O
widespread	O
in	O
studies	O
of	O
regulation	O
,	O
signaling	O
,	O
development	O
,	O
the	O
characterization	O
of	O
bacterial	O
species	O
and	O
host	O
responses	O
during	O
pathogenesis	O
[	O
40	O
]	O
-	O
[	O
49	O
]	O
,	O
only	O
a	O
limited	O
number	O
of	O
studies	O
have	O
demonstrated	O
that	O
bacterial	O
phosphoproteomes	O
are	O
dynamic	O
[	O
44	O
]	O
,	O
[	O
46	O
]	O
,	O
[	O
48	O
]	O
.	O

We	O
therefore	O
used	O
a	O
combination	O
of	O
2D	O
/	O
PAGE	O
and	O
immunoblot	O
analysis	O
using	O
commercially	O
available	O
anti	O
-	O
phospho	O
Ser	O
/	O
Thr	O
antibodies	O
(	O
see	O
Suppl	O
.	O
Fig	O
.	O
S1A	O
-	O
B	O
for	O
an	O
example	O
)	O
to	O
probe	O
for	O
the	O
presence	O
of	O
signal	O
transduction	O
events	O
that	O
occur	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
.	O

Immunoblots	O
of	O
whole	O
cell	O
extracts	O
obtained	O
from	O
planktonic	O
cells	O
and	O
biofilm	O
cells	O
representing	O
five	O
developmental	O
stages	O
(	O
reversibly	O
and	O
irreversibly	O
attached	O
cells	O
,	O
maturation	O
-	O
1	O
and	O
-	O
2	O
and	O
dispersion	O
stage	O
;	O
following	O
8	O
,	O
24	O
,	O
72	O
,	O
144	O
,	O
and	O
216	O
hr	O
of	O
growth	O
,	O
respectively	O
,	O
see	O
[	O
12	O
]	O
,	O
[	O
50	O
]	O
for	O
timing	O
of	O
biofilm	O
stages	O
)	O
were	O
thus	O
analyzed	O
for	O
the	O
presence	O
of	O
planktonic	O
-	O
and	O
biofilm	O
-	O
specific	O
phosphorylation	O
events	O
.	O

The	O
planktonic	O
mode	O
of	O
growth	O
coincided	O
with	O
24	O
phosphorylated	O
proteins	O
that	O
were	O
not	O
phosphorylated	O
following	O
the	O
transition	O
of	O
P	O
.	O
aeruginosa	O
to	O
surface	O
-	O
associated	O
mode	O
of	O
growth	O
(	O
Fig	O
.	O
1A	O
,	O
stage	O
-	O
specific	O
events	O
)	O
.	O

Additional	O
stage	O
-	O
specific	O
events	O
were	O
detected	O
for	O
biofilms	O
differing	O
in	O
age	O
.	O

For	O
instance	O
,	O
8	O
hr	O
and	O
24	O
hr	O
old	O
biofilms	O
displayed	O
23	O
and	O
21	O
phosphorylation	O
events	O
,	O
respectively	O
,	O
not	O
detected	O
at	O
any	O
other	O
stage	O
.	O

Regardless	O
of	O
the	O
biofilm	O
developmental	O
stage	O
,	O
7	O
phosphorylation	O
events	O
were	O
detected	O
that	O
were	O
absent	O
in	O
planktonic	O
cells	O
(	O
Fig	O
.	O
1A	O
,	O
biofilm	O
-	O
specific	O
events	O
)	O
.	O

In	O
both	O
modes	O
of	O
growth	O
,	O
26	O
proteins	O
were	O
constitutively	O
phosphorylated	O
.	O

In	O
addition	O
to	O
biofilm	O
stage	O
-	O
specific	O
phosphorylation	O
of	O
proteins	O
,	O
protein	O
phosphorylation	O
events	O
were	O
detectable	O
at	O
more	O
than	O
one	O
biofilm	O
growth	O
stage	O
indicating	O
that	O
the	O
transition	O
to	O
surface	O
-	O
associated	O
growth	O
coincides	O
with	O
distinct	O
protein	O
phosphorylation	O
and	O
dephosphorylation	O
events	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
<EOS>	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

1A	O
,	O
these	O
phosphorylation	O
events	O
are	O
subcategorized	O
as	O
occurring	O
during	O
the	O
reversible	O
and	O
irreversible	O
attachment	O
,	O
biofilm	O
formation	O
and	O
maturation	O
stage	O
depending	O
on	O
when	O
and	O
for	O
how	O
long	O
protein	O
phosphorylation	O
was	O
detected	O
.	O

For	O
instance	O
,	O
four	O
proteins	O
were	O
phosphorylated	O
both	O
in	O
planktonic	O
and	O
reversible	O
attached	O
cells	O
(	O
8	O
hr	O
biofilms	O
)	O
but	O
not	O
at	O
any	O
other	O
biofilm	O
stage	O
(	O
Fig	O
.	O
1A	O
,	O
reversible	O
attachment	O
)	O
while	O
4	O
different	O
proteins	O
were	O
phosphorylated	O
only	O
in	O
planktonic	O
cells	O
and	O
biofilm	O
cells	O
after	O
8	O
hr	O
and	O
24	O
hr	O
of	O
growth	O
under	O
flowing	O
conditions	O
(	O
Fig	O
.	O
1A	O
,	O
irreversible	O
attachment	O
)	O
.	O

Furthermore	O
,	O
evidence	O
of	O
proteins	O
being	O
dephosphorylated	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
was	O
detected	O
.	O

Multiple	O
proteins	O
were	O
found	O
to	O
be	O
dephosphorylated	O
at	O
either	O
a	O
single	O
or	O
at	O
multiple	O
stages	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
and	O
maturation	O
(	O
Fig	O
.	O
1B	O
)	O
.	O
<EOS>	B-X
The	B-X
channel	B-X
has	B-X
several	B-X
interacting	B-X
proteins	B-X
,	B-X
some	B-X
of	B-X
which	B-X
(	B-X
e.g	B-X
.	B-X
Four	B-X
TRPV1	B-X
subunits	B-X
form	B-X
a	B-X
non-selective	B-X
,	B-X
outwardly	B-X
rectifying	B-X
ion	B-X
channel	B-X
permeable	B-X
to	B-X
monovalent	B-X
and	B-X
divalent	B-X
cations	B-X
with	B-X
a	B-X
single-channel	B-X
conductance	B-X
of	B-X
50-100	B-X
pS	B-X
.	B-X
TRPV1	B-X
channel	B-X
kinetics	B-X
reveal	B-X
multiple	B-X
open	B-X
and	B-X
closed	B-X
states	B-X
,	B-X
and	B-X
several	B-X
models	B-X
for	B-X
channel	B-X
activation	B-X
by	B-X
voltage	B-X
,	B-X
ligand	B-X
binding	B-X
and	B-X
temperature	B-X
have	B-X
been	B-X
proposed	B-X
.	B-X
Protein	B-X
phosphatases	B-X
and	B-X
kinases	B-X
control	B-X
multiple	B-X
cellular	B-X
events	B-X
including	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
stress	B-X
responses	B-X
through	B-X
regulating	B-X
reversible	B-X
protein	B-X
phosphorylation	B-X
,	B-X
the	B-X
most	B-X
important	B-X
post-translational	B-X
modification	B-X
.	B-X

Moreover	O
,	O
the	O
similarity	O
of	O
the	O
biofilm	O
phosphoproteome	O
to	O
the	O
planktonic	O
phosphorylation	O
patterns	O
decreased	O
from	O
59	O
%	O
in	O
8	O
-	O
hr	O
-	O
old	O
biofilms	O
to	O
35	O
%	O
in	O
144	O
-	O
hr	O
-	O
old	O
,	O
mature	O
biofilms	O
.	O

The	O
reduced	O
similarity	O
in	O
phosphorylation	O
events	O
between	O
biofilms	O
and	O
planktonic	O
cells	O
was	O
mainly	O
due	O
to	O
biofilm	O
specific	O
phosphorylation	O
events	O
detected	O
at	O
one	O
or	O
more	O
stages	O
of	O
development	O
.	O
<EOS>	B-X
The	B-X
early	B-X
development	B-X
of	B-X
the	B-X
flower	B-X
of	B-X
Arabidopsis	B-X
thaliana	B-X
is	B-X
described	B-X
from	B-X
initiation	B-X
until	B-X
the	B-X
opening	B-X
of	B-X
the	B-X
bud	B-X
.	B-X
Flower	B-X
development	B-X
has	B-X
been	B-X
divided	B-X
into	B-X
12	B-X
stages	B-X
using	B-X
a	B-X
series	B-X
of	B-X
landmark	B-X
events	B-X
.	B-X
Under	B-X
our	B-X
growing	B-X
conditions	B-X
1.9	B-X
buds	B-X
were	B-X
initiated	B-X
per	B-X
day	B-X
on	B-X
average	B-X
,	B-X
and	B-X
they	B-X
took	B-X
13.25	B-X
days	B-X
to	B-X
progress	B-X
through	B-X
the	B-X
12	B-X
stages	B-X
from	B-X
initiation	B-X
until	B-X
opening	B-X
.	B-X
Plasticity	B-X
in	B-X
hatching	B-X
potentially	B-X
adjusts	B-X
risks	B-X
of	B-X
benthic	B-X
and	B-X
planktonic	B-X
development	B-X
for	B-X
benthic	B-X
marine	B-X
invertebrates	B-X
.	B-X
As	B-X
another	B-X
example	B-X
,	B-X
the	B-X
spionid	B-X
annelid	B-X
Boccardia	B-X
proboscidea	B-X
broods	B-X
capsules	B-X
,	B-X
each	B-X
with	B-X
both	B-X
cannibalistic	B-X
and	B-X
developmentally	B-X
arrested	B-X
planktivorous	B-X
siblings	B-X
plus	B-X
nurse	B-X
eggs	B-X
.	B-X
Early	B-X
hatching	B-X
produces	B-X
mainly	B-X
planktivorous	B-X
larvae	B-X
with	B-X
a	B-X
planktonic	B-X
duration	B-X
of	B-X
15	B-X
days	B-X
.	B-X
Late	B-X
hatching	B-X
produces	B-X
mainly	B-X
adelphophages	B-X
who	B-X
have	B-X
eaten	B-X
their	B-X
planktivorous	B-X
siblings	B-X
and	B-X
metamorphose	B-X
with	B-X
little	B-X
or	B-X
no	B-X
period	B-X
of	B-X
swimming	B-X
.	B-X
Mothers	B-X
actively	B-X
hatch	B-X
their	B-X
offspring	B-X
by	B-X
tearing	B-X
the	B-X
capsules	B-X
,	B-X
and	B-X
appeared	B-X
to	B-X
time	B-X
hatching	B-X
in	B-X
response	B-X
to	B-X
their	B-X
environment	B-X
and	B-X
not	B-X
to	B-X
the	B-X
stage	B-X
of	B-X
development	B-X
of	B-X
their	B-X
offspring	B-X
.	B-X
Females	B-X
appeared	B-X
to	B-X
hatch	B-X
capsules	B-X
at	B-X
an	B-X
earlier	B-X
developmental	B-X
stage	B-X
at	B-X
lower	B-X
temperatures	B-X
.	B-X
Their	B-X
embryos	B-X
develop	B-X
singly	B-X
with	B-X
little	B-X
protection	B-X
and	B-X
hatch	B-X
at	B-X
early	B-X
stages	B-X
,	B-X
often	B-X
as	B-X
blastulae	B-X
or	B-X
gastrulae	B-X
.	B-X

Dispersion	O
-	O
stage	O
biofilms	O
(	O
216	O
-	O
hr	O
-	O
old	O
)	O
shared	O
43	O
%	O
similarity	O
with	O
the	O
phosphorylation	O
patterns	O
of	O
planktonically	O
-	O
grown	O
P	O
.	O
aeruginosa	O
cells	O
(	O
not	O
shown	O
)	O
.	O

The	O
increase	O
in	O
similarity	O
between	O
the	O
planktonic	O
and	O
the	O
216	O
-	O
hr	O
-	O
old	O
biofilm	O
phosphoproteomes	O
is	O
consistent	O
with	O
previous	O
reports	O
indicating	O
that	O
cells	O
within	O
dispersion	O
-	O
stage	O
biofilms	O
are	O
returning	O
to	O
the	O
planktonic	O
mode	O
of	O
growth	O
[	O
12	O
]	O
,	O
[	O
50	O
]	O
.	O

Protein	O
phosphorylation	O
in	O
bacteria	O
is	O
not	O
restricted	O
to	O
serine	O
and	O
threonine	O
amino	O
acid	O
residues	O
;	O
however	O
,	O
the	O
analysis	O
of	O
phosphorylation	O
events	O
by	O
immunoblotting	O
is	O
limited	O
to	O
the	O
availability	O
of	O
anti	O
-	O
phospho	O
Ser	O
/	O
Thr	O
(	O
and	O
tyrosine	O
)	O
antibodies	O
.	O
<EOS>	B-X
Most	B-X
prokaryotic	B-X
signal-transduction	B-X
systems	B-X
and	B-X
a	B-X
few	B-X
eukaryotic	B-X
pathways	B-X
use	B-X
phosphotransfer	B-X
schemes	B-X
involving	B-X
two	B-X
conserved	B-X
components	B-X
,	B-X
a	B-X
histidine	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
response	B-X
regulator	B-X
protein	B-X
.	B-X
The	B-X
histidine	B-X
protein	B-X
kinase	B-X
,	B-X
which	B-X
is	B-X
regulated	B-X
by	B-X
environmental	B-X
stimuli	B-X
,	B-X
autophosphorylates	B-X
at	B-X
a	B-X
histidine	B-X
residue	B-X
,	B-X
creating	B-X
a	B-X
high-energy	B-X
phosphoryl	B-X
group	B-X
that	B-X
is	B-X
subsequently	B-X
transferred	B-X
to	B-X
an	B-X
aspartate	B-X
residue	B-X
in	B-X
the	B-X
response	B-X
regulator	B-X
protein	B-X
.	B-X
It	B-X
has	B-X
been	B-X
nearly	B-X
three	B-X
decades	B-X
since	B-X
the	B-X
discovery	B-X
of	B-X
the	B-X
first	B-X
bacterial	B-X
serine/threonine	B-X
protein	B-X
kinase	B-X
(	B-X
STPK	B-X
)	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
a	B-X
blend	B-X
of	B-X
technological	B-X
advances	B-X
has	B-X
led	B-X
to	B-X
the	B-X
characterization	B-X
of	B-X
a	B-X
multitude	B-X
of	B-X
STPKs	B-X
and	B-X
phosphorylation	B-X
substrates	B-X
in	B-X
several	B-X
bacterial	B-X
species	B-X
that	B-X
finely	B-X
regulate	B-X
intricate	B-X
signaling	B-X
cascades	B-X
.	B-X
Years	B-X
of	B-X
intense	B-X
research	B-X
from	B-X
several	B-X
laboratories	B-X
have	B-X
demonstrated	B-X
unexpected	B-X
roles	B-X
for	B-X
serine/threonine	B-X
phosphorylation	B-X
,	B-X
regulating	B-X
not	B-X
only	B-X
bacterial	B-X
growth	B-X
and	B-X
cell	B-X
division	B-X
but	B-X
also	B-X
antibiotic	B-X
persistence	B-X
,	B-X
virulence	B-X
and	B-X
infection	B-X
,	B-X
metabolism	B-X
,	B-X
chromosomal	B-X
biology	B-X
,	B-X
and	B-X
cellular	B-X
differentiation	B-X
.	B-X

We	O
therefore	O
also	O
purified	O
phosphorylated	O
proteins	O
using	O
metal	O
oxide	O
affinity	O
chromatography	O
(	O
MOAC	O
,	O
see	O
Fig	O
.	O
S1	O
)	O
,	O
a	O
gel	O
-	O
independent	O
approach	O
allowing	O
for	O
the	O
enrichment	O
of	O
phosphoproteins	O
independent	O
of	O
the	O
phosphorylation	O
site	O
with	O
an	O
up	O
to	O
100	O
%	O
specificity	O
[	O
51	O
]	O
,	O
[	O
52	O
]	O
,	O
followed	O
by	O
cleavable	O
isotope	O
coded	O
affinity	O
tag	O
(	O
cICAT	O
)	O
labeling	O
and	O
analysis	O
by	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
)	O
.	O

This	O
quantitative	O
mass	O
spectrometric	O
approach	O
was	O
used	O
to	O
analyze	O
protein	O
phosphorylation	O
patterns	O
of	O
biofilm	O
cells	O
grown	O
to	O
the	O
reversible	O
,	O
irreversible	O
,	O
maturation	O
-	O
1	O
and	O
maturation	O
-	O
2	O
biofilm	O
stages	O
(	O
8	O
-	O
,	O
24	O
-	O
,	O
7	O
-	O
2	O
,	O
and	O
144	O
-	O
hr	O
-	O
old	O
biofilms	O
,	O
respectively	O
[	O
12	O
]	O
)	O
in	O
comparison	O
to	O
those	O
of	O
planktonic	O
cells	O
.	O

Similarly	O
to	O
the	O
results	O
obtained	O
via	O
immunoblot	O
analysis	O
,	O
the	O
changes	O
in	O
phosphorylation	O
events	O
over	O
the	O
course	O
of	O
biofilm	O
development	O
detected	O
using	O
LC	O
-	O
MS	O
-	O
MS	O
analysis	O
appeared	O
to	O
be	O
stage	O
-	O
specific	O
(	O
two	O
examples	O
are	O
shown	O
in	O
Suppl	O
.	O
Fig	O
.	O
S2	O
)	O
,	O
with	O
the	O
similarity	O
to	O
the	O
planktonic	O
patterns	O
decreasing	O
from	O
72	O
%	O
in	O
8	O
hr	O
biofilms	O
to	O
38	O
%	O
in	O
144	O
hr	O
biofilms	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

The	O
overall	O
stage	O
-	O
specific	O
(	O
de	O
)	O
phosphorylation	O
events	O
as	O
well	O
as	O
the	O
differences	O
in	O
the	O
phosphoproteome	O
were	O
similar	O
to	O
those	O
detected	O
by	O
immunoblot	O
analysis	O
using	O
anti	O
-	O
Ser	O
/	O
Thr	O
antibodies	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
the	O
dynamic	O
changes	O
of	O
the	O
phosphoproteome	O
occurring	O
during	O
biofilm	O
development	O
.	O

The	O
combination	O
of	O
approaches	O
used	O
here	O
has	O
not	O
been	O
previously	O
used	O
to	O
identify	O
phosphorylated	O
proteins	O
in	O
biofilms	O
.	O
<EOS>	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
aim	B-X
to	B-X
explore	B-X
the	B-X
potential	B-X
biological	B-X
rationale	B-X
behind	B-X
the	B-X
use	B-X
of	B-X
sequential	B-X
and	B-X
combination	B-X
therapies	B-X
in	B-X
IBD	B-X
,	B-X
to	B-X
summarise	B-X
the	B-X
current	B-X
knowledge	B-X
on	B-X
this	B-X
topic	B-X
and	B-X
to	B-X
propose	B-X
a	B-X
management	B-X
algorithm	B-X
that	B-X
combines	B-X
these	B-X
notions	B-X
.	B-X
Identifying	B-X
synergistic	B-X
combinations	B-X
with	B-X
various	B-X
compounds	B-X
and	B-X
structures	B-X
requires	B-X
testing	B-X
a	B-X
large	B-X
number	B-X
of	B-X
compound	B-X
combinations	B-X
.	B-X
However	B-X
,	B-X
in	B-X
practice	B-X
,	B-X
examining	B-X
different	B-X
compounds	B-X
by	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
approaches	B-X
is	B-X
costly	B-X
,	B-X
infeasible	B-X
and	B-X
challenging	B-X
.	B-X
As	B-X
promising	B-X
tools	B-X
,	B-X
computational	B-X
approaches	B-X
such	B-X
as	B-X
machine	B-X
learning	B-X
algorithms	B-X
(	B-X
MLAs	B-X
)	B-X
are	B-X
used	B-X
for	B-X
prioritizing	B-X
combinational	B-X
pharmacotherapies	B-X
.	B-X
This	B-X
review	B-X
aims	B-X
to	B-X
provide	B-X
the	B-X
models	B-X
developed	B-X
to	B-X
predict	B-X
synergistic	B-X
drug	B-X
combinations	B-X
in	B-X
cancer	B-X
by	B-X
MLAs	B-X
with	B-X
various	B-X
information	B-X
,	B-X
including	B-X
gene	B-X
expression	B-X
,	B-X
protein-protein	B-X
interactions	B-X
,	B-X
metabolite	B-X
interactions	B-X
,	B-X
pathways	B-X
and	B-X
pharmaceutical	B-X
information	B-X
such	B-X
as	B-X
chemical	B-X
structure	B-X
,	B-X
molecular	B-X
descriptor	B-X
and	B-X
drug-target	B-X
interactions	B-X
.	B-X

Identification	O
of	O
regulatory	O
proteins	O
involved	O
in	O
sensing	O
environmental	O
signals	O
associated	O
with	O
planktonic	O
and	O
biofilm	O
growth	O

The	O
quantitative	O
mass	O
spectrometric	O
approach	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
allowed	O
for	O
the	O
simultaneous	O
determination	O
of	O
peptide	O
amino	O
acid	O
sequences	O
by	O
collision	O
-	O
induced	O
dissociation	O
(	O
CID	O
)	O
in	O
the	O
MS	O
/	O
MS	O
mode	O
.	O

Examples	O
of	O
two	O
CID	O
spectra	O
are	O
shown	O
in	O
Suppl	O
.	O

Fig	O
.	O
<EOS>	B-X
Fig	B-X
mosaic	B-X
disease	B-X
(	B-X
FMD	B-X
)	B-X
is	B-X
a	B-X
complex	B-X
viral	B-X
disease	B-X
with	B-X
which	B-X
12	B-X
viruses	B-X
,	B-X
including	B-X
a	B-X
confirmed	B-X
causal	B-X
agent	B-X
,	B-X
fig	B-X
mosaic	B-X
emaravirus	B-X
(	B-X
FMV	B-X
)	B-X
,	B-X
and	B-X
three	B-X
viroids	B-X
are	B-X
associated	B-X
worldwide	B-X
.	B-X
Fig	B-X
pollination	B-X
is	B-X
now	B-X
widely	B-X
regarded	B-X
as	B-X
a	B-X
model	B-X
system	B-X
for	B-X
the	B-X
study	B-X
of	B-X
coevolved	B-X
mutualism	B-X
,	B-X
and	B-X
earlier	B-X
reviews	B-X
have	B-X
focused	B-X
on	B-X
the	B-X
evolution	B-X
of	B-X
resource	B-X
conflicts	B-X
between	B-X
pollinating	B-X
fig	B-X
wasps	B-X
,	B-X
their	B-X
hosts	B-X
,	B-X
and	B-X
their	B-X
parasites	B-X
.	B-X
Fig	B-X
wasps	B-X
have	B-X
also	B-X
been	B-X
a	B-X
focus	B-X
of	B-X
research	B-X
on	B-X
sex	B-X
ratio	B-X
evolution	B-X
,	B-X
the	B-X
evolution	B-X
of	B-X
virulence	B-X
,	B-X
coevolution	B-X
,	B-X
population	B-X
genetics	B-X
,	B-X
host-parasitoid	B-X
interactions	B-X
,	B-X
community	B-X
ecology	B-X
,	B-X
historical	B-X
biogeography	B-X
,	B-X
and	B-X
conservation	B-X
biology	B-X
.	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X

S2	O
.	O
<EOS>	B-X
The	B-X
proximal	B-X
subfragment	B-X
2	B-X
region	B-X
(	B-X
S2	B-X
)	B-X
,	B-X
126	B-X
amino	B-X
acids	B-X
of	B-X
myosin	B-X
,	B-X
binds	B-X
with	B-X
the	B-X
C0-C2	B-X
region	B-X
of	B-X
cardiac	B-X
myosin-binding	B-X
protein-C	B-X
to	B-X
regulate	B-X
cardiac	B-X
muscle	B-X
contractility	B-X
in	B-X
a	B-X
manner	B-X
dependent	B-X
on	B-X
PKA-mediated	B-X
phosphorylation	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
unknown	B-X
if	B-X
HCM-associated	B-X
mutations	B-X
within	B-X
S2	B-X
dysregulate	B-X
actomyosin	B-X
dynamics	B-X
by	B-X
disrupting	B-X
its	B-X
interaction	B-X
with	B-X
C0-C2	B-X
,	B-X
ultimately	B-X
leading	B-X
to	B-X
HCM	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
study	B-X
three	B-X
S2	B-X
mutations	B-X
known	B-X
to	B-X
cause	B-X
HCM	B-X
:	B-X
R870H	B-X
,	B-X
E924K	B-X
,	B-X
and	B-X
E930Δ	B-X
.	B-X
First	B-X
,	B-X
experiments	B-X
using	B-X
recombinant	B-X
proteins	B-X
,	B-X
solid-phase	B-X
binding	B-X
,	B-X
and	B-X
isothermal	B-X
titrating	B-X
calorimetry	B-X
assays	B-X
independently	B-X
revealed	B-X
that	B-X
mutant	B-X
S2	B-X
proteins	B-X
displayed	B-X
significantly	B-X
reduced	B-X
binding	B-X
with	B-X
C0-C2	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
CD	B-X
revealed	B-X
greater	B-X
instability	B-X
of	B-X
the	B-X
coiled-coil	B-X
structure	B-X
in	B-X
mutant	B-X
S2	B-X
proteins	B-X
compared	B-X
with	B-X
S2	B-X

Proteins	O
that	O
were	O
confirmed	O
to	O
be	O
phosphorylated	O
by	O
immunoblot	O
analysis	O
were	O
identified	O
using	O
a	O
mass	O
spectrometric	O
approach	O
as	O
well	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
,	B-X
a	B-X
proteomic	B-X
approach	B-X
was	B-X
used	B-X
to	B-X
study	B-X
these	B-X
responses	B-X
.	B-X
We	B-X
have	B-X
performed	B-X
high-resolution	B-X
two-dimensional	B-X
polyacrylamide	B-X
gel	B-X
electrophoresis	B-X
(	B-X
2D-PAGE	B-X
)	B-X
analysis	B-X
of	B-X
(	B-X
solar	B-X
simulated	B-X
)	B-X
UV-exposed	B-X
reconstructed	B-X
skin	B-X
equivalents	B-X
as	B-X
well	B-X
as	B-X
native	B-X
skin	B-X
.	B-X
Differentially	B-X
expressed	B-X
proteins	B-X
were	B-X
processed	B-X
for	B-X
mass	B-X
spectrometric	B-X
analysis	B-X
,	B-X
when	B-X
consistent	B-X
differences	B-X
were	B-X
observed	B-X
in	B-X
all	B-X
individual	B-X
human	B-X
skin	B-X
equivalents	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
proteins	B-X
known	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
UV	B-X
responses	B-X
(	B-X
HSP27	B-X
,	B-X
MnSOD	B-X
,	B-X
and	B-X
PDX-2	B-X
)	B-X
,	B-X
we	B-X
identified	B-X
two	B-X
novel	B-X
proteins	B-X
that	B-X
were	B-X
downregulated	B-X
following	B-X
UV	B-X
exposure	B-X
.	B-X
Further	B-X
analysis	B-X
revealed	B-X
that	B-X
these	B-X
proteins	B-X
were	B-X
the	B-X
phosphorylated	B-X
forms	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
modulators	B-X
cofilin-1	B-X
and	B-X
destrin	B-X
.	B-X
The	B-X
de-phosphorylation	B-X
of	B-X
cofilin-1	B-X
was	B-X
confirmed	B-X
using	B-X
western	B-X
blotting	B-X
of	B-X
UV-exposed	B-X
skin	B-X
equivalents	B-X
and	B-X
ex	B-X
vivo	B-X
skin	B-X
protein	B-X
extracts	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
study	B-X
indicates	B-X
the	B-X
potency	B-X
of	B-X
a	B-X
proteomic	B-X
approach	B-X
to	B-X
study	B-X
UV-induced	B-X
changes	B-X
in	B-X
a	B-X
tissue	B-X
culture	B-X
system	B-X
mimicking	B-X
human	B-X
skin	B-X
as	B-X
well	B-X
as	B-X
excised	B-X
human	B-X
skin	B-X
.	B-X

We	O
thus	O
identified	O
48	O
proteins	O
that	O
were	O
differentially	O
phosphorylated	O
at	O
one	O
or	O
more	O
biofilm	O
developmental	O
stage	O
including	O
elongation	O
factors	O
,	O
ribosomal	O
proteins	O
,	O
several	O
enzymes	O
including	O
reductases	O
and	O
GMP	O
synthase	O
,	O
sigma	O
factor	O
RpoD	B-Protein
(	O
Suppl	O
.	O
Table	O
S1	O
)	O
and	O
11	O
regulatory	O
proteins	O
(	O
Table	O
1	O
)	O
.	O

The	O
majority	O
of	O
regulatory	O
proteins	O
found	O
to	O
be	O
uniquely	O
phosphorylated	O
during	O
planktonic	O
growth	O
were	O
transcriptional	O
regulators	O
,	O
while	O
with	O
the	O
exception	O
of	O
PA2096	B-Protein
,	O
all	O
regulatory	O
proteins	O
found	O
to	O
be	O
phosphorylated	O
during	O
surface	O
attached	O
growth	O
were	O
identified	O
as	O
belonging	O
to	O
two	O
-	O
component	O
systems	O
(	O
TCS	O
)	O
(	O
Table	O
1	O
)	O
.	O

Of	O
those	O
,	O
the	O
sensor	O
/	O
response	O
regulator	O
hybrid	O
GacS	B-Protein
and	O
PA4197	B-Protein
(	O
BfiS	B-Protein
)	O
were	O
found	O
to	O
be	O
phosphorylated	O
as	O
soon	O
as	O
8	O
hr	O
following	O
attachment	O
,	O
and	O
PA2096	B-Protein
and	O
PA4101	B-Protein
(	O
BfmR	B-Protein
)	O
following	O
24	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
(	O
Table	O
1	O
)	O
.	O

Interestingly	O
,	O
PA4102	B-Protein
(	O
BfmS	B-Protein
)	O
,	O
the	O
cognate	O
sensor	O
of	O
PA4101	B-Protein
,	O
was	O
found	O
to	O
be	O
phosphorylated	O
following	O
PA4101	B-Protein
phosphorylation	O
after	O
72	O
hr	O
of	O
biofilm	O
growth	O
(	O
Table	O
1	O
)	O
.	O

The	O
reason	O
for	O
the	O
difference	O
in	O
the	O
timing	O
of	O
phosphorylation	O
between	O
sensor	O
and	O
response	O
regulator	O
is	O
unclear	O
.	O

It	O
is	O
possible	O
that	O
this	O
due	O
to	O
the	O
different	O
detection	O
methods	O
used	O
.	O

The	O
probable	O
TCS	O
regulatory	O
protein	O
PA5511	B-Protein
(	O
MifR	B-Protein
)	O
was	O
phosphorylated	O
following	O
72	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
.	O

The	O
stage	O
-	O
specific	O
detection	O
and	O
phosphorylation	O
of	O
PA5511	B-Protein
as	O
determined	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
analysis	O
in	O
conjunction	O
with	O
cICAT	O
as	O
well	O
as	O
the	O
CID	O
spectra	O
of	O
a	O
tryptic	O
peptide	O
of	O
PA5511	B-Protein
is	O
shown	O
in	O
Suppl	O
.	O

Fig	O
.	O
<EOS>	B-X
Fig	B-X
mosaic	B-X
disease	B-X
(	B-X
FMD	B-X
)	B-X
is	B-X
a	B-X
complex	B-X
viral	B-X
disease	B-X
with	B-X
which	B-X
12	B-X
viruses	B-X
,	B-X
including	B-X
a	B-X
confirmed	B-X
causal	B-X
agent	B-X
,	B-X
fig	B-X
mosaic	B-X
emaravirus	B-X
(	B-X
FMV	B-X
)	B-X
,	B-X
and	B-X
three	B-X
viroids	B-X
are	B-X
associated	B-X
worldwide	B-X
.	B-X
Fig	B-X
pollination	B-X
is	B-X
now	B-X
widely	B-X
regarded	B-X
as	B-X
a	B-X
model	B-X
system	B-X
for	B-X
the	B-X
study	B-X
of	B-X
coevolved	B-X
mutualism	B-X
,	B-X
and	B-X
earlier	B-X
reviews	B-X
have	B-X
focused	B-X
on	B-X
the	B-X
evolution	B-X
of	B-X
resource	B-X
conflicts	B-X
between	B-X
pollinating	B-X
fig	B-X
wasps	B-X
,	B-X
their	B-X
hosts	B-X
,	B-X
and	B-X
their	B-X
parasites	B-X
.	B-X
Fig	B-X
wasps	B-X
have	B-X
also	B-X
been	B-X
a	B-X
focus	B-X
of	B-X
research	B-X
on	B-X
sex	B-X
ratio	B-X
evolution	B-X
,	B-X
the	B-X
evolution	B-X
of	B-X
virulence	B-X
,	B-X
coevolution	B-X
,	B-X
population	B-X
genetics	B-X
,	B-X
host-parasitoid	B-X
interactions	B-X
,	B-X
community	B-X
ecology	B-X
,	B-X
historical	B-X
biogeography	B-X
,	B-X
and	B-X
conservation	B-X
biology	B-X
.	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X

S2	O
.	O
<EOS>	B-X
The	B-X
proximal	B-X
subfragment	B-X
2	B-X
region	B-X
(	B-X
S2	B-X
)	B-X
,	B-X
126	B-X
amino	B-X
acids	B-X
of	B-X
myosin	B-X
,	B-X
binds	B-X
with	B-X
the	B-X
C0-C2	B-X
region	B-X
of	B-X
cardiac	B-X
myosin-binding	B-X
protein-C	B-X
to	B-X
regulate	B-X
cardiac	B-X
muscle	B-X
contractility	B-X
in	B-X
a	B-X
manner	B-X
dependent	B-X
on	B-X
PKA-mediated	B-X
phosphorylation	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
unknown	B-X
if	B-X
HCM-associated	B-X
mutations	B-X
within	B-X
S2	B-X
dysregulate	B-X
actomyosin	B-X
dynamics	B-X
by	B-X
disrupting	B-X
its	B-X
interaction	B-X
with	B-X
C0-C2	B-X
,	B-X
ultimately	B-X
leading	B-X
to	B-X
HCM	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
study	B-X
three	B-X
S2	B-X
mutations	B-X
known	B-X
to	B-X
cause	B-X
HCM	B-X
:	B-X
R870H	B-X
,	B-X
E924K	B-X
,	B-X
and	B-X
E930Δ	B-X
.	B-X
First	B-X
,	B-X
experiments	B-X
using	B-X
recombinant	B-X
proteins	B-X
,	B-X
solid-phase	B-X
binding	B-X
,	B-X
and	B-X
isothermal	B-X
titrating	B-X
calorimetry	B-X
assays	B-X
independently	B-X
revealed	B-X
that	B-X
mutant	B-X
S2	B-X
proteins	B-X
displayed	B-X
significantly	B-X
reduced	B-X
binding	B-X
with	B-X
C0-C2	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
CD	B-X
revealed	B-X
greater	B-X
instability	B-X
of	B-X
the	B-X
coiled-coil	B-X
structure	B-X
in	B-X
mutant	B-X
S2	B-X
proteins	B-X
compared	B-X
with	B-X
S2	B-X

Neither	O
the	O
cognate	O
sensory	O
protein	O
PA5512	B-Protein
nor	O
the	O
response	O
regulator	O
PA4196	B-Protein
were	O
identified	O
in	O
this	O
study	O
.	O

This	O
may	O
be	O
due	O
to	O
detection	O
limitation	O
(	O
low	O
protein	O
concentrations	O
,	O
poor	O
protein	O
solubility	O
,	O
poor	O
ionization	O
)	O
and	O
/	O
or	O
limitation	O
in	O
the	O
number	O
of	O
phosphorylated	O
proteins	O
identified	O
(	O
see	O
Suppl	O
.	O
Tables	O
S1	O
and	O
S2	O
for	O
comparison	O
)	O
.	O

As	O
PA4197	B-Protein
,	O
PA4101	B-Protein
and	O
GacS	B-Protein
were	O
all	O
phosphorylated	O
by	O
24	O
hr	O
of	O
biofilm	O
growth	O
,	O
we	O
asked	O
whether	O
the	O
three	O
proteins	O
are	O
modified	O
simultaneously	O
or	O
in	O
a	O
sequential	O
manner	O
.	O

We	O
reasoned	O
that	O
if	O
protein	O
phosphorylation	O
occurs	O
in	O
sequence	O
,	O
inactivation	O
of	O
one	O
of	O
the	O
proteins	O
would	O
potentially	O
prevent	O
phosphorylation	O
of	O
the	O
other	O
proteins	O
of	O
the	O
phosphorelay	O
.	O

We	O
therefore	O
analyzed	O
GacS	B-Protein
,	O
PA4101	B-Protein
,	O
and	O
PA4197	B-Protein
mutant	O
biofilm	O
phosphorylation	O
patterns	O
for	O
the	O
presence	O
/	O
absence	O
of	O
these	O
regulators	O
.	O

No	O
evidence	O
of	O
phosphorylation	O
of	O
PA4197	B-Protein
,	O
PA4101	B-Protein
,	O
or	O
GacS	B-Protein
was	O
detected	O
in	O
DeltaPA4197	B-Protein
mutant	O
biofilm	O
phosphorylation	O
patterns	O
.	O

However	O
,	O
phosphorylation	O
of	O
both	O
GacS	B-Protein
and	O
PA4197	B-Protein
was	O
detected	O
in	O
DeltaPA4101	B-Protein
mutant	O
biofilms	O
,	O
indicating	O
that	O
PA4101	B-Protein
phosphorylation	O
may	O
occur	O
downstream	O
of	O
GacS	B-Protein
and	O
PA4197	B-Protein
.	O

DeltagacS	B-Protein
biofilm	O
phosphorylation	O
patterns	O
showed	O
an	O
intermediate	O
phosphorylation	O
phenotype	O
with	O
PA4197	B-Protein
being	O
phosphorylated	O
but	O
PA4101	B-Protein
phosphorylation	O
lacking	O
(	O
not	O
shown	O
)	O
.	O

PA5511	B-Protein
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
mutant	O
biofilms	O
analyzed	O
(	O
Suppl	O
.	O
Fig	O
.	O
S3	O
)	O
.	O
<EOS>	B-X
MifS	B-X
(	B-X
PA5512	B-X
)	B-X
and	B-X
MifR	B-X
(	B-X
PA5511	B-X
)	B-X
form	B-X
one	B-X
such	B-X
TCS	B-X
implicated	B-X
in	B-X
biofilm	B-X
formation	B-X
.	B-X
Phenotypic	B-X
microarray	B-X
(	B-X
BioLOG	B-X
)	B-X
analyses	B-X
of	B-X
PAO∆mifS	B-X
and	B-X
PAO∆mifR	B-X
revealed	B-X
that	B-X
these	B-X
mutants	B-X
were	B-X
unable	B-X
to	B-X
utilize	B-X
C5-dicarboxylate	B-X
α-ketoglutarate	B-X
(	B-X
α-KG	B-X
)	B-X
,	B-X
a	B-X
key	B-X
tricarboxylic	B-X
acid	B-X
cycle	B-X
intermediate	B-X
.	B-X
These	B-X
mifSR	B-X
mutants	B-X
were	B-X
able	B-X
to	B-X
utilize	B-X
all	B-X
the	B-X
other	B-X
TCA	B-X
cycle	B-X
intermediates	B-X
(	B-X
citrate	B-X
,	B-X
succinate	B-X
,	B-X
fumarate	B-X
,	B-X
oxaloacetate	B-X
or	B-X
malate	B-X
)	B-X
and	B-X
sugars	B-X
(	B-X
glucose	B-X
or	B-X
sucrose	B-X
)	B-X
except	B-X
α-KG	B-X
as	B-X
the	B-X
sole	B-X
carbon	B-X
source	B-X
.	B-X
We	B-X
confirmed	B-X
that	B-X
the	B-X
mifSR	B-X
mutants	B-X
have	B-X
functional	B-X
dehydrogenase	B-X
complex	B-X
suggesting	B-X
a	B-X
possible	B-X
defect	B-X
in	B-X
α-KG	B-X
transport	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
mutants	B-X
to	B-X
utilize	B-X
α-KG	B-X
was	B-X
rescued	B-X
by	B-X
expressing	B-X
PA5530	B-X
,	B-X
encoding	B-X
C5-dicarboxylate	B-X
transporter	B-X
,	B-X
under	B-X
a	B-X
regulatable	B-X
promoter	B-X
.	B-X

The	O
findings	O
suggest	O
that	O
phosphorylation	O
of	O
regulatory	O
proteins	O
occurs	O
in	O
a	O
sequential	O
(	O
but	O
probably	O
indirect	O
)	O
manner	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
.	O

To	O
determine	O
whether	O
phosphorylation	O
coincided	O
with	O
de	O
novo	O
gene	O
expression	O
or	O
reflected	O
biofilm	O
-	O
specific	O
patterns	O
of	O
posttranslational	O
modification	O
,	O
RT	O
-	O
PCR	O
was	O
used	O
.	O

PA4101	B-Protein
expression	O
was	O
detected	O
to	O
be	O
biofilm	O
-	O
specific	O
,	O
while	O
PA4197	B-Protein
and	O
PA5511	B-Protein
were	O
constitutively	O
expressed	O
regardless	O
of	O
the	O
mode	O
of	O
growth	O
(	O
Suppl	O
.	O
Fig	O
.	O
S4	O
)	O
.	O

Similarly	O
,	O
retS	B-Protein
and	O
ladS	B-Protein
were	O
also	O
constitutively	O
expressed	O
indicating	O
that	O
posttranslational	O
modifications	O
are	O
essential	O
for	O
their	O
activity	O
.	O

Inactivation	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
that	O
are	O
phosphorylated	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
leads	O
to	O
altered	O
biofilm	O
formation	O

As	O
differential	O
and	O
sequential	O
phosphorylation	O
of	O
regulatory	O
proteins	O
was	O
detected	O
over	O
the	O
course	O
of	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
,	O
we	O
asked	O
whether	O
inactivation	O
of	O
these	O
regulatory	O
proteins	O
would	O
alter	O
or	O
affect	O
the	O
stage	O
-	O
specific	O
progression	O
of	O
biofilm	O
formation	O
.	O
<EOS>	B-X
Moraxella	B-X
catarrhalis	B-X
is	B-X
a	B-X
leading	B-X
cause	B-X
of	B-X
otitis	B-X
media	B-X
(	B-X
OM	B-X
)	B-X
and	B-X
chronic	B-X
obstructive	B-X
pulmonary	B-X
disease	B-X
(	B-X
COPD	B-X
)	B-X
.	B-X
Phase-variable	B-X
DNA	B-X
methyltransferases	B-X
mediate	B-X
epigenetic	B-X
regulation	B-X
and	B-X
modulate	B-X
pathogenesis	B-X
in	B-X
several	B-X
bacteria	B-X
.	B-X

We	O
therefore	O
focused	O
on	O
biofilm	O
-	O
specific	O
regulatory	O
proteins	O
.	O
<EOS>	B-X
There	B-X
is	B-X
a	B-X
growing	B-X
interest	B-X
in	B-X
the	B-X
bacterial	B-X
pellicle	B-X
,	B-X
a	B-X
biofilm	B-X
floating	B-X
at	B-X
the	B-X
air-liquid	B-X
interface	B-X
.	B-X
Pellicles	B-X
have	B-X
been	B-X
well	B-X
studied	B-X
in	B-X
the	B-X
Gram-positive	B-X
bacterium	B-X
Bacillus	B-X
subtilis	B-X
,	B-X
but	B-X
far	B-X
less	B-X
in	B-X
Gram-negative	B-X
bacteria	B-X
,	B-X
where	B-X
pellicle	B-X
studies	B-X
have	B-X
mostly	B-X
focused	B-X
on	B-X
matrix	B-X
components	B-X
rather	B-X
than	B-X
on	B-X
the	B-X
regulatory	B-X
cascades	B-X
involved	B-X
.	B-X
We	B-X
also	B-X
propose	B-X
that	B-X
the	B-X
pellicle	B-X
is	B-X
a	B-X
specific	B-X
biofilm	B-X
,	B-X
and	B-X
that	B-X
its	B-X
formation	B-X
involves	B-X
particular	B-X
processes	B-X
.	B-X
The	B-X
multitude	B-X
of	B-X
biomolecular	B-X
and	B-X
regulatory	B-X
factors	B-X
involved	B-X
in	B-X
staphylococcal	B-X
adhesion	B-X
and	B-X
biofilm	B-X
formation	B-X
owe	B-X
much	B-X
to	B-X
their	B-X
ability	B-X
to	B-X
colonize	B-X
surfaces	B-X
,	B-X
allowing	B-X
the	B-X
biofilm	B-X
form	B-X
to	B-X
become	B-X
the	B-X
preferential	B-X
bacterial	B-X
phenotype	B-X
.	B-X
This	B-X
review	B-X
focuses	B-X
on	B-X
the	B-X
specific	B-X
pathways	B-X
involved	B-X
in	B-X
the	B-X
adhesion	B-X
of	B-X
the	B-X
Gram-positive	B-X
bacteria	B-X
Staphylococcus	B-X
epidermidis	B-X
and	B-X
Staphylococcus	B-X
aureus	B-X
with	B-X
reference	B-X
to	B-X
the	B-X
role	B-X
of	B-X
specific	B-X
cell	B-X
surface	B-X
adhesins	B-X
,	B-X
the	B-X
ica	B-X
operon	B-X
,	B-X
accumulation-associated	B-X
proteins	B-X
and	B-X
quorum-sensing	B-X
systems	B-X
and	B-X
their	B-X
significance	B-X
in	B-X
medical	B-X
device-related	B-X
infection	B-X
.	B-X

Since	O
the	O
proteins	O
PA4101	B-Protein
,	O
PA4197	B-Protein
,	O
and	O
PA5511	B-Protein
were	O
found	O
to	O
be	O
phosphorylated	O
following	O
8	O
,	O
24	O
,	O
and	O
72	O
hr	O
of	O
biofilm	O
growth	O
,	O
respectively	O
(	O
Table	O
1	O
)	O
,	O
corresponding	O
to	O
three	O
biofilm	O
developmental	O
stages	O
[	O
9	O
]	O
,	O
[	O
12	O
]	O
,	O
mutants	O
in	O
these	O
three	O
genes	O
were	O
chosen	O
and	O
allowed	O
to	O
form	O
biofilms	O
for	O
144	O
hr	O
in	O
flow	O
cells	O
to	O
test	O
for	O
biofilm	O
formation	O
defects	O
.	O

Under	O
the	O
conditions	O
tested	O
,	O
wild	O
type	O
P	O
.	O
aeruginosa	O
biofilms	O
reached	O
maturity	O
following	O
144	O
hr	O
of	O
growth	O
as	O
characterized	O
by	O
biofilms	O
being	O
composed	O
of	O
large	O
microcolonies	O
exceeding	O
100	O
microm	O
in	O
diameter	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

In	O
contrast	O
,	O
PA4197	B-Protein
and	O
PA4101	B-Protein
mutant	O
biofilms	O
lacked	O
microcolonies	O
after	O
144	O
hr	O
of	O
growth	O
(	O
Fig	O
.	O
2B	O
)	O
and	O
were	O
only	O
composed	O
of	O
a	O
thin	O
layer	O
of	O
cells	O
at	O
the	O
substratum	O
with	O
an	O
average	O
height	O
of	O
0	O
.	O
5	O
and	O
1	O
.	O
4	O
microm	O
,	O
respectively	O
(	O
Table	O
2	O
)	O
.	O

However	O
,	O
in	O
contrast	O
to	O
PA4197	B-Protein
mutant	O
biofilms	O
,	O
PA4101	B-Protein
mutant	O
biofilms	O
demonstrated	O
the	O
formation	O
of	O
some	O
cellular	O
aggregates	O
which	O
were	O
less	O
than	O
10	O
microm	O
in	O
height	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Furthermore	O
,	O
the	O
mutant	O
biofilms	O
differed	O
significantly	O
from	O
wild	O
type	O
biofilms	O
with	O
respect	O
to	O
biomass	O
,	O
surface	O
coverage	O
,	O
and	O
roughness	O
coefficient	O
.	O

Complementation	O
of	O
both	O
PA4101	B-Protein
and	O
PA4197	B-Protein
mutants	O
restored	O
biofilm	O
formation	O
to	O
wild	O
type	O
levels	O
(	O
Fig	O
.	O
2C	O
,	O
Table	O
2	O
)	O
.	O

These	O
results	O
allowed	O
us	O
to	O
firmly	O
conclude	O
that	O
the	O
mutant	O
biofilm	O
phenotypes	O
are	O
caused	O
by	O
a	O
defect	O
in	O
the	O
PA4197	B-Protein
and	O
PA4101	B-Protein
ORF	O
.	O

Based	O
on	O
the	O
role	O
of	O
PA4197	B-Protein
in	O
the	O
initiation	O
of	O
biofilm	O
formation	O
,	O
we	O
named	O
the	O
PA4197	B-Protein
ORF	O
Biofilm	O
initiation	O
Sensor	O
(	O
BfiS	O
)	O
.	O

BfiS	B-Protein
is	O
an	O
unusual	O
sensor	O
that	O
harbors	O
a	O
His	O
kinase	O
A	O
domain	O
typically	O
found	O
in	O
two	O
-	O
component	O
system	O
(	O
TCS	O
)	O
sensor	O
proteins	O
,	O
a	O
Histidine	O
kinase	O
-	O
like	O
ATPase	O
domain	O
involved	O
in	O
autophosphorylation	O
but	O
also	O
in	O
protein	O
dephosphorylation	O
events	O
,	O
and	O
a	O
PAS	O
signal	O
receiver	O
domain	O
[	O
53	O
]	O
.	O

The	O
cognate	O
response	O
regulator	O
BfiR	B-Protein
(	O
PA4196	B-Protein
)	O
harbors	O
a	O
CheY	O
-	O
like	O
signal	O
receiver	O
domain	O
and	O
a	O
LuxR	B-Protein
-	O
like	O
DNA	O
binding	O
domain	O
,	O
which	O
is	O
also	O
present	O
in	O
the	O
quorum	O
-	O
sensing	O
regulatory	O
proteins	O
LasR	B-Protein
,	O
RhlR	B-Protein
,	O
and	O
QscR	B-Protein
and	O
in	O
response	O
regulators	O
with	O
established	O
roles	O
in	O
biofilm	O
formation	O
(	O
GacA	B-Protein
,	O
RocA1	B-Protein
/	O
SadA	B-Protein
)	O
[	O
53	O
]	O
.	O

BfiR	B-Protein
also	O
harbors	O
region	O
4	O
of	O
Sigma	B-Protein
-	I-Protein
70	I-Protein
(	O
RpoD	B-Protein
)	O
-	O
like	O
sigma	O
factors	O
,	O
a	O
domain	O
involved	O
in	O
binding	O
to	O
-	O
35	O
promoter	O
elements	O
[	O
53	O
]	O
.	O

Due	O
to	O
its	O
role	O
in	O
biofilm	O
maturation	O
,	O
we	O
named	O
the	O
PA4101	B-Protein
ORF	O
Biofilm	O
maturation	O
Regulator	O
(	O
BfmR	B-Protein
)	O
.	O

The	O
protein	O
harbors	O
an	O
OmpR	B-Protein
-	O
like	O
transcriptional	O
regulator	O
domain	O
encompassing	O
the	O
common	O
signal	O
receiver	O
and	O
DNA	O
-	O
binding	O
effector	O
domains	O
[	O
53	O
]	O
.	O

The	O
cognate	O
sensor	O
BfmS	B-Protein
(	O
PA4102	B-Protein
)	O
is	O
unusual	O
in	O
that	O
it	O
lacks	O
an	O
autophosphorylation	O
site	O
typically	O
found	O
in	O
sensor	O
kinases	O
[	O
53	O
]	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
probable	O
TCS	O
regulatory	O
protein	O
PA5511	B-Protein
was	O
phosphorylated	O
following	O
72	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
.	O

PA5511	B-Protein
mutant	O
biofilms	O
grown	O
for	O
144	O
hr	O
lacked	O
clusters	O
and	O
microcolonies	O
typically	O
found	O
in	O
wild	O
type	O
biofilms	O
following	O
72	O
-	O
144	O
hr	O
of	O
growth	O
(	O
Fig	O
.	O
2A	O
-	O
B	O
)	O
.	O

Complementation	O
restored	O
biofilm	O
formation	O
to	O
wild	O
type	O
levels	O
(	O
Fig	O
.	O
2C	O
,	O
Table	O
2	O
)	O
.	O

However	O
,	O
when	O
placed	O
in	O
a	O
PAO1	O
background	O
(	O
PAO1	O
/	O
pJN5511	O
)	O
,	O
overexpression	O
of	O
PA5511	B-Protein
resulted	O
in	O
biofilms	O
composed	O
of	O
large	O
microcolonies	O
exceeding	O
250	O
microm	O
in	O
diameter	O
(	O
compared	O
to	O
an	O
average	O
cluster	O
diameter	O
of	O
150	O
microm	O
in	O
P	O
.	O
aeruginosa	O
PAO1	O
,	O
Fig	O
.	O
2A	O
,	O
D	O
)	O
.	O

Since	O
cluster	O
formation	O
correlated	O
with	O
PA5511	B-Protein
expression	O
levels	O
,	O
we	O
named	O
PA5511	B-Protein
Microcolony	O
formation	O
Regulator	O
(	O
MifR	B-Protein
)	O
.	O

MifR	B-Protein
harbors	O
a	O
CheY	B-Protein
-	O
like	O
receiver	O
and	O
a	O
sigma	B-Protein
-	I-Protein
54	I-Protein
interaction	O
domain	O
[	O
53	O
]	O
.	O

The	O
protein	O
is	O
on	O
average	O
30	O
-	O
50	O
%	O
identical	O
to	O
known	O
P	O
.	O
aeruginosa	O
NtrC	B-Protein
-	O
like	O
enhancer	O
binding	O
proteins	O
including	O
PilR	B-Protein
,	O
FleQ	B-Protein
,	O
FleR	B-Protein
,	O
AlgB	B-Protein
,	O
CbrB	B-Protein
,	O
and	O
NtrC	B-Protein
[	O
53	O
]	O
,	O
[	O
54	O
]	O
.	O

The	O
cognate	O
sensor	O
(	O
MifS	B-Protein
,	O
PA5512	B-Protein
)	O
is	O
a	O
typical	O
sensor	O
kinase	O
harboring	O
both	O
a	O
His	O
kinase	O
A	O
and	O
a	O
His	O
kinase	O
-	O
like	O
ATPase	O
domain	O
[	O
53	O
]	O
.	O

Since	O
individual	O
carbon	O
and	O
nitrogen	O
sources	O
have	O
been	O
demonstrated	O
to	O
modulate	O
P	O
.	O
aeruginosa	O
in	O
vitro	O
biofilm	O
development	O
and	O
architecture	O
[	O
16	O
]	O
,	O
[	O
55	O
]	O
-	O
[	O
58	O
]	O
,	O
surface	O
motility	O
[	O
59	O
]	O
and	O
P	O
.	O
aeruginosa	O
cell	O
-	O
cell	O
signaling	O
(	O
quorum	O
sensing	O
)	O
[	O
60	O
]	O
-	O
[	O
63	O
]	O
,	O
the	O
biofilm	O
architecture	O
of	O
all	O
four	O
mutant	O
biofilms	O
was	O
tested	O
using	O
three	O
different	O
media	O
including	O
LB	O
medium	O
and	O
two	O
minimal	O
media	O
containing	O
glutamate	O
[	O
17	O
]	O
or	O
citrate	O
[	O
64	O
]	O
as	O
sole	O
carbon	O
source	O
.	O
<EOS>	B-X
Dissecting	B-X
carbon	B-X
metabolism	B-X
of	B-X
Tricarboxylates	B-X
such	B-X
as	B-X
citrate	B-X
are	B-X
the	B-X
preferred	B-X
carbon	B-X
sources	B-X
for	B-X
Pseudomonas	B-X
aeruginosa	B-X
,	B-X
an	B-X
opportunistic	B-X
pathogen	B-X
that	B-X
causes	B-X
chronic	B-X
human	B-X
infections	B-X
.	B-X
However	B-X
,	B-X
the	B-X
membrane	B-X
transport	B-X
process	B-X
for	B-X
the	B-X
tricarboxylic	B-X
acid	B-X
cycle	B-X
intermediates	B-X
citrate	B-X
and	B-X
Most	B-X
of	B-X
the	B-X
genes	B-X
encoding	B-X
the	B-X
enzymes	B-X
involved	B-X
in	B-X
polyP	B-X
synthesis	B-X
and	B-X
degradation	B-X
and	B-X
in	B-X
phosphate	B-X
transport	B-X
have	B-X
been	B-X
studied	B-X
in	B-X
various	B-X
Gram-negative	B-X
bacteria	B-X
.	B-X
Progress	B-X
has	B-X
also	B-X
been	B-X
made	B-X
in	B-X
studying	B-X
the	B-X
biochemical	B-X
mechanisms	B-X
underlying	B-X
the	B-X
process	B-X
of	B-X
enhanced	B-X
biological	B-X
phosphorus	B-X
removal	B-X
(	B-X
EBPR	B-X
)	B-X
,	B-X
in	B-X
particular	B-X
in	B-X
lab-scale	B-X
systems	B-X
fed	B-X
with	B-X
acetate	B-X
or	B-X
acetate	B-X
plus	B-X
glucose	B-X
as	B-X
the	B-X
sole	B-X
carbon	B-X
and	B-X
energy	B-X
sources	B-X
.	B-X
By	B-X
applying	B-X
13C-NMR	B-X
,	B-X
previous	B-X
models	B-X
concerning	B-X
anaerobic	B-X
carbon	B-X
metabolism	B-X
have	B-X
been	B-X
advanced	B-X
and	B-X
the	B-X
role	B-X
of	B-X
glycogen	B-X
in	B-X
providing	B-X
reducing	B-X
equivalents	B-X
in	B-X
EBPR	B-X
is	B-X
definitely	B-X
demonstrated	B-X
.	B-X
Polyphosphate	B-X
:	B-X
AMP	B-X
phosphotransferase	B-X
and	B-X
polyphosphatase	B-X
were	B-X
readily	B-X
detectable	B-X
in	B-X
EBPR	B-X
sludge	B-X
fed	B-X
with	B-X
acetate	B-X
plus	B-X
glucose	B-X
,	B-X
but	B-X
polyphosphate	B-X
kinase	B-X
remained	B-X
undetected	B-X
.	B-X
In	B-X
a	B-X
lab-scale	B-X
EBPR	B-X
system	B-X
,	B-X
fed	B-X
for	B-X
several	B-X
months	B-X
with	B-X
only	B-X
acetate	B-X
as	B-X
carbon	B-X
source	B-X
,	B-X
a	B-X
Rhodocyclus-like	B-X
bacterium	B-X
(	B-X
R6	B-X
)	B-X
was	B-X
highly	B-X
enriched	B-X
and	B-X
is	B-X
therefore	B-X
probably	B-X
responsible	B-X
for	B-X
EBPR	B-X
in	B-X
systems	B-X
fed	B-X
with	B-X
acetate	B-X
only	B-X
.	B-X
This	B-X
R6-type	B-X
bacterium	B-X
was	B-X
however	B-X
also	B-X
present	B-X
in	B-X
other	B-X
EBPR	B-X
sludges	B-X
(	B-X
but	B-X
to	B-X
a	B-X
lesser	B-X
extent	B-X
)	B-X
,	B-X
and	B-X
may	B-X
therefore	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
EBPR	B-X
in	B-X
general	B-X
.	B-X
This	B-X
organism	B-X
accumulates	B-X
polyhydroxyalkanoates	B-X
anaerobically	B-X
and	B-X
polyP	B-X
under	B-X
aerobic	B-X
conditions	B-X
.	B-X

Under	O
the	O
conditions	O
tested	O
,	O
the	O
biofilm	O
architecture	O
of	O
all	O
three	O
mutants	O
was	O
similar	O
to	O
the	O
biofilm	O
architecture	O
shown	O
in	O
Fig	O
.	O

2	O
independent	O
of	O
the	O
media	O
used	O
.	O
<EOS>	B-X
Calcium	B-X
imaging	B-X
techniques	B-X
take	B-X
advantage	B-X
of	B-X
calcium	B-X
indicator	B-X
dyes	B-X
,	B-X
which	B-X
are	B-X
BAPTA-based	B-X
organic	B-X
molecules	B-X
that	B-X
change	B-X
their	B-X
spectral	B-X
properties	B-X
in	B-X
response	B-X
to	B-X
the	B-X
binding	B-X
of	B-X
Ca2+	B-X
ions	B-X
.	B-X
Calcium	B-X
indicator	B-X
dyes	B-X
fall	B-X
into	B-X
two	B-X
categories	B-X
,	B-X
ratio-metric	B-X
dyes	B-X
like	B-X
Fura-2	B-X
and	B-X
Indo-1	B-X
and	B-X
single-wavelength	B-X
dyes	B-X
like	B-X
Fluo-4	B-X
.	B-X
The	B-X
main	B-X
advantage	B-X
of	B-X
using	B-X
ratio-metric	B-X
dyes	B-X
over	B-X
single	B-X
wavelength	B-X
probes	B-X
is	B-X
that	B-X
the	B-X
ratio	B-X
signal	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
dye	B-X
concentration	B-X
,	B-X
illumination	B-X
intensity	B-X
,	B-X
and	B-X
optical	B-X
path	B-X
length	B-X
allowing	B-X
the	B-X
concentration	B-X
of	B-X
intracellular	B-X
calcium	B-X
to	B-X
be	B-X
determined	B-X
independently	B-X
of	B-X
these	B-X
artifacts	B-X
.	B-X
One	B-X
of	B-X
the	B-X
most	B-X
common	B-X
calcium	B-X
indicators	B-X
is	B-X
Fura-2	B-X
,	B-X
which	B-X
has	B-X
an	B-X
emission	B-X
peak	B-X
at	B-X
505	B-X
nM	B-X
and	B-X
changes	B-X
its	B-X
excitation	B-X
peak	B-X
from	B-X
340	B-X
nm	B-X
to	B-X
380	B-X
nm	B-X
in	B-X
response	B-X
to	B-X
calcium	B-X
binding	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
the	B-X
use	B-X
of	B-X
Fura-2	B-X
to	B-X
measure	B-X
intracellular	B-X
calcium	B-X
elevations	B-X
in	B-X
neurons	B-X
and	B-X
other	B-X
excitable	B-X
cells	B-X
.	B-X

TCS	O
mutant	O
biofilms	O
are	O
arrested	O
in	O
the	O
transition	O
to	O
later	O
biofilm	O
developmental	O
stages	O

To	O
determine	O
whether	O
the	O
altered	O
biofilm	O
structure	O
was	O
due	O
to	O
arrested	O
biofilm	O
formation	O
or	O
attachment	O
defects	O
,	O
we	O
first	O
determined	O
whether	O
the	O
P	O
.	O
aeruginosa	O
mutants	O
are	O
defective	O
in	O
attachment	O
.	O

Inactivation	O
of	O
BfiS	B-Protein
,	O
BfmR	B-Protein
,	O
and	O
MifR	B-Protein
(	O
PA4197	B-Protein
,	O
PA4101	B-Protein
,	O
PA5511	B-Protein
,	O
respectively	O
)	O
did	O
not	O
affect	O
initial	O
attachment	O
to	O
polystyrene	O
compared	O
to	O
wild	O
type	O
biofilms	O
as	O
revealed	O
by	O
the	O
crystal	O
violet	O
microtiter	O
plate	O
assay	O
and	O
confirmed	O
by	O
microscopy	O
(	O
not	O
shown	O
)	O
.	O

Furthermore	O
,	O
no	O
difference	O
in	O
growth	O
in	O
broth	O
or	O
defect	O
with	O
respect	O
to	O
twitching	O
,	O
swimming	O
,	O
and	O
swarming	O
or	O
Pel	B-Protein
and	O
Psl	B-Protein
polysaccharide	O
production	O
was	O
detected	O
for	O
any	O
of	O
the	O
mutant	O
strains	O
(	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
Although	B-X
Bcc	B-X
plays	B-X
a	B-X
role	B-X
in	B-X
crop	B-X
growth	B-X
due	B-X
to	B-X
its	B-X
fungicidal	B-X
activity	B-X
and	B-X
pesticide	B-X
metabolizer	B-X
,	B-X
it	B-X
has	B-X
been	B-X
frequently	B-X
implicated	B-X
in	B-X
outbreaks	B-X
in	B-X
the	B-X
United	B-X
States	B-X
and	B-X
Worldwide	B-X
due	B-X
to	B-X
contaminated	B-X
medicines	B-X
or	B-X
medical	B-X
devices	B-X
.	B-X
Disc	B-X
diffusion	B-X
is	B-X
a	B-X
poorly	B-X
reproducible	B-X
method	B-X
for	B-X
antibiotic	B-X
susceptibility	B-X
testing	B-X
of	B-X
Bcc	B-X
when	B-X
compared	B-X
to	B-X
broth	B-X
microdilution	B-X
,	B-X
agar	B-X
dilution	B-X
or	B-X
Etest	B-X
.	B-X
However	B-X
,	B-X
trimethoprim-sulfamethoxazole	B-X
,	B-X
meropenem	B-X
,	B-X
doripenem	B-X
,	B-X
doxycycline	B-X
,	B-X
minocycline	B-X
,	B-X
and	B-X
ceftazidime	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
among	B-X
the	B-X
most	B-X
active	B-X
antimicrobial	B-X
agents	B-X
to	B-X
date	B-X
.	B-X
Furthermore	B-X
,	B-X
harmonization	B-X
of	B-X
the	B-X
Clinical	B-X
and	B-X
Laboratory	B-X
Standards	B-X
Institute	B-X
(	B-X
CLSI	B-X
)	B-X
and	B-X
the	B-X
European	B-X
Committee	B-X
on	B-X
Antimicrobial	B-X
Susceptibility	B-X
Testing	B-X
(	B-X
EUCAST	B-X
)	B-X
guidelines	B-X
is	B-X
highly	B-X
important	B-X
to	B-X
fight	B-X
against	B-X
the	B-X
rapidly	B-X
emerging	B-X
resistant	B-X
bacteria	B-X
e.g	B-X
.	B-X

In	O
addition	O
,	O
no	O
difference	O
in	O
transcript	O
abundance	O
,	O
as	O
determined	O
by	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
,	O
of	O
genes	O
involved	O
in	O
Pel	B-Protein
and	O
Psl	B-Protein
polysaccharide	O
biosynthesis	O
compared	O
to	O
wild	O
type	O
was	O
detected	O
(	O
not	O
shown	O
)	O
.	O

However	O
,	O
a	O
DeltagacS	B-Protein
mutant	O
showed	O
10	O
-	O
fold	O
reduced	O
initial	O
attachment	O
compared	O
to	O
the	O
wild	O
type	O
(	O
not	O
shown	O
)	O
,	O
consistent	O
with	O
previous	O
findings	O
by	O
Parkins	O
and	O
colleagues	O
[	O
65	O
]	O
.	O

These	O
findings	O
implied	O
that	O
the	O
novel	O
regulatory	O
proteins	O
were	O
involved	O
in	O
the	O
regulation	O
of	O
biofilm	O
formation	O
at	O
later	O
stages	O
following	O
initial	O
attachment	O
.	O

To	O
determine	O
the	O
stage	O
at	O
which	O
DeltabfiS	B-Protein
and	O
DeltabfmR	B-Protein
mutant	O
biofilms	O
were	O
arrested	O
,	O
the	O
biofilm	O
architecture	O
of	O
the	O
mutant	O
strains	O
after	O
144	O
hr	O
of	O
growth	O
was	O
compared	O
to	O
the	O
wild	O
type	O
P	O
.	O
aeruginosa	O
biofilm	O
architecture	O
following	O
24	O
,	O
72	O
,	O
and	O
144	O
hr	O
of	O
growth	O
(	O
Table	O
2	O
)	O
.	O

Based	O
on	O
the	O
comparison	O
of	O
5	O
biofilm	O
variables	O
,	O
both	O
mutant	O
biofilms	O
were	O
more	O
similar	O
to	O
24	O
-	O
hr	O
-	O
old	O
biofilms	O
,	O
with	O
DeltabfmR	B-Protein
forming	O
more	O
substantial	O
biofilms	O
than	O
DeltabfiS	B-Protein
or	O
24	O
hr	O
wild	O
type	O
biofilms	O
(	O
Table	O
2	O
)	O
.	O

Arrest	O
of	O
biofilm	O
formation	O
at	O
the	O
1	O
-	O
day	O
time	O
point	O
correlated	O
with	O
the	O
timing	O
of	O
BfiS	B-Protein
and	O
BfmR	B-Protein
phosphorylation	O
(	O
Tables	O
1	O
-	O
2	O
)	O
.	O

Comparison	O
of	O
the	O
DeltamifR	B-Protein
biofilm	O
architecture	O
following	O
144	O
hr	O
of	O
growth	O
to	O
wild	O
type	O
biofilms	O
indicated	O
that	O
DeltamifR	B-Protein
biofilms	O
were	O
comparable	O
to	O
72	O
-	O
hr	O
-	O
old	O
biofilms	O
.	O

Since	O
MifR	B-Protein
was	O
detected	O
to	O
be	O
phosphorylated	O
following	O
72	O
hr	O
of	O
biofilm	O
growth	O
(	O
Table	O
1	O
)	O
,	O
our	O
findings	O
indicate	O
that	O
phosphorylation	O
of	O
MifR	B-Protein
is	O
essential	O
for	O
the	O
progression	O
of	O
P	O
.	O
aeruginosa	O
biofilms	O
from	O
the	O
maturation	O
-	O
1	O
stage	O
(	O
72	O
hr	O
)	O
to	O
the	O
maturation	O
-	O
2	O
stage	O
(	O
144	O
hr	O
)	O
.	O

To	O
exclude	O
the	O
possibility	O
that	O
the	O
DeltabfiS	B-Protein
,	O
DeltabfmR	B-Protein
,	O
and	O
DeltamifR	B-Protein
mutant	O
biofilms	O
may	O
have	O
disaggregated	O
prematurely	O
,	O
the	O
formation	O
of	O
mutant	O
biofilms	O
was	O
monitored	O
daily	O
by	O
confocal	O
microscopy	O
over	O
a	O
period	O
of	O
144	O
hr	O
.	O

The	O
DeltabfiS	B-Protein
and	O
DeltabfmR	B-Protein
biofilms	O
resembled	O
wild	O
type	O
biofilms	O
with	O
respect	O
to	O
biomass	O
and	O
overall	O
architecture	O
at	O
the	O
24	O
hr	O
time	O
point	O
(	O
see	O
Fig	O
.	O
2A	O
-	O
B	O
)	O
.	O

However	O
,	O
while	O
wild	O
type	O
biofilms	O
continued	O
to	O
mature	O
/	O
develop	O
upon	O
prolonged	O
incubation	O
(	O
see	O
Fig	O
.	O
2A	O
)	O
,	O
no	O
additional	O
biomass	O
accumulation	O
or	O
alteration	O
in	O
architecture	O
was	O
observed	O
for	O
DeltabfiS	B-Protein
and	O
DeltabfmR	B-Protein
biofilms	O
post	O
24	O
hr	O
of	O
growth	O
.	O

Furthermore	O
,	O
for	O
DeltamifR	B-Protein
biofilms	O
,	O
the	O
progression	O
of	O
biofilm	O
formation	O
was	O
indistinguishable	O
from	O
wild	O
type	O
P	O
.	O
aeruginosa	O
biofilm	O
formation	O
for	O
the	O
first	O
72	O
hr	O
of	O
growth	O
.	O

However	O
,	O
continued	O
incubation	O
did	O
not	O
result	O
in	O
increased	O
DeltamifR	B-Protein
biofilm	O
growth	O
(	O
biomass	O
,	O
thickness	O
)	O
or	O
microcolony	O
formation	O
typically	O
seen	O
in	O
wild	O
type	O
biofilms	O
at	O
the	O
maturation	O
-	O
2	O
stage	O
(	O
post	O
72	O
hr	O
of	O
growth	O
,	O
Table	O
2	O
,	O
Fig	O
.	O
2	O
)	O
.	O

The	O
findings	O
clearly	O
indicate	O
that	O
inactivation	O
of	O
these	O
novel	O
regulatory	O
proteins	O
did	O
not	O
cause	O
biofilm	O
disaggregation	O
.	O
<EOS>	B-X
Histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
remove	B-X
acetyl	B-X
moieties	B-X
from	B-X
lysine	B-X
residues	B-X
at	B-X
histone	B-X
tails	B-X
and	B-X
nuclear	B-X
regulatory	B-X
proteins	B-X
and	B-X
thus	B-X
significantly	B-X
impact	B-X
chromatin	B-X
remodeling	B-X
and	B-X
transcriptional	B-X
regulation	B-X
in	B-X
eukaryotes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
a	B-X
fungus-specific	B-X
C-terminal	B-X
region	B-X
of	B-X
only	B-X
a	B-X
few	B-X
acidic	B-X
amino	B-X
acids	B-X
is	B-X
required	B-X
for	B-X
both	B-X
the	B-X
nuclear	B-X
localization	B-X
and	B-X
catalytic	B-X
activity	B-X
of	B-X
the	B-X
enzyme	B-X
in	B-X
the	B-X
model	B-X
organism	B-X
Aspergillus	B-X
nidulans	B-X
Since	B-X
strains	B-X
with	B-X
single	B-X
or	B-X
multiple	B-X
deletions	B-X
of	B-X
other	B-X
classical	B-X
HDACs	B-X
revealed	B-X
no	B-X
or	B-X
only	B-X
moderate	B-X
growth	B-X
deficiencies	B-X
,	B-X
it	B-X
is	B-X
highly	B-X
probable	B-X
that	B-X
the	B-X
significant	B-X
delay	B-X
of	B-X
germination	B-X
and	B-X
the	B-X
growth	B-X
defects	B-X
observed	B-X
in	B-X
strains	B-X
growing	B-X
under	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
are	B-X
caused	B-X
primarily	B-X
by	B-X
inhibition	B-X
of	B-X
catalytic	B-X
RpdA	B-X
activity	B-X
.	B-X
Considering	B-X
these	B-X
results	B-X
,	B-X
RpdA	B-X
with	B-X
its	B-X
fungus-specific	B-X
motif	B-X
represents	B-X
a	B-X
promising	B-X
target	B-X
for	B-X
novel	B-X
HDAC	B-X
inhibitors	B-X
that	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
their	B-X
increasing	B-X
impact	B-X
as	B-X
anticancer	B-X
drugs	B-X
,	B-X
might	B-X
gain	B-X
in	B-X
importance	B-X
as	B-X
antifungals	B-X
against	B-X
life-threatening	B-X
invasive	B-X
infections	B-X
,	B-X
apart	B-X
from	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
classical	B-X
antifungal	B-X
therapy	B-X
regimes	B-X
.	B-X
Lung	B-X
cancer	B-X
remains	B-X
the	B-X
most	B-X
lethal	B-X
cancer	B-X
worldwide	B-X
because	B-X
of	B-X
its	B-X
high	B-X
metastasis	B-X
potential	B-X
.	B-X
Epithelial-mesenchymal	B-X
transition	B-X
(	B-X
EMT	B-X
)	B-X
is	B-X
known	B-X
as	B-X
the	B-X
first	B-X
step	B-X
of	B-X
the	B-X
metastasis	B-X
cascade	B-X
,	B-X
but	B-X
the	B-X
potential	B-X
regulatory	B-X
mechanisms	B-X
of	B-X
EMT	B-X
have	B-X
not	B-X
been	B-X
clearly	B-X
established	B-X
.	B-X
Immunoprecipitation	B-X
(	B-X
IP	B-X
)	B-X
assays	B-X
showed	B-X
that	B-X
Smurf2	B-X
is	B-X
a	B-X
novel	B-X
CUEDC1-interacting	B-X
protein	B-X
.	B-X

Instead	O
,	O
our	O
findings	O
suggested	O
that	O
the	O
mutant	O
biofilms	O
were	O
incapable	O
of	O
progressing	O
from	O
the	O
initial	O
attachment	O
stage	O
to	O
more	O
mature	O
biofilm	O
stages	O
.	O

GacS	B-Protein
plays	O
a	O
dual	O
role	O
in	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O

Since	O
GacS	B-Protein
was	O
found	O
to	O
be	O
phosphorylated	O
in	O
a	O
BfiS	B-Protein
-	O
dependent	O
manner	O
following	O
8	O
hrs	O
of	O
growth	O
,	O
we	O
asked	O
whether	O
a	O
DeltagacS	B-Protein
mutant	O
forms	O
biofilms	O
similar	O
in	O
architecture	O
to	O
DeltabfiS	B-Protein
biofilms	O
.	O

Inactivation	O
of	O
gacS	B-Protein
resulted	O
in	O
the	O
formation	O
of	O
biofilms	O
following	O
144	O
hr	O
of	O
growth	O
that	O
were	O
similar	O
in	O
appearance	O
to	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
.	O

Closer	O
inspection	O
of	O
biofilm	O
formation	O
by	O
DeltagacS	B-Protein
over	O
a	O
period	O
of	O
144	O
hr	O
,	O
however	O
,	O
indicated	O
that	O
the	O
biofilm	O
architecture	O
(	O
seen	O
after	O
144	O
hr	O
)	O
was	O
due	O
to	O
accelerated	O
biofilm	O
growth	O
followed	O
by	O
premature	O
disaggregation	O
of	O
biofilms	O
as	O
compared	O
to	O
wild	O
type	O
biofilms	O
.	O

DeltagacS	B-Protein
mutant	O
biofilms	O
were	O
significantly	O
thicker	O
than	O
wild	O
type	O
biofilms	O
following	O
1	O
and	O
72	O
hr	O
of	O
growth	O
under	O
flowing	O
conditions	O
,	O
forming	O
microcolonies	O
and	O
clusters	O
exceeding	O
150	O
microm	O
in	O
diameter	O
(	O
Fig	O
.	O
3	O
)	O
.	O

At	O
both	O
time	O
points	O
,	O
DeltagacS	B-Protein
biofilms	O
not	O
only	O
exceeded	O
the	O
average	O
microcolony	O
size	O
typically	O
seen	O
for	O
wild	O
type	O
biofilms	O
of	O
the	O
same	O
age	O
,	O
but	O
also	O
the	O
biomass	O
and	O
thickness	O
of	O
wild	O
type	O
biofilms	O
at	O
more	O
mature	O
ages	O
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
.	O

Continued	O
growth	O
for	O
more	O
than	O
72	O
hr	O
,	O
however	O
,	O
resulted	O
in	O
the	O
disaggregation	O
of	O
DeltagacS	B-Protein
mutant	O
biofilms	O
as	O
indicated	O
by	O
the	O
presence	O
of	O
large	O
,	O
detached	O
clusters	O
floating	O
in	O
the	O
bulk	O
liquid	O
,	O
and	O
a	O
significantly	O
reduced	O
attached	O
biofilm	O
biomass	O
and	O
biofilm	O
thickness	O
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
.	O

Thus	O
,	O
while	O
growth	O
of	O
DeltagacS	B-Protein
mutant	O
biofilms	O
following	O
24	O
hr	O
post	O
attachment	O
was	O
accelerated	O
(	O
Fig	O
.	O
3	O
)	O
,	O
initial	O
attachment	O
was	O
significantly	O
reduced	O
in	O
this	O
mutant	O
(	O
not	O
shown	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
GacS	B-Protein
may	O
play	O
a	O
dual	O
role	O
in	O
regulating	O
biofilm	O
formation	O
,	O
which	O
in	O
turn	O
may	O
be	O
dependent	O
on	O
the	O
phosphorylation	O
status	O
of	O
GacS	B-Protein
(	O
Table	O
1	O
)	O
.	O

Mutant	O
biofilms	O
display	O
protein	O
and	O
phosphorylation	O
patterns	O
indicative	O
of	O
stage	O
-	O
specific	O
arrest	O
of	O
biofilm	O
development	O

Based	O
on	O
qualitative	O
and	O
quantitative	O
analyses	O
,	O
BfiS	B-Protein
(	O
PA4197	B-Protein
)	O
and	O
BfmR	B-Protein
(	O
PA4101	B-Protein
)	O
mutant	O
biofilm	O
architecture	O
appeared	O
to	O
be	O
the	O
result	O
of	O
arrested	O
biofilm	O
formation	O
following	O
initial	O
attachment	O
,	O
while	O
inactivation	O
of	O
MifR	B-Protein
(	O
PA5511	B-Protein
)	O
coincided	O
with	O
biofilms	O
impaired	O
in	O
microcolony	O
formation	O
at	O
the	O
maturation	O
-	O
1	O
stage	O
.	O

Since	O
each	O
of	O
these	O
biofilm	O
developmental	O
stages	O
is	O
characterized	O
by	O
a	O
unique	O
phosphorylation	O
pattern	O
(	O
Figs	O
.	O
1	O
,	O
4	O
,	O
Table	O
1	O
)	O
,	O
we	O
reasoned	O
that	O
if	O
the	O
mutant	O
biofilms	O
are	O
indeed	O
arrested	O
in	O
biofilm	O
development	O
,	O
their	O
phosphoproteomes	O
will	O
correspond	O
to	O
the	O
stage	O
at	O
which	O
they	O
are	O
arrested	O
.	O

We	O
,	O
therefore	O
,	O
analyzed	O
the	O
phosphorylation	O
patterns	O
of	O
DeltabfiS	B-Protein
,	O
DeltabfmR	B-Protein
,	O
and	O
DeltamifR	B-Protein
biofilms	O
grown	O
for	O
144	O
hr	O
in	O
comparison	O
to	O
P	O
.	O
aeruginosa	O
wild	O
type	O
biofilms	O
grown	O
for	O
8	O
,	O
24	O
,	O
72	O
,	O
and	O
144	O
hr	O
.	O

The	O
phosphoproteomes	O
were	O
analyzed	O
using	O
two	O
approaches	O
,	O
(	O
i	O
)	O
immunoblot	O
analysis	O
of	O
whole	O
biofilm	O
cell	O
extracts	O
and	O
(	O
ii	O
)	O
LC	O
-	O
MS	O
/	O
MS	O
analysis	O
in	O
conjunction	O
with	O
cICAT	O
labeling	O
following	O
MOAC	O
purification	O
.	O

The	O
phosphoproteome	O
of	O
DeltabfiS	B-Protein
biofilms	O
as	O
determined	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
was	O
74	O
%	O
similar	O
(	O
26	O
%	O
difference	O
)	O
to	O
planktonic	O
cells	O
while	O
DeltabfmR	B-Protein
biofilms	O
shared	O
60	O
%	O
of	O
all	O
detected	O
phosphorylation	O
events	O
with	O
planktonic	O
cells	O
(	O
40	O
%	O
difference	O
)	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
phosphoproteome	O
of	O
144	O
-	O
hr	O
-	O
old	O
P	O
.	O
aeruginosa	O
wild	O
type	O
biofilms	O
,	O
which	O
was	O
62	O
-	O
65	O
%	O
different	O
from	O
that	O
of	O
planktonic	O
cells	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Furthermore	O
,	O
both	O
mutant	O
biofilms	O
failed	O
to	O
exhibit	O
phosphorylation	O
events	O
typically	O
observed	O
during	O
normal	O
biofilm	O
development	O
following	O
144	O
hr	O
of	O
growth	O
(	O
see	O
Fig	O
.	O
1	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
.	O

For	O
instance	O
,	O
DeltabfiS	B-Protein
and	O
DeltabfmR	B-Protein
biofilms	O
lacked	O
all	O
phosphorylated	O
proteins	O
typically	O
found	O
in	O
mature	O
,	O
144	O
-	O
hr	O
-	O
old	O
biofilms	O
.	O

In	O
addition	O
,	O
both	O
mutant	O
biofilms	O
lacked	O
evidence	O
for	O
MifR	B-Protein
phosphorylation	O
(	O
phosphorylated	O
following	O
72	O
hr	O
of	O
wild	O
type	O
growth	O
,	O
Table	O
1	O
,	O
Suppl	O
.	O
Fig	O
.	O
S3	O
)	O
.	O

Instead	O
,	O
DeltabfiS	B-Protein
biofilms	O
exhibited	O
stage	O
-	O
specific	O
phosphorylation	O
events	O
typically	O
detected	O
in	O
8	O
-	O
hr	O
-	O
and	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
:	O
the	O
Ser	O
/	O
Thr	O
phosphoproteome	O
contained	O
15	O
out	O
of	O
23	O
phosphorylated	O
proteins	O
and	O
2	O
out	O
of	O
21	O
phosphorylated	O
proteins	O
that	O
are	O
specific	O
for	O
8	O
-	O
hr	O
-	O
and	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
,	O
respectively	O
(	O
see	O
Fig	O
.	O
1	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
.	O

Similarly	O
,	O
the	O
phosphorylation	O
patterns	O
of	O
DeltabfmR	B-Protein
biofilms	O
indicated	O
the	O
presence	O
of	O
24	O
-	O
and	O
72	O
-	O
hr	O
stage	O
-	O
specific	O
phosphorylated	O
proteins	O
(	O
not	O
shown	O
)	O
.	O

The	O
phosphorylation	O
patterns	O
of	O
144	O
-	O
hr	O
-	O
old	O
DeltamifR	B-Protein
biofilms	O
were	O
62	O
%	O
different	O
relative	O
to	O
planktonic	O
cells	O
,	O
but	O
only	O
shared	O
58	O
%	O
similarity	O
with	O
mature	O
,	O
144	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Furthermore	O
,	O
DeltamifR	B-Protein
biofilms	O
exhibited	O
8	O
out	O
of	O
27	O
maturation	O
-	O
1	O
specific	O
protein	O
phosphorylation	O
events	O
,	O
and	O
only	O
16	O
out	O
of	O
37	O
maturation	O
-	O
2	O
phosphorylation	O
events	O
(	O
Suppl	O
.	O
Table	O
S2	O
,	O
see	O
Fig	O
.	O
1	O
)	O
.	O

We	O
further	O
reasoned	O
that	O
if	O
the	O
mutant	O
biofilms	O
are	O
indeed	O
arrested	O
in	O
biofilm	O
development	O
,	O
their	O
whole	O
proteomes	O
will	O
also	O
correspond	O
to	O
the	O
stage	O
at	O
which	O
they	O
are	O
arrested	O
.	O

We	O
therefore	O
compared	O
the	O
protein	O
production	O
patterns	O
of	O
144	O
-	O
hr	O
-	O
old	O
DeltabfiS	B-Protein
,	O
DeltabfmR	B-Protein
,	O
and	O
DeltamifR	B-Protein
biofilms	O
to	O
the	O
2D	O
-	O
patterns	O
of	O
P	O
.	O
aeruginosa	O
wild	O
type	O
biofilms	O
grown	O
for	O
24	O
,	O
72	O
and	O
144	O
hr	O
using	O
2D	O
/	O
PAGE	O
,	O
2D	O
ImageMaster	O
Platinum	O
software	O
and	O
heuristic	O
clustering	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
<EOS>	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

4B	O
,	O
cluster	O
analysis	O
based	O
on	O
protein	O
similarity	O
confirmed	O
our	O
previous	O
findings	O
obtained	O
by	O
microscopic	O
and	O
phosphoproteome	O
analyses	O
of	O
mutant	O
biofilms	O
.	O

DeltabfiS	B-Protein
biofilms	O
were	O
more	O
similar	O
to	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
than	O
to	O
wild	O
type	O
biofilms	O
at	O
more	O
mature	O
stages	O
.	O

The	O
two	O
protein	O
patterns	O
were	O
more	O
than	O
80	O
%	O
similar	O
.	O
<EOS>	B-X
Although	B-X
more	B-X
than	B-X
80	B-X
%	B-X
of	B-X
the	B-X
global	B-X
burden	B-X
of	B-X
cardiovascular	B-X
disease	B-X
occurs	B-X
in	B-X
low-income	B-X
and	B-X
middle-income	B-X
countries	B-X
,	B-X
knowledge	B-X
of	B-X
the	B-X
importance	B-X
of	B-X
risk	B-X
factors	B-X
is	B-X
largely	B-X
derived	B-X
from	B-X
developed	B-X
countries	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
directly	B-X
compared	B-X
the	B-X
expression	B-X
of	B-X
HLA-DR	B-X
,	B-X
Iba1	B-X
and	B-X
CD68	B-X
in	B-X
microglia	B-X
with	B-X
different	B-X
phenotypes	B-X
,	B-X
ranging	B-X
from	B-X
ramified	B-X
to	B-X
amoeboid	B-X
,	B-X
to	B-X
foamy	B-X
phagocytizing	B-X
macrophages	B-X
,	B-X
in	B-X
adjacent	B-X
sections	B-X
immunocytochemically	B-X
double	B-X
stained	B-X
for	B-X
two	B-X
of	B-X
the	B-X
markers	B-X
.	B-X
We	B-X
found	B-X
a	B-X
similar	B-X
,	B-X
yet	B-X
not	B-X
identical	B-X
,	B-X
overall	B-X
expression	B-X
pattern	B-X
.	B-X
To	B-X
understand	B-X
the	B-X
diversity	B-X
in	B-X
the	B-X
cell	B-X
culture	B-X
harvest	B-X
(	B-X
i.e.	B-X
,	B-X
feedstock	B-X
)	B-X
provided	B-X
for	B-X
downstream	B-X
processing	B-X
,	B-X
we	B-X
compared	B-X
host	B-X
cell	B-X
protein	B-X
(	B-X
HCP	B-X
)	B-X
profiles	B-X
using	B-X
three	B-X
Chinese	B-X
Hamster	B-X
Ovary	B-X
(	B-X
CHO	B-X
)	B-X
cell	B-X
lines	B-X
in	B-X
null	B-X
runs	B-X
which	B-X
did	B-X
not	B-X
generate	B-X
any	B-X
recombinant	B-X
product	B-X
.	B-X
Despite	B-X
differences	B-X
in	B-X
CHO	B-X
lineage	B-X
,	B-X
upstream	B-X
process	B-X
,	B-X
and	B-X
culture	B-X
performance	B-X
,	B-X
the	B-X
cell	B-X
lines	B-X
yielded	B-X
similar	B-X
cell-specific	B-X
productivities	B-X
for	B-X
immunogenic	B-X
HCPs	B-X
.	B-X
To	B-X
compare	B-X
the	B-X
dynamics	B-X
of	B-X
HCP	B-X
production	B-X
,	B-X
we	B-X
searched	B-X
for	B-X
correlations	B-X
between	B-X
the	B-X
time-course	B-X
profiles	B-X
of	B-X
HCP	B-X
(	B-X
as	B-X
measured	B-X
by	B-X
multi-analyte	B-X
ELISA	B-X
)	B-X
and	B-X
those	B-X
of	B-X
two	B-X
intracellular	B-X
HCP	B-X
species	B-X
,	B-X
phospholipase	B-X
B-like	B-X
2	B-X
(	B-X
PLBL2	B-X
)	B-X
and	B-X
lactate	B-X
dehydrogenase	B-X
(	B-X
LDH	B-X
)	B-X
.	B-X
Across	B-X
the	B-X
cell	B-X
lines	B-X
,	B-X
proteins	B-X
in	B-X
the	B-X
day	B-X
14	B-X
supernatants	B-X
analyzed	B-X
by	B-X
two-dimensional	B-X
polyacrylamide	B-X
gel	B-X
electrophoresis	B-X
(	B-X
2D-PAGE	B-X
)	B-X
showed	B-X
different	B-X
spot	B-X
patterns	B-X
.	B-X
However	B-X
,	B-X
subsequent	B-X
analysis	B-X
by	B-X
liquid	B-X
chromatography	B-X
coupled	B-X
with	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
LC-MS/MS	B-X
)	B-X
indicated	B-X
otherwise	B-X
:	B-X
the	B-X
total	B-X
number	B-X
of	B-X
peptides	B-X
and	B-X
proteins	B-X
identified	B-X
were	B-X
comparable	B-X
,	B-X
and	B-X
80	B-X
%	B-X
of	B-X
the	B-X
top	B-X
1,000	B-X
proteins	B-X
identified	B-X
were	B-X
common	B-X
to	B-X
all	B-X
three	B-X
lines	B-X
.	B-X
The	B-X
amounts	B-X
of	B-X
HCP	B-X
and	B-X
PLBL2	B-X
(	B-X
quantified	B-X
by	B-X
their	B-X
respective	B-X
ELISAs	B-X
)	B-X
as	B-X
well	B-X
as	B-X
the	B-X
numbers	B-X
and	B-X
major	B-X
populations	B-X
of	B-X
HCPs	B-X
(	B-X
identified	B-X
by	B-X
LC-MS/MS	B-X
)	B-X
were	B-X
similar	B-X
across	B-X
days	B-X
10	B-X
,	B-X
14	B-X
,	B-X
and	B-X
17	B-X
,	B-X
during	B-X
which	B-X
viabilities	B-X
declined	B-X
from	B-X
∼80	B-X
%	B-X
to	B-X
<	B-X
20	B-X
%	B-X
and	B-X
extracellular	B-X
LDH	B-X
levels	B-X
increased	B-X
several-fold	B-X
.	B-X

In	O
contrast	O
,	O
DeltabfmR	B-Protein
biofilms	O
were	O
most	O
similar	O
to	O
protein	O
patterns	O
obtained	O
from	O
72	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
(	O
85	O
%	O
similarity	O
)	O
,	O
while	O
those	O
of	O
DeltamifR	B-Protein
biofilms	O
were	O
similar	O
to	O
both	O
72	O
-	O
and	O
144	O
-	O
hr	O
-	O
old	O
biofilms	O
sharing	O
76	O
and	O
82	O
%	O
similarity	O
,	O
respectively	O
,	O
to	O
both	O
protein	O
patterns	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

Based	O
on	O
analyses	O
of	O
biofilm	O
architecture	O
,	O
as	O
well	O
as	O
of	O
protein	O
production	O
and	O
phosphorylation	O
patterns	O
,	O
our	O
findings	O
indicate	O
that	O
DeltabfiS	B-Protein
biofilms	O
are	O
arrested	O
in	O
the	O
transition	O
from	O
reversible	O
to	O
the	O
irreversible	O
attachment	O
stage	O
(	O
8	O
hr	O
to	O
24	O
-	O
hr	O
-	O
old	O
biofilms	O
,	O
respectively	O
)	O
.	O

Inactivation	O
of	O
MifR	B-Protein
appeared	O
to	O
result	O
in	O
the	O
arrest	O
of	O
biofilm	O
development	O
in	O
the	O
transition	O
between	O
the	O
maturation	O
-	O
1	O
and	O
-	O
2	O
stages	O
(	O
72	O
to	O
144	O
hr	O
)	O
while	O
DeltabfmR	B-Protein
biofilms	O
were	O
arrested	O
in	O
the	O
transition	O
between	O
irreversible	O
attachment	O
to	O
maturation	O
-	O
1	O
stage	O
.	O

Expression	O
of	O
bfiS	B-Protein
,	O
bfmR	B-Protein
,	O
and	O
mifR	B-Protein
is	O
required	O
for	O
maintenance	O
of	O
normal	O
biofilm	O
architecture	O
while	O
loss	O
of	O
expression	O
results	O
in	O
biofilm	O
architecture	O
collapse	O

Our	O
observations	O
indicated	O
that	O
BfiS	B-Protein
(	O
PA4197	B-Protein
)	O
,	O
BfmR	B-Protein
(	O
PA4101	B-Protein
)	O
and	O
MifR	B-Protein
(	O
PA5511	B-Protein
)	O
are	O
essential	O
in	O
the	O
stage	O
-	O
specific	O
development	O
of	O
P	O
.	O
aeruginosa	O
biofilm	O
formation	O
.	O

To	O
determine	O
whether	O
these	O
regulatory	O
proteins	O
are	O
only	O
essential	O
during	O
biofilm	O
formation	O
or	O
are	O
also	O
necessary	O
for	O
the	O
maintenance	O
of	O
established	O
biofilms	O
,	O
we	O
asked	O
whether	O
inactivation	O
of	O
these	O
regulatory	O
proteins	O
in	O
mature	O
biofilms	O
would	O
affect	O
biofilm	O
architecture	O
.	O

Complemented	O
mutant	O
strains	O
,	O
harboring	O
the	O
respective	O
regulator	O
genes	O
under	O
the	O
control	O
of	O
the	O
arabinose	O
-	O
inducible	O
PBAD	O
promoter	O
,	O
were	O
allowed	O
to	O
grow	O
for	O
144	O
hr	O
in	O
flow	O
cells	O
to	O
maturity	O
(	O
Fig	O
.	O
2C	O
,	O
Fig	O
.	O
5	O
-	O
0	O
hr	O
)	O
in	O
the	O
presence	O
of	O
arabinose	O
,	O
after	O
which	O
time	O
arabinose	O
was	O
removed	O
from	O
the	O
growth	O
medium	O
to	O
stop	O
the	O
transcription	O
of	O
the	O
respective	O
genes	O
.	O

The	O
resulting	O
biofilm	O
architecture	O
was	O
viewed	O
over	O
a	O
period	O
of	O
144	O
hr	O
post	O
arabinose	O
removal	O
using	O
confocal	O
microscopy	O
.	O

P	O
.	O
aeruginosa	O
wild	O
type	O
harboring	O
an	O
empty	O
pJN105	O
vector	O
was	O
used	O
as	O
control	O
.	O

Loss	O
of	O
bfiS	B-Protein
,	O
bfmR	B-Protein
,	O
and	O
mifR	B-Protein
expression	O
due	O
to	O
arabinose	O
removal	O
resulted	O
in	O
the	O
collapse	O
of	O
the	O
mutant	O
biofilm	O
architecture	O
within	O
three	O
days	O
.	O

For	O
DeltabfiS	B-Protein
and	O
DeltabfmR	B-Protein
mutant	O
biofilms	O
,	O
biofilm	O
disaggregation	O
was	O
noticeable	O
as	O
early	O
as	O
24	O
hr	O
post	O
arabinose	O
removal	O
(	O
not	O
shown	O
)	O
.	O

The	O
collapse	O
was	O
apparent	O
by	O
significant	O
reduction	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
of	O
biofilm	O
variables	O
including	O
biofilm	O
biomass	O
and	O
thickness	O
,	O
which	O
further	O
decreased	O
upon	O
continued	O
incubation	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

Post	O
144	O
hr	O
of	O
arabinose	O
removal	O
,	O
the	O
biofilm	O
architecture	O
of	O
the	O
complemented	O
mutants	O
was	O
similar	O
to	O
mutant	O
biofilms	O
lacking	O
the	O
respective	O
regulatory	O
gene	O
(	O
Figs	O
.	O
2	O
,	O
5	O
)	O
.	O

In	O
contrast	O
,	O
no	O
reduction	O
of	O
the	O
wild	O
type	O
biofilm	O
architecture	O
was	O
observed	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

These	O
findings	O
indicated	O
that	O
the	O
three	O
novel	O
regulators	O
are	O
not	O
only	O
essential	O
for	O
the	O
stage	O
-	O
specific	O
progression	O
of	O
P	O
.	O
aeruginosa	O
biofilms	O
but	O
also	O
in	O
the	O
maintenance	O
of	O
the	O
biofilm	O
structure	O
.	O
<EOS>	B-X
Presently	B-X
,	B-X
there	B-X
is	B-X
no	B-X
comprehensive	B-X
analysis	B-X
of	B-X
multiomics	B-X
data	B-X
to	B-X
mine	B-X
a	B-X
better	B-X
one	B-X
.	B-X
First	B-X
,	B-X
t-SNE	B-X
and	B-X
ssGSEA	B-X
analysis	B-X
were	B-X
used	B-X
to	B-X
establish	B-X
tumor	B-X
subtypes	B-X
related	B-X
to	B-X
hypoxia-immune	B-X
,	B-X
and	B-X
we	B-X
investigated	B-X
the	B-X
hypoxia-immune-related	B-X
differences	B-X
in	B-X
three	B-X
types	B-X
of	B-X
genetic	B-X
or	B-X
epigenetic	B-X
characteristics	B-X
(	B-X
gene	B-X
expression	B-X
profiles	B-X
,	B-X
somatic	B-X
mutation	B-X
,	B-X
and	B-X
DNA	B-X
methylation	B-X
)	B-X
by	B-X
analyzing	B-X
the	B-X
multiomics	B-X
data	B-X
from	B-X
The	B-X
Cancer	B-X
Genome	B-X
Atlas	B-X
(	B-X
TCGA	B-X
)	B-X
portal	B-X
.	B-X
Furthermore	B-X
,	B-X
it	B-X
was	B-X
indicated	B-X
high-risk	B-X
patients	B-X
have	B-X
a	B-X
better	B-X
response	B-X
for	B-X
immunotherapy	B-X
in	B-X
immunophenoscore	B-X
(	B-X
IPS	B-X
)	B-X
analysis	B-X
and	B-X
TIDE	B-X
algorithm	B-X
.	B-X
Meanwhile	B-X
,	B-X
estimated	B-X
by	B-X
GDSC	B-X
and	B-X
cMAP	B-X
database	B-X
,	B-X
the	B-X
high-risk	B-X
patients	B-X
showed	B-X
sensitive	B-X
responses	B-X
to	B-X
six	B-X
chemotherapy	B-X
drugs	B-X
and	B-X
six	B-X
candidate	B-X
small-molecule	B-X
drugs	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
the	B-X
signature	B-X
can	B-X
accurately	B-X
predict	B-X
the	B-X
prognosis	B-X
of	B-X
ccRCC	B-X
and	B-X
may	B-X
shed	B-X
light	B-X
on	B-X
the	B-X
development	B-X
of	B-X
novel	B-X
hypoxia-immune	B-X
biomarkers	B-X
and	B-X
target	B-X
therapy	B-X
of	B-X
ccRCC	B-X
.	B-X

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Evidence	O
showing	O
that	O
biofilm	O
development	O
is	O
a	O
coordinated	O
series	O
of	O
events	O
coinciding	O
with	O
distinct	O
phenotypes	O
has	O
led	O
to	O
the	O
assumption	O
that	O
the	O
formation	O
of	O
biofilms	O
is	O
a	O
regulated	O
progression	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
66	O
]	O
.	O

However	O
,	O
biofilm	O
development	O
has	O
been	O
considered	O
to	O
be	O
distinct	O
from	O
other	O
developmental	O
processes	O
including	O
the	O
programmed	O
differentiation	O
seen	O
in	O
spore	O
formation	O
in	O
Bacillus	O
subtilis	O
or	O
fruiting	O
body	O
formation	O
in	O
Myxococcus	O
xanthus	O
[	O
11	O
]	O
,	O
mainly	O
because	O
no	O
regulatory	O
pathways	O
have	O
yet	O
been	O
identified	O
that	O
are	O
responsible	O
for	O
regulating	O
committed	O
steps	O
in	O
the	O
formation	O
of	O
biofilms	O
with	O
the	O
exception	O
of	O
attachment	O
.	O

In	O
this	O
study	O
we	O
describe	O
the	O
identification	O
and	O
initial	O
characterization	O
of	O
three	O
novel	O
two	O
-	O
component	O
systems	O
(	O
TCS	O
)	O
essential	O
in	O
regulating	O
three	O
committed	O
steps	O
in	O
biofilm	O
development	O
.	O

Mutation	O
in	O
these	O
regulatory	O
pathways	O
did	O
not	O
affect	O
initial	O
attachment	O
,	O
motility	O
,	O
or	O
Pel	B-Protein
and	O
Psl	B-Protein
polysaccharide	O
production	O
,	O
but	O
instead	O
arrested	O
biofilm	O
development	O
in	O
the	O
transition	O
from	O
reversible	O
to	O
irreversible	O
attachment	O
[	O
8	O
hr	O
to	O
24	O
hr	O
,	O
BfiRS	B-Protein
(	O
PA4196	B-Protein
-	O
4197	B-Protein
)	O
]	O
,	O
from	O
initial	O
attachment	O
to	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
(	O
24	O
hr	O
to	O
72	O
hr	O
,	O
BfmRS	B-Protein
(	O
PA4101	B-Protein
-	O
4102	B-Protein
)	O
]	O
,	O
and	O
following	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
72	O
hr	O
to	O
144	O
hr	O
,	O
MifRS	B-Protein
(	O
PA5511	B-Protein
-	O
5512	B-Protein
)	O
]	O
(	O
Fig	O
.	O
6	O
)	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
description	O
of	O
a	O
regulatory	O
program	O
for	O
stage	O
-	O
specific	O
biofilm	O
development	O
.	O

The	O
stage	O
-	O
specific	O
arrest	O
in	O
biofilm	O
formation	O
of	O
the	O
mutant	O
strains	O
coincided	O
with	O
the	O
timing	O
of	O
phosphorylation	O
of	O
the	O
respective	O
regulatory	O
or	O
sensory	O
proteins	O
indicating	O
that	O
the	O
phosphorylation	O
status	O
of	O
the	O
three	O
novel	O
two	O
-	O
component	O
systems	O
is	O
essential	O
for	O
their	O
function	O
in	O
regulating	O
biofilm	O
development	O
by	O
P	O
.	O
aeruginosa	O
.	O

Furthermore	O
,	O
the	O
phosphorylation	O
of	O
these	O
two	O
-	O
component	O
systems	O
occurred	O
in	O
sequence	O
with	O
BfiS	B-Protein
being	O
phosphorylated	O
first	O
,	O
followed	O
by	O
GacS	B-Protein
,	O
and	O
lastly	O
,	O
MifR	B-Protein
(	O
Table	O
1	O
,	O
Fig	O
.	O
6	O
)	O
.	O

The	O
sequential	O
phosphorylation	O
of	O
sensors	O
/	O
regulatory	O
proteins	O
is	O
reminiscent	O
of	O
a	O
regulatory	O
cascade	O
in	O
which	O
each	O
phosphorylation	O
event	O
acts	O
as	O
a	O
trigger	O
for	O
bacterial	O
biofilm	O
cells	O
to	O
transition	O
to	O
the	O
next	O
developmental	O
stage	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Furthermore	O
,	O
the	O
novel	O
TCS	O
systems	O
described	O
here	O
appear	O
to	O
be	O
linked	O
via	O
GacS	B-Protein
to	O
the	O
multicomponent	O
system	O
RetS	B-Protein
/	O
LadS	B-Protein
/	O
GacAS	B-Protein
/	O
RsmA	B-Protein
essential	O
for	O
regulating	O
the	O
switch	O
between	O
the	O
planktonic	O
and	O
the	O
sessile	O
mode	O
of	O
growth	O
.	O

While	O
it	O
is	O
not	O
clear	O
how	O
the	O
three	O
two	O
-	O
component	O
systems	O
interact	O
to	O
form	O
the	O
observed	O
sequential	O
phosphorylation	O
cascade	O
,	O
it	O
is	O
apparent	O
from	O
our	O
observations	O
that	O
phosphorylation	O
of	O
each	O
of	O
the	O
three	O
novel	O
TCS	O
has	O
to	O
occur	O
for	O
P	O
.	O
aeruginosa	O
biofilms	O
to	O
mature	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Possible	O
scenarios	O
for	O
the	O
sequential	O
phosphorylation	O
events	O
to	O
occur	O
are	O
by	O
direct	O
interaction	O
or	O
activation	O
of	O
a	O
TCS	O
system	O
by	O
one	O
that	O
is	O
upstream	O
in	O
the	O
cascade	O
(	O
Fig	O
.	O
6	O
)	O
,	O
or	O
indirectly	O
.	O
<EOS>	B-X
The	B-X
evidence	B-X
suggests	B-X
that	B-X
Reuss	B-X
did	B-X
indeed	B-X
discover	B-X
electro-osmosis	B-X
,	B-X
which	B-X
takes	B-X
its	B-X
name	B-X
(	B-X
indirectly	B-X
)	B-X
from	B-X
the	B-X
work	B-X
of	B-X
Porrett	B-X
.	B-X
The	B-X
aim	B-X
of	B-X
this	B-X
review	B-X
was	B-X
to	B-X
elucidate	B-X
the	B-X
impact	B-X
of	B-X
child	B-X
sexual	B-X
abuse	B-X
on	B-X
all	B-X
clinical	B-X
phenomena	B-X
that	B-X
occur	B-X
after	B-X
the	B-X
onset	B-X
of	B-X
bipolar	B-X
disorder	B-X
,	B-X
including	B-X
associated	B-X
clinical	B-X
features	B-X
that	B-X
are	B-X
not	B-X
part	B-X
of	B-X
the	B-X
diagnostic	B-X
criteria	B-X
for	B-X
the	B-X
disorder	B-X
.	B-X
The	B-X
underlying	B-X
mechanisms	B-X
and	B-X
associated	B-X
phenomenological	B-X
lipid	B-X
membrane	B-X
transports	B-X
are	B-X
linked	B-X
directly	B-X
or	B-X
indirectly	B-X
to	B-X
the	B-X
cell	B-X
health	B-X
condition	B-X
.	B-X
A	B-X
large	B-X
number	B-X
of	B-X
ion	B-X
channels	B-X
active	B-X
across	B-X
MOM	B-X
and	B-X
MIM	B-X
are	B-X
known	B-X
to	B-X
belong	B-X
to	B-X
vital	B-X
cell-based	B-X
structures	B-X
found	B-X
to	B-X
be	B-X
linked	B-X
directly	B-X
to	B-X
cellular	B-X
signaling	B-X
.	B-X
This	B-X
article	B-X
aims	B-X
to	B-X
pinpoint	B-X
ion	B-X
channels	B-X
that	B-X
are	B-X
directly	B-X
or	B-X
indirectly	B-X
linked	B-X
to	B-X
especially	B-X
aging	B-X
and	B-X
related	B-X
abnormalities	B-X
in	B-X
health	B-X
conditions	B-X
.	B-X
The	B-X
malfunction	B-X
of	B-X
ion	B-X
channel	B-X
subunits	B-X
,	B-X
especially	B-X
various	B-X
proteins	B-X
,	B-X
involved	B-X
directly	B-X
in	B-X
channel	B-X
formation	B-X
and/or	B-X
indirectly	B-X
in	B-X
channel	B-X
stabilization	B-X
leads	B-X
to	B-X
the	B-X
rise	B-X
of	B-X
various	B-X
channel-specific	B-X
diseases	B-X
,	B-X
which	B-X
are	B-X
known	B-X
as	B-X
channelopathies	B-X
.	B-X

Since	O
inactivation	O
of	O
each	O
TCS	O
system	O
resulted	O
in	O
altered	O
or	O
arrested	O
biofilms	O
which	O
failed	O
to	O
exhibit	O
stage	O
-	O
specific	O
protein	O
production	O
and	O
phosphorylation	O
events	O
(	O
Figs	O
.	O
1	O
,	O
4	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
,	O
it	O
is	O
likely	O
that	O
the	O
mutant	O
biofilms	O
in	O
turn	O
do	O
not	O
produce	O
the	O
necessary	O
signal	O
(	O
s	O
)	O
to	O
activate	O
or	O
phosphorylate	O
TCS	O
system	O
(	O
s	O
)	O
that	O
are	O
further	O
downstream	O
.	O
<EOS>	B-X
Two-component	B-X
signaling	B-X
(	B-X
TCS	B-X
)	B-X
is	B-X
the	B-X
primary	B-X
means	B-X
by	B-X
which	B-X
bacteria	B-X
,	B-X
as	B-X
well	B-X
as	B-X
certain	B-X
plants	B-X
and	B-X
fungi	B-X
,	B-X
respond	B-X
to	B-X
external	B-X
stimuli	B-X
.	B-X
Signal	B-X
transduction	B-X
involves	B-X
stimulus-dependent	B-X
autophosphorylation	B-X
of	B-X
a	B-X
sensor	B-X
histidine	B-X
kinase	B-X
and	B-X
phosphoryl	B-X
transfer	B-X
to	B-X
the	B-X
receiver	B-X
domain	B-X
of	B-X
a	B-X
downstream	B-X
response	B-X
regulator	B-X
.	B-X
Due	B-X
to	B-X
their	B-X
transient	B-X
nature	B-X
,	B-X
phosphorylated	B-X
receiver	B-X
domains	B-X
are	B-X
challenging	B-X
to	B-X
characterize	B-X
structurally	B-X
.	B-X
In	B-X
this	B-X
work	B-X
,	B-X
we	B-X
provide	B-X
a	B-X
methodology	B-X
for	B-X
simulating	B-X
receiver	B-X
domain	B-X
phosphorylation	B-X
to	B-X
predict	B-X
conformations	B-X
that	B-X
are	B-X
nearly	B-X
identical	B-X
to	B-X
experimental	B-X
structures	B-X
.	B-X
Using	B-X
restrained	B-X
molecular	B-X
dynamics	B-X
,	B-X
phosphorylated	B-X
conformations	B-X
of	B-X
receiver	B-X
domains	B-X
can	B-X
be	B-X
reliably	B-X
sampled	B-X
on	B-X
nanosecond	B-X
timescales	B-X
.	B-X
These	B-X
simulations	B-X
also	B-X
provide	B-X
data	B-X
on	B-X
conformational	B-X
dynamics	B-X
that	B-X
can	B-X
be	B-X
used	B-X
to	B-X
identify	B-X
regions	B-X
of	B-X
functional	B-X
significance	B-X
related	B-X
to	B-X
phosphorylation	B-X
.	B-X
We	B-X
first	B-X
validated	B-X
this	B-X
approach	B-X
on	B-X
several	B-X
well-characterized	B-X
receiver	B-X
domains	B-X
and	B-X
then	B-X
used	B-X
it	B-X
to	B-X
compare	B-X
the	B-X
upstream	B-X
and	B-X
downstream	B-X
components	B-X
of	B-X
the	B-X
fungal	B-X
Sln1	B-X
phosphorelay	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
this	B-X
technique	B-X
provides	B-X
structural	B-X
insight	B-X
,	B-X
obtained	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
crystallographic	B-X
or	B-X
NMR	B-X
information	B-X
,	B-X
regarding	B-X
phosphorylation-induced	B-X
conformational	B-X
changes	B-X
in	B-X
receiver	B-X
domains	B-X
that	B-X
regulate	B-X
the	B-X
output	B-X
of	B-X
their	B-X
associated	B-X
signaling	B-X
pathway	B-X
.	B-X
To	B-X
our	B-X
knowledge	B-X
,	B-X
this	B-X
is	B-X
the	B-X
first	B-X
time	B-X
such	B-X
a	B-X
protocol	B-X
has	B-X
been	B-X
described	B-X
that	B-X
can	B-X
be	B-X
broadly	B-X
applied	B-X
to	B-X
TCS	B-X
proteins	B-X
for	B-X
predictive	B-X
purposes	B-X
.	B-X
Proteins	B-X
2016	B-X
;	B-X
85:155-176	B-X
.	B-X
©	B-X
2016	B-X
Wiley	B-X
Periodicals	B-X
,	B-X
Inc	B-X
.	B-X

Thus	O
,	O
it	O
is	O
likely	O
that	O
inactivation	O
of	O
one	O
TCS	O
system	O
(	O
in	O
)	O
directly	O
results	O
in	O
altered	O
or	O
arrested	O
phosphorylation	O
patterns	O
and	O
thus	O
,	O
lack	O
of	O
phosphorylation	O
of	O
downstream	O
TCS	O
systems	O
(	O
as	O
observed	O
here	O
)	O
.	O

Independent	O
of	O
the	O
mechanism	O
,	O
it	O
is	O
evident	O
that	O
inactivation	O
not	O
only	O
disrupts	O
the	O
sequence	O
of	O
phosphorylation	O
events	O
but	O
also	O
leads	O
to	O
the	O
collapse	O
of	O
mature	O
biofilms	O
to	O
an	O
earlier	O
biofilm	O
developmental	O
stage	O
at	O
which	O
the	O
respective	O
regulatory	O
proteins	O
play	O
a	O
role	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O
<EOS>	B-X
There	B-X
is	B-X
also	B-X
a	B-X
substantially	B-X
increased	B-X
incidence	B-X
of	B-X
autoimmune	B-X
disease	B-X
in	B-X
females	B-X
compared	B-X
to	B-X
males	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
driving	B-X
the	B-X
sexually	B-X
dimorphic	B-X
immune	B-X
response	B-X
are	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Several	B-X
studies	B-X
have	B-X
identified	B-X
a	B-X
sex-specific	B-X
transcriptome	B-X
and	B-X
methylome	B-X
,	B-X
independent	B-X
of	B-X
the	B-X
well-described	B-X
phenomenon	B-X
of	B-X
X-chromosome	B-X
inactivation	B-X
,	B-X
suggesting	B-X
that	B-X
sexual	B-X
dimorphism	B-X
also	B-X
occurs	B-X
at	B-X
the	B-X
epigenetic	B-X
level	B-X
.	B-X
These	B-X
changes	B-X
are	B-X
also	B-X
mirrored	B-X
by	B-X
changes	B-X
in	B-X
immune	B-X
cell	B-X
function	B-X
.	B-X

This	O
is	O
even	O
more	O
important	O
as	O
this	O
biofilm	O
collapse	O
was	O
observed	O
under	O
two	O
different	O
nutritional	O
conditions	O
,	O
when	O
grown	O
on	O
minimal	O
medium	O
using	O
either	O
glutamate	O
or	O
citrate	O
as	O
a	O
sole	O
carbon	O
source	O
(	O
see	O
also	O
Figs	O
.	O
2	O
and	O
5	O
for	O
comparison	O
of	O
LB	O
and	O
glutamate	O
minimal	O
medium	O
)	O
.	O

The	O
finding	O
suggests	O
that	O
while	O
biofilm	O
formation	O
,	O
architecture	O
and	O
cell	O
-	O
cell	O
signaling	O
is	O
modulated	O
by	O
environmental	O
and	O
nutritional	O
conditions	O
resulting	O
in	O
biofilm	O
development	O
proceeding	O
via	O
distinctly	O
different	O
pathways	O
[	O
16	O
]	O
,	O
[	O
55	O
]	O
-	O
[	O
63	O
]	O
,	O
it	O
is	O
possible	O
that	O
the	O
novel	O
regulatory	O
proteins	O
identified	O
here	O
play	O
a	O
role	O
under	O
more	O
than	O
one	O
discrete	O
culturing	O
condition	O
or	O
pathway	O
.	O
<EOS>	B-X
Various	B-X
forms	B-X
of	B-X
cell	B-X
death	B-X
have	B-X
been	B-X
identified	B-X
over	B-X
the	B-X
last	B-X
decades	B-X
with	B-X
each	B-X
relying	B-X
on	B-X
a	B-X
different	B-X
subset	B-X
of	B-X
proteins	B-X
for	B-X
the	B-X
activation	B-X
and	B-X
execution	B-X
of	B-X
their	B-X
respective	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
three	B-X
best	B-X
characterized	B-X
pathways-apoptosis	B-X
,	B-X
necroptosis	B-X
,	B-X
and	B-X
pyroptosis-other	B-X
forms	B-X
of	B-X
regulated	B-X
cell	B-X
death	B-X
including	B-X
autophagy-dependent	B-X
cell	B-X
death	B-X
(	B-X
ADCD	B-X
)	B-X
,	B-X
mitochondrial	B-X
permeability	B-X
transition	B-X
pore	B-X
(	B-X
MPTP	B-X
)	B-X
-mediated	B-X
necrosis	B-X
,	B-X
parthanatos	B-X
,	B-X
NETosis	B-X
and	B-X
ferroptosis	B-X
,	B-X
and	B-X
their	B-X
relevance	B-X
for	B-X
organismal	B-X
homeostasis	B-X
are	B-X
becoming	B-X
better	B-X
understood	B-X
.	B-X
Importantly	B-X
,	B-X
it	B-X
is	B-X
increasingly	B-X
clear	B-X
that	B-X
none	B-X
of	B-X
these	B-X
pathways	B-X
operate	B-X
alone	B-X
.	B-X
Instead	B-X
,	B-X
a	B-X
more	B-X
complex	B-X
picture	B-X
is	B-X
emerging	B-X
with	B-X
many	B-X
pathways	B-X
sharing	B-X
components	B-X
and	B-X
signaling	B-X
principles	B-X
.	B-X
Finally	B-X
,	B-X
a	B-X
number	B-X
of	B-X
cell	B-X
death	B-X
regulators	B-X
are	B-X
implicated	B-X
in	B-X
human	B-X
diseases	B-X
and	B-X
represent	B-X
attractive	B-X
therapeutic	B-X
targets	B-X
.	B-X
Therefore	B-X
,	B-X
better	B-X
understanding	B-X
of	B-X
physiological	B-X
and	B-X
mechanistic	B-X
aspects	B-X
of	B-X
cell	B-X
death	B-X
signaling	B-X
should	B-X
yield	B-X
improved	B-X
reagents	B-X
for	B-X
addressing	B-X
unmet	B-X
medical	B-X
needs	B-X
.	B-X

The	O
novelty	O
of	O
these	O
TCS	O
is	O
further	O
supported	O
by	O
the	O
finding	O
that	O
a	O
search	O
for	O
BfiS	B-Protein
(	O
PA4197	B-Protein
)	O
and	O
BfmR	B-Protein
(	O
PA4101	B-Protein
)	O
homologues	O
using	O
BLAST	O
(	O
http	O
:	O
/	O
/	O
blast	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Blast	O
.	O
cgi	O
)	O
and	O
BLINK	O
(	O
precomputed	O
BLAST	O
,	O
[	O
53	O
]	O
)	O
,	O
did	O
not	O
reveal	O
any	O
proteins	O
that	O
have	O
been	O
previously	O
characterized	O
in	O
the	O
literature	O
.	O

However	O
,	O
BfiS	B-Protein
-	O
like	O
sensory	O
proteins	O
with	O
identities	O
ranging	O
between	O
28	O
-	O
68	O
%	O
were	O
detected	O
in	O
a	O
variety	O
of	O
Gram	O
-	O
negative	O
bacteria	O
,	O
in	O
particular	O
in	O
alpha	O
-	O
,	O
beta	O
-	O
,	O
and	O
gamma	O
-	O
proteobacteria	O
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

No	O
homologues	O
,	O
however	O
,	O
were	O
detected	O
in	O
lambda	O
-	O
proteobacteria	O
or	O
E	O
.	O
coli	O
,	O
Klebsiella	O
pneumoniae	O
,	O
and	O
Enterobacter	O
sp	O
.	O
<EOS>	B-X
Empirical	B-X
antibiotic	B-X
therapy	B-X
with	B-X
a	B-X
beta-lactam	B-X
is	B-X
the	B-X
standard	B-X
of	B-X
care	B-X
in	B-X
febrile	B-X
neutropenia	B-X
(	B-X
FN	B-X
)	B-X
and	B-X
is	B-X
given	B-X
to	B-X
prevent	B-X
early	B-X
death	B-X
.	B-X
In	B-X
order	B-X
to	B-X
characterize	B-X
the	B-X
epidemiology	B-X
of	B-X
early	B-X
death	B-X
and	B-X
shock	B-X
in	B-X
FN	B-X
,	B-X
we	B-X
reviewed	B-X
all	B-X
episodes	B-X
of	B-X
FN	B-X
from	B-X
2003	B-X
to	B-X
2017	B-X
at	B-X
University	B-X
Hospital	B-X
,	B-X
Federal	B-X
University	B-X
of	B-X
Rio	B-X
de	B-X
Janeiro	B-X
,	B-X
and	B-X
looked	B-X
at	B-X
factors	B-X
associated	B-X
with	B-X
shock	B-X
at	B-X
first	B-X
fever	B-X
and	B-X
early	B-X
death	B-X
(	B-X
within	B-X
3	B-X
days	B-X
from	B-X
first	B-X
fever	B-X
)	B-X
by	B-X
univariate	B-X
and	B-X
multivariate	B-X
analyses	B-X
.	B-X
To	B-X
analyze	B-X
the	B-X
resistance	B-X
profiles	B-X
of	B-X
Enterobacteriaceae	B-X
isolated	B-X
from	B-X
patients	B-X
with	B-X
chronic	B-X
osteomyelitis	B-X
to	B-X
cephalosporin	B-X
drugs	B-X
over	B-X
a	B-X
three-year	B-X
period	B-X
.	B-X
The	B-X
resistance	B-X
profiles	B-X
of	B-X
912	B-X
clinical	B-X
strains	B-X
of	B-X
Enterobacteriaceae	B-X
were	B-X
analyzed	B-X
:	B-X
Klebsiella	B-X
pneumoniae	B-X
(	B-X
n=349	B-X
)	B-X
,	B-X
Proteus	B-X
sp	B-X
.	B-X
(	B-X
n=208	B-X
)	B-X
,	B-X
Escherichia	B-X
coli	B-X
(	B-X
n=176	B-X
)	B-X
,	B-X
Enterobacter	B-X
cloacae	B-X
(	B-X
n=179	B-X
)	B-X
for	B-X
the	B-X
period	B-X
from	B-X
2018-2020	B-X
to	B-X
cephalosporin	B-X
drugs	B-X
.	B-X
In	B-X
2018	B-X
,	B-X
66.2	B-X
%	B-X
of	B-X
Enterobacteriaceace	B-X
were	B-X
resistant	B-X
to	B-X
the	B-X
1st	B-X
generation	B-X
cephalosporins	B-X
,	B-X
in	B-X
2019	B-X
-	B-X
78.7	B-X
%	B-X
,	B-X
in	B-X
2020	B-X
-	B-X
79.5	B-X
%	B-X
.	B-X
Generation	B-X
II	B-X
cephalosporins	B-X
were	B-X
most	B-X
active	B-X
against	B-X
Proteus	B-X
sp	B-X
.	B-X
Among	B-X
the	B-X
third	B-X
generation	B-X
cephalosporins	B-X
in	B-X
2018	B-X
,	B-X
cefotaxime	B-X
was	B-X
most	B-X
active	B-X
,	B-X
but	B-X
in	B-X
2020	B-X
the	B-X
number	B-X
of	B-X
resistant	B-X
strains	B-X
doubled	B-X
and	B-X
amounted	B-X
to	B-X
86.3	B-X
%	B-X
.	B-X
Ceftazidime	B-X
was	B-X
active	B-X
against	B-X
47.1	B-X
%	B-X
of	B-X
Enterobacteriaceae	B-X
isolates	B-X
in	B-X
2018	B-X
,	B-X
in	B-X
2019	B-X
-	B-X
45	B-X
%	B-X
of	B-X
strains	B-X
,	B-X
in	B-X
2020	B-X
-	B-X
37.2	B-X
%	B-X
of	B-X
bacterial	B-X
strains	B-X
.	B-X
High	B-X
activity	B-X
of	B-X
ceftriaxone	B-X
was	B-X
noted	B-X
only	B-X
in	B-X
2018	B-X
against	B-X
Proteus	B-X
sp	B-X
.	B-X
Preparations	B-X
of	B-X
the	B-X
IV	B-X
generation	B-X
in	B-X
2018	B-X
showed	B-X
the	B-X
highest	B-X
activity	B-X
against	B-X
bacteria	B-X
of	B-X
the	B-X
genus	B-X
Proteus	B-X
,	B-X
the	B-X
least	B-X
-	B-X
against	B-X
bacteria	B-X
K.	B-X
pneumoniae	B-X
.	B-X
In	B-X
the	B-X
period	B-X
from	B-X
2019-2020	B-X
,	B-X
a	B-X
significant	B-X
decrease	B-X
in	B-X
the	B-X
effectiveness	B-X
of	B-X
cefepime	B-X
was	B-X
observed.The	B-X
monitoring	B-X
of	B-X
the	B-X
resistance	B-X
profiles	B-X
to	B-X
antibiotics	B-X
of	B-X
the	B-X
cephalosporin	B-X
series	B-X
revealed	B-X
their	B-X
low	B-X
efficacy	B-X
against	B-X
Enterobacteriaceae	B-X
isolated	B-X
from	B-X
wounds	B-X
and	B-X
fistulas	B-X
of	B-X
patients	B-X
with	B-X
chronic	B-X
osteomyelitis	B-X
,	B-X
which	B-X
shows	B-X
the	B-X
inexpediency	B-X
of	B-X
their	B-X
empirical	B-X
use	B-X
.	B-X

Similarly	O
,	O
BfmR	B-Protein
homologues	O
were	O
detected	O
among	O
proteobacteria	O
including	O
Yersinia	O
sp	O
.	O
,	O
Burkholderia	O
sp	O
.	O
,	O
Rhizobium	O
sp	O
.	O
,	O
Vibrio	O
sp	O
,	O
Geobacter	O
sp	O
.	O
,	O
and	O
M	O
.	O
xanthus	O
with	O
identities	O
ranging	O
between	O
50	O
-	O
92	O
%	O
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

MifR	B-Protein
homologues	O
harboring	O
a	O
sigma	O
-	O
54	O
binding	O
domain	O
are	O
present	O
in	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
including	O
M	O
.	O
xanthus	O
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

The	O
closest	O
MifR	B-Protein
homologue	O
in	O
M	O
.	O
xanthus	O
was	O
identified	O
as	O
the	O
NtrC	B-Protein
-	O
like	O
chemosensory	O
regulator	O
of	O
development	O
CrdA	B-Protein
(	O
48	O
%	O
identity	O
)	O
.	O

Inactivation	O
of	O
crdA	B-Protein
has	O
been	O
shown	O
to	O
result	O
in	O
delayed	O
M	O
.	O
xanthus	O
multicellular	O
development	O
[	O
67	O
]	O
.	O

NtrC	B-Protein
-	O
like	O
regulators	O
belong	O
to	O
a	O
family	O
of	O
transcriptional	O
activators	O
which	O
control	O
a	O
variety	O
of	O
physiological	O
processes	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
68	O
]	O
.	O

This	O
family	O
of	O
regulators	O
control	O
transcription	O
from	O
-	O
12	O
,	O
-	O
24	O
promoters	O
recognized	O
by	O
RNA	B-Protein
polymerase	I-Protein
that	O
utilizes	O
the	O
alternative	O
sigma	O
54	O
factor	O
encoded	O
by	O
rpoN	B-Protein
and	O
its	O
analogs	O
.	O

At	O
least	O
8	O
NtrC	B-Protein
-	O
like	O
transcriptional	O
regulators	O
are	O
involved	O
in	O
coordinating	O
M	O
.	O
xanthus	O
fruiting	O
body	O
formation	O
at	O
distinct	O
stages	O
of	O
the	O
developmental	O
process	O
[	O
69	O
]	O
-	O
[	O
71	O
]	O
.	O

The	O
preponderance	O
of	O
developmental	O
promoters	O
with	O
sigma	O
54	O
hallmarks	O
led	O
to	O
the	O
suggestion	O
that	O
NtrC	B-Protein
-	O
like	O
activators	O
are	O
key	O
components	O
of	O
the	O
transcriptional	O
machinery	O
that	O
coordinates	O
gene	O
expression	O
during	O
M	O
.	O
xanthus	O
development	O
[	O
72	O
]	O
.	O

While	O
fruiting	O
body	O
formation	O
is	O
governed	O
by	O
a	O
cascade	O
of	O
RpoN	B-Protein
-	O
dependent	O
transcription	O
factors	O
in	O
starving	O
cells	O
,	O
endospore	O
formation	O
in	O
B	O
.	O
subtilis	O
requires	O
the	O
consecutive	O
activity	O
of	O
multiple	O
sigma	O
factors	O
including	O
Sigma	B-Protein
E	I-Protein
,	O
F	B-Protein
,	O
G	B-Protein
,	O
and	O
K	B-Protein
.	O

Their	O
activity	O
is	O
regulated	O
by	O
posttranslational	O
processes	O
,	O
either	O
by	O
cleaving	O
the	O
precursor	O
molecules	O
or	O
by	O
sequestration	O
of	O
sigma	O
factors	O
by	O
"	O
anti	O
-	O
sigma	O
factor	O
"	O
proteins	O
in	O
response	O
to	O
intercellular	O
cues	O
,	O
and	O
compartmentalization	O
[	O
68	O
]	O
,	O
[	O
73	O
]	O
.	O

Similarly	O
,	O
biofilm	O
developmental	O
processes	O
appear	O
to	O
be	O
controlled	O
by	O
sigma	O
factors	O
.	O

Based	O
on	O
domain	O
structure	O
,	O
two	O
TCS	O
regulatory	O
proteins	O
identified	O
here	O
regulate	O
genes	O
controlled	O
by	O
the	O
sigma	O
factors	O
RpoD	B-Protein
and	O
RpoN	B-Protein
[	O
53	O
]	O
,	O
[	O
74	O
]	O
,	O
[	O
75	O
]	O
.	O

BfiR	B-Protein
harbors	O
region	O
4	O
of	O
Sigma	B-Protein
-	I-Protein
70	I-Protein
(	O
RpoD	B-Protein
)	O
-	O
like	O
sigma	O
factors	O
,	O
a	O
domain	O
involved	O
in	O
binding	O
to	O
-	O
35	O
promoter	O
elements	O
.	O

Activation	O
of	O
BfiR	B-Protein
coincides	O
with	O
BfiS	B-Protein
phosphorylation	O
following	O
8	O
hours	O
of	O
surface	O
attached	O
growth	O
and	O
dephosphorylation	O
of	O
RpoD	B-Protein
(	O
Table	O
1	O
)	O
.	O

MifR	B-Protein
harbors	O
a	O
sigma	B-Protein
-	I-Protein
54	I-Protein
binding	O
(	O
RpoN	B-Protein
)	O
binding	O
domain	O
and	O
is	O
dependent	O
on	O
the	O
consecutive	O
phosphorylation	O
of	O
BfiRS	B-Protein
and	O
BfmRS	B-Protein
(	O
see	O
Suppl	O
.	O
Fig	O
.	O
S3	O
)	O
.	O

These	O
results	O
are	O
consistent	O
with	O
the	O
idea	O
that	O
biofilm	O
development	O
by	O
P	O
.	O
aeruginosa	O
is	O
orchestrated	O
by	O
a	O
regulatory	O
cascade	O
(	O
Fig	O
.	O
6	O
)	O
that	O
is	O
analogous	O
to	O
other	O
developmental	O
systems	O
including	O
spore	O
formation	O
in	O
B	O
.	O
subtilis	O
or	O
fruiting	O
body	O
formation	O
in	O
M	O
.	O
xanthus	O
,	O
requiring	O
the	O
consecutive	O
action	O
of	O
at	O
least	O
two	O
sigma	O
factors	O
and	O
three	O
two	O
-	O
component	O
regulatory	O
systems	O
in	O
response	O
to	O
environmental	O
signals	O
.	O

In	O
summary	O
,	O
we	O
have	O
evidence	O
of	O
three	O
novel	O
regulatory	O
systems	O
playing	O
a	O
role	O
in	O
the	O
progression	O
of	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

The	O
only	O
other	O
regulatory	O
system	O
having	O
been	O
identified	O
to	O
play	O
a	O
role	O
at	O
later	O
stages	O
of	O
biofilm	O
formation	O
,	O
in	O
particular	O
the	O
formation	O
of	O
large	O
microcolonies	O
and	O
fluid	O
-	O
filled	O
channels	O
,	O
is	O
the	O
three	O
-	O
component	O
system	O
SadARS	B-Protein
(	O
RocS1RA1	B-Protein
)	O
,	O
probably	O
by	O
controlling	O
the	O
expression	O
of	O
fimbrial	O
cup	O
genes	O
[	O
66	O
]	O
,	O
[	O
76	O
]	O
.	O

In	O
addition	O
,	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
via	O
two	O
-	O
component	O
systems	O
has	O
also	O
been	O
shown	O
to	O
play	O
a	O
role	O
in	O
attachment	O
.	O

A	O
multi	O
-	O
component	O
switch	O
composed	O
of	O
three	O
unusual	O
hybrid	O
sensor	O
kinases	O
,	O
RetS	B-Protein
,	O
LadS	B-Protein
,	O
and	O
GacS	B-Protein
,	O
has	O
recently	O
been	O
demonstrated	O
to	O
reciprocally	O
orchestrate	O
the	O
transition	O
from	O
acute	O
to	O
chronic	O
infection	O
in	O
P	O
.	O
aeruginosa	O
,	O
as	O
well	O
as	O
to	O
reciprocally	O
regulate	O
the	O
transition	O
between	O
the	O
planktonic	O
and	O
biofilm	O
modes	O
of	O
growth	O
by	O
inversely	O
coordinating	O
repression	O
of	O
genes	O
required	O
for	O
initial	O
colonization	O
,	O
mainly	O
genes	O
responsible	O
for	O
exopolysaccharide	O
components	O
of	O
the	O
P	O
.	O
aeruginosa	O
biofilm	O
matrix	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

While	O
our	O
study	O
did	O
not	O
result	O
in	O
the	O
identification	O
of	O
RetS	B-Protein
or	O
LadS	B-Protein
,	O
we	O
identified	O
GacS	B-Protein
by	O
two	O
different	O
approaches	O
and	O
confirmed	O
GacS	B-Protein
phosphorylation	O
by	O
immunoblot	O
analysis	O
(	O
Table	O
1	O
)	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
criticized	B-X
on	B-X
many	B-X
grounds	B-X
,	B-X
and	B-X
yet	B-X
a	B-X
majority	B-X
of	B-X
textbook	B-X
authors	B-X
have	B-X
ignored	B-X
these	B-X
criticisms	B-X
in	B-X
their	B-X
discussions	B-X
of	B-X
the	B-X
SPE	B-X
,	B-X
thereby	B-X
misleading	B-X
both	B-X
students	B-X
and	B-X
the	B-X
general	B-X
public	B-X
about	B-X
the	B-X
study	B-X
's	B-X
questionable	B-X
scientific	B-X
validity	B-X
.	B-X
Data	B-X
collected	B-X
from	B-X
a	B-X
thorough	B-X
investigation	B-X
of	B-X
the	B-X
SPE	B-X
archives	B-X
and	B-X
interviews	B-X
with	B-X
15	B-X
of	B-X
the	B-X
participants	B-X
in	B-X
the	B-X
experiment	B-X
further	B-X
question	B-X
the	B-X
study	B-X
's	B-X
scientific	B-X
merit	B-X
.	B-X
(	B-X
PsycINFO	B-X
Database	B-X
Record	B-X
(	B-X
c	B-X
)	B-X
2019	B-X
APA	B-X
,	B-X
all	B-X
rights	B-X
reserved	B-X
)	B-X
.	B-X
The	B-X
study	B-X
is	B-X
aiming	B-X
to	B-X
determine	B-X
the	B-X
most	B-X
common	B-X
study	B-X
habits	B-X
of	B-X
highly	B-X
successful	B-X
medical	B-X
students	B-X
and	B-X
their	B-X
relation	B-X
to	B-X
academic	B-X
achievement	B-X
.	B-X

GacS	B-Protein
acts	O
as	O
a	O
suppressor	O
of	O
RetS	B-Protein
(	O
and	O
vice	O
versa	O
)	O
with	O
RetS	B-Protein
regulating	O
the	O
suppressor	O
activity	O
of	O
the	O
membrane	O
-	O
bound	O
sensor	O
GacS	B-Protein
by	O
directly	O
modulating	O
its	O
phosphorylation	O
state	O
[	O
38	O
]	O
.	O

The	O
finding	O
is	O
consistent	O
with	O
our	O
observation	O
of	O
GacS	B-Protein
playing	O
a	O
dual	O
role	O
in	O
biofilm	O
formation	O
,	O
with	O
phosphorylation	O
acting	O
as	O
a	O
switch	O
in	O
the	O
function	O
of	O
GacS	B-Protein
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
:	O
GacS	B-Protein
participates	O
in	O
the	O
planktonic	O
/	O
biofilm	O
switch	O
in	O
its	O
non	O
-	O
phosphorylated	O
state	O
,	O
but	O
limits	O
/	O
regulates	O
the	O
rate	O
of	O
biomass	O
accumulation	O
and	O
biofilm	O
development	O
when	O
phosphorylated	O
.	O

Since	O
phosphorylation	O
of	O
GacS	B-Protein
occurred	O
following	O
8	O
hr	O
of	O
surface	O
attached	O
growth	O
(	O
Table	O
1	O
)	O
and	O
since	O
RetS	B-Protein
directly	O
modulates	O
the	O
phosphorylation	O
state	O
of	O
GacS	B-Protein
[	O
38	O
]	O
,	O
the	O
findings	O
may	O
suggest	O
that	O
RetS	B-Protein
only	O
remains	O
functional	O
for	O
a	O
period	O
of	O
8	O
hours	O
during	O
initial	O
attachment	O
after	O
which	O
RetS	B-Protein
is	O
rendered	O
non	O
-	O
functional	O
.	O

Here	O
,	O
GacS	B-Protein
was	O
found	O
to	O
be	O
phosphorylated	O
in	O
a	O
BfiS	B-Protein
dependent	O
manner	O
.	O

In	O
turn	O
,	O
expression	O
of	O
the	O
BfiS	B-Protein
cognate	O
response	O
regulator	O
,	O
BfiR	B-Protein
,	O
was	O
found	O
to	O
be	O
RsmA	B-Protein
dependent	O
[	O
77	O
]	O
(	O
see	O
Fig	O
.	O
6	O
)	O
.	O

Taken	O
together	O
,	O
our	O
observations	O
suggest	O
a	O
link	O
between	O
the	O
multi	O
-	O
component	O
switch	O
RetS	B-Protein
/	O
LadS	B-Protein
/	O
GacAS	B-Protein
/	O
RsmA	B-Protein
which	O
reciprocally	O
regulates	O
virulence	O
and	O
the	O
transition	O
between	O
the	O
planktonic	O
and	O
the	O
surface	O
attached	O
mode	O
of	O
growth	O
and	O
the	O
previously	O
undescribed	O
signaling	O
network	O
which	O
regulates	O
developmental	O
steps	O
once	O
P	O
.	O
aeruginosa	O
has	O
committed	O
to	O
the	O
surface	O
associated	O
lifestyle	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Taken	O
together	O
,	O
this	O
work	O
identifies	O
a	O
previously	O
undescribed	O
signal	O
transduction	O
network	O
composed	O
of	O
BfiSR	B-Protein
(	O
PA4196	B-Protein
-	O
4197	B-Protein
)	O
,	O
BfmSR	B-Protein
PA4101	B-Protein
-	O
4102	B-Protein
)	O
,	O
and	O
MifSR	B-Protein
(	O
PA5511	B-Protein
-	O
5512	B-Protein
)	O
that	O
sequentially	O
regulates	O
committed	O
biofilm	O
developmental	O
steps	O
following	O
attachment	O
by	O
transcriptional	O
and	O
posttranscriptional	O
mechanisms	O
,	O
which	O
is	O
linked	O
via	O
GacS	B-Protein
and	O
RsmA	B-Protein
to	O
the	O
previously	O
described	O
multi	O
-	O
component	O
switch	O
RetS	B-Protein
/	O
LadS	B-Protein
/	O
GacAS	B-Protein
/	O
RsmA	B-Protein
.	O

Furthermore	O
,	O
the	O
finding	O
of	O
sequential	O
and	O
essential	O
regulatory	O
steps	O
in	O
biofilm	O
formation	O
and	O
the	O
involvement	O
of	O
at	O
least	O
two	O
sigma	O
factors	O
suggests	O
that	O
biofilm	O
development	O
is	O
analogous	O
to	O
other	O
programmed	O
developmental	O
processes	O
.	O

However	O
,	O
in	O
contrast	O
to	O
known	O
developmental	O
processes	O
,	O
our	O
findings	O
suggest	O
that	O
both	O
two	O
-	O
component	O
regulatory	O
systems	O
and	O
sigma	O
factor	O
dependent	O
response	O
regulators	O
are	O
key	O
components	O
of	O
the	O
transcriptional	O
and	O
regulatory	O
machinery	O
that	O
coordinate	O
gene	O
expression	O
during	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
.	O

Structural	O
and	O
Biochemical	O
Characterization	O
of	O
SrcA	B-Protein
,	O
a	O
Multi	O
-	O
Cargo	O
Type	O
III	O
Secretion	O
Chaperone	O
in	O
Salmonella	O
Required	O
for	O
Pathogenic	O
Association	O
with	O
a	O
Host	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
In	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
,	B-X
a	B-X
T3SS	B-X
encoded	B-X
in	B-X
a	B-X
large	B-X
genomic	B-X
island	B-X
(	B-X
SPI-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
intracellular	B-X
infection	B-X
,	B-X
but	B-X
the	B-X
chaperone	B-X
complement	B-X
required	B-X
for	B-X
effector	B-X
translocation	B-X
by	B-X
this	B-X
system	B-X
is	B-X
not	B-X
known	B-X
.	B-X
Crystallographic	B-X
analysis	B-X
of	B-X
SrcA	B-X
at	B-X
a	B-X
resolution	B-X
of	B-X
2.5	B-X
A	B-X
revealed	B-X
a	B-X
dimer	B-X
similar	B-X
to	B-X
the	B-X
CesT	B-X
chaperone	B-X
from	B-X
enteropathogenic	B-X
E.	B-X
coli	B-X
but	B-X
lacking	B-X
a	B-X
17-amino	B-X
acid	B-X
extension	B-X
at	B-X
the	B-X
carboxyl	B-X
terminus	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

Many	O
Gram	O
-	O
negative	O
bacteria	O
colonize	O
and	O
exploit	O
host	O
niches	O
using	O
a	O
protein	O
apparatus	O
called	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
that	O
translocates	O
bacterial	O
effector	O
proteins	O
into	O
host	O
cells	O
where	O
their	O
functions	O
are	O
essential	O
for	O
pathogenesis	O
.	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
A	B-X
suite	B-X
of	B-X
T3SS-associated	B-X
chaperone	B-X
proteins	B-X
bind	B-X
cargo	B-X
in	B-X
the	B-X
bacterial	B-X
cytosol	B-X
,	B-X
establishing	B-X
protein	B-X
interaction	B-X
networks	B-X
needed	B-X
for	B-X
effector	B-X
translocation	B-X
into	B-X
host	B-X
cells	B-X
.	B-X
In	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
,	B-X
a	B-X
T3SS	B-X
encoded	B-X
in	B-X
a	B-X
large	B-X
genomic	B-X
island	B-X
(	B-X
SPI-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
intracellular	B-X
infection	B-X
,	B-X
but	B-X
the	B-X
chaperone	B-X
complement	B-X
required	B-X
for	B-X
effector	B-X
translocation	B-X
by	B-X
this	B-X
system	B-X
is	B-X
not	B-X
known	B-X
.	B-X
Using	B-X
a	B-X
reverse	B-X
genetics	B-X
approach	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
multi-cargo	B-X
secretion	B-X
chaperone	B-X
that	B-X
is	B-X
functionally	B-X
integrated	B-X
with	B-X
the	B-X
SPI-2-encoded	B-X
T3SS	B-X
and	B-X
required	B-X
for	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

A	O
suite	O
of	O
T3SS	O
-	O
associated	O
chaperone	O
proteins	O
bind	O
cargo	O
in	O
the	O
bacterial	O
cytosol	O
,	O
establishing	O
protein	O
interaction	O
networks	O
needed	O
for	O
effector	O
translocation	O
into	O
host	O
cells	O
.	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
A	B-X
suite	B-X
of	B-X
T3SS-associated	B-X
chaperone	B-X
proteins	B-X
bind	B-X
cargo	B-X
in	B-X
the	B-X
bacterial	B-X
cytosol	B-X
,	B-X
establishing	B-X
protein	B-X
interaction	B-X
networks	B-X
needed	B-X
for	B-X
effector	B-X
translocation	B-X
into	B-X
host	B-X
cells	B-X
.	B-X
In	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
,	B-X
a	B-X
T3SS	B-X
encoded	B-X
in	B-X
a	B-X
large	B-X
genomic	B-X
island	B-X
(	B-X
SPI-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
intracellular	B-X
infection	B-X
,	B-X
but	B-X
the	B-X
chaperone	B-X
complement	B-X
required	B-X
for	B-X
effector	B-X
translocation	B-X
by	B-X
this	B-X
system	B-X
is	B-X
not	B-X
known	B-X
.	B-X
Using	B-X
a	B-X
reverse	B-X
genetics	B-X
approach	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
multi-cargo	B-X
secretion	B-X
chaperone	B-X
that	B-X
is	B-X
functionally	B-X
integrated	B-X
with	B-X
the	B-X
SPI-2-encoded	B-X
T3SS	B-X
and	B-X
required	B-X
for	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
Crystallographic	B-X
analysis	B-X
of	B-X
SrcA	B-X
at	B-X
a	B-X
resolution	B-X
of	B-X
2.5	B-X
A	B-X
revealed	B-X
a	B-X
dimer	B-X
similar	B-X
to	B-X
the	B-X
CesT	B-X
chaperone	B-X
from	B-X
enteropathogenic	B-X
E.	B-X
coli	B-X
but	B-X
lacking	B-X
a	B-X
17-amino	B-X
acid	B-X
extension	B-X
at	B-X
the	B-X
carboxyl	B-X
terminus	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

In	O
Salmonella	O
enterica	O
serovar	O
Typhimurium	O
,	O
a	O
T3SS	O
encoded	O
in	O
a	O
large	O
genomic	O
island	O
(	O
SPI	O
-	O
2	O
)	O
is	O
required	O
for	O
intracellular	O
infection	O
,	O
but	O
the	O
chaperone	O
complement	O
required	O
for	O
effector	O
translocation	O
by	O
this	O
system	O
is	O
not	O
known	O
.	O

Using	O
a	O
reverse	O
genetics	O
approach	O
,	O
we	O
identified	O
a	O
multi	O
-	O
cargo	O
secretion	O
chaperone	O
that	O
is	O
functionally	O
integrated	O
with	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
and	O
required	O
for	O
systemic	O
infection	O
in	O
mice	O
.	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
A	B-X
suite	B-X
of	B-X
T3SS-associated	B-X
chaperone	B-X
proteins	B-X
bind	B-X
cargo	B-X
in	B-X
the	B-X
bacterial	B-X
cytosol	B-X
,	B-X
establishing	B-X
protein	B-X
interaction	B-X
networks	B-X
needed	B-X
for	B-X
effector	B-X
translocation	B-X
into	B-X
host	B-X
cells	B-X
.	B-X
In	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
,	B-X
a	B-X
T3SS	B-X
encoded	B-X
in	B-X
a	B-X
large	B-X
genomic	B-X
island	B-X
(	B-X
SPI-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
intracellular	B-X
infection	B-X
,	B-X
but	B-X
the	B-X
chaperone	B-X
complement	B-X
required	B-X
for	B-X
effector	B-X
translocation	B-X
by	B-X
this	B-X
system	B-X
is	B-X
not	B-X
known	B-X
.	B-X
Using	B-X
a	B-X
reverse	B-X
genetics	B-X
approach	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
multi-cargo	B-X
secretion	B-X
chaperone	B-X
that	B-X
is	B-X
functionally	B-X
integrated	B-X
with	B-X
the	B-X
SPI-2-encoded	B-X
T3SS	B-X
and	B-X
required	B-X
for	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
Crystallographic	B-X
analysis	B-X
of	B-X
SrcA	B-X
at	B-X
a	B-X
resolution	B-X
of	B-X
2.5	B-X
A	B-X
revealed	B-X
a	B-X
dimer	B-X
similar	B-X
to	B-X
the	B-X
CesT	B-X
chaperone	B-X
from	B-X
enteropathogenic	B-X
E.	B-X
coli	B-X
but	B-X
lacking	B-X
a	B-X
17-amino	B-X
acid	B-X
extension	B-X
at	B-X
the	B-X
carboxyl	B-X
terminus	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

Crystallographic	O
analysis	O
of	O
SrcA	B-Protein
at	O
a	O
resolution	O
of	O
2	O
.	O
5	O
A	O
revealed	O
a	O
dimer	O
similar	O
to	O
the	O
CesT	B-Protein
chaperone	O
from	O
enteropathogenic	O
E	O
.	O
coli	O
but	O
lacking	O
a	O
17	O
-	O
amino	O
acid	O
extension	O
at	O
the	O
carboxyl	O
terminus	O
.	O

Further	O
biochemical	O
and	O
quantitative	O
proteomics	O
data	O
revealed	O
three	O
protein	O
interactions	O
with	O
SrcA	B-Protein
,	O
including	O
two	O
effector	O
cargos	O
(	O
SseL	B-Protein
and	O
PipB2	B-Protein
)	O
and	O
the	O
type	O
III	O
-	O
associated	O
ATPase	O
,	O
SsaN	B-Protein
,	O
that	O
increases	O
the	O
efficiency	O
of	O
effector	O
translocation	O
.	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
A	B-X
suite	B-X
of	B-X
T3SS-associated	B-X
chaperone	B-X
proteins	B-X
bind	B-X
cargo	B-X
in	B-X
the	B-X
bacterial	B-X
cytosol	B-X
,	B-X
establishing	B-X
protein	B-X
interaction	B-X
networks	B-X
needed	B-X
for	B-X
effector	B-X
translocation	B-X
into	B-X
host	B-X
cells	B-X
.	B-X
In	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
,	B-X
a	B-X
T3SS	B-X
encoded	B-X
in	B-X
a	B-X
large	B-X
genomic	B-X
island	B-X
(	B-X
SPI-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
intracellular	B-X
infection	B-X
,	B-X
but	B-X
the	B-X
chaperone	B-X
complement	B-X
required	B-X
for	B-X
effector	B-X
translocation	B-X
by	B-X
this	B-X
system	B-X
is	B-X
not	B-X
known	B-X
.	B-X
Crystallographic	B-X
analysis	B-X
of	B-X
SrcA	B-X
at	B-X
a	B-X
resolution	B-X
of	B-X
2.5	B-X
A	B-X
revealed	B-X
a	B-X
dimer	B-X
similar	B-X
to	B-X
the	B-X
CesT	B-X
chaperone	B-X
from	B-X
enteropathogenic	B-X
E.	B-X
coli	B-X
but	B-X
lacking	B-X
a	B-X
17-amino	B-X
acid	B-X
extension	B-X
at	B-X
the	B-X
carboxyl	B-X
terminus	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

Using	O
competitive	O
infections	O
in	O
mice	O
we	O
show	O
that	O
SrcA	B-Protein
increases	O
bacterial	O
fitness	O
during	O
host	O
infection	O
,	O
highlighting	O
the	O
in	O
vivo	O
importance	O
of	O
effector	O
chaperones	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
.	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
A	B-X
suite	B-X
of	B-X
T3SS-associated	B-X
chaperone	B-X
proteins	B-X
bind	B-X
cargo	B-X
in	B-X
the	B-X
bacterial	B-X
cytosol	B-X
,	B-X
establishing	B-X
protein	B-X
interaction	B-X
networks	B-X
needed	B-X
for	B-X
effector	B-X
translocation	B-X
into	B-X
host	B-X
cells	B-X
.	B-X
In	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
,	B-X
a	B-X
T3SS	B-X
encoded	B-X
in	B-X
a	B-X
large	B-X
genomic	B-X
island	B-X
(	B-X
SPI-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
intracellular	B-X
infection	B-X
,	B-X
but	B-X
the	B-X
chaperone	B-X
complement	B-X
required	B-X
for	B-X
effector	B-X
translocation	B-X
by	B-X
this	B-X
system	B-X
is	B-X
not	B-X
known	B-X
.	B-X
Using	B-X
a	B-X
reverse	B-X
genetics	B-X
approach	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
multi-cargo	B-X
secretion	B-X
chaperone	B-X
that	B-X
is	B-X
functionally	B-X
integrated	B-X
with	B-X
the	B-X
SPI-2-encoded	B-X
T3SS	B-X
and	B-X
required	B-X
for	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
Crystallographic	B-X
analysis	B-X
of	B-X
SrcA	B-X
at	B-X
a	B-X
resolution	B-X
of	B-X
2.5	B-X
A	B-X
revealed	B-X
a	B-X
dimer	B-X
similar	B-X
to	B-X
the	B-X
CesT	B-X
chaperone	B-X
from	B-X
enteropathogenic	B-X
E.	B-X
coli	B-X
but	B-X
lacking	B-X
a	B-X
17-amino	B-X
acid	B-X
extension	B-X
at	B-X
the	B-X
carboxyl	B-X
terminus	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

Introduction	O

Many	O
Gram	O
-	O
negative	O
bacteria	O
that	O
colonize	O
host	O
animals	O
use	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
to	O
deliver	O
effector	O
proteins	O
directly	O
into	O
host	O
cells	O
where	O
their	O
interaction	O
with	O
host	O
proteins	O
and	O
membranes	O
contribute	O
to	O
pathogenesis	O
.	O

Comprised	O
of	O
over	O
20	O
proteins	O
,	O
T3SS	O
are	O
complex	O
structures	O
with	O
relation	O
to	O
the	O
flagellar	O
T3SS	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
and	O
include	O
several	O
central	O
features	O
;	O
(	O
i	O
)	O
inner	O
and	O
outer	O
membrane	O
ring	O
structures	O
,	O
(	O
ii	O
)	O
an	O
extracellular	O
needle	O
structure	O
with	O
pore	O
-	O
forming	O
proteins	O
at	O
the	O
distal	O
tip	O
that	O
engage	O
a	O
host	O
cell	O
membrane	O
,	O
(	O
iii	O
)	O
an	O
ATPase	O
at	O
the	O
base	O
of	O
the	O
apparatus	O
with	O
energetic	O
and	O
chaperone	O
-	O
effector	O
recruitment	O
roles	O
,	O
and	O
(	O
iv	O
)	O
a	O
suite	O
of	O
chaperones	O
to	O
coordinate	O
the	O
assembly	O
and	O
function	O
of	O
the	O
apparatus	O
during	O
infection	O
.	O

Secretion	O
chaperones	O
are	O
proteins	O
required	O
for	O
T3SS	O
function	O
with	O
roles	O
in	O
apparatus	O
assembly	O
and	O
effector	O
delivery	O
,	O
but	O
are	O
not	O
themselves	O
subject	O
to	O
secretion	O
[	O
3	O
]	O
.	O

These	O
chaperones	O
often	O
have	O
common	O
physical	O
features	O
such	O
as	O
low	O
molecular	O
weight	O
(	O
<	O
15	O
kDa	O
)	O
,	O
an	O
acidic	O
isoelectric	O
point	O
and	O
a	O
predicted	O
amphipathic	O
helix	O
at	O
the	O
carboxyl	O
terminus	O
.	O

Current	O
literature	O
groups	O
secretion	O
chaperones	O
into	O
three	O
classes	O
based	O
on	O
their	O
physical	O
interactions	O
with	O
cargo	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

Class	O
I	O
chaperones	O
bind	O
to	O
translocated	O
effector	O
proteins	O
at	O
a	O
chaperone	O
binding	O
domain	O
(	O
CBD	O
)	O
located	O
in	O
the	O
amino	O
terminus	O
of	O
the	O
effector	O
.	O

Class	O
I	O
chaperones	O
have	O
a	O
structural	O
fold	O
of	O
five	O
beta	O
-	O
strands	O
and	O
three	O
alpha	O
-	O
helices	O
,	O
forming	O
homodimers	O
that	O
bind	O
to	O
the	O
CBD	O
in	O
a	O
horseshoe	O
-	O
like	O
structure	O
.	O

These	O
chaperones	O
have	O
been	O
further	O
sub	O
-	O
classified	O
based	O
on	O
their	O
substrate	O
repertoire	O
and	O
location	O
with	O
respect	O
to	O
the	O
genes	O
encoding	O
the	O
T3SS	O
[	O
3	O
]	O
.	O

Class	O
II	O
chaperones	O
bind	O
to	O
translocon	O
proteins	O
that	O
make	O
up	O
the	O
secretion	O
pore	O
in	O
the	O
host	O
target	O
membrane	O
and	O
class	O
III	O
chaperones	O
bind	O
the	O
extracellular	O
filament	O
proteins	O
(	O
or	O
flagellin	O
rod	O
in	O
the	O
orthologous	O
flagellar	O
system	O
)	O
that	O
polymerize	O
into	O
a	O
helical	O
structure	O
following	O
secretion	O
from	O
the	O
bacterial	O
cell	O
.	O

Secondary	O
structure	O
predictions	O
suggest	O
class	O
III	O
chaperones	O
adopt	O
an	O
extended	O
alpha	O
helical	O
structure	O
,	O
which	O
was	O
confirmed	O
by	O
the	O
crystal	O
structure	O
of	O
the	O
CesA	B-Protein
chaperone	O
in	O
enteropathogenic	O
E	O
.	O
coli	O
that	O
binds	O
the	O
EspA	B-Protein
filament	O
protein	O
[	O
5	O
]	O
.	O

Much	O
of	O
the	O
virulence	O
potential	O
of	O
Salmonella	O
enterica	O
,	O
a	O
group	O
of	O
more	O
than	O
2300	O
serotypes	O
,	O
is	O
attributed	O
to	O
horizontally	O
acquired	O
genomic	O
islands	O
termed	O
Salmonella	O
Pathogenicity	O
Islands	O
(	O
SPI	O
)	O
.	O

SPI	O
-	O
1	O
encodes	O
a	O
T3SS	O
required	O
for	O
host	O
cell	O
invasion	O
and	O
SPI	O
-	O
2	O
encodes	O
a	O
second	O
T3SS	O
needed	O
for	O
intracellular	O
survival	O
and	O
immune	O
evasion	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

To	O
date	O
,	O
13	O
effectors	O
have	O
been	O
identified	O
as	O
substrates	O
of	O
the	O
SPI	O
-	O
1	O
T3SS	O
and	O
21	O
effectors	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
,	O
although	O
the	O
chaperones	O
orchestrating	O
the	O
latter	O
system	O
have	O
been	O
elusive	O
.	O

Whereas	O
80	O
%	O
of	O
the	O
effectors	O
of	O
the	O
SPI	O
-	O
1	O
system	O
have	O
defined	O
chaperones	O
,	O
only	O
two	O
effector	O
-	O
chaperone	O
interactions	O
are	O
known	O
for	O
the	O
SPI	O
-	O
2	O
system	O
.	O

These	O
include	O
the	O
effector	O
-	O
chaperone	O
pair	O
of	O
SseF	B-Protein
-	O
SscB	B-Protein
,	O
and	O
the	O
chaperone	O
SseA	B-Protein
that	O
binds	O
translocon	O
components	O
SseD	B-Protein
and	O
SseB	B-Protein
[	O
8	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Crystal	O
structures	O
have	O
been	O
determined	O
for	O
three	O
chaperones	O
that	O
coordinate	O
translocation	O
of	O
effectors	O
through	O
the	O
SPI	O
-	O
1	O
T3SS	O
(	O
InvB	B-Protein
[	O
11	O
]	O
,	O
SicP	B-Protein
[	O
12	O
]	O
and	O
SigE	B-Protein
[	O
13	O
]	O
)	O
.	O

However	O
no	O
structures	O
are	O
available	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
chaperones	O
whose	O
effector	O
repertoire	O
seems	O
considerably	O
larger	O
than	O
that	O
of	O
the	O
SPI	O
-	O
1	O
system	O
.	O

In	O
addition	O
to	O
maintaining	O
a	O
region	O
of	O
localized	O
effector	O
unfolding	O
[	O
12	O
]	O
,	O
T3SS	O
chaperones	O
have	O
an	O
emerging	O
role	O
as	O
escorts	O
that	O
deliver	O
their	O
cargo	O
to	O
the	O
cytoplasmic	O
face	O
of	O
the	O
inner	O
membrane	O
through	O
physical	O
interactions	O
with	O
an	O
ATPase	O
.	O

These	O
ATPases	O
form	O
a	O
hexameric	O
structure	O
at	O
the	O
base	O
of	O
the	O
T3SS	O
[	O
14	O
]	O
and	O
are	O
a	O
conserved	O
feature	O
of	O
both	O
flagellar	O
and	O
non	O
-	O
flagellar	O
type	O
III	O
systems	O
to	O
enhance	O
secretion	O
activity	O
by	O
promoting	O
chaperone	O
release	O
and	O
effector	O
unfolding	O
prior	O
to	O
secretion	O
[	O
15	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
.	O

A	O
chaperone	O
-	O
ATPase	O
interaction	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
has	O
not	O
been	O
described	O
previously	O
and	O
so	O
whether	O
this	O
system	O
conforms	O
to	O
the	O
emerging	O
escort	O
paradigm	O
is	O
not	O
known	O
.	O
<EOS>	B-X
A	B-X
number	B-X
of	B-X
Gram-negative	B-X
pathogens	B-X
utilize	B-X
type	B-X
III	B-X
secretion	B-X
systems	B-X
(	B-X
T3SSs	B-X
)	B-X
to	B-X
inject	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
the	B-X
host	B-X
.	B-X
An	B-X
important	B-X
component	B-X
of	B-X
T3SSs	B-X
is	B-X
a	B-X
conserved	B-X
ATPase	B-X
that	B-X
captures	B-X
chaperone-effector	B-X
complexes	B-X
and	B-X
energizes	B-X
their	B-X
dissociation	B-X
to	B-X
facilitate	B-X
effector	B-X
translocation	B-X
.	B-X
To	B-X
date	B-X
,	B-X
there	B-X
has	B-X
been	B-X
limited	B-X
work	B-X
characterizing	B-X
the	B-X
chaperone-T3SS	B-X
ATPase	B-X
interaction	B-X
despite	B-X
it	B-X
being	B-X
a	B-X
fundamental	B-X
aspect	B-X
of	B-X
T3SS	B-X
function	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
present	B-X
the	B-X
2.1	B-X
Å	B-X
resolution	B-X
crystal	B-X
structure	B-X
of	B-X
the	B-X
Salmonella	B-X
enterica	B-X
SPI-2-encoded	B-X
ATPase	B-X
,	B-X
SsaN	B-X
.	B-X
Our	B-X
structure	B-X
revealed	B-X
a	B-X
local	B-X
and	B-X
functionally	B-X
important	B-X
novel	B-X
feature	B-X
in	B-X
helix	B-X
10	B-X
that	B-X
we	B-X
used	B-X
to	B-X
define	B-X
the	B-X
interaction	B-X
domain	B-X
relevant	B-X
to	B-X
chaperone	B-X
binding	B-X
.	B-X
We	B-X
modeled	B-X
the	B-X
interaction	B-X
between	B-X
the	B-X
multicargo	B-X
chaperone	B-X
,	B-X
SrcA	B-X
,	B-X
and	B-X
SsaN	B-X
and	B-X
validated	B-X
this	B-X
model	B-X
using	B-X
mutagenesis	B-X
to	B-X
identify	B-X
the	B-X
residues	B-X
on	B-X
both	B-X
the	B-X
chaperone	B-X
and	B-X
ATPase	B-X
that	B-X
mediate	B-X
the	B-X
interaction	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
quantified	B-X
the	B-X
benefit	B-X
of	B-X
this	B-X
molecular	B-X
interaction	B-X
on	B-X
bacterial	B-X
fitness	B-X
in	B-X
vivo	B-X
using	B-X
chromosomal	B-X
exchange	B-X
of	B-X
wild-type	B-X
ssaN	B-X
with	B-X
mutants	B-X
that	B-X
retain	B-X
ATPase	B-X
activity	B-X
but	B-X
no	B-X
longer	B-X
capture	B-X
the	B-X
chaperone	B-X
.	B-X
Our	B-X
findings	B-X
provide	B-X
insight	B-X
into	B-X
chaperone	B-X
recognition	B-X
by	B-X
T3SS	B-X
ATPases	B-X
and	B-X
demonstrate	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
chaperone-T3SS	B-X
ATPase	B-X
interaction	B-X
for	B-X
the	B-X
pathogenesis	B-X
of	B-X
Salmonella	B-X
.	B-X

The	O
regulation	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
its	O
associated	O
effector	O
genes	O
is	O
coordinated	O
by	O
environmental	O
cues	O
signifying	O
the	O
intracellular	O
environment	O
[	O
18	O
]	O
.	O

These	O
cues	O
activate	O
a	O
two	O
-	O
component	O
signaling	O
system	O
encoded	O
in	O
the	O
SPI	O
-	O
2	O
island	O
comprising	O
the	O
SsrA	B-Protein
sensor	O
kinase	O
and	O
SsrB	B-Protein
response	O
regulator	O
.	O

In	O
addition	O
to	O
activating	O
all	O
of	O
the	O
T3SS	O
structural	O
operons	O
,	O
transcriptional	O
profiling	O
has	O
uncovered	O
new	O
genes	O
in	O
the	O
SsrB	B-Protein
regulon	O
that	O
are	O
required	O
for	O
bacterial	O
pathogenesis	O
including	O
a	O
translocated	O
effector	O
,	O
SseL	B-Protein
[	O
19	O
]	O
,	O
[	O
20	O
]	O
,	O
and	O
a	O
gene	O
of	O
unknown	O
function	O
called	O
srfN	B-Protein
that	O
is	O
common	O
to	O
the	O
Salmonella	O
genus	O
[	O
21	O
]	O
.	O

Using	O
a	O
reverse	O
genetics	O
approach	O
we	O
identified	O
an	O
SsrB	B-Protein
-	O
regulated	O
gene	O
(	O
STM2138	B-Protein
)	O
that	O
we	O
named	O
srcA	B-Protein
(	O
SsrB	B-Protein
-	I-Protein
regulated	I-Protein
chaperone	I-Protein
A	I-Protein
)	O
,	O
whose	O
gene	O
product	O
satisfied	O
several	O
a	O
priori	O
predictions	O
relating	O
to	O
the	O
physical	O
properties	O
associated	O
with	O
T3SS	O
chaperones	O
.	O

We	O
solved	O
the	O
crystal	O
structure	O
of	O
SrcA	B-Protein
and	O
performed	O
additional	O
biochemical	O
,	O
proteomic	O
and	O
in	O
vivo	O
experiments	O
that	O
revealed	O
SrcA	B-Protein
to	O
be	O
a	O
class	O
I	O
chaperone	O
required	O
for	O
bacterial	O
fitness	O
in	O
the	O
host	O
environment	O
.	O

Despite	O
being	O
genetically	O
disconnected	O
from	O
SPI	O
-	O
2	O
,	O
SrcA	B-Protein
is	O
integrated	O
functionally	O
with	O
this	O
system	O
by	O
binding	O
to	O
the	O
T3SS	O
ATPase	O
,	O
SsaN	B-Protein
,	O
and	O
providing	O
chaperone	O
activity	O
towards	O
two	O
important	O
effectors	O
,	O
SseL	B-Protein
(	O
STM2287	B-Protein
)	O
and	O
PipB2	B-Protein
(	O
STM2780	B-Protein
)	O
,	O
necessary	O
for	O
immune	O
escape	O
and	O
cell	O
-	O
to	O
-	O
cell	O
transmission	O
.	O

These	O
data	O
reveal	O
structural	O
and	O
biochemical	O
insight	O
into	O
a	O
T3SS	O
secretion	O
chaperone	O
required	O
for	O
intracellular	O
pathogenesis	O
of	O
Salmonella	O
.	O

Results	O

Identification	O
of	O
an	O
SsrB	B-Protein
-	O
regulated	O
secretion	O
chaperone	O
Transcriptional	O
profiling	O
of	O
SsrB	B-Protein
-	O
regulated	O
genes	O
in	O
S	O
.	O
enterica	O
serovar	O
Typhimurium	O
(	O
S	O
.	O
Typhimurium	O
)	O
[	O
22	O
]	O
identified	O
a	O
hypothetical	O
gene	O
,	O
STM2138	B-Protein
(	O
named	O
srcA	B-Protein
hereafter	O
)	O
,	O
that	O
was	O
co	O
-	O
regulated	O
with	O
genes	O
in	O
SPI	O
-	O
2	O
and	O
repressed	O
approximately20	O
-	O
fold	O
in	O
an	O
ssrB	B-Protein
mutant	O
compared	O
to	O
wild	O
type	O
.	O

This	O
gene	O
was	O
also	O
down	O
regulated	O
in	O
Salmonella	O
mutants	O
lacking	O
the	O
SsrA	B-Protein
sensor	O
kinase	O
[	O
20	O
]	O
,	O
and	O
was	O
predicted	O
to	O
encode	O
a	O
possible	O
chaperone	O
in	O
a	O
bioinformatics	O
-	O
based	O
screen	O
[	O
23	O
]	O
.	O

The	O
srcA	B-Protein
gene	O
is	O
not	O
located	O
in	O
the	O
vicinity	O
of	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
(	O
STM1378	B-Protein
-	O
STM1425	B-Protein
)	O
,	O
but	O
is	O
713	O
genes	O
downstream	O
on	O
the	O
chromosome	O
(	O
STM	O
numbers	O
are	O
based	O
on	O
the	O
LT2	O
genome	O
and	O
ordered	O
sequentially	O
on	O
the	O
chromosome	O
beginning	O
at	O
STM0001	O
,	O
thrL	B-Protein
)	O
.	O

The	O
predicted	O
srcA	B-Protein
gene	O
product	O
was	O
a	O
small	O
protein	O
approximately16	O
kDa	O
with	O
a	O
pI	O
of	O
4	O
.	O
6	O
,	O
similar	O
to	O
secretion	O
chaperones	O
associated	O
with	O
T3SS	O
.	O

To	O
verify	O
SsrB	B-Protein
input	O
on	O
srcA	B-Protein
expression	O
,	O
we	O
analyzed	O
SsrB	B-Protein
binding	O
in	O
vivo	O
at	O
the	O
region	O
of	O
DNA	O
surrounding	O
srcA	B-Protein
using	O
genome	O
-	O
wide	O
ChIP	O
-	O
on	O
-	O
chip	O
[	O
21	O
]	O
(	O
and	O
unpublished	O
data	O
)	O
.	O

This	O
analysis	O
revealed	O
a	O
strong	O
SsrB	B-Protein
binding	O
site	O
spanning	O
10	O
syntenic	O
probes	O
within	O
the	O
intergenic	O
region	O
(	O
IGR	O
)	O
upstream	O
of	O
srcA	B-Protein
,	O
that	O
together	O
with	O
the	O
transcriptional	O
data	O
corroborated	O
a	O
direct	O
regulatory	O
role	O
for	O
SsrB	B-Protein
on	O
srcA	B-Protein
expression	O
(	O
Fig	O
.	O
1A	B-Protein
)	O
.	O

To	O
determine	O
the	O
cellular	O
distribution	O
of	O
SrcA	B-Protein
we	O
constructed	O
a	O
srcA	B-Protein
-	O
HA	O
allele	O
and	O
expressed	O
this	O
gene	O
in	O
wild	O
type	O
and	O
in	O
ssrB	B-Protein
mutant	O
cells	O
under	O
conditions	O
that	O
activate	O
the	O
SPI	O
-	O
2	O
T3SS	O
[	O
24	O
]	O
.	O

In	O
whole	O
cell	O
lysates	O
,	O
SrcA	B-Protein
protein	O
was	O
reduced	O
approximately10	O
-	O
fold	O
in	O
DeltassrB	O
cells	O
compared	O
to	O
wild	O
type	O
(	O
Fig	O
.	O
1B	O
)	O
and	O
the	O
protein	O
was	O
not	O
detected	O
in	O
the	O
secreted	O
fraction	O
from	O
wild	O
type	O
cells	O
(	O
Fig	O
.	O
1C	O
)	O
,	O
consistent	O
with	O
the	O
expected	O
properties	O
of	O
a	O
T3SS	O
chaperone	O
.	O

As	O
a	O
positive	O
control	O
,	O
SseC	B-Protein
,	O
an	O
SsrB	B-Protein
-	O
regulated	O
translocon	O
protein	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
was	O
present	O
in	O
the	O
secreted	O
fraction	O
from	O
wild	O
type	O
cells	O
but	O
not	O
from	O
an	O
ssrB	B-Protein
mutant	O
.	O

SrcA	B-Protein
contributes	O
to	O
Salmonella	O
fitness	O
in	O
an	O
animal	O
host	O

Most	O
SsrB	B-Protein
-	O
regulated	O
gene	O
products	O
contribute	O
to	O
the	O
intracellular	O
survival	O
of	O
Salmonella	O
in	O
a	O
host	O
.	O

In	O
comparative	O
genomics	O
analyses	O
,	O
srcA	B-Protein
was	O
found	O
in	O
all	O
virulent	O
strains	O
of	O
Salmonella	O
enterica	O
containing	O
SPI	O
-	O
2	O
,	O
but	O
was	O
absent	O
from	O
the	O
cold	O
-	O
blooded	O
animal	O
commensal	O
,	O
S	O
.	O
bongori	O
,	O
which	O
lacks	O
SPI	O
-	O
2	O
(	O
Table	O
S1	O
)	O
.	O

This	O
suggested	O
a	O
co	O
-	O
evolution	O
of	O
srcA	B-Protein
with	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
a	O
possible	O
functional	O
relationship	O
.	O

If	O
so	O
,	O
we	O
reasoned	O
that	O
SrcA	B-Protein
should	O
contribute	O
to	O
animal	O
colonization	O
because	O
the	O
SPI	O
-	O
2	O
T3SS	O
is	O
essential	O
for	O
host	O
infection	O
.	O

To	O
determine	O
whether	O
SrcA	B-Protein
contributes	O
to	O
Salmonella	O
fitness	O
in	O
a	O
host	O
,	O
we	O
created	O
an	O
unmarked	O
in	O
-	O
frame	O
srcA	B-Protein
deletion	O
in	O
S	O
.	O

Typhimurium	O
and	O
competed	O
this	O
strain	O
against	O
wild	O
type	O
cells	O
in	O
mixed	O
oral	O
infections	O
of	O
mice	O
[	O
25	O
]	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
mouse	B-X
model	B-X
for	B-X
Salmonella	B-X
colitis	B-X
and	B-X
a	B-X
mixed	B-X
inoculum	B-X
approach	B-X
to	B-X
identify	B-X
barriers	B-X
limiting	B-X
the	B-X
gut	B-X
luminal	B-X
pathogen	B-X
population	B-X
.	B-X
Mice	B-X
were	B-X
infected	B-X
via	B-X
the	B-X
oral	B-X
route	B-X
with	B-X
wild	B-X
type	B-X
S.	B-X
Typhimurium	B-X
(	B-X
S.	B-X
Tm	B-X
)	B-X
and/or	B-X
mixtures	B-X
of	B-X
phenotypically	B-X
identical	B-X
but	B-X
differentially	B-X
tagged	B-X
S.	B-X
Tm	B-X
strains	B-X
(	B-X
``	B-X
WITS	B-X
''	B-X
,	B-X
wild-type	B-X
isogenic	B-X
tagged	B-X
strains	B-X
)	B-X
,	B-X
which	B-X
can	B-X
be	B-X
individually	B-X
tracked	B-X
by	B-X
quantitative	B-X
real-time	B-X
PCR	B-X
.	B-X
The	B-X
diversity-loss	B-X
was	B-X
not	B-X
attributable	B-X
to	B-X
overgrowth	B-X
by	B-X
S.	B-X
Tm	B-X
mutants	B-X
,	B-X
but	B-X
required	B-X
inflammation	B-X
,	B-X
Gr-1+	B-X
cells	B-X
(	B-X
mainly	B-X
neutrophilic	B-X
granulocytes	B-X
)	B-X
and	B-X
most	B-X
likely	B-X
NADPH-oxidase-mediated	B-X
defense	B-X
,	B-X
but	B-X
not	B-X
iNOS	B-X
.	B-X
Mathematical	B-X
modelling	B-X
indicated	B-X
that	B-X
inflammation	B-X
inflicts	B-X
a	B-X
bottleneck	B-X
transiently	B-X
restricting	B-X
the	B-X
gut	B-X
luminal	B-X
S.	B-X
Tm	B-X
population	B-X
to	B-X
approximately	B-X
6000	B-X
cells	B-X
and	B-X
plating	B-X
experiments	B-X
verified	B-X
a	B-X
transient	B-X
,	B-X
inflammation-	B-X
and	B-X
Gr-1+	B-X
cell-dependent	B-X
dip	B-X
in	B-X
the	B-X
gut	B-X
luminal	B-X
S.	B-X
Tm	B-X
population	B-X
at	B-X
day	B-X
2	B-X
post	B-X
infection	B-X
.	B-X

After	O
three	O
days	O
of	O
infection	O
the	O
geometric	O
mean	O
competitive	O
index	O
(	O
CI	O
)	O
for	O
the	O
mutant	O
was	O
0	O
.	O
20	O
(	O
95	O
%	O
CI	O
0	O
.	O
13	O
-	O
0	O
.	O
29	O
)	O
and	O
0	O
.	O
18	O
(	O
95	O
%	O
CI	O
0	O
.	O
06	O
-	O
0	O
.	O
5	O
)	O
in	O
the	O
spleen	O
and	O
liver	O
respectively	O
(	O
P	O
<	O
0	O
.	O
0001	O
;	O
Fig	O
.	O
1D	O
)	O
indicating	O
that	O
bacteria	O
lacking	O
srcA	B-Protein
were	O
significantly	O
out	O
competed	O
by	O
wild	O
type	O
cells	O
during	O
systemic	O
infection	O
.	O

To	O
verify	O
the	O
role	O
of	O
srcA	B-Protein
on	O
this	O
phenotype	O
,	O
we	O
complemented	O
the	O
srcA	B-Protein
mutant	O
with	O
a	O
wild	O
type	O
srcA	B-Protein
gene	O
under	O
the	O
control	O
of	O
its	O
endogenous	O
promoter	O
,	O
which	O
restored	O
in	O
vivo	O
fitness	O
to	O
that	O
of	O
wild	O
type	O
(	O
Fig	O
.	O
1D	O
)	O
.	O

The	O
level	O
of	O
attenuation	O
of	O
the	O
srcA	B-Protein
mutant	O
was	O
generally	O
higher	O
than	O
most	O
single	O
effector	O
gene	O
mutants	O
[	O
26	O
]	O
,	O
which	O
suggested	O
to	O
us	O
that	O
SrcA	B-Protein
contributes	O
to	O
an	O
important	O
aspect	O
of	O
T3SS	O
function	O
in	O
vivo	O
.	O

Crystal	O
structure	O
of	O
SrcA	B-Protein
<EOS>	B-X
Most	B-X
of	B-X
these	B-X
monobodies	B-X
competed	B-X
with	B-X
pY	B-X
ligand	B-X
binding	B-X
and	B-X
showed	B-X
strong	B-X
selectivity	B-X
for	B-X
either	B-X
the	B-X
SrcA	B-X
(	B-X
Yes	B-X
,	B-X
Src	B-X
,	B-X
Fyn	B-X
,	B-X
Fgr	B-X
)	B-X
or	B-X
SrcB	B-X
subgroup	B-X
(	B-X
Lck	B-X
,	B-X
Lyn	B-X
,	B-X
Blk	B-X
,	B-X
Hck	B-X
)	B-X
.	B-X
Three	B-X
crystal	B-X
structures	B-X
of	B-X
monobody-SH2	B-X
complexes	B-X
unveiled	B-X
different	B-X
and	B-X
only	B-X
partly	B-X
overlapping	B-X
binding	B-X
modes	B-X
,	B-X
which	B-X
rationalized	B-X
the	B-X
observed	B-X
selectivity	B-X
and	B-X
enabled	B-X
structure-based	B-X
mutagenesis	B-X
to	B-X
modulate	B-X
inhibition	B-X
mode	B-X
and	B-X
selectivity	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
present	B-X
the	B-X
2.1	B-X
Å	B-X
resolution	B-X
crystal	B-X
structure	B-X
of	B-X
the	B-X
Salmonella	B-X
enterica	B-X
SPI-2-encoded	B-X
ATPase	B-X
,	B-X
SsaN	B-X
.	B-X
Our	B-X
structure	B-X
revealed	B-X
a	B-X
local	B-X
and	B-X
functionally	B-X
important	B-X
novel	B-X
feature	B-X
in	B-X
helix	B-X
10	B-X
that	B-X
we	B-X
used	B-X
to	B-X
define	B-X
the	B-X
interaction	B-X
domain	B-X
relevant	B-X
to	B-X
chaperone	B-X
binding	B-X
.	B-X
We	B-X
modeled	B-X
the	B-X
interaction	B-X
between	B-X
the	B-X
multicargo	B-X
chaperone	B-X
,	B-X
SrcA	B-X
,	B-X
and	B-X
SsaN	B-X
and	B-X
validated	B-X
this	B-X
model	B-X
using	B-X
mutagenesis	B-X
to	B-X
identify	B-X
the	B-X
residues	B-X
on	B-X
both	B-X
the	B-X
chaperone	B-X
and	B-X
ATPase	B-X
that	B-X
mediate	B-X
the	B-X
interaction	B-X
.	B-X

Sequence	O
analysis	O
showed	O
59	O
%	O
amino	O
acid	O
identity	O
between	O
SrcA	B-Protein
and	O
CesT	B-Protein
,	O
a	O
secretion	O
chaperone	O
in	O
enteropathogenic	O
E	O
.	O
coli	O
(	O
EPEC	O
)	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

As	O
a	O
means	O
to	O
address	O
the	O
biological	O
function	O
of	O
SrcA	B-Protein
,	O
we	O
solved	O
the	O
crystal	O
structure	O
at	O
2	O
.	O
5	O
-	O
A	O
resolution	O
(	O
PDB	B-Protein
3EPU	I-Protein
)	O
.	O

A	O
summary	O
of	O
crystallographic	O
data	O
collection	O
and	O
model	O
refinement	O
statistics	O
is	O
in	O
Table	O
1	O
.	O

The	O
structure	O
was	O
solved	O
by	O
molecular	O
replacement	O
using	O
an	O
initial	O
model	O
based	O
on	O
CesT	B-Protein
(	O
PDB	B-Protein
1K3E	I-Protein
)	O
[	O
13	O
]	O
.	O

SrcA	B-Protein
crystallized	O
in	O
space	O
group	O
C2	O
with	O
two	O
molecules	O
related	O
by	O
a	O
2	O
-	O
fold	O
symmetry	O
axis	O
in	O
each	O
asymmetric	O
unit	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Each	O
monomer	O
consisted	O
of	O
a	O
small	O
and	O
large	O
domain	O
.	O
<EOS>	B-X
After	B-X
binding	B-X
four	B-X
molecules	B-X
of	B-X
cAMP	B-X
,	B-X
the	B-X
holoenzyme	B-X
dissociates	B-X
into	B-X
a	B-X
regulatory	B-X
subunit	B-X
dimer	B-X
(	B-X
each	B-X
monomer	B-X
binds	B-X
two	B-X
cAMP	B-X
)	B-X
and	B-X
two	B-X
free	B-X
and	B-X
active	B-X
catalytic	B-X
subunits	B-X
.	B-X
PKA	B-X
and	B-X
all	B-X
other	B-X
protein	B-X
kinase	B-X
domains	B-X
have	B-X
a	B-X
small	B-X
amino-terminal	B-X
lobe	B-X
and	B-X
large	B-X
carboxyterminal	B-X
lobe	B-X
as	B-X
determined	B-X
by	B-X
X-ray	B-X
crystallography	B-X
.	B-X
Imatinib	B-X
was	B-X
approved	B-X
by	B-X
the	B-X
United	B-X
States	B-X
FDA	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
chronic	B-X
myelogenous	B-X
leukemia	B-X
in	B-X
2001	B-X
;	B-X
this	B-X
small	B-X
molecule	B-X
inhibits	B-X
the	B-X
BCR-Abl	B-X
protein	B-X
kinase	B-X
oncoprotein	B-X
that	B-X
results	B-X
from	B-X
the	B-X
formation	B-X
of	B-X
the	B-X
Philadelphia	B-X
chromosome	B-X
.	B-X
More	B-X
than	B-X
two	B-X
dozen	B-X
other	B-X
orally	B-X
effective	B-X
mechanism-based	B-X
small	B-X
molecule	B-X
protein	B-X
kinase	B-X
inhibitors	B-X
have	B-X
been	B-X
subsequently	B-X
approved	B-X
by	B-X
the	B-X
FDA	B-X
.	B-X

The	O
smaller	O
domain	O
formed	O
by	O
alpha1	O
and	O
the	O
extended	O
loop	O
region	O
preceding	O
beta1	O
adopts	O
a	O
distinct	O
conformation	O
in	O
each	O
subunit	O
.	O

The	O
larger	O
domain	O
mediates	O
dimerization	O
and	O
is	O
comprised	O
of	O
a	O
twisted	O
anti	O
-	O
parallel	O
beta	O
-	O
sheet	O
(	O
beta1	O
-	O
beta2	O
-	O
beta3	O
-	O
beta5	O
-	O
beta4	O
)	O
flanked	O
by	O
alpha	O
-	O
helices	O
alpha2	O
and	O
alpha3	O
.	O

The	O
dimer	O
interface	O
formed	O
between	O
SrcA	B-Protein
monomers	O
occurs	O
primarily	O
through	O
reciprocal	O
hydrophobic	O
interactions	O
between	O
alpha2	O
and	O
alpha2	O
'	O
with	O
additional	O
interface	O
-	O
stabilizing	O
interactions	O
occurring	O
between	O
the	O
alpha2	O
helix	O
of	O
one	O
monomer	O
and	O
beta4	O
and	O
beta5	O
strands	O
of	O
the	O
opposing	O
monomer	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

The	O
total	O
surface	O
area	O
buried	O
at	O
the	O
dimer	O
interface	O
is	O
1258	O
A2	O
,	O
suggesting	O
that	O
SrcA	B-Protein
would	O
exist	O
as	O
a	O
dimer	O
in	O
solution	O
,	O
which	O
we	O
confirmed	O
by	O
gel	O
filtration	O
analysis	O
(	O
see	O
below	O
)	O
.	O

A	O
structure	O
similarity	O
search	O
with	O
SrcA	B-Protein
revealed	O
proteins	O
identified	O
as	O
T3SS	O
secretion	O
chaperones	O
.	O

CesT	B-Protein
and	O
SicP	B-Protein
were	O
the	O
most	O
structurally	O
similar	O
to	O
SrcA	B-Protein
,	O
aligning	O
with	O
RMSD	O
of	O
1	O
.	O
8	O
A	O
and	O
2	O
.	O
2	O
A	O
respectively	O
.	O

With	O
the	O
exception	O
of	O
CesT	B-Protein
,	O
SrcA	B-Protein
has	O
weak	O
overall	O
sequence	O
identity	O
(	O
<	O
20	O
%	O
)	O
with	O
other	O
T3SS	O
chaperones	O
.	O

CesT	B-Protein
,	O
SicP	B-Protein
and	O
SrcA	B-Protein
contain	O
several	O
clusters	O
of	O
highly	O
conserved	O
amino	O
acids	O
notable	O
on	O
primary	O
sequence	O
alignments	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Most	O
of	O
these	O
conserved	O
sites	O
are	O
located	O
in	O
the	O
alpha2	O
-	O
interface	O
helix	O
and	O
in	O
strands	O
beta4	O
and	O
beta5	O
that	O
help	O
stabilize	O
this	O
interface	O
.	O

Although	O
the	O
N	O
-	O
terminus	O
of	O
these	O
proteins	O
is	O
conserved	O
structurally	O
,	O
the	O
tertiary	O
structures	O
differ	O
for	O
each	O
protein	O
.	O

In	O
CesT	B-Protein
,	O
alpha1	O
and	O
beta1	O
adopt	O
an	O
extended	O
conformation	O
while	O
the	O
equivalent	O
domain	O
in	O
SicP	B-Protein
remains	O
closely	O
packed	O
against	O
the	O
dimerization	O
domain	O
[	O
12	O
]	O
.	O

In	O
SrcA	B-Protein
,	O
both	O
extended	O
and	O
closely	O
packed	O
conformations	O
are	O
observed	O
in	O
separate	O
subunits	O
of	O
the	O
same	O
dimer	O
within	O
the	O
asymmetric	O
unit	O
.	O

In	O
the	O
extended	O
conformation	O
the	O
N	O
-	O
terminal	O
helix	O
from	O
one	O
dimer	O
interacts	O
with	O
the	O
beta4	O
region	O
of	O
an	O
adjacent	O
dimer	O
,	O
similar	O
to	O
a	O
domain	O
swap	O
seen	O
in	O
CesT	B-Protein
[	O
13	O
]	O
.	O

At	O
this	O
time	O
,	O
the	O
possible	O
biological	O
relevance	O
for	O
such	O
a	O
domain	O
swap	O
is	O
unclear	O
and	O
may	O
reflect	O
an	O
artifact	O
of	O
crystallization	O
as	O
critically	O
discussed	O
[	O
13	O
]	O
.	O

A	O
comparison	O
of	O
the	O
SrcA	B-Protein
dimer	O
interface	O
with	O
other	O
class	O
I	O
chaperone	O
family	O
members	O
indicates	O
the	O
overall	O
similarity	O
of	O
quaternary	O
structure	O
shared	O
between	O
SrcA	B-Protein
,	O
CesT	B-Protein
and	O
SicP	B-Protein
(	O
Fig	O
.	O
3A	O
)	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
class	O
II	O
chaperone	O
interface	O
of	O
Spa15	B-Protein
,	O
which	O
despite	O
having	O
similar	O
tertiary	O
structure	O
to	O
SrcA	B-Protein
adopts	O
a	O
distinct	O
dimer	O
interface	O
.	O

A	O
structural	O
alignment	O
of	O
SrcA	B-Protein
and	O
Spa15	B-Protein
generated	O
through	O
alignment	O
of	O
single	O
monomers	O
shows	O
the	O
relative	O
difference	O
in	O
subunit	O
orientation	O
between	O
SrcA	B-Protein
and	O
Spa15	B-Protein
reflected	O
by	O
the	O
positions	O
of	O
each	O
monomer	O
in	O
the	O
dimer	O
configuration	O
.	O

These	O
unique	O
orientations	O
produce	O
an	O
80degrees	O
rotational	O
offset	O
between	O
respective	O
subunits	O
and	O
could	O
be	O
expected	O
to	O
influence	O
the	O
mode	O
of	O
effector	O
interactions	O
utilized	O
by	O
these	O
proteins	O
.	O

To	O
evaluate	O
the	O
potential	O
for	O
an	O
effector	O
-	O
binding	O
surface	O
on	O
SrcA	B-Protein
,	O
the	O
structure	O
of	O
SicP	B-Protein
in	O
complex	O
with	O
its	O
effector	O
SptP	B-Protein
was	O
aligned	O
with	O
SrcA	B-Protein
and	O
represented	O
as	O
a	O
space	O
-	O
filling	O
model	O
(	O
Fig	O
.	O
3B	O
)	O
.	O

Binding	O
of	O
SptP	B-Protein
occurs	O
primarily	O
in	O
the	O
N	O
-	O
terminus	O
of	O
SicP	B-Protein
[	O
12	O
]	O
,	O
which	O
is	O
similar	O
to	O
the	O
effector	O
binding	O
surface	O
for	O
SrcA	B-Protein
predicted	O
in	O
silico	O
.	O

This	O
surface	O
contains	O
several	O
conserved	O
hydrophobic	O
residues	O
including	O
L16	O
,	O
D24	O
,	O
N26	O
,	O
and	O
I32	O
(	O
Fig	O
.	O
2A	O
)	O
,	O
which	O
is	O
consistent	O
with	O
SrcA	B-Protein
using	O
a	O
similar	O
mechanism	O
for	O
interaction	O
with	O
effectors	O
.	O

SrcA	B-Protein
interacts	O
with	O
the	O
SPI	O
-	O
2	O
T3SS	O
ATPase	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
A	B-X
suite	B-X
of	B-X
T3SS-associated	B-X
chaperone	B-X
proteins	B-X
bind	B-X
cargo	B-X
in	B-X
the	B-X
bacterial	B-X
cytosol	B-X
,	B-X
establishing	B-X
protein	B-X
interaction	B-X
networks	B-X
needed	B-X
for	B-X
effector	B-X
translocation	B-X
into	B-X
host	B-X
cells	B-X
.	B-X
In	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
,	B-X
a	B-X
T3SS	B-X
encoded	B-X
in	B-X
a	B-X
large	B-X
genomic	B-X
island	B-X
(	B-X
SPI-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
intracellular	B-X
infection	B-X
,	B-X
but	B-X
the	B-X
chaperone	B-X
complement	B-X
required	B-X
for	B-X
effector	B-X
translocation	B-X
by	B-X
this	B-X
system	B-X
is	B-X
not	B-X
known	B-X
.	B-X
Using	B-X
a	B-X
reverse	B-X
genetics	B-X
approach	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
multi-cargo	B-X
secretion	B-X
chaperone	B-X
that	B-X
is	B-X
functionally	B-X
integrated	B-X
with	B-X
the	B-X
SPI-2-encoded	B-X
T3SS	B-X
and	B-X
required	B-X
for	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
Crystallographic	B-X
analysis	B-X
of	B-X
SrcA	B-X
at	B-X
a	B-X
resolution	B-X
of	B-X
2.5	B-X
A	B-X
revealed	B-X
a	B-X
dimer	B-X
similar	B-X
to	B-X
the	B-X
CesT	B-X
chaperone	B-X
from	B-X
enteropathogenic	B-X
E.	B-X
coli	B-X
but	B-X
lacking	B-X
a	B-X
17-amino	B-X
acid	B-X
extension	B-X
at	B-X
the	B-X
carboxyl	B-X
terminus	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

An	O
emerging	O
function	O
for	O
T3SS	O
chaperones	O
is	O
delivery	O
of	O
cargo	O
to	O
the	O
base	O
of	O
the	O
apparatus	O
through	O
interactions	O
with	O
an	O
ATPase	O
.	O

This	O
was	O
shown	O
for	O
the	O
flagellar	O
T3SS	O
[	O
17	O
]	O
and	O
later	O
in	O
the	O
virulence	O
-	O
associated	O
T3SS	O
in	O
E	O
.	O
coli	O
[	O
16	O
]	O
,	O
[	O
27	O
]	O
and	O
the	O
SPI	O
-	O
1	O
T3SS	O
in	O
Salmonella	O
[	O
15	O
]	O
.	O

However	O
,	O
analogous	O
interactions	O
have	O
not	O
been	O
described	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
.	O
<EOS>	B-X
The	B-X
route	B-X
involves	B-X
a	B-X
generalization	B-X
of	B-X
mother-infant	B-X
interaction	B-X
patterns	B-X
to	B-X
all	B-X
adults	B-X
via	B-X
a	B-X
process	B-X
(	B-X
cuteness	B-X
selection	B-X
)	B-X
analogous	B-X
to	B-X
,	B-X
but	B-X
distinct	B-X
from	B-X
,	B-X
RA	B-X
Fisher	B-X
's	B-X
runaway	B-X
sexual	B-X
selection	B-X
.	B-X
Two	B-X
evolutionarily	B-X
related	B-X
domains	B-X
,	B-X
called	B-X
CUBAN	B-X
(	B-X
cullin-binding	B-X
domain	B-X
associating	B-X
with	B-X
NEDD8	B-X
)	B-X
and	B-X
CoCUN	B-X
(	B-X
cousin	B-X
of	B-X
CUBAN	B-X
)	B-X
,	B-X
have	B-X
been	B-X
recently	B-X
described	B-X
.	B-X
Indeed	B-X
,	B-X
these	B-X
domains	B-X
diverged	B-X
towards	B-X
two	B-X
recognition	B-X
modes	B-X
,	B-X
that	B-X
recall	B-X
respectively	B-X
the	B-X
electrostatic	B-X
interaction	B-X
utilized	B-X
by	B-X
the	B-X
E3-ligase	B-X
RBX1/2	B-X
in	B-X
the	B-X
interaction	B-X
with	B-X
NEDD8	B-X
,	B-X
and	B-X
the	B-X
hydrophobic	B-X
features	B-X
described	B-X
in	B-X
the	B-X
recognition	B-X
of	B-X
ubiquitin	B-X
by	B-X
CUE	B-X
(	B-X
coupling	B-X
ubiquitin	B-X
conjugation	B-X
to	B-X
ER	B-X
degradation	B-X
)	B-X
domains	B-X
.	B-X
The	B-X
discovery	B-X
of	B-X
the	B-X
details	B-X
of	B-X
minor	B-X
groove	B-X
binding	B-X
drugs	B-X
,	B-X
such	B-X
as	B-X
netropsin	B-X
and	B-X
distamycin	B-X
A	B-X
,	B-X
oligoamides	B-X
built	B-X
of	B-X
4-amino-1-methylpyrrole-2-carboxylic	B-X
acid	B-X
residues	B-X
,	B-X
allowed	B-X
to	B-X
develop	B-X
various	B-X
DNA	B-X
sequence-reading	B-X
molecules	B-X
,	B-X
named	B-X
lexitropsins	B-X
,	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
DNA	B-X
precisely	B-X
,	B-X
strongly	B-X
and	B-X
with	B-X
a	B-X
high	B-X
specificity	B-X
,	B-X
and	B-X
at	B-X
the	B-X
same	B-X
time	B-X
exhibiting	B-X
significant	B-X
cytotoxic	B-X
potential	B-X
.	B-X

Since	O
srcA	B-Protein
expression	O
was	O
co	O
-	O
regulated	O
with	O
genes	O
in	O
SPI	O
-	O
2	O
,	O
we	O
hypothesized	O
that	O
it	O
had	O
a	O
functional	O
role	O
in	O
this	O
system	O
.	O

To	O
address	O
this	O
biochemically	O
we	O
purified	O
SrcA	B-Protein
and	O
the	O
predicted	O
ATPase	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
,	O
SsaN	B-Protein
,	O
and	O
performed	O
binding	O
experiments	O
and	O
gel	O
filtration	O
chromatography	O
of	O
the	O
protein	O
mixtures	O
.	O

SsaN	B-Protein
contains	O
conserved	O
amino	O
acid	O
residues	O
characteristic	O
of	O
Walker	O
-	O
A	O
and	O
Walker	O
-	O
B	O
motifs	O
of	O
P	O
-	O
loop	O
nucleoside	B-Protein
triphosphate	I-Protein
hydrolases	I-Protein
,	O
as	O
well	O
as	O
a	O
number	O
of	O
residues	O
shown	O
to	O
contribute	O
to	O
ATP	O
binding	O
or	O
ring	O
stacking	O
with	O
the	O
adenine	O
base	O
of	O
ATP	O
in	O
the	O
E	O
.	O
coli	O
orthologue	O
,	O
EscN	B-Protein
,	O
(	O
Q412	O
,	O
E191	O
,	O
R366	O
)	O
(	O
Fig	O
.	O
S1	O
)	O
.	O

Since	O
SsaN	B-Protein
had	O
not	O
been	O
characterized	O
biochemically	O
we	O
first	O
verified	O
that	O
our	O
purified	O
protein	O
had	O
ATPase	O
activity	O
(	O
Fig	O
.	O
S1	O
)	O
.	O
<EOS>	B-X
This	B-X
study	B-X
sought	B-X
to	B-X
investigate	B-X
the	B-X
shift	B-X
of	B-X
leading	B-X
pacemaker	B-X
locations	B-X
in	B-X
healthy	B-X
and	B-X
failing	B-X
mammalian	B-X
hearts	B-X
over	B-X
the	B-X
entire	B-X
range	B-X
of	B-X
physiological	B-X
heart	B-X
rates	B-X
(	B-X
HRs	B-X
)	B-X
,	B-X
and	B-X
to	B-X
molecularly	B-X
characterize	B-X
spatial	B-X
regions	B-X
of	B-X
spontaneous	B-X
activity	B-X
.	B-X
One	B-X
essential	B-X
component	B-X
of	B-X
a	B-X
T3SS	B-X
is	B-X
an	B-X
ATPase	B-X
that	B-X
catalyzes	B-X
the	B-X
unfolding	B-X
of	B-X
proteins	B-X
,	B-X
which	B-X
is	B-X
followed	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
effectors	B-X
through	B-X
an	B-X
injectisome	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
functional	B-X
role	B-X
of	B-X
the	B-X
ATPase	B-X
SsaN	B-X
,	B-X
a	B-X
component	B-X
of	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
T3SS	B-X
(	B-X
T3SS-2	B-X
)	B-X
in	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
.	B-X
SsaN	B-X
hydrolyzed	B-X
ATP	B-X
in	B-X
vitro	B-X
and	B-X
was	B-X
essential	B-X
for	B-X
T3SS	B-X
function	B-X
and	B-X
Salmonella	B-X
virulence	B-X
in	B-X
vivo	B-X
.	B-X
Protein-protein	B-X
interaction	B-X
analyses	B-X
revealed	B-X
that	B-X
SsaN	B-X
interacted	B-X
with	B-X
SsaK	B-X
and	B-X
SsaQ	B-X
to	B-X
form	B-X
the	B-X
C	B-X
ring	B-X
complex	B-X
.	B-X
SsaN	B-X
and	B-X
its	B-X
complex	B-X
co-localized	B-X
to	B-X
the	B-X
membrane	B-X
fraction	B-X
under	B-X
T3SS-2	B-X
inducing	B-X
conditions	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
SsaN	B-X
bound	B-X
to	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
2	B-X
(	B-X
SPI-2	B-X
)	B-X
specific	B-X
chaperones	B-X
,	B-X
including	B-X
SsaE	B-X
,	B-X
SseA	B-X
,	B-X
SscA	B-X
,	B-X
and	B-X
SscB	B-X
that	B-X
facilitated	B-X
translocator/effector	B-X
secretion	B-X
.	B-X
Using	B-X
an	B-X
in	B-X
vitro	B-X
chaperone	B-X
release	B-X
assay	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
SsaN	B-X
dissociated	B-X
a	B-X
chaperone-effector	B-X
complex	B-X
,	B-X
SsaE	B-X
and	B-X
SseB	B-X
,	B-X
in	B-X
an	B-X
ATP-dependent	B-X
manner	B-X
.	B-X
Effector	B-X
release	B-X
was	B-X
dependent	B-X
on	B-X
a	B-X
conserved	B-X
arginine	B-X
residue	B-X
at	B-X
position	B-X
192	B-X
of	B-X
SsaN	B-X
,	B-X
and	B-X
this	B-X
was	B-X
essential	B-X
for	B-X
its	B-X
enzymatic	B-X
activity	B-X
.	B-X
These	B-X
results	B-X
strongly	B-X
suggest	B-X
that	B-X
the	B-X
T3SS-2-associated	B-X
ATPase	B-X
SsaN	B-X
contributes	B-X
to	B-X
T3SS-2	B-X
effector	B-X
translocation	B-X
efficiency	B-X
.	B-X

We	O
then	O
mixed	O
SrcA	B-Protein
and	O
SsaN	B-Protein
proteins	O
and	O
resolved	O
the	O
protein	O
complexes	O
by	O
gel	O
filtration	O
chromatography	O
.	O

By	O
itself	O
,	O
SrcA	B-Protein
existed	O
as	O
a	O
dimer	O
in	O
solution	O
(	O
Fig	O
.	O
4A	O
)	O
with	O
no	O
higher	O
oligomers	O
present	O
,	O
substantiating	O
the	O
stoichiometry	O
obtained	O
from	O
our	O
crystal	O
data	O
.	O

SsaN	B-Protein
existed	O
as	O
a	O
monomer	O
with	O
a	O
minor	O
population	O
eluting	O
in	O
a	O
volume	O
consistent	O
with	O
a	O
probable	O
dimer	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

When	O
SrcA	B-Protein
was	O
mixed	O
with	O
SsaN	B-Protein
,	O
a	O
new	O
protein	O
complex	O
of	O
high	O
molecular	O
weight	O
was	O
observed	O
,	O
along	O
with	O
diminished	O
peaks	O
corresponding	O
to	O
the	O
SrcA	B-Protein
dimer	O
and	O
SsaN	B-Protein
monomer	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

This	O
new	O
complex	O
elutes	O
with	O
a	O
Stokes	O
radius	O
consistent	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
approximately600	O
kDa	O
.	O

We	O
verified	O
the	O
identities	O
of	O
protein	O
originating	O
from	O
each	O
peak	O
by	O
western	O
blot	O
(	O
Fig	O
.	O
4D	O
)	O
and	O
LC	O
-	O
MS	O
/	O
MS	O
,	O
which	O
showed	O
the	O
new	O
complex	O
was	O
comprised	O
of	O
both	O
SsaN	B-Protein
and	O
SrcA	B-Protein
.	O

SrcA	B-Protein
binds	O
effector	O
cargo	O
destined	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O

Since	O
structural	O
and	O
biochemical	O
data	O
unambiguously	O
defined	O
SrcA	B-Protein
as	O
a	O
T3SS	O
-	O
associated	O
chaperone	O
,	O
we	O
used	O
two	O
experimental	O
approaches	O
to	O
identify	O
SrcA	B-Protein
cargo	O
(	O
s	O
)	O
.	O

First	O
,	O
we	O
used	O
stable	O
isotope	O
labeling	O
of	O
amino	O
acids	O
in	O
cell	O
culture	O
(	O
SILAC	O
)	O
[	O
28	O
]	O
in	O
conjunction	O
with	O
quantitative	O
mass	O
spectrometry	O
-	O
based	O
proteomics	O
to	O
identify	O
cargo	O
immunoprecipitated	O
with	O
SrcA	B-Protein
from	O
Salmonella	O
.	O

For	O
this	O
series	O
of	O
experiments	O
we	O
constructed	O
a	O
mutant	O
in	O
which	O
the	O
srcA	B-Protein
gene	O
was	O
replaced	O
on	O
the	O
chromosome	O
with	O
srcA	B-Protein
-	O
FLAG	O
to	O
enable	O
immunoprecipitation	O
from	O
cell	O
lysates	O
.	O

Lysates	O
prepared	O
from	O
wild	O
type	O
cells	O
grown	O
in	O
2H4	O
-	O
Lys	O
and	O
13C6	O
-	O
Arg	O
containing	O
SILAC	O
medium	O
(	O
heavy	O
)	O
and	O
srcA	B-Protein
mutant	O
cells	O
grown	O
in	O
medium	O
containing	O
natural	O
amino	O
acids	O
of	O
Lys	O
and	O
Arg	O
(	O
light	O
)	O
were	O
mixed	O
and	O
subjected	O
to	O
an	O
immunoprecipitation	O
procedure	O
with	O
an	O
anti	O
-	O
FLAG	O
antibody	O
followed	O
by	O
quantitative	O
mass	O
spectrometry	O
.	O

Peptides	O
originating	O
from	O
wild	O
type	O
cells	O
contained	O
heavy	O
atom	O
-	O
substituted	O
lysine	O
and	O
arginine	O
such	O
that	O
putative	O
SrcA	B-Protein
cargo	O
proteins	O
would	O
generate	O
low	O
heavy	O
:	O
light	O
SILAC	O
peptide	O
ratios	O
from	O
the	O
complex	O
mixtures	O
(	O
Fig	O
.	O
5A	O
)	O
.	O

In	O
these	O
experiments	O
the	O
T3SS	O
effector	O
protein	O
SseL	B-Protein
was	O
identified	O
by	O
quantitative	O
SILAC	O
mass	O
spectrometry	O
as	O
a	O
specific	O
SrcA	B-Protein
cargo	O
protein	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

SseL	B-Protein
was	O
immunoprecipitated	O
specifically	O
along	O
with	O
SrcA	B-Protein
-	O
FLAG	O
with	O
a	O
SILAC	O
ratio	O
of	O
0	O
.	O
08	O
,	O
whereas	O
additional	O
abundant	O
proteins	O
displayed	O
SILAC	O
ratios	O
closer	O
to	O
approximately1	O
(	O
OmpF	B-Protein
is	O
shown	O
,	O
Fig	O
.	O
5B	O
)	O
(	O
mean	O
SILAC	O
ratio	O
of	O
all	O
other	O
peptides	O
identified	O
was	O
0	O
.	O
93	O
(	O
Dataset	O
S1	O
)	O
.	O

Secondly	O
,	O
to	O
verify	O
the	O
mass	O
spectrometry	O
data	O
and	O
to	O
identify	O
other	O
possible	O
effector	O
cargo	O
,	O
we	O
examined	O
the	O
secretion	O
profiles	O
of	O
wild	O
type	O
cells	O
and	O
an	O
srcA	B-Protein
mutant	O
that	O
each	O
expressed	O
HA	O
-	O
tagged	O
effector	O
genes	O
,	O
the	O
products	O
of	O
which	O
are	O
secreted	O
by	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

Using	O
this	O
approach	O
SseL	B-Protein
-	O
HA	O
and	O
PipB2	B-Protein
-	O
HA	O
were	O
depleted	O
from	O
the	O
secreted	O
protein	O
fraction	O
of	O
srcA	B-Protein
mutant	O
cells	O
(	O
Fig	O
.	O
5C	O
)	O
but	O
reached	O
similar	O
levels	O
in	O
the	O
bacterial	O
cytoplasm	O
(	O
Fig	O
.	O
5D	O
)	O
.	O

As	O
expected	O
from	O
data	O
with	O
the	O
complemented	O
mutant	O
in	O
vivo	O
,	O
expression	O
of	O
srcA	B-Protein
in	O
trans	O
restored	O
effector	O
secretion	O
in	O
the	O
srcA	B-Protein
mutant	O
(	O
data	O
not	O
shown	O
)	O
.	O

SrcA	B-Protein
is	O
required	O
for	O
PipB2	B-Protein
-	O
dependent	O
centrifugal	O
displacement	O
of	O
the	O
Salmonella	O
-	O
containing	O
vacuole	O

To	O
further	O
show	O
a	O
role	O
for	O
SrcA	B-Protein
in	O
chaperoning	O
PipB2	B-Protein
,	O
we	O
set	O
up	O
experiments	O
to	O
test	O
whether	O
deleting	O
srcA	B-Protein
would	O
phenocopy	O
DeltapipB2	O
cells	O
for	O
PipB2	B-Protein
-	O
dependent	O
centrifugal	O
displacement	O
of	O
the	O
Salmonella	O
containing	O
vacuole	O
(	O
SCV	O
)	O
in	O
epithelial	O
cells	O
,	O
an	O
event	O
linked	O
to	O
cell	O
-	O
to	O
-	O
cell	O
transfer	O
during	O
infection	O
in	O
vitro	O
[	O
29	O
]	O
.	O

At	O
10	O
h	O
after	O
infection	O
the	O
majority	O
of	O
SCVs	O
were	O
situated	O
near	O
the	O
nucleus	O
in	O
accordance	O
with	O
previous	O
work	O
(	O
Fig	O
.	O
6A	O
)	O
[	O
29	O
]	O
.	O

By	O
24	O
h	O
after	O
infection	O
SCVs	O
containing	O
wild	O
type	O
bacteria	O
were	O
displaced	O
centrifugally	O
towards	O
the	O
cell	O
periphery	O
whereas	O
SCVs	O
containing	O
either	O
pipB2	B-Protein
or	O
srcA	B-Protein
mutant	O
bacteria	O
remained	O
juxtaposed	O
to	O
the	O
nucleus	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

The	O
average	O
distance	O
from	O
the	O
nucleus	O
of	O
LAMP1	O
+	O
SCVs	O
containing	O
wild	O
type	O
bacteria	O
was	O
2	O
.	O
19	O
microm	O
at	O
10h	O
post	O
infection	O
and	O
increased	O
to	O
7	O
.	O
86	O
microm	O
by	O
24	O
h	O
after	O
infection	O
.	O

Conversely	O
,	O
SCVs	O
containing	O
either	O
DeltapipB2	O
cells	O
or	O
DeltasrcA	O
cells	O
were	O
1	O
.	O
38	O
microm	O
and	O
2	O
.	O
09	O
microm	O
at	O
10h	O
but	O
lacked	O
centrifugal	O
displacement	O
at	O
24	O
h	O
(	O
2	O
.	O
23	O
microm	O
and	O
2	O
.	O
85	O
microm	O
,	O
respectively	O
)	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Structural	O
features	O
of	O
SrcA	B-Protein
We	O
used	O
a	O
reverse	O
genetics	O
approach	O
to	O
define	O
a	O
new	O
secretion	O
chaperone	O
in	O
S	O
.	O

Typhimurium	O
that	O
is	O
integrated	O
functionally	O
with	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
,	O
a	O
system	O
well	O
described	O
for	O
its	O
role	O
in	O
immune	O
subversion	O
and	O
intracellular	O
infection	O
during	O
host	O
colonization	O
.	O

Consistent	O
with	O
other	O
class	O
I	O
secretion	O
chaperones	O
,	O
SrcA	B-Protein
has	O
extensive	O
electronegative	O
charge	O
distributed	O
over	O
the	O
surface	O
of	O
the	O
molecule	O
.	O

The	O
exact	O
function	O
of	O
this	O
charge	O
distribution	O
is	O
not	O
known	O
,	O
but	O
data	O
from	O
other	O
systems	O
suggests	O
a	O
docking	O
recognition	O
function	O
with	O
other	O
components	O
of	O
the	O
type	O
III	O
apparatus	O
,	O
possibly	O
the	O
T3SS	O
-	O
accociated	O
ATPase	O
.	O
<EOS>	B-X
The	B-X
ANO-R	B-X
basis	B-X
set	B-X
is	B-X
an	B-X
all-electron	B-X
basis	B-X
set	B-X
that	B-X
was	B-X
constructed	B-X
including	B-X
scalar-relativistic	B-X
effects	B-X
of	B-X
the	B-X
exact-two	B-X
component	B-X
(	B-X
X2C	B-X
)	B-X
Hamiltonian	B-X
and	B-X
modeling	B-X
the	B-X
atomic	B-X
nucleus	B-X
by	B-X
a	B-X
Gaussian	B-X
charge	B-X
distribution	B-X
,	B-X
which	B-X
makes	B-X
the	B-X
basis	B-X
set	B-X
suitable	B-X
for	B-X
calculations	B-X
of	B-X
both	B-X
light	B-X
and	B-X
heavy	B-X
elements	B-X
.	B-X
The	B-X
distinguishing	B-X
feature	B-X
of	B-X
the	B-X
ANO-R	B-X
basis	B-X
set	B-X
is	B-X
its	B-X
compactness	B-X
in	B-X
terms	B-X
of	B-X
both	B-X
primitive	B-X
and	B-X
contracted	B-X
basis	B-X
functions	B-X
,	B-X
thus	B-X
containing	B-X
no	B-X
superfluous	B-X
functions	B-X
for	B-X
a	B-X
given	B-X
quality	B-X
.	B-X
An	B-X
optimum	B-X
number	B-X
of	B-X
primitive	B-X
basis	B-X
functions	B-X
was	B-X
selected	B-X
based	B-X
on	B-X
studying	B-X
the	B-X
convergence	B-X
toward	B-X
the	B-X
complete	B-X
basis	B-X
set	B-X
limit	B-X
for	B-X
each	B-X
element	B-X
individually	B-X
.	B-X
These	B-X
data	B-X
provide	B-X
a	B-X
solid	B-X
foundation	B-X
for	B-X
future	B-X
functional	B-X
studies	B-X
,	B-X
in	B-X
particular	B-X
the	B-X
mechanism	B-X
of	B-X
water	B-X
oxidation	B-X
and	B-X
oxygen	B-X
release	B-X
.	B-X
The	B-X
function	B-X
of	B-X
the	B-X
OEC	B-X
rests	B-X
on	B-X
its	B-X
ability	B-X
to	B-X
cycle	B-X
through	B-X
five	B-X
metastable	B-X
states	B-X
(	B-X
Si	B-X
,	B-X
i	B-X
=	B-X
0-4	B-X
)	B-X
,	B-X
transiently	B-X
storing	B-X
four	B-X
oxidizing	B-X
equivalents	B-X
,	B-X
and	B-X
in	B-X
so	B-X
doing	B-X
,	B-X
facilitates	B-X
the	B-X
four	B-X
electron	B-X
water	B-X
splitting	B-X
reaction	B-X
.	B-X
While	B-X
the	B-X
latest	B-X
crystallographic	B-X
model	B-X
of	B-X
PSII	B-X
gives	B-X
an	B-X
atomic	B-X
picture	B-X
of	B-X
the	B-X
OEC	B-X
,	B-X
the	B-X
exact	B-X
connectivity	B-X
within	B-X
the	B-X
inorganic	B-X
core	B-X
and	B-X
the	B-X
S-state	B-X
(	B-X
s	B-X
)	B-X
that	B-X
the	B-X
X-ray	B-X
model	B-X
represents	B-X
remain	B-X
uncertain	B-X
.	B-X
In	B-X
this	B-X
Account	B-X
,	B-X
we	B-X
describe	B-X
our	B-X
joint	B-X
experimental	B-X
and	B-X
theoretical	B-X
efforts	B-X
to	B-X
eliminate	B-X
these	B-X
ambiguities	B-X
by	B-X
combining	B-X
the	B-X
X-ray	B-X
data	B-X
with	B-X
spectroscopic	B-X
constraints	B-X
and	B-X
introducing	B-X
computational	B-X
modeling	B-X
.	B-X
We	B-X
are	B-X
developing	B-X
quantum	B-X
chemical	B-X
methods	B-X
to	B-X
predict	B-X
electron	B-X
paramagnetic	B-X
resonance	B-X
(	B-X
EPR	B-X
)	B-X
parameters	B-X
for	B-X
transition	B-X
metal	B-X
clusters	B-X
,	B-X
especially	B-X
focusing	B-X
on	B-X
spin-projection	B-X
approaches	B-X
combined	B-X
with	B-X
density	B-X
functional	B-X
theory	B-X
(	B-X
DFT	B-X
)	B-X
calculations	B-X
.	B-X
The	B-X
sequence	B-X
of	B-X
manganese	B-X
oxidations	B-X
and	B-X
concomitant	B-X
charge	B-X
compensation	B-X
events	B-X
via	B-X
proton	B-X
transfer	B-X
allow	B-X
us	B-X
to	B-X
rationalize	B-X
the	B-X
multielectron	B-X
S-state	B-X
cycle	B-X
.	B-X
These	B-X
two	B-X
structures	B-X
differ	B-X
in	B-X
their	B-X
valence	B-X
distribution	B-X
and	B-X
spin	B-X
multiplicity	B-X
,	B-X
which	B-X
has	B-X
important	B-X
consequences	B-X
for	B-X
substrate	B-X
binding	B-X
and	B-X
may	B-X
explain	B-X
its	B-X
low	B-X
barrier	B-X
exchange	B-X
with	B-X
solvent	B-X
water	B-X
.	B-X

For	O
instance	O
,	O
electronegative	O
surface	O
residues	O
on	O
the	O
SigE	B-Protein
chaperone	O
in	O
the	O
SPI	O
-	O
1	O
-	O
encoded	O
T3SS	O
negatively	O
affect	O
cargo	O
secretion	O
,	O
but	O
not	O
cargo	O
stability	O
[	O
30	O
]	O
.	O

In	O
enteropathogenic	O
E	O
.	O
coli	O
,	O
a	O
surface	O
-	O
exposed	O
electronegative	O
residue	O
in	O
the	O
CesT	B-Protein
chaperone	O
(	O
Glu142	O
)	O
likewise	O
contributes	O
to	O
Tir	B-Protein
secretion	O
but	O
not	O
Tir	B-Protein
binding	O
[	O
16	O
]	O
,	O
suggesting	O
a	O
role	O
in	O
either	O
targeting	O
bound	O
cargo	O
to	O
the	O
T3SS	O
or	O
in	O
the	O
secretion	O
process	O
itself	O
.	O
<EOS>	B-X
Essential	B-X
for	B-X
the	B-X
host-response	B-X
and	B-X
resistance	B-X
to	B-X
pathogens	B-X
,	B-X
it	B-X
also	B-X
exacerbates	B-X
damage	B-X
during	B-X
chronic	B-X
disease	B-X
and	B-X
acute	B-X
tissue	B-X
injury	B-X
.	B-X
It	B-X
does	B-X
not	B-X
follow	B-X
the	B-X
conventional	B-X
ER-Golgi	B-X
route	B-X
of	B-X
secretion	B-X
.	B-X
Here	B-X
we	B-X
summarise	B-X
these	B-X
observations	B-X
and	B-X
propose	B-X
that	B-X
secretion	B-X
of	B-X
IL-1β	B-X
occurs	B-X
on	B-X
a	B-X
continuum	B-X
,	B-X
dependent	B-X
upon	B-X
stimulus	B-X
strength	B-X
and	B-X
the	B-X
extracellular	B-X
IL-1β	B-X
requirement	B-X
.	B-X
Cellular	B-X
senescence	B-X
is	B-X
a	B-X
process	B-X
that	B-X
results	B-X
from	B-X
a	B-X
variety	B-X
of	B-X
stresses	B-X
and	B-X
leads	B-X
to	B-X
a	B-X
state	B-X
of	B-X
irreversible	B-X
growth	B-X
arrest	B-X
.	B-X
Cellular	B-X
senescence	B-X
may	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
tumor	B-X
suppression	B-X
,	B-X
wound	B-X
healing	B-X
,	B-X
and	B-X
protection	B-X
against	B-X
tissue	B-X
fibrosis	B-X
;	B-X
however	B-X
,	B-X
accumulating	B-X
evidence	B-X
that	B-X
senescent	B-X
cells	B-X
may	B-X
have	B-X
harmful	B-X
effects	B-X
in	B-X
vivo	B-X
and	B-X
may	B-X
contribute	B-X
to	B-X
tissue	B-X
remodeling	B-X
,	B-X
organismal	B-X
aging	B-X
,	B-X
and	B-X
many	B-X
age-related	B-X
diseases	B-X
also	B-X
exists	B-X
.	B-X
The	B-X
pathways	B-X
for	B-X
the	B-X
proteins	B-X
p53/p21	B-X
and	B-X
p16Ink4a/retinoblastoma	B-X
protein	B-X
are	B-X
important	B-X
for	B-X
irreversible	B-X
growth	B-X
arrest	B-X
and	B-X
senescent	B-X
cells	B-X
.	B-X
Senescent	B-X
cells	B-X
secrete	B-X
numerous	B-X
biologically	B-X
active	B-X
factors	B-X
;	B-X
the	B-X
specific	B-X
secretion	B-X
phenotype	B-X
by	B-X
senescent	B-X
cell	B-X
contributes	B-X
to	B-X
physiological	B-X
and	B-X
pathological	B-X
consequences	B-X
in	B-X
organisms	B-X
.	B-X

Interestingly	O
,	O
SrcA	B-Protein
lacks	O
17	O
-	O
amino	O
acids	O
that	O
make	O
up	O
the	O
carboxyl	O
terminus	O
of	O
CesT	B-Protein
,	O
which	O
includes	O
Glu142	O
,	O
and	O
yet	O
it	O
still	O
retains	O
effector	O
binding	O
,	O
ATPase	O
binding	O
and	O
effector	O
secretion	O
functionalities	O
.	O

Thus	O
,	O
it	O
is	O
likely	O
that	O
other	O
surface	O
charged	O
residues	O
of	O
SrcA	B-Protein
are	O
involved	O
in	O
these	O
functions	O
or	O
that	O
SrcA	B-Protein
targets	O
effector	O
cargo	O
to	O
the	O
secretion	O
apparatus	O
through	O
a	O
mechanism	O
distinct	O
from	O
CesT	B-Protein
.	O

The	O
interface	O
for	O
the	O
SrcA	B-Protein
homodimer	O
is	O
extensive	O
and	O
is	O
more	O
in	O
keeping	O
with	O
the	O
structural	O
features	O
of	O
single	O
-	O
effector	O
class	O
IA	O
chaperones	O
(	O
approximately1100	O
-	O
1300	O
A2	O
)	O
compared	O
to	O
the	O
reduced	O
dimer	O
interface	O
of	O
Spa15	B-Protein
,	O
a	O
multi	O
-	O
cargo	O
class	O
IB	O
chaperone	O
from	O
Shigella	O
[	O
31	O
]	O
.	O

Similar	O
to	O
CesT	B-Protein
and	O
SicP	B-Protein
,	O
the	O
dimer	O
interface	O
of	O
SrcA	B-Protein
adopts	O
a	O
parallel	O
configuration	O
when	O
comparing	O
alpha2	O
helices	O
of	O
opposing	O
subunits	O
.	O

In	O
contrast	O
,	O
the	O
subunits	O
of	O
Spa15	B-Protein
undergo	O
a	O
significant	O
relative	O
rotation	O
(	O
80degrees	O
)	O
about	O
the	O
alpha2	O
-	O
axis	O
resulting	O
in	O
a	O
different	O
interface	O
.	O

These	O
features	O
may	O
relate	O
to	O
biological	O
function	O
in	O
the	O
SPI2	O
T3SS	O
and	O
/	O
or	O
in	O
vetting	O
effector	O
cargo	O
amongst	O
the	O
>	O
30	O
effectors	O
identified	O
in	O
Salmonella	O
.	O

We	O
found	O
no	O
evidence	O
of	O
interactions	O
between	O
SrcA	B-Protein
and	O
translocon	O
components	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
so	O
it	O
appears	O
as	O
though	O
SrcA	B-Protein
functions	O
specifically	O
in	O
effector	O
translocation	O
events	O
.	O

Implications	O
for	O
type	O
III	O
secretion	O
function	O
<EOS>	B-X
We	B-X
review	B-X
firstly	B-X
the	B-X
specificities	B-X
of	B-X
the	B-X
different	B-X
types	B-X
of	B-X
dentin	B-X
present	B-X
in	B-X
mammalian	B-X
teeth	B-X
.	B-X
Secondly	B-X
,	B-X
we	B-X
evaluate	B-X
the	B-X
role	B-X
of	B-X
odontoblasts	B-X
in	B-X
dentin	B-X
formation	B-X
,	B-X
their	B-X
implication	B-X
in	B-X
the	B-X
synthesis	B-X
and	B-X
secretion	B-X
of	B-X
type	B-X
I	B-X
collagen	B-X
fibrils	B-X
and	B-X
non-collagenous	B-X
molecules	B-X
.	B-X
Thirdly	B-X
,	B-X
we	B-X
study	B-X
the	B-X
composition	B-X
and	B-X
functions	B-X
of	B-X
dentin	B-X
extracellular	B-X
matrix	B-X
(	B-X
ECM	B-X
)	B-X
molecules	B-X
implicated	B-X
in	B-X
dentinogenesis	B-X
.	B-X
Three	B-X
different	B-X
forms	B-X
of	B-X
dentinogenesis	B-X
are	B-X
identified	B-X
:	B-X
i	B-X
)	B-X
matrix	B-X
vesicles	B-X
are	B-X
implicated	B-X
in	B-X
early	B-X
dentin	B-X
formation	B-X
,	B-X
ii	B-X
)	B-X
collagen	B-X
and	B-X
some	B-X
proteoglycans	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
predentin	B-X
,	B-X
further	B-X
transformed	B-X
into	B-X
intertubular	B-X
dentin	B-X
,	B-X
iii	B-X
)	B-X
the	B-X
distal	B-X
secretion	B-X
of	B-X
some	B-X
non-collagenous	B-X
ECM	B-X
molecules	B-X
and	B-X
some	B-X
serum	B-X
proteins	B-X
contribute	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
peritubular	B-X
dentin	B-X
.	B-X

The	O
interaction	O
between	O
SrcA	B-Protein
and	O
SsaN	B-Protein
supports	O
an	O
emerging	O
paradigm	O
whereby	O
secretion	O
chaperones	O
bring	O
effector	O
cargo	O
to	O
the	O
T3SS	O
through	O
physical	O
interaction	O
with	O
the	O
hexameric	O
ATPase	O
at	O
the	O
base	O
of	O
the	O
apparatus	O
[	O
14	O
]	O
.	O

This	O
was	O
demonstrated	O
for	O
chaperone	O
-	O
ATPase	O
components	O
in	O
the	O
flagellar	O
type	O
III	O
system	O
[	O
17	O
]	O
and	O
in	O
non	O
-	O
flagellar	O
type	O
III	O
systems	O
in	O
E	O
.	O
coli	O
[	O
27	O
]	O
and	O
the	O
SPI	O
-	O
1	O
system	O
in	O
Salmonella	O
[	O
15	O
]	O
.	O

Our	O
work	O
shows	O
the	O
first	O
chaperone	O
-	O
ATPase	O
interaction	O
for	O
a	O
T3SS	O
functioning	O
from	O
within	O
an	O
intracellular	O
vacuolar	O
compartment	O
and	O
supports	O
this	O
interaction	O
as	O
a	O
more	O
generalize	O
feature	O
of	O
type	O
III	O
secretion	O
function	O
.	O

In	O
our	O
experiments	O
,	O
we	O
could	O
induce	O
the	O
ATPase	O
domain	O
of	O
SsaN	B-Protein
to	O
oligomerize	O
in	O
the	O
presence	O
of	O
SrcA	B-Protein
,	O
but	O
not	O
in	O
its	O
absence	O
,	O
which	O
was	O
intriguing	O
because	O
the	O
purified	O
enzyme	O
lacked	O
a	O
domain	O
at	O
the	O
carboxyl	O
terminus	O
thought	O
to	O
be	O
involved	O
in	O
oligomer	O
stability	O
,	O
at	O
least	O
for	O
E	O
.	O
coli	O
EscN	B-Protein
[	O
14	O
]	O
.	O

These	O
data	O
suggest	O
that	O
type	O
III	O
chaperones	O
might	O
have	O
an	O
as	O
yet	O
undefined	O
role	O
in	O
assembly	O
of	O
the	O
ATPase	O
homohexamer	O
that	O
gives	O
rise	O
to	O
efficient	O
effector	O
translocation	O
.	O

This	O
will	O
be	O
an	O
important	O
area	O
for	O
further	O
experimentation	O
in	O
this	O
and	O
other	O
systems	O
.	O

Genetic	O
and	O
functional	O
integration	O
of	O
SrcA	B-Protein
with	O
type	O
III	O
secretion	O
<EOS>	B-X
Many	B-X
Gram-negative	B-X
bacteria	B-X
colonize	B-X
and	B-X
exploit	B-X
host	B-X
niches	B-X
using	B-X
a	B-X
protein	B-X
apparatus	B-X
called	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
that	B-X
translocates	B-X
bacterial	B-X
effector	B-X
proteins	B-X
into	B-X
host	B-X
cells	B-X
where	B-X
their	B-X
functions	B-X
are	B-X
essential	B-X
for	B-X
pathogenesis	B-X
.	B-X
Using	B-X
a	B-X
reverse	B-X
genetics	B-X
approach	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
multi-cargo	B-X
secretion	B-X
chaperone	B-X
that	B-X
is	B-X
functionally	B-X
integrated	B-X
with	B-X
the	B-X
SPI-2-encoded	B-X
T3SS	B-X
and	B-X
required	B-X
for	B-X
systemic	B-X
infection	B-X
in	B-X
mice	B-X
.	B-X
Crystallographic	B-X
analysis	B-X
of	B-X
SrcA	B-X
at	B-X
a	B-X
resolution	B-X
of	B-X
2.5	B-X
A	B-X
revealed	B-X
a	B-X
dimer	B-X
similar	B-X
to	B-X
the	B-X
CesT	B-X
chaperone	B-X
from	B-X
enteropathogenic	B-X
E.	B-X
coli	B-X
but	B-X
lacking	B-X
a	B-X
17-amino	B-X
acid	B-X
extension	B-X
at	B-X
the	B-X
carboxyl	B-X
terminus	B-X
.	B-X
Further	B-X
biochemical	B-X
and	B-X
quantitative	B-X
proteomics	B-X
data	B-X
revealed	B-X
three	B-X
protein	B-X
interactions	B-X
with	B-X
SrcA	B-X
,	B-X
including	B-X
two	B-X
effector	B-X
cargos	B-X
(	B-X
SseL	B-X
and	B-X
PipB2	B-X
)	B-X
and	B-X
the	B-X
type	B-X
III-associated	B-X
ATPase	B-X
,	B-X
SsaN	B-X
,	B-X
that	B-X
increases	B-X
the	B-X
efficiency	B-X
of	B-X
effector	B-X
translocation	B-X
.	B-X
Using	B-X
competitive	B-X
infections	B-X
in	B-X
mice	B-X
we	B-X
show	B-X
that	B-X
SrcA	B-X
increases	B-X
bacterial	B-X
fitness	B-X
during	B-X
host	B-X
infection	B-X
,	B-X
highlighting	B-X
the	B-X
in	B-X
vivo	B-X
importance	B-X
of	B-X
effector	B-X
chaperones	B-X
for	B-X
the	B-X
SPI-2	B-X
T3SS	B-X
.	B-X

The	O
genes	O
encoding	O
the	O
srcA	B-Protein
chaperone	O
and	O
the	O
effector	O
cargos	O
(	O
pipB2	B-Protein
and	O
sseL	B-Protein
)	O
are	O
found	O
in	O
all	O
serotypes	O
of	O
Salmonella	O
enterica	O
that	O
contain	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

Conversely	O
,	O
these	O
genes	O
are	O
absent	O
from	O
S	O
.	O
bongori	O
,	O
which	O
lacks	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

The	O
expression	O
of	O
srcA	B-Protein
is	O
coordinated	O
with	O
T3SS	O
transcriptional	O
activity	O
via	O
the	O
SsrA	B-Protein
-	O
SsrB	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
encoded	O
in	O
SPI	O
-	O
2	O
.	O

The	O
direct	O
binding	O
of	O
SsrB	B-Protein
to	O
the	O
promoter	O
region	O
upstream	O
of	O
srcA	B-Protein
,	O
along	O
with	O
SsrB	B-Protein
-	O
regulation	O
of	O
both	O
sseL	B-Protein
[	O
19	O
]	O
,	O
[	O
20	O
]	O
and	O
pipB2	B-Protein
[	O
32	O
]	O
is	O
indicative	O
of	O
multiple	O
cis	O
-	O
regulatory	O
mutation	O
events	O
that	O
have	O
allowed	O
for	O
functional	O
coordination	O
of	O
the	O
distributed	O
secretion	O
apparatus	O
,	O
chaperone	O
and	O
effector	O
cargos	O
.	O

We	O
recently	O
described	O
this	O
type	O
of	O
regulatory	O
evolution	O
for	O
pathogenic	O
adaptation	O
of	O
Salmonella	O
to	O
its	O
host	O
[	O
21	O
]	O
and	O
srcA	B-Protein
is	O
consistent	O
with	O
regulatory	O
evolution	O
of	O
chaperone	O
-	O
effector	O
gene	O
pairs	O
that	O
are	O
not	O
co	O
-	O
transcribed	O
in	O
operons	O
.	O

Due	O
to	O
low	O
G	O
+	O
C	O
base	O
content	O
compared	O
to	O
the	O
genome	O
average	O
of	O
52	O
%	O
,	O
it	O
'	O
s	O
likely	O
that	O
srcA	B-Protein
(	O
32	O
%	O
G	O
+	O
C	O
)	O
and	O
an	O
adjacent	O
gene	O
,	O
STM2137	B-Protein
(	O
37	O
%	O
G	O
+	O
C	O
)	O
,	O
were	O
acquired	O
as	O
a	O
foreign	O
islet	O
that	O
was	O
retained	O
in	O
organisms	O
containing	O
the	O
SPI	O
-	O
2	O
T3SS	O
due	O
to	O
the	O
selective	O
advantage	O
afforded	O
by	O
the	O
new	O
protein	O
interactions	O
so	O
created	O
.	O

Interestingly	O
,	O
STM2137	B-Protein
(	O
also	O
known	O
as	O
SseK2	B-Protein
)	O
is	O
a	O
likely	O
paralog	O
of	O
SseK1	B-Protein
,	O
an	O
effector	O
translocated	O
by	O
the	O
SPI	O
-	O
2	O
T3SS	O
[	O
33	O
]	O
.	O

SseK2	B-Protein
is	O
also	O
regulated	O
by	O
the	O
SsrA	B-Protein
-	O
SsrB	B-Protein
two	O
-	O
component	O
system	O
but	O
compared	O
to	O
SseK1	B-Protein
,	O
it	O
is	O
translocated	O
in	O
much	O
less	O
abundance	O
into	O
host	O
cells	O
[	O
33	O
]	O
.	O

Using	O
the	O
methods	O
described	O
here	O
,	O
we	O
were	O
not	O
able	O
to	O
detect	O
SseK2	B-Protein
secretion	O
or	O
a	O
physical	O
interaction	O
with	O
SrcA	B-Protein
,	O
however	O
it	O
remains	O
possible	O
that	O
SrcA	B-Protein
also	O
chaperones	O
SseK2	B-Protein
for	O
low	O
-	O
level	O
translocation	O
.	O
<EOS>	B-X
Knowledge	B-X
of	B-X
sampling	B-X
methods	B-X
is	B-X
essential	B-X
to	B-X
design	B-X
quality	B-X
research	B-X
.	B-X
This	B-X
article	B-X
reviews	B-X
probability	B-X
and	B-X
non-probability	B-X
sampling	B-X
methods	B-X
,	B-X
lists	B-X
and	B-X
defines	B-X
specific	B-X
sampling	B-X
techniques	B-X
,	B-X
and	B-X
provides	B-X
pros	B-X
and	B-X
cons	B-X
for	B-X
consideration	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
issues	B-X
related	B-X
to	B-X
sampling	B-X
methods	B-X
are	B-X
described	B-X
to	B-X
highlight	B-X
potential	B-X
problems	B-X
.	B-X
There	B-X
are	B-X
often	B-X
multiple	B-X
potential	B-X
interventions	B-X
to	B-X
treat	B-X
a	B-X
disease	B-X
;	B-X
therefore	B-X
,	B-X
we	B-X
need	B-X
a	B-X
method	B-X
for	B-X
simultaneously	B-X
comparing	B-X
and	B-X
ranking	B-X
all	B-X
of	B-X
these	B-X
available	B-X
interventions	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
pairwise	B-X
meta-analysis	B-X
,	B-X
which	B-X
allows	B-X
for	B-X
the	B-X
comparison	B-X
of	B-X
one	B-X
intervention	B-X
to	B-X
another	B-X
based	B-X
on	B-X
head-to-head	B-X
data	B-X
from	B-X
randomized	B-X
trials	B-X
,	B-X
network	B-X
meta-analysis	B-X
(	B-X
NMA	B-X
)	B-X
facilitates	B-X
simultaneous	B-X
comparison	B-X
of	B-X
the	B-X
efficacy	B-X
or	B-X
safety	B-X
of	B-X
multiple	B-X
interventions	B-X
that	B-X
may	B-X
not	B-X
have	B-X
been	B-X
directly	B-X
compared	B-X
in	B-X
a	B-X
randomized	B-X
trial	B-X
.	B-X
NMAs	B-X
help	B-X
researchers	B-X
study	B-X
important	B-X
and	B-X
previously	B-X
unanswerable	B-X
questions	B-X
,	B-X
which	B-X
have	B-X
contributed	B-X
to	B-X
a	B-X
rapid	B-X
rise	B-X
in	B-X
the	B-X
number	B-X
of	B-X
NMA	B-X
publications	B-X
in	B-X
the	B-X
biomedical	B-X
literature	B-X
.	B-X

SrcA	B-Protein
is	O
unique	O
among	O
other	O
multi	O
-	O
effector	O
chaperones	O
most	O
closely	O
related	O
to	O
it	O
in	O
that	O
it	O
is	O
unlinked	O
from	O
the	O
T3SS	O
genomic	O
island	O
.	O

For	O
example	O
,	O
InvB	B-Protein
and	O
SicP	B-Protein
(	O
Salmonella	O
SPI	O
-	O
1	O
)	O
,	O
CesT	B-Protein
(	O
enteropathogenic	O
E	O
.	O
coli	O
locus	O
of	O
enterocyte	O
effacement	O
)	O
and	O
Spa15	O
(	O
Shigella	O
mxi	O
/	O
spa	O
virulence	O
plasmid	O
region	O
)	O
chaperones	O
are	O
all	O
encoded	O
within	O
the	O
T3SS	O
structural	O
operons	O
,	O
implying	O
they	O
have	O
co	O
-	O
evolved	O
as	O
a	O
single	O
genetic	O
entity	O
from	O
a	O
common	O
ancestor	O
.	O

Given	O
its	O
genetic	O
neighborhood	O
,	O
srcA	B-Protein
appears	O
to	O
be	O
a	O
genetic	O
acquisition	O
separate	O
from	O
SPI	O
-	O
2	O
that	O
functionally	O
links	O
some	O
effectors	O
to	O
the	O
T3SS	O
apparatus	O
via	O
the	O
ATPase	O
.	O

The	O
role	O
of	O
horizontal	O
gene	O
transfer	O
and	O
regulatory	O
evolution	O
in	O
allowing	O
for	O
uncoupling	O
of	O
chaperones	O
,	O
effectors	O
and	O
the	O
T3SS	O
has	O
many	O
possible	O
implications	O
for	O
T3SS	O
function	O
,	O
including	O
plasticity	O
in	O
chaperone	O
-	O
effector	O
interaction	O
networks	O
,	O
expansion	O
of	O
effector	O
repertoires	O
,	O
and	O
alterations	O
to	O
the	O
kinetics	O
and	O
hierarchical	O
delivery	O
of	O
effectors	O
to	O
a	O
host	O
cell	O
.	O

These	O
events	O
may	O
improve	O
host	O
adaptability	O
or	O
even	O
expand	O
the	O
host	O
range	O
of	O
bacteria	O
that	O
acquire	O
and	O
integrate	O
new	O
functional	O
secretion	O
chaperones	O
.	O
<EOS>	B-X
Nonetheless	B-X
,	B-X
influenza	B-X
virus	B-X
infection	B-X
may	B-X
result	B-X
in	B-X
pneumonia	B-X
and	B-X
acute	B-X
respiratory	B-X
failure	B-X
,	B-X
frequently	B-X
complicated	B-X
by	B-X
bacterial	B-X
coinfection	B-X
.	B-X
Pandemics	B-X
are	B-X
,	B-X
in	B-X
contrary	B-X
,	B-X
unexpected	B-X
rare	B-X
events	B-X
related	B-X
to	B-X
the	B-X
emergence	B-X
of	B-X
a	B-X
reassorted	B-X
human-pathogenic	B-X
influenza	B-X
A	B-X
virus	B-X
(	B-X
IAV	B-X
)	B-X
strains	B-X
that	B-X
often	B-X
causes	B-X
increased	B-X
morbidity	B-X
and	B-X
spreads	B-X
extremely	B-X
rapidly	B-X
in	B-X
the	B-X
immunologically	B-X
naive	B-X
human	B-X
population	B-X
,	B-X
with	B-X
huge	B-X
clinical	B-X
and	B-X
economic	B-X
impact	B-X
.	B-X
Accordingly	B-X
,	B-X
particular	B-X
efforts	B-X
are	B-X
made	B-X
to	B-X
advance	B-X
our	B-X
knowledge	B-X
on	B-X
the	B-X
disease	B-X
biology	B-X
and	B-X
pathology	B-X
and	B-X
recent	B-X
studies	B-X
have	B-X
brought	B-X
new	B-X
insights	B-X
into	B-X
IAV	B-X
adaptation	B-X
mechanisms	B-X
to	B-X
the	B-X
human	B-X
host	B-X
,	B-X
as	B-X
well	B-X
as	B-X
into	B-X
the	B-X
key	B-X
players	B-X
in	B-X
disease	B-X
pathogenesis	B-X
on	B-X
the	B-X
host	B-X
side	B-X
.	B-X
Current	B-X
antiviral	B-X
strategies	B-X
are	B-X
only	B-X
efficient	B-X
at	B-X
the	B-X
early	B-X
stages	B-X
of	B-X
the	B-X
disease	B-X
and	B-X
are	B-X
challenged	B-X
by	B-X
the	B-X
genomic	B-X
instability	B-X
of	B-X
the	B-X
virus	B-X
,	B-X
highlighting	B-X
the	B-X
need	B-X
for	B-X
novel	B-X
antiviral	B-X
therapies	B-X
targeting	B-X
the	B-X
pulmonary	B-X
host	B-X
response	B-X
to	B-X
improve	B-X
viral	B-X
clearance	B-X
,	B-X
reduce	B-X
the	B-X
risk	B-X
of	B-X
bacterial	B-X
coinfection	B-X
,	B-X
and	B-X
prevent	B-X
or	B-X
attenuate	B-X
acute	B-X
lung	B-X
injury	B-X
.	B-X
This	B-X
review	B-X
article	B-X
summarizes	B-X
our	B-X
current	B-X
knowledge	B-X
on	B-X
the	B-X
molecular	B-X
basis	B-X
of	B-X
influenza	B-X
infection	B-X
and	B-X
disease	B-X
progression	B-X
,	B-X
the	B-X
key	B-X
players	B-X
in	B-X
pathogenesis	B-X
driving	B-X
severe	B-X
disease	B-X
and	B-X
progression	B-X
to	B-X
lung	B-X
failure	B-X
,	B-X
as	B-X
well	B-X
as	B-X
available	B-X
and	B-X
envisioned	B-X
prevention	B-X
and	B-X
treatment	B-X
strategies	B-X
against	B-X
influenza	B-X
virus	B-X
infection	B-X
.	B-X

Transit	O
through	O
the	O
Flea	O
Vector	O
Induces	O
a	O
Pretransmission	O
Innate	O
Immunity	O
Resistance	O
Phenotype	O
in	O
Yersinia	O
pestis	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
is	B-X
transmitted	B-X
to	B-X
mammals	B-X
by	B-X
infected	B-X
fleas	B-X
.	B-X
Y.	B-X
pestis	B-X
exhibits	B-X
a	B-X
distinct	B-X
life	B-X
stage	B-X
in	B-X
the	B-X
flea	B-X
,	B-X
where	B-X
it	B-X
grows	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
cohesive	B-X
biofilm	B-X
that	B-X
promotes	B-X
transmission	B-X
.	B-X
After	B-X
transmission	B-X
,	B-X
the	B-X
temperature	B-X
shift	B-X
to	B-X
37	B-X
degrees	B-X
C	B-X
induces	B-X
many	B-X
known	B-X
virulence	B-X
factors	B-X
of	B-X
Y.	B-X
pestis	B-X
that	B-X
confer	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
.	B-X
These	B-X
factors	B-X
are	B-X
not	B-X
produced	B-X
in	B-X
the	B-X
low-temperature	B-X
environment	B-X
of	B-X
the	B-X
flea	B-X
,	B-X
however	B-X
,	B-X
suggesting	B-X
that	B-X
Y.	B-X
pestis	B-X
is	B-X
vulnerable	B-X
to	B-X
the	B-X
initial	B-X
encounter	B-X
with	B-X
innate	B-X
immune	B-X
cells	B-X
at	B-X
the	B-X
flea	B-X
bite	B-X
site	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
whole-genome	B-X
microarrays	B-X
to	B-X
compare	B-X
the	B-X
Y.	B-X
pestis	B-X
in	B-X
vivo	B-X
transcriptome	B-X
in	B-X
infective	B-X
fleas	B-X
to	B-X
in	B-X
vitro	B-X
transcriptomes	B-X
in	B-X
temperature-matched	B-X
biofilm	B-X
and	B-X
planktonic	B-X
cultures	B-X
,	B-X
and	B-X
to	B-X
the	B-X
previously	B-X
characterized	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
profile	B-X
in	B-X
the	B-X
rat	B-X
bubo	B-X
.	B-X
Y.	B-X
pestis	B-X
from	B-X
infected	B-X
fleas	B-X
were	B-X
more	B-X
resistant	B-X
to	B-X
phagocytosis	B-X
by	B-X
macrophages	B-X
than	B-X
in	B-X
vitro-grown	B-X
bacteria	B-X
,	B-X
in	B-X
part	B-X
attributable	B-X
to	B-X
a	B-X
cluster	B-X
of	B-X
insecticidal-like	B-X
toxin	B-X
genes	B-X
that	B-X
were	B-X
highly	B-X
expressed	B-X
only	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
transit	B-X
through	B-X
the	B-X
flea	B-X
vector	B-X
induces	B-X
a	B-X
phenotype	B-X
that	B-X
enhances	B-X
survival	B-X
and	B-X
dissemination	B-X
of	B-X
Y.	B-X
pestis	B-X
after	B-X
transmission	B-X
to	B-X
the	B-X
mammalian	B-X
host	B-X
.	B-X

Yersinia	O
pestis	O
,	O
the	O
agent	O
of	O
plague	O
,	O
is	O
transmitted	O
to	O
mammals	O
by	O
infected	O
fleas	O
.	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
causative	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
must	B-X
survive	B-X
in	B-X
blood	B-X
in	B-X
order	B-X
to	B-X
cause	B-X
disease	B-X
and	B-X
to	B-X
be	B-X
transmitted	B-X
from	B-X
host	B-X
to	B-X
host	B-X
by	B-X
fleas	B-X
.	B-X
The	B-X
Y.	B-X
pestis	B-X
KIM	B-X
genome	B-X
is	B-X
predicted	B-X
to	B-X
encode	B-X
four	B-X
Ail/Lom	B-X
family	B-X
proteins	B-X
.	B-X
Y.	B-X
pestis	B-X
mutants	B-X
specifically	B-X
deficient	B-X
in	B-X
expression	B-X
of	B-X
each	B-X
of	B-X
these	B-X
proteins	B-X
were	B-X
constructed	B-X
using	B-X
lambda	B-X
Red-mediated	B-X
recombination	B-X
.	B-X
The	B-X
Ail	B-X
outer	B-X
membrane	B-X
protein	B-X
was	B-X
essential	B-X
for	B-X
Y.	B-X
pestis	B-X
to	B-X
resist	B-X
complement-mediated	B-X
killing	B-X
at	B-X
26	B-X
and	B-X
37	B-X
degrees	B-X
C.	B-X
Ail	B-X
was	B-X
expressed	B-X
at	B-X
high	B-X
levels	B-X
at	B-X
both	B-X
26	B-X
and	B-X
37	B-X
degrees	B-X
C	B-X
,	B-X
but	B-X
not	B-X
at	B-X
6	B-X
degrees	B-X
C.	B-X
Expression	B-X
of	B-X
Ail	B-X
in	B-X
Escherichia	B-X
coli	B-X
provided	B-X
protection	B-X
from	B-X
the	B-X
bactericidal	B-X
activity	B-X
of	B-X
complement	B-X
.	B-X
High-level	B-X
expression	B-X
of	B-X
the	B-X
three	B-X
other	B-X
Y.	B-X
pestis	B-X
Ail/Lom	B-X
family	B-X
proteins	B-X
(	B-X
the	B-X
y1682	B-X
,	B-X
y2034	B-X
,	B-X
and	B-X
y2446	B-X
proteins	B-X
)	B-X
provided	B-X
no	B-X
protection	B-X
against	B-X
complement-mediated	B-X
bacterial	B-X
killing	B-X
.	B-X
A	B-X
Y.	B-X
pestis	B-X
ail	B-X
deletion	B-X
mutant	B-X
was	B-X
rapidly	B-X
killed	B-X
by	B-X
sera	B-X
obtained	B-X
from	B-X
all	B-X
mammals	B-X
tested	B-X
except	B-X
mouse	B-X
serum	B-X
.	B-X
The	B-X
role	B-X
of	B-X
Ail	B-X
in	B-X
infection	B-X
of	B-X
mice	B-X
,	B-X
Caenorhabditis	B-X
elegans	B-X
,	B-X
and	B-X
fleas	B-X
was	B-X
investigated	B-X
.	B-X

Y	O
.	O
pestis	O
exhibits	O
a	O
distinct	O
life	O
stage	O
in	O
the	O
flea	O
,	O
where	O
it	O
grows	O
in	O
the	O
form	O
of	O
a	O
cohesive	O
biofilm	O
that	O
promotes	O
transmission	O
.	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
is	B-X
transmitted	B-X
to	B-X
mammals	B-X
by	B-X
infected	B-X
fleas	B-X
.	B-X
Y.	B-X
pestis	B-X
exhibits	B-X
a	B-X
distinct	B-X
life	B-X
stage	B-X
in	B-X
the	B-X
flea	B-X
,	B-X
where	B-X
it	B-X
grows	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
cohesive	B-X
biofilm	B-X
that	B-X
promotes	B-X
transmission	B-X
.	B-X
After	B-X
transmission	B-X
,	B-X
the	B-X
temperature	B-X
shift	B-X
to	B-X
37	B-X
degrees	B-X
C	B-X
induces	B-X
many	B-X
known	B-X
virulence	B-X
factors	B-X
of	B-X
Y.	B-X
pestis	B-X
that	B-X
confer	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
.	B-X
These	B-X
factors	B-X
are	B-X
not	B-X
produced	B-X
in	B-X
the	B-X
low-temperature	B-X
environment	B-X
of	B-X
the	B-X
flea	B-X
,	B-X
however	B-X
,	B-X
suggesting	B-X
that	B-X
Y.	B-X
pestis	B-X
is	B-X
vulnerable	B-X
to	B-X
the	B-X
initial	B-X
encounter	B-X
with	B-X
innate	B-X
immune	B-X
cells	B-X
at	B-X
the	B-X
flea	B-X
bite	B-X
site	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
whole-genome	B-X
microarrays	B-X
to	B-X
compare	B-X
the	B-X
Y.	B-X
pestis	B-X
in	B-X
vivo	B-X
transcriptome	B-X
in	B-X
infective	B-X
fleas	B-X
to	B-X
in	B-X
vitro	B-X
transcriptomes	B-X
in	B-X
temperature-matched	B-X
biofilm	B-X
and	B-X
planktonic	B-X
cultures	B-X
,	B-X
and	B-X
to	B-X
the	B-X
previously	B-X
characterized	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
profile	B-X
in	B-X
the	B-X
rat	B-X
bubo	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
genes	B-X
involved	B-X
in	B-X
metabolic	B-X
adaptation	B-X
to	B-X
the	B-X
flea	B-X
gut	B-X
and	B-X
biofilm	B-X
formation	B-X
,	B-X
several	B-X
genes	B-X
with	B-X
known	B-X
or	B-X
predicted	B-X
roles	B-X
in	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
and	B-X
pathogenicity	B-X
in	B-X
the	B-X
mammal	B-X
were	B-X
upregulated	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Y.	B-X
pestis	B-X
from	B-X
infected	B-X
fleas	B-X
were	B-X
more	B-X
resistant	B-X
to	B-X
phagocytosis	B-X
by	B-X
macrophages	B-X
than	B-X
in	B-X
vitro-grown	B-X
bacteria	B-X
,	B-X
in	B-X
part	B-X
attributable	B-X
to	B-X
a	B-X
cluster	B-X
of	B-X
insecticidal-like	B-X
toxin	B-X
genes	B-X
that	B-X
were	B-X
highly	B-X
expressed	B-X
only	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
transit	B-X
through	B-X
the	B-X
flea	B-X
vector	B-X
induces	B-X
a	B-X
phenotype	B-X
that	B-X
enhances	B-X
survival	B-X
and	B-X
dissemination	B-X
of	B-X
Y.	B-X
pestis	B-X
after	B-X
transmission	B-X
to	B-X
the	B-X
mammalian	B-X
host	B-X
.	B-X

After	O
transmission	O
,	O
the	O
temperature	O
shift	O
to	O
37degreesC	O
induces	O
many	O
known	O
virulence	O
factors	O
of	O
Y	O
.	O
pestis	O
that	O
confer	O
resistance	O
to	O
innate	O
immunity	O
.	O

These	O
factors	O
are	O
not	O
produced	O
in	O
the	O
low	O
-	O
temperature	O
environment	O
of	O
the	O
flea	O
,	O
however	O
,	O
suggesting	O
that	O
Y	O
.	O
pestis	O
is	O
vulnerable	O
to	O
the	O
initial	O
encounter	O
with	O
innate	O
immune	O
cells	O
at	O
the	O
flea	O
bite	O
site	O
.	O
<EOS>	B-X
Neural	B-X
differentiation	B-X
of	B-X
the	B-X
ectoderm	B-X
is	B-X
inhibited	B-X
by	B-X
bone	B-X
morphogenetic	B-X
protein	B-X
4	B-X
(	B-X
BMP-4	B-X
)	B-X
in	B-X
amphibia	B-X
as	B-X
well	B-X
as	B-X
mammalia	B-X
.	B-X
In	B-X
homogenates	B-X
from	B-X
Xenopus	B-X
oocytes	B-X
and	B-X
embryos	B-X
neural	B-X
inducing	B-X
factors	B-X
were	B-X
found	B-X
in	B-X
the	B-X
supernatant	B-X
(	B-X
centrifuged	B-X
at	B-X
105000	B-X
g	B-X
)	B-X
,	B-X
in	B-X
small	B-X
vesicles	B-X
and	B-X
a	B-X
ribonucleoprotein	B-X
fraction	B-X
.	B-X
The	B-X
differentiation	B-X
of	B-X
cells	B-X
with	B-X
a	B-X
neuronal	B-X
fate	B-X
starts	B-X
in	B-X
the	B-X
neural	B-X
plate	B-X
immediately	B-X
after	B-X
neural	B-X
induction	B-X
.	B-X
It	B-X
has	B-X
long	B-X
been	B-X
thought	B-X
to	B-X
be	B-X
caused	B-X
by	B-X
a	B-X
circulating	B-X
factor	B-X
(	B-X
s	B-X
)	B-X
that	B-X
may	B-X
be	B-X
produced	B-X
by	B-X
cells	B-X
of	B-X
the	B-X
immune	B-X
system	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
used	O
whole	O
-	O
genome	O
microarrays	O
to	O
compare	O
the	O
Y	O
.	O
pestis	O
in	O
vivo	O
transcriptome	O
in	O
infective	O
fleas	O
to	O
in	O
vitro	O
transcriptomes	O
in	O
temperature	O
-	O
matched	O
biofilm	O
and	O
planktonic	O
cultures	O
,	O
and	O
to	O
the	O
previously	O
characterized	O
in	O
vivo	O
gene	O
expression	O
profile	O
in	O
the	O
rat	O
bubo	O
.	O

In	O
addition	O
to	O
genes	O
involved	O
in	O
metabolic	O
adaptation	O
to	O
the	O
flea	O
gut	O
and	O
biofilm	O
formation	O
,	O
several	O
genes	O
with	O
known	O
or	O
predicted	O
roles	O
in	O
resistance	O
to	O
innate	O
immunity	O
and	O
pathogenicity	O
in	O
the	O
mammal	O
were	O
upregulated	O
in	O
the	O
flea	O
.	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
is	B-X
transmitted	B-X
to	B-X
mammals	B-X
by	B-X
infected	B-X
fleas	B-X
.	B-X
Y.	B-X
pestis	B-X
exhibits	B-X
a	B-X
distinct	B-X
life	B-X
stage	B-X
in	B-X
the	B-X
flea	B-X
,	B-X
where	B-X
it	B-X
grows	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
cohesive	B-X
biofilm	B-X
that	B-X
promotes	B-X
transmission	B-X
.	B-X
After	B-X
transmission	B-X
,	B-X
the	B-X
temperature	B-X
shift	B-X
to	B-X
37	B-X
degrees	B-X
C	B-X
induces	B-X
many	B-X
known	B-X
virulence	B-X
factors	B-X
of	B-X
Y.	B-X
pestis	B-X
that	B-X
confer	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
.	B-X
These	B-X
factors	B-X
are	B-X
not	B-X
produced	B-X
in	B-X
the	B-X
low-temperature	B-X
environment	B-X
of	B-X
the	B-X
flea	B-X
,	B-X
however	B-X
,	B-X
suggesting	B-X
that	B-X
Y.	B-X
pestis	B-X
is	B-X
vulnerable	B-X
to	B-X
the	B-X
initial	B-X
encounter	B-X
with	B-X
innate	B-X
immune	B-X
cells	B-X
at	B-X
the	B-X
flea	B-X
bite	B-X
site	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
whole-genome	B-X
microarrays	B-X
to	B-X
compare	B-X
the	B-X
Y.	B-X
pestis	B-X
in	B-X
vivo	B-X
transcriptome	B-X
in	B-X
infective	B-X
fleas	B-X
to	B-X
in	B-X
vitro	B-X
transcriptomes	B-X
in	B-X
temperature-matched	B-X
biofilm	B-X
and	B-X
planktonic	B-X
cultures	B-X
,	B-X
and	B-X
to	B-X
the	B-X
previously	B-X
characterized	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
profile	B-X
in	B-X
the	B-X
rat	B-X
bubo	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
genes	B-X
involved	B-X
in	B-X
metabolic	B-X
adaptation	B-X
to	B-X
the	B-X
flea	B-X
gut	B-X
and	B-X
biofilm	B-X
formation	B-X
,	B-X
several	B-X
genes	B-X
with	B-X
known	B-X
or	B-X
predicted	B-X
roles	B-X
in	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
and	B-X
pathogenicity	B-X
in	B-X
the	B-X
mammal	B-X
were	B-X
upregulated	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Y.	B-X
pestis	B-X
from	B-X
infected	B-X
fleas	B-X
were	B-X
more	B-X
resistant	B-X
to	B-X
phagocytosis	B-X
by	B-X
macrophages	B-X
than	B-X
in	B-X
vitro-grown	B-X
bacteria	B-X
,	B-X
in	B-X
part	B-X
attributable	B-X
to	B-X
a	B-X
cluster	B-X
of	B-X
insecticidal-like	B-X
toxin	B-X
genes	B-X
that	B-X
were	B-X
highly	B-X
expressed	B-X
only	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
transit	B-X
through	B-X
the	B-X
flea	B-X
vector	B-X
induces	B-X
a	B-X
phenotype	B-X
that	B-X
enhances	B-X
survival	B-X
and	B-X
dissemination	B-X
of	B-X
Y.	B-X
pestis	B-X
after	B-X
transmission	B-X
to	B-X
the	B-X
mammalian	B-X
host	B-X
.	B-X

Y	O
.	O
pestis	O
from	O
infected	O
fleas	O
were	O
more	O
resistant	O
to	O
phagocytosis	O
by	O
macrophages	O
than	O
in	O
vitro	O
-	O
grown	O
bacteria	O
,	O
in	O
part	O
attributable	O
to	O
a	O
cluster	O
of	O
insecticidal	O
-	O
like	O
toxin	O
genes	O
that	O
were	O
highly	O
expressed	O
only	O
in	O
the	O
flea	O
.	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
is	B-X
transmitted	B-X
to	B-X
mammals	B-X
by	B-X
infected	B-X
fleas	B-X
.	B-X
Y.	B-X
pestis	B-X
exhibits	B-X
a	B-X
distinct	B-X
life	B-X
stage	B-X
in	B-X
the	B-X
flea	B-X
,	B-X
where	B-X
it	B-X
grows	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
cohesive	B-X
biofilm	B-X
that	B-X
promotes	B-X
transmission	B-X
.	B-X
After	B-X
transmission	B-X
,	B-X
the	B-X
temperature	B-X
shift	B-X
to	B-X
37	B-X
degrees	B-X
C	B-X
induces	B-X
many	B-X
known	B-X
virulence	B-X
factors	B-X
of	B-X
Y.	B-X
pestis	B-X
that	B-X
confer	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
.	B-X
These	B-X
factors	B-X
are	B-X
not	B-X
produced	B-X
in	B-X
the	B-X
low-temperature	B-X
environment	B-X
of	B-X
the	B-X
flea	B-X
,	B-X
however	B-X
,	B-X
suggesting	B-X
that	B-X
Y.	B-X
pestis	B-X
is	B-X
vulnerable	B-X
to	B-X
the	B-X
initial	B-X
encounter	B-X
with	B-X
innate	B-X
immune	B-X
cells	B-X
at	B-X
the	B-X
flea	B-X
bite	B-X
site	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
whole-genome	B-X
microarrays	B-X
to	B-X
compare	B-X
the	B-X
Y.	B-X
pestis	B-X
in	B-X
vivo	B-X
transcriptome	B-X
in	B-X
infective	B-X
fleas	B-X
to	B-X
in	B-X
vitro	B-X
transcriptomes	B-X
in	B-X
temperature-matched	B-X
biofilm	B-X
and	B-X
planktonic	B-X
cultures	B-X
,	B-X
and	B-X
to	B-X
the	B-X
previously	B-X
characterized	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
profile	B-X
in	B-X
the	B-X
rat	B-X
bubo	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
genes	B-X
involved	B-X
in	B-X
metabolic	B-X
adaptation	B-X
to	B-X
the	B-X
flea	B-X
gut	B-X
and	B-X
biofilm	B-X
formation	B-X
,	B-X
several	B-X
genes	B-X
with	B-X
known	B-X
or	B-X
predicted	B-X
roles	B-X
in	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
and	B-X
pathogenicity	B-X
in	B-X
the	B-X
mammal	B-X
were	B-X
upregulated	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Y.	B-X
pestis	B-X
from	B-X
infected	B-X
fleas	B-X
were	B-X
more	B-X
resistant	B-X
to	B-X
phagocytosis	B-X
by	B-X
macrophages	B-X
than	B-X
in	B-X
vitro-grown	B-X
bacteria	B-X
,	B-X
in	B-X
part	B-X
attributable	B-X
to	B-X
a	B-X
cluster	B-X
of	B-X
insecticidal-like	B-X
toxin	B-X
genes	B-X
that	B-X
were	B-X
highly	B-X
expressed	B-X
only	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
transit	B-X
through	B-X
the	B-X
flea	B-X
vector	B-X
induces	B-X
a	B-X
phenotype	B-X
that	B-X
enhances	B-X
survival	B-X
and	B-X
dissemination	B-X
of	B-X
Y.	B-X
pestis	B-X
after	B-X
transmission	B-X
to	B-X
the	B-X
mammalian	B-X
host	B-X
.	B-X

Our	O
results	O
suggest	O
that	O
transit	O
through	O
the	O
flea	O
vector	O
induces	O
a	O
phenotype	O
that	O
enhances	O
survival	O
and	O
dissemination	O
of	O
Y	O
.	O
pestis	O
after	O
transmission	O
to	O
the	O
mammalian	O
host	O
.	O

Introduction	O

Arthropod	O
-	O
borne	O
transmission	O
of	O
bacterial	O
pathogens	O
is	O
somewhat	O
rare	O
but	O
has	O
evolved	O
in	O
a	O
phylogenetically	O
diverse	O
group	O
that	O
includes	O
the	O
rickettsiae	O
,	O
Borrelia	O
spirochetes	O
,	O
and	O
the	O
gram	O
-	O
negative	O
bacteria	O
Francisella	O
tularensis	O
and	O
Yersinia	O
pestis	O
,	O
the	O
plague	O
bacillus	O
.	O

Y	O
.	O
pestis	O
circulates	O
among	O
many	O
species	O
of	O
wild	O
rodents	O
,	O
its	O
primary	O
reservoir	O
hosts	O
,	O
via	O
flea	O
bite	O
.	O

As	O
it	O
alternates	O
between	O
fleas	O
and	O
mammals	O
,	O
it	O
is	O
postulated	O
that	O
Y	O
.	O
pestis	O
regulates	O
gene	O
expression	O
appropriately	O
to	O
adapt	O
to	O
the	O
two	O
disparate	O
host	O
environments	O
,	O
and	O
that	O
different	O
sets	O
of	O
genes	O
are	O
required	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
the	O
flea	O
and	O
disease	O
in	O
the	O
mammal	O
.	O

Many	O
important	O
Y	O
.	O
pestis	O
virulence	O
factors	O
that	O
are	O
required	O
for	O
plague	O
in	O
mammals	O
have	O
been	O
identified	O
,	O
and	O
most	O
of	O
them	O
are	O
induced	O
by	O
a	O
temperature	O
shift	O
from	O
<	O
26degreesC	O
to	O
37degreesC	O
,	O
which	O
mimics	O
the	O
transition	O
from	O
a	O
flea	O
to	O
the	O
warm	O
-	O
blooded	O
host	O
[	O
1	O
]	O
.	O

To	O
date	O
,	O
only	O
three	O
transmission	O
factors	O
(	O
genes	O
specifically	O
required	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
the	O
flea	O
)	O
have	O
been	O
characterized	O
.	O

One	O
,	O
the	O
yersinia	B-Protein
murine	I-Protein
toxin	I-Protein
(	O
ymt	B-Protein
)	O
gene	O
,	O
encodes	O
a	O
phospholipase	B-Protein
D	I-Protein
that	O
is	O
required	O
for	O
survival	O
in	O
the	O
flea	O
midgut	O
[	O
2	O
]	O
.	O

The	O
other	O
two	O
,	O
(	O
hmsHFRS	O
and	O
gmhA	B-Protein
)	O
,	O
are	O
responsible	O
for	O
an	O
extracellular	O
polysaccharide	O
and	O
a	O
lipopolysaccharide	O
(	O
LPS	O
)	O
core	O
modification	O
that	O
are	O
required	O
for	O
normal	O
biofilm	O
formation	O
and	O
blockage	O
in	O
the	O
flea	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

Biofilm	O
development	O
in	O
the	O
flea	O
digestive	O
tract	O
is	O
important	O
for	O
biological	O
transmission	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

After	O
being	O
taken	O
up	O
in	O
a	O
blood	O
meal	O
,	O
Y	O
.	O
pestis	O
proliferates	O
in	O
the	O
lumen	O
of	O
the	O
flea	O
midgut	O
to	O
form	O
cohesive	O
multicellular	O
biofilm	O
aggregates	O
.	O

In	O
some	O
infected	O
fleas	O
,	O
the	O
proventricular	O
valve	O
between	O
the	O
midgut	O
and	O
esophagus	O
is	O
colonized	O
.	O

The	O
subsequent	O
growth	O
and	O
consolidation	O
of	O
the	O
adherent	O
Y	O
.	O
pestis	O
biofilm	O
amongst	O
the	O
rows	O
of	O
cuticle	O
-	O
covered	O
spines	O
that	O
line	O
the	O
proventriculus	O
interferes	O
with	O
normal	O
blood	O
feeding	O
,	O
resulting	O
in	O
regurgitation	O
of	O
bacteria	O
and	O
transmission	O
.	O

Fleas	O
with	O
a	O
completely	O
blocked	O
proventriculus	O
make	O
prolonged	O
,	O
repeated	O
attempts	O
to	O
feed	O
,	O
increasing	O
the	O
opportunities	O
for	O
transmission	O
.	O

Formation	O
of	O
a	O
Y	O
.	O
pestis	O
biofilm	O
in	O
vitro	O
and	O
in	O
the	O
flea	O
proventriculus	O
depends	O
on	O
synthesis	O
of	O
an	O
extracellular	O
polysaccharide	O
matrix	O
(	O
ECM	O
)	O
that	O
is	O
synthesized	O
only	O
at	O
temperatures	O
below	O
26degreesC	O
[	O
3	O
]	O
,	O
[	O
7	O
]	O
.	O

In	O
common	O
with	O
many	O
other	O
bacteria	O
,	O
ECM	O
synthesis	O
in	O
Y	O
.	O
pestis	O
is	O
controlled	O
by	O
intracellular	O
levels	O
of	O
cyclic	O
di	O
-	O
GMP	O
,	O
which	O
are	O
determined	O
by	O
competing	O
activities	O
of	O
the	O
hmsT	B-Protein
diguanylate	B-Protein
cyclase	I-Protein
and	O
hmsP	B-Protein
phosphodiesterase	B-Protein
gene	O
products	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

Bacterial	O
adhesins	O
are	O
typically	O
required	O
for	O
initial	O
adherence	O
and	O
autoaggregation	O
in	O
biofilm	O
development	O
[	O
10	O
]	O
,	O
but	O
such	O
factors	O
have	O
yet	O
to	O
be	O
identified	O
in	O
Y	O
.	O
pestis	O
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
reported	O
the	O
in	O
vivo	O
gene	O
expression	O
profile	O
of	O
Y	O
.	O
pestis	O
during	O
bubonic	O
plague	O
in	O
rats	O
[	O
11	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
the	O
Y	O
.	O
pestis	O
transcriptome	O
in	O
blocked	O
Xenopsylla	O
cheopis	O
rat	O
fleas	O
,	O
an	O
important	O
vector	O
of	O
plague	O
to	O
humans	O
.	O

Comparing	O
the	O
Y	O
.	O
pestis	O
gene	O
expression	O
profile	O
in	O
the	O
flea	O
to	O
those	O
of	O
in	O
vitro	O
biofilm	O
and	O
planktonic	O
cells	O
cultured	O
at	O
the	O
low	O
temperature	O
typical	O
of	O
the	O
flea	O
implicated	O
several	O
genes	O
in	O
a	O
flea	O
-	O
specific	O
adaptive	O
response	O
and	O
in	O
proventricular	O
blockage	O
.	O

In	O
addition	O
,	O
comparing	O
the	O
gene	O
expression	O
patterns	O
in	O
the	O
flea	O
and	O
in	O
the	O
rat	O
bubo	O
confirmed	O
that	O
distinct	O
subsets	O
of	O
genes	O
are	O
differentially	O
expressed	O
during	O
the	O
Y	O
.	O
pestis	O
life	O
cycle	O
.	O

Notably	O
,	O
several	O
genes	O
with	O
known	O
or	O
predicted	O
roles	O
in	O
protection	O
against	O
the	O
mammalian	O
innate	O
immune	O
system	O
and	O
in	O
pathogenesis	O
were	O
upregulated	O
in	O
the	O
flea	O
,	O
suggesting	O
that	O
transit	O
through	O
the	O
insect	O
vector	O
preinduces	O
a	O
phenotype	O
that	O
enhances	O
Y	O
.	O
pestis	O
survival	O
and	O
dissemination	O
in	O
the	O
mammal	O
after	O
flea	O
-	O
borne	O
transmission	O
.	O
<EOS>	B-X
Through	B-X
a	B-X
systematic	B-X
investigation	B-X
of	B-X
EIS	B-X
across	B-X
33	B-X
cancers	B-X
from	B-X
9,599	B-X
tumor	B-X
transcriptomes	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
EIS	B-X
affected	B-X
63	B-X
%	B-X
of	B-X
human	B-X
coding	B-X
genes	B-X
and	B-X
that	B-X
95	B-X
%	B-X
of	B-X
those	B-X
events	B-X
were	B-X
tumor	B-X
specific	B-X
.	B-X
Notably	B-X
,	B-X
we	B-X
observed	B-X
a	B-X
mutually	B-X
exclusive	B-X
pattern	B-X
between	B-X
EIS	B-X
and	B-X
somatic	B-X
mutations	B-X
in	B-X
their	B-X
affected	B-X
genes	B-X
.	B-X
Functionally	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
EIS	B-X
altered	B-X
known	B-X
and	B-X
novel	B-X
cancer	B-X
driver	B-X
genes	B-X
for	B-X
causing	B-X
gain-	B-X
or	B-X
loss-of-function	B-X
,	B-X
which	B-X
promotes	B-X
tumor	B-X
progression	B-X
.	B-X
It	B-X
is	B-X
paternally	B-X
expressed	B-X
and	B-X
belongs	B-X
to	B-X
a	B-X
group	B-X
of	B-X
imprinted	B-X
genes	B-X
located	B-X
on	B-X
chromosome	B-X
band	B-X
14q32	B-X
in	B-X
humans	B-X
and	B-X
12qF1	B-X
in	B-X
mice	B-X
.	B-X
Although	B-X
the	B-X
exact	B-X
mechanism	B-X
through	B-X
which	B-X
DLK1	B-X
functions	B-X
is	B-X
not	B-X
fully	B-X
understood	B-X
,	B-X
it	B-X
is	B-X
known	B-X
to	B-X
maintain	B-X
cells	B-X
in	B-X
an	B-X
undifferentiated	B-X
phenotype	B-X
and	B-X
has	B-X
oncogenic	B-X
properties	B-X
.	B-X

Results	O
/	O
Discussion	O
<EOS>	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X
Results	B-X
suggest	B-X
that	B-X
discussing	B-X
a	B-X
negative	B-X
societal	B-X
stereotype	B-X
(	B-X
relative	B-X
to	B-X
individual	B-X
rumination	B-X
in	B-X
Studies	B-X
1	B-X
and	B-X
3	B-X
and	B-X
alternative	B-X
discussions	B-X
in	B-X
Studies	B-X
2	B-X
and	B-X
3	B-X
)	B-X
increases	B-X
intentions	B-X
to	B-X
engage	B-X
in	B-X
discrimination	B-X
against	B-X
the	B-X
out-group	B-X
target	B-X
of	B-X
the	B-X
stereotype	B-X
.	B-X
Discussion	B-X
of	B-X
religion	B-X
and/or	B-X
spirituality	B-X
in	B-X
the	B-X
medical	B-X
consultation	B-X
is	B-X
desired	B-X
by	B-X
patients	B-X
and	B-X
known	B-X
to	B-X
be	B-X
beneficial	B-X
.	B-X

Transcriptional	O
profile	O
of	O
Y	O
.	O
pestis	O
in	O
the	O
flea	O
Little	O
is	O
known	O
about	O
the	O
environmental	O
conditions	O
in	O
the	O
flea	O
digestive	O
tract	O
,	O
how	O
Y	O
.	O
pestis	O
adapts	O
to	O
them	O
,	O
or	O
the	O
physiological	O
state	O
of	O
the	O
bacteria	O
at	O
transmission	O
when	O
they	O
exit	O
the	O
flea	O
and	O
enter	O
the	O
mammal	O
.	O

Adult	O
fleas	O
are	O
obligate	O
blood	O
feeders	O
and	O
take	O
frequent	O
blood	O
meals	O
,	O
consisting	O
primarily	O
of	O
protein	O
and	O
lipid	O
with	O
relatively	O
little	O
carbohydrate	O
.	O

Flea	O
proteases	O
,	O
lipases	O
,	O
and	O
other	O
digestive	O
enzymes	O
begin	O
to	O
process	O
the	O
blood	O
meal	O
in	O
the	O
midgut	O
immediately	O
after	O
feeding	O
,	O
yielding	O
amino	O
acids	O
and	O
peptides	O
,	O
glycerol	O
,	O
fatty	O
acids	O
,	O
and	O
simple	O
carbohydrates	O
[	O
12	O
]	O
.	O

This	O
provides	O
the	O
"	O
medium	O
"	O
for	O
Y	O
.	O
pestis	O
growth	O
,	O
but	O
these	O
and	O
other	O
factors	O
such	O
as	O
pH	O
,	O
oxygen	O
tension	O
,	O
osmolarity	O
,	O
and	O
flea	O
antibacterial	O
immune	O
components	O
are	O
poorly	O
defined	O
.	O

During	O
the	O
first	O
week	O
after	O
being	O
ingested	O
in	O
an	O
infectious	O
blood	O
meal	O
,	O
Y	O
.	O
pestis	O
grows	O
rapidly	O
in	O
the	O
flea	O
midgut	O
to	O
form	O
large	O
bacterial	O
aggregates	O
.	O

Bacterial	O
load	O
peaks	O
at	O
about	O
106	O
cells	O
per	O
flea	O
as	O
the	O
Y	O
.	O
pestis	O
biofilm	O
accumulates	O
in	O
the	O
proventriculus	O
to	O
cause	O
blockage	O
,	O
and	O
then	O
plateaus	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
Y	O
.	O
pestis	O
gene	O
expression	O
profile	O
in	O
infective	O
,	O
blocked	O
fleas	O
,	O
in	O
which	O
the	O
proventriculus	O
was	O
occluded	O
with	O
a	O
mature	O
bacterial	O
biofilm	O
.	O

Y	O
.	O
pestis	O
KIM6	O
+	O
,	O
which	O
lacks	O
the	O
70	O
-	O
kb	O
virulence	O
plasmid	O
that	O
is	O
not	O
required	O
for	O
flea	O
infection	O
or	O
blockage	O
[	O
3	O
]	O
was	O
used	O
for	O
this	O
analysis	O
.	O
<EOS>	B-X
Biological	B-X
nanopore	B-X
approach	B-X
has	B-X
proved	B-X
successful	B-X
for	B-X
single-molecule	B-X
DNA	B-X
sequencing	B-X
,	B-X
which	B-X
resolves	B-X
the	B-X
identities	B-X
of	B-X
4	B-X
natural	B-X
deoxyribonucleotides	B-X
based	B-X
on	B-X
the	B-X
current	B-X
blockages	B-X
and	B-X
duration	B-X
times	B-X
of	B-X
their	B-X
translocations	B-X
across	B-X
the	B-X
nanopore	B-X
confinement	B-X
.	B-X
This	B-X
PRISMA-compliant	B-X
systematic	B-X
review	B-X
and	B-X
meta-analysis	B-X
analysed	B-X
the	B-X
outcomes	B-X
of	B-X
patients	B-X
undergoing	B-X
EVD	B-X
procedures	B-X
,	B-X
comparing	B-X
continuous	B-X
versus	B-X
intermittent	B-X
drainage	B-X
and	B-X
rapid	B-X
versus	B-X
gradual	B-X
weaning	B-X
.	B-X
Other	B-X
inclusion	B-X
criteria	B-X
were	B-X
the	B-X
description	B-X
of	B-X
the	B-X
EVD	B-X
drainage	B-X
and	B-X
weaning	B-X
strategies	B-X
used	B-X
and	B-X
a	B-X
comparison	B-X
of	B-X
continuous	B-X
versus	B-X
intermittent	B-X
drainage	B-X
or	B-X
rapid	B-X
versus	B-X
gradual	B-X
weaning	B-X
within	B-X
the	B-X
study	B-X
.	B-X
Random	B-X
effect	B-X
meta-analyses	B-X
were	B-X
used	B-X
to	B-X
compare	B-X
functional	B-X
outcomes	B-X
,	B-X
incidence	B-X
of	B-X
complications	B-X
and	B-X
hospital	B-X
length	B-X
of	B-X
stay	B-X
.	B-X
Intermittent	B-X
external	B-X
CSF	B-X
drainage	B-X
was	B-X
associated	B-X
with	B-X
lower	B-X
incidence	B-X
of	B-X
EVD-related	B-X
infections	B-X
(	B-X
RR	B-X
=	B-X
0.20	B-X
,	B-X
95	B-X
%	B-X
CI	B-X
0.05-0.72	B-X
,	B-X
I-squared	B-X
=	B-X
0	B-X
%	B-X
)	B-X
and	B-X
EVD	B-X
blockages	B-X
compared	B-X
to	B-X
continuous	B-X
CSF	B-X
drainage	B-X
(	B-X
RR	B-X
=	B-X
0.45	B-X
,	B-X
95	B-X
%	B-X
CI	B-X
0.27-0.74	B-X
,	B-X
I-squared	B-X
=	B-X
0	B-X
%	B-X
)	B-X
.	B-X
There	B-X
was	B-X
no	B-X
clear	B-X
advantage	B-X
in	B-X
using	B-X
gradual	B-X
EVD	B-X
weaning	B-X
strategies	B-X
compared	B-X
to	B-X
rapid	B-X
EVD	B-X
weaning	B-X
;	B-X
however	B-X
,	B-X
patients	B-X
who	B-X
underwent	B-X
rapid	B-X
EVD	B-X
weaning	B-X
had	B-X
a	B-X
shorter	B-X
hospital	B-X
length	B-X
of	B-X
stay	B-X
(	B-X
SMD	B-X
=	B-X
0.34	B-X
,	B-X
95	B-X
%	B-X
CI	B-X
0.22-0.47	B-X
,	B-X
I-squared	B-X
=	B-X
0	B-X
%	B-X
)	B-X
.	B-X
Intermittent	B-X
external	B-X
CSF	B-X
drainage	B-X
after	B-X
SAH	B-X
is	B-X
associated	B-X
with	B-X
lower	B-X
incidence	B-X
of	B-X
EVD-related	B-X
infections	B-X
and	B-X
EVD	B-X
blockages	B-X
compared	B-X
to	B-X
continuous	B-X
CSF	B-X
drainage	B-X
.	B-X

Blockage	O
occurred	O
between	O
1	O
.	O
5	O
and	O
3	O
.	O
5	O
weeks	O
after	O
the	O
initial	O
infectious	O
blood	O
meal	O
,	O
during	O
which	O
time	O
the	O
fleas	O
fed	O
on	O
uninfected	O
mice	O
twice	O
weekly	O
.	O

The	O
Y	O
.	O
pestis	O
in	O
vivo	O
biofilm	O
transcriptome	O
was	O
compared	O
to	O
the	O
transcriptomes	O
of	O
in	O
vitro	O
biofilm	O
and	O
planktonic	O
cultures	O
grown	O
at	O
21degreesC	O
,	O
the	O
same	O
temperature	O
at	O
which	O
the	O
fleas	O
were	O
maintained	O
.	O

Expression	O
of	O
55	O
%	O
of	O
Y	O
.	O
pestis	O
ORFs	O
was	O
detected	O
in	O
the	O
flea	O
samples	O
;	O
and	O
74	O
to	O
79	O
%	O
in	O
the	O
in	O
vitro	O
biofilm	O
,	O
exponential	O
phase	O
planktonic	O
and	O
stationary	O
phase	O
planktonic	O
cultures	O
.	O

Principal	O
component	O
analysis	O
to	O
visualize	O
overall	O
clustering	O
of	O
the	O
microarray	O
data	O
showed	O
that	O
the	O
transcriptional	O
profiles	O
were	O
reproducible	O
and	O
discrete	O
for	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
conditions	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

Profiles	O
of	O
the	O
exponential	O
and	O
stationary	O
phase	O
planktonic	O
cultures	O
clustered	O
most	O
closely	O
,	O
whereas	O
the	O
profiles	O
from	O
in	O
vitro	O
and	O
in	O
vivo	O
biofilm	O
growth	O
were	O
more	O
distinct	O
from	O
each	O
other	O
and	O
from	O
the	O
planktonic	O
culture	O
profiles	O
.	O

There	O
were	O
214	O
Y	O
.	O
pestis	O
genes	O
whose	O
expression	O
was	O
significantly	O
upregulated	O
and	O
56	O
genes	O
downregulated	O
in	O
the	O
flea	O
compared	O
to	O
all	O
in	O
vitro	O
growth	O
conditions	O
(	O
Fig	O
.	O
1B	O
;	O
Tables	O
S1	O
and	O
S2	O
)	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
analysis	O
of	O
a	O
subset	O
of	O
Y	O
.	O
pestis	O
genes	O
differentially	O
expressed	O
in	O
the	O
flea	O
was	O
confirmatory	O
of	O
the	O
microarray	O
results	O
(	O
Fig	O
.	O
S2	O
)	O
.	O

Y	O
.	O
pestis	O
metabolic	O
adaptation	O
to	O
the	O
flea	O
gut	O
environment	O

Of	O
the	O
214	O
genes	O
upregulated	O
in	O
the	O
flea	O
gut	O
compared	O
to	O
all	O
in	O
vitro	O
conditions	O
,	O
78	O
are	O
metabolic	O
genes	O
,	O
60	O
of	O
which	O
are	O
involved	O
in	O
uptake	O
and	O
catabolism	O
of	O
amino	O
acids	O
and	O
carbohydrates	O
(	O
Table	O
S1	O
)	O
.	O

In	O
particular	O
,	O
genes	O
involved	O
in	O
transport	O
and	O
catabolism	O
of	O
the	O
L	O
-	O
glutamate	O
group	O
of	O
amino	O
acids	O
(	O
Gln	O
,	O
His	O
,	O
Arg	O
,	O
and	O
Pro	O
)	O
were	O
specifically	O
upregulated	O
in	O
the	O
flea	O
(	O
Fig	O
.	O
2	O
)	O
.	O

The	O
degradation	O
of	O
these	O
amino	O
acids	O
gives	O
rise	O
to	O
L	O
-	O
glutamate	O
and	O
the	O
TCA	O
cycle	O
intermediates	O
succinate	O
,	O
formate	O
,	O
and	O
alpha	O
-	O
ketoglutarate	O
.	O

The	O
gabD	B-Protein
and	O
gabT	B-Protein
genes	O
involved	O
in	O
the	O
production	O
of	O
succinate	O
from	O
gamma	O
-	O
aminobutyrate	O
(	O
GABA	O
)	O
,	O
another	O
member	O
of	O
the	O
L	O
-	O
glutamate	O
group	O
,	O
were	O
also	O
highly	O
induced	O
in	O
the	O
flea	O
.	O

The	O
gabD	B-Protein
gene	O
functions	O
to	O
produce	O
succinate	O
from	O
both	O
GABA	O
and	O
hydroxyphenylacetate	O
(	O
HPA	O
)	O
,	O
an	O
aromatic	O
degradation	O
product	O
of	O
Tyr	O
and	O
Phe	O
;	O
and	O
the	O
HPA	B-Protein
transport	I-Protein
(	O
hpaX	B-Protein
)	O
and	O
catabolism	O
(	O
hpaCBIFHDE	B-Protein
)	O
genes	O
of	O
Y	O
.	O
pestis	O
were	O
also	O
highly	O
upregulated	O
in	O
the	O
flea	O
gut	O
(	O
Table	O
S1	O
,	O
Fig	O
.	O
2	O
)	O
.	O

As	O
Y	O
.	O
pestis	O
does	O
not	O
have	O
homologs	O
of	O
genes	O
required	O
to	O
produce	O
GABA	O
or	O
HPA	O
,	O
these	O
metabolites	O
may	O
be	O
taken	O
up	O
from	O
the	O
flea	O
digestive	O
tract	O
.	O

Alternatively	O
,	O
the	O
gabD	B-Protein
and	O
gabT	B-Protein
gene	O
products	O
might	O
act	O
in	O
the	O
reverse	O
direction	O
to	O
synthesize	O
GABA	O
,	O
which	O
has	O
osmoprotective	O
properties	O
[	O
13	O
]	O
.	O

The	O
central	O
role	O
of	O
the	O
L	O
-	O
glutamate	O
family	O
of	O
amino	O
acids	O
may	O
also	O
confer	O
this	O
advantage	O
in	O
the	O
flea	O
gut	O
,	O
because	O
Glu	O
and	O
Pro	O
are	O
osmoprotectants	O
.	O

Interestingly	O
,	O
both	O
glutamate	O
and	O
GABA	O
are	O
important	O
neurotransmitters	O
at	O
the	O
neuromuscular	O
junction	O
of	O
insects	O
,	O
and	O
the	O
concentration	O
of	O
glutamate	O
is	O
very	O
low	O
in	O
insect	O
hemolymph	O
,	O
suggesting	O
that	O
it	O
is	O
converted	O
to	O
glutamine	O
before	O
it	O
is	O
absorbed	O
[	O
14	O
]	O
.	O

Insect	O
midgut	O
epithelium	O
is	O
typified	O
by	O
multiple	O
amino	O
acid	O
transporters	O
with	O
specific	O
substrates	O
and	O
rapid	O
absorption	O
kinetics	O
,	O
but	O
different	O
amino	O
acids	O
enter	O
the	O
hemocoel	O
at	O
different	O
rates	O
and	O
amounts	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

Thus	O
,	O
Y	O
.	O
pestis	O
metabolism	O
in	O
the	O
flea	O
may	O
reflect	O
the	O
available	O
pool	O
of	O
amino	O
acids	O
in	O
the	O
midgut	O
.	O

In	O
contrast	O
to	O
the	O
amino	O
acids	O
,	O
hexoses	O
do	O
not	O
appear	O
to	O
be	O
an	O
important	O
energy	O
source	O
during	O
infection	O
of	O
the	O
flea	O
.	O

Only	O
the	O
genes	O
encoding	O
for	O
chitobiose	B-Protein
phosphotransferase	I-Protein
(	O
PTS	B-Protein
)	O
uptake	O
and	O
utilization	O
systems	O
(	O
chbBC	B-Protein
;	O
chbF	B-Protein
)	O
,	O
and	O
for	O
a	O
PTS	O
system	O
of	O
unknown	O
specificity	O
(	O
frwBCD	B-Protein
)	O
were	O
significantly	O
upregulated	O
in	O
the	O
flea	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
.	O

Chitobiose	B-Protein
could	O
be	O
present	O
in	O
the	O
flea	O
gut	O
due	O
to	O
turnover	O
of	O
the	O
chitin	O
layer	O
on	O
the	O
proventricular	O
spines	O
.	O

Expression	O
of	O
the	O
glucose	O
PTS	O
system	O
was	O
only	O
slightly	O
increased	O
relative	O
to	O
LB	O
cultures	O
,	O
and	O
other	O
PTS	O
systems	O
were	O
downregulated	O
(	O
Table	O
S2	O
)	O
.	O

Glycolytic	O
pathways	O
were	O
not	O
upregulated	O
in	O
the	O
flea	O
;	O
instead	O
,	O
available	O
hexoses	O
and	O
the	O
gluconeogenesis	O
pathway	O
may	O
be	O
used	O
to	O
synthesize	O
polysaccharide	O
components	O
required	O
for	O
cell	O
growth	O
.	O
<EOS>	B-X
Excessive	B-X
lactate	B-X
secreted	B-X
by	B-X
metabolism-reprogrammed	B-X
cancer	B-X
cells	B-X
regulates	B-X
immune	B-X
responses	B-X
via	B-X
causing	B-X
extracellular	B-X
acidification	B-X
,	B-X
acting	B-X
as	B-X
an	B-X
energy	B-X
source	B-X
by	B-X
shuttling	B-X
between	B-X
different	B-X
cell	B-X
populations	B-X
,	B-X
and	B-X
inhibiting	B-X
the	B-X
mechanistic	B-X
(	B-X
previously	B-X
'mammalian	B-X
'	B-X
)	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
pathway	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X
Several	B-X
molecular	B-X
event	B-X
cascade	B-X
in	B-X
different	B-X
metabolic	B-X
pathways	B-X
such	B-X
as	B-X
glycolytic	B-X
,	B-X
hexosamine	B-X
,	B-X
protein	B-X
kinase	B-X
C	B-X
,	B-X
polyol	B-X
and	B-X
advanced	B-X
glycation	B-X
end-product	B-X
(	B-X
AGE	B-X
)	B-X
pathways	B-X
have	B-X
been	B-X
identified	B-X
as	B-X
pro-oxidative	B-X
processes	B-X
and	B-X
are	B-X
usually	B-X
up-regulated	B-X
in	B-X
the	B-X
diabetics	B-X
.	B-X
Increased	B-X
level	B-X
of	B-X
glyceraldehyde-3-P	B-X
activates	B-X
two	B-X
major	B-X
pro-oxidative	B-X
pathways	B-X
in	B-X
diabetes	B-X
:	B-X
(	B-X
i	B-X
)	B-X
It	B-X
activates	B-X
the	B-X
AGE	B-X
pathway	B-X
,	B-X
precisely	B-X
the	B-X
synthesis	B-X
of	B-X
methylglyoxal	B-X
from	B-X
non-enzymatic	B-X
dephosphorylation	B-X
of	B-X
the	B-X
triose	B-X
phosphates	B-X
(	B-X
ii	B-X
)	B-X
It	B-X
activates	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
pathway	B-X
by	B-X
promoting	B-X
the	B-X
synthesis	B-X
of	B-X
diacylglycerol	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
it	B-X
causes	B-X
the	B-X
accumulation	B-X
of	B-X
glycolytic	B-X
metabolites	B-X
upstream	B-X
,	B-X
and	B-X
this	B-X
leads	B-X
to	B-X
excessive	B-X
stimulation	B-X
of	B-X
other	B-X
pro-oxidative	B-X
pathways	B-X
such	B-X
as	B-X
hexosamine	B-X
and	B-X
polyol	B-X
pathways	B-X
.	B-X

Upregulation	O
of	O
the	O
actP	B-Protein
and	O
acs	B-Protein
genes	O
in	O
the	O
flea	O
,	O
which	O
direct	O
the	O
uptake	O
of	O
acetate	O
and	O
its	O
conversion	O
to	O
acetyl	O
-	O
CoA	O
,	O
also	O
suggests	O
that	O
insufficient	O
acetyl	O
-	O
CoA	O
is	O
produced	O
by	O
glycolysis	O
to	O
potentiate	O
the	O
TCA	O
cycle	O
.	O

The	O
switch	O
from	O
acetate	O
secretion	O
to	O
acetate	O
uptake	O
is	O
typical	O
of	O
growth	O
in	O
a	O
glucose	O
-	O
limited	O
,	O
amino	O
acid	O
rich	O
environment	O
[	O
18	O
]	O
.	O

In	O
contrast	O
to	O
hexose	O
uptake	O
systems	O
,	O
Y	O
.	O
pestis	O
genes	O
that	O
encode	O
permeases	B-Protein
for	O
the	O
pentoses	O
ribose	O
,	O
xylose	O
,	O
and	O
arabinose	O
were	O
induced	O
in	O
the	O
flea	O
gut	O
.	O

Acquisition	O
of	O
pentoses	O
from	O
the	O
environment	O
may	O
be	O
important	O
because	O
Y	O
.	O
pestis	O
does	O
not	O
possess	O
glucose	B-Protein
6	I-Protein
-	I-Protein
phosphate	I-Protein
dehydrogenase	I-Protein
activity	O
,	O
the	O
first	O
step	O
of	O
the	O
pentose	O
phosphate	O
pathway	O
[	O
19	O
]	O
.	O

Although	O
the	O
flea	O
gut	O
contains	O
lipid	O
derived	O
from	O
the	O
blood	O
meal	O
,	O
Y	O
.	O
pestis	O
does	O
not	O
appear	O
to	O
use	O
it	O
as	O
a	O
major	O
energy	O
source	O
.	O

None	O
of	O
the	O
fatty	O
acid	O
uptake	O
or	O
catabolism	O
genes	O
were	O
upregulated	O
in	O
the	O
flea	O
compared	O
to	O
growth	O
in	O
LB	O
.	O
<EOS>	B-X
Adipocytes	B-X
can	B-X
be	B-X
activated	B-X
by	B-X
cancer	B-X
cells	B-X
to	B-X
lipolyze	B-X
their	B-X
triglyceride	B-X
stores	B-X
,	B-X
delivering	B-X
secreted	B-X
fatty	B-X
acids	B-X
to	B-X
cancer	B-X
cells	B-X
for	B-X
uptake	B-X
through	B-X
numerous	B-X
fatty	B-X
acid	B-X
transporters	B-X
.	B-X
Cancer-associated	B-X
fibroblasts	B-X
are	B-X
also	B-X
implicated	B-X
in	B-X
lipid	B-X
secretion	B-X
for	B-X
cancer	B-X
cell	B-X
catabolism	B-X
and	B-X
lipid	B-X
signaling	B-X
leading	B-X
to	B-X
activation	B-X
of	B-X
mitogenic	B-X
and	B-X
migratory	B-X
pathways	B-X
.	B-X
As	B-X
these	B-X
cancer-stromal	B-X
interactions	B-X
are	B-X
exacerbated	B-X
during	B-X
tumor	B-X
progression	B-X
,	B-X
fatty	B-X
acids	B-X
secreted	B-X
into	B-X
the	B-X
microenvironment	B-X
can	B-X
impact	B-X
infiltrating	B-X
immune	B-X
cell	B-X
function	B-X
and	B-X
phenotype	B-X
.	B-X
Lipid	B-X
metabolic	B-X
abnormalities	B-X
such	B-X
as	B-X
increased	B-X
fatty	B-X
acid	B-X
oxidation	B-X
and	B-X
de	B-X
novo	B-X
lipid	B-X
synthesis	B-X
can	B-X
provide	B-X
survival	B-X
advantages	B-X
for	B-X
the	B-X
tumor	B-X
to	B-X
resist	B-X
chemotherapeutic	B-X
and	B-X
radiation	B-X
treatments	B-X
and	B-X
alleviate	B-X
cellular	B-X
stresses	B-X
involved	B-X
in	B-X
the	B-X
metastatic	B-X
cascade	B-X
.	B-X

However	O
,	O
genes	O
for	O
glycerol	O
and	O
glycerol	O
-	O
3	O
-	O
phosphate	O
uptake	O
and	O
utilization	O
were	O
upregulated	O
,	O
suggesting	O
that	O
flea	O
digestion	O
products	O
derived	O
from	O
blood	O
glycerolipids	O
may	O
be	O
used	O
by	O
Y	O
.	O
pestis	O
.	O

In	O
summary	O
,	O
Y	O
.	O
pestis	O
appears	O
to	O
use	O
amino	O
acids	O
,	O
particularly	O
the	O
L	O
-	O
glutamate	O
family	O
,	O
as	O
primary	O
carbon	O
,	O
nitrogen	O
,	O
and	O
energy	O
sources	O
in	O
the	O
flea	O
.	O

Amino	O
acid	O
carbon	O
is	O
presumably	O
funneled	O
into	O
the	O
TCA	O
cycle	O
,	O
the	O
genes	O
for	O
which	O
are	O
highly	O
expressed	O
in	O
the	O
flea	O
(	O
Table	O
S3	O
)	O
.	O

Y	O
.	O
pestis	O
genes	O
involved	O
in	O
infection	O
and	O
biofilm	O
formation	O
in	O
the	O
flea	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
causative	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
is	B-X
transmitted	B-X
primarily	B-X
by	B-X
infected	B-X
fleas	B-X
in	B-X
nature	B-X
.	B-X
Y.	B-X
pestis	B-X
can	B-X
produce	B-X
biofilms	B-X
that	B-X
block	B-X
flea	B-X
's	B-X
proventriculus	B-X
and	B-X
promote	B-X
flea-borne	B-X
transmission	B-X
.	B-X
Transcriptional	B-X
regulation	B-X
of	B-X
Y.	B-X
pestis	B-X
biofilm	B-X
formation	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
response	B-X
to	B-X
complex	B-X
changes	B-X
in	B-X
environments	B-X
,	B-X
including	B-X
temperature	B-X
,	B-X
pH	B-X
,	B-X
oxidative	B-X
stress	B-X
,	B-X
and	B-X
restrictive	B-X
nutrition	B-X
conditions	B-X
,	B-X
and	B-X
contributes	B-X
to	B-X
Y.	B-X
pestis	B-X
growth	B-X
,	B-X
reproduction	B-X
,	B-X
transmission	B-X
,	B-X
and	B-X
pathogenesis	B-X
.	B-X
A	B-X
set	B-X
of	B-X
transcriptional	B-X
regulators	B-X
involved	B-X
in	B-X
Y.	B-X
pestis	B-X
biofilm	B-X
production	B-X
simultaneously	B-X
controls	B-X
a	B-X
variety	B-X
of	B-X
biological	B-X
functions	B-X
and	B-X
physiological	B-X
pathways	B-X
.	B-X
Interactions	B-X
between	B-X
these	B-X
regulators	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
Y.	B-X
pestis	B-X
gene	B-X
regulatory	B-X
networks	B-X
,	B-X
which	B-X
are	B-X
helpful	B-X
for	B-X
a	B-X
quick	B-X
response	B-X
to	B-X
complex	B-X
environmental	B-X
changes	B-X
and	B-X
better	B-X
survival	B-X
.	B-X
The	B-X
roles	B-X
of	B-X
crucial	B-X
factors	B-X
and	B-X
regulators	B-X
involved	B-X
in	B-X
response	B-X
to	B-X
complex	B-X
environmental	B-X
signals	B-X
and	B-X
Y.	B-X
pestis	B-X
biofilm	B-X
formation	B-X
as	B-X
well	B-X
as	B-X
the	B-X
precise	B-X
gene	B-X
regulatory	B-X
networks	B-X
are	B-X
discussed	B-X
in	B-X
this	B-X
review	B-X
,	B-X
which	B-X
will	B-X
give	B-X
a	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
complicated	B-X
mechanisms	B-X
of	B-X
transcriptional	B-X
regulation	B-X
in	B-X
Y.	B-X
pestis	B-X
biofilm	B-X
formation	B-X
.	B-X

Because	O
blockage	O
of	O
the	O
flea	O
vector	O
is	O
essentially	O
a	O
biofilm	O
phenomenon	O
,	O
Y	O
.	O
pestis	O
genes	O
whose	O
expression	O
patterns	O
are	O
significantly	O
upregulated	O
in	O
the	O
flea	O
and	O
flowcell	O
biofilms	O
relative	O
to	O
planktonic	O
cultures	O
(	O
Table	O
S4	O
)	O
might	O
indicate	O
that	O
they	O
are	O
transmission	O
factors	O
.	O

Several	O
studies	O
comparing	O
the	O
transcriptional	O
profiles	O
of	O
Escherichia	O
coli	O
and	O
other	O
gram	O
negative	O
bacteria	O
during	O
biofilm	O
and	O
planktonic	O
growth	O
in	O
vitro	O
have	O
been	O
published	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

Certain	O
genes	O
whose	O
mutational	O
loss	O
resulted	O
in	O
an	O
altered	O
biofilm	O
phenotype	O
have	O
been	O
identified	O
in	O
these	O
studies	O
;	O
but	O
in	O
general	O
a	O
consistent	O
,	O
distinct	O
biofilm	O
gene	O
expression	O
profile	O
has	O
not	O
emerged	O
.	O

This	O
is	O
probably	O
because	O
different	O
media	O
and	O
experimental	O
systems	O
have	O
been	O
employed	O
and	O
the	O
fact	O
that	O
a	O
biofilm	O
consists	O
of	O
a	O
physiologically	O
heterogeneous	O
community	O
[	O
24	O
]	O
,	O
[	O
25	O
]	O
.	O

Nevertheless	O
,	O
common	O
biofilm	O
-	O
related	O
adaptations	O
include	O
the	O
repression	O
of	O
motility	O
and	O
the	O
induction	O
of	O
specific	O
adhesins	O
,	O
an	O
extracellular	O
polysaccharide	O
matrix	O
(	O
ECM	O
)	O
,	O
and	O
an	O
envelope	O
stress	O
response	O
(	O
ESR	O
)	O
[	O
10	O
]	O
,	O
[	O
23	O
]	O
.	O

However	O
,	O
Y	O
.	O
pestis	O
is	O
constitutively	O
nonmotile	O
,	O
and	O
synthesis	O
of	O
the	O
Hms	O
-	O
dependent	O
biofilm	O
ECM	O
is	O
regulated	O
post	O
-	O
translationally	O
[	O
26	O
]	O
.	O

The	O
ymt	B-Protein
gene	O
was	O
among	O
the	O
most	O
highly	O
expressed	O
genes	O
in	O
the	O
flea	O
(	O
Table	O
S3	O
)	O
,	O
but	O
neither	O
it	O
nor	O
the	O
known	O
transmission	O
factors	O
(	O
hmsHFRS	B-Protein
,	O
hmsT	B-Protein
,	O
hmsP	B-Protein
,	O
and	O
gmhA	B-Protein
)	O
showed	O
significantly	O
higher	O
expression	O
in	O
the	O
flea	O
than	O
in	O
vitro	O
at	O
21degreesC	O
,	O
indicating	O
that	O
they	O
are	O
induced	O
primarily	O
by	O
low	O
temperature	O
,	O
and	O
not	O
by	O
environmental	O
factors	O
specific	O
to	O
the	O
flea	O
gut	O
.	O

Y	O
.	O
pestis	O
homologs	O
of	O
two	O
genes	O
with	O
previously	O
identified	O
roles	O
in	O
biofilm	O
,	O
yidE	B-Protein
,	O
which	O
encodes	O
a	O
hyperadherence	O
factor	O
in	O
E	O
.	O
coli	O
[	O
27	O
]	O
,	O
and	O
cpxP	B-Protein
,	O
a	O
member	O
of	O
the	O
cpxPAR	B-Protein
ESR	O
system	O
,	O
were	O
upregulated	O
in	O
the	O
flowcell	O
;	O
but	O
predicted	O
adhesin	O
genes	O
were	O
not	O
upregulated	O
.	O

The	O
transcriptional	O
profile	O
of	O
Y	O
.	O
pestis	O
in	O
blocked	O
fleas	O
showed	O
greater	O
similarity	O
to	O
the	O
transcriptional	O
profile	O
reported	O
for	O
E	O
.	O
coli	O
in	O
mature	O
,	O
four	O
-	O
day	O
-	O
old	O
in	O
vitro	O
biofilms	O
[	O
23	O
]	O
.	O

In	O
addition	O
to	O
yidE	B-Protein
and	O
cpxP	B-Protein
,	O
other	O
Y	O
.	O
pestis	O
predicted	O
adhesins	O
and	O
components	O
of	O
an	O
ESR	O
were	O
upregulated	O
in	O
the	O
flea	O
.	O

The	O
Y	O
.	O
pestis	O
homologs	O
of	O
Pseudomonas	O
aeruginosa	O
cupA1	B-Protein
and	O
cupA3	B-Protein
in	O
a	O
predicted	O
fimbrial	O
biosynthesis	O
operon	O
and	O
yapL	B-Protein
,	O
a	O
predicted	O
autotransporter	O
adhesin	O
similar	O
to	O
E	O
.	O
coli	O
tibA	B-Protein
,	O
were	O
specifically	O
upregulated	O
in	O
the	O
flea	O
(	O
Table	O
S1	O
)	O
.	O

The	O
cupA	B-Protein
fimbrial	O
locus	O
and	O
tibA	B-Protein
are	O
important	O
for	O
surface	O
adherence	O
and	O
for	O
biofilm	O
formation	O
in	O
P	O
.	O
aeruginosa	O
and	O
E	O
.	O
coli	O
,	O
respectively	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

Evidence	O
for	O
induction	O
of	O
an	O
ESR	O
in	O
the	O
flea	O
included	O
the	O
high	O
expression	O
levels	O
of	O
rpoE	B-Protein
,	O
the	O
gene	O
for	O
the	O
alternate	O
transcription	O
factor	O
sigmaE	B-Protein
(	O
as	O
well	O
as	O
the	O
anti	O
-	O
sigmaE	O
negative	O
regulator	O
genes	O
rseA	B-Protein
and	O
rseB	B-Protein
)	O
,	O
cpxP	B-Protein
;	O
and	O
pspA	B-Protein
and	O
pspG	B-Protein
,	O
components	O
of	O
the	O
phage	O
-	O
shock	O
protein	O
(	O
Psp	O
)	O
response	O
(	O
Tables	O
S1	O
and	O
S3	O
)	O
.	O

These	O
genes	O
were	O
also	O
found	O
to	O
be	O
upregulated	O
in	O
mature	O
E	O
.	O
coli	O
biofilms	O
[	O
23	O
]	O
,	O
suggesting	O
that	O
the	O
three	O
prominent	O
ESR	O
systems	O
are	O
important	O
for	O
integrating	O
signals	O
required	O
for	O
survival	O
in	O
a	O
biofilm	O
.	O

Because	O
homologs	O
of	O
the	O
yidE	B-Protein
,	O
cpxP	B-Protein
,	O
tibA	B-Protein
(	O
yapL	B-Protein
)	O
,	O
cupA	B-Protein
fimbriae	I-Protein
,	O
and	O
pspABC	B-Protein
genes	O
were	O
upregulated	O
in	O
the	O
flea	O
and	O
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
biofilm	O
formation	O
in	O
other	O
bacteria	O
[	O
23	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
we	O
made	O
a	O
series	O
of	O
Y	O
.	O
pestis	O
strains	O
containing	O
deletions	O
of	O
these	O
loci	O
.	O

However	O
,	O
the	O
single	O
loss	O
of	O
any	O
of	O
these	O
genes	O
did	O
not	O
result	O
in	O
a	O
noticeable	O
defect	O
in	O
biofilm	O
formation	O
in	O
vitro	O
,	O
or	O
in	O
flea	O
infection	O
or	O
blockage	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
Recent	B-X
data	B-X
from	B-X
some	B-X
settings	B-X
suggest	B-X
that	B-X
head	B-X
lice	B-X
may	B-X
harbor	B-X
pathogens	B-X
.	B-X
Tungiasis	B-X
is	B-X
an	B-X
ectoparasitic	B-X
disease	B-X
caused	B-X
by	B-X
skin	B-X
penetration	B-X
by	B-X
the	B-X
female	B-X
Tunga	B-X
penetrans	B-X
or	B-X
,	B-X
less	B-X
commonly	B-X
,	B-X
Tunga	B-X
trimamillata	B-X
flea	B-X
.	B-X
Disappearance	B-X
of	B-X
the	B-X
disease	B-X
is	B-X
unlikely	B-X
due	B-X
to	B-X
the	B-X
wide	B-X
range	B-X
of	B-X
mammalian	B-X
hosts	B-X
and	B-X
their	B-X
attendant	B-X
fleas	B-X
.	B-X
The	B-X
flea/rodent	B-X
life	B-X
cycle	B-X
of	B-X
Y.	B-X
pestis	B-X
,	B-X
a	B-X
gram-negative	B-X
obligate	B-X
pathogen	B-X
,	B-X
exposes	B-X
it	B-X
to	B-X
very	B-X
different	B-X
environmental	B-X
conditions	B-X
and	B-X
has	B-X
resulted	B-X
in	B-X
some	B-X
novel	B-X
traits	B-X
facilitating	B-X
transmission	B-X
and	B-X
infection	B-X
.	B-X

These	O
genes	O
may	O
contribute	O
to	O
biofilm	O
formation	O
,	O
but	O
are	O
not	O
individually	O
essential	O
for	O
this	O
phenotype	O
.	O
<EOS>	B-X
Capsule	B-X
,	B-X
type	B-X
1	B-X
and	B-X
3	B-X
fimbriae	B-X
(	B-X
mrkA	B-X
gene	B-X
)	B-X
,	B-X
type	B-X
2	B-X
quorum-sensing	B-X
system	B-X
(	B-X
luxS	B-X
)	B-X
,	B-X
synthesis	B-X
of	B-X
D-galactan	B-X
I	B-X
(	B-X
wbbM	B-X
)	B-X
,	B-X
LPS	B-X
transport	B-X
(	B-X
wzm	B-X
)	B-X
and	B-X
poly-beta-1,6-N-acetyl-D-glucosamine	B-X
(	B-X
pgaA	B-X
)	B-X
seem	B-X
involved	B-X
in	B-X
K.	B-X
pneumoniae	B-X
biofilm	B-X
.	B-X
The	B-X
aim	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
analyse	B-X
some	B-X
virulence	B-X
factors	B-X
of	B-X
K.	B-X
pneumoniae	B-X
isolates	B-X
,	B-X
and	B-X
to	B-X
evaluate	B-X
possible	B-X
correlations	B-X
between	B-X
their	B-X
antibiotic	B-X
resistance	B-X
profile	B-X
and	B-X
ability	B-X
to	B-X
form	B-X
biofilm	B-X
.	B-X
Most	B-X
Staphylococcus	B-X
aureus	B-X
strains	B-X
can	B-X
grow	B-X
as	B-X
a	B-X
multicellular	B-X
biofilm	B-X
,	B-X
a	B-X
phenotype	B-X
of	B-X
utmost	B-X
importance	B-X
to	B-X
clinical	B-X
infections	B-X
such	B-X
as	B-X
endocarditis	B-X
,	B-X
osteomyelitis	B-X
,	B-X
and	B-X
implanted	B-X
medical	B-X
device	B-X
infection	B-X
.	B-X
As	B-X
biofilms	B-X
are	B-X
inherently	B-X
more	B-X
tolerant	B-X
to	B-X
the	B-X
host	B-X
immune	B-X
system	B-X
and	B-X
antibiotics	B-X
,	B-X
understanding	B-X
the	B-X
S.	B-X
aureus	B-X
genes	B-X
and	B-X
regulatory	B-X
circuits	B-X
that	B-X
contribute	B-X
to	B-X
biofilm	B-X
development	B-X
is	B-X
an	B-X
active	B-X
and	B-X
on-going	B-X
field	B-X
of	B-X
research	B-X
.	B-X
This	B-X
chapter	B-X
details	B-X
a	B-X
high-throughput	B-X
and	B-X
standardized	B-X
way	B-X
to	B-X
grow	B-X
S.	B-X
aureus	B-X
biofilms	B-X
using	B-X
a	B-X
classical	B-X
microtiter	B-X
plate	B-X
assay	B-X
.	B-X

Although	O
genes	O
in	O
the	O
polyamine	O
transport	O
gabTpotDBC	B-Protein
locus	O
are	O
among	O
the	O
most	O
highly	O
induced	O
genes	O
in	O
the	O
flea	O
(	O
Table	O
S1	O
)	O
and	O
polyamines	O
are	O
essential	O
for	O
Y	O
.	O
pestis	O
biofilm	O
formation	O
[	O
30	O
]	O
,	O
we	O
have	O
previously	O
reported	O
that	O
a	O
Y	O
.	O
pestis	O
Deltapot	O
mutant	O
has	O
no	O
defect	O
in	O
flea	O
infection	O
or	O
blockage	O
[	O
31	O
]	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
risk	B-X
factors	B-X
for	B-X
coronary	B-X
artery	B-X
disease	B-X
-	B-X
the	B-X
most	B-X
common	B-X
cause	B-X
of	B-X
CVD	B-X
-	B-X
are	B-X
well	B-X
known	B-X
and	B-X
include	B-X
hypertension	B-X
,	B-X
high	B-X
cholesterol	B-X
,	B-X
age	B-X
,	B-X
and	B-X
genetics	B-X
,	B-X
CVDs	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
chronic	B-X
inflammatory	B-X
conditions	B-X
.	B-X
Arterial	B-X
blockages	B-X
,	B-X
known	B-X
as	B-X
atherosclerosis	B-X
,	B-X
develop	B-X
due	B-X
to	B-X
excess	B-X
cholesterol	B-X
accumulating	B-X
within	B-X
the	B-X
arterial	B-X
wall	B-X
,	B-X
creating	B-X
a	B-X
perpetually	B-X
inflammatory	B-X
state	B-X
.	B-X
Biological	B-X
nanopore	B-X
approach	B-X
has	B-X
proved	B-X
successful	B-X
for	B-X
single-molecule	B-X
DNA	B-X
sequencing	B-X
,	B-X
which	B-X
resolves	B-X
the	B-X
identities	B-X
of	B-X
4	B-X
natural	B-X
deoxyribonucleotides	B-X
based	B-X
on	B-X
the	B-X
current	B-X
blockages	B-X
and	B-X
duration	B-X
times	B-X
of	B-X
their	B-X
translocations	B-X
across	B-X
the	B-X
nanopore	B-X
confinement	B-X
.	B-X
Intermittent	B-X
external	B-X
CSF	B-X
drainage	B-X
was	B-X
associated	B-X
with	B-X
lower	B-X
incidence	B-X
of	B-X
EVD-related	B-X
infections	B-X
(	B-X
RR	B-X
=	B-X
0.20	B-X
,	B-X
95	B-X
%	B-X
CI	B-X
0.05-0.72	B-X
,	B-X
I-squared	B-X
=	B-X
0	B-X
%	B-X
)	B-X
and	B-X
EVD	B-X
blockages	B-X
compared	B-X
to	B-X
continuous	B-X
CSF	B-X
drainage	B-X
(	B-X
RR	B-X
=	B-X
0.45	B-X
,	B-X
95	B-X
%	B-X
CI	B-X
0.27-0.74	B-X
,	B-X
I-squared	B-X
=	B-X
0	B-X
%	B-X
)	B-X
.	B-X
Intermittent	B-X
external	B-X
CSF	B-X
drainage	B-X
after	B-X
SAH	B-X
is	B-X
associated	B-X
with	B-X
lower	B-X
incidence	B-X
of	B-X
EVD-related	B-X
infections	B-X
and	B-X
EVD	B-X
blockages	B-X
compared	B-X
to	B-X
continuous	B-X
CSF	B-X
drainage	B-X
.	B-X

This	O
is	O
likely	O
due	O
to	O
the	O
fact	O
that	O
Y	O
.	O
pestis	O
is	O
able	O
to	O
synthesize	O
polyamines	O
de	O
novo	O
.	O

Differential	O
gene	O
expression	O
during	O
the	O
Y	O
.	O
pestis	O
life	O
cycle	O

With	O
this	O
study	O
,	O
the	O
in	O
vivo	O
transcriptome	O
of	O
Y	O
.	O
pestis	O
in	O
blocked	O
fleas	O
and	O
in	O
the	O
rat	O
bubo	O
[	O
11	O
]	O
have	O
now	O
both	O
been	O
characterized	O
.	O

A	O
comparison	O
of	O
normalized	O
gene	O
expression	O
levels	O
from	O
the	O
two	O
data	O
sets	O
provides	O
insight	O
into	O
the	O
biology	O
of	O
the	O
flea	O
-	O
mammal	O
life	O
cycle	O
.	O

About	O
15	O
%	O
of	O
Y	O
.	O
pestis	O
genes	O
showed	O
significantly	O
higher	O
relative	O
expression	O
levels	O
or	O
expression	O
only	O
in	O
the	O
flea	O
than	O
in	O
the	O
bubo	O
;	O
24	O
%	O
were	O
more	O
highly	O
expressed	O
in	O
the	O
bubo	O
than	O
in	O
the	O
flea	O
;	O
and	O
61	O
%	O
were	O
not	O
differentially	O
expressed	O
in	O
the	O
two	O
hosts	O
(	O
Fig	O
.	O
3	O
)	O
.	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
is	B-X
transmitted	B-X
to	B-X
mammals	B-X
by	B-X
infected	B-X
fleas	B-X
.	B-X
Y.	B-X
pestis	B-X
exhibits	B-X
a	B-X
distinct	B-X
life	B-X
stage	B-X
in	B-X
the	B-X
flea	B-X
,	B-X
where	B-X
it	B-X
grows	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
cohesive	B-X
biofilm	B-X
that	B-X
promotes	B-X
transmission	B-X
.	B-X
After	B-X
transmission	B-X
,	B-X
the	B-X
temperature	B-X
shift	B-X
to	B-X
37	B-X
degrees	B-X
C	B-X
induces	B-X
many	B-X
known	B-X
virulence	B-X
factors	B-X
of	B-X
Y.	B-X
pestis	B-X
that	B-X
confer	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
.	B-X
These	B-X
factors	B-X
are	B-X
not	B-X
produced	B-X
in	B-X
the	B-X
low-temperature	B-X
environment	B-X
of	B-X
the	B-X
flea	B-X
,	B-X
however	B-X
,	B-X
suggesting	B-X
that	B-X
Y.	B-X
pestis	B-X
is	B-X
vulnerable	B-X
to	B-X
the	B-X
initial	B-X
encounter	B-X
with	B-X
innate	B-X
immune	B-X
cells	B-X
at	B-X
the	B-X
flea	B-X
bite	B-X
site	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
whole-genome	B-X
microarrays	B-X
to	B-X
compare	B-X
the	B-X
Y.	B-X
pestis	B-X
in	B-X
vivo	B-X
transcriptome	B-X
in	B-X
infective	B-X
fleas	B-X
to	B-X
in	B-X
vitro	B-X
transcriptomes	B-X
in	B-X
temperature-matched	B-X
biofilm	B-X
and	B-X
planktonic	B-X
cultures	B-X
,	B-X
and	B-X
to	B-X
the	B-X
previously	B-X
characterized	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
profile	B-X
in	B-X
the	B-X
rat	B-X
bubo	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
genes	B-X
involved	B-X
in	B-X
metabolic	B-X
adaptation	B-X
to	B-X
the	B-X
flea	B-X
gut	B-X
and	B-X
biofilm	B-X
formation	B-X
,	B-X
several	B-X
genes	B-X
with	B-X
known	B-X
or	B-X
predicted	B-X
roles	B-X
in	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
and	B-X
pathogenicity	B-X
in	B-X
the	B-X
mammal	B-X
were	B-X
upregulated	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Y.	B-X
pestis	B-X
from	B-X
infected	B-X
fleas	B-X
were	B-X
more	B-X
resistant	B-X
to	B-X
phagocytosis	B-X
by	B-X
macrophages	B-X
than	B-X
in	B-X
vitro-grown	B-X
bacteria	B-X
,	B-X
in	B-X
part	B-X
attributable	B-X
to	B-X
a	B-X
cluster	B-X
of	B-X
insecticidal-like	B-X
toxin	B-X
genes	B-X
that	B-X
were	B-X
highly	B-X
expressed	B-X
only	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
transit	B-X
through	B-X
the	B-X
flea	B-X
vector	B-X
induces	B-X
a	B-X
phenotype	B-X
that	B-X
enhances	B-X
survival	B-X
and	B-X
dissemination	B-X
of	B-X
Y.	B-X
pestis	B-X
after	B-X
transmission	B-X
to	B-X
the	B-X
mammalian	B-X
host	B-X
.	B-X

Several	O
virulence	O
factors	O
were	O
differentially	O
regulated	O
in	O
the	O
two	O
hosts	O
,	O
but	O
others	O
were	O
not	O
(	O
Table	O
1	O
)	O
.	O

In	O
addition	O
to	O
the	O
known	O
temperature	O
-	O
induced	O
virulence	O
factors	O
,	O
iron	O
acquisition	O
systems	O
,	O
including	O
the	O
ybt	O
and	O
yfe	O
operons	O
that	O
are	O
required	O
for	O
virulence	O
;	O
and	O
oxidative	O
and	O
nitrosative	O
stress	O
response	O
genes	O
,	O
including	O
the	O
hmp	B-Protein
virulence	I-Protein
factor	I-Protein
,	O
are	O
highly	O
upregulated	O
in	O
the	O
rat	O
bubo	O
,	O
but	O
not	O
the	O
flea	O
.	O

The	O
analysis	O
also	O
reinforces	O
the	O
model	O
that	O
Y	O
.	O
pestis	O
produces	O
a	O
hexaacylated	O
lipid	O
A	O
in	O
the	O
flea	O
,	O
and	O
that	O
the	O
change	O
to	O
the	O
less	O
immunostimulatory	O
tetraacylated	O
form	O
occurs	O
only	O
after	O
transmission	O
[	O
32	O
]	O
.	O

Other	O
virulence	O
and	O
transmission	O
factors	O
were	O
not	O
differentially	O
regulated	O
,	O
including	O
the	O
hms	O
genes	O
;	O
and	O
the	O
Y	B-Protein
.	I-Protein
pestis	I-Protein
plasminogen	I-Protein
activator	I-Protein
(	O
pla	B-Protein
)	O
,	O
critical	O
for	O
dissemination	O
from	O
extravascular	O
tissue	O
at	O
the	O
fleabite	O
site	O
[	O
33	O
]	O
,	O
and	O
ymt	B-Protein
were	O
highly	O
expressed	O
in	O
both	O
hosts	O
(	O
Table	O
S3	O
and	O
[	O
11	O
]	O
)	O
.	O
<EOS>	B-X
Invasion	B-X
of	B-X
the	B-X
CNS	B-X
largely	B-X
depends	B-X
on	B-X
the	B-X
immune	B-X
status	B-X
of	B-X
the	B-X
host	B-X
and	B-X
the	B-X
virulence	B-X
of	B-X
the	B-X
fungal	B-X
strain	B-X
.	B-X
Infections	B-X
with	B-X
fungi	B-X
cause	B-X
a	B-X
significant	B-X
morbidity	B-X
in	B-X
immunocompromised	B-X
hosts	B-X
,	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
the	B-X
CNS	B-X
may	B-X
lead	B-X
to	B-X
fatal	B-X
consequences	B-X
.	B-X
This	B-X
blurred	B-X
gradation	B-X
in	B-X
terms	B-X
of	B-X
pathogenicity	B-X
is	B-X
reflected	B-X
by	B-X
species-	B-X
and	B-X
strain-specific	B-X
virulence	B-X
factors	B-X
and	B-X
the	B-X
development	B-X
of	B-X
different	B-X
host-defending	B-X
strategies	B-X
.	B-X
Clearly	B-X
,	B-X
CoNS	B-X
possess	B-X
fewer	B-X
virulence	B-X
properties	B-X
than	B-X
S.	B-X
aureus	B-X
,	B-X
with	B-X
a	B-X
respectively	B-X
different	B-X
disease	B-X
spectrum	B-X
.	B-X

The	O
Y	O
.	O
pestis	O
outer	O
surface	O
protein	O
gene	O
yadB	B-Protein
,	O
recently	O
shown	O
to	O
be	O
required	O
for	O
dissemination	O
and	O
bubonic	O
plague	O
pathogenesis	O
from	O
a	O
subcutaneous	O
inoculation	O
site	O
[	O
34	O
]	O
,	O
was	O
significantly	O
upregulated	O
in	O
both	O
the	O
flea	O
and	O
the	O
bubo	O
compared	O
to	O
in	O
vitro	O
conditions	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
.	O

Expression	O
of	O
genes	O
in	O
the	O
pH	O
6	O
antigen	O
locus	O
(	O
psaEFABC	B-Protein
)	O
,	O
responsible	O
for	O
the	O
synthesis	O
and	O
transport	O
of	O
the	O
PsaA	B-Protein
fimbriae	O
that	O
enhance	O
resistance	O
to	O
phagocytosis	O
by	O
macrophages	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
,	O
were	O
higher	O
in	O
the	O
bubo	O
than	O
the	O
flea	O
,	O
although	O
the	O
usher	O
protein	O
gene	O
psaC	B-Protein
was	O
upregulated	O
in	O
the	O
flea	O
compared	O
to	O
in	O
vitro	O
growth	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
.	O

The	O
psa	O
locus	O
is	O
regulated	O
by	O
RovA	B-Protein
[	O
36	O
]	O
.	O
<EOS>	B-X
The	B-X
pathogenic	B-X
species	B-X
of	B-X
Yersinia	B-X
contain	B-X
the	B-X
transcriptional	B-X
regulator	B-X
RovA	B-X
.	B-X
In	B-X
Yersinia	B-X
pseudotuberculosis	B-X
and	B-X
Yersinia	B-X
enterocolitica	B-X
,	B-X
RovA	B-X
regulates	B-X
expression	B-X
of	B-X
the	B-X
invasion	B-X
factor	B-X
invasin	B-X
(	B-X
inv	B-X
)	B-X
,	B-X
which	B-X
mediates	B-X
translocation	B-X
across	B-X
the	B-X
intestinal	B-X
epithelium	B-X
.	B-X
A	B-X
Y.	B-X
enterocolitica	B-X
rovA	B-X
mutant	B-X
has	B-X
a	B-X
significant	B-X
decrease	B-X
in	B-X
virulence	B-X
by	B-X
LD	B-X
(	B-X
50	B-X
)	B-X
analysis	B-X
and	B-X
an	B-X
altered	B-X
rate	B-X
of	B-X
dissemination	B-X
compared	B-X
with	B-X
either	B-X
wild	B-X
type	B-X
or	B-X
an	B-X
inv	B-X
mutant	B-X
,	B-X
suggesting	B-X
that	B-X
RovA	B-X
regulates	B-X
multiple	B-X
virulence	B-X
factors	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
the	B-X
involvement	B-X
of	B-X
RovA	B-X
in	B-X
the	B-X
virulence	B-X
of	B-X
Yersinia	B-X
pestis	B-X
,	B-X
which	B-X
naturally	B-X
lacks	B-X
a	B-X
functional	B-X
inv	B-X
gene	B-X
.	B-X
route	B-X
,	B-X
indicating	B-X
a	B-X
more	B-X
important	B-X
role	B-X
for	B-X
RovA	B-X
in	B-X
bubonic	B-X
plague	B-X
than	B-X
pneumonic	B-X
plague	B-X
or	B-X
systemic	B-X
infection	B-X
.	B-X
Microarray	B-X
analysis	B-X
was	B-X
used	B-X
to	B-X
define	B-X
the	B-X
RovA	B-X
regulon	B-X
.	B-X
The	B-X
psa	B-X
locus	B-X
was	B-X
among	B-X
the	B-X
most	B-X
highly	B-X
down-regulated	B-X
loci	B-X
in	B-X
the	B-X
DeltarovA	B-X
mutant	B-X
.	B-X
A	B-X
DeltapsaA	B-X
mutant	B-X
had	B-X
a	B-X
significant	B-X
dissemination	B-X
defect	B-X
after	B-X
s.c.	B-X
infection	B-X
but	B-X
only	B-X
slight	B-X
attenuation	B-X
by	B-X
the	B-X
pneumonic-disease	B-X
model	B-X
,	B-X
closely	B-X
mimicking	B-X
the	B-X
virulence	B-X
defect	B-X
seen	B-X
with	B-X
the	B-X
DeltarovA	B-X
mutant	B-X
.	B-X
DNA-binding	B-X
studies	B-X
revealed	B-X
that	B-X
RovA	B-X
specifically	B-X
interacts	B-X
with	B-X
the	B-X
psaE	B-X
and	B-X
psaA	B-X
promoter	B-X
regions	B-X
,	B-X
indicating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
RovA	B-X
in	B-X
regulating	B-X
this	B-X
locus	B-X
.	B-X
Thus	B-X
,	B-X
RovA	B-X
appears	B-X
to	B-X
be	B-X
a	B-X
global	B-X
transcription	B-X
factor	B-X
in	B-X
Y.	B-X
pestis	B-X
and	B-X
,	B-X
through	B-X
its	B-X
regulatory	B-X
influence	B-X
on	B-X
genes	B-X
such	B-X
as	B-X
psaEFABC	B-X
,	B-X
contributes	B-X
to	B-X
the	B-X
virulence	B-X
of	B-X
Y.	B-X
pestis	B-X
.	B-X

Consistent	O
with	O
these	O
findings	O
,	O
rovA	B-Protein
expression	O
was	O
downregulated	O
in	O
the	O
flea	O
;	O
whereas	O
expression	O
of	O
rovM	B-Protein
,	O
a	O
negative	O
regulator	O
of	O
rovA	B-Protein
[	O
37	O
]	O
,	O
was	O
upregulated	O
.	O

The	O
transcriptional	O
regulator	O
gene	O
phoP	B-Protein
of	O
the	O
PhoPQ	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
and	O
the	O
PhoP	B-Protein
-	O
regulated	O
mgtC	B-Protein
gene	O
were	O
expressed	O
at	O
levels	O
>	O
2	O
-	O
fold	O
higher	O
in	O
fleas	O
than	O
in	O
any	O
other	O
condition	O
(	O
Tables	O
1	O
,	O
S1	O
,	O
S3	O
)	O
.	O

PhoP	B-Protein
and	O
MgtC	B-Protein
are	O
established	O
virulence	O
factors	O
known	O
to	O
be	O
important	O
for	O
survival	O
of	O
Y	O
.	O
pestis	O
and	O
other	O
gram	O
-	O
negative	O
bacteria	O
in	O
macrophages	O
and	O
for	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAMPs	O
)	O
of	O
the	O
mammalian	O
innate	O
immune	O
response	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

The	O
PhoPQ	B-Protein
system	O
is	O
induced	O
in	O
low	O
Mg2	O
+	O
or	O
low	O
pH	O
environments	O
,	O
or	O
by	O
exposure	O
to	O
CAMPs	O
[	O
41	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O
<EOS>	B-X
The	B-X
acid	B-X
tolerance	B-X
response	B-X
enables	B-X
Salmonella	B-X
typhimurium	B-X
to	B-X
survive	B-X
exposures	B-X
to	B-X
potentially	B-X
lethal	B-X
acidic	B-X
environments	B-X
.	B-X
The	B-X
acid	B-X
stress	B-X
imposed	B-X
in	B-X
a	B-X
typical	B-X
assay	B-X
for	B-X
acid	B-X
tolerance	B-X
(	B-X
log-phase	B-X
cells	B-X
in	B-X
minimal	B-X
glucose	B-X
medium	B-X
)	B-X
was	B-X
shown	B-X
to	B-X
comprise	B-X
both	B-X
inorganic	B-X
(	B-X
i.e.	B-X
,	B-X
low	B-X
pH	B-X
)	B-X
and	B-X
organic	B-X
acid	B-X
components	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
PhoP	B-X
(	B-X
identified	B-X
as	B-X
acid	B-X
shock	B-X
protein	B-X
ASP29	B-X
)	B-X
and	B-X
PhoQ	B-X
proved	B-X
to	B-X
be	B-X
important	B-X
for	B-X
tolerance	B-X
to	B-X
inorganic	B-X
[	B-X
corrected	B-X
]	B-X
acid	B-X
stress	B-X
but	B-X
had	B-X
little	B-X
effect	B-X
against	B-X
organic	B-X
acid	B-X
stress	B-X
.	B-X
Acid	B-X
shock	B-X
induction	B-X
of	B-X
PhoP	B-X
appears	B-X
to	B-X
occur	B-X
at	B-X
the	B-X
transcriptional	B-X
level	B-X
and	B-X
requires	B-X
the	B-X
PhoPQ	B-X
system	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
PhoQ	B-X
can	B-X
sense	B-X
both	B-X
Mg2+	B-X
and	B-X
pH	B-X
.	B-X
Since	B-X
phoP	B-X
mutants	B-X
are	B-X
avirulent	B-X
,	B-X
the	B-X
low	B-X
pH	B-X
activation	B-X
of	B-X
this	B-X
system	B-X
has	B-X
important	B-X
implications	B-X
concerning	B-X
the	B-X
pathogenesis	B-X
of	B-X
S.	B-X
typhimurium	B-X
.	B-X

The	O
Mg2	O
+	O
concentration	O
and	O
pH	O
of	O
the	O
flea	O
digestive	O
tract	O
have	O
not	O
been	O
defined	O
,	O
so	O
the	O
inducing	O
stimulus	O
is	O
unknown	O
,	O
but	O
CAMPs	O
are	O
induced	O
and	O
secreted	O
into	O
the	O
gut	O
by	O
blood	O
feeding	O
insects	O
when	O
they	O
take	O
a	O
blood	O
meal	O
containing	O
bacteria	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
.	O

X	O
.	O
cheopis	O
fleas	O
encode	O
homologs	O
of	O
the	O
insect	O
CAMPs	O
cecropin	B-Protein
and	O
defensin	B-Protein
,	O
and	O
mount	O
an	O
inducible	O
antibacterial	O
response	O
to	O
infection	O
(	O
unpublished	O
data	O
)	O
.	O

Thus	O
,	O
the	O
PhoPQ	B-Protein
regulatory	O
system	O
may	O
be	O
induced	O
by	O
the	O
flea	O
'	O
s	O
immune	O
system	O
in	O
response	O
to	O
Y	O
.	O
pestis	O
in	O
the	O
midgut	O
.	O

Despite	O
the	O
upregulation	O
of	O
phoP	B-Protein
in	O
the	O
flea	O
,	O
with	O
the	O
notable	O
exception	O
of	O
mgtC	B-Protein
there	O
was	O
little	O
correlation	O
between	O
predicted	O
PhoP	B-Protein
-	O
regulated	O
genes	O
in	O
vitro	O
and	O
genes	O
upregulated	O
in	O
the	O
flea	O
[	O
39	O
]	O
,	O
[	O
46	O
]	O
,	O
[	O
47	O
]	O
.	O

Differential	O
regulation	O
of	O
members	O
of	O
the	O
PhoP	B-Protein
regulon	O
may	O
occur	O
depending	O
on	O
the	O
inducing	O
stimulus	O
,	O
however	O
[	O
48	O
]	O
.	O

Induction	O
of	O
a	O
phagocytosis	O
-	O
resistant	O
phenotype	O
in	O
the	O
flea	O

Soon	O
after	O
transmission	O
,	O
Y	O
.	O
pestis	O
would	O
be	O
expected	O
to	O
encounter	O
rapidly	O
-	O
responding	O
phagocytic	O
cells	O
in	O
the	O
dermis	O
.	O

To	O
assess	O
the	O
overall	O
effect	O
of	O
the	O
flea	O
-	O
specific	O
phenotype	O
on	O
this	O
encounter	O
,	O
we	O
compared	O
the	O
interaction	O
of	O
Y	O
.	O
pestis	O
recovered	O
from	O
infected	O
fleas	O
and	O
from	O
in	O
vitro	O
cultures	O
with	O
murine	O
bone	O
marrow	O
macrophages	O
.	O

Bacteria	O
from	O
fleas	O
showed	O
significantly	O
lower	O
levels	O
of	O
phagocytosis	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

We	O
have	O
previously	O
reported	O
analogous	O
findings	O
using	O
human	O
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
[	O
7	O
]	O
.	O
<EOS>	B-X
An	B-X
acute	B-X
inflammatory	B-X
response	B-X
begins	B-X
during	B-X
the	B-X
reperfusion	B-X
phase	B-X
following	B-X
an	B-X
ischemic	B-X
insult	B-X
in	B-X
which	B-X
polymorphonuclear	B-X
neutrophils	B-X
(	B-X
PMNs	B-X
)	B-X
play	B-X
an	B-X
important	B-X
role	B-X
and	B-X
the	B-X
release	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
(	B-X
ROS	B-X
)	B-X
causes	B-X
further	B-X
damage	B-X
and	B-X
a	B-X
reduction	B-X
in	B-X
endogenous	B-X
antioxidant	B-X
storage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
butylated	B-X
hydroxyanisole	B-X
(	B-X
BHA	B-X
)	B-X
and	B-X
some	B-X
phenolic	B-X
,	B-X
aliphatic	B-X
and	B-X
aromatic	B-X
BHA	B-X
derivatives	B-X
to	B-X
reduce	B-X
the	B-X
human	B-X
PMN	B-X
oxidative	B-X
burst	B-X
evoked	B-X
by	B-X
particulate	B-X
(	B-X
Candida	B-X
albicans	B-X
and	B-X
zymosan	B-X
)	B-X
or	B-X
soluble	B-X
stimulants	B-X
[	B-X
N-formyl-methionyl-leucyl-phenylalanine	B-X
(	B-X
fMLP	B-X
)	B-X
and	B-X
phorbol	B-X
myristate	B-X
acetate	B-X
(	B-X
PMA	B-X
)	B-X
]	B-X
was	B-X
investigated	B-X
using	B-X
luminol-amplified	B-X
chemiluminescence	B-X
.	B-X
BHA	B-X
and	B-X
the	B-X
derivative	B-X
dt-BHA	B-X
[	B-X
3,5-di-t-butyl-4-hydroxyanisole	B-X
]	B-X
significantly	B-X
reduced	B-X
the	B-X
PMN	B-X
oxidative	B-X
burst	B-X
at	B-X
concentrations	B-X
ranging	B-X
from	B-X
5	B-X
x	B-X
10	B-X
(	B-X
-6	B-X
)	B-X
to	B-X
5	B-X
x	B-X
10	B-X
(	B-X
-5	B-X
)	B-X
mol/l	B-X
for	B-X
C.	B-X
albicans	B-X
stimulation	B-X
,	B-X
while	B-X
for	B-X
zymosan	B-X
stimulation	B-X
,	B-X
reduction	B-X
was	B-X
seen	B-X
at	B-X
concentrations	B-X
ranging	B-X
from	B-X
5	B-X
x	B-X
10	B-X
(	B-X
-6	B-X
)	B-X
to	B-X
5	B-X
x	B-X
10	B-X
(	B-X
-5	B-X
)	B-X
mol/l	B-X
for	B-X
BHA	B-X
,	B-X
and	B-X
at	B-X
concentrations	B-X
ranging	B-X
from	B-X
5	B-X
x	B-X
10	B-X
(	B-X
-7	B-X
)	B-X
to	B-X
5	B-X
x	B-X
10	B-X
(	B-X
-5	B-X
)	B-X
mol/l	B-X
for	B-X
dt-BHA	B-X
,	B-X
with	B-X
dt-BHA	B-X
being	B-X
the	B-X
most	B-X
active	B-X
.	B-X
The	B-X
findings	B-X
obtained	B-X
with	B-X
fMLP	B-X
and	B-X
PMA	B-X
were	B-X
very	B-X
similar	B-X
to	B-X
those	B-X
previously	B-X
reported	B-X
.	B-X

The	O
yit	O
and	O
yip	O
genes	O
in	O
a	O
Y	O
.	O
pestis	O
locus	O
(	O
y0181	O
-	O
0191	O
)	O
that	O
encode	O
predicted	O
insecticidal	O
-	O
like	O
toxins	O
of	O
the	O
toxin	O
complex	O
(	O
Tc	O
)	O
family	O
and	O
three	O
linked	O
phage	O
-	O
related	O
genes	O
were	O
upregulated	O
4	O
-	O
to	O
50	O
-	O
fold	O
in	O
the	O
flea	O
midgut	O
(	O
Tables	O
1	O
and	O
S1	O
)	O
.	O

We	O
previously	O
reported	O
that	O
the	O
genes	O
for	O
these	O
Tc	O
-	O
like	O
proteins	O
are	O
highly	O
expressed	O
in	O
fleas	O
,	O
but	O
that	O
their	O
products	O
are	O
nontoxic	O
to	O
fleas	O
[	O
49	O
]	O
.	O

yitR	B-Protein
,	O
a	O
LysR	O
-	O
type	O
regulator	O
that	O
activates	O
the	O
Tc	O
-	O
like	O
yit	O
genes	O
[	O
50	O
]	O
,	O
was	O
upregulated	O
>	O
10	O
-	O
fold	O
in	O
the	O
flea	O
,	O
but	O
its	O
expression	O
was	O
not	O
detected	O
in	O
the	O
rat	O
bubo	O
(	O
Table	O
1	O
)	O
.	O

The	O
specific	O
induction	O
in	O
the	O
flea	O
of	O
yitR	B-Protein
and	O
genes	O
in	O
the	O
adjacent	O
Tc	O
-	O
like	O
yit	O
and	O
yip	O
loci	O
suggests	O
that	O
they	O
are	O
involved	O
in	O
adaptation	O
to	O
and	O
colonization	O
of	O
the	O
flea	O
.	O

However	O
,	O
deletion	O
of	O
yitR	B-Protein
or	O
yitA	B-Protein
-	O
yipB	B-Protein
(	O
y0183	O
-	O
y0191	O
)	O
does	O
not	O
affect	O
the	O
ability	O
of	O
Y	O
.	O
pestis	O
KIM6	O
+	O
to	O
infect	O
or	O
block	O
fleas	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
Vector-borne	B-X
pathogens	B-X
have	B-X
developed	B-X
a	B-X
close	B-X
relationship	B-X
with	B-X
blood	B-X
feeding	B-X
arthropod	B-X
ectoparasites	B-X
(	B-X
e.g.	B-X
,	B-X
mosquitoes	B-X
,	B-X
ticks	B-X
,	B-X
phlebotomine	B-X
sand	B-X
flies	B-X
,	B-X
black	B-X
flies	B-X
,	B-X
fleas	B-X
,	B-X
kissing	B-X
bugs	B-X
,	B-X
lice	B-X
)	B-X
and	B-X
exploited	B-X
a	B-X
huge	B-X
variety	B-X
of	B-X
vector	B-X
transmission	B-X
routes	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
life	B-X
cycles	B-X
of	B-X
these	B-X
pathogens	B-X
result	B-X
in	B-X
a	B-X
long	B-X
evolved	B-X
balance	B-X
with	B-X
the	B-X
respective	B-X
arthropod	B-X
biology	B-X
,	B-X
ecology	B-X
and	B-X
blood	B-X
feeding	B-X
habits	B-X
,	B-X
instrumentally	B-X
to	B-X
the	B-X
infection	B-X
of	B-X
several	B-X
animal	B-X
species	B-X
,	B-X
including	B-X
humans	B-X
.	B-X
Scientific	B-X
data	B-X
available	B-X
on	B-X
transmission	B-X
times	B-X
for	B-X
each	B-X
pathogen	B-X
are	B-X
discussed	B-X
relative	B-X
to	B-X
their	B-X
impact	B-X
for	B-X
the	B-X
success	B-X
of	B-X
vector-borne	B-X
disease	B-X
control	B-X
strategies	B-X
.	B-X
Blocking	B-X
pathogen	B-X
transmission	B-X
,	B-X
and	B-X
thus	B-X
preventing	B-X
the	B-X
infection	B-X
of	B-X
dogs	B-X
and	B-X
cats	B-X
,	B-X
may	B-X
be	B-X
achievable	B-X
by	B-X
the	B-X
use	B-X
of	B-X
chemical	B-X
compounds	B-X
if	B-X
they	B-X
are	B-X
characterised	B-X
by	B-X
a	B-X
fast	B-X
onset	B-X
of	B-X
killing	B-X
activity	B-X
or	B-X
repellence	B-X
against	B-X
arthropods	B-X
.	B-X
However	B-X
,	B-X
endosymbionts	B-X
and	B-X
vaccines	B-X
targeting	B-X
arthropods	B-X
or	B-X
pathogen	B-X
antigens	B-X
should	B-X
be	B-X
further	B-X
investigated	B-X
as	B-X
alternative	B-X
strategies	B-X
towards	B-X
the	B-X
goal	B-X
of	B-X
achieving	B-X
an	B-X
effective	B-X
integrated	B-X
control	B-X
of	B-X
vector-borne	B-X
diseases	B-X
.	B-X

These	O
observations	O
,	O
and	O
the	O
fact	O
that	O
the	O
Yersinia	O
Tc	O
proteins	O
have	O
toxicity	O
to	O
certain	O
eukaryotic	O
cell	O
lines	O
in	O
vitro	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
prompted	O
us	O
to	O
investigate	O
a	O
possible	O
post	O
-	O
transmission	O
antiphagocytic	O
role	O
for	O
these	O
proteins	O
in	O
the	O
mammalian	O
host	O
.	O

To	O
determine	O
if	O
the	O
insecticidal	O
-	O
like	O
toxins	O
were	O
involved	O
in	O
resistance	O
to	O
phagocytosis	O
,	O
we	O
repeated	O
the	O
macrophage	O
experiments	O
with	O
a	O
Y	O
.	O
pestis	O
DeltayitR	O
mutant	O
,	O
which	O
as	O
expected	O
showed	O
greatly	O
reduced	O
expression	O
of	O
the	O
yit	O
and	O
yip	O
genes	O
in	O
vitro	O
and	O
in	O
the	O
flea	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

Loss	O
of	O
yitR	B-Protein
significantly	O
reduced	O
the	O
increased	O
resistance	O
to	O
phagocytosis	O
of	O
Y	O
.	O
pestis	O
isolated	O
from	O
infected	O
fleas	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

Since	O
the	O
yit	O
and	O
yip	O
genes	O
are	O
not	O
required	O
for	O
Y	O
.	O
pestis	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
fleas	O
,	O
it	O
was	O
possible	O
to	O
compare	O
the	O
virulence	O
of	O
wild	O
-	O
type	O
and	O
DeltayitR	O
Y	O
.	O
pestis	O
following	O
transmission	O
by	O
fleabite	O
.	O

The	O
incidence	O
rate	O
and	O
time	O
to	O
disease	O
onset	O
were	O
identical	O
for	O
both	O
Y	O
.	O
pestis	O
strains	O
,	O
demonstrating	O
that	O
expression	O
of	O
yit	O
and	O
yip	O
is	O
not	O
essential	O
for	O
flea	O
-	O
borne	O
transmission	O
or	O
disease	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
According	B-X
to	B-X
the	B-X
disease	B-X
module	B-X
hypothesis	B-X
,	B-X
the	B-X
cellular	B-X
components	B-X
associated	B-X
with	B-X
a	B-X
disease	B-X
segregate	B-X
in	B-X
the	B-X
same	B-X
neighborhood	B-X
of	B-X
the	B-X
human	B-X
interactome	B-X
,	B-X
the	B-X
map	B-X
of	B-X
biologically	B-X
relevant	B-X
molecular	B-X
interactions	B-X
.	B-X
Yet	B-X
,	B-X
given	B-X
the	B-X
incompleteness	B-X
of	B-X
the	B-X
interactome	B-X
and	B-X
the	B-X
limited	B-X
knowledge	B-X
of	B-X
disease-associated	B-X
genes	B-X
,	B-X
it	B-X
is	B-X
not	B-X
obvious	B-X
if	B-X
the	B-X
available	B-X
data	B-X
have	B-X
sufficient	B-X
coverage	B-X
to	B-X
map	B-X
out	B-X
modules	B-X
associated	B-X
with	B-X
each	B-X
disease	B-X
.	B-X
Here	B-X
we	B-X
derive	B-X
mathematical	B-X
conditions	B-X
for	B-X
the	B-X
identifiability	B-X
of	B-X
disease	B-X
modules	B-X
and	B-X
show	B-X
that	B-X
the	B-X
network-based	B-X
location	B-X
of	B-X
each	B-X
disease	B-X
module	B-X
determines	B-X
its	B-X
pathobiological	B-X
relationship	B-X
to	B-X
other	B-X
diseases	B-X
.	B-X
For	B-X
example	B-X
,	B-X
diseases	B-X
with	B-X
overlapping	B-X
network	B-X
modules	B-X
show	B-X
significant	B-X
coexpression	B-X
patterns	B-X
,	B-X
symptom	B-X
similarity	B-X
,	B-X
and	B-X
comorbidity	B-X
,	B-X
whereas	B-X
diseases	B-X
residing	B-X
in	B-X
separated	B-X
network	B-X
neighborhoods	B-X
are	B-X
phenotypically	B-X
distinct	B-X
.	B-X
These	B-X
tools	B-X
represent	B-X
an	B-X
interactome-based	B-X
platform	B-X
to	B-X
predict	B-X
molecular	B-X
commonalities	B-X
between	B-X
phenotypically	B-X
related	B-X
diseases	B-X
,	B-X
even	B-X
if	B-X
they	B-X
do	B-X
not	B-X
share	B-X
primary	B-X
disease	B-X
genes	B-X
.	B-X

On	O
average	O
,	O
the	O
mice	O
challenged	O
with	O
Y	O
.	O
pestis	O
DeltayitR	O
-	O
infected	O
fleas	O
,	O
both	O
those	O
that	O
developed	O
disease	O
and	O
those	O
that	O
did	O
not	O
,	O
received	O
a	O
higher	O
cumulative	O
number	O
of	O
bites	O
from	O
blocked	O
fleas	O
than	O
the	O
mice	O
challenged	O
with	O
Y	O
.	O
pestis	O
-	O
infected	O
fleas	O
,	O
but	O
this	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
Fig	O
.	O
5	O
)	O
.	O
<EOS>	B-X
A	B-X
flea-to-mouse	B-X
transmission	B-X
model	B-X
was	B-X
developed	B-X
for	B-X
use	B-X
in	B-X
testing	B-X
new	B-X
candidate	B-X
vaccines	B-X
for	B-X
the	B-X
ability	B-X
to	B-X
protect	B-X
against	B-X
flea-borne	B-X
plague	B-X
.	B-X
The	B-X
model	B-X
was	B-X
used	B-X
to	B-X
evaluate	B-X
a	B-X
recombinant	B-X
fusion	B-X
protein	B-X
vaccine	B-X
consisting	B-X
of	B-X
the	B-X
Yersinia	B-X
pestis	B-X
F1	B-X
and	B-X
V	B-X
antigens	B-X
.	B-X
After	B-X
one	B-X
to	B-X
three	B-X
challenges	B-X
with	B-X
Y.	B-X
pestis-infected	B-X
fleas	B-X
,	B-X
14	B-X
of	B-X
15	B-X
unvaccinated	B-X
control	B-X
mice	B-X
developed	B-X
plague	B-X
,	B-X
with	B-X
an	B-X
average	B-X
septicemia	B-X
level	B-X
of	B-X
9.2	B-X
x	B-X
10	B-X
(	B-X
8	B-X
)	B-X
Y.	B-X
pestis	B-X
CFU/ml	B-X
.	B-X
None	B-X
of	B-X
15	B-X
vaccinated	B-X
mice	B-X
developed	B-X
the	B-X
disease	B-X
after	B-X
similar	B-X
challenges	B-X
,	B-X
and	B-X
serological	B-X
testing	B-X
indicated	B-X
that	B-X
transmitted	B-X
bacteria	B-X
were	B-X
eliminated	B-X
by	B-X
the	B-X
immune	B-X
system	B-X
before	B-X
extensive	B-X
replication	B-X
and	B-X
systemic	B-X
infection	B-X
could	B-X
occur	B-X
.	B-X
The	B-X
transmission	B-X
and	B-X
development	B-X
of	B-X
disease	B-X
in	B-X
control	B-X
mice	B-X
correlated	B-X
with	B-X
the	B-X
number	B-X
of	B-X
bites	B-X
by	B-X
blocked	B-X
fleas	B-X
but	B-X
not	B-X
with	B-X
the	B-X
total	B-X
number	B-X
of	B-X
fleabites	B-X
.	B-X
The	B-X
model	B-X
provides	B-X
a	B-X
means	B-X
to	B-X
directly	B-X
assess	B-X
the	B-X
efficacy	B-X
of	B-X
new	B-X
vaccines	B-X
to	B-X
prevent	B-X
naturally	B-X
acquired	B-X
bubonic	B-X
plague	B-X
and	B-X
to	B-X
study	B-X
events	B-X
at	B-X
the	B-X
vector-host	B-X
interface	B-X
that	B-X
lead	B-X
to	B-X
dissemination	B-X
and	B-X
disease	B-X
.	B-X

However	O
,	O
it	O
was	O
not	O
possible	O
to	O
detect	O
any	O
relatively	O
minor	O
difference	O
in	O
LD50	O
because	O
the	O
number	O
of	O
bacteria	O
transmitted	O
by	O
a	O
blocked	O
flea	O
varies	O
widely	O
[	O
1	O
]	O
,	O
[	O
52	O
]	O
.	O

Even	O
a	O
small	O
decrease	O
in	O
LD50	O
provided	O
by	O
the	O
Yit	O
-	O
Yip	O
proteins	O
would	O
be	O
significant	O
at	O
the	O
ecological	O
level	O
in	O
the	O
maintenance	O
of	O
plague	O
transmission	O
cycles	O
,	O
because	O
the	O
transmission	O
efficiency	O
of	O
blocked	O
fleas	O
is	O
very	O
low	O
-	O
often	O
only	O
a	O
few	O
or	O
no	O
bacterial	O
cells	O
are	O
transmitted	O
in	O
an	O
individual	O
fleabite	O
[	O
52	O
]	O
.	O

Because	O
phoP	B-Protein
is	O
required	O
by	O
Y	O
.	O
pestis	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
fleas	O
(	O
unpublished	O
data	O
)	O
,	O
it	O
was	O
not	O
possible	O
to	O
similarly	O
assess	O
the	O
effect	O
on	O
disease	O
transmission	O
of	O
phoP	B-Protein
induction	O
in	O
the	O
flea	O
.	O

Does	O
transit	O
through	O
the	O
flea	O
vector	O
preadapt	O
Y	O
.	O
pestis	O
to	O
resist	O
mammalian	O
innate	O
immunity	O
?	O

When	O
Y	O
.	O
pestis	O
is	O
transmitted	O
into	O
the	O
dermis	O
by	O
an	O
infected	O
flea	O
,	O
it	O
is	O
immediately	O
exposed	O
to	O
the	O
mammalian	O
innate	O
immune	O
system	O
.	O

The	O
most	O
important	O
antiphagocytic	O
virulence	O
factors	O
,	O
the	O
cytotoxic	O
Yersinia	O
outer	O
proteins	O
(	O
Yops	O
)	O
,	O
part	O
of	O
the	O
T3SS	O
encoded	O
by	O
the	O
Y	O
.	O
pestis	O
virulence	O
plasmid	O
and	O
the	O
F1	O
capsule	O
encoded	O
by	O
the	O
pMT1	O
plasmid	O
,	O
are	O
not	O
present	O
at	O
this	O
initial	O
stage	O
of	O
infection	O
.	O

Their	O
expression	O
is	O
strictly	O
temperature	O
-	O
regulated	O
and	O
are	O
not	O
produced	O
in	O
vivo	O
until	O
3	O
-	O
5	O
hours	O
after	O
the	O
temperature	O
shift	O
to	O
37degreesC	O
that	O
accompanies	O
transmission	O
[	O
1	O
]	O
,	O
[	O
3	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
.	O
<EOS>	B-X
In	B-X
addition	B-X
to	B-X
globally	B-X
regulating	B-X
gene	B-X
expression	B-X
,	B-X
cyanobacteria	B-X
are	B-X
one	B-X
of	B-X
the	B-X
only	B-X
systems	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
fitness	B-X
of	B-X
a	B-X
circadian	B-X
system	B-X
has	B-X
been	B-X
rigorously	B-X
evaluated	B-X
.	B-X
A	B-X
biochemical	B-X
oscillator	B-X
can	B-X
be	B-X
reconstituted	B-X
in	B-X
vitro	B-X
with	B-X
these	B-X
three	B-X
purified	B-X
Kai	B-X
proteins	B-X
and	B-X
displays	B-X
the	B-X
key	B-X
properties	B-X
of	B-X
temperature-compensated	B-X
rhythmicity	B-X
.	B-X
This	B-X
result	B-X
spectacularly	B-X
demonstrates	B-X
that	B-X
a	B-X
strictly	B-X
posttranslational	B-X
clock	B-X
is	B-X
sufficient	B-X
to	B-X
elaborate	B-X
circadian	B-X
phenomena	B-X
and	B-X
that	B-X
a	B-X
transcription-translation	B-X
feedback	B-X
loop	B-X
is	B-X
not	B-X
obligatory	B-X
.	B-X
The	B-X
irreversible	B-X
change	B-X
from	B-X
the	B-X
vegetative	B-X
to	B-X
the	B-X
reproductive	B-X
stage	B-X
is	B-X
strictly	B-X
controlled	B-X
to	B-X
ensure	B-X
the	B-X
progeny	B-X
's	B-X
success	B-X
.	B-X

Consequently	O
,	O
Y	O
.	O
pestis	O
grown	O
at	O
<	O
28degreesC	O
in	O
vitro	O
are	O
initially	O
susceptible	O
to	O
in	O
vivo	O
uptake	O
and	O
killing	O
by	O
phagocytes	O
until	O
the	O
Yop	O
and	O
F1	O
virulence	O
factors	O
are	O
produced	O
,	O
effectively	O
preventing	O
further	O
phagocytosis	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
.	O

Our	O
results	O
indicate	O
that	O
Y	O
.	O
pestis	O
entering	O
the	O
mammal	O
from	O
an	O
infective	O
flea	O
is	O
relatively	O
resistant	O
to	O
macrophages	O
,	O
as	O
well	O
as	O
PMNs	O
[	O
7	O
]	O
;	O
a	O
vector	O
-	O
specific	O
phenotype	O
that	O
is	O
not	O
related	O
to	O
the	O
T3SS	O
or	O
capsule	O
.	O

Coming	O
from	O
the	O
flea	O
,	O
Y	O
.	O
pestis	O
is	O
also	O
associated	O
with	O
the	O
biofilm	O
ECM	O
,	O
identical	O
or	O
closely	O
related	O
to	O
the	O
poly	O
-	O
beta	O
-	O
1	O
,	O
6	O
-	O
N	O
-	O
acetyl	O
glucosamine	O
ECM	O
of	O
staphylococcal	O
biofilms	O
,	O
which	O
has	O
been	O
shown	O
to	O
provide	O
protection	O
from	O
innate	O
immune	O
components	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

In	O
addition	O
,	O
although	O
the	O
antiphagocytic	O
F1	O
capsule	O
and	O
Psa	O
fimbriae	O
do	O
not	O
appear	O
to	O
be	O
produced	O
in	O
the	O
flea	O
,	O
upregulation	O
in	O
the	O
flea	O
of	O
most	O
F1	O
genes	O
in	O
the	O
cafRcaf1M1A1	B-Protein
locus	O
and	O
the	O
Psa	O
usher	O
protein	O
gene	O
psaC	B-Protein
(	O
Tables	O
1	O
,	O
S1	O
)	O
suggests	O
that	O
components	O
of	O
the	O
F1	O
and	O
Psa	O
translocation	O
system	O
are	O
made	O
,	O
which	O
may	O
prime	O
Y	O
.	O
pestis	O
for	O
rapid	O
secretion	O
of	O
these	O
extracellular	O
virulence	O
factors	O
after	O
transmission	O
.	O

The	O
upregulation	O
of	O
the	O
innate	O
immunity	O
resistance	O
genes	O
phoP	B-Protein
and	O
mgtC	B-Protein
suggest	O
that	O
those	O
Y	O
.	O
pestis	O
that	O
are	O
phagocytized	O
may	O
be	O
prepared	O
for	O
resistance	O
to	O
CAMPs	O
and	O
intracellular	O
survival	O
while	O
still	O
in	O
the	O
flea	O
vector	O
.	O

Finally	O
,	O
the	O
major	O
essential	O
virulence	O
factors	O
yadBC	B-Protein
and	O
pla	B-Protein
,	O
essential	O
for	O
Y	O
.	O
pestis	O
dissemination	O
from	O
the	O
dermis	O
,	O
were	O
maximally	O
or	O
very	O
highly	O
expressed	O
in	O
the	O
flea	O
(	O
Tables	O
1	O
,	O
S3	O
)	O
.	O

Besides	O
degrading	O
plasminogen	O
,	O
the	O
Pla	B-Protein
protease	O
may	O
also	O
inactivate	O
CAMPs	O
,	O
particularly	O
when	O
the	O
F1	O
capsule	O
is	O
not	O
present	O
[	O
57	O
]	O
,	O
which	O
matches	O
the	O
phenotype	O
of	O
Y	O
.	O
pestis	O
in	O
the	O
flea	O
.	O

In	O
summary	O
,	O
Y	O
.	O
pestis	O
appears	O
to	O
be	O
prepared	O
for	O
pathogenesis	O
in	O
the	O
mammal	O
while	O
still	O
in	O
the	O
flea	O
vector	O
.	O

The	O
biofilm	O
phenotype	O
of	O
Y	O
.	O
pestis	O
and	O
the	O
virulence	O
factors	O
upregulated	O
or	O
highly	O
expressed	O
in	O
the	O
flea	O
may	O
enhance	O
the	O
earliest	O
stages	O
of	O
plague	O
pathogenesis	O
while	O
the	O
full	O
complement	O
of	O
temperature	O
-	O
shift	O
-	O
regulated	O
virulence	O
factors	O
is	O
still	O
being	O
induced	O
.	O
<EOS>	B-X
Yersinia	B-X
pestis	B-X
,	B-X
the	B-X
agent	B-X
of	B-X
plague	B-X
,	B-X
is	B-X
transmitted	B-X
to	B-X
mammals	B-X
by	B-X
infected	B-X
fleas	B-X
.	B-X
Y.	B-X
pestis	B-X
exhibits	B-X
a	B-X
distinct	B-X
life	B-X
stage	B-X
in	B-X
the	B-X
flea	B-X
,	B-X
where	B-X
it	B-X
grows	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
cohesive	B-X
biofilm	B-X
that	B-X
promotes	B-X
transmission	B-X
.	B-X
After	B-X
transmission	B-X
,	B-X
the	B-X
temperature	B-X
shift	B-X
to	B-X
37	B-X
degrees	B-X
C	B-X
induces	B-X
many	B-X
known	B-X
virulence	B-X
factors	B-X
of	B-X
Y.	B-X
pestis	B-X
that	B-X
confer	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
.	B-X
These	B-X
factors	B-X
are	B-X
not	B-X
produced	B-X
in	B-X
the	B-X
low-temperature	B-X
environment	B-X
of	B-X
the	B-X
flea	B-X
,	B-X
however	B-X
,	B-X
suggesting	B-X
that	B-X
Y.	B-X
pestis	B-X
is	B-X
vulnerable	B-X
to	B-X
the	B-X
initial	B-X
encounter	B-X
with	B-X
innate	B-X
immune	B-X
cells	B-X
at	B-X
the	B-X
flea	B-X
bite	B-X
site	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
whole-genome	B-X
microarrays	B-X
to	B-X
compare	B-X
the	B-X
Y.	B-X
pestis	B-X
in	B-X
vivo	B-X
transcriptome	B-X
in	B-X
infective	B-X
fleas	B-X
to	B-X
in	B-X
vitro	B-X
transcriptomes	B-X
in	B-X
temperature-matched	B-X
biofilm	B-X
and	B-X
planktonic	B-X
cultures	B-X
,	B-X
and	B-X
to	B-X
the	B-X
previously	B-X
characterized	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
profile	B-X
in	B-X
the	B-X
rat	B-X
bubo	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
genes	B-X
involved	B-X
in	B-X
metabolic	B-X
adaptation	B-X
to	B-X
the	B-X
flea	B-X
gut	B-X
and	B-X
biofilm	B-X
formation	B-X
,	B-X
several	B-X
genes	B-X
with	B-X
known	B-X
or	B-X
predicted	B-X
roles	B-X
in	B-X
resistance	B-X
to	B-X
innate	B-X
immunity	B-X
and	B-X
pathogenicity	B-X
in	B-X
the	B-X
mammal	B-X
were	B-X
upregulated	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Y.	B-X
pestis	B-X
from	B-X
infected	B-X
fleas	B-X
were	B-X
more	B-X
resistant	B-X
to	B-X
phagocytosis	B-X
by	B-X
macrophages	B-X
than	B-X
in	B-X
vitro-grown	B-X
bacteria	B-X
,	B-X
in	B-X
part	B-X
attributable	B-X
to	B-X
a	B-X
cluster	B-X
of	B-X
insecticidal-like	B-X
toxin	B-X
genes	B-X
that	B-X
were	B-X
highly	B-X
expressed	B-X
only	B-X
in	B-X
the	B-X
flea	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
transit	B-X
through	B-X
the	B-X
flea	B-X
vector	B-X
induces	B-X
a	B-X
phenotype	B-X
that	B-X
enhances	B-X
survival	B-X
and	B-X
dissemination	B-X
of	B-X
Y.	B-X
pestis	B-X
after	B-X
transmission	B-X
to	B-X
the	B-X
mammalian	B-X
host	B-X
.	B-X

Increased	O
resistance	O
to	O
innate	O
immunity	O
that	O
is	O
preinduced	O
in	O
the	O
flea	O
vector	O
may	O
be	O
critical	O
to	O
productive	O
transmission	O
because	O
blocked	O
fleas	O
transmit	O
relatively	O
few	O
bacteria	O
,	O
often	O
below	O
the	O
LD50	O
of	O
Y	O
.	O
pestis	O
grown	O
in	O
vitro	O
at	O
<	O
28degreesC	O
[	O
1	O
]	O
,	O
[	O
52	O
]	O
.	O

Transcriptome	O
Analysis	O
of	O
the	O
Brucella	O
abortus	O
BvrR	B-Protein
/	O
BvrS	B-Protein
Two	O
-	O
Component	O
Regulatory	O
System	O
<EOS>	B-X
The	B-X
two-component	B-X
BvrR/BvrS	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
Brucella	B-X
abortus	B-X
virulence	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

Background	O
The	O
two	O
-	O
component	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
is	O
essential	O
for	O
Brucella	O
abortus	O
virulence	O
.	O
<EOS>	B-X
The	B-X
two-component	B-X
BvrR/BvrS	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
Brucella	B-X
abortus	B-X
virulence	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

It	O
was	O
shown	O
previously	O
that	O
its	O
dysfunction	O
alters	O
the	O
expression	O
of	O
some	O
major	O
outer	O
membrane	O
proteins	O
and	O
the	O
pattern	O
of	O
lipid	O
A	O
acylation	O
.	O
<EOS>	B-X
It	B-X
was	B-X
shown	B-X
previously	B-X
that	B-X
its	B-X
dysfunction	B-X
alters	B-X
the	B-X
expression	B-X
of	B-X
some	B-X
major	B-X
outer	B-X
membrane	B-X
proteins	B-X
and	B-X
the	B-X
pattern	B-X
of	B-X
lipid	B-X
A	B-X
acylation	B-X
.	B-X

To	O
determine	O
the	O
genes	O
regulated	O
by	O
BvrR	B-Protein
/	O
BvrS	B-Protein
,	O
we	O
performed	O
a	O
whole	O
-	O
genome	O
microarray	O
analysis	O
using	O
B	O
.	O
abortus	O
RNA	O
obtained	O
from	O
wild	O
type	O
and	O
bvrR	B-Protein
mutant	O
cells	O
grown	O
in	O
the	O
same	O
conditions	O
.	O
<EOS>	B-X
The	B-X
two-component	B-X
BvrR/BvrS	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
Brucella	B-X
abortus	B-X
virulence	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

Methodology	O
/	O
Principal	O
Findings	O
A	O
total	O
of	O
127	O
differentially	O
expressed	O
genes	O
were	O
found	O
:	O
83	O
were	O
over	O
expressed	O
and	O
44	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O
<EOS>	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

Two	O
operons	O
,	O
the	O
phosphotransferase	O
system	O
and	O
the	O
maltose	O
transport	O
system	O
,	O
were	O
down	O
-	O
regulated	O
.	O
<EOS>	B-X
The	B-X
two-component	B-X
BvrR/BvrS	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
Brucella	B-X
abortus	B-X
virulence	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

Several	O
genes	O
involved	O
in	O
cell	O
envelope	O
or	O
outer	O
membrane	O
biogenesis	O
were	O
differentially	O
expressed	O
:	O
genes	O
for	O
outer	O
membrane	O
proteins	O
(	O
omp25a	B-Protein
,	O
omp25d	B-Protein
)	O
,	O
lipoproteins	O
,	O
LPS	O
and	O
fatty	O
acid	O
biosynthesis	O
,	O
stress	O
response	O
proteins	O
,	O
chaperones	O
,	O
flagellar	O
genes	O
,	O
and	O
twelve	O
genes	O
encoding	O
ABC	O
transport	O
systems	O
.	O
<EOS>	B-X
The	B-X
use	B-X
of	B-X
lentiviral	B-X
vectors	B-X
has	B-X
become	B-X
commonplace	B-X
and	B-X
applications	B-X
in	B-X
the	B-X
fields	B-X
of	B-X
neuroscience	B-X
,	B-X
hematology	B-X
,	B-X
developmental	B-X
biology	B-X
,	B-X
stem	B-X
cell	B-X
biology	B-X
and	B-X
transgenesis	B-X
are	B-X
rapidly	B-X
emerging	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
improved	B-X
protocols	B-X
to	B-X
generate	B-X
highly	B-X
concentrated	B-X
lentiviral	B-X
vector	B-X
pseudotypes	B-X
involving	B-X
different	B-X
envelope	B-X
glycoproteins	B-X
.	B-X
In	B-X
this	B-X
protocol	B-X
,	B-X
vector	B-X
stocks	B-X
are	B-X
prepared	B-X
by	B-X
transient	B-X
transfection	B-X
using	B-X
standard	B-X
cell	B-X
culture	B-X
media	B-X
or	B-X
serum-free	B-X
media	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
reliable	B-X
real-time	B-X
PCR	B-X
protocols	B-X
to	B-X
titrate	B-X
lentiviral	B-X
vectors	B-X
based	B-X
on	B-X
proviral	B-X
DNA	B-X
copies	B-X
present	B-X
in	B-X
genomic	B-X
DNA	B-X
extracted	B-X
from	B-X
transduced	B-X
cells	B-X
or	B-X
on	B-X
vector	B-X
RNA	B-X
.	B-X

Ten	O
genes	O
related	O
with	O
carbon	O
metabolism	O
(	O
pckA	B-Protein
and	O
fumB	B-Protein
among	O
others	O
)	O
were	O
up	O
-	O
regulated	O
in	O
the	O
bvrR	B-Protein
mutant	O
,	O
and	O
denitrification	O
genes	O
(	O
nirK	B-Protein
,	O
norC	B-Protein
and	O
nosZ	B-Protein
)	O
were	O
also	O
regulated	O
.	O
<EOS>	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
were	O
affected	O
,	O
including	O
VjbR	B-Protein
,	O
ExoR	B-Protein
and	O
OmpR	B-Protein
that	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O
<EOS>	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

Finally	O
,	O
the	O
expression	O
of	O
eleven	O
genes	O
which	O
have	O
been	O
previously	O
related	O
with	O
Brucella	O
virulence	O
was	O
also	O
altered	O
.	O
<EOS>	B-X
The	B-X
two-component	B-X
BvrR/BvrS	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
Brucella	B-X
abortus	B-X
virulence	B-X
.	B-X
It	B-X
was	B-X
shown	B-X
previously	B-X
that	B-X
its	B-X
dysfunction	B-X
alters	B-X
the	B-X
expression	B-X
of	B-X
some	B-X
major	B-X
outer	B-X
membrane	B-X
proteins	B-X
and	B-X
the	B-X
pattern	B-X
of	B-X
lipid	B-X
A	B-X
acylation	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X

Conclusions	O
/	O
Significance	O
All	O
these	O
data	O
corroborate	O
the	O
impact	O
of	O
BvrR	B-Protein
/	O
BvrS	B-Protein
on	O
cell	O
envelope	O
modulation	O
,	O
confirm	O
that	O
this	O
system	O
controls	O
the	O
carbon	O
and	O
nitrogen	O
metabolism	O
,	O
and	O
suggest	O
a	O
cross	O
-	O
talk	O
among	O
some	O
regulators	O
to	O
adjust	O
the	O
Brucella	O
physiology	O
to	O
the	O
shift	O
expected	O
to	O
occur	O
during	O
the	O
transit	O
from	O
the	O
extracellular	O
to	O
the	O
intracellular	O
niche	O
.	O

Introduction	O

Facultative	O
intracellular	O
bacteria	O
such	O
as	O
Brucella	O
must	O
survive	O
in	O
varied	O
and	O
changing	O
conditions	O
ranging	O
from	O
the	O
open	O
environment	O
to	O
the	O
intracellular	O
medium	O
.	O

For	O
this	O
,	O
the	O
bacterium	O
must	O
coordinate	O
an	O
intricate	O
network	O
of	O
factors	O
to	O
generate	O
a	O
suitable	O
adaptive	O
response	O
to	O
the	O
various	O
signals	O
.	O

This	O
attribute	O
is	O
often	O
accomplished	O
by	O
two	O
-	O
component	O
transduction	O
systems	O
,	O
consisting	O
of	O
a	O
sensor	O
kinase	O
and	O
a	O
response	O
regulator	O
.	O

These	O
regulatory	O
systems	O
are	O
highly	O
conserved	O
among	O
bacteria	O
and	O
widely	O
used	O
for	O
controlling	O
gene	O
expression	O
in	O
response	O
to	O
environmental	O
signals	O
.	O

In	O
response	O
to	O
stimuli	O
,	O
the	O
sensor	O
kinase	O
autophosphorylates	O
,	O
then	O
transfers	O
its	O
phosphate	O
to	O
its	O
cognate	O
response	O
regulator	O
to	O
control	O
the	O
transcription	O
of	O
target	O
genes	O
[	O
1	O
]	O
.	O

Up	O
to	O
now	O
,	O
BvrR	B-Protein
/	O
BvrS	B-Protein
is	O
the	O
best	O
characterized	O
two	O
-	O
component	O
regulatory	O
system	O
of	O
Brucella	O
[	O
2	O
]	O
-	O
[	O
4	O
]	O
.	O

BvrS	B-Protein
is	O
a	O
membrane	O
-	O
bound	O
homodimeric	O
protein	O
that	O
has	O
three	O
conserved	O
regions	O
frequently	O
found	O
in	O
members	O
of	O
the	O
histidine	O
protein	O
kinase	O
superfamily	O
:	O
an	O
amino	O
-	O
terminal	O
periplasmic	O
sensing	O
domain	O
with	O
transmembrane	O
segments	O
,	O
a	O
cytoplasmic	O
dimerisation	O
domain	O
with	O
a	O
specific	O
His	O
residue	O
,	O
and	O
the	O
carboxy	O
-	O
terminal	O
ATP	O
-	O
binding	O
kinase	O
domain	O
[	O
5	O
]	O
.	O

BvrR	B-Protein
is	O
a	O
cytoplasmic	O
protein	O
that	O
shows	O
significant	O
similarity	O
to	O
OmpR	B-Protein
/	O
PhoB	B-Protein
subfamily	O
of	O
response	O
regulator	O
proteins	O
with	O
a	O
specific	O
Asp	O
residue	O
located	O
within	O
a	O
conserved	O
regulatory	O
domain	O
and	O
an	O
effector	O
domain	O
with	O
DNA	O
-	O
binding	O
activity	O
[	O
5	O
]	O
.	O

Although	O
genome	O
sequencing	O
has	O
revealed	O
21	O
putative	O
two	O
-	O
component	O
regulatory	O
systems	O
in	O
the	O
Brucella	O
genus	O
,	O
the	O
best	O
characterized	O
one	O
implicated	O
in	O
virulence	O
is	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
.	O

BvrR	B-Protein
/	O
bvrS	B-Protein
mutants	O
are	O
avirulent	O
in	O
mice	O
,	O
have	O
increased	O
susceptibility	O
to	O
killing	O
by	O
nonimmune	O
serum	O
,	O
show	O
reduced	O
invasiveness	O
to	O
epithelial	O
cells	O
and	O
macrophages	O
,	O
and	O
are	O
incapable	O
of	O
inhibiting	O
lysosome	O
fusion	O
and	O
of	O
intracellular	O
replication	O
[	O
4	O
]	O
.	O

As	O
demonstrated	O
for	O
other	O
two	O
-	O
component	O
systems	O
,	O
multiple	O
genes	O
are	O
expected	O
to	O
be	O
under	O
the	O
control	O
of	O
BvrR	B-Protein
/	O
BvrS	B-Protein
[	O
1	O
]	O
.	O

B	O
.	O
abortus	O
mutants	O
in	O
this	O
system	O
were	O
more	O
susceptible	O
to	O
bactericidal	O
polycationic	O
substances	O
like	O
polymyxin	O
B	O
,	O
melittin	O
or	O
poly	O
-	O
L	O
-	O
lysine	O
,	O
and	O
displayed	O
a	O
more	O
hydrophobic	O
outer	O
membrane	O
surface	O
than	O
the	O
parental	O
strain	O
[	O
4	O
]	O
.	O

This	O
evidence	O
suggests	O
an	O
altered	O
outer	O
membrane	O
structure	O
.	O
<EOS>	B-X
This	B-X
evidence	B-X
indicates	B-X
an	B-X
outer	B-X
membrane	B-X
defect	B-X
in	B-X
these	B-X
mutants	B-X
.	B-X
The	B-X
inner	B-X
and	B-X
outer	B-X
membranes	B-X
of	B-X
one	B-X
mutant	B-X
were	B-X
separated	B-X
and	B-X
subjected	B-X
to	B-X
compositional	B-X
analysis	B-X
.	B-X
A	B-X
deficiency	B-X
in	B-X
galactose	B-X
containing	B-X
lipopolysaccharide	B-X
in	B-X
the	B-X
outer	B-X
membrane	B-X
of	B-X
the	B-X
mutant	B-X
was	B-X
observed	B-X
.	B-X
Two	B-X
possible	B-X
causes	B-X
of	B-X
this	B-X
deficiency	B-X
were	B-X
examined	B-X
and	B-X
discounted	B-X
:	B-X
defective	B-X
galactose	B-X
uptake	B-X
into	B-X
the	B-X
cell	B-X
,	B-X
and	B-X
defective	B-X
translocation	B-X
of	B-X
lipopolysaccharide	B-X
from	B-X
the	B-X
inner	B-X
membrane	B-X
.	B-X
Extraction	B-X
and	B-X
chemical	B-X
analysis	B-X
of	B-X
mutant	B-X
and	B-X
wild	B-X
type	B-X
lipopolysaccharides	B-X
suggests	B-X
that	B-X
the	B-X
mutant	B-X
is	B-X
defective	B-X
in	B-X
the	B-X
enzyme	B-X
which	B-X
transfers	B-X
glucose	B-X
to	B-X
the	B-X
growing	B-X
lipopolysaccharide	B-X
core	B-X
,	B-X
UDPglucose	B-X
transferase	B-X
.	B-X

Later	O
studies	O
demonstrated	O
that	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
regulates	O
transcription	O
of	O
at	O
least	O
two	O
major	O
outer	O
membrane	O
proteins	O
,	O
Omp22	B-Protein
(	O
Omp3b	B-Protein
)	O
and	O
Omp25a	B-Protein
(	O
Omp3a	B-Protein
)	O
.	O

Changes	O
in	O
non	O
-	O
protein	O
envelope	O
molecules	O
such	O
as	O
lipid	O
A	O
underacylation	O
and	O
increased	O
LPS	O
acyl	O
-	O
chain	O
fluidity	O
have	O
been	O
also	O
found	O
in	O
these	O
mutants	O
[	O
3	O
]	O
.	O

To	O
further	O
understand	O
the	O
role	O
of	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
two	O
-	O
component	O
signal	O
transduction	O
system	O
,	O
global	O
gene	O
expression	O
profiles	O
were	O
analyzed	O
by	O
using	O
ORFeome	O
-	O
based	O
Brucella	O
whole	O
-	O
genome	O
DNA	O
microarrays	O
and	O
confirmed	O
by	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
.	O

Our	O
results	O
link	O
the	O
regulation	O
of	O
carbon	O
and	O
nitrogen	O
metabolism	O
to	O
the	O
expression	O
of	O
cell	O
envelope	O
components	O
and	O
suggest	O
the	O
existence	O
of	O
a	O
complex	O
regulatory	O
network	O
with	O
the	O
interplay	O
of	O
several	O
transcriptional	O
regulators	O
.	O

Results	O
and	O
Discussion	O
<EOS>	B-X
Discussion	B-X
of	B-X
religion	B-X
and/or	B-X
spirituality	B-X
in	B-X
the	B-X
medical	B-X
consultation	B-X
is	B-X
desired	B-X
by	B-X
patients	B-X
and	B-X
known	B-X
to	B-X
be	B-X
beneficial	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Brucella	O
mutants	O
in	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
are	O
pleiotropic	O
[	O
3	O
]	O
-	O
[	O
6	O
]	O
.	O

Whole	O
-	O
genome	O
microarray	O
analysis	O
was	O
made	O
to	O
determine	O
the	O
effect	O
of	O
the	O
mutation	O
in	O
BvrR	B-Protein
/	O
BvrS	B-Protein
in	O
the	O
gene	O
expression	O
pattern	O
of	O
Brucella	O
.	O

B	O
.	O
abortus	O
RNA	O
was	O
obtained	O
from	O
three	O
independent	O
cultures	O
of	O
each	O
wild	O
type	O
and	O
bvrR	B-Protein
mutant	O
cells	O
grown	O
in	O
the	O
same	O
conditions	O
.	O

To	O
confirm	O
the	O
reproducibility	O
of	O
the	O
gene	O
expression	O
data	O
,	O
the	O
array	O
experiment	O
was	O
composed	O
of	O
six	O
slides	O
(	O
three	O
for	O
each	O
type	O
of	O
cells	O
)	O
yielding	O
six	O
measurements	O
per	O
gene	O
,	O
representing	O
three	O
biological	O
replicates	O
(	O
since	O
each	O
gene	O
is	O
present	O
twice	O
on	O
each	O
slide	O
)	O
.	O

The	O
ORFeome	O
-	O
based	O
Brucella	O
whole	O
-	O
genome	O
DNA	O
microarray	O
used	O
in	O
this	O
study	O
has	O
been	O
previously	O
validated	O
for	O
the	O
analysis	O
of	O
gene	O
expression	O
under	O
any	O
experimental	O
conditions	O
[	O
7	O
]	O
.	O

The	O
microarray	O
experimental	O
design	O
was	O
made	O
according	O
to	O
the	O
MIAME	O
recommendations	O
[	O
8	O
]	O
.	O

A	O
change	O
in	O
gene	O
expression	O
was	O
considered	O
both	O
statistically	O
and	O
biologically	O
significant	O
if	O
the	O
p	O
-	O
value	O
was	O
less	O
than	O
0	O
.	O
01	O
.	O

The	O
statistical	O
analysis	O
resulted	O
in	O
the	O
identification	O
of	O
a	O
total	O
of	O
127	O
genes	O
differentially	O
transcribed	O
in	O
the	O
bvrR	B-Protein
mutant	O
versus	O
the	O
wild	O
type	O
.	O

Eighty	O
three	O
genes	O
(	O
65	O
%	O
)	O
were	O
up	O
-	O
and	O
44	O
(	O
35	O
%	O
)	O
were	O
down	O
-	O
regulated	O
(	O
the	O
complete	O
list	O
of	O
differentially	O
expressed	O
genes	O
in	O
the	O
bvrR	B-Protein
mutant	O
versus	O
the	O
wild	O
type	O
is	O
show	O
in	O
Table	O
S1	O
)	O
.	O

Twenty	O
three	O
%	O
of	O
the	O
differentially	O
transcribed	O
genes	O
(	O
30	O
)	O
encoded	O
for	O
hypothetical	O
proteins	O
.	O
<EOS>	B-X
Using	B-X
a	B-X
mixed	B-X
model	B-X
analysis	B-X
,	B-X
193	B-X
genes	B-X
were	B-X
found	B-X
to	B-X
be	B-X
differentially	B-X
transcribed	B-X
at	B-X
P	B-X
<	B-X
0.0042	B-X
with	B-X
a	B-X
q	B-X
value	B-X
<	B-X
0.1	B-X
.	B-X
The	B-X
111	B-X
downregulated	B-X
genes	B-X
include	B-X
the	B-X
curli	B-X
pili-associated	B-X
genes	B-X
csgABCDEFG	B-X
,	B-X
maltose	B-X
transport-associated	B-X
proteins	B-X
malEFK	B-X
,	B-X
and	B-X
NADH	B-X
dehydrogenase	B-X
subunit	B-X
encoding	B-X
nuoCEHIJN	B-X
.	B-X
The	B-X
82	B-X
genes	B-X
upregulated	B-X
include	B-X
the	B-X
HS-induced	B-X
genes	B-X
rpoH	B-X
,	B-X
dnaK	B-X
,	B-X
dnaJ	B-X
,	B-X
groEL	B-X
,	B-X
groES	B-X
,	B-X
and	B-X
grpE	B-X
along	B-X
with	B-X
two	B-X
LEE-encoded	B-X
genes	B-X
:	B-X
hypothetical	B-X
gene	B-X
Z5121	B-X
and	B-X
sepZ	B-X
.	B-X
Twenty-three	B-X
additional	B-X
genes	B-X
located	B-X
in	B-X
O-islands	B-X
were	B-X
found	B-X
to	B-X
be	B-X
differentially	B-X
expressed	B-X
.	B-X
Also	B-X
,	B-X
samples	B-X
subjected	B-X
to	B-X
a	B-X
30-42	B-X
degrees	B-X
C	B-X
shift	B-X
were	B-X
examined	B-X
by	B-X
qRT-PCR	B-X
to	B-X
confirm	B-X
differential	B-X
transcription	B-X
of	B-X
selected	B-X
genes	B-X
.	B-X

For	O
genes	O
of	O
annotated	O
function	O
,	O
59	O
appeared	O
to	O
be	O
up	O
regulated	O
and	O
38	O
down	O
regulated	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O

Genes	O
encoding	O
proteins	O
involved	O
in	O
metabolism	O
and	O
cellular	O
process	O
are	O
among	O
the	O
most	O
up	O
regulated	O
genes	O
,	O
and	O
those	O
encoding	O
proteins	O
involved	O
in	O
membrane	O
transport	O
are	O
among	O
the	O
most	O
down	O
regulated	O
(	O
Figure	O
1	O
)	O
.	O

To	O
further	O
validate	O
some	O
data	O
generated	O
in	O
the	O
microarray	O
experiment	O
,	O
forty	O
-	O
eight	O
differentially	O
expressed	O
genes	O
were	O
chosen	O
to	O
be	O
analyzed	O
by	O
real	O
-	O
time	O
quantitative	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
.	O

Total	O
RNA	O
from	O
both	O
Brucella	O
strains	O
were	O
reverse	O
transcribed	O
into	O
cDNA	O
.	O

The	O
reactions	O
were	O
made	O
by	O
triplicate	O
from	O
at	O
least	O
two	O
independent	O
cultures	O
,	O
and	O
the	O
cycle	O
of	O
threshold	O
(	O
Ct	O
)	O
was	O
determined	O
for	O
each	O
reaction	O
.	O

Data	O
were	O
normalized	O
by	O
the	O
2	O
-	O
DeltaDeltaCt	O
method	O
[	O
9	O
]	O
using	O
the	O
IF	O
-	O
1	O
housekeeping	O
gene	O
of	O
Brucella	O
as	O
reference	O
(	O
Table	O
1	O
)	O
.	O

Transcriptional	O
data	O
of	O
forty	O
-	O
one	O
(	O
85	O
%	O
)	O
of	O
the	O
genes	O
selected	O
gave	O
identical	O
tendency	O
by	O
both	O
methods	O
microarray	O
and	O
RT	O
-	O
PCR	O
:	O
22	O
were	O
up	O
and	O
19	O
were	O
down	O
regulated	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O

Interestingly	O
,	O
the	O
level	O
of	O
transcription	O
obtained	O
by	O
RT	O
-	O
PCR	O
of	O
the	O
flagellar	O
genes	O
fliM	B-Protein
(	O
BAB2	B-Protein
_	I-Protein
0124	I-Protein
)	O
and	O
motB	B-Protein
(	O
BAB2	B-Protein
_	I-Protein
1103	I-Protein
)	O
,	O
and	O
the	O
pckA	B-Protein
gene	O
(	O
BAB1	B-Protein
_	I-Protein
2091	I-Protein
)	O
were	O
the	O
highest	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O

On	O
the	O
other	O
hand	O
,	O
exoR	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
0891	I-Protein
)	O
,	O
omp25a	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
0722	I-Protein
)	O
,	O
hpr	B-Protein
-	I-Protein
K	I-Protein
(	O
BAB1	B-Protein
_	I-Protein
2094	I-Protein
)	O
,	O
bvrS	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
2093	I-Protein
)	O
and	O
the	O
lipoproteins	O
(	O
BAB1	B-Protein
_	I-Protein
2147	I-Protein
,	O
BAB1	B-Protein
_	I-Protein
0589	I-Protein
,	O
BAB1	B-Protein
_	I-Protein
0358	I-Protein
)	O
were	O
among	O
the	O
less	O
expressed	O
genes	O
(	O
Table	O
1	O
)	O
.	O

These	O
results	O
confirmed	O
a	O
good	O
correlation	O
between	O
microarray	O
and	O
RT	O
-	O
PCR	O
data	O
,	O
thus	O
validating	O
the	O
model	O
.	O

Next	O
,	O
we	O
will	O
focus	O
on	O
the	O
genes	O
differentially	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
(	O
a	O
complete	O
representation	O
of	O
the	O
differentially	O
expressed	O
genes	O
is	O
show	O
in	O
Figure	O
2	O
)	O
.	O

Cell	O
envelope	O
modulation	O
It	O
is	O
well	O
know	O
that	O
the	O
transcription	O
of	O
omp25a	B-Protein
y	O
omp22	B-Protein
genes	O
is	O
under	O
the	O
control	O
of	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
,	O
and	O
that	O
bvrR	B-Protein
/	O
bvrS	B-Protein
mutants	O
have	O
increased	O
amount	O
of	O
underacylated	O
lipid	O
A	O
species	O
in	O
the	O
LPS	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

In	O
addition	O
,	O
proteomic	O
analysis	O
of	O
Brucella	O
outer	O
membrane	O
fragments	O
demonstrated	O
that	O
the	O
expression	O
of	O
several	O
OMPs	O
,	O
lipoproteins	O
and	O
chaperones	O
was	O
altered	O
in	O
these	O
mutants	O
[	O
6	O
]	O
.	O

These	O
observations	O
led	O
to	O
the	O
hypothesis	O
that	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
is	O
involved	O
in	O
cell	O
envelope	O
changes	O
required	O
for	O
adaptation	O
to	O
the	O
intracellular	O
environment	O
.	O

Our	O
microarray	O
results	O
demonstrated	O
several	O
genes	O
directly	O
involved	O
in	O
cell	O
envelope	O
or	O
outer	O
membrane	O
biogenesis	O
differentially	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O
<EOS>	B-X
The	B-X
two-component	B-X
BvrR/BvrS	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
Brucella	B-X
abortus	B-X
virulence	B-X
.	B-X
It	B-X
was	B-X
shown	B-X
previously	B-X
that	B-X
its	B-X
dysfunction	B-X
alters	B-X
the	B-X
expression	B-X
of	B-X
some	B-X
major	B-X
outer	B-X
membrane	B-X
proteins	B-X
and	B-X
the	B-X
pattern	B-X
of	B-X
lipid	B-X
A	B-X
acylation	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
genes	B-X
regulated	B-X
by	B-X
BvrR/BvrS	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
whole-genome	B-X
microarray	B-X
analysis	B-X
using	B-X
B.	B-X
abortus	B-X
RNA	B-X
obtained	B-X
from	B-X
wild	B-X
type	B-X
and	B-X
bvrR	B-X
mutant	B-X
cells	B-X
grown	B-X
in	B-X
the	B-X
same	B-X
conditions	B-X
.	B-X
Our	B-X
recent	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
extracellular	B-X
,	B-X
recombinant	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
I	B-X
(	B-X
HIV-1	B-X
)	B-X
Vpr	B-X
protein	B-X
is	B-X
highly	B-X
neurotoxic	B-X
in	B-X
the	B-X
microenvironment	B-X
of	B-X
differentiated	B-X
mature	B-X
human	B-X
neurons	B-X
and	B-X
undifferentiated	B-X
neuronal	B-X
precursors	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
direct	B-X
neurotoxic	B-X
effects	B-X
of	B-X
HIV-1	B-X
have	B-X
been	B-X
attributed	B-X
previously	B-X
to	B-X
the	B-X
envelope	B-X
gene	B-X
product	B-X
,	B-X
gp120	B-X
,	B-X
and	B-X
the	B-X
Tat	B-X
regulatory	B-X
protein	B-X
,	B-X
it	B-X
was	B-X
demonstrated	B-X
that	B-X
Vpr	B-X
protein	B-X
caused	B-X
apoptosis	B-X
comparable	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
gp120	B-X
protein	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
in	B-X
the	B-X
neuronal	B-X
system	B-X
.	B-X
Having	B-X
observed	B-X
the	B-X
neurocytopathic	B-X
effects	B-X
of	B-X
extracellular	B-X
Vpr	B-X
protein	B-X
previously	B-X
,	B-X
the	B-X
effects	B-X
of	B-X
virally	B-X
expressed	B-X
Vpr	B-X
on	B-X
nondividing	B-X
,	B-X
terminally	B-X
differentiated	B-X
human	B-X
neurons	B-X
were	B-X
investigated	B-X
.	B-X
An	B-X
HIV-1-based	B-X
three-plasmid	B-X
expression	B-X
vector	B-X
system	B-X
was	B-X
utilized	B-X
to	B-X
study	B-X
the	B-X
effects	B-X
of	B-X
intracellularly	B-X
expressed	B-X
Vpr	B-X
.	B-X
These	B-X
virion	B-X
preparations	B-X
were	B-X
then	B-X
used	B-X
to	B-X
transduce	B-X
neurons	B-X
generated	B-X
from	B-X
the	B-X
human	B-X
neuronal	B-X
precursor	B-X
NT2	B-X
cell-line	B-X
.	B-X
Intracellularly	B-X
expressed	B-X
Vpr	B-X
induced	B-X
apoptosis	B-X
within	B-X
terminally	B-X
differentiated	B-X
neurons	B-X
,	B-X
as	B-X
demonstrated	B-X
by	B-X
TUNEL	B-X
assays	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
HIV-1	B-X
Vpr	B-X
may	B-X
also	B-X
be	B-X
leading	B-X
directly	B-X
to	B-X
selective	B-X
neurotoxicity	B-X
through	B-X
intracellular	B-X
expression	B-X
.	B-X
Furthermore	B-X
,	B-X
human	B-X
apoptosis	B-X
gene	B-X
microarray	B-X
comparisons	B-X
exhibited	B-X
an	B-X
up-regulation	B-X
of	B-X
Bcl-2-related	B-X
mRNA	B-X
,	B-X
as	B-X
well	B-X
as	B-X
other	B-X
apoptosis	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
,	B-X
for	B-X
the	B-X
Vpr-transduced	B-X
neuronal	B-X
cells	B-X
,	B-X
when	B-X
compared	B-X
to	B-X
Vpr-negative	B-X
controls	B-X
.	B-X
Thus	B-X
,	B-X
Vpr	B-X
delivered	B-X
intracellularly	B-X
,	B-X
as	B-X
well	B-X
as	B-X
extracellularly	B-X
,	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
significant	B-X
neuronal	B-X
apoptosis	B-X
and	B-X
may	B-X
be	B-X
one	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
in	B-X
HIV-1-induced	B-X
encephalopathy	B-X
.	B-X

As	O
expected	O
,	O
these	O
included	O
genes	O
that	O
encoded	O
OMPs	O
like	O
Omp25a	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
0722	I-Protein
)	O
and	O
Omp25d	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
0115	I-Protein
)	O
which	O
were	O
down	O
-	O
regulated	O
.	O

Other	O
bvrR	B-Protein
regulated	O
genes	O
related	O
with	O
cell	O
envelope	O
were	O
:	O
three	O
lipoprotein	O
genes	O
(	O
BAB1	B-Protein
_	I-Protein
0358	I-Protein
;	O
BAB1	B-Protein
_	I-Protein
0589	I-Protein
;	O
BAB1	B-Protein
_	I-Protein
2147	I-Protein
)	O
,	O
which	O
were	O
down	O
-	O
regulated	O
;	O
six	O
genes	O
for	O
periplasmic	O
proteins	O
and	O
chaperones	O
(	O
htpX	B-Protein
,	O
heat	O
shock	O
protein	O
,	O
BAB1	B-Protein
_	I-Protein
1821	I-Protein
;	O
clpA	B-Protein
and	O
clpB	B-Protein
,	O
stress	O
response	O
proteins	O
,	O
BAB1	B-Protein
_	I-Protein
1573	I-Protein
and	O
BAB1	B-Protein
_	I-Protein
1868	I-Protein
,	O
respectively	O
;	O
BAB2	B-Protein
_	I-Protein
1107	I-Protein
;	O
BAB1	B-Protein
_	I-Protein
0505	I-Protein
;	O
BAB1	B-Protein
_	I-Protein
1022	I-Protein
)	O
,	O
which	O
were	O
all	O
up	O
-	O
regulated	O
;	O
one	O
gene	O
related	O
with	O
LPS	O
biosynthesis	O
(	O
glycosyl	O
transferase	O
,	O
BAB1	B-Protein
_	I-Protein
1620	I-Protein
)	O
,	O
which	O
was	O
up	O
-	O
regulated	O
;	O
and	O
five	O
genes	O
for	O
fatty	O
acids	O
biosynthesis	O
(	O
fabG	B-Protein
,	O
ketoacyl	O
-	O
acyl	O
-	O
carrier	O
-	O
protein	O
reductase	O
,	O
BAB1	B-Protein
_	I-Protein
2043	I-Protein
;	O
fabF	B-Protein
,	O
oxoacyl	O
-	O
acyl	O
-	O
carrier	O
-	O
protein	O
synthase	O
,	O
BAB1	B-Protein
_	I-Protein
0872	I-Protein
;	O
fadD	B-Protein
,	O
fatty	O
-	O
acyl	O
-	O
CoA	O
synthase	O
,	O
BAB1	B-Protein
_	I-Protein
0320	I-Protein
;	O
cfa	B-Protein
,	O
cyclopropane	O
-	O
fatty	O
-	O
acyl	O
-	O
phospholipid	O
synthase	O
,	O
BAB1	B-Protein
_	I-Protein
0476	I-Protein
;	O
BAB1	B-Protein
_	I-Protein
1357	I-Protein
)	O
.	O

These	O
data	O
confirm	O
that	O
BvrR	B-Protein
/	O
BvrS	B-Protein
regulates	O
bacterial	O
envelope	O
changes	O
that	O
could	O
modify	O
surface	O
properties	O
relevant	O
for	O
Brucella	O
virulence	O
[	O
6	O
]	O
.	O

Regulation	O
of	O
carbon	O
and	O
nitrogen	O
metabolism	O
<EOS>	B-X
Complex	B-X
mechanisms	B-X
regulate	B-X
C	B-X
and	B-X
N	B-X
metabolism	B-X
to	B-X
optimize	B-X
plant	B-X
growth	B-X
,	B-X
agricultural	B-X
crop	B-X
production	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
the	B-X
agroecosystem	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
,	B-X
we	B-X
cover	B-X
the	B-X
recent	B-X
advances	B-X
in	B-X
understanding	B-X
C	B-X
and	B-X
N	B-X
metabolism	B-X
,	B-X
regulation	B-X
,	B-X
and	B-X
transport	B-X
in	B-X
plants	B-X
,	B-X
as	B-X
well	B-X
as	B-X
their	B-X
underlying	B-X
molecular	B-X
mechanisms	B-X
.	B-X
Special	B-X
emphasis	B-X
is	B-X
given	B-X
to	B-X
the	B-X
mechanisms	B-X
of	B-X
starch	B-X
metabolism	B-X
in	B-X
plastids	B-X
and	B-X
the	B-X
changes	B-X
in	B-X
responses	B-X
to	B-X
environmental	B-X
stress	B-X
that	B-X
were	B-X
previously	B-X
overlooked	B-X
,	B-X
since	B-X
these	B-X
changes	B-X
provide	B-X
an	B-X
essential	B-X
store	B-X
of	B-X
C	B-X
that	B-X
fuels	B-X
plant	B-X
metabolism	B-X
and	B-X
growth	B-X
.	B-X
We	B-X
present	B-X
general	B-X
insights	B-X
into	B-X
the	B-X
system	B-X
biology	B-X
approaches	B-X
that	B-X
have	B-X
expanded	B-X
our	B-X
understanding	B-X
of	B-X
core	B-X
biological	B-X
questions	B-X
related	B-X
to	B-X
C	B-X
and	B-X
N	B-X
metabolism	B-X
.	B-X

One	O
of	O
the	O
remarkable	O
findings	O
observed	O
in	O
our	O
microarray	O
analysis	O
was	O
that	O
several	O
genes	O
related	O
with	O
metabolism	O
were	O
also	O
differentially	O
expressed	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
relevance	B-X
of	B-X
these	B-X
models	B-X
to	B-X
smoking-related	B-X
lung	B-X
disease	B-X
in	B-X
humans	B-X
is	B-X
uncertain	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
developed	B-X
an	B-X
exon-junction	B-X
microarray-based	B-X
assay	B-X
and	B-X
profiled	B-X
1532	B-X
mRNA	B-X
splice	B-X
isoforms	B-X
from	B-X
364	B-X
potential	B-X
prostate	B-X
cancer	B-X
related	B-X
genes	B-X
in	B-X
38	B-X
prostate	B-X
tissues	B-X
.	B-X
Maternal	B-X
diet	B-X
is	B-X
associated	B-X
with	B-X
the	B-X
development	B-X
of	B-X
metabolism-related	B-X
and	B-X
other	B-X
non-communicable	B-X
diseases	B-X
in	B-X
offspring	B-X
.	B-X
The	B-X
impact	B-X
of	B-X
maternal	B-X
WSD	B-X
on	B-X
the	B-X
pups	B-X
'	B-X
liver	B-X
gene	B-X
expression	B-X
was	B-X
characterised	B-X
by	B-X
whole-transcriptome	B-X
microarray	B-X
analysis	B-X
.	B-X
In	B-X
total	B-X
,	B-X
686	B-X
and	B-X
604	B-X
genes	B-X
were	B-X
differentially	B-X
expressed	B-X
in	B-X
liver	B-X
(	B-X
p≤0.01	B-X
)	B-X
of	B-X
males	B-X
and	B-X
females	B-X
,	B-X
respectively	B-X
.	B-X
Only	B-X
10	B-X
%	B-X
of	B-X
these	B-X
significantly	B-X
changed	B-X
genes	B-X
overlapped	B-X
in	B-X
both	B-X
sexes	B-X
.	B-X
In	B-X
males	B-X
,	B-X
in	B-X
particular	B-X
alterations	B-X
of	B-X
gene	B-X
expression	B-X
with	B-X
respect	B-X
to	B-X
developmental	B-X
functions	B-X
and	B-X
processes	B-X
were	B-X
observed	B-X
,	B-X
such	B-X
as	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
In	B-X
females	B-X
,	B-X
mainly	B-X
genes	B-X
important	B-X
for	B-X
lipid	B-X
metabolism	B-X
,	B-X
including	B-X
cholesterol	B-X
synthesis	B-X
,	B-X
were	B-X
changed	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
observed	B-X
biological	B-X
responses	B-X
of	B-X
the	B-X
offspring	B-X
reveal	B-X
pronounced	B-X
sex-specificity	B-X
.	B-X

These	O
included	O
twelve	O
genes	O
encoding	O
ABC	O
transport	O
systems	O
(	O
matE	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
0340	I-Protein
;	O
dctM	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
0372	I-Protein
;	O
fhuD	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
1366	I-Protein
;	O
yadH	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
1368	I-Protein
;	O
oppA	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
1601	I-Protein
;	O
oppC	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
1051	I-Protein
;	O
oppD	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
0817	I-Protein
;	O
potC	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
1624	I-Protein
;	O
ssuB	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
0917	I-Protein
;	O
ugpC	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
1143	I-Protein
;	O
BAB2	B-Protein
_	I-Protein
0794	I-Protein
;	O
BAB2	B-Protein
_	I-Protein
1139	I-Protein
)	O
,	O
ten	O
genes	O
related	O
with	O
carbohydrate	O
,	O
amino	O
or	O
fatty	O
acids	O
metabolism	O
and	O
five	O
related	O
with	O
nitrogen	O
metabolism	O
.	O

Interestingly	O
,	O
all	O
genes	O
related	O
with	O
carbohydrate	O
,	O
amino	O
or	O
fatty	O
acids	O
metabolism	O
were	O
up	O
-	O
regulated	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O
<EOS>	B-X
Interestingly	B-X
,	B-X
these	B-X
lectins	B-X
accumulate	B-X
in	B-X
the	B-X
nucleocytoplasmic	B-X
compartment	B-X
of	B-X
plant	B-X
cells	B-X
.	B-X
At	B-X
present	B-X
at	B-X
least	B-X
six	B-X
carbohydrate	B-X
recognition	B-X
domains	B-X
have	B-X
been	B-X
identified	B-X
within	B-X
the	B-X
group	B-X
of	B-X
nucleocytoplasmic	B-X
plant	B-X
lectins	B-X
.	B-X
The	B-X
tobacco	B-X
lectin	B-X
is	B-X
a	B-X
38	B-X
kDa	B-X
nucleocytoplasmic	B-X
protein	B-X
which	B-X
is	B-X
only	B-X
expressed	B-X
upon	B-X
treatment	B-X
with	B-X
jasmonate-related	B-X
compounds	B-X
or	B-X
after	B-X
insect	B-X
herbivory	B-X
.	B-X
Extensive	B-X
searches	B-X
revealed	B-X
that	B-X
Nictaba-related	B-X
sequences	B-X
are	B-X
widespread	B-X
in	B-X
the	B-X
plant	B-X
kingdom	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
different	B-X
transcriptome	B-X
databases	B-X
showed	B-X
that	B-X
the	B-X
Nictaba	B-X
domain	B-X
is	B-X
often	B-X
part	B-X
of	B-X
chimeric	B-X
proteins	B-X
comprising	B-X
one	B-X
or	B-X
more	B-X
Nictaba	B-X
domain	B-X
(	B-X
s	B-X
)	B-X
fused	B-X
to	B-X
unrelated	B-X
N-	B-X
and	B-X
C-terminal	B-X
domains	B-X
with	B-X
(	B-X
un	B-X
)	B-X
known	B-X
function	B-X
.	B-X
At	B-X
present	B-X
only	B-X
few	B-X
proteins	B-X
of	B-X
these	B-X
Nictaba-related	B-X
proteins	B-X
have	B-X
been	B-X
studied	B-X
and	B-X
characterized	B-X
for	B-X
their	B-X
biological	B-X
properties	B-X
and	B-X
physiological	B-X
role	B-X
.	B-X
Despite	B-X
the	B-X
sequence	B-X
similarity	B-X
and	B-X
the	B-X
conserved	B-X
amino	B-X
acids	B-X
constituting	B-X
the	B-X
binding	B-X
site	B-X
,	B-X
the	B-X
Nictaba	B-X
domain	B-X
has	B-X
a	B-X
promiscuous	B-X
carbohydrate	B-X
binding	B-X
site	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
different	B-X
carbohydrate	B-X
motifs	B-X
,	B-X
suggesting	B-X
that	B-X
subtle	B-X
changes	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
binding	B-X
site	B-X
can	B-X
alter	B-X
its	B-X
sugar	B-X
specificity	B-X
.	B-X

These	O
included	O
the	O
first	O
enzyme	O
in	O
gluconeogenesis	O
(	O
pckA	B-Protein
,	O
phosphoenolpyruvate	O
carboxykinase	O
,	O
BAB1	B-Protein
_	I-Protein
2091	I-Protein
)	O
,	O
four	O
genes	O
involved	O
in	O
TCA	O
cycle	O
and	O
pyruvate	O
metabolism	O
(	O
fumB	B-Protein
,	O
fumarate	O
hydratase	O
,	O
BAB1	B-Protein
_	I-Protein
0977	I-Protein
;	O
lpdA	B-Protein
,	O
dihydrolipoamide	O
dehydrogenase	O
,	O
BAB2	B-Protein
_	I-Protein
0712	I-Protein
;	O
pyruvate	O
dehydrogenase	O
,	O
BAB2	B-Protein
_	I-Protein
0032	I-Protein
;	O
acetyl	O
-	O
CoA	O
acetyltransferase	O
,	O
BAB2	B-Protein
_	I-Protein
0443	I-Protein
)	O
,	O
three	O
genes	O
involved	O
in	O
amino	O
or	O
fatty	O
acid	O
metabolism	O
(	O
aldehyde	O
dehydrogenases	O
,	O
BAB2	B-Protein
_	I-Protein
1130	I-Protein
,	O
BAB2	B-Protein
_	I-Protein
1114	I-Protein
;	O
hydroxymethylglutaryl	O
-	O
CoA	O
lyase	O
,	O
BAB1	B-Protein
_	I-Protein
0017	I-Protein
)	O
,	O
and	O
two	O
genes	O
involve	O
in	O
benzoate	O
degradation	O
(	O
pcaC	B-Protein
,	O
carboxymuconolactone	O
decarboxylase	O
,	O
BAB2	B-Protein
_	I-Protein
0597	I-Protein
;	O
pcaI	B-Protein
,	O
coenzyme	O
A	O
transferase	O
,	O
BAB2	B-Protein
_	I-Protein
0604	I-Protein
)	O
.	O

In	O
addition	O
,	O
the	O
complete	O
maltose	O
transport	O
system	O
of	O
Brucella	O
,	O
which	O
consists	O
in	O
a	O
large	O
operon	O
containing	O
thirteen	O
genes	O
(	O
BAB1	B-Protein
_	I-Protein
0236	I-Protein
-	O
0248	B-Protein
)	O
was	O
also	O
affected	O
.	O

Ten	O
of	O
these	O
genes	O
,	O
including	O
malK	B-Protein
,	O
malG	B-Protein
,	O
malF	B-Protein
,	O
malE	B-Protein
and	O
an	O
iclR	B-Protein
regulator	O
,	O
were	O
down	O
-	O
regulated	O
suggesting	O
that	O
the	O
complete	O
operon	O
was	O
negatively	O
regulated	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O

Although	O
it	O
has	O
been	O
showed	O
that	O
the	O
mutants	O
in	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
have	O
no	O
obvious	O
defects	O
with	O
regard	O
to	O
the	O
ability	O
to	O
grow	O
on	O
standard	O
media	O
[	O
4	O
]	O
,	O
our	O
microarray	O
results	O
suggests	O
that	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
controls	O
elements	O
directly	O
involved	O
in	O
adjusting	O
the	O
Brucella	O
metabolism	O
to	O
the	O
nutrient	O
shift	O
expected	O
to	O
occur	O
during	O
the	O
transit	O
to	O
the	O
intracellular	O
niche	O
.	O

To	O
determine	O
if	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
affects	O
the	O
metabolism	O
,	O
bvrR	B-Protein
mutant	O
and	O
wild	O
type	O
strains	O
were	O
grown	O
in	O
synthetic	O
minimal	O
media	O
.	O

As	O
show	O
in	O
Figure	O
3	O
,	O
growth	O
of	O
the	O
bvrR	B-Protein
mutant	O
was	O
significantly	O
reduced	O
in	O
minimal	O
media	O
.	O

Other	O
genes	O
differentially	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
included	O
denitrification	O
genes	O
.	O

The	O
nitrite	O
reductase	O
gene	O
(	O
nirK	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
0943	I-Protein
)	O
was	O
down	O
regulated	O
and	O
the	O
nitric	O
oxide	O
and	O
nitrous	O
oxide	O
reductases	O
genes	O
(	O
nor	B-Protein
C	I-Protein
,	O
BAB2	B-Protein
_	I-Protein
0955	I-Protein
;	O
nosZ	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
0928	I-Protein
)	O
were	O
up	O
regulated	O
.	O

On	O
the	O
other	O
hand	O
,	O
two	O
deaminases	O
(	O
glutaminase	O
,	O
BAB2	B-Protein
_	I-Protein
0863	I-Protein
;	O
guanine	O
deaminase	O
,	O
BAB1	B-Protein
_	I-Protein
0383	I-Protein
)	O
were	O
also	O
affected	O
.	O

Since	O
Brucella	O
is	O
an	O
intracellular	O
facultative	O
pathogen	O
,	O
the	O
bacteria	O
could	O
use	O
these	O
denitrification	O
reactions	O
to	O
grow	O
under	O
low	O
-	O
oxygen	O
condition	O
by	O
respiration	O
of	O
nitrate	O
.	O

Brucella	O
may	O
also	O
take	O
advantage	O
of	O
denitrification	O
to	O
cope	O
with	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
in	O
the	O
macrophage	O
during	O
the	O
innate	O
response	O
against	O
infection	O
.	O

In	O
fact	O
,	O
some	O
of	O
these	O
denitrification	O
genes	O
have	O
been	O
related	O
with	O
the	O
virulence	O
in	O
mice	O
[	O
10	O
]	O
,	O
[	O
11	O
]	O
.	O

Interestingly	O
,	O
our	O
experiments	O
to	O
study	O
the	O
intracellular	O
transcriptional	O
level	O
of	O
BvrR	B-Protein
/	O
BvrS	B-Protein
controlled	O
genes	O
(	O
see	O
below	O
)	O
showed	O
that	O
whereas	O
norC	B-Protein
was	O
induced	O
intracellularly	O
,	O
nirK	B-Protein
and	O
nosZ	B-Protein
were	O
less	O
expressed	O
.	O

Taken	O
together	O
all	O
these	O
data	O
support	O
the	O
proposal	O
that	O
one	O
role	O
of	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
could	O
be	O
neutralize	O
the	O
production	O
of	O
toxic	O
reactive	O
nitrogen	O
molecules	O
,	O
as	O
NO	O
,	O
by	O
the	O
host	O
.	O

These	O
results	O
also	O
demonstrated	O
a	O
connection	O
between	O
carbon	O
and	O
nitrogen	O
metabolism	O
and	O
BvrR	B-Protein
/	O
BvrS	B-Protein
in	O
Brucella	O
.	O

Our	O
results	O
also	O
demonstrated	O
that	O
gene	O
hpr	B-Protein
-	I-Protein
K	I-Protein
(	O
BAB1	B-Protein
_	I-Protein
2094	I-Protein
)	O
,	O
a	O
member	O
of	O
the	O
Brucella	O
phosphotransferase	O
system	O
(	O
PTS	O
;	O
BAB1	B-Protein
_	I-Protein
2097	I-Protein
-	O
2094	B-Protein
)	O
adjacent	O
to	O
the	O
bvrR	B-Protein
/	O
bvrS	B-Protein
,	O
was	O
down	O
-	O
regulated	O
.	O

As	O
mentioned	O
before	O
,	O
phosphoenolpyruvate	O
carboxykinase	O
gene	O
(	O
pckA	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
2091	I-Protein
)	O
which	O
is	O
located	O
upstream	O
of	O
the	O
regulatory	O
gene	O
bvrR	B-Protein
and	O
divergently	O
expressed	O
was	O
up	O
-	O
regulated	O
.	O

Comparative	O
genome	O
analysis	O
revealed	O
that	O
in	O
addition	O
to	O
the	O
bvrR	B-Protein
/	O
bvrS	B-Protein
genes	O
,	O
the	O
genome	O
structure	O
around	O
these	O
genes	O
is	O
essentially	O
the	O
same	O
for	O
all	O
the	O
alpha	O
-	O
proteobacteria	O
[	O
5	O
]	O
.	O

Genes	O
encoding	O
proteins	O
related	O
to	O
the	O
PTS	O
,	O
including	O
a	O
HPr	B-Protein
Ser	O
-	O
kinase	O
,	O
an	O
EIIA	O
permease	O
of	O
the	O
mannose	O
family	O
and	O
a	O
HPr	B-Protein
homologue	O
precede	O
those	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
.	O

In	O
most	O
of	O
these	O
loci	O
,	O
upstream	O
of	O
the	O
regulatory	O
gene	O
the	O
pckA	B-Protein
is	O
divergently	O
expressed	O
(	O
Figure	O
2	O
)	O
.	O

This	O
gene	O
catalyzes	O
the	O
reversible	O
decarboxylation	O
and	O
phosphorylation	O
of	O
oxaloacetate	O
to	O
form	O
phosphoenolpyruvate	O
.	O
<EOS>	B-X
The	B-X
pckA	B-X
gene	B-X
,	B-X
encoding	B-X
phosphoenolpyruvate	B-X
carboxykinase	B-X
,	B-X
catalyzes	B-X
the	B-X
reversible	B-X
decarboxylation	B-X
and	B-X
phosphorylation	B-X
of	B-X
oxaloacetate	B-X
to	B-X
form	B-X
phosphoenolpyruvate	B-X
.	B-X
Using	B-X
a	B-X
reporter	B-X
gene	B-X
fusion	B-X
,	B-X
studies	B-X
showed	B-X
that	B-X
the	B-X
pckA	B-X
gene	B-X
is	B-X
induced	B-X
by	B-X
acidic	B-X
pH	B-X
but	B-X
not	B-X
by	B-X
acetosyringone	B-X
.	B-X
This	B-X
acid	B-X
induction	B-X
is	B-X
regulated	B-X
by	B-X
the	B-X
chvG-chvI	B-X
regulatory	B-X
system	B-X
,	B-X
which	B-X
controls	B-X
acid-inducible	B-X
genes	B-X
.	B-X
A	B-X
pckA	B-X
mutant	B-X
was	B-X
highly	B-X
attenuated	B-X
in	B-X
tumor-inducing	B-X
ability	B-X
on	B-X
tobacco	B-X
leaf	B-X
disks	B-X
and	B-X
was	B-X
severely	B-X
attenuated	B-X
in	B-X
vir	B-X
gene	B-X
expression	B-X
.	B-X
Although	B-X
vir	B-X
gene	B-X
induction	B-X
was	B-X
completely	B-X
restored	B-X
when	B-X
a	B-X
constitutive	B-X
virG	B-X
gene	B-X
was	B-X
introduced	B-X
into	B-X
the	B-X
mutant	B-X
strain	B-X
,	B-X
virulence	B-X
was	B-X
only	B-X
partially	B-X
restored	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
avirulence	B-X
may	B-X
be	B-X
due	B-X
to	B-X
a	B-X
combination	B-X
of	B-X
the	B-X
inhibition	B-X
of	B-X
this	B-X
mutant	B-X
in	B-X
the	B-X
acidic	B-X
plant	B-X
wound	B-X
environment	B-X
and	B-X
the	B-X
poor	B-X
induction	B-X
of	B-X
the	B-X
vir	B-X
genes	B-X
.	B-X

In	O
alpha	O
-	O
proteobacteria	O
,	O
it	O
has	O
been	O
proposed	O
that	O
HPr	B-Protein
might	O
control	O
the	O
phosphorylation	O
state	O
of	O
the	O
transcription	O
regulator	O
[	O
12	O
]	O
-	O
[	O
14	O
]	O
.	O

In	O
this	O
regard	O
,	O
Letesson	O
and	O
col	O
.	O

[	O
15	O
]	O
have	O
suggested	O
that	O
in	O
Brucella	O
the	O
PTS	O
could	O
interact	O
with	O
the	O
BvrS	B-Protein
sensor	O
kinase	O
,	O
which	O
in	O
turn	O
phosphorylates	O
the	O
response	O
regulator	O
.	O

Then	O
,	O
the	O
BvrR	B-Protein
could	O
control	O
transcription	O
of	O
the	O
pckA	B-Protein
gene	O
,	O
which	O
encodes	O
an	O
essential	O
control	O
enzyme	O
of	O
the	O
gluconeogenesis	O
and	O
Krebs	O
cycle	O
.	O

This	O
hypothesis	O
could	O
explain	O
the	O
observation	O
that	O
mutants	O
in	O
the	O
regulatory	O
gene	O
bvrR	B-Protein
were	O
inhibited	O
in	O
minimal	O
media	O
(	O
see	O
above	O
)	O
.	O

According	O
to	O
this	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
in	O
A	O
.	O
tumefaciens	O
the	O
pckA	B-Protein
genes	O
is	O
indeed	O
under	O
the	O
control	O
of	O
ChvG	B-Protein
/	O
ChvI	B-Protein
[	O
16	O
]	O
and	O
that	O
null	O
mutants	O
in	O
S	O
.	O
meliloti	O
exoS	B-Protein
and	O
chvI	B-Protein
have	O
pleiotropic	O
growth	O
defects	O
and	O
were	O
unable	O
to	O
grow	O
on	O
several	O
carbon	O
sources	O
[	O
17	O
]	O
.	O

A	O
link	O
between	O
carbon	O
and	O
nitrogen	O
metabolism	O
,	O
PTS	O
and	O
two	O
-	O
component	O
regulatory	O
systems	O
have	O
been	O
proposed	O
for	O
some	O
bacteria	O
[	O
18	O
]	O
,	O
and	O
our	O
microarray	O
results	O
strongly	O
suggest	O
that	O
same	O
relationship	O
could	O
be	O
made	O
for	O
Brucella	O
.	O

BvrR	B-Protein
/	O
BvrS	B-Protein
and	O
the	O
expression	O
of	O
other	O
transcriptional	O
regulators	O
<EOS>	B-X
The	B-X
two-component	B-X
BvrS/BvrR	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
Brucella	B-X
abortus	B-X
virulence	B-X
.	B-X
It	B-X
was	B-X
shown	B-X
previously	B-X
that	B-X
its	B-X
dysfunction	B-X
abrogates	B-X
expression	B-X
of	B-X
some	B-X
major	B-X
outer	B-X
membrane	B-X
proteins	B-X
and	B-X
increases	B-X
bactericidal	B-X
peptide	B-X
sensitivity	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
BvrS/BvrR	B-X
mutants	B-X
have	B-X
increased	B-X
surface	B-X
hydrophobicity	B-X
and	B-X
susceptibility	B-X
to	B-X
killing	B-X
by	B-X
nonimmune	B-X
serum	B-X
.	B-X
The	B-X
bvrS	B-X
and	B-X
bvrR	B-X
mutant	B-X
lipopolysaccharides	B-X
(	B-X
LPSs	B-X
)	B-X
bound	B-X
more	B-X
polymyxin	B-X
B	B-X
,	B-X
chimeras	B-X
constructed	B-X
with	B-X
bvrS	B-X
mutant	B-X
cells	B-X
and	B-X
parental	B-X
LPS	B-X
showed	B-X
augmented	B-X
polymyxin	B-X
B	B-X
resistance	B-X
,	B-X
and	B-X
,	B-X
conversely	B-X
,	B-X
parental	B-X
cells	B-X
and	B-X
bvrS	B-X
mutant	B-X
LPS	B-X
chimeras	B-X
were	B-X
more	B-X
sensitive	B-X
and	B-X
displayed	B-X
polymyxin	B-X
B-characteristic	B-X
outer	B-X
membrane	B-X
lesions	B-X
,	B-X
implicating	B-X
LPS	B-X
as	B-X
being	B-X
responsible	B-X
for	B-X
the	B-X
phenotype	B-X
of	B-X
the	B-X
BvrS/BvrR	B-X
mutants	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
in	B-X
Brucella	B-X
the	B-X
outer	B-X
membrane	B-X
homeostasis	B-X
depends	B-X
on	B-X
the	B-X
functioning	B-X
of	B-X
BvrS/BvrR	B-X
.	B-X
Accordingly	B-X
,	B-X
disruption	B-X
of	B-X
BvrS/BvrR	B-X
damages	B-X
the	B-X
outer	B-X
membrane	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
severe	B-X
attenuation	B-X
manifested	B-X
by	B-X
bvrS	B-X
and	B-X
bvrR	B-X
mutants	B-X
.	B-X

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
genes	O
were	O
also	O
differentially	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
compared	O
to	O
parental	O
strain	O
:	O
BAB1	B-Protein
_	I-Protein
0237	I-Protein
,	O
BAB1	B-Protein
_	I-Protein
0891	I-Protein
(	O
exoR	B-Protein
)	O
,	O
BAB1	B-Protein
_	I-Protein
1397	I-Protein
,	O
BAB2	B-Protein
_	I-Protein
0118	I-Protein
(	O
vjbR	B-Protein
)	O
,	O
BAB2	B-Protein
_	I-Protein
0762	I-Protein
(	O
ompR	B-Protein
)	O
,	O
BAB2	B-Protein
_	I-Protein
1127	I-Protein
and	O
BAB2	B-Protein
_	I-Protein
1152	I-Protein
.	O

Three	O
of	O
these	O
,	O
namely	O
exoR	B-Protein
,	O
ompR	B-Protein
and	O
vjbR	B-Protein
are	O
down	O
regulated	O
and	O
have	O
been	O
previously	O
implicated	O
in	O
Brucella	O
virulence	O
.	O

B	O
.	O
melitensis	O
vjbR	B-Protein
mutant	O
is	O
highly	O
attenuated	O
in	O
both	O
cellular	O
and	O
mouse	O
models	O
of	O
infection	O
[	O
19	O
]	O
.	O
<EOS>	B-X
Brucellosis	B-X
,	B-X
caused	B-X
by	B-X
Brucella	B-X
spp.	B-X
,	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
serious	B-X
zoonotic	B-X
bacterial	B-X
diseases	B-X
.	B-X
Small	B-X
RNAs	B-X
(	B-X
sRNAs	B-X
)	B-X
are	B-X
recognized	B-X
as	B-X
a	B-X
key	B-X
player	B-X
in	B-X
bacterial	B-X
post-transcription	B-X
regulation	B-X
,	B-X
since	B-X
they	B-X
participate	B-X
in	B-X
many	B-X
biological	B-X
processes	B-X
with	B-X
high	B-X
efficiency	B-X
and	B-X
may	B-X
govern	B-X
the	B-X
intracellular	B-X
biochemistry	B-X
and	B-X
virulence	B-X
of	B-X
some	B-X
pathogenic	B-X
bacteria	B-X
.	B-X
Here	B-X
,	B-X
a	B-X
novel	B-X
small	B-X
regulatory	B-X
RNA	B-X
,	B-X
Bmsr1	B-X
(	B-X
Brucella	B-X
melitensis	B-X
M28	B-X
small	B-X
RNA	B-X
1	B-X
)	B-X
,	B-X
was	B-X
identified	B-X
in	B-X
a	B-X
virulent	B-X
Brucella	B-X
melitensis	B-X
M28	B-X
strain	B-X
based	B-X
on	B-X
bioinformatic	B-X
analysis	B-X
,	B-X
reverse	B-X
transcription	B-X
PCR	B-X
(	B-X
RT-PCR	B-X
)	B-X
,	B-X
and	B-X
Northern	B-X
blot	B-X
.	B-X
The	B-X
Bmsr1	B-X
expression	B-X
level	B-X
was	B-X
highly	B-X
induced	B-X
after	B-X
infection	B-X
of	B-X
macrophage	B-X
cells	B-X
RAW264.7	B-X
at	B-X
48	B-X
h	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
Bmsr1	B-X
during	B-X
in	B-X
vitro	B-X
infection	B-X
.	B-X
Indeed	B-X
,	B-X
bmsr1	B-X
deletion	B-X
mutant	B-X
of	B-X
M28	B-X
attenuated	B-X
its	B-X
intracellular	B-X
survival	B-X
in	B-X
RAW264.7	B-X
at	B-X
24	B-X
h	B-X
and	B-X
48	B-X
h	B-X
post-infection	B-X
.	B-X
In	B-X
a	B-X
mouse	B-X
model	B-X
of	B-X
chronic	B-X
infection	B-X
,	B-X
bmsr1	B-X
deletion	B-X
strain	B-X
displayed	B-X
decreased	B-X
colonization	B-X
in	B-X
the	B-X
spleen	B-X
while	B-X
Bmsr1-overexpressed	B-X
strain	B-X
showed	B-X
higher	B-X
colonization	B-X
levels	B-X
than	B-X
wild	B-X
type	B-X
pathogen	B-X
.	B-X
iTRAQ	B-X
results	B-X
combined	B-X
with	B-X
target	B-X
prediction	B-X
identified	B-X
several	B-X
potential	B-X
target	B-X
genes	B-X
related	B-X
to	B-X
virulence	B-X
,	B-X
including	B-X
virB2	B-X
,	B-X
virB9	B-X
,	B-X
virB10	B-X
,	B-X
virB11	B-X
,	B-X
and	B-X
vjbR	B-X
and	B-X
many	B-X
metabolism	B-X
genes	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
revealed	B-X
the	B-X
contribution	B-X
of	B-X
a	B-X
novel	B-X
sRNA	B-X
Bmsr1	B-X
to	B-X
virulence	B-X
of	B-X
B.	B-X
melitensis	B-X
M28	B-X
,	B-X
probably	B-X
by	B-X
influencing	B-X
genes	B-X
involved	B-X
in	B-X
T4SS	B-X
,	B-X
virulence	B-X
regulator	B-X
VjbR	B-X
and	B-X
other	B-X
metabolism	B-X
genes	B-X
.	B-X

VjbR	B-Protein
has	O
been	O
described	O
as	O
a	O
transcriptional	O
regulator	O
able	O
to	O
activate	O
directly	O
the	O
secretion	O
system	O
virB	B-Protein
operon	O
and	O
the	O
flagellar	O
genes	O
,	O
both	O
virulence	O
factors	O
associated	O
to	O
the	O
surface	O
of	O
the	O
bacteria	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

Moreover	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
VjbR	B-Protein
controls	O
the	O
synthesis	O
of	O
exopolysaccharides	O
and	O
the	O
productions	O
of	O
several	O
OMPs	O
,	O
some	O
of	O
which	O
are	O
also	O
involved	O
in	O
virulence	O
[	O
22	O
]	O
.	O

Interestingly	O
,	O
our	O
results	O
also	O
showed	O
that	O
the	O
expression	O
of	O
vjbR	B-Protein
was	O
also	O
induced	O
intracellularly	O
(	O
see	O
below	O
)	O
.	O

All	O
these	O
data	O
suggest	O
that	O
VjbR	B-Protein
,	O
similarly	O
to	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
,	O
is	O
involved	O
in	O
the	O
control	O
of	O
outer	O
membrane	O
composition	O
and	O
virulence	O
.	O

In	O
addition	O
,	O
DeJong	O
and	O
col	O
[	O
20	O
]	O
have	O
demonstrated	O
that	O
among	O
the	O
promoters	O
which	O
expression	O
is	O
dependent	O
of	O
the	O
VjbR	B-Protein
regulator	O
,	O
is	O
the	O
ompR	B-Protein
gene	O
,	O
the	O
regulator	O
of	O
the	O
OmpR	B-Protein
/	O
EnvZ	B-Protein
two	O
component	O
system	O
.	O

E	O
.	O
coli	O
OmpR	B-Protein
/	O
EnvZ	B-Protein
system	O
controls	O
the	O
transcription	O
of	O
the	O
outer	O
membrane	O
porins	O
OmpF	B-Protein
and	O
OmpC	B-Protein
in	O
response	O
to	O
osmolarity	O
[	O
23	O
]	O
.	O
<EOS>	B-X
The	B-X
two-component	B-X
system	B-X
(	B-X
TCS	B-X
)	B-X
is	B-X
a	B-X
sophisticated	B-X
bacterial	B-X
signal	B-X
transduction	B-X
system	B-X
for	B-X
regulation	B-X
of	B-X
genome	B-X
transcription	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
conditions	B-X
.	B-X
The	B-X
EnvZ-OmpR	B-X
system	B-X
is	B-X
one	B-X
of	B-X
the	B-X
well-characterized	B-X
TCS	B-X
of	B-X
Escherichia	B-X
coli	B-X
,	B-X
responding	B-X
to	B-X
changes	B-X
in	B-X
environmental	B-X
osmolality	B-X
.	B-X
Regulation	B-X
has	B-X
largely	B-X
focused	B-X
on	B-X
the	B-X
differential	B-X
expression	B-X
of	B-X
two	B-X
porins	B-X
,	B-X
OmpF	B-X
and	B-X
OmpC	B-X
,	B-X
which	B-X
transport	B-X
small	B-X
molecules	B-X
across	B-X
the	B-X
outer	B-X
membrane	B-X
.	B-X
Recently	B-X
,	B-X
it	B-X
has	B-X
become	B-X
apparent	B-X
that	B-X
OmpR	B-X
serves	B-X
a	B-X
more	B-X
global	B-X
regulatory	B-X
role	B-X
and	B-X
regulates	B-X
additional	B-X
targets	B-X
.	B-X
To	B-X
identify	B-X
the	B-X
entire	B-X
set	B-X
of	B-X
regulatory	B-X
targets	B-X
of	B-X
OmpR	B-X
,	B-X
we	B-X
performed	B-X
the	B-X
genomic	B-X
SELEX	B-X
screening	B-X
of	B-X
OmpR-binding	B-X
sites	B-X
along	B-X
the	B-X
E.	B-X
coli	B-X
genome	B-X
.	B-X
As	B-X
a	B-X
result	B-X
,	B-X
more	B-X
than	B-X
30	B-X
novel	B-X
genes	B-X
have	B-X
been	B-X
identified	B-X
to	B-X
be	B-X
under	B-X
the	B-X
direct	B-X
control	B-X
of	B-X
OmpR	B-X
.	B-X
One	B-X
abundant	B-X
group	B-X
includes	B-X
the	B-X
genes	B-X
encoding	B-X
a	B-X
variety	B-X
of	B-X
membrane-associated	B-X
transporters	B-X
that	B-X
mediate	B-X
uptake	B-X
or	B-X
efflux	B-X
of	B-X
small	B-X
molecules	B-X
,	B-X
while	B-X
another	B-X
group	B-X
encodes	B-X
a	B-X
set	B-X
of	B-X
transcription	B-X
regulators	B-X
,	B-X
raising	B-X
a	B-X
concept	B-X
that	B-X
OmpR	B-X
is	B-X
poised	B-X
to	B-X
control	B-X
a	B-X
diverse	B-X
set	B-X
of	B-X
responses	B-X
by	B-X
altering	B-X
downstream	B-X
transcriptional	B-X
regulators	B-X
.	B-X

Moreover	O
,	O
a	O
systematically	O
transcriptome	O
analysis	O
of	O
all	O
two	O
component	O
regulatory	O
systems	O
in	O
E	O
.	O
coli	O
has	O
demonstrated	O
that	O
the	O
OmpR	B-Protein
/	O
EnvZ	B-Protein
system	O
also	O
controls	O
the	O
metabolism	O
of	O
amino	O
acids	O
,	O
flagellar	O
synthesis	O
and	O
nutrient	O
transport	O
[	O
24	O
]	O
.	O

As	O
we	O
have	O
show	O
in	O
this	O
study	O
,	O
the	O
expression	O
of	O
at	O
least	O
three	O
flagellar	O
genes	O
(	O
fliM	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
0124	I-Protein
/	I-Protein
5	I-Protein
;	O
flgJ	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
0260	I-Protein
;	O
motB	B-Protein
,	O
BAB2	B-Protein
_	I-Protein
1103	I-Protein
)	O
were	O
increased	O
also	O
in	O
the	O
bvrR	B-Protein
mutant	O
(	O
Figure	O
2	O
)	O
.	O

The	O
two	O
-	O
regulatory	O
systems	O
ChvG	B-Protein
(	O
ExoS	B-Protein
)	O
/	O
ChvI	B-Protein
in	O
S	O
.	O
meliloti	O
and	O
A	O
.	O
tumefaciens	O
posses	O
a	O
high	O
level	O
of	O
identity	O
with	O
the	O
Brucella	O
BvrR	B-Protein
/	O
BvrS	B-Protein
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Chaves	O
-	O
Olarte	O
et	O
al	O
have	O
reported	O
that	O
B	O
.	O
abortus	O
bvrS	B-Protein
mutant	O
complemented	O
with	O
the	O
ExoS	B-Protein
protein	O
recuperated	O
the	O
ability	O
to	O
invade	O
and	O
replicated	O
successfully	O
in	O
HeLa	O
and	O
macrophage	O
cells	O
[	O
27	O
]	O
,	O
suggesting	O
that	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
is	O
functionally	O
interchangeable	O
with	O
the	O
ExoS	B-Protein
/	O
ChvI	B-Protein
system	O
.	O

A	O
.	O
tumefaciens	O
ChvI	B-Protein
/	O
ChvG	B-Protein
system	O
controls	O
the	O
expression	O
of	O
the	O
Aop	B-Protein
,	O
an	O
OMP	O
homologous	O
to	O
Brucella	O
Omp25a	B-Protein
[	O
28	O
]	O
,	O
and	O
in	O
S	O
.	O
meliloti	O
,	O
ExoS	B-Protein
/	O
ChvI	B-Protein
is	O
a	O
key	O
regulator	O
of	O
gene	O
expression	O
for	O
exopolysaccharide	O
synthesis	O
,	O
motility	O
and	O
nutrient	O
utilization	O
[	O
26	O
]	O
.	O

It	O
has	O
been	O
described	O
in	O
S	O
.	O
meliloti	O
that	O
exoR	B-Protein
gene	O
encodes	O
a	O
global	O
regulator	O
of	O
transcription	O
and	O
that	O
ExoR	B-Protein
interacts	O
genetically	O
with	O
both	O
ExoS	B-Protein
and	O
ChvI	B-Protein
and	O
inhibits	O
ExoS	B-Protein
/	O
ChvI	B-Protein
activity	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
.	O

Further	O
analysis	O
indicated	O
that	O
both	O
the	O
ExoR	B-Protein
protein	O
and	O
the	O
ExoS	B-Protein
/	O
ChvI	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
both	O
polysaccharides	O
and	O
flagellum	O
biosynthesis	O
[	O
31	O
]	O
.	O
<EOS>	B-X
Systematic	B-X
analyses	B-X
of	B-X
the	B-X
symbiotic	B-X
phenotypes	B-X
of	B-X
the	B-X
two	B-X
mutants	B-X
demonstrated	B-X
their	B-X
reduced	B-X
efficiency	B-X
of	B-X
root	B-X
hair	B-X
colonization	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
both	B-X
the	B-X
exoR95	B-X
and	B-X
exoS96	B-X
mutations	B-X
caused	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
biosynthesis	B-X
of	B-X
flagella	B-X
and	B-X
consequent	B-X
loss	B-X
of	B-X
ability	B-X
of	B-X
the	B-X
cells	B-X
to	B-X
swarm	B-X
and	B-X
swim	B-X
.	B-X
Succinoglycan	B-X
overproduction	B-X
did	B-X
not	B-X
appear	B-X
to	B-X
be	B-X
the	B-X
cause	B-X
of	B-X
the	B-X
suppression	B-X
of	B-X
flagellum	B-X
biosynthesis	B-X
.	B-X
Further	B-X
analysis	B-X
indicated	B-X
that	B-X
both	B-X
the	B-X
exoR95	B-X
and	B-X
exoS96	B-X
mutations	B-X
affected	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
flagellum	B-X
biosynthesis	B-X
genes	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
both	B-X
the	B-X
ExoR	B-X
protein	B-X
and	B-X
the	B-X
ExoS/ChvI	B-X
two-component	B-X
regulatory	B-X
system	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
both	B-X
succinoglycan	B-X
and	B-X
flagellum	B-X
biosynthesis	B-X
.	B-X

In	O
addition	O
,	O
the	O
transcription	O
of	O
the	O
S	O
.	O
meliloti	O
lpsS	B-Protein
gene	O
,	O
that	O
encodes	O
a	O
sulfotransferase	O
that	O
modifies	O
LPS	O
,	O
is	O
dependent	O
on	O
the	O
exoR	B-Protein
gene	O
[	O
32	O
]	O
.	O

Other	O
authors	O
[	O
29	O
]	O
suggest	O
that	O
ExoR	B-Protein
is	O
an	O
inhibitor	O
of	O
two	O
-	O
component	O
signaling	O
that	O
may	O
be	O
conserved	O
in	O
a	O
large	O
number	O
of	O
alpha	O
-	O
proteobacteria	O
.	O

Our	O
results	O
also	O
support	O
this	O
hypothesis	O
:	O
the	O
functional	O
relationship	O
between	O
the	O
exoR	B-Protein
gene	O
and	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
system	O
.	O

Based	O
on	O
all	O
these	O
findings	O
,	O
obvious	O
comparison	O
about	O
the	O
function	O
of	O
all	O
these	O
regulators	O
in	O
Brucella	O
could	O
be	O
made	O
.	O

The	O
fact	O
that	O
the	O
expression	O
of	O
VjbR	B-Protein
,	O
OmpR	B-Protein
and	O
ExoR	B-Protein
was	O
altered	O
in	O
the	O
bvrR	B-Protein
mutant	O
demonstrated	O
for	O
the	O
first	O
time	O
an	O
interaction	O
or	O
cross	O
-	O
talk	O
among	O
these	O
global	O
regulators	O
,	O
all	O
involved	O
in	O
the	O
control	O
of	O
composition	O
and	O
structure	O
of	O
the	O
cell	O
envelope	O
(	O
OMPs	O
,	O
LPS	O
,	O
chaperones	O
,	O
flagella	O
,	O
em	O
)	O
.	O

Virulence	O
and	O
the	O
adaptation	O
to	O
intracellular	O
growth	O
<EOS>	B-X
The	B-X
redundancy	B-X
of	B-X
DNA	B-X
replication	B-X
and	B-X
recombination	B-X
systems	B-X
of	B-X
T4	B-X
reveals	B-X
how	B-X
phage	B-X
and	B-X
other	B-X
genomes	B-X
are	B-X
stably	B-X
replicated	B-X
and	B-X
repaired	B-X
in	B-X
different	B-X
environments	B-X
,	B-X
providing	B-X
insight	B-X
into	B-X
genome	B-X
evolution	B-X
and	B-X
adaptations	B-X
to	B-X
new	B-X
hosts	B-X
and	B-X
growth	B-X
environments	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
active	B-X
destruction	B-X
of	B-X
the	B-X
engulfed	B-X
microbes	B-X
by	B-X
antimicrobial	B-X
compounds	B-X
,	B-X
restriction	B-X
of	B-X
essential	B-X
nutrients	B-X
in	B-X
the	B-X
phagosomal	B-X
compartment	B-X
contributes	B-X
to	B-X
microbial	B-X
growth	B-X
inhibition	B-X
and	B-X
killing	B-X
.	B-X
However	B-X
,	B-X
some	B-X
pathogenic	B-X
microorganisms	B-X
have	B-X
not	B-X
only	B-X
developed	B-X
various	B-X
strategies	B-X
to	B-X
efficiently	B-X
withstand	B-X
or	B-X
counteract	B-X
antimicrobial	B-X
activities	B-X
,	B-X
but	B-X
also	B-X
to	B-X
acquire	B-X
nutrients	B-X
within	B-X
macrophages	B-X
for	B-X
intracellular	B-X
replication	B-X
.	B-X
Successful	B-X
intracellular	B-X
pathogens	B-X
are	B-X
able	B-X
to	B-X
utilize	B-X
host-derived	B-X
amino	B-X
acids	B-X
,	B-X
carbohydrates	B-X
and	B-X
lipids	B-X
as	B-X
well	B-X
as	B-X
trace	B-X
metals	B-X
and	B-X
vitamins	B-X
during	B-X
intracellular	B-X
growth	B-X
.	B-X
This	B-X
requires	B-X
sophisticated	B-X
strategies	B-X
such	B-X
as	B-X
phagosome	B-X
modification	B-X
or	B-X
escape	B-X
,	B-X
efficient	B-X
nutrient	B-X
transporters	B-X
and	B-X
metabolic	B-X
adaptation	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
discuss	B-X
the	B-X
metabolic	B-X
adaptation	B-X
of	B-X
facultative	B-X
intracellular	B-X
bacteria	B-X
and	B-X
fungi	B-X
to	B-X
the	B-X
intracellular	B-X
lifestyle	B-X
inside	B-X
macrophages	B-X
.	B-X

BvrR	B-Protein
/	O
bvrS	B-Protein
mutants	O
are	O
unable	O
to	O
multiply	O
intracellularly	O
and	O
are	O
avirulent	O
in	O
the	O
mouse	O
model	O
[	O
4	O
]	O
.	O

Our	O
microarray	O
results	O
demonstrated	O
that	O
at	O
least	O
127	O
genes	O
were	O
differentially	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
.	O

Although	O
this	O
general	O
expression	O
changes	O
could	O
explain	O
the	O
complete	O
loss	O
of	O
virulence	O
of	O
these	O
mutants	O
,	O
it	O
was	O
remarkable	O
the	O
presence	O
among	O
them	O
of	O
ten	O
genes	O
,	O
in	O
addition	O
to	O
bvrS	B-Protein
,	O
whose	O
products	O
are	O
already	O
known	O
to	O
be	O
associated	O
with	O
Brucella	O
virulence	O
[	O
10	O
]	O
,	O
[	O
11	O
]	O
,	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

These	O
included	O
the	O
already	O
mentioned	O
vjbR	B-Protein
,	O
but	O
also	O
motB	B-Protein
(	O
BAB2	B-Protein
_	I-Protein
1103	I-Protein
)	O
,	O
malK	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
0241	I-Protein
)	O
,	O
norC	B-Protein
(	O
BAB2	B-Protein
_	I-Protein
0955	I-Protein
)	O
,	O
oppA	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
1601	I-Protein
)	O
,	O
aspB	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
1397	I-Protein
)	O
,	O
mosA	B-Protein
(	O
BAB1	B-Protein
_	I-Protein
0666	I-Protein
)	O
and	O
three	O
genes	O
encoding	O
hypothetical	O
proteins	O
(	O
BAB1	B-Protein
_	I-Protein
1717	I-Protein
,	O
BAB1	B-Protein
_	I-Protein
0597	I-Protein
y	O
BAB2	B-Protein
_	I-Protein
1127	I-Protein
)	O
.	O

B	O
.	O
melitensis	O
malK	B-Protein
mutant	O
and	O
B	O
.	O
suis	O
aspB	B-Protein
mutant	O
were	O
attenuated	O
in	O
cellular	O
model	O
of	O
infection	O
,	O
and	O
B	O
.	O
melitensis	O
mutants	O
in	O
vjbR	B-Protein
,	O
motB	B-Protein
,	O
oppA	B-Protein
,	O
mosA	B-Protein
and	O
the	O
hypothetical	O
proteins	O
BAB1	B-Protein
_	I-Protein
0597	I-Protein
,	O
BAB1	B-Protein
_	I-Protein
1717	I-Protein
,	O
BAB2	B-Protein
_	I-Protein
1127	I-Protein
were	O
attenuated	O
in	O
both	O
cellular	O
and	O
mouse	O
models	O
of	O
infection	O
(	O
for	O
a	O
review	O
see	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
)	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
some	O
denitrification	O
genes	O
of	O
the	O
nor	B-Protein
operon	O
are	O
required	O
for	O
Brucella	O
virulence	O
:	O
norD	B-Protein
in	O
B	O
.	O
suis	O
and	O
norB	B-Protein
in	O
B	O
.	O
melitensis	O
[	O
10	O
]	O
,	O
[	O
11	O
]	O
.	O

Most	O
of	O
the	O
genes	O
candidate	O
to	O
be	O
regulated	O
by	O
BvrR	B-Protein
/	O
BvrS	B-Protein
identified	O
in	O
our	O
microarray	O
experiments	O
can	O
be	O
involved	O
with	O
the	O
changes	O
needed	O
for	O
intracellular	O
survival	O
of	O
Brucella	O
.	O

In	O
order	O
to	O
investigate	O
if	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
controlled	O
genes	O
were	O
expressed	O
intracellularly	O
,	O
bacterial	O
RNA	O
was	O
obtained	O
from	O
B	O
.	O
abortus	O
wild	O
type	O
recovered	O
from	O
infected	O
cells	O
as	O
described	O
in	O
Material	O
and	O
Methods	O
.	O

The	O
amount	O
of	O
bacterial	O
RNA	O
was	O
not	O
enough	O
to	O
perform	O
microarray	O
hybridizations	O
.	O
<EOS>	B-X
More	B-X
than	B-X
90	B-X
different	B-X
modified	B-X
nucleosides	B-X
have	B-X
been	B-X
identified	B-X
in	B-X
tRNA	B-X
.	B-X
Among	B-X
the	B-X
tRNA	B-X
modifications	B-X
,	B-X
the	B-X
7-methylguanosine	B-X
(	B-X
m⁷G	B-X
)	B-X
modification	B-X
is	B-X
found	B-X
widely	B-X
in	B-X
eubacteria	B-X
,	B-X
eukaryotes	B-X
,	B-X
and	B-X
a	B-X
few	B-X
archaea	B-X
.	B-X
In	B-X
most	B-X
cases	B-X
,	B-X
the	B-X
m⁷G	B-X
modification	B-X
occurs	B-X
at	B-X
position	B-X
46	B-X
in	B-X
the	B-X
variable	B-X
region	B-X
and	B-X
is	B-X
a	B-X
product	B-X
of	B-X
tRNA	B-X
(	B-X
m⁷G46	B-X
)	B-X
methyltransferase	B-X
.	B-X
The	B-X
m⁷G46	B-X
modification	B-X
forms	B-X
a	B-X
tertiary	B-X
base	B-X
pair	B-X
with	B-X
C13-G22	B-X
,	B-X
and	B-X
stabilizes	B-X
the	B-X
tRNA	B-X
structure	B-X
.	B-X
A	B-X
reaction	B-X
mechanism	B-X
for	B-X
eubacterial	B-X
tRNA	B-X
m⁷G	B-X
methyltransferase	B-X
has	B-X
been	B-X
proposed	B-X
based	B-X
on	B-X
the	B-X
results	B-X
of	B-X
biochemical	B-X
,	B-X
bioinformatic	B-X
,	B-X
and	B-X
structural	B-X
studies	B-X
.	B-X
The	B-X
physiological	B-X
functions	B-X
of	B-X
m⁷G46	B-X
in	B-X
tRNA	B-X
have	B-X
started	B-X
to	B-X
be	B-X
determined	B-X
over	B-X
the	B-X
past	B-X
decade	B-X
.	B-X
For	B-X
example	B-X
,	B-X
tRNA	B-X
m⁷G46	B-X
or	B-X
tRNA	B-X
(	B-X
m⁷G46	B-X
)	B-X
methyltransferase	B-X
controls	B-X
the	B-X
amount	B-X
of	B-X
other	B-X
tRNA	B-X
modifications	B-X
in	B-X
thermophilic	B-X
bacteria	B-X
,	B-X
contributes	B-X
to	B-X
the	B-X
pathogenic	B-X
infectivity	B-X
,	B-X
and	B-X
is	B-X
also	B-X
associated	B-X
with	B-X
several	B-X
diseases	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
information	B-X
of	B-X
tRNA	B-X
m⁷G	B-X
modifications	B-X
and	B-X
tRNA	B-X
m⁷G	B-X
methyltransferases	B-X
is	B-X
summarized	B-X
and	B-X
the	B-X
differences	B-X
in	B-X
reaction	B-X
mechanism	B-X
between	B-X
tRNA	B-X
m⁷G	B-X
methyltransferase	B-X
and	B-X
rRNA	B-X
or	B-X
mRNA	B-X
m⁷G	B-X
methylation	B-X
enzyme	B-X
are	B-X
discussed	B-X
.	B-X

For	O
this	O
reason	O
,	O
the	O
analysis	O
of	O
intracellular	O
expression	O
of	O
32	O
selected	O
genes	O
was	O
done	O
by	O
RT	O
-	O
PCR	O
by	O
using	O
total	O
RNA	O
from	O
intracellular	O
bacteria	O
and	O
from	O
the	O
same	O
strain	O
(	O
B	O
.	O
abortus	O
2308	O
)	O
grown	O
in	O
laboratory	O
conditions	O
(	O
Table	O
2	O
)	O
.	O

VirB8	B-Protein
(	O
BAB2	B-Protein
_	I-Protein
0061	I-Protein
)	O
was	O
used	O
as	O
control	O
of	O
intracellularly	O
expressed	O
gene	O
[	O
35	O
]	O
.	O

The	O
results	O
showed	O
significant	O
differences	O
in	O
the	O
expression	O
of	O
at	O
least	O
fifteen	O
genes	O
controlled	O
by	O
BvrR	B-Protein
/	O
BvrS	B-Protein
.	O

The	O
expression	O
of	O
genes	O
vjbR	B-Protein
,	O
malF	B-Protein
,	O
norC	B-Protein
,	O
pckA	B-Protein
,	O
fumB	B-Protein
,	O
BAB1	B-Protein
_	I-Protein
0017	I-Protein
(	O
fatty	O
acids	O
metabolism	O
)	O
and	O
BAB1	B-Protein
_	I-Protein
1620	I-Protein
(	O
LPS	O
glycosyl	O
transferase	O
)	O
were	O
induced	O
intracellularly	O
.	O

On	O
the	O
other	O
hand	O
,	O
two	O
genes	O
for	O
cell	O
envelope	O
proteins	O
(	O
omp25d	B-Protein
and	O
one	O
lipoprotein	O
)	O
and	O
three	O
denitrification	O
genes	O
(	O
norC	B-Protein
,	O
nirK	B-Protein
and	O
glutaminase	O
BAB2	B-Protein
_	I-Protein
0863	I-Protein
)	O
were	O
less	O
expressed	O
intracellularly	O
.	O

In	O
conclusion	O
,	O
all	O
these	O
results	O
and	O
previous	O
findings	O
support	O
the	O
proposal	O
that	O
BvrR	B-Protein
/	O
BvrS	B-Protein
controls	O
a	O
significantly	O
broad	O
set	O
of	O
phenotypes	O
and	O
define	O
an	O
important	O
and	O
coordinate	O
gateway	O
between	O
the	O
free	O
-	O
living	O
and	O
intracellular	O
states	O
of	O
Brucella	O
.	O

However	O
,	O
30	O
of	O
the	O
genes	O
differentially	O
expressed	O
in	O
the	O
bvrR	B-Protein
mutant	O
compared	O
with	O
the	O
parental	O
strain	O
have	O
a	O
yet	O
uncharacterized	O
function	O
.	O

This	O
group	O
may	O
contain	O
unknown	O
essential	O
information	O
to	O
completely	O
understand	O
the	O
regulatory	O
role	O
of	O
the	O
BvrR	B-Protein
/	O
BvrS	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
.	O

IgG	B-Protein
Endopeptidase	I-Protein
SeMac	B-Protein
does	O
not	O
Inhibit	O
Opsonophagocytosis	O
of	O
Streptococcus	O
equi	O
Subspecies	O
equi	O
by	O
Horse	O
Polymorphonuclear	O
Leukocytes	O

The	O
secreted	O
Mac	B-Protein
protein	O
made	O
by	O
group	O
A	O
Streptococcus	O
(	O
GAS	O
)	O
inhibits	O
opsonophagocytosis	O
of	O
GAS	B-Protein
by	O
human	O
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
.	O
<EOS>	B-X
Recently	B-X
,	B-X
it	B-X
was	B-X
reported	B-X
that	B-X
a	B-X
streptococcal	B-X
Mac	B-X
protein	B-X
(	B-X
designated	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
)	B-X
made	B-X
by	B-X
serotype	B-X
M1	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
is	B-X
a	B-X
homologue	B-X
of	B-X
human	B-X
CD11b	B-X
that	B-X
inhibits	B-X
opsonophagocytosis	B-X
and	B-X
killing	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
polymorphonuclear	B-X
leukocytes	B-X
(	B-X
PMNs	B-X
)	B-X
(	B-X
B.	B-X
Lei	B-X
,	B-X
F.	B-X
R.	B-X
DeLeo	B-X
,	B-X
N.	B-X
P.	B-X
Hoe	B-X
,	B-X
M.	B-X
R.	B-X
Graham	B-X
,	B-X
S.	B-X
M.	B-X
Mackie	B-X
,	B-X
R.	B-X
L.	B-X
Cole	B-X
,	B-X
M.	B-X
Liu	B-X
,	B-X
H.	B-X
R.	B-X
Hill	B-X
,	B-X
D.	B-X
E.	B-X
Low	B-X
,	B-X
M.	B-X
J.	B-X
Federle	B-X
,	B-X
J.	B-X
R.	B-X
Scott	B-X
,	B-X
and	B-X
J.	B-X
M.	B-X
Musser	B-X
,	B-X
Nat	B-X
.	B-X
To	B-X
study	B-X
mac	B-X
variation	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
Mac	B-X
protein	B-X
,	B-X
the	B-X
gene	B-X
in	B-X
67	B-X
GAS	B-X
strains	B-X
representing	B-X
36	B-X
distinct	B-X
M	B-X
protein	B-X
serotypes	B-X
was	B-X
sequenced	B-X
.	B-X
Mac	B-X
variants	B-X
in	B-X
each	B-X
of	B-X
the	B-X
two	B-X
complexes	B-X
were	B-X
closely	B-X
related	B-X
,	B-X
but	B-X
complex	B-X
I	B-X
and	B-X
complex	B-X
II	B-X
variants	B-X
differed	B-X
on	B-X
average	B-X
at	B-X
50.66	B-X
+/-	B-X
5.8	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
most	B-X
of	B-X
which	B-X
were	B-X
located	B-X
in	B-X
the	B-X
middle	B-X
one-third	B-X
of	B-X
the	B-X
protein	B-X
.	B-X
Complex	B-X
I	B-X
Mac	B-X
variants	B-X
have	B-X
greater	B-X
homology	B-X
with	B-X
CD11b	B-X
than	B-X
complex	B-X
II	B-X
variants	B-X
.	B-X
GAS	B-X
strains	B-X
belonging	B-X
to	B-X
serotypes	B-X
M1	B-X
and	B-X
M3	B-X
,	B-X
the	B-X
most	B-X
abundant	B-X
M	B-X
protein	B-X
serotypes	B-X
responsible	B-X
for	B-X
human	B-X
infections	B-X
in	B-X
many	B-X
case	B-X
series	B-X
,	B-X
have	B-X
complex	B-X
I	B-X
Mac	B-X
variants	B-X
.	B-X
The	B-X
mac	B-X
gene	B-X
was	B-X
cloned	B-X
from	B-X
representative	B-X
strains	B-X
assigned	B-X
to	B-X
complexes	B-X
I	B-X
and	B-X
II	B-X
,	B-X
and	B-X
the	B-X
Mac	B-X
proteins	B-X
were	B-X
purified	B-X
to	B-X
apparent	B-X
homogeneity	B-X
.	B-X
Both	B-X
Mac	B-X
variants	B-X
had	B-X
immunoglobulin	B-X
G	B-X
(	B-X
IgG	B-X
)	B-X
-endopeptidase	B-X
activity	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
(	B-X
complex	B-X
I	B-X
)	B-X
,	B-X
Mac	B-X
(	B-X
8345	B-X
)	B-X
(	B-X
complex	B-X
II	B-X
)	B-X
underwent	B-X
autooxidation	B-X
of	B-X
its	B-X
cysteine	B-X
residues	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
loss	B-X
of	B-X
IgG-endopeptidase	B-X
activity	B-X
.	B-X
A	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
Cys94Ala	B-X
site-specific	B-X
mutant	B-X
protein	B-X
was	B-X
unable	B-X
to	B-X
cleave	B-X
IgG	B-X
but	B-X
retained	B-X
the	B-X
ability	B-X
to	B-X
inhibit	B-X
IgG-mediated	B-X
phagocytosis	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
IgG-endopeptidase	B-X
activity	B-X
was	B-X
not	B-X
essential	B-X
for	B-X
the	B-X
key	B-X
biological	B-X
function	B-X
of	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
.	B-X
Although	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
and	B-X
Mac	B-X
(	B-X
8345	B-X
)	B-X
each	B-X
have	B-X
an	B-X
Arg-Gly-Asp	B-X
(	B-X
RGD	B-X
)	B-X
motif	B-X
,	B-X
the	B-X
proteins	B-X
differed	B-X
in	B-X
their	B-X
interactions	B-X
with	B-X
human	B-X
integrins	B-X
alpha	B-X
(	B-X
v	B-X
)	B-X
beta	B-X
(	B-X
3	B-X
)	B-X
and	B-X
alpha	B-X
(	B-X
IIb	B-X
)	B-X
beta	B-X
(	B-X
3	B-X
)	B-X
.	B-X
Binding	B-X
of	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
to	B-X
integrins	B-X
alpha	B-X
(	B-X
v	B-X
)	B-X
beta	B-X
(	B-X
3	B-X
)	B-X
and	B-X
alpha	B-X
(	B-X
IIb	B-X
)	B-X
beta	B-X
(	B-X
3	B-X
)	B-X
was	B-X
mediated	B-X
primarily	B-X
by	B-X
the	B-X
RGD	B-X
motif	B-X
in	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
,	B-X
whereas	B-X
binding	B-X
of	B-X
Mac	B-X
(	B-X
8345	B-X
)	B-X
involved	B-X
the	B-X
RGD	B-X
motif	B-X
and	B-X
a	B-X
region	B-X
in	B-X
the	B-X
middle	B-X
one-third	B-X
of	B-X
the	B-X
molecule	B-X
whose	B-X
sequence	B-X
is	B-X
different	B-X
in	B-X
Mac	B-X
(	B-X
8345	B-X
)	B-X
and	B-X
Mac	B-X
(	B-X
5005	B-X
)	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
add	B-X
to	B-X
the	B-X
emerging	B-X
theme	B-X
in	B-X
GAS	B-X
pathogenesis	B-X
that	B-X
allelic	B-X
variation	B-X
in	B-X
virulence	B-X
genes	B-X
contributes	B-X
to	B-X
fundamental	B-X
differences	B-X
in	B-X
host-pathogen	B-X
interactions	B-X
among	B-X
strains	B-X
.	B-X

This	O
protein	O
also	O
has	O
the	O
endopeptidase	O
activity	O
against	O
human	O
immunoglobulin	B-Protein
G	I-Protein
(	O
IgG	B-Protein
)	O
,	O
and	O
the	O
Cys94	O
,	O
His262	O
and	O
Asp284	O
are	O
critical	O
for	O
the	O
enzymatic	O
activity	O
.	O
<EOS>	B-X
The	B-X
secreted	B-X
Mac	B-X
protein	B-X
made	B-X
by	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
polymorphonuclear	B-X
leukocytes	B-X
(	B-X
PMNs	B-X
)	B-X
.	B-X
This	B-X
protein	B-X
also	B-X
has	B-X
the	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
immunoglobulin	B-X
G	B-X
(	B-X
IgG	B-X
)	B-X
,	B-X
and	B-X
the	B-X
Cys94	B-X
,	B-X
His262	B-X
and	B-X
Asp284	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
However	B-X
,	B-X
the	B-X
protein	B-X
just	B-X
cleaves	B-X
a	B-X
small	B-X
fraction	B-X
,	B-X
which	B-X
may	B-X
be	B-X
IgG1	B-X
only	B-X
,	B-X
of	B-X
horse	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

The	O
horse	O
pathogen	O
Streptococcus	O
equi	O
subspecies	O
equi	O
produces	O
a	O
homologue	O
of	O
Mac	B-Protein
(	O
SeMac	B-Protein
)	O
.	O
<EOS>	B-X
The	B-X
secreted	B-X
Mac	B-X
protein	B-X
made	B-X
by	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
polymorphonuclear	B-X
leukocytes	B-X
(	B-X
PMNs	B-X
)	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
However	B-X
,	B-X
the	B-X
protein	B-X
just	B-X
cleaves	B-X
a	B-X
small	B-X
fraction	B-X
,	B-X
which	B-X
may	B-X
be	B-X
IgG1	B-X
only	B-X
,	B-X
of	B-X
horse	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

SeMac	B-Protein
was	O
characterized	O
to	O
determine	O
whether	O
SeMac	B-Protein
has	O
IgG	B-Protein
endopeptidase	I-Protein
activity	O
and	O
inhibits	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
.	O
<EOS>	B-X
The	B-X
secreted	B-X
Mac	B-X
protein	B-X
made	B-X
by	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
polymorphonuclear	B-X
leukocytes	B-X
(	B-X
PMNs	B-X
)	B-X
.	B-X
This	B-X
protein	B-X
also	B-X
has	B-X
the	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
immunoglobulin	B-X
G	B-X
(	B-X
IgG	B-X
)	B-X
,	B-X
and	B-X
the	B-X
Cys94	B-X
,	B-X
His262	B-X
and	B-X
Asp284	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
However	B-X
,	B-X
the	B-X
protein	B-X
just	B-X
cleaves	B-X
a	B-X
small	B-X
fraction	B-X
,	B-X
which	B-X
may	B-X
be	B-X
IgG1	B-X
only	B-X
,	B-X
of	B-X
horse	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

The	O
gene	O
was	O
cloned	O
and	O
recombinant	O
SeMac	B-Protein
was	O
overexpressed	O
in	O
Escherichia	O
coli	O
and	O
purified	O
to	O
homogeneity	O
.	O
<EOS>	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

Mice	O
with	O
experimental	O
S	O
.	O
equi	O
infection	O
and	O
horses	O
with	O
strangles	O
caused	O
by	O
S	O
.	O
equi	O
seroconverted	O
to	O
SeMac	B-Protein
,	O
indicating	O
that	O
SeMac	B-Protein
is	O
produced	O
in	O
vivo	O
during	O
infection	O
.	O
<EOS>	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

SeMac	B-Protein
has	O
endopeptidase	O
activity	O
against	O
human	O
IgG	B-Protein
.	O
<EOS>	B-X
The	B-X
secreted	B-X
Mac	B-X
protein	B-X
made	B-X
by	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
polymorphonuclear	B-X
leukocytes	B-X
(	B-X
PMNs	B-X
)	B-X
.	B-X
This	B-X
protein	B-X
also	B-X
has	B-X
the	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
immunoglobulin	B-X
G	B-X
(	B-X
IgG	B-X
)	B-X
,	B-X
and	B-X
the	B-X
Cys94	B-X
,	B-X
His262	B-X
and	B-X
Asp284	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
However	B-X
,	B-X
the	B-X
protein	B-X
just	B-X
cleaves	B-X
a	B-X
small	B-X
fraction	B-X
,	B-X
which	B-X
may	B-X
be	B-X
IgG1	B-X
only	B-X
,	B-X
of	B-X
horse	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

However	O
,	O
the	O
protein	O
just	O
cleaves	O
a	O
small	O
fraction	O
,	O
which	O
may	O
be	O
IgG1	B-Protein
only	O
,	O
of	O
horse	O
IgG	B-Protein
.	O

Replacement	O
of	O
Cys102	O
with	O
Ser	O
or	O
His272	O
with	O
Ala	O
abolishes	O
the	O
enzymatic	O
activity	O
of	O
SeMac	B-Protein
,	O
and	O
the	O
Asp294Ala	O
mutation	O
greatly	O
decreases	O
the	O
enzymatic	O
activity	O
.	O
<EOS>	B-X
This	B-X
protein	B-X
also	B-X
has	B-X
the	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
immunoglobulin	B-X
G	B-X
(	B-X
IgG	B-X
)	B-X
,	B-X
and	B-X
the	B-X
Cys94	B-X
,	B-X
His262	B-X
and	B-X
Asp284	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

SeMac	B-Protein
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
but	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	O
PMNs	O
.	O
<EOS>	B-X
The	B-X
SEMAC	B-X
technique	B-X
does	B-X
not	B-X
require	B-X
additional	B-X
hardware	B-X
and	B-X
can	B-X
be	B-X
deployed	B-X
to	B-X
the	B-X
large	B-X
installed	B-X
base	B-X
of	B-X
whole-body	B-X
MRI	B-X
systems	B-X
.	B-X

Thus	O
,	O
SeMac	B-Protein
is	O
a	O
cysteine	B-Protein
endopeptidase	I-Protein
with	O
a	O
limited	O
activity	O
against	O
horse	O
IgG	B-Protein
and	O
must	O
have	O
other	O
function	O
.	O
<EOS>	B-X
This	B-X
protein	B-X
also	B-X
has	B-X
the	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
immunoglobulin	B-X
G	B-X
(	B-X
IgG	B-X
)	B-X
,	B-X
and	B-X
the	B-X
Cys94	B-X
,	B-X
His262	B-X
and	B-X
Asp284	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
However	B-X
,	B-X
the	B-X
protein	B-X
just	B-X
cleaves	B-X
a	B-X
small	B-X
fraction	B-X
,	B-X
which	B-X
may	B-X
be	B-X
IgG1	B-X
only	B-X
,	B-X
of	B-X
horse	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

INTRODUCTION	O

Gram	O
-	O
positive	O
bacterium	O
Streptococcus	O
equi	O
subspeices	O
equi	O
(	O
S	O
.	O
equi	O
)	O
causes	O
equine	O
strangles	O
,	O
a	O
highly	O
contagious	O
purulent	O
lymphadenitis	O
and	O
one	O
of	O
the	O
most	O
common	O
infectious	O
diseases	O
in	O
horses	O
[	O
1	O
,	O
2	O
]	O
.	O

The	O
infection	O
initially	O
causes	O
nasal	O
discharge	O
and	O
fever	O
and	O
,	O
then	O
,	O
leads	O
to	O
abscess	O
formation	O
in	O
local	O
lymph	O
nodes	O
,	O
causing	O
enormous	O
pain	O
and	O
respiratory	O
difficulty	O
.	O

There	O
is	O
massive	O
infiltration	O
of	O
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
to	O
the	O
infection	O
site	O
.	O

However	O
,	O
S	O
.	O
equi	O
effectively	O
evades	O
the	O
horse	O
innate	O
immunity	O
by	O
being	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

Horses	O
recovered	O
from	O
strangles	O
acquire	O
immunity	O
against	O
S	O
.	O
equi	O
reinfection	O
[	O
3	O
]	O
.	O

The	O
immunity	O
is	O
primarily	O
mediated	O
by	O
protective	O
antibodies	O
[	O
4	O
]	O
,	O
which	O
opsonize	O
and	O
thus	O
enhance	O
phagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
.	O

To	O
survive	O
in	O
hosts	O
,	O
bacterial	O
pathogens	O
have	O
evolved	O
multiple	O
mechanisms	O
to	O
evade	O
host	O
defense	O
.	O
<EOS>	B-X
Pathogenic	B-X
microbes	B-X
have	B-X
evolved	B-X
highly	B-X
sophisticated	B-X
mechanisms	B-X
for	B-X
colonizing	B-X
host	B-X
tissues	B-X
and	B-X
evading	B-X
or	B-X
deflecting	B-X
assault	B-X
by	B-X
the	B-X
immune	B-X
response	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
these	B-X
microbes	B-X
to	B-X
avoid	B-X
clearance	B-X
prolongs	B-X
infection	B-X
,	B-X
thereby	B-X
promoting	B-X
their	B-X
long-term	B-X
survival	B-X
within	B-X
individual	B-X
hosts	B-X
and	B-X
,	B-X
through	B-X
transmission	B-X
,	B-X
between	B-X
hosts	B-X
.	B-X
Many	B-X
pathogens	B-X
are	B-X
capable	B-X
of	B-X
extensive	B-X
antigenic	B-X
changes	B-X
in	B-X
the	B-X
face	B-X
of	B-X
the	B-X
multiple	B-X
constitutive	B-X
and	B-X
dynamic	B-X
components	B-X
of	B-X
host	B-X
immune	B-X
defenses	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
consider	B-X
the	B-X
molecular	B-X
and	B-X
genetic	B-X
features	B-X
of	B-X
antigenic	B-X
variation	B-X
and	B-X
corresponding	B-X
host-parasite	B-X
interactions	B-X
of	B-X
different	B-X
pathogenic	B-X
bacterial	B-X
,	B-X
fungal	B-X
,	B-X
and	B-X
protozoan	B-X
microorganisms	B-X
.	B-X
The	B-X
host	B-X
and	B-X
microbial	B-X
molecules	B-X
involved	B-X
in	B-X
these	B-X
interactions	B-X
often	B-X
determine	B-X
the	B-X
adhesive	B-X
,	B-X
invasive	B-X
,	B-X
and	B-X
antigenic	B-X
properties	B-X
of	B-X
the	B-X
infecting	B-X
organisms	B-X
and	B-X
can	B-X
dramatically	B-X
affect	B-X
the	B-X
virulence	B-X
and	B-X
pathobiology	B-X
of	B-X
individual	B-X
infections	B-X
.	B-X
Pathogens	B-X
capable	B-X
of	B-X
such	B-X
antigenic	B-X
variation	B-X
exhibit	B-X
mechanisms	B-X
of	B-X
rapid	B-X
mutability	B-X
in	B-X
confined	B-X
chromosomal	B-X
regions	B-X
containing	B-X
specialized	B-X
genes	B-X
designated	B-X
contingency	B-X
genes	B-X
.	B-X
The	B-X
mechanisms	B-X
of	B-X
hypermutability	B-X
of	B-X
contingency	B-X
genes	B-X
are	B-X
common	B-X
to	B-X
a	B-X
variety	B-X
of	B-X
bacterial	B-X
and	B-X
eukaryotic	B-X
pathogens	B-X
and	B-X
include	B-X
promoter	B-X
alterations	B-X
,	B-X
reading-frame	B-X
shifts	B-X
,	B-X
gene	B-X
conversion	B-X
events	B-X
,	B-X
genomic	B-X
rearrangements	B-X
,	B-X
and	B-X
point	B-X
mutations	B-X
.	B-X

For	O
examples	O
,	O
both	O
S	O
.	O
equi	O
and	O
group	O
A	O
Streptococcus	O
(	O
GAS	O
)	O
produce	O
the	O
hyaluronic	O
acid	O
capsule	O
and	O
surface	O
protein	O
M	B-Protein
protein	I-Protein
to	O
contribute	O
to	O
resistance	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

We	O
found	O
that	O
GAS	O
produces	O
a	O
secreted	O
Mac	B-Protein
protein	O
(	O
also	O
known	O
as	O
IdeE	B-Protein
)	O
,	O
which	O
inhibits	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	O
PMNs	O
[	O
5	O
]	O
.	O

This	O
protein	O
can	O
cleave	O
the	O
heavy	O
chain	O
of	O
human	O
immunoglobulin	B-Protein
G	I-Protein
(	O
IgG	B-Protein
)	O
using	O
Cys94	O
,	O
His262	O
and	O
Asp284	O
as	O
its	O
catalytic	O
triad	O
[	O
6	O
-	O
8	O
]	O
.	O

There	O
are	O
two	O
kinds	O
of	O
Mac	B-Protein
produced	O
by	O
GAS	O
isolates	O
[	O
7	O
]	O
,	O
which	O
use	O
different	O
mechanisms	O
to	O
block	O
the	O
interaction	O
between	O
IgG	B-Protein
and	O
Fc	B-Protein
receptor	I-Protein
on	O
the	O
surface	O
of	O
PMNs	O
.	O

The	O
type	O
-	O
1	O
Mac	B-Protein
,	O
such	O
as	O
M1	O
Mac	B-Protein
produced	O
by	O
serotype	O
M1	O
GAS	O
strains	O
,	O
has	O
high	O
enzymatic	O
activity	O
and	O
low	O
affinity	O
to	O
Fc	B-Protein
receptor	I-Protein
on	O
the	O
surface	O
of	O
PMNs	O
,	O
while	O
the	O
type	O
-	O
2	O
Mac	B-Protein
can	O
bind	O
to	O
the	O
Fc	B-Protein
receptor	I-Protein
and	O
has	O
lower	O
enzymatic	O
activity	O
[	O
9	O
]	O
.	O

S	O
.	O
equi	O
has	O
a	O
homologue	O
of	O
GAS	O
M1	O
Mac	B-Protein
(	O
designated	O
SeMac	B-Protein
)	O
.	O

In	O
this	O
study	O
,	O
SeMac	B-Protein
was	O
prepared	O
and	O
characterized	O
.	O

The	O
results	O
indicate	O
that	O
SeMac	B-Protein
is	O
a	O
cysteine	B-Protein
endopeptidase	I-Protein
but	O
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
,	O
suggesting	O
that	O
SeMac	B-Protein
has	O
function	O
other	O
than	O
evading	O
horse	O
acquired	O
immunity	O
against	O
S	O
.	O
equi	O
infection	O
.	O

RESULTS	O

S	O
.	O
equi	O
Mac	B-Protein
Gene	O
S	O
.	O
equi	O
genome	O
encodes	O
a	O
Mac	B-Protein
homologue	O
SeMac	B-Protein
.	O

The	O
protein	O
shares	O
62	O
.	O
4	O
%	O
identity	O
in	O
amino	O
acid	O
sequence	O
with	O
Mac	B-Protein
made	O
by	O
serotype	O
M1	O
GAS	O
and	O
a	O
putative	O
secretion	O
signal	O
sequence	O
(	O
amino	O
acids	O
1	O
-	O
34	O
)	O
,	O
and	O
the	O
catalytic	O
residues	O
of	O
GAS	O
Mac	B-Protein
consisting	O
of	O
Cys94	O
,	O
His262	O
and	O
Asp284	O
are	O
conserved	O
in	O
SeMac	B-Protein
(	O
Cys102	O
,	O
His272	O
and	O
Asp	O
294	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

To	O
test	O
whether	O
other	O
S	O
.	O
equi	O
strains	O
have	O
the	O
mac	B-Protein
gene	O
,	O
10	O
S	O
.	O
equi	O
isolates	O
representing	O
various	O
geographic	O
locations	O
were	O
tested	O
with	O
PCR	O
using	O
mac	B-Protein
-	O
specific	O
primers	O
.	O

All	O
the	O
strains	O
tested	O
had	O
the	O
mac	B-Protein
gene	O
(	O
Fig	O
.	O
2	O
)	O
.	O

DNA	O
sequencing	O
found	O
that	O
the	O
mac	B-Protein
gene	O
is	O
100	O
%	O
conserved	O
in	O
DNA	O
sequence	O
in	O
these	O
strains	O
.	O
<EOS>	B-X
A	B-X
M.	B-X
paratuberculosis	B-X
gene	B-X
(	B-X
hspX	B-X
)	B-X
was	B-X
cloned	B-X
,	B-X
sequenced	B-X
,	B-X
and	B-X
a	B-X
30	B-X
bp	B-X
species-specific	B-X
oligonucleotide	B-X
was	B-X
synthesized	B-X
.	B-X
As	B-X
an	B-X
internal	B-X
control	B-X
to	B-X
identify	B-X
mycobacterial	B-X
strains	B-X
,	B-X
a	B-X
33	B-X
bp	B-X
Mycobacterium	B-X
genus-specific	B-X
oligonucleotide	B-X
was	B-X
synthesized	B-X
based	B-X
on	B-X
the	B-X
conserved	B-X
5	B-X
'	B-X
terminus	B-X
of	B-X
the	B-X
mycobacterial	B-X
recA	B-X
gene	B-X
.	B-X
Dioligonucleotide	B-X
hybridization	B-X
(	B-X
dOH	B-X
)	B-X
analysis	B-X
identified	B-X
28/28	B-X
(	B-X
100	B-X
%	B-X
)	B-X
mycobacterial	B-X
strains	B-X
and	B-X
specifically	B-X
identified	B-X
14/14	B-X
(	B-X
100	B-X
%	B-X
)	B-X
reference	B-X
(	B-X
ATCC	B-X
19698	B-X
)	B-X
,	B-X
bovine	B-X
,	B-X
ovine	B-X
and	B-X
human	B-X
isolates	B-X
of	B-X
M.	B-X
paratuberculosis	B-X
.	B-X
The	B-X
members	B-X
of	B-X
MAC	B-X
tested	B-X
in	B-X
this	B-X
study	B-X
included	B-X
Mycobacterium	B-X
avium	B-X
subspecies	B-X
avium	B-X
(	B-X
M.	B-X
paratuberculosis	B-X
,	B-X
Mycobacterium	B-X
avium	B-X
subspecies	B-X
silvaticum	B-X
(	B-X
M.	B-X
silvaticum	B-X
)	B-X
and	B-X
Mycobacterium	B-X
intracellulare	B-X
strains	B-X
.	B-X
Hybridization	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
DNA	B-X
extracted	B-X
from	B-X
a	B-X
selected	B-X
group	B-X
of	B-X
other	B-X
bacterial	B-X
pathogens	B-X
.	B-X

Recombinant	O
SeMac	B-Protein
and	O
In	O
Vitro	O
and	O
In	O
Vivo	O
Expression	O
of	O
SeMac	B-Protein

To	O
characterize	O
SeMac	B-Protein
,	O
the	O
fragment	O
of	O
S	O
.	O
equi	O
mac	B-Protein
gene	O
encoding	O
mature	O
SeMac	B-Protein
was	O
cloned	O
,	O
and	O
recombinant	O
SeMac	B-Protein
was	O
purified	O
to	O
>	O
95	O
%	O
purity	O
as	O
assessed	O
by	O
SDS	O
-	O
PAGE	O
(	O
Fig	O
.	O
3A	O
)	O
.	O

To	O
assess	O
the	O
in	O
vitro	O
production	O
of	O
SeMac	B-Protein
,	O
culture	O
supernatant	O
of	O
the	O
10	O
S	O
.	O
equi	O
strains	O
was	O
prepared	O
by	O
the	O
method	O
of	O
Lei	O
et	O
al	O
.	O

[	O
16	O
]	O
,	O
resolved	O
by	O
SDS	O
-	O
PAGE	O
,	O
and	O
probed	O
by	O
Western	O
immunoblot	O
with	O
anti	O
-	O
SeMac	B-Protein
mouse	O
antisera	O
.	O

No	O
SeMac	B-Protein
was	O
detected	O
in	O
all	O
the	O
samples	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
SeMac	B-Protein
is	O
not	O
produced	O
in	O
vitro	O
.	O

To	O
test	O
whether	O
SeMac	B-Protein
is	O
produced	O
in	O
vivo	O
during	O
S	O
.	O
equi	O
infection	O
,	O
the	O
presence	O
of	O
SeMac	B-Protein
-	O
specific	O
antibody	O
was	O
assessed	O
by	O
Western	O
immunoblot	O
analysis	O
with	O
convalescent	O
sera	O
from	O
3	O
horses	O
suffered	O
from	O
strangles	O
and	O
mice	O
with	O
experimental	O
S	O
.	O
equi	O
infection	O
.	O

All	O
the	O
convalescent	O
sera	O
tested	O
had	O
SeMac	B-Protein
-	O
specific	O
antibody	O
(	O
Fig	O
.	O
3B	O
)	O
,	O
indicating	O
that	O
SeMac	B-Protein
is	O
produced	O
in	O
vivo	O
during	O
infection	O
.	O

Endopeptidase	O
Activity	O
of	O
SeMac	B-Protein
against	O
Horse	O
IgG1	B-Protein
and	O
Human	O
IgG	B-Protein
<EOS>	B-X
This	B-X
protein	B-X
also	B-X
has	B-X
the	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
immunoglobulin	B-X
G	B-X
(	B-X
IgG	B-X
)	B-X
,	B-X
and	B-X
the	B-X
Cys94	B-X
,	B-X
His262	B-X
and	B-X
Asp284	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
However	B-X
,	B-X
the	B-X
protein	B-X
just	B-X
cleaves	B-X
a	B-X
small	B-X
fraction	B-X
,	B-X
which	B-X
may	B-X
be	B-X
IgG1	B-X
only	B-X
,	B-X
of	B-X
horse	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

GAS	O
Mac	B-Protein
can	O
cleave	O
the	O
heavy	O
chain	O
of	O
human	O
IgG	B-Protein
at	O
the	O
lower	O
hinge	O
region	O
between	O
Fab	O
and	O
Fc	O
fragments	O
.	O

A	O
catalytic	O
triad	O
of	O
Cys94	O
,	O
His262	O
,	O
and	O
Asp284	O
residues	O
is	O
critical	O
for	O
the	O
enzymatic	O
activity	O
of	O
GAS	O
Mac	B-Protein
[	O
7	O
,	O
8	O
]	O
.	O

SeMac	B-Protein
possesses	O
putative	O
catalytic	O
residues	O
of	O
Cys102	O
,	O
His272	O
,	O
and	O
Asp294	O
(	O
Fig	O
.	O
1	O
)	O
.	O

To	O
determine	O
whether	O
SeMac	B-Protein
also	O
is	O
a	O
cysteine	O
endopeptidase	O
targeting	O
IgG	B-Protein
,	O
Cys102	O
and	O
His272	O
or	O
Asp294	O
of	O
SeMac	B-Protein
were	O
replaced	O
with	O
Ser	O
and	O
Ala	O
,	O
respectively	O
,	O
by	O
site	O
-	O
directed	O
mutagenesis	O
,	O
and	O
wild	O
-	O
type	O
and	O
mutant	O
(	O
SeMacCys102Ser	B-Protein
,	O
SeMacHis272Ala	B-Protein
and	O
SeMacAsp294Ala	B-Protein
)	O
SeMac	B-Protein
proteins	O
expressed	O
in	O
E	O
.	O
coli	O
were	O
tested	O
for	O
IgG	B-Protein
endopeptidase	I-Protein
activity	O
using	O
human	O
IgG	B-Protein
.	O

Wild	O
-	O
type	O
SeMac	B-Protein
cleaved	O
the	O
heavy	O
chain	O
of	O
human	O
IgG	B-Protein
,	O
while	O
SeMacCys102Ser	B-Protein
and	O
SeMacHis272Ala	B-Protein
completely	O
lost	O
the	O
IgG	B-Protein
endopeptidase	I-Protein
activity	O
,	O
and	O
SeMacAsp294Ala	B-Protein
had	O
dramatically	O
lower	O
enzymatic	O
activity	O
than	O
the	O
wild	O
-	O
type	O
protein	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

The	O
results	O
indicate	O
that	O
SeMac	B-Protein
is	O
a	O
cysteine	B-Protein
endopeptidase	I-Protein
,	O
which	O
uses	O
Cys102	O
,	O
His272	O
and	O
Asp294	O
as	O
its	O
catalytic	O
triad	O
to	O
cleave	O
human	O
IgG	B-Protein
.	O

Purified	O
recombinant	O
SeMac	B-Protein
and	O
GAS	O
Mac	B-Protein
were	O
then	O
tested	O
for	O
activity	O
to	O
cleave	O
horse	O
IgG	B-Protein
.	O

While	O
both	O
proteins	O
cleaved	O
human	O
IgG	B-Protein
efficiently	O
,	O
only	O
a	O
small	O
fraction	O
of	O
horse	O
IgG	B-Protein
was	O
cleaved	O
by	O
either	O
protein	O
(	O
Fig	O
.	O
4B	O
)	O
,	O
suggesting	O
that	O
SeMac	B-Protein
or	O
GAS	O
Mac	B-Protein
cannot	O
digest	O
all	O
subgroups	O
of	O
horse	O
IgG	B-Protein
.	O

To	O
test	O
this	O
possibility	O
,	O
available	O
horse	O
IgG1	B-Protein
and	O
a	O
mixture	O
of	O
IgG1	B-Protein
and	O
IgG4	B-Protein
were	O
treated	O
with	O
SeMac	B-Protein
or	O
GAS	O
Mac	B-Protein
.	O
<EOS>	B-X
First	B-X
,	B-X
isoflurane	B-X
induction	B-X
was	B-X
video	B-X
recorded	B-X
under	B-X
all	B-X
test	B-X
conditions	B-X
,	B-X
and	B-X
the	B-X
videos	B-X
were	B-X
scored	B-X
according	B-X
to	B-X
a	B-X
behavioral	B-X
ethogram	B-X
to	B-X
identify	B-X
signs	B-X
of	B-X
distress	B-X
.	B-X
The	B-X
partial	B-X
pressure	B-X
cascade	B-X
from	B-X
delivered	B-X
to	B-X
inspired	B-X
to	B-X
end-expired	B-X
is	B-X
re-examined	B-X
to	B-X
better	B-X
understand	B-X
the	B-X
effect	B-X
of	B-X
rebreathing	B-X
during	B-X
low-flow	B-X
anaesthesia	B-X
,	B-X
including	B-X
the	B-X
possibility	B-X
of	B-X
developing	B-X
a	B-X
hypoxic	B-X
inspired	B-X
mixture	B-X
despite	B-X
existing	B-X
machine	B-X
standards	B-X
.	B-X
The	B-X
secreted	B-X
Mac	B-X
protein	B-X
made	B-X
by	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
polymorphonuclear	B-X
leukocytes	B-X
(	B-X
PMNs	B-X
)	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
However	B-X
,	B-X
the	B-X
protein	B-X
just	B-X
cleaves	B-X
a	B-X
small	B-X
fraction	B-X
,	B-X
which	B-X
may	B-X
be	B-X
IgG1	B-X
only	B-X
,	B-X
of	B-X
horse	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

SeMac	B-Protein
or	O
GAS	O
Mac	B-Protein
cleaved	O
a	O
small	O
portion	O
of	O
the	O
IgG1	B-Protein
/	O
IgG4	B-Protein
mixture	O
,	O
but	O
not	O
IgG4	B-Protein
.	O
<EOS>	B-X
This	B-X
article	B-X
reviews	B-X
basic	B-X
and	B-X
advanced	B-X
metal	B-X
artifact	B-X
reduction	B-X
MR	B-X
imaging	B-X
techniques	B-X
applied	B-X
to	B-X
various	B-X
clinical	B-X
protocols	B-X
for	B-X
successful	B-X
postoperative	B-X
MR	B-X
imaging	B-X
of	B-X
small	B-X
and	B-X
large	B-X
joints	B-X
.	B-X

Therefore	O
,	O
the	O
Mac	B-Protein
proteins	O
can	O
cleave	O
IgG1	B-Protein
but	O
not	O
IgG4	B-Protein
.	O

Due	O
to	O
the	O
unavailability	O
of	O
other	O
purified	O
subgroup	O
IgG	B-Protein
,	O
it	O
is	O
not	O
known	O
whether	O
SeMac	B-Protein
cleaves	O
the	O
other	O
IgG	B-Protein
subgroups	O
.	O

SeMac	B-Protein
does	O
not	O
Inhibit	O
Opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
Horse	O
PMN	O
<EOS>	B-X
The	B-X
secreted	B-X
Mac	B-X
protein	B-X
made	B-X
by	B-X
group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
polymorphonuclear	B-X
leukocytes	B-X
(	B-X
PMNs	B-X
)	B-X
.	B-X
The	B-X
horse	B-X
pathogen	B-X
Streptococcus	B-X
equi	B-X
subspecies	B-X
equi	B-X
produces	B-X
a	B-X
homologue	B-X
of	B-X
Mac	B-X
(	B-X
SeMac	B-X
)	B-X
.	B-X
SeMac	B-X
was	B-X
characterized	B-X
to	B-X
determine	B-X
whether	B-X
SeMac	B-X
has	B-X
IgG	B-X
endopeptidase	B-X
activity	B-X
and	B-X
inhibits	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
.	B-X
The	B-X
gene	B-X
was	B-X
cloned	B-X
and	B-X
recombinant	B-X
SeMac	B-X
was	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
and	B-X
purified	B-X
to	B-X
homogeneity	B-X
.	B-X
Mice	B-X
with	B-X
experimental	B-X
S.	B-X
equi	B-X
infection	B-X
and	B-X
horses	B-X
with	B-X
strangles	B-X
caused	B-X
by	B-X
S.	B-X
equi	B-X
seroconverted	B-X
to	B-X
SeMac	B-X
,	B-X
indicating	B-X
that	B-X
SeMac	B-X
is	B-X
produced	B-X
in	B-X
vivo	B-X
during	B-X
infection	B-X
.	B-X
SeMac	B-X
has	B-X
endopeptidase	B-X
activity	B-X
against	B-X
human	B-X
IgG	B-X
.	B-X
Replacement	B-X
of	B-X
Cys102	B-X
with	B-X
Ser	B-X
or	B-X
His272	B-X
with	B-X
Ala	B-X
abolishes	B-X
the	B-X
enzymatic	B-X
activity	B-X
of	B-X
SeMac	B-X
,	B-X
and	B-X
the	B-X
Asp294Ala	B-X
mutation	B-X
greatly	B-X
decreases	B-X
the	B-X
enzymatic	B-X
activity	B-X
.	B-X
SeMac	B-X
does	B-X
not	B-X
inhibit	B-X
opsonophagocytosis	B-X
of	B-X
S.	B-X
equi	B-X
by	B-X
horse	B-X
PMNs	B-X
but	B-X
opsonophagocytosis	B-X
of	B-X
GAS	B-X
by	B-X
human	B-X
PMNs	B-X
.	B-X
Thus	B-X
,	B-X
SeMac	B-X
is	B-X
a	B-X
cysteine	B-X
endopeptidase	B-X
with	B-X
a	B-X
limited	B-X
activity	B-X
against	B-X
horse	B-X
IgG	B-X
and	B-X
must	B-X
have	B-X
other	B-X
function	B-X
.	B-X

A	O
whole	O
blood	O
based	O
phagocytosis	O
assay	O
[	O
13	O
,	O
14	O
]	O
was	O
used	O
to	O
test	O
whether	O
SeMac	B-Protein
inhibits	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
.	O

The	O
bacteria	O
were	O
labeled	O
with	O
FITC	O
,	O
treated	O
with	O
S	O
.	O
equi	O
-	O
specific	O
horse	O
convalescent	O
serum	O
in	O
the	O
absence	O
or	O
presence	O
of	O
SeMac	B-Protein
,	O
and	O
incubated	O
with	O
horse	O
blood	O
.	O

Percentage	O
of	O
PMNs	O
with	O
phagocytosed	O
S	O
.	O
equi	O
was	O
determined	O
by	O
flow	O
cytometry	O
.	O

As	O
expected	O
,	O
percentage	O
of	O
PMNs	O
with	O
phagocytosed	O
S	O
.	O
equi	O
with	O
the	O
serum	O
treatment	O
was	O
significantly	O
higher	O
than	O
that	O
for	O
S	O
.	O
equi	O
without	O
serum	O
treatment	O
.	O

But	O
the	O
inclusion	O
of	O
SeMac	B-Protein
in	O
the	O
assay	O
did	O
not	O
affect	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
(	O
Fig	O
.	O
5A	O
)	O
,	O
suggesting	O
that	O
SeMac	B-Protein
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
.	O

The	O
inability	O
of	O
SeMac	B-Protein
to	O
inhibit	O
S	O
.	O
equi	O
opsonophagocytosis	O
by	O
horse	O
PMNs	O
may	O
be	O
due	O
to	O
its	O
inability	O
to	O
cleave	O
the	O
majority	O
of	O
horse	O
IgG	B-Protein
.	O

If	O
this	O
is	O
true	O
,	O
SeMac	B-Protein
should	O
inhibit	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	O
PMNs	O
,	O
since	O
SeMac	B-Protein
efficiently	O
cleaves	O
human	O
IgG	B-Protein
.	O

To	O
test	O
this	O
idea	O
,	O
the	O
phagocytosis	O
assay	O
was	O
repeated	O
using	O
GAS	O
and	O
human	O
blood	O
.	O

SeMac	B-Protein
indeed	O
inhibits	O
the	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	O
PMNs	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

These	O
results	O
suggest	O
that	O
IgG	B-Protein
endopeptidase	I-Protein
activity	O
of	O
SeMac	B-Protein
is	O
critical	O
for	O
inhibition	O
of	O
phagocytosis	O
.	O

DISCUSSION	O

In	O
this	O
study	O
we	O
describe	O
that	O
SeMac	B-Protein
is	O
a	O
cysteine	B-Protein
endopeptidase	I-Protein
with	O
limited	O
activity	O
against	O
horse	O
IgG	B-Protein
and	O
is	O
unable	O
to	O
inhibit	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
in	O
a	O
whole	O
blood	O
assay	O
.	O

SeMac	B-Protein
efficiently	O
cleaves	O
the	O
heavy	O
chain	O
of	O
human	O
IgG	B-Protein
.	O

The	O
residues	O
of	O
Cys102	O
and	O
His272	O
are	O
essential	O
and	O
Asp294	O
important	O
for	O
the	O
enzymatic	O
activity	O
of	O
SeMac	B-Protein
.	O

Thus	O
,	O
like	O
GAS	O
M1	O
Mac	B-Protein
[	O
7	O
,	O
8	O
]	O
,	O
SeMac	B-Protein
is	O
a	O
cysteine	B-Protein
endopeptidase	I-Protein
.	O

Although	O
both	O
SeMac	B-Protein
and	O
GAS	O
Mac	B-Protein
efficiently	O
cleave	O
human	O
IgG	B-Protein
,	O
they	O
cannot	O
cleave	O
the	O
majority	O
of	O
total	O
horse	O
IgG	B-Protein
.	O

The	O
peptide	O
fragment	O
,	O
PELLGG	O
,	O
in	O
the	O
lower	O
hinge	O
region	O
is	O
proposed	O
to	O
bind	O
to	O
the	O
active	O
site	O
of	O
Mac	B-Protein
[	O
9	O
]	O
,	O
and	O
the	O
cleavage	O
occurs	O
between	O
the	O
two	O
Gly	O
residues	O
(	O
Table	O
1	O
)	O
.	O

This	O
lower	O
hinge	O
region	O
is	O
not	O
well	O
conserved	O
in	O
the	O
seven	O
subgroups	O
of	O
horse	O
IgG	B-Protein
[	O
17	O
]	O
(	O
Table	O
1	O
)	O
.	O
<EOS>	B-X
Typically	B-X
,	B-X
MMPs	B-X
have	B-X
a	B-X
propeptide	B-X
sequence	B-X
,	B-X
a	B-X
catalytic	B-X
metalloproteinase	B-X
domain	B-X
with	B-X
catalytic	B-X
zinc	B-X
,	B-X
a	B-X
hinge	B-X
region	B-X
or	B-X
linker	B-X
peptide	B-X
,	B-X
and	B-X
a	B-X
hemopexin	B-X
domain	B-X
.	B-X
MMPs	B-X
cause	B-X
degradation	B-X
of	B-X
ECM	B-X
proteins	B-X
such	B-X
as	B-X
collagen	B-X
and	B-X
elastin	B-X
,	B-X
but	B-X
could	B-X
influence	B-X
endothelial	B-X
cell	B-X
function	B-X
as	B-X
well	B-X
as	B-X
VSM	B-X
cell	B-X
migration	B-X
,	B-X
proliferation	B-X
,	B-X
Ca	B-X
Typically	B-X
,	B-X
MMPs	B-X
have	B-X
a	B-X
propeptide	B-X
sequence	B-X
,	B-X
a	B-X
catalytic	B-X
metalloproteinase	B-X
domain	B-X
with	B-X
catalytic	B-X
zinc	B-X
,	B-X
a	B-X
hinge	B-X
region	B-X
or	B-X
linker	B-X
peptide	B-X
,	B-X
and	B-X
a	B-X
hemopexin	B-X
domain	B-X
.	B-X
MMPs	B-X
could	B-X
also	B-X
influence	B-X
endothelial	B-X
cell	B-X
function	B-X
as	B-X
well	B-X
as	B-X
VSM	B-X
cell	B-X
migration	B-X
,	B-X
proliferation	B-X
,	B-X
Ca	B-X

Cleavable	O
horse	O
IgG1	B-Protein
has	O
PELLGG	O
,	O
while	O
the	O
non	O
-	O
cleavable	O
horse	O
IgG4	B-Protein
has	O
PECLSVG	O
in	O
the	O
same	O
region	O
,	O
suggesting	O
that	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
lower	O
hinge	O
region	O
are	O
important	O
for	O
cleavability	O
by	O
SeMac	B-Protein
and	O
GAS	O
Mac	B-Protein
.	O

If	O
this	O
is	O
true	O
,	O
horse	O
IgG3	B-Protein
may	O
be	O
also	O
cleavable	O
by	O
SeMac	B-Protein
,	O
while	O
the	O
other	O
five	O
horse	O
IgG	B-Protein
subgroups	O
may	O
not	O
be	O
cleaved	O
.	O

These	O
horse	O
IgG	B-Protein
antibodies	O
that	O
cannot	O
be	O
cleaved	O
by	O
SeMac	B-Protein
thus	O
still	O
can	O
mediate	O
the	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
.	O

SeMac	B-Protein
and	O
GAS	O
M1	O
Mac	B-Protein
show	O
similar	O
enzymatic	O
specificity	O
(	O
Fig	O
.	O
4	O
and	O
Table	O
1	O
)	O
,	O
confirming	O
the	O
previous	O
finding	O
[	O
18	O
]	O
.	O

SeMac	B-Protein
can	O
cleave	O
human	O
IgG	B-Protein
and	O
inhibit	O
the	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	O
PMNs	O
,	O
but	O
it	O
has	O
limited	O
enzymatic	O
activity	O
against	O
horse	O
IgG	B-Protein
and	O
is	O
unable	O
to	O
inhibit	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
.	O

Thus	O
,	O
there	O
is	O
a	O
correlation	O
between	O
the	O
enzymatic	O
activity	O
of	O
SeMac	B-Protein
and	O
its	O
ability	O
to	O
inhibit	O
opsonophagocytosis	O
,	O
suggesting	O
that	O
SeMac	B-Protein
functions	O
like	O
GAS	O
M1	O
Mac	B-Protein
in	O
the	O
inhibition	O
of	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	O
PMNs	O
.	O

Timoney	O
et	O
al	O
.	O
recently	O
reported	O
that	O
IdeE	B-Protein
/	O
SeMac	B-Protein
reduces	O
the	O
bactericidal	O
activity	O
of	O
isolated	O
equine	O
PMNs	O
for	O
S	O
.	O
equi	O
[	O
19	O
]	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
inhibition	O
of	O
the	O
bactericidal	O
activity	O
of	O
PMNs	O
may	O
not	O
be	O
mediated	O
by	O
opsonophagocytosis	O
or	O
may	O
be	O
insignificant	O
in	O
whole	O
blood	O
.	O
<EOS>	B-X
Biopsies	B-X
performed	B-X
with	B-X
magnetic	B-X
resonance	B-X
imaging	B-X
(	B-X
MRI	B-X
)	B-X
targeting	B-X
may	B-X
reduce	B-X
the	B-X
misclassification	B-X
of	B-X
prostate	B-X
cancer	B-X
in	B-X
men	B-X
with	B-X
MRI-visible	B-X
lesions	B-X
.	B-X
A	B-X
total	B-X
of	B-X
nine	B-X
cross-sectional	B-X
studies	B-X
and	B-X
three	B-X
case-control	B-X
studies	B-X
were	B-X
included	B-X
,	B-X
which	B-X
assessed	B-X
Mn	B-X
from	B-X
diet	B-X
,	B-X
serum	B-X
,	B-X
urine	B-X
,	B-X
and	B-X
whole	B-X
blood	B-X
.	B-X
=	B-X
0.59	B-X
,	B-X
1.19	B-X
)	B-X
,	B-X
and	B-X
whole	B-X
blood	B-X
(	B-X
two	B-X
studies	B-X
,	B-X
OR	B-X
:	B-X
0.92	B-X
,	B-X
95	B-X
%	B-X
C.I	B-X
.	B-X
=	B-X
0.53	B-X
,	B-X
1.60	B-X
)	B-X
were	B-X
insignificant	B-X
,	B-X
but	B-X
some	B-X
included	B-X
studies	B-X
have	B-X
suggested	B-X
a	B-X
non-linear	B-X
relationship	B-X
of	B-X
urinary	B-X
and	B-X
blood	B-X
Mn	B-X
with	B-X
MetS	B-X
,	B-X
and	B-X
higher	B-X
dietary	B-X
Mn	B-X
may	B-X
associate	B-X
with	B-X
a	B-X
lower	B-X
MetS	B-X
risk	B-X
in	B-X
some	B-X
of	B-X
the	B-X
included	B-X
studies	B-X
.	B-X

SeMac	B-Protein
is	O
not	O
produced	O
in	O
vitro	O
,	O
whereas	O
GAS	O
Mac	B-Protein
is	O
[	O
16	O
]	O
.	O
<EOS>	B-X
Our	B-X
aim	B-X
was	B-X
to	B-X
evaluate	B-X
whether	B-X
multiple-slab	B-X
acquisition	B-X
with	B-X
view	B-X
angle	B-X
tilting	B-X
gradient	B-X
based	B-X
on	B-X
a	B-X
sampling	B-X
perfection	B-X
with	B-X
application-optimized	B-X
contrasts	B-X
by	B-X
using	B-X
different	B-X
flip	B-X
angle	B-X
evolution	B-X
(	B-X
MSVAT-SPACE	B-X
)	B-X
-STIR	B-X
and	B-X
slice-encoding	B-X
for	B-X
metal	B-X
artifact	B-X
correction	B-X
(	B-X
SEMAC	B-X
)	B-X
-STIR	B-X
are	B-X
beneficial	B-X
regarding	B-X
artifact	B-X
suppression	B-X
compared	B-X
with	B-X
the	B-X
SPACE-STIR	B-X
and	B-X
TSE-STIR	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
.	B-X

The	O
mac	B-Protein
gene	O
is	O
controlled	O
by	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
CovRS	B-Protein
[	O
5	O
]	O
,	O
which	O
also	O
controls	O
the	O
expression	O
of	O
many	O
virulence	O
factors	O
including	O
the	O
hyaluronic	O
capsule	O
[	O
20	O
]	O
.	O

The	O
hyaluronic	O
capsule	O
of	O
S	O
.	O
equi	O
is	O
highly	O
produced	O
in	O
vitro	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
semac	B-Protein
and	O
mac	B-Protein
genes	O
are	O
regulated	O
by	O
different	O
mechanisms	O
.	O

This	O
suggestion	O
is	O
supported	O
by	O
only	O
29	O
%	O
DNA	O
sequence	O
identity	O
between	O
S	O
.	O
equi	O
and	O
M1	O
GAS	O
in	O
the	O
upstream	O
region	O
of	O
the	O
semac	B-Protein
and	O
mac	B-Protein
genes	O
.	O

S	O
.	O
equi	O
is	O
a	O
horse	O
pathogen	O
.	O
<EOS>	B-X
Rhodococcus	B-X
equi	B-X
is	B-X
the	B-X
only	B-X
recognized	B-X
animal	B-X
pathogenic	B-X
species	B-X
within	B-X
an	B-X
extended	B-X
genus	B-X
of	B-X
metabolically	B-X
versatile	B-X
Actinobacteria	B-X
of	B-X
considerable	B-X
biotechnological	B-X
interest	B-X
.	B-X
Best	B-X
known	B-X
as	B-X
a	B-X
horse	B-X
pathogen	B-X
,	B-X
R.	B-X
equi	B-X
is	B-X
commonly	B-X
isolated	B-X
from	B-X
other	B-X
animal	B-X
species	B-X
,	B-X
particularly	B-X
pigs	B-X
and	B-X
ruminants	B-X
,	B-X
and	B-X
causes	B-X
severe	B-X
opportunistic	B-X
infections	B-X
in	B-X
people	B-X
.	B-X
As	B-X
typical	B-X
in	B-X
the	B-X
rhodococci	B-X
,	B-X
R.	B-X
equi	B-X
niche	B-X
specialization	B-X
is	B-X
extrachromosomally	B-X
determined	B-X
,	B-X
via	B-X
a	B-X
conjugative	B-X
virulence	B-X
plasmid	B-X
that	B-X
promotes	B-X
intramacrophage	B-X
survival	B-X
.	B-X
Progress	B-X
in	B-X
the	B-X
molecular	B-X
understanding	B-X
of	B-X
R.	B-X
equi	B-X
and	B-X
its	B-X
recent	B-X
rise	B-X
as	B-X
a	B-X
novel	B-X
paradigm	B-X
of	B-X
multihost	B-X
adaptation	B-X
has	B-X
been	B-X
accompanied	B-X
by	B-X
an	B-X
unusual	B-X
nomenclatural	B-X
instability	B-X
,	B-X
with	B-X
a	B-X
confusing	B-X
succession	B-X
of	B-X
names	B-X
:	B-X
``	B-X
Prescottia	B-X
equi	B-X
''	B-X
,	B-X
``	B-X
Prescotella	B-X
equi	B-X
''	B-X
,	B-X
Corynebacterium	B-X
hoagii	B-X
and	B-X
Rhodococcus	B-X
hoagii	B-X
.	B-X
This	B-X
article	B-X
reviews	B-X
current	B-X
advances	B-X
in	B-X
the	B-X
genomics	B-X
,	B-X
biology	B-X
and	B-X
virulence	B-X
of	B-X
this	B-X
pathogenic	B-X
actinobacterium	B-X
with	B-X
a	B-X
unique	B-X
mechanism	B-X
of	B-X
plasmid-transferable	B-X
animal	B-X
host	B-X
tropism	B-X
.	B-X
It	B-X
also	B-X
discusses	B-X
the	B-X
taxonomic	B-X
and	B-X
nomenclatural	B-X
issues	B-X
around	B-X
R.	B-X
equi	B-X
in	B-X
the	B-X
light	B-X
of	B-X
recent	B-X
phylogenomic	B-X
evidence	B-X
that	B-X
confirms	B-X
its	B-X
membership	B-X
as	B-X
a	B-X
bona	B-X
fide	B-X
Rhodococcus	B-X
.	B-X

The	O
fact	O
that	O
SeMac	B-Protein
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
indicates	O
that	O
SeMac	B-Protein
is	O
not	O
involved	O
in	O
the	O
evasion	O
of	O
the	O
acquired	O
horse	O
immunity	O
against	O
S	O
.	O
equi	O
.	O

This	O
suggests	O
that	O
SeMac	B-Protein
has	O
other	O
unknown	O
function	O
.	O